Citrus Sinensis ID: 035895
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 527 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.943 | 0.507 | 0.296 | 3e-52 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.933 | 0.419 | 0.286 | 3e-52 | |
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.903 | 0.471 | 0.299 | 3e-51 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.925 | 0.487 | 0.296 | 1e-48 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.920 | 0.433 | 0.292 | 5e-48 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.963 | 0.426 | 0.295 | 8e-48 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.899 | 0.472 | 0.300 | 1e-47 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.922 | 0.438 | 0.285 | 2e-47 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.929 | 0.468 | 0.281 | 4e-47 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.984 | 0.537 | 0.288 | 9e-47 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 206 bits (525), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 191/645 (29%), Positives = 287/645 (44%), Gaps = 148/645 (22%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV-------DELSLSDNYLTS---STP 79
NKL G V ++ N + LK D+++N + G L S V L LS N+ S +T
Sbjct: 201 NKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTN 260
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIG-- 137
F +S++N L++L+++ N L G + V + S +L I + I G I EI
Sbjct: 261 LEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNL 320
Query: 138 ----------------------NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNE 175
L+ L + L N L G I + LG + +L L N
Sbjct: 321 LNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNN 380
Query: 176 LEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIP-SILWN 233
L GSIP+ +L+ L +L L GN LSG++P G L L L N LT +IP ++ N
Sbjct: 381 LSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSN 440
Query: 234 LKDI-LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFL---- 288
L+++ LYL+ SN GP+P ++ + ++ +D S N L G IP + +L+ L
Sbjct: 441 LRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSR 500
Query: 289 ---------SLGH-----------NRLQGSIPNSFDDLVSLESLDLSNNNLSEII----- 323
SLG NRL G+IP SF +L+ L+ S N LS +
Sbjct: 501 NGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGS 560
Query: 324 --PLSLEKLLYLNIL---------------------------LIVVVILALKFGLISRCQ 354
L++E L ++L + V+ + L+ R +
Sbjct: 561 FSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSR 620
Query: 355 ---------KRATKLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR 405
K + N Q R SYQ+L+ AT GF+A++LIG G FG VYK
Sbjct: 621 FGKNLTVYAKEEVEDEEKQN-QNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGV 679
Query: 406 LQDGMEFAIKV------FHFS------------------------CSNEDFRALVLEYTT 435
L++ + A+KV FS CS F ALVL
Sbjct: 680 LRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMP 739
Query: 436 NGSLEKVLYSSNYI---LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN 492
NGSLE+ LY Y LD++Q +NI DV + YLH ++HCDLKP N LLDD
Sbjct: 740 NGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDE 799
Query: 493 IVAHLSDFGIAKLLTGEDQSMTQTQTLAI----------IGYMAP 527
+ A ++DFGI++L+ G +++++ +++ +GY+AP
Sbjct: 800 MTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAP 844
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 176/614 (28%), Positives = 284/614 (46%), Gaps = 122/614 (19%)
Query: 29 QNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELS------LSDNYLTSSTPELS 82
+N G + IFN S L+ V +N + G L ++ +L +S N LT P
Sbjct: 440 RNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR-- 497
Query: 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142
+ N K L L + N G +PR + N + L+ + M ++ G I EE+ ++ L
Sbjct: 498 ---EIGNLKDLNILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLL 553
Query: 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR------ 196
+DL NK +G I KL+ L +LS +GN+ GSIP L L++L D+
Sbjct: 554 SVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTG 613
Query: 197 --------------------GNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLK 235
N L+G+IP G L ++ + L +N + SIP L K
Sbjct: 614 TIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACK 673
Query: 236 DILYLDFWSN-------------------------LFVGPLPSKIGNLKVLTRIDFSRNN 270
++ LDF N F G +P GN+ L +D S NN
Sbjct: 674 NVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNN 733
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN-----NLSEIIPL 325
L G+IP ++ L +L+ L L N L+G +P S ++ + DL N + + P
Sbjct: 734 LTGEIPESLANLSTLKHLKLASNNLKGHVPES-GVFKNINASDLMGNTDLCGSKKPLKPC 792
Query: 326 SLEKL--LYLNILLIVVVILA---------LKFGLISRCQKRATKLPNVS-----NMQPQ 369
++++ + ++++IL L +++ C+K+ K+ N S ++
Sbjct: 793 TIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSA 852
Query: 370 ASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFH---FSCSNEDF 426
+RF +EL +ATD F++ N+IG S +VYK +L+DG A+KV + FS ++ +
Sbjct: 853 LKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKW 912
Query: 427 -----------------------------RALVLEYTTNGSLEKVLY-SSNYILDILQRL 456
+ALVL + NG+LE ++ S+ I +L+++
Sbjct: 913 FYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKI 972
Query: 457 NIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516
++ + + S ++YLH GY PI+HCDLKP N LLD + VAH+SDFG A++L + T
Sbjct: 973 DLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTA 1032
Query: 517 QTLAI---IGYMAP 527
T A IGY+AP
Sbjct: 1033 STSAFEGTIGYLAP 1046
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 176/588 (29%), Positives = 274/588 (46%), Gaps = 112/588 (19%)
Query: 20 CYRICTID-SQNKLVGIVSITIFNLST-LKVFDVDNNYVLGRLSSIV------DELSLSD 71
C ++ T+ +N+L G + I+I NLS L D+ + G + + +L L
Sbjct: 335 CTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQ 394
Query: 72 NYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGG 131
N L+ P +S+ L+ L + N L G +P +GN + LE + +S+ G
Sbjct: 395 NMLSGPLP-----TSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM-LETLDLSNNGFEGI 448
Query: 132 ISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLF 191
+ +GN + L+ + +G NKLNG+I + + K+Q+L L GN L GS+P + L L
Sbjct: 449 VPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLG 508
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251
L L NKLSG +P GN + +L L+ NLF G +
Sbjct: 509 TLSLGDNKLSGKLPQTLGNCLTMESLFLE-----------------------GNLFYGDI 545
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP--NSFDDLVSL 309
P G + V +D S N+L G IP L++L+L N L+G +P F++ ++
Sbjct: 546 PDLKGLVGV-KEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTV 604
Query: 310 ESLDLSNNNL-SEIIPLSLEKLL---------------------YLNILLIVVVILALKF 347
+ NN+L I+ L+ L + I L++++ +A
Sbjct: 605 SI--VGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVT 662
Query: 348 GLISRCQKRATKLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKA-RL 406
+ R +K+ + N + + + SY +L AT+GFS++N++G GSFG+VYKA L
Sbjct: 663 LIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLL 722
Query: 407 QDGMEFAIKVFHF-----------------------------SCSNED-----FRALVLE 432
+ A+KV + +CS+ D FRAL+ E
Sbjct: 723 TEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYE 782
Query: 433 YTTNGSLEKVLYSS--------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484
+ NGSL+ L+ + L +L+RLNI IDV S L+YLH PI HCDLKP
Sbjct: 783 FMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKP 842
Query: 485 HNKLLDDNIVAHLSDFGIAKLLTGEDQS-----MTQTQTLAIIGYMAP 527
N LLDD++ AH+SDFG+A+LL D+ ++ IGY AP
Sbjct: 843 SNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 172/580 (29%), Positives = 257/580 (44%), Gaps = 92/580 (15%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDE------LSLSDNYLTSSTPEL 81
S N G + + L L + ++ N + G + + E L L +N T S P+
Sbjct: 295 SNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQ- 353
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
+ L LD+S N L G LP + + ++ + I + + + G I + +G
Sbjct: 354 ----KLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNF-LFGSIPDSLGKCES 408
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAV-LFQLDLRGNKL 200
L I +G N LNGSI L L KL + + N L G +P ++ L Q+ L N+L
Sbjct: 409 LTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQL 468
Query: 201 SGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
SGS+P GNL+ ++ L LD N+ + SIP + L+ + LDF NLF G + +I K
Sbjct: 469 SGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCK 528
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
+LT +D SRN L GDIP + G+K L +L+L N L GSIP + + SL S+D S NNL
Sbjct: 529 LLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNL 588
Query: 320 SEIIPLSLEKLLYLNILLIV------------------------------------VVIL 343
S ++P S + Y N V ++
Sbjct: 589 SGLVP-STGQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFC 647
Query: 344 ALKFGLISRCQKRATKLPNVSNMQPQASRRRFSYQELLRATD----GFSANNLIGRGSFG 399
++ F +++ + R+ + N + R ++Q L D +N+IG+G G
Sbjct: 648 SMVFAIVAIIKARSLR-----NASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAG 702
Query: 400 SVYKARLQDGMEFAIK----VFHFS---------------------------CSNEDFRA 428
VYK + G A+K + H S CSN +
Sbjct: 703 IVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 762
Query: 429 LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNK 487
LV EY NGSL +VL+ L R I ++ L YLH S I+H D+K +N
Sbjct: 763 LVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNI 822
Query: 488 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LLD N AH++DFG+AK L S + GY+AP
Sbjct: 823 LLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 862
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 5e-48, Method: Compositional matrix adjust.
Identities = 173/591 (29%), Positives = 257/591 (43%), Gaps = 106/591 (17%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV------DELSLSDNYLTSSTPELSF 83
N L G + + N S L +D N G V +SL N+L P+
Sbjct: 448 NHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPK--- 504
Query: 84 LSSMSNCKYLKK------------------------LDISRNPLDGFLPRVVGNFSQS-- 117
S+ +CK L + +D S N G + N+ +S
Sbjct: 505 --SLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHG---EISSNWEKSPK 559
Query: 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE 177
L + MS+ NI+G I EI N+T L+ +DL N L G + +G L L L GN+L
Sbjct: 560 LGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLS 619
Query: 178 GSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKD 236
G +P L L L LDL N S IP F + L +++L N+ SIP L L
Sbjct: 620 GRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQ 678
Query: 237 ILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296
+ LD N G +PS++ +L+ L ++D S NNL G IPTT +G+ +L + + +N+L+
Sbjct: 679 LTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLE 738
Query: 297 GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK---------------LLYLNILLIVVV 341
G +P++ + N L IP K + L +L V+V
Sbjct: 739 GPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLV 798
Query: 342 ILALKFGLISRCQKRATKLPNVSNMQPQASRR--------RFSYQELLRATDGFSANNLI 393
IL++ + C R KL N N P+ +F YQ+++ +T+ F +LI
Sbjct: 799 ILSICANTFTYC-IRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLI 857
Query: 394 GRGSFGSVYKARLQDGM---------------------EF--------------AIKVFH 418
G G + VY+A LQD + EF +K+F
Sbjct: 858 GTGGYSKVYRANLQDTIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFG 917
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYSSNYI--LDILQRLNIMIDVTSALEYLHFGYSTP 476
F CS+ L+ EY GSL K+L + L +R+N++ V AL Y+H TP
Sbjct: 918 F-CSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITP 976
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I+H D+ N LLD++ A +SDFG AKLL + S + GY+AP
Sbjct: 977 IVHRDISSGNILLDNDYTAKISDFGTAKLL--KTDSSNWSAVAGTYGYVAP 1025
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (487), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 182/616 (29%), Positives = 280/616 (45%), Gaps = 108/616 (17%)
Query: 12 DGGMTGDVCYRICTIDS-------QNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV 64
D +TG++ I + S N G + + + + ++L D+ +N + G++ +
Sbjct: 481 DNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKI 540
Query: 65 DELS------LSDNYLTSS-------------TPELSFLSSMSNCKYLKKLDISRNPLDG 105
L+ LS N L+ S P+LSFL ++ D+S N L G
Sbjct: 541 TALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFL------QHHGIFDLSYNRLSG 594
Query: 106 FLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQK 165
+P +G +E I +S+ ++SG I + LT+L +DL GN L GSI +G K
Sbjct: 595 PIPEELGECLVLVE-ISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLK 653
Query: 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225
LQ L+ N+L G IP L L +L+L NKL G +P GNL L ++ L N L+
Sbjct: 654 LQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLS 713
Query: 226 -SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKS 284
+ S L ++ ++ L N F G +PS++GNL L +D S N L G+IPT I GL +
Sbjct: 714 GELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPN 773
Query: 285 LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK--------------- 329
L+FL+L N L+G +P+ ++L N L + S K
Sbjct: 774 LEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAGL 833
Query: 330 LLYLNILLIVVVILALKFGLISRCQKR-------ATKLP-----NVSNMQPQASRRRFSY 377
+L I++ V V ++ + R ++R ++L N+ + SR S
Sbjct: 834 MLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSI 893
Query: 378 ------QELLR--------ATDGFSANNLIGRGSFGSVYK----------------ARLQ 407
Q LL+ ATD FS N+IG G FG+VYK A+ Q
Sbjct: 894 NIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQ 953
Query: 408 DGMEFAI------KVFHFS-------CSNEDFRALVLEYTTNGSLEKVLYSSNYILDIL- 453
EF KV H + CS + + LV EY NGSL+ L + +L++L
Sbjct: 954 GNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLD 1013
Query: 454 --QRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
+RL I + L +LH G+ IIH D+K N LLD + ++DFG+A+L++ +
Sbjct: 1014 WSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISA-CE 1072
Query: 512 SMTQTQTLAIIGYMAP 527
S T GY+ P
Sbjct: 1073 SHVSTVIAGTFGYIPP 1088
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (485), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 181/603 (30%), Positives = 257/603 (42%), Gaps = 129/603 (21%)
Query: 46 LKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDG 105
+ VF + LG LSS+ + LS+N T P +S + K L L++ RN L G
Sbjct: 272 VNVFSGPLTWELGTLSSL-KSMDLSNNMFTGEIP-----ASFAELKNLTLLNLFRNKLHG 325
Query: 106 FLPRVVGNFSQSLEFIWMSDCNISGGISEEIG-----NLTDLISIDL---------GGNK 151
+P +G+ + LE + + + N +G I +++G NL DL S L GNK
Sbjct: 326 EIPEFIGDLPE-LEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNK 384
Query: 152 LN----------GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR----- 196
L GSI +LGK + L + N L GSIP L L L Q++L+
Sbjct: 385 LETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLS 444
Query: 197 -------------------GNKLSGSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKD 236
N+LSG +P GN T ++ L LD N+ IPS + L+
Sbjct: 445 GELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQ 504
Query: 237 ILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296
+ +DF NLF G + +I K+LT +D SRN L G+IP I +K L +L+L N L
Sbjct: 505 LSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLV 564
Query: 297 GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL-------LIVVVILALKFGL 349
GSIP S + SL SLD S NNLS ++P + Y N L + K G+
Sbjct: 565 GSIPGSISSMQSLTSLDFSYNNLSGLVP-GTGQFSYFNYTSFLGNPDLCGPYLGPCKDGV 623
Query: 350 ISRCQKRATKLPNVSNMQ--------------------PQASRRRFSYQELLRAT----- 384
+ +K P ++M+ S ++ S R T
Sbjct: 624 AKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRL 683
Query: 385 --------DGFSANNLIGRGSFGSVYKARLQDGMEFAIK--------------------- 415
D +N+IG+G G VYK + +G A+K
Sbjct: 684 DFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQT 743
Query: 416 ---VFHFS-------CSNEDFRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTS 464
+ H CSN + LV EY NGSL +VL+ L R I ++
Sbjct: 744 LGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAK 803
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524
L YLH S I+H D+K +N LLD N AH++DFG+AK L S + GY
Sbjct: 804 GLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 863
Query: 525 MAP 527
+AP
Sbjct: 864 IAP 866
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 190 bits (483), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 168/589 (28%), Positives = 258/589 (43%), Gaps = 103/589 (17%)
Query: 29 QNKLVGIVSITIFNLSTLKVFDVDNNYVLGRL------SSIVDELSLSDNYLTSSTPELS 82
+N G++ + S+L+V D+ N G + + L L NYL S P
Sbjct: 413 ENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVP--- 469
Query: 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142
S + C L++L + N L G LP V Q+L F +S N +G I +GNL ++
Sbjct: 470 --SDLGGCSTLERLILEENNLRGGLPDFVEK--QNLLFFDLSGNNFTGPIPPSLGNLKNV 525
Query: 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG 202
+I L N+L+GSI LG L KL+ L+ N L+G +P+ L + L +LD N L+G
Sbjct: 526 TAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNG 585
Query: 203 SIPTCFGNLTALRNLHLDSNELTS-IPSILWN-----------------------LKDIL 238
SIP+ G+LT L L L N + IP+ L+ L+ +
Sbjct: 586 SIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPPVGALQALR 645
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298
L+ SN G LP +G LK+L +D S NNL G + + ++SL F+++ HN G
Sbjct: 646 SLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGP 704
Query: 299 IPNSFDDLVSLESLDLSNNN---------------LSEIIPLSLE-------------KL 330
+P S ++ S N+ S + P +++ +
Sbjct: 705 VPPSLTKFLNSSPTSFSGNSDLCINCPADGLACPESSILRPCNMQSNTGKGGLSTLGIAM 764
Query: 331 LYLNILLIVVVILALKFGLISRCQKRATKLPNVSNMQPQASRRRFSYQELLRATDGFSAN 390
+ L LL ++ + L C+K ++ +S + S ++L AT+ +
Sbjct: 765 IVLGALLFIICLFLFSAFLFLHCKKSVQEIA-ISAQEGDGSL----LNKVLEATENLNDK 819
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRALVLE------------------ 432
+IG+G+ G++YKA L +A+K F+ ++V E
Sbjct: 820 YVIGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSVSMVREIETIGKVRHRNLIKLEEF 879
Query: 433 ------------YTTNGSLEKVLYSSN--YILDILQRLNIMIDVTSALEYLHFGYSTPII 478
Y NGSL +L+ +N LD R NI + L YLHF I+
Sbjct: 880 WLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIV 939
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
H D+KP N LLD ++ H+SDFGIAKLL S+ IGYMAP
Sbjct: 940 HRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAP 988
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 189 bits (480), Expect = 4e-47, Method: Compositional matrix adjust.
Identities = 166/590 (28%), Positives = 259/590 (43%), Gaps = 100/590 (16%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV------DELSLSDNYLTSSTPELSF 83
N+L G + I N + L V +D N G L + + L+L DN+ P+
Sbjct: 368 NQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPK--- 424
Query: 84 LSSMSNCKYLKKLDISRNPLDGFLPRVVG-------------NFSQSLEFIW-------- 122
S+ +CK L ++ N G + G NF L W
Sbjct: 425 --SLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVA 482
Query: 123 --MSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSI 180
+S+ +I+G I EI N+T L +DL N++ G + ++ + ++ L GN L G I
Sbjct: 483 FILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKI 542
Query: 181 PNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNEL-TSIPSILWNLKDILY 239
P+ + L L LDL N+ S IP NL L ++L N+L +IP L L +
Sbjct: 543 PSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQM 602
Query: 240 LDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI 299
LD N G + S+ +L+ L R+D S NNL G IP + + + +L + + HN LQG I
Sbjct: 603 LDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPI 662
Query: 300 PNSF-------DDLVSLESLDLSNNNLSEIIPLSLEK----------LLYLNILLI-VVV 341
P++ D + L S N + P S+ ++Y+ + +I ++
Sbjct: 663 PDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAII 722
Query: 342 ILALKFGLISRCQKRATKLPNVSNMQPQASR-------RRFSYQELLRATDGFSANNLIG 394
IL++ G+ +KR ++ ++ + + YQE+++AT F LIG
Sbjct: 723 ILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIG 782
Query: 395 RGSFGSVYKARLQDGM---------------------EF--------------AIKVFHF 419
G G VYKA+L + + EF +K+F F
Sbjct: 783 TGGHGKVYKAKLPNAIMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGF 842
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYI--LDILQRLNIMIDVTSALEYLHFGYSTPI 477
CS+ LV EY GSL KVL + + LD +R+N++ V AL Y+H S I
Sbjct: 843 -CSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAI 901
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H D+ N LL ++ A +SDFG AKLL + S + GY+AP
Sbjct: 902 VHRDISSGNILLGEDYEAKISDFGTAKLL--KPDSSNWSAVAGTYGYVAP 949
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 9e-47, Method: Compositional matrix adjust.
Identities = 184/637 (28%), Positives = 282/637 (44%), Gaps = 118/637 (18%)
Query: 2 WSEKLNNRQLDGGM-TGDVCYRICTIDS-------QNKLVGIVSITIFNLSTLKVFDVDN 53
W+E L L G M TG + +C + N L G + +I N ++ ++ D+
Sbjct: 189 WNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISY 248
Query: 54 NYVLGRLSS-----IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLP 108
N + G + V LSL N LT PE+ L + L LD+S N L G +P
Sbjct: 249 NQITGEIPYNIGFLQVATLSLQGNRLTGRIPEVIGL-----MQALAVLDLSDNELVGPIP 303
Query: 109 RVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQF 168
++GN S + + +++ ++G I E+GN++ L + L NKL G+I LGKL++L
Sbjct: 304 PILGNLSFTGK-LYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFE 362
Query: 169 LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT--- 225
L+ N L G IP+ + A L Q ++ GN LSGSIP F NL +L L+L SN
Sbjct: 363 LNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKI 422
Query: 226 ----------------------SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTR 263
SIP L +L+ +L L+ N G LP++ GNL+ +
Sbjct: 423 PVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQM 482
Query: 264 IDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 323
ID S N L G IPT + L++L L L +N+L G IP+ + +L +L++S NNLS I+
Sbjct: 483 IDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIV 542
Query: 324 P----------------------------------LSLEKLLYLNILLIVVVILALKFGL 349
P + + I+L V+ +L + F
Sbjct: 543 PPMKNFSRFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLA 602
Query: 350 ISRCQKRATKLPNVSNMQPQASR--------RRFSYQELLRATDGFSANNLIGRGSFGSV 401
+ + ++ L S ++ ++ +++R T+ + +IG G+ +V
Sbjct: 603 VYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTV 662
Query: 402 YKARLQDGMEFAIKVFH--FSCSNEDFRA---------------------------LVLE 432
YK L+ AIK + + + +F L +
Sbjct: 663 YKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYD 722
Query: 433 YTTNGSLEKVLYSS--NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD 490
Y NGSL +L+ S LD RL I + L YLH + IIH D+K N LLD
Sbjct: 723 YMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLD 782
Query: 491 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+N AHLSDFGIAK + ++ T L IGY+ P
Sbjct: 783 ENFEAHLSDFGIAKSIPA-SKTHASTYVLGTIGYIDP 818
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 527 | ||||||
| 255585401 | 843 | serine-threonine protein kinase, plant-t | 0.981 | 0.613 | 0.434 | 1e-117 | |
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.937 | 0.249 | 0.487 | 1e-116 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.941 | 0.456 | 0.446 | 1e-110 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.943 | 0.487 | 0.415 | 1e-108 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.943 | 0.413 | 0.429 | 1e-107 | |
| 359483683 | 1228 | PREDICTED: LRR receptor-like serine/thre | 0.943 | 0.404 | 0.415 | 1e-106 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.941 | 0.467 | 0.408 | 1e-106 | |
| 359483675 | 1250 | PREDICTED: LRR receptor-like serine/thre | 0.988 | 0.416 | 0.401 | 1e-104 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.924 | 0.342 | 0.416 | 1e-104 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.941 | 0.455 | 0.415 | 1e-104 |
| >gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1100), Expect = e-117, Method: Compositional matrix adjust.
Identities = 271/623 (43%), Positives = 359/623 (57%), Gaps = 106/623 (17%)
Query: 6 LNNRQLDGGMTGDVCYRICTID----SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS 61
+N QL G + + Y + ++ ++N+ +G + +I N S L + + +N + G +
Sbjct: 106 INVNQLSGHLPSTLGYGLPNLEELYITRNQFIGTLPPSISNASKLTILESSSNSLSGPIP 165
Query: 62 SIV------DELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS 115
+ L+L+DN S T EL FL+S++ CK L++L + NPL+ LP +GN S
Sbjct: 166 DTLCNLKNLKRLNLADN---SFTDELGFLASLARCKELRRLVLIGNPLNSTLPTSIGNLS 222
Query: 116 QSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNE 175
S+E+ + CNI G I EIG L++LI++ L N+L GSI +T+G LQKLQ L GN
Sbjct: 223 -SIEYFNVQSCNIKGNIPSEIGVLSNLITLHLQNNELVGSIPVTIGGLQKLQRLYLHGNL 281
Query: 176 LEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-IPSILWNL 234
L GSIP +CHL+ L +L L N L G +P CFG+L +LR LHL SN TS IP LW+L
Sbjct: 282 LYGSIPTDICHLSNLGELFLSNNSLFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSL 341
Query: 235 KDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR 294
KD+L L+ SN G +P IGNLKVLT++DFS N+L G IP I L++L LSL HNR
Sbjct: 342 KDVLELNLSSNSLSGHIPLSIGNLKVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNR 401
Query: 295 LQGSIPNSFDDLVSLESLDLSN------------------------NNLSEIIP------ 324
+G IP F +L+SLESLDLS+ NNL +P
Sbjct: 402 FEGPIPEPFGELISLESLDLSSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFA 461
Query: 325 ------------LSLEKLLYL---------------NILLIVVV---ILALKFGLIS-RC 353
L +LL L +LLI V+ IL + F L+ RC
Sbjct: 462 NFSASSFLGNLALCGSRLLPLMPCKNNTHGGSKTSTKLLLIYVLPASILTIAFILVFLRC 521
Query: 354 QKRATKLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFA 413
QK +L NV ++ + RR S+QEL +ATDGF A+NL+G G +GSVYK RL+DG A
Sbjct: 522 QKVKLELENVMDIITVGTWRRISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVA 581
Query: 414 IKVFHFS-----------------------------CSNEDFRALVLEYTTNGSLEKVLY 444
IKVF+ CSN+DF+A+VLEY NGSLEK LY
Sbjct: 582 IKVFNLGVEGAFKIFDTECEVMSSIRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLY 641
Query: 445 SSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
S NY L+I QRL +MIDV SALEYLH G+S PI+HCDLKP N LLD ++V H++DFG+AK
Sbjct: 642 SHNYCLNIQQRLEVMIDVASALEYLHHGFSAPIVHCDLKPSNVLLDQDMVGHVADFGMAK 701
Query: 505 LLTGEDQSMTQTQTLAIIGYMAP 527
LL GE +TQT+TLA IGYMAP
Sbjct: 702 LL-GEGDLITQTKTLATIGYMAP 723
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1097), Expect = e-116, Method: Compositional matrix adjust.
Identities = 271/556 (48%), Positives = 338/556 (60%), Gaps = 62/556 (11%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLT--SSTPEL 81
N L GI+ +I N S L+ D N + G + ++ L+L N L S EL
Sbjct: 827 NWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQEL 886
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
SFL+S++NCK L+ L +S NPL G LP +GN S SL+ + C + G I EIGNL++
Sbjct: 887 SFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSN 946
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
L + L N L G+I ++G+LQKLQ L N+L+GSIPN +C L L +L L N+LS
Sbjct: 947 LYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLS 1006
Query: 202 GSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
GSIP C G LT LR+L+L SN+L S IPS LW+L IL LD SN VG LPS +GNLKV
Sbjct: 1007 GSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKV 1066
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
L +ID SRN L G+IP+ I GL+ L LSL HNR +G I +SF +L SLE +DLS+N L
Sbjct: 1067 LVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALF 1126
Query: 321 EIIPLSLEKLLYLNILLIVVVILALKFGLI------------------SRCQKRATKLPN 362
IP SLE L+YL L + L +G I + C+KR LP
Sbjct: 1127 GEIPKSLEGLVYLKYLDVSFNGL---YGEIPPEGPFANFSAESFMMNKALCRKRNAVLPT 1183
Query: 363 VSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF--- 419
S A+ RR SYQE+ +AT+GFSA NL+GRGS GSVY+ L DG AIKVF+
Sbjct: 1184 QSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEE 1243
Query: 420 --------------------------SCSNE--DFRALVLEYTTNGSLEKVLYSSNYILD 451
SCSN DF+ALVLEY NGSLE+ LYS NY LD
Sbjct: 1244 AAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLD 1303
Query: 452 ILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
ILQRLNIMIDV A+EYLH G STP++HCDLKP N LLD++ H+ DFGIAKLL E++
Sbjct: 1304 ILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLR-EEE 1362
Query: 512 SMTQTQTLAIIGYMAP 527
S+ +TQTLA IGYMAP
Sbjct: 1363 SIRETQTLATIGYMAP 1378
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1039), Expect = e-110, Method: Compositional matrix adjust.
Identities = 269/602 (44%), Positives = 337/602 (55%), Gaps = 106/602 (17%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLT--SSTPEL 81
N L GI+ +I N S L+ D N + G + ++ L+L N L S EL
Sbjct: 375 NWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQEL 434
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
SFL+S++NCK L+ L +S NPL G LP +GN S SL+ + C + G I EIGNL++
Sbjct: 435 SFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSN 494
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
L + L N L G+I ++G+LQKLQ L N+L+GSIPN +C L L +L L N+LS
Sbjct: 495 LYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLS 554
Query: 202 GSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
GSIP C G LT LR+L+L SN+L S IPS LW+L IL LD SN VG LPS +GNLKV
Sbjct: 555 GSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKV 614
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG----------------------- 297
L +ID SRN L G+IP+ I GL+ L LSL HNR +G
Sbjct: 615 LVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALF 674
Query: 298 -SIPNSFDDLVSLESLDLSNNNLSEIIP-------LSLEKLLY----------------- 332
IP S + LV L+ LD+S N L IP S E +
Sbjct: 675 GEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRT 734
Query: 333 ----------------LNILLIVVVILALKFGLISRCQKRATKLPNVSNMQPQASRRRFS 376
L +L ++ LAL F + +RC+KR LP S A+ RR S
Sbjct: 735 GTRWSTTISWLLLKYILPAILSTLLFLALIF-VWTRCRKRNAVLPTQSESLLTATWRRIS 793
Query: 377 YQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------- 419
YQE+ +AT+GFSA NL+GRGS GSVY+ L DG AIKVF+
Sbjct: 794 YQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMH 853
Query: 420 ------------SCSNE--DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSA 465
SCSN DF+ALVLEY NGSLE+ LYS NY LDILQRLNIMIDV A
Sbjct: 854 HIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALA 913
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525
+EYLH G STP++HCDLKP N LLD++ H+ DFGIAKLL E++S+ +TQTLA IGYM
Sbjct: 914 MEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLR-EEESIRETQTLATIGYM 972
Query: 526 AP 527
AP
Sbjct: 973 AP 974
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1023), Expect = e-108, Method: Compositional matrix adjust.
Identities = 249/599 (41%), Positives = 333/599 (55%), Gaps = 102/599 (17%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTS--STPEL 81
N + G + + N+S L++ D+ N + G + + LSL N T+ S+ L
Sbjct: 302 NGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTL 361
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
+F++S++N + LK+L I NPLDG LP VGN S L ++ + G I EIGNL++
Sbjct: 362 NFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSN 421
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
LI + L N L G I T+G L+K+Q L N L GSIP+ +C L + L N LS
Sbjct: 422 LIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLS 481
Query: 202 GSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
G IP+C GNLT+LRNL+L N L+S IP LW+LKD+L L+ SN G LPS++G ++
Sbjct: 482 GEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEA 541
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
I S N L G+IP+TI L++L SL N QGSIP +F LVSLE LDLS NNLS
Sbjct: 542 AIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLS 601
Query: 321 -----------------------------------------------------EIIPLSL 327
++ P S+
Sbjct: 602 GEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSI 661
Query: 328 E---------KLLYLNILLIVVVILALKF-GLISRCQKRATKLPNVSNMQPQASRRRFSY 377
E +LL ++ + ++L + F L+ C++R K P + A +RR SY
Sbjct: 662 ESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISY 721
Query: 378 QELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF------------------ 419
ELL AT+ F +NL+G GSFGSVY+ RL+DG+ A+K+F+
Sbjct: 722 LELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRN 781
Query: 420 -----------SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEY 468
SCSN DF+ALVLEY GSLEK LYS NY LDI+QR+NIMIDV SALEY
Sbjct: 782 IRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEY 841
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LH GY +P++HCDLKP N LLD+++VAH+ DFGIAKLL GE++S QT+TLA IGYMAP
Sbjct: 842 LHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GENESFAQTRTLATIGYMAP 899
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1011), Expect = e-107, Method: Compositional matrix adjust.
Identities = 257/598 (42%), Positives = 333/598 (55%), Gaps = 101/598 (16%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDEL------SLSDNYLTS--STPEL 81
N+ GI+ ++I N+S L D+ +N+ +G + + L LS N LT+ S EL
Sbjct: 490 NEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASEL 549
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
+FL+S++NC +L+ L IS NPL G +P +GN S SLE I+ SDC + G I I NLT+
Sbjct: 550 AFLTSLTNCIFLRTLSISDNPLKGMIPNSLGNLSISLEIIYASDCQLRGTIPTGISNLTN 609
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
LI + L N L G I G+LQKLQ LS N + GSIP+ LCHL L LDL NKLS
Sbjct: 610 LIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLS 669
Query: 202 GSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
G+IP+C GNLT LRN++L SN L S IPS L NL+ +L L+ SN LP ++GN+K
Sbjct: 670 GTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKS 729
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSL----------- 309
L +D S+N G+IP+TI L++L L L HN+LQG IP +F DLVSL
Sbjct: 730 LVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLS 789
Query: 310 -------------ESLDLSNNNLSEIIP---------------------------LSLEK 329
E L++S N L IP ++ EK
Sbjct: 790 GTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACEK 849
Query: 330 LLYLN---ILLIVVVILALKFG------LISRCQKRATK--LPNVSNMQPQASRRRFSYQ 378
N +LL +V L++ L + ++R TK P ++ R +Q
Sbjct: 850 DSRKNTKSLLLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSLPRMHRMIPHQ 909
Query: 379 ELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF------------------- 419
ELL AT+ F +NLIG+GS G VYK L DG+ A+KVF+
Sbjct: 910 ELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNI 969
Query: 420 ----------SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL 469
SCSN DF+ALVLEY NGSLEK LYS NY LD +QRL IMIDV S LEYL
Sbjct: 970 RHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYL 1029
Query: 470 HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
H YS P++HCDLKP N LLDD++VAH+SDFGIAKLL G + M +T+TL +GYMAP
Sbjct: 1030 HHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMG-SEFMKRTKTLGTVGYMAP 1086
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1003), Expect = e-106, Method: Compositional matrix adjust.
Identities = 249/599 (41%), Positives = 333/599 (55%), Gaps = 102/599 (17%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGR----LSSI--VDELSLSDNYLTSS--TPEL 81
N+ G + ++I N+S L + +NY G LS++ ++ L+L+ N LT T E+
Sbjct: 519 NEFSGTIPVSISNMSKLIRLHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEV 578
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
FL+S++NCK+L+ L I NPL G LP +GN S +LE S C+ G I IGNLT+
Sbjct: 579 GFLTSLTNCKFLRTLWIDYNPLKGTLPNSLGNLSVALESFTASACHFRGTIPTGIGNLTN 638
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
LI +DLG N L GSI TLG LQKLQ L GN ++GSIPN LCHL L L L NKLS
Sbjct: 639 LIWLDLGANDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKLS 698
Query: 202 GSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
GSIP+CFG+L ALR L LDSN L +IP W+L+D++ L SN G LP ++GN+K
Sbjct: 699 GSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMKS 758
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD--------------- 305
+T +D S+N + G IP + L++L L L N+LQGSIP F D
Sbjct: 759 ITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLF 818
Query: 306 ---------LVSLESLDLSNNNLSEIIP-------LSLEKLLY----------------- 332
L+ L+ L++S N L IP + E ++
Sbjct: 819 GTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDK 878
Query: 333 -------------LNILLIVV--VILALKFGLISRCQKRATKLPNVSNMQPQASRRRFSY 377
L +L+ V + + F ++ ++ T++P + + + S
Sbjct: 879 NNRTQSWKTKSFILKYILLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLPGAHEKISQ 938
Query: 378 QELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------- 420
Q+LL AT+GF +NLIG+GS G VYK L +G+ AIKVF+
Sbjct: 939 QQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQG 998
Query: 421 ------------CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEY 468
CSN DF+ALVLEY GSL+K LYS NY LD+ QRLNIMIDV SALEY
Sbjct: 999 ICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEY 1058
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LH S+ ++HCDLKP N LLD+N+VAH++DFGIA+LLT E +SM QT+TL IGYMAP
Sbjct: 1059 LHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLLT-ETESMQQTKTLGTIGYMAP 1116
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1002), Expect = e-106, Method: Compositional matrix adjust.
Identities = 246/602 (40%), Positives = 328/602 (54%), Gaps = 106/602 (17%)
Query: 29 QNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV------DELSLSDNYLTSSTPELS 82
+N+L G + +I N S L V D+ N GR+ ++ +L+L++N LTS +
Sbjct: 341 KNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSE 400
Query: 83 FLSSMS--NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
S NC+ L L + NPL G LP +GN S SLE ++ DC I G I IGNL+
Sbjct: 401 LSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLS 460
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
+LI + L N+L G+I +G+L+ LQ S N+L+G IPN +CHL L L L N
Sbjct: 461 NLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGF 520
Query: 201 SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
SGS+P C N+T+LR L+L SN TSIP+ W+LKD+L ++ N G LP +IGNLKV
Sbjct: 521 SGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKV 580
Query: 261 LTRIDFSRNNLLGDIPTTIQGLK------------------------SLQFLSLGHNRLQ 296
+T IDFS N L GDIPT+I L+ SL+FL L N L
Sbjct: 581 VTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLS 640
Query: 297 GSIPNSFDDLVSLESLDLSNNNLS-EII-------------------------------- 323
G+IP S + LV L++ ++S N L EI+
Sbjct: 641 GAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKS 700
Query: 324 ---------PLSLEKLLYLNILLIVVVILALKFGLISRCQKRATKLPNVSNMQPQASRRR 374
P + + ++++LAL + R KR KL + P A+ R+
Sbjct: 701 ISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKR--KLSTQEDPLPPATWRK 758
Query: 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF--------------- 419
SY EL RAT+GF+ NL+G GS GSVYK L DG+ A+KVFH
Sbjct: 759 ISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEV 818
Query: 420 --------------SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSA 465
SC N DF+AL+LE+ +GSLEK LYS NY LDILQRLNIMIDV SA
Sbjct: 819 LRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASA 878
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525
LEYLH G + P++HCDLKP N L+++++VAH+SDFGI++LL GE ++TQT TLA IGYM
Sbjct: 879 LEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLTLATIGYM 937
Query: 526 AP 527
AP
Sbjct: 938 AP 939
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 385 bits (990), Expect = e-104, Method: Compositional matrix adjust.
Identities = 252/627 (40%), Positives = 343/627 (54%), Gaps = 106/627 (16%)
Query: 6 LNNRQLDGGMTGDVCYRICTIDS----QNKLVGIVSITIFNLSTLKVFDVDNNYVLGR-- 59
L L GG+ + + ++ N+ G + ++I N+S L + +NY +G
Sbjct: 491 LAQNHLSGGLPSSISTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFIGNVP 550
Query: 60 --LSSI--VDELSLSDNYLTSS--TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGN 113
LS++ ++ L+L+ N LT T E+ FL+S++NCK+L+ L I NPL G LP +GN
Sbjct: 551 KDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTLPNSLGN 610
Query: 114 FSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRG 173
S +LE S C+ G I IGNLT+LI +DLG N L GSI TLG+LQKLQ L G
Sbjct: 611 LSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQRLYIAG 670
Query: 174 NELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILW 232
N ++GSIPN L HL L L L NKLSGSIP+CFG+L ALR L LDSN L +IP W
Sbjct: 671 NRIQGSIPNDLFHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFW 730
Query: 233 NLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGH 292
+L+D+L L SN G LP ++GN+K +T +D S+N + G IP + L++L L L
Sbjct: 731 SLRDLLVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQ 790
Query: 293 NRLQGSIPNSFDDLVS------------------------LESLDLSNNNLSEIIP---- 324
N+LQGSIP F DL+S L+ L++S N L IP
Sbjct: 791 NKLQGSIPVEFGDLLSLESMDLSQNNLSGTIPKSLEALIYLKHLNVSFNKLQGEIPDGGP 850
Query: 325 ---LSLEKLLY------------------------------LNILLIVV--VILALKFGL 349
+ E ++ L +L+ V ++ + F +
Sbjct: 851 FVNFTAESFIFNEALCGAPHFQVIACDKNNHTQSWKTKSFILKYILLPVGSIVTLVAFIV 910
Query: 350 ISRCQKRATKLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDG 409
+ ++ T++P + + + S Q+LL AT+ F +NLIG+GS G VYK L +G
Sbjct: 911 LWIRRQDNTEIPAPIDSWLPGAHEKISQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSNG 970
Query: 410 MEFAIKVFHFS-----------------------------CSNEDFRALVLEYTTNGSLE 440
+ AIKVF+ CSN DF+ALVLEY GSL+
Sbjct: 971 LTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLD 1030
Query: 441 KVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500
K LYS NY LD+ QRLNIMIDV ALEYLH S+ ++HCDLKP N LLD+N+VAH++DF
Sbjct: 1031 KWLYSHNYFLDLFQRLNIMIDVALALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADF 1090
Query: 501 GIAKLLTGEDQSMTQTQTLAIIGYMAP 527
GIA+LLT E +SM QT+TL IGYMAP
Sbjct: 1091 GIARLLT-ETESMQQTKTLGTIGYMAP 1116
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 385 bits (989), Expect = e-104, Method: Compositional matrix adjust.
Identities = 253/608 (41%), Positives = 324/608 (53%), Gaps = 121/608 (19%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTS--STPEL 81
N+ GI+ ++I N+S L V D+ N+ G + ++ L+L N LT ST E+
Sbjct: 491 NEFSGIIPMSISNMSELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGFNQLTDEHSTSEV 550
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
FL+S++NCK+L++L I NPL G LP +GN S SLE S C G I IGNL +
Sbjct: 551 GFLTSLTNCKFLRRLWIEDNPLKGILPNSLGNLSISLESFDASACQFKGTIPTGIGNLIN 610
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
LI + L N L G I I+ G LQKLQ+ + GN + GSIP+VLCHL L LDL NKLS
Sbjct: 611 LIDLRLNDNDLTGLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLS 670
Query: 202 GSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
G+IP CFGNLTALRN+ L SN L S IPS LW L+D+L L+ SN LP ++GN+K
Sbjct: 671 GTIPGCFGNLTALRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKS 730
Query: 261 LTRIDFSRN------------------------------------------------NLL 272
L +D S+N N
Sbjct: 731 LLVLDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFS 790
Query: 273 GDIPTTIQGLKSLQFLSLGHNRLQGSIPN-------SFDDLVSLESL------------- 312
G IPT+++ LK L++L++ N+LQG IPN + + +S +L
Sbjct: 791 GTIPTSLEALKYLKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACEK 850
Query: 313 DLSNNN----LSEIIPLSLEKLLYLNILLIVVVILALKFGLISRCQKRATKLPNVSNMQP 368
D N L I+PLS+ + +IL + F L R Q + V + P
Sbjct: 851 DARRNTKSLLLKCIVPLSVS---------LSTMILVVLFTLWKRRQTESESPVQVDLLLP 901
Query: 369 QASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF--------- 419
+ R S+QELL AT F NLIG+GS G VYK L DG+ A+KVF+
Sbjct: 902 RM-HRLISHQELLYATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSF 960
Query: 420 --------------------SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIM 459
SCSN DF+ALVLEY N SLEK LYS NY LD +QRL IM
Sbjct: 961 EVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIM 1020
Query: 460 IDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519
IDV S LEYLH YS P++HCDLKP N LLDD++VAH+SDFGIAKLL G + M +T+TL
Sbjct: 1021 IDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGS-EFMKRTKTL 1079
Query: 520 AIIGYMAP 527
IGYMAP
Sbjct: 1080 GTIGYMAP 1087
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 384 bits (987), Expect = e-104, Method: Compositional matrix adjust.
Identities = 250/602 (41%), Positives = 324/602 (53%), Gaps = 106/602 (17%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDEL------SLSDNYLTS--STPEL 81
NKL G + I N S L + ++ +N G + + +L L N L+S ++ EL
Sbjct: 371 NKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQEL 430
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
+ SS+ NC+ LK L +S NPLDG+LP VGN S SLE SD I G + E IGNL+
Sbjct: 431 TIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSS 490
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
L ++LG N L G I T+G L+ LQ L GN+L+GSIP+ LC L L+ L+L GNKLS
Sbjct: 491 LTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLS 550
Query: 202 GSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
GSIPTCF NLT+LRNL L SN S I S LW LKDIL ++ SN G LPS+I NL+
Sbjct: 551 GSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRA 610
Query: 261 LTRIDFSRNNLLGDIPTTIQGL------------------------KSLQFLSLGHNRLQ 296
+ I+ S+N L G+IP +I GL KSL+FL L N L
Sbjct: 611 VYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLS 670
Query: 297 GSIPNSFDDLVSLESLDLSNNNLSEIIP-------LSLEKLL------------------ 331
G IP S D+L+ L+ ++S N L IP S + +
Sbjct: 671 GMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKD 730
Query: 332 -----------------YLNILLIVVVILALKFGLISRCQKRATKLPNVSNMQPQASRRR 374
L ++ V +LA L C+++A K + + RR
Sbjct: 731 DNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKA-KFSIEDDFLALTTIRR 789
Query: 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF--------------- 419
SY EL AT+GF +N +G GSFGSVYK L DG A KVF+
Sbjct: 790 ISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEV 849
Query: 420 --------------SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSA 465
SCS +F+ALVLE+ N SLEK LYS +Y L+ LQRLNIM+DV S
Sbjct: 850 LRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASV 909
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525
LEYLH GY+ P+ HCD+KP N LL++++VA L+DFGI+KLL GE+ S+ QT TLA IGYM
Sbjct: 910 LEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLL-GEEGSVMQTMTLATIGYM 968
Query: 526 AP 527
AP
Sbjct: 969 AP 970
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 527 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.514 | 0.264 | 0.370 | 5.7e-66 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.516 | 0.269 | 0.347 | 7.5e-65 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.567 | 0.290 | 0.302 | 1.9e-62 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.516 | 0.269 | 0.319 | 2.8e-62 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.516 | 0.269 | 0.325 | 4.7e-62 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.516 | 0.265 | 0.352 | 8.5e-61 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.514 | 0.276 | 0.338 | 1.3e-53 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.504 | 0.237 | 0.362 | 2.3e-51 | |
| TAIR|locus:2007918 | 1088 | PEPR2 "PEP1 receptor 2" [Arabi | 0.554 | 0.268 | 0.331 | 4.3e-51 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.555 | 0.300 | 0.322 | 1.5e-50 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 410 (149.4 bits), Expect = 5.7e-66, Sum P(3) = 5.7e-66
Identities = 104/281 (37%), Positives = 156/281 (55%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYV-------LGRLSSIVDELSLSDNYLTS-STPEL 81
N G + T+ N+S+L+ D+ +N++ GRL +++ L L++N L + S+ +L
Sbjct: 284 NSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLL-LLGLNNNSLGNYSSGDL 342
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
FL +++NC L+ L++ N L G LP + N S L + + ISG I IGNL
Sbjct: 343 DFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVS 402
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
L ++DLG N L G + +LG+L +L+ + N L G IP+ L +++ L L L N
Sbjct: 403 LQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFE 462
Query: 202 GSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
GSIP+ G+ + L +L+L +N+L SIP L L ++ L+ NL VGPL IG LK
Sbjct: 463 GSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKF 522
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301
L +D S N L G IP T+ SL+FL L N G IP+
Sbjct: 523 LLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD 563
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 377 (137.8 bits), Expect = 7.5e-65, Sum P(3) = 7.5e-65
Identities = 97/279 (34%), Positives = 145/279 (51%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSI--VDELSL---SDNYLTS-STPELSF 83
N G + T+ N+STL+ ++ N + G + + V L L N L S S+ +L F
Sbjct: 269 NYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLGSDSSRDLEF 328
Query: 84 LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143
L+S++NC L+ L I RN L G LP + N S L + + ISG I +IGNL +L
Sbjct: 329 LTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQ 388
Query: 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGS 203
+ L N L+G + +LGKL L++LS N L G IP + ++ +L LDL N G
Sbjct: 389 KLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGI 448
Query: 204 IPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262
+PT GN + L L + N+L +IP + ++ +L LD N +G LP IG L+ L
Sbjct: 449 VPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLG 508
Query: 263 RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301
+ N L G +P T+ +++ L L N G IP+
Sbjct: 509 TLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD 547
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 393 (143.4 bits), Expect = 1.9e-62, Sum P(3) = 1.9e-62
Identities = 94/311 (30%), Positives = 156/311 (50%)
Query: 3 SEKLNNRQLDGGMTGDVCYRICTID----SQNKLVGIVSITIFNLSTLKVFDVDNNYVLG 58
S L + G + D Y + + N+ G + T+ N+S+L+ FD+ +NY+ G
Sbjct: 245 SLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSG 304
Query: 59 RLSSIVDEL------SLSDNYL-TSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVV 111
+ +L + +N L +S+ L F+ +++NC L+ LD+ N L G LP +
Sbjct: 305 SIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASI 364
Query: 112 GNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171
N S +L +++ ISG I +IGNL L + L N L+G + ++ GKL LQ +
Sbjct: 365 ANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDL 424
Query: 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSI 230
N + G IP+ ++ L +L L N G IP G L +L +D+N L +IP
Sbjct: 425 YSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQE 484
Query: 231 LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSL 290
+ + + Y+D +N G P ++G L++L + S N L G +P I G S++FL +
Sbjct: 485 ILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFM 544
Query: 291 GHNRLQGSIPN 301
N G+IP+
Sbjct: 545 QGNSFDGAIPD 555
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 363 (132.8 bits), Expect = 2.8e-62, Sum P(3) = 2.8e-62
Identities = 90/282 (31%), Positives = 145/282 (51%)
Query: 29 QNKLVGIVSITIFNLSTLKVFDVDNNYV-------LGRLSSIVDELSLSDNYLTSST-PE 80
+N LVG + T+ N+STL+ F ++ N + G++ S+ L LS+N L S T +
Sbjct: 268 ENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSL-QYLDLSENPLGSYTFGD 326
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
L F+ S++NC +L+ L + L G LP + N S L + + + G I ++IGNL
Sbjct: 327 LEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLI 386
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
L + LG N L G + +LGKL +L LS N + G IP+ + +L L L L N
Sbjct: 387 GLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSF 446
Query: 201 SGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
G +P G + + +L + N+L +IP + + ++ L N G LP+ IG+L+
Sbjct: 447 EGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQ 506
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301
L ++ N G +P T+ +++ L L N G+IPN
Sbjct: 507 NLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPN 548
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 356 (130.4 bits), Expect = 4.7e-62, Sum P(3) = 4.7e-62
Identities = 91/280 (32%), Positives = 144/280 (51%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELS------LSDNYLTS-STPELS 82
N L G + T+ N+STL++F + N + G +S +L L++N L S S +L+
Sbjct: 269 NFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLA 328
Query: 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142
FL +++NC +L L +S N L G LP + N S L + + I G I +IGNL L
Sbjct: 329 FLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGL 388
Query: 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG 202
S+ L N L G + +LG L L L N G IP+ + +L L +L L N G
Sbjct: 389 QSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEG 448
Query: 203 SIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVL 261
+P G+ + + +L + N+L +IP + + +++L+ SN G LP+ IG L+ L
Sbjct: 449 IVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNL 508
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301
+ NNL G +P T+ S++ + L N G+IP+
Sbjct: 509 VELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPD 548
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 366 (133.9 bits), Expect = 8.5e-61, Sum P(3) = 8.5e-61
Identities = 99/281 (35%), Positives = 147/281 (52%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDEL-SLSDNYL------TSSTPELS 82
N+ G + ++ N S L V + N G ++S L +L++ YL T +
Sbjct: 283 NRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWG 342
Query: 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142
F+S ++NC L+ L++ N L G LP N S SL F+ + I+G I ++IGNL L
Sbjct: 343 FISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGL 402
Query: 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG 202
+ L N GS+ +LG+L+ L L N L GSIP + +L L L L NK SG
Sbjct: 403 QHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSG 462
Query: 203 SIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDI-LYLDFWSNLFVGPLPSKIGNLKV 260
IP NLT L +L L +N L+ IPS L+N++ + + ++ N G +P +IG+LK
Sbjct: 463 WIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKN 522
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301
L N L G IP T+ + L++L L +N L GSIP+
Sbjct: 523 LVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPS 563
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 329 (120.9 bits), Expect = 1.3e-53, Sum P(3) = 1.3e-53
Identities = 96/284 (33%), Positives = 145/284 (51%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRL-SSIVDE------LSLSDNYLTSSTPELS 82
NKL G V ++ N + LK D+++N + G L S ++ + L LS N+ S +
Sbjct: 201 NKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTN 260
Query: 83 ---FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139
F +S++N L++L+++ N L G + V + S +L I + I G I EI NL
Sbjct: 261 LEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNL 320
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
+L ++L N L+G I L KL KL+ + N L G IP L + L LD+ N
Sbjct: 321 LNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNN 380
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKI-GN 257
LSGSIP FGNL+ LR L L N L+ ++P L ++ LD N G +P ++ N
Sbjct: 381 LSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSN 440
Query: 258 LKVLTR-IDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300
L+ L ++ S N+L G IP + + + + L N L G IP
Sbjct: 441 LRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIP 484
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 394 (143.8 bits), Expect = 2.3e-51, Sum P(2) = 2.3e-51
Identities = 102/281 (36%), Positives = 153/281 (54%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-------LGRLSSIVDELSLSDNYLTSSTPE 80
SQNKL G + ++ NL L V + NY+ LG + S+ D L+LS N LT S P
Sbjct: 182 SQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTD-LALSQNKLTGSIP- 239
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
S++ N K L L + N L G +P +GN +S+ + +S ++G I +GNL
Sbjct: 240 ----STLGNLKNLMVLYLYENYLTGVIPPEIGNM-ESMTNLALSQNKLTGSIPSSLGNLK 294
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
+L + L N L G I LG ++ + L N+L GSIP+ L +L L L L N L
Sbjct: 295 NLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYL 354
Query: 201 SGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
+G IP GN+ ++ +L L++N+LT SIPS NLK++ YL + N G +P ++GN++
Sbjct: 355 TGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNME 414
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300
+ +D S+N L G +P + L+ L L N L G+IP
Sbjct: 415 SMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIP 455
|
|
| TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 344 (126.2 bits), Expect = 4.3e-51, Sum P(3) = 4.3e-51
Identities = 100/302 (33%), Positives = 153/302 (50%)
Query: 6 LNNRQLDGGMTGDVCYRICTID---SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS 62
L+ L G + V I +D S N L G + + N S L+ ++NN + G L +
Sbjct: 155 LDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPELLGNCSKLEYLALNNNKLNGSLPA 214
Query: 63 IVDEL-SLSDNYLTSST--PELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
+ L +L + ++++++ L F SS NCK L LD+S N G +P +GN S SL
Sbjct: 215 SLYLLENLGELFVSNNSLGGRLHFGSS--NCKKLVSLDLSFNDFQGGVPPEIGNCS-SLH 271
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179
+ M CN++G I +G L + IDL N+L+G+I LG L+ L N+L+G
Sbjct: 272 SLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGE 331
Query: 180 IPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDIL 238
IP L L L L+L NKLSG IP + +L + + +N LT +P + LK +
Sbjct: 332 IPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLK 391
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298
L ++N F G +P +G + L +D N G+IP + + L+ LG N+L G
Sbjct: 392 KLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGK 451
Query: 299 IP 300
IP
Sbjct: 452 IP 453
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 360 (131.8 bits), Expect = 1.5e-50, Sum P(3) = 1.5e-50
Identities = 101/313 (32%), Positives = 161/313 (51%)
Query: 2 WSEKLNNRQLDGG-MTGDVCYRICTIDS-------QNKLVGIVSITIFNLSTLKVFDVDN 53
W+E L L G + G++ +C + N L G + TI N + +V D+
Sbjct: 186 WNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSY 245
Query: 54 NYVLGRLS-SI----VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLP 108
N + G + I V LSL N L+ P S + M + L LD+S N L G +P
Sbjct: 246 NQLTGEIPFDIGFLQVATLSLQGNQLSGKIP--SVIGLM---QALAVLDLSGNLLSGSIP 300
Query: 109 RVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQF 168
++GN + + E +++ ++G I E+GN++ L ++L N L G I LGKL L
Sbjct: 301 PILGNLTFT-EKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFD 359
Query: 169 LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-I 227
L+ N+LEG IP+ L L L++ GNK SG+IP F L ++ L+L SN + I
Sbjct: 360 LNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPI 419
Query: 228 PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQF 287
P L + ++ LD +N G +PS +G+L+ L +++ SRN++ G +P L+S+
Sbjct: 420 PVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIME 479
Query: 288 LSLGHNRLQGSIP 300
+ L +N + G IP
Sbjct: 480 IDLSNNDISGPIP 492
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 527 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-25 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.001 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.001 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.001 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.002 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.002 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 0.002 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.002 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.002 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.002 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 0.002 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.003 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.003 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.003 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.003 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.003 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.003 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 0.003 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.003 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.003 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 0.004 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.004 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.004 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 1e-41
Identities = 125/345 (36%), Positives = 169/345 (48%), Gaps = 21/345 (6%)
Query: 6 LNNRQLDGGMTGDVCYRICTID----SQNKLVG-IVSITIFNLSTLKVFDVDNNYVLGRL 60
L+N QL G + D+ ++ S N G I +I NL TL D+ NN + G +
Sbjct: 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETL---DLSNNMLSGEI 156
Query: 61 S------SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNF 114
S + L L N L P +S++N L+ L ++ N L G +PR +G
Sbjct: 157 PNDIGSFSSLKVLDLGGNVLVGKIP-----NSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 115 SQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGN 174
+SL++I++ N+SG I EIG LT L +DL N L G I +LG L+ LQ+L N
Sbjct: 212 -KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270
Query: 175 ELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWN 233
+L G IP + L L LDL N LSG IP L L LHL SN T IP L +
Sbjct: 271 KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 234 LKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHN 293
L + L WSN F G +P +G LT +D S NNL G+IP + +L L L N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 294 RLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLI 338
L+G IP S SL + L +N+ S +P KL + L I
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-39
Identities = 112/317 (35%), Positives = 162/317 (51%), Gaps = 27/317 (8%)
Query: 22 RICTIDSQNK-LVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPE 80
R+ +ID K + G +S IF L ++ + LS+N L+ P+
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTIN------------------LSNNQLSGPIPD 111
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
F +S S L+ L++S N G +PR +LE + +S+ +SG I +IG+ +
Sbjct: 112 DIFTTSSS----LRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFS 164
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
L +DLGGN L G I +L L L+FL+ N+L G IP L + L + L N L
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 201 SGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
SG IP G LT+L +L L N LT IPS L NLK++ YL + N GP+P I +L+
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
L +D S N+L G+IP + L++L+ L L N G IP + L L+ L L +N
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 320 SEIIPLSLEKLLYLNIL 336
S IP +L K L +L
Sbjct: 345 SGEIPKNLGKHNNLTVL 361
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 133/521 (25%), Positives = 229/521 (43%), Gaps = 67/521 (12%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDE------LSLSDNYLTSSTPELSF 83
N G + + + +L L+V + +N G + + + L LS N LT PE
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE--- 374
Query: 84 LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143
+ + L KL + N L+G +P+ +G +SL + + D + SG + E L +
Sbjct: 375 --GLCSSGNLFKLILFSNSLEGEIPKSLGA-CRSLRRVRLQDNSFSGELPSEFTKLPLVY 431
Query: 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGS 203
+D+ N L G I+ + LQ LS N+ G +P+ L LDL N+ SG+
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD-SFGSKRLENLDLSRNQFSGA 490
Query: 204 IPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262
+P G+L+ L L L N+L+ IP L + K ++ LD N G +P+ + VL+
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 263 RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL--- 319
++D S+N L G+IP + ++SL +++ HN L GS+P++ L S N +L
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610
Query: 320 --------SEIIPLSLEKLLYLNILLIVVVILAL-KFGLISRCQKRATKLPNVSN----- 365
+ + + Y+ L ++LAL FG + + +L V N
Sbjct: 611 DTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTW 670
Query: 366 -MQPQASR--RRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFS- 420
+Q S+ + + ++L + N+I RG G+ YK + +++GM+F +K +
Sbjct: 671 ELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN 727
Query: 421 ------------------------CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRL 456
C +E L+ EY +L +VL + L +R
Sbjct: 728 SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRR 783
Query: 457 NIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497
I I + AL +LH S ++ +L P ++D HL
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-31
Identities = 101/319 (31%), Positives = 157/319 (49%), Gaps = 21/319 (6%)
Query: 29 QNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELS------LSDNYLTSSTPELS 82
QNKL G + +IF+L L D+ +N + G + +V +L L N T P
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV-- 326
Query: 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI---GNL 139
++++ L+ L + N G +P+ +G +L + +S N++G I E + GNL
Sbjct: 327 ---ALTSLPRLQVLQLWSNKFSGEIPKNLGK-HNNLTVLDLSTNNLTGEIPEGLCSSGNL 382
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
LI L N L G I +LG + L+ + + N G +P+ L +++ LD+ N
Sbjct: 383 FKLI---LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
L G I + ++ +L+ L L N+ + K + LD N F G +P K+G+L
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
L ++ S N L G+IP + K L L L HN+L G IP SF ++ L LDLS N L
Sbjct: 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559
Query: 320 SEIIPLSL---EKLLYLNI 335
S IP +L E L+ +NI
Sbjct: 560 SGEIPKNLGNVESLVQVNI 578
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 89/231 (38%), Positives = 123/231 (53%), Gaps = 7/231 (3%)
Query: 110 VVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKL-QKLQF 168
+ N S + I +S NISG IS I L + +I+L N+L+G I + L++
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 169 LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-I 227
L+ N GSIP + L LDL N LSG IP G+ ++L+ L L N L I
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 228 PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQF 287
P+ L NL + +L SN VG +P ++G +K L I NNL G+IP I GL SL
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 288 LSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP---LSLEKLLYLNI 335
L L +N L G IP+S +L +L+ L L N LS IP SL+KL+ L++
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 58/168 (34%), Positives = 77/168 (45%), Gaps = 39/168 (23%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFS------------------------------C 421
+G G FG+VY AR + G + AIK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 422 SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
+E+ LV+EY GSL+ +L + L + L I++ + LEYLH S IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 482 LKPHNKLLD-DNIVAHLSDFGIAKLLT-GEDQSMTQTQTLAIIGYMAP 527
LKP N LLD DN L+DFG++KLLT + T T A YMAP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA---YMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 54/168 (32%), Positives = 71/168 (42%), Gaps = 38/168 (22%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKV------------------------------FHF 419
+G GSFG VY AR + G AIKV +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
+ED LV+EY G L +L L + + + SALEYLH S I+H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
DLKP N LLD++ L+DFG+A+ L ++ T T YMAP
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 56/168 (33%), Positives = 72/168 (42%), Gaps = 40/168 (23%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKVF---------------------HFSCSN------- 423
+G GSFG+VYKA+ + G A+K+ S N
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 424 ---EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
+D LV+EY G L L L + I + + LEYLH S IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
DLKP N LLD+N V ++DFG+AK L S+T T YMAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLT---TFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 53/183 (28%), Positives = 70/183 (38%), Gaps = 62/183 (33%)
Query: 391 NLIGRGSFGSVYKARLQD-GMEFAIKVFHFSCSNE------------------------- 424
L+GRGSFGSVY A +D G A+K S +E
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 425 --------DFRALVLEYTTNGSLEKVLYS---------SNYILDILQRLNIMIDVTSALE 467
+ + LEY + GSL +L Y IL+ L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE----------GLA 115
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---Y 524
YLH S I+H D+K N L+D + V L+DFG AK L T T ++ G +
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL---GDIETGEGTGSVRGTPYW 169
Query: 525 MAP 527
MAP
Sbjct: 170 MAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 3e-18
Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 46/175 (26%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA--------------------- 428
IG+GSFG VY R DG + +K S +E R
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDIL---QRLNIMIDVTSALEYLHFGYST 475
+V+EY G L + + Q L+ + + AL+YLH S
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
I+H D+KP N L N + L DFGI+K+L+ + +T ++G Y++P
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKT----VVGTPYYLSP 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 62/184 (33%), Positives = 97/184 (52%), Gaps = 4/184 (2%)
Query: 158 ITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP-TCFGNLTALRN 216
IT ++ + G + G I + + L + ++L N+LSG IP F ++LR
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 217 LHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI 275
L+L +N T SIP ++ ++ LD +N+ G +P+ IG+ L +D N L+G I
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 276 PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
P ++ L SL+FL+L N+L G IP + SL+ + L NNLS IP + L LN
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 336 LLIV 339
L +V
Sbjct: 241 LDLV 244
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 41/170 (24%), Positives = 64/170 (37%), Gaps = 38/170 (22%)
Query: 393 IGRGSFGSVYKARLQDGMEF-----AIKVFHFSCSNEDFRA------------------- 428
+G G+FG VYK L+ E A+K S E+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+V EY G L L L + L + + + +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H DL N L+ +N+V +SDFG+++ + +D + I +MAP
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 39/173 (22%)
Query: 390 NNLIGRGSFGSVYKARLQD-----GMEFAIKVFHFSCSN---EDFRA------------- 428
+G G+FG VYK +L+ +E A+K S E+F
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 429 --------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS 474
+V+EY G L L + L + L+ + + +EYL S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
IH DL N L+ +N+V +SDFG+++ L +D + I +MAP
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAP 172
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 52/165 (31%), Positives = 72/165 (43%), Gaps = 36/165 (21%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFS-----------------CSN----------- 423
IG+G FG VYKAR + G E AIKV C +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 424 -EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+D +V+E+ + GSL+ +L S+N L Q + ++ LEYLH S IIH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
K N LL + L DFG++ L+ T T +MAP
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTP---YWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 44/179 (24%), Positives = 67/179 (37%), Gaps = 45/179 (25%)
Query: 391 NLIGRGSFGSVYKARLQDG----MEFAIKV---FHFSCSNEDFRA--------------- 428
+G G+FG VYK +L+ E A+K +DF
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 429 ------------LVLEYTTNGSLEKVL--------YSSNYILDILQRLNIMIDVTSALEY 468
LVLEY G L L L + L+ I + +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L S +H DL N L+ +++V +SDFG+++ + +D +T I +MAP
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 44/174 (25%), Positives = 67/174 (38%), Gaps = 40/174 (22%)
Query: 390 NNLIGRGSFGSVYKARLQDG-----MEFAIKVFHFSCSN---EDFRA------------- 428
+G G+FG VYK L+ +E A+K S E+F
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 429 --------------LVLEYTTNGSLEKVL-YSSNYILDILQRLNIMIDVTSALEYLHFGY 473
+V+EY G L L + L + L+ + + +EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S IH DL N L+ +N+V +SDFG+++ L +D I +MAP
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAP 173
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 46/171 (26%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFSCSNEDFR------------------------ 427
+G+GS G VYK R + G +A+K H +E+FR
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVD-GDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 428 -------ALVLEYTTNGSLEKVLYSSNYILD-ILQRLNIMIDVTSALEYLHFGYSTPIIH 479
++VLEY GSL +L I + +L + I L+YLH IIH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI--LKGLDYLH--TKRHIIH 123
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
D+KP N L++ ++DFGI+K+L + ++ Q T +G YM+P
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTF--VGTVTYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 52/169 (30%), Positives = 69/169 (40%), Gaps = 41/169 (24%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVF--------------------------------HF 419
+G+GSFG V R G +A+KV H+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
+ E+ LVLEY G L L + R ++ ALEYLH S II+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGIIY 116
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
DLKP N LLD + L+DFG+AK L+ E +T T Y+AP
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 48/181 (26%), Positives = 74/181 (40%), Gaps = 52/181 (28%)
Query: 386 GFSANNLIGRGSFGSVYKARLQDGME-FAIKV---------------------------- 416
F +IG+G+FG V + +D + FA+K
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 417 ----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLN------IMIDVTSAL 466
+S +E+ LV++ G L Y L + + + ++ AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526
EYLH S IIH D+KP N LLD+ H++DF IA +T + + + + T GYMA
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGT---PGYMA 167
Query: 527 P 527
P
Sbjct: 168 P 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 50/175 (28%), Positives = 75/175 (42%), Gaps = 45/175 (25%)
Query: 387 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRAL--------------VL 431
F +G GS+GSVYKA + G AIKV ED + + ++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIV 61
Query: 432 EYTTNGSLEKVLY------SSNYILDILQRLN----------IMIDVTSALEYLHFGYST 475
+Y + L+ + + DI++ N I+ LEYLH S
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SN 118
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
IH D+K N LL++ A L+DFG++ LT +M + T+ IG +MAP
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 47/177 (26%), Positives = 66/177 (37%), Gaps = 47/177 (26%)
Query: 393 IGRGSFGSVYKA-RLQDGMEFAIKVFHFSCSNE--------DFRAL-------------- 429
IG+GSFG+V K R DG K + E + L
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 430 -----------VLEYTTNGSLEKVL---YSSNYILDILQRLNIMIDVTSALEYLHFGY-- 473
V+EY G L +++ ++ I+ + AL H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
++H DLKP N LD N L DFG+AK+L G D S +T +G YM+P
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT----YVGTPYYMSP 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 49/166 (29%), Positives = 71/166 (42%), Gaps = 43/166 (25%)
Query: 392 LIGRGSFGSVYKARLQ-DGMEFAIKVF--------------------------------- 417
+IG GSF +V A+ + E+AIK+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVL--YSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
+++ +E+ VLEY NG L + + Y S LD ++ ALEYLH S
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI 521
IIH DLKP N LLD ++ ++DFG AK+L + S + A
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDAT 166
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 55/178 (30%), Positives = 69/178 (38%), Gaps = 52/178 (29%)
Query: 391 NLIGRGSFGSVYKA--------------RLQDGMEFAIKVFHFSCSN------------- 423
N IG G+FG VY A R+QD IK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 424 --EDFRALVL---EYTTNGSLEKVLYSSNYILD--ILQRLNIMIDVTSALEYLHFGYSTP 476
E R V EY + G+LE++L ILD +++ + + L YLH S
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHG 119
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT-------GEDQSMTQTQTLAIIGYMAP 527
I+H D+KP N LD N V L DFG A L E QS+ T YMAP
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA-----YMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 50/180 (27%), Positives = 71/180 (39%), Gaps = 48/180 (26%)
Query: 386 GFSANNLIGRGSFGSVYKA-RLQDGMEFAIKVF--------------------------H 418
F +G+GS+GSVYK RL D +A+K +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 419 FSCSNEDF-----RALVLEYTTNGSLEKVLYSSNYILDILQR---LNIMIDVTSALEYLH 470
E F +V+EY G L K + ++ I I + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 471 FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
I+H DLK N LL N + + D GI+K+L ++M +TQ IG YMAP
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQ----IGTPHYMAP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 48/181 (26%), Positives = 70/181 (38%), Gaps = 62/181 (34%)
Query: 391 NLIGRGSFGSVYKARLQDGMEF-AIKVF---------HFSCSNE---------------- 424
+LIGRG+FG VYK + +F AIK S E
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 425 ------DFRALVLEYTTNGSLEKVL---------YSSNYILDILQRLNIMIDVTSALEYL 469
D ++LEY NGSL +++ + Y+ +LQ L YL
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ----------GLAYL 115
Query: 470 HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMA 526
H +IH D+K N L + V L+DFG+A L + +++G +MA
Sbjct: 116 H---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-----DDASVVGTPYWMA 167
Query: 527 P 527
P
Sbjct: 168 P 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 31/79 (39%), Positives = 48/79 (60%)
Query: 249 GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS 308
G +P+ I L+ L I+ S N++ G+IP ++ + SL+ L L +N GSIP S L S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 309 LESLDLSNNNLSEIIPLSL 327
L L+L+ N+LS +P +L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 96 LDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS 155
L + L GF+P + + L+ I +S +I G I +G++T L +DL N NGS
Sbjct: 423 LGLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 156 ISITLGKLQKLQFLSFRGNELEGSIPNVL 184
I +LG+L L+ L+ GN L G +P L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 47/167 (28%), Positives = 70/167 (41%), Gaps = 40/167 (23%)
Query: 393 IGRGSFGSVYKA-RLQDGMEFAIKVFHFSCSNEDFRA----------------------- 428
IG G+ G VYKA G E AIK N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 429 -----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLK 483
+V+EY GSL ++ + ++ Q + +V LEYLH S +IH D+K
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIK 143
Query: 484 PHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
N LL + L+DFG A LT +++S + ++G +MAP
Sbjct: 144 SDNILLSKDGSVKLADFGFAAQLT-KEKSKRNS----VVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 65.1 bits (157), Expect = 3e-11
Identities = 59/176 (33%), Positives = 72/176 (40%), Gaps = 45/176 (25%)
Query: 392 LIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------- 420
+G GSFG VY AR D A+KV
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 421 --CSNEDFRALVLEYTTNGSLEKVL--YSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+E LV+EY GSLE +L L + L I+ + SALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 477 IIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAII----GYMAP 527
IIH D+KP N LLD D V L DFG+AKLL + + + GYMAP
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
|
Length = 384 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 33/80 (41%), Positives = 42/80 (52%)
Query: 130 GGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAV 189
G I +I L L SI+L GN + G+I +LG + L+ L N GSIP L L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 190 LFQLDLRGNKLSGSIPTCFG 209
L L+L GN LSG +P G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 30/68 (44%), Positives = 41/68 (60%)
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330
L G IP I L+ LQ ++L N ++G+IP S + SLE LDLS N+ + IP SL +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 331 LYLNILLI 338
L IL +
Sbjct: 490 TSLRILNL 497
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 34/88 (38%), Positives = 49/88 (55%), Gaps = 1/88 (1%)
Query: 145 IDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI 204
+ L L G I + KL+ LQ ++ GN + G+IP L + L LDL N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 205 PTCFGNLTALRNLHLDSNELTS-IPSIL 231
P G LT+LR L+L+ N L+ +P+ L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 52/183 (28%), Positives = 68/183 (37%), Gaps = 66/183 (36%)
Query: 392 LIGRGSFGSVYKA-RLQDGMEFAIKVFHFSCSNEDFRALV-------------------- 430
L+G GSFGSVY+ L DG FA+K + + + V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 431 --------------LEYTTNGSLEKVL--YSS-------NYILDILQRLNIMIDVTSALE 467
LE GSL K+L Y S Y IL LE
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----------LGLE 116
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---Y 524
YLH +H D+K N L+D N V L+DFG+AK Q + + + G +
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYW 167
Query: 525 MAP 527
MAP
Sbjct: 168 MAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 43/174 (24%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV--------------------------------FHF 419
I +G++G V+ A+ G +AIKV ++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
S + LV+EY G L +L + + + + R + ++ ALEYLH S IIH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLH---SNGIIH 116
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKL-LTGE--DQSMTQTQTLAIIG---YMAP 527
DLKP N L+D N L+DFG++K+ L + + + + I+G Y+AP
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 39/147 (26%), Positives = 58/147 (39%), Gaps = 41/147 (27%)
Query: 392 LIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRAL---------------------- 429
IG+G+FG VYK L+ E A+K +C + L
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 430 ------------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
V+E GSL L L + + L + +D + +EYL S
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAK 504
IH DL N L+ +N V +SDFG+++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 51/169 (30%), Positives = 66/169 (39%), Gaps = 40/169 (23%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVF---------------------------------H 418
IG+GSFG V A+ DG +A+KV H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
+S D VL+Y G L L + R ++ SAL YLH S II
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNII 118
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+ DLKP N LLD L+DFG+ K G + S T + Y+AP
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 43/168 (25%), Positives = 64/168 (38%), Gaps = 41/168 (24%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFSCSNEDFRALV--------------------- 430
+G G+ G V K + G A+K + + ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 431 ---------LEYTTNGSLEKVL-YSSNYI-LDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
+EY GSL+K+L I IL + I + V L YLH + IIH
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIH 124
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
D+KP N L++ L DFG++ L + T T + YMAP
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFVGTSS---YMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 44/149 (29%), Positives = 61/149 (40%), Gaps = 36/149 (24%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKVFHFSCSNED------------------------- 425
++G G++G V K R + G AIK F S +ED
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 426 -FRA-----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
FR LV EY LE +L +S L + + + A+ Y H S IIH
Sbjct: 68 AFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508
D+KP N L+ ++ V L DFG A+ L
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 4e-09
Identities = 43/160 (26%), Positives = 61/160 (38%), Gaps = 37/160 (23%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA----------------------- 428
+G G++G VYKAR + G A+K E +
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 429 --------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
LV EY L+K L L +IM + L Y H S I+H
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT-QTL 519
DLKP N L++ + V L+DFG+A+ ++ T TL
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 47/173 (27%), Positives = 68/173 (39%), Gaps = 40/173 (23%)
Query: 387 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRAL---------------- 429
F+ IG+GSFG VYKA + AIKV + ++ +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 430 --------------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
++EY GS +L LD I+ +V LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLH---EE 117
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY-MAP 527
IH D+K N LL + L+DFG++ LT +M++ T + MAP
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNTFVGTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 1e-08
Identities = 25/59 (42%), Positives = 30/59 (50%)
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
L +D S N L +GL +L+ L L N L P +F L SL SLDLS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 48/197 (24%), Positives = 78/197 (39%), Gaps = 52/197 (26%)
Query: 364 SNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSCS 422
S+ A S EL R N IG G+ G+VYK + G +A+KV +
Sbjct: 60 SSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNH 111
Query: 423 NEDFR-------------------------------ALVLEYTTNGSLEKVLYSSNYILD 451
+ R ++LE+ GSLE +I D
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-----GTHIAD 166
Query: 452 ILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
++ + S + YLH I+H D+KP N L++ ++DFG++++L Q
Sbjct: 167 EQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA---Q 220
Query: 512 SMTQ-TQTLAIIGYMAP 527
+M ++ I YM+P
Sbjct: 221 TMDPCNSSVGTIAYMSP 237
|
Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 41/149 (27%), Positives = 63/149 (42%), Gaps = 39/149 (26%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIK---VFHFSCSNE--DFRA---------------- 428
+G G++ VYKAR + G AIK + + + +F A
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 429 -------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
LV E+ LEKV+ + +L + M+ LEYLH +
Sbjct: 66 GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
I+H DLKP+N L+ + V L+DFG+A+
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 45/172 (26%), Positives = 70/172 (40%), Gaps = 42/172 (24%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRAL--------------VLEYTTNG 437
IG G+ VY A L + + AIK L V++Y T+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 438 SLEKVLY------SSNYILDILQRLN------------IMIDVTSALEYLHFGYSTPIIH 479
+ L+ S +LDI++ ++ +V LEYLH S IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125
Query: 480 CDLKPHNKLLDDNIVAHLSDFGI-AKLLTGEDQSMTQTQTLAIIG---YMAP 527
D+K N LL ++ ++DFG+ A L G D++ +T +G +MAP
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT--FVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 43/167 (25%), Positives = 68/167 (40%), Gaps = 37/167 (22%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHF-------------------SCSNED------- 425
IG G+ G V+KA+ + G A+K +C +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 426 FR-----ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
F LV+EY L +VL L Q + M + + Y+H + I+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
DLKP N L+ + V ++DFG+A+L + E+ + +A Y AP
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 38/146 (26%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKV---------------------------------FH 418
I +G+FGSVY A+ + G FAIKV +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
+S ++D+ LV+EY G ++ + + + + + +V +E LH II
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAK 504
H D+KP N L+D L+DFG+++
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 46/171 (26%), Positives = 66/171 (38%), Gaps = 46/171 (26%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKV--------------------------------FHF 419
+G G FG V +++ FA+K +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
+ ++ + +++EY G L +L + R I V A EYLH + II+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLH---NRGIIY 116
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
DLKP N LLD N L DFG AK L +S +T T G Y+AP
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWT--FCGTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 48/169 (28%), Positives = 71/169 (42%), Gaps = 43/169 (25%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRAL---------------------- 429
IG G++G VYKAR + G AIKV +DF +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE-PGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 430 --------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
V+EY GSL+ + + L LQ + + L YLH T IH D
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRD 126
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
+K N LL ++ L+DFG++ LT ++ + ++ IG +MAP
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSF--IGTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 429 LVLEYTTNGSLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNK 487
+V EY GSL L S ++ + Q+L +DV +EYL +H DL N
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNV 133
Query: 488 LLDDNIVAHLSDFGIAK 504
L+ +++VA +SDFG+AK
Sbjct: 134 LVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 64/255 (25%), Positives = 112/255 (43%), Gaps = 9/255 (3%)
Query: 37 SITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDN--YLTSSTPELSFLSSMSNCKYLK 94
+ +LS L D+ + + L + L+L + S +S + L
Sbjct: 60 LLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLT 119
Query: 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNG 154
LD+ N + +P ++G +L+ + +SD N + + NL +L ++DL N L+
Sbjct: 120 SLDLDNNNITD-IPPLIGLLKSNLKELDLSD-NKIESLPSPLRNLPNLKNLDLSFNDLS- 176
Query: 155 SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTAL 214
+ L L L L GN++ +P + L+ L +LDL N + + + NL L
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 215 RNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274
L L +N+L +P + NL ++ LD +N S +G+L L +D S N+L
Sbjct: 235 SGLELSNNKLEDLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNA 292
Query: 275 IPTTIQGLKSLQFLS 289
+P L L+ L
Sbjct: 293 LPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 51/187 (27%), Positives = 75/187 (40%), Gaps = 57/187 (30%)
Query: 387 FSANNL-----IGRGSFGSVYKARLQD-GMEFAIKVFHFSCSNEDFRALVLEYTTNGSLE 440
F+A +L IGRG+FG+V K + G A+K + ++ + L+++ L+
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD------LD 54
Query: 441 KVLYSSN--YI-----------------------LDILQRL-----------NIMIDVT- 463
V+ SS+ YI LD + I+ +
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAV 114
Query: 464 ---SALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
AL YL IIH D+KP N LLD N L DFGI+ L S+ +T+
Sbjct: 115 ATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAG 169
Query: 521 IIGYMAP 527
YMAP
Sbjct: 170 CRPYMAP 176
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 5e-08
Identities = 42/157 (26%), Positives = 60/157 (38%), Gaps = 39/157 (24%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDF-----------RAL----------- 429
IG G++G VYKAR + G A+K E F + L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 430 -----------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
V EY + L +L S Q M + L+YLH S I+
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGIL 122
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE-DQSMT 514
H D+K N L++++ V L+DFG+A+ T T
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 6e-08
Identities = 45/171 (26%), Positives = 69/171 (40%), Gaps = 49/171 (28%)
Query: 387 FSANNLIGRGSFGSVYKAR-LQDGMEFAIK----VF-----------------HFSCSN- 423
+ IG G++G V A + G + AIK VF H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 424 ------------EDFRAL--VLEYT-TNGSLEKVLYSSNYI-LDILQRLNIMIDVTSALE 467
EDF + V E T+ L KV+ S + D +Q + + L+
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY--FLYQILRGLK 117
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS---MTQ 515
YLH S +IH DLKP N L++ N + DFG+A+ + ++ +T+
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 47/177 (26%), Positives = 71/177 (40%), Gaps = 44/177 (24%)
Query: 387 FSANNLIGRGSFGSVYKA-RLQDGMEFAIK------------------------------ 415
F N IG+GSFG V+K R D +A+K
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 416 VFHFSCSNEDFR-ALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGY 473
+ ++ + + +V+EY NG L K+L L Q I + L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--- 118
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
S I+H D+K N LD + D G+AKLL ++ + T I+G Y++P
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANT----IVGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 39/154 (25%), Positives = 58/154 (37%), Gaps = 36/154 (23%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFH-------FSCSN-------------------ED 425
IG G++G VYKAR G AIK + +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 426 FR-----ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
FR LV E+ + L K++ L + + + L + H S I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514
DLKP N L++ V L+DFG+A+ + T
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 32/163 (19%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIK-VFHFSCSNEDFR------------------------ 427
IG G FG V+ + + AIK + + S EDF
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 428 ---ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484
LV E+ +G L L + L + +DV + YL S+ +IH DL
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAA 128
Query: 485 HNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
N L+ +N V +SDFG+ + + +DQ + T T + + +P
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSP 170
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 36/157 (22%), Positives = 58/157 (36%), Gaps = 40/157 (25%)
Query: 391 NLIGRGSFGSVYKARL-----QDGMEFAIKVFHFSCSNE---DFR--------------- 427
+G G FG V R G + A+K + S + DF
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 428 --------------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
L++EY +GSL L +++ + L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
S IH DL N L++ + +SDFG+AK+L +
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 51/184 (27%), Positives = 69/184 (37%), Gaps = 74/184 (40%)
Query: 393 IGRGSFGSVYKARLQDGME-FAIKVFHFS----------CSNE----------------- 424
+G GSFG V R + + +A+K+ + NE
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 425 ---DFRAL--VLEYTTNGSL-----------EKV--LYSSNYILDILQRLNIMIDVTSAL 466
D L V+EY G L E V Y++ V AL
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ--------------VVLAL 114
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG--- 523
EYLH S I++ DLKP N LLD + ++DFG AK + G +T TL G
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLC--GTPE 163
Query: 524 YMAP 527
Y+AP
Sbjct: 164 YLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 49/193 (25%), Positives = 72/193 (37%), Gaps = 56/193 (29%)
Query: 380 LLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHF-SCSNEDFRA--------- 428
L T F +IG G++G VYKAR + G AIK+ E+ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 429 -------------------------LVLEYTTNGSLEKVLYSSNYILDILQRLN------ 457
LV+E GS+ ++ + +RL
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAY 117
Query: 458 IMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 517
I+ + L YLH +IH D+K N LL N L DFG++ L D ++ +
Sbjct: 118 ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRN 171
Query: 518 TLAIIG---YMAP 527
T IG +MAP
Sbjct: 172 T--FIGTPYWMAP 182
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 43/187 (22%), Positives = 65/187 (34%), Gaps = 58/187 (31%)
Query: 393 IGRGSFGSVYKARL------QDGMEFAIKVFHFSCSN---EDFRA--------------- 428
+G G+FG V+ D A+K + SN +DF
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 429 ------------LVLEYTTNGSLEKVLYSSNYILDIL-------------QRLNIMIDVT 463
+V EY +G L K L S L Q L I + +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 464 SALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
S + YL HF +H DL N L+ ++V + DFG+++ + D T+
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 521 IIGYMAP 527
I +M P
Sbjct: 187 PIRWMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 51/170 (30%), Positives = 67/170 (39%), Gaps = 40/170 (23%)
Query: 392 LIGRGSFGSVYKA-RLQDGMEFAIKVF--------------------------------- 417
+IG+GSFG V A R DG +A+KV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
H+S + VL++ G L L + R ++ SAL YLH S I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
++ DLKP N LLD L+DFG+ K G QS T T Y+AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 47/173 (27%), Positives = 73/173 (42%), Gaps = 48/173 (27%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTTNGSLEKVLYS--SNY 448
IG G+ G VYK R + G A+K + + E+ + ++++ L+ VL S Y
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD------LDVVLKSHDCPY 75
Query: 449 I-----------------------LD-ILQRLN----------IMIDVTSALEYLHFGYS 474
I LD +L+R+ + + + AL YL +
Sbjct: 76 IVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+IH D+KP N LLD + L DFGI+ L S +T++ YMAP
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAP 183
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 45/142 (31%), Positives = 65/142 (45%), Gaps = 29/142 (20%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFS--CSNE---------------------DFRA 428
IG GSFG+VY AR ++ AIK +S SNE +++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 429 LVL-EYTTNGSLEKVLYSSNYILDI----LQRLNIMIDVTSALEYLHFGYSTPIIHCDLK 483
L E+T +E L S++ IL++ LQ + I AL+ L + +S IH D+K
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIK 142
Query: 484 PHNKLLDDNIVAHLSDFGIAKL 505
N LL + L+DFG A L
Sbjct: 143 AGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 39/152 (25%), Positives = 66/152 (43%), Gaps = 39/152 (25%)
Query: 390 NNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFSCSNE---DFRA-------------- 428
+IG G FG V + RL+ ++ AIK S++ DF
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 429 -------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL-HFGYS 474
++ EY NGSL+K L ++ + Q + ++ + S ++YL Y
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506
+H DL N L++ N+V +SDFG+++ L
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 6/101 (5%)
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH-FGYSTPIIHCDLKPHNK 487
+V EY NGSL+ L + ++Q + ++ + S ++YL GY +H DL N
Sbjct: 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNI 137
Query: 488 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
L++ N+V +SDFG++++L + ++ T+ I I + AP
Sbjct: 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 52/181 (28%), Positives = 69/181 (38%), Gaps = 47/181 (25%)
Query: 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKV------------------FHFSCSNED 425
+ + +G G+ GSV K RL GM FA+K + SC +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 426 FR--------------ALVLEYTTNGSLE----KVLYSSNYILD-ILQRLNIMIDVTSAL 466
+ +EY GSL+ KV I + +L + I V L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK--IAESVLKGL 118
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526
YLH S IIH D+KP N LL L DFG++ L + T T T YMA
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSF---YMA 171
Query: 527 P 527
P
Sbjct: 172 P 172
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 39/140 (27%), Positives = 58/140 (41%), Gaps = 31/140 (22%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFH-FSCSNEDFRA----------------------- 428
+G G FG V+ + + ++ AIK+ + S +DF
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 429 ----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484
+V EY NG L L L L++ DV A+EYL S IH DL
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAA 128
Query: 485 HNKLLDDNIVAHLSDFGIAK 504
N L+ ++ V +SDFG+A+
Sbjct: 129 RNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKL 488
L+L+Y G L LY + + R+ I ++ AL++LH II+ D+K N L
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137
Query: 489 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LD L+DFG++K E++ + I YMAP
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 31/77 (40%), Positives = 41/77 (53%), Gaps = 7/77 (9%)
Query: 451 DILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
DIL + I + + ALEYLH S +IH D+KP N L++ N L DFGI+ L
Sbjct: 103 DILGK--IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--- 155
Query: 511 QSMTQTQTLAIIGYMAP 527
S+ +T YMAP
Sbjct: 156 DSVAKTIDAGCKPYMAP 172
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 27/84 (32%), Positives = 38/84 (45%), Gaps = 3/84 (3%)
Query: 421 CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
C+ + +V EY +NG L L Q L + DV + YL S IH
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAK 504
DL N L+DD +SDFG+++
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 50/179 (27%), Positives = 70/179 (39%), Gaps = 47/179 (26%)
Query: 392 LIGRGSFGSVY----------------------------KARLQDGMEFAIK-------- 415
LIG GSFGSVY K + D + I
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 416 --VFHFSCS-NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG 472
V + S + D + LEY GS+ +L + + L R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM-TQTQTLAIIG---YMAP 527
+ IIH D+K N L+D+ +SDFGI+K L S T ++ G +MAP
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 42/168 (25%), Positives = 65/168 (38%), Gaps = 41/168 (24%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNE--DFRA--------------------- 428
+G G+FG VYKA+ + G+ A K+ E DF
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 429 ------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+++E+ G+L+ ++ L Q + + AL +LH S +IH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
K N LL + L+DFG++ Q IG +MAP
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRD-----TFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 33/150 (22%), Positives = 59/150 (39%), Gaps = 33/150 (22%)
Query: 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKV-----------------------------F 417
F+ +G G FG V++ ++ + AIK+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTP 476
CS + ++ E GSL L S +L + +++ V + YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506
IH DL N L+ +++V ++DFG+A+L+
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI 154
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 35/139 (25%), Positives = 60/139 (43%), Gaps = 31/139 (22%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA------------------------ 428
IG G FG+V + G + A+K + + F
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 429 --LVLEYTTNGSLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPH 485
+V+E + G+L L + ++ ++Q L +DV +EYL S ++H DL
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAAR 129
Query: 486 NKLLDDNIVAHLSDFGIAK 504
N L+ ++ VA +SDFG+A+
Sbjct: 130 NILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 51/170 (30%), Positives = 67/170 (39%), Gaps = 40/170 (23%)
Query: 392 LIGRGSFGSVYKA-RLQDGMEFAIKVF--------------------------------- 417
+IG+GSFG V A R DG +A+KV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
H+S + VL+Y G L L L+ R +V SA+ YLH S I
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I+ DLKP N LLD L+DFG+ K G + T + Y+AP
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 217 LHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI 275
L LD+ L IP+ + L+ + ++ N G +P +G++ L +D S N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 276 PTTIQGLKSLQFLSLGHNRLQGSIPNS 302
P ++ L SL+ L+L N L G +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 45/147 (30%), Positives = 59/147 (40%), Gaps = 38/147 (25%)
Query: 392 LIGRGSFGSVYKARLQ-DGMEFAIKVF--------------------------------- 417
+IG+GSFG V AR + + +A+KV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
HFS D VL+Y G L L L+ R ++ SAL YLH S I
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAK 504
++ DLKP N LLD L+DFG+ K
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 43/171 (25%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
LIGRG++G+VY+ + + G A+K+ + ++D
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+++EY GS+ ++ + + I+ +V AL+Y+H +
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVALKYIH---KVGV 122
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY-MAP 527
IH D+K N L+ + L DFG+A LL Q+ ++ T Y MAP
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 42/154 (27%), Positives = 59/154 (38%), Gaps = 36/154 (23%)
Query: 393 IGRGSFGSVYKARLQD-GMEFAIKVF------------------------HFSCSN--ED 425
IG GS+G V+K R ++ G AIK F H + N E
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 426 FRA-----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
FR LV EY + ++ L + + I+ A+ + H IH
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHR 124
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514
D+KP N L+ L DFG A++LTG T
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 421 CSNEDFRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
C+ E ++ E+ T G+L L N ++ + L + ++SA+EYL IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509
DL N L+ +N + ++DFG+++L+TG+
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 37/154 (24%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKV--------------------------------FHF 419
I RG+FG VY R + + +A+KV ++
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
S + + LV+EY G ++ +L+ Y + + I +V AL+YLH IIH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLH---RHGIIH 127
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513
DLKP N L+ + L+DFG++K+ + +M
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 5/64 (7%)
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG--EDQSMTQTQTLAIIG 523
L+Y+H S +IH DLKP N L++++ + DFG+A+ L+ + T+ +A
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 524 YMAP 527
Y AP
Sbjct: 177 YRAP 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 50/168 (29%), Positives = 71/168 (42%), Gaps = 42/168 (25%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFH------FS-----------CSNEDFRA------ 428
+G G++G VYKAR L G A+K+ FS C + + A
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 429 ------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+ +EY GSL+ + Y L LQ + + L YLH S +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQDI-YHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
K N LL DN L+DFG+A +T T + + IG +MAP
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 42/174 (24%), Positives = 67/174 (38%), Gaps = 44/174 (25%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKVFHFSCSNEDFRALV-------------------- 430
L+G+G+FG VY D G E A+K F + + + V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 431 --------------LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+EY GS++ L + + + + R + +EYLH S
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
I+H D+K N L D L DFG +K L + + T ++ G +M+P
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVTGTPYWMSP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 429 LVLEYTTNGSLEKVLYSSNYI-LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNK 487
LV+ G L+ +Y+ L++ + ++ +T + +LH S I++ D+KP N
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126
Query: 488 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LLDD LSD G+A L T TQ GYMAP
Sbjct: 127 LLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 45/169 (26%), Positives = 64/169 (37%), Gaps = 42/169 (24%)
Query: 392 LIGRGSFGSVYKARLQDGMEF-AIKVFHFS------------------------------ 420
+G G+FG V+ R + + A+KV
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 421 CSNEDFRAL--VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
+ D R L ++EY G L L +S + ++ ALEYLH S I+
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+ DLKP N LLD L+DFG AK L ++ T Y+AP
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE-----YLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 50/172 (29%), Positives = 72/172 (41%), Gaps = 41/172 (23%)
Query: 392 LIGRGSFGSVYKARLQDGME----FAIKVF-------------HFSCSNEDFRA------ 428
++G+G +G V++ R G + FA+KV H A
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 429 --LVLEYTTNGSLEKVL--YSSNYILDILQRLNIMIDVTS---------ALEYLHFGYST 475
L+ + T G L +L S + L+R I ++ T+ ALE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQ 119
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
II+ DLKP N LLD L+DFG+ K E ++T T I YMAP
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYMAP 169
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 38/153 (24%), Positives = 59/153 (38%), Gaps = 52/153 (33%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKV----------------------------FHFSCSNE 424
+G G FG V+ + A+K + CS E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQ-------RLNIMID----VTSALEYLHFGY 473
+ +V EY + GSL LD L+ RL ++D + + YL
Sbjct: 74 EPIYIVTEYMSKGSL----------LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--- 120
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506
S IH DL N L+ +N+V ++DFG+A+L+
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 43/155 (27%), Positives = 63/155 (40%), Gaps = 36/155 (23%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKVF------------------------HFSCSN--E 424
L+G GS+G V K + ++ G AIK F H + N E
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 425 DFRA-----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
FR LV E+ + L+ + N LD + + + +E+ H S IIH
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH---SHNIIH 123
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514
D+KP N L+ + V L DFG A+ L + T
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 63 IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIW 122
+D L L + L P + +S ++L+ +++S N + G +P +G+ + SLE +
Sbjct: 419 FIDGLGLDNQGLRGFIP-----NDISKLRHLQSINLSGNSIRGNIPPSLGSIT-SLEVLD 472
Query: 123 MSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLG 161
+S + +G I E +G LT L ++L GN L+G + LG
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 42/170 (24%), Positives = 63/170 (37%), Gaps = 38/170 (22%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNE--------DFRALV----------L 431
N IG G++G VY+AR G A+K + + L+
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 432 EYTTNGSLEKVLYSSNYILDILQRL--------------NIMIDVTSALEYLHFGYSTPI 477
E L+ + Y L L +M+ + L+YLH + I
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---I 129
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
IH DLK N LL D ++DFG+A+ + M T + + Y AP
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 12/101 (11%)
Query: 431 LEYTTNGSL-EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489
+EY G+L +K++ + + L + + SA+ Y+H I+H D+K N L
Sbjct: 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFL 134
Query: 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
+ L DFGI+K+L G + SM +T ++G YM+P
Sbjct: 135 TKAGLIKLGDFGISKIL-GSEYSMAET----VVGTPYYMSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 429 LVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNK 487
+V+EY G+L + + N +LD L+ + + AL ++H + I+H DLK N
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNI 132
Query: 488 LLDDN-IVAHLSDFGIAKLLTGEDQSMT 514
LLD + +V + DFGI+K+L+ + ++ T
Sbjct: 133 LLDKHKMVVKIGDFGISKILSSKSKAYT 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 44/164 (26%), Positives = 64/164 (39%), Gaps = 38/164 (23%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA------------------------ 428
IG+G FG V + G + A+K + + F A
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 429 ----LVLEYTTNGSLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLK 483
+V EY GSL L S +L L +DV A+EYL + +H DL
Sbjct: 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLA 129
Query: 484 PHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
N L+ ++ VA +SDFG+ K + S TQ + + AP
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 29/169 (17%)
Query: 387 FSANNLIGRGSFGSVYKARLQDGMEF-AIKVFHFSCSNEDFRALVLE------------- 432
F ++G G++G V K R ++ E AIK F S NE+ + L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 433 ------YTTNGSLEKVL-YSSNYILDILQRL-------NIMIDVTSALEYLHFGYSTPII 478
+ G L V Y +L++L+ + + + ++ +H+ + I+
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
H D+KP N L+ N V L DFG A+ L+ E + T+ +A Y +P
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSP 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 43/156 (27%), Positives = 65/156 (41%), Gaps = 43/156 (27%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------- 416
D F +IGRG+FG V+ R G +A+KV
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH- 470
++S +E+ LV+EY G L +L + + R I ++ AL+ +H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHK 119
Query: 471 FGYSTPIIHCDLKPHNKLLDDNIVAH--LSDFGIAK 504
G+ IH D+KP N L+D H L+DFG+ K
Sbjct: 120 LGF----IHRDIKPDNILID--ADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 17/141 (12%)
Query: 369 QASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS--CSNEDF 426
+ +R+RF+ +++ + NLI R V+ R D + FA F S CS E
Sbjct: 23 KETRQRFAMKKINK-------QNLILRNQIQQVFVER--DILTFAENPFVVSMFCSFETK 73
Query: 427 RAL--VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484
R L V+EY G +L + + + R+ V ALEYLH + I+H DLKP
Sbjct: 74 RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLH---NYGIVHRDLKP 129
Query: 485 HNKLLDDNIVAHLSDFGIAKL 505
N L+ L+DFG++K+
Sbjct: 130 DNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 43/185 (23%), Positives = 73/185 (39%), Gaps = 55/185 (29%)
Query: 391 NLIGRGSFGSVYKARLQ-DG--MEFAIKVFH----------------------------- 418
++IG G+FG V +A ++ DG M AIK+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 419 --FSCSNEDFRALVLEYTTNGSLEKVLYSSNYI---------------LDILQRLNIMID 461
+C N + + +EY G+L L S + L Q L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI 521
V + ++YL IH DL N L+ +N+ + ++DFG+++ GE+ + +T
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 522 IGYMA 526
+ +MA
Sbjct: 182 VRWMA 186
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 417 FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
H++ E L+L+Y + G + LY + + R ++ ALE+LH
Sbjct: 70 LHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH---KLG 125
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I++ D+K N LLD L+DFG++K E++ T + I YMAP
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 42/168 (25%)
Query: 393 IGRGSFGSVYKAR--------------LQDGMEFAIK----VFHFSCSNEDFRA------ 428
IG G++G VYKAR L+ G +FA+ + C + + A
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 429 ------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+ +E+ GSL+ + + + L I L+ L++ +S +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
K N LL DN L+DFG++ +T T + + IG +MAP
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA-----TIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 37/172 (21%), Positives = 63/172 (36%), Gaps = 53/172 (30%)
Query: 387 FSANNLIGRGSFGSVYKARL-QDGMEF------AIKVFHFSCSN-EDFRA---------- 428
++G G FGSV + +L QD +K+ + S E+F +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 429 -----------------------LVLEYTTNGSLEKVLYSS-------NYILDILQRLNI 458
++L + +G L L S L L L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL--LKF 118
Query: 459 MIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
M+D+ +EYL + IH DL N +L +++ ++DFG++K + D
Sbjct: 119 MVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 43/168 (25%)
Query: 393 IGRGSFGSVYKA-RLQDGMEFAIKVFHFSCS-------NE-------------------- 424
IG+G+ G+VY A + G E AIK + NE
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 425 --DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
D +V+EY GSL V+ + +D Q + + ALE+LH S +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
K N LL + L+DFG +T E Q++ ++G +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 50/179 (27%)
Query: 392 LIGRGSFGSVYKA-------------------------RLQDGMEFAIK----------- 415
LIG+G++G VY A Q M A++
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 416 ---VFHFSCSN-EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF 471
V + E++ ++ LEY GS+ L + + L R V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL---LTGEDQSMTQTQTLAIIGYMAP 527
S I+H DLK N L+D + + +SDFGI+K + DQ+M+ + + +MAP
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS---VFWMAP 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 44/183 (24%), Positives = 71/183 (38%), Gaps = 58/183 (31%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIK---------------------------------- 415
IG G++G+VYKAR L G A+K
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 416 ----VFHFSCSNEDFR-ALVLEYTT---NGSLEKVL---YSSNYILDILQRLNIMIDVTS 464
V H ++ + + LV E+ L K I D++++L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL------LR 118
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524
+++LH S I+H DLKP N L+ + ++DFG+A++ + E M T + + Y
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWY 172
Query: 525 MAP 527
AP
Sbjct: 173 RAP 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 44/187 (23%), Positives = 67/187 (35%), Gaps = 58/187 (31%)
Query: 393 IGRGSFGSVYKARL------QDGMEFAIKV-----------------------------F 417
+G G+FG V+ A QD M A+K F
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVLYSSN---YILD-----------ILQRLNIMIDVT 463
+ C+ +V EY +G L + L S IL + Q L I +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 464 SALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
S + YL HF +H DL N L+ +V + DFG+++ + D +T+
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 521 IIGYMAP 527
I +M P
Sbjct: 187 PIRWMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 39/164 (23%), Positives = 66/164 (40%), Gaps = 34/164 (20%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFH---------------------------FSCSNED 425
+G+G FG V+ AIK ++ +E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 426 FRALVLEYTTNGSLEKVLY-SSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484
+V EY + GSL L L + Q +++ + S + Y+ +H DL+
Sbjct: 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRA 130
Query: 485 HNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
N L+ +N+V ++DFG+A+L+ ED T Q I + AP
Sbjct: 131 ANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 18/122 (14%)
Query: 421 CSNEDFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSA 465
C+ E ++ EY +G L + L ++ LD L+I I + +
Sbjct: 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAG 136
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525
+EYL S +H DL N L+ + + +SDFG+++ + D Q+++L + +M
Sbjct: 137 MEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWM 193
Query: 526 AP 527
P
Sbjct: 194 PP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 39/169 (23%), Positives = 62/169 (36%), Gaps = 59/169 (34%)
Query: 391 NLIGRGSFGSVYKARLQD-GMEFAIK---------------------------------- 415
+ +G G++G V A G + AIK
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 416 -VFHFSCSNEDFRA--LVLEYTTNGSLEKVLYSSNYILDILQRLN------IMIDVTSAL 466
VF + S EDF+ LV L ++ Q+L+ ++ + L
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGL 131
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
+Y+H S IIH DLKP N ++++ + DFG+A+ D MT
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTG 174
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 39/166 (23%), Positives = 71/166 (42%), Gaps = 39/166 (23%)
Query: 392 LIGRGSFGSVYKARL-QDGME---FAIKVFHFSCSNE---DFRA---------------- 428
+IG G FG V + RL G AIK + + DF +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
++ E+ NG+L+ L ++ ++Q + ++ + + ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG 523
+H DL N L++ N+V +SDFG+++ L ED + T T ++ G
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGG 171
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 55/185 (29%)
Query: 391 NLIGRGSFGSVYKARL-QDG--MEFAIK-----------------------------VFH 418
++IG G+FG V KAR+ +DG M+ AIK + +
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 419 F--SCSNEDFRALVLEYTTNGSLEKVLYSSNYI---------------LDILQRLNIMID 461
+C + + L +EY +G+L L S + L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI 521
V ++YL IH DL N L+ +N VA ++DFG+++ G++ + +T
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186
Query: 522 IGYMA 526
+ +MA
Sbjct: 187 VRWMA 191
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 12/106 (11%)
Query: 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489
V EY +L +VL +++ L + +M+ V AL H + I+H DLKP N ++
Sbjct: 57 VFEYVPGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMV 112
Query: 490 ---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA--IIG---YMAP 527
A + DFGI LL G + T T ++G Y AP
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 54/186 (29%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
S+N+ G V + +LS L +L LS+N L+ P+ +
Sbjct: 483 SRNQFSGAVPRKLGSLSELM------------------QLKLSENKLSGEIPD-----EL 519
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDL 147
S+CK L LD+S N L G +P +FS E +S +DL
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIP---ASFS---EMPVLSQ-------------------LDL 554
Query: 148 GGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTC 207
N+L+G I LG ++ L ++ N L GS+P+ LA+ + ++G+I C
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI------NASAVAGNIDLC 608
Query: 208 FGNLTA 213
G+ T+
Sbjct: 609 GGDTTS 614
|
Length = 968 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 19/47 (40%), Positives = 27/47 (57%)
Query: 284 SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330
+L+ L L +NRL +F L +L+ LDLS NNL+ I P + L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGL 47
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 1e-04
Identities = 24/82 (29%), Positives = 29/82 (35%), Gaps = 23/82 (28%)
Query: 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG 273
L++L L +N LT IP L L +D S NNL
Sbjct: 2 LKSLDLSNNRLTVIP-----------------------DGAFKGLPNLKVLDLSGNNLTS 38
Query: 274 DIPTTIQGLKSLQFLSLGHNRL 295
P GL SL+ L L N L
Sbjct: 39 ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 208 FGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV-LTRIDF 266
NL L +L L+ N L S S L L ++ LD +N + +P IG LK L +D
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNN-ITDIPPLIGLLKSNLKELDL 147
Query: 267 SRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 326
S N + +P+ ++ L +L+ L L N L +P +L +L +LDLS N +S+ +P
Sbjct: 148 SDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPE 204
Query: 327 LEKLLYLNILLI 338
+E L L L +
Sbjct: 205 IELLSALEELDL 216
|
Length = 394 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 41/152 (26%), Positives = 60/152 (39%), Gaps = 51/152 (33%)
Query: 393 IGRGSFGSVYKARLQDGMEF-AIKVF-----HFS-CSN--------------------ED 425
+G G+FGSVY AR ++ E AIK + C N E
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 426 FRA-----LVLEYTTNGSLEKVLYSSNYILDILQRL-------NIMIDVTSALEYLH-FG 472
FR V EY +E LY + D + +I+ + L ++H G
Sbjct: 67 FRENDELYFVFEY-----MEGNLY--QLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
+ H DLKP N L+ V ++DFG+A+
Sbjct: 120 F----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 26/100 (26%), Positives = 50/100 (50%), Gaps = 4/100 (4%)
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKL 488
++ EY NG+L+K L + Q + ++ + + ++YL +H DL N L
Sbjct: 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNIL 139
Query: 489 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
++ N+ +SDFG++++L + + T I I + AP
Sbjct: 140 VNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 449 ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT- 507
IL+ + + IM + AL+Y+H S +IH DLKP N LL+ + L+DFG+A+ L+
Sbjct: 103 ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 508 --GEDQSMTQTQTLAIIGYMAP 527
++ T +A Y AP
Sbjct: 160 LEENPENPVLTDYVATRWYRAP 181
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 15/74 (20%)
Query: 439 LEKVLYSSNYILDILQRL---------NIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489
LEK++ ++ +I +R+ NIM D+ + LEY+H I H D+KP N ++
Sbjct: 106 LEKLVENTK---EIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159
Query: 490 DDNIVAHLSDFGIA 503
D N ++ D+GIA
Sbjct: 160 DGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 49/164 (29%)
Query: 387 FSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFH---FSCSN-EDF------------ 426
F+ ++G+G FGSV +A+L+ + A+K+ FS S+ E+F
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 427 -------------RA--------LVLEYTTNGSLEKVLYSSN-----YILDILQRLNIMI 460
RA ++L + +G L L S + L + + MI
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 461 DVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
D+ S +EYL S IH DL N +L++N+ ++DFG++K
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 45/179 (25%)
Query: 387 FSANN---LIGRGSFGSVYKAR-LQDGMEFAIK-----------------VFHF------ 419
+ N ++G+G++G VY AR L + AIK H
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 420 ------SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMI----DVTSALEYL 469
S S F + +E GSL +L S L +I + L+YL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLK--DNEQTIIFYTKQILEGLKYL 124
Query: 470 HFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
H I+H D+K N L++ + V +SDFG +K L G + T+T T + YMAP
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 20/181 (11%)
Query: 66 ELSLSDNYLTSSTPEL-SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQS--LEFIW 122
EL LS N L S L ++ L++LD+S N L V+ + +S L+ +
Sbjct: 55 ELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELK 114
Query: 123 MSDCNISGGISEEIG-----NLTDLISIDLGGNKLNGSISITLGKL----QKLQFLSFRG 173
+++ + + L + LG N+L G+ L K + L+ L+
Sbjct: 115 LNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLAN 174
Query: 174 NELEGSIPNVLC----HLAVLFQLDLRGNKL----SGSIPTCFGNLTALRNLHLDSNELT 225
N + + L L LDL N L + ++ +L +L L+L N LT
Sbjct: 175 NGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234
Query: 226 S 226
Sbjct: 235 D 235
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 35/143 (24%), Positives = 54/143 (37%), Gaps = 33/143 (23%)
Query: 392 LIGRGSFGSVYKARLQDGMEFAIKV----------FHF--------------------SC 421
L+G+G+FG V+K L+D A+K F C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 422 SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
+ +V+E G L L Q + +D + + YL S IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 482 LKPHNKLLDDNIVAHLSDFGIAK 504
L N L+ +N V +SDFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 44/179 (24%)
Query: 359 KLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSV-----------YKARL- 406
K N+ N + + +L + F +IGRG+FG V Y +L
Sbjct: 17 KNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL 76
Query: 407 -----------------QDGMEFA----IKVFHFSCSNEDFRALVLEYTTNGSLEKVLYS 445
+D M A I H++ ++ + +V+EY G L V
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL--VNLM 134
Query: 446 SNYILDILQRLNIM--IDVTSALEYLH-FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501
SNY DI ++ +V AL+ +H G+ IH D+KP N LLD + L+DFG
Sbjct: 135 SNY--DIPEKWARFYTAEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 27/76 (35%), Positives = 38/76 (50%), Gaps = 5/76 (6%)
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKL 488
L++EY GSL L L++ Q L + + YLH S IH DL N L
Sbjct: 85 LIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVL 139
Query: 489 LDDNIVAHLSDFGIAK 504
LD++ + + DFG+AK
Sbjct: 140 LDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 48/174 (27%), Positives = 71/174 (40%), Gaps = 42/174 (24%)
Query: 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVF------------HFS------------- 420
F +G GSFG V A+ + G +AIK H +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 421 -----CSNEDFRAL--VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
CS +D + +LE+ G L L + + + + ++ A EYLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLH--- 135
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S II+ DLKP N LLD+ ++DFG AK + D++ T T Y+AP
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGTPE---YLAP 184
|
Length = 329 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 32/126 (25%), Positives = 53/126 (42%), Gaps = 18/126 (14%)
Query: 417 FHFSCSNEDFRALVLEYTTNGSLEKVLYS---------------SNYILDILQRLNIMID 461
F+ C + D +V EY +G L K L + + L + Q L+I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI 521
+ S + YL S +H DL N L+ N++ + DFG+++ + D T+
Sbjct: 132 IASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 522 IGYMAP 527
I +M P
Sbjct: 189 IRWMPP 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 37/142 (26%), Positives = 60/142 (42%), Gaps = 30/142 (21%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALV---------LEYTTNGSLEKV 442
IG G++G VYK R + G A+K E + L++ L+ V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 443 LYSSNYILDILQRLNI-------------MIDVTSALEYLH-------FGYSTPIIHCDL 482
L + + I + L++ +D YL+ F +S ++H DL
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDL 127
Query: 483 KPHNKLLDDNIVAHLSDFGIAK 504
KP N L+D+ V L+DFG+A+
Sbjct: 128 KPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 45/163 (27%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKV--------------------------------FH 418
L+G+G G V+ RL+ G FA+KV +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVL--YSSNYILDILQRLNIMIDVTSALEYLH-FGYST 475
S E + LV++Y G L ++L + + + R +V ALEYLH G
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLG--- 123
Query: 476 PIIHCDLKPHNKLL--DDNIVAHLSDFGIAKLLTGEDQSMTQT 516
I++ DLKP N LL +I+ LSDF ++K E +++
Sbjct: 124 -IVYRDLKPENILLHESGHIM--LSDFDLSKQSDVEPPPVSKA 163
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 25/62 (40%), Positives = 36/62 (58%), Gaps = 4/62 (6%)
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525
L+YLH S I+H D+KP N L++ N V + DFG+A+ + D+S TQ + Y
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYR 171
Query: 526 AP 527
AP
Sbjct: 172 AP 173
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 27/68 (39%), Positives = 37/68 (54%), Gaps = 8/68 (11%)
Query: 461 DVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTL 519
++T LE LH I++ DLKP N LLDD +SD G+A ++ GE T +
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRV 162
Query: 520 AIIGYMAP 527
+GYMAP
Sbjct: 163 GTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 26/67 (38%), Positives = 38/67 (56%), Gaps = 7/67 (10%)
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLA 520
+ S LE+LH II+ DLKP N LLD++ +SD G+A +L G+ ++ T
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT-- 160
Query: 521 IIGYMAP 527
G+MAP
Sbjct: 161 -PGFMAP 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 48/177 (27%)
Query: 387 FSANNLIGRGSFGSVYKA---RLQDGMEFAIKVFHFSCSNEDFRAL-------------- 429
F+ IG+GSFG V+K R Q + AIK+ + ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVV--AIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 430 ----------------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
++EY GS +L + + D Q ++ ++ L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH--- 118
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
S IH D+K N LL + L+DFG+A LT TQ + +G +MAP
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-----TQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 42/174 (24%)
Query: 387 FSANNLIGRGSFGSVYKA---RLQDGMEFAIKVFHFSCSNEDFRAL-------------- 429
F+ IG+GSFG V+K R Q + AIK+ + ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVV--AIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 430 ----------------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
++EY GS +L LD Q I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S IH D+K N LL ++ L+DFG+A LT D + + + +MAP
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 36/159 (22%), Positives = 56/159 (35%), Gaps = 49/159 (30%)
Query: 390 NNLIGRGSFGSVYKAR-LQDGMEFAIKV---------------------FHFSCSNE--- 424
+G G++G V KA G AIK HF+ E
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 425 -------------------DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSA 465
DF LV++ L+KV+ L Q I++ + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV-DRKIRLTESQVKCILLQILNG 131
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
L LH Y +H DL P N ++ + ++DFG+A+
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 25/67 (37%), Positives = 32/67 (47%), Gaps = 6/67 (8%)
Query: 461 DVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
+ LE+LH I++ DLKP N LLDD+ +SD G+A L G
Sbjct: 103 QIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAG 156
Query: 521 IIGYMAP 527
GYMAP
Sbjct: 157 TPGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 6/67 (8%)
Query: 461 DVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
++ LE LH I++ DLKP N LLDD+ +SD G+A + E Q++ +
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVG 163
Query: 521 IIGYMAP 527
+GYMAP
Sbjct: 164 TVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 53/161 (32%)
Query: 392 LIGRGSFGSVYKARLQDGME--FAIKVFHFSC---------SNEDFRALVLEYTTNGSLE 440
+G G+FG VYK R ++ + A+K + ++ +V E T ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI---IK 63
Query: 441 KVLYSSN--------------YIL-DILQ---------------------RL-NIMIDVT 463
+ L N YI+ D+++ R+ NI + +
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 464 SALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
AL YLH I+H DL P+N +L ++ ++DFG+AK
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 4e-04
Identities = 21/59 (35%), Positives = 24/59 (40%)
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
L S+DL N+L L L+ L GN L P L L LDL GN L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 34/170 (20%)
Query: 387 FSANNLIGRGSFGSVYKARLQDGMEF-AIKVFHFSCSNEDFRALVLEYTTNGSLEK---V 442
F+ IG+GSFG VYK E AIK+ + ++ + E T +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 443 LYSSNYI-----------------LDILQR--------LNIMIDVTSALEYLHFGYSTPI 477
Y +Y+ LD+L+ I+ ++ L+YLH S
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERK 122
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
IH D+K N LL + L+DFG+A LT D + + + +MAP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 29/144 (20%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSC--SNEDFRALV------------------- 430
IG GSFG+VY AR +++ AIK +S SNE ++ ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 431 ---LEYTTNGSLEKVLYSSNYILDI----LQRLNIMIDVTSALEYLHFGYSTPIIHCDLK 483
E+T +E L S++ +L++ LQ + I AL+ L + +S +IH D+K
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 484 PHNKLLDDNIVAHLSDFGIAKLLT 507
N LL + + L DFG A ++
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIMA 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 42/159 (26%), Positives = 63/159 (39%), Gaps = 51/159 (32%)
Query: 393 IGRGSFGSVYKARLQ---DGMEFAIKVFHFSCSNED------------FRALVLEYTTNG 437
IGRG++G VYKA+ + DG E+AIK F R L E
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVV-- 65
Query: 438 SLEKVLYSSN----YIL------DILQRLN-----------------IMIDVTSALEYLH 470
SL +V Y+L D+ Q + ++ + + + YLH
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125
Query: 471 FGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKL 505
S ++H DLKP N L+ + V + D G+A+L
Sbjct: 126 ---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 42/183 (22%), Positives = 66/183 (36%), Gaps = 47/183 (25%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFH-FSCSNEDFRA------------- 428
F IG+G F VYKA L DG A+K F + R
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 429 ------------------LVLEYTTNGSLEKVL---YSSNYILDILQRLNIMIDVTSALE 467
+VLE G L +++ ++ + + SALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---Y 524
++H S I+H D+KP N + V L D G+ + + + T +++G Y
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYY 172
Query: 525 MAP 527
M+P
Sbjct: 173 MSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 5e-04
Identities = 21/60 (35%), Positives = 25/60 (41%)
Query: 165 KLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNEL 224
L+ L N L L L LDL GN L+ P F L +LR+L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 51/176 (28%)
Query: 392 LIGRGSFGSVYKARLQDGME----FAIKVF------------------------------ 417
++G+GSFG V+ R G + +A+KV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 418 -HFSCSNEDFRALVLEYTTNGSL-----EKVLYSSNYILDILQRLNIMIDVTSALEYLHF 471
H++ E L+L++ G L ++V+++ + L L + AL++LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------ALDHLH- 115
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S II+ DLKP N LLD+ L+DFG++K D + YMAP
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 36/153 (23%), Positives = 64/153 (41%), Gaps = 42/153 (27%)
Query: 385 DGFSANNLIGRGSFGSVYKARLQD-GMEFAIKV--------------------------- 416
D F +IGRG+FG V ++++ G +A+K+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYS-SNYILDILQRLNI--MIDVTSALEY 468
H++ +E+ LV++Y G L +L + + + + R + M+ ++
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501
L + +H D+KP N LLD N L+DFG
Sbjct: 121 LGY------VHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 47/177 (26%), Positives = 71/177 (40%), Gaps = 56/177 (31%)
Query: 382 RATDGFSANNLIGRGSFGSVYKARLQDGMEFA---------------------IKVF--- 417
R D F IG G++G VYKAR +D E IK+
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 418 -HFSCSN-----------EDFRA------LVLEYTTN---GSLEK--VLYSSNYILDILQ 454
H + N DF+ LV EY + G LE V +S ++I ++
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 455 RLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
+L LE L++ + +H D+K N LL++ L+DFG+A+L E+
Sbjct: 124 QL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 40/172 (23%), Positives = 61/172 (35%), Gaps = 39/172 (22%)
Query: 390 NNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA--------------------- 428
IG G FG VY+ I V +C N +
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 429 ------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+V+E G L L + Y LD+ + +++AL YL S
Sbjct: 71 KLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKR 127
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+H D+ N L+ L DFG+++ L ED+S + + I +MAP
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAP 177
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 46/168 (27%), Positives = 67/168 (39%), Gaps = 52/168 (30%)
Query: 393 IGRGSFGSVYKAR-------------------------------LQDGMEFAIKVFHFSC 421
IG GSFG +Y A+ L M+ V F+
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 422 SNEDFRA-LVLEYTTNGSLEK-------VLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
E+ R +V+EY G L K VL+S + IL + + ++ L+++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL------SWFVQISLGLKHIH--- 118
Query: 474 STPIIHCDLKPHNKLLDDN-IVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
I+H D+K N L N +VA L DFGIA+ L + SM T
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCV 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 41/179 (22%), Positives = 76/179 (42%), Gaps = 43/179 (24%)
Query: 385 DGFSANNLIGRGSFGSVYKARLQDGME-FAIKVF-------------------------- 417
D F +IGRG+FG V +++ +A+K+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 418 ------HFSCSNEDFRALVLEYTTNGSLEKVLYS-SNYILDILQRLNI--MIDVTSALEY 468
H++ +E++ LV++Y G L +L + + + + R I M+ ++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LH+ +H D+KP N LLD N L+DFG + L +D ++ + + Y++P
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 47/174 (27%), Positives = 69/174 (39%), Gaps = 48/174 (27%)
Query: 393 IGRGSFGSVYKARLQD-GMEFAIKV----------------------------------- 416
IG+G+FG VY+ R +D +A+KV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 417 --FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS 474
F F ++ + LV +Y + G L L + + I ++ ALE+LH
Sbjct: 61 LKFSFQTDSDLY--LVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---K 114
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL-LTGEDQSMTQTQTLAIIGYMAP 527
I++ DLKP N LLD L DFG++K LT + T T Y+AP
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTE---YLAP 165
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 51/208 (24%), Positives = 75/208 (36%), Gaps = 66/208 (31%)
Query: 368 PQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKA--RLQDG----MEFAIKVFHFSC 421
P+ R LLRA +G G+FG VY+ R +DG ++ A+K SC
Sbjct: 1 PEVPRDSI---TLLRA---------LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC 48
Query: 422 SNE---DF---------------------------RALVLEYTTNGSLEKVLYSSN---- 447
S + DF R ++LE G L+ L +
Sbjct: 49 SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE 108
Query: 448 --YILDILQRLNIMIDVTSALEYL---HFGYSTPIIHCDLKPHNKLLDD---NIVAHLSD 499
L + L DV +YL HF IH D+ N LL VA ++D
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIAD 162
Query: 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
FG+A+ + + + I +M P
Sbjct: 163 FGMARDIYRASYYRKGGRAMLPIKWMPP 190
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 19/50 (38%), Positives = 30/50 (60%), Gaps = 3/50 (6%)
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
L+Y+H S ++H DLKP N LL+ N + DFG+A+ + + MT+
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 35/112 (31%), Positives = 51/112 (45%), Gaps = 7/112 (6%)
Query: 417 FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMI-DVTSALEYLHFGYST 475
H++ + L+L+Y G L L + Q + I ++ ALE+LH
Sbjct: 70 LHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH---KL 124
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
II+ D+K N LLD N L+DFG++K ED+ I YMAP
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 29/150 (19%)
Query: 387 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSC--SNEDFRALV------------- 430
F+ IG GSFG+VY AR ++ AIK +S SNE ++ ++
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 431 ---------LEYTTNGSLEKVLYSSNYILDI----LQRLNIMIDVTSALEYLHFGYSTPI 477
E+T +E L S++ +L++ LQ + I AL+ L + +S +
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507
IH D+K N LL + L+DFG A + +
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIAS 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 7/99 (7%)
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKL 488
+V+EY GSL V+ + +D Q + + ALE+LH S +IH D+K N L
Sbjct: 94 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 148
Query: 489 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L + L+DFG +T E ++ + +MAP
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 39/144 (27%), Positives = 57/144 (39%), Gaps = 35/144 (24%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYI-- 449
IG G++G VYKAR G A+K E + + SL K L N +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI---SLLKELNHPNIVKL 64
Query: 450 LDIL--------------QRLNIMIDVTSALE--------YLH-------FGYSTPIIHC 480
LD++ Q L +D + YL F +S ++H
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAK 504
DLKP N L++ L+DFG+A+
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 39/164 (23%), Positives = 66/164 (40%), Gaps = 34/164 (20%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFH---------------------------FSCSNED 425
+G+G FG V+ + AIK ++ +E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 426 FRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484
+V E+ GSL L + L + Q +++ + + Y+ IH DL+
Sbjct: 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRA 130
Query: 485 HNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
N L+ DN+V ++DFG+A+L+ ED T Q I + AP
Sbjct: 131 ANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 31/117 (26%), Positives = 55/117 (47%), Gaps = 14/117 (11%)
Query: 421 CSNEDFRALVLEYTTNGSLEKVL-----YS----SNYI--LDILQRLNIMIDVTSALEYL 469
C ++D ++ EY NG L + L S +N I + I L + + + S ++YL
Sbjct: 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145
Query: 470 HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526
S +H DL N L+ ++ ++DFG+++ L D Q + + I +MA
Sbjct: 146 A---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA 199
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 22/74 (29%), Positives = 38/74 (51%), Gaps = 7/74 (9%)
Query: 456 LNIMIDVTSALEYL--HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513
L+I I + + +EYL HF +H DL N L+ + + +SD G+++ + D
Sbjct: 127 LHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 514 TQTQTLAIIGYMAP 527
Q ++L I +M P
Sbjct: 182 VQPKSLLPIRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 13/102 (12%)
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKL 488
+V+EY GSL V+ + +D Q + + ALE+LH + +IH D+K N L
Sbjct: 93 VVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVL 147
Query: 489 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
L + L+DFG +T E Q++ ++G +MAP
Sbjct: 148 LGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 39/145 (26%), Positives = 57/145 (39%), Gaps = 37/145 (25%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVF--HFSCSNED--------FRAL-----------V 430
IG G+F V KA+ + G +AIK HF + R L V
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 431 LEYTTNGSLEKV-------LY----SSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
L G L V LY L + + M + +L+++H I H
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFH 123
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAK 504
D+KP N L+ D+I+ L+DFG +
Sbjct: 124 RDIKPENILIKDDIL-KLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 49/173 (28%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFSCSNEDFRALV--------------------- 430
+G+G++GSVYK + G+ A+K F ++
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 431 ---------LEYTTNGSLEKVLYSSNYIL----DILQRLNIMIDVTSALEYLHFGYSTPI 477
+EY GSL+K+ D+L+R I V L++L ++ I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEHN--I 124
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
IH D+KP N L++ N L DFG++ L S+ +T IG YMAP
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAP 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 36/144 (25%)
Query: 393 IGRGSFGSVYKARLQDGMEF-AIKVFHFSCSNED-----FR------------------- 427
IG G++G+V+KA+ ++ E A+K +E R
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 428 -------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
LV EY + L+K S N +D + M + L + H S ++H
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAK 504
DLKP N L++ N L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKL 488
LV+E + G L K L + + + +M V+ ++YL +H DL N L
Sbjct: 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVL 127
Query: 489 LDDNIVAHLSDFGIAKLLTGED 510
L + A +SDFG++K L +D
Sbjct: 128 LVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 429 LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNK 487
+V EY + GSL L L + +++ V + + Y+ IH DL+ N
Sbjct: 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANI 133
Query: 488 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
L+ D +V ++DFG+A+L+ ED T Q I + AP
Sbjct: 134 LVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 9/111 (8%)
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
++ +D LVL G L+ +Y+ N + + L ++ LE LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENT 123
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLAIIGYMAP 527
++ DLKP N LLDD +SD G+A K+ GE + + +GYMAP
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 42/147 (28%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFSCSNE---DFRA-------------------- 428
IGRG+FG V+ RL+ D A+K SC D +A
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 58
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+V+E G L + L + + + ++ + + +EYL S
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHC 115
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAK 504
IH DL N L+ + V +SDFG+++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 47/185 (25%), Positives = 76/185 (41%), Gaps = 55/185 (29%)
Query: 391 NLIGRGSFGSVYKARLQ-DG--MEFAIKVF-----------------------HF----- 419
++IG G+FG V KAR++ DG M+ AIK H
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 420 ---SCSNEDFRALVLEYTTNGSLEKVLYSSNYI---------------LDILQRLNIMID 461
+C + + L +EY +G+L L S + L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI 521
V ++YL IH DL N L+ +N VA ++DFG+++ G++ + +T
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 522 IGYMA 526
+ +MA
Sbjct: 175 VRWMA 179
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 19/49 (38%), Positives = 31/49 (63%), Gaps = 6/49 (12%)
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514
L+Y+H S ++H DLKP N L+++N + DFG+A++ +D MT
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMT 163
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 42/180 (23%), Positives = 78/180 (43%), Gaps = 45/180 (25%)
Query: 385 DGFSANNLIGRGSFGSVYKARLQDGME-FAIKVF-------------------------- 417
+ F +IGRG+FG V +L++ + FA+K+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 418 ------HFSCSNEDFRALVLEYTTNGSLEKVLYS-SNYILDILQRLNI--MIDVTSALEY 468
H++ +E+ LV++Y G L +L + + + + R + M+ ++
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG-IAKLLTGEDQSMTQTQTLAIIGYMAP 527
LH+ +H D+KP N L+D N L+DFG KL+ ED ++ + + Y++P
Sbjct: 121 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 38/147 (25%), Positives = 56/147 (38%), Gaps = 38/147 (25%)
Query: 392 LIGRGSFGSVYKARLQDGME-FAIKVFH-------------------------------- 418
++G+GSFG V A L+ E +A+KV
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 419 FSC-SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
SC +D V+EY G L + S D + ++ L++LH I
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGI 117
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAK 504
I+ DLK N LLD ++DFG+ K
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 43/168 (25%)
Query: 393 IGRGSFGSVYKA-RLQDGMEFAIKVFHFSCS-------NE-------------------- 424
IG+G+ G+VY A + G E AIK + NE
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 425 --DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
D +V+EY GSL V+ + +D Q + + AL++LH S +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
K N LL + L+DFG +T E Q++ ++G +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 47/170 (27%), Positives = 64/170 (37%), Gaps = 40/170 (23%)
Query: 392 LIGRGSFGSVYKARLQDGME-FAIKVF--------------------------------- 417
++G+GSFG V A L+ E +AIKV
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
H +D V+EY G L + S + R +VT AL +LH +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RHGV 117
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I+ DLK N LLD L+DFG+ K G +T T Y+AP
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.003
Identities = 19/56 (33%), Positives = 23/56 (41%), Gaps = 1/56 (1%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLF 247
LDL N+L+ F L L+ L L N LTSI L + LD N
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.003
Identities = 11/26 (42%), Positives = 15/26 (57%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFH 418
I S V++A L+DG E A+KV
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVKVQR 44
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 46/171 (26%), Positives = 69/171 (40%), Gaps = 42/171 (24%)
Query: 392 LIGRGSFGSVYKARLQDGMEF-AIKVF-------------------------------HF 419
++G+GSFG V A L+ EF AIK H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 420 SCS--NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
C+ ++ V+EY G L + SS D + ++ L++LH I
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KKGI 117
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKL-LTGEDQSMTQTQTLAIIGYMAP 527
I+ DLK N LLD + ++DFG+ K + GE ++ T T Y+AP
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT---PDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 23/64 (35%), Positives = 35/64 (54%), Gaps = 4/64 (6%)
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLAIIG 523
L+Y+H S ++H DLKP N LL+ N + DFG+A++ D + T+ +A
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 524 YMAP 527
Y AP
Sbjct: 175 YRAP 178
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 42/147 (28%), Positives = 60/147 (40%), Gaps = 38/147 (25%)
Query: 392 LIGRGSFGSVYKARL-QDGMEFAIKVFH---------FSCSNEDFRAL------------ 429
++G+GSFG V ARL + G +A+KV C+ + R L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 430 ------------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
V+E+ G L + S + R ++TSAL +LH I
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DKGI 117
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAK 504
I+ DLK N LLD L+DFG+ K
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 38/169 (22%), Positives = 66/169 (39%), Gaps = 37/169 (21%)
Query: 392 LIGRGSFGSVYKA-RLQDG----MEFAIKVFHFSCSNEDFRA------------------ 428
L+G G FG+V+K + +G + AIK + F+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
LV + + GSL + LD + LN + + + YL +
Sbjct: 74 LLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRM 130
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526
+H +L N LL + + ++DFG+A LL +D+ ++ I +MA
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 11/105 (10%)
Query: 429 LVLEYTTNGSLEKVLYSSNYI------LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
LV+E+ G L+ L S LQR+ ++ L +LH IH DL
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH---KNNFIHSDL 126
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
N LL ++ + D+G++ ED +T Q + ++AP
Sbjct: 127 ALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 38/142 (26%), Positives = 56/142 (39%), Gaps = 35/142 (24%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIK-VFHFSCSNEDFRA----------------------- 428
+G G FG V+ + + ++ AIK + + S EDF
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 429 ----LVLEYTTNGSLEKVLYSSNYIL--DILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+V E+ NG L L L D+L L++ DV +EYL IH DL
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLE---RNSFIHRDL 126
Query: 483 KPHNKLLDDNIVAHLSDFGIAK 504
N L+ V +SDFG+ +
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 40/153 (26%), Positives = 58/153 (37%), Gaps = 53/153 (34%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTTNG---------SLEKV 442
IG G++G VYKAR G A+K + LE G SL K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALK------------KIRLETEDEGVPSTAIREISLLKE 54
Query: 443 LYSSNYI--LDIL---QRL-------------------NIMIDVTSALEYLH-------F 471
L N + LD++ +L +D YL+ +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
+S ++H DLKP N L+D L+DFG+A+
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 31/185 (16%)
Query: 347 FGLISRCQKRAT-KLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR 405
FG + CQ RAT K+ ++ + ++R +G ++ + R
Sbjct: 13 FGEVCACQVRATGKMYACKKLEKKRIKKR--------------------KGEAMALNEKR 52
Query: 406 LQDGMEFAIKV-FHFSCSNEDFRALVLEYTTNGSLEKVLYS-SNYILDILQRLNIMIDVT 463
+ + + V ++ +D LVL G L+ +Y+ N D + + ++
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELC 112
Query: 464 SALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLAII 522
LE L I++ DLKP N LLDD +SD G+A ++ GE T + +
Sbjct: 113 CGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTV 165
Query: 523 GYMAP 527
GYMAP
Sbjct: 166 GYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.2 bits (82), Expect = 0.003
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 2/44 (4%)
Query: 283 KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 326
+L+ L L +N++ +P +L +LE+LDLS N ++++ PLS
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKITDLSPLS 42
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 54/174 (31%)
Query: 393 IGRGSFGSVYKARLQDGMEF-AIKVFH--------------------------------F 419
+G+G +G V+ A+ +D E A+K +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH-FGYSTPII 478
+ ++++ L +EY G + L ++ +L M ++ A++ LH GY I
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA--IIG---YMAP 527
H DLKP N L+D + L+DFG++K T A ++G YMAP
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSK----------GIVTYANSVVGSPDYMAP 167
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 33/180 (18%), Positives = 63/180 (35%), Gaps = 48/180 (26%)
Query: 393 IGRGSFGSVYKARLQD------GMEFAIKVFHFSCSNEDFRA------------------ 428
+G+GSFG VY+ + AIK + + S +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 429 ------------LVLEYTTNGSLEKVLYS--------SNYILDILQR-LNIMIDVTSALE 467
+V+E G L+ L S LQ+ + + ++ +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
YL + +H DL N ++ +++ + DFG+ + + D + L + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 36/157 (22%), Positives = 54/157 (34%), Gaps = 45/157 (28%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILD 451
IG G++G VYKAR G A+K E L SL ++L S YI+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI---SLLQMLSESIYIVR 65
Query: 452 ILQRLNIMIDVTSALEYLHFGY----------------STP------------------- 476
+L ++ YL F Y P
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 477 -----IIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLT 507
++H DLKP N L+D + ++D G+ + +
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 411 EFAIKVFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH 470
E+ +K++ +S ++D V++Y G + +L + L R I ++T A+E +H
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH 118
Query: 471 -FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508
G+ IH D+KP N L+D + L+DFG L TG
Sbjct: 119 KMGF----IHRDIKPDNILIDRDGHIKLTDFG---LCTG 150
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 35/146 (23%), Positives = 57/146 (39%), Gaps = 37/146 (25%)
Query: 392 LIGRGSFGSVYKARLQ-DGMEFAIKVFH-------------------------------- 418
L+G+G+FG V R + G +A+K+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
++ D V+EY G L L + R ++ SALEYLH S ++
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAK 504
+ D+K N +LD + ++DFG+ K
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 30/123 (24%), Positives = 52/123 (42%), Gaps = 15/123 (12%)
Query: 417 FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDIL------------QRLNIMIDVTS 464
F+ C D +V EY +G L K L + ++ Q L+I + +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524
+ YL S +H DL N L+ +N++ + DFG+++ + D T+ I +
Sbjct: 132 GMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 525 MAP 527
M P
Sbjct: 189 MPP 191
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 527 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.95 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.94 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.93 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.93 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.93 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.93 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.93 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.92 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.91 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.9 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.9 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.9 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.9 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.9 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.89 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.89 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.88 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.88 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.88 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.88 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.88 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.87 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.87 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.87 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.87 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.87 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.87 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.87 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.87 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.87 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.87 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.87 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.87 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.87 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.86 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.86 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.86 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.86 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.86 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.86 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.86 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.86 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.86 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.86 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.86 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.85 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.85 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.85 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.85 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.85 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.85 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.85 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.85 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.85 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.85 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.85 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.85 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.85 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.85 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.85 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.84 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.84 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.84 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.84 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.84 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.84 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.84 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.84 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.84 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.84 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.84 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.84 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.84 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.84 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.84 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.84 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.83 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.83 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.83 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.83 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.83 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.83 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.83 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.83 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.82 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.82 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.82 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.82 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.82 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.82 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.82 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.82 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.82 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.82 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.82 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.82 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.82 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.82 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.82 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.82 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.82 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.81 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.81 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.81 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.81 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.81 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.81 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.81 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.81 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.81 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.81 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.81 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.81 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.81 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.81 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.81 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.8 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.8 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.8 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.8 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.8 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.8 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.8 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.8 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.8 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.8 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.8 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.8 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.8 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.8 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.8 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.8 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.8 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.8 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.8 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.8 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.8 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.79 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.79 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.79 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.79 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.79 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.79 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.79 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.79 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.79 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.79 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.79 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.79 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.79 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.79 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.79 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.79 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.79 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.79 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.79 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.79 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.79 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.79 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.79 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.79 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.78 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.78 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.78 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.78 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.78 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.78 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.78 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.78 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.78 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.78 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.78 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.78 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.78 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.78 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.78 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.78 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.78 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.78 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.78 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.78 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.78 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.78 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.78 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.78 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.78 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.78 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.78 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.78 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.77 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.77 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.77 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.77 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.77 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.77 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.77 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.77 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.77 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.77 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.76 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.76 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.76 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.76 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.76 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.76 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.76 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.76 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.76 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.76 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.76 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.76 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.76 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.76 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.76 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.76 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.76 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.76 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.76 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.76 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.76 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.75 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.75 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.75 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.75 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.75 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.75 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.75 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.75 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.75 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.75 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.75 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.75 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.75 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.75 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.75 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.75 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.75 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.75 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.74 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.74 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.74 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.74 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.74 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.74 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.74 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.74 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.74 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.74 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.74 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.74 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.74 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.74 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.74 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.74 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.74 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.74 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.73 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.73 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.73 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.73 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.73 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.73 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.73 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.73 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.73 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.73 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.72 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.72 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.72 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.72 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.72 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.72 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.72 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.72 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.72 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.72 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.72 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.72 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.71 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.71 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.71 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.71 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.71 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.71 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.71 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.71 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.7 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.7 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.7 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.7 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.7 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.7 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.69 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.69 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.69 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.67 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.67 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.67 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.67 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.65 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.65 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.65 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.62 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.62 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.57 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.55 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.53 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.52 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.52 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.52 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.49 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.49 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.48 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.47 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.38 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.36 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.33 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.3 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.25 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.21 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.16 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.16 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.14 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.06 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.05 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.99 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.97 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.96 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.95 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.9 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.83 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.64 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.64 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.62 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.62 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.59 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.55 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.44 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.38 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.33 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.28 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.17 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.09 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.05 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.0 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.98 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.96 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.94 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.92 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-56 Score=507.89 Aligned_cols=487 Identities=28% Similarity=0.453 Sum_probs=330.0
Q ss_pred hcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCCC
Q 035895 20 CYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCKY 92 (527)
Q Consensus 20 ~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~ 92 (527)
+..+..++ ++|++++..|..|.++++|+.|++++|.+.+.+|. .++.|+|++|.++...+. .+.++++
T Consensus 235 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l~~ 309 (968)
T PLN00113 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE-----LVIQLQN 309 (968)
T ss_pred CCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCCh-----hHcCCCC
Confidence 34666777 77778877787888888888888888877665553 356777777777643221 2344455
Q ss_pred CCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCc------------------------CCcEEEee
Q 035895 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT------------------------DLISIDLG 148 (527)
Q Consensus 93 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~------------------------~L~~L~L~ 148 (527)
|+.|++++|.+++..|..+..+. +|+.|++++|.+++.+|..+..++ +|+.|+++
T Consensus 310 L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~ 388 (968)
T PLN00113 310 LEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388 (968)
T ss_pred CcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECc
Confidence 55555555555544444444432 345555555544444444444444 44444444
Q ss_pred cCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC-C
Q 035895 149 GNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-I 227 (527)
Q Consensus 149 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-l 227 (527)
+|++.+..|..+..+++|+.|++++|++++..|..|..++.|+.|++++|.+++.+|..+..+++|+.|++++|++.+ +
T Consensus 389 ~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~ 468 (968)
T PLN00113 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468 (968)
T ss_pred CCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeec
Confidence 554444455555555556666666666655556566666666666666666666566555566666666666666654 3
Q ss_pred chhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCC
Q 035895 228 PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV 307 (527)
Q Consensus 228 p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 307 (527)
|. .....+|+.|++++|++.+..|..+..+++|+.|++++|++.+.+|..+..+++|++|++++|.+++.+|..|..++
T Consensus 469 p~-~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 547 (968)
T PLN00113 469 PD-SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMP 547 (968)
T ss_pred Cc-ccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcc
Confidence 33 23456777888888888888888888888999999999999888999999999999999999999999999999999
Q ss_pred CCCEEeCCCCcccccCccchhhhccCCeeEeeeeeeecccc---------------ch-----------hhhcccccCCC
Q 035895 308 SLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILALKFG---------------LI-----------SRCQKRATKLP 361 (527)
Q Consensus 308 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~~~~~---------------~l-----------~~c~~~~~~~~ 361 (527)
+|+.|+|++|++++.+|..+..+..|+.++++.+.+....+ .. +.|........
T Consensus 548 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~ 627 (968)
T PLN00113 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPS 627 (968)
T ss_pred cCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccce
Confidence 99999999999999999999999999998888655521110 00 11111000000
Q ss_pred C---C----------------------CC---CC----ccccc----------ccccHHHHhhhcCCccccceeccCCce
Q 035895 362 N---V----------------------SN---MQ----PQASR----------RRFSYQELLRATDGFSANNLIGRGSFG 399 (527)
Q Consensus 362 ~---~----------------------~~---~~----~~~~~----------~~~~~~~~~~~~~~~~~~~~lg~G~~g 399 (527)
. + .. .. ....+ +.++++ ...+.|+..++||+|+||
T Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ig~G~~g 704 (968)
T PLN00113 628 WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIN---DILSSLKEENVISRGKKG 704 (968)
T ss_pred eeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHH---HHHhhCCcccEEccCCCe
Confidence 0 0 00 00 00000 011222 223457778899999999
Q ss_pred EEEEEEc-cCCcEEEEEEEee-------------------------ccCccceeEEEEEeccCCcHHHHHHhcCCCCCHH
Q 035895 400 SVYKARL-QDGMEFAIKVFHF-------------------------SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDIL 453 (527)
Q Consensus 400 ~vy~~~~-~~~~~vavK~~~~-------------------------~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~ 453 (527)
.||+|+. .+++.||||++.. .|..++..++||||+++|+|.++++. ++|.
T Consensus 705 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~ 780 (968)
T PLN00113 705 ASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWE 780 (968)
T ss_pred eEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHH
Confidence 9999986 5789999998642 23345567899999999999999853 7899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 454 QRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 454 ~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.+|+.++|+|++|+|+.++++|+|||+||+||+++.++.+++. ||.+...... +...+|.+||||
T Consensus 781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aP 847 (968)
T PLN00113 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAP 847 (968)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCc
Confidence 999999999999999997778899999999999999999888876 6665543211 123567889998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=351.15 Aligned_cols=322 Identities=34% Similarity=0.518 Sum_probs=190.9
Q ss_pred Cccccccchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc-------ccceEEcccccccCCCCC
Q 035895 9 RQLDGGMTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS-------IVDELSLSDNYLTSSTPE 80 (527)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~-------~l~~L~Ls~N~l~~~~~~ 80 (527)
-|-|.|+.++...++..+| +.|.+++..+.+|..+++|+.|+|++|.+.+.+|. .++.|+|++|++++..+.
T Consensus 57 ~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~ 136 (968)
T PLN00113 57 VCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136 (968)
T ss_pred CCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc
Confidence 4555666655445788888 88999999999999999999999999998876653 477889999988753221
Q ss_pred CcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccc
Q 035895 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITL 160 (527)
Q Consensus 81 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 160 (527)
..+++|++|+|++|.+++.+|..+..+. +|++|+|++|.+.+..|..+.++++|++|+|++|.+++..|..+
T Consensus 137 -------~~l~~L~~L~Ls~n~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l 208 (968)
T PLN00113 137 -------GSIPNLETLDLSNNMLSGEIPNDIGSFS-SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPREL 208 (968)
T ss_pred -------cccCCCCEEECcCCcccccCChHHhcCC-CCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHH
Confidence 2345556666666655555555555543 45666666555555555555555555555555555555555555
Q ss_pred cCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC-CchhhhCCCCccE
Q 035895 161 GKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILY 239 (527)
Q Consensus 161 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~ 239 (527)
+.+++|+.|++++|.+.+.+|..+..+++|++|++++|.+++..|..|+++++|++|++++|++++ +|..+.++++|+.
T Consensus 209 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 288 (968)
T PLN00113 209 GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288 (968)
T ss_pred cCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCE
Confidence 555555555555555555555555555555555555555555555555555555555555555543 4555555555555
Q ss_pred EEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcc
Q 035895 240 LDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319 (527)
Q Consensus 240 l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 319 (527)
|++++|.+.+.+|..+..+++|++|++++|.+.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++
T Consensus 289 L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l 368 (968)
T PLN00113 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368 (968)
T ss_pred EECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCee
Confidence 55555555555555555555555555555555555555555555555555555555544555555555555555555555
Q ss_pred cccCccchhhhccCCeeEe
Q 035895 320 SEIIPLSLEKLLYLNILLI 338 (527)
Q Consensus 320 ~~~~p~~~~~l~~L~~L~~ 338 (527)
++.+|..+..+..|+.|++
T Consensus 369 ~~~~p~~~~~~~~L~~L~l 387 (968)
T PLN00113 369 TGEIPEGLCSSGNLFKLIL 387 (968)
T ss_pred EeeCChhHhCcCCCCEEEC
Confidence 4444444444333333333
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=302.28 Aligned_cols=331 Identities=25% Similarity=0.250 Sum_probs=209.5
Q ss_pred ccccchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccc-----ccccceEEcccccccCCCCCC-cc-
Q 035895 12 DGGMTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRL-----SSIVDELSLSDNYLTSSTPEL-SF- 83 (527)
Q Consensus 12 ~~~~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~-----~~~l~~L~Ls~N~l~~~~~~~-~~- 83 (527)
++.+.|+.=+..+++| |+|+++.+.+..|.++++|+++++.+|.+...+ ...++.|+|.+|.|+++..+- .+
T Consensus 69 ~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l 148 (873)
T KOG4194|consen 69 KSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSAL 148 (873)
T ss_pred ccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhH
Confidence 4455666667788899 999999999999999999999999999875221 123556666666666543320 00
Q ss_pred -----------------cccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEE
Q 035895 84 -----------------LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISID 146 (527)
Q Consensus 84 -----------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 146 (527)
.++|..-.++++|+|++|.|+..-...|..+. +|..|.|++|+|+..++..|.++++|+.|+
T Consensus 149 ~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~Ld 227 (873)
T KOG4194|consen 149 PALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLD 227 (873)
T ss_pred hhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccc-hheeeecccCcccccCHHHhhhcchhhhhh
Confidence 01233334455555555555544444444443 455555555555555555555555555555
Q ss_pred eecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC
Q 035895 147 LGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS 226 (527)
Q Consensus 147 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 226 (527)
|..|+|...--.+|.+|++|+.|.|..|.+.......|..+.++++|+|+.|+++..-.+++-+|++|+.|+||+|.|..
T Consensus 228 LnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~r 307 (873)
T KOG4194|consen 228 LNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQR 307 (873)
T ss_pred ccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhhe
Confidence 55555543333445555555555555555554444555566666666666666665555556666666666666666666
Q ss_pred Cc-hhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCC---C
Q 035895 227 IP-SILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN---S 302 (527)
Q Consensus 227 lp-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~ 302 (527)
+- +.+...+.|..|+++.|+++...+.+|..|..|++|+|++|++...-..+|.++++|++|||++|.+++.+.+ .
T Consensus 308 ih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~ 387 (873)
T KOG4194|consen 308 IHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVA 387 (873)
T ss_pred eecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhh
Confidence 53 2333345666666666666666666666666666666666666655556677777888888888887765543 5
Q ss_pred CCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeee
Q 035895 303 FDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 303 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
|.++++|+.|++.+|++..+....|..+..|..|++..+.+
T Consensus 388 f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 388 FNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred hccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 77888888888888888888888888888888888776555
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=290.68 Aligned_cols=316 Identities=23% Similarity=0.276 Sum_probs=281.1
Q ss_pred hhhhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc------cccceEEcccccccCCCCCCcccccCCC
Q 035895 17 GDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS------SIVDELSLSDNYLTSSTPELSFLSSMSN 89 (527)
Q Consensus 17 ~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~------~~l~~L~Ls~N~l~~~~~~~~~~~~~~~ 89 (527)
+.-...+..++ .+|.|+.+.+.++.-++.|+.||||.|.++.... ..+++|+|++|.|+.+... .|.+
T Consensus 121 ~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~-----~F~~ 195 (873)
T KOG4194|consen 121 GHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETG-----HFDS 195 (873)
T ss_pred cccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccc-----cccc
Confidence 34444566677 7899999999999999999999999998763221 2478999999999987553 6888
Q ss_pred CCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEE
Q 035895 90 CKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFL 169 (527)
Q Consensus 90 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 169 (527)
+.+|.+|.|++|+++...+..|.++. .|+.|+|..|+|....--.|.++++|+.|.|..|.|....+..|-.+.++++|
T Consensus 196 lnsL~tlkLsrNrittLp~r~Fk~L~-~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l 274 (873)
T KOG4194|consen 196 LNSLLTLKLSRNRITTLPQRSFKRLP-KLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHL 274 (873)
T ss_pred cchheeeecccCcccccCHHHhhhcc-hhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeeccccee
Confidence 99999999999999988777887775 69999999999987768889999999999999999999889999999999999
Q ss_pred eccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch-hhhCCCCccEEEccCCccc
Q 035895 170 SFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFV 248 (527)
Q Consensus 170 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~l~l~~n~~~ 248 (527)
+|+.|++...-..++.++++|++|+||+|.|..+.++++.-.++|++|+|++|+|+.+|+ .+..+..|+.|.++.|.+.
T Consensus 275 ~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~ 354 (873)
T KOG4194|consen 275 NLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID 354 (873)
T ss_pred ecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence 999999998888899999999999999999999999999999999999999999999875 5667889999999999998
Q ss_pred ccCCccccCCCCCCEEEccCCCCCCCChh---hhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCcc
Q 035895 249 GPLPSKIGNLKVLTRIDFSRNNLLGDIPT---TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 325 (527)
Q Consensus 249 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 325 (527)
..-...|..+++|+.|||++|.++..+.+ .|.+|++|+.|.+.+|++.......|.++++|+.|||.+|.|..+.|.
T Consensus 355 ~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~n 434 (873)
T KOG4194|consen 355 HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPN 434 (873)
T ss_pred HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccc
Confidence 88888899999999999999999876654 589999999999999999988888999999999999999999999999
Q ss_pred chhhhccCCeeEee
Q 035895 326 SLEKLLYLNILLIV 339 (527)
Q Consensus 326 ~~~~l~~L~~L~~~ 339 (527)
.|..+ .|+.|.+.
T Consensus 435 AFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 435 AFEPM-ELKELVMN 447 (873)
T ss_pred ccccc-hhhhhhhc
Confidence 99887 66665433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=266.83 Aligned_cols=156 Identities=46% Similarity=0.704 Sum_probs=135.7
Q ss_pred ccccccHHHHhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEee-----------------------------cc
Q 035895 371 SRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF-----------------------------SC 421 (527)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~-----------------------------~~ 421 (527)
..+.|+++++..||++|...++||+|+||.||+|.+++|+.||||++.. +|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5677999999999999999999999999999999999999999997632 35
Q ss_pred Cccc-eeEEEEEeccCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 035895 422 SNED-FRALVLEYTTNGSLEKVLYSSNY-ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSD 499 (527)
Q Consensus 422 ~~~~-~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~D 499 (527)
.+.+ .+.+|||||++|+|.++++.... .++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 5556 48999999999999999987665 889999999999999999999998888999999999999999999999999
Q ss_pred cccccccCCCCCccceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+|+..+... ....+...||.+|+||
T Consensus 221 FGLa~~~~~~~-~~~~~~~~gt~gY~~P 247 (361)
T KOG1187|consen 221 FGLAKLGPEGD-TSVSTTVMGTFGYLAP 247 (361)
T ss_pred ccCcccCCccc-cceeeecCCCCccCCh
Confidence 99998765411 1111111789999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=243.49 Aligned_cols=139 Identities=36% Similarity=0.545 Sum_probs=118.1
Q ss_pred hhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee-------------------------------ccCccceeEE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-------------------------------SCSNEDFRAL 429 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-------------------------------~~~~~~~~~l 429 (527)
...++|...+.||+|+||+||+|+++ ++.+||||.+.. .+...+..++
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 45678999999999999999999974 689999998742 2345678899
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC------CcEEEeecccc
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN------IVAHLSDFGIA 503 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~------~~~kl~Dfg~a 503 (527)
|||||.||||.+++++.+ .++......++.|+|.|+++|| +++||||||||+|||++.. -.+||+|||+|
T Consensus 87 VMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999998765 5677778889999999999999 9999999999999999754 46899999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|.+.... .....+|++.||||
T Consensus 163 R~L~~~~---~a~tlcGSplYMAP 183 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAP 183 (429)
T ss_pred hhCCchh---HHHHhhCCccccCH
Confidence 9986432 22347899999999
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-31 Score=260.72 Aligned_cols=311 Identities=25% Similarity=0.326 Sum_probs=259.4
Q ss_pred ccCCCccccccchhhhcchhcccCCCceeecCchhhhcCCCCCEEEccccccccccccc------cceEEcccccccCCC
Q 035895 5 KLNNRQLDGGMTGDVCYRICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSI------VDELSLSDNYLTSST 78 (527)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~------l~~L~Ls~N~l~~~~ 78 (527)
||+...+.|.+.--.|.|-..+-.+|--.+-+|..++.|..|++||||+|++.. .|.. .-.|+||+|+|.++|
T Consensus 64 HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~IetIP 142 (1255)
T KOG0444|consen 64 HNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIETIP 142 (1255)
T ss_pred hhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccccCC
Confidence 444455666666655655443333333345567788899999999999998864 3433 346999999999988
Q ss_pred CCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCccc-ccCc
Q 035895 79 PELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLN-GSIS 157 (527)
Q Consensus 79 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~ 157 (527)
..+ |.+++.|-.||||+|++.. +|..+..+. .|+.|+|++|.+....-..+..|++|.+|.+++.+=+ ..+|
T Consensus 143 n~l-----finLtDLLfLDLS~NrLe~-LPPQ~RRL~-~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 143 NSL-----FINLTDLLFLDLSNNRLEM-LPPQIRRLS-MLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred chH-----HHhhHhHhhhccccchhhh-cCHHHHHHh-hhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCC
Confidence 754 7789999999999999985 677777776 7999999999987655566677888999999887643 3578
Q ss_pred ccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCc
Q 035895 158 ITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDI 237 (527)
Q Consensus 158 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L 237 (527)
.++..+.+|..+|+|.|.+. .+|..+..+++|+.|+||+|+|+. +.-+.+...+|++|+||.|+++.+|+.++.++.|
T Consensus 216 tsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL 293 (1255)
T KOG0444|consen 216 TSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKL 293 (1255)
T ss_pred CchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhccchHHHhhhHHH
Confidence 88999999999999999998 889999999999999999999984 5556777789999999999999999999999999
Q ss_pred cEEEccCCccc-ccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCC
Q 035895 238 LYLDFWSNLFV-GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316 (527)
Q Consensus 238 ~~l~l~~n~~~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 316 (527)
+.|.+.+|+++ .-+|..++.+.+|+.+..++|.+. .+|..++.+..|+.|.|++|++. .+|+.+.-++.|+.||+..
T Consensus 294 ~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre 371 (1255)
T KOG0444|consen 294 TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE 371 (1255)
T ss_pred HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence 99999999886 458999999999999999999986 89999999999999999999997 7999999999999999999
Q ss_pred CcccccCccch
Q 035895 317 NNLSEIIPLSL 327 (527)
Q Consensus 317 N~l~~~~p~~~ 327 (527)
|.-...+|..-
T Consensus 372 NpnLVMPPKP~ 382 (1255)
T KOG0444|consen 372 NPNLVMPPKPN 382 (1255)
T ss_pred CcCccCCCCcc
Confidence 97666666543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-30 Score=256.56 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=175.4
Q ss_pred CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCE
Q 035895 89 NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQF 168 (527)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 168 (527)
.+..|.+||||+|+++. .|..+... .++-+|+||+|+|..++...|.+++.|-.||||+|++. .+|+....|..|+.
T Consensus 101 ~l~dLt~lDLShNqL~E-vP~~LE~A-Kn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~Lqt 177 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLRE-VPTNLEYA-KNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQT 177 (1255)
T ss_pred ccccceeeecchhhhhh-cchhhhhh-cCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhh
Confidence 44555555555555553 34444433 24555555555555444445555555555555555554 33444455555555
Q ss_pred EeccCcccccccChhhhcCcccCeeeeecccCC-CCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcc
Q 035895 169 LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS-GSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLF 247 (527)
Q Consensus 169 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~ 247 (527)
|+|++|.+...--..+-.+++|++|.+++.+-+ .-+|.++..|.+|+.+|+|.|.+..+|..+.++.+|+.|++++|.+
T Consensus 178 L~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 178 LKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred hhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCce
Confidence 555555543222222233444555555554322 2467888899999999999999999999999999999999999998
Q ss_pred cccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccce-eecCCCCCCCCCCCEEeCCCCcccccCccc
Q 035895 248 VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ-GSIPNSFDDLVSLESLDLSNNNLSEIIPLS 326 (527)
Q Consensus 248 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 326 (527)
+. +....+...+|++|++|+|+++ .+|++++.++.|+.|++.+|+++ .-+|..++++.+|+++..++|.+ +..|..
T Consensus 258 te-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L-ElVPEg 334 (1255)
T KOG0444|consen 258 TE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL-ELVPEG 334 (1255)
T ss_pred ee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc-ccCchh
Confidence 74 4445566778999999999997 79999999999999999999986 34788999999999999998888 578999
Q ss_pred hhhhccCCeeEeeeeeee
Q 035895 327 LEKLLYLNILLIVVVILA 344 (527)
Q Consensus 327 ~~~l~~L~~L~~~~~~~~ 344 (527)
++.+..|+.|.++.+-+.
T Consensus 335 lcRC~kL~kL~L~~NrLi 352 (1255)
T KOG0444|consen 335 LCRCVKLQKLKLDHNRLI 352 (1255)
T ss_pred hhhhHHHHHhccccccee
Confidence 999999999988876664
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=228.81 Aligned_cols=140 Identities=35% Similarity=0.473 Sum_probs=117.6
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRA 428 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~ 428 (527)
...++|++.++||+|+||+||.++. ++++.+|+|+++. ..++++..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 3467899999999999999999986 5689999998742 235667889
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+|+||+.||+|..+|.+++ .++...+..++.+|+.||+||| +.+|||||+||+|||+|++|+++++|||+++..-.
T Consensus 102 lVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999997654 4666667778899999999999 99999999999999999999999999999996432
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.. ..+ ...+||+.||||
T Consensus 178 ~~-~~t-~tfcGT~eYmAP 194 (357)
T KOG0598|consen 178 DG-DAT-RTFCGTPEYMAP 194 (357)
T ss_pred CC-Ccc-ccccCCccccCh
Confidence 21 122 237899999999
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=223.35 Aligned_cols=135 Identities=28% Similarity=0.448 Sum_probs=113.4
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEee------------------------------ccCccc-eeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF------------------------------SCSNED-FRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~------------------------------~~~~~~-~~~lv~ey 433 (527)
+.+..+.||+|..|+|||++++ +++.+|+|+++. .+..+. ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3456789999999999999975 689999999843 112334 58899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
|.+|+|++++... +.++....-+|+.+|++||.|||+ +++||||||||+|||++..|++||||||.++.+...
T Consensus 160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 9999999998765 346777888999999999999993 389999999999999999999999999999987543
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....+||..||||
T Consensus 233 ~a~tfvGT~~YMsP 246 (364)
T KOG0581|consen 233 IANTFVGTSAYMSP 246 (364)
T ss_pred hcccccccccccCh
Confidence 23457899999999
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-29 Score=237.49 Aligned_cols=309 Identities=29% Similarity=0.432 Sum_probs=205.5
Q ss_pred CCCceeecCchhhhcCCCCCEEEccccccccccccc-----cceEEcccccccCCCCCCccc-----------------c
Q 035895 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSI-----VDELSLSDNYLTSSTPELSFL-----------------S 85 (527)
Q Consensus 28 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~-----l~~L~Ls~N~l~~~~~~~~~~-----------------~ 85 (527)
|+|+++.+ |.++.++.+|+.++.++|.+....+++ +..++..+|+++++++...+. +
T Consensus 99 s~n~ls~l-p~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~ 177 (565)
T KOG0472|consen 99 SHNKLSEL-PEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPE 177 (565)
T ss_pred ccchHhhc-cHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCH
Confidence 55555544 334555555666666666554333332 233444455554444322110 0
Q ss_pred cCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCC
Q 035895 86 SMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQK 165 (527)
Q Consensus 86 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 165 (527)
..-+++.|++||...|-+.. +|+.++.+. +|+.|||++|.|. ..| .|.++..|++|+++.|.|..........+++
T Consensus 178 ~~i~m~~L~~ld~~~N~L~t-lP~~lg~l~-~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~ 253 (565)
T KOG0472|consen 178 NHIAMKRLKHLDCNSNLLET-LPPELGGLE-SLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNS 253 (565)
T ss_pred HHHHHHHHHhcccchhhhhc-CChhhcchh-hhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhccccc
Confidence 12236677777777777764 566666664 6788888888886 344 6778888888888888887444444448888
Q ss_pred CCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCC--------------------
Q 035895 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-------------------- 225 (527)
Q Consensus 166 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------------------- 225 (527)
+.+|||++|+++ ..|..++-+.+|++||+|+|.|++ .|.++++| .|+.|-+.+|.+.
T Consensus 254 l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs 330 (565)
T KOG0472|consen 254 LLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS 330 (565)
T ss_pred ceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH
Confidence 899999999988 788888989999999999999884 56667887 6777777776543
Q ss_pred ---------------------------------------------CCchhhhCCCC---ccEEEccCCcc----------
Q 035895 226 ---------------------------------------------SIPSILWNLKD---ILYLDFWSNLF---------- 247 (527)
Q Consensus 226 ---------------------------------------------~lp~~~~~l~~---L~~l~l~~n~~---------- 247 (527)
.+|...|.... ....+++.|++
T Consensus 331 ~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~l 410 (565)
T KOG0472|consen 331 KIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVEL 410 (565)
T ss_pred hhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHH
Confidence 22222211111 22344444443
Q ss_pred -------------cccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccccccee-----------------
Q 035895 248 -------------VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG----------------- 297 (527)
Q Consensus 248 -------------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----------------- 297 (527)
.+.+|..++.+++|..|+|++|-+- .+|..++.+..||.|+++.|++..
T Consensus 411 kelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas 489 (565)
T KOG0472|consen 411 KELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLAS 489 (565)
T ss_pred HHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhc
Confidence 3345666778899999999877775 789999999999999999887752
Q ss_pred ------ecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeeecc
Q 035895 298 ------SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILALK 346 (527)
Q Consensus 298 ------~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~~~ 346 (527)
..|+.+..+.+|..|||.+|.+. .+|..++++.+|+.|+++.++|..|
T Consensus 490 ~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~P 543 (565)
T KOG0472|consen 490 NNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQP 543 (565)
T ss_pred cccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCCC
Confidence 12333677888889999988885 4777888889999998888887643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=229.48 Aligned_cols=139 Identities=34% Similarity=0.500 Sum_probs=120.3
Q ss_pred cCCccccceeccCCceEEEEEE-ccCCcEEEEEEEeeccCc---------------------------------cceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSN---------------------------------EDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~---------------------------------~~~~~l 429 (527)
.+.|+..++||+|.||.||+|+ ..+|+.||+|++++.... ....|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568889999999999999998 478999999998753211 235689
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
|+|||+. ||.-++...+-.++..+...++.|++.||+|+| .++|+|||||.+|||+|.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999986 999999877777899999999999999999999 999999999999999999999999999999988654
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
. ....|..+.|+||.||
T Consensus 272 ~-~~~~T~rVvTLWYRpP 288 (560)
T KOG0600|consen 272 G-SAPYTSRVVTLWYRPP 288 (560)
T ss_pred C-CcccccceEEeeccCh
Confidence 3 2335677889999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=219.84 Aligned_cols=141 Identities=26% Similarity=0.371 Sum_probs=122.2
Q ss_pred hhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeeccC---------------------------------ccce
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSCS---------------------------------NEDF 426 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~---------------------------------~~~~ 426 (527)
.+.++.|+..+.|++|+||.||+|+. ++++.||+|++++.-. .-+.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 45667899999999999999999996 5789999999865321 1234
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.|+|||||+. ||..++...+..+...+...+..|+++|++||| .+.|+|||||++|+|+.++|.+||+|||+||.+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 6899999986 999999988878888899999999999999999 999999999999999999999999999999998
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ...|..+.|+||.||
T Consensus 228 gsp~--k~~T~lVVTLWYRaP 246 (419)
T KOG0663|consen 228 GSPL--KPYTPLVVTLWYRAP 246 (419)
T ss_pred cCCc--ccCcceEEEeeecCH
Confidence 6542 345667889999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=207.17 Aligned_cols=137 Identities=32% Similarity=0.503 Sum_probs=117.5
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------CccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------SNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~~~~~~~lv~e 432 (527)
+.|...+++|||.||.||+|+. .+|+.||||++.... .+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4578889999999999999984 689999999986421 22344569999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++. ||+.+++.....+...+...++.++.+|++|+| ++.|+|||+||.|+|++++|.+|++|||+||.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9985 999999988888999999999999999999999 999999999999999999999999999999998755432
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.+..+.|.||.||
T Consensus 158 --~~~~V~TRWYRAP 170 (318)
T KOG0659|consen 158 --QTHQVVTRWYRAP 170 (318)
T ss_pred --cccceeeeeccCh
Confidence 2334778999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=211.09 Aligned_cols=136 Identities=35% Similarity=0.469 Sum_probs=117.9
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~l 429 (527)
..++|+..+.||.|+||+|..++.+ +|.-+|+|++.. .+.+.+..++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3467899999999999999999975 578899998632 3456678899
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||++||.|..++++.+ .++...+..+|.+|+.|++||| +.+|++||+||+|||+|.+|.+||+|||+|+.+.+.
T Consensus 122 vmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999998765 4677778889999999999999 999999999999999999999999999999987643
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
+ -..+||+.|+||
T Consensus 198 ----T-~TlCGTPeYLAP 210 (355)
T KOG0616|consen 198 ----T-WTLCGTPEYLAP 210 (355)
T ss_pred ----E-EEecCCccccCh
Confidence 1 237899999999
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=227.69 Aligned_cols=143 Identities=34% Similarity=0.537 Sum_probs=120.5
Q ss_pred hhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee---------------------------------ccCccce
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF---------------------------------SCSNEDF 426 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~---------------------------------~~~~~~~ 426 (527)
.+...+|...+.||+|+|++||+|+. ++++++|||++.. ...++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45567899999999999999999985 5789999998632 1235567
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.|+|+||+++|+|-++|.+.+ .++......+|.+|+.|++||| ++|||||||||+|||+|++|++||+|||-|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 789999999999999998774 5788888889999999999999 999999999999999999999999999999987
Q ss_pred CCCCCc---------cc--eeccccccccccC
Q 035895 507 TGEDQS---------MT--QTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~---------~~--~~~~~~t~~y~aP 527 (527)
...... .. ...++||..|.+|
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP 256 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSP 256 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCH
Confidence 643211 11 1457899999988
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=211.87 Aligned_cols=137 Identities=30% Similarity=0.390 Sum_probs=112.7
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc-------------------------------CccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC-------------------------------SNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~~~lv~e 432 (527)
+.|+...++|||+||+||+++.+ +|+.||||++...- ......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45888899999999999999975 69999999985421 22345679999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
||+..-|.+ +......++.....+|+.|++.|+.|+| +++||||||||+|||++..|.+|+||||+||.+.....
T Consensus 82 ~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred ecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 998754444 4444455777788899999999999999 99999999999999999999999999999999874332
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
..|..++|.||+||
T Consensus 157 -~YTDYVATRWYRaP 170 (396)
T KOG0593|consen 157 -NYTDYVATRWYRAP 170 (396)
T ss_pred -hhhhhhhhhhccCh
Confidence 23556789999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=225.42 Aligned_cols=136 Identities=32% Similarity=0.524 Sum_probs=114.5
Q ss_pred ccccceeccCCceEEEEEEccCCcEEEEEEEee-------------------------------ccCccc-eeEEEEEec
Q 035895 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF-------------------------------SCSNED-FRALVLEYT 434 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~-------------------------------~~~~~~-~~~lv~ey~ 434 (527)
....+.||+|+||+||+|.++....||||++.. .|..+. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 445567999999999999998666699998753 233333 578999999
Q ss_pred cCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCeeeCCCC-cEEEeecccccccCCCCC
Q 035895 435 TNGSLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTP-IIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 435 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~-iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~~~~ 511 (527)
++|+|.++++. .+..+++..++.+|.+||+|++||| +++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999987 3678999999999999999999999 777 99999999999999997 99999999999765321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
...+...||+.||||
T Consensus 199 -~~~~~~~GT~~wMAP 213 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAP 213 (362)
T ss_pred -ccccCCCCCccccCh
Confidence 233346789999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=214.32 Aligned_cols=136 Identities=31% Similarity=0.457 Sum_probs=112.2
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------------cCcccee
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------------CSNEDFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------------~~~~~~~ 427 (527)
+.|.+.+.+|+|+||.|-+|.. ++|+.||||+++.. ...++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4578889999999999999974 68999999997531 1234566
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeccccc
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN---IVAHLSDFGIAK 504 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~---~~~kl~Dfg~a~ 504 (527)
|+||||++||+|.+.+...+ .+.......++.|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 89999999999999886544 4555566779999999999999 9999999999999999644 889999999999
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... +... ..+||+.|.||
T Consensus 328 ~~g~~--sfm~-TlCGTpsYvAP 347 (475)
T KOG0615|consen 328 VSGEG--SFMK-TLCGTPSYVAP 347 (475)
T ss_pred ccccc--eehh-hhcCCccccCh
Confidence 87522 2233 37899999999
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-27 Score=211.97 Aligned_cols=140 Identities=28% Similarity=0.479 Sum_probs=115.8
Q ss_pred CCccccceeccCCceEEEEEE-ccCCcEEEEEEEeecc---------------------------------CccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSC---------------------------------SNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~---------------------------------~~~~~~~lv 430 (527)
.+|++.++||+|+||+|||+. ..+|..||.|.++... .+.+..+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 458899999999999999997 5789999999886410 112236799
Q ss_pred EEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 431 LEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTP--IIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~--iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
||||.+|||...++. .+..++.....+++.|+++||..+|.-. ++ |+||||||.||+++.+|.+|++|||++|.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999998864 3456788889999999999999999321 44 89999999999999999999999999999
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+..... -+...+||+.||+|
T Consensus 178 l~s~~t--fA~S~VGTPyYMSP 197 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGTPYYMSP 197 (375)
T ss_pred hcchhH--HHHhhcCCCcccCH
Confidence 875432 23457899999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-27 Score=226.19 Aligned_cols=124 Identities=27% Similarity=0.389 Sum_probs=102.4
Q ss_pred eeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCC
Q 035895 194 DLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG 273 (527)
Q Consensus 194 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 273 (527)
++++|.+ +.+|..+..+++|..|+|++|-+..+|..++.+..|+.++++.|++. .+|..+..+..++.+-.++|++..
T Consensus 418 ~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~ 495 (565)
T KOG0472|consen 418 VLSNNKI-SFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS 495 (565)
T ss_pred HhhcCcc-ccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence 3344444 36677778888888888888888888888888888888888888665 567777777777777777788876
Q ss_pred CChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc
Q 035895 274 DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 274 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 320 (527)
..|..+.+|.+|..|||.+|.+. .+|..++++++|++|++++|+|.
T Consensus 496 vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 496 VDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 66677999999999999999998 78999999999999999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-26 Score=219.25 Aligned_cols=137 Identities=29% Similarity=0.447 Sum_probs=118.5
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
.+.|...+.||.|.||.||+|+- .+|..||||+++.. ...+...++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 35688999999999999999984 67899999986421 1122378899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||||+. +|++++...+..++..+...|+.||.+||+|+| .+|+.|||+||+|||+.....+||+|||+||.+...
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC-
Confidence 999986 999999988888999999999999999999999 999999999999999998889999999999988543
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
...|+.+.|.||+||
T Consensus 164 --pPYTeYVSTRWYRAP 178 (538)
T KOG0661|consen 164 --PPYTEYVSTRWYRAP 178 (538)
T ss_pred --CCcchhhhcccccch
Confidence 345677889999998
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=222.41 Aligned_cols=147 Identities=28% Similarity=0.482 Sum_probs=119.1
Q ss_pred ccHHHHhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------cCc
Q 035895 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------CSN 423 (527)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------~~~ 423 (527)
.+.+++....+.+.+.+.||+|.||+||+|+|.. .||||++.+. |..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3335555566677888999999999999999975 8999998542 223
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
... +||+.+|+|-+|+.+++..+..++..+...||.|||+|+.||| +++|||||||+.||++.++++|||+|||++
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence 333 7999999999999999988888999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
..............-.|.+.||||
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAP 559 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAP 559 (678)
T ss_pred eeeeeeccccccCCCccchhhhcH
Confidence 754322111111223467889998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=217.92 Aligned_cols=137 Identities=29% Similarity=0.448 Sum_probs=119.5
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
..|+..+.||+|||+.||+++. .+|+.||+|++.. +..+.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4589999999999999999997 8899999999742 234567889999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+|+.|+|..++. ..+.+++.++..+..||+.|+.||| +++|||||||..|++++++.++||+|||+|..+..+..
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999987 4557888889999999999999999 99999999999999999999999999999998864322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
. ....+||+-|+||
T Consensus 174 r--k~TlCGTPNYIAP 187 (592)
T KOG0575|consen 174 R--KKTLCGTPNYIAP 187 (592)
T ss_pred c--cceecCCCcccCh
Confidence 1 2247899999999
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=219.96 Aligned_cols=139 Identities=29% Similarity=0.424 Sum_probs=116.7
Q ss_pred hhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee---------------------------------ccCcccee
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF---------------------------------SCSNEDFR 427 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~---------------------------------~~~~~~~~ 427 (527)
...++|.+.++||+|+||+|++|..+ +++.+|||+++. +...++..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34678999999999999999999974 678999999753 22456788
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+.|||+..+. ....++..++..||.+|+.||+||| +++||+||||.+|||+|.+|.+||+|||+++.--
T Consensus 445 ~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999955443 2346888899999999999999999 9999999999999999999999999999999643
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
... . .....+||+.||||
T Consensus 520 ~~g-~-~TsTfCGTpey~aP 537 (694)
T KOG0694|consen 520 GQG-D-RTSTFCGTPEFLAP 537 (694)
T ss_pred CCC-C-ccccccCChhhcCh
Confidence 221 1 23458999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=212.66 Aligned_cols=120 Identities=30% Similarity=0.473 Sum_probs=105.4
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRA 428 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~ 428 (527)
...++|++.++||+|+||.||.|+. .+|..+|+|++.. +..+.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3678999999999999999999986 5699999998742 235667889
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
+||||++|||+..+|.+.+ .++...+..++.+.+.|++.+| +.|+|||||||+|+|||..|++|++|||+++-
T Consensus 218 LiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999997654 5666667778889999999999 99999999999999999999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-24 Score=211.57 Aligned_cols=135 Identities=30% Similarity=0.430 Sum_probs=116.4
Q ss_pred CccccceeccCCceEEEEEE-ccCCcEEEEEEEeeccC-----------------------------ccceeEEEEEecc
Q 035895 386 GFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCS-----------------------------NEDFRALVLEYTT 435 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~-----------------------------~~~~~~lv~ey~~ 435 (527)
.|+.-..||+|+.|.||.|+ ..+++.||||++...+. ..+..++||||++
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 47777899999999999997 46789999999865432 1356689999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
||+|.+++.. ..++..+...|+.++++||+||| .++|+|||||.+|||++.+|.+||+|||+++.+..+.. ..
T Consensus 354 ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTK--TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR 426 (550)
T ss_pred CCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence 9999999854 46889999999999999999999 99999999999999999999999999999998865432 33
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
...+||++||||
T Consensus 427 ~TmVGTPYWMAP 438 (550)
T KOG0578|consen 427 STMVGTPYWMAP 438 (550)
T ss_pred ccccCCCCccch
Confidence 457899999998
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-24 Score=200.42 Aligned_cols=138 Identities=30% Similarity=0.421 Sum_probs=112.6
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeeccC--------------------------------ccc-----
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSCS--------------------------------NED----- 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~--------------------------------~~~----- 425 (527)
...|+..++||+|+||+||+|+. .+|+.||+|+++.... .++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577778899999999999985 5789999999854211 112
Q ss_pred -eeEEEEEeccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 035895 426 -FRALVLEYTTNGSLEKVLYSSN---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 426 -~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
..++|+||+.. ||.+++.... ..++......++.|+++|++||| +++|+||||||+|||++++|.+|++|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 55689999975 9999998654 35676778889999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|+.+.-... +.+..++|.||.||
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaP 189 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAP 189 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCH
Confidence 9997652222 23446789999998
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=229.65 Aligned_cols=144 Identities=28% Similarity=0.456 Sum_probs=121.9
Q ss_pred HHhhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEe--------------------------------eccCccc
Q 035895 379 ELLRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFH--------------------------------FSCSNED 425 (527)
Q Consensus 379 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~--------------------------------~~~~~~~ 425 (527)
++....++|++.++||+|+||.|..++++ +++.||+|++. ++..++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34445678999999999999999999974 68899999763 2345778
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
+.|+||||++||||-.++.+.+ .++..-+..|+.+|+.||.-+| +.|.|||||||+|||+|..|++|++|||-+-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence 8999999999999999998877 5666667778899999999999 99999999999999999999999999999877
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+.... .......+|||.|++|
T Consensus 225 m~~dG-~V~s~~aVGTPDYISP 245 (1317)
T KOG0612|consen 225 MDADG-TVRSSVAVGTPDYISP 245 (1317)
T ss_pred cCCCC-cEEeccccCCCCccCH
Confidence 75433 2333456899999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=201.63 Aligned_cols=140 Identities=36% Similarity=0.540 Sum_probs=115.5
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccc-eeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNED-FRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~-~~~lv~e 432 (527)
..+...+.||+|+||.||+|... +|..+|||.+... ...++ ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34667799999999999999864 5899999986542 01122 5789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCC-C
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTGE-D 510 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~~~~~~-~ 510 (527)
|+++|+|.+++.+.+..++......+..||++||+||| +++||||||||+|||++. ++.+||+|||+|+..... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999887657888899999999999999999 999999999999999999 799999999999877531 1
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.........||+.||||
T Consensus 174 ~~~~~~~~~Gtp~~maP 190 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAP 190 (313)
T ss_pred cccccccccCCccccCc
Confidence 11122346799999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=210.11 Aligned_cols=140 Identities=31% Similarity=0.424 Sum_probs=116.5
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----c------------------------------Cccc
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----C------------------------------SNED 425 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----~------------------------------~~~~ 425 (527)
...+.|.+.+.||+|+||.||.|+. .+++.||+|++... . ..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467899999999999999999975 57899999975432 1 1123
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-IVAHLSDFGIAK 504 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-~~~kl~Dfg~a~ 504 (527)
..++|||||.||+|.+++.. ...+....+..++.|++.|++|+| +++|+||||||+|||+|.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 45799999999999999988 556777888999999999999999 9999999999999999998 999999999999
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.....+. .....+||+.|+||
T Consensus 170 ~~~~~~~--~l~t~cGsp~Y~aP 190 (370)
T KOG0583|consen 170 ISPGEDG--LLKTFCGSPAYAAP 190 (370)
T ss_pred ccCCCCC--cccCCCCCcccCCH
Confidence 8741211 12346899999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=210.95 Aligned_cols=138 Identities=28% Similarity=0.485 Sum_probs=117.5
Q ss_pred CccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEeccCC
Q 035895 386 GFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTTNG 437 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~~g 437 (527)
.++..+.||+|.||+||.|++.....||+|.+.. .|..++..+||||||+.|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3567799999999999999999888999998643 355556689999999999
Q ss_pred cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 438 SLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 438 ~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
+|.++|+. .+..+...+.+.++.|||+|++||+ ++++|||||.++|||++++..+||+|||+||...++ .+....
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASE 362 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeecC
Confidence 99999987 4567888899999999999999999 999999999999999999999999999999965433 333334
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
.....+.|.||
T Consensus 363 ~~kfPIkWtAP 373 (468)
T KOG0197|consen 363 GGKFPIKWTAP 373 (468)
T ss_pred CCCCCceecCH
Confidence 44557789998
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=222.80 Aligned_cols=262 Identities=24% Similarity=0.294 Sum_probs=205.3
Q ss_pred ccc-CCCceeecCchhhhcCCCCCEEEccccccccc--cccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccC
Q 035895 25 TID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGR--LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRN 101 (527)
Q Consensus 25 ~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~--~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N 101 (527)
.+| +.|.++.+++ .+. ++|+.|++++|.+... .+..|+.|+|++|+|+.++.. .++|+.|++++|
T Consensus 205 ~LdLs~~~LtsLP~-~l~--~~L~~L~L~~N~Lt~LP~lp~~Lk~LdLs~N~LtsLP~l---------p~sL~~L~Ls~N 272 (788)
T PRK15387 205 VLNVGESGLTTLPD-CLP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSLPVL---------PPGLLELSIFSN 272 (788)
T ss_pred EEEcCCCCCCcCCc-chh--cCCCEEEccCCcCCCCCCCCCCCcEEEecCCccCcccCc---------ccccceeeccCC
Confidence 344 6778886554 443 4799999999998742 235789999999999987532 357999999999
Q ss_pred CCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccC
Q 035895 102 PLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP 181 (527)
Q Consensus 102 ~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 181 (527)
.++. +|.. ..+|+.|++++|+++.. |. ..++|+.|+|++|++++. |.. ..+|+.|++++|++++ +|
T Consensus 273 ~L~~-Lp~l----p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 273 PLTH-LPAL----PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LP 338 (788)
T ss_pred chhh-hhhc----hhhcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCC---cccccccccccCcccc-cc
Confidence 9986 3443 34799999999999854 43 247899999999999864 332 3468889999999984 55
Q ss_pred hhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCC
Q 035895 182 NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVL 261 (527)
Q Consensus 182 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L 261 (527)
.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+.+|... .+|+.|++++|.+.+ +|.. .++|
T Consensus 339 ~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~-LP~l---~s~L 404 (788)
T PRK15387 339 TL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTS-LPVL---PSEL 404 (788)
T ss_pred cc---ccccceEecCCCccCC-CCCC---CcccceehhhccccccCcccc---cccceEEecCCcccC-CCCc---ccCC
Confidence 42 2579999999999996 4543 357888999999999998643 578999999999885 5543 3579
Q ss_pred CEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhc
Q 035895 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 331 (527)
Q Consensus 262 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 331 (527)
+.|++++|++++ +|..+ .+|+.|++++|+++ .+|..+..+++|+.|+|++|+|++..+..+..+.
T Consensus 405 ~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 405 KELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 469 (788)
T ss_pred CEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence 999999999985 66543 46889999999998 6899999999999999999999998887775543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=209.25 Aligned_cols=136 Identities=35% Similarity=0.465 Sum_probs=117.2
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+... +......++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888899999999999999875 6789999987431 233456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
||.| +|..++... +.++..+...|+.+++.||.||| +.+|+|||+||.|||++..|.+|+||||+||.+... .
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--T 154 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC--c
Confidence 9997 999999754 46888899999999999999999 999999999999999999999999999999988653 3
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
..-+.+.||+.||||
T Consensus 155 ~vltsikGtPlYmAP 169 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAP 169 (808)
T ss_pred eeeeeccCcccccCH
Confidence 345668899999998
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=203.59 Aligned_cols=141 Identities=30% Similarity=0.410 Sum_probs=116.9
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec--------------------------cC------ccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS--------------------------CS------NEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~--------------------------~~------~~~~~~lv~ 431 (527)
.+..+..++||+|.||.||||.+.+ +.||||++... +. ..-.+.+|+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC-ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 4556677899999999999999975 89999997421 11 122567999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF------GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~------~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
||.+.|+|.++|.. ...+|....+|+..+++||+|||. .++++|+|||||+.|||+..|+++.|+|||+|..
T Consensus 288 ~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999965 468999999999999999999994 4788999999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+............+||.+||||
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAP 387 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAP 387 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCH
Confidence 7644332222346799999998
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=204.91 Aligned_cols=139 Identities=26% Similarity=0.432 Sum_probs=115.8
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+.. +++.||+|++.. .+..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999864 678999998742 122455678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||++||+|.+++...+..+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875556788888889999999999999 99999999999999999999999999999987643322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.......||++||||
T Consensus 158 -~~~~~~~gt~~y~aP 172 (331)
T cd05624 158 -VQSSVAVGTPDYISP 172 (331)
T ss_pred -eeeccccCCcccCCH
Confidence 122234588999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=207.01 Aligned_cols=119 Identities=28% Similarity=0.452 Sum_probs=103.5
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|+..+.||+|+||+||+|+. .+++.||||++... +..++..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4689999999999999999985 46899999997521 12345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
|||+||+|.+++... ..+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999998754 35788888999999999999999 9999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-23 Score=207.75 Aligned_cols=141 Identities=25% Similarity=0.410 Sum_probs=115.9
Q ss_pred hhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCcccee
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFR 427 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~ 427 (527)
....++|++.+.||+|+||.||+|+.. +++.||+|++.. .+..++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999865 578999998742 12234567
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++... .++......++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 8999999999999998653 4677788889999999999999 9999999999999999999999999999998764
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.... .......||++||||
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aP 212 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISP 212 (370)
T ss_pred cCCc-eecccCCCCcccCCH
Confidence 3221 112235689999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=202.88 Aligned_cols=139 Identities=27% Similarity=0.442 Sum_probs=115.5
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||+||+|+. .+++.||+|++.. .+..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4689999999999999999986 4689999999742 122345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++...+..++...+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999765556788888899999999999999 99999999999999999999999999999976643221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.......||+.||||
T Consensus 158 -~~~~~~~gt~~y~aP 172 (331)
T cd05597 158 -VQSNVAVGTPDYISP 172 (331)
T ss_pred -ccccceeccccccCH
Confidence 112234588999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-23 Score=182.34 Aligned_cols=138 Identities=28% Similarity=0.426 Sum_probs=115.0
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~l 429 (527)
+.++|++.+.||+|.||.||.|+. +++..||+|++.. ..-++...|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 357799999999999999999996 4678999999732 1123456789
Q ss_pred EEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 430 VLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
++||.++|+++..|+... ..++......++.|+|.|+.|+| .++||||||||+|+|++.++..|++|||.+..-+.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999998543 34677777889999999999999 99999999999999999999999999999876532
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
. .....+||+.|.+|
T Consensus 177 ~----kR~tlcgt~dyl~p 191 (281)
T KOG0580|consen 177 N----KRKTLCGTLDYLPP 191 (281)
T ss_pred C----CceeeecccccCCH
Confidence 2 22346799999988
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-23 Score=199.25 Aligned_cols=142 Identities=31% Similarity=0.444 Sum_probs=112.2
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c--------
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C-------- 421 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~-------- 421 (527)
.....|++.+.||+|+||.|-+|+. .+++.||||++... |
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457799999999999999999985 57899999997420 1
Q ss_pred ------CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 035895 422 ------SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495 (527)
Q Consensus 422 ------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~ 495 (527)
...+..|+|+|||..|.+...= ..+..++..++.+|+.++..||+||| .++||||||||+|+|++++|++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 1235678999999999775321 11223788899999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCCCCC---ccceeccccccccccC
Q 035895 496 HLSDFGIAKLLTGEDQ---SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 496 kl~Dfg~a~~~~~~~~---~~~~~~~~~t~~y~aP 527 (527)
||+|||.+-....... ...-..++||+.||||
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP 284 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP 284 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence 9999999987632211 1111236899999998
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=201.88 Aligned_cols=139 Identities=27% Similarity=0.420 Sum_probs=115.2
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+.+ +++.||+|++.. .+..++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999865 578899998742 122345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++...+..+++.....++.|++.|++|+| +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999875556788888889999999999999 99999999999999999999999999999976543221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.......||+.||||
T Consensus 158 -~~~~~~~gt~~y~aP 172 (332)
T cd05623 158 -VQSSVAVGTPDYISP 172 (332)
T ss_pred -ceecccccCccccCH
Confidence 122234689999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-23 Score=196.49 Aligned_cols=134 Identities=37% Similarity=0.529 Sum_probs=105.1
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEee-----------------------------ccCc-cceeEEEEEecc
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-----------------------------SCSN-EDFRALVLEYTT 435 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-----------------------------~~~~-~~~~~lv~ey~~ 435 (527)
|+..+++|.|+||.||+|... +++.||||++-. .... +-+..+||||||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 667799999999999999964 568999998511 1111 224458999999
Q ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCCCC
Q 035895 436 NGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 436 ~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~~~~~~~~ 511 (527)
. +|+++++.. +..++.....-+..|+.+|++||| +.+||||||||+|+|+|. .|.+||||||-|+.+..+..
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 7 999988742 445666666778999999999999 899999999999999995 59999999999998865543
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
..+ ..-|..|+||
T Consensus 182 niS---YicSRyYRaP 194 (364)
T KOG0658|consen 182 NIS---YICSRYYRAP 194 (364)
T ss_pred cee---EEEeccccCH
Confidence 322 2235678988
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=201.48 Aligned_cols=139 Identities=30% Similarity=0.441 Sum_probs=116.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+. .+++.||+|++... +..++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999986 46899999987531 12345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++......+++.....++.|++.||+|+| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999876556888888889999999999999 99999999999999999999999999999987653322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
. ......+|+.|+||
T Consensus 158 ~-~~~~~~gt~~y~aP 172 (330)
T cd05601 158 V-NSKLPVGTPDYIAP 172 (330)
T ss_pred e-eeecccCCccccCH
Confidence 1 22234578899998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=203.69 Aligned_cols=141 Identities=25% Similarity=0.428 Sum_probs=109.4
Q ss_pred cCCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec-------------------------------cC-ccc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS-------------------------------CS-NED 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~-------------------------------~~-~~~ 425 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +. ..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999973 23568999987421 11 123
Q ss_pred eeEEEEEeccCCcHHHHHHhcC----------------------------------------------------------
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN---------------------------------------------------------- 447 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~---------------------------------------------------------- 447 (527)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 4678999999999999986421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceecccccccc
Q 035895 448 ---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524 (527)
Q Consensus 448 ---~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 524 (527)
..+++.+...++.|+++||+||| +++|+||||||+||++++++.+|++|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23567778889999999999999 999999999999999999999999999999876432222112223356789
Q ss_pred ccC
Q 035895 525 MAP 527 (527)
Q Consensus 525 ~aP 527 (527)
|||
T Consensus 243 ~aP 245 (338)
T cd05102 243 MAP 245 (338)
T ss_pred cCc
Confidence 998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=195.50 Aligned_cols=136 Identities=29% Similarity=0.450 Sum_probs=112.4
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~e 432 (527)
.|+..+.||+|+||.||+|.. .+|+.||+|.+.. .+...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 477889999999999999986 5789999998642 1223456789999
Q ss_pred eccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++.... ..+++..+..++.|++.|++|+| +++|+||||||+||++++++.+|++|||+++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999999998876433 35788889999999999999999 99999999999999999999999999999987643221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....||.+||||
T Consensus 158 ---~~~~~g~~~y~aP 170 (285)
T cd05631 158 ---VRGRVGTVGYMAP 170 (285)
T ss_pred ---ecCCCCCCCccCH
Confidence 1234688999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=203.57 Aligned_cols=143 Identities=26% Similarity=0.419 Sum_probs=117.2
Q ss_pred HHhhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccc
Q 035895 379 ELLRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNED 425 (527)
Q Consensus 379 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~ 425 (527)
++....++|++.+.||+|+||.||+|+.. +++.||+|++.. .+..++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 44555688999999999999999999865 688999998742 112345
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||||+++|+|.+++... .++......++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 678999999999999998653 4677778889999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... .......||+.||||
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aP 212 (371)
T cd05622 192 MNKEGM-VRCDTAVGTPDYISP 212 (371)
T ss_pred cCcCCc-ccccCcccCccccCH
Confidence 643321 122245689999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=199.60 Aligned_cols=136 Identities=27% Similarity=0.348 Sum_probs=111.8
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVL 431 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ 431 (527)
+|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999864 5789999987421 12334567999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+.+... ..+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999988654 35788889999999999999999 99999999999999999999999999999986432211
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......||+.||||
T Consensus 157 --~~~~~~gt~~y~aP 170 (323)
T cd05616 157 --TTKTFCGTPDYIAP 170 (323)
T ss_pred --ccccCCCChhhcCH
Confidence 12235688999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=199.13 Aligned_cols=136 Identities=27% Similarity=0.340 Sum_probs=111.3
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVL 431 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ 431 (527)
+|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999864 5789999987421 12335678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999988654 35678888999999999999999 99999999999999999999999999999875322111
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......||..|+||
T Consensus 157 --~~~~~~gt~~y~aP 170 (324)
T cd05587 157 --TTRTFCGTPDYIAP 170 (324)
T ss_pred --ceeeecCCccccCh
Confidence 12234688999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-23 Score=198.63 Aligned_cols=139 Identities=29% Similarity=0.471 Sum_probs=119.0
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEe--------------------------------eccCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFH--------------------------------FSCSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~--------------------------------~~~~~~~~~~l 429 (527)
....|..-++||+||||.||-++. .+|+.+|+|.+. .+....+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 345688889999999999999886 468888887642 13456778899
Q ss_pred EEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 430 VLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||..|.||||.-+|...+ ..++..+...+|.+|+.||++|| ..+||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999988765 46888899999999999999999 99999999999999999999999999999998875
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .++.+||.|||||
T Consensus 340 g~~---~~~rvGT~GYMAP 355 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAP 355 (591)
T ss_pred CCc---cccccCcccccCH
Confidence 432 2345899999999
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=204.44 Aligned_cols=140 Identities=26% Similarity=0.423 Sum_probs=114.5
Q ss_pred hhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRA 428 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~ 428 (527)
...++|++.+.||+|+||.||+|+.. +++.||+|++.. .+..++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567999999999999999999864 688999998742 122345678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||++||+|.+++... .++......++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999998653 4566677888999999999999 99999999999999999999999999999987643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .......||+.||||
T Consensus 195 ~~~-~~~~~~~gt~~y~aP 212 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISP 212 (370)
T ss_pred CCc-ccCCCCCCCcCeECH
Confidence 221 112235689999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=203.12 Aligned_cols=118 Identities=31% Similarity=0.501 Sum_probs=103.3
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999864 6899999997521 22345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||+++|+|.+++...+ .++...+..++.|++.||+|+| +++|+||||||+|||++.++.+|++|||+++.+
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999987643 5788888899999999999999 999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=199.41 Aligned_cols=137 Identities=29% Similarity=0.421 Sum_probs=111.9
Q ss_pred CccccceeccCCceEEEEEEc----cCCcEEEEEEEeec----------------------------------cCcccee
Q 035895 386 GFSANNLIGRGSFGSVYKARL----QDGMEFAIKVFHFS----------------------------------CSNEDFR 427 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~----------------------------------~~~~~~~ 427 (527)
+|++.+.||+|+||.||+|+. .+++.||+|++... ...++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999975 36789999987421 1223456
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++... ..+++.+...++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 7999999999999998654 35788888899999999999999 9999999999999999999999999999998654
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
..... ......||+.||||
T Consensus 157 ~~~~~-~~~~~~gt~~y~aP 175 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAP 175 (332)
T ss_pred ccCCC-ccccccCCccccCH
Confidence 32221 12235689999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-24 Score=206.14 Aligned_cols=279 Identities=20% Similarity=0.256 Sum_probs=191.1
Q ss_pred cccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCC
Q 035895 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139 (527)
Q Consensus 60 ~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 139 (527)
+|....+++|..|.|+.+++. +|+.+++|+.||||+|.|+.+-|+.|.++..-++.++.++|+|+.+..+.|++|
T Consensus 65 LP~~tveirLdqN~I~~iP~~-----aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL 139 (498)
T KOG4237|consen 65 LPPETVEIRLDQNQISSIPPG-----AFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGL 139 (498)
T ss_pred CCCcceEEEeccCCcccCChh-----hccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhH
Confidence 444455677777777776664 567777777777777777777777776665433334444477776666677777
Q ss_pred cCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccC------------CCCCCcc
Q 035895 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL------------SGSIPTC 207 (527)
Q Consensus 140 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l------------~~~~p~~ 207 (527)
..|+-|.+.-|++.-+....|..+++|..|.+.+|.+.......|..+..++.+.+..|.+ ....|..
T Consensus 140 ~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ie 219 (498)
T KOG4237|consen 140 SSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIE 219 (498)
T ss_pred HHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhh
Confidence 7777777777777666666667777777777777766644344666666666666666652 1222333
Q ss_pred ccCCccCceeeCCCCCCCCCchhhh--CCCCccEEEccCCcccccCC-ccccCCCCCCEEEccCCCCCCCChhhhhcCCC
Q 035895 208 FGNLTALRNLHLDSNELTSIPSILW--NLKDILYLDFWSNLFVGPLP-SKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKS 284 (527)
Q Consensus 208 ~~~l~~L~~L~L~~N~l~~lp~~~~--~l~~L~~l~l~~n~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 284 (527)
++......-..+.++++..++..-+ .+.++..--.+.....+..| ..|..|++|++|+|++|+++++-+.+|.++..
T Consensus 220 tsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~ 299 (498)
T KOG4237|consen 220 TSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAE 299 (498)
T ss_pred cccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhh
Confidence 4444444444444455444433211 11122111111222222333 45889999999999999999999999999999
Q ss_pred CCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeee
Q 035895 285 LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 285 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
+++|.|..|+|.......|.++..|+.|+|.+|+|+...|..|..+.+|..|++..+++
T Consensus 300 l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 300 LQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred hhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 99999999999988888999999999999999999999999999999999998776665
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=198.35 Aligned_cols=136 Identities=27% Similarity=0.346 Sum_probs=111.7
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------cCccceeEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------CSNEDFRALVL 431 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ 431 (527)
+|+..+.||+|+||.||+|+. .+|+.||+|++... +..++..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999986 46899999987421 12334678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++... ..+++.++..++.|++.|++||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999988654 35788899999999999999999 99999999999999999999999999999986432211
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......||+.||||
T Consensus 157 --~~~~~~gt~~y~aP 170 (323)
T cd05615 157 --TTRTFCGTPDYIAP 170 (323)
T ss_pred --cccCccCCccccCH
Confidence 12234578899998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=202.59 Aligned_cols=117 Identities=26% Similarity=0.398 Sum_probs=100.9
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~e 432 (527)
.|+..+.||+|+||+||+|+. .+++.||||++.. .+...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999985 5688999998742 1223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
|++||+|.+++...+ .+++.....++.|++.||+||| +.+|+||||||+||+++.++++|++|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999999987643 4677778889999999999999 999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=200.88 Aligned_cols=118 Identities=30% Similarity=0.467 Sum_probs=102.5
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
++|+..+.||+|+||.||+|+.. +++.||||++.. .+..++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999864 689999998742 112345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||++||+|.+++... ..++......++.|++.||+|+| +++|+||||||+||+++.++.+|++|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 999999999998754 35778888889999999999999 999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=193.09 Aligned_cols=135 Identities=27% Similarity=0.430 Sum_probs=114.3
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~e 432 (527)
.|++.+.||+|.||.|-+|.. ..|+.||||.++.. ....+...||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 478889999999999999985 67999999987431 234456779999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|..+|+|++++...+ .++..++..++.||..|+.|+| +++++|||||.+|||+|.++.+||+|||++-.+.+...
T Consensus 134 YaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf- 208 (668)
T KOG0611|consen 134 YASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF- 208 (668)
T ss_pred ecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccccH-
Confidence 999999999997654 5788888899999999999999 99999999999999999999999999999988754432
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
. +.++|++-|.+|
T Consensus 209 -L-qTFCGSPLYASP 221 (668)
T KOG0611|consen 209 -L-QTFCGSPLYASP 221 (668)
T ss_pred -H-HHhcCCcccCCc
Confidence 2 236788888776
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=198.83 Aligned_cols=134 Identities=28% Similarity=0.464 Sum_probs=113.1
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999975 5899999987521 22345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++...+ .+++.+...++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997543 5678888899999999999999 99999999999999999999999999999986543
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......||+.|+||
T Consensus 154 --~~~~~~gt~~y~aP 167 (333)
T cd05600 154 --YANSVVGSPDYMAP 167 (333)
T ss_pred --ccCCcccCccccCh
Confidence 12234688899998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=202.16 Aligned_cols=116 Identities=28% Similarity=0.427 Sum_probs=100.5
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~e 432 (527)
+|++.+.||+|+||.||+|+. .+++.||||++.. .+..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 689999999999999999985 4689999998742 1123456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
||++|+|.+++...+ .++......++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+.
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 999999999997643 4677777888999999999999 99999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=199.90 Aligned_cols=120 Identities=33% Similarity=0.528 Sum_probs=104.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+.. +++.||||++... +..++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999865 6899999997521 22345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||+++|+|.+++... ..++......++.|++.||+||| +++|+||||||+||+++.++.+|++|||+++....
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999765 46788888899999999999999 89999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-23 Score=204.86 Aligned_cols=131 Identities=35% Similarity=0.470 Sum_probs=111.0
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c-CccceeEEEEEe
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C-SNEDFRALVLEY 433 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~-~~~~~~~lv~ey 433 (527)
|...+.||.|+||.||.|+. ++.+.||||++.+. | -.+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66678999999999999985 56789999997532 1 123345689999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
|-| +-.+++...+..+...+...|..+.+.||+||| +++.||||||+.|||+.+.|.||++|||-|....+.
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 975 888888777777887788889999999999999 999999999999999999999999999999887532
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
..++||++||||
T Consensus 180 --nsFvGTPywMAP 191 (948)
T KOG0577|consen 180 --NSFVGTPYWMAP 191 (948)
T ss_pred --hcccCCccccch
Confidence 357899999999
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=201.31 Aligned_cols=117 Identities=28% Similarity=0.434 Sum_probs=101.2
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+. .+++.||||++.. .+...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999985 5789999998742 112345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
||+++|+|.+++... ..++......++.|++.||+||| +.+|+||||||+||+++.++.+|++|||+|+.
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999998754 35677778889999999999999 99999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=171.66 Aligned_cols=136 Identities=28% Similarity=0.418 Sum_probs=113.8
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeeccCc-------------------------------cceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSCSN-------------------------------EDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-------------------------------~~~~~lv~ey 433 (527)
.|+..++||||.||+||+|+. .+++.||+|.++....+ +....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466778999999999999985 57899999998753222 2234589999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
|.. +|.++.....+.++......++.|+.+|+.++| ++.+.|||+||+|.+++.+|+.|++|||+||.+.-.-.
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr-- 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-- 156 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--
Confidence 975 999999888888999888999999999999999 99999999999999999999999999999998764322
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....+.|+||.+|
T Consensus 157 cysaevvtlwyrpp 170 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPP 170 (292)
T ss_pred eeeceeeeeeccCc
Confidence 22345678999887
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=193.62 Aligned_cols=134 Identities=33% Similarity=0.465 Sum_probs=112.6
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+.. +++.||+|++... +.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999865 6899999987421 12345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++...+ .+++.....++.|++.||+|+| +++|+||||||+||++++++.+|++|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 9999999999987643 5678888899999999999999 9999999999999999999999999999998764321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
....||+.|+||
T Consensus 156 ----~~~~gt~~y~aP 167 (291)
T cd05612 156 ----WTLCGTPEYLAP 167 (291)
T ss_pred ----ccccCChhhcCH
Confidence 124578889998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=196.41 Aligned_cols=131 Identities=29% Similarity=0.420 Sum_probs=107.6
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|+. .+|+.||||++... +...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999986 57899999987521 22345678999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceec
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 517 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 517 (527)
+|.+++... ..+++.+...++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 154 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence 999988754 35788888899999999999999 99999999999999999999999999999986432211 1223
Q ss_pred cccccccccC
Q 035895 518 TLAIIGYMAP 527 (527)
Q Consensus 518 ~~~t~~y~aP 527 (527)
..||+.||||
T Consensus 155 ~~gt~~y~aP 164 (323)
T cd05571 155 FCGTPEYLAP 164 (323)
T ss_pred eecCccccCh
Confidence 4689999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=201.37 Aligned_cols=116 Identities=28% Similarity=0.415 Sum_probs=100.1
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~e 432 (527)
.|+..+.||+|+||+||+|+. .+++.||+|++.. .+..++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 488899999999999999986 5688999998742 1223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
||++|+|.+++...+ .++......++.|++.||+|+| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 999999999987543 4677777889999999999999 99999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=189.61 Aligned_cols=142 Identities=27% Similarity=0.393 Sum_probs=116.8
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVL 431 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ 431 (527)
..++|++..+||.|..++||+|+. +.++.||||++... ...+...++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457799999999999999999984 67899999997531 12244567999
Q ss_pred EeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 432 EYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 432 ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
.||.+|++.+++... ...++......|..+++.||.||| .+|.||||||+.|||++++|.||++|||++..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998753 344788888889999999999999 9999999999999999999999999999987765432
Q ss_pred Cc-cce-eccccccccccC
Q 035895 511 QS-MTQ-TQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~-~~~-~~~~~t~~y~aP 527 (527)
.. ... ...+||++||||
T Consensus 181 ~R~~~rf~tfvgtp~wmAP 199 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAP 199 (516)
T ss_pred ceeeEeeccccCcccccCh
Confidence 11 111 346799999999
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.9e-22 Score=197.56 Aligned_cols=135 Identities=30% Similarity=0.404 Sum_probs=112.5
Q ss_pred cCCccccceeccCCceEEEEEEccC--CcEEEEEEEee--------------------------------ccCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD--GMEFAIKVFHF--------------------------------SCSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~--------------------------------~~~~~~~~~l 429 (527)
.++|++.+.||+|+||.||+|..+. +..||+|++.. .+..++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4579999999999999999998543 36899998742 1223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|++|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999987543 5788888899999999999999 999999999999999999999999999999876432
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
. ....||+.||||
T Consensus 185 ~-----~~~~gt~~y~aP 197 (340)
T PTZ00426 185 T-----YTLCGTPEYIAP 197 (340)
T ss_pred c-----ceecCChhhcCH
Confidence 1 234688899998
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=196.51 Aligned_cols=135 Identities=32% Similarity=0.427 Sum_probs=113.5
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||.||+|+.. +++.||+|++.. .+..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467999999999999999999875 689999998742 12234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++...+ .++......++.|++.||+||| +++|+||||||+||++++++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999987643 4677778889999999999999 9999999999999999999999999999998764321
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
....||+.||||
T Consensus 173 -----~~~~gt~~y~aP 184 (329)
T PTZ00263 173 -----FTLCGTPEYLAP 184 (329)
T ss_pred -----ceecCChhhcCH
Confidence 124578899998
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=193.92 Aligned_cols=140 Identities=26% Similarity=0.446 Sum_probs=109.1
Q ss_pred CCccccceeccCCceEEEEEEcc-----------------CCcEEEEEEEeec---------------------------
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-----------------DGMEFAIKVFHFS--------------------------- 420 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-----------------~~~~vavK~~~~~--------------------------- 420 (527)
++|++.+.||+|+||.||+|..+ ++..||+|++...
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46888999999999999999753 2347999987431
Q ss_pred ---cCccceeEEEEEeccCCcHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 035895 421 ---CSNEDFRALVLEYTTNGSLEKVLYSSN------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479 (527)
Q Consensus 421 ---~~~~~~~~lv~ey~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiH 479 (527)
+..++..++||||+++|+|.+++.... ..+++.....++.|++.|++||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 123345689999999999999886421 23567788899999999999999 999999
Q ss_pred cCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 480 rdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||||+||++++++.+|++|||+++.+.............++..||||
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW 209 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence 999999999999999999999999876433221112223356789988
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=194.56 Aligned_cols=131 Identities=30% Similarity=0.428 Sum_probs=107.2
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
++||+|+||.||+|+.. +++.||||+++.. +..++..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999864 5789999987521 1123467899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++...+ .++..+...++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--ccc
Confidence 99999886543 5788888889999999999999 99999999999999999999999999999986532221 222
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||..||||
T Consensus 155 ~~~gt~~y~aP 165 (316)
T cd05592 155 TFCGTPDYIAP 165 (316)
T ss_pred cccCCccccCH
Confidence 35688999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=206.53 Aligned_cols=255 Identities=25% Similarity=0.292 Sum_probs=201.0
Q ss_pred CCCCEEEcccccccccc---ccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccE
Q 035895 44 STLKVFDVDNNYVLGRL---SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120 (527)
Q Consensus 44 ~~L~~L~Ls~N~~~~~~---~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~ 120 (527)
..-..|||+.|.+...+ +..++.|++++|+|+.++.. +++|++|++++|+|+.+ |.. ..+|+.
T Consensus 201 ~~~~~LdLs~~~LtsLP~~l~~~L~~L~L~~N~Lt~LP~l---------p~~Lk~LdLs~N~LtsL-P~l----p~sL~~ 266 (788)
T PRK15387 201 NGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPAL---------PPELRTLEVSGNQLTSL-PVL----PPGLLE 266 (788)
T ss_pred CCCcEEEcCCCCCCcCCcchhcCCCEEEccCCcCCCCCCC---------CCCCcEEEecCCccCcc-cCc----ccccce
Confidence 44678999999887432 23578999999999986542 47899999999999964 542 357999
Q ss_pred EEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccC
Q 035895 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200 (527)
Q Consensus 121 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 200 (527)
|++++|.++. +|.. ..+|+.|++++|+++.. |. .+++|+.|++++|++++ +|.. ...|+.|++++|+|
T Consensus 267 L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L 334 (788)
T PRK15387 267 LSIFSNPLTH-LPAL---PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQL 334 (788)
T ss_pred eeccCCchhh-hhhc---hhhcCEEECcCCccccc-cc---cccccceeECCCCcccc-CCCC---cccccccccccCcc
Confidence 9999999984 3433 35788999999999854 43 35789999999999985 4543 24688899999999
Q ss_pred CCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhh
Q 035895 201 SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ 280 (527)
Q Consensus 201 ~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 280 (527)
++ +|.. ..+|+.|+|++|+|+.+|... .+|..|++++|.+.. +|.. ...|+.|++++|++.+ +|..
T Consensus 335 ~~-LP~l---p~~Lq~LdLS~N~Ls~LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l-- 400 (788)
T PRK15387 335 TS-LPTL---PSGLQELSVSDNQLASLPTLP---SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL-- 400 (788)
T ss_pred cc-cccc---ccccceEecCCCccCCCCCCC---cccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc--
Confidence 85 4542 257999999999999998743 467788999999875 5653 3578999999999985 5543
Q ss_pred cCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 281 GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 281 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
.++|+.|++++|++++ +|..+ .+|+.|++++|+++. +|..+..+..|..++++.+.+.
T Consensus 401 -~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~-LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 401 -PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred -ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCcccc-cChHHhhccCCCeEECCCCCCC
Confidence 3679999999999984 66543 468899999999985 6888999999999999988774
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=189.77 Aligned_cols=140 Identities=29% Similarity=0.357 Sum_probs=113.2
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc------------------------------------Cccc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC------------------------------------SNED 425 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~------------------------------------~~~~ 425 (527)
....|...+.||+|+||.|+.|.. ++|+.||||++.... ..-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345566678999999999999985 578999999875210 1123
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..|+|+|+|+ .||.++++.. ..+.......+..|+.+|+.|+| +.+|+|||+||.|++++.+...||+|||+||.
T Consensus 100 DvYiV~elMe-tDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 5689999995 5999998754 34777778889999999999999 99999999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+......-.|+.+.|.||.||
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAP 196 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAP 196 (359)
T ss_pred ccccCcccchhcceeeeeecCH
Confidence 8643222234667889999998
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=193.45 Aligned_cols=131 Identities=28% Similarity=0.420 Sum_probs=106.9
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|+. .+++.||+|++... +..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 57899999987421 12345678999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
+|..++... ..+++.+...++.|++.||+||| + .+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 999888654 35788889999999999999999 7 7999999999999999999999999999886432211 112
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.||||
T Consensus 155 ~~~gt~~y~aP 165 (325)
T cd05594 155 TFCGTPEYLAP 165 (325)
T ss_pred cccCCcccCCH
Confidence 34588999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=194.49 Aligned_cols=131 Identities=30% Similarity=0.428 Sum_probs=107.6
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|+. .+++.||+|++... +..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999986 46899999987521 12345678999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceec
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 517 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 517 (527)
+|..++... ..+++.+...++.|++.||+||| +++|+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 154 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKT 154 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cccc
Confidence 999888654 35788888999999999999999 99999999999999999999999999999986432211 1223
Q ss_pred cccccccccC
Q 035895 518 TLAIIGYMAP 527 (527)
Q Consensus 518 ~~~t~~y~aP 527 (527)
..||+.||||
T Consensus 155 ~~gt~~y~aP 164 (328)
T cd05593 155 FCGTPEYLAP 164 (328)
T ss_pred ccCCcCccCh
Confidence 4688999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=205.43 Aligned_cols=143 Identities=29% Similarity=0.403 Sum_probs=114.6
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------C------------cc-----
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------S------------NE----- 424 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------~------------~~----- 424 (527)
...+.|++.+.||+|+||+||+|+. .+|+.||||++.... . ..
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 578999999874210 0 00
Q ss_pred ---ceeEEEEEeccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 035895 425 ---DFRALVLEYTTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 425 ---~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~ 498 (527)
...++||||+++|+|.+++... ...++......++.|++.||+|+| +++|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 1256999999999999998643 235778888899999999999999 9999999999999999999999999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++.+.............||++||||
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP 214 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAP 214 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCH
Confidence 99999876432222222335689999998
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=190.78 Aligned_cols=138 Identities=25% Similarity=0.440 Sum_probs=112.8
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|+..+.||+|+||.||+|+.+ +++.||+|++... ...++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999864 6889999987421 122345679999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++ +|.+++...+..+++.....++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 9985 999988766666788888999999999999999 99999999999999999999999999999986542221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......+++.||||
T Consensus 159 -~~~~~~~~~~y~aP 172 (288)
T cd07871 159 -TYSNEVVTLWYRPP 172 (288)
T ss_pred -cccCceecccccCh
Confidence 11234568889998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=193.85 Aligned_cols=131 Identities=29% Similarity=0.430 Sum_probs=107.4
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|+. .+|+.||+|++... +...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999986 46899999987421 12345678999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceec
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 517 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 517 (527)
+|..++... ..+++.....++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 154 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence 999888654 35788888999999999999999 99999999999999999999999999999886432211 1223
Q ss_pred cccccccccC
Q 035895 518 TLAIIGYMAP 527 (527)
Q Consensus 518 ~~~t~~y~aP 527 (527)
..||+.||||
T Consensus 155 ~~gt~~y~aP 164 (323)
T cd05595 155 FCGTPEYLAP 164 (323)
T ss_pred ccCCcCcCCc
Confidence 4588999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=191.68 Aligned_cols=138 Identities=27% Similarity=0.436 Sum_probs=112.8
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|++.+.||+|+||.||+|+.. +++.||||++... +..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999975 6899999987421 123446689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++ ++|.+++......++...+..++.|++.||+|+| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 996 5888887765556788888999999999999999 99999999999999999999999999999986532221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......+|+.||||
T Consensus 159 -~~~~~~~~~~y~aP 172 (303)
T cd07869 159 -TYSNEVVTLWYRPP 172 (303)
T ss_pred -cCCCCcccCCCCCh
Confidence 12234578889998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-22 Score=196.72 Aligned_cols=139 Identities=27% Similarity=0.497 Sum_probs=118.0
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc-------------------------------Cccce-eEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC-------------------------------SNEDF-RALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-------------------------------~~~~~-~~lv 430 (527)
.+.|...+++|+|+||.++.++++ ++..+++|.+.... ..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467999999999999999999864 57899999985421 12333 7899
Q ss_pred EEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 431 LEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+||++++.+...+ ..++..+...++.|++.|+.||| +..|+|||||+.||++..++.||++|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998765 56788889999999999999999 999999999999999999999999999999998755
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .+...+||+.||.|
T Consensus 160 ~~--~a~tvvGTp~YmcP 175 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCP 175 (426)
T ss_pred hh--hhheecCCCcccCH
Confidence 42 22346799999988
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=193.42 Aligned_cols=131 Identities=34% Similarity=0.443 Sum_probs=107.3
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||.||+|+.. +++.||||++... +...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999864 6889999987421 1233457899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++... ..++...+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS 154 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence 9999988754 35788888999999999999999 99999999999999999999999999999886432211 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.||||
T Consensus 155 ~~~gt~~y~aP 165 (320)
T cd05590 155 TFCGTPDYIAP 165 (320)
T ss_pred ccccCccccCH
Confidence 35688999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=198.45 Aligned_cols=132 Identities=28% Similarity=0.462 Sum_probs=112.7
Q ss_pred cccceeccCCceEEEEEEccCCcEEEEEEEe----------------------eccCccceeEEEEEeccCCcHHHHHHh
Q 035895 388 SANNLIGRGSFGSVYKARLQDGMEFAIKVFH----------------------FSCSNEDFRALVLEYTTNGSLEKVLYS 445 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~----------------------~~~~~~~~~~lv~ey~~~g~L~~~l~~ 445 (527)
...+-||.|+.|.||+|+++ ++.||||+++ ..|.....++||||||+.|.|+.+|+.
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka 205 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA 205 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc
Confidence 44678999999999999997 4789999753 246677788999999999999999975
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccc
Q 035895 446 SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525 (527)
Q Consensus 446 ~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 525 (527)
.. .+.....+.+..+||.|+.||| .+.|||||||+-|||+..+-.+||+|||.++.+.+.. +.-.++||..||
T Consensus 206 ~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWM 278 (904)
T KOG4721|consen 206 GR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAGTVAWM 278 (904)
T ss_pred cC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhhhHhhh
Confidence 44 4566677889999999999999 9999999999999999999999999999999876442 233578999999
Q ss_pred cC
Q 035895 526 AP 527 (527)
Q Consensus 526 aP 527 (527)
||
T Consensus 279 AP 280 (904)
T KOG4721|consen 279 AP 280 (904)
T ss_pred CH
Confidence 98
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-22 Score=185.01 Aligned_cols=138 Identities=30% Similarity=0.406 Sum_probs=114.9
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|+..++||+|.||+|..++. .+++-+|||+++. +.+..+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46789999999999999999985 5789999998642 23456788999
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+.||.|.-++... ..++..+...+..+|..||.||| +++||.||+|.+|.|+|.+|++||+|||+++.--...
T Consensus 247 MeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 9999999999888754 45666667778999999999999 9999999999999999999999999999998532111
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.+....+||+.|.||
T Consensus 323 --~t~kTFCGTPEYLAP 337 (516)
T KOG0690|consen 323 --DTTKTFCGTPEYLAP 337 (516)
T ss_pred --ceeccccCChhhcCc
Confidence 123357899999998
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-22 Score=182.40 Aligned_cols=136 Identities=33% Similarity=0.534 Sum_probs=114.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------------cCccc
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------------CSNED 425 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------------~~~~~ 425 (527)
..|+..+.+|+|..++|.++.+ ++|.++|+|++... +..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3467788999999999988865 57899999987532 22344
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
+.++|+|.|+.|.|.+++... -.++..+..+|+.|+.+|++|+| +++|||||+||+|||+|++.++||+|||+|..
T Consensus 97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeec
Confidence 667999999999999999753 34677788899999999999999 99999999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+..... -...+||++|.||
T Consensus 173 l~~Gek---LrelCGTPgYLAP 191 (411)
T KOG0599|consen 173 LEPGEK---LRELCGTPGYLAP 191 (411)
T ss_pred cCCchh---HHHhcCCCcccCh
Confidence 764432 2357899999998
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=215.61 Aligned_cols=286 Identities=22% Similarity=0.236 Sum_probs=154.2
Q ss_pred cCchhhhcCCCCCEEEcccccc------cc-------ccccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccC
Q 035895 35 IVSITIFNLSTLKVFDVDNNYV------LG-------RLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRN 101 (527)
Q Consensus 35 ~~~~~~~~l~~L~~L~Ls~N~~------~~-------~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N 101 (527)
+.+.+|.+|++|+.|.+..+.. .. .+|..++.|++.++.++.++..+ .+.+|++|+|++|
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-------~~~~L~~L~L~~s 621 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-------RPENLVKLQMQGS 621 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-------CccCCcEEECcCc
Confidence 4456788899999888866531 11 12345677777777777665532 2456677777777
Q ss_pred CCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccC
Q 035895 102 PLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP 181 (527)
Q Consensus 102 ~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 181 (527)
++.. ++..+..+. +|+.|+|++|.....+|. +..+++|++|+|++|.....+|..++.+++|+.|++++|..-+.+|
T Consensus 622 ~l~~-L~~~~~~l~-~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp 698 (1153)
T PLN03210 622 KLEK-LWDGVHSLT-GLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILP 698 (1153)
T ss_pred cccc-cccccccCC-CCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccC
Confidence 6664 344444443 577777766554334443 5566677777776665545566666666777777776654333455
Q ss_pred hhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhh------------------------------
Q 035895 182 NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSIL------------------------------ 231 (527)
Q Consensus 182 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~------------------------------ 231 (527)
..+ ++++|+.|++++|...+.+|.. .++|+.|++++|.++.+|..+
T Consensus 699 ~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~ 774 (1153)
T PLN03210 699 TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMT 774 (1153)
T ss_pred CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhh
Confidence 443 5566666666666544344432 234555555555555555321
Q ss_pred hCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCE
Q 035895 232 WNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311 (527)
Q Consensus 232 ~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 311 (527)
...++|+.|++++|.....+|.+++++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.. .++|+.
T Consensus 775 ~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~ 850 (1153)
T PLN03210 775 MLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISD 850 (1153)
T ss_pred hccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCE
Confidence 001245555555555555556666666666666666554334444433 3445555555544332222221 123444
Q ss_pred EeCCCCcccccCccchhhhccCCeeEee
Q 035895 312 LDLSNNNLSEIIPLSLEKLLYLNILLIV 339 (527)
Q Consensus 312 L~ls~N~l~~~~p~~~~~l~~L~~L~~~ 339 (527)
|+|++|.++. +|.++..+..|+.|+++
T Consensus 851 L~Ls~n~i~~-iP~si~~l~~L~~L~L~ 877 (1153)
T PLN03210 851 LNLSRTGIEE-VPWWIEKFSNLSFLDMN 877 (1153)
T ss_pred eECCCCCCcc-ChHHHhcCCCCCEEECC
Confidence 4444444432 33344444444444433
|
syringae 6; Provisional |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=192.93 Aligned_cols=131 Identities=34% Similarity=0.409 Sum_probs=106.8
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
++||+|+||.||+|+.. +++.||||++... +..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 5789999987421 1233456899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|...+... ..+++.....++.+++.||+||| +++|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 9999988654 35788888899999999999999 99999999999999999999999999999886432221 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.||||
T Consensus 155 ~~~gt~~y~aP 165 (321)
T cd05591 155 TFCGTPDYIAP 165 (321)
T ss_pred ccccCccccCH
Confidence 34588899998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-20 Score=214.22 Aligned_cols=292 Identities=20% Similarity=0.250 Sum_probs=214.2
Q ss_pred ceeecCchhhhcC-CCCCEEEcccccccccc----ccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCc
Q 035895 31 KLVGIVSITIFNL-STLKVFDVDNNYVLGRL----SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDG 105 (527)
Q Consensus 31 ~l~~~~~~~~~~l-~~L~~L~Ls~N~~~~~~----~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 105 (527)
.+....|..|..+ .+|+.|++++|.+...+ +..++.|+|++|++..+.. .+..+++|+.|+|++|....
T Consensus 575 ~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f~~~~L~~L~L~~s~l~~L~~------~~~~l~~Lk~L~Ls~~~~l~ 648 (1153)
T PLN03210 575 EVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNFRPENLVKLQMQGSKLEKLWD------GVHSLTGLRNIDLRGSKNLK 648 (1153)
T ss_pred cceeecCcchhhcCcccEEEEecCCCCCCCCCcCCccCCcEEECcCcccccccc------ccccCCCCCEEECCCCCCcC
Confidence 3444556666666 46899999888764322 2457889999998877543 34678888999998876444
Q ss_pred ccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhh
Q 035895 106 FLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185 (527)
Q Consensus 106 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 185 (527)
.+|. +..+ ++|+.|+|++|.....+|..+..+++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|..
T Consensus 649 ~ip~-ls~l-~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~-- 723 (1153)
T PLN03210 649 EIPD-LSMA-TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI-- 723 (1153)
T ss_pred cCCc-cccC-CcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc--
Confidence 5564 4444 478888988887666788888888888899888865444555544 6788888888887655455543
Q ss_pred cCcccCeeeeecccCCCCCCccc------------------------------cCCccCceeeCCCCC-CCCCchhhhCC
Q 035895 186 HLAVLFQLDLRGNKLSGSIPTCF------------------------------GNLTALRNLHLDSNE-LTSIPSILWNL 234 (527)
Q Consensus 186 ~l~~L~~L~L~~N~l~~~~p~~~------------------------------~~l~~L~~L~L~~N~-l~~lp~~~~~l 234 (527)
..+|+.|++++|.+.. +|..+ ...++|+.|++++|. +..+|..+.++
T Consensus 724 -~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L 801 (1153)
T PLN03210 724 -STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNL 801 (1153)
T ss_pred -cCCcCeeecCCCcccc-ccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCC
Confidence 3467777777777653 33221 123578888888885 45589999999
Q ss_pred CCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeC
Q 035895 235 KDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDL 314 (527)
Q Consensus 235 ~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 314 (527)
++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|++
T Consensus 802 ~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L 876 (1153)
T PLN03210 802 HKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDM 876 (1153)
T ss_pred CCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEEC
Confidence 999999999887777788766 7899999999998766666653 367899999999997 67888999999999999
Q ss_pred CCC-cccccCccchhhhccCCeeEeeee
Q 035895 315 SNN-NLSEIIPLSLEKLLYLNILLIVVV 341 (527)
Q Consensus 315 s~N-~l~~~~p~~~~~l~~L~~L~~~~~ 341 (527)
++| ++.. +|.....+++|+.++++.+
T Consensus 877 ~~C~~L~~-l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 877 NGCNNLQR-VSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCCCcCc-cCcccccccCCCeeecCCC
Confidence 985 5544 6667778888888876644
|
syringae 6; Provisional |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=192.07 Aligned_cols=131 Identities=28% Similarity=0.436 Sum_probs=107.2
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||.||+|+.. +|+.||+|+++.. +...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999865 6889999987521 1233567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++... ..+++.+...++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence 9999988654 35788888899999999999999 99999999999999999999999999999875322111 223
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||..|+||
T Consensus 155 ~~~gt~~y~aP 165 (316)
T cd05620 155 TFCGTPDYIAP 165 (316)
T ss_pred ccCCCcCccCH
Confidence 35688999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=191.40 Aligned_cols=129 Identities=33% Similarity=0.423 Sum_probs=106.6
Q ss_pred eccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEEEEeccCCcH
Q 035895 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 393 lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ey~~~g~L 439 (527)
||+|+||.||+|+.. +++.||+|++.. .+..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999864 688999998742 12234567899999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 519 (527)
.+++... ..+++.....++.|++.||+||| +++|+||||||+||+++.++.+|++|||+++....... ......
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 154 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC 154 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence 9998754 35788888999999999999999 99999999999999999999999999999986432211 122346
Q ss_pred cccccccC
Q 035895 520 AIIGYMAP 527 (527)
Q Consensus 520 ~t~~y~aP 527 (527)
||+.||||
T Consensus 155 gt~~y~aP 162 (312)
T cd05585 155 GTPEYLAP 162 (312)
T ss_pred CCcccCCH
Confidence 88999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=197.02 Aligned_cols=139 Identities=30% Similarity=0.451 Sum_probs=111.3
Q ss_pred cCCccccceeccCCceEEEEEEccC--C---cEEEEEEEee--------------------------------ccCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD--G---MEFAIKVFHF--------------------------------SCSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~--~---~~vavK~~~~--------------------------------~~~~~~~ 426 (527)
-++-...++||+|+||.||+|+++. + ..||||.... .+..+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3445566999999999999998643 2 2389998753 1234455
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++|||+|+||+|.++|++.+..++..++..++.+.|.||+||| ++++|||||-++|+|++.++.+||+|||+++.-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 67999999999999999987767899999999999999999999 999999999999999999999999999998864
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.. ...........+.|+||
T Consensus 313 ~~--~~~~~~~~klPirWLAP 331 (474)
T KOG0194|consen 313 SQ--YVMKKFLKKLPIRWLAP 331 (474)
T ss_pred cc--eeeccccccCcceecCh
Confidence 31 11111122356789998
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=192.40 Aligned_cols=134 Identities=29% Similarity=0.438 Sum_probs=110.2
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------------cCccceeEEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------------CSNEDFRALV 430 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------------~~~~~~~~lv 430 (527)
|++.+.||+|+||.||+|+. .+++.||||++... +...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67789999999999999986 46899999997521 1123456899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|...+.. ..+++.+...++.|++.|++|+| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999988754 35788899999999999999999 9999999999999999999999999999987543221
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ......|++.||||
T Consensus 156 ~--~~~~~~g~~~y~aP 170 (324)
T cd05589 156 D--RTSTFCGTPEFLAP 170 (324)
T ss_pred C--cccccccCccccCH
Confidence 1 12234688899998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=192.00 Aligned_cols=131 Identities=35% Similarity=0.458 Sum_probs=107.2
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||+||+|+.. +|+.||+|++... +...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999864 6899999987421 1233466899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++... ..+++.....++.||+.||+||| +++|+||||||+||++++++.+|++|||+++....... ...
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTS 154 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccc
Confidence 9999988754 35778888889999999999999 99999999999999999999999999999876432211 223
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.||||
T Consensus 155 ~~~gt~~y~aP 165 (323)
T cd05575 155 TFCGTPEYLAP 165 (323)
T ss_pred cccCChhhcCh
Confidence 35688999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=196.95 Aligned_cols=140 Identities=26% Similarity=0.441 Sum_probs=109.2
Q ss_pred CCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec-------------------------------cCcccee
Q 035895 385 DGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS-------------------------------CSNEDFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~-------------------------------~~~~~~~ 427 (527)
++|++.+.||+|+||.||+|+. .++..||||+++.. +...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4588899999999999999963 34668999987421 2233456
Q ss_pred EEEEEeccCCcHHHHHHhcC------------------------------------------------------------
Q 035895 428 ALVLEYTTNGSLEKVLYSSN------------------------------------------------------------ 447 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~------------------------------------------------------------ 447 (527)
++|||||++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 79999999999999886421
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 448 --------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 448 --------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
..+++.....++.||+.|++|+| +++|+||||||+||++++++.+|++|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 13677788899999999999999 9999999999999999999999999999998764332211
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++..||||
T Consensus 272 ~~~~~~~~~~y~aP 285 (375)
T cd05104 272 VKGNARLPVKWMAP 285 (375)
T ss_pred ccCCCCCCcceeCh
Confidence 11122345679998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-21 Score=191.93 Aligned_cols=131 Identities=34% Similarity=0.446 Sum_probs=107.3
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||+||+|+. .+|+.||+|++... +..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 56899999987421 1234567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++... ..+++.+...++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 9999888654 35788888899999999999999 99999999999999999999999999999875422211 223
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||..||||
T Consensus 155 ~~~gt~~y~aP 165 (325)
T cd05604 155 TFCGTPEYLAP 165 (325)
T ss_pred cccCChhhCCH
Confidence 45688999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=199.03 Aligned_cols=134 Identities=35% Similarity=0.561 Sum_probs=110.8
Q ss_pred cccceeccCCceEEEEEE-ccCCcEEEEEEEeec---------------------------c--Cc-------cceeEEE
Q 035895 388 SANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFS---------------------------C--SN-------EDFRALV 430 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~---------------------------~--~~-------~~~~~lv 430 (527)
...+.||+||||.||+|+ ..+|+.||||.+... + .+ .+...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 445789999999999999 568999999986431 1 11 2345699
Q ss_pred EEeccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCc--EEEeeccccc
Q 035895 431 LEYTTNGSLEKVLYSSN--YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD--DNIV--AHLSDFGIAK 504 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~--~~~~--~kl~Dfg~a~ 504 (527)
||||+||||+.++.+.+ +.++..+.+.+..+++.|+.||| .++||||||||.||++- ++|+ -|++|||.||
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999998764 45888899999999999999999 99999999999999994 4443 5899999999
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.++++. ..+..+||..|.||
T Consensus 173 el~d~s---~~~S~vGT~~YLhP 192 (732)
T KOG4250|consen 173 ELDDNS---LFTSLVGTEEYLHP 192 (732)
T ss_pred cCCCCC---eeeeecCchhhcCh
Confidence 987654 34567899999998
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=191.32 Aligned_cols=140 Identities=24% Similarity=0.377 Sum_probs=111.2
Q ss_pred CCccccceeccCCceEEEEEEcc-CCc----EEEEEEEeecc-----------------------------CccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIKVFHFSC-----------------------------SNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~-----------------------------~~~~~~~lv 430 (527)
.+|+..+.||+|+||.||+|++. +++ .||+|++.... ...+..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46899999999999999999853 333 48999874211 012345689
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
+||+++|+|.+++......+++.....++.||+.||+||| +++|+||||||+||++++++.+||+|||+++.+....
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 9999999999999876666788888999999999999999 9999999999999999999999999999999775332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.........++..||||
T Consensus 164 ~~~~~~~~~~~~~y~ap 180 (316)
T cd05108 164 KEYHAEGGKVPIKWMAL 180 (316)
T ss_pred cceeccCCccceeecCh
Confidence 22222223346679987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=197.04 Aligned_cols=141 Identities=26% Similarity=0.463 Sum_probs=109.2
Q ss_pred cCCccccceeccCCceEEEEEEc------cCCcEEEEEEEee-------------------------------ccCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHF-------------------------------SCSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~-------------------------------~~~~~~~ 426 (527)
.++|++.+.||+|+||.||+|+. .++..||||++.. .+...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34688999999999999999873 2346799998742 1223456
Q ss_pred eEEEEEeccCCcHHHHHHhcC-----------------------------------------------------------
Q 035895 427 RALVLEYTTNGSLEKVLYSSN----------------------------------------------------------- 447 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~----------------------------------------------------------- 447 (527)
.++|||||++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 789999999999999886421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceec
Q 035895 448 ----------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 517 (527)
Q Consensus 448 ----------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 517 (527)
..+++.+..+++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 13567788899999999999999 99999999999999999999999999999987643322111112
Q ss_pred cccccccccC
Q 035895 518 TLAIIGYMAP 527 (527)
Q Consensus 518 ~~~t~~y~aP 527 (527)
..++..||||
T Consensus 274 ~~~~~~y~aP 283 (374)
T cd05106 274 ARLPVKWMAP 283 (374)
T ss_pred CCCccceeCH
Confidence 2345679998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-23 Score=187.34 Aligned_cols=137 Identities=31% Similarity=0.454 Sum_probs=114.9
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------cC------------ccceeEEEEEeccCC
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------CS------------NEDFRALVLEYTTNG 437 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------~~------------~~~~~~lv~ey~~~g 437 (527)
-|.+..+||+|+||.||+|.+ .+|+.+|||.+... |. .....++|||||..|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 378889999999999999976 46999999987431 21 223457999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceec
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 517 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 517 (527)
+..++++.....+...+...+....+.||+||| ...-||||||+.|||++-+|.+|++|||+|-.+.+.. .....
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNT 188 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNT 188 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCc
Confidence 999999988788888888889999999999999 7778999999999999999999999999998775321 22334
Q ss_pred cccccccccC
Q 035895 518 TLAIIGYMAP 527 (527)
Q Consensus 518 ~~~t~~y~aP 527 (527)
..||+.||||
T Consensus 189 VIGTPFWMAP 198 (502)
T KOG0574|consen 189 VIGTPFWMAP 198 (502)
T ss_pred cccCcccccH
Confidence 6699999998
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-23 Score=219.58 Aligned_cols=196 Identities=31% Similarity=0.385 Sum_probs=106.2
Q ss_pred CCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCC
Q 035895 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLD 220 (527)
Q Consensus 141 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 220 (527)
+|+++++++|++++ +|..++.+.+|+.++..+|++. .+|..+....+|+.|++..|.++ -+|+....+.+|++|+|.
T Consensus 242 nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 35556666666654 3366666666666666666664 45555555555555555555555 234444555555566665
Q ss_pred CCCCCCCchh--------------------------------------------------hhCCCCccEEEccCCccccc
Q 035895 221 SNELTSIPSI--------------------------------------------------LWNLKDILYLDFWSNLFVGP 250 (527)
Q Consensus 221 ~N~l~~lp~~--------------------------------------------------~~~l~~L~~l~l~~n~~~~~ 250 (527)
.|+|..+|+. +-+.+.|+.|+++.|++...
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 5555555432 22333444444444444333
Q ss_pred CCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhh
Q 035895 251 LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330 (527)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 330 (527)
....+.++..|+.|+||+|.+. .+|+++..++.|++|...+|++. ..| .+..++.|+.+|+|.|+|+...-......
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 3333444444444444444443 34444444455555555555554 345 66777777888888887776532222223
Q ss_pred ccCCeeEeeeee
Q 035895 331 LYLNILLIVVVI 342 (527)
Q Consensus 331 ~~L~~L~~~~~~ 342 (527)
+.|+.|+++++.
T Consensus 476 p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 476 PNLKYLDLSGNT 487 (1081)
T ss_pred cccceeeccCCc
Confidence 677777777655
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=191.32 Aligned_cols=131 Identities=34% Similarity=0.441 Sum_probs=106.1
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEee---------------------------------ccCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHF---------------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~---------------------------------~~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||+||+|+.. +++.||+|++.. .+..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999864 578899998742 11234567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++...+ .+.......++.|++.||+|+| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~ 154 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS 154 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence 99999987543 4566677789999999999999 99999999999999999999999999999986432211 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.||||
T Consensus 155 ~~~gt~~y~aP 165 (325)
T cd05602 155 TFCGTPEYLAP 165 (325)
T ss_pred cccCCccccCH
Confidence 35688999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=191.48 Aligned_cols=131 Identities=31% Similarity=0.399 Sum_probs=107.1
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||.||+|+. .+++.||+|++... +...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999986 46789999997521 1223456899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++... ..+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 9999888654 35788889999999999999999 99999999999999999999999999999975322211 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.||||
T Consensus 155 ~~~gt~~y~aP 165 (327)
T cd05617 155 TFCGTPNYIAP 165 (327)
T ss_pred cccCCcccCCH
Confidence 35688999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=203.28 Aligned_cols=141 Identities=29% Similarity=0.362 Sum_probs=109.9
Q ss_pred hcCCccccceeccCCceEEEEEEcc-C----CcEEEEEEEeec-------------------------------cCccce
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-D----GMEFAIKVFHFS-------------------------------CSNEDF 426 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~----~~~vavK~~~~~-------------------------------~~~~~~ 426 (527)
..++|++.+.||+|+||.||+|+.. + +..||+|++... +..++.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 4678999999999999999999874 4 689999986421 123456
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCC-------------------CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYIL-------------------DILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNK 487 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~ni 487 (527)
.++||||+++|+|.+++....... .......++.|++.||+|+| +++|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHE
Confidence 789999999999999986532111 12234468999999999999 99999999999999
Q ss_pred eeCC-CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 488 LLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 488 ll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+++ ++.+||+|||+|+.+...... ......++++||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~AP 326 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAP 326 (566)
T ss_pred EEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccCh
Confidence 9985 689999999999876433222 22345678899998
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=191.39 Aligned_cols=131 Identities=28% Similarity=0.362 Sum_probs=107.1
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
++||+|+||.||+|+.. +++.||+|+++.. +..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999864 6889999987521 1223456899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence 9999888654 45788889999999999999999 99999999999999999999999999999875322111 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.||||
T Consensus 155 ~~~gt~~y~aP 165 (329)
T cd05588 155 TFCGTPNYIAP 165 (329)
T ss_pred cccCCccccCH
Confidence 35688999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-21 Score=189.91 Aligned_cols=131 Identities=30% Similarity=0.432 Sum_probs=106.7
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||+||+|+.. +++.||||+++.. +...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 5789999987531 1223456799999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++... ..+++.+...++.|++.|++||| +++|+||||||+||++++++.+|++|||+++....... ...
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 9999998653 35788888899999999999999 99999999999999999999999999999875422111 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||..||||
T Consensus 155 ~~~gt~~y~aP 165 (316)
T cd05619 155 TFCGTPDYIAP 165 (316)
T ss_pred eecCCccccCH
Confidence 34588899998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=186.22 Aligned_cols=139 Identities=27% Similarity=0.349 Sum_probs=114.1
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRA 428 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~ 428 (527)
...+|....+||+|+||.|.+|..+ +.+.+|||+++.. ...-+..|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3457999999999999999999765 5678999987531 12335678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+.||+|..+++..+. +....+..+|.+||.||-+|| +++||.||||..||++|.+|++||+|||+++.--.
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999999976553 455677889999999999999 99999999999999999999999999999985322
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
++ .+....+||+.||||
T Consensus 503 ~~--~TTkTFCGTPdYiAP 519 (683)
T KOG0696|consen 503 DG--VTTKTFCGTPDYIAP 519 (683)
T ss_pred CC--cceeeecCCCccccc
Confidence 22 123347899999998
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=190.63 Aligned_cols=131 Identities=35% Similarity=0.454 Sum_probs=106.2
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEee---------------------------------ccCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHF---------------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~---------------------------------~~~~~~~~~lv~ey~~~ 436 (527)
++||+|+||.||+|+.. +++.||+|++.. .+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999874 688999998742 11234567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|...+... ..+...+...++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTS 154 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccc
Confidence 9999888654 35677778889999999999999 99999999999999999999999999999885422211 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.|+||
T Consensus 155 ~~~gt~~y~aP 165 (321)
T cd05603 155 TFCGTPEYLAP 165 (321)
T ss_pred cccCCcccCCH
Confidence 34688999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=191.11 Aligned_cols=131 Identities=31% Similarity=0.382 Sum_probs=106.9
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||.||+|+. .+++.||+|++... +..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999986 46789999987531 1223467899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++... ..+++.....++.+++.|++|+| +++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 9999888654 35788888999999999999999 99999999999999999999999999999986432211 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||..|+||
T Consensus 155 ~~~gt~~y~aP 165 (329)
T cd05618 155 TFCGTPNYIAP 165 (329)
T ss_pred cccCCccccCH
Confidence 34688999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=191.65 Aligned_cols=129 Identities=31% Similarity=0.411 Sum_probs=105.5
Q ss_pred eccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------------cCccceeEEEEEeccC
Q 035895 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 393 lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------------~~~~~~~~lv~ey~~~ 436 (527)
||+|+||+||+|+.. +++.||||++... +...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 6899999987420 1123456899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++... ..++......++.||++||+||| +++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 9999988654 45788888999999999999999 99999999999999999999999999999976432221 122
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||..||||
T Consensus 155 ~~~gt~~y~aP 165 (330)
T cd05586 155 TFCGTTEYLAP 165 (330)
T ss_pred CccCCccccCH
Confidence 35688999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=189.60 Aligned_cols=132 Identities=30% Similarity=0.497 Sum_probs=110.5
Q ss_pred cceeccCCceEEEEEEc-cCCcEEEEEEEee-------------------------------ccCccceeEEEEEeccCC
Q 035895 390 NNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-------------------------------SCSNEDFRALVLEYTTNG 437 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-------------------------------~~~~~~~~~lv~ey~~~g 437 (527)
.++||.|.||+||-|.+ ++|+.||||++.. -+...+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 58999999999999986 5799999999743 134567788999999876
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCCCCCccc
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
-|+-++...++.++......++.||+.||.||| -++|+|+||||+|||+.+ --++|+||||+||++.... ..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence 677777777778888888889999999999999 899999999999999963 3589999999999996443 22
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
...+||+.|.||
T Consensus 724 -rsVVGTPAYLaP 735 (888)
T KOG4236|consen 724 -RSVVGTPAYLAP 735 (888)
T ss_pred -hhhcCCccccCH
Confidence 246799999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=193.10 Aligned_cols=137 Identities=35% Similarity=0.469 Sum_probs=110.9
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeeccCc------------------------------cceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSCSN------------------------------EDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~------------------------------~~~~~lv~ey 433 (527)
..|+..+.||+|+||.||+|.. ++++.||+|++...... ....+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3477789999999999999985 67899999998642211 1123478999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
|.||++.+.+... ..++......|..++..|+.|+| .++.+|||||+.||++..+|.+|++|||++..+.....
T Consensus 93 ~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred hcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 9999999998643 34466566678899999999999 99999999999999999999999999999988753321
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
....++||+.||||
T Consensus 167 rr~tfvGTPfwMAP 180 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAP 180 (467)
T ss_pred ccccccccccccch
Confidence 22457899999999
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=205.79 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=189.0
Q ss_pred CCCCEEEccccccccc---cccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccE
Q 035895 44 STLKVFDVDNNYVLGR---LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120 (527)
Q Consensus 44 ~~L~~L~Ls~N~~~~~---~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~ 120 (527)
.+...|+++++.++.. +|..++.|+|++|+|++++..+ .++|++|++++|+++. +|..+. .+|+.
T Consensus 178 ~~~~~L~L~~~~LtsLP~~Ip~~L~~L~Ls~N~LtsLP~~l--------~~nL~~L~Ls~N~Lts-LP~~l~---~~L~~ 245 (754)
T PRK15370 178 NNKTELRLKILGLTTIPACIPEQITTLILDNNELKSLPENL--------QGNIKTLYANSNQLTS-IPATLP---DTIQE 245 (754)
T ss_pred cCceEEEeCCCCcCcCCcccccCCcEEEecCCCCCcCChhh--------ccCCCEEECCCCcccc-CChhhh---ccccE
Confidence 3567888888876532 3456889999999999876542 2579999999999986 465543 47999
Q ss_pred EEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccC
Q 035895 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200 (527)
Q Consensus 121 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 200 (527)
|+|++|++. .+|..+. .+|+.|++++|+++. +|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|++
T Consensus 246 L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~L 316 (754)
T PRK15370 246 MELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSL 316 (754)
T ss_pred EECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcc
Confidence 999999998 4565554 579999999999985 455443 589999999999984 555443 4789999999999
Q ss_pred CCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhh
Q 035895 201 SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ 280 (527)
Q Consensus 201 ~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 280 (527)
+. +|..+. ++|+.|++++|.++.+|..+. ++|+.|++++|++. .+|..+. +.|++|++++|+++. +|..+.
T Consensus 317 t~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~ 387 (754)
T PRK15370 317 TA-LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP 387 (754)
T ss_pred cc-CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH
Confidence 85 454332 689999999999999997664 68999999999887 4666553 689999999999984 565554
Q ss_pred cCCCCCEEEcccccceeecCCCC----CCCCCCCEEeCCCCcccc
Q 035895 281 GLKSLQFLSLGHNRLQGSIPNSF----DDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 281 ~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~ls~N~l~~ 321 (527)
.+|+.|++++|+++ .+|..+ ..++.+..|++.+|+++.
T Consensus 388 --~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 388 --AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred --HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 36899999999998 455543 445788999999999863
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-22 Score=212.12 Aligned_cols=263 Identities=29% Similarity=0.347 Sum_probs=200.8
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
++.|+.++|.++..... ..-.+|+.+|+++|++++ +|+++..+. +|+.+...+|+++ .+|..+..+.+|+
T Consensus 221 l~~L~a~~n~l~~~~~~-------p~p~nl~~~dis~n~l~~-lp~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~ 290 (1081)
T KOG0618|consen 221 LTALYADHNPLTTLDVH-------PVPLNLQYLDISHNNLSN-LPEWIGACA-NLEALNANHNRLV-ALPLRISRITSLV 290 (1081)
T ss_pred hheeeeccCcceeeccc-------cccccceeeecchhhhhc-chHHHHhcc-cceEecccchhHH-hhHHHHhhhhhHH
Confidence 45555666655532211 123568888888888886 457777664 6888888888885 5666677777888
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhh--------------------------cCcccCeeeeec
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC--------------------------HLAVLFQLDLRG 197 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~--------------------------~l~~L~~L~L~~ 197 (527)
.|.+.+|.+. -+|....++++|+.|+|..|+|. .+|+.|- ..+.|+.|++.+
T Consensus 291 ~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lylan 368 (1081)
T KOG0618|consen 291 SLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLAN 368 (1081)
T ss_pred HHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhc
Confidence 8888888887 35566777888889999888887 3443221 124578888999
Q ss_pred ccCCCCCCccccCCccCceeeCCCCCCCCCchh-hhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh
Q 035895 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI-LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276 (527)
Q Consensus 198 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 276 (527)
|.++...-+.+.+..+|++|+|++|+|..+|+. +.++..|+.|++++|.++ .+|+.+..++.|++|....|++. ..|
T Consensus 369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 999876666788999999999999999999975 577899999999999987 57899999999999999999997 677
Q ss_pred hhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeee
Q 035895 277 TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVV 341 (527)
Q Consensus 277 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~ 341 (527)
.+..++.|+.+|++.|+++...-..-...++|++||+++|.-....-..|..++.+...++..+
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 8999999999999999998543333333489999999999854555567777777777766644
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-21 Score=189.66 Aligned_cols=131 Identities=34% Similarity=0.464 Sum_probs=106.3
Q ss_pred ceeccCCceEEEEEEc----cCCcEEEEEEEee---------------------------------ccCccceeEEEEEe
Q 035895 391 NLIGRGSFGSVYKARL----QDGMEFAIKVFHF---------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~----~~~~~vavK~~~~---------------------------------~~~~~~~~~lv~ey 433 (527)
+.||+|+||.||+|+. .+++.||+|++.. .+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 3578999998742 11234567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++...+ .+.......++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 99999999987543 4566777889999999999999 99999999999999999999999999999985432221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......||+.|+||
T Consensus 156 ~~~~~~gt~~y~aP 169 (323)
T cd05584 156 VTHTFCGTIEYMAP 169 (323)
T ss_pred cccccCCCccccCh
Confidence 12234588999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.2e-21 Score=193.77 Aligned_cols=138 Identities=29% Similarity=0.391 Sum_probs=115.8
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~l 429 (527)
.++-|++.+.||.|+-|.|-.|++ .+|+.+|||++.. ........|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 356688999999999999999986 6899999998742 1234567789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
|.||++||.|.+++...+ .+...++.+++.||..|+.|+| +.+|||||+||+|+|+|.++.+||+|||+|..-..+
T Consensus 90 vlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999998765 4566677889999999999999 999999999999999999999999999999875433
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
. .-. ..+|++.|.||
T Consensus 166 k--lLe-TSCGSPHYA~P 180 (786)
T KOG0588|consen 166 K--LLE-TSCGSPHYAAP 180 (786)
T ss_pred c--ccc-ccCCCcccCCc
Confidence 2 222 35799999998
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=198.82 Aligned_cols=139 Identities=22% Similarity=0.317 Sum_probs=112.6
Q ss_pred CccccceeccCCceEEEEEEcc-C-CcEEEEEEEee-----------------------------ccCccceeEEEEEec
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-D-GMEFAIKVFHF-----------------------------SCSNEDFRALVLEYT 434 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~-~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey~ 434 (527)
.|.+.+.||+|+||.||+|... + ++.||+|.+.. .+..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999753 3 57788886521 233456788999999
Q ss_pred cCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 435 TNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 435 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
++|+|.+++... ...+++.+...++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999987542 345778888889999999999999 99999999999999999999999999999987653322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.......+||++||||
T Consensus 225 ~~~~~~~~gt~~y~aP 240 (478)
T PTZ00267 225 LDVASSFCGTPYYLAP 240 (478)
T ss_pred cccccccCCCccccCH
Confidence 1222345689999998
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=189.44 Aligned_cols=136 Identities=31% Similarity=0.452 Sum_probs=114.3
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~l 429 (527)
.+.|++.+.||+|+||+||+++.+ +|+.+|+|++... ...++..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 356888899999999999999975 5999999987421 223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC----CCcEEEeecccccc
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD----NIVAHLSDFGIAKL 505 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~----~~~~kl~Dfg~a~~ 505 (527)
|||+|.||+|.+.+... . ++..++..++.+++.++.|+| +.+|+|||+||+|+|+.. ++.+|++|||+|..
T Consensus 114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999998766 3 788889999999999999999 999999999999999963 35899999999998
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ......+||++|+||
T Consensus 189 ~~~~---~~~~~~~Gtp~y~AP 207 (382)
T KOG0032|consen 189 IKPG---ERLHTIVGTPEYVAP 207 (382)
T ss_pred ccCC---ceEeeecCCccccCc
Confidence 7652 123457899999999
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=184.26 Aligned_cols=136 Identities=30% Similarity=0.460 Sum_probs=112.4
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~e 432 (527)
.|+..+.||+|+||.||+|.. .+++.||+|++.. .+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999986 4689999998742 1123456789999
Q ss_pred eccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++.... ..+++.....++.|++.|++|+| +.+|+||||||+||++++++.++++|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999998886543 45788889999999999999999 99999999999999999999999999999987643221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....++..||||
T Consensus 158 ---~~~~~~~~~y~aP 170 (285)
T cd05605 158 ---IRGRVGTVGYMAP 170 (285)
T ss_pred ---cccccCCCCccCc
Confidence 1234578889998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=183.73 Aligned_cols=139 Identities=22% Similarity=0.354 Sum_probs=111.4
Q ss_pred CCccccceeccCCceEEEEEEcc----CCcEEEEEEEeec------------------------------cCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFS------------------------------CSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~------------------------------~~~~~~~~lv 430 (527)
.+|++.+.||+|+||.||+|.+. .+..||+|+++.. +...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999753 4578999986532 2234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++......+++.+...++.+++.|++|+| +++++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999876567889999999999999999999 9999999999999999999999999999876543221
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.. ......++..|+||
T Consensus 162 ~~-~~~~~~~~~~y~aP 177 (266)
T cd05064 162 IY-TTMSGKSPVLWAAP 177 (266)
T ss_pred hh-cccCCCCceeecCH
Confidence 11 11122345678887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=195.36 Aligned_cols=140 Identities=24% Similarity=0.263 Sum_probs=114.7
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee-----------------------ccCccceeEEEEEeccCCcH
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-----------------------SCSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-----------------------~~~~~~~~~lv~ey~~~g~L 439 (527)
..+|.+.+.||+|+||.||+|+.. +++.||||.... .+...+..++||||+. |+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 457999999999999999999875 578999996321 1234567789999995 689
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 519 (527)
..++......+++.++..|+.|++.||+||| +++||||||||+|||++.++.+||+|||+++...............
T Consensus 247 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 323 (461)
T PHA03211 247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323 (461)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence 8888765556899999999999999999999 9999999999999999999999999999998764332222222456
Q ss_pred cccccccC
Q 035895 520 AIIGYMAP 527 (527)
Q Consensus 520 ~t~~y~aP 527 (527)
||..||||
T Consensus 324 GT~~Y~AP 331 (461)
T PHA03211 324 GTVDTNAP 331 (461)
T ss_pred CCcCCcCH
Confidence 89999998
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=181.78 Aligned_cols=139 Identities=24% Similarity=0.385 Sum_probs=113.4
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEeccC
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~~ 436 (527)
++|++.+.||+|+||.||+|+.+++..+|+|.+.. .+...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45888899999999999999998888999998642 12344567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++......+++.....++.+++.|++|+| +++|+||||||+||++++++.+|++|||.++....... ....
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~ 159 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSS 159 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccC
Confidence 9999998765556788889999999999999999 99999999999999999999999999999987543221 1112
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 160 ~~~~~~~y~aP 170 (256)
T cd05114 160 GAKFPVKWSPP 170 (256)
T ss_pred CCCCchhhCCh
Confidence 22345678887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=190.32 Aligned_cols=140 Identities=27% Similarity=0.436 Sum_probs=109.5
Q ss_pred CCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec-------------------------------c-Cccce
Q 035895 385 DGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS-------------------------------C-SNEDF 426 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~-------------------------------~-~~~~~ 426 (527)
+.|++.+.||+|+||.||+|+. .+++.||+|++... | ..+..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4688999999999999999963 23578999986421 1 12234
Q ss_pred eEEEEEeccCCcHHHHHHhcC-----------------------------------------------------------
Q 035895 427 RALVLEYTTNGSLEKVLYSSN----------------------------------------------------------- 447 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~----------------------------------------------------------- 447 (527)
.++||||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 678999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceecccccccccc
Q 035895 448 -YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526 (527)
Q Consensus 448 -~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 526 (527)
..+++.....++.||+.|++|+| +.+|+||||||+||++++++.+||+|||+++.+.............++..|||
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 14678889999999999999999 99999999999999999999999999999987643322222222335667999
Q ss_pred C
Q 035895 527 P 527 (527)
Q Consensus 527 P 527 (527)
|
T Consensus 244 P 244 (337)
T cd05054 244 P 244 (337)
T ss_pred c
Confidence 8
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=183.89 Aligned_cols=138 Identities=28% Similarity=0.381 Sum_probs=111.3
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
++|++.+.||+|+||.||+|+.+ +++.||+|++... +..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999975 6789999987531 223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++++.+..+.. ....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 999987765543 3345788888999999999999999 99999999999999999999999999999987643221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.......++.+|+||
T Consensus 156 ~~~~~~~~~~~y~aP 170 (287)
T cd07848 156 ANYTEYVATRWYRSP 170 (287)
T ss_pred ccccccccccccCCc
Confidence 112234578899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=184.14 Aligned_cols=141 Identities=26% Similarity=0.388 Sum_probs=110.9
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCc----EEEEEEEeeccC-----------------------------ccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGM----EFAIKVFHFSCS-----------------------------NEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~-----------------------------~~~~~~l 429 (527)
.++|+..+.||+|+||+||+|++ .++. .||+|++..... .....++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 35688899999999999999985 3444 489998743110 1224468
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
+|||+++|+|.+++......+++.....++.|++.|++|+| +++|+||||||+||++++++.+|++|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999765566888899999999999999999 999999999999999999999999999999876533
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
..........++..||||
T Consensus 163 ~~~~~~~~~~~~~~y~~P 180 (279)
T cd05109 163 ETEYHADGGKVPIKWMAL 180 (279)
T ss_pred cceeecCCCccchhhCCH
Confidence 221111222345678887
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=204.16 Aligned_cols=119 Identities=29% Similarity=0.379 Sum_probs=101.2
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 67999999999999999999864 6899999987531 12345668999
Q ss_pred EeccCCcHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 035895 432 EYTTNGSLEKVLYSS----------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 432 ey~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
||++||+|.+++... ....++.....++.||++||+|+| +++|+||||||+||+++.++.+|++|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988642 122456677889999999999999 9999999999999999999999999999
Q ss_pred ccccc
Q 035895 502 IAKLL 506 (527)
Q Consensus 502 ~a~~~ 506 (527)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-21 Score=182.03 Aligned_cols=119 Identities=30% Similarity=0.416 Sum_probs=103.9
Q ss_pred cCCccccceeccCCceEEEEEEccC-CcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.+.|+..+.||.|.-|+||+|+.+. +..+|+|++.. ..+.+.+.++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3457888999999999999999864 68999999843 12345678899
Q ss_pred EEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 431 LEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
||||+||+|..+.+++ +.+++...+..+|.+|..||+||| -.|||.|||||+|||+.++|++.++||-++..
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999988765 456888888889999999999999 99999999999999999999999999998754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=182.36 Aligned_cols=140 Identities=27% Similarity=0.431 Sum_probs=114.3
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeecc-----------------------------Cc---cceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC-----------------------------SN---EDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~-----------------------------~~---~~~~~lv~e 432 (527)
++..+.+.||+|.||+||+|+++ |+.||||++...- .+ -.+.++|++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 34567899999999999999997 6899999984310 00 125679999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF-----GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~-----~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
|-+.|+|+++|.. ..++....++++..+|.||++||. .-++.|.|||||+.|||+..++.+.|+|+|+|-...
T Consensus 290 YHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred cccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 9999999999975 468888899999999999999992 246789999999999999999999999999997654
Q ss_pred CCCC--ccceeccccccccccC
Q 035895 508 GEDQ--SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~--~~~~~~~~~t~~y~aP 527 (527)
.... .......+||-+||||
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAP 389 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAP 389 (513)
T ss_pred ccCCcccCCCCCccceeeccCh
Confidence 3321 1233457899999999
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=183.70 Aligned_cols=140 Identities=26% Similarity=0.371 Sum_probs=111.0
Q ss_pred CCccccceeccCCceEEEEEEcc-CCc----EEEEEEEeec-----------------------------cCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIKVFHFS-----------------------------CSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~-----------------------------~~~~~~~~lv 430 (527)
++|+..+.||+|+||+||+|.+. +++ .||+|.+... +......+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 46888899999999999999863 444 4777776321 1112344689
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++......+++.....++.|++.|++|+| +++++||||||+||++++++.+|++|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999876667899999999999999999999 9999999999999999999999999999998764332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.....+...++..|+||
T Consensus 164 ~~~~~~~~~~~~~y~~p 180 (279)
T cd05111 164 KKYFYSEHKTPIKWMAL 180 (279)
T ss_pred cccccCCCCCcccccCH
Confidence 22222234466789887
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=191.98 Aligned_cols=141 Identities=26% Similarity=0.456 Sum_probs=110.5
Q ss_pred cCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee-------------------------------ccCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF-------------------------------SCSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~-------------------------------~~~~~~~ 426 (527)
.++|.+.+.||+|+||.||+|+.. .+..||||++.. .+...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467889999999999999999742 235799998742 1233456
Q ss_pred eEEEEEeccCCcHHHHHHhcC-----------------------------------------------------------
Q 035895 427 RALVLEYTTNGSLEKVLYSSN----------------------------------------------------------- 447 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~----------------------------------------------------------- 447 (527)
.++|||||++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 789999999999999886421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 035895 448 ------------------------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD 491 (527)
Q Consensus 448 ------------------------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~ 491 (527)
..+++.+...++.|++.|++||| +.+|+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 13567777889999999999999 999999999999999999
Q ss_pred CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.+|++|||+++...............++..||||
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 308 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP 308 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence 999999999999876433222222233456789998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=188.97 Aligned_cols=140 Identities=26% Similarity=0.437 Sum_probs=108.3
Q ss_pred CCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec-------------------------------c-Cccce
Q 035895 385 DGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS-------------------------------C-SNEDF 426 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~-------------------------------~-~~~~~ 426 (527)
++|++.+.||+|+||.||+|+. .+++.||||+++.. + .....
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5689999999999999999973 35788999987431 1 11234
Q ss_pred eEEEEEeccCCcHHHHHHhcC-----------------------------------------------------------
Q 035895 427 RALVLEYTTNGSLEKVLYSSN----------------------------------------------------------- 447 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~----------------------------------------------------------- 447 (527)
.++|||||++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 578999999999999986421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceecccc
Q 035895 448 -------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520 (527)
Q Consensus 448 -------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 520 (527)
..+++.+...++.|++.|++|+| +++|+||||||+||++++++.+|++|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 13567778889999999999999 99999999999999999999999999999987543222111112234
Q ss_pred ccccccC
Q 035895 521 IIGYMAP 527 (527)
Q Consensus 521 t~~y~aP 527 (527)
+..|+||
T Consensus 244 ~~~y~aP 250 (343)
T cd05103 244 PLKWMAP 250 (343)
T ss_pred CcceECc
Confidence 5678888
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=181.40 Aligned_cols=140 Identities=28% Similarity=0.490 Sum_probs=112.9
Q ss_pred CCccccceeccCCceEEEEEEcc----CCcEEEEEEEeec------------------------------cCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFS------------------------------CSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~------------------------------~~~~~~~~lv 430 (527)
++|++.+.||+|+||.||+|++. +...||||+++.. +...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56889999999999999999864 2457999986431 1233456899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++......+++.+...++.+++.|++||| +++|+||||||+||++++++.++++|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999776567889999999999999999999 9999999999999999999999999999999875222
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.........++..|+||
T Consensus 161 ~~~~~~~~~~~~~y~~P 177 (266)
T cd05033 161 ATYTTKGGKIPIRWTAP 177 (266)
T ss_pred cceeccCCCCCccccCh
Confidence 21111122345678887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=183.29 Aligned_cols=136 Identities=28% Similarity=0.417 Sum_probs=109.5
Q ss_pred CCccccceeccCCceEEEEEEc-c-CCcEEEEEEEeecc---------------------------------------Cc
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-Q-DGMEFAIKVFHFSC---------------------------------------SN 423 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~-~~~~vavK~~~~~~---------------------------------------~~ 423 (527)
+.|++.+.||+|+||+||+|+. . +++.||+|+++... ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999985 3 46889999874210 01
Q ss_pred cceeEEEEEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGI 502 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~ 502 (527)
....++||||++ |+|.+++... ...+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+|++|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 234679999997 5899988653 244788889999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCccceeccccccccccC
Q 035895 503 AKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++...... ......+|+.|+||
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aP 178 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAP 178 (290)
T ss_pred eEeccCCc---ccccccccccccCh
Confidence 98764321 12234578899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=182.77 Aligned_cols=130 Identities=29% Similarity=0.413 Sum_probs=105.7
Q ss_pred eccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEEeccCCcH
Q 035895 393 IGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 393 lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ey~~~g~L 439 (527)
||+|+||+||+|.. .+++.||+|++.. .+..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999986 4688999998742 11234457899999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 440 EKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 440 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
..++.. ....+++..+..++.|++.|++|+| +++|+||||||+||++++++.++++|||+++.+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988753 2345788889999999999999999 99999999999999999999999999999987643221 112
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...+|+.|+||
T Consensus 156 ~~~g~~~y~aP 166 (280)
T cd05608 156 GYAGTPGFMAP 166 (280)
T ss_pred ccCCCcCccCH
Confidence 34578899998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=186.30 Aligned_cols=131 Identities=31% Similarity=0.466 Sum_probs=107.9
Q ss_pred ceeccCCceEEEEEEc----cCCcEEEEEEEee-------------------------------ccCccceeEEEEEecc
Q 035895 391 NLIGRGSFGSVYKARL----QDGMEFAIKVFHF-------------------------------SCSNEDFRALVLEYTT 435 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~----~~~~~vavK~~~~-------------------------------~~~~~~~~~lv~ey~~ 435 (527)
+.||+|+||.||+++. .+|+.||+|++.. .+..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 4688999998752 1223456789999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+|+|.+++.+. ..+++.....++.|++.||+||| +++|+||||||+||++++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~ 155 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA 155 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence 99999998654 35788889999999999999999 99999999999999999999999999999986543211 12
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....||+.||||
T Consensus 156 ~~~~g~~~y~aP 167 (318)
T cd05582 156 YSFCGTVEYMAP 167 (318)
T ss_pred ecccCChhhcCH
Confidence 235678899998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-21 Score=178.02 Aligned_cols=142 Identities=28% Similarity=0.412 Sum_probs=112.7
Q ss_pred hhcCCccccceeccCCceEEEEEEcc---C--CcEEEEEEEeec--------------------------------cCcc
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ---D--GMEFAIKVFHFS--------------------------------CSNE 424 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~---~--~~~vavK~~~~~--------------------------------~~~~ 424 (527)
+....|+....||+|.||.||+|... + .+++|||+++.. ...+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34567999999999999999999532 2 347999987532 1234
Q ss_pred ceeEEEEEeccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC----CcEE
Q 035895 425 DFRALVLEYTTNGSLEKVLYSS----NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN----IVAH 496 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~----~~~k 496 (527)
..+++++||++. ||.++|+-+ ...++......|..||..|+.||| ++-|+||||||+|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 567899999986 999988643 234666677889999999999999 9999999999999999766 9999
Q ss_pred EeecccccccCCCCCc-cceeccccccccccC
Q 035895 497 LSDFGIAKLLTGEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 497 l~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aP 527 (527)
|+|||+||.+...-.. .+....+.|+||.||
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAP 208 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAP 208 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecCh
Confidence 9999999998654322 233456789999998
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=184.63 Aligned_cols=138 Identities=22% Similarity=0.424 Sum_probs=112.3
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|...+.||+|+||.||+|+.+ +++.||+|++... +..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 467999999999999999999864 6788999987521 123456689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++ +|.+++...+..+++.....++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 9985 888888766666788888899999999999999 99999999999999999999999999999986533221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 160 -~~~~~~~~~~y~aP 173 (309)
T cd07872 160 -TYSNEVVTLWYRPP 173 (309)
T ss_pred -ccccccccccccCC
Confidence 11223467889998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=189.56 Aligned_cols=138 Identities=25% Similarity=0.250 Sum_probs=111.7
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------ccCccceeEEEEEeccCCcH
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------SCSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------~~~~~~~~~lv~ey~~~g~L 439 (527)
..+|++.+.||+|+||.||+|.. .+++.||+|.... .+..+...++||||+. ++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 35799999999999999999985 5689999997532 1233456789999996 689
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 519 (527)
.+++... ..+++.+...++.|++.||+|+| +++||||||||+||+++.++.+||+|||+|+....... .......
T Consensus 170 ~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~ 244 (391)
T PHA03212 170 YCYLAAK-RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWA 244 (391)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccccccc
Confidence 8888654 35788889999999999999999 99999999999999999999999999999976432211 1122356
Q ss_pred cccccccC
Q 035895 520 AIIGYMAP 527 (527)
Q Consensus 520 ~t~~y~aP 527 (527)
||+.|+||
T Consensus 245 gt~~y~aP 252 (391)
T PHA03212 245 GTIATNAP 252 (391)
T ss_pred CccCCCCh
Confidence 89999998
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=182.64 Aligned_cols=142 Identities=22% Similarity=0.388 Sum_probs=110.7
Q ss_pred hcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccCccce
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCSNEDF 426 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~~~~~ 426 (527)
..++|++.+.||+|+||.||+|... ++..||+|++.. .+.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998742 356799998642 1223456
Q ss_pred eEEEEEeccCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 035895 427 RALVLEYTTNGSLEKVLYSSN---------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl 497 (527)
.++||||+++|+|.+++.... ..+++.....++.+++.|++|+| +.+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 789999999999999987532 12467788899999999999999 899999999999999999999999
Q ss_pred eecccccccCCCCCccceeccccccccccC
Q 035895 498 SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 498 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|||+++...............+++.||||
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcCh
Confidence 999999865432221111122346779998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=185.43 Aligned_cols=131 Identities=30% Similarity=0.387 Sum_probs=106.9
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||+||+|+.. +++.||||++... +...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 5789999987521 1223467899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++... ..+++.+...++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 9999988654 35788899999999999999999 99999999999999999999999999999875322211 112
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||..||||
T Consensus 155 ~~~g~~~y~aP 165 (318)
T cd05570 155 TFCGTPDYIAP 165 (318)
T ss_pred ceecCccccCH
Confidence 34578899998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-22 Score=191.58 Aligned_cols=269 Identities=20% Similarity=0.221 Sum_probs=178.9
Q ss_pred CCCceeecCchhhhcCCCCCEEEccccccccccccccceEEcccccccCCCCCCcccccCCCCCCCCEEEccc-CCCCcc
Q 035895 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISR-NPLDGF 106 (527)
Q Consensus 28 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~ 106 (527)
.+|+|+.+++++|.++++|+.||||+|.| +.+.+. +|.++++|.+|-+.+ |+|+.+
T Consensus 75 dqN~I~~iP~~aF~~l~~LRrLdLS~N~I------------------s~I~p~-----AF~GL~~l~~Lvlyg~NkI~~l 131 (498)
T KOG4237|consen 75 DQNQISSIPPGAFKTLHRLRRLDLSKNNI------------------SFIAPD-----AFKGLASLLSLVLYGNNKITDL 131 (498)
T ss_pred ccCCcccCChhhccchhhhceecccccch------------------hhcChH-----hhhhhHhhhHHHhhcCCchhhh
Confidence 45555555555555555555555555544 443332 455555555544433 666665
Q ss_pred cChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCccc----------
Q 035895 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNEL---------- 176 (527)
Q Consensus 107 ~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l---------- 176 (527)
....|.++. +++.|.+.-|++.-+..+.|..+++|..|.+..|.+..+...+|..+..++.+.+..|.+
T Consensus 132 ~k~~F~gL~-slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla 210 (498)
T KOG4237|consen 132 PKGAFGGLS-SLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLA 210 (498)
T ss_pred hhhHhhhHH-HHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhh
Confidence 555555554 566666666666666666666666666666666666655555666666666666666652
Q ss_pred --ccccChhhhcCcccCeeeeecccCCCCCCccccCC-ccCc-eeeCCCCCCCCCch-hhhCCCCccEEEccCCcccccC
Q 035895 177 --EGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNL-TALR-NLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPL 251 (527)
Q Consensus 177 --~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~-~L~L~~N~l~~lp~-~~~~l~~L~~l~l~~n~~~~~~ 251 (527)
....|..++......-..+.++++..+.+..|... ..+. .+....+.....|. .|..+++|+.+++++|+++..-
T Consensus 211 ~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~ 290 (498)
T KOG4237|consen 211 DDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIE 290 (498)
T ss_pred hHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhh
Confidence 12334455555555556666666665555555432 1221 12222222333443 4667778888888888888888
Q ss_pred CccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc
Q 035895 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 252 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 320 (527)
+.+|..+..++.|.|..|++...-...|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|++.
T Consensus 291 ~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 291 DGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 889999999999999999998777889999999999999999999999999999999999999988874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=192.40 Aligned_cols=137 Identities=33% Similarity=0.479 Sum_probs=107.5
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------c----CccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------C----SNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~----~~~~~~~l 429 (527)
.+.|++.+.||+|+||.||+|.. .+++.||||++... + ....+.++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 45799999999999999999986 46899999986321 0 01124568
Q ss_pred EEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccc
Q 035895 430 VLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-IVAHLSDFGIAKL 505 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-~~~kl~Dfg~a~~ 505 (527)
||||+++ ++.+++.. .+..+++.....++.|++.||+||| +++||||||||+||+++.+ +.+||+|||+|+.
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 9999985 67666543 3456788888899999999999999 9999999999999999965 5799999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+..... .....+|++||||
T Consensus 221 ~~~~~~---~~~~~~t~~y~aP 239 (440)
T PTZ00036 221 LLAGQR---SVSYICSRFYRAP 239 (440)
T ss_pred ccCCCC---cccCCCCcCccCH
Confidence 643321 1234578889998
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-20 Score=180.48 Aligned_cols=135 Identities=29% Similarity=0.447 Sum_probs=111.1
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEEe
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ey 433 (527)
|+..+.||+|+||+||+|+. .+++.||+|.+.. .+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67778999999999999986 4689999998742 11234566799999
Q ss_pred ccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++|+|.+++...+ ..+++.....++.|++.|++|+| +++|+||||||+||++++++.++++|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999998886543 35889999999999999999999 99999999999999999999999999999976543221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 158 --~~~~~g~~~~~aP 170 (285)
T cd05632 158 --IRGRVGTVGYMAP 170 (285)
T ss_pred --ccCCCCCcCccCh
Confidence 1234578889998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=189.76 Aligned_cols=133 Identities=29% Similarity=0.483 Sum_probs=106.7
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
++|+..+.||+|+||.||+|+.. +++.||||++... +..++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45777899999999999999864 6899999987421 2234566899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.... ..+......++.||+.||+||| +++|+||||||+||++++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999986532 2455667789999999999999 99999999999999999999999999999987643221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......||..|+||
T Consensus 224 ~~~~~~gt~~y~aP 237 (353)
T PLN00034 224 PCNSSVGTIAYMSP 237 (353)
T ss_pred cccccccCccccCc
Confidence 11234688899998
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-20 Score=182.40 Aligned_cols=142 Identities=21% Similarity=0.382 Sum_probs=109.4
Q ss_pred hcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccCccce
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCSNEDF 426 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~~~~~ 426 (527)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.. .+...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999643 245899997531 1223445
Q ss_pred eEEEEEeccCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 035895 427 RALVLEYTTNGSLEKVLYSSN---------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl 497 (527)
.++||||+++|+|.+++...+ ...++.....++.+++.|++|+| +++|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 689999999999999997532 22356677889999999999999 999999999999999999999999
Q ss_pred eecccccccCCCCCccceeccccccccccC
Q 035895 498 SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 498 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|||+++...............++..|+||
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p 190 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCH
Confidence 999999866432221112222345678887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-20 Score=200.31 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=192.0
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
...|+++++.+++++..++ +.|+.|+|++|+++. +|..+. .+|+.|++++|+++. +|..+. .+|+
T Consensus 180 ~~~L~L~~~~LtsLP~~Ip--------~~L~~L~Ls~N~Lts-LP~~l~---~nL~~L~Ls~N~Lts-LP~~l~--~~L~ 244 (754)
T PRK15370 180 KTELRLKILGLTTIPACIP--------EQITTLILDNNELKS-LPENLQ---GNIKTLYANSNQLTS-IPATLP--DTIQ 244 (754)
T ss_pred ceEEEeCCCCcCcCCcccc--------cCCcEEEecCCCCCc-CChhhc---cCCCEEECCCCcccc-CChhhh--cccc
Confidence 4679999999998776542 479999999999996 465543 479999999999985 455553 4799
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNE 223 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 223 (527)
.|+|++|++.. +|..+. .+|+.|++++|+++ .+|..+. ++|+.|++++|++++ +|..+. ++|+.|++++|+
T Consensus 245 ~L~Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~ 315 (754)
T PRK15370 245 EMELSINRITE-LPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNS 315 (754)
T ss_pred EEECcCCccCc-CChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCc
Confidence 99999999984 455443 58999999999998 5676554 589999999999996 455443 479999999999
Q ss_pred CCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCC
Q 035895 224 LTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF 303 (527)
Q Consensus 224 l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 303 (527)
++.+|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|++. .+|..+. ++|+.|++++|+++ .+|..+
T Consensus 316 Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l 386 (754)
T PRK15370 316 LTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENL 386 (754)
T ss_pred cccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhH
Confidence 999987553 689999999999875 666554 68999999999997 5776664 68999999999998 456655
Q ss_pred CCCCCCCEEeCCCCcccccCccchhh----hccCCeeEeeeeee
Q 035895 304 DDLVSLESLDLSNNNLSEIIPLSLEK----LLYLNILLIVVVIL 343 (527)
Q Consensus 304 ~~l~~L~~L~ls~N~l~~~~p~~~~~----l~~L~~L~~~~~~~ 343 (527)
. ..|+.|++++|+++. +|..+.. ++.+..+++..+.+
T Consensus 387 ~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npl 427 (754)
T PRK15370 387 P--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPF 427 (754)
T ss_pred H--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCc
Confidence 4 369999999999985 4554443 35667777776665
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-20 Score=187.16 Aligned_cols=138 Identities=24% Similarity=0.265 Sum_probs=113.4
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee-----------------------ccCccceeEEEEEeccCCc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-----------------------SCSNEDFRALVLEYTTNGS 438 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-----------------------~~~~~~~~~lv~ey~~~g~ 438 (527)
...+|++.+.||+|+||.||+|+.. +++.||+|+... .+...+..++||||+. |+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 3467999999999999999999875 578899997421 1234456789999995 58
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceecc
Q 035895 439 LEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518 (527)
Q Consensus 439 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 518 (527)
|.+++......+++..+..|+.||+.||+||| +++||||||||+||+++.++.+||+|||+++...... .....
T Consensus 143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~ 216 (357)
T PHA03209 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGL 216 (357)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccc
Confidence 98888766667899999999999999999999 9999999999999999999999999999998643221 12234
Q ss_pred ccccccccC
Q 035895 519 LAIIGYMAP 527 (527)
Q Consensus 519 ~~t~~y~aP 527 (527)
.||..|+||
T Consensus 217 ~gt~~y~aP 225 (357)
T PHA03209 217 AGTVETNAP 225 (357)
T ss_pred cccccccCC
Confidence 578899998
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-20 Score=178.46 Aligned_cols=139 Identities=28% Similarity=0.422 Sum_probs=112.3
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEeccC
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~~ 436 (527)
.+|++.+.||+|+||.||+|+.+++..+|+|++.. .+...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 34788899999999999999988778899998642 12234456899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
++|.+++......+++.....++.|++.|++|+| +.+|+||||||+||++++++.+|++|||+++....... ....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccC
Confidence 9999999765556789899999999999999999 99999999999999999999999999999987643221 1111
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 160 ~~~~~~~y~~P 170 (256)
T cd05059 160 GTKFPVKWAPP 170 (256)
T ss_pred CCCCCccccCH
Confidence 12234568887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=179.82 Aligned_cols=135 Identities=29% Similarity=0.455 Sum_probs=110.8
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEEe
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ey 433 (527)
|+..+.||+|+||.||+|.. .+++.||+|.+.. .+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67788999999999999986 4689999998642 11234567899999
Q ss_pred ccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++|+|.+++...+ ..++..+...++.|++.|++|+| +++|+||||||+||++++++.++++|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999886433 35788889999999999999999 99999999999999999999999999999976543221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....|+..||||
T Consensus 158 --~~~~~g~~~y~aP 170 (285)
T cd05630 158 --IKGRVGTVGYMAP 170 (285)
T ss_pred --ccCCCCCccccCh
Confidence 1234578889998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-20 Score=178.61 Aligned_cols=140 Identities=21% Similarity=0.412 Sum_probs=113.7
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||.||+|...++..||+|.+.. .+...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 456899999999999999999988888999998642 1233456689999999
Q ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 436 NGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 436 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+|+|.+++... +..+++.++..++.+++.|++|+| +.+++||||||+||++++++.++++|||+++....... ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence 99999998753 345788888999999999999999 89999999999999999999999999999987643221 11
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 161 ~~~~~~~~~y~aP 173 (261)
T cd05072 161 REGAKFPIKWTAP 173 (261)
T ss_pred cCCCccceecCCH
Confidence 1223346678887
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=185.36 Aligned_cols=137 Identities=26% Similarity=0.379 Sum_probs=108.9
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------C-----ccceeE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------S-----NEDFRA 428 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~-----~~~~~~ 428 (527)
.|++.+.||+|+||.||+|+. .+++.||||++.... . .....+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 378889999999999999985 478999999874210 0 012368
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+|||||. ++|.+++... ..+++.....++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999996 6899888654 35788889999999999999999 99999999999999999999999999999986532
Q ss_pred CCCc-cceeccccccccccC
Q 035895 509 EDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~-~~~~~~~~t~~y~aP 527 (527)
.... .......+|..|+||
T Consensus 156 ~~~~~~~~~~~~~t~~y~aP 175 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAP 175 (338)
T ss_pred ccCccccccCCCCCCCcCCH
Confidence 2111 111234688899998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=200.19 Aligned_cols=138 Identities=30% Similarity=0.470 Sum_probs=113.2
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
.++|.+.+.||+|+||.||+|+.. +++.||||+++.. +...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999875 6899999987521 1223567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++...+ .+++.....|+.||+.||+||| .++||||||||+|||++.++.+||+|||+++......
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~ 158 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc
Confidence 99999999999987543 4677888999999999999999 8999999999999999999999999999999764332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ......+|+.|+||
T Consensus 159 ~--~~~~~~~t~~~~~p 173 (669)
T cd05610 159 L--NMMDILTTPSMAKP 173 (669)
T ss_pred c--cccccccCccccCc
Confidence 1 12234566777776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=177.62 Aligned_cols=139 Identities=26% Similarity=0.413 Sum_probs=112.6
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEeccC
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~~ 436 (527)
++|++.+.||+|+||.||+|+..++..||+|.+.. .+...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46888899999999999999987777899997642 12234456899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++......+++.+...++.+++.|++|+| +++++||||||+||++++++.+|++|||.++...... .....
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSV 159 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecC
Confidence 9999999765556889999999999999999999 9999999999999999999999999999998664322 11111
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 160 ~~~~~~~y~~p 170 (256)
T cd05113 160 GSKFPVRWSPP 170 (256)
T ss_pred CCccChhhCCH
Confidence 22345668877
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-20 Score=183.26 Aligned_cols=136 Identities=27% Similarity=0.405 Sum_probs=112.1
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|++.+.||+|+||.||+|+.. ++..||+|++... +..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999865 6889999987531 123456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST-PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~-~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++.... .+++.....++.+++.|++|+| +. +|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999987543 4678888899999999999999 64 69999999999999999999999999998664321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 159 ---~~~~~g~~~y~aP 171 (331)
T cd06649 159 ---ANSFVGTRSYMSP 171 (331)
T ss_pred ---cccCCCCcCcCCH
Confidence 1234578899998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-20 Score=193.33 Aligned_cols=138 Identities=22% Similarity=0.304 Sum_probs=109.6
Q ss_pred HhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------c-Cc
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------C-SN 423 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~-~~ 423 (527)
+....+.|++.+.||+|+||+||+|.. .+++.||||+++.. + ..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 344567899999999999999999986 46789999987420 0 11
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCC---------
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNI--------- 493 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~--------- 493 (527)
....++|||++ +++|.+++.+. ..+++.....|+.||+.||+||| + .+||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccccc
Confidence 23567899988 67898888654 35788888999999999999999 7 5999999999999998665
Q ss_pred -------cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 494 -------VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 -------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+||+|||.+..... ..+..+||.+||||
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~AP 314 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSP 314 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCc
Confidence 499999998864321 12345689999998
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=188.34 Aligned_cols=117 Identities=28% Similarity=0.452 Sum_probs=98.0
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEe--------------------------------eccCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFH--------------------------------FSCSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~--------------------------------~~~~~~~~~~lv~e 432 (527)
-|-.++.||-|+||+|++++. ++...+|+|.++ ....+++..|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 477788999999999999974 455667777542 23456778899999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
|++|||+..+|.+.+ .++..-+..++.++..|+++.| ..|+|||||||.|||||.+|++|++|||++.-+
T Consensus 710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccc
Confidence 999999999987765 4565556667789999999999 999999999999999999999999999998643
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-20 Score=175.94 Aligned_cols=134 Identities=27% Similarity=0.434 Sum_probs=106.1
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEee------------------------------ccCccceeEEEEEeccCCcH
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHF------------------------------SCSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~------------------------------~~~~~~~~~lv~ey~~~g~L 439 (527)
+.||+|+||.||+|+. .+++.||+|.+.. .+..++..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999986 4789999997532 12344567899999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 519 (527)
.+++...+..+++.....++.|++.||+|+| +++|+||||||+||+++.++.+|++|||+++...............
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766556889899999999999999999 9999999999999999999999999999998654221111111112
Q ss_pred cccccccC
Q 035895 520 AIIGYMAP 527 (527)
Q Consensus 520 ~t~~y~aP 527 (527)
.+..|+||
T Consensus 158 ~~~~y~aP 165 (252)
T cd05084 158 IPVKWTAP 165 (252)
T ss_pred CceeecCc
Confidence 24568887
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-21 Score=194.87 Aligned_cols=152 Identities=27% Similarity=0.494 Sum_probs=121.6
Q ss_pred ccccHHHHhhhcCCc---------cccceeccCCceEEEEEEcc----CCcEEEEEEEeeccC-----------------
Q 035895 373 RRFSYQELLRATDGF---------SANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFSCS----------------- 422 (527)
Q Consensus 373 ~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~----------------- 422 (527)
..++|++-.+|...| ++.++||.|.||+||+|+++ ....||||.++....
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 455666554444433 67899999999999999975 245799999865322
Q ss_pred -------------ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 423 -------------NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 423 -------------~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
...-++||+|||++|+|+.+|+...+.+.+.+...+.++||.|+.||- .++.|||||-++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheee
Confidence 123456899999999999999988888999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeecccccccCCCC-CccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGED-QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~t~~y~aP 527 (527)
+.+..+||+|||++|.+.++. ...+..+..-.++|.||
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAP 803 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAP 803 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecCh
Confidence 999999999999999875432 22222233446789998
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=179.21 Aligned_cols=141 Identities=26% Similarity=0.473 Sum_probs=115.0
Q ss_pred hhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec-----------------------------cCccceeEEEEE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-----------------------------CSNEDFRALVLE 432 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~e 432 (527)
++..+|++.+.||+|+||.||+|...++..+|+|++... +...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 345678999999999999999999888999999986421 233456689999
Q ss_pred eccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++... +..+++.+...++.+++.|++|+| +++|+||||||+||++++++.+|++|||+++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999764 345788899999999999999999 99999999999999999999999999999987643221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 160 --~~~~~~~~~~~~~P 173 (261)
T cd05148 160 --LSSDKKIPYKWTAP 173 (261)
T ss_pred --cccCCCCceEecCH
Confidence 11123345678887
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-20 Score=176.96 Aligned_cols=140 Identities=25% Similarity=0.407 Sum_probs=113.2
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||.||+|...+++.||+|.++.. +...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4568899999999999999999877889999987531 223445689999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 436 NGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 436 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+++|.+++.... ..+++.+...++.+++.|++|+| +++|+||||||+||++++++.+|++|||+++....... ..
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EA 160 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cc
Confidence 999999987543 45789999999999999999999 99999999999999999999999999999987653211 11
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
......+..|+||
T Consensus 161 ~~~~~~~~~y~aP 173 (261)
T cd05068 161 REGAKFPIKWTAP 173 (261)
T ss_pred cCCCcCceeccCc
Confidence 1122234568888
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-20 Score=189.01 Aligned_cols=141 Identities=23% Similarity=0.337 Sum_probs=108.0
Q ss_pred hcCCccccceeccCCceEEEEEEc-----------------cCCcEEEEEEEeec-------------------------
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-----------------QDGMEFAIKVFHFS------------------------- 420 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-----------------~~~~~vavK~~~~~------------------------- 420 (527)
..++|++.++||+|+||+||+|.. ..++.||||++...
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999963 23568999986421
Q ss_pred ----------------c---------------CccceeEEEEEeccCCcHHHHHHhcC----------------------
Q 035895 421 ----------------C---------------SNEDFRALVLEYTTNGSLEKVLYSSN---------------------- 447 (527)
Q Consensus 421 ----------------~---------------~~~~~~~lv~ey~~~g~L~~~l~~~~---------------------- 447 (527)
| ..++..++||||+++|+|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 0 01234689999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceecccccccccc
Q 035895 448 -YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526 (527)
Q Consensus 448 -~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 526 (527)
...++.....++.+++.+++|+| +.+|+||||||+||+++.++.+|++|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 12356677889999999999999 89999999999999999999999999999976543221 11112234678999
Q ss_pred C
Q 035895 527 P 527 (527)
Q Consensus 527 P 527 (527)
|
T Consensus 379 P 379 (507)
T PLN03224 379 P 379 (507)
T ss_pred h
Confidence 8
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-20 Score=183.33 Aligned_cols=136 Identities=27% Similarity=0.423 Sum_probs=111.7
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee------------------------------ccCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~------------------------------~~~~~~~~~lv~e 432 (527)
.++|++.+.||+|+||.||+|... ++..+|+|.+.. .+...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999875 688899998642 1223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++...+ .+++.....++.+++.|++|+| + .+|+||||||+||++++++.+|++|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999987543 4677788899999999999999 5 479999999999999999999999999998653221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 159 ---~~~~~~~~~y~aP 171 (333)
T cd06650 159 ---ANSFVGTRSYMSP 171 (333)
T ss_pred ---cccCCCCccccCH
Confidence 1234578889998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-20 Score=185.77 Aligned_cols=140 Identities=30% Similarity=0.403 Sum_probs=118.5
Q ss_pred hhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------CccceeE
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------SNEDFRA 428 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~~~~~~~ 428 (527)
...+..|.+.+.||+|.|+.|..|++ .++..||||.++..+ ..+...+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 44577899999999999999999986 468999999885421 2345678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+.+|++++++.+.+...+ ..+..++.|+..|++|+| ++.|||||||++||+++.+..+||+|||++..+..
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999999988765555 667778999999999999 99999999999999999999999999999998864
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... ....+|++.|.||
T Consensus 208 ~~~---lqt~cgsppyAaP 223 (596)
T KOG0586|consen 208 GLM---LQTFCGSPPYAAP 223 (596)
T ss_pred ccc---ccccCCCCCccCh
Confidence 322 2236799999998
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-20 Score=181.24 Aligned_cols=141 Identities=26% Similarity=0.452 Sum_probs=109.8
Q ss_pred cCCccccceeccCCceEEEEEEc--------cCCcEEEEEEEeec-------------------------------cCcc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL--------QDGMEFAIKVFHFS-------------------------------CSNE 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~~-------------------------------~~~~ 424 (527)
.++|++.+.||+|+||.||+|+. .++..||+|.+... +..+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688899999999999999973 13457999986421 1223
Q ss_pred ceeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
...++||||+++|+|.+++.... ..+++.+...++.|++.|++||| +++|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 45679999999999999987532 24677888999999999999999 9999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++++.+|++|||+++...............++..|+||
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP 208 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP 208 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence 99999999999999876432221111222345679988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=177.70 Aligned_cols=140 Identities=29% Similarity=0.421 Sum_probs=110.8
Q ss_pred CCccccceeccCCceEEEEEEc-----cCCcEEEEEEEeec-----------------------------c--CccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHFS-----------------------------C--SNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~-----------------------------~--~~~~~~~ 428 (527)
.+|++.+.||+|+||.||+|.. .+++.||+|.+... + ......+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 35789999987421 0 1123567
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+++|+|.+++......+++..+..++.+++.||+||| +++|+||||||+||++++++.+|++|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999765556889999999999999999999 99999999999999999999999999999987653
Q ss_pred CCCccc-eeccccccccccC
Q 035895 509 EDQSMT-QTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~-~~~~~~t~~y~aP 527 (527)
...... .....++..|+||
T Consensus 161 ~~~~~~~~~~~~~~~~y~aP 180 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAP 180 (284)
T ss_pred CCcceeecCCCCCceEeeCH
Confidence 322111 1112233458887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-20 Score=177.18 Aligned_cols=140 Identities=25% Similarity=0.451 Sum_probs=112.6
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEeccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~~ 436 (527)
.+.|++.+.||+|+||.||+|+..++..||+|++... ...++..++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 3568999999999999999999877778999987531 0123456799999999
Q ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 437 GSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 437 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
|+|.+++... +..+++..+..++.+++.||+|+| +.+|+||||||+||++++++.++++|||.++.+...... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~ 160 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-AR 160 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-cc
Confidence 9999999753 345788899999999999999999 999999999999999999999999999999876433211 11
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 161 ~~~~~~~~y~~P 172 (262)
T cd05071 161 QGAKFPIKWTAP 172 (262)
T ss_pred cCCcccceecCH
Confidence 123356678887
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-20 Score=179.25 Aligned_cols=140 Identities=27% Similarity=0.441 Sum_probs=110.0
Q ss_pred CCccccceeccCCceEEEEEEc-----cCCcEEEEEEEee------------------------------ccCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHF------------------------------SCSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~------------------------------~~~~~~~~~l 429 (527)
++|++.+.||+|+||.||+|+. .++..||+|.+.. .+...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999974 3567899998742 0123345689
Q ss_pred EEEeccCCcHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 035895 430 VLEYTTNGSLEKVLYSSN----------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI 493 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~ 493 (527)
||||+++|+|.+++.... ..+++.+...++.+++.|++|+| +++|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 999999999999985321 23678888899999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 494 VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+|++|||+++...............++..|+||
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecCh
Confidence 9999999999876433222222233356678887
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-20 Score=187.34 Aligned_cols=141 Identities=24% Similarity=0.449 Sum_probs=109.2
Q ss_pred cCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee-------------------------------ccCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF-------------------------------SCSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~-------------------------------~~~~~~~ 426 (527)
.++|.+.+.||+|+||.||+|+++ .++.||+|++.. .+..++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345778899999999999999853 346899998742 1223345
Q ss_pred eEEEEEeccCCcHHHHHHhcC-----------------------------------------------------------
Q 035895 427 RALVLEYTTNGSLEKVLYSSN----------------------------------------------------------- 447 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~----------------------------------------------------------- 447 (527)
.++|||||++|+|.++++..+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 689999999999999986421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 448 --------------------------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 448 --------------------------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
..+++.+...++.+++.||+|+| +++|+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence 12566777889999999999999 8999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++++.+|++|||+++...............++..||||
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 310 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP 310 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence 99999999999999865332211111223456789987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=176.86 Aligned_cols=129 Identities=32% Similarity=0.484 Sum_probs=105.6
Q ss_pred eccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEEEeccCCcH
Q 035895 393 IGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 393 lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ey~~~g~L 439 (527)
||+|+||.||+|+. .+|+.||+|++.. .+..+...++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999986 4689999998742 11234567899999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceecc
Q 035895 440 EKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518 (527)
Q Consensus 440 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 518 (527)
.+++...+ ..+++.....++.|++.|++|+| +++|+||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 98876533 35788888899999999999999 9999999999999999999999999999998764322 12234
Q ss_pred ccccccccC
Q 035895 519 LAIIGYMAP 527 (527)
Q Consensus 519 ~~t~~y~aP 527 (527)
.++..|+||
T Consensus 155 ~~~~~y~aP 163 (277)
T cd05607 155 AGTNGYMAP 163 (277)
T ss_pred CCCCCccCH
Confidence 578889998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=176.92 Aligned_cols=135 Identities=36% Similarity=0.569 Sum_probs=110.9
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEec
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~ 434 (527)
|++.+.||+|+||+||+|+.. +++.||+|++... ...++..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999975 5678999997531 11345677999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++++|.+++.. ...+++..+..++.++++||+||| +.+|+||||||+||++++++.++++|||.+....... ..
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--EN 154 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SE
T ss_pred ccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc--cc
Confidence 99999999973 345788899999999999999999 8999999999999999999999999999997642111 12
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 155 ~~~~~~~~~y~aP 167 (260)
T PF00069_consen 155 FNPFVGTPEYMAP 167 (260)
T ss_dssp BSSSSSSGGGSCH
T ss_pred ccccccccccccc
Confidence 2345578889988
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-20 Score=180.41 Aligned_cols=140 Identities=25% Similarity=0.429 Sum_probs=108.6
Q ss_pred CCccccceeccCCceEEEEEEccC---------------CcEEEEEEEeec-----------------------------
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQD---------------GMEFAIKVFHFS----------------------------- 420 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~---------------~~~vavK~~~~~----------------------------- 420 (527)
++|++.+.||+|+||.||+|+... ...||+|+++..
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468899999999999999987532 235899987431
Q ss_pred -cCccceeEEEEEeccCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 035895 421 -CSNEDFRALVLEYTTNGSLEKVLYSSN-----------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKL 488 (527)
Q Consensus 421 -~~~~~~~~lv~ey~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nil 488 (527)
+...+..++||||+++++|.+++.... ..+++.+...++.+++.|++||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 223456679999999999999986432 13578888999999999999999 999999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 489 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 489 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++++.+|++|||+++...............++..|+||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 200 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW 200 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence 999999999999999865433221111223346679887
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=178.00 Aligned_cols=139 Identities=24% Similarity=0.432 Sum_probs=110.8
Q ss_pred CccccceeccCCceEEEEEEc-----cCCcEEEEEEEeec------------------------------cCc--cceeE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHFS------------------------------CSN--EDFRA 428 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~------------------------------~~~--~~~~~ 428 (527)
-|++.+.||+|+||.||+|+. .++..||+|.++.. +.. ....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 468889999999999999973 35788999987421 111 24568
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||++||+|.+++......+++.++..++.+++.||+|+| +++|+||||||+||+++.++.++++|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999998765556789999999999999999999 99999999999999999999999999999987653
Q ss_pred CCCccc-eeccccccccccC
Q 035895 509 EDQSMT-QTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~-~~~~~~t~~y~aP 527 (527)
...... .....++..|+||
T Consensus 162 ~~~~~~~~~~~~~~~~y~ap 181 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAP 181 (284)
T ss_pred CccceeecCCCCCCccccCH
Confidence 322111 1123355668887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-20 Score=179.07 Aligned_cols=140 Identities=29% Similarity=0.470 Sum_probs=111.0
Q ss_pred CCccccceeccCCceEEEEEEc------cCCcEEEEEEEee-----------------------------ccCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHF-----------------------------SCSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~-----------------------------~~~~~~~~~l 429 (527)
.+|.+.+.||+|+||.||+|.. .++..+|+|.+.. .+...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4688899999999999999974 2356689998642 1234456789
Q ss_pred EEEeccCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 035895 430 VLEYTTNGSLEKVLYSSN------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl 497 (527)
||||+++|+|.+++...+ ..+++.+...++.|++.||+|+| +++++||||||+||++++++.+|+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999987533 23788899999999999999999 999999999999999999999999
Q ss_pred eecccccccCCCCCccceeccccccccccC
Q 035895 498 SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 498 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|||+++...............++..|+||
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 191 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCH
Confidence 999999876433221112223356779998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-20 Score=178.47 Aligned_cols=140 Identities=29% Similarity=0.535 Sum_probs=110.6
Q ss_pred CCccccceeccCCceEEEEEEccC------CcEEEEEEEeec------------------------------cCccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQD------GMEFAIKVFHFS------------------------------CSNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~------------------------------~~~~~~~~ 428 (527)
++|++.+.||+|+||.||+|.... ...||+|.+... +...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998532 257999987421 12334567
Q ss_pred EEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 035895 429 LVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI 493 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~ 493 (527)
++|||+++|+|.+++.... ..+++.+...++.|++.|++||| +.+|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999986531 34677888899999999999999 99999999999999999999
Q ss_pred cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 494 VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+||+|||+++...............+++.||||
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP 195 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCH
Confidence 9999999999865433222222234457789998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=177.29 Aligned_cols=128 Identities=29% Similarity=0.470 Sum_probs=105.1
Q ss_pred eeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------------cCccceeEEEEEecc
Q 035895 392 LIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 392 ~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------------~~~~~~~~lv~ey~~ 435 (527)
.||+|+||.||+|+. .+++.||+|.+... +..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 46889999976421 112345679999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+|+|.+++...+ .+++.....++.|++.|++|+| +.+|+||||||+||++++++.++++|||+++...... .
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 999999887543 5788899999999999999999 9999999999999999999999999999987654221 1
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..||||
T Consensus 153 ~~~~~~~~y~aP 164 (279)
T cd05633 153 HASVGTHGYMAP 164 (279)
T ss_pred cCcCCCcCccCH
Confidence 223578889998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=176.77 Aligned_cols=134 Identities=26% Similarity=0.359 Sum_probs=102.3
Q ss_pred ceeccCCceEEEEEEccC---CcEEEEEEEee------------------------------ccCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARLQD---GMEFAIKVFHF------------------------------SCSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~---~~~vavK~~~~------------------------------~~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|.... ...+|+|.+.. .+...+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997533 35688886532 123345678999999999
Q ss_pred cHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 438 SLEKVLYSSNY----ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 438 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+|.+++..... ..++.....++.|++.|++|+| +++|+||||||+||++++++.+|++|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999876432 2456677889999999999999 9999999999999999999999999999987653322211
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 158 ~~~~~~~~~~y~aP 171 (269)
T cd05042 158 TKDCHAVPLRWLAP 171 (269)
T ss_pred ccCCCCCcccccCH
Confidence 22223356678887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-21 Score=174.78 Aligned_cols=137 Identities=29% Similarity=0.494 Sum_probs=109.5
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-------------------------------ccCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-------------------------------~~~~~~~~~lv~ 431 (527)
.+.|++-++||+|.|+.||+... .+|+.+|+|.+.. ..+.+.+.++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 35688889999999999999864 5788888887531 234567889999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~ 508 (527)
|+|+||+|..-|-.. ...+...+--++.||+++|.|+| .++|||||+||+|+++.. ..-+|++|||+|..+.+
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999997655433 34556666678899999999999 999999999999999963 35689999999998863
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
+. ...+.+||++||||
T Consensus 166 g~---~~~G~~GtP~fmaP 181 (355)
T KOG0033|consen 166 GE---AWHGFAGTPGYLSP 181 (355)
T ss_pred cc---ccccccCCCcccCH
Confidence 22 23457899999998
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-20 Score=192.27 Aligned_cols=142 Identities=27% Similarity=0.365 Sum_probs=109.8
Q ss_pred CCccccceeccCCceEEEEEEccCC-cEEEEEEEeec---------------------------cC-------c---cce
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDG-MEFAIKVFHFS---------------------------CS-------N---EDF 426 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~-~~vavK~~~~~---------------------------~~-------~---~~~ 426 (527)
-.+++.++|.||||+.||.|+...+ ..||+|++... +. . .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3467889999999999999997655 99999986320 10 1 124
Q ss_pred eEEEEEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
+.|.||||.||.|-+++... ...+...+.++|+.++++|+++||+. .++|||||||.||||+..++..|+||||-|..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 56899999999999999753 34488999999999999999999944 78899999999999999999999999999864
Q ss_pred cCCCC-Cc----cc--eeccccccccccC
Q 035895 506 LTGED-QS----MT--QTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~-~~----~~--~~~~~~t~~y~aP 527 (527)
..... .. .. .-....|+-|+||
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsP 224 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSP 224 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence 32111 10 00 0123357889998
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-20 Score=180.85 Aligned_cols=140 Identities=26% Similarity=0.424 Sum_probs=109.1
Q ss_pred CCccccceeccCCceEEEEEEcc--------CCcEEEEEEEeec-------------------------------cCccc
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKVFHFS-------------------------------CSNED 425 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~-------------------------------~~~~~ 425 (527)
++|.+.+.||+|+||.||+|+.. +...+|+|.+... +...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999742 2357999987521 12234
Q ss_pred eeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD 490 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~ 490 (527)
..++||||+++|+|.+++.... ..+++.+...++.|++.||+|+| +++++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 5679999999999999997532 24788889999999999999999 99999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 491 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 491 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++.+|++|||+++...............++..||||
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 211 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 211 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence 9999999999999866432111111112234679988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.6e-20 Score=181.58 Aligned_cols=136 Identities=21% Similarity=0.215 Sum_probs=101.6
Q ss_pred hhhcCCccccceeccCCceEEEEEEcc--CCcEEEEEEEeecc-------------------------------Ccccee
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQ--DGMEFAIKVFHFSC-------------------------------SNEDFR 427 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~-------------------------------~~~~~~ 427 (527)
....++|.+.+.||+|+||+||+|+.+ +++.||||++.... ...+..
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~ 93 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKD 93 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCc
Confidence 344677999999999999999999864 57788999853110 011245
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeeeCCCCcEEEeeccccccc
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL-KPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdl-k~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
++||||++|++|... ... . ...++.+++++|+|+| +++|+|||| ||+|||++.++.+||+|||+|+.+
T Consensus 94 ~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred EEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 799999999999732 111 1 1357789999999999 999999999 999999999999999999999977
Q ss_pred CCCCCccc------eeccccccccccC
Q 035895 507 TGEDQSMT------QTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~------~~~~~~t~~y~aP 527 (527)
........ -+...+++.|+||
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~p 189 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAP 189 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCc
Confidence 54321111 1234466778877
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=175.01 Aligned_cols=140 Identities=24% Similarity=0.446 Sum_probs=112.9
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEeccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~~ 436 (527)
.++|++.+.||+|+||.||+|...++..||+|.+... ...++..++||||+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 3568899999999999999999888889999987531 1123456799999999
Q ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 437 GSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 437 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
|+|.+++... ...+++.++..++.+++.|++|+| +++|+||||||+||++++++.++++|||+++.+..... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-ccc
Confidence 9999998754 245788899999999999999999 89999999999999999999999999999987643221 111
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 161 ~~~~~~~~y~aP 172 (260)
T cd05070 161 QGAKFPIKWTAP 172 (260)
T ss_pred cCCCCCccccCh
Confidence 122345679988
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-20 Score=199.18 Aligned_cols=138 Identities=29% Similarity=0.531 Sum_probs=112.4
Q ss_pred ccccceeccCCceEEEEEEccC--C----cEEEEEEEeec------------------------------cCccceeEEE
Q 035895 387 FSANNLIGRGSFGSVYKARLQD--G----MEFAIKVFHFS------------------------------CSNEDFRALV 430 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~--~----~~vavK~~~~~------------------------------~~~~~~~~lv 430 (527)
-+..+.||+|+||.||+|...+ | ..||||.+... |-....++|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 4567899999999999998643 3 34999987543 2234566799
Q ss_pred EEeccCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 431 LEYTTNGSLEKVLYSS------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
+|||+||||..+|++. ...+...+.+.++.+||+|+.||+ ++++|||||-++|+|+++...|||+|||+||
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999976 556888999999999999999999 9999999999999999999999999999999
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+-+.+.+.......-...||||
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~P 873 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPP 873 (1025)
T ss_pred hhhhchheeccCccccceecCCH
Confidence 65544433333332345689998
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=179.00 Aligned_cols=142 Identities=27% Similarity=0.440 Sum_probs=111.0
Q ss_pred hcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEeec-------------------------------cCccc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHFS-------------------------------CSNED 425 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~-------------------------------~~~~~ 425 (527)
..++|+..+.||+|+||.||+|... ....||+|.+... +..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888999999999999999853 2367999986431 12234
Q ss_pred eeEEEEEeccCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 035895 426 FRALVLEYTTNGSLEKVLYSS---------------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD 490 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~ 490 (527)
..++||||+++|+|.+++... ...+++.....++.|++.|++||| +++|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 567999999999999998642 235788889999999999999999 99999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 491 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 491 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++.+|++|||+++.+.............++..|+||
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 203 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP 203 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence 9999999999999876543221111222345678887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=175.26 Aligned_cols=134 Identities=25% Similarity=0.385 Sum_probs=103.7
Q ss_pred ceeccCCceEEEEEEcc---CCcEEEEEEEee------------------------------ccCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARLQ---DGMEFAIKVFHF------------------------------SCSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~---~~~~vavK~~~~------------------------------~~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|... ++..+|+|.++. .+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999754 346789998642 122334567999999999
Q ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 438 SLEKVLYSSN----YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 438 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+|.+++.... ...++.....++.|++.|++|+| +++++||||||+||++++++.+|++|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 23466677789999999999999 9999999999999999999999999999997654332222
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 158 ~~~~~~~~~~y~aP 171 (269)
T cd05087 158 TPDQLWVPLRWIAP 171 (269)
T ss_pred cCCCcCCcccccCH
Confidence 22234467789988
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-20 Score=185.26 Aligned_cols=138 Identities=26% Similarity=0.452 Sum_probs=116.7
Q ss_pred ccccceeccCCceEEEEEEccCCcEEEEEEEee------------------------------ccCccceeEEEEEeccC
Q 035895 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF------------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~------------------------------~~~~~~~~~lv~ey~~~ 436 (527)
..+.++||+|.||+|..+....+..||||+++. .|..++-.++|||||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 456789999999999999998889999999864 24445566789999999
Q ss_pred CcHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 437 GSLEKVLYSSNYIL-DILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 437 g~L~~~l~~~~~~~-~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
|+|.+++.+.+... +-...+.|+.|||.|++||. +.++||||+.++|+|+|.++++||+|||++|.+-..+.+..+
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 99999998765433 55567789999999999999 999999999999999999999999999999977655555555
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
...+-.+.||||
T Consensus 697 gr~vlpiRwmaw 708 (807)
T KOG1094|consen 697 GRAVLPIRWMAW 708 (807)
T ss_pred cceeeeeeehhH
Confidence 566677899996
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=183.66 Aligned_cols=136 Identities=29% Similarity=0.416 Sum_probs=108.6
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccc-----eeE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNED-----FRA 428 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~-----~~~ 428 (527)
+|+..+.||+|+||.||+|+. .+++.||||++... +..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999986 57899999986321 11122 578
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+. ++|.+.+... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 5788877543 45788889999999999999999 99999999999999999999999999999987543
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... ...+...++.+|+||
T Consensus 156 ~~~-~~~~~~~~~~~y~aP 173 (372)
T cd07853 156 DES-KHMTQEVVTQYYRAP 173 (372)
T ss_pred Ccc-ccCCCCCcCCCcCCH
Confidence 221 112234567889998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-20 Score=198.68 Aligned_cols=98 Identities=26% Similarity=0.425 Sum_probs=78.4
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.||-||||+.-.++++++.....-......+++.+|++||+|+| +++||||||||.||++|++..|||+|||+|...
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 36889999998888888654332245556789999999999999 999999999999999999999999999999872
Q ss_pred C------C----------CCCccceeccccccccccC
Q 035895 507 T------G----------EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~------~----------~~~~~~~~~~~~t~~y~aP 527 (527)
. . .......|+.+||.-|+||
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 1 0 0011234667899999999
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=175.02 Aligned_cols=140 Identities=27% Similarity=0.482 Sum_probs=111.3
Q ss_pred CCccccceeccCCceEEEEEEcc----CCcEEEEEEEee------------------------------ccCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHF------------------------------SCSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~------------------------------~~~~~~~~~lv 430 (527)
++|++.+.||+|+||.||+|+.. ++..+|+|.+.. .+..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999863 234799998642 12234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++......+++.+...++.+++.|++|+| +.+++||||||+||+++.++.++++|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999876666889899999999999999999 9999999999999999999999999999998765432
Q ss_pred Cccc-eeccccccccccC
Q 035895 511 QSMT-QTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~-~~~~~~t~~y~aP 527 (527)
.... .....++..|+||
T Consensus 161 ~~~~~~~~~~~~~~y~~p 178 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAP 178 (267)
T ss_pred ceeeecCCCccceeecCH
Confidence 2111 1112234568887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=176.31 Aligned_cols=141 Identities=29% Similarity=0.468 Sum_probs=110.8
Q ss_pred cCCccccceeccCCceEEEEEEcc------CCcEEEEEEEeec------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHFS------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~------------------------------~~~~~~~ 427 (527)
.++|.+.+.||+|+||.||+|+.. +++.||||.+... +......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888999999999999999863 3478999987431 1223456
Q ss_pred EEEEEeccCCcHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 035895 428 ALVLEYTTNGSLEKVLYSSN-------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV 494 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~ 494 (527)
++||||+++|+|.+++...+ ..+++.+...++.+++.|++|+| +++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 89999999999999997542 23677788899999999999999 999999999999999999999
Q ss_pred EEEeecccccccCCCCCccceeccccccccccC
Q 035895 495 AHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 495 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|++|||+++...............+++.|+||
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP 193 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecCh
Confidence 999999999865332221112223356779998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=172.12 Aligned_cols=133 Identities=29% Similarity=0.452 Sum_probs=107.1
Q ss_pred ceeccCCceEEEEEEccCCcEEEEEEEeec------------------------------cCccceeEEEEEeccCCcHH
Q 035895 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------CSNEDFRALVLEYTTNGSLE 440 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~~~g~L~ 440 (527)
++||+|+||.||+|..+++..||+|.++.. +...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 479999999999999888899999986421 22344668999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceecccc
Q 035895 441 KVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520 (527)
Q Consensus 441 ~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 520 (527)
+++......+++.....++.+++.|+.|+| +++++||||||+||++++++.+|++|||+++........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 998765556789999999999999999999 999999999999999999999999999999765322111 1111223
Q ss_pred ccccccC
Q 035895 521 IIGYMAP 527 (527)
Q Consensus 521 t~~y~aP 527 (527)
+..|+||
T Consensus 157 ~~~y~aP 163 (250)
T cd05085 157 PIKWTAP 163 (250)
T ss_pred cccccCH
Confidence 5568887
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=185.92 Aligned_cols=139 Identities=22% Similarity=0.215 Sum_probs=111.8
Q ss_pred cCCccccceeccCCceEEEEEEcc---CCcEEEEEEEee------------------------ccCccceeEEEEEeccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ---DGMEFAIKVFHF------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~------------------------~~~~~~~~~lv~ey~~~ 436 (527)
...|++.+.||+|+||.||+|... .++.||+|.+.. .+..+...++||||+.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 356999999999999999999753 467899998632 1223456789999996
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
++|.+++.. ...+++.++..++.|++.||+||| +++||||||||+||+++.++.++|+|||+++............
T Consensus 170 ~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~ 245 (392)
T PHA03207 170 CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245 (392)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence 688888843 356789999999999999999999 9999999999999999999999999999998765432222223
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.|+||
T Consensus 246 ~~~gt~~y~aP 256 (392)
T PHA03207 246 GWSGTLETNSP 256 (392)
T ss_pred ccccccCccCH
Confidence 45689999998
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=174.17 Aligned_cols=137 Identities=30% Similarity=0.432 Sum_probs=112.0
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
++|++.+.||+|+||.||+|+. .+++.||+|++... +..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4699999999999999999986 57889999987531 12345668999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|.+++... ..+++.+...++.|++.|++|+| +.+|+|||+||+||++++++.++++|||+++....... .
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 999999988654 35688888999999999999999 99999999999999999999999999999986642211 1
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 163 ~~~~~~~~~y~~P 175 (267)
T cd06646 163 RKSFIGTPYWMAP 175 (267)
T ss_pred cCccccCccccCH
Confidence 1223467788887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=187.30 Aligned_cols=148 Identities=29% Similarity=0.415 Sum_probs=122.9
Q ss_pred ccHHHHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc--------------------------------
Q 035895 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------- 421 (527)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------- 421 (527)
..++.+...++.|++.++||.|.+|.||+++. ++++.+|+|+++...
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 44555666678899999999999999999984 678899999875321
Q ss_pred --CccceeEEEEEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 035895 422 --SNEDFRALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 422 --~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~ 498 (527)
...++.++|||||.||+..+++.+- +..++|.....|+.++++|+.+|| ...++|||+|-.|||++.++.+|+.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence 1245778999999999999998753 456888888999999999999999 9999999999999999999999999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++.++... .......||+.||||
T Consensus 166 DFGvSaQldsT~--grRnT~iGtP~WMAP 192 (953)
T KOG0587|consen 166 DFGVSAQLDSTV--GRRNTFIGTPYWMAP 192 (953)
T ss_pred eeeeeeeeeccc--ccccCcCCCcccccc
Confidence 999999875332 222345799999998
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=175.29 Aligned_cols=140 Identities=24% Similarity=0.381 Sum_probs=110.3
Q ss_pred CCccccceeccCCceEEEEEEcc-CC----cEEEEEEEeecc-----------------------------CccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DG----MEFAIKVFHFSC-----------------------------SNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~----~~vavK~~~~~~-----------------------------~~~~~~~lv 430 (527)
++|++.+.||+|+||.||+|... +| ..||+|++.... ......++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 56888899999999999999864 33 358999864211 011456799
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++......+++.....++.|++.|++|+| +++|+||||||+||++++++.+|++|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999876666889999999999999999999 8999999999999999999999999999998765332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.........++..|+||
T Consensus 164 ~~~~~~~~~~~~~y~~P 180 (279)
T cd05057 164 KEYHAEGGKVPIKWMAL 180 (279)
T ss_pred cceecCCCcccccccCH
Confidence 22211122235678887
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=177.14 Aligned_cols=141 Identities=26% Similarity=0.389 Sum_probs=111.3
Q ss_pred cCCccccceeccCCceEEEEEEcc-----------------CCcEEEEEEEeec--------------------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-----------------DGMEFAIKVFHFS-------------------------- 420 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-----------------~~~~vavK~~~~~-------------------------- 420 (527)
.++|++.+.||+|+||.||+|... .+..||+|++...
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457899999999999999998753 2346899987421
Q ss_pred ----cCccceeEEEEEeccCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 035895 421 ----CSNEDFRALVLEYTTNGSLEKVLYSSN----------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHN 486 (527)
Q Consensus 421 ----~~~~~~~~lv~ey~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~n 486 (527)
+..++..++||||+++++|.+++.... ..+++.....++.+++.|++||| +.+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 223356789999999999999987543 25788889999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 487 KLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 487 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|++++++.++++|||+++...............++..||||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW 201 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence 99999999999999999875433221122223356789988
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=173.18 Aligned_cols=139 Identities=25% Similarity=0.456 Sum_probs=111.2
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEeccCC
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTTNG 437 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~~g 437 (527)
++|.+.+.||+|+||.||+|....+..||+|.+... +...+..++||||+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKG 85 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCC
Confidence 458888999999999999999877778999986421 11234567999999999
Q ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 438 SLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 438 ~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
+|.+++.... ..+++..+..++.+++.|++|+| +.+|+||||||+||++++++.++++|||+++....... ....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~ 161 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQ 161 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccC
Confidence 9999997543 34788889999999999999999 99999999999999999999999999999987643221 1111
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 162 ~~~~~~~y~~P 172 (260)
T cd05069 162 GAKFPIKWTAP 172 (260)
T ss_pred CCccchhhCCH
Confidence 22345678887
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=173.30 Aligned_cols=140 Identities=22% Similarity=0.424 Sum_probs=113.1
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEeccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~~ 436 (527)
.++|++.++||+|+||.||+|..++++.||+|.+... ....+..++||||+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 3568899999999999999999988999999987431 1123456899999999
Q ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 437 GSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 437 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
|+|.+++... +..+++.+...++.+++.|++||| +.+++||||||+||++++++.++++|||+++....... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccc
Confidence 9999998653 345788889999999999999999 99999999999999999999999999999987652221 111
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 161 ~~~~~~~~y~~p 172 (260)
T cd05067 161 EGAKFPIKWTAP 172 (260)
T ss_pred cCCcccccccCH
Confidence 223345678887
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=176.77 Aligned_cols=138 Identities=24% Similarity=0.422 Sum_probs=112.2
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|+..+.||+|+||.||+|+.+ +++.||+|.+... +..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 467999999999999999999864 6789999987521 123456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++ ++|.+++...+..+++.....++.|++.||+|+| +++|+||||||+||++++++.+|++|||+++.......
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 997 5899888766666788888999999999999999 99999999999999999999999999999986532221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 160 -~~~~~~~~~~y~~P 173 (301)
T cd07873 160 -TYSNEVVTLWYRPP 173 (301)
T ss_pred -cccccceeecccCc
Confidence 11223457789988
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=175.77 Aligned_cols=148 Identities=26% Similarity=0.370 Sum_probs=118.2
Q ss_pred ccHHHHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------c---
Q 035895 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------C--- 421 (527)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~--- 421 (527)
+.++.+....++|++.+.||+|+||.||+|.. .+++.+|+|++... +
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 44556667788999999999999999999986 46789999986320 1
Q ss_pred --CccceeEEEEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 035895 422 --SNEDFRALVLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496 (527)
Q Consensus 422 --~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~k 496 (527)
...+..++||||+++|+|.+++.. .+..+++.....++.+++.|+.|+| +++|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence 122457899999999999998753 2345778888889999999999999 99999999999999999999999
Q ss_pred EeecccccccCCCCCccceeccccccccccC
Q 035895 497 LSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 497 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++|||+++....... ......++..|+||
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 193 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAP 193 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccCh
Confidence 999999987643221 11223578889998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=175.22 Aligned_cols=135 Identities=30% Similarity=0.418 Sum_probs=108.7
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc----------------------C-----------------ccc
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC----------------------S-----------------NED 425 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~----------------------~-----------------~~~ 425 (527)
.|++.+.||+|+||+||+|+.. +++.||+|.+.... . ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999864 68999999864210 0 112
Q ss_pred eeEEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
..++||||+++ +|.+++.... ..+++.....++.|++.||+|+| +.+|+||||||+||+++.++.+|++|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 35799999985 8988886543 34788889999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... ..+...+|..|+||
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aP 176 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAP 176 (288)
T ss_pred cccCcc---cCCCccccccccCc
Confidence 764322 12234578889998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=174.96 Aligned_cols=141 Identities=29% Similarity=0.421 Sum_probs=113.3
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cC------ccc
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CS------NED 425 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~------~~~ 425 (527)
.+.+.|+..+.||+|+||.||+|+. .+++.||+|++... +. .+.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3456788999999999999999986 46889999986421 00 023
Q ss_pred eeEEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
..++||||+++|+|.+++.... ..+++.....++.|++.|++||| +++|+|||+||+||++++++.++++|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 5689999999999999987643 45788888999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... ......|+..|+||
T Consensus 160 ~~~~~~~--~~~~~~g~~~y~aP 180 (272)
T cd06637 160 QLDRTVG--RRNTFIGTPYWMAP 180 (272)
T ss_pred ecccccc--cCCcccccccccCH
Confidence 6543211 12234577889987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=173.65 Aligned_cols=134 Identities=22% Similarity=0.366 Sum_probs=99.7
Q ss_pred ceeccCCceEEEEEEccCC---cEEEEEEEee------------------------------ccCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARLQDG---MEFAIKVFHF------------------------------SCSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~---~~vavK~~~~------------------------------~~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|+..++ ..+++|.+.. .+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 3456665432 122334568999999999
Q ss_pred cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 438 SLEKVLYSSN---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 438 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+|.+++.... ...+......++.||+.||+|+| +.+|+||||||+||+++.++.+|++|||+++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999987542 23455666789999999999999 89999999999999999999999999999865322211111
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 158 ~~~~~~~~~y~aP 170 (268)
T cd05086 158 EDDKCVPLRWLAP 170 (268)
T ss_pred ccCCcCcccccCc
Confidence 2234467778887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=171.40 Aligned_cols=134 Identities=34% Similarity=0.565 Sum_probs=110.0
Q ss_pred ceeccCCceEEEEEEccC----CcEEEEEEEeec------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQD----GMEFAIKVFHFS------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||.||+|.... +..||+|.+... +......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998753 788999987532 2234566899999999
Q ss_pred CcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 437 GSLEKVLYSS--------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 437 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
|+|.+++... ...+++.+...++.+++.|++|+| +++++||||||+||++++++.+|++|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 366899999999999999999999 99999999999999999999999999999987754
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
...........++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~y~aP 176 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAP 176 (262)
T ss_pred ccccccccCCCcCccccCH
Confidence 3221222334467789988
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=172.58 Aligned_cols=139 Identities=27% Similarity=0.482 Sum_probs=111.4
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee----------------------------ccCccceeEEEEEecc
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTT 435 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~ 435 (527)
.+|++.+.||+|+||.||+|... +++.||+|.+.. .+..++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45788899999999999999864 588999998642 1233456679999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 436 NGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 436 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+|+|.+++.... ..+++..+..++.|+++|++|+| +.+++||||||+||++++++.+|++|||+++........ .
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~ 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-A 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-c
Confidence 999999987543 45788889999999999999999 999999999999999999999999999999876433211 1
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 162 ~~~~~~~~~y~aP 174 (263)
T cd05052 162 HAGAKFPIKWTAP 174 (263)
T ss_pred cCCCCCccccCCH
Confidence 1112235578887
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=173.17 Aligned_cols=138 Identities=25% Similarity=0.464 Sum_probs=106.0
Q ss_pred ccccceeccCCceEEEEEEcc----CCcEEEEEEEeec-------------------------------cCcc------c
Q 035895 387 FSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFS-------------------------------CSNE------D 425 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~-------------------------------~~~~------~ 425 (527)
|++.+.||+|+||.||+|... .+..||+|.++.. +... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2467999987521 0011 1
Q ss_pred eeEEEEEeccCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 035895 426 FRALVLEYTTNGSLEKVLYSS-----NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Df 500 (527)
..++||||+++|+|..++... ...+++.....++.|++.||+|+| +.+|+||||||+||++++++.+|++||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 257999999999999988543 135788888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccceeccccccccccC
Q 035895 501 GIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+++................+..|+||
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~p 184 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAI 184 (273)
T ss_pred cceeeccccccccccccccCCccccCH
Confidence 999876433221111122235568776
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=171.77 Aligned_cols=135 Identities=29% Similarity=0.425 Sum_probs=109.0
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||.||+|..+ |..||+|.+... ....+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 356889999999999999999765 678999986421 122345789999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 436 NGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 436 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+|+|.+++...+ ..+++.....++.+++.|++|+| +++|+||||||+||++++++.+|++|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--- 157 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC---
Confidence 999999987643 34788888999999999999999 99999999999999999999999999999886532211
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
....+..||||
T Consensus 158 --~~~~~~~y~aP 168 (256)
T cd05082 158 --TGKLPVKWTAP 168 (256)
T ss_pred --CCccceeecCH
Confidence 12234568887
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=175.71 Aligned_cols=140 Identities=29% Similarity=0.479 Sum_probs=110.7
Q ss_pred CCccccceeccCCceEEEEEEc------cCCcEEEEEEEee-----------------------------ccCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHF-----------------------------SCSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~-----------------------------~~~~~~~~~l 429 (527)
++|.+.+.||+|+||.||+|+. .++..+|+|.+.. .+...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 4588889999999999999974 2456789998642 1233456789
Q ss_pred EEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 035895 430 VLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV 494 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~ 494 (527)
||||+++|+|.+++...+ ..+++.++..++.+++.|++|+| +++|+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999997532 23788899999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCCCCCccceeccccccccccC
Q 035895 495 AHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 495 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++++|||+++...............++..|+||
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 194 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence 999999999865432211112223456789988
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=174.46 Aligned_cols=141 Identities=22% Similarity=0.384 Sum_probs=110.7
Q ss_pred cCCccccceeccCCceEEEEEEcc------CCcEEEEEEEeec------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHFS------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~------------------------------~~~~~~~ 427 (527)
.++|++.+.||+|+||.||+|... ++..||+|.+... +......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 356888999999999999999753 3468999986421 1233567
Q ss_pred EEEEEeccCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 035895 428 ALVLEYTTNGSLEKVLYSSN---------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~ 498 (527)
++||||+++|+|.+++.... ..+++.....++.|++.|++|+| +.+|+||||||+||++++++.+|++
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 89999999999999986432 23577888999999999999999 9999999999999999999999999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++.+.............++..|+||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCH
Confidence 99999876433221112223456789988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=174.05 Aligned_cols=136 Identities=38% Similarity=0.583 Sum_probs=106.1
Q ss_pred ccceeccCCceEEEEEEcc-----CCcEEEEEEEee------------------------------ccCccceeEEEEEe
Q 035895 389 ANNLIGRGSFGSVYKARLQ-----DGMEFAIKVFHF------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 389 ~~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~------------------------------~~~~~~~~~lv~ey 433 (527)
..+.||+|+||.||+|.+. .+..|+||++.. .|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999876 357899999842 12233456899999
Q ss_pred ccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++|+|.+++... ...+++.++..|+.||+.||+||| +.+++|++|+++||++++++.+||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 567899999999999999999999 899999999999999999999999999999876322221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
...........|+||
T Consensus 160 ~~~~~~~~~~~~~aP 174 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAP 174 (259)
T ss_dssp EESTTSESGGGGS-H
T ss_pred ccccccccccccccc
Confidence 111223356678887
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=177.04 Aligned_cols=140 Identities=24% Similarity=0.390 Sum_probs=108.3
Q ss_pred CCccccceeccCCceEEEEEEcc------CCcEEEEEEEeec------------------------------cCccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHFS------------------------------CSNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~------------------------------~~~~~~~~ 428 (527)
.+|++.+.||+|+||.||+|+.. +++.||||++... +...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34778899999999999999853 3578999997521 12234567
Q ss_pred EEEEeccCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 035895 429 LVLEYTTNGSLEKVLYSS---------------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI 493 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~ 493 (527)
+++||+++++|.+++... ...+++.....++.|++.||+|+| +++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 899999999999998532 123677788899999999999999 99999999999999999999
Q ss_pred cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 494 VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+|++|||+++...............+++.||||
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP 195 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCH
Confidence 9999999999876433221111123346789998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=177.99 Aligned_cols=140 Identities=26% Similarity=0.439 Sum_probs=108.4
Q ss_pred CCccccceeccCCceEEEEEEcc--------CCcEEEEEEEee-------------------------------ccCccc
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKVFHF-------------------------------SCSNED 425 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~-------------------------------~~~~~~ 425 (527)
++|.+.+.||+|+||.||+|+.. ....||+|++.. .+..++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56888999999999999999731 245789998642 122344
Q ss_pred eeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD 490 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~ 490 (527)
..++||||+++|+|.+++.... ..+++.+...++.|++.|++|+| +++|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 5789999999999999996532 34788888999999999999999 99999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 491 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 491 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++.+|++|||+++...............++..||||
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP 205 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCH
Confidence 9999999999999876432211111112234568887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=173.09 Aligned_cols=120 Identities=27% Similarity=0.530 Sum_probs=102.8
Q ss_pred CCccccceeccCCceEEEEEEccC-C---cEEEEEEEeec------------------------------cCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQD-G---MEFAIKVFHFS------------------------------CSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~-~---~~vavK~~~~~------------------------------~~~~~~~~lv 430 (527)
.+|++.+.||+|+||.||+|.... + ..||||++... +..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457889999999999999998642 3 36999986421 2234456899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
|||+++|+|.+++...+..+++.+...++.|++.|++|+| +++++||||||+||+++.++.+|++|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999766667889999999999999999999 9999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=174.33 Aligned_cols=134 Identities=34% Similarity=0.459 Sum_probs=112.0
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|... +++.||+|++... +...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999864 6899999987421 12334668999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++... ..++......++.|++.||+|+| +.+|+||||+|+||++++++.+|++|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998765 45788888899999999999999 999999999999999999999999999999876433
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....+++.|+||
T Consensus 155 ---~~~~~~~~~y~aP 167 (290)
T cd05580 155 ---TYTLCGTPEYLAP 167 (290)
T ss_pred ---CCCCCCCccccCh
Confidence 1223567789988
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=173.17 Aligned_cols=128 Identities=29% Similarity=0.462 Sum_probs=105.1
Q ss_pred eeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------------cCccceeEEEEEecc
Q 035895 392 LIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 392 ~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------------~~~~~~~~lv~ey~~ 435 (527)
+||+|+||.||+|+. .+++.||+|.+... +..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 46889999986421 112345679999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
||+|.+++... ..+++.++..++.|++.|++|+| +++|+||||||+||++++++.+|++|||+++.+.....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---- 152 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---- 152 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----
Confidence 99999988654 45789999999999999999999 89999999999999999999999999999886543211
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....|+..|+||
T Consensus 153 ~~~~~~~~y~aP 164 (278)
T cd05606 153 HASVGTHGYMAP 164 (278)
T ss_pred cCcCCCcCCcCc
Confidence 123578889988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-19 Score=174.09 Aligned_cols=138 Identities=29% Similarity=0.364 Sum_probs=112.7
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
+.|++.+.||+|+||.||+|+.. +++.||+|++... +..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999874 5889999987421 12345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++++|..++......+++..+..++.|++.|++|+| +.+|+||||||+||+++.++.++|+|||+++....... .
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--R 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc--c
Confidence 999999888765566889999999999999999999 99999999999999999999999999999876432211 1
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 167 ~~~~~~~~~y~aP 179 (292)
T cd06644 167 RDSFIGTPYWMAP 179 (292)
T ss_pred cceecCCccccCc
Confidence 1223467778887
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=176.93 Aligned_cols=140 Identities=25% Similarity=0.426 Sum_probs=110.3
Q ss_pred CCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec-------------------------------cCcccee
Q 035895 385 DGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS-------------------------------CSNEDFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~-------------------------------~~~~~~~ 427 (527)
++|.+.+.||+|+||.||+|.. .++..||+|++... +...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688899999999999999963 23567999976421 1233456
Q ss_pred EEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 428 ALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
++||||+++|+|.+++.... ..+++.+...++.+++.|++|+| +++|+||||||+||+++.++.++++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 89999999999999997543 34789999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.............++..|+||
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aP 212 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAP 212 (302)
T ss_pred cCCCceeecCCCCcccccCCH
Confidence 433221111122346679988
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=173.88 Aligned_cols=137 Identities=31% Similarity=0.430 Sum_probs=112.5
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
++|++.+.||+|+||.||+|+. .+++.||+|+++.. +...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999986 46889999987531 12245678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|.+++...+ .++..+...++.+++.|++|+| +.+|+||||||+||+++.++.++++|||+++...... ..
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 9999999886543 5788889999999999999999 8999999999999999999999999999987654221 11
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 163 ~~~~~~~~~y~aP 175 (267)
T cd06645 163 RKSFIGTPYWMAP 175 (267)
T ss_pred cccccCcccccCh
Confidence 2234578889998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=177.48 Aligned_cols=141 Identities=24% Similarity=0.396 Sum_probs=109.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCc----EEEEEEEeecc-----------------------------CccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGM----EFAIKVFHFSC-----------------------------SNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~-----------------------------~~~~~~~l 429 (527)
.++|+..+.||+|+||.||+|.. .++. .||+|.+.... ......++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~ 85 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL 85 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCcee
Confidence 35688889999999999999985 3444 47888764211 01123458
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
++||+++|+|.+++......+++.....++.|++.|++|+| +++|+||||||+||++++++.+|++|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999998766556788888999999999999999 999999999999999999999999999999876533
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
..........++..||||
T Consensus 163 ~~~~~~~~~~~~~~y~~P 180 (303)
T cd05110 163 EKEYNADGGKMPIKWMAL 180 (303)
T ss_pred ccccccCCCccccccCCH
Confidence 222122223346678887
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=178.01 Aligned_cols=136 Identities=26% Similarity=0.348 Sum_probs=110.3
Q ss_pred hhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cC------
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CS------ 422 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~------ 422 (527)
.+..+.|+..+.||+|+||.||+|.. .+++.||||++... +.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34467899999999999999999985 56889999987421 00
Q ss_pred ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 035895 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGI 502 (527)
Q Consensus 423 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~ 502 (527)
.....+++||++ +++|.+++.. ..++......++.|++.||+||| +++|+||||||+||++++++.+|++|||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 012357899988 7799888753 35788889999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCccceeccccccccccC
Q 035895 503 AKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++..... .+...+|..|+||
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aP 184 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAP 184 (343)
T ss_pred ceecCCC-----cCCccccccccCc
Confidence 9876432 1234578889998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-19 Score=176.21 Aligned_cols=134 Identities=24% Similarity=0.411 Sum_probs=102.8
Q ss_pred cceeccCCceEEEEEEcc---CCcEEEEEEEeec---------------------------c--CccceeEEEEEeccCC
Q 035895 390 NNLIGRGSFGSVYKARLQ---DGMEFAIKVFHFS---------------------------C--SNEDFRALVLEYTTNG 437 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~---------------------------~--~~~~~~~lv~ey~~~g 437 (527)
.++||+|+||+||+|+.. +++.||+|.+... + ......++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 368999999999999864 4678999987421 0 123356799999864
Q ss_pred cHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeecccccc
Q 035895 438 SLEKVLYSS--------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKL 505 (527)
Q Consensus 438 ~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill----~~~~~~kl~Dfg~a~~ 505 (527)
+|.+++... ...++......++.|++.||+||| +++|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888877532 124677788899999999999999 9999999999999999 4568999999999987
Q ss_pred cCCCCCc-cceeccccccccccC
Q 035895 506 LTGEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~-~~~~~~~~t~~y~aP 527 (527)
+...... .......+|++||||
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred cCCCCccccccCCccccccccCC
Confidence 6533211 112235678999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=171.77 Aligned_cols=140 Identities=28% Similarity=0.497 Sum_probs=112.9
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||.||+|..++++.||||.+... +..+...++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4678999999999999999999888889999987531 123356789999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 436 NGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 436 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+++|.+++.... ..+++.+...++.+++.|++|+| +.+++||||||+||++++++.+|++|||+++....... ..
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TA 160 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-hh
Confidence 999999997643 46788899999999999999999 99999999999999999999999999999987643211 11
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
......+..|+||
T Consensus 161 ~~~~~~~~~y~~P 173 (261)
T cd05034 161 REGAKFPIKWTAP 173 (261)
T ss_pred hhccCCCccccCH
Confidence 1122234568776
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=171.77 Aligned_cols=138 Identities=25% Similarity=0.439 Sum_probs=111.4
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+. .+++.||||.+... +...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999986 47899999976320 11234567999
Q ss_pred EeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||+++|+|.+++.. ....++......++.+++.|++|+| +++++||||||+||+++.++.++++|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2334677888899999999999999 99999999999999999999999999999987643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... ......+++.|+||
T Consensus 159 ~~~--~~~~~~~~~~~~aP 175 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSP 175 (267)
T ss_pred hhH--HHhcCCCCccccCh
Confidence 221 11223567789988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-19 Score=170.78 Aligned_cols=133 Identities=28% Similarity=0.456 Sum_probs=104.1
Q ss_pred eeccCCceEEEEEEcc---CCcEEEEEEEeec-----------------------------cCccceeEEEEEeccCCcH
Q 035895 392 LIGRGSFGSVYKARLQ---DGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 392 ~lg~G~~g~vy~~~~~---~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~~~g~L 439 (527)
.||+|+||.||+|.++ ++..||+|++... +...+..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999753 4567999986421 1123456799999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc-cceecc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS-MTQTQT 518 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~ 518 (527)
.+++......+++.++..++.+++.|++|+| +++++||||||+||+++.++.+|++|||+++........ ...+..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999765567889999999999999999999 899999999999999999999999999999865432211 111112
Q ss_pred ccccccccC
Q 035895 519 LAIIGYMAP 527 (527)
Q Consensus 519 ~~t~~y~aP 527 (527)
.++..|+||
T Consensus 159 ~~~~~y~aP 167 (257)
T cd05115 159 KWPLKWYAP 167 (257)
T ss_pred CCCcccCCH
Confidence 235678887
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-19 Score=169.13 Aligned_cols=137 Identities=32% Similarity=0.463 Sum_probs=112.9
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEee-------------------------------ccCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-------------------------------~~~~~~~~~lv~ey 433 (527)
+|+..+.||+|+||.||+|... +++.||+|.+.. .+...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999864 689999998642 12234567899999
Q ss_pred ccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++++|.+++... +..+++.+...++.+++.|++|+| +.+++||||||+||++++++.++++|||+++.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 456788888999999999999999 999999999999999999999999999999876533211
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....++.+|+||
T Consensus 158 --~~~~~~~~~y~aP 170 (256)
T cd08529 158 --ANTIVGTPYYLSP 170 (256)
T ss_pred --hhccccCccccCH
Confidence 1223467789887
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=170.44 Aligned_cols=138 Identities=27% Similarity=0.446 Sum_probs=112.1
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|... +|+.||+|.++.. +...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999876 7899999977421 11234567999
Q ss_pred EeccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||+++|+|..++... +..+++.+...++.+++.|++|+| +.+|+||||||+||+++.++.++++|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 344788889999999999999999 99999999999999999999999999999987643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.... .....++..|+||
T Consensus 159 ~~~~--~~~~~~~~~y~ap 175 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSP 175 (267)
T ss_pred CCcc--cceecCCccccCH
Confidence 2211 1223467778887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=180.95 Aligned_cols=135 Identities=26% Similarity=0.272 Sum_probs=107.9
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------------Ccc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------------SNE 424 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------------~~~ 424 (527)
..+.|+..+.||+|+||.||+|.. .+++.||||++.... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999986 468899999874210 011
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
...++||||+++ ++.+.+.. .+++.+...++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 245899999976 66666643 4678888889999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... ......+|..|+||
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aP 187 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAP 187 (355)
T ss_pred cCCCcc---ccCCccccCCccCH
Confidence 754321 12234578899998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=180.69 Aligned_cols=135 Identities=25% Similarity=0.269 Sum_probs=108.2
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------C------cc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------S------NE 424 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~------~~ 424 (527)
..+.|+..+.||+|+||.||+|.. .+++.||||++.... . ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999986 468899999874210 0 11
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
...++||||+++ +|.+.+.. .+++.+...++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 245899999975 67776643 3677888899999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... ..+...+|..|+||
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aP 194 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAP 194 (364)
T ss_pred ccCCCC---cccCCcccCCcCCH
Confidence 754321 12234578899998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.6e-19 Score=172.80 Aligned_cols=137 Identities=29% Similarity=0.430 Sum_probs=110.7
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
++|++.+.||+|+||.||+|+.. +++.||+|.+... +..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999875 7899999987531 1234567899999
Q ss_pred ccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 434 TTNGSLEKVLYSS--NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 434 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
+++++|..++... ...+++.....++.+++.|++|||. +.+|+||||||+||+++.++.++++|||+++.+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 9999999988653 2357888999999999999999992 35899999999999999999999999999986532211
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
....++.+|+||
T Consensus 159 ----~~~~~~~~y~aP 170 (286)
T cd06622 159 ----KTNIGCQSYMAP 170 (286)
T ss_pred ----ccCCCccCccCc
Confidence 123466778887
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.3e-19 Score=174.55 Aligned_cols=139 Identities=25% Similarity=0.421 Sum_probs=107.5
Q ss_pred CccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccCccceeEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCSNEDFRAL 429 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~~~~~~~l 429 (527)
+|++.+.||+|+||.||+|+.. ....+|+|.+.. .+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999742 235788987642 1233455679
Q ss_pred EEEeccCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 035895 430 VLEYTTNGSLEKVLYSSN-----------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHN 486 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~n 486 (527)
||||+++|+|.+++.... ..+++.....++.+++.|++||| +++|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999986421 23678888999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 487 KLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 487 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|++++++.+|++|||+++...............++..|+||
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap 198 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence 99999999999999999865433222122223345678887
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-19 Score=175.01 Aligned_cols=140 Identities=24% Similarity=0.398 Sum_probs=106.9
Q ss_pred CCccccceeccCCceEEEEEEcc-----------------CCcEEEEEEEeec---------------------------
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-----------------DGMEFAIKVFHFS--------------------------- 420 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-----------------~~~~vavK~~~~~--------------------------- 420 (527)
++|++.+.||+|+||.||+|+.. ++..||+|++...
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 2346899987531
Q ss_pred ---cCccceeEEEEEeccCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 035895 421 ---CSNEDFRALVLEYTTNGSLEKVLYSSN----------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNK 487 (527)
Q Consensus 421 ---~~~~~~~~lv~ey~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~ni 487 (527)
+...+..++||||+++|+|.+++.... ..+++.+...++.+++.|++|+| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 122345679999999999999987532 13567788999999999999999 99999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 488 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 488 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++++++.++++|||+++.+.............++..|+||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 9999999999999999866432211111112234567776
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=162.21 Aligned_cols=113 Identities=22% Similarity=0.264 Sum_probs=92.0
Q ss_pred cceeccCCceEEEEEEccCCcEEEEEEEeeccCc---------------------------------c------------
Q 035895 390 NNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSN---------------------------------E------------ 424 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~---------------------------------~------------ 424 (527)
...||+|+||.||+|..++|+.||||+++..... |
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999889999999998643110 0
Q ss_pred --------ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCeeeCCCCcE
Q 035895 425 --------DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL-HFGYSTPIIHCDLKPHNKLLDDNIVA 495 (527)
Q Consensus 425 --------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yl-H~~~~~~iiHrdlk~~nill~~~~~~ 495 (527)
...++||||++|+++...... ...++..+...++.|++.+++|+ | +.+|+||||||+||+++ ++.+
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcE
Confidence 112699999999877654332 24578888899999999999999 6 88999999999999998 4789
Q ss_pred EEeecccccccC
Q 035895 496 HLSDFGIAKLLT 507 (527)
Q Consensus 496 kl~Dfg~a~~~~ 507 (527)
+++|||+|....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=180.41 Aligned_cols=135 Identities=26% Similarity=0.298 Sum_probs=107.3
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------C------cc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------S------NE 424 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~------~~ 424 (527)
..+.|++.+.||+|+||.||+|+. .+|+.||+|++.... . ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999986 468999999874210 0 01
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
...++||||+++ ++.+.+.. .++..+...++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 235899999976 56665532 3677778889999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... ..+...+|..|+||
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aP 191 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAP 191 (359)
T ss_pred ccccCc---cCCCCcccCCCCCc
Confidence 653221 12234678899998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=173.87 Aligned_cols=139 Identities=28% Similarity=0.388 Sum_probs=114.6
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------cCccceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey 433 (527)
.++|++.+.||+|+||.||+|... ++..||+|++... +..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356899999999999999999864 6889999987421 2234567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++...+..+++.....++.|++.|++|+| +.+|+||||||+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999876667888899999999999999999 99999999999999999999999999999876533221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 159 ~~~~~~~~~~y~~P 172 (280)
T cd06611 159 KRDTFIGTPYWMAP 172 (280)
T ss_pred ccceeecchhhcCH
Confidence 11223467778887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.8e-19 Score=177.90 Aligned_cols=140 Identities=26% Similarity=0.422 Sum_probs=108.3
Q ss_pred CCccccceeccCCceEEEEEEcc--------CCcEEEEEEEee-------------------------------ccCccc
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKVFHF-------------------------------SCSNED 425 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~-------------------------------~~~~~~ 425 (527)
..|++.+.||+|+||.||+|+.. .+..||+|++.. .+..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 45888999999999999999742 124689997642 122344
Q ss_pred eeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD 490 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~ 490 (527)
..++||||+++|+|.+++.... ..+++.+...++.|++.|++||| +++|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 5689999999999999987532 23678888999999999999999 99999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 491 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 491 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++.+|++|||+++...............++..||||
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence 9999999999999876432211111222335679988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=170.97 Aligned_cols=128 Identities=23% Similarity=0.390 Sum_probs=102.0
Q ss_pred ceeccCCceEEEEEEccC-------------CcEEEEEEEee-----------------------------ccCccceeE
Q 035895 391 NLIGRGSFGSVYKARLQD-------------GMEFAIKVFHF-----------------------------SCSNEDFRA 428 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~-------------~~~vavK~~~~-----------------------------~~~~~~~~~ 428 (527)
+.||+|+||.||+|...+ ...||+|++.. .+..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 23588887532 223445678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-------EEEeecc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV-------AHLSDFG 501 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~-------~kl~Dfg 501 (527)
+||||+++|+|..++......+++.....++.|++.|++|+| +++|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998766666888899999999999999999 999999999999999986654 8999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++...... ....++..||||
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aP 177 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAP 177 (262)
T ss_pred CCccccCc------ccccccccccCh
Confidence 98765321 123466779988
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=173.41 Aligned_cols=141 Identities=26% Similarity=0.375 Sum_probs=108.5
Q ss_pred cCCccccceeccCCceEEEEEEcc------CCcEEEEEEEeec------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHFS------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~------------------------------~~~~~~~ 427 (527)
.++|++.+.||+|+||.||+|... .+..||+|.+... +...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 466899999999999999999864 3578999976421 2233456
Q ss_pred EEEEEeccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEe
Q 035895 428 ALVLEYTTNGSLEKVLYSSN------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI---VAHLS 498 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~---~~kl~ 498 (527)
++||||+++|+|.+++...+ ..+++.+...++.+|+.|++||| +++++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 79999999999999987543 24788899999999999999999 89999999999999998654 69999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++................+..||||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPP 190 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCH
Confidence 99999876322211111112234568887
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=172.92 Aligned_cols=138 Identities=25% Similarity=0.427 Sum_probs=111.2
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|+..+.||+|+||.||+|..+ +++.||||.+... +..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 467999999999999999999865 6889999987421 223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++ +|.+++......+++.....++.|++.||+|+| +.+|+||||||+||++++++.+|++|||+++.......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 9985 999988766557788889999999999999999 99999999999999999999999999999876432211
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 159 -~~~~~~~~~~~~aP 172 (291)
T cd07844 159 -TYSNEVVTLWYRPP 172 (291)
T ss_pred -cccccccccccCCc
Confidence 11122346678887
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-20 Score=185.32 Aligned_cols=136 Identities=29% Similarity=0.403 Sum_probs=110.1
Q ss_pred ccccceeccCCceEEEEEEccC-CcEEEEEEEee-----------------cc------------CccceeEEEEEeccC
Q 035895 387 FSANNLIGRGSFGSVYKARLQD-GMEFAIKVFHF-----------------SC------------SNEDFRALVLEYTTN 436 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~-----------------~~------------~~~~~~~lv~ey~~~ 436 (527)
++++..||.|+||.||+|.-++ +...|-|++.. .| ..++..++..|||+|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4566789999999999998653 44455666531 12 234566789999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|....++-.-+..+...+...++.+++.||.||| +..|||||||+.|||++-+|.++++|||++....... ....
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--QKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH--hhhc
Confidence 9999998887888999999999999999999999 9999999999999999999999999999976543221 2233
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
.+.||++||||
T Consensus 189 sFIGTPYWMAP 199 (1187)
T KOG0579|consen 189 SFIGTPYWMAP 199 (1187)
T ss_pred cccCCcccccc
Confidence 57899999999
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-19 Score=171.33 Aligned_cols=141 Identities=26% Similarity=0.481 Sum_probs=110.7
Q ss_pred cCCccccceeccCCceEEEEEEcc-CC---cEEEEEEEeec------------------------------cCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DG---MEFAIKVFHFS------------------------------CSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~------------------------------~~~~~~~~l 429 (527)
...|+..+.||+|+||.||+|+.. ++ ..+|+|.+... +...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346788899999999999999864 23 37999986421 123345689
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++......+++.+...++.+++.|++|+| +.+++||||||+||++++++.+|++|||+++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999766567889999999999999999999 999999999999999999999999999999876432
Q ss_pred CCc-cceeccccccccccC
Q 035895 510 DQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~-~~~~~~~~t~~y~aP 527 (527)
... ........+..|+||
T Consensus 161 ~~~~~~~~~~~~~~~y~~P 179 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAP 179 (268)
T ss_pred cccceeccCCCcCceecCH
Confidence 211 111112234568887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=168.66 Aligned_cols=139 Identities=29% Similarity=0.416 Sum_probs=111.7
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------cCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------CSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~~~~~~~~l 429 (527)
++|+..+.||+|+||.||+|.. .+++.||+|.++.. +..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999985 56899999986421 123456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++++|.+.+...+ .++......++.+++.|++||| +.+|+||||||+||++++++.++++|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999987543 4677788899999999999999 999999999999999999999999999999865422
Q ss_pred CCccc-eeccccccccccC
Q 035895 510 DQSMT-QTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~-~~~~~~t~~y~aP 527 (527)
..... .....++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~y~aP 176 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSP 176 (263)
T ss_pred ccccccccCCCcCccccCc
Confidence 11111 1223467789988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=171.78 Aligned_cols=136 Identities=29% Similarity=0.383 Sum_probs=111.2
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEee-----------------------------ccCccceeEEEEEeccC
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-----------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey~~~ 436 (527)
|++.+.||+|+||.||+|+.. ++..+|+|.+.. .+..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999865 578889998642 12234567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||+++....... ...
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccc
Confidence 9999988765566888899999999999999999 99999999999999999999999999999876532211 112
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 162 ~~~~~~~y~aP 172 (282)
T cd06643 162 SFIGTPYWMAP 172 (282)
T ss_pred cccccccccCH
Confidence 34577889988
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=168.01 Aligned_cols=137 Identities=26% Similarity=0.494 Sum_probs=111.4
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------c-CccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------C-SNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~-~~~~~~~lv~e 432 (527)
+|++.+.||+|++|.||+|... +++.||+|.+... + ..+...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999864 5789999987421 1 12235679999
Q ss_pred eccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++++|.+++... ...+++.+...++.+++.|++|+| +.+|+||||||+||+++.++.++++|||+++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998753 345788899999999999999999 99999999999999999999999999999987643221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......+++.|+||
T Consensus 158 --~~~~~~~~~~y~aP 171 (257)
T cd08223 158 --MASTLIGTPYYMSP 171 (257)
T ss_pred --ccccccCCcCccCh
Confidence 11234467789998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-19 Score=172.74 Aligned_cols=136 Identities=32% Similarity=0.419 Sum_probs=108.8
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
++|++.+.||+|+||.||+|+.. +|+.||+|++... +..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999864 6899999987431 122345689999
Q ss_pred eccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 433 YTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYST-PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 433 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~-~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
|++ |+|.+++.. .+..+++.....++.|++.|++|+| ++ +++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 688887754 2345788889999999999999999 76 999999999999999999999999999987642
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.. ..+...++..|+||
T Consensus 157 ~~---~~~~~~~~~~y~aP 172 (283)
T cd06617 157 SV---AKTIDAGCKPYMAP 172 (283)
T ss_pred cc---ccccccCCccccCh
Confidence 21 11223467778887
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-19 Score=172.41 Aligned_cols=149 Identities=29% Similarity=0.365 Sum_probs=118.7
Q ss_pred cccHHHHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cC-
Q 035895 374 RFSYQELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CS- 422 (527)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~- 422 (527)
.++.+++..++++|++.+.||+|+||.||+|.. .+++.+|+|++... +.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 345566677789999999999999999999986 56889999987421 00
Q ss_pred ----ccceeEEEEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 035895 423 ----NEDFRALVLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495 (527)
Q Consensus 423 ----~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~ 495 (527)
..+..++||||+++|+|.+++.. .+..+++.....++.+++.|++|+| +++|+||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 01346899999999999998863 2345788888999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCCCCCccceeccccccccccC
Q 035895 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 496 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|++|||+++........ .....++..|+||
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aP 197 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAP 197 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccCh
Confidence 99999999876432211 1123467778887
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-19 Score=173.98 Aligned_cols=135 Identities=28% Similarity=0.387 Sum_probs=110.6
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee------------------------------ccCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~------------------------------~~~~~~~~~lv~ey 433 (527)
++|++.+.||+|+||.||+|+.. ++..+|+|.++. .+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999864 688899998642 12345677899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++|+|.+++... ..+++.....++.+++.|++|+| + .+++||||||+||++++++.+|++|||+++......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999999765 35678788899999999999999 6 589999999999999999999999999987653221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 155 --~~~~~~~~~~~aP 167 (308)
T cd06615 155 --ANSFVGTRSYMSP 167 (308)
T ss_pred --cccCCCCcCccCh
Confidence 1224567788887
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=171.15 Aligned_cols=137 Identities=26% Similarity=0.459 Sum_probs=102.8
Q ss_pred cccceeccCCceEEEEEEccC-C--cEEEEEEEeec-------------------------------cC------cccee
Q 035895 388 SANNLIGRGSFGSVYKARLQD-G--MEFAIKVFHFS-------------------------------CS------NEDFR 427 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~-~--~~vavK~~~~~-------------------------------~~------~~~~~ 427 (527)
.+.+.||+|+||.||+|+..+ + ..||+|.+... |. .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456899999999999998754 3 26899975321 10 01134
Q ss_pred EEEEEeccCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 035895 428 ALVLEYTTNGSLEKVLYSS-----NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGI 502 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~ 502 (527)
++||||+++|+|.+++... ...+++.....++.|++.|++|+| +++|+||||||+||++++++.+|++|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 7899999999999887432 234788888999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccceeccccccccccC
Q 035895 503 AKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.+.............++..|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~p 183 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAI 183 (272)
T ss_pred ccccCcccceecCCcccCCcccCCH
Confidence 9876433211111112245567776
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.9e-19 Score=172.27 Aligned_cols=137 Identities=29% Similarity=0.404 Sum_probs=109.8
Q ss_pred CccccceeccCCceEEEEEEc----cCCcEEEEEEEeec----------------------------------cCcccee
Q 035895 386 GFSANNLIGRGSFGSVYKARL----QDGMEFAIKVFHFS----------------------------------CSNEDFR 427 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~----------------------------------~~~~~~~ 427 (527)
+|++.+.||+|+||.||+|+. .+|+.||+|++... +..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 46889999987421 1123356
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++... ..+++.....++.+++.|++|+| +.+++||||||+||++++++.+|++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 7999999999999998754 34677778888889999999999 9999999999999999999999999999998764
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
..... ......++..|+||
T Consensus 157 ~~~~~-~~~~~~~~~~y~aP 175 (290)
T cd05613 157 EDEVE-RAYSFCGTIEYMAP 175 (290)
T ss_pred ccccc-ccccccCCcccCCh
Confidence 32211 11234467789988
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=172.21 Aligned_cols=127 Identities=23% Similarity=0.385 Sum_probs=99.3
Q ss_pred eeccCCceEEEEEEccC-------------------------CcEEEEEEEee---------------------------
Q 035895 392 LIGRGSFGSVYKARLQD-------------------------GMEFAIKVFHF--------------------------- 419 (527)
Q Consensus 392 ~lg~G~~g~vy~~~~~~-------------------------~~~vavK~~~~--------------------------- 419 (527)
.||+|+||.||+|.... ...||+|++..
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999997421 13588887632
Q ss_pred --ccCccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----
Q 035895 420 --SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI---- 493 (527)
Q Consensus 420 --~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~---- 493 (527)
.|..+...++||||+++|+|..++......+++..+..++.|+++||+|+| +++|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 123345678999999999999998765667888889999999999999999 99999999999999997543
Q ss_pred ---cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 494 ---VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+|++|||+++..... ....++..|+||
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aP 189 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAP 189 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCc
Confidence 4899999998654221 112356678887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=168.24 Aligned_cols=137 Identities=22% Similarity=0.384 Sum_probs=111.3
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEec
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~ 434 (527)
+|++.+.||+|+||.||+++.. +++.||+|.++.. +..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999864 6889999987421 12345678999999
Q ss_pred cCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++|+|.+++... +..++......++.+++.|++|+| +++|+|+||||+||++++++.++++|||.++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 999999988653 345678888899999999999999 999999999999999999999999999999876433221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 157 -~~~~~~~~~~~aP 169 (255)
T cd08219 157 -ACTYVGTPYYVPP 169 (255)
T ss_pred -cccccCCccccCH
Confidence 1224467778887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-19 Score=171.79 Aligned_cols=137 Identities=30% Similarity=0.437 Sum_probs=113.1
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
+|++.+.||+|+||.||+|+. .+|+.||+|++... +......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999986 46899999987531 1223466899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+ +++|.+++......+++.++..++.+++.|++|+| +.+++|+||||+||++++++.++++|||+++....... .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999998766666889999999999999999999 99999999999999999999999999999987653321 1
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++.+|+||
T Consensus 156 ~~~~~~~~~~y~aP 169 (286)
T cd07832 156 LYSHQVATRWYRAP 169 (286)
T ss_pred ccccccCcccccCc
Confidence 11234577889988
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-19 Score=174.08 Aligned_cols=141 Identities=26% Similarity=0.451 Sum_probs=109.6
Q ss_pred cCCccccceeccCCceEEEEEEcc------CCcEEEEEEEeec------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHFS------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~------------------------------~~~~~~~ 427 (527)
.++|+..+.||+|+||.||+|+.. ++..||+|++... +...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 4678999986421 2233456
Q ss_pred EEEEEeccCCcHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 035895 428 ALVLEYTTNGSLEKVLYSSN---------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHN 486 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~n 486 (527)
++||||+++|+|.+++.... ..+++.+...++.+++.||+|+| +++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 89999999999999987421 13567788899999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 487 KLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 487 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|++++++.++++|||+++................+..|+||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence 99999999999999999865432211111112235568887
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=172.63 Aligned_cols=142 Identities=21% Similarity=0.369 Sum_probs=112.3
Q ss_pred hcCCccccceeccCCceEEEEEEccC-----CcEEEEEEEeec------------------------------c-Cccce
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQD-----GMEFAIKVFHFS------------------------------C-SNEDF 426 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~------------------------------~-~~~~~ 426 (527)
..++|++.+.||+|+||.||+|.... +..||+|++... + .....
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678899999999999999998754 688999986421 1 11345
Q ss_pred eEEEEEeccCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 035895 427 RALVLEYTTNGSLEKVLYSSN-------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSD 499 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~D 499 (527)
.++++||+++|+|.+++.... ..+++.+...++.+++.|++||| +++++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 679999999999999986532 34788889999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCCccceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+++.+.............++..|+||
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~ap 188 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMAL 188 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCH
Confidence 9999876433221111223346678887
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.2e-19 Score=171.00 Aligned_cols=139 Identities=27% Similarity=0.436 Sum_probs=110.2
Q ss_pred CCccccceeccCCceEEEEEEccC----CcEEEEEEEeecc-----------------------------CccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQD----GMEFAIKVFHFSC-----------------------------SNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~-----------------------------~~~~~~~lv~ 431 (527)
++|.+.+.||+|+||.||+|...+ ...||||...... ...+..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457888999999999999998643 3468999864210 1124457999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++......+++..+..++.+++.|++|+| +++++||||||+||+++.++.+|++|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999765556899999999999999999999 99999999999999999999999999999987654321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
...+...++..|+||
T Consensus 163 -~~~~~~~~~~~y~aP 177 (270)
T cd05056 163 -YKASKGKLPIKWMAP 177 (270)
T ss_pred -eecCCCCccccccCh
Confidence 112222344578887
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=171.78 Aligned_cols=139 Identities=26% Similarity=0.392 Sum_probs=109.8
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVL 431 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ 431 (527)
++++|.+.+.||+|+||.||+|.. .+++.||+|++... +..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999985 46889999987421 12234567999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+. +++.+.+......+.+.+...++.|++.||+|+| +.+|+||||||+||+++.++.+|++|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 6777766554445677788889999999999999 89999999999999999999999999999986532221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
. .....++..|+||
T Consensus 159 ~--~~~~~~~~~y~aP 172 (291)
T cd07870 159 T--YSSEVVTLWYRPP 172 (291)
T ss_pred C--CCCccccccccCC
Confidence 1 1223457789888
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-19 Score=171.71 Aligned_cols=136 Identities=29% Similarity=0.444 Sum_probs=109.2
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
+|++.+.||+|+||.||+|+.. +++.||+|++... +..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999864 6899999987421 1234567899999
Q ss_pred ccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 434 TTNGSLEKVLYSSN--YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 434 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
++ |+|.+++.... ..+++.+...++.|++.||+|+| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 98 58888876432 45788888999999999999999 99999999999999999999999999999986542211
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......+++.|+||
T Consensus 157 --~~~~~~~~~~y~aP 170 (285)
T cd07861 157 --VYTHEVVTLWYRAP 170 (285)
T ss_pred --cccCCcccccccCh
Confidence 11223457789888
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=169.19 Aligned_cols=139 Identities=27% Similarity=0.437 Sum_probs=112.3
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEeccC
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~~ 436 (527)
.+|++.+.||+|+||.||+|....+..+|+|.+.. .+......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46888899999999999999987788999998642 12233456799999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++......+++.....++.+++.|++|+| +.+++||||||+||+++.++.+|++|||+++....... ....
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 159 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSST 159 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cccC
Confidence 9999999766556788888999999999999999 99999999999999999999999999999986543211 1111
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++.+|+||
T Consensus 160 ~~~~~~~~~aP 170 (256)
T cd05112 160 GTKFPVKWSSP 170 (256)
T ss_pred CCccchhhcCH
Confidence 22345678887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.7e-19 Score=174.39 Aligned_cols=120 Identities=34% Similarity=0.592 Sum_probs=99.3
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCc--EEEEEEEee-------------------------------ccCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGM--EFAIKVFHF-------------------------------SCSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~-------------------------------~~~~~~~~~l 429 (527)
.++|++.+.||+|+||.||+|+.+ ++. .+|+|.+.. .+..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356888999999999999999864 444 457776532 1223456789
Q ss_pred EEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 035895 430 VLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV 494 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~ 494 (527)
||||+++|+|.+++...+ ..+++.+...++.|++.|++||| +++|+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999997532 24678889999999999999999 999999999999999999999
Q ss_pred EEEeeccccccc
Q 035895 495 AHLSDFGIAKLL 506 (527)
Q Consensus 495 ~kl~Dfg~a~~~ 506 (527)
+|++|||+++..
T Consensus 163 ~kl~dfg~~~~~ 174 (303)
T cd05088 163 AKIADFGLSRGQ 174 (303)
T ss_pred EEeCccccCccc
Confidence 999999998743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=169.48 Aligned_cols=142 Identities=30% Similarity=0.416 Sum_probs=111.6
Q ss_pred hhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEE
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALV 430 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv 430 (527)
+.+++.+.....||+|+||.||+|+. +++..||+|.+.. .+..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 44566676778999999999999985 4678899998642 12344567899
Q ss_pred EEeccCCcHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccC
Q 035895 431 LEYTTNGSLEKVLYSSNYIL--DILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLT 507 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~~~~ 507 (527)
|||+++++|.+++......+ +......++.|++.|++||| +.+|+||||||+||+++. ++.++++|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999997653344 67778889999999999999 999999999999999986 6799999999987654
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ......++..|+||
T Consensus 161 ~~~~--~~~~~~~~~~~~aP 178 (268)
T cd06624 161 GINP--CTETFTGTLQYMAP 178 (268)
T ss_pred cCCC--ccccCCCCccccCh
Confidence 2211 11123467778887
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=171.99 Aligned_cols=136 Identities=32% Similarity=0.498 Sum_probs=110.3
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec----------------------------------cCccceeEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS----------------------------------CSNEDFRALV 430 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----------------------------------~~~~~~~~lv 430 (527)
.|+..+.||+|+||.||+|... +++.||||.+... +..++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3778899999999999999864 6899999987532 1123456899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+ +|+|.+++......+++.....++.||++||+||| +++|+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 89999999765446889999999999999999999 9999999999999999999999999999998764332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.. .....++..|+||
T Consensus 157 ~~--~~~~~~~~~y~aP 171 (298)
T cd07841 157 RK--MTHQVVTRWYRAP 171 (298)
T ss_pred cc--ccccccceeeeCH
Confidence 11 1122356678887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=168.49 Aligned_cols=139 Identities=28% Similarity=0.373 Sum_probs=110.5
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------cCc--ccee
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------CSN--EDFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~~~--~~~~ 427 (527)
.+|++.+.||+|+||.||+|.. .++..||||.+... +.. ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688999999999999999986 46899999986420 011 2346
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++...+ .+++.....++.+++.||+|+| +.+|+||||||+||+++.++.++++|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 78999999999999987543 4677788899999999999999 9999999999999999999999999999998654
Q ss_pred CCCCc-cceeccccccccccC
Q 035895 508 GEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~-~~~~~~~~t~~y~aP 527 (527)
..... .......++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aP 178 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSP 178 (265)
T ss_pred cccccccccccCCCCccccCh
Confidence 22111 111223477889998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-19 Score=179.33 Aligned_cols=133 Identities=30% Similarity=0.407 Sum_probs=107.0
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------cCccceeEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------CSNEDFRALV 430 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~~~~~~~~lv 430 (527)
.|++.++||+|+||.|-+|.. ++++.||||+++.. ....+..+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 578899999999999999985 67999999998531 1234566899
Q ss_pred EEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEeecccccccC
Q 035895 431 LEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD--NIVAHLSDFGIAKLLT 507 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~--~~~~kl~Dfg~a~~~~ 507 (527)
+|.+.. +|++++...+ ..++......++.||+.||..|| ..+|||+||||+|||+.+ ...+||+|||.|....
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999865 9999997543 34778888899999999999999 999999999999999964 4589999999998765
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
+.-. + ..-+..|+||
T Consensus 343 q~vy--t---YiQSRfYRAP 357 (586)
T KOG0667|consen 343 QRVY--T---YIQSRFYRAP 357 (586)
T ss_pred Ccce--e---eeeccccccc
Confidence 3322 1 1234568888
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.1e-19 Score=173.65 Aligned_cols=136 Identities=32% Similarity=0.446 Sum_probs=111.9
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey~ 434 (527)
..|++.+.||+|+||.||+|.. .+++.||+|.+.. .+...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5689999999999999999985 5789999998742 122345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++++|.+++.+ ..+++.+...++.+++.|++||| +.+|+||||||+||+++.++.++++|||+++........
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 99999999864 34688888999999999999999 999999999999999999999999999999876433211
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....+++.|+||
T Consensus 172 ~~~~~~~~~y~aP 184 (297)
T cd06656 172 RSTMVGTPYWMAP 184 (297)
T ss_pred cCcccCCccccCH
Confidence 1223467778887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=167.95 Aligned_cols=135 Identities=29% Similarity=0.484 Sum_probs=110.6
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||.||+|... |+.||+|.+... +..++..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 457889999999999999999875 788999987431 223456789999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 436 NGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 436 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+++|.+++.... ..+++.....++.|++.|+.|+| +++++||||||+||+++.++.+|++|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999987543 25789999999999999999999 99999999999999999999999999999987642211
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
....+..|+||
T Consensus 158 --~~~~~~~~~ap 168 (256)
T cd05039 158 --SGKLPVKWTAP 168 (256)
T ss_pred --cCCCcccccCc
Confidence 12234567776
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.4e-19 Score=169.79 Aligned_cols=138 Identities=27% Similarity=0.489 Sum_probs=112.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||.||+|+. .+++.||||.+.. .+..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999985 5789999997642 112334678999
Q ss_pred EeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||+++++|.+++.. ....+++.....++.+++.|++||| +++++|+||||+||+++.++.++++|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864 2345788888999999999999999 99999999999999999999999999999887643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... ......++..|+||
T Consensus 159 ~~~--~~~~~~~~~~~~ap 175 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSP 175 (267)
T ss_pred CCc--ccccccCCcCccCH
Confidence 221 11123467788887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=168.38 Aligned_cols=137 Identities=23% Similarity=0.325 Sum_probs=111.2
Q ss_pred hhhcCCcccccee--ccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------cCccceeEEEEE
Q 035895 381 LRATDGFSANNLI--GRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------CSNEDFRALVLE 432 (527)
Q Consensus 381 ~~~~~~~~~~~~l--g~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------~~~~~~~~lv~e 432 (527)
....+.|++.+.+ |+|+||.||+++. .++..+|+|.+... +..++..++|||
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 3345667776666 9999999999986 46788999986421 123456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++...+ .+++.+...++.|++.|++|+| +.+++||||||+||+++.++ .++++|||+++......
T Consensus 90 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 90 YIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 999999999987654 6789999999999999999999 99999999999999999888 99999999988664321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 165 -----~~~~~~~y~aP 175 (267)
T PHA03390 165 -----CYDGTLDYFSP 175 (267)
T ss_pred -----cCCCCCcccCh
Confidence 12467778887
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=172.32 Aligned_cols=119 Identities=31% Similarity=0.571 Sum_probs=98.4
Q ss_pred CCccccceeccCCceEEEEEEcc-CCc--EEEEEEEeec-------------------------------cCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGM--EFAIKVFHFS-------------------------------CSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~-------------------------------~~~~~~~~lv 430 (527)
++|++.+.||+|+||.||+|..+ ++. .+|+|.+... +...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999864 333 4688876421 1123456799
Q ss_pred EEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 035895 431 LEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~ 495 (527)
|||+++|+|.+++.... ..+++.....++.|++.|++|+| +++|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999986532 23678888999999999999999 9999999999999999999999
Q ss_pred EEeeccccccc
Q 035895 496 HLSDFGIAKLL 506 (527)
Q Consensus 496 kl~Dfg~a~~~ 506 (527)
|++|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=168.90 Aligned_cols=140 Identities=20% Similarity=0.400 Sum_probs=111.8
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEeccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~~ 436 (527)
.++|++.+.||+|+||.||+|...++..+|+|.+... .......+++|||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 4678999999999999999999877888999976421 0112456899999999
Q ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 437 GSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 437 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
|+|.+++.+. +...++.++..++.+++.|++|+| +.+++||||||+||+++.++.+|++|||.++.+..... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 160 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR 160 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccc
Confidence 9999999764 345788888999999999999999 89999999999999999999999999999987643221 111
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 161 ~~~~~~~~y~~P 172 (260)
T cd05073 161 EGAKFPIKWTAP 172 (260)
T ss_pred cCCcccccccCH
Confidence 122345568887
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.6e-19 Score=192.23 Aligned_cols=144 Identities=22% Similarity=0.346 Sum_probs=111.8
Q ss_pred hhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------c--Cccce
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------C--SNEDF 426 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~--~~~~~ 426 (527)
....++|++.+.||+|+||.||+|+.. ++..||+|++... + ...+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344678999999999999999999864 5778999986421 0 12245
Q ss_pred eEEEEEeccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecCCCCCCeeeCC--------
Q 035895 427 RALVLEYTTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGY----STPIIHCDLKPHNKLLDD-------- 491 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~----~~~iiHrdlk~~nill~~-------- 491 (527)
.++||||+++|+|.++|... ...+++.....|+.||+.||+|||... .++||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 78999999999999998652 245788899999999999999999321 156999999999999964
Q ss_pred ---------CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 ---------NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+.+||+|||+++.+..... .....+|+.||||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAP 210 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSP 210 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCH
Confidence 24589999999987643221 2234688999998
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.3e-19 Score=172.02 Aligned_cols=139 Identities=29% Similarity=0.456 Sum_probs=108.4
Q ss_pred CccccceeccCCceEEEEEEc------cCCcEEEEEEEee-----------------------------ccCccceeEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHF-----------------------------SCSNEDFRALV 430 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~-----------------------------~~~~~~~~~lv 430 (527)
+|...+.||+|+||.||+|.. .++..+|+|.+.. .+...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 467789999999999999963 2456789997632 12234567899
Q ss_pred EEeccCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 035895 431 LEYTTNGSLEKVLYSSN--------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~k 496 (527)
|||+++|+|.+++...+ ..+++.+...++.|++.|++||| +++++||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEE
Confidence 99999999999987543 23678889999999999999999 99999999999999999999999
Q ss_pred EeecccccccCCCCCccceeccccccccccC
Q 035895 497 LSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 497 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++|||+++...............+++.|+||
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCH
Confidence 9999999865432211111122345678887
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.7e-19 Score=173.34 Aligned_cols=136 Identities=32% Similarity=0.444 Sum_probs=111.6
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
..|+..+.||+|+||.||+|+. .+++.||+|.+... +......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4688899999999999999985 56889999987431 12345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|.+++.. ..+++.+...++.|++.|++|+| +.+|+||||||+||+++.++.+|++|||+++........
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 172 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--
Confidence 99999999854 34688889999999999999999 999999999999999999999999999998865432211
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 173 ~~~~~~~~~y~aP 185 (296)
T cd06654 173 RSTMVGTPYWMAP 185 (296)
T ss_pred cCcccCCccccCH
Confidence 1223567789988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.6e-19 Score=169.14 Aligned_cols=127 Identities=26% Similarity=0.425 Sum_probs=101.2
Q ss_pred ceeccCCceEEEEEEccCC-----------cEEEEEEEee----------------------------ccCccceeEEEE
Q 035895 391 NLIGRGSFGSVYKARLQDG-----------MEFAIKVFHF----------------------------SCSNEDFRALVL 431 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~-----------~~vavK~~~~----------------------------~~~~~~~~~lv~ 431 (527)
+.||+|+||.||+|..... ..||+|.+.. .+.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 4689999999999987542 2577886532 1222 4567999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-------cEEEeeccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-------VAHLSDFGIAK 504 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-------~~kl~Dfg~a~ 504 (527)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+|++|||+++
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999876556888889999999999999999 99999999999999999887 79999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... ....++..|+||
T Consensus 157 ~~~~~------~~~~~~~~y~aP 173 (259)
T cd05037 157 TVLSR------EERVERIPWIAP 173 (259)
T ss_pred ccccc------cccccCCCccCh
Confidence 75431 112345567777
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-19 Score=177.58 Aligned_cols=132 Identities=32% Similarity=0.443 Sum_probs=107.0
Q ss_pred ceeccCCceEEEEEEcc-CCcEEEEEEEee-----------------------------ccCccceeEEEEEeccCCcHH
Q 035895 391 NLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-----------------------------SCSNEDFRALVLEYTTNGSLE 440 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey~~~g~L~ 440 (527)
-++|+|.||+||-|+.. +...+|||-+.. +|+..++.-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999964 567799997632 355667778999999999999
Q ss_pred HHHHhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeecccccccCCCCCccceec
Q 035895 441 KVLYSSNYIL--DILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQ 517 (527)
Q Consensus 441 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 517 (527)
++++..=+.+ .....-.+..||.+||.||| ...|||||||-.|+|++ -.|.+||+|||.++.+.+-. .....
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence 9998653334 34445568899999999999 99999999999999997 68999999999999875432 22234
Q ss_pred cccccccccC
Q 035895 518 TLAIIGYMAP 527 (527)
Q Consensus 518 ~~~t~~y~aP 527 (527)
+.||+-||||
T Consensus 736 FTGTLQYMAP 745 (1226)
T KOG4279|consen 736 FTGTLQYMAP 745 (1226)
T ss_pred cccchhhhCh
Confidence 6799999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-19 Score=178.79 Aligned_cols=136 Identities=28% Similarity=0.466 Sum_probs=114.7
Q ss_pred cccceeccCCceEEEEEEccC---C--cEEEEEEEeeccCcc-----------------------------ceeEEEEEe
Q 035895 388 SANNLIGRGSFGSVYKARLQD---G--MEFAIKVFHFSCSNE-----------------------------DFRALVLEY 433 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~---~--~~vavK~~~~~~~~~-----------------------------~~~~lv~ey 433 (527)
+..++||+|.||.||+|...+ | ..||||..+..|..+ ...+||||.
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL 471 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMEL 471 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEec
Confidence 456889999999999998532 2 358999987755432 234699999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++-|.|+.++...+..++......++.||+.|++||| +.++|||||-.+|||+.....+|++|||++|.+.++..+.
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999988888999889999999999999999 9999999999999999999999999999999997665443
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.+...-.+.||||
T Consensus 549 -aS~~kLPIKWmaP 561 (974)
T KOG4257|consen 549 -ASRGKLPIKWMAP 561 (974)
T ss_pred -ccccccceeecCc
Confidence 3344457789998
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=168.07 Aligned_cols=132 Identities=27% Similarity=0.405 Sum_probs=103.9
Q ss_pred eeccCCceEEEEEEc---cCCcEEEEEEEeec------------------------------cCccceeEEEEEeccCCc
Q 035895 392 LIGRGSFGSVYKARL---QDGMEFAIKVFHFS------------------------------CSNEDFRALVLEYTTNGS 438 (527)
Q Consensus 392 ~lg~G~~g~vy~~~~---~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~~~g~ 438 (527)
.||+|+||.||+|.+ .++..||+|++... ....+..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999964 35788999987421 012345579999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc-eec
Q 035895 439 LEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT-QTQ 517 (527)
Q Consensus 439 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~ 517 (527)
|.+++... ..+++.....++.|++.|++|+| +++|+||||||+||++++++.+|++|||+++.......... .+.
T Consensus 82 L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 82 LNKFLQKN-KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99998654 35788889999999999999999 99999999999999999999999999999987643322111 112
Q ss_pred cccccccccC
Q 035895 518 TLAIIGYMAP 527 (527)
Q Consensus 518 ~~~t~~y~aP 527 (527)
..++..|+||
T Consensus 158 ~~~~~~y~aP 167 (257)
T cd05116 158 GKWPVKWYAP 167 (257)
T ss_pred CCCCccccCH
Confidence 2235678887
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=188.93 Aligned_cols=139 Identities=31% Similarity=0.503 Sum_probs=113.4
Q ss_pred CccccceeccCCceEEEEEEc------cCCcEEEEEEEee------------------------------ccCccceeEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHF------------------------------SCSNEDFRAL 429 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~------------------------------~~~~~~~~~l 429 (527)
+....+.||+|+||+||+|+. ++.+.||||.++. .|...+-.++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 345668899999999999974 3456799998753 2556667789
Q ss_pred EEEeccCCcHHHHHHhcC---------C----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 035895 430 VLEYTTNGSLEKVLYSSN---------Y----ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~---------~----~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~k 496 (527)
|+|||..|||.++|+... . .++..+.+.||.|||.|++||- ++.+|||||-.+|+|+.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence 999999999999997531 1 2778899999999999999999 99999999999999999999999
Q ss_pred EeecccccccCCCCCccceeccccccccccC
Q 035895 497 LSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 497 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+|||++|.+-..+.+.......-.++||+|
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMpp 674 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP 674 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCH
Confidence 9999999976544444333334457889998
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=168.16 Aligned_cols=138 Identities=23% Similarity=0.401 Sum_probs=110.9
Q ss_pred CccccceeccCCceEEEEEEccCCcEEEEEEEee-----------------------------------ccCccceeEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF-----------------------------------SCSNEDFRALV 430 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~-----------------------------------~~~~~~~~~lv 430 (527)
+|+..+.||+|+||.||+|...+++.+|+|.+.. .+...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999997642 12234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++.+.+ .+++.....++.|++.|++|+| +.+|+|+||||+||++++++.++++|||+++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997543 4678888889999999999999 8999999999999999999999999999988653211
Q ss_pred Cc----cceeccccccccccC
Q 035895 511 QS----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~----~~~~~~~~t~~y~aP 527 (527)
.. .......++..|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~p 177 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAP 177 (265)
T ss_pred ccccccccccccCCCccccCh
Confidence 10 011123467788887
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=169.64 Aligned_cols=136 Identities=27% Similarity=0.417 Sum_probs=109.8
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
.|+..+.||+|+||.||+|+.. +|+.||+|++... .......++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3778899999999999999864 6899999987421 1123456899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++ ++|.+++......+++.....++.||++|++||| +++|+||||||+||+++.++.+|++|||+++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 97 4788887665566899999999999999999999 999999999999999999999999999999865432211
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 156 -~~~~~~~~~y~aP 168 (284)
T cd07839 156 -YSAEVVTLWYRPP 168 (284)
T ss_pred -cCCCccccCCcCh
Confidence 1223467789988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=170.08 Aligned_cols=148 Identities=28% Similarity=0.413 Sum_probs=117.1
Q ss_pred ccHHHHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------c---
Q 035895 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------C--- 421 (527)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~--- 421 (527)
.+..++..+.+.|++.+.||+|+||.||+|+. .+++.||+|++... +
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34555566778899999999999999999986 56889999986321 0
Q ss_pred ---CccceeEEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 035895 422 ---SNEDFRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497 (527)
Q Consensus 422 ---~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl 497 (527)
...+..++||||+++|+|.+++.... ..+++.....++.|++.|++|+| +++|+|||+||+||++++++.+++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 01346689999999999999987533 34677778889999999999999 999999999999999999999999
Q ss_pred eecccccccCCCCCccceeccccccccccC
Q 035895 498 SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 498 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|||+++....... ......++..|+||
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 190 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAP 190 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCH
Confidence 99999886532211 11224567789887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=166.90 Aligned_cols=114 Identities=33% Similarity=0.538 Sum_probs=99.1
Q ss_pred ceeccCCceEEEEEEccCCcEEEEEEEeec------------------------------cCccceeEEEEEeccCCcHH
Q 035895 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------CSNEDFRALVLEYTTNGSLE 440 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~~~g~L~ 440 (527)
+.||+|+||.||+|...+++.||+|.+... +......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999986421 22344568999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 441 KVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 441 ~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
+++......+++.....++.+++.|++|+| +++++||||||+||+++.++.+|++|||+++...
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 999765556788888999999999999999 9999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=171.73 Aligned_cols=117 Identities=31% Similarity=0.505 Sum_probs=100.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|+..+.||+|+||.||+|+.. +++.||+|.+... +..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999864 5789999986421 12345668999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
||++||+|.+++...+ .+++.....++.+++.|++|+| +++++||||||+||+++.++.+|++|||+++.
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 9999999999997653 5778888889999999999999 99999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=171.08 Aligned_cols=127 Identities=24% Similarity=0.298 Sum_probs=104.6
Q ss_pred ceeccCCceEEEEEEccCCcEEEEEEEeec--------------------------------cCc----cceeEEEEEec
Q 035895 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFS--------------------------------CSN----EDFRALVLEYT 434 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~--------------------------------~~~----~~~~~lv~ey~ 434 (527)
..||+|++|.||+|.. +|+.||||++... +.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999998 5889999987421 111 23567999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++|+|.+++... ..+++.....++.+++.|++|+| + .+++||||||+||++++++.+|++|||+++......
T Consensus 105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999999764 45788889999999999999999 6 488899999999999999999999999998764321
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 178 --~~~~~~~~y~aP 189 (283)
T PHA02988 178 --FKNVNFMVYFSY 189 (283)
T ss_pred --ccccCcccccCH
Confidence 123467789998
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=168.18 Aligned_cols=137 Identities=30% Similarity=0.435 Sum_probs=109.5
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEee---------------------------------------ccCccce
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF---------------------------------------SCSNEDF 426 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~---------------------------------------~~~~~~~ 426 (527)
|...+.||+|+||.||+|.. .+++.||+|.++. .+...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 66788999999999999985 4688999997642 1122345
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||+++|+|.+++... ..+++..+..++.+++.|++|+| +++++||||+|+||++++++.++++|||+++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 67999999999999998765 35788888889999999999999 899999999999999999999999999999865
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.............++..|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~P 179 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAP 179 (272)
T ss_pred cccccccccccccCCccccCH
Confidence 422111112233467778887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=159.29 Aligned_cols=113 Identities=25% Similarity=0.290 Sum_probs=91.9
Q ss_pred cceeccCCceEEEEEEccCCcEEEEEEEeeccCc-------------------------------------------c--
Q 035895 390 NNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSN-------------------------------------------E-- 424 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-------------------------------------------~-- 424 (527)
.+.||+|+||.||+|+..+|+.||||+++..... .
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999888999999997642100 0
Q ss_pred --------ceeEEEEEeccCCcHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCc
Q 035895 425 --------DFRALVLEYTTNGSLEKV-LYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIV 494 (527)
Q Consensus 425 --------~~~~lv~ey~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~ 494 (527)
...++||||++|+++... +.. ..++..+...++.+++.++.|+| . .+|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CCC
Confidence 012699999999865433 322 34667788899999999999999 7 9999999999999999 889
Q ss_pred EEEeecccccccCC
Q 035895 495 AHLSDFGIAKLLTG 508 (527)
Q Consensus 495 ~kl~Dfg~a~~~~~ 508 (527)
++++|||+|+....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-20 Score=169.97 Aligned_cols=141 Identities=25% Similarity=0.462 Sum_probs=113.9
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cC--------
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CS-------- 422 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~-------- 422 (527)
....|+....||+|.||+||+|+.+ +|+.||+|++-+. |.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3456777889999999999999864 5788898864210 11
Q ss_pred ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 035895 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGI 502 (527)
Q Consensus 423 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~ 502 (527)
.....++||++|+. ||.-++......++..+..+++.++..||.|+| ...|+|||+||+|+|++.+|.+|++|||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 11236799999985 999999877677888889999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCC--CccceeccccccccccC
Q 035895 503 AKLLTGED--QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~--~~~~~~~~~~t~~y~aP 527 (527)
||.++... .....|..+.|+||..|
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrpp 197 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPP 197 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCH
Confidence 98775432 22334556779999887
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=166.16 Aligned_cols=137 Identities=24% Similarity=0.413 Sum_probs=111.9
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
.|+..+.||+|+||.||.++. .+++.+|+|.+... +..++..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999985 56889999976421 2234566799999
Q ss_pred ccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++|+|.+++... +..+++.+...++.+++.|++|+| +.+++||||||+||++++++.+|++|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999998764 345788889999999999999999 89999999999999999999999999999987643321
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 157 -~~~~~~~~~~y~ap 170 (256)
T cd08221 157 -MAETVVGTPYYMSP 170 (256)
T ss_pred -cccccCCCccccCH
Confidence 11234467788887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=169.33 Aligned_cols=137 Identities=31% Similarity=0.413 Sum_probs=109.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
+.|+..+.||+|+||.||+|+.+ +++.||+|++... +...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999875 6899999986421 112345679999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++++.|..++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++|||++.........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 99999888876543 35788899999999999999999 899999999999999999999999999999876543211
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 157 --~~~~~~~~~~~aP 169 (286)
T cd07847 157 --YTDYVATRWYRAP 169 (286)
T ss_pred --ccCcccccccCCH
Confidence 1122356678877
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=166.61 Aligned_cols=137 Identities=31% Similarity=0.546 Sum_probs=110.0
Q ss_pred ccccceeccCCceEEEEEEccC-----CcEEEEEEEeec------------------------------cCccceeEEEE
Q 035895 387 FSANNLIGRGSFGSVYKARLQD-----GMEFAIKVFHFS------------------------------CSNEDFRALVL 431 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~------------------------------~~~~~~~~lv~ 431 (527)
|++.+.||+|+||.||+|+... +..||+|++... +...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998753 488999987532 12234678999
Q ss_pred EeccCCcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYI-LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||+++++|.+++...... +++.+...++.|++.|++|+| +.+++||||||+||++++++.++++|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765433 789999999999999999999 9999999999999999999999999999998765432
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.... ....++..|+||
T Consensus 158 ~~~~-~~~~~~~~y~~P 173 (258)
T smart00219 158 YYKK-KGGKLPIRWMAP 173 (258)
T ss_pred cccc-ccCCCcccccCh
Confidence 2211 122356778887
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=170.39 Aligned_cols=137 Identities=30% Similarity=0.430 Sum_probs=111.4
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee-------------------------------ccCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-------------------------------~~~~~~~~~lv~e 432 (527)
++|+..+.||+|+||.||+|..+ +++.||+|++.. .+..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 589999998632 1223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++++.|..+.... ..+++.+...++.+++.|++||| +.+|+|||++|+||++++++.++++|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999998876543 34789999999999999999999 89999999999999999999999999999987643321
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
..+...++.+|+||
T Consensus 156 -~~~~~~~~~~y~aP 169 (286)
T cd07846 156 -VYTDYVATRWYRAP 169 (286)
T ss_pred -ccCcccceeeccCc
Confidence 11223467788887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=167.94 Aligned_cols=134 Identities=27% Similarity=0.477 Sum_probs=103.4
Q ss_pred ceeccCCceEEEEEEcc----CCcEEEEEEEee------------------------------cc-CccceeEEEEEecc
Q 035895 391 NLIGRGSFGSVYKARLQ----DGMEFAIKVFHF------------------------------SC-SNEDFRALVLEYTT 435 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~----~~~~vavK~~~~------------------------------~~-~~~~~~~lv~ey~~ 435 (527)
+.||+|+||.||+|... +...||+|.+.. .+ ..++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799998631 01 12345679999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc--
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM-- 513 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 513 (527)
+|+|.+++.......++.....++.+++.|++|+| +.+++||||||+||++++++.+|++|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999765555677788889999999999999 8999999999999999999999999999998654321110
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 158 ~~~~~~~~~~y~aP 171 (262)
T cd05058 158 NHTGAKLPVKWMAL 171 (262)
T ss_pred ccccCcCCccccCh
Confidence 11122345678887
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=172.24 Aligned_cols=133 Identities=25% Similarity=0.425 Sum_probs=101.8
Q ss_pred ceeccCCceEEEEEEcc---CCcEEEEEEEeec---------------------------c--CccceeEEEEEeccCCc
Q 035895 391 NLIGRGSFGSVYKARLQ---DGMEFAIKVFHFS---------------------------C--SNEDFRALVLEYTTNGS 438 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~---------------------------~--~~~~~~~lv~ey~~~g~ 438 (527)
..||+|+||.||+|+.. ++..||+|.+... + ..+...++||||+++ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence 58999999999999864 4578999986421 1 123456799999875 7
Q ss_pred HHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeeccccccc
Q 035895 439 LEKVLYSS--------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 439 L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill----~~~~~~kl~Dfg~a~~~ 506 (527)
|.+++... ...+++.....++.|++.||+||| +.+|+||||||+||++ ++++.+||+|||+|+..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 87776421 123677788899999999999999 9999999999999999 46689999999999876
Q ss_pred CCCCCc-cceeccccccccccC
Q 035895 507 TGEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~-~~~~~~~~t~~y~aP 527 (527)
...... .......+|.+|+||
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred CCCcccccccCcceecccccCc
Confidence 533211 112234578899998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=171.73 Aligned_cols=139 Identities=27% Similarity=0.409 Sum_probs=113.2
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCcc--ceeE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNE--DFRA 428 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~--~~~~ 428 (527)
..++|+..+.||+|+||.||+|... +++.||+|.+... +... +..+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 3467999999999999999999875 6889999987421 1112 5678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+++ +|.+++......+++.+...++.|++.||+||| +.+++||||||+||++++++.+|++|||+++....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99999984 999988765556889999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... ......++..|+||
T Consensus 159 ~~~--~~~~~~~~~~~~aP 175 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAP 175 (293)
T ss_pred Ccc--ccccccccccccCc
Confidence 321 11223457789988
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=168.95 Aligned_cols=131 Identities=28% Similarity=0.395 Sum_probs=106.7
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
++|+..+.||+|+||.||+|+. .+++.||+|++... +...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999985 57889999987421 1223456799999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|..+. .+++.....++.+++.|++|+| +.+|+|+||||+||+++.++.++++|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999997542 3567777889999999999999 9999999999999999999999999999998664321
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 150 -~~~~~~~~~y~aP 162 (279)
T cd06619 150 -AKTYVGTNAYMAP 162 (279)
T ss_pred -ccCCCCChhhcCc
Confidence 2234577889988
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-19 Score=166.39 Aligned_cols=140 Identities=29% Similarity=0.369 Sum_probs=116.2
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee---------------------------------ccCcccee
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF---------------------------------SCSNEDFR 427 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~---------------------------------~~~~~~~~ 427 (527)
....+|...++||+|+|++|..+++ ++.+.+|+|+++. +...+...
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3457899999999999999999996 5688999998642 22445667
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++|.||++||+|.-+++.. ..++...+..+..+|..||.||| +++||.||+|..|+|+|..|.+|++|+|+++.--
T Consensus 327 ffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 8999999999999888754 35677777789999999999999 9999999999999999999999999999998643
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.... +....+||+.|+||
T Consensus 403 ~~gd--~tstfcgtpnyiap 420 (593)
T KOG0695|consen 403 GPGD--TTSTFCGTPNYIAP 420 (593)
T ss_pred CCCc--ccccccCCCcccch
Confidence 2221 22347899999998
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=168.72 Aligned_cols=140 Identities=27% Similarity=0.436 Sum_probs=110.5
Q ss_pred CCccccceeccCCceEEEEEEcc-----CCcEEEEEEEeec------------------------------cCc--ccee
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-----DGMEFAIKVFHFS------------------------------CSN--EDFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~------------------------------~~~--~~~~ 427 (527)
+.|+..+.||+|+||.||+|+.. +++.||||++... +.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999853 4688999987421 111 2356
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++......+++.....++.+++.||+|+| +.+++||||||+||+++.++.++++|||.++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 7999999999999999876556899999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCCccc-eeccccccccccC
Q 035895 508 GEDQSMT-QTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~-~~~~~~t~~y~aP 527 (527)
....... .....++..|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~P 181 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAP 181 (284)
T ss_pred cCCcceeccCCCCCcccccCc
Confidence 3322111 1112234457776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=168.46 Aligned_cols=139 Identities=21% Similarity=0.379 Sum_probs=109.7
Q ss_pred CCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccCccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCSNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~~~~~~~ 428 (527)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+.. .+...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999853 346799997632 123345678
Q ss_pred EEEEeccCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 035895 429 LVLEYTTNGSLEKVLYSSN--------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Df 500 (527)
+||||+++|+|.+++.... ..+++.++..++.+++.||+||| +.+|+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543 14789999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCccceeccccccccccC
Q 035895 501 GIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+++....... .......++..|+||
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~P 187 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAP 187 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecCh
Confidence 99876532211 111223355668887
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=165.27 Aligned_cols=134 Identities=34% Similarity=0.416 Sum_probs=109.9
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEeec----------------------------------cCccceeEEEE
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS----------------------------------CSNEDFRALVL 431 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----------------------------------~~~~~~~~lv~ 431 (527)
|+..+.||+|+||+||+|... +++.||+|.+... +...+..++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 667789999999999999875 7899999986431 12234567999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++++|.+++...+ .+++.....++.+++.|++|+| +.+|+|+||+|+||+++.++.+|++|||+++......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999987643 4788888899999999999999 9999999999999999999999999999988764322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 157 --~~~~~~~~~~y~~p 170 (258)
T cd06632 157 --FAKSFKGSPYWMAP 170 (258)
T ss_pred --cccccCCCcceeCH
Confidence 11234467778887
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=170.51 Aligned_cols=120 Identities=34% Similarity=0.482 Sum_probs=103.1
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
++|+..+.||+|+||.||+|... +++.||+|.+... +...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999875 5899999987421 12334678999
Q ss_pred EeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 432 EYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 432 ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
||+++++|.+++... +..+++.....++.|++.||+|+| +.+++||||||+||+++.++.++++|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998753 346788888899999999999999 9999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.1e-19 Score=172.49 Aligned_cols=137 Identities=25% Similarity=0.360 Sum_probs=114.9
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
+-|.+.+.||+|.|++|-+|++ -+|+.||||++... ...+...|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3488889999999999999986 58999999998531 123345689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~~~~~~~~ 511 (527)
.-.+|||+++|-+++..+...-+.+++.||..|+.|+| +..+|||||||+|+.+-+ -|-+|++|||++-.+.+...
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999888777888888999999999999999 888999999999999875 58999999999977654332
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
-+..+|++.|-||
T Consensus 175 ---L~TsCGSLAYSAP 187 (864)
T KOG4717|consen 175 ---LTTSCGSLAYSAP 187 (864)
T ss_pred ---hhcccchhhccCc
Confidence 2346788999988
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=167.09 Aligned_cols=118 Identities=29% Similarity=0.519 Sum_probs=100.7
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeec--------------------------cCccceeEEEEEeccCCc
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS--------------------------CSNEDFRALVLEYTTNGS 438 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~--------------------------~~~~~~~~lv~ey~~~g~ 438 (527)
++|++.+.||+|+||.||+|.. +++.||+|++... +...+..++||||+++|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~ 84 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN 84 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence 4688999999999999999874 6778999987421 112234679999999999
Q ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 439 LEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 439 L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
|.+++.... ..+++.....++.|++.|++|+| +.+++||||||+||+++.++.+|++|||+++..
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence 999997543 35788888999999999999999 999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=169.82 Aligned_cols=138 Identities=24% Similarity=0.370 Sum_probs=100.0
Q ss_pred CCccccceeccCCceEEEEEEccC----CcEEEEEEEeecc----------------------------Cc---------
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQD----GMEFAIKVFHFSC----------------------------SN--------- 423 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~----------------------------~~--------- 423 (527)
+.|++.+.||+|+||.||+|...+ +..+|+|+..... .+
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 569999999999999999998654 4566777532100 00
Q ss_pred ---c----ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 035895 424 ---E----DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496 (527)
Q Consensus 424 ---~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~k 496 (527)
. ...+++||++.. ++.+.+... ...++.....++.|++.|++|+| +++|+||||||+|||++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence 0 123567777653 566655432 23466777889999999999999 99999999999999999999999
Q ss_pred EeecccccccCCCCCc-----cceeccccccccccC
Q 035895 497 LSDFGIAKLLTGEDQS-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 497 l~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aP 527 (527)
++|||+|+.+...... .......||+.||||
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap 202 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL 202 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence 9999999876422111 111224588999997
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=170.11 Aligned_cols=139 Identities=32% Similarity=0.436 Sum_probs=112.5
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc---------------------------------CccceeE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC---------------------------------SNEDFRA 428 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~---------------------------------~~~~~~~ 428 (527)
..++|++.+.||+|+||.||+|.. .+|+.||+|+++... ...+..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 467899999999999999999986 468999999875210 0113468
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+++ +|.+++......+++.+...++.|++.|++|+| +.+++||||||+||++++++.+|++|||+++....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999975 898888765566889899999999999999999 99999999999999999999999999999987653
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.... .+...++..|+||
T Consensus 161 ~~~~--~~~~~~~~~y~aP 177 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAP 177 (309)
T ss_pred ccCC--CCcccccccccCh
Confidence 3211 1223356778888
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-19 Score=173.33 Aligned_cols=138 Identities=25% Similarity=0.328 Sum_probs=113.9
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEee--------------------------------ccCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF--------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~e 432 (527)
..|++.+.||.||.+.||++...+.+.+|+|++.. +-..+++.|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45899999999999999999988888888886421 1224678899999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|-+ -||.++|.+............|..|+++|+.++| .++|||.||||.|+|+- +|.+|++|||+|..+......
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 865 5999999877655442357779999999999999 99999999999999886 579999999999988765555
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......+||+-||||
T Consensus 516 I~kdsQvGT~NYMsP 530 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSP 530 (677)
T ss_pred eeeccccCcccccCH
Confidence 555567899999998
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-18 Score=164.17 Aligned_cols=139 Identities=33% Similarity=0.459 Sum_probs=115.4
Q ss_pred cCCccccceeccCCceEEEEEEccC-CcEEEEEEEeec---------------------------cCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKVFHFS---------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~ 435 (527)
.++|+..+.||+|+||.||+|.... ++.||+|.+... +..++..+++|||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3578999999999999999999764 789999987531 223456789999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+++|.+++...+..+++.....++.+++.|++|+| +.+|+|||++|+||++++++.++++|||++........ ..
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~ 156 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KR 156 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--cc
Confidence 99999999766667899999999999999999999 89999999999999999999999999999987653321 11
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 157 ~~~~~~~~y~~P 168 (256)
T cd06612 157 NTVIGTPFWMAP 168 (256)
T ss_pred ccccCCccccCH
Confidence 223467788887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=167.79 Aligned_cols=136 Identities=28% Similarity=0.413 Sum_probs=106.4
Q ss_pred ccccceeccCCceEEEEEEc-----cCCcEEEEEEEeecc------------------------------C--ccceeEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHFSC------------------------------S--NEDFRAL 429 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~------------------------------~--~~~~~~l 429 (527)
|+..+.||+|+||+||++.. .++..||+|++.... . .....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988652 467889999875311 1 1224679
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++... .+++.++..++.+++.|++|+| +++|+||||||+||++++++.++++|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999998653 4789999999999999999999 999999999999999999999999999999876432
Q ss_pred CCcc-ceeccccccccccC
Q 035895 510 DQSM-TQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~-~~~~~~~t~~y~aP 527 (527)
.... ......++..|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~P 179 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAV 179 (283)
T ss_pred chhhccCCCCCCCceeeCH
Confidence 2111 11112345568877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=168.98 Aligned_cols=136 Identities=31% Similarity=0.456 Sum_probs=112.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
..|+..+.||.|+||.||+|.. .+++.||+|.+... +..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4589999999999999999985 57899999987431 22345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|..++... .+++.++..++.+++.|++||| +.+++||||||+||+++.++.+|++|||+++....... .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 171 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K 171 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence 999999988643 5788999999999999999999 99999999999999999999999999999886643321 1
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 172 ~~~~~~~~~y~aP 184 (296)
T cd06655 172 RSTMVGTPYWMAP 184 (296)
T ss_pred CCCcCCCccccCc
Confidence 1223467789998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=168.28 Aligned_cols=137 Identities=28% Similarity=0.423 Sum_probs=107.1
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccc-----e
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNED-----F 426 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~-----~ 426 (527)
+.|+..+.||+|+||.||+|... +++.||+|+++.. +...+ .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999864 6899999986421 00111 2
Q ss_pred eEEEEEeccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecc
Q 035895 427 RALVLEYTTNGSLEKVLYSSN----YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFG 501 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg 501 (527)
.++||||+++ +|.+++.... ..+++.....++.||+.||+||| +++|+||||||+||+++. ++.+|++|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 6899999986 8988876432 34788899999999999999999 999999999999999998 8999999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++.+..... ..+...+++.|+||
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aP 180 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAP 180 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCCh
Confidence 9986543211 11222456778887
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=164.43 Aligned_cols=138 Identities=33% Similarity=0.449 Sum_probs=113.0
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
++|+..+.||+|+||.||+|.. .+++.+|+|++... ....+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788999999999999999986 45788999987531 12345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++++|.+++......++..+...++.|++.|++||| +.+|+||||||+||++++++.+|++|||++........ .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence 999999998765456788889999999999999999 99999999999999999999999999999987643211 1
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 158 ~~~~~~~~~y~~P 170 (262)
T cd06613 158 RKSFIGTPYWMAP 170 (262)
T ss_pred cccccCCccccCc
Confidence 1223467778887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-18 Score=164.62 Aligned_cols=135 Identities=35% Similarity=0.476 Sum_probs=111.4
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~e 432 (527)
+|++.+.||.|+||.||+|+.. +++.||+|++... +...+..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999875 6899999987421 123456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++++|.+++... ..++..+...++.++++|++|+| .++++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 155 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL- 155 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence 99999999998754 46788889999999999999999 89999999999999999999999999999886643321
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 156 --~~~~~~~~~y~~P 168 (258)
T cd05578 156 --TTSTSGTPGYMAP 168 (258)
T ss_pred --ccccCCChhhcCH
Confidence 1223466678887
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=165.13 Aligned_cols=140 Identities=30% Similarity=0.395 Sum_probs=113.6
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
++|++.+.||.|+||+||+|.. .++..+|+|++... +...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4689999999999999999985 46789999987421 1234567899999
Q ss_pred ccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 434 TTNGSLEKVLYSSN--YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 434 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
+++++|.+++.... ..+++.....++.|++.|++|+| +.+|+||||||+||++++++.++++|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997542 35788888999999999999999 99999999999999999999999999999987654322
Q ss_pred cc--ceeccccccccccC
Q 035895 512 SM--TQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~--~~~~~~~t~~y~aP 527 (527)
.. ......++..|+||
T Consensus 158 ~~~~~~~~~~~~~~y~~P 175 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAP 175 (267)
T ss_pred ccccccccccCChhhcCh
Confidence 21 11234577889987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-19 Score=163.78 Aligned_cols=139 Identities=29% Similarity=0.366 Sum_probs=110.3
Q ss_pred hcCCcccc-ceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEE
Q 035895 383 ATDGFSAN-NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVL 431 (527)
Q Consensus 383 ~~~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ 431 (527)
.+++|++. ++||-|-.|.|..+.. ++++.+|+|++... ........+||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 46778764 7899999999998875 57889999986431 11223345899
Q ss_pred EeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccC
Q 035895 432 EYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~---~~~~~kl~Dfg~a~~~~ 507 (527)
|.++||+|...+...+ ..+...++-.|+.||+.|+.||| +.+|.||||||+|+|.. .+..+|++|||+|+.-.
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 9999999999998765 35788889999999999999999 99999999999999995 45789999999999753
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+.|++|.||
T Consensus 216 ~~~---~L~TPc~TPyYvaP 232 (400)
T KOG0604|consen 216 EPG---DLMTPCFTPYYVAP 232 (400)
T ss_pred CCc---cccCCcccccccCH
Confidence 221 11234678999998
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-18 Score=164.14 Aligned_cols=138 Identities=28% Similarity=0.389 Sum_probs=109.5
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------cC--ccceeE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------CS--NEDFRA 428 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~~--~~~~~~ 428 (527)
+|+..+.||+|+||.||+|.. .++..||+|++... .. .....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688899999999999999986 46889999986410 00 124567
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
++|||+++++|.+++...+ .+++.....++.|++.|++||| +.+|+||||||+||+++.++.+|++|||+++....
T Consensus 83 l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 8999999999999987543 4688888899999999999999 99999999999999999999999999999986532
Q ss_pred CCCc-cceeccccccccccC
Q 035895 509 EDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~-~~~~~~~~t~~y~aP 527 (527)
.... .......++.+|+||
T Consensus 159 ~~~~~~~~~~~~~~~~y~aP 178 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSP 178 (266)
T ss_pred ccccCCccccCCccccccCH
Confidence 1111 111123467789987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=169.09 Aligned_cols=134 Identities=28% Similarity=0.372 Sum_probs=107.9
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEeccC
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~~~ 436 (527)
|.....||+|+||.||+|.. .++..||||.+... +...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34456799999999999986 46889999987431 1234567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
++|.+++.. ..+++.+...++.+++.|++|+| +++|+||||||+||++++++.++++|||++........ ...
T Consensus 104 ~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 104 GALTDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 999998754 34788889999999999999999 89999999999999999999999999999876543221 112
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 177 ~~~~~~~y~aP 187 (292)
T cd06658 177 SLVGTPYWMAP 187 (292)
T ss_pred eeecCccccCH
Confidence 23467889998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=168.65 Aligned_cols=128 Identities=26% Similarity=0.393 Sum_probs=100.8
Q ss_pred ceeccCCceEEEEEEccC--------CcEEEEEEEee-----------------------------ccCccceeEEEEEe
Q 035895 391 NLIGRGSFGSVYKARLQD--------GMEFAIKVFHF-----------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey 433 (527)
+.||+|+||.||+|..+. ...||+|.+.. .+...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 23478877532 12233566799999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--------EEEeecccccc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV--------AHLSDFGIAKL 505 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~--------~kl~Dfg~a~~ 505 (527)
+++|+|.+++...+..+++.....++.|++.|++|+| +++|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876666888899999999999999999 999999999999999987665 69999999875
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ....++..||||
T Consensus 158 ~~~~------~~~~~~~~y~aP 173 (258)
T cd05078 158 VLPK------EILLERIPWVPP 173 (258)
T ss_pred cCCc------hhccccCCccCc
Confidence 5321 123456778887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=166.33 Aligned_cols=136 Identities=29% Similarity=0.408 Sum_probs=111.7
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
++|+..+.||+|+||.||+|... +++.||+|.+... +..+...++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999875 6899999987432 1233567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++++|.+++......++......++.+++.|++|+| + .+++||||||+||++++++.++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999999765456788888899999999999999 8 9999999999999999999999999999876532211
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
. ...++..|+||
T Consensus 157 --~-~~~~~~~y~~P 168 (265)
T cd06605 157 --K-TFVGTSSYMAP 168 (265)
T ss_pred --h-cccCChhccCH
Confidence 1 14466778887
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=177.65 Aligned_cols=137 Identities=28% Similarity=0.395 Sum_probs=112.6
Q ss_pred cCCccccceeccCCceEEEEEEccCCc-EEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGM-EFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
..+++....||-||||.|-+++..... .+|+|+++. ...++.++|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 456677788999999999998865433 477776532 12345677899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||-|-||++...+++.+ .++......++..+.+|++||| +++||.|||||+|.++|.+|.+|+.|||+|+.+....
T Consensus 499 mEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999998765 4566667778889999999999 9999999999999999999999999999999987554
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.+. .++||+.|.||
T Consensus 575 KTw---TFcGTpEYVAP 588 (732)
T KOG0614|consen 575 KTW---TFCGTPEYVAP 588 (732)
T ss_pred cee---eecCCcccccc
Confidence 332 47899999999
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.7e-19 Score=169.77 Aligned_cols=140 Identities=30% Similarity=0.479 Sum_probs=110.0
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------c----------------------Ccccee
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------C----------------------SNEDFR 427 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------~----------------------~~~~~~ 427 (527)
.|-+...||+|||+.||+|-. ...+-||||+-+.. | -+.+..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 355678899999999999974 45677899874321 1 122344
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeccccc
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAK 504 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~---~~~~~kl~Dfg~a~ 504 (527)
+-|.|||+|.||.-++... ..++..++..|+.||+.||.||... +++|||-||||.|||+- ..|.+||+|||+++
T Consensus 544 CTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 6799999999999998654 3567778889999999999999844 89999999999999994 56999999999999
Q ss_pred ccCCCCCcc-----ceeccccccccccC
Q 035895 505 LLTGEDQSM-----TQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~-----~~~~~~~t~~y~aP 527 (527)
+++++.... ......||.||.+|
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPP 649 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPP 649 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCc
Confidence 987654321 12356799999988
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=164.34 Aligned_cols=134 Identities=24% Similarity=0.349 Sum_probs=105.5
Q ss_pred ceeccCCceEEEEEEccC--C--cEEEEEEEeeccC-----------------------------ccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARLQD--G--MEFAIKVFHFSCS-----------------------------NEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~--~--~~vavK~~~~~~~-----------------------------~~~~~~lv~ey~~~g 437 (527)
+.||+|++|.||+|.+.+ + ..||||.+..... .....++||||+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 468999999999998643 2 3699998643110 114567999999999
Q ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc-ce
Q 035895 438 SLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM-TQ 515 (527)
Q Consensus 438 ~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 515 (527)
+|.+.+.... ..+++.....++.|++.||+|+| +++++||||||+||+++.++.+|++|||+++.+....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999997654 46789999999999999999999 9999999999999999999999999999998775432211 11
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++.+|+||
T Consensus 158 ~~~~~~~~y~~p 169 (257)
T cd05040 158 EHLKVPFAWCAP 169 (257)
T ss_pred cCCCCCceecCH
Confidence 123456778887
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.3e-18 Score=163.66 Aligned_cols=133 Identities=27% Similarity=0.378 Sum_probs=103.6
Q ss_pred ceeccCCceEEEEEEcc----CCcEEEEEEEeec-----------------------------cCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARLQ----DGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|... .+..||+|.+... ....+..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 47999999999999752 2368999986421 11123467999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc-ee
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT-QT 516 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~ 516 (527)
+|.+++...+ .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+|++|||+++.......... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 81 PLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9999997654 5788899999999999999999 89999999999999999999999999999987643322111 11
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 157 ~~~~~~~y~aP 167 (257)
T cd05060 157 AGRWPLKWYAP 167 (257)
T ss_pred CccccccccCH
Confidence 12234568887
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.4e-18 Score=164.93 Aligned_cols=131 Identities=34% Similarity=0.544 Sum_probs=99.9
Q ss_pred ceeccCCceEEEEEEcc-CCc--EEEEEEEeec-------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARLQ-DGM--EFAIKVFHFS-------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~-------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||.||+|+.. ++. .+|+|.+... +...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999874 343 4688876421 1223456799999999
Q ss_pred CcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 035895 437 GSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 437 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
|+|.+++.... ..+++.+...++.+++.|++|+| +++++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 23678888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++..... ........+..|+||
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~ap 180 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAI 180 (270)
T ss_pred Cccccchh---hhccCCCCccccCCh
Confidence 98643211 111112234568887
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-18 Score=168.45 Aligned_cols=134 Identities=28% Similarity=0.362 Sum_probs=108.7
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEeccC
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~~~ 436 (527)
|+....||+|+||.||+|.. .+++.||+|++... +..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 45556899999999999986 46899999997431 1234567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
++|..++.. ..+++.+...++.|++.|++|+| +.+|+||||||+||+++.++.+|++|||+++....... ...
T Consensus 103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 999998754 35788889999999999999999 99999999999999999999999999999976543221 112
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++.+|+||
T Consensus 176 ~~~~~~~y~aP 186 (297)
T cd06659 176 SLVGTPYWMAP 186 (297)
T ss_pred ceecCccccCH
Confidence 34577889987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-18 Score=168.29 Aligned_cols=141 Identities=26% Similarity=0.405 Sum_probs=111.7
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc-------------------------------Cc-------
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC-------------------------------SN------- 423 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-------------------------------~~------- 423 (527)
..++|+..+.||+|+||.||+|+.. +++.||||.+.... ..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4567999999999999999999864 68999999874210 00
Q ss_pred -cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 035895 424 -EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGI 502 (527)
Q Consensus 424 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~ 502 (527)
....++||||+++ ++.+.+......+++.+...++.|++.|++||| +++++||||||+||+++.++.+|++|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 1234899999975 888888765556789999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc--cceeccccccccccC
Q 035895 503 AKLLTGEDQS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~~~--~~~~~~~~t~~y~aP 527 (527)
++........ .......++..|+||
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aP 192 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPP 192 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCc
Confidence 9876432211 111223467789998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.8e-18 Score=163.17 Aligned_cols=139 Identities=27% Similarity=0.381 Sum_probs=110.2
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------c--Ccccee
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------C--SNEDFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~--~~~~~~ 427 (527)
.+|++.+.||+|+||.||+|.. .++..||+|.+... + ......
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999986 46899999986421 0 012346
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++++|.+++...+ .+++.....++.+++.|++|+| +.+++||||||+||+++.++.++++|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 78999999999999987543 4678888899999999999999 9999999999999999999999999999998653
Q ss_pred CCCC-ccceeccccccccccC
Q 035895 508 GEDQ-SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~-~~~~~~~~~t~~y~aP 527 (527)
.... ....+...++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aP 178 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSP 178 (264)
T ss_pred cccccCccccccCCcccccCH
Confidence 2111 0111234467889988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-19 Score=181.38 Aligned_cols=234 Identities=24% Similarity=0.260 Sum_probs=133.4
Q ss_pred CCCCCCCEEEcccCCCCcc----cChhHhhccccccEEEcccCcccc------ccchhhcCCcCCcEEEeecCcccccCc
Q 035895 88 SNCKYLKKLDISRNPLDGF----LPRVVGNFSQSLEFIWMSDCNISG------GISEEIGNLTDLISIDLGGNKLNGSIS 157 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~~L~~L~Ls~n~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~~ 157 (527)
..++.|++|++++|.++.. ++..+... ++++.|+++++.+.+ .++..+..+++|+.|++++|.+.+..+
T Consensus 20 ~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~-~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~ 98 (319)
T cd00116 20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQ-PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGC 98 (319)
T ss_pred HHHhhccEEeecCCCCcHHHHHHHHHHHhhC-CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHH
Confidence 3444566666666665421 12222222 246666666665541 223445556666777776666654444
Q ss_pred ccccCCCC---CCEEeccCccccc----ccChhhhcC-cccCeeeeecccCCCC----CCccccCCccCceeeCCCCCCC
Q 035895 158 ITLGKLQK---LQFLSFRGNELEG----SIPNVLCHL-AVLFQLDLRGNKLSGS----IPTCFGNLTALRNLHLDSNELT 225 (527)
Q Consensus 158 ~~~~~l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 225 (527)
..+..+.+ |+.|++++|.+.+ .+...+..+ ++|+.|++++|.+++. .+..+..+++|++|++++|.++
T Consensus 99 ~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 99 GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIG 178 (319)
T ss_pred HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCc
Confidence 44444444 6777777666652 122334444 6667777777766632 2234555566777777777766
Q ss_pred C-----CchhhhCCCCccEEEccCCccccc----CCccccCCCCCCEEEccCCCCCCCChhhhh-c----CCCCCEEEcc
Q 035895 226 S-----IPSILWNLKDILYLDFWSNLFVGP----LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ-G----LKSLQFLSLG 291 (527)
Q Consensus 226 ~-----lp~~~~~l~~L~~l~l~~n~~~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~----l~~L~~L~L~ 291 (527)
. ++..+...++|+.|++++|.+.+. ++..+..+++|++|++++|.+.+.....+. . .+.|+.|+++
T Consensus 179 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~ 258 (319)
T cd00116 179 DAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLS 258 (319)
T ss_pred hHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEcc
Confidence 3 233344445677777776665422 234455677788888888877653333322 2 3678888888
Q ss_pred ccccee----ecCCCCCCCCCCCEEeCCCCccccc
Q 035895 292 HNRLQG----SIPNSFDDLVSLESLDLSNNNLSEI 322 (527)
Q Consensus 292 ~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~ 322 (527)
+|.++. .+...+..+++|+.+++++|.++..
T Consensus 259 ~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 259 CNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred CCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 887751 2333455557788888888888754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=166.10 Aligned_cols=135 Identities=27% Similarity=0.469 Sum_probs=110.2
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------cCccceeEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------CSNEDFRALVL 431 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ 431 (527)
.|+..+.||+|+||.||+|.. .+++.||+|.+... +......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 377789999999999999986 57899999986421 11234567999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++++|.+++... .+++.....++.+++.|++|+| +.+|+||||+|+||++++++.++++|||++........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998653 5788889999999999999999 99999999999999999999999999999987654321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 157 --~~~~~~~~~~y~aP 170 (277)
T cd06917 157 --KRSTFVGTPYWMAP 170 (277)
T ss_pred --ccccccCCcceeCH
Confidence 11223467788887
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=166.25 Aligned_cols=137 Identities=29% Similarity=0.444 Sum_probs=109.2
Q ss_pred CccccceeccCCceEEEEEEc----cCCcEEEEEEEeec----------------------------------cCcccee
Q 035895 386 GFSANNLIGRGSFGSVYKARL----QDGMEFAIKVFHFS----------------------------------CSNEDFR 427 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~----------------------------------~~~~~~~ 427 (527)
+|++.+.||+|+||.||+|+. .+++.||||++... .......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 35788999987521 1122456
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++... ..+++.....++.|+++|++|+| +.+++||||||+||+++.++.++++|||+++.+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 7999999999999998654 35678888889999999999999 8999999999999999999999999999998764
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
..... ......++..|+||
T Consensus 157 ~~~~~-~~~~~~~~~~y~aP 175 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAP 175 (288)
T ss_pred ccccc-ccccccCCccccCH
Confidence 33211 11223467788887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-18 Score=164.34 Aligned_cols=136 Identities=28% Similarity=0.453 Sum_probs=109.8
Q ss_pred CccccceeccCCceEEEEEEccC--CcEEEEEEEee----------------------------------------ccCc
Q 035895 386 GFSANNLIGRGSFGSVYKARLQD--GMEFAIKVFHF----------------------------------------SCSN 423 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~----------------------------------------~~~~ 423 (527)
+|++.+.||+|+||.||+|.... ++.+|+|.+.. .+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58888999999999999999754 68899997631 1123
Q ss_pred cceeEEEEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEee
Q 035895 424 EDFRALVLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSD 499 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~D 499 (527)
.+..++||||+++++|.+++.. .+..+++.....++.+++.|++|+| + .+++||||||+||++++++.+|++|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 3566899999999999988753 3345788888999999999999999 5 6799999999999999999999999
Q ss_pred cccccccCCCCCccceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||.+....... ......++..|+||
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~P 182 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCP 182 (269)
T ss_pred ccceeeccccc---ccccccCcccCcCh
Confidence 99998765332 12234567778887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-18 Score=166.35 Aligned_cols=135 Identities=32% Similarity=0.416 Sum_probs=109.4
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEee------------------------------ccCccceeEEEEEec
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF------------------------------SCSNEDFRALVLEYT 434 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~------------------------------~~~~~~~~~lv~ey~ 434 (527)
.|+..+.||+|+||.||+|.. .+++.||+|.+.. .+......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 467778999999999999985 4678999998642 122345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|.+++.. ..+++.....++.++++|++|+| +++++|+||+|+||++++++.++++|||+++.+..... .
T Consensus 85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06642 85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--h
Confidence 99999998854 35678888899999999999999 89999999999999999999999999999987653221 1
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 158 ~~~~~~~~~y~aP 170 (277)
T cd06642 158 RNTFVGTPFWMAP 170 (277)
T ss_pred hhcccCcccccCH
Confidence 1223467778887
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.2e-18 Score=163.41 Aligned_cols=127 Identities=33% Similarity=0.481 Sum_probs=103.7
Q ss_pred ceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ey~~~ 436 (527)
+.||+|+||.||+|.. .+++.||+|++... +...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999986 46889999987421 1123466899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++...+ .++......++.|++.||+|+| +.+++||||+|+||++++++.+|++|||+++..... .
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------K 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc------c
Confidence 99999987543 4677888899999999999999 899999999999999999999999999998864321 1
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 152 ~~~~~~~y~~p 162 (260)
T cd05611 152 KFVGTPDYLAP 162 (260)
T ss_pred cCCCCcCccCh
Confidence 23356678877
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.4e-18 Score=167.09 Aligned_cols=141 Identities=30% Similarity=0.444 Sum_probs=111.5
Q ss_pred hhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc-------------------------------Cc------
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC-------------------------------SN------ 423 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-------------------------------~~------ 423 (527)
...++|++.+.||+|+||.||+|... +++.||+|+++... ..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999975 58899999875310 01
Q ss_pred ----cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 035895 424 ----EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSD 499 (527)
Q Consensus 424 ----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~D 499 (527)
.+..++||||+++ ++.+.+......+++.+...++.|++.||+||| +.+|+||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 1256799999986 777777655456789999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCCccceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+++........ ......++..|+||
T Consensus 160 fg~~~~~~~~~~~-~~~~~~~~~~y~~P 186 (302)
T cd07864 160 FGLARLYNSEESR-PYTNKVITLWYRPP 186 (302)
T ss_pred ccccccccCCccc-ccccceeccCccCh
Confidence 9999876533211 11122345678887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-20 Score=158.54 Aligned_cols=154 Identities=29% Similarity=0.510 Sum_probs=81.0
Q ss_pred CCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCcee
Q 035895 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNL 217 (527)
Q Consensus 138 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 217 (527)
++.+++.|.|++|+++ .+|..+..+.+|+.|++++|+++ .+|..+..+++|+.|+++-|++. ..|..|+.++.|++|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4455556666666665 33445566666666666666665 55666666666666666666665 456666666666666
Q ss_pred eCCCCCCCC--CchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccc
Q 035895 218 HLDSNELTS--IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL 295 (527)
Q Consensus 218 ~L~~N~l~~--lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 295 (527)
||.+|++.+ +|..++.++.|+.|.+++|.+. .+|..++.+++|+.|.+..|.+. .+|..++.+..|++|.+.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 666666654 3433333333333333333221 22333344444444444444443 3444455555555555555555
Q ss_pred e
Q 035895 296 Q 296 (527)
Q Consensus 296 ~ 296 (527)
+
T Consensus 186 ~ 186 (264)
T KOG0617|consen 186 T 186 (264)
T ss_pred e
Confidence 4
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.3e-18 Score=166.39 Aligned_cols=138 Identities=32% Similarity=0.395 Sum_probs=110.4
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
+.|++.+.||+|+||.||+|... +++.||+|+++.. +...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 35888999999999999999875 5889999976421 122346789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++++.+..+... ...+++.+...++.+++.|++||| ..+++|||++|+||++++++.+|++|||+++.......
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9998777765543 345788889999999999999999 89999999999999999999999999999987654322
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.......++.+|+||
T Consensus 156 ~~~~~~~~~~~~~~P 170 (288)
T cd07833 156 SPLTDYVATRWYRAP 170 (288)
T ss_pred ccccCcccccCCcCC
Confidence 112234567789988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-18 Score=165.45 Aligned_cols=136 Identities=27% Similarity=0.441 Sum_probs=109.5
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEec
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~ 434 (527)
+|+..+.||+|++|.||+|+.. +|+.||||++... +...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4888999999999999999974 6889999987431 12334568999999
Q ss_pred cCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 435 TNGSLEKVLYSSN--YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 435 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
++ +|.+++.... ..+++.++..++.|++.|++|+| +.+++||||||+||++++++.++++|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888876543 45789999999999999999999 89999999999999999999999999999986543211
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 156 -~~~~~~~~~~y~~P 169 (284)
T cd07836 156 -TFSNEVVTLWYRAP 169 (284)
T ss_pred -ccccccccccccCh
Confidence 11223456778887
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-18 Score=169.48 Aligned_cols=136 Identities=18% Similarity=0.273 Sum_probs=105.2
Q ss_pred ccceeccC--CceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEec
Q 035895 389 ANNLIGRG--SFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 389 ~~~~lg~G--~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~ 434 (527)
+.++||+| +|++||+++. .+|+.||+|++... +..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999986 57899999987531 22345678999999
Q ss_pred cCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++|+|.+++... ...+++.....++.|++.||+||| +++|+||||||+||+++.++.++++|||.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998653 234788889999999999999999 9999999999999999999999999998754432111100
Q ss_pred -----ceeccccccccccC
Q 035895 514 -----TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 -----~~~~~~~t~~y~aP 527 (527)
......++..||||
T Consensus 159 ~~~~~~~~~~~~~~~y~aP 177 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSP 177 (327)
T ss_pred cccccccccccceecccCh
Confidence 01112356779988
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.2e-18 Score=164.80 Aligned_cols=136 Identities=33% Similarity=0.419 Sum_probs=112.0
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
++|+..+.||.|+||.||+|+.. +++.||+|++... +..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35888899999999999999864 6889999987421 1223456799999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++++|.+++... .+++.....++.|++.|++|+| +++++||||+|+||++++++.++++|||+++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-- 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence 9999999998654 6788899999999999999999 99999999999999999999999999999987753321
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 154 ~~~~~~~~~~y~~P 167 (274)
T cd06609 154 KRNTFVGTPFWMAP 167 (274)
T ss_pred ccccccCCccccCh
Confidence 12234567789988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-19 Score=191.63 Aligned_cols=137 Identities=33% Similarity=0.481 Sum_probs=107.0
Q ss_pred ccccceeccCCceEEEEEE-ccCCcEEEEEEEeec-------------------------------cCccceeEEEEEec
Q 035895 387 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~ 434 (527)
......||.|.||.||-|. ..+|+..|+|-+... -.+.+..+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 3445789999999999997 577888898865321 11234556889999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc-
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM- 513 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~- 513 (527)
++|+|++.+... ...+..-...+..|++.|++||| +++||||||||+||+++.+|.+|.+|||.|+.+....+..
T Consensus 1317 ~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1317 EGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred ccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 999999998643 33444444557789999999999 9999999999999999999999999999999876543221
Q ss_pred -ceeccccccccccC
Q 035895 514 -TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 -~~~~~~~t~~y~aP 527 (527)
.-...+||+.||||
T Consensus 1393 ~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAP 1407 (1509)
T ss_pred HHHHhhcCCchhcCc
Confidence 11246799999999
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.9e-18 Score=166.51 Aligned_cols=136 Identities=27% Similarity=0.384 Sum_probs=109.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
++|++.+.||+|+||+||+|... +++.||+|++... +...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888999999999999999864 6889999976421 2234567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++... ..+++.....++.+++.|+.|||+ .++++||||||+||++++++.++++|||+++......
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 9999999988754 357888889999999999999992 2589999999999999999999999999987653221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 159 -~~~~~~~~~~~aP 171 (284)
T cd06620 159 -ADTFVGTSTYMSP 171 (284)
T ss_pred -cCccccCcccCCH
Confidence 1123577788887
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-18 Score=152.42 Aligned_cols=137 Identities=30% Similarity=0.389 Sum_probs=104.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
++......||+|++|.|-+-++ .+|+..|+|.+... ...+...++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4444567899999999998886 57999999987531 123455678899
Q ss_pred eccCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 433 YTTNGSLEKVLY---SSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 433 y~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
-|.- +|..+-. +.+...+..-.-+||..|..|+.|||. +..|||||+||+|||++.+|++|+||||++-.+.+.
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 8864 6655433 345556666677899999999999994 678999999999999999999999999999876532
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
- ..+...|--.||||
T Consensus 203 i---Akt~daGCkpYmaP 217 (282)
T KOG0984|consen 203 I---AKTMDAGCKPYMAP 217 (282)
T ss_pred h---HHHHhcCCCccCCh
Confidence 1 22223355679998
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=162.10 Aligned_cols=136 Identities=32% Similarity=0.503 Sum_probs=112.4
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEec
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~ 434 (527)
+|++.+.||+|++|.||+|+.. +++.||+|++... +...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6888999999999999999876 5899999986431 22345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++++|.+++... ..++......++.++++|++|+| + .+++||||+|+||+++.++.++++|||+++.........
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 999999999754 45788889999999999999999 8 999999999999999999999999999998765332211
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 158 --~~~~~~~~y~~p 169 (264)
T cd06623 158 --NTFVGTVTYMSP 169 (264)
T ss_pred --cceeecccccCH
Confidence 123466778887
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=167.20 Aligned_cols=138 Identities=28% Similarity=0.462 Sum_probs=107.9
Q ss_pred CccccceeccCCceEEEEEEcc---CCcEEEEEEEeec--------------------------------cCcc--ceeE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ---DGMEFAIKVFHFS--------------------------------CSNE--DFRA 428 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~--------------------------------~~~~--~~~~ 428 (527)
+|++.+.||+|+||.||+|... +++.||+|.+... +... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999864 4789999987541 1122 5678
Q ss_pred EEEEeccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC----CCcEEEeec
Q 035895 429 LVLEYTTNGSLEKVLYSS----NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD----NIVAHLSDF 500 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~----~~~~kl~Df 500 (527)
+||||+++ ++.+.+... ...++......++.|++.|++||| +.+|+||||||+||+++. ++.+|++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999985 676666432 125677788899999999999999 999999999999999999 999999999
Q ss_pred ccccccCCCCC-ccceeccccccccccC
Q 035895 501 GIAKLLTGEDQ-SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~-~~~~~~~~~t~~y~aP 527 (527)
|+++....... ........++.+|+||
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aP 184 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAP 184 (316)
T ss_pred ccccccCCCcccccccCCccccccccCH
Confidence 99987643322 1122234567889998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-18 Score=169.42 Aligned_cols=138 Identities=28% Similarity=0.371 Sum_probs=109.2
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-----------------------------------Ccccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-----------------------------------SNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-----------------------------------~~~~~~ 427 (527)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999985 578999999874200 011236
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++ ++.+++.. ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|++|||+++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 899999975 88887753 35788888999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCcc-ceeccccccccccC
Q 035895 508 GEDQSM-TQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~-~~~~~~~t~~y~aP 527 (527)
...... ......++..||||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aP 178 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAP 178 (336)
T ss_pred ccccccCCcCCcCcCCCccCh
Confidence 322111 11234578889998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=161.46 Aligned_cols=140 Identities=29% Similarity=0.433 Sum_probs=112.2
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c--CccceeEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C--SNEDFRALVL 431 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~--~~~~~~~lv~ 431 (527)
+|++.+.||.|+||.||+|.. .+++.||+|.+... + ......+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 56889999987421 0 1123467999
Q ss_pred EeccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 432 EYTTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGY--STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 432 ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~--~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||+++++|.+++... ...+++.+...++.+++.|++|+|..+ +.+++||||||+||++++++.+|++|||+++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 356788899999999999999999544 778999999999999999999999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... .....++..|+||
T Consensus 161 ~~~~~~--~~~~~~~~~~~~p 179 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSP 179 (265)
T ss_pred cCCccc--ccccccCCCccCh
Confidence 533211 1223567788887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.6e-18 Score=162.71 Aligned_cols=137 Identities=32% Similarity=0.465 Sum_probs=108.7
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------------cCcccee
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------------CSNEDFR 427 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------------~~~~~~~ 427 (527)
|.+.+.||+|+||.||+|.. .+++.||+|.+... +..++..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 66778999999999999986 46789999976421 1133456
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++++|.+++... ..+++.....++.+++.|++|+| +.+++||||||+||++++++.++++|||.++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 7999999999999999754 35678888899999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcc----ceeccccccccccC
Q 035895 508 GEDQSM----TQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~----~~~~~~~t~~y~aP 527 (527)
...... ......++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~p 181 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAP 181 (267)
T ss_pred cccccCCccccccccCCCcCccCh
Confidence 321110 11123466778887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=163.89 Aligned_cols=135 Identities=30% Similarity=0.425 Sum_probs=109.9
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEec
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~ 434 (527)
.|+..+.||+|+||.||+|... ++..||+|++... +......++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4778899999999999999864 6889999987521 12335678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|.+++.. ..+++.+...++.+++.|++|+| +.+++|+||+|+||+++.++.++++|||+++....... .
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence 99999999864 34678888899999999999999 99999999999999999999999999999987653321 1
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 158 ~~~~~~~~~y~ap 170 (277)
T cd06640 158 RNTFVGTPFWMAP 170 (277)
T ss_pred cccccCcccccCH
Confidence 1223467778887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.6e-18 Score=164.03 Aligned_cols=133 Identities=27% Similarity=0.374 Sum_probs=107.5
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCcc--ceeEEEEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNE--DFRALVLE 432 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~--~~~~lv~e 432 (527)
|++.+.||+|+||.||+|.. .+++.||+|+++.. +... +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999985 46889999986421 1122 56789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++ |++.+.+......+++.+...++.|++.||+||| +.+|+||||||+||+++. +.+|++|||+++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 997 5888887765556899999999999999999999 999999999999999999 99999999999876432211
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
+...++..|+||
T Consensus 156 ---~~~~~~~~y~aP 167 (282)
T cd07831 156 ---TEYISTRWYRAP 167 (282)
T ss_pred ---CCCCCCcccCCh
Confidence 223467788888
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.2e-18 Score=168.97 Aligned_cols=138 Identities=26% Similarity=0.386 Sum_probs=110.0
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-----------------------------------CccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-----------------------------------SNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-----------------------------------~~~~~~~ 428 (527)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6799999999999999999986 468999999874310 0123468
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+. |+|.+++... ..+++.....++.|++.||+||| +++|+||||||+||++++++.+|++|||+++....
T Consensus 85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999996 5899888654 34788889999999999999999 89999999999999999999999999999987543
Q ss_pred CCCc--cceeccccccccccC
Q 035895 509 EDQS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~--~~~~~~~~t~~y~aP 527 (527)
.... ...+...++.+|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~P 180 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAP 180 (334)
T ss_pred cCcCCCcccccccccccccCh
Confidence 2211 111233577788887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=169.72 Aligned_cols=138 Identities=32% Similarity=0.468 Sum_probs=110.4
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cC--ccceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CS--NEDFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~--~~~~~~ 428 (527)
.++|++.+.||+|+||.||+|... +++.||+|++... +. .....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467899999999999999999865 6889999976320 11 122468
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||++ ++|..++... .+++..+..++.+++.||+||| +.+|+||||||+||+++.++.+|++|||+++....
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999998 5999888653 6788888899999999999999 99999999999999999999999999999987643
Q ss_pred CCCc---cceeccccccccccC
Q 035895 509 EDQS---MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~---~~~~~~~~t~~y~aP 527 (527)
.... .......++.+|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aP 181 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAP 181 (337)
T ss_pred ccccccCcchhcccccccccCc
Confidence 3221 112234578889998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=161.93 Aligned_cols=138 Identities=29% Similarity=0.449 Sum_probs=109.6
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------------cCccceeEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------------CSNEDFRAL 429 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------------~~~~~~~~l 429 (527)
+|+..+.||+|+||.||+|.. .+++.||+|++... +...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 67899999987531 122345679
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTG 508 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~ 508 (527)
||||+++++|.+++...+ .+++.....++.|++.|++|+| +++++||||||+||+++.++ .++++|||.++....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999987543 5678888899999999999999 99999999999999998765 699999999987653
Q ss_pred CCCc--cceeccccccccccC
Q 035895 509 EDQS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~--~~~~~~~~t~~y~aP 527 (527)
.... .......++..|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~P 177 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAP 177 (268)
T ss_pred ccccCCccccccccccceeCH
Confidence 2111 111123467789887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=163.36 Aligned_cols=134 Identities=32% Similarity=0.448 Sum_probs=109.1
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEEEecc
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~~ 435 (527)
|+..+.||+|+||.||+|.. .+++.||+|++... +..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 77788999999999999985 46889999986421 123456789999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+|+|.+++.. ..+++.....++.+++.|++|+| +.+++|+||||+||+++.++.++++|||+++.+..... ..
T Consensus 86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06641 86 GGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence 9999998864 35788888999999999999999 99999999999999999999999999999987643221 11
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++.+|+||
T Consensus 159 ~~~~~~~~y~~P 170 (277)
T cd06641 159 NTFVGTPFWMAP 170 (277)
T ss_pred ccccCCccccCh
Confidence 223467778887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.6e-18 Score=163.87 Aligned_cols=141 Identities=31% Similarity=0.437 Sum_probs=113.3
Q ss_pred hhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------c------Cccc
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------C------SNED 425 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------~------~~~~ 425 (527)
.+.++|++.+.||+|+||.||+|... +++.+|+|++... + ...+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35678999999999999999999974 6789999986421 0 0123
Q ss_pred eeEEEEEeccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGI 502 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~ 502 (527)
..++||||+++++|.+++... +..+++..+..++.|++.|++|+| +.+++||||+|+||++++++.+|++|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 468999999999999988653 346788888999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCccceeccccccccccC
Q 035895 503 AKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++....... ......++..|+||
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aP 182 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAP 182 (275)
T ss_pred ceecccchh--hhcCccccccccCH
Confidence 876543211 11223467788887
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-18 Score=173.26 Aligned_cols=145 Identities=25% Similarity=0.438 Sum_probs=118.7
Q ss_pred HHhhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee----------------------------ccCccceeEE
Q 035895 379 ELLRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF----------------------------SCSNEDFRAL 429 (527)
Q Consensus 379 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~----------------------------~~~~~~~~~l 429 (527)
.++....+.....+||-|.||.||.|.|+ ....||||.++. .|..+.-.||
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 44444556777899999999999999985 467899998642 3777788899
Q ss_pred EEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 430 VLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
|+|||.+|+|-++|+... ..+...-.+++|.||+.|++||. ++.+|||||-++|+|+.++..+||+|||++|++..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999998653 34566677889999999999999 99999999999999999999999999999999865
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
+. +....+....+.|.||
T Consensus 418 DT-YTAHAGAKFPIKWTAP 435 (1157)
T KOG4278|consen 418 DT-YTAHAGAKFPIKWTAP 435 (1157)
T ss_pred Cc-eecccCccCcccccCc
Confidence 43 2222233456778887
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=164.98 Aligned_cols=138 Identities=28% Similarity=0.411 Sum_probs=110.3
Q ss_pred hcCCccccceeccCCceEEEEEEccC-CcEEEEEEEeec-------------------------------cCccceeEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKVFHFS-------------------------------CSNEDFRALV 430 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~-------------------------------~~~~~~~~lv 430 (527)
..++|++.+.||+|+||.||+|...+ ++.||||.+... +......++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678999999999999999999864 899999997521 1233456899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
|||++ +++.++.......+++..+..++.+++.|++|+| + ++|+||||+|+||++++++.+||+|||++..+...
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99985 4787777654556888888899999999999999 6 58999999999999999999999999999876432
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .....++..|+||
T Consensus 169 ~~---~~~~~~~~~y~aP 183 (296)
T cd06618 169 KA---KTRSAGCAAYMAP 183 (296)
T ss_pred Cc---ccCCCCCccccCH
Confidence 21 1223456778887
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=164.78 Aligned_cols=136 Identities=32% Similarity=0.451 Sum_probs=111.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
+.|++.+.||+|+||.||+|.. .++..||+|.+... +...+..++||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5688899999999999999985 46789999986421 12345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|.+++.+. .+++.++..++.+++.|++||| +++++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-- 171 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--
Confidence 999999998653 4678888999999999999999 999999999999999999999999999998766433221
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....+++.|+||
T Consensus 172 ~~~~~~~~~y~~P 184 (293)
T cd06647 172 RSTMVGTPYWMAP 184 (293)
T ss_pred cccccCChhhcCc
Confidence 1223467789888
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=162.72 Aligned_cols=134 Identities=28% Similarity=0.424 Sum_probs=109.4
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEec
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~ 434 (527)
|++.+.||+|+||+||+|+.. +++.||||++... +..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 5789999986421 12245678999999
Q ss_pred cCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+|+|.+++.... ..+++.++..++.|++.+++||| +++++|+||+|+||++++++.++++|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999887654 46789999999999999999999 89999999999999999999999999999987643221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.+...++..|+||
T Consensus 155 -~~~~~~~~~~~aP 167 (283)
T cd07830 155 -YTDYVSTRWYRAP 167 (283)
T ss_pred -cCCCCCcccccCc
Confidence 1223466778887
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=161.29 Aligned_cols=131 Identities=35% Similarity=0.511 Sum_probs=105.4
Q ss_pred eccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEEEeccCCcH
Q 035895 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 393 lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~~g~L 439 (527)
||+|+||.||+|+.. +|+.||+|++... ...+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 4899999987421 1234567899999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC------cc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ------SM 513 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~------~~ 513 (527)
.+++.+.+ .+++..+..++.|++.||+|+| +.+++||||+|+||++++++.++++|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997654 5788899999999999999999 99999999999999999999999999999876432211 01
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++..|+||
T Consensus 157 ~~~~~~~~~~~~~P 170 (265)
T cd05579 157 EDKRIVGTPDYIAP 170 (265)
T ss_pred cccCcccCccccCH
Confidence 12233456778887
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=162.90 Aligned_cols=120 Identities=39% Similarity=0.565 Sum_probs=104.2
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~lv 430 (527)
++|.+.+.||+|+||.||+|... +++.||+|++... +...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999864 7899999987421 1233567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
|||+++++|.+++.+.+ .+++.....++.+++.|++||| +.+++|+|+||+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997653 5889999999999999999999 99999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=160.50 Aligned_cols=137 Identities=26% Similarity=0.449 Sum_probs=110.6
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEee-------------------------------ccCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-------------------------------~~~~~~~~~lv~ey 433 (527)
.|+..+.||+|+||.||+++. .+|+.||+|.+.. .+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478899999999999999986 4688999998642 12234567899999
Q ss_pred ccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++++|.+++.... ..+++.+...++.+++.|++|+| +.+++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999887532 35688888999999999999999 899999999999999999999999999999876432211
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....+++.|+||
T Consensus 158 --~~~~~~~~~~~~p 170 (256)
T cd08218 158 --ARTCIGTPYYLSP 170 (256)
T ss_pred --hhhccCCccccCH
Confidence 1123466778887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=160.57 Aligned_cols=138 Identities=34% Similarity=0.500 Sum_probs=110.9
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
.|+..+.||+|+||.||+|.. .+++.||+|+++.. +...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 377889999999999999986 46889999997531 1123466899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++++|.+++... ..+++.....++.+++.|++|+| +.+|+||||+|+||++++++.+|++|||.+..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998754 34678888899999999999999 9999999999999999999999999999998765432211
Q ss_pred ce--eccccccccccC
Q 035895 514 TQ--TQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~--~~~~~t~~y~aP 527 (527)
.. ....++..|+||
T Consensus 157 ~~~~~~~~~~~~~~~P 172 (264)
T cd06626 157 GEEVQSLAGTPAYMAP 172 (264)
T ss_pred cccccCCcCCcCccCh
Confidence 11 123456778887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=163.35 Aligned_cols=129 Identities=30% Similarity=0.453 Sum_probs=104.1
Q ss_pred eccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEEeccCCcH
Q 035895 393 IGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 393 lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~~g~L 439 (527)
||+|+||+||+|.. .+|+.||+|.+... +...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 46889999987421 1223567899999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceecc
Q 035895 440 EKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518 (527)
Q Consensus 440 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 518 (527)
.+++...+ ..+++.+...++.|++.|+.|+| +.+++||||+|+||++++++.++++|||+++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccc
Confidence 99987644 35788888999999999999999 99999999999999999999999999999986643211 1123
Q ss_pred ccccccccC
Q 035895 519 LAIIGYMAP 527 (527)
Q Consensus 519 ~~t~~y~aP 527 (527)
.++..|+||
T Consensus 155 ~~~~~y~~P 163 (277)
T cd05577 155 AGTPGYMAP 163 (277)
T ss_pred cCCCCcCCH
Confidence 456678887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=162.13 Aligned_cols=138 Identities=28% Similarity=0.496 Sum_probs=103.7
Q ss_pred ccccceeccCCceEEEEEEcc----CCcEEEEEEEeeccC-------------------------------c---c---c
Q 035895 387 FSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFSCS-------------------------------N---E---D 425 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~-------------------------------~---~---~ 425 (527)
|++.+.||+|+||.||+|.+. +++.||||++..... . . .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 468899998743100 0 0 1
Q ss_pred eeEEEEEeccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN-----YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Df 500 (527)
..++++||+++|+|.+++.... ..+++.....++.+++.|++|+| +.+|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 24678888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccceeccccccccccC
Q 035895 501 GIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+++...............++..|+||
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~p 184 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLAL 184 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCH
Confidence 999876432211111122334567766
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.5e-18 Score=164.10 Aligned_cols=134 Identities=28% Similarity=0.490 Sum_probs=102.6
Q ss_pred ceeccCCceEEEEEEccC-------CcEEEEEEEee------------------------------ccCccceeEEEEEe
Q 035895 391 NLIGRGSFGSVYKARLQD-------GMEFAIKVFHF------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~-------~~~vavK~~~~------------------------------~~~~~~~~~lv~ey 433 (527)
+.||+|+||.||+|+..+ ++.||+|.+.. .+...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998542 25788887532 12334567899999
Q ss_pred ccCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-----cEEEeeccc
Q 035895 434 TTNGSLEKVLYSS------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-----VAHLSDFGI 502 (527)
Q Consensus 434 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-----~~kl~Dfg~ 502 (527)
+++|+|.+++... ...+++.+...++.+++.|++|+| +.+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998752 234678889999999999999999 89999999999999999877 899999999
Q ss_pred ccccCCCCCccceeccccccccccC
Q 035895 503 AKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++................+..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred ccccccccccccCcccCCCccccCH
Confidence 9866433221111122345678887
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=162.55 Aligned_cols=136 Identities=29% Similarity=0.449 Sum_probs=109.1
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
+|+..+.||+|+||.||+|+.. +++.||||.+... +...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999864 6899999987421 1234566899999
Q ss_pred ccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+. ++|.+++... +..+++.+...++.+++.|++|+| +++++||||+|+||++++++.+|++|||+++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 5898888653 345788889999999999999999 999999999999999999999999999999866432211
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....++.+|+||
T Consensus 157 --~~~~~~~~~y~aP 169 (284)
T cd07860 157 --YTHEVVTLWYRAP 169 (284)
T ss_pred --cccccccccccCC
Confidence 1223356778887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=168.85 Aligned_cols=135 Identities=27% Similarity=0.310 Sum_probs=108.1
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cC------cc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CS------NE 424 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~------~~ 424 (527)
..+.|+..+.||+|+||.||+|+. .+++.||||.+... +. +.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357799999999999999999985 47899999986320 00 11
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
...++||||+.+ +|.+.+... ++..+...++.|++.||+||| +.+|+||||||+||+++.++.+|++|||+++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 245899999964 888877532 778888889999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... .....++..|+||
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aP 186 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAP 186 (353)
T ss_pred eCCCCCC---CCCCcccccccCH
Confidence 7643211 1223467789988
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=149.69 Aligned_cols=140 Identities=26% Similarity=0.368 Sum_probs=110.6
Q ss_pred hcCCccccceeccCCceEEEEEE-ccCCcEEEEEEEee----------------------------ccCccceeEEEEEe
Q 035895 383 ATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey 433 (527)
..+.|.+.+.||.|+||.+|.|. ..+|++||||+=.. ...++++-.+|||.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 45679999999999999999997 67899999998422 12344566799998
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCCCC
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~---~~~~~kl~Dfg~a~~~~~~~ 510 (527)
. |.+|++++.-....++....+-+|-|+..-++|+| .++.|||||||+|+|+. ....+.++|||+|+.+.+..
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 7 78999998766666788888999999999999999 99999999999999996 34678899999998764322
Q ss_pred C-----ccceecccccccccc
Q 035895 511 Q-----SMTQTQTLAIIGYMA 526 (527)
Q Consensus 511 ~-----~~~~~~~~~t~~y~a 526 (527)
. +.......||..|.+
T Consensus 169 t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred ccccCccccCCccceeeeehh
Confidence 1 112223457777754
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-17 Score=158.15 Aligned_cols=136 Identities=37% Similarity=0.527 Sum_probs=112.4
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------cCccceeEEEEEecc
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~~ 435 (527)
+|+..+.||+|++|.||+|... +++.||+|++... +...+..+++|||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 6889999987432 122346679999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+++|.+++......+++.....++.+++.|++|+| ..+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999998765456789899999999999999999 89999999999999999999999999999987654321 1
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 155 ~~~~~~~~~~~P 166 (253)
T cd05122 155 NTMVGTPYWMAP 166 (253)
T ss_pred cceecCCcccCH
Confidence 223466778887
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=158.84 Aligned_cols=136 Identities=29% Similarity=0.487 Sum_probs=109.5
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... ...++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999986 46889999987421 1123457899999
Q ss_pred ccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccccCCCCC
Q 035895 434 TTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-IVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 434 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-~~~kl~Dfg~a~~~~~~~~ 511 (527)
+++++|.+++.... ..+++.....++.+++.|++|+| +++|+||||||+||+++++ +.+|++|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997643 44788888999999999999999 9999999999999999854 5689999999987643321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 158 ---~~~~~~~~~y~aP 170 (256)
T cd08220 158 ---AYTVVGTPCYISP 170 (256)
T ss_pred ---ccccccCCcccCc
Confidence 1123467789988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=164.26 Aligned_cols=133 Identities=34% Similarity=0.423 Sum_probs=107.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
+.|+..+.||+|+||.||+|... +++.||+|++.. .+..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999864 689999998742 122345667999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||++ |++.+.+......+++..+..++.|++.|+.|+| +.+|+||||+|+||++++++.++++|||+++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence 9997 5777776654556889899999999999999999 9999999999999999999999999999987653221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 170 -----~~~~~~~y~aP 180 (307)
T cd06607 170 -----SFVGTPYWMAP 180 (307)
T ss_pred -----CccCCccccCc
Confidence 23456678887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=162.42 Aligned_cols=136 Identities=30% Similarity=0.462 Sum_probs=110.1
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCcc--ceeEEEEE
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNE--DFRALVLE 432 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~--~~~~lv~e 432 (527)
|++.+.||+|+||.||+|+.. +++.||+|++... +... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999865 5889999997532 1122 56789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++ +|.+++......+++.+...++.+++.|++||| +.+++|+||||+||++++++.+|++|||+++.......
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9985 899888765456888899999999999999999 89999999999999999999999999999987653321
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
...+...++..|+||
T Consensus 156 ~~~~~~~~~~~y~~P 170 (287)
T cd07840 156 ADYTNRVITLWYRPP 170 (287)
T ss_pred ccccccccccccCCc
Confidence 112223456778888
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=162.55 Aligned_cols=140 Identities=33% Similarity=0.447 Sum_probs=114.4
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec----------------------------cCccceeEEEEEe
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS----------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey 433 (527)
..+.|+..+.||+|+||.||+|..+ ++..||+|++... +..++..++||||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567888999999999999999976 6889999987532 1223567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++++|.+++......+++.++..++.+++.|++|+| +.+|+|+|++|+||+++.++.++++|||++........
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 171 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-- 171 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence 9999999999875546889999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......++.+|+||
T Consensus 172 ~~~~~~~~~~y~~P 185 (286)
T cd06614 172 KRNSVVGTPYWMAP 185 (286)
T ss_pred hhccccCCcccCCH
Confidence 11122356678887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-18 Score=175.00 Aligned_cols=138 Identities=32% Similarity=0.474 Sum_probs=113.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------cCc------------cceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------CSN------------EDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------~~~------------~~~~~lv~ey 433 (527)
-++|+...++|.|.||.||||+. ++++..|+|+++.. |.+ .+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46799999999999999999995 57899999998642 222 2344699999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
|.||+|.+.-+. ...++..+....+++..+|++|+| +.+-+|||||-.||++.+.|.+|++|||.+..+..- -.
T Consensus 94 cgggslQdiy~~-TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA 167 (829)
T ss_pred cCCCcccceeee-cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence 999999987643 346778888889999999999999 999999999999999999999999999998876421 12
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......||++||||
T Consensus 168 KrksfiGtpywmap 181 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAP 181 (829)
T ss_pred hhhcccCCccccch
Confidence 23356799999998
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=157.95 Aligned_cols=137 Identities=31% Similarity=0.532 Sum_probs=112.4
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
+|+..+.||+|+||.||+|... ++..||+|++... ....+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999864 6889999987531 1123566799999
Q ss_pred ccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 434 TTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 434 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
+++++|.+++... +..+++.+...++.+++.|++|+| +.+++|+||+|+||++++++.++++|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998764 356889999999999999999999 8999999999999999999999999999998764332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ......++..|+||
T Consensus 158 ~--~~~~~~~~~~y~~p 172 (258)
T cd08215 158 D--LAKTVVGTPYYLSP 172 (258)
T ss_pred c--eecceeeeecccCh
Confidence 1 11223467778887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=162.55 Aligned_cols=137 Identities=31% Similarity=0.453 Sum_probs=105.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
++|+..+.||+|++|.||+|... +++.||+|.+... +...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999864 6889999986421 123456789999
Q ss_pred eccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCCC
Q 035895 433 YTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~~~~~~~ 510 (527)
|++ ++|.+++.... ...++.....++.+|+.||+||| +++|+||||||+||++++ ++.+|++|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 57887775433 33567777889999999999999 899999999999999985 5679999999998653221
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ..+...+++.|+||
T Consensus 158 ~--~~~~~~~~~~y~~P 172 (294)
T PLN00009 158 R--TFTHEVVTLWYRAP 172 (294)
T ss_pred c--ccccCceeecccCH
Confidence 1 11223456778887
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.3e-17 Score=160.39 Aligned_cols=135 Identities=31% Similarity=0.442 Sum_probs=108.4
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEec
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~ 434 (527)
|+..+.||+|++|.||+|.. .+|..||+|++... +..++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 66788999999999999986 47899999987521 22345678999999
Q ss_pred cCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+ ++|.+++.... ..+++..+..++.+++.||+|+| +++++||||+|+||++++++.++++|||+++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999886543 35789999999999999999999 899999999999999999999999999999865422211
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 156 -~~~~~~~~~~~aP 168 (283)
T cd07835 156 -YTHEVVTLWYRAP 168 (283)
T ss_pred -cCccccccCCCCC
Confidence 1122356778888
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=161.43 Aligned_cols=134 Identities=27% Similarity=0.358 Sum_probs=108.6
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEeccC
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~~~ 436 (527)
|+..+.||+|++|.||+|.. .+++.||+|++... +...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 45567999999999999985 56889999987421 1234567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
++|.+++.. ..+++.+...++.+++.|++|+| +++|+||||||+||+++.++.++++|||+++....... ...
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 173 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK 173 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence 999999876 35788888999999999999999 99999999999999999999999999999876543211 112
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...++..|+||
T Consensus 174 ~~~~~~~y~aP 184 (285)
T cd06648 174 SLVGTPYWMAP 184 (285)
T ss_pred cccCCccccCH
Confidence 23467789887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.9e-18 Score=154.69 Aligned_cols=136 Identities=29% Similarity=0.404 Sum_probs=100.1
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc----------------CccceeEEE---------------EEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC----------------SNEDFRALV---------------LEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~----------------~~~~~~~lv---------------~ey 433 (527)
+.+....||.|+.|.|++++.+ +|..+|||.++..- ...+..||| ||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3456678999999999999975 58999999986421 112233444 444
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
|. .-+++++....+.++..-.-++...+..||.||.. +++|||||+||+|||+|+.|.+|+||||++-.+.+...
T Consensus 173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 42 23455555555556665566788889999999984 78999999999999999999999999999987654332
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.+...|-+.||||
T Consensus 248 -htrsAGC~~YMaP 260 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAP 260 (391)
T ss_pred -cccccCCccccCc
Confidence 2334577789998
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=163.42 Aligned_cols=131 Identities=34% Similarity=0.427 Sum_probs=107.1
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEEe
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey 433 (527)
|+..+.||+|+||.||+|+. .++..||+|++... +..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77789999999999999986 46889999987421 1233456799999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++| ++.+.+......+++.++..++.+++.|+.|+| +++|+||||+|+||+++.++.++++|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 975 787877655566889999999999999999999 999999999999999999999999999998765322
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 179 --~~~~~~~~y~aP 190 (317)
T cd06635 179 --NSFVGTPYWMAP 190 (317)
T ss_pred --ccccCCccccCh
Confidence 123466778887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.7e-18 Score=170.33 Aligned_cols=134 Identities=29% Similarity=0.472 Sum_probs=105.3
Q ss_pred cccceeccCCceEEEEEEc-cCCcEEE---EEE----------------------------Eee--ccC--ccceeEEEE
Q 035895 388 SANNLIGRGSFGSVYKARL-QDGMEFA---IKV----------------------------FHF--SCS--NEDFRALVL 431 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~-~~~~~va---vK~----------------------------~~~--~~~--~~~~~~lv~ 431 (527)
+...+||+|+|=+||||-. .+|.+|| ||. +++ +.. ......+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4457899999999999975 3566666 221 111 111 123456899
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeecccccccCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|.++.|+|+.|..+.+ .++......|+.||..||.||| .+.++|||||||..||+++ ..|.|||+|.|+|+.....
T Consensus 123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLH-s~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLH-SQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhh-cCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 9999999999997764 4677788899999999999999 4689999999999999997 5699999999999987432
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.+....||+.||||
T Consensus 200 ---~aksvIGTPEFMAP 213 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAP 213 (632)
T ss_pred ---ccceeccCccccCh
Confidence 12346799999999
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=157.19 Aligned_cols=136 Identities=32% Similarity=0.459 Sum_probs=111.2
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
+|++.+.||+|++|.||+|... +++.||+|.+... +..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999864 6789999987421 1223456799999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++++|.+++... ..+++.....++.+++.|++|+| +.+|+||||||+||+++.++.++++|||+++........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998754 45788889999999999999999 999999999999999999999999999999876543221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 156 -~~~~~~~~~y~~p 168 (254)
T cd06627 156 -DASVVGTPYWMAP 168 (254)
T ss_pred -ccccccchhhcCH
Confidence 1223467778887
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-19 Score=153.07 Aligned_cols=160 Identities=26% Similarity=0.439 Sum_probs=85.4
Q ss_pred ccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec
Q 035895 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 197 (527)
++.|-||+|.++ ..|+.+..+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.|||+.
T Consensus 35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlty 111 (264)
T KOG0617|consen 35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTY 111 (264)
T ss_pred hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccc
Confidence 333444444443 23333444444455555555544 23444455555555555555544 4455555555555555555
Q ss_pred ccCC-CCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh
Q 035895 198 NKLS-GSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276 (527)
Q Consensus 198 N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 276 (527)
|.+. ...|+.|-.|+.|+.|+|++|.+.-+|+.++++++|+.|.+..|.+. .+|..++.++.|+.|.+.+|+++ .+|
T Consensus 112 nnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlp 189 (264)
T KOG0617|consen 112 NNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLP 189 (264)
T ss_pred cccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecC
Confidence 5543 23455555555555555555555555555555555555555555554 35566667777777777777776 555
Q ss_pred hhhhcC
Q 035895 277 TTIQGL 282 (527)
Q Consensus 277 ~~~~~l 282 (527)
+.++.+
T Consensus 190 pel~~l 195 (264)
T KOG0617|consen 190 PELANL 195 (264)
T ss_pred hhhhhh
Confidence 555543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=149.08 Aligned_cols=123 Identities=28% Similarity=0.387 Sum_probs=103.8
Q ss_pred cCCccccceeccCCceEEEEEE-ccCCcEEEEEEEeecc----------------------------------CccceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSC----------------------------------SNEDFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~----------------------------------~~~~~~~ 428 (527)
...|.+.+.+|+|||+.||.++ ..++..+|+|++.... ......|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3568999999999999999998 5788999999874211 1234578
Q ss_pred EEEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 429 LVLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
+++.|...|+|.+.+.. .+..++..+.+.|+.+|++||+++|.. .++..||||||.|||+.+.+.+++.|||-+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999874 345789999999999999999999932 44599999999999999999999999999876
Q ss_pred cC
Q 035895 506 LT 507 (527)
Q Consensus 506 ~~ 507 (527)
..
T Consensus 179 a~ 180 (302)
T KOG2345|consen 179 AP 180 (302)
T ss_pred cc
Confidence 43
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=162.00 Aligned_cols=140 Identities=26% Similarity=0.406 Sum_probs=110.5
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc---------------------------------------Cc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC---------------------------------------SN 423 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---------------------------------------~~ 423 (527)
.++|++.+.||+|+||.||+|... +++.||+|++.... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999864 68899999874210 01
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
....++||||+++ ++...+......+++.+...++.|+++||+|+| +.+|+||||||+||++++++.++++|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 1235899999975 777777655556889999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcc---------ceeccccccccccC
Q 035895 504 KLLTGEDQSM---------TQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~---------~~~~~~~t~~y~aP 527 (527)
+......... ..+...++..|+||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP 195 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCCh
Confidence 8654322111 11223457779988
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=158.50 Aligned_cols=128 Identities=32% Similarity=0.468 Sum_probs=104.5
Q ss_pred eccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEEEeccCCcH
Q 035895 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 393 lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~~g~L 439 (527)
||+|+||.||+|+.. +++.||+|++... +..+...++||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 5889999987431 1223456799999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 519 (527)
.+++.+.. .++......++.+++.|++|+| +++++|+||||+||+++.++.++++|||+++...... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99997643 4678888889999999999999 9999999999999999999999999999998765332 112234
Q ss_pred cccccccC
Q 035895 520 AIIGYMAP 527 (527)
Q Consensus 520 ~t~~y~aP 527 (527)
++..|+||
T Consensus 154 ~~~~~~~P 161 (262)
T cd05572 154 GTPEYVAP 161 (262)
T ss_pred CCcCccCh
Confidence 67778887
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=164.91 Aligned_cols=140 Identities=25% Similarity=0.370 Sum_probs=111.0
Q ss_pred HHHHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------C--
Q 035895 377 YQELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------S-- 422 (527)
Q Consensus 377 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~-- 422 (527)
..++....+.|+..+.||+|+||.||+|.. .+++.||+|++.... .
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566778999999999999999999985 578999999874210 0
Q ss_pred ----ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 035895 423 ----NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 423 ----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~ 498 (527)
.....++++|++ +++|.+++... .+++..+..++.|+++|++|+| +.+|+||||||+||++++++.+|++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence 012246777776 78998887543 4788889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++..... .....++..|+||
T Consensus 163 dfg~~~~~~~~-----~~~~~~~~~y~aP 186 (345)
T cd07877 163 DFGLARHTDDE-----MTGYVATRWYRAP 186 (345)
T ss_pred ccccccccccc-----ccccccCCCccCH
Confidence 99998865322 1223467788887
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=164.56 Aligned_cols=135 Identities=26% Similarity=0.372 Sum_probs=108.2
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCcc-----
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNE----- 424 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~----- 424 (527)
...+.|++.+.||+|+||.||+|.. .++..||||++... +...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3456799999999999999999985 57899999987321 0000
Q ss_pred -ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 425 -DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 425 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
...++||||+ +++|.+++.. ..+++..+..++.|++.|++|+| +.+|+||||||+||+++.++.++++|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 1347999999 7799988754 35788889999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+...... ....++..|+||
T Consensus 166 ~~~~~~~-----~~~~~~~~y~aP 184 (343)
T cd07880 166 RQTDSEM-----TGYVVTRWYRAP 184 (343)
T ss_pred cccccCc-----cccccCCcccCH
Confidence 8654221 123456778887
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-17 Score=151.61 Aligned_cols=118 Identities=25% Similarity=0.428 Sum_probs=98.9
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee------------------------------ccCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~------------------------------~~~~~~~~~lv~e 432 (527)
.+.|.+.+.+|+|.||.+-+++++ +.+.+++|.++. .....++.+++||
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 356999999999999999999975 567899998642 1234567889999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeccccccc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD--DNIVAHLSDFGIAKLL 506 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~--~~~~~kl~Dfg~a~~~ 506 (527)
|+|.|||+.-+... .+......+++.|++.|++|+| +.++||||||.+|||+- +..++|+||||..+..
T Consensus 103 ~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred cCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999887543 3566677889999999999999 99999999999999993 4568999999998754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=155.75 Aligned_cols=123 Identities=24% Similarity=0.185 Sum_probs=100.3
Q ss_pred CCceEEEEEEc-cCCcEEEEEEEeec------------------------cCccceeEEEEEeccCCcHHHHHHhcCCCC
Q 035895 396 GSFGSVYKARL-QDGMEFAIKVFHFS------------------------CSNEDFRALVLEYTTNGSLEKVLYSSNYIL 450 (527)
Q Consensus 396 G~~g~vy~~~~-~~~~~vavK~~~~~------------------------~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~ 450 (527)
|.||.||+|+. .+++.||+|++... +...+..++||||+++|+|.+++.... .+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l 82 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NI 82 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CC
Confidence 88999999986 56899999997531 123456789999999999999986543 47
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 451 DILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 451 ~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.....++.|++.|++|+| +++|+||||||+||+++.++.++++|||.++...... ....++..||||
T Consensus 83 ~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aP 151 (237)
T cd05576 83 PEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAP 151 (237)
T ss_pred CHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCC
Confidence 88889999999999999999 9999999999999999999999999999887654221 112345568887
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.5e-17 Score=156.65 Aligned_cols=138 Identities=34% Similarity=0.452 Sum_probs=112.5
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCcc--ceeEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNE--DFRALVL 431 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~--~~~~lv~ 431 (527)
+|+..+.||+|++|.||+|... +++.|++|++... +... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3777899999999999999875 6899999986431 1123 5678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++++|.+++.... .+++.++..++.+++.|++|+| +.+++|+|++|+||+++.++.++++|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999987654 6788999999999999999999 89999999999999999999999999999987754322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
........++..|+||
T Consensus 157 ~~~~~~~~~~~~y~~p 172 (260)
T cd06606 157 GEGTGSVRGTPYWMAP 172 (260)
T ss_pred cccccCCCCCccccCH
Confidence 1112234466778887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=161.91 Aligned_cols=131 Identities=28% Similarity=0.352 Sum_probs=105.9
Q ss_pred cceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEeccCCcH
Q 035895 390 NNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey~~~g~L 439 (527)
...||+|+||.||+|.. .+++.||||++.. .+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46899999999999986 5789999998642 11234567899999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 519 (527)
.+++.. ..+++.....++.+++.|++|+| +.+++||||||+||++++++.++++|||++........ ......
T Consensus 105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 998754 34688888899999999999999 89999999999999999999999999999876543221 112234
Q ss_pred cccccccC
Q 035895 520 AIIGYMAP 527 (527)
Q Consensus 520 ~t~~y~aP 527 (527)
++.+|+||
T Consensus 178 ~~~~y~~p 185 (292)
T cd06657 178 GTPYWMAP 185 (292)
T ss_pred cCccccCH
Confidence 67788887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.5e-17 Score=156.90 Aligned_cols=137 Identities=28% Similarity=0.458 Sum_probs=109.7
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
+|+..+.||+|+||.||+|... +|..||+|.+... +...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999864 5889999987421 2234466899999
Q ss_pred ccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCCC
Q 035895 434 TTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 434 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~~~~ 511 (527)
+++++|.+++.... ..+++.....++.++++|++|+| +.+++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999987543 35788899999999999999999 89999999999999999775 569999999987643321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
. .....+++.|+||
T Consensus 158 ~--~~~~~~~~~~~ap 171 (257)
T cd08225 158 L--AYTCVGTPYYLSP 171 (257)
T ss_pred c--ccccCCCccccCH
Confidence 1 1123467778887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.9e-17 Score=159.11 Aligned_cols=136 Identities=32% Similarity=0.407 Sum_probs=108.4
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------c--CccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------C--SNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~--~~~~~~~lv~ 431 (527)
++|+..+.||.|++|.||+|.. .+++.||+|.+... + ......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688899999999999999997 46889999986421 1 1123568999
Q ss_pred EeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||+++|+|.+++.. ....++......++.+++.|++|+| +.+++||||+|+||++++++.++++|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988653 2345677888899999999999999 99999999999999999999999999999876532
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... ....++..|+||
T Consensus 158 ~~~----~~~~~~~~y~~p 172 (287)
T cd06621 158 SLA----GTFTGTSFYMAP 172 (287)
T ss_pred ccc----ccccCCccccCH
Confidence 211 123356678887
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-17 Score=176.49 Aligned_cols=139 Identities=21% Similarity=0.239 Sum_probs=100.6
Q ss_pred cCCccccceeccCCceEEEEEEccC--CcEEEEE------------------EE--------------------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD--GMEFAIK------------------VF-------------------------- 417 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK------------------~~-------------------------- 417 (527)
.++|++.+.||+|+||+||+|..+. +..++.| .+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4679999999999999999986432 1111111 11
Q ss_pred --eeccCccceeEEEEEeccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 035895 418 --HFSCSNEDFRALVLEYTTNGSLEKVLYSSN----YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD 491 (527)
Q Consensus 418 --~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~ 491 (527)
...+..++..++|||++. +++..++.... ......+...|+.|++.||+||| +++||||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 011233456789999986 57777765322 11234456679999999999999 999999999999999999
Q ss_pred CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.+||+|||+++.+...... ......||..|+||
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aP 337 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSP 337 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCc
Confidence 999999999999877543221 12235688999998
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=155.92 Aligned_cols=135 Identities=30% Similarity=0.490 Sum_probs=109.9
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
+|++.+.||+|+||.||+|.. .+++.+|+|.+... .......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999975 47889999987431 1223567899999
Q ss_pred ccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 434 TTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 434 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
+++++|.+++... +..+++.....++.+++.|++|+| +.+++||||+|+||++++++.+|++|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988652 245788888999999999999999 9999999999999999999999999999998765431
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 158 ----~~~~~~~~~~~~P 170 (256)
T cd08530 158 ----AKTQIGTPHYMAP 170 (256)
T ss_pred ----cccccCCccccCH
Confidence 1123356678776
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-18 Score=173.03 Aligned_cols=249 Identities=23% Similarity=0.229 Sum_probs=185.9
Q ss_pred EEEcccCCCC-cccChhHhhccccccEEEcccCccccc----cchhhcCCcCCcEEEeecCcccc------cCcccccCC
Q 035895 95 KLDISRNPLD-GFLPRVVGNFSQSLEFIWMSDCNISGG----ISEEIGNLTDLISIDLGGNKLNG------SISITLGKL 163 (527)
Q Consensus 95 ~L~Ls~N~l~-~~~~~~~~~~~~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l 163 (527)
.|+|..+.++ ...+..+..+. .|+.|++++|.++.. ++..+...+++++|+++++.+.+ .++..+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~-~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLL-CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHh-hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 4677777776 33344455554 699999999998542 45667778889999999998862 234567778
Q ss_pred CCCCEEeccCcccccccChhhhcCcc---cCeeeeecccCCC----CCCccccCC-ccCceeeCCCCCCCC-----Cchh
Q 035895 164 QKLQFLSFRGNELEGSIPNVLCHLAV---LFQLDLRGNKLSG----SIPTCFGNL-TALRNLHLDSNELTS-----IPSI 230 (527)
Q Consensus 164 ~~L~~L~l~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~-----lp~~ 230 (527)
++|+.|++++|.+.+..+..+..+.. |+.|++++|+++. .+...+..+ ++|+.|++++|.++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 99999999999998767777777766 9999999999873 233445666 899999999999983 3445
Q ss_pred hhCCCCccEEEccCCccccc----CCccccCCCCCCEEEccCCCCCCCC----hhhhhcCCCCCEEEcccccceeecCCC
Q 035895 231 LWNLKDILYLDFWSNLFVGP----LPSKIGNLKVLTRIDFSRNNLLGDI----PTTIQGLKSLQFLSLGHNRLQGSIPNS 302 (527)
Q Consensus 231 ~~~l~~L~~l~l~~n~~~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~ 302 (527)
+..+..|+.|++++|.+.+. ++..+..+++|++|++++|.+.+.. +..+..+++|++|++++|.+++.....
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~ 240 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence 66778899999999988742 3344566679999999999987543 345677889999999999987532222
Q ss_pred CC-----CCCCCCEEeCCCCccccc----CccchhhhccCCeeEeeeeeee
Q 035895 303 FD-----DLVSLESLDLSNNNLSEI----IPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 303 ~~-----~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
+. ..+.|+.|++++|.++.. +...+..++.|+.++++.+.+.
T Consensus 241 l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 21 347899999999999732 3344556677888888776664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=163.33 Aligned_cols=137 Identities=27% Similarity=0.383 Sum_probs=109.3
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------Ccc-----ce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------SNE-----DF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~~~-----~~ 426 (527)
...|++.+.||+|+||+||+|+. .+++.||||.+.... ... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35689999999999999999985 568999999874210 000 23
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||+. ++|.+++... ..++......++.|++.|++||| +++++||||||+||+++.++.+|++|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 689999996 6898888654 45788889999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... .....++..|+||
T Consensus 159 ~~~~~~--~~~~~~~~~y~aP 177 (337)
T cd07858 159 SEKGDF--MTEYVVTRWYRAP 177 (337)
T ss_pred CCCccc--ccccccccCccCh
Confidence 432211 1223467789888
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.5e-17 Score=158.14 Aligned_cols=135 Identities=30% Similarity=0.411 Sum_probs=109.3
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEec
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~ 434 (527)
|+..+.||+|++|.||+|... +++.+|+|.+... +..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 6889999986421 12335668999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++ ++.+++......+++.++..++.+++.|++||| +.+|+|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence 85 898888765567889999999999999999999 99999999999999999999999999999987654321 1
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 155 ~~~~~~~~~~~~P 167 (283)
T cd05118 155 YTHYVVTRWYRAP 167 (283)
T ss_pred ccCccCcccccCc
Confidence 1223456678887
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=162.98 Aligned_cols=137 Identities=26% Similarity=0.339 Sum_probs=107.1
Q ss_pred CccccceeccCCceEEEEEEcc-C--CcEEEEEEEeecc------------------------------------Cccce
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-D--GMEFAIKVFHFSC------------------------------------SNEDF 426 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~--~~~vavK~~~~~~------------------------------------~~~~~ 426 (527)
+|++.+.||+|+||.||+|+.. + +..||+|++.... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 4 7889999864210 00123
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.+++|||+. ++|.+.+... ..+++.....++.|++.||+|+| +.+|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 568888886 6898888643 45788888999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCc--cceeccccccccccC
Q 035895 507 TGEDQS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~--~~~~~~~~t~~y~aP 527 (527)
...... .......++..|+||
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aP 178 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAP 178 (332)
T ss_pred ccccccccccccCcccCccccCc
Confidence 432211 111234578889998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=158.65 Aligned_cols=134 Identities=30% Similarity=0.442 Sum_probs=107.1
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEeec----------------------------------cCccce-----
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS----------------------------------CSNEDF----- 426 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----------------------------------~~~~~~----- 426 (527)
|++.+.||+|+||.||+|+.+ +++.||+|++... +...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 667899999999999999976 4899999987521 011122
Q ss_pred eEEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
.+++|||+.+ +|.+++.... ..+++.++..++.+++.||+||| +.+++|+|++|+||++++++.+|++|||+++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 6799999975 8988886543 35789999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... ....++..|+||
T Consensus 157 ~~~~~~~---~~~~~~~~~~~P 175 (287)
T cd07838 157 YSFEMAL---TSVVVTLWYRAP 175 (287)
T ss_pred ccCCccc---ccccccccccCh
Confidence 6433211 123456778887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-17 Score=153.13 Aligned_cols=133 Identities=26% Similarity=0.411 Sum_probs=105.0
Q ss_pred ceeccCCceEEEEEE-ccCCcEEEEEEEee------------------------------ccCccceeEEEEEeccCCcH
Q 035895 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHF------------------------------SCSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~-~~~~~~vavK~~~~------------------------------~~~~~~~~~lv~ey~~~g~L 439 (527)
+.||+|+|+.|--+. +.+|.++|||++.. ...+++..|+|||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 789999999998876 68899999999743 12345677899999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecccccccCCCC-Ccc--
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN---IVAHLSDFGIAKLLTGED-QSM-- 513 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~---~~~kl~Dfg~a~~~~~~~-~~~-- 513 (527)
-.+|++.. .+...++-++..+||.||.+|| .++|.|||+||+|||-.+. .-+||+||.++.-+.-.. -+.
T Consensus 164 LshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 99998654 4677788889999999999999 9999999999999998643 458999998876442111 111
Q ss_pred --ceeccccccccccC
Q 035895 514 --TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 --~~~~~~~t~~y~aP 527 (527)
.-...+|+..||||
T Consensus 240 tP~L~tPvGSAEfMAP 255 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAP 255 (463)
T ss_pred CccccCcccchhhcch
Confidence 11234577789998
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=158.25 Aligned_cols=135 Identities=33% Similarity=0.445 Sum_probs=109.1
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEEec
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~ 434 (527)
|+..+.||+|+||.||+|+.. +++.||+|++... +...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999875 5899999987542 11234678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+ ++|.+++......+++..+..++.+++.|++||| +.+|+||||+|+||++++++.++++|||+++........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-- 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--
Confidence 8 5899999765456889999999999999999999 899999999999999999999999999999876433211
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 155 ~~~~~~~~~~~aP 167 (282)
T cd07829 155 YTHEVVTLWYRAP 167 (282)
T ss_pred cCccccCcCcCCh
Confidence 1122345678887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.8e-18 Score=156.98 Aligned_cols=134 Identities=33% Similarity=0.392 Sum_probs=100.3
Q ss_pred cccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEecc
Q 035895 388 SANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~~ 435 (527)
+....||.|+||+|+|-.+ +.|+..|||+++.. +-.|+..++-||.|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3457899999999999876 57999999998642 234567789999996
Q ss_pred CCcHHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 436 NGSLEKVL---YS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 436 ~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
- ++..+. +. .+..++..-.-.|...+..||.||-. ...|||||+||+|||+|..|.+|+||||++-.+.+
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--- 220 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--- 220 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---
Confidence 3 565432 21 12334444445577778899999974 57899999999999999999999999999976642
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
+...|.-+|-..||||
T Consensus 221 SiAkT~daGCrpYmAP 236 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAP 236 (361)
T ss_pred HHHhhhccCCccccCh
Confidence 2334445577789998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.2e-19 Score=159.51 Aligned_cols=135 Identities=26% Similarity=0.435 Sum_probs=103.1
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------c--Ccc-----------------ceeEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------C--SNE-----------------DFRAL 429 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------~--~~~-----------------~~~~l 429 (527)
.+..+.||-|+||+||-+.. ++|+.||+|++... | .++ ++.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45568999999999999986 57999999986321 1 111 13356
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
++|.+.. ||.+++-..+ .++.....-+..||.+||.||| +.+|.||||||.|.|++.+...||||||+||.....
T Consensus 135 ~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 7777764 7877765433 4555555667899999999999 999999999999999999999999999999976533
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
+ ....|..+.|.+|.||
T Consensus 210 ~-~~hMTqEVVTQYYRAP 226 (449)
T KOG0664|consen 210 D-RLNMTHEVVTQYYRAP 226 (449)
T ss_pred h-hhhhHHHHHHHHhccH
Confidence 2 3334556678899998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.1e-17 Score=162.47 Aligned_cols=136 Identities=24% Similarity=0.319 Sum_probs=112.3
Q ss_pred cCCccccceeccCCceEEEEEEccC-CcEEEEEEEee----------------------------------------ccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKVFHF----------------------------------------SCS 422 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~----------------------------------------~~~ 422 (527)
..+|...+.+|+|+||.|+.|.++. ..+|+||.+.. ...
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468899999999999999998754 67899998632 124
Q ss_pred ccceeEEEEEec-cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 035895 423 NEDFRALVLEYT-TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 423 ~~~~~~lv~ey~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
++++.|++||-- +|-||.++|.. +..++..++..|+.||+.|+++|| +.+|||||||-+|+.++.+|-+|+.|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 567888999976 45699999864 456788888899999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
-|...... .-...+||.+|.||
T Consensus 716 saa~~ksg----pfd~f~gtv~~aap 737 (772)
T KOG1152|consen 716 SAAYTKSG----PFDVFVGTVDYAAP 737 (772)
T ss_pred chhhhcCC----Ccceeeeeccccch
Confidence 99876432 12346799999998
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=158.28 Aligned_cols=131 Identities=33% Similarity=0.414 Sum_probs=106.2
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEEe
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey 433 (527)
|...+.||+|+||.||+|+. .+++.||+|++... +...+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56667899999999999986 46889999987421 1233457899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+. |++.+.+......+++.++..++.+++.|++||| +.+|+||||||+||++++++.+|++|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 96 5788877665566889999999999999999999 899999999999999999999999999998653211
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 175 --~~~~~~~~y~aP 186 (313)
T cd06633 175 --NSFVGTPYWMAP 186 (313)
T ss_pred --CCccccccccCh
Confidence 123467778887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.3e-17 Score=161.36 Aligned_cols=137 Identities=28% Similarity=0.366 Sum_probs=109.4
Q ss_pred CccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc-------------------------------Ccc-----ceeE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC-------------------------------SNE-----DFRA 428 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-------------------------------~~~-----~~~~ 428 (527)
.|++.+.||+|+||.||+|+.. +++.||||++.... ... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3788899999999999999865 58999999864311 111 2568
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||++ ++|.+++.... .+++.....++.+++.|++||| +++|+||||||+||+++.++.++++|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999998 48988886543 6788889999999999999999 99999999999999999999999999999987654
Q ss_pred CCCc-cceeccccccccccC
Q 035895 509 EDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~-~~~~~~~~t~~y~aP 527 (527)
.... .......++..|+||
T Consensus 156 ~~~~~~~~~~~~~~~~y~aP 175 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAP 175 (330)
T ss_pred cccccccccccccccCcCCc
Confidence 3210 112234467789988
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.4e-17 Score=159.37 Aligned_cols=137 Identities=32% Similarity=0.398 Sum_probs=103.2
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
++|+..+.||+|+||.||++.. .+++.||+|.+... +..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3566778999999999999986 46899999987421 112345578999
Q ss_pred eccCCcHHHH---HHh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 433 YTTNGSLEKV---LYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 433 y~~~g~L~~~---l~~-~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
|+.. ++.++ +.. ....+++.....++.+++.|++|+|+ ..+|+||||||+||+++.++.+|++|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9875 54443 322 23457888899999999999999992 35899999999999999999999999999986543
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....++..|+||
T Consensus 161 ~~~---~~~~~~~~~y~aP 176 (288)
T cd06616 161 SIA---KTRDAGCRPYMAP 176 (288)
T ss_pred CCc---cccccCccCccCH
Confidence 211 1223467778887
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.6e-17 Score=160.74 Aligned_cols=137 Identities=28% Similarity=0.383 Sum_probs=108.2
Q ss_pred HhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-------------------------------c-cCccce
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-------------------------------S-CSNEDF 426 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-------------------------------~-~~~~~~ 426 (527)
+....++|+..+.||+|+||.||+|+. .+++.||+|++.. . ......
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 344678899999999999999999985 4789999997531 0 112345
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||+ +++|.+++.. ..++......++.|++.|++||| +.+|+||||||+||++++++.++++|||.++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 67999998 5689888753 34577777889999999999999 999999999999999999999999999998865
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ....++..|+||
T Consensus 159 ~~~~-----~~~~~~~~y~aP 174 (328)
T cd07856 159 DPQM-----TGYVSTRYYRAP 174 (328)
T ss_pred CCCc-----CCCcccccccCc
Confidence 3221 122356678887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=158.88 Aligned_cols=132 Identities=34% Similarity=0.446 Sum_probs=106.7
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~e 432 (527)
.|+..+.||+|+||.||+|+. .+++.||+|.+... +..+...++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 377778999999999999986 46789999987421 112345679999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+. |++.+.+......+++.++..++.+++.|++|+| +.+++||||||+||+++.++.++++|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 997 5888877655556788888999999999999999 999999999999999999999999999998765422
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 169 ---~~~~~~~~y~aP 180 (308)
T cd06634 169 ---NXFVGTPYWMAP 180 (308)
T ss_pred ---ccccCCccccCH
Confidence 123456678887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=160.23 Aligned_cols=132 Identities=28% Similarity=0.397 Sum_probs=104.9
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------Cc------cc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------SN------ED 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~~------~~ 425 (527)
.+.|...+.||+|+||.||+|+. .+|+.||+|++.... .. ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999985 578999999874210 00 01
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||||+.. ++..+.. ..+++.....++.|++.|++|+| +.+|+||||||+||+++.++.+|++|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 34799999974 7776642 34678888899999999999999 99999999999999999999999999999986
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... ....++..|+||
T Consensus 167 ~~~~~-----~~~~~~~~y~aP 183 (342)
T cd07879 167 ADAEM-----TGYVVTRWYRAP 183 (342)
T ss_pred CCCCC-----CCceeeecccCh
Confidence 53221 123457778888
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-17 Score=170.34 Aligned_cols=137 Identities=26% Similarity=0.408 Sum_probs=112.0
Q ss_pred ccccceeccCCceEEEEEEc-cCC----cEEEEEEEeeccCc-----------------------------cceeEEEEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDG----MEFAIKVFHFSCSN-----------------------------EDFRALVLE 432 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~----~~vavK~~~~~~~~-----------------------------~~~~~lv~e 432 (527)
....++||+|+||+||+|.+ +.| .+||||++...-.. .....||++
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 34568999999999999975 333 47899997542111 122458999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++.|.|.++++.++..+.....+.|..|||+|+.||| .+++|||||-++|||+.+-..+||+|||+|+.+..+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999987777888888999999999999999 999999999999999999999999999999998766554
Q ss_pred cceecccccccccc
Q 035895 513 MTQTQTLAIIGYMA 526 (527)
Q Consensus 513 ~~~~~~~~t~~y~a 526 (527)
.........+.|||
T Consensus 855 y~~~~gK~pikwma 868 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMA 868 (1177)
T ss_pred ccccccccCcHHHH
Confidence 44445555677876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=160.72 Aligned_cols=134 Identities=27% Similarity=0.358 Sum_probs=108.5
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccc-----
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNED----- 425 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~----- 425 (527)
..++|+..+.||+|+||.||+|+.. +++.||||++... ....+
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999874 6789999986421 00111
Q ss_pred -eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 426 -FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 426 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
..++|+||+ +++|.+++.. ..+++.++..++.+++.|++|+| +.+|+||||||+||++++++.++++|||+++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 278999998 5699998864 35788889999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... ....++..|+||
T Consensus 167 ~~~~~~-----~~~~~~~~y~aP 184 (343)
T cd07851 167 HTDDEM-----TGYVATRWYRAP 184 (343)
T ss_pred cccccc-----cCCcccccccCH
Confidence 764321 123456778887
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-16 Score=150.25 Aligned_cols=129 Identities=37% Similarity=0.501 Sum_probs=105.0
Q ss_pred eccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEEEeccCCcH
Q 035895 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 393 lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~~g~L 439 (527)
||+|+||.||+|... +++.||+|++... +..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 5889999987431 1234567899999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 519 (527)
.+++.... .+++.....++.++++|+.|+| +.+++|+||||+||+++.++.++++|||.+........ ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence 99987543 5788888999999999999999 89999999999999999999999999999987643211 112234
Q ss_pred cccccccC
Q 035895 520 AIIGYMAP 527 (527)
Q Consensus 520 ~t~~y~aP 527 (527)
++..|+||
T Consensus 155 ~~~~~~~P 162 (250)
T cd05123 155 GTPEYLAP 162 (250)
T ss_pred CCccccCh
Confidence 56778887
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=150.54 Aligned_cols=118 Identities=19% Similarity=0.176 Sum_probs=95.5
Q ss_pred CccccceeccCCceEEEEEE--ccCCcEEEEEEEeeccC-----------------------------------------
Q 035895 386 GFSANNLIGRGSFGSVYKAR--LQDGMEFAIKVFHFSCS----------------------------------------- 422 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~--~~~~~~vavK~~~~~~~----------------------------------------- 422 (527)
.|++.+.||+|+||.||+|. ..+|+.||||+++....
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58889999999999999998 57899999998763210
Q ss_pred ----------ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCeeeCC
Q 035895 423 ----------NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP-IIHCDLKPHNKLLDD 491 (527)
Q Consensus 423 ----------~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~-iiHrdlk~~nill~~ 491 (527)
.....++||||++|+++....... ...+..+...++.+++.+++|+| ..+ |+|||+||+||+++
T Consensus 109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEecCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-
Confidence 011246999999998887654222 23455556789999999999999 999 99999999999999
Q ss_pred CCcEEEeecccccccCC
Q 035895 492 NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 492 ~~~~kl~Dfg~a~~~~~ 508 (527)
++.++++|||.|+....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 88999999999986543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=156.02 Aligned_cols=135 Identities=19% Similarity=0.181 Sum_probs=100.5
Q ss_pred ccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------cCccceeEEEEEeccCC
Q 035895 389 ANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYTTNG 437 (527)
Q Consensus 389 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~~~g 437 (527)
+.+.+|.|+++.||++.. +++.||||++... +..++..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344555556665665555 6899999997531 11335678999999999
Q ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc----
Q 035895 438 SLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS---- 512 (527)
Q Consensus 438 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~---- 512 (527)
+|.+++... ...++......++.|++.||+||| +++|+||||||+||+++.++.+|++|||.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999998753 335778888889999999999999 999999999999999999999999999998755322110
Q ss_pred -cceeccccccccccC
Q 035895 513 -MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 -~~~~~~~~t~~y~aP 527 (527)
.......++..|+||
T Consensus 162 ~~~~~~~~~~~~y~aP 177 (314)
T cd08216 162 HDFPKSSVKNLPWLSP 177 (314)
T ss_pred ccccccccccccccCH
Confidence 011123356678887
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-16 Score=157.14 Aligned_cols=117 Identities=27% Similarity=0.411 Sum_probs=97.1
Q ss_pred Ccc-ccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------------------
Q 035895 386 GFS-ANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------------------- 420 (527)
Q Consensus 386 ~~~-~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------------------- 420 (527)
.|. +.+.||+|+||+||+|+. .+++.||||++...
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 354 457899999999999985 46899999986421
Q ss_pred cCccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 035895 421 CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500 (527)
Q Consensus 421 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Df 500 (527)
+..++..++||||++ |+|.+++... ..++......++.|++.|++||| +.+|+||||||+||+++.++.++++||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCc
Confidence 112345679999997 5899888643 35788888999999999999999 999999999999999999999999999
Q ss_pred ccccccC
Q 035895 501 GIAKLLT 507 (527)
Q Consensus 501 g~a~~~~ 507 (527)
|.++...
T Consensus 164 g~~~~~~ 170 (335)
T PTZ00024 164 GLARRYG 170 (335)
T ss_pred cceeecc
Confidence 9998654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.4e-16 Score=150.44 Aligned_cols=135 Identities=28% Similarity=0.425 Sum_probs=103.3
Q ss_pred ccccceeccCCceEEEEEEcc-CCcEEEEEEEee----------------------------------ccCccceeEEEE
Q 035895 387 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF----------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~----------------------------------~~~~~~~~~lv~ 431 (527)
|.+.+.||+|+||.||+|+.. .+..+++|+++. .+..++..++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 778899999999999999864 344555555431 112234567999
Q ss_pred EeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||+++++|.+++.. .+..+++.+...++.+++.|++|+| +.+++|+|+||+||++++ +.++++|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998864 2345788899999999999999999 999999999999999975 5699999999987643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.... .....++..|+||
T Consensus 158 ~~~~--~~~~~~~~~~~~p 174 (260)
T cd08222 158 SCDL--ATTFTGTPYYMSP 174 (260)
T ss_pred Cccc--ccCCCCCcCccCH
Confidence 2211 1123356678877
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.8e-16 Score=157.43 Aligned_cols=137 Identities=25% Similarity=0.358 Sum_probs=105.7
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-----------------------------C------------
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-----------------------------S------------ 422 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-----------------------------~------------ 422 (527)
..|+..+.||+|+||.||+|.. .+++.||+|++.... .
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5689999999999999999986 568999999864210 0
Q ss_pred --ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEee
Q 035895 423 --NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSD 499 (527)
Q Consensus 423 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-~~~~~kl~D 499 (527)
.....++||||++ ++|.+++.. ..+++.....++.|++.|++||| +.+|+||||||+||+++ +++.+|++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence 0124579999997 589888753 34778888999999999999999 99999999999999998 566899999
Q ss_pred cccccccCCCCCcc-ceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSM-TQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~-~~~~~~~t~~y~aP 527 (527)
||.++......... ......++..|+||
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP 187 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSP 187 (342)
T ss_pred cccceecCCccccccccccccccccccCH
Confidence 99998654321111 11123467788887
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-16 Score=156.96 Aligned_cols=112 Identities=22% Similarity=0.301 Sum_probs=93.1
Q ss_pred ceeccC--CceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEEeccC
Q 035895 391 NLIGRG--SFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 391 ~~lg~G--~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey~~~ 436 (527)
..||+| +||+||+|+. .+|+.||+|++... +..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999986 47899999987421 1233456799999999
Q ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 437 GSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 437 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
|++.+++.... ..+++.....++.|++.||+|+| +.+|+||||||+||+++.++.++++|||.+..
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 99999887542 34778888899999999999999 99999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6e-16 Score=143.15 Aligned_cols=113 Identities=25% Similarity=0.226 Sum_probs=92.6
Q ss_pred CccccceeccCCceEEEEEEccCCcEEEEEEEeecc-----------------------------------------C--
Q 035895 386 GFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC-----------------------------------------S-- 422 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~-----------------------------------------~-- 422 (527)
-|...+.||+|+||.||+|..++|+.||||++.... .
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 378889999999999999998889999999754210 0
Q ss_pred ------ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 035895 423 ------NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496 (527)
Q Consensus 423 ------~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~k 496 (527)
.....++||||++|++|...... .....++.+++.++.++| ..+|+||||||+||+++++++++
T Consensus 96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPIDWNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceeecCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEE
Confidence 01234789999999999765421 234568889999999999 89999999999999999999999
Q ss_pred EeecccccccCC
Q 035895 497 LSDFGIAKLLTG 508 (527)
Q Consensus 497 l~Dfg~a~~~~~ 508 (527)
++|||.+.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999976643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.9e-16 Score=145.50 Aligned_cols=139 Identities=24% Similarity=0.373 Sum_probs=109.1
Q ss_pred cCCccccceeccCCceEEEEEE-ccCCcEEEEEEEee------------------ccC----------ccceeEEEEEec
Q 035895 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHF------------------SCS----------NEDFRALVLEYT 434 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~------------------~~~----------~~~~~~lv~ey~ 434 (527)
--.|++.++||+|+||+.+.|. +-+++.||||.=.. .|. ..-+-.+|||.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 3469999999999999999997 56789999996311 011 111224899977
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-----CcEEEeecccccccCCC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-----IVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-----~~~kl~Dfg~a~~~~~~ 509 (527)
|.+|++++.-.+..++......+|.|+..-++|+| ++..|.|||||+|+||... ..+.+.|||+|+.+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 78999999877888999999999999999999999 9999999999999999643 46889999999987543
Q ss_pred CC--c---cceecccccccccc
Q 035895 510 DQ--S---MTQTQTLAIIGYMA 526 (527)
Q Consensus 510 ~~--~---~~~~~~~~t~~y~a 526 (527)
.. . .......||..||+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred cccccCccccccccccceeeeE
Confidence 32 1 12224558889986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-16 Score=167.64 Aligned_cols=140 Identities=28% Similarity=0.463 Sum_probs=111.0
Q ss_pred cCCccccceeccCCceEEEEEEcc--------CCcEEEEEEEee-------------------------------ccCcc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKVFHF-------------------------------SCSNE 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~-------------------------------~~~~~ 424 (527)
.++.++.+.+|+|.||.|++|... ....||||++.. .|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344456679999999999999732 146799998642 34456
Q ss_pred ceeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
+..++|+||+..|+|.++++..+ ..+...+.+.++.|||.|++||+ +.++||||+-++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence 67789999999999999998765 23778889999999999999999 9999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccc--cccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTL--AIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--~t~~y~aP 527 (527)
.++..+||+|||+||.......+.. .... -.+.||||
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmAp 490 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAP 490 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCH
Confidence 9999999999999997654433221 1122 24459998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-16 Score=165.30 Aligned_cols=136 Identities=33% Similarity=0.592 Sum_probs=104.2
Q ss_pred ccccceeccCCceE-EEEEEccCCcEEEEEEE-------------------------eeccC--ccceeEEEEEeccCCc
Q 035895 387 FSANNLIGRGSFGS-VYKARLQDGMEFAIKVF-------------------------HFSCS--NEDFRALVLEYTTNGS 438 (527)
Q Consensus 387 ~~~~~~lg~G~~g~-vy~~~~~~~~~vavK~~-------------------------~~~~~--~~~~~~lv~ey~~~g~ 438 (527)
|...+++|.|+-|+ ||+|..+ |++||||.+ +.+|. ++++.||+.|.|.. +
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 44567899998885 5899885 679999974 23443 45678999999986 9
Q ss_pred HHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---C--CcEEEeecccccccCCCC
Q 035895 439 LEKVLYSSNYIL---DILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---N--IVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 439 L~~~l~~~~~~~---~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~--~~~kl~Dfg~a~~~~~~~ 510 (527)
|.+++....... .......+..|++.||++|| +.+||||||||+|||++. + .+++|+|||+++.+....
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 999997631111 11345667899999999999 999999999999999964 2 578999999999887655
Q ss_pred Cccce-eccccccccccC
Q 035895 511 QSMTQ-TQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~-~~~~~t~~y~aP 527 (527)
.+... ....||-||+||
T Consensus 666 sS~~r~s~~sGt~GW~AP 683 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAP 683 (903)
T ss_pred chhhcccCCCCcccccCH
Confidence 44333 345689999999
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.7e-17 Score=163.62 Aligned_cols=138 Identities=25% Similarity=0.407 Sum_probs=109.0
Q ss_pred ccccceeccCCceEEEEEEcc--CC--cEEEEEEEeeccC------------------cc-----------ceeEEEEEe
Q 035895 387 FSANNLIGRGSFGSVYKARLQ--DG--MEFAIKVFHFSCS------------------NE-----------DFRALVLEY 433 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~--~~--~~vavK~~~~~~~------------------~~-----------~~~~lv~ey 433 (527)
....+.||+|.||+|++|.|. .| ..||||.++.... ++ .-..+|||.
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 455689999999999999874 33 5689999864211 11 122479999
Q ss_pred ccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
++.|+|-+.|++ .+..+-......++.|||.|++||. ++++|||||-.+|+++...-.+||+|||+.|.+...+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999987 3445666667789999999999999 999999999999999999999999999999998766554
Q ss_pred ccee-ccccccccccC
Q 035895 513 MTQT-QTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~-~~~~t~~y~aP 527 (527)
...+ .....+.|.||
T Consensus 269 Yvm~p~rkvPfAWCaP 284 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAP 284 (1039)
T ss_pred eEecCCCcCcccccCH
Confidence 4333 33346678887
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-16 Score=140.56 Aligned_cols=121 Identities=24% Similarity=0.440 Sum_probs=98.5
Q ss_pred hcCCccccceeccCCceEEEEEE-ccCCcEEEEEEEeec---------------c--------------CccceeEEEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFS---------------C--------------SNEDFRALVLE 432 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~---------------~--------------~~~~~~~lv~e 432 (527)
..++|++.+.+|+|.|++||.|. ..+.+.++||+++.. + .....+.+|+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 45789999999999999999997 456788999987531 0 12235678999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~~~~~~~ 510 (527)
|+.+.|...+.. .+...+...++.+++.||.|+| ++||+|||+||+|+++|. .-..++.|.|+|.+.....
T Consensus 116 ~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 116 YVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 999988877653 2445566778999999999999 999999999999999995 5679999999999886544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.7e-16 Score=155.79 Aligned_cols=134 Identities=26% Similarity=0.350 Sum_probs=106.6
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------cCccceeEEEEEeccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------~~~~~~~~lv~ey~~~ 436 (527)
.++|+....+|+|+|+.|-++.. .+++..|+|++... +.+....++|||++.|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 57788888999999999988875 56888999987543 1223356799999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-CCCCcEEEeecccccccCCCCCccce
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL-DDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill-~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
|-+-+.+...... . .++..|+.+++.|+.||| +++|||||+||+|||+ ++.+.++++|||.++..... ..
T Consensus 401 ~ell~ri~~~~~~-~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~ 471 (612)
T KOG0603|consen 401 GELLRRIRSKPEF-C-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CD 471 (612)
T ss_pred cHHHHHHHhcchh-H-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hc
Confidence 9888777654322 2 567779999999999999 9999999999999999 58999999999999987543 11
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
.-+-|..|.||
T Consensus 472 -tp~~t~~y~AP 482 (612)
T KOG0603|consen 472 -TPALTLQYVAP 482 (612)
T ss_pred -ccchhhcccCh
Confidence 12356778887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.5e-15 Score=137.71 Aligned_cols=137 Identities=32% Similarity=0.450 Sum_probs=109.0
Q ss_pred ccccceeccCCceEEEEEEccC-CcEEEEEEEeecc------------------------------CccceeEEEEEecc
Q 035895 387 FSANNLIGRGSFGSVYKARLQD-GMEFAIKVFHFSC------------------------------SNEDFRALVLEYTT 435 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~lv~ey~~ 435 (527)
|+..+.||+|++|.||+|.... ++.+|+|.+.... ...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999765 8899999986421 12245679999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+++|.+++......+++.....++.+++.++.|+| +.+++|+|++|+||+++.++.++++|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999998765433788888999999999999999 889999999999999999999999999999877543200 11
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..|++|
T Consensus 157 ~~~~~~~~~~~p 168 (225)
T smart00221 157 KTVKGTPFYLAP 168 (225)
T ss_pred cceeccCCcCCH
Confidence 123355667776
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.9e-15 Score=135.76 Aligned_cols=112 Identities=21% Similarity=0.238 Sum_probs=86.2
Q ss_pred cceeccCCceEEEEEEccCCcEEEEEEEeeccC-------------------------------c---------------
Q 035895 390 NNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCS-------------------------------N--------------- 423 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~-------------------------------~--------------- 423 (527)
.+.||+|+||.||+|+..+++.||||+++.... .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999988899999998753110 0
Q ss_pred -----cceeEEEEEeccCCcHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEE
Q 035895 424 -----EDFRALVLEYTTNGSLEK-VLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAH 496 (527)
Q Consensus 424 -----~~~~~lv~ey~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~k 496 (527)
....++||||++++++.. .+.... .. .+...++.+++.++.++| . ++|+|||+||+||+++ ++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEE
Confidence 013368999999954321 111110 11 456778999999999999 7 9999999999999999 89999
Q ss_pred EeecccccccCC
Q 035895 497 LSDFGIAKLLTG 508 (527)
Q Consensus 497 l~Dfg~a~~~~~ 508 (527)
++|||.++....
T Consensus 155 liDfg~a~~~~~ 166 (187)
T cd05119 155 IIDVPQAVEIDH 166 (187)
T ss_pred EEECcccccccC
Confidence 999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.6e-17 Score=162.82 Aligned_cols=214 Identities=29% Similarity=0.392 Sum_probs=159.4
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEE
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 145 (527)
+|.|++-+++..+... .-..+.--...||+.|++.. +|..+..+. .|+.+.|.+|.+. .+|..+.++..|+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a----~~~~ltdt~~aDlsrNR~~e-lp~~~~~f~-~Le~liLy~n~~r-~ip~~i~~L~~lt~l 126 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGA----ASYDLTDTVFADLSRNRFSE-LPEEACAFV-SLESLILYHNCIR-TIPEAICNLEALTFL 126 (722)
T ss_pred ccccccchhhcCCCcc----ccccccchhhhhcccccccc-CchHHHHHH-HHHHHHHHhccce-ecchhhhhhhHHHHh
Confidence 5778888877654432 11345556788999999985 566666554 6888888888887 678888888888999
Q ss_pred EeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCC
Q 035895 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225 (527)
Q Consensus 146 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 225 (527)
||+.|+++ ..|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++.
T Consensus 127 ~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 127 DLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred hhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 99988887 4566666665 888888888887 67777888888888888888887 46666888888888888888888
Q ss_pred CCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcC---CCCCEEEcccc
Q 035895 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGL---KSLQFLSLGHN 293 (527)
Q Consensus 226 ~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N 293 (527)
.+|..+.. -.|..||++.|++. .+|-.|.+|+.|++|.|.+|.+. .+|..++-. .=.++|+...+
T Consensus 203 ~lp~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 203 DLPEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred hCCHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 88888773 35778888888775 57778888888888888888776 566655432 22345555555
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-15 Score=137.53 Aligned_cols=106 Identities=27% Similarity=0.396 Sum_probs=87.8
Q ss_pred ceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------------cCccceeEEEEEe
Q 035895 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------------~~~~~~~~lv~ey 433 (527)
+.||+|++|.||+|+. .|..|++|+.... +...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6678999974310 1122345689999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
++|++|.+.+.... . .+..++.+++.+++++| +.+++|||++|.||+++ ++.++++|||.++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999886432 2 67789999999999999 99999999999999999 789999999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=144.20 Aligned_cols=138 Identities=29% Similarity=0.375 Sum_probs=105.8
Q ss_pred CccccceeccCCceEEEEEEccCC--cEEEEEEEeec---------------------------------c-CccceeEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQDG--MEFAIKVFHFS---------------------------------C-SNEDFRAL 429 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~~~--~~vavK~~~~~---------------------------------~-~~~~~~~l 429 (527)
.|++.+.||+|+||.||.|..... ..+|+|+-... - ..+++.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986543 57888875321 0 23456789
Q ss_pred EEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-----CcEEEeecccc
Q 035895 430 VLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-----IVAHLSDFGIA 503 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-----~~~kl~Dfg~a 503 (527)
||+.+ |.+|.++..... ..++......|+.|+..+|+++| +.+++||||||+|++++.. ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 679999875444 66888899999999999999999 9999999999999999854 46899999999
Q ss_pred c--ccCCCCC---ccc---eeccccccccccC
Q 035895 504 K--LLTGEDQ---SMT---QTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~--~~~~~~~---~~~---~~~~~~t~~y~aP 527 (527)
+ .+..... ... .....||..|+++
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccH
Confidence 9 3322211 111 1234488888764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.9e-14 Score=132.02 Aligned_cols=113 Identities=44% Similarity=0.670 Sum_probs=96.8
Q ss_pred eccCCceEEEEEEccC-CcEEEEEEEeecc------------------------------CccceeEEEEEeccCCcHHH
Q 035895 393 IGRGSFGSVYKARLQD-GMEFAIKVFHFSC------------------------------SNEDFRALVLEYTTNGSLEK 441 (527)
Q Consensus 393 lg~G~~g~vy~~~~~~-~~~vavK~~~~~~------------------------------~~~~~~~lv~ey~~~g~L~~ 441 (527)
||+|++|.||++.... ++.+++|++.... ......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 8999999875421 11235679999999999999
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCC
Q 035895 442 VLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 442 ~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~~~~~ 508 (527)
++.......++..+..++.+++++++|+| +.+++|+||+|.||+++. ++.++++|||.+.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 98765345788899999999999999999 889999999999999998 89999999999987643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.1e-14 Score=133.02 Aligned_cols=103 Identities=25% Similarity=0.381 Sum_probs=83.7
Q ss_pred eeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------------cCccceeEEEEEec
Q 035895 392 LIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 392 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------------~~~~~~~~lv~ey~ 434 (527)
.||+|+||.||+|.+ +|..|++|+.... +..++..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5678999984310 01123347999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
+|++|.+.+..... .++.+++.+++++| +.+++|||++|.||+++ ++.+++.|||.++...
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999988754211 68899999999999 99999999999999999 8899999999988643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.6e-14 Score=128.03 Aligned_cols=108 Identities=20% Similarity=0.209 Sum_probs=83.0
Q ss_pred cccceeccCCceEEEEEEccCCcEEEEEEEeecc---------------------C---------ccceeEEEEEeccCC
Q 035895 388 SANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC---------------------S---------NEDFRALVLEYTTNG 437 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~---------------------~---------~~~~~~lv~ey~~~g 437 (527)
.....|++|+||+||.+.. .+..++.+.+.... . .-+..+++|||++|.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~ 83 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA 83 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence 3567899999999998776 56677655543210 0 012347999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeeeCCCCcEEEeecccccccC
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL-KPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdl-k~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
+|.+.... ....++.+++++++|+| +.+|+|||| ||+||+++.++.++|+|||+|....
T Consensus 84 ~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 84 AMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99765421 12346789999999999 999999999 7999999999999999999998654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.4e-14 Score=136.80 Aligned_cols=135 Identities=23% Similarity=0.336 Sum_probs=104.5
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------cCccceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------CSNEDFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~~~~~~~~ 428 (527)
...|++...+|+|.||.|..+.. +++..||||+++.. ....+..+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 56789999999999999999875 34789999987421 11123456
Q ss_pred EEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC----------------
Q 035895 429 LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---------------- 491 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---------------- 491 (527)
+|+|.+ |-++.+++...+ ..++......++.|++++++||| +.+++|=||||+|||+-+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 888877 458999997644 34678888899999999999999 999999999999999821
Q ss_pred ----CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 ----NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...+||.|||-|+.-.+.. +..+.|.-|.||
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAP 278 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAP 278 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc-----ceeeeccccCCc
Confidence 2347999999998754322 234567779988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.9e-14 Score=130.65 Aligned_cols=110 Identities=14% Similarity=0.150 Sum_probs=88.3
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeecc---------------------------------------Cc-
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC---------------------------------------SN- 423 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~---------------------------------------~~- 423 (527)
.+.|+..+++|+|+||.||.+.. ++..+|||+++... ..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46799999999999999999766 56789999985200 00
Q ss_pred ------cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 035895 424 ------EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497 (527)
Q Consensus 424 ------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl 497 (527)
....++||||++|.+|.++.. .+. ....+++.+++.+| ..+++|||+||+||++++++ +++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEE
Confidence 123679999999999988631 122 24568999999999 99999999999999999888 999
Q ss_pred eecccccccC
Q 035895 498 SDFGIAKLLT 507 (527)
Q Consensus 498 ~Dfg~a~~~~ 507 (527)
+|||..+...
T Consensus 176 iDfg~~~~~~ 185 (232)
T PRK10359 176 IDLSGKRCTA 185 (232)
T ss_pred EECCCccccc
Confidence 9999887653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.8e-14 Score=132.49 Aligned_cols=124 Identities=42% Similarity=0.520 Sum_probs=100.3
Q ss_pred CceEEEEEEcc-CCcEEEEEEEeecc------------------------------CccceeEEEEEeccCCcHHHHHHh
Q 035895 397 SFGSVYKARLQ-DGMEFAIKVFHFSC------------------------------SNEDFRALVLEYTTNGSLEKVLYS 445 (527)
Q Consensus 397 ~~g~vy~~~~~-~~~~vavK~~~~~~------------------------------~~~~~~~lv~ey~~~g~L~~~l~~ 445 (527)
+||.||+|... +++.+|+|++.... ......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999975321 123466899999999999999875
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccc
Q 035895 446 SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525 (527)
Q Consensus 446 ~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 525 (527)
... +++.....++.+++.+++|+| +.+++|+||+|.||++++++.++++|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 433 788889999999999999999 8999999999999999999999999999998765332 112234566788
Q ss_pred cC
Q 035895 526 AP 527 (527)
Q Consensus 526 aP 527 (527)
||
T Consensus 154 ~p 155 (244)
T smart00220 154 AP 155 (244)
T ss_pred CH
Confidence 76
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.3e-14 Score=151.43 Aligned_cols=110 Identities=24% Similarity=0.285 Sum_probs=85.7
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEe-e------------------------------------ccCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFH-F------------------------------------SCSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~-~------------------------------------~~~~~~~ 426 (527)
...|...+.||+|+||.||+|.+.... +++|+.. . .+..++.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344567899999999999999875443 3333211 0 0112234
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||++|++|.+++. ....++.+++++++|+| +.+|+|||+||+||++ +++.++++|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 579999999999998874 34678999999999999 9999999999999999 5789999999999875
Q ss_pred C
Q 035895 507 T 507 (527)
Q Consensus 507 ~ 507 (527)
.
T Consensus 478 ~ 478 (535)
T PRK09605 478 D 478 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.6e-16 Score=153.97 Aligned_cols=215 Identities=30% Similarity=0.404 Sum_probs=170.5
Q ss_pred EEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCc
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGN 174 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 174 (527)
.|.|++-++..+.-..+..-.......||+.|++. .+|..+..+..|+.+.|.+|.+. .+|..++.+..|++|||+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 45566666665433333211123456889999998 67888888889999999999998 56788999999999999999
Q ss_pred ccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCcc
Q 035895 175 ELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSK 254 (527)
Q Consensus 175 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~ 254 (527)
+++ .+|..+|.|+ |+.|.+++|+++ .+|+.++.+..|..|+.+.|.+..+|..++.+..|+.|.+..|++. .+|..
T Consensus 132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~E 207 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEE 207 (722)
T ss_pred hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHH
Confidence 998 7888888887 899999999998 6778888889999999999999999999999999999999998876 46677
Q ss_pred ccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCC---CCCCCEEeCCCCc
Q 035895 255 IGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD---LVSLESLDLSNNN 318 (527)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---l~~L~~L~ls~N~ 318 (527)
+..|+ |..||+|+|+++ .+|-.|..|+.|++|.|.+|.++ ..|..+.. ..-.++|+..-++
T Consensus 208 l~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 208 LCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred HhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 77665 888999999997 68999999999999999999997 56655432 2234566665553
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4e-14 Score=137.03 Aligned_cols=115 Identities=32% Similarity=0.433 Sum_probs=96.8
Q ss_pred cCCccccceeccCCceEEEEEEcc----CCcEEEEEEEeec----------------------------cCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFS----------------------------CSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~----------------------------~~~~~~~~lv~ 431 (527)
...|...++||+|.|++||+|... ..+.||+|.+... ...++.+.+||
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 456889999999999999999753 4678999987431 13467889999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeecccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKL 505 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-~~~~~kl~Dfg~a~~ 505 (527)
||++.-+..++... ++..+...+...+..||+++| ..|||||||||.|+|.+ ..++-.+.|||+|..
T Consensus 115 p~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence 99999888888754 456677789999999999999 99999999999999998 567889999999973
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-14 Score=135.25 Aligned_cols=130 Identities=28% Similarity=0.299 Sum_probs=98.1
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------------cCccceeE
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------------CSNEDFRA 428 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------------~~~~~~~~ 428 (527)
|--.+.+|.|+- .|..|-. -.+++||+|++... .......+
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 445567777777 5555543 25678888875210 01112457
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+|||||.. +|...+. ..++......|..|++.|+.|+| +.+|+||||||+||++..++.+||.|||+|+.-..
T Consensus 98 ~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 98 LVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCc
Confidence 89999974 8888876 34677788889999999999999 99999999999999999999999999999986432
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
....+..+.|..|.||
T Consensus 171 ---~~~mtpyVvtRyyrap 186 (369)
T KOG0665|consen 171 ---DFMMTPYVVTRYYRAP 186 (369)
T ss_pred ---ccccCchhheeeccCc
Confidence 2345566778889998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.8e-14 Score=137.02 Aligned_cols=135 Identities=29% Similarity=0.403 Sum_probs=106.7
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec----------------------------------cCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS----------------------------------CSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----------------------------------~~~~~~~~l 429 (527)
..|.+....|+|-|+.|.+|+.. .|..||||+++.. ..+.+..|+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 35778888999999999999864 5789999998531 123457789
Q ss_pred EEEeccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeccccccc
Q 035895 430 VLEYTTNGSLEKVLYSSNY--ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-IVAHLSDFGIAKLL 506 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-~~~kl~Dfg~a~~~ 506 (527)
|+|-+. -+|.+++.+.+. .+.......++.|+..||..|- ..+|+|.||||.|||+++. ..+|+||||-|...
T Consensus 512 VFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 512 VFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred Eehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 999886 499999987654 3566677789999999999999 9999999999999999864 67899999999887
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
..+.- |....+..|.||
T Consensus 588 ~enei----tPYLVSRFYRaP 604 (752)
T KOG0670|consen 588 SENEI----TPYLVSRFYRAP 604 (752)
T ss_pred ccccc----cHHHHHHhccCc
Confidence 64431 222334567777
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-13 Score=149.25 Aligned_cols=119 Identities=33% Similarity=0.427 Sum_probs=99.6
Q ss_pred hcCCccccceeccCCceEEEEEEccCCcEEEEEEEeecc-----------------------------CccceeEEEEEe
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC-----------------------------SNEDFRALVLEY 433 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~~lv~ey 433 (527)
..+.|.+.+.||+|+||.||+|...+|+.||+|+=...+ ...+...+|+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 345688899999999999999999889999999843211 123445699999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-------CCCcEEEeecccccc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-------DNIVAHLSDFGIAKL 505 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-------~~~~~kl~Dfg~a~~ 505 (527)
.+.|+|-+++. ....+++.-.+.++.+++..++.+| ..+|||+||||+|++|. +...++|+|||.+--
T Consensus 776 ~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 776 SPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred cccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 99999999997 4456888888999999999999999 99999999999999993 235689999999853
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.3e-13 Score=123.97 Aligned_cols=109 Identities=17% Similarity=0.335 Sum_probs=77.2
Q ss_pred cccceeccCCceEEEEEEccCCcEEEEEEEeec-----------------c-----------------Ccc---ceeE-E
Q 035895 388 SANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-----------------C-----------------SNE---DFRA-L 429 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-----------------~-----------------~~~---~~~~-l 429 (527)
+-.+.||+|+||.||. .-.++.. +||++... . .++ +..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467999999999996 3234444 68876421 0 001 1223 7
Q ss_pred EEEe--ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCeeeCC----CCcEEEee-cc
Q 035895 430 VLEY--TTNGSLEKVLYSSNYILDILQRLNIMIDVTSAL-EYLHFGYSTPIIHCDLKPHNKLLDD----NIVAHLSD-FG 501 (527)
Q Consensus 430 v~ey--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~ylH~~~~~~iiHrdlk~~nill~~----~~~~kl~D-fg 501 (527)
|||| +++|+|.+++... .++.. ..++.+++.++ +|+| +++||||||||+||+++. +..++|+| ||
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 6689999999653 34443 34567777777 9999 999999999999999973 34899999 55
Q ss_pred cccc
Q 035895 502 IAKL 505 (527)
Q Consensus 502 ~a~~ 505 (527)
.+..
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 5444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.6e-13 Score=138.01 Aligned_cols=113 Identities=27% Similarity=0.324 Sum_probs=87.1
Q ss_pred cceeccCCceEEEEEEccCCcEEEEEEEeecc------------------------------------------------
Q 035895 390 NNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC------------------------------------------------ 421 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~------------------------------------------------ 421 (527)
.+.||.|++|.||+|++++|+.||||+.+...
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999964210
Q ss_pred -------------Cc-------------cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 035895 422 -------------SN-------------EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTS-ALEYLHFGYS 474 (527)
Q Consensus 422 -------------~~-------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~ylH~~~~ 474 (527)
.+ ....++||||++|++|.++........+ +..++..++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence 00 0123599999999999887643221222 3446666655 467788 8
Q ss_pred CCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 475 ~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
.+++|+|++|.||++++++++++.|||++..++.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.9e-13 Score=138.23 Aligned_cols=200 Identities=34% Similarity=0.496 Sum_probs=126.8
Q ss_pred EEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCC-CCCEEeccCcccccccChhhhcCcccCeeeeecc
Q 035895 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQ-KLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198 (527)
Q Consensus 120 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 198 (527)
.++++.|.+.. ....+..++.++.|++.+|.++. ++.....+. +|+.|++++|++. .+|..+..++.|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 34555555431 22233344566666666666663 333344443 6777777777666 44455666777777777777
Q ss_pred cCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhh
Q 035895 199 KLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTT 278 (527)
Q Consensus 199 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 278 (527)
+++. +|...+.++.|+.|++++|+++.+|........|..+.+++|... ..+..+..+..+..+.+++|++. .++..
T Consensus 174 ~l~~-l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 174 DLSD-LPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhhh-hhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence 7763 444344666777777777777777766555555667777766432 34455667777777777777775 34667
Q ss_pred hhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccch
Q 035895 279 IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 327 (527)
Q Consensus 279 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 327 (527)
++.++++++|++++|.++.. +. +..+.+++.|++++|.+...+|...
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhhh
Confidence 77778888888888888743 33 7778888888888888877666543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-12 Score=126.95 Aligned_cols=136 Identities=42% Similarity=0.581 Sum_probs=107.0
Q ss_pred ccccceeccCCceEEEEEEccCCcEEEEEEEeecc---------------------------------CccceeEEEEEe
Q 035895 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC---------------------------------SNEDFRALVLEY 433 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~---------------------------------~~~~~~~lv~ey 433 (527)
|...+.||+|+||.||++... ..+|+|.+.... ......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999877 678888763210 112234799999
Q ss_pred ccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 035895 434 TTNGSLEKVLYSSN--YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTGED 510 (527)
Q Consensus 434 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~~~ 510 (527)
+.++++.+++.... ..........++.+++.+++|+| +.+++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543 25777788899999999999999 99999999999999999888 79999999998664332
Q ss_pred Ccc----ceeccccccccccC
Q 035895 511 QSM----TQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~----~~~~~~~t~~y~aP 527 (527)
... ......++.+|+||
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~p 177 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAP 177 (384)
T ss_pred ccccccccccccccccccCCH
Confidence 211 12345688999998
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=6.9e-13 Score=148.21 Aligned_cols=76 Identities=14% Similarity=0.248 Sum_probs=63.7
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--------------
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-------------- 491 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-------------- 491 (527)
..+.+|||+ +++|.+++......+++.++..++.||++||+||| +++||||||||+|||++.
T Consensus 54 ~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~ 129 (793)
T PLN00181 54 SIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSD 129 (793)
T ss_pred hhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeeccccCc
Confidence 455678887 56999999765566899999999999999999999 999999999999999954
Q ss_pred -----CCcEEEeecccccc
Q 035895 492 -----NIVAHLSDFGIAKL 505 (527)
Q Consensus 492 -----~~~~kl~Dfg~a~~ 505 (527)
++.+|++|||+++.
T Consensus 130 ~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 130 SGSDEDATTKSREIGSSRR 148 (793)
T ss_pred ccccccCcccccccccccc
Confidence 45667777777764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.6e-12 Score=111.16 Aligned_cols=109 Identities=22% Similarity=0.295 Sum_probs=87.4
Q ss_pred ccceeccCCceEEEEEEccCCcEEEEEEEeecc-----------------------------CccceeEEEEEeccCCcH
Q 035895 389 ANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC-----------------------------SNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 389 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~~lv~ey~~~g~L 439 (527)
+.+.||+|.++.||+++..+ ..+++|...... ...+..+++|||++++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 35789999999999999865 688999864311 112346799999998877
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 440 EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 440 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus 81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 643 44566778899999999999554468999999999999999899999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-12 Score=133.90 Aligned_cols=202 Identities=32% Similarity=0.440 Sum_probs=144.7
Q ss_pred EEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCc-CCcEEEeecCcccccCcccccCCCCCCEEeccC
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT-DLISIDLGGNKLNGSISITLGKLQKLQFLSFRG 173 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 173 (527)
.++++.|.+.... ..+... ..++.|++.+|.++. ++.....+. +|+.|++++|.+.. .|..++.+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~-~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLEL-TNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCc-hhhhcc-cceeEEecCCccccc-Cccccccchhhcccccccccchhh-hhhhhhccccccccccCC
Confidence 5777777764322 223333 357788888888874 444445553 78888888888874 335567788888888888
Q ss_pred cccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCc
Q 035895 174 NELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPS 253 (527)
Q Consensus 174 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~ 253 (527)
|++. .+|...+.++.|+.|++++|+++ .+|.....+..|++|.+++|.+..++..+.++..+..+.+.+|++.. ++.
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-ccc
Confidence 8887 56666667788888888888887 45554555566888888888777777777777888877777776653 366
Q ss_pred cccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCC
Q 035895 254 KIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 305 (527)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 305 (527)
.++.++.+++|++++|.++...+ +..+.+++.|++++|.+....|.....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence 77888889999999998874433 888889999999999888666655443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.8e-12 Score=117.96 Aligned_cols=107 Identities=20% Similarity=0.300 Sum_probs=81.8
Q ss_pred ceec-cCCceEEEEEEccCCcEEEEEEEee----------c---------------------------c-------C-cc
Q 035895 391 NLIG-RGSFGSVYKARLQDGMEFAIKVFHF----------S---------------------------C-------S-NE 424 (527)
Q Consensus 391 ~~lg-~G~~g~vy~~~~~~~~~vavK~~~~----------~---------------------------~-------~-~~ 424 (527)
..|| .||.|+||++... +..++||.+.. . + . ..
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5787 8999999998875 66788886521 0 0 0 00
Q ss_pred c---eeEEEEEeccC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 035895 425 D---FRALVLEYTTN-GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500 (527)
Q Consensus 425 ~---~~~lv~ey~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Df 500 (527)
. ..++||||++| ++|.+++... .++.. .+.++++++.++| +.+|+||||||+|||++.++.++++||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 1 12499999997 6999887542 23332 3568999999999 999999999999999998889999999
Q ss_pred ccccccC
Q 035895 501 GIAKLLT 507 (527)
Q Consensus 501 g~a~~~~ 507 (527)
|.++...
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9988754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=8.2e-12 Score=122.92 Aligned_cols=105 Identities=32% Similarity=0.411 Sum_probs=85.7
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------------cCc
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------------CSN 423 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------------~~~ 423 (527)
+.|.+.++||=|.|++||+|.. ...+-||+|+.+.+ -..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 4578899999999999999985 56789999997531 011
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNY-ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN 492 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~ 492 (527)
...+++|+||+ |-+|-.+|.+..+ .++.....+|+.||+.||.|||. ..+|||-||||+|||+...
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCST 224 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeecc
Confidence 23568999998 5688888876543 47888899999999999999995 5699999999999999644
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.5e-12 Score=120.86 Aligned_cols=145 Identities=20% Similarity=0.279 Sum_probs=108.9
Q ss_pred HhhhcCCccccceeccCCceEEEEEEccC------CcEEEEEEEe-------------------------------eccC
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARLQD------GMEFAIKVFH-------------------------------FSCS 422 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~-------------------------------~~~~ 422 (527)
+......++....+-||.||.||+|.+++ .+.|-+|.++ .+..
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 33344457778889999999999996643 2344455431 1122
Q ss_pred ccceeEEEEEeccCCcHHHHHHh-----cC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 035895 423 NEDFRALVLEYTTNGSLEKVLYS-----SN--YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495 (527)
Q Consensus 423 ~~~~~~lv~ey~~~g~L~~~l~~-----~~--~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~ 495 (527)
+.+.++..+.|+.-|+|..++.. .. ..+...+.+-++.|++.|++|+| +++|||.||-++|+++|+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeE
Confidence 34567788999999999999972 11 23566677889999999999999 9999999999999999999999
Q ss_pred EEeecccccccCCCCCccceeccccccccccC
Q 035895 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 496 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|++|-.++|.+.+.+...-....-....||||
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl 467 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSL 467 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCH
Confidence 99999999987666554433333456778885
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-12 Score=119.36 Aligned_cols=206 Identities=23% Similarity=0.296 Sum_probs=134.8
Q ss_pred hhhhcchhcc---------cCCCceeecCchhhhcCCCCCEEEccccc---cccc--cccccceEEcccccccCCCCCCc
Q 035895 17 GDVCYRICTI---------DSQNKLVGIVSITIFNLSTLKVFDVDNNY---VLGR--LSSIVDELSLSDNYLTSSTPELS 82 (527)
Q Consensus 17 ~~~~~~~~~~---------~s~N~l~~~~~~~~~~l~~L~~L~Ls~N~---~~~~--~~~~l~~L~Ls~N~l~~~~~~~~ 82 (527)
-|+|.|+-.+ +..|-+....|--+.-+.+|+.+.+|+.. +.+. ..+.++.+...+.-++..+.-++
T Consensus 178 ldf~~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~p 257 (490)
T KOG1259|consen 178 LDFCTQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLLP 257 (490)
T ss_pred HHhhhheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccccccccc
Confidence 4667665432 33444444445434445566666666553 3322 22345566555554443221111
Q ss_pred ------------------ccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcE
Q 035895 83 ------------------FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLIS 144 (527)
Q Consensus 83 ------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 144 (527)
....+..++.|++||||+|.|+.+ .++. .+.+.+++|++|+|.|..+ ..+..+++|+.
T Consensus 258 e~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~~i-DESv-KL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~ 333 (490)
T KOG1259|consen 258 ETILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLITQI-DESV-KLAPKLRRLILSQNRIRTV--QNLAELPQLQL 333 (490)
T ss_pred hhhhcCccCCCCCccCCceEEecchHhhhhhccccccchhhh-hhhh-hhccceeEEeccccceeee--hhhhhcccceE
Confidence 011233456788999999998864 3443 3446799999999998743 33788899999
Q ss_pred EEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCC-CccccCCccCceeeCCCCC
Q 035895 145 IDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI-PTCFGNLTALRNLHLDSNE 223 (527)
Q Consensus 145 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~ 223 (527)
|||++|.++. +...-.++.+.+.|.|++|.|.. -+.+..+-+|..||+++|+|.... -..+++++.|+.+.|.+|.
T Consensus 334 LDLS~N~Ls~-~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 334 LDLSGNLLAE-CVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred eecccchhHh-hhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 9999999874 44455678888999999998863 245677888899999999987432 2458889999999999999
Q ss_pred CCCCch
Q 035895 224 LTSIPS 229 (527)
Q Consensus 224 l~~lp~ 229 (527)
+..+|+
T Consensus 411 l~~~vd 416 (490)
T KOG1259|consen 411 LAGSVD 416 (490)
T ss_pred ccccch
Confidence 988775
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.3e-11 Score=123.23 Aligned_cols=117 Identities=21% Similarity=0.228 Sum_probs=81.3
Q ss_pred CCccccceeccCCceEEEEEEccC-CcEEEEEEEeecc------------------------------------------
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQD-GMEFAIKVFHFSC------------------------------------------ 421 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~------------------------------------------ 421 (527)
..|+. +.||.|++|+||+|++++ |+.||||+.+...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34666 789999999999999987 9999999975210
Q ss_pred -------------------Ccc-------------ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHH
Q 035895 422 -------------------SNE-------------DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTS-ALEY 468 (527)
Q Consensus 422 -------------------~~~-------------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~y 468 (527)
.+. ...++||||++|+++.++-.-.....+. ..++...+. .+.-
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHHHHHH
Confidence 001 1224999999999998752211111221 122222221 1222
Q ss_pred HhcCCCCCeEecCCCCCCeeeCCCC----cEEEeecccccccCC
Q 035895 469 LHFGYSTPIIHCDLKPHNKLLDDNI----VAHLSDFGIAKLLTG 508 (527)
Q Consensus 469 lH~~~~~~iiHrdlk~~nill~~~~----~~kl~Dfg~a~~~~~ 508 (527)
++ ..+++|+|+||.||+++.++ ++++.|||+...++.
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 78999999999999999887 999999999987754
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-12 Score=126.04 Aligned_cols=135 Identities=24% Similarity=0.260 Sum_probs=59.5
Q ss_pred CcCCcEEEeecCccccc-CcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCC-ccccCCccCce
Q 035895 139 LTDLISIDLGGNKLNGS-ISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP-TCFGNLTALRN 216 (527)
Q Consensus 139 l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~ 216 (527)
+++|+.|.|+.|.++.. +......+|+|+.|+|.+|..-........-+..|+.|||++|.+-.... ...+.++.|+.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence 34444444444444311 11122234455555555553211222223334445555555555442210 12344555555
Q ss_pred eeCCCCCCCCC--chh-----hhCCCCccEEEccCCcccc-cCCccccCCCCCCEEEccCCCCCC
Q 035895 217 LHLDSNELTSI--PSI-----LWNLKDILYLDFWSNLFVG-PLPSKIGNLKVLTRIDFSRNNLLG 273 (527)
Q Consensus 217 L~L~~N~l~~l--p~~-----~~~l~~L~~l~l~~n~~~~-~~p~~~~~l~~L~~L~Ls~N~l~~ 273 (527)
|+++.+.+.++ |+. ....+.|++|++..|++.. ..-..+..+++|+.|.+..|.+..
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 55555555442 222 2234455555555555421 111223445667777777777753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.5e-11 Score=128.15 Aligned_cols=93 Identities=26% Similarity=0.352 Sum_probs=78.2
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
+||||++ ||...+... ..+...++-.++.|+..|+.|+| ..+|.|||+|++|+++..+|.+||+|||.+..+...
T Consensus 399 ~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 4999999 999988653 35677788889999999999999 999999999999999999999999999999865422
Q ss_pred --CCccceeccccccccccC
Q 035895 510 --DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 --~~~~~~~~~~~t~~y~aP 527 (527)
.........+|+-+|+||
T Consensus 474 ~e~~~~~~~g~~gS~pY~ap 493 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAP 493 (601)
T ss_pred cchhhhhhcCcccCCcCcCc
Confidence 222445567788899998
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.5e-12 Score=121.42 Aligned_cols=214 Identities=20% Similarity=0.190 Sum_probs=116.7
Q ss_pred CCCCCCCEEEcccCCCCcccC-hhHhhccccccEEEcccCcccccc--chhhcCCcCCcEEEeecCcccccCcc-cccCC
Q 035895 88 SNCKYLKKLDISRNPLDGFLP-RVVGNFSQSLEFIWMSDCNISGGI--SEEIGNLTDLISIDLGGNKLNGSISI-TLGKL 163 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~~~-~~~~~~~~~L~~L~Ls~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l 163 (527)
+++++|++..|.+..+..... .....+ ++++.||||+|-+.... -.....+++|+.|+|+.|++.-.... .-..+
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~-~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKIL-PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhC-CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 356677777777776653211 123333 36777777777665332 23446677777888887777522211 12246
Q ss_pred CCCCEEeccCcccccc-cChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch--hhhCCCCccEE
Q 035895 164 QKLQFLSFRGNELEGS-IPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS--ILWNLKDILYL 240 (527)
Q Consensus 164 ~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~l 240 (527)
++|+.|.|+.|.++-. +-.....+++|+.|+|..|............+..|++|+|++|++-..+. ....++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 6777777877777521 22234556777778877775333333445556677777777777766652 33444444444
Q ss_pred EccCCccccc-CCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceee-cCCCCCCCCCCCEEeCCCCc
Q 035895 241 DFWSNLFVGP-LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS-IPNSFDDLVSLESLDLSNNN 318 (527)
Q Consensus 241 ~l~~n~~~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~ 318 (527)
+++.+.+.+. .|+. ..-+--..+++|++|+++.|+|..- .-+.+..+++|+.|.+..|.
T Consensus 277 nls~tgi~si~~~d~-------------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ 337 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDV-------------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNY 337 (505)
T ss_pred hccccCcchhcCCCc-------------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhccccc
Confidence 4444443321 1110 0000123445667777777766311 11223345566666666666
Q ss_pred ccc
Q 035895 319 LSE 321 (527)
Q Consensus 319 l~~ 321 (527)
++.
T Consensus 338 ln~ 340 (505)
T KOG3207|consen 338 LNK 340 (505)
T ss_pred ccc
Confidence 653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.1e-11 Score=106.65 Aligned_cols=125 Identities=28% Similarity=0.345 Sum_probs=46.3
Q ss_pred cCcccCeeeeecccCCCCCCcccc-CCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEE
Q 035895 186 HLAVLFQLDLRGNKLSGSIPTCFG-NLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRI 264 (527)
Q Consensus 186 ~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L 264 (527)
+...+++|+|++|+|+.+ +.++ .+.+|+.|++++|.|+.++ .+..++.|++|
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~-------------------------~l~~L~~L~~L 69 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE-------------------------GLPGLPRLKTL 69 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S--T-------------------------T----TT--EE
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc-------------------------CccChhhhhhc
Confidence 333455566666665532 1233 3455555666665555443 25567889999
Q ss_pred EccCCCCCCCChhhhhcCCCCCEEEcccccceeec-CCCCCCCCCCCEEeCCCCcccccCc---cchhhhccCCeeE
Q 035895 265 DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI-PNSFDDLVSLESLDLSNNNLSEIIP---LSLEKLLYLNILL 337 (527)
Q Consensus 265 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~L~ 337 (527)
++++|+++...+.....+++|++|++++|+|...- -..+..+++|+.|+|.+|+++...- ..+..+++|+.||
T Consensus 70 ~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 70 DLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp E--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred ccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 99999998543333357899999999999997421 1345678999999999999986532 2456778888776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-12 Score=117.72 Aligned_cols=132 Identities=26% Similarity=0.330 Sum_probs=73.7
Q ss_pred ccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccC
Q 035895 189 VLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSR 268 (527)
Q Consensus 189 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~ 268 (527)
.|+.||||+|.|+ .+.++..-++.++.|++|+|.|..+.. +..+.+|+.||+++|.++. +..+-..+.+.++|.|+.
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHh-hhhhHhhhcCEeeeehhh
Confidence 3444444444443 233333344444444444444444332 3344444444444444332 112223455667777777
Q ss_pred CCCCCCChhhhhcCCCCCEEEcccccceee-cCCCCCCCCCCCEEeCCCCcccccCcc
Q 035895 269 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGS-IPNSFDDLVSLESLDLSNNNLSEIIPL 325 (527)
Q Consensus 269 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p~ 325 (527)
|.+.. -..++.+-+|..||+++|+|... .-..++++|-|+.+.|.+|++.+++.-
T Consensus 362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 77652 23466777888888888888632 224678888899999999998876543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=7e-11 Score=127.49 Aligned_cols=107 Identities=34% Similarity=0.484 Sum_probs=97.2
Q ss_pred CCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCC
Q 035895 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLD 220 (527)
Q Consensus 141 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 220 (527)
.++.|+|++|.+++.+|..++.+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|+.++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-CchhhhCC-CCccEEEccCCcc
Q 035895 221 SNELTS-IPSILWNL-KDILYLDFWSNLF 247 (527)
Q Consensus 221 ~N~l~~-lp~~~~~l-~~L~~l~l~~n~~ 247 (527)
+|++++ +|..+..+ .++..+++.+|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcc
Confidence 999986 88887654 4667888888854
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-10 Score=124.86 Aligned_cols=109 Identities=29% Similarity=0.475 Sum_probs=100.9
Q ss_pred CCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC-CchhhhCCCCccEEEcc
Q 035895 165 KLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFW 243 (527)
Q Consensus 165 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~l~l~ 243 (527)
.++.|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++ +|..+.++++|+.|+++
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999996 89999999999999999
Q ss_pred CCcccccCCccccCC-CCCCEEEccCCCCCC
Q 035895 244 SNLFVGPLPSKIGNL-KVLTRIDFSRNNLLG 273 (527)
Q Consensus 244 ~n~~~~~~p~~~~~l-~~L~~L~Ls~N~l~~ 273 (527)
+|.+.+.+|..++.+ .++..+++++|....
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc
Confidence 999999999988764 467889999987554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.2e-11 Score=105.48 Aligned_cols=79 Identities=28% Similarity=0.389 Sum_probs=23.3
Q ss_pred CCCCCCEEeccCcccccccChhh-hcCcccCeeeeecccCCCCCC-ccccCCccCceeeCCCCCCCCCch----hhhCCC
Q 035895 162 KLQKLQFLSFRGNELEGSIPNVL-CHLAVLFQLDLRGNKLSGSIP-TCFGNLTALRNLHLDSNELTSIPS----ILWNLK 235 (527)
Q Consensus 162 ~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~lp~----~~~~l~ 235 (527)
.+++|+.|++++|+|+. ++..+ ..+++|+.|++++|+|...-. ..+..+++|++|+|.+|.++.-+. .+..++
T Consensus 62 ~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP 140 (175)
T PF14580_consen 62 GLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLP 140 (175)
T ss_dssp --TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-T
T ss_pred ChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcC
Confidence 34444444444444442 22222 234444444444444432111 234455666666666666654332 233444
Q ss_pred CccEEE
Q 035895 236 DILYLD 241 (527)
Q Consensus 236 ~L~~l~ 241 (527)
+|+.||
T Consensus 141 ~Lk~LD 146 (175)
T PF14580_consen 141 SLKVLD 146 (175)
T ss_dssp T-SEET
T ss_pred hhheeC
Confidence 444444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.6e-11 Score=125.05 Aligned_cols=126 Identities=29% Similarity=0.390 Sum_probs=96.5
Q ss_pred eeccCCceEEEEEEc----cCCcEEEEEEEeec--------------------------------cCccceeEEEEEecc
Q 035895 392 LIGRGSFGSVYKARL----QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 392 ~lg~G~~g~vy~~~~----~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ey~~ 435 (527)
++|+|+||.|+.++. +.|..+|+|+.... ...+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998753 44667787765321 122334467889999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
||++...+.... .++......+..+++-+++.+| +.+|+|||+|++||+++.+|++++.|||+++......
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 999988775543 3444455566778899999999 9999999999999999999999999999999875432
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
..+||..||||
T Consensus 152 -~~cgt~eymAp 162 (612)
T KOG0603|consen 152 -IACGTYEYRAP 162 (612)
T ss_pred -hcccchhhhhh
Confidence 12789999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.05 E-value=5e-10 Score=100.66 Aligned_cols=103 Identities=20% Similarity=0.279 Sum_probs=77.8
Q ss_pred cceeccCCceEEEEEEccCCcEEEEEEEeecc---------------------------CccceeEEEEEeccCCcHHHH
Q 035895 390 NNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC---------------------------SNEDFRALVLEYTTNGSLEKV 442 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~lv~ey~~~g~L~~~ 442 (527)
.+.++.|.++.||+++.. +..|++|+..... ...+..++||||++|.++.+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 467899999999999865 6789999853211 011234799999999887643
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 443 LYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP-----IIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 443 l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~-----iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
. . ....++.+++++++.+| +.+ ++|+|++|.||+++ ++.+++.|||.+..-
T Consensus 82 ----~-~----~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 82 ----D-F----SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ----c-c----cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 0 0 11235678999999999 555 59999999999999 668999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.9e-11 Score=113.87 Aligned_cols=64 Identities=20% Similarity=0.309 Sum_probs=27.3
Q ss_pred cCCCCCCEEEccCCCCCCCChhhh-----hcCCCCCEEEccccccee----ecCCCCCCCCCCCEEeCCCCcc
Q 035895 256 GNLKVLTRIDFSRNNLLGDIPTTI-----QGLKSLQFLSLGHNRLQG----SIPNSFDDLVSLESLDLSNNNL 319 (527)
Q Consensus 256 ~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l 319 (527)
+.+++|+.|++++|.+...-..+| ...++|+.|.|.+|.|+. .+-......+.|+.|+|++|++
T Consensus 238 ~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 238 SSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 334445555555555443222211 123455555555555431 1112223344555555555555
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.6e-09 Score=102.41 Aligned_cols=116 Identities=28% Similarity=0.478 Sum_probs=80.8
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeeccC-------------------------------------------
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSCS------------------------------------------- 422 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~------------------------------------------- 422 (527)
+...+.||.|+|+.||.++. ++++++|+|++.....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 45568999999999999997 4699999999743100
Q ss_pred -----------ccc-----eeEEEEEeccCCcHHHHHHh---cCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 035895 423 -----------NED-----FRALVLEYTTNGSLEKVLYS---SNY---ILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480 (527)
Q Consensus 423 -----------~~~-----~~~lv~ey~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHr 480 (527)
+.. ..+++|.-+ .+||.+++.. ... ......++.+..|+.+.++++| ..+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 000 113566666 4588887542 111 1334455677789999999999 9999999
Q ss_pred CCCCCCeeeCCCCcEEEeeccccccc
Q 035895 481 DLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 481 dlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||||+|++++.+|.+.++||+.....
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~ 195 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRA 195 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEET
T ss_pred ccceeeEEEcCCCCEEEcChHHHeec
Confidence 99999999999999999999887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.3e-09 Score=95.02 Aligned_cols=111 Identities=23% Similarity=0.206 Sum_probs=80.7
Q ss_pred ceeccCCceEEEEEEccC-------CcEEEEEEEeeccC-----------c-----------------------------
Q 035895 391 NLIGRGSFGSVYKARLQD-------GMEFAIKVFHFSCS-----------N----------------------------- 423 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~~-----------~----------------------------- 423 (527)
.+||.|.=+.||.|.-.+ +..+|||+++.... +
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997543 47999998753100 0
Q ss_pred -------------cceeEEEEEeccCCcHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCee
Q 035895 424 -------------EDFRALVLEYTTNGSLEK-VLYSSNYILDILQRLNIMIDVTSALEYL-HFGYSTPIIHCDLKPHNKL 488 (527)
Q Consensus 424 -------------~~~~~lv~ey~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~yl-H~~~~~~iiHrdlk~~nil 488 (527)
-...++||||+.++.+.. .+.. ..++..+...+..+++.++.++ | ..+|||+|+++.||+
T Consensus 83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL 157 (197)
T cd05146 83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYNML 157 (197)
T ss_pred HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 011248999998754422 2221 1234445566778999999998 7 889999999999999
Q ss_pred eCCCCcEEEeecccccccC
Q 035895 489 LDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 489 l~~~~~~kl~Dfg~a~~~~ 507 (527)
++ ++.+.++|||-|-...
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.1e-10 Score=81.49 Aligned_cols=61 Identities=39% Similarity=0.559 Sum_probs=52.8
Q ss_pred CCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcc
Q 035895 259 KVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319 (527)
Q Consensus 259 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 319 (527)
++|++|++++|++....+..|.++++|++|++++|+++...|+.|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4678889999988877778888999999999999999888888999999999999998875
|
... |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.3e-11 Score=121.37 Aligned_cols=245 Identities=25% Similarity=0.288 Sum_probs=153.1
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
++.+++..|.+.... ..+..+++|+.|++..|+|..+.. .+..+ .+|++|++++|.|+.+. .+..++.|+
T Consensus 74 l~~l~l~~n~i~~~~------~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~-~~L~~L~ls~N~I~~i~--~l~~l~~L~ 143 (414)
T KOG0531|consen 74 LKELNLRQNLIAKIL------NHLSKLKSLEALDLYDNKIEKIEN-LLSSL-VNLQVLDLSFNKITKLE--GLSTLTLLK 143 (414)
T ss_pred HHhhccchhhhhhhh------cccccccceeeeeccccchhhccc-chhhh-hcchheecccccccccc--chhhccchh
Confidence 344556666665421 124566777778888887776432 13333 36778888888777543 345566678
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccC-hhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 222 (527)
.|++++|.|+.. ..+..+++|+.+++++|++...-+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|
T Consensus 144 ~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 144 ELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDN 218 (414)
T ss_pred hheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccc
Confidence 888888887643 235557778888888888764333 2 4667777888888887753 233444555666677777
Q ss_pred CCCCCchhhhCCC--CccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceee--
Q 035895 223 ELTSIPSILWNLK--DILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS-- 298 (527)
Q Consensus 223 ~l~~lp~~~~~l~--~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-- 298 (527)
.++.+-... .+. .|+.++++.|.+.. .+..+..+..+..|+++.|++...- .+.....+..+.+..|.+...
T Consensus 219 ~i~~~~~l~-~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 294 (414)
T KOG0531|consen 219 KISKLEGLN-ELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEA 294 (414)
T ss_pred cceeccCcc-cchhHHHHHHhcccCcccc-ccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhh
Confidence 776653211 111 26667777776653 2245566778888888888876432 244556677777777776521
Q ss_pred -cCCC-CCCCCCCCEEeCCCCcccccCccch
Q 035895 299 -IPNS-FDDLVSLESLDLSNNNLSEIIPLSL 327 (527)
Q Consensus 299 -~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~ 327 (527)
.... ....+.++...+..|.+....+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKISSLDL 325 (414)
T ss_pred hhccccccccccccccccccCcccccccccH
Confidence 1121 4566788888999998877655433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5e-10 Score=120.15 Aligned_cols=127 Identities=31% Similarity=0.454 Sum_probs=90.3
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------cCccceeEEEEEeccCCcHHHHHHhcCCCCCHHHH
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQR 455 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~ 455 (527)
...+|+.++.|-.|+||.||.++++ +.+.+|+|+=+.. ....+..+.| ||-+..+...+. ++.
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~npfvv------gDc~tllk~~g~-lPv--- 150 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNPFVV------GDCATLLKNIGP-LPV--- 150 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCccee------chhhhhcccCCC-Ccc---
Confidence 3568999999999999999999976 4678999642211 1122333344 566666654332 111
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC-------------CCccceecccccc
Q 035895 456 LNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE-------------DQSMTQTQTLAII 522 (527)
Q Consensus 456 ~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~t~ 522 (527)
+.+.+++|+| +.+|+|||+||+|.++..-|++|++|||+++..... .......+.+||+
T Consensus 151 -----dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTP 222 (1205)
T KOG0606|consen 151 -----DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTP 222 (1205)
T ss_pred -----hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCc
Confidence 1166899999 999999999999999999999999999998753211 0112233568999
Q ss_pred ccccC
Q 035895 523 GYMAP 527 (527)
Q Consensus 523 ~y~aP 527 (527)
.|+||
T Consensus 223 eyiaP 227 (1205)
T KOG0606|consen 223 EYIAP 227 (1205)
T ss_pred cccCh
Confidence 99998
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-09 Score=80.21 Aligned_cols=58 Identities=24% Similarity=0.386 Sum_probs=30.4
Q ss_pred ccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcc
Q 035895 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNE 175 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 175 (527)
|++|++++|+++.+.+..|..+++|++|++++|+++...+..|.++++|+.|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4555555555554444555555555555555555554444455555555555555554
|
... |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-10 Score=120.19 Aligned_cols=193 Identities=27% Similarity=0.317 Sum_probs=85.4
Q ss_pred ccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec
Q 035895 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 197 (527)
++.++++.|.|.. .-..+..+.+|+.|++..|+|..+.. .+..+++|++|++++|+|+... .+..++.|+.|++++
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG 149 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheecccccccccc--chhhccchhhheecc
Confidence 4444444444432 12223444455555555555543221 1344555555555555554321 133444455555555
Q ss_pred ccCCCCCCccccCCccCceeeCCCCCCCCCchh-hhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh
Q 035895 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI-LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276 (527)
Q Consensus 198 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 276 (527)
|.|+.. ..+..++.|+.+++++|.++.++.. ...+..++.+.+..|.+... ..+..+..+..+++..|.++..-+
T Consensus 150 N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~ 225 (414)
T KOG0531|consen 150 NLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG 225 (414)
T ss_pred Ccchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC
Confidence 555421 2233355555555555555554432 23444444444544444321 122223333333555555442211
Q ss_pred hhhhcCC--CCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccc
Q 035895 277 TTIQGLK--SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 277 ~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 321 (527)
+..+. .|+.+++++|++. ..+..+..+..+..|++++|++..
T Consensus 226 --l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 226 --LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred --cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccc
Confidence 11111 2555666666655 222444455556666666665543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.1e-09 Score=96.05 Aligned_cols=73 Identities=26% Similarity=0.201 Sum_probs=62.5
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|.+++...+..+++.++..|+.|++.||+|+| +++ ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 7899999876667899999999999999999999 555 999999999999999 99998764321
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
..||+.||||
T Consensus 64 -~~g~~~y~aP 73 (176)
T smart00750 64 -SRVDPYFMAP 73 (176)
T ss_pred -CCCcccccCh
Confidence 2467899998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-09 Score=103.63 Aligned_cols=185 Identities=18% Similarity=0.126 Sum_probs=122.5
Q ss_pred ccCCCCCCEEeccCcccccccChh----hhcCcccCeeeeecccCCCCC-------------CccccCCccCceeeCCCC
Q 035895 160 LGKLQKLQFLSFRGNELEGSIPNV----LCHLAVLFQLDLRGNKLSGSI-------------PTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 160 ~~~l~~L~~L~l~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~-------------p~~~~~l~~L~~L~L~~N 222 (527)
+.+.++|+.||||+|.+.-..+.. +..+..|++|.|.+|.+...- ..-.+.-+.|+++..+.|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 344556666666666554333322 334556666666666553111 111234567999999999
Q ss_pred CCCCCch-----hhhCCCCccEEEccCCccccc----CCccccCCCCCCEEEccCCCCCCC----ChhhhhcCCCCCEEE
Q 035895 223 ELTSIPS-----ILWNLKDILYLDFWSNLFVGP----LPSKIGNLKVLTRIDFSRNNLLGD----IPTTIQGLKSLQFLS 289 (527)
Q Consensus 223 ~l~~lp~-----~~~~l~~L~~l~l~~n~~~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ 289 (527)
++..-+. .+...+.|..+.+..|.+... +...+..+++|+.|||.+|-++.. +...+..+++|+.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 9876553 445567888888888876522 234578899999999999988743 345678889999999
Q ss_pred cccccceeecCCC----C-CCCCCCCEEeCCCCccccc----CccchhhhccCCeeEeeeeeee
Q 035895 290 LGHNRLQGSIPNS----F-DDLVSLESLDLSNNNLSEI----IPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 290 L~~N~l~~~~p~~----~-~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
++++.+...-... | ...++|++|.|.+|.++.. +...+...+.|..|+++.+-++
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9999887432211 1 2468999999999999753 2334455677777877776664
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.3e-08 Score=86.89 Aligned_cols=103 Identities=24% Similarity=0.361 Sum_probs=78.7
Q ss_pred ceeccCCceEEEEEEccCCcEEEEEEEee-------------------------------------ccCccceeEEEEEe
Q 035895 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHF-------------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~-------------------------------------~~~~~~~~~lv~ey 433 (527)
..+++|+=+.+|.+.+. |.++.+|.-.. ...+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999998764 33466664210 01123445699999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
++|..|.+.+... +..++..|...++-|| ..+|||+|+.++||++..+. +.+.|||++..-
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998888543 3557788888899999 99999999999999998764 999999999854
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.6e-09 Score=94.70 Aligned_cols=110 Identities=19% Similarity=0.387 Sum_probs=85.5
Q ss_pred ccccceeccCCceEEEEEEccCCcEEEEEEEee-------------------------------ccCccceeEEEEEecc
Q 035895 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF-------------------------------SCSNEDFRALVLEYTT 435 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~-------------------------------~~~~~~~~~lv~ey~~ 435 (527)
.....+|.+...|+.|+|+++.. .+++|++.. .|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 44567889999999999999754 344444321 2444556678999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 035895 436 NGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 436 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~ 498 (527)
.|+|+.+++... ...+..+++++|.++|+|++|||.. .+-|..-.+.+..+++|++.+++|+
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence 999999998654 3468889999999999999999943 4445566899999999999988874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.9e-09 Score=114.71 Aligned_cols=113 Identities=24% Similarity=0.280 Sum_probs=91.1
Q ss_pred CccccceeccCCceEEEEEEccCCcEEEEEEEeecc--------------------------------CccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC--------------------------------SNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--------------------------------~~~~~~~lv~ey 433 (527)
+|...+.+|.+.|=+|.+|+.+.|. |+||++-... ..+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999999997 8899873210 012233566677
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
+.. +|++.+.. +..+...+..-|+-|+..|+.-+| ..+|+|+|||.+|||++.-.=+.++||.--+
T Consensus 103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccC
Confidence 754 88888753 345677777889999999999999 9999999999999999998889999997544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.4e-08 Score=96.60 Aligned_cols=73 Identities=27% Similarity=0.353 Sum_probs=56.6
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee--CCCC--cEEEeecc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL--DDNI--VAHLSDFG 501 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill--~~~~--~~kl~Dfg 501 (527)
..|+||.-.+. +|+.++.... .+...+.-+..|+.+|+.||| +++|.|||+|++|||+ |+|+ ...|+|||
T Consensus 317 tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 317 TLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred eEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 34678877664 8888886543 333345557889999999999 9999999999999999 4444 56799999
Q ss_pred ccc
Q 035895 502 IAK 504 (527)
Q Consensus 502 ~a~ 504 (527)
.+-
T Consensus 391 CcL 393 (598)
T KOG4158|consen 391 CCL 393 (598)
T ss_pred eee
Confidence 875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5e-09 Score=105.14 Aligned_cols=97 Identities=25% Similarity=0.419 Sum_probs=79.5
Q ss_pred ceeEEEEEeccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSS--NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGI 502 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~ 502 (527)
.+.+|.|++|...+|.+++... ....++...+.++.|++.|++| ++.+|||+||.||....+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3568999999999999999643 3346777788899999999998 6789999999999999998999999999
Q ss_pred ccccCCCC----CccceeccccccccccC
Q 035895 503 AKLLTGED----QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~----~~~~~~~~~~t~~y~aP 527 (527)
........ .....++.+||.+||+|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsP 431 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSP 431 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCH
Confidence 87765433 12234566799999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.1e-07 Score=87.33 Aligned_cols=114 Identities=18% Similarity=0.190 Sum_probs=84.9
Q ss_pred ceeccCCceEEEEEEccCCcEEEEEEEeec--------------------------------cCcc---ceeEEEEEecc
Q 035895 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFS--------------------------------CSNE---DFRALVLEYTT 435 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~--------------------------------~~~~---~~~~lv~ey~~ 435 (527)
+.|+.|.++.||+++..+|+.+++|..... .... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 578999999999999877788999975321 0111 24579999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG------------------------------------------- 472 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~------------------------------------------- 472 (527)
|+++.+.+.. ..++..+...++.++++++.++|..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888765421 2345666677778888888888731
Q ss_pred ----------CCCCeEecCCCCCCeeeCC--CCcEEEeeccccccc
Q 035895 473 ----------YSTPIIHCDLKPHNKLLDD--NIVAHLSDFGIAKLL 506 (527)
Q Consensus 473 ----------~~~~iiHrdlk~~nill~~--~~~~kl~Dfg~a~~~ 506 (527)
....+||+|++|.||+++. ++.+.+.||+.+..-
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 1356799999999999998 667899999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.6e-08 Score=111.93 Aligned_cols=261 Identities=23% Similarity=0.209 Sum_probs=148.2
Q ss_pred ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCC--CCcccChhHhhccccccEEEcccCccccccchhhcCCc
Q 035895 63 IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNP--LDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140 (527)
Q Consensus 63 ~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 140 (527)
..+...+-+|.+..+... ..++.|++|-+..|. +....++.|..+ +.|++|||++|.=-+.+|..++.+-
T Consensus 524 ~~rr~s~~~~~~~~~~~~-------~~~~~L~tLll~~n~~~l~~is~~ff~~m-~~LrVLDLs~~~~l~~LP~~I~~Li 595 (889)
T KOG4658|consen 524 SVRRMSLMNNKIEHIAGS-------SENPKLRTLLLQRNSDWLLEISGEFFRSL-PLLRVLDLSGNSSLSKLPSSIGELV 595 (889)
T ss_pred heeEEEEeccchhhccCC-------CCCCccceEEEeecchhhhhcCHHHHhhC-cceEEEECCCCCccCcCChHHhhhh
Confidence 356667777766654332 344578888888885 443333334444 4788888888776667888888888
Q ss_pred CCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCC--CCCCccccCCccCceee
Q 035895 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS--GSIPTCFGNLTALRNLH 218 (527)
Q Consensus 141 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~ 218 (527)
+|++|++++..++ .+|..+++|++|.+|++..+.-...+|.....+.+|++|.+-.-... ...-..+.++.+|+.+.
T Consensus 596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls 674 (889)
T KOG4658|consen 596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLS 674 (889)
T ss_pred hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhe
Confidence 8888888888887 56777888888888888877655455777777888888877654321 11222334455555555
Q ss_pred CCCCCCCCCchhhhCCCCcc----EEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhc------CCCCCEE
Q 035895 219 LDSNELTSIPSILWNLKDIL----YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQG------LKSLQFL 288 (527)
Q Consensus 219 L~~N~l~~lp~~~~~l~~L~----~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L 288 (527)
...... .+-..+..+..|. .+.+.. ......+..+..+.+|+.|.+.++.+.......... ++++..+
T Consensus 675 ~~~~s~-~~~e~l~~~~~L~~~~~~l~~~~-~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~ 752 (889)
T KOG4658|consen 675 ITISSV-LLLEDLLGMTRLRSLLQSLSIEG-CSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKV 752 (889)
T ss_pred eecchh-HhHhhhhhhHHHHHHhHhhhhcc-cccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHH
Confidence 533332 1111111111111 111111 111234456677788888888877775322222111 1122222
Q ss_pred EcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCe
Q 035895 289 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335 (527)
Q Consensus 289 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 335 (527)
...++... ..+.+..-.++|+.|.+..+...+.+....+.+..+..
T Consensus 753 ~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~ 798 (889)
T KOG4658|consen 753 SILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKE 798 (889)
T ss_pred Hhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhccc
Confidence 22222111 12222234578888888888766666666666655554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.8e-08 Score=109.94 Aligned_cols=203 Identities=19% Similarity=0.245 Sum_probs=126.6
Q ss_pred CCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCc--cccccchhhcCCcCCcEEEeecCcccccCcccccCCCC
Q 035895 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCN--ISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQK 165 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 165 (527)
.+....+...+-+|.+.. ++..... +.|+.|-+..|. +..+..+.|..++.|++|||++|.--+.+|..++.|-+
T Consensus 520 ~~~~~~rr~s~~~~~~~~-~~~~~~~--~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIEH-IAGSSEN--PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH 596 (889)
T ss_pred cchhheeEEEEeccchhh-ccCCCCC--CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence 344567777777777653 2333222 257788888875 55555666778888888888887766678888888888
Q ss_pred CCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCc---hhhhCCCCccEEEc
Q 035895 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP---SILWNLKDILYLDF 242 (527)
Q Consensus 166 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp---~~~~~l~~L~~l~l 242 (527)
|++|++++..++ .+|..+.++..|.+|++..+.-...+|.....|++|++|.+.......-. ..+.++.+|+.+..
T Consensus 597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 888888888887 77888888888888888887766666777777888888888776532211 22334444444443
Q ss_pred cCCcccccCCccccCCCCCC----EEEccCCCCCCCChhhhhcCCCCCEEEccccccee
Q 035895 243 WSNLFVGPLPSKIGNLKVLT----RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297 (527)
Q Consensus 243 ~~n~~~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 297 (527)
..... .+-..+..++.|. .+.+..+... ..+..+..+.+|+.|.+.++.+..
T Consensus 676 ~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 676 TISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred ecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 22211 0001112222222 2222222222 345567777888888888877753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.7e-07 Score=79.36 Aligned_cols=113 Identities=21% Similarity=0.250 Sum_probs=80.6
Q ss_pred ccceeccCCceEEEEEEccCCcEEEEEEEe-e------------------------------------ccCccceeEEEE
Q 035895 389 ANNLIGRGSFGSVYKARLQDGMEFAIKVFH-F------------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 389 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~-~------------------------------------~~~~~~~~~lv~ 431 (527)
....+-+|+=+.|+++.+. |+...||.-. . ...+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678899999999999875 5666666410 0 001122335899
Q ss_pred EeccC-CcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecccccc
Q 035895 432 EYTTN-GSLEKVLYSSNYI-LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN---IVAHLSDFGIAKL 505 (527)
Q Consensus 432 ey~~~-g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~---~~~kl~Dfg~a~~ 505 (527)
||++| .++.+++...-.. .+......++..|.+.++-|| ..+|||+||..+||++..+ ..+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4778877654222 222223578899999999999 9999999999999999644 3458999999864
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.1e-09 Score=110.82 Aligned_cols=180 Identities=27% Similarity=0.286 Sum_probs=114.2
Q ss_pred ChhHhhccccccEEEcccCccccccchhhcCC-cCCcEEEeecCcccc---cCc---cccc---CCCCCCEEeccCcccc
Q 035895 108 PRVVGNFSQSLEFIWMSDCNISGGISEEIGNL-TDLISIDLGGNKLNG---SIS---ITLG---KLQKLQFLSFRGNELE 177 (527)
Q Consensus 108 ~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~---~~~---~~~~---~l~~L~~L~l~~N~l~ 177 (527)
|-.+..+. +|++|.|+++.|.. ...+..+ ..|++|-. +|.+.. ++. ..+. ..-.|..-+.++|.+.
T Consensus 102 pi~ifpF~-sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFR-SLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV 177 (1096)
T ss_pred Cceecccc-ceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH
Confidence 33444443 78888888888864 1111111 12333322 222210 000 0111 1235677788888887
Q ss_pred cccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccC
Q 035895 178 GSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGN 257 (527)
Q Consensus 178 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~ 257 (527)
....++.-++.|+.|+|++|+++... .+..++.|++|||++|.++.+|..-..-..|..|.+.+|.++.. ..+.+
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeecccHHHhh--hhHHh
Confidence 56667888888889999999887543 67888889999999999888886332223477788888877643 33567
Q ss_pred CCCCCEEEccCCCCCCCCh-hhhhcCCCCCEEEcccccce
Q 035895 258 LKVLTRIDFSRNNLLGDIP-TTIQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 258 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 296 (527)
|++|+.||+++|-+++.-. ..+..|..|+.|+|.+|.+-
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8888888888888765322 22456677888888888764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.4e-09 Score=86.46 Aligned_cols=112 Identities=24% Similarity=0.261 Sum_probs=70.2
Q ss_pred ccEEEcccCcccccc--chhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeee
Q 035895 118 LEFIWMSDCNISGGI--SEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDL 195 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 195 (527)
+..++|++|.+-.+. +..+.....|+..+|++|.+...++..-...+.++.|++++|+|+ .+|..+..++.|+.|++
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 555666666554211 222334455666777777776544433344556777777777776 56666777777777777
Q ss_pred ecccCCCCCCccccCCccCceeeCCCCCCCCCchhh
Q 035895 196 RGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSIL 231 (527)
Q Consensus 196 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~ 231 (527)
+.|.+. ..|..+..|.+|-.|+..+|.+..+|-.+
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl 142 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDL 142 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHH
Confidence 777776 45555666777777777777777766543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-07 Score=97.34 Aligned_cols=85 Identities=34% Similarity=0.559 Sum_probs=75.6
Q ss_pred ccCccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EecCCCCCCeeeCCCCcEEEe
Q 035895 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI-IHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 420 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~i-iHrdlk~~nill~~~~~~kl~ 498 (527)
.+......+.|.+||..|+|.+.+......+++.-...++.+|+.|++|+| ..+| .|+.+++.|+++|....+|++
T Consensus 15 ~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s~nClvd~~w~lklt 91 (484)
T KOG1023|consen 15 ASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKSSNCLVDSRWVLKLT 91 (484)
T ss_pred eEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeeccccceeeeeEEEEec
Confidence 344456778999999999999999887778899989999999999999999 5555 999999999999999999999
Q ss_pred ecccccccC
Q 035895 499 DFGIAKLLT 507 (527)
Q Consensus 499 Dfg~a~~~~ 507 (527)
|||+.....
T Consensus 92 ~~Gl~~~~~ 100 (484)
T KOG1023|consen 92 DFGLNSLLE 100 (484)
T ss_pred hhhhccccc
Confidence 999988763
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.1e-07 Score=82.39 Aligned_cols=73 Identities=26% Similarity=0.351 Sum_probs=47.9
Q ss_pred EEEEEecc--CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 428 ALVLEYTT--NGSLEKVLYSSNYILDILQRLNIMIDVTSALEY-LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 428 ~lv~ey~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~y-lH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
++||||++ |..+..+.... ++......++.++...+.. +| ..+|||+|+.+.||+++++ .+.++|||-|.
T Consensus 82 ~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp EEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred EEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecCcce
Confidence 48999999 65554433221 1122344566777775555 57 8999999999999999987 99999999887
Q ss_pred ccC
Q 035895 505 LLT 507 (527)
Q Consensus 505 ~~~ 507 (527)
...
T Consensus 155 ~~~ 157 (188)
T PF01163_consen 155 DSS 157 (188)
T ss_dssp ETT
T ss_pred ecC
Confidence 654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.8e-07 Score=94.88 Aligned_cols=113 Identities=24% Similarity=0.247 Sum_probs=81.5
Q ss_pred ceeccCCceEEEEEEccCCcEEEEEEEeecc-------------------------------------------------
Q 035895 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSC------------------------------------------------- 421 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~------------------------------------------------- 421 (527)
+.|+.++-|+||+|++++|+.||||+.+...
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999964210
Q ss_pred -------------------------CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 035895 422 -------------------------SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476 (527)
Q Consensus 422 -------------------------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~ 476 (527)
.-.....++|||++|-.+.+...-.....+. ..++..++++ |+-+....+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHH--HHHHHHhcC
Confidence 0012335899999999998874333233442 2233333322 221112568
Q ss_pred eEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 477 iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
++|.|..|-||+++.+|++-.-|||+...+++
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887754
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.2e-09 Score=109.54 Aligned_cols=178 Identities=23% Similarity=0.231 Sum_probs=99.6
Q ss_pred cCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccc---cccchh---hc---CCcCCcEEEeecCcccccC
Q 035895 86 SMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNIS---GGISEE---IG---NLTDLISIDLGGNKLNGSI 156 (527)
Q Consensus 86 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~---~~~~~~---~~---~l~~L~~L~L~~N~l~~~~ 156 (527)
++..++.|++|.|.++.+... ..+..+...|+.|.- +|.++ .++... +. ....|.+.+.+.|.+. .+
T Consensus 104 ~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~m 179 (1096)
T KOG1859|consen 104 SIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LM 179 (1096)
T ss_pred eeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hH
Confidence 345678899999999988642 222223334555432 22221 001000 00 1124666677777765 45
Q ss_pred cccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCc-cccCCccCceeeCCCCCCCCCchhhhCCC
Q 035895 157 SITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLK 235 (527)
Q Consensus 157 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~lp~~~~~l~ 235 (527)
+.++.-++.|+.|+|++|++... ..+..++.|++|||+.|.+.. +|. ....+ .|+.|.+++|.++++- .+.+++
T Consensus 180 D~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~lrnN~l~tL~-gie~Lk 254 (1096)
T KOG1859|consen 180 DESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNLRNNALTTLR-GIENLK 254 (1096)
T ss_pred HHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhh-hheeeeecccHHHhhh-hHHhhh
Confidence 56666667777777777776633 256666777777777777763 333 22223 3777777777766652 345666
Q ss_pred CccEEEccCCcccccC-CccccCCCCCCEEEccCCCCC
Q 035895 236 DILYLDFWSNLFVGPL-PSKIGNLKVLTRIDFSRNNLL 272 (527)
Q Consensus 236 ~L~~l~l~~n~~~~~~-p~~~~~l~~L~~L~Ls~N~l~ 272 (527)
+|+.||++.|-+.+.- -..++.|..|+.|.|.+|.+-
T Consensus 255 sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 255 SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7777777776554321 112344556666777776653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.3e-06 Score=81.60 Aligned_cols=110 Identities=23% Similarity=0.257 Sum_probs=78.8
Q ss_pred cccceeccCCceEEEEEEccCCcEEEEEEEeec-----------------------------c----------C------
Q 035895 388 SANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-----------------------------C----------S------ 422 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-----------------------------~----------~------ 422 (527)
.+...||.|.=|.||.|..+.|.++|||.-+.. + .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 456899999999999999999999999963210 0 0
Q ss_pred ----ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 035895 423 ----NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 423 ----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~ 498 (527)
.-+..++||||++|-.|+..= ++....-.+...|.+-+.-+- ..||||+|+.+-||+++++|.+.+.
T Consensus 174 P~P~~~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 174 PKPIAWNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCccccccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCEEEE
Confidence 012346999999997776431 122223334444444444444 6789999999999999999999999
Q ss_pred eccccccc
Q 035895 499 DFGIAKLL 506 (527)
Q Consensus 499 Dfg~a~~~ 506 (527)
||-=+...
T Consensus 245 DwPQ~v~~ 252 (304)
T COG0478 245 DWPQAVPI 252 (304)
T ss_pred eCcccccC
Confidence 99766544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.38 E-value=9e-08 Score=102.25 Aligned_cols=141 Identities=26% Similarity=0.320 Sum_probs=101.5
Q ss_pred CCccccceeccCCceEEEEEEccC--CcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQD--GMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
..|...+.||+|+|+.|-.+.... ...+|+|.+.. .....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 446777889999999997765432 23344443211 01123456789
Q ss_pred EEeccCCcHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCC
Q 035895 431 LEYTTNGSLEKVL-YSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTG 508 (527)
Q Consensus 431 ~ey~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~ 508 (527)
+||..||++...+ .......+......+..|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999888 4332134444566788999999999994 67899999999999999998 999999999988765
Q ss_pred -CCCccceecccc-ccccccC
Q 035895 509 -EDQSMTQTQTLA-IIGYMAP 527 (527)
Q Consensus 509 -~~~~~~~~~~~~-t~~y~aP 527 (527)
..........+| ++.|+||
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~ 198 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAP 198 (601)
T ss_pred cCCcceeeecccCCCCCCCCc
Confidence 332233334567 8889997
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.4e-06 Score=78.31 Aligned_cols=79 Identities=25% Similarity=0.273 Sum_probs=65.9
Q ss_pred ceeEEEEEeccCC-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeec
Q 035895 425 DFRALVLEYTTNG-SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI---VAHLSDF 500 (527)
Q Consensus 425 ~~~~lv~ey~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~---~~kl~Df 500 (527)
...++|||++++. +|.+++..... .+......++.++++.++-|| ..+|+|+|+++.|||++.+. .+.+.||
T Consensus 90 ~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDl 165 (206)
T PF06293_consen 90 YRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDL 165 (206)
T ss_pred eeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcc
Confidence 4557999999984 89998865322 455567789999999999999 99999999999999998776 8899999
Q ss_pred ccccccC
Q 035895 501 GIAKLLT 507 (527)
Q Consensus 501 g~a~~~~ 507 (527)
+-++...
T Consensus 166 d~~~~~~ 172 (206)
T PF06293_consen 166 DRMRFRP 172 (206)
T ss_pred hhceeCC
Confidence 9887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=2e-06 Score=82.63 Aligned_cols=77 Identities=18% Similarity=0.104 Sum_probs=63.0
Q ss_pred eeEEEEEeccCC-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-------CCcEE
Q 035895 426 FRALVLEYTTNG-SLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-------NIVAH 496 (527)
Q Consensus 426 ~~~lv~ey~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-------~~~~k 496 (527)
..++|||++++. +|.+++... ....+......++.+++..+.-|| ..+|+|+|+++.|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 467999999986 899887532 223345566688999999999999 999999999999999975 47899
Q ss_pred Eeecccccc
Q 035895 497 LSDFGIAKL 505 (527)
Q Consensus 497 l~Dfg~a~~ 505 (527)
++||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998854
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=3e-06 Score=88.03 Aligned_cols=113 Identities=25% Similarity=0.323 Sum_probs=79.9
Q ss_pred ceeccCCceEEEEEEccCCcEEEEEEEeecc-------------------------------------------------
Q 035895 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSC------------------------------------------------- 421 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~------------------------------------------------- 421 (527)
+.||.-+.|.||+|++++|+.||||+-|...
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999854200
Q ss_pred -------------------------CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 035895 422 -------------------------SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476 (527)
Q Consensus 422 -------------------------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~ 476 (527)
.-...+.++||||+|..+.+.-.-.+...+.. .++..+.++ |++.....|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~--~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEA--YLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHH--HHHHHHhcC
Confidence 00113459999999988776533222334443 333333333 333223678
Q ss_pred eEecCCCCCCeeeCC----CCcEEEeecccccccCC
Q 035895 477 IIHCDLKPHNKLLDD----NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 477 iiHrdlk~~nill~~----~~~~kl~Dfg~a~~~~~ 508 (527)
++|.|=.|-||++.. ++++.+-|||+.+.++.
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999887653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.4e-08 Score=80.61 Aligned_cols=106 Identities=25% Similarity=0.306 Sum_probs=70.2
Q ss_pred cCCcEEEeecCccccc--CcccccCCCCCCEEeccCcccccccChhhhc-CcccCeeeeecccCCCCCCccccCCccCce
Q 035895 140 TDLISIDLGGNKLNGS--ISITLGKLQKLQFLSFRGNELEGSIPNVLCH-LAVLFQLDLRGNKLSGSIPTCFGNLTALRN 216 (527)
Q Consensus 140 ~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 216 (527)
..+..+||+.+++..+ .+..+.+...|+..+|++|.+. .+|+.|.. .+.++.|+|++|.|+ .+|..+..++.|+.
T Consensus 27 kE~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 27 KELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HHhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3466777777776521 1223445566667788888887 45555543 457778888888887 46666888888888
Q ss_pred eeCCCCCCCCCchhhhCCCCccEEEccCCcc
Q 035895 217 LHLDSNELTSIPSILWNLKDILYLDFWSNLF 247 (527)
Q Consensus 217 L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~ 247 (527)
|+++.|.+...|..+..+.++-+|+..+|.+
T Consensus 105 lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 105 LNLRFNPLNAEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred cccccCccccchHHHHHHHhHHHhcCCCCcc
Confidence 8888888877777666666665555555544
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.2e-06 Score=81.93 Aligned_cols=187 Identities=21% Similarity=0.248 Sum_probs=85.2
Q ss_pred ccccEEEcccCcccc--ccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCccccc-ccChhhhcCcccCe
Q 035895 116 QSLEFIWMSDCNISG--GISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG-SIPNVLCHLAVLFQ 192 (527)
Q Consensus 116 ~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~ 192 (527)
+.++.+||.+|.|+. .+...+.+||.|++|+|+.|.+...+...-..+.+|+.|-|.+..+.- .....+..++.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 345555555555542 223334556666666666666654332221344556666665555431 11223344555555
Q ss_pred eeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCC---CCccEEEccCCcccccCCccccCCCCCCEEEccCC
Q 035895 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNL---KDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRN 269 (527)
Q Consensus 193 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l---~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N 269 (527)
|.+|.|.+. .++++.|.+....+....+ +.+..+-.+-|++.. -.+++..+.+..|
T Consensus 151 lHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r-------~Fpnv~sv~v~e~ 209 (418)
T KOG2982|consen 151 LHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR-------IFPNVNSVFVCEG 209 (418)
T ss_pred hhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHh-------hcccchheeeecC
Confidence 555554322 1222222222211111000 000011111111111 1234455555555
Q ss_pred CCCCC-ChhhhhcCCCCCEEEccccccee-ecCCCCCCCCCCCEEeCCCCcccccC
Q 035895 270 NLLGD-IPTTIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEII 323 (527)
Q Consensus 270 ~l~~~-~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~ 323 (527)
.+... ....+..++.+.-|+|+.|+|.. ..-+.+.++++|..|.+++|++.+..
T Consensus 210 PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l 265 (418)
T KOG2982|consen 210 PLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPL 265 (418)
T ss_pred cccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccc
Confidence 44322 12344555666677777777642 12235566777778888888776543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.6e-07 Score=84.15 Aligned_cols=83 Identities=17% Similarity=0.259 Sum_probs=37.9
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccc-cchhhcCCcCC
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGG-ISEEIGNLTDL 142 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~-~~~~~~~l~~L 142 (527)
++++||..|.|+.-.... .-+.++|.|++|+|+.|++...+....... .+|++|-|.+..+.-. ....+..+|.+
T Consensus 73 v~elDL~~N~iSdWseI~---~ile~lP~l~~LNls~N~L~s~I~~lp~p~-~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 73 VKELDLTGNLISDWSEIG---AILEQLPALTTLNLSCNSLSSDIKSLPLPL-KNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred hhhhhcccchhccHHHHH---HHHhcCccceEeeccCCcCCCccccCcccc-cceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 455666666665321110 113455666666666666553322111111 2455555555544311 12333445555
Q ss_pred cEEEeecC
Q 035895 143 ISIDLGGN 150 (527)
Q Consensus 143 ~~L~L~~N 150 (527)
++|+++.|
T Consensus 149 telHmS~N 156 (418)
T KOG2982|consen 149 TELHMSDN 156 (418)
T ss_pred hhhhhccc
Confidence 55555555
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3e-07 Score=85.97 Aligned_cols=221 Identities=19% Similarity=0.252 Sum_probs=128.7
Q ss_pred CCCEEEcccCCCCcccChhHhhcc-ccccEEEcccCccccc-cchhhcC-CcCCcEEEeecCcccc-cCcccccCCCCCC
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFS-QSLEFIWMSDCNISGG-ISEEIGN-LTDLISIDLGGNKLNG-SISITLGKLQKLQ 167 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~-~~L~~L~Ls~n~l~~~-~~~~~~~-l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~ 167 (527)
.-+.||+.+-.|. |.+...+. +...++.+.+--+... +.+.+.. -+.|++|||++..|+. .+-..+..+.+|+
T Consensus 137 lW~~lDl~~r~i~---p~~l~~l~~rgV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~stl~~iLs~C~kLk 213 (419)
T KOG2120|consen 137 LWQTLDLTGRNIH---PDVLGRLLSRGVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVSTLHGILSQCSKLK 213 (419)
T ss_pred ceeeeccCCCccC---hhHHHHHHhCCeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHHHHHHHHHHHhhh
Confidence 3467788776664 44444332 2344455543333321 1222222 2358888888888763 2233455678888
Q ss_pred EEeccCcccccccChhhhcCcccCeeeeeccc-CCCC-CCccccCCccCceeeCCCCCCCC--CchhhhC-CCCccEEEc
Q 035895 168 FLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK-LSGS-IPTCFGNLTALRNLHLDSNELTS--IPSILWN-LKDILYLDF 242 (527)
Q Consensus 168 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~-~p~~~~~l~~L~~L~L~~N~l~~--lp~~~~~-l~~L~~l~l 242 (527)
.|.+.++++...+-..+..-..|+.|+++.+. ++.. ..--|.+++.|..|+++.+.+.. +...+.. -.+|..|++
T Consensus 214 ~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNl 293 (419)
T KOG2120|consen 214 NLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAHISETLTQLNL 293 (419)
T ss_pred hccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHHhhhchhhhhhhh
Confidence 88888888887777777777888888888753 2211 01125678888888888887764 2222222 234566666
Q ss_pred cCCccc---ccCCccccCCCCCCEEEccCCCCC-CCChhhhhcCCCCCEEEcccccceeecCCC---CCCCCCCCEEeCC
Q 035895 243 WSNLFV---GPLPSKIGNLKVLTRIDFSRNNLL-GDIPTTIQGLKSLQFLSLGHNRLQGSIPNS---FDDLVSLESLDLS 315 (527)
Q Consensus 243 ~~n~~~---~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~ls 315 (527)
++..-. ..+..-...+++|.+||||+|... ...-..|..++.|++|.++.+.. .+|.. |...++|.+||+-
T Consensus 294 sG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~ 371 (419)
T KOG2120|consen 294 SGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVF 371 (419)
T ss_pred hhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEec
Confidence 654321 111122345678888888876532 22233466777788888777764 45553 4556777777765
Q ss_pred CC
Q 035895 316 NN 317 (527)
Q Consensus 316 ~N 317 (527)
+.
T Consensus 372 g~ 373 (419)
T KOG2120|consen 372 GC 373 (419)
T ss_pred cc
Confidence 43
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.3e-06 Score=56.15 Aligned_cols=39 Identities=33% Similarity=0.579 Sum_probs=19.3
Q ss_pred ccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCc
Q 035895 189 VLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP 228 (527)
Q Consensus 189 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp 228 (527)
+|++|++++|+|+. +|..+++|++|++|++++|+++.+|
T Consensus 2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~~i~ 40 (44)
T PF12799_consen 2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPISDIS 40 (44)
T ss_dssp T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCSBEG
T ss_pred cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCCCCc
Confidence 45555555555553 3334555555555555555555443
|
... |
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.3e-05 Score=78.60 Aligned_cols=119 Identities=17% Similarity=0.306 Sum_probs=65.3
Q ss_pred CCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecC-cccccCcccccCCCCC
Q 035895 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGN-KLNGSISITLGKLQKL 166 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L 166 (527)
..+++++.|++++|.++.+ | .++.+|+.|.+++|.--..+|+.+. ++|++|++++| .+. .+| .+|
T Consensus 49 ~~~~~l~~L~Is~c~L~sL-P----~LP~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~-sLP------~sL 114 (426)
T PRK15386 49 EEARASGRLYIKDCDIESL-P----VLPNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEIS-GLP------ESV 114 (426)
T ss_pred HHhcCCCEEEeCCCCCccc-C----CCCCCCcEEEccCCCCcccCCchhh--hhhhheEccCccccc-ccc------ccc
Confidence 3457788888888877753 4 2455788888877544345555442 46777888777 443 233 246
Q ss_pred CEEeccCcccc--cccChhhhcCcccCeeeeeccc-CCC-CCCccccCC-ccCceeeCCCCCCCCCch
Q 035895 167 QFLSFRGNELE--GSIPNVLCHLAVLFQLDLRGNK-LSG-SIPTCFGNL-TALRNLHLDSNELTSIPS 229 (527)
Q Consensus 167 ~~L~l~~N~l~--~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l-~~L~~L~L~~N~l~~lp~ 229 (527)
+.|+++.+... +.+|. +|+.|.+.+++ ... ..|. .+ ++|++|++++|....+|.
T Consensus 115 e~L~L~~n~~~~L~~LPs------sLk~L~I~~~n~~~~~~lp~---~LPsSLk~L~Is~c~~i~LP~ 173 (426)
T PRK15386 115 RSLEIKGSATDSIKNVPN------GLTSLSINSYNPENQARIDN---LISPSLKTLSLTGCSNIILPE 173 (426)
T ss_pred ceEEeCCCCCcccccCcc------hHhheecccccccccccccc---ccCCcccEEEecCCCcccCcc
Confidence 66666655432 12333 34455553322 110 0111 12 467777777766555443
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.9e-05 Score=70.20 Aligned_cols=121 Identities=21% Similarity=0.261 Sum_probs=79.5
Q ss_pred CCEEEcccccc-----ccccccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccE
Q 035895 46 LKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120 (527)
Q Consensus 46 L~~L~Ls~N~~-----~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~ 120 (527)
-+.+||-+.++ .|..-..++.+||++|.+..+ +.|..++.|.+|.|++|.|+.+-|. +..+.++|+.
T Consensus 21 e~e~~LR~lkip~ienlg~~~d~~d~iDLtdNdl~~l-------~~lp~l~rL~tLll~nNrIt~I~p~-L~~~~p~l~~ 92 (233)
T KOG1644|consen 21 ERELDLRGLKIPVIENLGATLDQFDAIDLTDNDLRKL-------DNLPHLPRLHTLLLNNNRITRIDPD-LDTFLPNLKT 92 (233)
T ss_pred ccccccccccccchhhccccccccceecccccchhhc-------ccCCCccccceEEecCCcceeeccc-hhhhccccce
Confidence 45555555543 233334567888999987654 2467888899999999999876554 4445567888
Q ss_pred EEcccCcccccc-chhhcCCcCCcEEEeecCcccccC---cccccCCCCCCEEeccCc
Q 035895 121 IWMSDCNISGGI-SEEIGNLTDLISIDLGGNKLNGSI---SITLGKLQKLQFLSFRGN 174 (527)
Q Consensus 121 L~Ls~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~l~~N 174 (527)
|.|.+|+|...- -.-+..++.|++|.+-+|.++..- -..+..+++|+.||++.-
T Consensus 93 L~LtnNsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 93 LILTNNSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred EEecCcchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhhh
Confidence 888888887321 233566777888888777776322 123556777777777643
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.5e-06 Score=56.04 Aligned_cols=36 Identities=31% Similarity=0.582 Sum_probs=17.6
Q ss_pred CCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccce
Q 035895 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 260 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 296 (527)
+|++|++++|+++ .+|..+++|++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555554 23444555555555555555554
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5e-06 Score=85.41 Aligned_cols=119 Identities=28% Similarity=0.381 Sum_probs=93.2
Q ss_pred hcCCccccceeccCCceEEEEEEcc--CCcEEEEEEEee--------------------------------ccCccceeE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ--DGMEFAIKVFHF--------------------------------SCSNEDFRA 428 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~--------------------------------~~~~~~~~~ 428 (527)
...+|.....||.|.|+.||....+ ++..+++|.+.. .....+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567888999999999999998754 577888885421 111223456
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-IVAHLSDFGIAKL 505 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-~~~kl~Dfg~a~~ 505 (527)
+--|||++++.+..+. -...++...++.+..+++.++.++| ++.++|+|+||+||++..+ +..+++|||.+..
T Consensus 343 ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence 7889999998876552 2234677778888999999999999 9999999999999999875 7888999999863
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 527 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-20 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-20 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-14 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 6e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 7e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 8e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-09 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 3e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-05 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 6e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-04 | ||
| 4fcg_A | 328 | Structure Of The Leucine-Rich Repeat Domain Of The | 4e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FCG|A Chain A, Structure Of The Leucine-Rich Repeat Domain Of The Type Iii Effector Xcv3220 (Xopl) Length = 328 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 527 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-74 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-67 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-67 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-66 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-62 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-57 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-55 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-50 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-41 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-28 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-25 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-23 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-66 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-65 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-60 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-50 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-39 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 9e-31 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-50 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-46 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-44 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-44 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-40 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-48 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-48 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-47 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-43 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-38 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-33 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-29 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-22 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-42 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-41 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-39 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-38 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-36 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-29 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-28 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-26 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-18 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-10 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-42 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-39 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-36 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-35 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-35 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-40 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-40 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-34 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-32 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-31 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-41 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-39 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-39 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-07 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-32 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-28 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-17 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-36 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-35 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-30 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-30 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-30 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-30 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-27 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-23 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-33 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-11 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-33 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-33 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-29 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-29 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-16 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-24 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 8e-08 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-32 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-30 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-23 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-18 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-07 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-30 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-29 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-24 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-26 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-23 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-17 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-29 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-29 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-23 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-29 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-28 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-28 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-27 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-17 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-29 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-23 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-09 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-24 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-23 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-16 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-13 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 9e-28 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-27 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-26 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-20 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-20 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-13 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-25 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-23 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-11 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-26 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-26 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-17 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-13 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-26 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-24 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-20 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-04 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-23 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-16 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 8e-25 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-25 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-24 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-21 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-16 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-10 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-10 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-18 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-22 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-22 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-18 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-18 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-07 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-21 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-21 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-09 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-04 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-21 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-19 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-11 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-04 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 9e-21 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-20 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-20 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-20 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 5e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-17 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 7e-11 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-11 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-07 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-19 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-19 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-19 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-11 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 9e-09 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-08 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-19 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-18 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-18 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-07 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-08 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-12 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-18 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-17 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-17 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-17 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-13 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-17 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-17 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-11 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-07 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-16 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-15 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-15 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-15 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-15 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-15 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-15 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-15 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 8e-15 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-15 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-14 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-14 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-14 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-14 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-07 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-14 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 6e-14 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-14 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-14 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 7e-14 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-13 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-13 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 8e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-13 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-06 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-13 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-07 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-13 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-13 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-13 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-13 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-13 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-13 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-13 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-13 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-13 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-13 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-13 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-13 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-13 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-13 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-13 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-13 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-13 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-13 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 8e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-12 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-12 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-12 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-10 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-12 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-12 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-12 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 9e-09 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-12 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-12 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-12 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-12 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 6e-12 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-12 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-05 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-12 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-12 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-12 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-12 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-11 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-11 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-11 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-06 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-11 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-11 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-11 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-08 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-11 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-11 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-11 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 7e-11 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-11 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 9e-11 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-10 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-10 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-10 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-10 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-10 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-10 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-10 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-10 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-05 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-10 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-10 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-10 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-10 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-10 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-10 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-10 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-10 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-10 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 9e-10 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-09 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-09 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-09 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-09 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-09 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-04 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-09 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-09 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-05 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 6e-09 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-09 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-09 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-09 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 8e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 9e-09 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-08 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-08 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-08 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-08 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-08 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-08 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-08 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-08 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-08 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-08 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-05 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-08 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-08 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-08 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-05 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 7e-08 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 8e-08 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 8e-08 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 8e-08 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-07 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-07 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-07 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-07 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-07 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-07 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-07 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-07 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-07 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-07 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-07 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-07 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-07 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 6e-07 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-07 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 7e-07 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-06 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-06 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-05 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 6e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-06 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-05 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-06 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-06 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-06 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-06 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 6e-06 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 6e-06 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 8e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-05 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-05 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-05 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-05 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-05 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-05 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-05 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 1e-04 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-04 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 7e-74
Identities = 89/319 (27%), Positives = 131/319 (41%), Gaps = 21/319 (6%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
N G + T+ N S L + NY LG LS + D L L N L P
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD-LKLWLNMLEGEIP- 459
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
+ K L+ L + N L G +P + N + +L +I +S+ ++G I + IG L
Sbjct: 460 ----QELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLE 514
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
+L + L N +G+I LG + L +L N G+IP + + N +
Sbjct: 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFI 570
Query: 201 SGSIPTCFGNLTALRNLHLDSNELT---SIPSILWNLKDILYLDFWSNLFVGPLPSKIGN 257
+G N + H N L L L + S ++ G N
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317
+ +D S N L G IP I + L L+LGHN + GSIP+ DL L LDLS+N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 318 NLSEIIPLSLEKLLYLNIL 336
L IP ++ L L +
Sbjct: 691 KLDGRIPQAMSALTMLTEI 709
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-67
Identities = 87/321 (27%), Positives = 142/321 (44%), Gaps = 21/321 (6%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-------LGRLSSIVDELSLSDNYLTSSTPE 80
S N + + + S L+ D+ N + + + + L++S N P
Sbjct: 208 SSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELK-LLNISSNQFVGPIPP 265
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
K L+ L ++ N G +P + +L + +S + G + G+ +
Sbjct: 266 -------LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318
Query: 141 DLISIDLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSIPNVLCHLAV-LFQLDLRGN 198
L S+ L N +G + + TL K++ L+ L NE G +P L +L+ L LDL N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 199 KLSGSIPTCFGN--LTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKI 255
SG I L+ L+L +N T IP L N +++ L N G +PS +
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 256 GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315
G+L L + N L G+IP + +K+L+ L L N L G IP+ + +L + LS
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 316 NNNLSEIIPLSLEKLLYLNIL 336
NN L+ IP + +L L IL
Sbjct: 499 NNRLTGEIPKWIGRLENLAIL 519
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-67
Identities = 94/321 (29%), Positives = 144/321 (44%), Gaps = 23/321 (7%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY------VLGRLSSIVDELSLSDNYLTSSTPEL 81
S NK+ G + + L+ DV +N LG S++ L +S N L+
Sbjct: 186 SGNKISG--DVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQ-HLDISGNKLSGDFS-- 240
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI-GNLT 140
++S C LK L+IS N G +P SL+++ +++ +G I + + G
Sbjct: 241 ---RAISTCTELKLLNISSNQFVGPIPP--LPLK-SLQYLSLAENKFTGEIPDFLSGACD 294
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGNK 199
L +DL GN G++ G L+ L+ N G +P + L + L LDL N+
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 200 LSGSIPTCFGNLTA-LRNLHLDSNELT-SIPSILWN--LKDILYLDFWSNLFVGPLPSKI 255
SG +P NL+A L L L SN + I L + L +N F G +P +
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 256 GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315
N L + S N L G IP+++ L L+ L L N L+G IP + +LE+L L
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 316 NNNLSEIIPLSLEKLLYLNIL 336
N+L+ IP L LN +
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWI 495
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-66
Identities = 91/330 (27%), Positives = 139/330 (42%), Gaps = 20/330 (6%)
Query: 28 SQNKLVGIVSITIF-NLSTLKVFDVDNNYV-------LGRLSSIVDELSLSDNYLTSSTP 79
++NK G + + TL D+ N+ G S + L+LS N + P
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE-SLALSSNNFSGELP 335
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGN- 138
++ + LK LD+S N G LP + N S SL + +S N SG I +
Sbjct: 336 M----DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391
Query: 139 -LTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
L + L N G I TL +L L N L G+IP+ L L+ L L L
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIG 256
N L G IP + L L LD N+LT IPS L N ++ ++ +N G +P IG
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 257 NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
L+ L + S N+ G+IP + +SL +L L N G+IP + S ++
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAA 567
Query: 317 NNLSEIIPLSLEKLLYLNILLIVVVILALK 346
N ++ + ++ +L +
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-62
Identities = 83/324 (25%), Positives = 138/324 (42%), Gaps = 23/324 (7%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY--------VLGRLSSIVDELSLSDNYLTSSTP 79
S N G V + S L+ + +N L ++ + L LS N + P
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK-VLDLSFNEFSGELP 360
Query: 80 ELSFLSSMSNCKY-LKKLDISRNPLDGFLPRVVGNFS-QSLEFIWMSDCNISGGISEEIG 137
S++N L LD+S N G + + +L+ +++ + +G I +
Sbjct: 361 -----ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
N ++L+S+ L N L+G+I +LG L KL+ L N LEG IP L ++ L L L
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIG 256
N L+G IP+ N T L + L +N LT IP + L+++ L +N F G +P+++G
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 257 NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
+ + L +D + N G IP + + N + G + + +
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAG 591
Query: 317 N--NLSEIIPLSLEKLLYLNILLI 338
N I L +L N I
Sbjct: 592 NLLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 1e-57
Identities = 86/323 (26%), Positives = 135/323 (41%), Gaps = 26/323 (8%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV---------LGRLSSIVDELSLSDNYLTSST 78
S + + G VS ++L D+ N + LG S + L++S N L
Sbjct: 85 SNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK-FLNVSSNTLDFPG 142
Query: 79 PELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS--QSLEFIWMSDCNISGGISEEI 136
+S L+ LD+S N + G L+ + +S ISG + +
Sbjct: 143 K----VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--V 196
Query: 137 GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196
+L +D+ N + I LG LQ L GN+L G + L L++
Sbjct: 197 SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSNELT-SIP-SILWNLKDILYLDFWSNLFVGPLPSK 254
N+ G IP L +L+ L L N+ T IP + + LD N F G +P
Sbjct: 256 SNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313
Query: 255 IGNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDL-VSLESL 312
G+ +L + S NN G++P T+ ++ L+ L L N G +P S +L SL +L
Sbjct: 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373
Query: 313 DLSNNNLSEIIPLSLEKLLYLNI 335
DLS+NN S I +L + +
Sbjct: 374 DLSSNNFSGPILPNLCQNPKNTL 396
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 6e-55
Identities = 72/281 (25%), Positives = 119/281 (42%), Gaps = 17/281 (6%)
Query: 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWM 123
V + LS L +S SS+ + L+ L +S + ++G + + SL + +
Sbjct: 52 VTSIDLSSKPLNVGFSAVS--SSLLSLTGLESLFLSNSHINGSVSGF-KCSA-SLTSLDL 107
Query: 124 SDCNISGGISE--EIGNLTDLISIDLGGNKLNGSISITLG-KLQKLQFLSFRGNELEGSI 180
S ++SG ++ +G+ + L +++ N L+ ++ G KL L+ L N + G+
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 181 PNVLC---HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKD 236
L L + GNK+SG + L L + SN + IP + +
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFL-GDCSA 224
Query: 237 ILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296
+ +LD N G I L ++ S N +G IP LKSLQ+LSL N+
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFT 282
Query: 297 GSIPNS-FDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
G IP+ +L LDLS N+ +P L L
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-50
Identities = 76/305 (24%), Positives = 124/305 (40%), Gaps = 37/305 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
S N L G + ++ +LS L+ + N L + ++ L L N LT P
Sbjct: 426 SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE-TLILDFNDLTGEIP- 483
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
S +SNC L + +S N L G +P+ +G +L + +S+ + SG I E+G+
Sbjct: 484 ----SGLSNCTNLNWISLSNNRLTGEIPKWIGRLE-NLAILKLSNNSFSGNIPAELGDCR 538
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQ----------------------FLSFRGNELEG 178
LI +DL N NG+I + K + E +G
Sbjct: 539 SLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG 598
Query: 179 SIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDI 237
L L+ ++ G F N ++ L + N L+ IP + ++ +
Sbjct: 599 IRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL 658
Query: 238 LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
L+ N G +P ++G+L+ L +D S N L G IP + L L + L +N L G
Sbjct: 659 FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718
Query: 298 SIPNS 302
IP
Sbjct: 719 PIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-41
Identities = 70/263 (26%), Positives = 112/263 (42%), Gaps = 21/263 (7%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-------LGRLSSIVDELSLSDNYLTSSTPE 80
N L G + + N + L + NN + +GRL ++ L LS+N + + P
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA-ILKLSNNSFSGNIP- 531
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
+ + +C+ L LD++ N +G +P + S ++ I+G I N
Sbjct: 532 ----AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK-----IAANFIAGKRYVYIKNDG 582
Query: 141 DLISIDLGGN--KLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198
GN + G S L +L + G + + LD+ N
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642
Query: 199 KLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKIGN 257
LSG IP G++ L L+L N+++ SIP + +L+ + LD SN G +P +
Sbjct: 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQ 280
L +LT ID S NNL G IP Q
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEMGQ 725
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 12/184 (6%)
Query: 161 GKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLD 220
K+ + S N ++ + L L L L L + ++GS+ F +L +L L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 221 SNELT-SIPSI--LWNLKDILYLDFWSNLFVGPLP-SKIGNLKVLTRIDFSRNNLLGDIP 276
N L+ + ++ L + + +L+ SN P S L L +D S N++ G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 277 TTIQ---GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL--SLEKLL 331
G L+ L++ N++ G + V+LE LD+S+NN S IP L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQ 226
Query: 332 YLNI 335
+L+I
Sbjct: 227 HLDI 230
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-25
Identities = 36/163 (22%), Positives = 67/163 (41%), Gaps = 10/163 (6%)
Query: 183 VLCHLAVLFQLDLRGNKLS---GSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILY 239
V C + +DL L+ ++ + +LT L +L L ++ + S +
Sbjct: 45 VTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTS 104
Query: 240 LDFWSNLFVGPLPSK--IGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQ 296
LD N GP+ + +G+ L ++ S N L + L SL+ L L N +
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 297 GSIPNSFDD---LVSLESLDLSNNNLSEIIPLS-LEKLLYLNI 335
G+ + L+ L +S N +S + +S L +L++
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDV 207
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-23
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 26/211 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELS--LSDNYLTSSTPEL---- 81
S N G + + + +L D++ N G + + + + S ++ N++
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND 581
Query: 82 -----------------SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMS 124
++ +I+ G N S+ F+ MS
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG-SMMFLDMS 640
Query: 125 DCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVL 184
+SG I +EIG++ L ++LG N ++GSI +G L+ L L N+L+G IP +
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 185 CHLAVLFQLDLRGNKLSGSIPTC--FGNLTA 213
L +L ++DL N LSG IP F
Sbjct: 701 SALTMLTEIDLSNNNLSGPIPEMGQFETFPP 731
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-66
Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 13/270 (4%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDG--FLPRVVGNFSQS 117
LSS + + + + + LD+S L +P + N
Sbjct: 24 LSSWLPTTDCCNRTWLGVLC-----DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-Y 77
Query: 118 LEFIWMSDCN-ISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNEL 176
L F+++ N + G I I LT L + + ++G+I L +++ L L F N L
Sbjct: 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137
Query: 177 EGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTAL-RNLHLDSNELT-SIPSILWNL 234
G++P + L L + GN++SG+IP +G+ + L ++ + N LT IP NL
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197
Query: 235 KDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR 294
+ ++D N+ G G+ K +I ++N+L D+ + K+L L L +NR
Sbjct: 198 N-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255
Query: 295 LQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324
+ G++P L L SL++S NNL IP
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 213 bits (546), Expect = 2e-65
Identities = 69/265 (26%), Positives = 106/265 (40%), Gaps = 12/265 (4%)
Query: 81 LSFLSSMSNCKYL----KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISG--GISE 134
L + N L D G L + + + +S N+ I
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70
Query: 135 EIGNLTDLISIDLGG-NKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQL 193
+ NL L + +GG N L G I + KL +L +L + G+IP+ L + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 194 DLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDIL-YLDFWSNLFVGPL 251
D N LSG++P +L L + D N ++ +IP + + + N G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311
P NL L +D SRN L GD K+ Q + L N L + +L
Sbjct: 191 PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 312 LDLSNNNLSEIIPLSLEKLLYLNIL 336
LDL NN + +P L +L +L+ L
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSL 273
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-60
Identities = 72/258 (27%), Positives = 120/258 (46%), Gaps = 10/258 (3%)
Query: 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDIS-RNPLDGFLPRVVGNFSQSLEFIW 122
V+ L LS L P SS++N YL L I N L G +P + +Q L +++
Sbjct: 52 VNNLDLSGLNLPKPYP---IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLY 107
Query: 123 MSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPN 182
++ N+SG I + + + L+++D N L+G++ ++ L L ++F GN + G+IP+
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 183 VLCHLAVLFQ-LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYL 240
+ LF + + N+L+G IP F NL L + L N L + + K+ +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 241 DFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300
N L +G K L +D N + G +P + LK L L++ N L G IP
Sbjct: 227 HLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 301 NSFDDLVSLESLDLSNNN 318
+L + +NN
Sbjct: 286 QGG-NLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 67/285 (23%), Positives = 113/285 (39%), Gaps = 22/285 (7%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV---------LGRLSSIVDELSLSD-NYLTSS 77
+G++ T + D+ + L L + L + N L
Sbjct: 34 CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN-FLYIGGINNLVGP 92
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIG 137
P +++ L L I+ + G +P + L + S +SG + I
Sbjct: 93 IP-----PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT-LVTLDFSYNALSGTLPPSIS 146
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKL-QFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196
+L +L+ I GN+++G+I + G KL ++ N L G IP +L L +DL
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSNLFVGPLPSKI 255
N L G FG+ + +HL N L + + K++ LD +N G LP +
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 256 GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300
LK L ++ S NNL G+IP L+ + +N+ P
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-39
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 29/229 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
+ + G + + + TL L S N L+ + P S+
Sbjct: 109 THTNVSGAIPDFLSQIKTLVT------------------LDFSYNALSGTLP-----PSI 145
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDL 147
S+ L + N + G +P G+FS+ + +S ++G I NL +L +DL
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDL 204
Query: 148 GGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTC 207
N L G S+ G + Q + N L + + L LDLR N++ G++P
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263
Query: 208 FGNLTALRNLHLDSNELT-SIPSILWNLKDILYLDFWSN--LFVGPLPS 253
L L +L++ N L IP NL+ + +N L PLP+
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 41/149 (27%), Positives = 59/149 (39%), Gaps = 4/149 (2%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT---SIPSILWNLKDILYLDFWS-NLFV 248
D G + + NL L L IPS L NL + +L N V
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 249 GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS 308
GP+P I L L + + N+ G IP + +K+L L +N L G++P S L +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 309 LESLDLSNNNLSEIIPLSLEKLLYLNILL 337
L + N +S IP S L +
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSM 179
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-50
Identities = 63/314 (20%), Positives = 113/314 (35%), Gaps = 28/314 (8%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNN-------YVLGRLSSIVDELSLSDNYLTSSTPE 80
S L I + L L+ ++++N + L ++ LSLS+++ + T
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK-YLSLSNSFTSLRTLT 371
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGIS-EEIGNL 139
S+++ L L++++N + LE + + I ++ +E L
Sbjct: 372 NETFVSLAH-SPLHILNLTKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGL 429
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG--SIPNVLCHLAVLFQLDLRG 197
++ I L NK + + LQ L R L+ S P+ L L LDL
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGN 257
N ++ L L L L N L + W + G +
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLARL---------------WKHANPGGPIYFLKG 534
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317
L L ++ N + L L+ + LG N L + F++ VSL+SL+L N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 318 NLSEIIPLSLEKLL 331
++ +
Sbjct: 595 LITSVEKKVFGPAF 608
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-46
Identities = 65/325 (20%), Positives = 119/325 (36%), Gaps = 31/325 (9%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
N + + S ++ L ++ ++ ++ + S+S L S
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFT---------KQSISLASLPKIDD-----FSF 325
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIG----NLTDLI 143
K L+ L++ N + G + +L+++ +S+ S + L
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGNKLSG 202
++L NK++ S L L+ L NE+ + L +F++ L NK
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 203 SIPTCFGNLTALRNLHLDSNELTSI---PSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
F + +L+ L L L ++ PS L+++ LD +N + L+
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 260 VLTRIDFSRNNL--------LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311
L +D NNL G ++GL L L+L N F DL L+
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 312 LDLSNNNLSEIIPLSLEKLLYLNIL 336
+DL NNL+ + + L L
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSL 589
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-44
Identities = 66/336 (19%), Positives = 124/336 (36%), Gaps = 33/336 (9%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
N+L + T + L + +N + +++ L LS N L+S+
Sbjct: 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI-TLDLSHNGLSSTKL- 138
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ-SLEFIWMSDCNISGGISEEIGNL 139
+ + L++L +S N + + F+ SL+ + +S I +
Sbjct: 139 ----GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194
Query: 140 TDLISIDLGGNKLNGSISITLG---KLQKLQFLSFRGNELEGSIPNVLCHLAV--LFQLD 194
L + L +L S++ L ++ LS ++L + L L LD
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 195 LRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPL-- 251
L N L+ F L L L+ N + + L L ++ YL+ + +
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 252 -------PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS--IPNS 302
LK L ++ N++ G GL +L++LSL ++ +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 303 FDDLV--SLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
F L L L+L+ N +S+I + L +L +L
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVL 410
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-44
Identities = 65/318 (20%), Positives = 120/318 (37%), Gaps = 31/318 (9%)
Query: 43 LSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKK 95
+ + V ++ +N R S + L + N ++ PE LK
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLT-SLDVGFNTISKLEPE-----LCQKLPMLKV 77
Query: 96 LDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS 155
L++ N L + + +L + + +I + +LI++DL N L+ +
Sbjct: 78 LNLQHNELSQLSDKTFAFCT-NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 156 ISITLGKLQKLQFLSFRGNELEGSIPNVL--CHLAVLFQLDLRGNKLSGSIPTCFGNLTA 213
T +L+ LQ L N+++ L + L +L+L N++ P CF +
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196
Query: 214 LRNLHLDSNELTSIP----SILWNLKDILYLDFWSNLFVGPLPSKIGNLKV--LTRIDFS 267
L L L++ +L + I L ++ + LK LT +D S
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256
Query: 268 RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN---------N 318
NNL + L L++ L +N +Q +S L ++ L+L + +
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316
Query: 319 LSEIIPLSLEKLLYLNIL 336
L +I S + L L L
Sbjct: 317 LPKIDDFSFQWLKCLEHL 334
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-40
Identities = 48/250 (19%), Positives = 89/250 (35%), Gaps = 10/250 (4%)
Query: 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNK 151
+ D S L +V + ++ + ++ + + + L S+D+G N
Sbjct: 5 SHEVADCSHLKLT----QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 152 LNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNL 211
++ KL L+ L+ + NEL L +L L N + F
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 212 TALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLK--VLTRIDFSR 268
L L L N L+S L+++ L +N ++ L +++ S
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 269 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF---DDLVSLESLDLSNNNLSEIIPL 325
N + P + L L L + +L S+ S+ +L LSN+ LS
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 326 SLEKLLYLNI 335
+ L + N+
Sbjct: 241 TFLGLKWTNL 250
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-22
Identities = 34/171 (19%), Positives = 58/171 (33%), Gaps = 26/171 (15%)
Query: 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225
+ +L ++ ++ VL +L N+L F + L +L + N ++
Sbjct: 6 HEVADCSHLKLTQVPDDLPTNITVL---NLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSL 285
+ P L +L ++ N L T +L
Sbjct: 63 KLE-----------------------PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99
Query: 286 QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
L L N +Q N F +L +LDLS+N LS + +L L L
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL 150
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 38/216 (17%), Positives = 73/216 (33%), Gaps = 23/216 (10%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY---------VLGRLSSIVDELSLSDNYLTSST 78
S NK + + + + +L+ + L ++ L LS+N + +
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT-ILDLSNNNIANIN 496
Query: 79 PELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS-------QSLEFIWMSDCNISGG 131
++ + + L+ LD+ N L L + +
Sbjct: 497 DDM-----LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 132 ISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCH-LAVL 190
E +L +L IDLG N LN + L+ L+ + N + V L
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 191 FQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS 226
+LD+R N + + + + H + EL+S
Sbjct: 612 TELDMRFNPFDCTCESIAWFVNWINETHTNIPELSS 647
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-48
Identities = 54/346 (15%), Positives = 121/346 (34%), Gaps = 46/346 (13%)
Query: 35 IVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFL-SSMSNCKYL 93
+ + S L ++++ + ++L D + + ++F+ ++ L
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSS-RITLKDTQIGQLSNNITFVSKAVMRLTKL 208
Query: 94 KKLDISRNPLDGFLPRVVGNFS------------------QSLEFIWMSDCNISGGISEE 135
++ + +P + L + + +C +
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268
Query: 136 IGNLTDLISIDLGGNKL--------NGSISITLGKLQKLQFLSFRGNEL-EGSIPNVLCH 186
+ L ++ I++ N+ + +K+Q + N L + L
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK 328
Query: 187 LAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDILYLDFWSN 245
+ L L+ N+L G +P FG+ L +L+L N++T IP + + + L F N
Sbjct: 329 MKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387
Query: 246 LFVG-PLPSKIGNLKVLTRIDFSRNNL-------LGDIPTTIQGLKSLQFLSLGHNRLQG 297
P ++ V++ IDFS N + + T ++ ++L +N++
Sbjct: 388 KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK 447
Query: 298 SIPNSFDDLVSLESLDLSNNNLSEI-------IPLSLEKLLYLNIL 336
F L S++L N L+EI + + L +
Sbjct: 448 FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-48
Identities = 58/345 (16%), Positives = 109/345 (31%), Gaps = 44/345 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY---------VLGRLSSIVD-----ELSLSDNY 73
+ + + L +++ +V N L+ + + N
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 74 LTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGIS 133
L + E S K L L+ N L+G LP G+ L + ++ I+ +
Sbjct: 317 LKTFPVETSL----QKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQITEIPA 370
Query: 134 EEIGNLTDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEG-------SIPNVLC 185
G + ++ NKL + + + F NE+ +
Sbjct: 371 NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP--------SILWNLKDI 237
+ ++L N++S F + L +++L N LT IP N +
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 238 LYLDFWSNLFVG-PLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGH---- 292
+D N + L L ID S N PT +L+ + +
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLS-YNSFSKFPTQPLNSSTLKGFGIRNQRDA 549
Query: 293 --NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
NR P SL L + +N++ ++ + L+I
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDI 594
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-47
Identities = 52/349 (14%), Positives = 116/349 (33%), Gaps = 51/349 (14%)
Query: 28 SQNKLVGIVSIT--------IFNLSTLKVFDVDNN--------YVLGRLSSIVDELSLSD 71
+ N+ + + +++ + N L ++ + L
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG-MLECLY 339
Query: 72 NYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISG- 130
N L P + L L+++ N + +P F++ +E + + +
Sbjct: 340 NQLEGKLPAFG------SEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYI 392
Query: 131 GISEEIGNLTDLISIDLGGNKLNG-------SISITLGKLQKLQFLSFRGNELEGSIPNV 183
+ +++ + +ID N++ + T K + ++ N++ +
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452
Query: 184 LCHLAVLFQLDLRGNKLSG-------SIPTCFGNLTALRNLHLDSNELTSIPS--ILWNL 234
+ L ++L GN L+ F N L ++ L N+LT + L
Sbjct: 453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTL 512
Query: 235 KDILYLDFWSNLFVGPLPSKIGNLKVLTRI------DFSRNNLLGDIPTTIQGLKSLQFL 288
++ +D N F P++ N L D N L + P I SL L
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 289 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILL 337
+G N ++ + ++ LD+ +N I + + + +
Sbjct: 572 QIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-43
Identities = 48/342 (14%), Positives = 99/342 (28%), Gaps = 55/342 (16%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
G V I L+ L+V L+L + + L +
Sbjct: 89 EGFGASGRVPDAIGQLTELEV------------------LALGSHGEKVNER-LFGPKGI 129
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQS-LEFIWMSDCNISGGISEEIGNLTDLISID 146
S ++ R S L ++ I + I
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 147 LGGNKLNGSISITLGKLQKLQFLSFRGNELEG-------------------SIPNVLCHL 187
N + +S + +L KL+ + + +L
Sbjct: 190 QLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL 248
Query: 188 AVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI---------LWNLKDIL 238
L +++ +PT L ++ +++ N S + + I
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ 308
Query: 239 YLDFWSN-LFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
+ N L P+ + + +K L ++ N L G +P L L+L +N++
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE 367
Query: 298 SIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLYLNI 335
N +E+L ++N L I + S+ + ++
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-38
Identities = 42/295 (14%), Positives = 90/295 (30%), Gaps = 28/295 (9%)
Query: 57 LGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDG----FLPRVVG 112
L + LSL + P ++ L+ L + + F P+ +
Sbjct: 77 LNSNGRVT-GLSLEGFGASGRVP-----DAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 113 NFSQSLEFIWMSDCNISGGISEEIG--NLTDLISIDLGGNKLNGSISITLGKLQKLQFLS 170
+ S E + + + +DLI + + SI + K +
Sbjct: 131 A-NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 171 FRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI 230
N + + + L L Q + + +
Sbjct: 190 QLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ----YKTEDLK 244
Query: 231 LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLL--------GDIPTTIQGL 282
NLKD+ ++ ++ + LP+ + L + I+ + N +
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVG 304
Query: 283 KSLQFLSLGHNRLQ-GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ +Q + +G+N L+ + S + L L+ N L +P + + L L
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL 358
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-33
Identities = 51/307 (16%), Positives = 93/307 (30%), Gaps = 38/307 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
N+L G + + L ++ N G + LS + N L
Sbjct: 338 LYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVE-NLSFAHNKLKY---- 391
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS------QSLEFIWMSDCNISGGISE 134
+ + + + +D S N + + ++ I +S+ IS E
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 135 EIGNLTDLISIDLGGNKLNG-------SISITLGKLQKLQFLSFRGNELEGSIPNV-LCH 186
+ L SI+L GN L + L + R N+L +
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT 511
Query: 187 LAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNE-------LTSIPSILWNLKDILY 239
L L +DL N S PT N + L+ + + L P + +
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ 570
Query: 240 LDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI 299
L SN + KI ++ +D N + + + L +++ Q
Sbjct: 571 LQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIR 627
Query: 300 PNSFDDL 306
D+
Sbjct: 628 GCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 24/245 (9%), Positives = 60/245 (24%), Gaps = 37/245 (15%)
Query: 124 SDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG----S 179
+ + + + L G +G + +G+L +L+ L+ + +
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 180 IPNVLCHLAVLFQLDLRGNKLSG--------------------------SIPTCFGNLTA 213
P + Q SI
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG 273
+ SN +T + + L + ++ FV + +
Sbjct: 185 DTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYK 239
Query: 274 DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI--IPLSLEKLL 331
LK L + + + +P L ++ ++++ N + + L
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 332 YLNIL 336
+
Sbjct: 300 DAPVG 304
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 24/173 (13%), Positives = 43/173 (24%), Gaps = 9/173 (5%)
Query: 178 GSIPNVLCH-LAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN-----ELTSIPSIL 231
G+ P V + + L L G SG +P G LT L L L S+ E P +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 232 WNLKDILYLDFWSNLFVGPLPSKIGNLKV--LTRIDFSRNNLLGDIPTTIQGLKSLQFLS 289
+ L + + + I + + +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 290 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVI 342
N + + + L L + N+ +
Sbjct: 190 QLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE 241
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-42
Identities = 56/348 (16%), Positives = 113/348 (32%), Gaps = 51/348 (14%)
Query: 28 SQNKLVGIVSI---------TIFNLSTLKVFDVDNN--------YVLGRLSSIVDELSLS 70
+ N+ + + +++F + N L ++ + L
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLG-LLDCV 581
Query: 71 DNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISG 130
N + L + L L + N ++ +P F+ +E + S +
Sbjct: 582 HNKVRH-------LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 131 -GISEEIGNLTDLISIDLGGNKL-----NGSISITLGKLQKLQFLSFRGNELEGSIPNVL 184
++ + S+D NK+ N S S+ K ++ NE++ +
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
Query: 185 CHLAVLFQLDLRGNKLS-------GSIPTCFGNLTALRNLHLDSNELTSIPS--ILWNLK 235
+ + + L N ++ + N L + L N+LTS+ L
Sbjct: 694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLP 753
Query: 236 DILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSR------NNLLGDIPTTIQGLKSLQFLS 289
+ +D N F P++ N L N +L PT I SL L
Sbjct: 754 YLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 290 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILL 337
+G N ++ + L LD+++N I S+ + + +
Sbjct: 813 IGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYV 857
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-41
Identities = 55/348 (15%), Positives = 102/348 (29%), Gaps = 52/348 (14%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY----------------VLGRLSSIVDELSLSD 71
+ + +++L L+ ++ N I +
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ-IFYMGY 557
Query: 72 NYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSDCNIS 129
N L S L LD N + R + F L + + I
Sbjct: 558 NNLEEFPASASL----QKMVKLGLLDCVHNKV-----RHLEAFGTNVKLTDLKLDYNQIE 608
Query: 130 GGISEEIG-NLTDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHL 187
I E+ + + NKL + + + F N++ N+ C +
Sbjct: 609 E-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 188 AV-----LFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS--------ILWNL 234
+ L N++ F + + + L +N +TSIP N
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727
Query: 235 KDILYLDFWSNLFVG-PLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGH- 292
+ +D N + L L+ +D S N PT L+ + H
Sbjct: 728 YLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVS-YNCFSSFPTQPLNSSQLKAFGIRHQ 786
Query: 293 -----NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
NR+ P SL L + +N++ ++ +L L+I
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDI 834
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-39
Identities = 44/355 (12%), Positives = 105/355 (29%), Gaps = 34/355 (9%)
Query: 7 NNRQLDGGMTGDVCYRICTIDSQNKLV--GIVSITIFNLSTLKVFDVDNNYVLGRLSSIV 64
++ + G + GD + + + + + L + D+ + +
Sbjct: 357 HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416
Query: 65 ----DELSLSDNYLTSSTPELSFL-SSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
+SL D + + T ++F+ ++ L+ + + +P V E
Sbjct: 417 IKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV------DWE 470
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG- 178
NL DL ++L + L L +LQ L+ N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 179 --------SIPNVLCHLAVLFQLDLRGNKLSG-SIPTCFGNLTALRNLHLDSNELTSIPS 229
+ + + + N L + L L N++ + +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA 590
Query: 230 ILWNLKDILYLDFWSNLFVGPLPSKIG-NLKVLTRIDFSRNNLLGDIPTT--IQGLKSLQ 286
+ L N +P + + FS +N L IP + + +
Sbjct: 591 F-GTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFS-HNKLKYIPNIFNAKSVYVMG 647
Query: 287 FLSLGHNRLQGSIPNSFDDL-----VSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ +N++ N + ++ ++ LS N + + ++ +
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTI 702
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-38
Identities = 57/356 (16%), Positives = 108/356 (30%), Gaps = 44/356 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY------VLGRLSSIVDELSLSDNYLTSSTPEL 81
+ G V I L+ LKV + + G D + + ++
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390
Query: 82 SFLSSMS-NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
N L + I+RNP + + + + ++ N IS+ I LT
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLT--NRITFISKAIQRLT 448
Query: 141 DLISIDLGGNKLNG-------------------SISITLGKLQKLQFLSFRGNELEGSIP 181
L I + + ++ L+ L + +P
Sbjct: 449 KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
Query: 182 NVLCHLAVLFQLDLRGNKLSG---------SIPTCFGNLTALRNLHLDSNELTSIPS--I 230
+ L L L L++ N+ + ++ ++ N L P+
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568
Query: 231 LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSL 290
L + + LD N L + G LT + N + ++ L
Sbjct: 569 LQKMVKLGLLDCVHNKVRH-LEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGF 626
Query: 291 GHNRLQGSIPNSFD--DLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344
HN+L+ IPN F+ + + S+D S N + + + V L+
Sbjct: 627 SHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 56/344 (16%), Positives = 107/344 (31%), Gaps = 38/344 (11%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRL-SSIVD-----ELSLSDNYLTSSTPEL 81
K ++ NL L ++ N + +L + D L+++ N S+
Sbjct: 475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK 534
Query: 82 SFLSSM----SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIG 137
+ + + ++ + N L+ F L + + E G
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFG 592
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNV--LCHLAVLFQLDL 195
L + L N++ +++ L F N+L+ IPN+ + V+ +D
Sbjct: 593 TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDF 651
Query: 196 RGNKLSGSIPTCFG-----NLTALRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLF-- 247
NK+ + L NE+ P + I + +NL
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711
Query: 248 -----VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ--GLKSLQFLSLGHNRLQGSIP 300
+ P N +LT ID N L + + L L + + +N S P
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCFS-SFP 769
Query: 301 NSFDDLVSLESLDL------SNNNLSEIIPLSLEKLLYLNILLI 338
+ L++ + N + P + L L I
Sbjct: 770 TQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 46/305 (15%), Positives = 92/305 (30%), Gaps = 37/305 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV------LGRLSSIVDELSLSDNYLTSSTPEL 81
NK+ + + L +D N + + V+ L S N L
Sbjct: 581 VHNKVRHLEAFG--TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIF 638
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ----SLEFIWMSDCNISGGISEEIG 137
+ + + +D S N + + + + + +S I +E
Sbjct: 639 NA----KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694
Query: 138 NLTDLISIDLGGNKL-------NGSISITLGKLQKLQFLSFRGNELEGSIPN--VLCHLA 188
+ + +I L N + L + R N+L S+ + L
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753
Query: 189 VLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNE-------LTSIPSILWNLKDILYLD 241
L +D+ N S S PT N + L+ + L P+ + ++ L
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 242 FWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301
SN + K+ L +D + N + T++ L +++ Q
Sbjct: 813 IGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGC 869
Query: 302 SFDDL 306
+
Sbjct: 870 DALGI 874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 43/275 (15%), Positives = 90/275 (32%), Gaps = 13/275 (4%)
Query: 62 SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLD--GFLPRVVGNFSQSLE 119
I D +L + + S N LD G P V + + +
Sbjct: 267 YIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVT 326
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179
+ ++ G + + IG LT+L + G + S + + R + +
Sbjct: 327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386
Query: 180 IPN-VLCHLAVLFQLDLRGNKLSG---SIPTCFGNLTALRNLHLD--SNELTSIPSILWN 233
L + L DL + ++ P + +L++ + +N +T I +
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQR 446
Query: 234 LKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHN 293
L + + F ++ F + + + + LK L + L +
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501
Query: 294 RLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 328
+P+ DL L+SL+++ N L +
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 33/218 (15%), Positives = 67/218 (30%), Gaps = 13/218 (5%)
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185
++ N + + L G G + +G+L +L+ LSF + S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 186 HLAVLFQLDLRGNKLSGSIPTCFGN-------LTALRNLHLDSNELTSIPSILWNLKDIL 238
+ R +++ F + L++ + E+ I
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298
+ +N + I L L I F+ + D + + + + +
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYEN 482
Query: 299 IPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
S+ +L L ++L N +P L L L L
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 4e-18
Identities = 22/173 (12%), Positives = 54/173 (31%), Gaps = 10/173 (5%)
Query: 174 NELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI--L 231
+ L + + L L G G +P G LT L+ L ++ T +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 232 WNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLG 291
L + + + + + + L D ++ + + ++ +K +SL
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLK 426
Query: 292 HNRLQG------SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLI 338
++ I + L L+ + +N+ + + +
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ 479
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 31/189 (16%), Positives = 60/189 (31%), Gaps = 6/189 (3%)
Query: 155 SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTAL 214
S ++ KL K + + E I + A+ LD + + +
Sbjct: 243 SFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW 302
Query: 215 RNLHLDSNELTSIPSI-LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG 273
N + + + P + L N + L G +P IG L L + F ++
Sbjct: 303 -NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361
Query: 274 DIPTTIQGLKSLQFLSLGHNRLQGSIPNSF-DDLVSLESLDLSNNNLS---EIIPLSLEK 329
+ +R++ F D L DL + ++ E+ P+ +
Sbjct: 362 SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421
Query: 330 LLYLNILLI 338
+ L I
Sbjct: 422 RISLKDTQI 430
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 65/320 (20%), Positives = 106/320 (33%), Gaps = 28/320 (8%)
Query: 26 IDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD---------ELSLSDNYLTS 76
++ L + L L + + Y+ L I+D SL +
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296
Query: 77 STPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI 136
S+ + L++ F + + + L F + GG +
Sbjct: 297 VKD-FSYNFG------WQHLELVNCKFGQFPTLKLKSL-KRLTF-----TSNKGGNAFSE 343
Query: 137 GNLTDLISIDLGGNKLN--GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLD 194
+L L +DL N L+ G S + L++L N + + + L L LD
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 402
Query: 195 LRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPL- 251
+ + L F +L L L + I L + L N F
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311
P L+ LT +D S+ L PT L SLQ L++ HN + L SL+
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522
Query: 312 LDLSNNNLSEIIPLSLEKLL 331
LD S N++ L+
Sbjct: 523 LDYSLNHIMTSKKQELQHFP 542
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-39
Identities = 62/343 (18%), Positives = 117/343 (34%), Gaps = 38/343 (11%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV-------DELSLSDNYLTSSTPE 80
S N + I F L + NN+ + + L +
Sbjct: 185 SLNPMNFI-QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 81 LSF-LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS--QSLEFIWMSDCNISGGISEEIG 137
F S++ L + LD +L ++ F+ ++ + I ++
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFS 301
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNEL--------------------- 176
++L K ++ L L++L F S +G
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 177 EGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI--PSILWNL 234
+G L LDL N + + + F L L +L + L + S+ +L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 235 KDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI-PTTIQGLKSLQFLSLGHN 293
++++YLD L L + + N+ + P L++L FL L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 294 RLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+L+ P +F+ L SL+ L++S+NN + + L L +L
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-36
Identities = 54/308 (17%), Positives = 102/308 (33%), Gaps = 16/308 (5%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
+ + + + ++ N + S LT ++ + S
Sbjct: 290 VSVTIERVKDFS--YNFGWQHLELVNC----KFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343
Query: 88 SNCKYLKKLDISRNPLD--GFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145
+ L+ LD+SRN L G + + SL+++ +S + +S L L +
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTT-SLKYLDLSFNGVIT-MSSNFLGLEQLEHL 401
Query: 146 DLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI 204
D + L L+ L +L + + L+ L L + GN +
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 205 PTC-FGNLTALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262
F L L L L +L + P+ +L + L+ N F L L
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 521
Query: 263 RIDFSRNNLLGDIPTTIQGL-KSLQFLSLGHNRLQGSIPNS--FDDLVSLESLDLSNNNL 319
+D+S N+++ +Q SL FL+L N + + + L + +
Sbjct: 522 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM 581
Query: 320 SEIIPLSL 327
P
Sbjct: 582 ECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 59/331 (17%), Positives = 108/331 (32%), Gaps = 33/331 (9%)
Query: 44 STLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKL 96
+ K D+ N + L LS + + + + +L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQ-VLDLSRCEIQTIEDG-----AYQSLSHLSTL 81
Query: 97 DISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNG-S 155
++ NP+ S SL+ + + N++ + IG+L L +++ N +
Sbjct: 82 ILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 156 ISITLGKLQKLQFLSFRGNELEGSIPNVLCHLA----VLFQLDLRGNKLSGSIPTCFGNL 211
+ L L+ L N+++ L L + LDL N ++ P F +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 212 TALRNLHLDSNELT--SIPSILWNLKDILYLDFWSNLFVG------PLPSKIGNLKVLTR 263
L L L +N + + + + L + F S + L LT
Sbjct: 201 R-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 264 IDFSRNNL---LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
+F L L DI L ++ SL ++ S+ + L+L N
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFG 317
Query: 321 EIIPLSLEKLLYLNILLIVVVILALKFGLIS 351
+ L L+ L L + L S
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 49/243 (20%), Positives = 87/243 (35%), Gaps = 14/243 (5%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166
++ N S + + +S + S + +L +DL ++ L L
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS 226
L GN ++ L+ L +L L+ G+L L+ L++ N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 227 --IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT----RIDFSRNNLLGDIPTTIQ 280
+P NL ++ +LD SN + + L + +D S N + P +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 281 GLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNN------NLSEIIPLSLEKLLYL 333
+ L L+L +N ++ L LE L NL + +LE L L
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 334 NIL 336
I
Sbjct: 258 TIE 260
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 61/204 (29%), Positives = 84/204 (41%), Gaps = 35/204 (17%)
Query: 356 RATKLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIK 415
+ S+ R +L AT+ F LIG G FG VYK L+DG + A+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 416 VFHFS-----------------------------CSNEDFRALVLEYTTNGSLEKVLYSS 446
C + L+ +Y NG+L++ LY S
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 447 NYILDIL---QRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503
+ + QRL I I L YLH IIH D+K N LLD+N V ++DFGI+
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 504 KLLTGEDQSMTQTQTLAIIGYMAP 527
K T DQ+ T +GY+ P
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDP 210
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-41
Identities = 62/324 (19%), Positives = 120/324 (37%), Gaps = 22/324 (6%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
+ N L+ + + LK L ++ L L N+++S
Sbjct: 89 TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE-SLYLGSNHISSIKL- 146
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ-SLEFIWMSDCNISGGISEEIGNL 139
+ LK LD N + + + Q + + ++ +I+G I +
Sbjct: 147 ----PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDS 201
Query: 140 TDLISIDLGGNKLNGSI--SITLGKLQKLQFLSFRGNELEGSIPNVLCHLAV--LFQLDL 195
S++ GG + I + +Q L +F + E P V L + ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 196 RGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKI 255
+ + F + L+ L L + L+ +PS L L + L +N F
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 256 GNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGS--IPNSFDDLVSLESL 312
N LT + N ++ T ++ L++L+ L L H+ ++ S +L L+SL
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 313 DLSNNNLSEIIPLSLEKLLYLNIL 336
+LS N + + ++ L +L
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELL 405
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-40
Identities = 65/321 (20%), Positives = 116/321 (36%), Gaps = 17/321 (5%)
Query: 25 TIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFL 84
I K I S+ + + D+ G V+ ++L +Y + +
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN---- 272
Query: 85 SSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLIS 144
+ L++LD++ L LP + S +L+ + +S N L
Sbjct: 273 -TFHCFSGLQELDLTATHLSE-LPSGLVGLS-TLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 145 IDLGGNKLNGSI-SITLGKLQKLQFLSFRGNELEGS--IPNVLCHLAVLFQLDLRGNKLS 201
+ + GN + + L L+ L+ L +++E S L +L+ L L+L N+
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 202 GSIPTCFGNLTALRNLHLDSNELTSI--PSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
F L L L L S NL + L+ +L L
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 260 VLTRIDFSRNNLLGDI---PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
L ++ N+ ++Q L L+ L L L ++F L + +DLS+
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 317 NNLSEIIPLSLEKL--LYLNI 335
N L+ +L L +YLN+
Sbjct: 510 NRLTSSSIEALSHLKGIYLNL 530
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-40
Identities = 75/310 (24%), Positives = 122/310 (39%), Gaps = 18/310 (5%)
Query: 37 SITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKL 96
S+ NL F++ +N S + EL L+ +L+ L LS+ LKKL
Sbjct: 255 SVESINLQKHYFFNISSN-TFHCFSGLQ-ELDLTATHLSELPSGLVGLST------LKKL 306
Query: 97 DISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEE-IGNLTDLISIDLGGNKLNGS 155
+S N + NF SL + + + + NL +L +DL + + S
Sbjct: 307 VLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365
Query: 156 --ISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP-TCFGNLT 212
++ L L LQ L+ NE L LDL +L + F NL
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 213 ALRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRI---DFSR 268
L+ L+L + L + L + +L+ N F K +L+ L R+ S
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 269 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 328
+L LK + + L HNRL S + L + L+L++N++S I+P L
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLP 544
Query: 329 KLLYLNILLI 338
L + +
Sbjct: 545 ILSQQRTINL 554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-39
Identities = 65/325 (20%), Positives = 119/325 (36%), Gaps = 22/325 (6%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD--------ELSLSDNYLTSSTP 79
+ N + GI F+ + + + L + + + D +P
Sbjct: 187 NGNDIAGI-EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139
+ + ++ +++ ++ FS L+ + ++ ++S + + L
Sbjct: 246 AVFEGLCEMS---VESINLQKHYFFNISSNTFHCFS-GLQELDLTATHLSE-LPSGLVGL 300
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSI-PNVLCHLAVLFQLDLRGN 198
+ L + L NK I+ L LS +GN + L +L L +LDL +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 199 KL--SGSIPTCFGNLTALRNLHLDSNELTSIPSILW-NLKDILYLDFWSNLFVG-PLPSK 254
+ S NL+ L++L+L NE S+ + + + LD S
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
Query: 255 IGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI---PNSFDDLVSLES 311
NL +L ++ S + L GL +LQ L+L N NS L LE
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480
Query: 312 LDLSNNNLSEIIPLSLEKLLYLNIL 336
L LS +LS I + L +N +
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHV 505
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 52/308 (16%), Positives = 102/308 (33%), Gaps = 23/308 (7%)
Query: 43 LSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKK 95
++ + + N RL ++ L L+ + + +F + L
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLT-FLDLTRCQIYWIHED-TF----QSQHRLDT 85
Query: 96 LDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS 155
L ++ NPL + +L+ ++ IS + N L S+ LG N ++
Sbjct: 86 LVLTANPLIFMAETALSGPK-ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 156 ISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVL--FQLDLRGNKLSGSIPTCFGNLTA 213
+KL+ L F+ N + + L L+L GN ++ I +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAV 203
Query: 214 LRNLHLDSNELTSIP---SILWNLKDILYLDFWSNLFVGPLPSKIGNLKV--LTRIDFSR 268
++L+ + + ++ + F P+ L + I+ +
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 269 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 328
+ T LQ L L L +P+ L +L+ L LS N + +S
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 329 KLLYLNIL 336
L L
Sbjct: 323 NFPSLTHL 330
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-32
Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 19/304 (6%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV-------DELSLSDNYLTSSTPE 80
S NK + I+ N +L + N L + EL LS + + +S
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI-GNL 139
L ++S+ L+ L++S N LE + ++ + ++ NL
Sbjct: 369 NLQLRNLSH---LQSLNLSYNEPLSLKTEAFKEC-PQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSI---PNVLCHLAVLFQLDLR 196
L ++L + L+ S L LQ L+ +GN N L L L L L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIG 256
LS F +L + ++ L N LTS + +YL+ SN LPS +
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLP 544
Query: 257 NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
L I+ +N L + L++ +L+ + ++ L + LS+
Sbjct: 545 ILSQQRTINLRQNPLDCTC--SNIYF--LEWYKENMQKLEDTEDTLCENPPLLRGVRLSD 600
Query: 317 NNLS 320
LS
Sbjct: 601 VTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 46/249 (18%), Positives = 81/249 (32%), Gaps = 8/249 (3%)
Query: 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLN 153
K + L+ + G S E + S + + L +L +DL ++
Sbjct: 15 KTYNCENLGLN----EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 154 GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTA 213
T +L L N L L L L +S N
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 214 LRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS-RNNL 271
L +L+L SN ++SI + + + LDF +N + +L+ T + + N
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 272 LGDIPTTIQGLKSLQFLSLGHNRLQGSIPN--SFDDLVSLESLDLSNNNLSEIIPLSLEK 329
+ I Q L+ G + I + SL + + +I P E
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 330 LLYLNILLI 338
L +++ I
Sbjct: 251 LCEMSVESI 259
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 67/189 (35%), Positives = 85/189 (44%), Gaps = 36/189 (19%)
Query: 373 RRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIK----------------- 415
+RFS +EL A+D FS N++GRG FG VYK RL DG A+K
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 416 ------VFH--------FSCSNEDFRALVLEYTTNGSLEKVLY---SSNYILDILQRLNI 458
H F C R LV Y NGS+ L S LD +R I
Sbjct: 78 VEMISMAVHRNLLRLRGF-CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 459 MIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
+ L YLH IIH D+K N LLD+ A + DFG+AKL+ +D +T T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAV 195
Query: 519 LAIIGYMAP 527
IG++AP
Sbjct: 196 RGTIGHIAP 204
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 49/302 (16%), Positives = 103/302 (34%), Gaps = 23/302 (7%)
Query: 40 IFNLSTLKVFDVDNNYVLGRL--SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLD 97
+ D + + R S+ + + L ++ L + L+
Sbjct: 32 LSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPG----RVALE 87
Query: 98 ISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSIS 157
+ PL P L+ + + + + + + L ++ L N L ++
Sbjct: 88 LRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALP 143
Query: 158 ITLGKLQKLQFLSFRGNELEGSIPNVLCHLAV---------LFQLDLRGNKLSGSIPTCF 208
++ L +L+ LS R +P L L L L + S+P
Sbjct: 144 ASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
Query: 209 GNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSR 268
NL L++L + ++ L+++ + +L + LD + P G L R+
Sbjct: 203 ANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262
Query: 269 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN---NLSEIIPL 325
+ L +P I L L+ L L +P+ L + + + + L + P+
Sbjct: 263 CSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPV 322
Query: 326 SL 327
+
Sbjct: 323 AR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 52/308 (16%), Positives = 112/308 (36%), Gaps = 20/308 (6%)
Query: 42 NLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRN 101
+ S + + L ++ + N + ++ +N + +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNN---PQIETRTGR 66
Query: 102 PLDGFLPRVVGNFSQ-SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITL 160
L ++ + +Q + + + ++ L+ L + + L + T+
Sbjct: 67 AL-KATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 161 GKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGN---------L 211
+ L+ L+ N L ++P + L L +L +R +P + L
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 212 TALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNL 271
L++L L+ + S+P+ + NL+++ L ++ L I +L L +D
Sbjct: 183 VNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241
Query: 272 LGDIPTTIQGLKSLQFLSL-GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330
L + P G L+ L L + L ++P L LE LDL +P + +L
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300
Query: 331 LYLNILLI 338
I+L+
Sbjct: 301 PANCIILV 308
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 18/134 (13%), Positives = 36/134 (26%), Gaps = 23/134 (17%)
Query: 224 LTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSR--------------- 268
+ S + L F + + P + + D +R
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 269 ----NNLLGDIPTTIQGLKS--LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322
L ++ L L L P+ L L+ + + L E
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118
Query: 323 IPLSLEKLLYLNIL 336
+P ++++ L L
Sbjct: 119 LPDTMQQFAGLETL 132
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-38
Identities = 67/329 (20%), Positives = 142/329 (43%), Gaps = 39/329 (11%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTP--- 79
+ + +V+ L ++ V V + L+++ + L+L+ N +T +P
Sbjct: 30 QKASVTDVVTQE--ELESITKLVVAGEKVASIQGIEYLTNL-EYLNLNGNQITDISPLSN 86
Query: 80 ------------ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCN 127
+++ +S++ N L++L ++ + + P + N ++ + + + +
Sbjct: 87 LVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LANLTK-MYSLNLGANH 143
Query: 128 ISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHL 187
+S + N+T L + + +K+ I L L LS N++E P L L
Sbjct: 144 NLSDLSP-LSNMTGLNYLTVTESKVKDVTPI--ANLTDLYSLSLNYNQIEDISP--LASL 198
Query: 188 AVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLF 247
L N+++ P N+T L +L + +N++T + L NL + +L+ +N
Sbjct: 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQI 255
Query: 248 VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV 307
+ + +L L ++ N + DI + L L L L +N+L L
Sbjct: 256 SDI--NAVKDLTKLKMLNVGSNQI-SDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 308 SLESLDLSNNNLSEIIPLS-LEKLLYLNI 335
+L +L LS N++++I PL+ L K+ +
Sbjct: 312 NLTTLFLSQNHITDIRPLASLSKMDSADF 340
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 5e-38
Identities = 64/299 (21%), Positives = 127/299 (42%), Gaps = 30/299 (10%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTPELS 82
+ N++ I + NL L + N + L L+++ EL L+++ ++
Sbjct: 74 NGNQITDI--SPLSNLVKLTNLYIGTNKITDISALQNLTNLR-ELYLNEDNISD------ 124
Query: 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142
+S ++N + L++ N + N + L ++ +++ + I NLTDL
Sbjct: 125 -ISPLANLTKMYSLNLGANHNLS-DLSPLSNMT-GLNYLTVTESKVKD--VTPIANLTDL 179
Query: 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG 202
S+ L N++ L L L + + N++ P + ++ L L + NK++
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
Query: 203 SIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262
P NL+ L L + +N+++ I + + +L + L+ SN S + NL L
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISDINA-VKDLTKLKMLNVGSNQISDI--SVLNNLSQLN 290
Query: 263 RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321
+ + N L + I GL +L L L N + P L ++S D +N + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 5e-32
Identities = 54/271 (19%), Positives = 106/271 (39%), Gaps = 25/271 (9%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
L +T + + + + KL ++ + + + LE++ ++
Sbjct: 26 RAVLQKASVTD-------VVTQEELESITKLVVAGEKVASIQG--IEYLTN-LEYLNLNG 75
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185
I+ + NL L ++ +G NK+ + L L L+ L + + P L
Sbjct: 76 NQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LA 129
Query: 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN 245
+L ++ L+L N + N+T L L + +++ + I NL D+ L N
Sbjct: 130 NLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPI-ANLTDLYSLSLNYN 187
Query: 246 LFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 305
P + +L L N + P + + L L +G+N++ P +
Sbjct: 188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LAN 241
Query: 306 LVSLESLDLSNNNLSEIIPLS-LEKLLYLNI 335
L L L++ N +S+I + L KL LN+
Sbjct: 242 LSQLTWLEIGTNQISDINAVKDLTKLKMLNV 272
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 134 EEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQL 193
+L + I L + +T +L+ + L G ++ SI + +L L L
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 194 DLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPS 253
+L GN+++ P NL L NL++ +N++T I + L NL ++ L + S
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA-LQNLTNLRELYLNEDNISD--IS 126
Query: 254 KIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLD 313
+ NL + ++ N+ L D+ + + L +L++ ++++ P +L L SL
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 314 LSNNNLSEIIPLS-LEKLLYLNI 335
L+ N + +I PL+ L L Y
Sbjct: 184 LNYNQIEDISPLASLTSLHYFTA 206
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 35/171 (20%), Positives = 65/171 (38%), Gaps = 12/171 (7%)
Query: 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225
L+ + P LA + L+ ++ + L ++ L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSL 285
SI I L ++ YL+ N P + NL LT + N + + +Q L +L
Sbjct: 58 SIQGI-EYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNL 112
Query: 286 QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ L L + + P +L + SL+L N+ + L + LN L
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYL 160
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-36
Identities = 64/307 (20%), Positives = 101/307 (32%), Gaps = 21/307 (6%)
Query: 37 SITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKL 96
+I F L+ F D L+++ +SL+ + L + + L
Sbjct: 262 TIDEFRLTYTNDFSDDIV-KFHCLANVS-AMSLAGVSIKY-------LEDVPKHFKWQSL 312
Query: 97 DISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSI 156
I R L F L+ + ++ S IS + L L +DL N L+ S
Sbjct: 313 SIIRCQLKQF----PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSG 366
Query: 157 SITL--GKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTA 213
+ L+ L N + L L LD + + L F +L
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 214 LRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPLPSKI-GNLKVLTRIDFSRNNL 271
L L + I L + L N F S + N LT +D S+ L
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485
Query: 272 LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 331
L LQ L++ HN L + ++ L SL +LD S N + +
Sbjct: 486 EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
Query: 332 YLNILLI 338
L +
Sbjct: 546 SLAFFNL 552
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-35
Identities = 57/315 (18%), Positives = 91/315 (28%), Gaps = 47/315 (14%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV-----DELSLSDNYLTSSTPE-- 80
+ + L+ + + + L + LS+ L
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVS-IKYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 81 ------------LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS-QSLEFIWMSDCN 127
S L LD+SRN L + SL + +S
Sbjct: 328 PFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387
Query: 128 ISGGISEEIGNLTDLISIDLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSIPNVLCH 186
+S L +L +D + L L+KL +L + +
Sbjct: 388 AII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446
Query: 187 LAVLFQLDLRGNKLSGSIPTC-FGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN 245
L L L + GN + + F N T L L L +L I
Sbjct: 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS----------------- 489
Query: 246 LFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 305
L L ++ S NNLL + L SL L NR++ S
Sbjct: 490 ------WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 306 LVSLESLDLSNNNLS 320
SL +L+NN+++
Sbjct: 544 PKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 75/332 (22%), Positives = 120/332 (36%), Gaps = 36/332 (10%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY--------VLGRLSSIVDELSLSDNYLTSSTP 79
+ KL + S I L TLK +V +N+ L+++V + LS NY+ + T
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV-HVDLSYNYIQTITV 170
Query: 80 E-LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEE-IG 137
L FL LD+S NP+D + L + + S I + +
Sbjct: 171 NDLQFLRENPQ--VNLSLDMSLNPIDFIQDQAFQGI--KLHELTLRGNFNSSNIMKTCLQ 226
Query: 138 NLTDLISIDLGGNKLNGSISI------TLGKLQKLQFLSFR--GNELEGSIPNVLCHLAV 189
NL L L + ++ + L + FR LA
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286
Query: 190 LFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVG 249
+ + L G + ++L + +L P++ +L + L N
Sbjct: 287 VSAMSLAGVSIKYLEDVPK--HFKWQSLSIIRCQLKQFPTL--DLPFLKSLTLTMNKGSI 342
Query: 250 PLPSKIGNLKVLTRIDFSRNNL--LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV 307
L L+ +D SRN L G + G SL+ L L N + +F L
Sbjct: 343 SFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLE 399
Query: 308 SLESLDLSNNNLSEIIPLS----LEKLLYLNI 335
L+ LD ++ L + S LEKLLYL+I
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-30
Identities = 64/332 (19%), Positives = 110/332 (33%), Gaps = 37/332 (11%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
+ N + + L++L+ +G+L ++ +L+++ N++ S
Sbjct: 88 TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK-KLNVAHNFIHS---- 142
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLP---RVVGNFSQSLEFIWMSDCNISGGISEEIG 137
+ SN L +D+S N + + + Q + MS I I ++
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAF 201
Query: 138 NLTDLISIDLGGNKLNGSI-SITLGKLQKLQFLSFRGNELEG---------SIPNVLCHL 187
L + L GN + +I L L L E + SI LC +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 188 AVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLF 247
+ + L F L + + L + + + L
Sbjct: 262 TID-EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED-VPKHFKWQSLSIIRCQL 319
Query: 248 VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDL- 306
+ LK L + N I L SL +L L N L S S+ DL
Sbjct: 320 KQFPTLDLPFLKSL---TLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 307 -VSLESLDLSNNNLSEIIP--LSLEKLLYLNI 335
SL LDLS N + + LE+L +L+
Sbjct: 375 TNSLRHLDLSFNGAIIMSANFMGLEELQHLDF 406
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 56/285 (19%), Positives = 101/285 (35%), Gaps = 25/285 (8%)
Query: 67 LSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDC 126
D L+ ++ K +D+S NPL NFS+ L+++ +S C
Sbjct: 16 YQCMDQKLSKVPDDIP--------SSTKNIDLSFNPLKILKSYSFSNFSE-LQWLDLSRC 66
Query: 127 NISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCH 186
I + L L ++ L GN + + L L+ L +L +
Sbjct: 67 EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126
Query: 187 LAVLFQLDLRGNKLSG-SIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKD----ILYL 240
L L +L++ N + +P F NLT L ++ L N + +I + L L++ L L
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 241 DFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP-TTIQGLKSLQFLSLGHNRLQGSI 299
D N + + L + N +I T +Q L L L +
Sbjct: 187 DMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245
Query: 300 ------PNSFDDLVSL--ESLDLSNNNLSEIIPLSLEKLLYLNIL 336
P+ + L + + L+ N + L ++ +
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-30
Identities = 57/323 (17%), Positives = 103/323 (31%), Gaps = 42/323 (13%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
S N L + S + N S L+ D+ + +I + ++
Sbjct: 40 SFNPLKILKSYSFSNFSELQWLDLSRC----EIETI---------------EDKAW---- 76
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDL 147
+L L ++ NP+ F P + SLE + + ++ S IG L L +++
Sbjct: 77 HGLHHLSNLILTGNPIQSFSPGSFSGLT-SLENLVAVETKLASLESFPIGQLITLKKLNV 135
Query: 148 GGNKLNG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHL----AVLFQLDLRGNKLSG 202
N ++ + L L + N ++ N L L V LD+ N +
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF 195
Query: 203 SIPTCFGNLTALRNLHLDSNELTS--IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
F + L L L N +S + + L NL + F +I +
Sbjct: 196 IQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 261 L--------TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESL 312
+ + N D L ++ +SL + +SL
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSL 312
Query: 313 DLSNNNLSEIIPLSLEKLLYLNI 335
+ L + L L L L +
Sbjct: 313 SIIRCQLKQFPTLDLPFLKSLTL 335
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 48/238 (20%), Positives = 82/238 (34%), Gaps = 12/238 (5%)
Query: 113 NFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172
+ S + I +S + S N ++L +DL ++ L L L
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88
Query: 173 GNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI--PSI 230
GN ++ P L L L KL+ G L L+ L++ N + S P+
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
Query: 231 LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS---RNNLLGDIPTTIQGLKSLQF 287
NL +++++D N + + L+ +++ S N + I L
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208
Query: 288 LSLGHNRLQGSIP-NSFDDLVSLESLDLS------NNNLSEIIPLSLEKLLYLNILLI 338
L+L N +I +L L L NL P +E L + I
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 44/217 (20%), Positives = 73/217 (33%), Gaps = 15/217 (6%)
Query: 28 SQNKLVGIVSITIFNLST--LKVFDVDNN------YVLGRLSSIVDELSLSDNYLTSSTP 79
S+N L + +L T L+ D+ N L + L + L T
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQ-HLDFQHSTLKRVTE 416
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI-GN 138
+F + + L LDIS + + SL + M+ + + N
Sbjct: 417 FSAF----LSLEKLLYLDISYTNTKIDFDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFAN 471
Query: 139 LTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198
T+L +DL +L L +LQ L+ N L + L L LD N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 199 KLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLK 235
++ S +L +L +N + I L+
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQ 568
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 38/209 (18%), Positives = 68/209 (32%), Gaps = 28/209 (13%)
Query: 130 GGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAV 189
G ++ I + ++ + KL+ + + + N L+ + +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS---KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 190 LFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVG 249
L LDL ++ + L L NL L N + S
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS--------------------- 96
Query: 250 PLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVS 308
P L L + L I L +L+ L++ HN + +P F +L +
Sbjct: 97 --PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154
Query: 309 LESLDLSNNNLSEIIPLSLEKLLYLNILL 337
L +DLS N + I L+ L +
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVN 183
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 78/314 (24%), Positives = 142/314 (45%), Gaps = 35/314 (11%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTPELS 82
+ + VS T +L + D + + L+++ +++ S+N LT
Sbjct: 32 GKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEYLNNLT-QINFSNNQLTD------ 82
Query: 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142
++ + N L + ++ N + P + N + L + + + I+ + + NLT+L
Sbjct: 83 -ITPLKNLTKLVDILMNNNQIADITP--LANLTN-LTGLTLFNNQITD--IDPLKNLTNL 136
Query: 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG 202
++L N ++ + L L LQ LSF GN++ P L +L L +LD+ NK+S
Sbjct: 137 NRLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD 191
Query: 203 SIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262
+ LT L +L +N+++ I L L ++ L N + +L LT
Sbjct: 192 --ISVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD--IGTLASLTNLT 246
Query: 263 RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322
+D + N + P + GL L L LG N++ P L +L +L+L+ N L +I
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302
Query: 323 IPLS-LEKLLYLNI 335
P+S L+ L YL +
Sbjct: 303 SPISNLKNLTYLTL 316
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 85/329 (25%), Positives = 145/329 (44%), Gaps = 40/329 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTP--- 79
+ N++ I + NL+ L + NN + L L+++ L LS N ++ +
Sbjct: 98 NNNQIADITPLA--NLTNLTGLTLFNNQITDIDPLKNLTNLN-RLELSSNTISDISALSG 154
Query: 80 -----------ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNI 128
+++ L ++N L++LDIS N + + + +LE + ++ I
Sbjct: 155 LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV--LAKLT-NLESLIATNNQI 211
Query: 129 SGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLA 188
S +G LT+L + L GN+L I TL L L L N++ P L L
Sbjct: 212 SD--ITPLGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISNLAP--LSGLT 265
Query: 189 VLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFV 248
L +L L N++S P LTAL NL L+ N+L I I NLK++ YL + N
Sbjct: 266 KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI-SNLKNLTYLTLYFNNIS 322
Query: 249 GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS 308
P + +L L R+ F NN + D+ + + L ++ +LS GHN++ P +L
Sbjct: 323 DISP--VSSLTKLQRLFFY-NNKVSDVSS-LANLTNINWLSAGHNQISDLTP--LANLTR 376
Query: 309 LESLDLSNNNLSEIIPLSLEKLLYLNILL 337
+ L L++ + + N +
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVSIPNTVK 405
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 62/269 (23%), Positives = 109/269 (40%), Gaps = 21/269 (7%)
Query: 68 SLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCN 127
L +T TP ++ + + + K + + + + + Q + +
Sbjct: 2 PLGSATITQDTP-INQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQ-VTTLQADRLG 57
Query: 128 ISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHL 187
I + + L +L I+ N+L L L KL + N++ P L +L
Sbjct: 58 IK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANL 111
Query: 188 AVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLF 247
L L L N+++ P NLT L L L SN ++ I ++ L + L F N
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS-GLTSLQQLSF-GNQV 167
Query: 248 VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV 307
P + NL L R+D S N + + + L +L+ L +N++ P L
Sbjct: 168 TDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILT 221
Query: 308 SLESLDLSNNNLSEIIPLS-LEKLLYLNI 335
+L+ L L+ N L +I L+ L L L++
Sbjct: 222 NLDELSLNGNQLKDIGTLASLTNLTDLDL 250
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 65/319 (20%), Positives = 126/319 (39%), Gaps = 31/319 (9%)
Query: 25 TIDSQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTP 79
+ N++ + + NL+TL+ D+ +N V L +L+++ + L ++N ++
Sbjct: 160 QLSFGNQVTDLKPLA--NLTTLERLDISSNKVSDISVLAKLTNL-ESLIATNNQISD--- 213
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139
++ + L +L ++ N L + + + L + +++ IS + L
Sbjct: 214 ----ITPLGILTNLDELSLNGNQLKDIGT--LASLTN-LTDLDLANNQISN--LAPLSGL 264
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
T L + LG N+++ L L L L N+LE P + +L L L L N
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
+S P +LT L+ L +N+++ + S L NL +I +L N P + NL
Sbjct: 321 ISDISP--VSSLTKLQRLFFYNNKVSDVSS-LANLTNINWLSAGHNQISDLTP--LANLT 375
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
+T++ + + + L P + D S D++ N
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLP 433
Query: 320 SEIIPLSLEKLLYLNILLI 338
S +S + I
Sbjct: 434 SYTNEVSYTFSQPVTIGKG 452
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 34/230 (14%), Positives = 85/230 (36%), Gaps = 24/230 (10%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTPELS 82
+ N++ + + L+ L + N + L L+++ L L++N L
Sbjct: 251 ANNQISNL--APLSGLTKLTELKLGANQISNISPLAGLTALT-NLELNENQLED------ 301
Query: 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142
+S +SN K L L + N + P V + ++ L+ ++ + +S + NLT++
Sbjct: 302 -ISPISNLKNLTYLTLYFNNISDISP--VSSLTK-LQRLFFYNNKVSD--VSSLANLTNI 355
Query: 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG 202
+ G N+++ + L ++ L + N ++++ + L
Sbjct: 356 NWLSAGHNQISDLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI- 412
Query: 203 SIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLP 252
P + + + N + + + + + + F G +
Sbjct: 413 -APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 50/196 (25%), Positives = 71/196 (36%), Gaps = 45/196 (22%)
Query: 373 RRFSYQELLRATDGFS------ANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS------ 420
FS+ EL T+ F N +G G FG VYK + + A+K
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 421 ---------------------------CSNEDFRALVLEYTTNGSLEKVLYSSNY--ILD 451
S+ D LV Y NGSL L + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 452 ILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
R I + + +LH IH D+K N LLD+ A +SDFG+A+ Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 512 SMTQTQTLAIIGYMAP 527
++ ++ + YMAP
Sbjct: 189 TVMTSRIVGTTAYMAP 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 48/264 (18%), Positives = 99/264 (37%), Gaps = 22/264 (8%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
++D+ L + L + +K+LD+S NPL + F+ LE + +S
Sbjct: 14 IEKVTDSSLKQALASL-----RQSAWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSS 67
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185
+ + ++ +L+ L ++DL N + L ++ L N + +
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP--SILWNLKDILYLDFW 243
+ L NK++ G + ++ L L NE+ ++ + + + +L+
Sbjct: 121 GKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 244 SNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF 303
N + ++ L +D S N L + Q + ++SL +N+L I +
Sbjct: 178 YNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 304 DDLVSLESLDLSNNNLSEIIPLSL 327
+LE DL N
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDF 257
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 41/224 (18%), Positives = 88/224 (39%), Gaps = 16/224 (7%)
Query: 116 QSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNE 175
+ ++D ++ ++ + ++ +DL GN L+ + L KL+ L+ N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 176 LEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNL 234
L + L L+ L LDL N + + ++ LH +N ++ + S
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRVSCSRGQGK 122
Query: 235 KDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG-DIPTTIQGLKSLQFLSLGHN 293
K + +N G + +D N + + +L+ L+L +N
Sbjct: 123 K---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 294 RLQGSIPNSFDDLVSLESLDLSNNNLSEIIP--LSLEKLLYLNI 335
+ + L++LDLS+N L+ + P S + ++++
Sbjct: 180 FIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISL 221
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 52/298 (17%), Positives = 107/298 (35%), Gaps = 33/298 (11%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD--------ELSLSDNYLTSSTP 79
S N L I + + + L++ ++ +N L +D L L++NY+
Sbjct: 42 SGNPLSQISAADLAPFTKLELLNLSSN----VLYETLDLESLSTLRTLDLNNNYVQ---- 93
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139
EL S ++ L + N + RV + Q + I++++ I+ + G
Sbjct: 94 ELLVGPS------IETLHAANNNIS----RVSCSRGQGKKNIYLANNKITMLRDLDEGCR 143
Query: 140 TDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198
+ + +DL N+++ + + L+ L+ + N + + A L LDL N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSN 201
Query: 199 KLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN-LFVGPLPSKIGN 257
KL+ + F + + + L +N+L I L +++ + D N G L
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315
+ + + L + G + D L++L
Sbjct: 261 NQRVQTVAKQTVKKLTGQN--EEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 29/177 (16%), Positives = 63/177 (35%), Gaps = 9/177 (5%)
Query: 155 SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTAL 214
+I + + + L+ ++ ++ + +LDL GN LS T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 215 RNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274
L+L SN L + +L + LD +N ++ + + + NN +
Sbjct: 61 ELLNLSSNVLYETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN-ISR 113
Query: 275 IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 331
+ + + + + L +N++ ++ LDL N + + L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 19/86 (22%), Positives = 33/86 (38%), Gaps = 1/86 (1%)
Query: 251 LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLE 310
+ N + ++L + + Q +++ L L N L LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 311 SLDLSNNNLSEIIPLS-LEKLLYLNI 335
L+LS+N L E + L L L L++
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDL 87
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 14/62 (22%), Positives = 26/62 (41%)
Query: 275 IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLN 334
I Q + + + L+ ++ + +++ LDLS N LS+I L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 335 IL 336
+L
Sbjct: 62 LL 63
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 56/280 (20%), Positives = 108/280 (38%), Gaps = 11/280 (3%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
+ + L L N + + ++ +L++L+++ N + P N +L
Sbjct: 30 IPTETRLLDLGKNRIKTLNQ-----DEFASFPHLEELELNENIVSAVEPGAFNNLF-NLR 83
Query: 120 FIWMSDCNISGGISEEI-GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG 178
+ + + I + L++L +D+ NK+ + L L+ L N+L
Sbjct: 84 TLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY 142
Query: 179 SIPNVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPS-ILWNLKD 236
L L QL L L+ SIPT +L L L L + +I L
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 237 ILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296
+ L+ ++ + LT + + NL ++ L L+FL+L +N +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 297 GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ +L+ L+ + L L+ + P + L YL +L
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVL 301
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-28
Identities = 61/305 (20%), Positives = 112/305 (36%), Gaps = 23/305 (7%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD----------ELSLSDNYLTSS 77
+N++ + + L+ +++ N +S++ L L N L
Sbjct: 40 GKNRIKTLNQDEFASFPHLEELELNEN----IVSAVEPGAFNNLFNLRTLGLRSNRLKLI 95
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI- 136
+ + +SN L KLDIS N + L + + L+ + + D ++ IS
Sbjct: 96 PLGV--FTGLSN---LTKLDISENKIVILLDYMFQDLYN-LKSLEVGDNDLVY-ISHRAF 148
Query: 137 GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196
L L + L L + L L L L R + L L L++
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKI 255
++ L +L + LT++P + +L + +L+ N S +
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSML 268
Query: 256 GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315
L L I L P +GL L+ L++ N+L + F + +LE+L L
Sbjct: 269 HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD 328
Query: 316 NNNLS 320
+N L+
Sbjct: 329 SNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 47/232 (20%), Positives = 79/232 (34%), Gaps = 23/232 (9%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166
V + + I +E + L ++L N ++ L L
Sbjct: 23 FVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS 226
+ L R N L+ V L+ L +LD+ NK+ + F +L L++L + N+L
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY 142
Query: 227 IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQ 286
I F G L L ++ + NL + L L
Sbjct: 143 ISH---------------RAFSG--------LNSLEQLTLEKCNLTSIPTEALSHLHGLI 179
Query: 287 FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLI 338
L L H + SF L L+ L++S+ + + + L L L I
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 48/264 (18%), Positives = 99/264 (37%), Gaps = 22/264 (8%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
++D+ L + L + +K+LD+S NPL + F+ LE + +S
Sbjct: 14 IEKVTDSSLKQALASL-----RQSAWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSS 67
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185
+ + ++ +L+ L ++DL N + L ++ L N + +
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP--SILWNLKDILYLDFW 243
+ L NK++ G + ++ L L NE+ ++ + + + +L+
Sbjct: 121 GKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 244 SNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF 303
N + ++ L +D S N L + Q + ++SL +N+L I +
Sbjct: 178 YNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 304 DDLVSLESLDLSNNNLSEIIPLSL 327
+LE DL N
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDF 257
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 50/363 (13%), Positives = 107/363 (29%), Gaps = 28/363 (7%)
Query: 39 TIFNLSTLKVFDVDNNYVLGRLSSI-------VDELSLSDNYLTSSTPELSFLSSMSNCK 91
+ +++ NN +S + + L++N +T
Sbjct: 94 ELLVGPSIETLHAANN----NISRVSCSRGQGKKNIYLANNKITMLRDL-----DEGCRS 144
Query: 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNK 151
++ LD+ N +D + S +LE + + I + ++ L ++DL NK
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNK 202
Query: 152 LNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS-GSIPTCFGN 210
L + + ++S R N+L I L L DLRGN G++ F
Sbjct: 203 LA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
Query: 211 LTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLP-SKIGNLKVLTRIDFS-- 267
++ + + + + L + LP L L R + +
Sbjct: 261 NQRVQTV--AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 268 --RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 325
+ + + + + + + + I + +L+ L E +
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN 378
Query: 326 SLEKLLYLNILLIVVVILALKFGLISRCQKRATKLPNVSNMQPQASRRRFSYQELLRATD 385
L+ L V V + ++ +R D
Sbjct: 379 GRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWD 438
Query: 386 GFS 388
+
Sbjct: 439 MYQ 441
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 52/320 (16%), Positives = 112/320 (35%), Gaps = 33/320 (10%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD--------ELSLSDNYLTSSTP 79
S N L I + + + L++ ++ +N L +D L L++NY+
Sbjct: 42 SGNPLSQISAADLAPFTKLELLNLSSN----VLYETLDLESLSTLRTLDLNNNYVQ---- 93
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139
EL S ++ L + N + + Q + I++++ I+ + G
Sbjct: 94 ELLVGPS------IETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCR 143
Query: 140 TDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198
+ + +DL N+++ + + L+ L+ + N + + + A L LDL N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSN 201
Query: 199 KLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN-LFVGPLPSKIGN 257
KL+ + F + + + L +N+L I L +++ + D N G L
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317
+ + + L + G + D L++L+ + +
Sbjct: 261 NQRVQTVAKQTVKKLTGQN--EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 318 NLSEIIPLSLEKLLYLNILL 337
+ LE
Sbjct: 319 SGQGSETERLECERENQARQ 338
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 41/224 (18%), Positives = 87/224 (38%), Gaps = 16/224 (7%)
Query: 116 QSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNE 175
+ ++D ++ ++ + ++ +DL GN L+ + L KL+ L+ N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 176 LEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNL 234
L ++ L L+ L LDL N + ++ LH +N ++ + S
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGK 122
Query: 235 KDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG-DIPTTIQGLKSLQFLSLGHN 293
K + +N G + +D N + + +L+ L+L +N
Sbjct: 123 K---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 294 RLQGSIPNSFDDLVSLESLDLSNNNLSEIIP--LSLEKLLYLNI 335
+ L++LDLS+N L+ + P S + ++++
Sbjct: 180 FIYDVKGQVV--FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISL 221
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 28/169 (16%), Positives = 61/169 (36%), Gaps = 9/169 (5%)
Query: 163 LQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222
+ + + L+ ++ ++ + +LDL GN LS T L L+L SN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 223 ELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGL 282
L + +L + LD +N ++ + + + NN + + +
Sbjct: 69 VLYETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN-ISRVSCSR--G 119
Query: 283 KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 331
+ + + L +N++ ++ LDL N + + L
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 24/159 (15%), Positives = 59/159 (37%), Gaps = 11/159 (6%)
Query: 179 SIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI-PSILWNLKDI 237
+I + + + + L ++ + + ++ L L N L+ I + L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 238 LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
L+ SN+ L + +L L +D + N + + S++ L +N +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 298 SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ +++ L+NN ++ + L + L
Sbjct: 114 VSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 27/269 (10%), Positives = 57/269 (21%), Gaps = 19/269 (7%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY------VLGRLSSIVDELSLSDNYLTSSTPEL 81
S NKL + + + + + NN L ++ + L N T
Sbjct: 199 SSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNL-EHFDLRGNGFHCGTLRD 256
Query: 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141
F K + +++ + L + L
Sbjct: 257 FFS------KNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309
Query: 142 LISIDLGGNKLNGS----ISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
L + GS + + + + + I V L+ +
Sbjct: 310 LKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGN 257
L + L + + + L + +
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSV 429
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQGLKSLQ 286
R + + LK L
Sbjct: 430 QNNAIRDWDMYQHKETQLAEENARLKKLN 458
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 62/316 (19%), Positives = 120/316 (37%), Gaps = 30/316 (9%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNN-------YVLGRLSSIVDELSLSDNYLTSSTPE 80
+ + + + + + +++ ++++ Y +I +L + N + P
Sbjct: 53 KNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQ-KLYMGFNAIRYLPPH 111
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI-GNL 139
+ N L L + RN L LPR + + + L + MS+ N+ I ++
Sbjct: 112 V-----FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 164
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
T L ++ L N+L + L + L + N L L + +LD N
Sbjct: 165 TSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 216
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
++ + L L L N LT L N ++ +D N + ++
Sbjct: 217 IN-VVR--GPVNVELTILKLQHNNLTDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
L R+ S NN L + Q + +L+ L L HN L + + LE+L L +N++
Sbjct: 273 RLERLYIS-NNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
Query: 320 SEIIPLSLEKLLYLNI 335
+ + L L +
Sbjct: 331 VTLKLSTHHTLKNLTL 346
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 54/277 (19%), Positives = 101/277 (36%), Gaps = 15/277 (5%)
Query: 61 SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120
S++ + D ++ T ++ F K + + + ++ +F Q +E
Sbjct: 15 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ-VEL 73
Query: 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSI 180
+ ++D I + + + +G N + + L L N+L
Sbjct: 74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 133
Query: 181 PNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDILY 239
+ + L L + N L F T+L+NL L SN LT + S++ +L +
Sbjct: 134 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF---H 190
Query: 240 LDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI 299
+ NL S + + +D S N+ + + + L L L HN L
Sbjct: 191 ANVSYNLL-----STLAIPIAVEELDASHNS-INVVRGPV--NVELTILKLQHNNLT-DT 241
Query: 300 PNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ L +DLS N L +I+ K+ L L
Sbjct: 242 A-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 57/317 (17%), Positives = 105/317 (33%), Gaps = 55/317 (17%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNN-------YVLGRLSSIVDELSLSDNYLTSSTPE 80
N + + N+ L V ++ N + + LS+S+N L +
Sbjct: 101 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT-TLSMSNNNLERIEDD 159
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
L+ L +S N L SL +S +S +
Sbjct: 160 T-----FQATTSLQNLQLSSNRLTHVDL---SLIP-SLFHANVSYNLLS-----TLAIPI 205
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
+ +D N +N + +L L + N L L + L ++DL N+L
Sbjct: 206 AVEELDASHNSIN---VVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNEL 260
Query: 201 SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
+ F + L L++ +N L ++ + LKV
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP---------------------TLKV 299
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
L D S N+LL + L+ L L HN + ++ +L++L LS+N+
Sbjct: 300 L---DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
Query: 321 EIIPLSLEKLLYLNILL 337
+L + + +
Sbjct: 353 CNSLRALFRNVARPAVD 369
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 26/159 (16%), Positives = 53/159 (33%), Gaps = 1/159 (0%)
Query: 179 SIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDI 237
I + L + V + + + L + + ++ + +P+ +L + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 238 LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
L+ + ++ N + P Q + L L L N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 298 SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
F + L +L +SNNNL I + + L L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 53/279 (18%), Positives = 100/279 (35%), Gaps = 15/279 (5%)
Query: 66 ELSLSDNYLTSSTPELSFLSSM-SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMS 124
L++ + L L + + + + + ++ Q LE +
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 125 DCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE--GSIPN 182
L L + NK + S L L+FL N L G
Sbjct: 316 FGQFPTL------KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 183 VLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP--SILWNLKDILYL 240
L LDL N + ++ + F L L +L + L + S+ +L++++YL
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 241 DFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSI 299
D L L + + N+ + I L++L FL L +L+
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 300 PNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLI 338
P +F+ L SL+ L++++N L + ++L L + +
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL 525
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 63/305 (20%), Positives = 107/305 (35%), Gaps = 14/305 (4%)
Query: 23 ICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDN--YLTSSTPE 80
+ ++ L + L L + + Y+ L I+D + N + +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
+ + S + L++ F +SL+ + + SE +L
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPT----LKLKSLKRLTFTSNKGGNAFSEV--DLP 347
Query: 141 DLISIDLGGNKLN--GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198
L +DL N L+ G S + L++L N + ++ + L L LD + +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 406
Query: 199 KLSGSIPTC-FGNLTALRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPLPSKI- 255
L F +L L L + I L + L N F I
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 256 GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315
L+ LT +D S+ L PT L SLQ L++ N+L+ FD L SL+ + L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526
Query: 316 NNNLS 320
N
Sbjct: 527 TNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 48/242 (19%), Positives = 85/242 (35%), Gaps = 12/242 (4%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166
++ N S + + +S + S + +L +DL ++ L L
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS 226
L GN ++ L+ L +L L+ G+L L+ L++ N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 227 I--PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS---RNNLLGDIPTTIQG 281
P NL ++ +LD SN + + L + ++ S N + I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 282 LKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDL------SNNNLSEIIPLSLEKLLYLN 334
L L+L +N ++ L LE L + NL + +LE L L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 335 IL 336
I
Sbjct: 259 IE 260
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 69/334 (20%), Positives = 119/334 (35%), Gaps = 40/334 (11%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
+ N + + LS+L+ +G L ++ EL+++ N + S
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK-ELNVAHNLIQS---- 138
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ---SLEFIWMSDCNISGGISEEIG 137
SN L+ LD+S N + + Q + +S ++ I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 138 NLTDLISIDLGGNKLNGSI-SITLGKLQKLQFLS------FRGNELEGSIPNVLCHLAVL 190
L + L N + ++ + L L+ LE + L L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 191 FQLDLRGNKLSGS---IPTCFGNLTALRNLHLDSNELTSIP--SILWNLKDILYLDFWSN 245
+ R L I F LT + + L S + + S + + + ++
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 246 LFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ--GSIPNSF 303
F LK L R+ F+ +N G+ + + L SL+FL L N L G S
Sbjct: 318 QF------PTLKLKSLKRLTFT-SNKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 304 DDLVSLESLDLSNNNLSEIIP--LSLEKLLYLNI 335
SL+ LDLS N + + L LE+L +L+
Sbjct: 370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF 403
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-23
Identities = 56/256 (21%), Positives = 96/256 (37%), Gaps = 13/256 (5%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152
K LD+S NPL +F + L+ + +S C I +L+ L ++ L GN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL-SGSIPTCFGNL 211
L LQ L L + HL L +L++ N + S +P F NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 212 TALRNLHLDSNELTSIPS----ILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS 267
T L +L L SN++ SI +L + + S + + L ++
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 268 RNNLLGDIP-TTIQGLKSLQFLSL------GHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
N ++ T IQGL L+ L L+ ++ + L +L + L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 321 EIIPLSLEKLLYLNIL 336
+ ++ L +
Sbjct: 269 YYLDDIIDLFNCLTNV 284
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-22
Identities = 48/279 (17%), Positives = 85/279 (30%), Gaps = 37/279 (13%)
Query: 28 SQNKLVGIVSITIF-NLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSS 86
+ + + L++ + + L+ + N + S
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-------AFS 342
Query: 87 MSNCKYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSDCNISGGISEEIGNLTDLIS 144
+ L+ LD+SRN L F + SL+++ +S + +S L L
Sbjct: 343 EVDLPSLEFLDLSRNGLS-FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEH 400
Query: 145 IDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGS 203
+D + L S L+ L +L + + L+ L L + GN +
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 204 IPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262
F L L L L +L + P+ +L L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLS-----------------------PTAFNSLSSLQ 497
Query: 263 RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301
++ + N L L SLQ + L N S P
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 59/325 (18%), Positives = 114/325 (35%), Gaps = 43/325 (13%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
S N L + S + F+ L+V D+ + +I + ++
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRC----EIQTI---------------EDGAY---- 72
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDL 147
+ +L L ++ NP+ L + SL+ + + N++ + IG+L L +++
Sbjct: 73 QSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 148 GGNKLN-GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVL----FQLDLRGNKLSG 202
N + + L L+ L N+++ L L + LDL N ++
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 203 SIPTCFGNLTALRNLHLDSNELTS--IPSILWNLK--DILYLDFWSNLFVGPLPSK-IGN 257
P F + L L L +N + + + + L ++ L G L
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 258 LKVLTRIDFSRNNL------LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311
L+ L + L L DI L ++ SL ++ S++ +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF--GWQH 308
Query: 312 LDLSNNNLSEIIPLSLEKLLYLNIL 336
L+L N + L L+ L L
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFT 333
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 40/148 (27%), Positives = 61/148 (41%), Gaps = 2/148 (1%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPL 251
LDL N L F + L+ L L E+ +I +L + L N
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ-GSIPNSFDDLVSLE 310
L L ++ NL I LK+L+ L++ HN +Q +P F +L +LE
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 311 SLDLSNNNLSEIIPLSLEKLLYLNILLI 338
LDLS+N + I L L + +L +
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 44/216 (20%), Positives = 80/216 (37%), Gaps = 20/216 (9%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNN---------YVLGRLSSIVDELSLSDNYLTSST 78
+ NK + +L +L+ D+ N +S+ L LS N + + +
Sbjct: 333 TSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK-YLDLSFNGVITMS 389
Query: 79 PELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGN 138
L L+ LD + L V ++L ++ +S + +
Sbjct: 390 SNFLGLEQ------LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 139 LTDLISIDLGGNKLNGSI-SITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
L+ L + + GN + +L+ L FL +LE P L+ L L++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELT-SIPSILW 232
N+L F LT+L+ + L +N S P I +
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 43/203 (21%), Positives = 67/203 (33%), Gaps = 48/203 (23%)
Query: 367 QPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDF 426
+S + L + + RG FG V+KA+L A+K+F
Sbjct: 6 HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ 64
Query: 427 RA--------------------------------LVLEYTTNGSLEKVLYSSNYILDILQ 454
L+ + GSL L ++ +
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNE 122
Query: 455 RLNIMIDVTSALEYLH------FGYSTP-IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507
+I + L YLH P I H D+K N LL +N+ A ++DFG+A
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF- 181
Query: 508 GEDQSMTQTQTLAIIG---YMAP 527
+ + T +G YMAP
Sbjct: 182 --EAGKSAGDTHGQVGTRRYMAP 202
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 50/231 (21%), Positives = 77/231 (33%), Gaps = 8/231 (3%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLG---KL 163
L V S + + + LT L + L N L+
Sbjct: 19 LTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGT 77
Query: 164 QKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTC-FGNLTALRNLHLDSN 222
L++L N + ++ + L L LD + + L F +L L L +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 223 ELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKI-GNLKVLTRIDFSRNNLLGDIPTTIQ 280
+ I L + L N F I L+ LT +D S+ L PT
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 281 GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 331
L SLQ L++ HN + L SL+ LD S N++ L+
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 53/259 (20%), Positives = 80/259 (30%), Gaps = 35/259 (13%)
Query: 67 LSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS--QSLEFIWMS 124
L L N L S L KL +S N L F + SL+++ +S
Sbjct: 33 LELESNKLQSLPH-----GVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGTTSLKYLDLS 86
Query: 125 DCNISGGISEEIGNLTDLISIDLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSIPNV 183
+ +S L L +D + L L+ L +L + +
Sbjct: 87 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145
Query: 184 LCHLAVLFQLDLRGNKLSGSI-PTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDF 242
L+ L L + GN + P F L L L L +L +
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP------------- 192
Query: 243 WSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS 302
F L L ++ S NN + L SLQ L N + S
Sbjct: 193 --TAFNS--------LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
Query: 303 FDDLV-SLESLDLSNNNLS 320
SL L+L+ N+ +
Sbjct: 243 LQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 52/197 (26%), Positives = 79/197 (40%), Gaps = 7/197 (3%)
Query: 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS-- 201
I L S+ G L N+L+ V L L +L L N LS
Sbjct: 11 EIRCNSKGLT---SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 202 GSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN-LFVGPLPSKIGNLKV 260
G T+L+ L L N + ++ S L+ + +LDF + L S +L+
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI-PNSFDDLVSLESLDLSNNNL 319
L +D S + GL SL+ L + N Q + P+ F +L +L LDLS L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 320 SEIIPLSLEKLLYLNIL 336
++ P + L L +L
Sbjct: 188 EQLSPTAFNSLSSLQVL 204
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 65/330 (19%), Positives = 118/330 (35%), Gaps = 42/330 (12%)
Query: 42 NLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLK 94
L+T + + NY L + L L Y + + +F N L+
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQ-LLELGSQYTPLTIDKEAF----RNLPNLR 76
Query: 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEE--IGNLTDLISIDLGGNKL 152
LD+ + + P L + + C +S + ++ NL L +DL N++
Sbjct: 77 ILDLGSSKIYFLHPDAFQGLF-HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
Query: 153 NG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAV--LFQLDLRGNKLSGSIPTCFG 209
+ + GKL L+ + F N++ + L L L L N L + +G
Sbjct: 136 RSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195
Query: 210 NL------TALRNLHLDSNELTSIPS-------------ILWNLKDILYLDFWSNLFVGP 250
L L + N T + L I+ F + P
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255
Query: 251 LPSKIGNLKV--LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS 308
+ L + +D S + + LK L+ L+L +N++ +F L +
Sbjct: 256 DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN 315
Query: 309 LESLDLSNNNLSEIIPLS---LEKLLYLNI 335
L+ L+LS N L E+ + L K+ Y+++
Sbjct: 316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 62/335 (18%), Positives = 116/335 (34%), Gaps = 35/335 (10%)
Query: 37 SITIFNLSTLKVFDVDNNYVLGRLSSIVD----ELSLSDNYLTSSTPELSF-------LS 85
+++ F+L+ ++ + ++ + L +S N T
Sbjct: 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234
Query: 86 SMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ-SLEFIWMSDCNISGGISEEIGNLTDLIS 144
S+ ++ + + ++ S+ + +S + S L DL
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294
Query: 145 IDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI 204
++L NK+N L LQ L+ N L + L + +DL+ N ++
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354
Query: 205 PTCFGNLTALRNLHLDSNELTSIPSI---------LWNLKDILYLDFWSN--------LF 247
F L L+ L L N LT+I I L + ++ +N L
Sbjct: 355 DQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE 414
Query: 248 VGPLPSKIGNLKVLTRIDFSRNNLLG-DIPTTIQGLKSLQFLSLGHNRLQGSI-----PN 301
+ + + L + ++N T SL+ L LG N LQ + +
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474
Query: 302 SFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
F+ L L+ L L++N L+ + P L L L
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 72/315 (22%), Positives = 108/315 (34%), Gaps = 24/315 (7%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSN 89
L+ I + D D N G S V L LS ++ S
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS-----RVFET 288
Query: 90 CKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGG 149
K LK L+++ N ++ +L+ + +S + S L + IDL
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 150 NKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFG 209
N + T L+KLQ L R N L + + + + L GNKL
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINL- 401
Query: 210 NLTALRNLHLDSNELTSIP--SILWNLKDILYLDFWSNLFVG-PLPSKIGNLKVLTRIDF 266
+HL N L ++ L + + L N F L ++
Sbjct: 402 ---TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 267 SRNNLLGDIPTTI-----QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321
N L T + +GL LQ L L HN L P F L +L L L++N L+
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV 518
Query: 322 IIPLSLEKLL-YLNI 335
+ L L L+I
Sbjct: 519 LSHNDLPANLEILDI 533
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 63/341 (18%), Positives = 112/341 (32%), Gaps = 37/341 (10%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV-------DELSLSDNYLTSSTPE 80
S N + + + + L L++ ++ + Y + L L + +
Sbjct: 32 SFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF-LHP 90
Query: 81 LSFLSSMSNCKYLKKLDISRNPL-DGFLPRVVGNFSQSLEFIWMSDCNISG-GISEEIGN 138
+F +L +L + L D L ++L + +S I + G
Sbjct: 91 DAF----QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK 146
Query: 139 LTDLISIDLGGNKLNGSISITLGKLQ--KLQFLSFRGNELEGSIPNVLCHLAVLFQ---- 192
L L SID N++ L LQ L F S N L + F+
Sbjct: 147 LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206
Query: 193 --LDLRGNKLSGSIPTCFGN------------LTALRNLHLDSNELTSIP-SILWNLKD- 236
LD+ GN + I F N + + + + L
Sbjct: 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 237 -ILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL 295
+ +LD LK L ++ + N + GL +LQ L+L +N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 296 QGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
++F L + +DL N+++ I + + L L L
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 39/180 (21%), Positives = 63/180 (35%), Gaps = 27/180 (15%)
Query: 163 LQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI-PTCFGNLTALRNLHLDS 221
L + L N + + L L L+L +I F NL LR L L S
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 222 NELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI--PTTI 279
+++ + + F G L L + L +
Sbjct: 83 SKIYFLHP---------------DAFQG--------LFHLFELRLYFCGLSDAVLKDGYF 119
Query: 280 QGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLI 338
+ LK+L L L N+++ + SF L SL+S+D S+N + + LE L +
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 42/163 (25%), Positives = 61/163 (37%), Gaps = 34/163 (20%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFR------------------------- 427
+GRG+FG V KA+ + + AIK + F
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV 74
Query: 428 ALVLEYTTNGSLEKVLYSSN--YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPH 485
LV+EY GSL VL+ + ++ + + + YLH +IH DLKP
Sbjct: 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 486 NKLLDDN-IVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
N LL V + DFG A + + A +MAP
Sbjct: 135 NLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAA---WMAP 172
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 39/169 (23%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSN----EDFR--------------------- 427
IG GSFG+V++A G + A+K+ + +F
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 428 ------ALVLEYTTNGSLEKVLYSSN--YILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
++V EY + GSL ++L+ S LD +RL++ DV + YLH + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLAIIGYMAP 527
+LK N L+D + DFG+++L S T +MAP
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE---WMAP 208
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 59/316 (18%), Positives = 117/316 (37%), Gaps = 30/316 (9%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNN-------YVLGRLSSIVDELSLSDNYLTSSTPE 80
+ + + + + + +++ ++++ Y +I +L + N + P
Sbjct: 59 KNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQ-KLYMGFNAIRYLPPH 117
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI-GNL 139
+ N L L + RN L + N L + MS+ N+ I ++
Sbjct: 118 V-----FQNVPLLTVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLE-RIEDDTFQAT 170
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
T L ++ L N+L + L + L + N L ++ + +LD N
Sbjct: 171 TSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLLS-TLAI----PIAVEELDASHNS 222
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
++ + L L L N LT L N ++ +D N + ++
Sbjct: 223 IN-VVR--GPVNVELTILKLQHNNLTDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
L R+ S NN L + Q + +L+ L L HN L + + LE+L L +N++
Sbjct: 279 RLERLYIS-NNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 336
Query: 320 SEIIPLSLEKLLYLNI 335
+ + L L +
Sbjct: 337 VTLKLSTHHTLKNLTL 352
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 54/277 (19%), Positives = 101/277 (36%), Gaps = 15/277 (5%)
Query: 61 SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120
S++ + D ++ T ++ F K + + + ++ +F Q +E
Sbjct: 21 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ-VEL 79
Query: 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSI 180
+ ++D I + + + +G N + + L L N+L
Sbjct: 80 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 139
Query: 181 PNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDILY 239
+ + L L + N L F T+L+NL L SN LT + S++ +L +
Sbjct: 140 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF---H 196
Query: 240 LDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI 299
+ NL S + + +D S N++ + + L L L HN L
Sbjct: 197 ANVSYNLL-----STLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNLT-DT 247
Query: 300 PNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ L +DLS N L +I+ K+ L L
Sbjct: 248 A-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 7e-23
Identities = 56/300 (18%), Positives = 100/300 (33%), Gaps = 55/300 (18%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNN-------YVLGRLSSIVDELSLSDNYLTSSTPE 80
N + + N+ L V ++ N + + LS+S+N L +
Sbjct: 107 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT-TLSMSNNNLERIEDD 165
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
L+ L +S N L SL +S +S +
Sbjct: 166 T-----FQATTSLQNLQLSSNRLTHVDL---SLIP-SLFHANVSYNLLS-----TLAIPI 211
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
+ +D N +N + +L L + N L L + L ++DL N+L
Sbjct: 212 AVEELDASHNSIN---VVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNEL 266
Query: 201 SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
+ F + L L++ +N L ++ + LKV
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP---------------------TLKV 305
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
L D S N+LL + L+ L L HN + ++ +L++L LS+N+
Sbjct: 306 L---DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 3e-18
Identities = 32/204 (15%), Positives = 72/204 (35%), Gaps = 23/204 (11%)
Query: 132 ISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLF 191
I + + + + L + ++F+ + + +L +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251
L+L ++ F ++ L++ N + +P ++F
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP---------------HVF---- 119
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311
N+ +LT + RN+L L LS+ +N L+ ++F SL++
Sbjct: 120 ----QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 312 LDLSNNNLSEIIPLSLEKLLYLNI 335
L LS+N L+ + + L + N+
Sbjct: 176 LQLSSNRLTHVDLSLIPSLFHANV 199
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 26/159 (16%), Positives = 53/159 (33%), Gaps = 1/159 (0%)
Query: 179 SIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDI 237
I + L + V + + + L + + ++ + +P ++L + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 238 LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
L+ + ++ N + P Q + L L L N L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137
Query: 298 SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
F + L +L +SNNNL I + + L L
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 176
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 15/121 (12%), Positives = 39/121 (32%)
Query: 216 NLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI 275
N+ E I S L + + L + F + +
Sbjct: 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 67
Query: 276 PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
+ + ++ L+L +++ +F +++ L + N + + P + + L +
Sbjct: 68 AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127
Query: 336 L 336
L
Sbjct: 128 L 128
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 56/199 (28%), Positives = 74/199 (37%), Gaps = 50/199 (25%)
Query: 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA------ 428
+ E D LIGRG +G+VYK L D A+KVF + ++F
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF-SFANRQNFINEKNIYR 60
Query: 429 ----------------------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMI 460
LV+EY NGSL K L S + D + +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAH 118
Query: 461 DVTSALEYLH------FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514
VT L YLH Y I H DL N L+ ++ +SDFG++ LTG
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 515 QTQTLAI------IGYMAP 527
+ A I YMAP
Sbjct: 179 GEEDNAAISEVGTIRYMAP 197
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 51/246 (20%), Positives = 91/246 (36%), Gaps = 36/246 (14%)
Query: 90 CKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGG 149
L++ + L LP + + + + D N++ + L L ++ G
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLPA---HITTLVIPDNNLT-SLPALPPELRTL---EVSG 90
Query: 150 NKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFG 209
N+L S+ + L +L S L L +L + GN+L+ S+P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLPP 141
Query: 210 NLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRN 269
L L + N+L S+P++ L L ++N LP L+ L+ +
Sbjct: 142 GLQ---ELSVSDNQLASLPALPSELC---KLWAYNNQLTS-LPMLPSGLQELS----VSD 190
Query: 270 NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 329
N L +PT L L + L L+ L +S N L+ +P+ +
Sbjct: 191 NQLASLPTLPSELYKLWAYNNRLTSLPALPSG-------LKELIVSGNRLTS-LPVLPSE 242
Query: 330 LLYLNI 335
L L +
Sbjct: 243 LKELMV 248
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 67/330 (20%), Positives = 115/330 (34%), Gaps = 51/330 (15%)
Query: 43 LSTLKVFDVDNNYVLGRLSSIVDE------LSLSDNYLTSSTPELSFLSSM--------- 87
+ + + +N L+S+ L +S N LTS L +
Sbjct: 60 PAHITTLVIPDN----NLTSLPALPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTH 115
Query: 88 --SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145
+ L KL I N L LP + L+ + +SD ++ + L L
Sbjct: 116 LPALPSGLCKLWIFGNQL-TSLPVLPPG----LQELSVSDNQLAS-LPALPSELCKL--- 166
Query: 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP 205
N+L S+ + LQ+L S N+L S+P + L +L N+L+ S+P
Sbjct: 167 WAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELY---KLWAYNNRLT-SLP 217
Query: 206 TCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRID 265
+ L+ L + N LTS+P + LK L N LP L L
Sbjct: 218 ---ALPSGLKELIVSGNRLTSLPVLPSELK---ELMVSGNRLTS-LPMLPSGLLSL---- 266
Query: 266 FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 325
N L +P ++ L S ++L N L + ++ S ++
Sbjct: 267 SVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAP-GYSGPIIRFDMAGA 325
Query: 326 SLEKLLYLNILLIVVVILALKFGLISRCQK 355
S + L ++ + G + +
Sbjct: 326 SAPRETRALHLAAADWLVPAREGEPAPADR 355
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 63/307 (20%), Positives = 105/307 (34%), Gaps = 39/307 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
S N+L + + L L +F ++ S + +L + N LTS
Sbjct: 89 SGNQLTSL-PVLPPGLLELSIFSNPLTHLPALPSGLC-KLWIFGNQLTSLPVLPP----- 141
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDL 147
L++L +S N L LP + L +W + ++ + L +L +
Sbjct: 142 ----GLQELSVSDNQLAS-LPALPSE----LCKLWAYNNQLTS-LPMLPSGLQEL---SV 188
Query: 148 GGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTC 207
N+L S+ +L KL + R L L +L + GN+L+ S+P
Sbjct: 189 SDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG-------LKELIVSGNRLT-SLPVL 239
Query: 208 FGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS 267
L L + N LTS+P + L L + N LP + +L T ++
Sbjct: 240 PSELK---ELMVSGNRLTSLPMLPSGLL---SLSVYRNQLTR-LPESLIHLSSETTVNLE 292
Query: 268 RNNLLGDIPTTIQGLKSLQFLSLGHNR---LQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324
N L ++ + S S R S P L + L E P
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352
Query: 325 LSLEKLL 331
+
Sbjct: 353 ADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 35/152 (23%), Positives = 59/152 (38%), Gaps = 19/152 (12%)
Query: 185 CHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWS 244
C L++ + L+ ++P C + L + N LTS+P++ L+ L+
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPALPPELR---TLEVSG 90
Query: 245 NLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFD 304
N LP L L+ +L P GL L + N+L S+P
Sbjct: 91 NQLTS-LPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLT-SLPVLPP 141
Query: 305 DLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
L+ L +S+N L+ +P +L L
Sbjct: 142 ---GLQELSVSDNQLAS-LPALPSELCKLWAY 169
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 29/133 (21%), Positives = 45/133 (33%), Gaps = 17/133 (12%)
Query: 203 SIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262
+ C L++ + LT++P L I L N LP+ L+ L
Sbjct: 33 KMRACL--NNGNAVLNVGESGLTTLPDCL--PAHITTLVIPDNNLTS-LPALPPELRTL- 86
Query: 263 RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322
+ S N L +P GL L S L L L + N L+
Sbjct: 87 --EVS-GNQLTSLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLTS- 135
Query: 323 IPLSLEKLLYLNI 335
+P+ L L++
Sbjct: 136 LPVLPPGLQELSV 148
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 39/175 (22%), Positives = 65/175 (37%), Gaps = 46/175 (26%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFSCSN---------EDFR--------------- 427
IG+G FG V+K RL D AIK S ++F+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 428 ----------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+V+E+ G L L + + +L +M+D+ +EY+ + PI
Sbjct: 87 KLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPI 145
Query: 478 IHCDLKPHNKLLD-----DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H DL+ N L + A ++DFG+++ +MAP
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQ---WMAP 195
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-27
Identities = 59/343 (17%), Positives = 124/343 (36%), Gaps = 45/343 (13%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD----------ELSLSDNYLTSS 77
S NK+ I + + L+V + ++ R+++I L LSDN+L+S
Sbjct: 34 SFNKITYIGHGDLRACANLQVLILKSS----RINTIEGDAFYSLGSLEHLDLSDNHLSSL 89
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEE-I 136
+ LK L++ NP + +L+ + + + I
Sbjct: 90 SSSW-----FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 137 GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196
LT L +++ L S +L ++ + L+ +E + L+ + L+LR
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSN-----------ELTSIPSILWNLKDILYLDF--- 242
L+ + + + EL + + L ++ + D
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264
Query: 243 ---WSNLFVGPLPSKIGNLKV--LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
N + S++G ++ + R+ + L D+ T L+ ++ +++ ++++
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324
Query: 298 SIPNSFDDLVSLESLDLSNNNLSEIIPLS------LEKLLYLN 334
+ L SLE LDLS N + E + L L
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 50/340 (14%), Positives = 122/340 (35%), Gaps = 39/340 (11%)
Query: 28 SQNKLVGIVSITIF-NLSTLKVFDVDNNYVLGRLSSIV-------DELSLSDNYLTSSTP 79
N + ++F NL+ L+ + N + I +EL + L +
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139
+ S+ + + + L + + FL + + S+ ++ + D N++ +
Sbjct: 166 Q-----SLKSIRDIHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219
Query: 140 TDLISIDLGGNKLNG----------SISITLGKLQKLQFLSFRGNELEGSIPNVLC---- 185
+ + + + + +L +++F N L P+
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE 279
Query: 186 ----HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILW-NLKDILYL 240
+ +L + L + T + L ++ + ++++++ +P +LK + +L
Sbjct: 280 LGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFL 339
Query: 241 DFWSNLF---VGPLPSKIGNLKVLTRIDFSRNNL--LGDIPTTIQGLKSLQFLSLGHNRL 295
D NL + G L + S+N+L + + LK+L L + N
Sbjct: 340 DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399
Query: 296 QGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
+P+S + L+LS+ + + + L L++
Sbjct: 400 H-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDV 438
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 56/301 (18%), Positives = 100/301 (33%), Gaps = 17/301 (5%)
Query: 25 TIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFL 84
+ S K + + + S ++ + + D S ++
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE 279
Query: 85 SSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLIS 144
+++L I + L L V + ++ I + + + +L L
Sbjct: 280 LGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK-VKRITVENSKVFLVPCSFSQHLKSLEF 338
Query: 145 IDLGGNKLNGSI---SITLGKLQKLQFLSFRGNELE--GSIPNVLCHLAVLFQLDLRGNK 199
+DL N + S G LQ L N L +L L L LD+ N
Sbjct: 339 LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT 398
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKIGNL 258
+P +R L+L S + + + I L+ +L + SN + + L
Sbjct: 399 FH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE-VLDV---SNNNLDSFSLFLPRL 453
Query: 259 KVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN 318
+ L SRN L +P L + + N+L+ FD L SL+ + L N
Sbjct: 454 QEL---YISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508
Query: 319 L 319
Sbjct: 509 W 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 47/235 (20%), Positives = 88/235 (37%), Gaps = 7/235 (2%)
Query: 137 GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196
G + S+DL NK+ L LQ L + + + + L L LDL
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIP--SILWNLKDILYLDFWS-NLFVGPLPS 253
N LS + FG L++L+ L+L N ++ S+ NL ++ L + F
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
Query: 254 KIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLD 313
L L ++ +L +++ ++ + L+L + + D L S+ L+
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 314 LSNNNLSEIIPLSLEKLLYLNIL----LIVVVILALKFGLISRCQKRATKLPNVS 364
L + NL+ L + + V+ F + + + +L V
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 52/298 (17%), Positives = 98/298 (32%), Gaps = 27/298 (9%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
L++ + L LS N +T + C L+ L + + + + SLE
Sbjct: 24 LTAAMKSLDLSFNKITYIGH-----GDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLE 77
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEG 178
+ +SD ++S S G L+ L ++L GN ++ L LQ L E
Sbjct: 78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 179 SIP-NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKD 236
I L L +L+++ L ++ + +L L +E + L
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 237 ILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNL----------LGDIPTTIQGLKSLQ 286
+ YL+ S + +V + + L + I L ++
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 287 FLSLGHNRLQGSIPNSFD--------DLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
F N L P+ D + V++ L + L + L + +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 57/298 (19%), Positives = 102/298 (34%), Gaps = 18/298 (6%)
Query: 4 EKLNNRQLDGGMTGDVCYRICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSI 63
+KL R +T + + + + V L+ L F+ + V+ L +
Sbjct: 226 KKLAFRGSV--LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283
Query: 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWM 123
+ +++ ++ + S + +K++ + + + +P +SLEF+ +
Sbjct: 284 -ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL 341
Query: 124 SDCNISGGI---SEEIGNLTDLISIDLGGNKLN--GSISITLGKLQKLQFLSFRGNELEG 178
S+ + S G L ++ L N L L L+ L L N
Sbjct: 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH- 400
Query: 179 SIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDIL 238
+P+ + L+L + + TC L L + +N L S L L+
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTC--IPQTLEVLDVSNNNLDSFSLFLPRLQ--- 454
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296
L N LP VL + SRN L L SLQ + L N
Sbjct: 455 ELYISRNKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 35/234 (14%), Positives = 79/234 (33%), Gaps = 3/234 (1%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166
+ + +++ + +S I+ ++ +L + L +++N L L
Sbjct: 17 FTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG-SIPTCFGNLTALRNLHLDS-NEL 224
+ L N L + L+ L L+L GN + + F NLT L+ L + +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 225 TSIP-SILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLK 283
+ I L + L+ + + +++ + + + + L
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 284 SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILL 337
S+++L L L + + S + S +LL L +
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 41/239 (17%), Positives = 76/239 (31%), Gaps = 37/239 (15%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
Q L +S L +K V+N+ L S+ L LS+N + +
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE-FLDLSENLMVEEYLK 352
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSDCNISGGISEEIGN 138
S + L+ L +S+N L + + +L + +S + +
Sbjct: 353 NS--ACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQW 408
Query: 139 LTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLF------- 191
+ ++L + + Q L+ L N L+ S L L L+
Sbjct: 409 PEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLK 464
Query: 192 ------------QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDIL 238
+ + N+L F LT+L+ + L +N + L L
Sbjct: 465 TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 523
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 31/169 (18%), Positives = 60/169 (35%), Gaps = 43/169 (25%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSNE----DFR--------------------- 427
+ G ++K R Q G + +KV + DF
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 428 --------ALVLEYTTNGSLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
L+ + GSL VL+ +N+++D Q + +D+ + +LH I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L + ++D+++ A +S + QS + A ++AP
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPA---WVAP 177
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 63/306 (20%), Positives = 103/306 (33%), Gaps = 52/306 (16%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD----------ELSLSDNYLTSS 77
NK+ I NL L + NN ++S I L LS N L
Sbjct: 60 QNNKITEIKDGDFKNLKNLHTLILINN----KISKISPGAFAPLVKLERLYLSKNQLKEL 115
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSDCNI-SGGISE 134
++ + L++L + N + F+ + + + + S GI
Sbjct: 116 PEKM-PKT-------LQELRVHENEITKVRK---SVFNGLNQMIVVELGTNPLKSSGIEN 164
Query: 135 EI-GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQL 193
+ L I + + +I G L L GN++ L L L +L
Sbjct: 165 GAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 221
Query: 194 DLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPS 253
L N +S N LR LHL++N+L +P L + K I + +N
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN-------- 273
Query: 254 KIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI--PNSFDDLVSLES 311
N+ + DF P S +SL N +Q P++F + +
Sbjct: 274 ---NISAIGSNDFCP-------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323
Query: 312 LDLSNN 317
+ L N
Sbjct: 324 VQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 50/233 (21%), Positives = 89/233 (38%), Gaps = 11/233 (4%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152
LD+ N + N L + + + IS L L + L N+L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI--PTCFGN 210
+ + LQ L NE+ +V L + ++L N L S F
Sbjct: 113 K---ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 211 LTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRN 269
+ L + + +T+IP + +L + L+LD N + + L L ++ S N
Sbjct: 170 MKKLSYIRIADTNITTIPQGLPPSLTE-LHLD--GNKITKVDAASLKGLNNLAKLGLSFN 226
Query: 270 NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322
++ ++ L+ L L +N+L +P D ++ + L NNN+S I
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 278
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 46/228 (20%), Positives = 90/228 (39%), Gaps = 12/228 (5%)
Query: 113 NFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172
+ + + + I+ + NL +L ++ L NK++ L KL+ L
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 173 GNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI---PS 229
N+L+ +P + L +L + N+++ + F L + + L +N L S
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 230 ILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQFL 288
+K + Y+ +P G LT + N + + +++GL +L L
Sbjct: 166 AFQGMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKL 221
Query: 289 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
L N + S + L L L+NN L + +P L Y+ ++
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVV 268
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 50/283 (17%), Positives = 102/283 (36%), Gaps = 26/283 (9%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
L L +N +T N K L L + N + + LE +++S
Sbjct: 56 LLDLQNNKITEIKD-----GDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSK 109
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSI--PNV 183
+ + E++ L + + N++ L ++ + N L+ S
Sbjct: 110 NQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 184 LCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDF 242
+ L + + ++ +IP G +L LHLD N++T + + L L ++ L
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 223
Query: 243 WSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS 302
N + N L + + N L+ +P + K +Q + L +N + +I ++
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSN 281
Query: 303 -------FDDLVSLESLDLSNNNL--SEIIPLSLEKLLYLNIL 336
S + L +N + EI P + + +
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 26/123 (21%), Positives = 45/123 (36%), Gaps = 5/123 (4%)
Query: 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG 273
LR + L +P L D LD +N NLK L + N +
Sbjct: 33 LRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 274 DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYL 333
P L L+ L L N+L+ +P +L+ L + N ++++ L +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQM 147
Query: 334 NIL 336
++
Sbjct: 148 IVV 150
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 41/177 (23%), Positives = 62/177 (35%), Gaps = 44/177 (24%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFR----------------------- 427
+G+G +G V++ Q G A+K+F FR
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 428 ---------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH-----FGY 473
L+ Y GSL L LD + L I++ + S L +LH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
I H DLK N L+ N ++D G+A + + + +G YMAP
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN-PRVGTKRYMAP 186
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 40/171 (23%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------ 420
LIG+G FG VY R E AI++
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 421 -CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
C + A++ +L V+ + +LD+ + I ++ + YLH + I+H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
DLK N D+ V ++DFG+ + + + G ++AP
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 40/176 (22%), Positives = 60/176 (34%), Gaps = 42/176 (23%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFR----------------------- 427
IG+G +G V+ + + G + A+KVF + FR
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 428 ---------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH-----FGY 473
L+ +Y NGSL L + LD L + S L +LH
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI--IGYMAP 527
I H DLK N L+ N ++D G+A + + + YM P
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 58/248 (23%), Positives = 102/248 (41%), Gaps = 8/248 (3%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152
K+ +R L +P+ + ++ + + NI ++ +L L + LG N +
Sbjct: 56 FSKVVCTRRGLS-EVPQ---GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLT 212
L L L N L +L+ L +L LR N + F +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVP 171
Query: 213 ALRNLHL-DSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270
+L L L + +L I L ++ YL+ +P+ + L L ++ S N+
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNH 229
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330
P + GL SL+ L + ++++ N+FD L SL L+L++NNLS + L
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289
Query: 331 LYLNILLI 338
YL L +
Sbjct: 290 RYLVELHL 297
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 54/229 (23%), Positives = 83/229 (36%), Gaps = 5/229 (2%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI-GNLTDLISIDLGGNK 151
+ L++ N + + LE + + +I I L L +++L N
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHH-LEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNW 134
Query: 152 LNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDL-RGNKLSGSIPTCFGN 210
L S L KL+ L R N +E + L +LDL KL F
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 211 LTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270
L L+ L+L + +P+ L L + L+ N F P L L ++ +
Sbjct: 195 LFNLKYLNLGMCNIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
+ GL SL L+L HN L + F L L L L +N
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 46/236 (19%), Positives = 79/236 (33%), Gaps = 16/236 (6%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS--QSLEFIWM 123
L+L +N + +F + +L+ L + RN + + G F+ SL + +
Sbjct: 79 YLNLMENNIQM-IQADTF----RHLHHLEVLQLGRNSI-RQIEV--GAFNGLASLNTLEL 130
Query: 124 SDCNISGGISEEI-GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS-FRGNELEGSIP 181
D ++ I L+ L + L N + S ++ L L +LE
Sbjct: 131 FDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE 189
Query: 182 NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYL 240
L L L+L + +P L L L + N I L + L
Sbjct: 190 GAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 241 DFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296
++ + L L ++ + NNL L+ L L L HN
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 25/207 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSI----------VDELSLSDNYLTSS 77
+N + I L++L ++ +N L+ I + EL L +N + S
Sbjct: 107 GRNSIRQIEVGAFNGLASLNTLELFDN----WLTVIPSGAFEYLSKLRELWLRNNPIESI 162
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS--QSLEFIWMSDCNISGGISEE 135
P +F + L +LD+ ++ G F +L+++ + CNI
Sbjct: 163 -PSYAF----NRVPSLMRLDLGELKKLEYISE--GAFEGLFNLKYLNLGMCNIKD--MPN 213
Query: 136 IGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDL 195
+ L L +++ GN + L L+ L +++ N LA L +L+L
Sbjct: 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273
Query: 196 RGNKLSGSIPTCFGNLTALRNLHLDSN 222
N LS F L L LHL N
Sbjct: 274 AHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 35/165 (21%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSNE----DFR--------------------- 427
IG GSFG+VYK + + A+K+ + + F+
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 428 -----ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
A+V ++ SL L++S ++ + ++I ++YLH + IIH DL
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
K +N L ++ + DFG+A + S Q I +MAP
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 61/305 (20%), Positives = 110/305 (36%), Gaps = 54/305 (17%)
Query: 40 IFNLSTLKVFDVDNNYVLGRLSSIVDE------LSLSDNYLTSSTPELSFLSSMSNCKYL 93
+ NL L DNN L + D + +N L L + N +L
Sbjct: 191 LQNLPFLTAIYADNN----SLKKLPDLPLSLESIVAGNNILEE-------LPELQNLPFL 239
Query: 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLN 153
+ N L + + + SLE + + D ++ + E +LT L + + L+
Sbjct: 240 TTIYADNNLL-----KTLPDLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS 293
Query: 154 GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTA 213
L +L+ NE+ S+ ++ L L ++ NKL +P L
Sbjct: 294 ELPP-------NLYYLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPALPPRLE- 340
Query: 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG 273
L N L +P + NLK L N P +++ L N+ L
Sbjct: 341 --RLIASFNHLAEVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDLRM-----NSHLA 389
Query: 274 DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYL 333
++P Q +L+ L + N L+ P+ S+E L +++ + + + E L
Sbjct: 390 EVPELPQ---NLKQLHVETNPLR-EFPDI---PESVEDLRMNSERVVDPYEFAHETTDKL 442
Query: 334 NILLI 338
+
Sbjct: 443 EDDVF 447
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 42/303 (13%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
+ ++ + V + + EL L++ L+S
Sbjct: 42 AWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----AHELELNNLGLSSLPELPP----- 91
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDL 147
+L+ L S N L LP + + +SL + +S L + +
Sbjct: 92 ----HLESLVASCNSLT-ELPELPQSL-KSLLVDNNNLKALSD-------LPPLLEYLGV 138
Query: 148 GGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTC 207
N+L + L+ + N L+ +P++ L + N+L +P
Sbjct: 139 SNNQLEKLPEL--QNSSFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELPE- 190
Query: 208 FGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS 267
NL L ++ D+N L +P + +L+ + +N+ ++ NL LT I
Sbjct: 191 LQNLPFLTAIYADNNSLKKLPDLPLSLE---SIVAGNNILE--ELPELQNLPFLTTIYAD 245
Query: 268 RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 327
NNLL +P SL+ L++ N L +P L L+ + + LSE+ P +L
Sbjct: 246 -NNLLKTLP---DLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-NL 299
Query: 328 EKL 330
L
Sbjct: 300 YYL 302
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 50/255 (19%), Positives = 90/255 (35%), Gaps = 31/255 (12%)
Query: 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGN 150
+L++ + L +P N +S + + G ++ L
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENV-KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 151 KLNGSISITLGK---------LQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
+ + L L+ L N L +P + L L + LS
Sbjct: 69 LDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127
Query: 202 GSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVL 261
P L L + +N+L +P + N + +D +N LP +L+ +
Sbjct: 128 DLPPL-------LEYLGVSNNQLEKLPEL-QNSSFLKIIDVDNNSLKK-LPDLPPSLEFI 178
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321
+ NN L ++P +Q L L + +N L+ +P+ +SLES+ NN L E
Sbjct: 179 A----AGNNQLEELP-ELQNLPFLTAIYADNNSLK-KLPDL---PLSLESIVAGNNILEE 229
Query: 322 IIPLS-LEKLLYLNI 335
+ L L L +
Sbjct: 230 LPELQNLPFLTTIYA 244
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 28/133 (21%), Positives = 44/133 (33%), Gaps = 17/133 (12%)
Query: 210 NLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS-- 267
+ T L+ S+ LT +P N+K + + P G + +
Sbjct: 9 SNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 268 ----------RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317
N L +P L+S L N L +P L SL + +
Sbjct: 69 LDRQAHELELNNLGLSSLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 318 NLSEIIPLSLEKL 330
LS++ P LE L
Sbjct: 125 ALSDLPP-LLEYL 136
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 16/97 (16%)
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV---- 307
P + N + ++ L ++P + +KS + + + P +
Sbjct: 5 PRNVSNTFLQE--PLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 308 ---------SLESLDLSNNNLSEIIPLSLEKLLYLNI 335
L+L+N LS +P L L
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSS-LPELPPHLESLVA 98
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 6/235 (2%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166
L V S + + + + I +L L + L N + L L
Sbjct: 55 LREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHL-DSNEL 224
L N L +L+ L +L LR N + SIP+ F + +LR L L + L
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173
Query: 225 TSIPS-ILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLK 283
+ I L ++ YL+ +P+ + L L +D S N+L P + QGL
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 284 SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLI 338
LQ L + +++Q N+FD+L SL ++L++NNL+ + L +L + +
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHL 286
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 5/229 (2%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI-GNLTDLISIDLGGNK 151
+ L++ N + + LE + +S +I I L +L +++L N+
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRH-LEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNR 123
Query: 152 LNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDL-RGNKLSGSIPTCFGN 210
L + L KL+ L R N +E + L +LDL +LS F
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 211 LTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270
L+ LR L+L L IP+ L L + LD N P L L ++ ++
Sbjct: 184 LSNLRYLNLAMCNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
+ L+SL ++L HN L + F L LE + L +N
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 24/230 (10%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD----------ELSLSDNYLTSS 77
+N++ I + +L L++ + N + +I L L DN LT+
Sbjct: 72 HENQIQIIKVNSFKHLRHLEILQLSRN----HIRTIEIGAFNGLANLNTLELFDNRLTTI 127
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI- 136
+S LK+L + NP++ +P N SL + + + ISE
Sbjct: 128 PNGA--FVYLSK---LKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 137 GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196
L++L ++L L I L L KL L GN L P L L +L +
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDILYLDFWSN 245
+++ F NL +L ++L N LT +P + L + + N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 28/131 (21%), Positives = 48/131 (36%), Gaps = 5/131 (3%)
Query: 206 TCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRID 265
+C + + L +P + + L+ N + +L+ L +
Sbjct: 40 SCSNQFSKVI---CVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQ 94
Query: 266 FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 325
SRN++ GL +L L L NRL +F L L+ L L NN + I
Sbjct: 95 LSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSY 154
Query: 326 SLEKLLYLNIL 336
+ ++ L L
Sbjct: 155 AFNRIPSLRRL 165
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 58/202 (28%), Positives = 80/202 (39%), Gaps = 4/202 (1%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
I L GN+++ + + + L L N L LA+L QLDL N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 200 LSGSIP-TCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKI-G 256
S+ F L L LHLD L + + L + YL N LP
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFR 150
Query: 257 NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
+L LT + N + +GL SL L L NR+ P++F DL L +L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 317 NNLSEIIPLSLEKLLYLNILLI 338
NNLS + +L L L L +
Sbjct: 211 NNLSALPTEALAPLRALQYLRL 232
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 45/210 (21%), Positives = 73/210 (34%), Gaps = 4/210 (1%)
Query: 113 NFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172
+ + I++ IS + +L + L N L + L L+ L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 173 GNELEGSIP-NVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPS- 229
N S+ L L L L L + F L AL+ L+L N L ++P
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 230 ILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLS 289
+L ++ +L N L L R+ +N + P + L L L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 290 LGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
L N L + L +L+ L L++N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 10/183 (5%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
L L N L + ++ L++LD+S N + + L + +
Sbjct: 60 ILWLHSNVLARIDAAA--FTGLAL---LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 126 CNISGGISEEI-GNLTDLISIDLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSIPNV 183
C + + + L L + L N L ++ T L L L GN +
Sbjct: 115 CGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 184 LCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDF 242
L L +L L N+++ P F +L L L+L +N L+++P+ L L+ + YL
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 243 WSN 245
N
Sbjct: 233 NDN 235
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 44/176 (25%), Positives = 63/176 (35%), Gaps = 48/176 (27%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSN------EDFR------------------- 427
IG G FG VY+A G E A+K E+ R
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 428 --------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
LV+E+ G L +VL + +N + + + YLH PIIH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 480 CDLKPHNKLLD--------DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
DLK N L+ N + ++DFG+A+ M+ A +MAP
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYA---WMAP 183
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 60/360 (16%), Positives = 116/360 (32%), Gaps = 61/360 (16%)
Query: 43 LSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELS----FLSSMSNC--KYLKKL 96
L F + N +S + + + +S + C +L
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 97 DISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSI 156
++R L LP N + + ++ + + E +L L D N+L+
Sbjct: 65 QLNRLNLS-SLPD---NLPPQITVLEITQNALIS-LPELPASLEYL---DACDNRLS--- 113
Query: 157 SITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRN 216
++P + L LD+ N+L+ +P L
Sbjct: 114 ----------------------TLPELPASLK---HLDVDNNQLT-MLPELPALL---EY 144
Query: 217 LHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276
++ D+N+LT +P + +L+ +L + N + LP +L+ L NLL +P
Sbjct: 145 INADNNQLTMLPELPTSLE-VLSV---RNNQLTFLPELPESLEAL----DVSTNLLESLP 196
Query: 277 TTIQGLKSLQ----FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLY 332
+ F NR+ IP + L ++ L +N LS I SL +
Sbjct: 197 AVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 333 LNILLIVVVILALKFGLISRCQK--RATKLPNVSNMQPQASRRRFSYQELLRATDGFSAN 390
+ ++ G + + + + + E + FSA
Sbjct: 256 QPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAF 315
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 40/176 (22%), Positives = 63/176 (35%), Gaps = 42/176 (23%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFR----------------------- 427
IG+G FG V++ + + G E A+K+F FR
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 428 ---------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH-----FGY 473
LV +Y +GSL L + Y + + + + + S L +LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI--IGYMAP 527
I H DLK N L+ N ++D G+A ++ + YMAP
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 54/305 (17%), Positives = 99/305 (32%), Gaps = 38/305 (12%)
Query: 35 IVSITIFNLSTLKVFDVDNNYV----LGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNC 90
I ++ + + L D+N + + L+ + L+ N LT S
Sbjct: 76 ITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLT-YLNCDTNKLTKLDV--------SQN 126
Query: 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGN 150
L L+ +RN L V + +Q L + ++ T L ++D N
Sbjct: 127 PLLTYLNCARNTLTEI---DVSHNTQ-LTELDCHLNKKIT--KLDVTPQTQLTTLDCSFN 180
Query: 151 KLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGN 210
K+ + + + + L L+ N + + L L LD NKL+ I
Sbjct: 181 KIT---ELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTP 231
Query: 211 LTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270
LT L N LT + + L + L + + + + L
Sbjct: 232 LTQLTYFDCSVNPLTELD--VSTLSKLTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGCR 286
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330
+ ++ + L L + + L L L+N L+E+ KL
Sbjct: 287 KIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTELDVSHNTKL 341
Query: 331 LYLNI 335
L+
Sbjct: 342 KSLSC 346
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 55/315 (17%), Positives = 104/315 (33%), Gaps = 61/315 (19%)
Query: 26 IDSQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTPE 80
+ + ++ +I+ L+TL D N+ + + +L+ + +L + N +T+
Sbjct: 24 VAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLT-KLICTSNNITT---- 78
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT 140
L S L L N L V + L ++ ++ ++
Sbjct: 79 LDL----SQNTNLTYLACDSNKLTNL---DVTPLT-KLTYLNCDTNKLT---KLDVSQNP 127
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
L ++ N L I + +L L N+ + + L LD NK+
Sbjct: 128 LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182
Query: 201 SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260
+ + L L+ D+N +T + +
Sbjct: 183 T-ELD--VSQNKLLNRLNCDTNNITKLD--------------------------LNQNIQ 213
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
LT +D S +N L +I + L L + N L + S L L +L +L
Sbjct: 214 LTFLDCS-SNKLTEID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL 267
Query: 321 EIIPLSLEKLLYLNI 335
EI +L+Y
Sbjct: 268 EIDLTHNTQLIYFQA 282
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 39/218 (17%), Positives = 78/218 (35%), Gaps = 18/218 (8%)
Query: 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE 177
+ + + L L S+D + + ++ + KL L L N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 178 GSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDI 237
++ L L L NKL+ ++ LT L L+ D+N+LT + + +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLD--VSQNPLL 129
Query: 238 LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
YL+ N + + + LT +D N + + + L L N++
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE 184
Query: 298 SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
L L+ NN++++ +L +L+
Sbjct: 185 L---DVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDC 219
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 52/297 (17%), Positives = 96/297 (32%), Gaps = 43/297 (14%)
Query: 35 IVSITIFNLSTLKVFDVDNNYVLGRLSSI----VDELSLSDNYLTSSTPELSFLSSMSNC 90
+ I + + + L D N + +L + L S N +T +S
Sbjct: 139 LTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL--------DVSQN 190
Query: 91 KYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSDCNISGGISEEIGNLTDLISIDLG 148
K L +L+ N + + +Q L F+ S ++ ++ LT L D
Sbjct: 191 KLLNRLNCDTNNITKL------DLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCS 241
Query: 149 GNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCF 208
N L + + L KL L +L I L H L G + +
Sbjct: 242 VNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--V 293
Query: 209 GNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSR 268
+ T L L + +T + L ++YL + L + + L +
Sbjct: 294 THNTQLYLLDCQAAGITELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVN 348
Query: 269 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP-----NSFDDLVSLESLDLSNNNLS 320
++ D + + + +L + NS VS + LD N ++
Sbjct: 349 AHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 59/306 (19%), Positives = 105/306 (34%), Gaps = 53/306 (17%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD----------ELSLSDNYLTSS 77
N + + L L + NN ++S I + +L +S N+L
Sbjct: 62 QNNDISELRKDDFKGLQHLYALVLVNN----KISKIHEKAFSPLRKLQKLYISKNHLVEI 117
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSDCNI-SGGISE 134
P L L +L I N + G FS ++ I M + + G
Sbjct: 118 PPNLP--------SSLVELRIHDNRIRKVPK---GVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 135 EIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQL 193
+ L + + KL I + L L N+++ +I L + L++L
Sbjct: 167 GAFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222
Query: 194 DLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPS 253
L N++ L LR LHLD+N+L+ +P+ L +LK + + +N
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTN-------- 274
Query: 254 KIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI--PNSFDDLVSLES 311
N+ + DF +SL +N + P +F + +
Sbjct: 275 ---NITKVGVNDFCPVGFGV-------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324
Query: 312 LDLSNN 317
+ N
Sbjct: 325 IQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 13/228 (5%)
Query: 113 NFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172
S + + + +IS ++ L L ++ L NK++ L+KLQ L
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 173 GNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI---PS 229
N L IP L + L +L + N++ F L + + + N L + P
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 230 ILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQFL 288
LK + YL G +P + L + N + I + L L
Sbjct: 168 AFDGLK-LNYLRISEAKLTG-IPK--DLPETLNELHLDHNKI-QAIELEDLLRYSKLYRL 222
Query: 289 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
LGHN+++ S L +L L L NN LS +P L L L ++
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVV 269
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 48/247 (19%), Positives = 83/247 (33%), Gaps = 10/247 (4%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152
LD+ N + L + + + IS + L L + + N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQH-LYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI--PTCFGN 210
I L L N + V L + +++ GN L S P F
Sbjct: 115 V---EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
Query: 211 LTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270
L L L + +LT IP L + + L N + L R+ N
Sbjct: 172 LK-LNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ 228
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330
+ ++ L +L+ L L +N+L +P DL L+ + L NN++++ +
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287
Query: 331 LYLNILL 337
+
Sbjct: 288 GFGVKRA 294
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 58/264 (21%), Positives = 93/264 (35%), Gaps = 47/264 (17%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
L L +N ++ + +F S + L+KL IS+N L + N SL + + D
Sbjct: 82 ALVLVNNKISKIHEK-AF----SPLRKLQKLYISKNHLV----EIPPNLPSSLVELRIHD 132
Query: 126 CNISGGISEEI-GNLTDLISIDLGGNKL-NGSISITLGKLQKLQFLSFRGNELEGSIPNV 183
I + + + L ++ I++GGN L N KL +L +L IP
Sbjct: 133 NRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKD 190
Query: 184 LCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDF 242
L L +L L NK+ +I + L L L N++ I +
Sbjct: 191 L--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIEN------------- 234
Query: 243 WSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS 302
L L + N L +P + LK LQ + L N + N
Sbjct: 235 --GSL--------SFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 303 FDDL------VSLESLDLSNNNLS 320
F + + L NN +
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 25/123 (20%), Positives = 42/123 (34%), Gaps = 5/123 (4%)
Query: 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG 273
LR + L ++P + D LD +N L+ L + N +
Sbjct: 35 LRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 274 DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYL 333
L+ LQ L + N L PN SL L + +N + ++ L +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVEIPPNLPS---SLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 334 NIL 336
N +
Sbjct: 150 NCI 152
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 52/273 (19%), Positives = 98/273 (35%), Gaps = 22/273 (8%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
L+ V L LS+N +T + S + C L+ L ++ N ++ + LE
Sbjct: 50 LTEAVKSLDLSNNRITYISN-----SDLQRCVNLQALVLTSNGINTIEEDSFSSLGS-LE 103
Query: 120 FIWMSDCNISGGISEEI-GNLTDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELE 177
+ +S +S +S L+ L ++L GN + L KLQ L +
Sbjct: 104 HLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 178 GSIP-NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILW-NLK 235
I L L +L++ + L P ++ + +L L + + I
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 236 DILYLDFWSNLFVGPLPSKI--------GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQF 287
+ L+ S++ + + +L + + + L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 288 LSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNL 319
L N+L+ S+P+ FD L SL+ + L N
Sbjct: 282 LEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 43/209 (20%), Positives = 82/209 (39%), Gaps = 13/209 (6%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
+ S+DL N++ + L + LQ L N + + L L LDL N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 200 LSGSIPT-CFGNLTALRNLHLDSNELTSIP--SILWNLKDILYLDFWSNLFVGPLPSKI- 255
LS ++ + F L++L L+L N ++ S+ +L + L + + K
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 256 GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315
L L ++ ++L P +++ ++++ L L + + D S+E L+L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230
Query: 316 NNNL--------SEIIPLSLEKLLYLNIL 336
+ +L S SL K +
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNV 259
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 35/218 (16%), Positives = 81/218 (37%), Gaps = 33/218 (15%)
Query: 28 SQNKLVGIVSITIF-NLSTLKVFDVDNNYVLGRLSSIV-------DELSLSDNYLTSSTP 79
N + ++F +L+ L++ V N ++ +EL + + L S P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139
+ S+ + + + L + L + + + S+E + + D ++ +
Sbjct: 192 K-----SLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF------HF 239
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
++L + + L K + + L + +L ++ L +L+ N+
Sbjct: 240 SELSTGETNS----------LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288
Query: 200 LSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKD 236
L S+P F LT+L+ + L +N + L
Sbjct: 289 LK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 325
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 38/174 (21%), Positives = 73/174 (41%), Gaps = 37/174 (21%)
Query: 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKV---------------------------FHF 419
F +++G G+ G++ + D + A+K +
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
+ + F+ + +E +L++ + ++ L+ + ++ TS L +LH S I+H
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 480 CDLKPHNKLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-IIGYMAP 527
DLKPHN L+ I A +SDFG+ K L S ++ + G++AP
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 48/254 (18%), Positives = 105/254 (41%), Gaps = 18/254 (7%)
Query: 84 LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143
+ K+ ++ + + + + + ++ E + L +LI
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDG-ITTLSAFGTGVTT--IEGVQYLNNLI 66
Query: 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGS 203
++L N++ ++ L L K+ L GN L+ ++ + L + LDL +++
Sbjct: 67 GLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDV 122
Query: 204 IPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTR 263
P L+ L+ L+LD N++T+I L L ++ YL + + + NL LT
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTT 177
Query: 264 IDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 323
+ +N + DI + L +L + L +N++ P + +L + L+N ++
Sbjct: 178 LKAD-DNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233
Query: 324 PLSLEKLLYLNILL 337
L+ N++
Sbjct: 234 VFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 47/270 (17%), Positives = 104/270 (38%), Gaps = 26/270 (9%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
+++ + +T + ++ + L + V + L + + D
Sbjct: 23 KIAAGKSNVTD-------TVTQADLDGITTLSAFGTGVTTIEG--VQYLNN-LIGLELKD 72
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185
I+ + NLT + ++L GN L ++S + LQ ++ L ++ P L
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN 245
L+ L L L N+++ P LT L+ L + + +++ + L NL + L N
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDN 183
Query: 246 LFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 305
S + +L L + NN + D+ + +L ++L + + ++
Sbjct: 184 KISDI--SPLASLPNLIEVHLK-NNQISDVSP-LANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 306 LVSLESLDLSNNNLSEIIPLSL-EKLLYLN 334
LV + + + I P ++ + Y +
Sbjct: 240 LVVP--NVVKGPSGAPIAPATISDNGTYAS 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 40/177 (22%), Positives = 65/177 (36%), Gaps = 45/177 (25%)
Query: 393 IGRGSFGSVYKARL-QDGMEFAIKVF---------------------------HF--SCS 422
+G+G FG K + G +K F
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+ + EY G+L ++ S + QR++ D+ S + YLH S IIH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ---------TLAIIG---YMAP 527
HN L+ +N ++DFG+A+L+ E + ++G +MAP
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-22
Identities = 76/329 (23%), Positives = 128/329 (38%), Gaps = 45/329 (13%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY---------VLGRLSSIVDELSLSDNYLTSST 78
N+ + + + L+ L+V + L+S ++ L L DN +
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIKKIQ 145
Query: 79 PELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ------SLEFIWMSDCNISGGI 132
P F +M LD++ N + + NF L I + D N
Sbjct: 146 PASFF-LNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201
Query: 133 SEEIGN---LTDLISIDLGGNKLNGSIS---ITLGKLQKLQFLSFRGNELEG-------- 178
E+ GN T + ++DL GN S++ K+Q L + G
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261
Query: 179 -SIPNVLCH---LAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWN 233
N + + DL +K+ + + F + T L L L NE+ I W
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG 321
Query: 234 LKDILYLDFWSNLFVGPLPSKI-GNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQFLSLG 291
L +L L+ N G + S++ NL L +D S N++ + + GL +L+ L+L
Sbjct: 322 LTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALD 379
Query: 292 HNRLQGSIPNS-FDDLVSLESLDLSNNNL 319
N+L+ S+P+ FD L SL+ + L N
Sbjct: 380 TNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 54/304 (17%), Positives = 98/304 (32%), Gaps = 38/304 (12%)
Query: 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWM 123
V+ + LS N + +S S + L+ L + + + SL + +
Sbjct: 32 VNYVDLSLNSIAELNE-----TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 124 SDCNISGGISEEI-GNLTDLISIDLGGNKLNGSI--SITLGKLQKLQFLSFRGNELEGSI 180
+ L +L + L L+G++ L L+ L R N ++
Sbjct: 87 DYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145
Query: 181 PN-VLCHLAVLFQLDLRGNKLSGSIPTCFGNLTA--LRNLHLDSNELTSIPSI------- 230
P ++ LDL NK+ N L L S L +
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 231 --LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRI-------------DFSRNNLLGDI 275
+ I LD N F + + + T+I F N
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 276 PTTIQGLK--SLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEIIPLSLEKLLY 332
T +GL+ ++ L +++ ++ F LE L L+ N +++I + L +
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324
Query: 333 LNIL 336
L L
Sbjct: 325 LLKL 328
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 43/240 (17%), Positives = 72/240 (30%), Gaps = 23/240 (9%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGN 198
+ +DL N + + +LQ LQFL I N L+ L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 199 KLSGSIPT-CFGNLTALRNLHLDSNELTSI---PSILWNLKDILYLDFWSNLFVGPLPSK 254
+ + T F L L L L L + L + L N P+
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 255 I-GNLKVLTRIDFSRNNL----------LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF 303
N++ +D + N + T+ L S+ + L +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 304 DDLVSLESLDLSNNNLSEIIP------LSLEKLLYLNILLIVVVILALKFGLISRCQKRA 357
S+ +LDLS N E + ++ K+ L + + +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 24/104 (23%), Positives = 42/104 (40%), Gaps = 4/104 (3%)
Query: 221 SNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT-TI 279
+ L +P + ++ Y+D N + L+ L + + I T
Sbjct: 19 NRGLHQVPELPAHVN---YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF 75
Query: 280 QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 323
+GL SL L L +N+ +F+ L +LE L L+ NL +
Sbjct: 76 RGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 35/230 (15%)
Query: 6 LNNRQLDGGMTGDVCYRICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVD 65
L+ M I Q+ ++ + D DN G +S V
Sbjct: 219 LSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK 278
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
LS + + + + F S+ L++L +++N + ++
Sbjct: 279 TCDLSKSKIF-ALLKSVF----SHFTDLEQLTLAQNEI------------NKID------ 315
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVL 184
LT L+ ++L N L S L KL+ L N + ++
Sbjct: 316 -------DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSF 367
Query: 185 CHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELT-SIPSILW 232
L L +L L N+L S+P F LT+L+ + L +N S P I +
Sbjct: 368 LGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 416
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 41/175 (23%), Positives = 64/175 (36%), Gaps = 51/175 (29%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHF------------------------SCSNED 425
+GRGSFG V++ + Q G + A+K +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGP 123
Query: 426 FRALVLEYTTNGSLEKVL---------YSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+ + +E GSL +++ + Y+ L+ LEYLH +
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE----------GLEYLH---TRR 170
Query: 477 IIHCDLKPHNKLLDDN-IVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
I+H D+K N LL + A L DFG A L + + I G +MAP
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 13/206 (6%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGN 198
++DL N L S + +LQ L E++ +I L+ L L L GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 199 KLSGSIPT-CFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSN-LFVGPLPSKI 255
+ S+ F L++L+ L L S+ + + +LK + L+ N + LP
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 256 GNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQF----LSLGHNRLQGSIPNSFDDLVSLE 310
NL L +D S N + I ++ L + L L N + P +F ++ L+
Sbjct: 146 SNLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLK 203
Query: 311 SLDLSNNNLSEIIPLSLEKLLYLNIL 336
L L N L + ++L L +
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKI 229
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 42/152 (27%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPL 251
LDL N L F + L+ L L E+ +I +L + L N + L
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP-IQSL 91
Query: 252 PSKI-GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP--NSFDDLVS 308
L L ++ NL I LK+L+ L++ HN +Q S F +L +
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTN 150
Query: 309 LESLDLSNNNLSEIIP---LSLEKLLYLNILL 337
LE LDLS+N + I L ++ LN+ L
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 57/231 (24%), Positives = 88/231 (38%), Gaps = 32/231 (13%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIG---NLTDLISIDLGG 149
K LD+S NPL +F + L+ + +S C I + E G +L+ L ++ L G
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQ---TIEDGAYQSLSHLSTLILTG 85
Query: 150 NKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGNKLSGSIPT-- 206
N + L LQ L L S+ + HL L +L++ N + S
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143
Query: 207 CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDF 266
F NLT L +L L SN++ SI + + +L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYC---------------TDL-----RVLHQMPLLNLSLD 183
Query: 267 SRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317
N + I L+ L+L N+L+ FD L SL+ + L N
Sbjct: 184 LSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 51/235 (21%), Positives = 83/235 (35%), Gaps = 53/235 (22%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSI----------VDELSLSDNYLTSS 77
S N L + S + F+ L+V D+ + +I + L L+ N + S
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRC----EIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIG 137
S L+KL L SLE + IG
Sbjct: 92 ALGAF-----SGLSSLQKLVAVETNL------------ASLE-------------NFPIG 121
Query: 138 NLTDLISIDLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVL----F 191
+L L +++ N + L L+ L N+++ SI L L +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSN 245
LDL N ++ P F + L+ L LD+N+L S+P I L + + +N
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 17/63 (26%), Positives = 27/63 (42%), Gaps = 6/63 (9%)
Query: 274 DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYL 333
++P S + L L N L+ SF L+ LDLS + I + + L +L
Sbjct: 25 NLPF------STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 334 NIL 336
+ L
Sbjct: 79 STL 81
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 50/185 (27%), Positives = 72/185 (38%), Gaps = 30/185 (16%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
D + L N L TL +L L+ EL + V L VL LDL N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQ 88
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
L S+P L AL L + N LTS+P +G L+
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPL---------------GAL-----RGLGELQ 127
Query: 260 VLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNN 317
L + + N L +P + L+ LSL +N L +P + L +L++L L N
Sbjct: 128 EL----YLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 318 NLSEI 322
+L I
Sbjct: 183 SLYTI 187
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 47/146 (32%), Positives = 61/146 (41%), Gaps = 4/146 (2%)
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251
L L N L T L L+LD ELT + + L + LD N L
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-VDGTLPVLGTLDLSHNQLQS-L 92
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLE 310
P L LT +D S N L ++GL LQ L L N L+ ++P LE
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLE 151
Query: 311 SLDLSNNNLSEIIPLSLEKLLYLNIL 336
L L+NNNL+E+ L L L+ L
Sbjct: 152 KLSLANNNLTELPAGLLNGLENLDTL 177
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 15/184 (8%)
Query: 65 DELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMS 124
L LS+N L + + +++ L +L++ R L L V L + +S
Sbjct: 34 TILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAEL-TKLQ--VDGTLPVLGTLDLS 85
Query: 125 DCNISGGISEEIGNLTDLISIDLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSIP-N 182
+ + L L +D+ N+L S+ + L L +LQ L +GNEL+ ++P
Sbjct: 86 HNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPG 142
Query: 183 VLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLD 241
+L L +L L N L+ +P L L L L N L +IP + + +
Sbjct: 143 LLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAF 201
Query: 242 FWSN 245
N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 36/137 (26%), Positives = 57/137 (41%), Gaps = 14/137 (10%)
Query: 205 PTC-FGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262
P C + + ++ D LT++P + + L NL + + LT
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPDLPKDTT---ILHLSENLLYTFSLATLMPYTRLT 58
Query: 263 RIDFSRNNLLGDIPTTIQ---GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
+++ R L T +Q L L L L HN+LQ S+P L +L LD+S N L
Sbjct: 59 QLNLDRAEL-----TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL 112
Query: 320 SEIIPLSLEKLLYLNIL 336
+ + +L L L L
Sbjct: 113 TSLPLGALRGLGELQEL 129
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 50/215 (23%), Positives = 79/215 (36%), Gaps = 50/215 (23%)
Query: 352 RCQKRATKLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGM 410
Q + + P V QPQ + R L F IGRG F VY+A L DG+
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTL---ANFRIEKKIGRGQFSEVYRAACLLDGV 58
Query: 411 EFAIK-VFHFSCSNEDFRA-------------------------------LVLEYTTNGS 438
A+K V F + RA +VLE G
Sbjct: 59 PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 118
Query: 439 LEKVL---YSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495
L +++ ++ + + SALE++H S ++H D+KP N + V
Sbjct: 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVV 175
Query: 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
L D G+ + + + + + +G YM+P
Sbjct: 176 KLGDLGLGRFFSSKT-TAAHSL----VGTPYYMSP 205
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 8e-21
Identities = 49/306 (16%), Positives = 103/306 (33%), Gaps = 14/306 (4%)
Query: 42 NLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRN 101
T K F + + ++++ + LS L+ + L L ++
Sbjct: 171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230
Query: 102 PLDGFLPRVVGNFSQ--SLEFIWMSDCNISGGISEEIG-----NLTDLISIDLGGNKLNG 154
+ ++ + +S+ + G + +L L + +
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 155 SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTAL 214
S + +F + ++ LD N L+ ++ G+LT L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 215 RNLHLDSNELTSIP---SILWNLKDILYLDFWSNLFVGPLPSKI-GNLKVLTRIDFSRNN 270
L L N+L + + +K + LD N K L ++ S N
Sbjct: 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330
L I + ++ L L N+++ SIP L +L+ L++++N L + ++L
Sbjct: 411 LTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
Query: 331 LYLNIL 336
L +
Sbjct: 468 TSLQKI 473
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 8e-19
Identities = 53/262 (20%), Positives = 97/262 (37%), Gaps = 32/262 (12%)
Query: 62 SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFI 121
+ V S+S+ L F S ++ K L + + + FS +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN-MNIK 305
Query: 122 WMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE--GS 179
+ ++ + +D N L ++ G L +L+ L + N+L+
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSK 365
Query: 180 IPNVLCHLAVLFQLDLRGNKLSGSIPTC-FGNLTALRNLHLDSNELTSIPSILWNLKDIL 238
I + + L QLD+ N +S +L +L++ SN LT
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF--------- 416
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298
LP + + +D N + IP + L++LQ L++ N+L+ S
Sbjct: 417 ----------RCLPPR------IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-S 458
Query: 299 IPN-SFDDLVSLESLDLSNNNL 319
+P+ FD L SL+ + L N
Sbjct: 459 VPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 56/338 (16%), Positives = 103/338 (30%), Gaps = 42/338 (12%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNY-------VLGRLSSIVDELSLSDNYLTSSTPE 80
SQN + + + I +LS L++ + +N V + + L LS N L
Sbjct: 29 SQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL-EYLDLSHNKLVK---- 83
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSDCNISGGISEEIGN 138
+S LK LD+S N D LP F L+F+ +S ++ I +
Sbjct: 84 ISC----HPTVNLKHLDLSFNAFDA-LPIC-KEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 139 LTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR-- 196
L + + G LQ S + + ++V +L
Sbjct: 138 LNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 197 --------------GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLK----DIL 238
+ L+ + L N+ N I ++W+ I
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298
+ L +LK L+ + + ++ + + +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 299 IPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ LD SNN L++ + + L L L
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 32/212 (15%), Positives = 65/212 (30%), Gaps = 7/212 (3%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
+++ N ++ + + L KL+ L N ++ +V L LDL NK
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIP--SILWNLKDILYLDFWSNLFVGPLPSKIGN 257
L I L++L L N ++P N+ + +L + I +
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317
L + + GL+ SL + D+ +L +
Sbjct: 138 LNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 318 NLSEIIPLSLEKLLYLNILLIVVVILALKFGL 349
N+ ++ + + + L
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTL 227
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 52/296 (17%), Positives = 99/296 (33%), Gaps = 28/296 (9%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
LS L++S NY++ S + + L+ L IS N + L V F+Q LE
Sbjct: 19 LSQKTTILNISQNYISELWT-----SDILSLSKLRILIISHNRIQY-LDISVFKFNQELE 72
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEG 178
++ +S + +L +DL N + I G + +L+FL LE
Sbjct: 73 YLDLSHNKLV---KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129
Query: 179 SIPNVLCHLAVL-FQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDI 237
S + HL + L L P + + + ++K +
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV 189
Query: 238 LYLDF---------WSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGL---KSL 285
L+ + + +K+ L+ + + + I L ++
Sbjct: 190 ANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTV 249
Query: 286 QFLSLGHNRLQG-----SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ S+ + +LQG S L +L + ++ E +NI
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 28/119 (23%), Positives = 44/119 (36%), Gaps = 26/119 (21%)
Query: 217 LHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276
+ N L +P L K T ++ S+N +
Sbjct: 5 VDRSKNGLIHVPK--------------------DLSQK------TTILNISQNYISELWT 38
Query: 277 TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
+ I L L+ L + HNR+Q + F LE LDLS+N L +I L +L++
Sbjct: 39 SDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDL 97
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 12/69 (17%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 268 RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 327
N L +P + + L++ N + + L L L +S+N + +
Sbjct: 8 SKNGLIHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF 65
Query: 328 EKLLYLNIL 336
+ L L
Sbjct: 66 KFNQELEYL 74
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 48/174 (27%)
Query: 392 LIGRGSFGSVYKARLQD---GMEFAIKVFHFS-CSNEDFRA------------------- 428
L+GRG G VY+A D A+K+ + S+ FR
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 429 ------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+ + L +L L + + I+ + SAL+ H +
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
H D+KP N L+ + A+L DFGIA T D+ +TQ +G YMAP
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGN--TVGTLYYMAP 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 41/169 (24%), Positives = 56/169 (33%), Gaps = 40/169 (23%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
+G GS+G V+K R +DG +A+K RA
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
L E SL++ + L Q + D AL +LH S ++
Sbjct: 124 QAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLV 179
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
H D+KP N L L DFG+ L Q YMAP
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGD---PRYMAP 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 41/172 (23%), Positives = 67/172 (38%), Gaps = 44/172 (25%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFS-CSNEDFRA--------------------- 428
+G G +VY A ++ AIK E+
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
LV+EY +L + + S+ L + +N + +++ H I+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
H D+KP N L+D N + DFGIAK L+ + S+TQT ++G Y +P
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNH--VLGTVQYFSP 181
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 46/178 (25%), Positives = 63/178 (35%), Gaps = 47/178 (26%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
IG GS+G K R DG K + E +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 429 -----------LVLEYTTNGSLEKVL---YSSNYILDILQRLNIMIDVTSALEYLH--FG 472
+V+EY G L V+ LD L +M +T AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
++H DLKP N LD L DFG+A++L D S +T +G YM+P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKT----FVGTPYYMSP 185
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 39/176 (22%), Positives = 68/176 (38%), Gaps = 46/176 (26%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFS-CSNEDFRA--------------------- 428
++G G V+ AR L+D + A+KV + F
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 429 --------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS 474
+V+EY +L ++ + + + + ++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH---Q 134
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
IIH D+KP N ++ + DFGIA+ + S+TQT +IG Y++P
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSP 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.5 bits (229), Expect = 5e-20
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
+ I +L + ++ T +L + + ++++ S+ + +L + +L L G
Sbjct: 19 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 74
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKI-- 255
NKL+ I NL L L LD N++ + S L +LK + L N S I
Sbjct: 75 NKLT-DIKP-LTNLKNLGWLFLDENKIKDLSS-LKDLKKLKSLSLEHNGI-----SDING 126
Query: 256 -GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDL 314
+L L + NN + DI T + L L LSL N++ I L L++L L
Sbjct: 127 LVHLPQLESLYLG-NNKITDI-TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182
Query: 315 SNNNLSEIIPLS-LEKLLYLNI 335
S N++S++ L+ L+ L L +
Sbjct: 183 SKNHISDLRALAGLKNLDVLEL 204
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.5 bits (229), Expect = 6e-20
Identities = 52/271 (19%), Positives = 94/271 (34%), Gaps = 47/271 (17%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
E + + K ++ + + + S++ I ++
Sbjct: 3 ETITVSTPIKQ-------IFPDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANN 52
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185
+I + I L ++ + L GNKL I L L+ L +L N+++ + + L
Sbjct: 53 SDIK--SVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLSS-LK 106
Query: 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN 245
L L L L N +S I +L L +L+L +N++T I +
Sbjct: 107 DLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVL--------------- 149
Query: 246 LFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 305
L L + N + DI + GL LQ L L N + S +
Sbjct: 150 ----------SRLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNLYLSKNHI--SDLRALAG 195
Query: 306 LVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
L +L+ L+L + L+ N +
Sbjct: 196 LKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 2e-17
Identities = 54/267 (20%), Positives = 109/267 (40%), Gaps = 27/267 (10%)
Query: 42 NLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKL 96
+ ++ V L+SI D++ +++ + S + + + KL
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQNELNSI-DQIIANNSDIKS-------VQGIQYLPNVTKL 70
Query: 97 DISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSI 156
++ N L P + N +L ++++ + I + +L L S+ L N ++ I
Sbjct: 71 FLNGNKLTDIKP--LTNLK-NLGWLFLDENKIK--DLSSLKDLKKLKSLSLEHNGIS-DI 124
Query: 157 SITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRN 216
+ L L +L+ L N++ I L L L L L N++S I LT L+N
Sbjct: 125 N-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQN 179
Query: 217 LHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276
L+L N ++ + + L LK++ L+ +S + + NL V + + +L P
Sbjct: 180 LYLSKNHISDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTP 236
Query: 277 TTIQGLKSLQFLSLGHNRLQGSIPNSF 303
I + ++ + + + SF
Sbjct: 237 EIISDDGDYEKPNVKWHLPEFTNEVSF 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 44/225 (19%), Positives = 80/225 (35%), Gaps = 36/225 (16%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTP--- 79
+ + V+ L+++ +N+ + + L ++ +L L+ N LT P
Sbjct: 29 KKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNVT-KLFLNGNKLTDIKPLTN 85
Query: 80 -----ELSF-------LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSD 125
L LSS+ + K LK L + N + + LE +++ +
Sbjct: 86 LKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGN 140
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185
I+ + LT L ++ L N+++ I L L KLQ L N + + L
Sbjct: 141 NKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LA 194
Query: 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI 230
L L L+L + NL + L + I
Sbjct: 195 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 6e-20
Identities = 33/178 (18%), Positives = 60/178 (33%), Gaps = 60/178 (33%)
Query: 392 LIGRGSFGSVYKA---RLQDGMEFAIKVFHFSCSNEDFRA-------------------- 428
I G G +Y A + +G +K S + + +A
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 429 ----------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG 472
+V+EY SL++ L + + + ++++ AL YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH-- 199
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
S +++ DLKP N +L + + L D G + + G + AP
Sbjct: 200 -SIGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFG--YLYGTPGFQAP 246
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 36/202 (17%), Positives = 70/202 (34%), Gaps = 5/202 (2%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDL-RG 197
+ I + KL L+ + N++ I +V +L L ++ + +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSK-I 255
N L P F NL L+ L + + + +P + + LD N+ + +
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 256 GNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDL 314
L + I + N + +I G + + +N L+ + F LD+
Sbjct: 150 VGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 315 SNNNLSEIIPLSLEKLLYLNIL 336
S + + LE L L
Sbjct: 210 SRTRIHSLPSYGLENLKKLRAR 231
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 49/250 (19%), Positives = 84/250 (33%), Gaps = 35/250 (14%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI-GNLTDLISIDL-GGN 150
+L L F LE I +S ++ I ++ NL L I + N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGD-LEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 151 KLNGSISITLGKLQKLQFLSFRGNELEGSIPN-VLCHLAVLFQLDLRGNKLSGSIPT-CF 208
L L LQ+L ++ +P+ H LD++ N +I F
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 209 GNLTA-LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS 267
L+ L L+ N + I + + F N L ++ S
Sbjct: 150 VGLSFESVILWLNKNGIQEIHN---------------SAF---------NGTQLDELNLS 185
Query: 268 RNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL- 325
NN L ++P + G L + R+ ++L L + S NL ++ L
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLKKLPTLE 243
Query: 326 SLEKLLYLNI 335
L L+ ++
Sbjct: 244 KLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 44/236 (18%), Positives = 78/236 (33%), Gaps = 19/236 (8%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
EL L + S L+K++IS+N + + V + L I +
Sbjct: 34 ELRFVLTKLRVIQK-----GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 126 CN----ISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP 181
N I+ + + NL L + + + + L + N +I
Sbjct: 89 ANNLLYINPEAFQNLPNLQYL---LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 182 -NVLCHLAV-LFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDIL 238
N L+ L L N + + F D+N L +P+ + +
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR 294
LD LPS L+ L ++ L +PT ++ L +L SL +
Sbjct: 206 ILDISRTRIH-SLPS--YGLENLKKLRARSTYNLKKLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 34/200 (17%), Positives = 56/200 (28%), Gaps = 35/200 (17%)
Query: 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGS 203
+K+ I + L F +L L ++++ N +
Sbjct: 13 VFLCQESKVT---EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 204 IPT-CFGNLTALRNLHL-DSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVL 261
I F NL L + + +N L I F LP+ L
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINP---------------EAFQN-LPN-------L 106
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP-NSFDDLVS-LESLDLSNNNL 319
+ S + L + N +I NSF L L L+ N +
Sbjct: 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 320 SEIIP-----LSLEKLLYLN 334
EI L++L +
Sbjct: 167 QEIHNSAFNGTQLDELNLSD 186
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 28/126 (22%), Positives = 50/126 (39%), Gaps = 4/126 (3%)
Query: 215 RNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274
R +++T IPS L ++ + L F L +I+ S+N++L
Sbjct: 12 RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 275 IPT-TIQGLKSLQFLSLGH-NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLY 332
I L L + + N L P +F +L +L+ L +SN + + + L
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129
Query: 333 LNILLI 338
+L I
Sbjct: 130 KVLLDI 135
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 41/222 (18%), Positives = 70/222 (31%), Gaps = 20/222 (9%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIV-------DELSLSDNYLTSSTPE 80
KL I L+ ++ N VL + + V E+ +
Sbjct: 38 VLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINP 97
Query: 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI--GN 138
+F N L+ L IS + LP V S + + D I G
Sbjct: 98 EAF----QNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152
Query: 139 LTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198
+ + + L N + + Q + N LE +V + LD+
Sbjct: 153 SFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212
Query: 199 KLSGSIPTC-FGNLTALRNLHLDSNELTSIPSI--LWNLKDI 237
++ S+P+ NL LR L +P++ L L +
Sbjct: 213 RIH-SLPSYGLENLKKLRARST--YNLKKLPTLEKLVALMEA 251
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 38/205 (18%), Positives = 64/205 (31%), Gaps = 20/205 (9%)
Query: 28 SQNKLVGIVSITIF-NLSTLKVFDVDNNYVLGRLSSIV-------DELSLSDNYLTSSTP 79
SQN ++ ++ +F NL L ++ L ++ L +S+ + P
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-P 120
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVV-GNFSQSLEFIWMSDCNISGGISEEIGN 138
++ + S+ LDI N + R S +W++ I I N
Sbjct: 121 DVHKIHSLQ----KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFN 175
Query: 139 LTDLISIDL-GGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
T L ++L N L + L + L +L L
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 235
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSN 222
K +PT L AL L
Sbjct: 236 LK---KLPT-LEKLVALMEASLTYP 256
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 44/172 (25%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
IG GSFG + +DG ++ IK + S + R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 429 ---------LVLEYTTNGSLEKVL-YSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
+V++Y G L K + + Q L+ + + AL+++H I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
H D+K N L + L DFGIA++L + + IG Y++P
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARA----CIGTPYYLSP 194
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 35/170 (20%), Positives = 61/170 (35%), Gaps = 39/170 (22%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
IG G V++ + +AIK + ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+V+E N L L +D +R + ++ A+ +H I
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H DLKP N L+ D ++ L DFGIA + + S+ + + + YM P
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 42/180 (23%), Positives = 67/180 (37%), Gaps = 49/180 (27%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKV-------------------------FHFSCSNE 424
LIG G FG V+KA+ DG + IK ++
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 425 DFRA----------------LVLEYTTNGSLEKVL-YSSNYILDILQRLNIMIDVTSALE 467
D+ + +E+ G+LE+ + LD + L + +T ++
Sbjct: 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD 136
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
Y+H S +I+ DLKP N L D + DFG+ L + + TL YM+P
Sbjct: 137 YIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR---YMSP 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 31/186 (16%), Positives = 67/186 (36%), Gaps = 11/186 (5%)
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
++ LG + +IT ++ L +++ + + + + + L +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIG 256
+ P L+ L L + ++TS L L + LD + + +KI
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 257 NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
L + ID S N + DI ++ L L+ L++ + + +D L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 317 NNLSEI 322
+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-14
Identities = 25/155 (16%), Positives = 55/155 (35%), Gaps = 6/155 (3%)
Query: 117 SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNEL 176
SL +I +++ N++ I ++ + + + + + L L+ L G ++
Sbjct: 45 SLTYITLANINVTD--LTGIEYAHNIKDLTINNIHAT-NYN-PISGLSNLERLRIMGKDV 100
Query: 177 EGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKD 236
L L L LD+ + SI T L + ++ L N + L L +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPE 160
Query: 237 ILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNL 271
+ L+ + I + L ++ +
Sbjct: 161 LKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-13
Identities = 31/198 (15%), Positives = 69/198 (34%), Gaps = 41/198 (20%)
Query: 35 IVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTPELSFLSSMSN 89
+IT +++L + N V + +I +L++++ + T+ + +S +SN
Sbjct: 35 TANITEAQMNSLTYITLANINVTDLTGIEYAHNIK-DLTINNIHATN----YNPISGLSN 89
Query: 90 CKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGG 149
L++L I +++ + LT L +D+
Sbjct: 90 ---LERLRIMGK-------------------------DVTSDKIPNLSGLTSLTLLDISH 121
Query: 150 NKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFG 209
+ + SI + L K+ + N I L L L L+++ + +
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IE 178
Query: 210 NLTALRNLHLDSNELTSI 227
+ L L+ S +
Sbjct: 179 DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 21/127 (16%), Positives = 43/127 (33%), Gaps = 6/127 (4%)
Query: 210 NLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRN 269
A N L + +I + + Y+ + I + + + N
Sbjct: 21 TFKAYLNGLLGQSSTANITEA--QMNSLTYITLANINVTDLTG--IEYAHNIKDLTIN-N 75
Query: 270 NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 329
+ I GL +L+ L + + + L SL LD+S++ + I +
Sbjct: 76 IHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 330 LLYLNIL 336
L +N +
Sbjct: 135 LPKVNSI 141
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-19
Identities = 55/293 (18%), Positives = 106/293 (36%), Gaps = 17/293 (5%)
Query: 37 SITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKL 96
+ + N+ L L+ L+++ ++ ++ L + ++ L
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 97 DISRNPLDGFLPRVVGNFS----QSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152
+I + + R +S +SL + + ++ L +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLT 212
+ FL+F N S+ L L L L+ N L +
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTK 400
Query: 213 ALRNLHLDSNELTSIPSILWN-----LKDILYLDFWSN-LFVGPLPSKIGNLKVLTRIDF 266
+ +L L S+ S ++ + IL L+ SN L +KVL D
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL---DL 457
Query: 267 SRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNN 318
N ++ IP + L++LQ L++ N+L+ S+P+ FD L SL+ + L +N
Sbjct: 458 HNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 39/201 (19%), Positives = 68/201 (33%), Gaps = 9/201 (4%)
Query: 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200
++ ++ + + + L+ L + S + A + L +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 201 SGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLF--VGPLPSKIGN 257
C + ++ L+ N T LK + L N + N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN 401
Query: 258 LKVLTRIDFSRNNLL-GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV-SLESLDLS 315
+ L +D S N+L T +S+ L+L N L GS+ F L ++ LDL
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLH 458
Query: 316 NNNLSEIIPLSLEKLLYLNIL 336
NN + IP + L L L
Sbjct: 459 NNRIMS-IPKDVTHLQALQEL 478
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 34/149 (22%), Positives = 53/149 (35%), Gaps = 8/149 (5%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPL 251
L L N +S L+ LR L L N + S+ + +D+ YLD N +
Sbjct: 57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-I 115
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTT--IQGLKSLQFLSLGHNRLQGSIPNSFDDL-VS 308
+ L +D S N +P L L FL L + + L +S
Sbjct: 116 SC--CPMASLRHLDLS-FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLS 172
Query: 309 LESLDLSNNNLSEIIPLSLEKLLYLNILL 337
LDL + ++ SL+ + L
Sbjct: 173 CILLDLVSYHIKGGETESLQIPNTTVLHL 201
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 47/290 (16%), Positives = 80/290 (27%), Gaps = 30/290 (10%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGF-LPRVVGNFSQSLEFIWMS 124
L +S N L + +S L+ LD+S N D + + GN + L F+ +S
Sbjct: 104 YLDVSHNRLQN----ISC----CPMASLRHLDLSFNDFDVLPVCKEFGNLT-KLTFLGLS 154
Query: 125 DCNISGGISEEIGNL-TDLISIDLGGNKLNGSISITLGKLQ-KLQFLSFRGNELEGSIPN 182
+ +L I +DL + G + +L + L F N L N
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN 214
Query: 183 VLCHLAVLFQLDLRGNKLSGSIPTCFGNLT------------ALRNLHLDSNELTSIPSI 230
+ + L L L KL+ L+++ +
Sbjct: 215 MS--VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 231 LWNLK----DILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQ 286
W +I L + LK L L +
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 287 FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
L + S L+ + N ++ + L L L
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 22/76 (28%), Positives = 36/76 (47%), Gaps = 2/76 (2%)
Query: 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNL 319
+ S+N++ I L L+ L L HNR++ S+ F LE LD+S+N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 320 SEIIPLSLEKLLYLNI 335
I + L +L++
Sbjct: 113 QNISCCPMASLRHLDL 128
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 51/334 (15%), Positives = 87/334 (26%), Gaps = 42/334 (12%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLP 252
+D L+ +P + L L N ++ +
Sbjct: 36 VDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELR-----------------------M 69
Query: 253 SKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311
I L L + S N + + + + L++L + HNRLQ +I + SL
Sbjct: 70 PDISFLSELRVLRLSHNR-IRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRH 125
Query: 312 LDLSNNNLSEIIPLSL-EKLLYLNIL-LIVVVILALKFGLISRCQKRATKLPNVSNMQPQ 369
LDLS N+ + L L L L L ++ L VS
Sbjct: 126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG 185
Query: 370 ASRRRFSYQELLRATDGFSANNLIGRGSFGSV-YKARLQDGMEFAIKVFHFSCSNEDFRA 428
F N+L SV LQ
Sbjct: 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSEL 245
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST---PIIHCDLKPH 485
N +L+ + + + + Q +EYL+ T I +
Sbjct: 246 TRGPTLLNVTLQHIETTWKCSVKLFQFFWP-----RPVEYLNIYNLTITERIDREEFTYS 300
Query: 486 NKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519
L ++ H+ + +
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 38/213 (17%), Positives = 75/213 (35%), Gaps = 46/213 (21%)
Query: 351 SRCQKRATKLPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGM 410
++ +++ P++ + + ++ +S IG G V++ +
Sbjct: 23 AKFERQHMDSPDLGTDDDDKASSSANECISVKGRI-YSILKQIGSGGSSKVFQVLNEKKQ 81
Query: 411 EFAIKV---------------------------------FHFSCSNEDFRALVLEYTTNG 437
+AIK + + + +V+E N
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NI 140
Query: 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497
L L +D +R + ++ A+ +H I+H DLKP N L+ D ++ L
Sbjct: 141 DLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KL 195
Query: 498 SDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
DFGIA + + S+ + +G YM P
Sbjct: 196 IDFGIANQMQPDTTSVVKDS---QVGAVNYMPP 225
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 35/170 (20%), Positives = 61/170 (35%), Gaps = 39/170 (22%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
IG G V++ + +AIK + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+V+E N L L +D +R + ++ A+ +H I
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H DLKP N L+ D ++ L DFGIA + + S+ + + + YM P
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 7/175 (4%)
Query: 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP-TCFGNLTALRNLHLDSNEL 224
+ L + N+L L L L L NKL ++P F L L L + N+L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 225 TSIPS-ILWNLKDILYLDFWSNLFVGPLPSKI-GNLKVLTRIDFSRNNLLGDIPTTI-QG 281
++P + L ++ L N LP ++ +L LT + N L +P +
Sbjct: 98 QALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 282 LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
L SL+ L L +N+L+ +FD L L++L L NN L + + + L L +L
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 53/196 (27%), Positives = 80/196 (40%), Gaps = 33/196 (16%)
Query: 138 NLTDLISIDLGGNKLNGSISITL-GKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDL 195
LT L + L NKL ++ + +L+ L+ L N+L+ ++P V L L +L L
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 196 RGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSK 254
N+L S+P F +LT L L L NEL S+P +F
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPK---------------GVFDK----- 155
Query: 255 IGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDL 314
L L + N L L L+ L L +N+L+ +FD L L+ L L
Sbjct: 156 ---LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 315 SNNNL----SEIIPLS 326
N + II ++
Sbjct: 213 QENPWDCTCNGIIYMA 228
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 45/142 (31%), Positives = 66/142 (46%), Gaps = 14/142 (9%)
Query: 199 KLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKIGN 257
K G + +C N ++ S +LT+IPS I + K LD SN
Sbjct: 6 KKDGGVCSCNNNKN---SVDCSSKKLTAIPSNIPADTK---KLDLQSNKLSSLPSKAFHR 59
Query: 258 LKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLS 315
L L + + N L +P I + LK+L+ L + N+LQ ++P FD LV+L L L
Sbjct: 60 LTKLRLLYLNDNK-LQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLD 117
Query: 316 NNNLSEI---IPLSLEKLLYLN 334
N L + + SL KL YL+
Sbjct: 118 RNQLKSLPPRVFDSLTKLTYLS 139
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 48/184 (26%), Positives = 74/184 (40%), Gaps = 24/184 (13%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
L L+DN L + P F + N L+ L ++ N L LP V + +L + +
Sbjct: 65 LLYLNDNKLQT-LPAGIF-KELKN---LETLWVTDNKLQA-LPIGVFDQLVNLAELRLDR 118
Query: 126 CNISGGISEEI-GNLTDLISIDLGGNKLNGSISITLG---KLQKLQFLSFRGNELEGSIP 181
+ + + +LT L + LG N+L S+ G KL L+ L N+L+
Sbjct: 119 NQLKS-LPPRVFDSLTKLTYLSLGYNELQ---SLPKGVFDKLTSLKELRLYNNQLKRVPE 174
Query: 182 NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWN--LKDILY 239
L L L L N+L F +L L+ L L N P W+ I+Y
Sbjct: 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN-----P---WDCTCNGIIY 226
Query: 240 LDFW 243
+ W
Sbjct: 227 MAKW 230
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 46/271 (16%), Positives = 80/271 (29%), Gaps = 37/271 (13%)
Query: 79 PELSFLSSMSNCKYLKKLDISRNPL-DGFLPRVVGNFSQS-LEFIWMSDCNISGGISEEI 136
+L + + LK+L + + L + S L+ + + + ++G +
Sbjct: 56 ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115
Query: 137 GNLT--DLISIDLGGNKLNGSIS----ITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVL 190
T DL ++L + + L+ LS + L
Sbjct: 116 LEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175
Query: 191 FQLDLRGNKLSGSIP----TCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNL 246
LDL N G C L+ L L + + + + L
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL------------ 223
Query: 247 FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDD 305
L +D S N+L L L+L L+ +P
Sbjct: 224 --------AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272
Query: 306 LVSLESLDLSNNNLSEI-IPLSLEKLLYLNI 335
L LDLS N L P L ++ L++
Sbjct: 273 PAKLSVLDLSYNRLDRNPSPDELPQVGNLSL 303
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 49/241 (20%), Positives = 84/241 (34%), Gaps = 36/241 (14%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSD 125
EL+L + +T + P ++ + L ++S D +L + L+ + ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 126 CNISGGISEEIGNLTDLISIDLGGNKLNGSI----SITLGKLQKLQFLSFRGNELE---G 178
+ E++ L ++DL N G ++ K LQ L+ R +E G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 179 SIPNVLCHLAVLFQLDLRGNKLSGSIP-TCFGNLTALRNLHLDSNELTSIPSILWNLKDI 237
+ L LDL N L + + L +L+L L +P
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK-------- 270
Query: 238 LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
LP+K L+ +D S N L P + L + LSL N
Sbjct: 271 ------------GLPAK------LSVLDLSYNR-LDRNP-SPDELPQVGNLSLKGNPFLD 310
Query: 298 S 298
S
Sbjct: 311 S 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 46/237 (19%), Positives = 84/237 (35%), Gaps = 23/237 (9%)
Query: 122 WMSDCNISGGISEEI--GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNEL-EG 178
W S N G E+ G + + + + + K L+ L+ R +
Sbjct: 24 WSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSR 83
Query: 179 SIPNVLCHLAV--LFQLDLRGNKLSGSIPTCFGNLT--ALRNLHLDSNELTSIPSIL--- 231
+ L L + L +L L +++G+ P T L L+L + + + L
Sbjct: 84 ILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAEL 143
Query: 232 --WNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ----GLKSL 285
W + L + ++ L+ +D S N LG+ +L
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203
Query: 286 QFLSLGHNRLQ---GSIPNSFDDLVSLESLDLSNNNLSEIIPLS----LEKLLYLNI 335
Q L+L + ++ G V L+ LDLS+N+L + +L LN+
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 31/162 (19%), Positives = 61/162 (37%), Gaps = 17/162 (10%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSI----------VDELSLSDNYLTSS 77
+Q + + L D+ +N LG I + L+L + + +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 78 TPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIG 137
+ S L + L+ LD+S N L ++ L + +S + + + +
Sbjct: 217 SGVCSAL--AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL- 272
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179
L +DL N+L+ + S +L ++ LS +GN S
Sbjct: 273 -PAKLSVLDLSYNRLDRNPSP--DELPQVGNLSLKGNPFLDS 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 46/182 (25%), Positives = 66/182 (36%), Gaps = 64/182 (35%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV-----------------------------FHFSC 421
++G+G++G VY R L + + AIK + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 422 SNEDFRALVLEYTTNGSLEKVLYS------------SNYILDILQRLNIMIDVTSALEYL 469
S F + +E GSL +L S Y IL+ L+YL
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE----------GLKYL 138
Query: 470 HFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YM 525
H I+H D+K N L++ + V +SDFG +K L G T G YM
Sbjct: 139 H---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-----INPCTETFTGTLQYM 190
Query: 526 AP 527
AP
Sbjct: 191 AP 192
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 32/205 (15%), Positives = 68/205 (33%), Gaps = 7/205 (3%)
Query: 139 LTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRG 197
++ L L S L + + + + + +L+ + +++R
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 198 NKLSGSIPT-CFGNLTALRNLHLDSNELTSIP--SILWNLKDILYLDFWSNLFVGPLPSK 254
+ I L L+ L + + L P + +++ L+ N ++ +P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 255 I-GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP-NSFDDLVS-LES 311
L T NN + L + L N+ I ++F + S
Sbjct: 150 AFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 312 LDLSNNNLSEIIPLSLEKLLYLNIL 336
LD+S +++ + LE L L
Sbjct: 210 LDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 21/134 (15%), Positives = 45/134 (33%), Gaps = 9/134 (6%)
Query: 206 TCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRID 265
C + + ++ IPS+ + + L NL ++RI
Sbjct: 9 ECHQE----EDFRVTCKDIQRIPSLPPSTQ---TLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 266 FSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEII 323
S + L + + L + + + + R I ++ +L L+ L + N L
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP 121
Query: 324 PLSLEKLLYLNILL 337
L+ + +L
Sbjct: 122 DLTKVYSTDIFFIL 135
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 41/189 (21%), Positives = 69/189 (36%), Gaps = 52/189 (27%)
Query: 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKV---------------------------FHF 419
+ ++G GS G+V G A+K ++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 420 SCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRL------NIMIDVTSALEYLHFGY 473
S + + F + LE N +L+ ++ S N + L+ +++ + S + +LH
Sbjct: 77 SETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 474 STPIIHCDLKPHNKLLD-------------DNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
S IIH DLKP N L+ +N+ +SDFG+ K L S
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 521 I--IGYMAP 527
G+ AP
Sbjct: 193 SGTSGWRAP 201
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 45/182 (24%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVF-----------------------H-- 418
+ ++++G+G+ +V++ R + G FAIKVF H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 419 -------FSCSNEDFRALVLEYTTNGSLEKVLYS--SNYILDILQRLNIMIDVTSALEYL 469
+ + L++E+ GSL VL + Y L + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 470 HFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525
I+H ++KP N + D V L+DFG A+ L ++Q ++ T Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE---EYL 182
Query: 526 AP 527
P
Sbjct: 183 HP 184
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 46/201 (22%), Positives = 71/201 (35%), Gaps = 57/201 (28%)
Query: 381 LRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV----------------------- 416
LR F ++G+G+FG V KAR D +AIK
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 417 ------FHFSCSNEDFRA------------LVLEYTTNGSLEKVLYSSNYILDILQRLNI 458
+ +F + +EY NG+L +++S N + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 459 MIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
+ AL Y+H S IIH DLKP N +D++ + DFG+AK + +
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 519 LAI---------IG---YMAP 527
IG Y+A
Sbjct: 179 NLPGSSDNLTSAIGTAMYVAT 199
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 37/180 (20%), Positives = 52/180 (28%), Gaps = 47/180 (26%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVF-------------------------------HF 419
+G G F V L DG +A+K +
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 420 SCSNEDFRA--LVLEYTTNGSLEKVLY---SSNYILDILQRLNIMIDVTSALEYLHFGYS 474
L+L + G+L + L Q L +++ + LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG-------YMAP 527
H DLKP N LL D L D G + Q TL Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 33/191 (17%), Positives = 62/191 (32%), Gaps = 58/191 (30%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRAL--------------------- 429
+GRG FG V++A+ D +AIK +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 430 ---------------------VLEYTTNGSLEKVL--YSSNYILDILQRLNIMIDVTSAL 466
++ +L+ + + + L+I + + A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG--- 523
E+LH S ++H DLKP N + V + DFG+ + +++ T +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 524 -------YMAP 527
YM+P
Sbjct: 189 GQVGTKLYMSP 199
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 53/253 (20%), Positives = 100/253 (39%), Gaps = 16/253 (6%)
Query: 84 LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143
+ S K ++ + + + S++ I ++ +I + I L ++
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIK--SVQGIQYLPNVT 71
Query: 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGS 203
+ L GNKL I L L+ L +L N+++ + + L L L L L N +S
Sbjct: 72 KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-D 126
Query: 204 IPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTR 263
I +L L +L+L +N++T I ++L L + L N + L L
Sbjct: 127 ING-LVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQN 182
Query: 264 IDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 323
+ S N + D+ + GLK+L L L N +LV ++ ++ +L
Sbjct: 183 LYLS-KNHISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 240
Query: 324 PLSLEKLLYLNIL 336
+S + +
Sbjct: 241 IISDDGDYEKPNV 253
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 51/305 (16%), Positives = 101/305 (33%), Gaps = 57/305 (18%)
Query: 25 TIDSQNKLVGIVSITIFNLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTP 79
TI + I S + ++ V L+SI D++ +++ + S
Sbjct: 7 TITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVTQNELNSI-DQIIANNSDIKS--- 60
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ--SLEFIWMSDCNISGGISEEIG 137
+ + + KL ++ N L + + +L ++++ + + +
Sbjct: 61 ----VQGIQYLPNVTKLFLNGNKL-----TDIKPLANLKNLGWLFLDENKVK--DLSSLK 109
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
+L L S+ L N ++ I+ L L +L+ L N++ I L L L L L
Sbjct: 110 DLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLED 165
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGN 257
N++S I LT L+NL+L N ++ + ++
Sbjct: 166 NQIS-DIV-PLAGLTKLQNLYLSKNHISDLRAL-------------------------AG 198
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317
LK L ++ L L + L P D E ++ +
Sbjct: 199 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 256
Query: 318 NLSEI 322
Sbjct: 257 LPEFT 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 41/170 (24%), Positives = 64/170 (37%), Gaps = 46/170 (27%)
Query: 393 IGRGSFGSVYKARL-QDGMEFAIKVFHFSCSNEDFRAL---------------------- 429
+G G+ G V+K G+ A K+ H +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 430 --------VLEYTTNGSLEKVLYSSNYIL-DILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
+E+ GSL++VL + I IL + + I V L YL + I+H
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLREKHK--IMHR 156
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
D+KP N L++ L DFG++ L SM + +G YM+P
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS----FVGTRSYMSP 199
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 40/182 (21%), Positives = 74/182 (40%), Gaps = 45/182 (24%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVF-----------------------H-- 418
+ ++++G+G+ +V++ R + G FAIKVF H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 419 -------FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQR--LNIMIDVTSALEYL 469
+ + L++E+ GSL VL + + + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 470 HFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYM 525
I+H ++KP N + D V L+DFG A+ L ++Q ++ T Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE---YL 182
Query: 526 AP 527
P
Sbjct: 183 HP 184
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 44/175 (25%), Positives = 67/175 (38%), Gaps = 50/175 (28%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTT---------------- 435
IGRG++GSV K G A+K + ++ + L+++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 436 --------------NGSLEKVLYSSNYIL------DILQRLNIMIDVTSALEYLHFGYST 475
+ S +K +L +IL + I + AL +L
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLKENLK- 146
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
IIH D+KP N LLD + L DFGI+ L S+ +T+ G YMAP
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRD---AGCRPYMAP 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 36/148 (24%), Positives = 56/148 (37%), Gaps = 30/148 (20%)
Query: 193 LDLRGNKLSGSIP--TCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGP 250
LDL N LS + LT L +L L N L I S +
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFV----------------- 85
Query: 251 LPSKIGNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIP-NSFDDLVS 308
+ L +D S N+L + L++L+ L L +N + + N+F+D+
Sbjct: 86 ------PVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQ 137
Query: 309 LESLDLSNNNLSEIIPLSLEKLLYLNIL 336
L+ L LS N +S ++ L L
Sbjct: 138 LQKLYLSQNQISRFPVELIKDGNKLPKL 165
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 42/189 (22%), Positives = 60/189 (31%), Gaps = 35/189 (18%)
Query: 140 TDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRG 197
+ +DL N L+ T +L L L N L I + L LDL
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 198 NKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIG 256
N L ++ F +L AL L L +N + + N F
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDR---------------NAFED------- 134
Query: 257 NLKVLTRIDFSRNNLLGDIP----TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSL--E 310
+ L ++ S N + P L L L L N+L+ L +
Sbjct: 135 -MAQLQKLYLS-QNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192
Query: 311 SLDLSNNNL 319
L L NN L
Sbjct: 193 GLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 42/174 (24%), Positives = 63/174 (36%), Gaps = 36/174 (20%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
L S L LS N L+ E + + ++N L L +S N L+ F+ F
Sbjct: 37 LPSYTALLDLSHNNLSRLRAEWTP-TRLTN---LHSLLLSHNHLN-FISS--EAFV---- 85
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179
+ +L +DL N L+ LQ L+ L N +
Sbjct: 86 ------------------PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-V 126
Query: 180 IP-NVLCHLAVLFQLDLRGNKLSGSIP----TCFGNLTALRNLHLDSNELTSIP 228
+ N +A L +L L N++S P L L L L SN+L +P
Sbjct: 127 VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLP 179
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 32/146 (21%), Positives = 58/146 (39%), Gaps = 27/146 (18%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLP 252
+ L N + P F LR + L +N+++ + + F G
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAP---------------DAFQG--- 78
Query: 253 SKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLE 310
L+ L + N + ++P ++ +GL SLQ L L N++ + +F DL +L
Sbjct: 79 -----LRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131
Query: 311 SLDLSNNNLSEIIPLSLEKLLYLNIL 336
L L +N L I + L + +
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 22/75 (29%), Positives = 35/75 (46%)
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321
T I +N + P K L+ + L +N++ P++F L SL SL L N ++E
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 322 IIPLSLEKLLYLNIL 336
+ E L L +L
Sbjct: 95 LPKSLFEGLFSLQLL 109
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 40/172 (23%), Positives = 58/172 (33%), Gaps = 39/172 (22%)
Query: 59 RLSSI-------VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVV 111
L+ I + E+ L N + P +F S K L+++D+S N + L
Sbjct: 22 GLTEIPTNLPETITEIRLEQNTIKV-IPPGAF----SPYKKLRRIDLSNNQIS-ELA--P 73
Query: 112 GNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171
F L L S+ L GNK+ L LQ L
Sbjct: 74 DAFQG----------------------LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111
Query: 172 RGNELEGSIPN-VLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222
N++ + L L L L NKL F L A++ +HL N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 41/178 (23%), Positives = 62/178 (34%), Gaps = 49/178 (27%)
Query: 390 NNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA-------------------- 428
+ IGRGSF +VYK + +E A + R
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 429 ---------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
LV E T+G+L+ L ++ I + + L++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 474 STPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
+ PIIH DLK N + + D G+A L + A+IG +MAP
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFMAP 199
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 31/194 (15%), Positives = 64/194 (32%), Gaps = 53/194 (27%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR------LQDGMEFAIKV--------------------- 416
+ ++L+G G+F VY+A ++ +F +KV
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 417 --------FHFSCSNEDFRALVLEYTTNGSL----EKVLYSSNYILDILQRLNIMIDVTS 464
F+ + ++ LV E + G+L + ++ ++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH-----------LSDFGIAKLLTGEDQSM 513
+E +H IIH D+KP N +L + + L D G + + +
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 514 TQTQTLAIIGYMAP 527
T G+
Sbjct: 241 IFTAKCETSGFQCV 254
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 35/194 (18%), Positives = 59/194 (30%), Gaps = 70/194 (36%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
IG G FGSV+K DG +AIK +
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDIL---QRLNIMIDVTSALEYLHFGYST 475
+ EY GSL + + I+ + ++++ V L Y+H S
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134
Query: 476 PIIHCDLKPHNKLLDDN-------------------IVAHLSDFGIAKLLTGEDQSMTQT 516
++H D+KP N + ++ + D G + S Q
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-----SSPQV 189
Query: 517 QTLAIIG---YMAP 527
+ G ++A
Sbjct: 190 E----EGDSRFLAN 199
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 51/175 (29%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTTN--------------- 436
+GRG++G V K R + G A+K + ++++ + L+++ +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 437 ---------------GSLEKVLYSSNYILDILQRLN------IMIDVTSALEYLHFGYST 475
SL+K ++D Q + I + + ALE+LH S
Sbjct: 75 LFREGDVWICMELMDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
+IH D+KP N L++ + DFGI+ L + + G YMAP
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDID---AGCKPYMAP 178
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 36/166 (21%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTTN--------------- 436
+G G+ G V+K R + G A+K S + E+ + ++++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 437 ---------------GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
EK+ + + + + AL YL + +IH D
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRD 150
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+KP N LLD+ L DFGI+ L + ++ YMAP
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAP 193
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 38/186 (20%), Positives = 64/186 (34%), Gaps = 51/186 (27%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHF-------SCSNE-----------------DF 426
++ G F VY+A+ + G E+A+K + E
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 427 RALVLEYTTNGSLEKVL---YSSNYILDILQR------------LNIMIDVTSALEYLHF 471
++ E + G E +L +++ L++ L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG-------- 523
PIIH DLK N LL + L DFG A ++ Q A++
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 524 --YMAP 527
Y P
Sbjct: 214 PMYRTP 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 76/216 (35%)
Query: 361 PNVSNMQPQASRRRFSYQ--ELLRATDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKVF 417
++ + QP R+ + + + ++G GSF +V AR E+AIK+
Sbjct: 13 GSLQHAQPPPQPRKKRPEDFKFGK---------ILGEGSFSTVVLARELATSREYAIKIL 63
Query: 418 --------------------------------HFSCSNEDFRALVLEYTTNGSLEKVLYS 445
+F+ +++ L Y NG L
Sbjct: 64 EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL------ 117
Query: 446 SNYILDILQRLNIMID---------VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496
L ++++ + + SALEYLH IIH DLKP N LL+++ H
Sbjct: 118 ----LKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED--MH 168
Query: 497 --LSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
++DFG AK+L+ E + + +G Y++P
Sbjct: 169 IQITDFGTAKVLSPESKQAR-ANSF--VGTAQYVSP 201
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 6e-15
Identities = 38/165 (23%), Positives = 64/165 (38%), Gaps = 32/165 (19%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFH-FSCSNEDFRA--------------------- 428
+G+G FG V+ AIK + S E F
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 429 -----LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+V EY + GSL L L + Q +++ + S + Y+ +H DL
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+ N L+ +N+V ++DFG+A+L+ + + Q I + AP
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAP 433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 38/165 (23%), Positives = 64/165 (38%), Gaps = 32/165 (19%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFH-FSCSNEDFRA--------------------- 428
+G+G FG V+ AIK + S E F
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 429 -----LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+V EY + GSL L L + Q +++ + S + Y+ +H DL
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+ N L+ +N+V ++DFG+A+L+ + + Q I + AP
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAP 350
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 42/194 (21%), Positives = 77/194 (39%), Gaps = 44/194 (22%)
Query: 370 ASRRRFSYQELLRATD---GFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------- 416
+ R+ Y+ + R D + +G G+FG VYKA+ + G A KV
Sbjct: 1 SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60
Query: 417 --------------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRL 456
+ ++ +++E+ G+++ ++ + L Q
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 457 NIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516
+ + AL +LH S IIH DLK N L+ L+DFG++ +++ +
Sbjct: 121 VVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKR 174
Query: 517 QTLAIIG---YMAP 527
+ IG +MAP
Sbjct: 175 DSF--IGTPYWMAP 186
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 45/177 (25%), Positives = 62/177 (35%), Gaps = 48/177 (27%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVF-----------------------H---------- 418
+G G FG V + G + AIK H
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 419 ---FSCSNEDFRALVLEYTTNGSLEKVL--YSSNYILDILQRLNIMIDVTSALEYLHFGY 473
+ D L +EY G L K L + + L ++ D++SAL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 474 STPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
IIH DLKP N +L ++ + D G AK L + TL Y+AP
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL---QYLAP 192
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 36/166 (21%), Positives = 60/166 (36%), Gaps = 34/166 (20%)
Query: 393 IGRGSFGSVYKARLQ-DGMEFAIKVFHFSCSNEDFRA----------------------- 428
IGRG+FG V+ RL+ D A+K + +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 429 -------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
+V+E G L + L + L ++ D + +EYL S IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L N L+ + V +SDFG+++ + + + + AP
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 40/174 (22%), Positives = 63/174 (36%), Gaps = 49/174 (28%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVF-------------------------------- 417
+G+G FG+VY AR Q A+KV
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 418 --HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
+F + + L+LEY G++ + L + + + ++ +AL Y H S
Sbjct: 75 YGYFHDATRVY--LILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SK 128
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ--TLAIIGYMAP 527
+IH D+KP N LL ++DFG + S TL Y+ P
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLD---YLPP 176
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 54/202 (26%), Positives = 78/202 (38%), Gaps = 44/202 (21%)
Query: 362 NVSNMQPQASRRRF--SYQELLRATDG---FSANNLIGRGSFGSVYKAR-LQDGMEFAIK 415
++ +Q + RR E F +G GS+GSVYKA + G AIK
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 416 V---------------------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNY 448
++ S +V+EY GS+ ++ N
Sbjct: 61 QVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK 120
Query: 449 ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508
L + I+ LEYLH IH D+K N LL+ A L+DFG+A LT
Sbjct: 121 TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT- 176
Query: 509 EDQSMTQTQTLAIIG---YMAP 527
+M + T +IG +MAP
Sbjct: 177 --DTMAKRNT--VIGTPFWMAP 194
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 39/171 (22%), Positives = 61/171 (35%), Gaps = 42/171 (24%)
Query: 393 IGRGSFGSVYKARLQDGMEF---AIKVFHFSCSNEDFRA--------------------- 428
+G G+FGSV + + + AIKV D
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 429 --------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTPI 477
LV+E G L K L + + ++ V+ ++YL +F
Sbjct: 78 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------ 131
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+H DL N LL + A +SDFG++K L +D T + + AP
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 42/203 (20%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 134 EEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQL 193
L + + +LG + + + +L +Q + + ++ S+ + L +L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 194 DLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPS 253
L N++S + + +LT L L ++ N L ++ I
Sbjct: 69 HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGI----------------------- 103
Query: 254 KIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLD 313
L+R+ N L D ++ LK+L+ LS+ +N+L+ SI L LE LD
Sbjct: 104 ---PSACLSRLFLDNNELR-DT-DSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLD 156
Query: 314 LSNNNLSEIIPLS-LEKLLYLNI 335
L N ++ L+ L+K+ ++++
Sbjct: 157 LHGNEITNTGGLTRLKKVNWIDL 179
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 40/247 (16%), Positives = 83/247 (33%), Gaps = 39/247 (15%)
Query: 80 ELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNL 139
++ + K ++ + + + S ++ + NI +
Sbjct: 8 PINQVFPDPGLANAVKQNLGKQSVTDLVS--QKELSG-VQNFNGDNSNIQ--SLAGMQFF 62
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
T+L + L N+++ +S L L KL+ LS N L+ ++ + A L +L L N+
Sbjct: 63 TNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNE 117
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
L +L L L + +N+L SI + G L
Sbjct: 118 LRD--TDSLIHLKNLEILSIRNNKLKSIVML-------------------------GFLS 150
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
L +D N + + + LK + ++ L + +L ++ +
Sbjct: 151 KLEVLDLH-GNEITNT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
Query: 320 SEIIPLS 326
+S
Sbjct: 209 ISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 18/117 (15%), Positives = 39/117 (33%), Gaps = 7/117 (5%)
Query: 219 LDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTT 278
+ + L + + + L + + N+ + +
Sbjct: 4 QRPTPINQV-FPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGD-NSNIQSL-AG 58
Query: 279 IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
+Q +L+ L L HN++ + DL LE L ++ N L + + L L +
Sbjct: 59 MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFL 113
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 41/189 (21%), Positives = 62/189 (32%), Gaps = 72/189 (38%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV----------------------------------F 417
IG+G F V + + G +FA+K+
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 418 HFSCSNEDFRALVLEYTTNGSL---------EKVLYS----SNYILDILQRLNIMIDVTS 464
+ S++ +V E+ L +YS S+Y+ IL
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI 521
AL Y H IIH D+KPH LL +++ L FG+A L
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-----R 193
Query: 522 IG---YMAP 527
+G +MAP
Sbjct: 194 VGTPHFMAP 202
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 38/171 (22%), Positives = 62/171 (36%), Gaps = 42/171 (24%)
Query: 393 IGRGSFGSVYKARLQDG---MEFAIKVFHFSCSNEDFRA--------------------- 428
+G G+FGSV + + ++ AIKV D
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 429 --------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTPI 477
LV+E G L K L + + ++ V+ ++YL +F
Sbjct: 404 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------ 457
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+H +L N LL + A +SDFG++K L +D T + + AP
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 41/166 (24%), Positives = 63/166 (37%), Gaps = 38/166 (22%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFH-FSCSNEDFRA----------------------- 428
IG G FG V+ + + AIK + S EDF
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 429 ----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTPIIHCD 481
LV E+ +G L L + + L + +DV + YL IH D
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHRD 129
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L N L+ +N V +SDFG+ + + +DQ + T T + + +P
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 174
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 52/201 (25%)
Query: 360 LPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKV-- 416
+P V + + F E+LRA IG+GSFG V + D +A+K
Sbjct: 2 MPPVFDENEDVNFDHF---EILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMN 49
Query: 417 --------------------------F----HFSCSNEDFRALVLEYTTNGSLEKVLYSS 446
F +S +E+ +V++ G L L +
Sbjct: 50 KQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN 109
Query: 447 NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506
+ + +L I ++ AL+YL + IIH D+KP N LLD++ H++DF IA +L
Sbjct: 110 VHFKEETVKLFIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165
Query: 507 TGEDQSMTQTQTLAIIGYMAP 527
E Q T T YMAP
Sbjct: 166 PRETQITTMAGTKP---YMAP 183
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 41/182 (22%), Positives = 63/182 (34%), Gaps = 65/182 (35%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV-------------------------------FHFS 420
+G+G+F V + + G E+A + H S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 421 CSNEDFRALVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSALEYLHF 471
S E L+ + T G L + YS S+ I IL A+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCH- 127
Query: 472 GYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YM 525
++H +LKP N LL L+DFG+A + GE Q+ G Y+
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-----FAGTPGYL 180
Query: 526 AP 527
+P
Sbjct: 181 SP 182
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 47/206 (22%), Positives = 77/206 (37%), Gaps = 48/206 (23%)
Query: 362 NVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV---- 416
++++ P S L F L+G G++G VYK R ++ G AIKV
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 417 ------------------------------FHFSCSNEDFRA-LVLEYTTNGSLEKVL-Y 444
+ D + LV+E+ GS+ ++
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 445 SSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
+ L I ++ L +LH +IH D+K N LL +N L DFG++
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 505 LLTGEDQSMTQTQTLAIIG---YMAP 527
L +++ + T IG +MAP
Sbjct: 178 QLD---RTVGRRNT--FIGTPYWMAP 198
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 44/169 (26%), Positives = 68/169 (40%), Gaps = 44/169 (26%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA----------------------- 428
IG+GSFG V+K + AIK+ + ++
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 429 -------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
+++EY GS +L LD Q I+ ++ L+YLH S IH D
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRD 144
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
+K N LL ++ L+DFG+A LT + + T +G +MAP
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTF--VGTPFWMAP 188
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 41/217 (18%), Positives = 77/217 (35%), Gaps = 53/217 (24%)
Query: 354 QKRATKLPNVSNMQPQASRRRFSYQELLRA----------TDGFSANNLIGRGSFGSVYK 403
+ ++ ++++ A + IG GS G V
Sbjct: 4 HHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCL 63
Query: 404 AR-LQDGMEFAIKV-----------------------------FHFSCSNEDFRALVLEY 433
AR G + A+K+ + S + +++E+
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI 493
G+L ++ S L+ Q + V AL YLH + +IH D+K + LL +
Sbjct: 124 LQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG 178
Query: 494 VAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
LSDFG ++ + + + ++L +G +MAP
Sbjct: 179 RVKLSDFGFCAQIS---KDVPKRKSL--VGTPYWMAP 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 40/176 (22%), Positives = 64/176 (36%), Gaps = 57/176 (32%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV---------------------------FHFSCSNE 424
+G GSF K + FA+K+ H ++
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 425 DFRALVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSALEYLHFGYST 475
LV+E G L +K +S S + ++ SA+ ++H
Sbjct: 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV----------SAVSHMH---DV 125
Query: 476 PIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQ-TLAIIGYMAP 527
++H DLKP N L +DN+ + DFG A+L ++Q + TL Y AP
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL---HYAAP 178
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 31/150 (20%)
Query: 193 LDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251
L L N+ + T F L LR ++ +N++T I F G
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEE---------------GAFEG-- 79
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSL 309
+ I + +N L ++ + +GL+SL+ L L NR+ + N SF L S+
Sbjct: 80 ------ASGVNEILLT-SNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSV 131
Query: 310 ESLDLSNNNLSEIIPL---SLEKLLYLNIL 336
L L +N ++ + P +L L LN+L
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 32/154 (20%), Positives = 59/154 (38%), Gaps = 28/154 (18%)
Query: 167 QFLSFRGNELEGSIPN-VLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225
L NE + L L +++ NK++ F + + + L SN L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT-TIQGLKS 284
++ +F G L+ L + +N + + + GL S
Sbjct: 95 NVQ---------------HKMFKG--------LESLKTLMLR-SNRITCVGNDSFIGLSS 130
Query: 285 LQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 317
++ LSL N++ ++ +FD L SL +L+L N
Sbjct: 131 VRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 27/117 (23%), Positives = 50/117 (42%), Gaps = 3/117 (2%)
Query: 221 SNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ 280
+ +L IP + L L+ + V L L +I+FS N + +
Sbjct: 20 NQKLNKIPEHIPQYTAELRLNN-NEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE 78
Query: 281 GLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
G + + L NRL+ ++ + F L SL++L L +N ++ + S L + +L
Sbjct: 79 GASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 25/113 (22%), Positives = 47/113 (41%), Gaps = 5/113 (4%)
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPN-VLCHLAVLFQLDLR 196
L L I+ NK+ + + N LE ++ + + L L L LR
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113
Query: 197 GNKLSGSIPT-CFGNLTALRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLF 247
N+++ + F L+++R L L N++T++ L + L+ +N F
Sbjct: 114 SNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 35/183 (19%), Positives = 63/183 (34%), Gaps = 40/183 (21%)
Query: 59 RLSSI-------VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVV 111
+L+ I EL L++N T F L+K++ S N +
Sbjct: 22 KLNKIPEHIPQYTAELRLNNNEFTVLEATGIF----KKLPQLRKINFSNNKI-------- 69
Query: 112 GNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171
+E G E + ++ L N+L L+ L+ L
Sbjct: 70 ----TDIE----------EGAFEGASGVNEI---LLTSNRLENVQHKMFKGLESLKTLML 112
Query: 172 RGNELEGSIPN-VLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPS 229
R N + + N L+ + L L N+++ ++ F L +L L+L +N
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFNCNCY 170
Query: 230 ILW 232
+ W
Sbjct: 171 LAW 173
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 61/198 (30%), Positives = 82/198 (41%), Gaps = 41/198 (20%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
D +DL L T L KL +L+ N+L+ V L L L L N+
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 200 LSGSIPT-CFGNLTALRNLHLDSNELTSIPS----ILWNLKDILYLDFWSNLFVGPLPSK 254
L+ S+P F +LT L L+L N+L S+PS L LK L L+
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLK-ELRLN------------- 139
Query: 255 IGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESL 312
N L IP L +LQ LSL N+LQ S+P +FD L L+++
Sbjct: 140 --------------TNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTI 184
Query: 313 DLSNNNL----SEIIPLS 326
L N EI+ LS
Sbjct: 185 TLFGNQFDCSRCEILYLS 202
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 34/149 (22%), Positives = 50/149 (33%), Gaps = 54/149 (36%)
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251
+LDL+ L+ F LT L L+LD N+L ++ + +F
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA---------------GVF---- 79
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLE 310
L L L L +N+L S+P FD L L+
Sbjct: 80 ----------------------------DDLTELGTLGLANNQLA-SLPLGVFDHLTQLD 110
Query: 311 SLDLSNNNLSEIIPLSLEKL-----LYLN 334
L L N L + ++L L LN
Sbjct: 111 KLYLGGNQLKSLPSGVFDRLTKLKELRLN 139
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 32/189 (16%)
Query: 65 DELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMS 124
++L L L + + ++ L L++ N L L V + L + ++
Sbjct: 38 EKLDLQSTGLATLSD-----ATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLA 91
Query: 125 DCNIS---GGISEEIGNLTDLISIDLGGNKLNGSISITLG---KLQKLQFLSFRGNELEG 178
+ ++ G+ + + L L LGGN+L S+ G +L KL+ L N+L+
Sbjct: 92 NNQLASLPLGVFDHLTQLDKL---YLGGNQLK---SLPSGVFDRLTKLKELRLNTNQLQ- 144
Query: 179 SIPN-VLCHLAVLFQLDLRGNKLSGSIP-TCFGNLTALRNLHLDSNELTSIPSILWN--L 234
SIP L L L L N+L S+P F L L+ + L N ++
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN-----Q---FDCSR 195
Query: 235 KDILYLDFW 243
+ILYL W
Sbjct: 196 CEILYLSQW 204
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 3/76 (3%)
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321
++D L T +GL L +L+L +N+LQ FDDL L +L L+NN L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 322 I---IPLSLEKLLYLN 334
+ + L +L L
Sbjct: 98 LPLGVFDHLTQLDKLY 113
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 37/166 (22%), Positives = 64/166 (38%), Gaps = 38/166 (22%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSN-EDFRA----------------------- 428
+G G FG V + + + AIK+ + ++F
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 429 ----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTPIIHCD 481
++ EY NG L L + Q L + DV A+EYL F +H D
Sbjct: 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHRD 145
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L N L++D V +SDFG+++ + +D+ + + + + P
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 190
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 40/176 (22%), Positives = 62/176 (35%), Gaps = 57/176 (32%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVF-------------HFSCSN-----------EDFR 427
IG GS+ + MEFA+K+ +D +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGK 89
Query: 428 A--LVLEYTTNGSLEKVLYSSNYILD-ILQRLN--------IMIDVTSALEYLHFGYSTP 476
+V E G L LD IL++ ++ +T +EYLH +
Sbjct: 90 YVYVVTELMKGGEL----------LDKILRQKFFSEREASAVLFTITKTVEYLH---AQG 136
Query: 477 IIHCDLKPHNKLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQ-TLAIIGYMAP 527
++H DLKP N L + + DFG AK L E+ + T ++AP
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA---NFVAP 189
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 56/184 (30%), Positives = 84/184 (45%), Gaps = 11/184 (5%)
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
L + I + + I L +++L+ GN+L I L L L L L G
Sbjct: 39 ELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTG 94
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPLPSKI- 255
N+L F LT L+ L L N+L S+P + L ++ YL+ N LP +
Sbjct: 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVF 153
Query: 256 GNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLD 313
L LT +D S N L +P + L L+ L L N+L+ S+P+ FD L SL+ +
Sbjct: 154 DKLTNLTELDLS-YNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIW 211
Query: 314 LSNN 317
L +N
Sbjct: 212 LHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 33/199 (16%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
+ I +L + + ++T +L + + ++++ S+ + +L + L L GNK
Sbjct: 19 AETIKANLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNK 74
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
L I LT L L L N+L S+P+ +F L
Sbjct: 75 LH-DISA-LKELTNLTYLILTGNQLQSLPN---------------GVFDK--------LT 109
Query: 260 VLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNN 317
L + N L +P + L +L +L+L HN+LQ S+P FD L +L LDLS N
Sbjct: 110 NLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN 167
Query: 318 NLSEIIPLSLEKLLYLNIL 336
L + +KL L L
Sbjct: 168 QLQSLPEGVFDKLTQLKDL 186
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 39/127 (30%), Positives = 55/127 (43%), Gaps = 26/127 (20%)
Query: 139 LTDLISIDLGGNKLNGSISITLG---KLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDL 195
LT+L + L N+L S+ G KL L +L+ N+L+ V L L +LDL
Sbjct: 108 LTNLKELVLVENQLQ---SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164
Query: 196 RGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPS-ILWNLK-----------------D 236
N+L S+P F LT L++L L N+L S+P + L
Sbjct: 165 SYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223
Query: 237 ILYLDFW 243
I YL W
Sbjct: 224 IRYLSEW 230
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 38/166 (22%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSN-EDFRA----------------------- 428
+G G FG V + + + A+K+ + ++F
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 429 ----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTPIIHCD 481
+V EY +NG L L S L+ Q L + DV + +L F IH D
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHRD 129
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L N L+D ++ +SDFG+ + + +DQ ++ T + + AP
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAP 174
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 46/215 (21%), Positives = 74/215 (34%), Gaps = 66/215 (30%)
Query: 360 LPNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV-- 416
+ +++ Q F + +D + +G+G+F V + G+EFA K+
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 417 -----------------------------FHFSCSNEDFRALVLEYTTNGSL-----EKV 442
H S E F LV + T G L +
Sbjct: 64 TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123
Query: 443 LYS----SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVA 495
YS S+ I IL ++ Y H S I+H +LKP N LL
Sbjct: 124 FYSEADASHCIQQIL----------ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 170
Query: 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
L+DFG+A + + ++ G Y++P
Sbjct: 171 KLADFGLAIEV-NDSEAWHG-----FAGTPGYLSP 199
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 43/174 (24%)
Query: 387 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKV----------------------------- 416
++ IG+G+ G+VY A + G E AI+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 417 FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+ S D +V+EY GSL V+ + +D Q + + ALE+LH S
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
+IH D+K N LL + L+DFG +T ++ T+ +G +MAP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTM--VGTPYWMAP 185
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 42/215 (19%), Positives = 77/215 (35%), Gaps = 40/215 (18%)
Query: 349 LISRCQKRATKL------PNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVY 402
L+ A L P +P +Y + + + +G G +G VY
Sbjct: 178 LVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVY 237
Query: 403 KARLQD-GMEFAIKVF-HFSCSNEDFRA---------------------------LVLEY 433
+ + + A+K + E+F ++ E+
Sbjct: 238 EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297
Query: 434 TTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN 492
T G+L L N + + L + ++SA+EYL IH +L N L+ +N
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGEN 354
Query: 493 IVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+ ++DFG+++L+T D I + AP
Sbjct: 355 HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 388
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 41/155 (26%), Positives = 63/155 (40%), Gaps = 40/155 (25%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVF--------------------------------- 417
L+G+GSF VY+A + G+E AIK+
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 418 -HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+F SN + LVLE NG + + L + + + M + + + YLH S
Sbjct: 78 NYFEDSNYVY--LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHG 132
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
I+H DL N LL N+ ++DFG+A L +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 30/153 (19%), Positives = 54/153 (35%), Gaps = 37/153 (24%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------------FH 418
+G+G F ++ FA K+ FH
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
+ DF +VLE SL ++ + + R + + +YLH +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
H DLK N L++++ + DFG+A + + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 50/215 (23%), Positives = 75/215 (34%), Gaps = 56/215 (26%)
Query: 357 ATKLPNVSNMQPQASRRRFSYQELLRATDGFSANN---------LIGRGSFGSVYKAR-L 406
L M P + R + + F ++ IG GSFG+VY AR +
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76
Query: 407 QDGMEFAIKVFHFSC--SNEDFRALVLE----------YTTN------------------ 436
++ AIK +S SNE ++ ++ E T
Sbjct: 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136
Query: 437 -GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495
GS +L L ++ + L YLH S +IH D+K N LL + +
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV 193
Query: 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
L DFG A M + +G +MAP
Sbjct: 194 KLGDFGSA-------SIMAPANSF--VGTPYWMAP 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 35/172 (20%), Positives = 56/172 (32%), Gaps = 43/172 (25%)
Query: 393 IGRGSFGSVYKARLQDGMEF-----AIKVFHFSCSNEDFRA------------------- 428
+G G+FG+VYK E AIK + S + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYST 475
L+ + G L + + LN + + + YL
Sbjct: 83 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL---- 138
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H DL N L+ ++DFG+AKLL E++ I +MA
Sbjct: 139 --VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 38/169 (22%), Positives = 60/169 (35%), Gaps = 37/169 (21%)
Query: 393 IGRGSFGSVYKARLQDGMEF-----AIKVFHFSCSNEDFRA------------------- 428
+G G FG+V+K E IKV + F+A
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
LV +Y GSL + L LN + + + YL ++
Sbjct: 81 LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMV 137
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
H +L N LL ++DFG+A LL +D+ + ++ I +MA
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 39/187 (20%), Positives = 59/187 (31%), Gaps = 71/187 (37%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV----------------------------------- 416
+GRG V + E+A+K+
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 417 ----FHFSCSNEDFRALVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVT 463
+ F LV + G L EKV S + +L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL---------- 134
Query: 464 SALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG 523
+ LH I+H DLKP N LLDD++ L+DFG + L + + + + G
Sbjct: 135 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRE-----VCG 185
Query: 524 ---YMAP 527
Y+AP
Sbjct: 186 TPSYLAP 192
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 41/179 (22%), Positives = 59/179 (32%), Gaps = 60/179 (33%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK-----------------------------VFHFSCS 422
+G G G V + + +FA+K V+ +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILD-ILQRLN----------IMIDVTSALEYLHF 471
+V+E G L I R + IM + A++YLH
Sbjct: 130 GRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 178
Query: 472 GYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S I H D+KP N L N + L+DFG AK T + T T Y+AP
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP---YYVAP 232
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 30/153 (19%), Positives = 54/153 (35%), Gaps = 37/153 (24%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------------FH 418
+G+G F ++ FA K+ FH
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
+ DF +VLE SL ++ + + R + + +YLH +I
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
H DLK N L++++ + DFG+A + + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 28/148 (18%), Positives = 55/148 (37%), Gaps = 31/148 (20%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSN-EDFRA--------------------- 428
+G G FG V+ A + A+K + E F A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 429 -----LVLEYTTNGSLEKVLYSSNY-ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
++ E+ GSL L S + + ++ + + ++ IH DL
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 310
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGED 510
+ N L+ ++V ++DFG+A+++ +
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 40/173 (23%), Positives = 60/173 (34%), Gaps = 49/173 (28%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV---------------------------------- 416
+G+G FG+VY AR Q+ A+KV
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 417 FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+F + L+LE+ G L K L + M ++ AL Y H
Sbjct: 81 NYFHDRKRIY--LMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCH---ERK 134
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ--TLAIIGYMAP 527
+IH D+KP N L+ ++DFG + +T TL Y+ P
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLD---YLPP 181
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 36/184 (19%), Positives = 60/184 (32%), Gaps = 44/184 (23%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRAL-------------- 429
D + +IG G+ V A + AIK + L
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 430 ----------------VLEYTTNGSLEKVL-YSSNYILDILQRLN------IMIDVTSAL 466
V++ + GS+ ++ + L+ I+ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG--- 523
EYLH IH D+K N LL ++ ++DFG++ L +G
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 524 YMAP 527
+MAP
Sbjct: 192 WMAP 195
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 51/232 (21%), Positives = 75/232 (32%), Gaps = 74/232 (31%)
Query: 351 SRCQKRATKLPNVSNMQPQASRRRFSYQELLRATDGFSAN----NLIGRGSFGSVYKAR- 405
+ +K P + S A F ++IGRG V +
Sbjct: 56 AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115
Query: 406 LQDGMEFAIKV--------------------------------------FHFSCSNEDFR 427
G EFA+K+ S + F
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 428 ALVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
LV + G L EKV S + + +L A+ +LH + I+
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL----------EAVSFLH---ANNIV 222
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
H DLKP N LLDDN+ LSDFG + L + + + + G Y+AP
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRE-----LCGTPGYLAP 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 44/173 (25%)
Query: 393 IGRGSFGSVYKARLQDG----MEFAIKVFHFSCSNE---DFRA----------------- 428
IG G G V RL+ + AIK + DF +
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYST 475
+V EY NGSL+ L + + I+Q + ++ V + + YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+H DL N L+D N+V +SDFG++++L + + T I I + AP
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 44/190 (23%), Positives = 63/190 (33%), Gaps = 38/190 (20%)
Query: 349 LISRCQKRATKLPN-----VSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYK 403
L+ A L A++ F IG+G FG V
Sbjct: 152 LVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVML 211
Query: 404 ARLQDGMEFAIKVFHFSCSNEDFRA----------------------------LVLEYTT 435
+ G + A+K + + F A +V EY
Sbjct: 212 GDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270
Query: 436 NGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV 494
GSL L S +L L +DV A+EYL +H DL N L+ ++ V
Sbjct: 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNV 327
Query: 495 AHLSDFGIAK 504
A +SDFG+ K
Sbjct: 328 AKVSDFGLTK 337
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 43/182 (23%), Positives = 64/182 (35%), Gaps = 66/182 (36%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV-------------------------------FHFS 420
+G+G+F V + G+EFA K+ H S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 421 CSNEDFRALVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSALEYLHF 471
E F LV + T G L + YS S+ I IL ++ Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH- 122
Query: 472 GYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YM 525
S I+H +LKP N LL L+DFG+A + + ++ G Y+
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHG-----FAGTPGYL 174
Query: 526 AP 527
+P
Sbjct: 175 SP 176
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 45/174 (25%)
Query: 393 IGRGSFGSVYKARLQDGMEF-----AIKVFHFSCSNE---DFRA---------------- 428
IG G FG VYK L+ AIK + + DF
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYS 474
++ EY NG+L+K L + +LQ + ++ + + ++YL ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+H DL N L++ N+V +SDFG++++L + ++ T I I + AP
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 46/202 (22%), Positives = 66/202 (32%), Gaps = 70/202 (34%)
Query: 383 ATDGFSAN---------NLIGRGSFGSVYKAR-LQDGMEFAIKV---------------- 416
+TD FS +++G G+ V L E+A+K+
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 417 --------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILD-ILQRLN---- 457
ED LV E GS+ L I +R +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----------LSHIHKRRHFNEL 111
Query: 458 ----IMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLT-GE 509
++ DV SAL++LH + I H DLKP N L + + DF + +
Sbjct: 112 EASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 510 DQSMTQTQTLAII----GYMAP 527
D S T L YMAP
Sbjct: 169 DCSPISTPELLTPCGSAEYMAP 190
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 53/279 (18%), Positives = 95/279 (34%), Gaps = 21/279 (7%)
Query: 61 SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120
S V L L P+ +F + K+ + ++ + + R Q
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRC 354
Query: 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS---FRGNELE 177
S + E+ + +L ++ +I + + L L + + L+
Sbjct: 355 E--LSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK 412
Query: 178 GSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI--LWNLK 235
P +L L L N + +R LHL +LT + + L +
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYAD------VRVLHLAHKDLTVLCHLEQLLLVT 466
Query: 236 DILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL 295
+LD N LP + L+ L + S +N L ++ + L LQ L L +NRL
Sbjct: 467 ---HLDLSHNRLRA-LPPALAALRCLEVLQAS-DNALENVDG-VANLPRLQELLLCNNRL 520
Query: 296 QG-SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYL 333
Q + L L+L N+L + + L
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 7e-08
Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 15/169 (8%)
Query: 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSN 89
+ L + + L L+ + N VL + V L L+ LT L +
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-------LCHLEQ 461
Query: 90 CKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGG 149
+ LD+S N L LP + + LE + SD + + + NL L + L
Sbjct: 462 LLLVTHLDLSHNRLRA-LPPALAAL-RCLEVLQASDNALE--NVDGVANLPRLQELLLCN 517
Query: 150 NKLNGSISI-TLGKLQKLQFLSFRGNEL---EGSIPNVLCHLAVLFQLD 194
N+L S +I L +L L+ +GN L EG + L + +
Sbjct: 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 32/154 (20%), Positives = 50/154 (32%), Gaps = 42/154 (27%)
Query: 393 IGRGSFGSVYKARLQDGMEF----AIKVFHFSCSNEDFRA-------------------- 428
IG G FG V++ AIK S+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 429 ---------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTP 476
+++E T G L L Y LD+ + +++AL YL F
Sbjct: 83 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF----- 137
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
+H D+ N L+ N L DFG+++ +
Sbjct: 138 -VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 44/173 (25%)
Query: 393 IGRGSFGSVYKARLQ----DGMEFAIKVFHFSCSNE---DFRA----------------- 428
+G G FG V RL+ + AIK + + DF
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYST 475
+V EY NGSL+ L + ++Q + ++ + S ++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+H DL N L++ N+V +SDFG+ ++L + ++ T+ I I + +P
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 34/174 (19%), Positives = 51/174 (29%), Gaps = 45/174 (25%)
Query: 393 IGRGSFGSVYKARLQ----DGMEFAIKV-----FHFSCSNEDFRA--------------- 428
+G GSFG V + + A+K + +DF
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYS 474
+V E GSL L + + V + YL F
Sbjct: 86 LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF--- 142
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
IH DL N LL + + DFG+ + L D + + + AP
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 67/349 (19%), Positives = 122/349 (34%), Gaps = 61/349 (17%)
Query: 42 NLSTLKVFDVDNNYV-----------LGRLSSIVDELSLSDNYLTSSTPELSFLSSM-SN 89
L TL+ + +N + L +++L L L++++ L+S+
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS--CEPLASVLRA 168
Query: 90 CKYLKKLDISRNPLDG----FLPRVVGNFSQSLEFIWMSDCNIS----GGISEEIGNLTD 141
K+L +S N ++ L + + + LE + + C ++ + + +
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS 228
Query: 142 LISIDLGGNKL--NGSISITLGKLQ---KLQFLSFRGNELE----GSIPNVLCHLAVLFQ 192
L + LG NKL G + G L +L+ L + G + VL L +
Sbjct: 229 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288
Query: 193 LDLRGNKLSGS-----IPTCFGNLTALRNLHLDSNELTS-----IPSILWNLKDILYLDF 242
L L GN+L T L +L + S T+ S+L + +L L
Sbjct: 289 LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348
Query: 243 WSN--------LFVGPLPSKIGNLKVLTRIDFSRNNL----LGDIPTTIQGLKSLQFLSL 290
+N L VL + + ++ + T+ SL+ L L
Sbjct: 349 SNNRLEDAGVRELCQGLGQ---PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 405
Query: 291 GHNRLQGSIPNSFDDLV-----SLESLDLSNNNLSEIIPLSLEKLLYLN 334
+N L + + V LE L L + SE + L+ L
Sbjct: 406 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 454
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 55/327 (16%), Positives = 112/327 (34%), Gaps = 51/327 (15%)
Query: 44 STLKVFDVDNNYV----LGRLSSIVD---ELSLSDNYLTSSTPELSFLSSM-SNCKYLKK 95
++ D+ + L ++ + L D LT + +SS L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA--RCKDISSALRVNPALAE 60
Query: 96 LDISRNPLDG----FLPRVVGNFSQSLEFIWMSDCNIS----GGISEEIGNLTDLISIDL 147
L++ N L + + + S ++ + + +C ++ G +S + L L + L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 148 GGNKLN--GSISITLGKLQ---KLQFLSFRGNEL--EG--SIPNVLCHLAVLFQLDLRGN 198
N L G + G L +L+ L L + +VL +L + N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 199 KLSGS----IPTCFGNLTA-LRNLHLDSNELT-----SIPSILWNLKDILYLDFWSNLF- 247
++ + + + L L L+S +T + I+ + + L SN
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 248 ----VGPLPSKIGNLKVLTRIDFSRNNL----LGDIPTTIQGLKSLQFLSLGHNRLQGSI 299
P + L + + GD+ ++ +SL+ LSL N L
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300
Query: 300 PNSFDDLV-----SLESLDLSNNNLSE 321
+ + LESL + + + +
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTA 327
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 57/346 (16%), Positives = 112/346 (32%), Gaps = 81/346 (23%)
Query: 42 NLSTLKVFDVDNNYV-----------LGRLSSIVDELSLSDNYLTSSTPELSFLSSM-SN 89
L ++ +N + L S + +LSL + LT + LSS
Sbjct: 54 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA--GCGVLSSTLRT 111
Query: 90 CKYLKKLDISRNPLDG----FLPRVVGNFSQSLEFIWMSDCNIS----GGISEEIGNLTD 141
L++L +S N L L + + LE + + C++S ++ + D
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 142 LISIDLGGNKLNGSISITLGKLQK-----LQFLSFRGNELE----GSIPNVLCHLAVLFQ 192
+ + N +N + L + K L+ L + + ++ A L +
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 193 LDLRGNKLSGS-----IPTCFGNLTALRNLHLDSNELTS-----IPSILWNLKDILYLDF 242
L L NKL P + LR L + +T+ + +L + + L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 243 WSNLFVGPLPSKIG-------------NLKVLTRIDFSRNNL----LGDIPTTIQGLKSL 285
N ++G L + + + + + L
Sbjct: 292 AGN--------ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 286 QFLSLGHNRLQGS----------IPNSFDDLVSLESLDLSNNNLSE 321
L + +NRL+ + P S L L L++ ++S+
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGS-----VLRVLWLADCDVSD 384
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 34/177 (19%), Positives = 62/177 (35%), Gaps = 46/177 (25%)
Query: 391 NLIGRGSFGSVYKARLQDG----MEFAIKVFHFSCSNEDFRAL----------------- 429
+IGRG FG VY L D + A+K + +
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 430 --------------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFG 472
VL Y +G L + + + + + + V +++L F
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI--IGYMAP 527
+H DL N +LD+ ++DFG+A+ + ++ +T A + +MA
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 31/146 (21%), Positives = 57/146 (39%), Gaps = 31/146 (21%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSN-EDFRA----------------------- 428
+G G FG V+ + A+K + + F A
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 429 ---LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484
++ EY NGSL L + + L I + L++ + + ++ IH DL+
Sbjct: 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRA 137
Query: 485 HNKLLDDNIVAHLSDFGIAKLLTGED 510
N L+ D + ++DFG+A+L+ +
Sbjct: 138 ANILVSDTLSCKIADFGLARLIEDNE 163
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 47/214 (21%), Positives = 72/214 (33%), Gaps = 66/214 (30%)
Query: 361 PNVSNMQPQASRRRFSYQELLRATDGFSAN----NLIGRGSFGSVYKAR-LQDGMEFAIK 415
++ P + Y D S + +GRG+ VY+ + +A+K
Sbjct: 25 SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84
Query: 416 VFHFSCSNEDFRA---------------------------LVLEYTTNGSL-----EKVL 443
V + + R LVLE T G L EK
Sbjct: 85 VLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY 144
Query: 444 YS----SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAH 496
YS ++ + IL A+ YLH I+H DLKP N L +
Sbjct: 145 YSERDAADAVKQIL----------EAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLK 191
Query: 497 LSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
++DFG++K++ M + G Y AP
Sbjct: 192 IADFGLSKIV-EHQVLMKT-----VCGTPGYCAP 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 35/172 (20%), Positives = 56/172 (32%), Gaps = 43/172 (25%)
Query: 393 IGRGSFGSVYKARLQDGMEF-----AIKVFHFSCSNEDFRA------------------- 428
+G G+FG+VYK E AIK + S + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYST 475
L+ + G L + + LN + + + YL
Sbjct: 83 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL---- 138
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H DL N L+ ++DFG+AKLL E++ I +MA
Sbjct: 139 --VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 42/128 (32%), Positives = 66/128 (51%), Gaps = 6/128 (4%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPL 251
L L N+++ P F +L L+ L+L SN+L ++P + +L + LD +N + L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ-LTVL 103
Query: 252 PSKI-GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSL 309
PS + L L + N L ++P I+ L L L+L N+L+ SIP+ +FD L SL
Sbjct: 104 PSAVFDRLVHLKELFMC-CNKLTELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSL 161
Query: 310 ESLDLSNN 317
L N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 36/146 (24%), Positives = 53/146 (36%), Gaps = 2/146 (1%)
Query: 125 DCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVL 184
DC S G T+ + L N++ L L+ L N+L V
Sbjct: 25 DCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF 84
Query: 185 CHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFW 243
L L LDL N+L+ +P+ F L L+ L + N+LT +P + L + +L
Sbjct: 85 DSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALD 143
Query: 244 SNLFVGPLPSKIGNLKVLTRIDFSRN 269
N L LT N
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 37/127 (29%), Positives = 53/127 (41%), Gaps = 25/127 (19%)
Query: 138 NLTDLISIDLGGNKLNGSISITLG---KLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLD 194
+L +L + LG N+L ++ +G L +L L N+L V L L +L
Sbjct: 62 SLINLKELYLGSNQLG---ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118
Query: 195 LRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLK-----------------D 236
+ NKL+ +P LT L +L LD N+L SIP L D
Sbjct: 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD 177
Query: 237 ILYLDFW 243
I+YL W
Sbjct: 178 IMYLRNW 184
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 40/183 (21%), Positives = 68/183 (37%), Gaps = 69/183 (37%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV-----------------------------FHFSC 421
++G G+F V+ + G FA+K
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 422 SNEDFRALVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSALEYLHFG 472
+ LV++ + G L E+ +Y+ S I +L SA++YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----------SAVKYLH-- 123
Query: 473 YSTPIIHCDLKPHNKLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---Y 524
I+H DLKP N L + I+ ++DFG++K+ ++ M+ G Y
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIM--ITDFGLSKME--QNGIMST-----ACGTPGY 173
Query: 525 MAP 527
+AP
Sbjct: 174 VAP 176
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 51/272 (18%), Positives = 94/272 (34%), Gaps = 82/272 (30%)
Query: 306 LVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILALKFGLISRCQKRATKLPNVSN 365
L LE L + S+E LL + ++ + + R + L
Sbjct: 6 LRQLEQFILDGPAQTNGQCFSVETLLDI----LICLYDECNNSPLRREKNILEYLEWAKP 61
Query: 366 MQPQASRRRFSYQ--ELLRATDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKV------ 416
+ + R + E+L+ +IGRG+FG V +L++ FA+K+
Sbjct: 62 FTSKVKQMRLHREDFEILK---------VIGRGAFGEVAVVKLKNADKVFAMKILNKWEM 112
Query: 417 --------------------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYIL 450
H++ +++ LV++Y G L L
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL----------L 162
Query: 451 DILQRLNIMID----------VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH--LS 498
+L + + + A++ +H +H D+KP N L+D N H L+
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLA 217
Query: 499 DFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
DFG L + + +G Y++P
Sbjct: 218 DFGSCLKLMEDGTVQSSV----AVGTPDYISP 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 30/154 (19%), Positives = 53/154 (34%), Gaps = 42/154 (27%)
Query: 393 IGRGSFGSVYKARLQDGMEF----AIKVFHFSCSN---EDFRA----------------- 428
+G G FG VY+ + A+K C+ E F +
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 429 ---------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTP 476
+++E G L L + L +L + + + A+ YL +
Sbjct: 80 GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC----- 134
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
+H D+ N L+ L DFG+++ + ED
Sbjct: 135 -VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 42/180 (23%), Positives = 68/180 (37%), Gaps = 61/180 (33%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVF------------HFSCSN-----------EDFR 427
++G G G V + + G + A+K+ H+ S E+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH 95
Query: 428 A------LVLEYTTNGSLEKVLYSSNYILD-ILQRLN----------IMIDVTSALEYLH 470
+++E G L I +R + IM D+ +A+++LH
Sbjct: 96 HGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 471 FGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S I H D+KP N L + + V L+DFG AK T ++ T T Y+AP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTP---YYVAP 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 41/178 (23%), Positives = 66/178 (37%), Gaps = 46/178 (25%)
Query: 387 FSANNLIGRGSFGSVYKARLQD-GMEFAIKVF---------------------------- 417
FS + +IGRG FG VY R D G +A+K
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 418 -------HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH 470
++ D + +L+ G L L + R ++ LE++H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMH 309
Query: 471 FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-IIGYMAP 527
+ +++ DLKP N LLD++ +SD G+A + + + GYMAP
Sbjct: 310 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 25/135 (18%), Positives = 51/135 (37%), Gaps = 15/135 (11%)
Query: 405 RLQDGMEFAIKVFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYI--LDILQRLNIMIDV 462
R+ S + + + ++ +L+ + + + L+I I +
Sbjct: 114 RMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI 173
Query: 463 TSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAII 522
A+E+LH S ++H DLKP N + V + DFG+ + +++ T +
Sbjct: 174 AEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 523 G----------YMAP 527
YM+P
Sbjct: 231 ATHTGQVGTKLYMSP 245
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 19/114 (16%), Positives = 37/114 (32%), Gaps = 5/114 (4%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTTNGSLEK----VLYSS 446
+GRG FG V++A+ D +AIK ++ E LE +++
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 447 NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500
+ M ++ E + S+P + +D +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 30/175 (17%), Positives = 58/175 (33%), Gaps = 43/175 (24%)
Query: 393 IGRG--SFGSVYKAR-LQDGMEFAIKVFHF-SCSNEDFRAL------------------- 429
IG+G +V AR G ++ + +CSNE L
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 430 -----------VLEYTTNGSLEKVL-YSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
V + GS + ++ ++ L I+ V AL+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLL--TGEDQSMTQTQTLAIIG---YMAP 527
+H +K + L+ + +LS + G+ Q + + +++P
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 37/171 (21%), Positives = 58/171 (33%), Gaps = 43/171 (25%)
Query: 393 IGRGSFGSVYKARLQDGMEF----AIKVFHFSCS---NEDFRA----------------- 428
IG G FG V++ AIK S E F
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 429 ---------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTP 476
+++E T G L L + LD+ + +++AL YL F
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF----- 512
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H D+ N L+ N L DFG+++ + ++ I +MAP
Sbjct: 513 -VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAP 561
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 35/177 (19%), Positives = 62/177 (35%), Gaps = 46/177 (25%)
Query: 391 NLIGRGSFGSVYKARLQDG----MEFAIKVFHFSCSNEDFRAL----------------- 429
+IGRG FG VY L D + A+K + +
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 430 --------------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFG 472
VL Y +G L + + + + + + V ++YL F
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI--IGYMAP 527
+H DL N +LD+ ++DFG+A+ + ++ +T A + +MA
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 7e-12
Identities = 45/204 (22%), Positives = 75/204 (36%), Gaps = 60/204 (29%)
Query: 367 QPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFH-FSCSNE 424
+ R +Q + ++ ++G+GSFG V K + E+A+KV + S N+
Sbjct: 6 HHSSGRENLYFQGTFA--ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 425 DFRA------------------------------LVLEYTTNGSL-----EKVLYSSNYI 449
D +V E T G L ++ +S +
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 450 LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLL 506
I + V S + Y+H I+H DLKP N LL + + + DFG++
Sbjct: 124 ARI------IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 507 TGEDQSMTQTQTLAIIG---YMAP 527
++ M IG Y+AP
Sbjct: 175 -QQNTKMKD-----RIGTAYYIAP 192
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 36/172 (20%), Positives = 64/172 (37%), Gaps = 44/172 (25%)
Query: 393 IGRGSFGSVYKARLQDGMEF---AIKVFHFSCSN----EDFRA----------------- 428
+G G+FG+V K Q A+K+ ++ ++ A
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 429 ---------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFGYSTP 476
LV+E G L K L + + + + ++ V+ ++YL +F
Sbjct: 85 GICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF----- 138
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+H DL N LL A +SDFG++K L ++ + + AP
Sbjct: 139 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 44/159 (27%), Positives = 62/159 (38%), Gaps = 44/159 (27%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIK-----------------------------VFHFSCSN 423
IG GSFG V++A+L + E AIK F+ +
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107
Query: 424 EDFRA--LVLEY--TTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+D LVLEY T + + + +L M + +L Y+H S
Sbjct: 108 KDEVFLNLVLEYVPET---VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIG 161
Query: 477 IIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMT 514
I H D+KP N LLD + V L DFG AK+L +
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNV 199
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/251 (20%), Positives = 90/251 (35%), Gaps = 68/251 (27%)
Query: 326 SLEKLLYLNILLIVVVILALKFGLISRCQKRAT-KLPNVSNMQPQASRRRFSYQELLRAT 384
S+++L+ L + +L L G+ + V++ A +E+
Sbjct: 1 SMQQLVLDPGFLGLEPLLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQR 60
Query: 385 DGFSANNLIGRGSFGSVYKARLQD-GMEFAIKV--------------------------- 416
D F +IGRG+F V +++ G +A+K+
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMID---------- 461
HF+ +E++ LV+EY G L L +L + I
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAE 170
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTL 519
+ A++ +H +H D+KP N LLD H L+DFG L + +
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV--- 222
Query: 520 AIIG---YMAP 527
+G Y++P
Sbjct: 223 -AVGTPDYLSP 232
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 39/187 (20%), Positives = 68/187 (36%), Gaps = 65/187 (34%)
Query: 387 FSANNLIGRGSFGSVYKARLQD-GMEFAIKVF---------------------------- 417
+ +IGRG+FG V R + +A+K+
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 418 ----HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMID--------VTSA 465
++ ++ + +V+EY G L ++++ ++ V A
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLA 180
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTLAIIG 523
L+ +H S IH D+KP N LLD + H L+DFG + E T +G
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDT----AVG 231
Query: 524 ---YMAP 527
Y++P
Sbjct: 232 TPDYISP 238
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 20/85 (23%), Positives = 37/85 (43%), Gaps = 6/85 (7%)
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLE 310
+ + LT + L + ++GL L+ L++ + L+ P++F L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 311 SLDLSNNNLSEI-----IPLSLEKL 330
L+LS N L + LSL++L
Sbjct: 84 RLNLSFNALESLSWKTVQGLSLQEL 108
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 13/76 (17%), Positives = 30/76 (39%), Gaps = 2/76 (2%)
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLS 320
+ + +R+ L D + G ++L L + + + + L L +L + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 321 EIIPLSLEKLLYLNIL 336
+ P + L+ L
Sbjct: 70 FVAPDAFHFTPRLSRL 85
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 23/142 (16%), Positives = 35/142 (24%), Gaps = 49/142 (34%)
Query: 179 SIPNVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDI 237
+ L L +L + + + L LRNL + + L +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA--------- 72
Query: 238 LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
P L L+L N L+
Sbjct: 73 --------------------------------------PDAFHFTPRLSRLNLSFNALES 94
Query: 298 SIPNSFDDLVSLESLDLSNNNL 319
+ L SL+ L LS N L
Sbjct: 95 LSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 4/104 (3%)
Query: 125 DCNISGGIS--EEIGNLTDLISIDLGGNKLNGSI-SITLGKLQKLQFLSFRGNELEGSIP 181
C G + + +L + + + + L L +L+ L+ + L P
Sbjct: 14 RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 182 NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225
+ L +L+L N L L+ L+ L L N L
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 41/187 (21%), Positives = 62/187 (33%), Gaps = 71/187 (37%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFH----------FSCSNEDFRA------------- 428
+G G+ G V A + + AIK+ + +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 429 -------------LVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSAL 466
+VLE G L Y +L A+
Sbjct: 78 IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----------LAV 127
Query: 467 EYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG 523
+YLH IIH DLKP N LL +++ + ++DFG +K+L GE M + G
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT-----LCG 178
Query: 524 ---YMAP 527
Y+AP
Sbjct: 179 TPTYLAP 185
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 35/177 (19%), Positives = 60/177 (33%), Gaps = 46/177 (25%)
Query: 391 NLIGRGSFGSVYKARLQDGMEF----AIKVFHFSCSNEDFRAL----------------- 429
+IG+G FG VY D + AIK + A
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 430 --------------VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFG 472
+L Y +G L + + S + ++ + V +EYL F
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF- 145
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI--IGYMAP 527
+H DL N +LD++ ++DFG+A+ + + Q A + + A
Sbjct: 146 -----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 37/165 (22%), Positives = 64/165 (38%), Gaps = 34/165 (20%)
Query: 393 IGRGSFGSVYKARLQDG-MEFAIKVFHFSCSN-EDFRA---------------------- 428
+G G +G VY+ + + A+K E+F
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 429 -----LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
++ E+ T G+L L N + + L + ++SA+EYL IH DL
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
N L+ +N + ++DFG+++L+T D I + AP
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 41/172 (23%), Positives = 63/172 (36%), Gaps = 44/172 (25%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKVF--------------------------------H 418
++G+G FG V +++ G +A K
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMI-DVTSALEYLHFGYSTPI 477
++ +D LVL G L+ +Y R ++ LE LH I
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERI 307
Query: 478 IHCDLKPHNKLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
++ DLKP N LLDD+ H +SD G+A + + T +GYMAP
Sbjct: 308 VYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGT---VGYMAP 354
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 33/127 (25%), Positives = 52/127 (40%), Gaps = 28/127 (22%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLP 252
L L GN+ + +P N L + L +N ++++ + F
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSN---------------QSF----- 74
Query: 253 SKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLE 310
N+ L + S N L IP GLKSL+ LSL N + +P +F+DL +L
Sbjct: 75 ---SNMTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALS 129
Query: 311 SLDLSNN 317
L + N
Sbjct: 130 HLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 25/122 (20%), Positives = 44/122 (36%), Gaps = 20/122 (16%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
D+ + L GN+ + L + L + N + ++ L L L N+
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 200 LSGSIPT-CFGNLTALRNLHLDSNELTSIP-SILWNLK----------------DILYLD 241
L IP F L +LR L L N+++ +P +L ++ +L
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLS 148
Query: 242 FW 243
W
Sbjct: 149 DW 150
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 5/103 (4%)
Query: 221 SNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ 280
+ L +P + LYLD N F +P ++ N K LT ID S N + +
Sbjct: 19 NKGLKVLPKGIPRDVTELYLD--GNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFS 75
Query: 281 GLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEI 322
+ L L L +NRL+ IP +FD L SL L L N++S +
Sbjct: 76 NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVV 117
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 20/68 (29%), Positives = 31/68 (45%)
Query: 269 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 328
N +P + K L + L +NR+ SF ++ L +L LS N L I P + +
Sbjct: 40 GNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFD 99
Query: 329 KLLYLNIL 336
L L +L
Sbjct: 100 GLKSLRLL 107
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 44/166 (26%), Positives = 63/166 (37%), Gaps = 38/166 (22%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
IG+G FG V + G + A+K + + F A
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 429 ------LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
+V EY GSL L S +L L +DV A+EYL +H D
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L N L+ ++ VA +SDFG+ K + S TQ + + AP
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 183
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 44/180 (24%), Positives = 68/180 (37%), Gaps = 43/180 (23%)
Query: 385 DGFSANNLIGRGSFGSVYKARLQD-GMEFAIKVF-------------------------- 417
D F ++GRG FG V+ +++ G +A K
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 418 ------HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDIL--QRLNIMI-DVTSALEY 468
++ + LV+ G + +Y+ + R + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-IIGYMAP 527
LH II+ DLKP N LLDD+ +SD G+A L T+T+ A G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMAP 358
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 16/81 (19%), Positives = 26/81 (32%), Gaps = 10/81 (12%)
Query: 450 LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509
L RL + + V L LH ++H L+P + +LD L+ F
Sbjct: 208 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----R 260
Query: 510 DQSMTQTQTLAIIG---YMAP 527
D + + A
Sbjct: 261 DGASAVSPIGRGFAPPETTAE 281
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 39/154 (25%), Positives = 57/154 (37%), Gaps = 39/154 (25%)
Query: 393 IGRGSFGSVYKARL-----QDGMEFAIKVFHFSCSN--EDFRA----------------- 428
+G+G+FGSV R G A+K S + DF+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 429 ------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
LV+EY +G L L LD + L + +EYL S
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
+H DL N L++ ++DFG+AKLL +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 42/204 (20%), Positives = 71/204 (34%), Gaps = 60/204 (29%)
Query: 367 QPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------- 416
+ R +Q + ++ ++G+GSFG V K + E+A+KV
Sbjct: 6 HHSSGRENLYFQGTFA--ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 417 ----------------------FHFSCSNEDFRALVLEYTTNGSL-----EKVLYSSNYI 449
+ +V E T G L ++ +S +
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 450 LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLL 506
I + V S + Y+H I+H DLKP N LL + + + DFG++
Sbjct: 124 ARI------IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 507 TGEDQSMTQTQTLAIIG---YMAP 527
++ M IG Y+AP
Sbjct: 175 -QQNTKMKD-----RIGTAYYIAP 192
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 38/161 (23%), Positives = 54/161 (33%), Gaps = 57/161 (35%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK-----------------------------VFHFSCS 422
+G G G V + + +FA+K V+ +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 85
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILD-ILQRLN----------IMIDVTSALEYLHF 471
+V+E G L I R + IM + A++YLH
Sbjct: 86 GRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 134
Query: 472 GYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGE 509
S I H D+KP N L N + L+DFG AK TGE
Sbjct: 135 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 32/173 (18%), Positives = 62/173 (35%), Gaps = 41/173 (23%)
Query: 393 IGRGSFGSVYKARL-----QDGMEFAIKVFHFSCSNEDFRA------------------- 428
+G G FG V R G + A+K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 429 -------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
L++E+ +GSL++ L + +++ Q+L + + ++YL S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLAIIGYMAP 527
+H DL N L++ + DFG+ K + T ++ + + + + AP
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 36/148 (24%), Positives = 58/148 (39%), Gaps = 42/148 (28%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV----------------------------FHFSCSN 423
IG G+FG + + L AIK+ ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 424 EDFRALVLEYTTNG-SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+ A+VLE G SLE + + + L I I + S +EY+H S +I+ D+
Sbjct: 77 GKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDV 131
Query: 483 KPHNKLL------DDNIVAHLSDFGIAK 504
KP N L+ ++ H+ DF +AK
Sbjct: 132 KPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 41/176 (23%), Positives = 58/176 (32%), Gaps = 56/176 (31%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV-----------------------------FHFSCS 422
IGRGS+G V A + A K + +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 423 NEDFRALVLEYTTNGSL-----EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+ LV+E T G L K ++ + I M DV SA+ Y H +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARI------MKDVLSAVAYCH---KLNV 127
Query: 478 IHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
H DLKP N L + L DFG+A + M +G Y++P
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRT-----KVGTPYYVSP 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 47/157 (29%), Positives = 62/157 (39%), Gaps = 39/157 (24%)
Query: 393 IGRGSFGSVYKARLQD-GMEFAIK-----------------------------VFHFSCS 422
IG GSFG VY+A+L D G AIK F+ S
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 423 NEDFRAL--VLEY--TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
+D L VL+Y T + + + L ++ M + +L Y+H S I
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGIC 178
Query: 479 HCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMT 514
H D+KP N LLD D V L DFG AK L +
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNV 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 44/207 (21%), Positives = 65/207 (31%), Gaps = 63/207 (30%)
Query: 367 QPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------- 416
+ R +Q + D F +G G+FG V+ G+E IK
Sbjct: 6 HHSSGRENLYFQGTID--DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63
Query: 417 ---------------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQR 455
+ +V+E G L I+ R
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL------LERIVSAQAR 117
Query: 456 L---------NIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIA 503
+M + +AL Y H S ++H DLKP N L + + DFG+A
Sbjct: 118 GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 504 KLLTGEDQSMTQTQTLAIIG---YMAP 527
+L D+ T G YMAP
Sbjct: 175 ELF-KSDEHSTN-----AAGTALYMAP 195
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 40/146 (27%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV----------------------------FHFSCSN 423
IG GSFG +Y + G E AIK+ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76
Query: 424 EDFRALVLEYTTNG-SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
D+ +V+E G SLE + + + L + + S +EY+H S IH D+
Sbjct: 77 GDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 131
Query: 483 KPHNKLL----DDNIVAHLSDFGIAK 504
KP N L+ N+V ++ DFG+AK
Sbjct: 132 KPDNFLMGLGKKGNLV-YIIDFGLAK 156
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 39/154 (25%), Positives = 54/154 (35%), Gaps = 36/154 (23%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA----------------------- 428
IG GS+G V+K R G AIK F S + +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 429 --------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
LV EY + ++ L + +I A+ + H IH
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514
D+KP N L+ + V L DFG A+LLTG
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 36/150 (24%), Positives = 54/150 (36%), Gaps = 39/150 (26%)
Query: 393 IGRGSFGSVYKARL-----QDGMEFAIKVFHFSCSNE--DFRA----------------- 428
+G+G+FGSV R G A+K S DF
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 429 ------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
L++EY GSL L +D ++ L + +EYL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506
IH DL N L+++ + DFG+ K+L
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVL 195
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 36/150 (24%), Positives = 54/150 (36%), Gaps = 39/150 (26%)
Query: 393 IGRGSFGSVYKARL-----QDGMEFAIKVFHFSCSN--EDFRA----------------- 428
+G+G+FGSV R G A+K S DF
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 429 ------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
L++EY GSL L +D ++ L + +EYL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506
IH DL N L+++ + DFG+ K+L
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVL 164
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 39/186 (20%), Positives = 63/186 (33%), Gaps = 69/186 (37%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFH----------FSCSNEDFRA------------- 428
+G G+ G V A + + AI++ + +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 429 -------------LVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSAL 466
+VLE G L Y +L A+
Sbjct: 203 IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----------LAV 252
Query: 467 EYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQ--TLAI 521
+YLH IIH DLKP N LL +++ + ++DFG +K+L + S+ +T T
Sbjct: 253 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP-- 305
Query: 522 IGYMAP 527
Y+AP
Sbjct: 306 -TYLAP 310
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 34/186 (18%), Positives = 57/186 (30%), Gaps = 58/186 (31%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV-------------------------- 416
D + + +G G+FG V++ G FA K
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 417 ---FHFSCSNEDFRALVLEYTTNGSL------EKVLYS----SNYILDILQRLNIMIDVT 463
H + +++ ++ E+ + G L E S Y+ +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC---------- 265
Query: 464 SALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL--SDFGIAKLLTGEDQSMTQTQTLAI 521
L ++H +H DLKP N + L DFG+ L + T T
Sbjct: 266 KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA-- 320
Query: 522 IGYMAP 527
+ AP
Sbjct: 321 -EFAAP 325
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 38/237 (16%), Positives = 69/237 (29%), Gaps = 75/237 (31%)
Query: 348 GLISRCQKRATKLPNVSNMQPQASRRRFSYQ--ELLRATDGFSANNLIGRGSFGSVYKAR 405
G + + + N+ + + ++R + +G F +
Sbjct: 1 GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIR---------TLNQGKFNKIILCE 51
Query: 406 LQDGMEFAI---------KVFHFSCSNEDFRA---------------------------- 428
+D +A+ K F+ SN D +
Sbjct: 52 -KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 429 ---------LVLEYTTNGSLEKVLYSSNYILDILQRL-------NIMIDVTSALEYLHFG 472
++ EY N S+ K + I+ V ++ Y+H
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH-- 168
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ--TLAIIGYMAP 527
I H D+KP N L+D N LSDFG ++ + + T +M P
Sbjct: 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIKGSRGTYE---FMPP 219
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 7/130 (5%)
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGP 250
LDL N L F LT+L L+L N+L S+P+ + L + YL+ +N
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS- 90
Query: 251 LPSKI-GNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLV 307
LP+ + L L + + N L +P + L L+ L L N+L+ S+P+ FD L
Sbjct: 91 LPNGVFDKLTQLKELALN-TNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 308 SLESLDLSNN 317
SL+ + L +N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 41/128 (32%), Positives = 55/128 (42%), Gaps = 26/128 (20%)
Query: 138 NLTDLISIDLGGNKLNGSISITLG---KLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLD 194
LT L + LGGNKL S+ G KL L +L+ N+L+ V L L +L
Sbjct: 50 ELTSLTQLYLGGNKLQ---SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106
Query: 195 LRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPS-ILWNLK----------------- 235
L N+L S+P F LT L++L L N+L S+P + L
Sbjct: 107 LNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165
Query: 236 DILYLDFW 243
I YL W
Sbjct: 166 GIRYLSEW 173
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 25/76 (32%), Positives = 32/76 (42%), Gaps = 3/76 (3%)
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321
T +D N+L L SL L LG N+LQ F+ L SL L+LS N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 322 IIPL---SLEKLLYLN 334
+ L +L L
Sbjct: 91 LPNGVFDKLTQLKELA 106
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 36/175 (20%), Positives = 63/175 (36%), Gaps = 52/175 (29%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV-------------------------------FHFS 420
+G G++G V R +E AIK+ +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 421 CSNEDFRALVLEYTTNGSL-----EKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
++ LV+E G L ++ ++ I + V S + YLH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI------IKQVLSGVTYLH---KH 155
Query: 476 PIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I+H DLKP N LL + + + + DFG++ + + + + T Y+AP
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT---AYYIAP 207
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 43/208 (20%), Positives = 68/208 (32%), Gaps = 53/208 (25%)
Query: 361 PNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--- 416
P A+ F +D + ++G+GSFG V + G E A+KV
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61
Query: 417 -----------------------------FHFSCSNEDFRALVLEYTTNGSL-----EKV 442
+ ++ + LV E T G L +
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121
Query: 443 LYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSD 499
+S I + V S + Y+H I+H DLKP N LL + + D
Sbjct: 122 RFSEVDAARI------IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIID 172
Query: 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
FG++ + + T Y+AP
Sbjct: 173 FGLSTHFEASKKMKDKIGT---AYYIAP 197
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 37/188 (19%), Positives = 60/188 (31%), Gaps = 68/188 (36%)
Query: 387 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSN--EDFRA--------------- 428
S ++G G FG V+K G++ A K+ E+ +
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 429 ------------LVLEYTTNGSL------EKVLYS----SNYILDILQRLNIMIDVTSAL 466
LV+EY G L E + ++ I +
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC----------EGI 200
Query: 467 EYLHFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAII 522
++H Y I+H DLKP N L I + DFG+A+ + +
Sbjct: 201 RHMHQMY---ILHLDLKPENILCVNRDAKQIK--IIDFGLARRY-KPREKLKV-----NF 249
Query: 523 G---YMAP 527
G ++AP
Sbjct: 250 GTPEFLAP 257
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 30/166 (18%), Positives = 59/166 (35%), Gaps = 54/166 (32%)
Query: 393 IGRGSFGSVYKARLQD--------GMEFAIKVFHFSCSN--EDFRA-------------- 428
+G+G+F ++K ++ E +KV + N E F
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 429 -------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL---HFG 472
LV E+ GSL+ L + ++IL +L + + +A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 473 YSTPIIHCDL--------KPHNKLLDDNIVAHLSDFGIAKLLTGED 510
IH ++ + ++ + LSD GI+ + +D
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 28/148 (18%), Positives = 55/148 (37%), Gaps = 42/148 (28%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV----------------------------FHFSCSN 423
IG GSFG +++ L + + AIK ++
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77
Query: 424 EDFRALVLEYTTNG-SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
LV++ G SLE +L + + + ++ +H +++ D+
Sbjct: 78 GLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDI 132
Query: 483 KPHNKLL------DDNIVAHLSDFGIAK 504
KP N L+ + N++ ++ DFG+ K
Sbjct: 133 KPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 36/177 (20%), Positives = 60/177 (33%), Gaps = 58/177 (32%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV-----------------------------FHFSCS 422
+G G+FG V++ G F K H +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 423 NEDFRALVLEYTTNGSL------EKVLYS----SNYILDILQRLNIMIDVTSALEYLHFG 472
++ L+LE+ + G L E S NY+ L+++H
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC----------EGLKHMH-- 166
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHL--SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I+H D+KP N + + + + DFG+A L D+ + T A + AP
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATA--EFAAP 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 28/176 (15%), Positives = 53/176 (30%), Gaps = 57/176 (32%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV----------------------------FHFSCSN 423
+GRG FG V++ + K H S +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 424 EDFRALVLEYTTNGSL------EKVLYS----SNYILDILQRLNIMIDVTSALEYLHFGY 473
+ ++ E+ + + + +Y+ + AL++LH
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC----------EALQFLHSHN 122
Query: 474 STPIIHCDLKPHNKLLDDNIVAHL--SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I H D++P N + + + +FG A+ L + T Y AP
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAP--EYYAP 172
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 42/187 (22%), Positives = 60/187 (32%), Gaps = 71/187 (37%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFH--------FSCSNEDFRA--------------- 428
+G G F V K R G+E+A K S E+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 429 ------------LVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSALE 467
L+LE + G L +K S +++I IL +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL----------DGVN 129
Query: 468 YLHFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG 523
YLH + I H DLKP N +L L DFG+A + + I G
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKN-----IFG 180
Query: 524 ---YMAP 527
++AP
Sbjct: 181 TPEFVAP 187
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 17/147 (11%), Positives = 36/147 (24%), Gaps = 43/147 (29%)
Query: 392 LIGRGSFGSVYKARLQD---GMEFAIKVFHFSCSN-EDFRA------------------- 428
G ++A D + A+ +D
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 429 ------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
+V E+ GSL++V +S + + M + +A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIA 503
+ P + + L+
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 37/157 (23%), Positives = 56/157 (35%), Gaps = 36/157 (22%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA--------------------- 428
L+G GS+G V K R G AIK F S ++ +
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
LV E+ + ++ L LD + + + + + H S II
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
H D+KP N L+ + V L DFG A+ L +
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 44/179 (24%), Positives = 65/179 (36%), Gaps = 48/179 (26%)
Query: 385 DGFSANNLIGRGSFGSVYKARLQD-GMEFAIKV--------------------------- 416
D F +G GSFG V + ++ G +A+K+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF 471
FS + +V+EY G + L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH- 158
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG---YMAP 527
S +I+ DLKP N L+D ++DFG AK + G +T TL G +AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLC--GTPEALAP 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 50/206 (24%), Positives = 77/206 (37%), Gaps = 65/206 (31%)
Query: 368 PQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKV---------- 416
P+ ++ R S Q L+ D F + ++G+GSFG V+ A + FAIK
Sbjct: 1 PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59
Query: 417 -------------------F----HFSCSNEDFRALVLEYTTNGSLEKVLYSSN------ 447
F + ++ V+EY G L + S +
Sbjct: 60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR 119
Query: 448 ---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN--IVAHLSDFGI 502
Y +I+ L++LH S I++ DLK N LLD + I ++DFG+
Sbjct: 120 ATFYAAEII----------LGLQFLH---SKGIVYRDLKLDNILLDKDGHIK--IADFGM 164
Query: 503 AKLLTGEDQSMTQTQTL-AIIGYMAP 527
K D T T Y+AP
Sbjct: 165 CKENMLGDAK---TNTFCGTPDYIAP 187
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 37/181 (20%), Positives = 61/181 (33%), Gaps = 61/181 (33%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV--------------------------------FHF 419
+GRG F V + G E+A K H
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 420 SCSNEDFRALVLEYTTNGSL-EKVLYSSNYILDILQRL------NIMIDVTSALEYLHFG 472
N L+LEY G + + ++ + + ++ + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAH---LSDFGIAKLLTGEDQSMTQTQTLAIIG---YMA 526
I+H DLKP N LL + DFG+++ + G + + I+G Y+A
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELRE-----IMGTPEYLA 201
Query: 527 P 527
P
Sbjct: 202 P 202
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 39/173 (22%), Positives = 62/173 (35%), Gaps = 47/173 (27%)
Query: 384 TDGFSANNLIGRGSFGSVYKARLQD-GMEFAIK-VF--------------------H--- 418
D F + G+G+FG+V + + GM AIK V H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 419 -------FSCSNEDFR----ALVLEY--TTNGSLEKVLYSSNYILDILQRLNI---MIDV 462
++ D R +V+EY T L + + + I + +
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPDT---LHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 463 TSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMT 514
++ LH S + H D+KPHN L++ + L DFG AK L +
Sbjct: 139 IRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNV 189
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 47/187 (25%), Positives = 66/187 (35%), Gaps = 78/187 (41%)
Query: 392 LIGRGSFGSVYKARLQDGME-FAIKVF--------------------------------H 418
+G GSFG V+ R + +A+KV
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 419 FSCSNEDFRALVLEYTTNGSL-----------EKV--LYSSNYILDILQRLNIMIDVTSA 465
+ + ++++Y G L V Y++ +V A
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA--------------EVCLA 118
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTLAIIG 523
LEYLH S II+ DLKP N LLD N H ++DFG AK + T TL G
Sbjct: 119 LEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP------DVTYTLC--G 165
Query: 524 ---YMAP 527
Y+AP
Sbjct: 166 TPDYIAP 172
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 20/105 (19%), Positives = 36/105 (34%), Gaps = 15/105 (14%)
Query: 429 LVLEYTTNGSLEKVL------YSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
L +L+ S++ L RL + + V L LH ++H L
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYL 232
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+P + +LD L+ F G + ++ G+ P
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLVRD-GARVVSSVSR-----GFEPP 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 6/30 (20%), Positives = 15/30 (50%), Gaps = 1/30 (3%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFS 420
++G+ + +A + G F + V +F+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFT 109
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 41/187 (21%), Positives = 59/187 (31%), Gaps = 71/187 (37%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFH--------FSCSNEDFRA--------------- 428
+G G F V K R G+E+A K E+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 429 ------------LVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSALE 467
L+LE + G L +K S +++I IL +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL----------DGVN 129
Query: 468 YLHFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG 523
YLH + I H DLKP N +L L DFG+A + + I G
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKN-----IFG 180
Query: 524 ---YMAP 527
++AP
Sbjct: 181 TPEFVAP 187
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 45/187 (24%), Positives = 60/187 (32%), Gaps = 71/187 (37%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV----------------------------------- 416
+G G F V K R G E+A K
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 417 FHFSCSNEDFRALVLEYTTNGSL-----EKVLYS----SNYILDILQRLNIMIDVTSALE 467
H N+ L+LE + G L EK + + ++ IL +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL----------DGVH 122
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDNIVAH----LSDFGIAKLLTGEDQSMTQTQTLAIIG 523
YLH S I H DLKP N +L D V + L DFGIA + I G
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKN-----IFG 173
Query: 524 ---YMAP 527
++AP
Sbjct: 174 TPEFVAP 180
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 40/179 (22%), Positives = 67/179 (37%), Gaps = 58/179 (32%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKVF--------------------------------H 418
L+G+G+FG V + + G +A+K+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 419 FSCSNEDFRALVLEYTTNGSL------EKVLYSSN---YILDILQRLNIMIDVTSALEYL 469
+S D V+EY G L E+V Y +I+ SAL+YL
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----------SALDYL 264
Query: 470 HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-AIIGYMAP 527
H + +++ DLK N +LD + ++DFG+ K + + +T Y+AP
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAP 318
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 33/128 (25%), Positives = 49/128 (38%), Gaps = 28/128 (21%)
Query: 193 LDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251
L L N+L FG L L L L N+LT I N F
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP---------------NAF---- 74
Query: 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSL 309
+ + N + +I + GL L+ L+L N++ + SF+ L SL
Sbjct: 75 ----EGASHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSL 128
Query: 310 ESLDLSNN 317
SL+L++N
Sbjct: 129 TSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 24/91 (26%), Positives = 39/91 (42%), Gaps = 3/91 (3%)
Query: 140 TDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198
+ L N+L S G+L L L + N+L G PN + + +L L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 199 KLSGSIPT-CFGNLTALRNLHLDSNELTSIP 228
K+ I F L L+ L+L N+++ +
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQISCVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 3/103 (2%)
Query: 221 SNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ 280
L IP + L L+ + L G L L +++ RN L G P +
Sbjct: 17 GRGLKEIPRDIPLHTTELLLND-NELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFE 75
Query: 281 GLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEI 322
G +Q L LG N+++ I N F L L++L+L +N +S +
Sbjct: 76 GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCV 117
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 22/70 (31%), Positives = 30/70 (42%), Gaps = 2/70 (2%)
Query: 269 NNLLGDIPTT--IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 326
+N LG I + L L L L N+L G PN+F+ ++ L L N + EI
Sbjct: 38 DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKM 97
Query: 327 LEKLLYLNIL 336
L L L
Sbjct: 98 FLGLHQLKTL 107
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 6e-09
Identities = 40/180 (22%), Positives = 65/180 (36%), Gaps = 37/180 (20%)
Query: 367 QPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDF 426
+S R Y + + + +G G++G VYKA+ G A+K +E
Sbjct: 5 HHHSSGRENLYFQ--GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI 62
Query: 427 -----R--------------------------ALVLEYTTNGSLEKVLYSSNYILDILQR 455
R LV E+ L+KVL + L Q
Sbjct: 63 PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQI 121
Query: 456 LNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
+ + + + H I+H DLKP N L++ + L+DFG+A+ +S T
Sbjct: 122 KIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 35/188 (18%), Positives = 60/188 (31%), Gaps = 63/188 (33%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------------- 416
+G G++G V + E AIKV
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 417 ---------FHFSCSNEDFRALVLEYTTNGSL-----EKVLYSSNYILDILQRLNIMIDV 462
++ + LV E+ G L + + +I M +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI------MKQI 155
Query: 463 TSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519
S + YLH I+H D+KP N LL + + + DFG++ + + + + T
Sbjct: 156 LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT- 211
Query: 520 AIIGYMAP 527
Y+AP
Sbjct: 212 --AYYIAP 217
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 41/185 (22%), Positives = 68/185 (36%), Gaps = 71/185 (38%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKV----------------------------F----H 418
L+G+G+FG V R + G +A+K+ F
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 419 FSCSNEDFRALVLEYTTNGSL-----------EK--VLYSSNYILDILQRLNIMIDVTSA 465
++ D V+EY G L E+ Y + ++ SA
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIVSA 117
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTL-AII 522
LEYLH S +++ D+K N +LD + H ++DFG+ K + + +T
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGAT---MKTFCGTP 169
Query: 523 GYMAP 527
Y+AP
Sbjct: 170 EYLAP 174
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 23/195 (11%), Positives = 46/195 (23%), Gaps = 22/195 (11%)
Query: 346 KFGLISRCQKRAT------KLPNVSNMQPQASRRRFSYQEL-LRATDGFSANNLIGRGSF 398
++ + K+ + ++ R G S R
Sbjct: 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 399 GSVYKARLQDGMEFAIKVFHFSCSNEDFRALVLEYTTNGSLEKV------LYSSNYILDI 452
A ++ L+L + LE + +Y I
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGI 193
Query: 453 LQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512
L + + L S ++H P N + + L D +
Sbjct: 194 LALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG----- 245
Query: 513 MTQTQTLAIIGYMAP 527
T+ ++ AP
Sbjct: 246 -TRGPASSVPVTYAP 259
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 8/30 (26%), Positives = 14/30 (46%), Gaps = 1/30 (3%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFS 420
+ G V+ R ++ +FA+KVF
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMG 98
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 29/128 (22%), Positives = 52/128 (40%), Gaps = 20/128 (15%)
Query: 217 LHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRI---DFSRNNLLG 273
LH + + + L LK +L +N KI +L + + RN +
Sbjct: 30 LHGMIPPIEKMDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLI-- 82
Query: 274 DIPTTIQGL----KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS-LE 328
I+ L +L+ L + +N++ S+ + LV+L L +SNN ++ + L
Sbjct: 83 ---KKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLA 137
Query: 329 KLLYLNIL 336
L L L
Sbjct: 138 ALDKLEDL 145
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 31/188 (16%), Positives = 60/188 (31%), Gaps = 34/188 (18%)
Query: 151 KLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGN 210
+ ++ K++ L +E + L L L L N + I +
Sbjct: 16 ERKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSG 68
Query: 211 LTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270
+ LR L L N + I ++ + L N +I +L +
Sbjct: 69 MENLRILSLGRNLIKKIENLDAVADTLEELWISYN--------QIASLSGI--------- 111
Query: 271 LLGDIPTTIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 329
+ L +L+ L + +N++ + L LE L L+ N L +
Sbjct: 112 ---------EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNAT 162
Query: 330 LLYLNILL 337
Y ++
Sbjct: 163 SEYRIEVV 170
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 30/146 (20%), Positives = 58/146 (39%), Gaps = 17/146 (11%)
Query: 132 ISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLF 191
+ + L + L N + IS +L ++ L+ LS N ++ I N+ L
Sbjct: 40 MDATLSTLKACKHLALSTNNI-EKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI--LWNLKDILYLDFWSNLFVG 249
+L + N+++ S+ + L LR L++ +N++T+ I L L + L N
Sbjct: 97 ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154
Query: 250 PLPSK----------IGNLKVLTRID 265
+ L L ++D
Sbjct: 155 DYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 37/146 (25%), Positives = 59/146 (40%), Gaps = 40/146 (27%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKV----------------------------FHFSCSN 423
IG GSFG +Y +Q E AIK+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 424 EDFRALVLEYTTNG-SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
D+ LV++ G SLE + + L + L + + + +E++H S +H D+
Sbjct: 75 GDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDI 129
Query: 483 KPHNKLL----DDNIVAHLSDFGIAK 504
KP N L+ N V ++ DFG+AK
Sbjct: 130 KPDNFLMGLGRRANQV-YIIDFGLAK 154
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 33/156 (21%), Positives = 50/156 (32%), Gaps = 39/156 (25%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVF--------------------------H------ 418
L+G GS+G V + + A+K+ H
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 419 ---FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
+ +V+EY G E + + Q + LEYLH S
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQ 128
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
I+H D+KP N LL +S G+A+ L
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 43/196 (21%), Positives = 62/196 (31%), Gaps = 71/196 (36%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVF------------------------- 417
D + +G G F V K R G+++A K
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 418 HFSCSN--------EDFRA--LVLEYTTNGSL-----EKVLYS----SNYILDILQRLNI 458
N E+ L+LE G L EK + + ++ IL
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL----- 124
Query: 459 MIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH----LSDFGIAKLLTGEDQSMT 514
+ + YLH S I H DLKP N +L D V + DFG+A +
Sbjct: 125 -----NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFK 175
Query: 515 QTQTLAIIG---YMAP 527
I G ++AP
Sbjct: 176 N-----IFGTPEFVAP 186
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 43/184 (23%), Positives = 64/184 (34%), Gaps = 68/184 (36%)
Query: 392 LIGRGSFGSVYKARLQDGME-FAIKV-----------------------------F---- 417
++G+GSFG V AR+++ + +A+KV F
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 418 HFSCSNEDFRALVLEYTTNGSL-----------EK--VLYSSNYILDILQRLNIMIDVTS 464
D V+E+ G L E Y++ ++ S
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------------EIIS 135
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-AIIG 523
AL +LH II+ DLK N LLD L+DFG+ K + T T
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPD 189
Query: 524 YMAP 527
Y+AP
Sbjct: 190 YIAP 193
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 29/180 (16%), Positives = 63/180 (35%), Gaps = 48/180 (26%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKVFHFSCSNEDFRAL----------------- 429
+G+GSFG VY+ + ++ AIK + + S +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 430 -------------VLEYTTNGSLEKVL---------YSSNYILDILQRLNIMIDVTSALE 467
++E T G L+ L + + + + ++ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
YL+ + +H DL N ++ ++ + DFG+ + + D + L + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 1e-08
Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 35/154 (22%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDF-----R-------------------- 427
IG G++G VYKA+ G FA+K +E R
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 428 ------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
LV E+ L+K+L L+ + + ++ + + + Y H ++H D
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
LKP N L++ ++DFG+A+ + T
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 42/215 (19%), Positives = 64/215 (29%), Gaps = 75/215 (34%)
Query: 361 PNVSNMQPQASRRRFSYQ--ELLRATDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKVF 417
+S +R R L ++G+GSFG V + + +A+K+
Sbjct: 324 NTISKFDNNGNRDRMKLTDFNFLM---------VLGKGSFGKVMLSERKGTDELYAVKIL 374
Query: 418 ---------------------------------HFSCSNEDFRALVLEYTTNGSL----- 439
H D V+EY G L
Sbjct: 375 KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ 434
Query: 440 -EKVLYSSN---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495
+ Y +I L +L S II+ DLK N +LD
Sbjct: 435 QVGRFKEPHAVFYAAEIA----------IGLFFLQ---SKGIIYRDLKLDNVMLDSE--G 479
Query: 496 H--LSDFGIAKLLTGEDQSMTQTQTLA-IIGYMAP 527
H ++DFG+ K + T+T Y+AP
Sbjct: 480 HIKIADFGMCKENIWDGV---TTKTFCGTPDYIAP 511
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 36/183 (19%), Positives = 64/183 (34%), Gaps = 54/183 (29%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKV-----------------F--------HFS------- 420
+G G FGSV + L+ ++KV F FS
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 421 ---CSNEDFRA-----LVLEYTTNGSLEKVL-----YSSNYILDILQRLNIMIDVTSALE 467
C + ++L + G L L + + + L M+D+ +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 468 YL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524
YL +F +H DL N +L D++ ++DFG++K + D + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 525 MAP 527
+A
Sbjct: 216 IAI 218
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 40/177 (22%), Positives = 55/177 (31%), Gaps = 58/177 (32%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV----------------------------FHFSCS 422
IG G+FG R A+K F
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLN----------IMIDVTSALEYLHFG 472
A+++EY + G L I + R + ++ S + Y H
Sbjct: 87 TPTHLAIIMEYASGGEL------YERICN-AGRFSEDEARFFFQQLL----SGVSYCH-- 133
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHL--SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S I H DLK N LLD + L DFG +K Q + T A Y+AP
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAP 186
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 37/173 (21%), Positives = 59/173 (34%), Gaps = 43/173 (24%)
Query: 393 IGRGSFGSVYKARLQD-----GMEFAIKVFHFSCS---NEDFRA---------------- 428
+G G FG V G A+K ++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 429 -------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
LV+EY GSL L + + + Q L + + YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLAIIGYMAP 527
IH DL N LLD++ + + DFG+AK + G + + + + + AP
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 42/162 (25%), Positives = 63/162 (38%), Gaps = 47/162 (29%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK------------------------------------ 415
+G G F +VYKAR AIK
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 416 --VFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
F ++ +LV ++ LE ++ ++ +L M+ LEYLH
Sbjct: 78 LDAFG----HKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH--- 129
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
I+H DLKP+N LLD+N V L+DFG+AK +++ T
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 27/109 (24%)
Query: 429 LVLEYTTNGSLEKVLYSSNYILDILQ--RLN------IMIDVTSALEYLHFGYSTPIIHC 480
+V E G + +++ L+ D+ +EYLH IIH
Sbjct: 115 MVFELVNQGPV----------MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHR 161
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ--TLAIIGYMAP 527
D+KP N L+ ++ ++DFG++ G D ++ T A +MAP
Sbjct: 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPA---FMAP 206
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 38/131 (29%), Positives = 52/131 (39%), Gaps = 35/131 (26%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS----ILWNLKDILYLDFWSNLFV 248
L+L NKL F LT L L L N++ S+P L L ILYL
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT-ILYLH------- 84
Query: 249 GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDL 306
N L +P + L L+ L+L N+L+ S+P+ FD L
Sbjct: 85 --------------------ENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRL 123
Query: 307 VSLESLDLSNN 317
SL+ + L N
Sbjct: 124 TSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-08
Identities = 37/123 (30%), Positives = 49/123 (39%), Gaps = 20/123 (16%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
+ ++L NKL KL +L LS N+++ V L L L L NK
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 200 LSGSIPT-CFGNLTALRNLHLDSNELTSIPS-ILWNLK-----------------DILYL 240
L S+P F LT L+ L LD+N+L S+P I L I YL
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 146
Query: 241 DFW 243
W
Sbjct: 147 SRW 149
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 25/76 (32%), Positives = 33/76 (43%), Gaps = 2/76 (2%)
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLS 320
TR++ N L L L LSL N++Q S+P+ FD L L L L N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 321 EIIPLSLEKLLYLNIL 336
+ +KL L L
Sbjct: 90 SLPNGVFDKLTQLKEL 105
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 44/188 (23%), Positives = 68/188 (36%), Gaps = 71/188 (37%)
Query: 392 LIGRGSFGSVYKARLQDGME----FAIKVF------------------------------ 417
++G G++G V+ R G + +A+KV
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 418 ----HFSCSNEDFRALVLEYTTNGSLEKVLYSSN---------YILDILQRLNIMIDVTS 464
H++ E L+L+Y G L L Y+ +I+
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV----------L 170
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTLAII 522
ALE+LH II+ D+K N LLD N +V L+DFG++K ++
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVV--LTDFGLSKEFVADETERAYD----FC 221
Query: 523 G---YMAP 527
G YMAP
Sbjct: 222 GTIEYMAP 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 2e-08
Identities = 35/155 (22%), Positives = 59/155 (38%), Gaps = 36/155 (23%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDF-----R------------------- 427
IG G++G+V+KA+ + A+K +E R
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 428 -------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
LV E+ L+K S N LD + + + L + H S ++H
Sbjct: 70 LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
DLKP N L++ N L++FG+A+ + +
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 35/184 (19%), Positives = 68/184 (36%), Gaps = 55/184 (29%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKV-----------------F--------HFS------- 420
+G+G FGSV +A+L+ +KV F F
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 421 ---CSNEDFRA------LVLEYTTNGSLEKVLYSS-----NYILDILQRLNIMIDVTSAL 466
+ ++L + +G L L +S + L + + M+D+ +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 467 EYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG 523
EYL +F IH DL N +L +++ ++DFG+++ + D + +
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 524 YMAP 527
++A
Sbjct: 205 WLAL 208
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 30/131 (22%), Positives = 47/131 (35%), Gaps = 30/131 (22%)
Query: 210 NLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRN 269
N R L L ++ I ++ L +DF N K+
Sbjct: 17 NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKLDGF----------- 60
Query: 270 NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN---LSEIIPLS 326
L+ L+ L + +NR+ L L L L+NN+ L ++ PL+
Sbjct: 61 ----------PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 110
Query: 327 -LEKLLYLNIL 336
L+ L YL IL
Sbjct: 111 SLKSLTYLCIL 121
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 31/147 (21%), Positives = 52/147 (35%), Gaps = 20/147 (13%)
Query: 133 SEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQ 192
+ + N +DL G K+ I L + + F NE+ + L L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKT 68
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI--LWNLKDILYLDFWSN----- 245
L + N++ L L L L +N L + + L +LK + YL N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 128
Query: 246 ----LFVGPLPSKIGNLKVLTRIDFSR 268
L+V I + + +DF +
Sbjct: 129 KHYRLYV------IYKVPQVRVLDFQK 149
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 27/112 (24%), Positives = 43/112 (38%), Gaps = 5/112 (4%)
Query: 184 LCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFW 243
+ +LDLRG K+ I L + NE+ + L+ + L
Sbjct: 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVN 72
Query: 244 SNLFVGPLPSKIGNLKVLTRIDFSRNNL--LGDIPTTIQGLKSLQFLSLGHN 293
+N L LT + + N+L LGD+ + LKSL +L + N
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 30/164 (18%), Positives = 52/164 (31%), Gaps = 41/164 (25%)
Query: 42 NLSTLKVFDVDNNYV-----LGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKL 96
N + D+ + LG D + SDN + L + LK L
Sbjct: 17 NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK-------LDGFPLLRRLKTL 69
Query: 97 DISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSI 156
++ N + C I G+ + + +LT+L L N L
Sbjct: 70 LVNNNRI----------------------CRIGEGLDQALPDLTEL---ILTNNSLVELG 104
Query: 157 SIT-LGKLQKLQFLSFRGN---ELEGSIPNVLCHLAVLFQLDLR 196
+ L L+ L +L N + V+ + + LD +
Sbjct: 105 DLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 148
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 29/167 (17%), Positives = 55/167 (32%), Gaps = 60/167 (35%)
Query: 392 LIGRGSFGSVYKAR------LQDGMEFAIKVFH--------------------------- 418
IG+G FG +Y A + +KV
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 419 -----------------FSCSNEDFRALVLEYTTNG-SLEKVLYSSNYILDILQRLNIMI 460
+ + +R ++++ G L+K+ ++ L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 461 DVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAK 504
+ LEY+H +H D+K N LL + + V +L D+G+A
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 52/186 (27%), Positives = 70/186 (37%), Gaps = 72/186 (38%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKV-----------------------------F---- 417
+IG+GSFG V AR + + +A+KV F
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 418 HFSCSNEDFRALVLEYTTNGSL-----------EK--VLYSSNYILDILQRLNIMIDVTS 464
HFS D VL+Y G L E Y++ ++ S
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EIAS 150
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTL-AI 521
AL YLH S I++ DLKP N LLD IV L+DFG+ K + + T T
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIV--LTDFGLCKENIEHNST---TSTFCGT 202
Query: 522 IGYMAP 527
Y+AP
Sbjct: 203 PEYLAP 208
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 46/186 (24%), Positives = 62/186 (33%), Gaps = 72/186 (38%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKV-----------------------------F---- 417
+IGRGS+ V RL+ +A+KV F
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 418 HFSCSNEDFRALVLEYTTNGSL-----------EK--VLYSSNYILDILQRLNIMIDVTS 464
H E V+EY G L E+ YS+ +++
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EISL 121
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTL-AI 521
AL YLH II+ DLK N LLD I L+D+G+ K T T
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIK--LTDYGMCKEGLRPGD---TTSTFCGT 173
Query: 522 IGYMAP 527
Y+AP
Sbjct: 174 PNYIAP 179
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 30/166 (18%), Positives = 53/166 (31%), Gaps = 60/166 (36%)
Query: 393 IGRGSFGSVYKAR---------LQDGMEFAIKV--------------------------- 416
R + G +Y+A +F++K+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 417 ------------FHFSCSNED-FRALVLEYTTNG-SLEKVL-YSSNYILDILQRLNIMID 461
++D +R LVL G SL+ L S ++L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAK 504
+ ALE+LH +H ++ N + D + V L+ +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 5e-08
Identities = 96/555 (17%), Positives = 162/555 (29%), Gaps = 160/555 (28%)
Query: 45 TLKVFDVDNNYVLGRLSSIVD---ELSLSDNY--LTSSTPELSFLSSMSNCKYLKKLDIS 99
TL++F +L + +V E L NY L S SM Y+++ D
Sbjct: 64 TLRLFWT----LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL 119
Query: 100 RNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISIT 159
N F V L+ + + + L ++ + G + GS
Sbjct: 120 YNDNQVFAKYNVSRLQPYLK------------LRQALLELRPAKNVLIDG--VLGS---- 161
Query: 160 LGK-------------LQKLQF----LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL-- 200
GK K+ F L+ + ++ +L L L+Q+D
Sbjct: 162 -GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL--LYQIDPNWTSRSD 218
Query: 201 -SGSIPTCFGNL-TALRNLHLDS---NELTSIPSIL---WNLKDILYLDFWSNLFVGPLP 252
S +I ++ LR L N L +L N K +
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLL----VLLNVQNAKAWNAFNL---------S 265
Query: 253 SKIGNLKVLTR----IDFSRNNLLGDIPT--TIQGL---KSLQFLSL------------- 290
KI L + TR DF I L + L
Sbjct: 266 CKI--L-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV 322
Query: 291 --GHNRLQGSIPNSFDDLVSL--ESLDLSNNNLSEIIPLSLEKL-------LY------- 332
+ R I S D ++ ++ + L+ II SL L ++
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 333 --LNILLIVVVIL--ALKFGLISRCQKRATKLPNVSNMQPQASRRRFS----YQELLRAT 384
+I I++ ++ + S KL S ++ Q S Y EL
Sbjct: 383 PSAHIPTILLSLIWFDVIK---SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL 439
Query: 385 DGFSA--NNLIGRGSFGSVYK-----ARLQDGMEFAIKVFHFSCSNED-----FRALVLE 432
+ A +++ + + D ++ H FR + L+
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 433 YTTNGSLE-KVLYS------SNYILDILQRLNI----MIDVTSALE-----YLHF--GYS 474
+ LE K+ + S IL+ LQ+L + D E L F
Sbjct: 500 F---RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIE 556
Query: 475 TPIIHCDLKPHNKLL 489
+I + LL
Sbjct: 557 ENLICS---KYTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 52/284 (18%), Positives = 103/284 (36%), Gaps = 65/284 (22%)
Query: 62 SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFI 121
SI D L+ DN+ + +L+ + S L L+ P L +
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESS----LNVLE----------PAEYRKMFDRL-SV 380
Query: 122 WMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP 181
+ +I T L+S+ + + + + + + KL K + + E SIP
Sbjct: 381 FPPSAHIP----------TILLSL-IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429
Query: 182 NVLCHLAVLFQLDLRG---NKL--SGSIPTCFGNLTALRNL-----------HLDSNELT 225
++ +L + +L+ + +IP F + + HL + E
Sbjct: 430 SI--YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
Query: 226 SIPSILWNLKDILYLDF-WSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKS 284
L +++LDF + L KI R D + N G I T+Q LK
Sbjct: 488 E----RMTLFRMVFLDFRF-------LEQKI-------RHDSTAWNASGSILNTLQQLKF 529
Query: 285 -LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 327
++ + + + D L +E +L + ++++ ++L
Sbjct: 530 YKPYICDNDPKYERLVNAILDFLPKIEE-NLICSKYTDLLRIAL 572
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 32/160 (20%), Positives = 54/160 (33%), Gaps = 53/160 (33%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV------------------------------FHFS 420
+G G++G V A A+K+ F+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 421 CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNI---------MIDVTSALEYLHF 471
+ + L LEY + G L + I + ++ + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL------FDRIEP-DIGMPEPDAQRFFHQLM---AGVVYLH- 122
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
I H D+KP N LLD+ +SDFG+A + ++
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 45/218 (20%), Positives = 68/218 (31%), Gaps = 83/218 (38%)
Query: 362 NVSNMQPQASRRRFSYQ--ELLRATDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKV-- 416
VS +R R L ++G+GSFG V + + +A+K+
Sbjct: 4 TVSKFDNNGNRDRMKLTDFNFLM---------VLGKGSFGKVMLSERKGTDELYAVKILK 54
Query: 417 ---------------------------F----HFSCSNEDFRALVLEYTTNGSL------ 439
F H D V+EY G L
Sbjct: 55 KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ 114
Query: 440 -----EK--VLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN 492
E V Y++ ++ L +L S II+ DLK N +LD
Sbjct: 115 VGRFKEPHAVFYAA--------------EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE 157
Query: 493 IVAH--LSDFGIAKLLTGEDQSMTQTQTL-AIIGYMAP 527
H ++DFG+ K + T+T Y+AP
Sbjct: 158 --GHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAP 190
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 45/186 (24%), Positives = 62/186 (33%), Gaps = 72/186 (38%)
Query: 392 LIGRGSFGSVYKARLQD-GMEFAIKV-----------------------------F---- 417
+IGRGS+ V RL+ +A++V F
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 418 HFSCSNEDFRALVLEYTTNGSL-----------EK--VLYSSNYILDILQRLNIMIDVTS 464
H E V+EY G L E+ YS+ +++
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EISL 164
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTL-AI 521
AL YLH II+ DLK N LLD H L+D+G+ K T T
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD---TTSTFCGT 216
Query: 522 IGYMAP 527
Y+AP
Sbjct: 217 PNYIAP 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 8e-08
Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 65/183 (35%)
Query: 392 LIGRGSFGSVYKARLQDGME----FAIKVF------------------------------ 417
++G+GSFG V+ + G + +A+KV
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 418 -HFSCSNEDFRALVLEYTTNGSL-----EKVLYSSN----YILDILQRLNIMIDVTSALE 467
H++ E L+L++ G L ++V+++ Y+ ++ AL+
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA----------LALD 140
Query: 468 YLHFGYSTPIIHCDLKPHNKLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTL-AIIGY 524
+LH S II+ DLKP N LLD+ I L+DFG++K ++ + + Y
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIK--LTDFGLSKESIDHEKK---AYSFCGTVEY 192
Query: 525 MAP 527
MAP
Sbjct: 193 MAP 195
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 36/169 (21%), Positives = 54/169 (31%), Gaps = 52/169 (30%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIK-------------VF-----------------HFSCS 422
I GS+G+V +G+ AIK + HF
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 423 N-------------EDFRA--LVLEY-TTNGSLEKVLYSSNYILDILQRLNIMIDVTSAL 466
N LV E T+ L +V++ ++ M + L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
LH ++H DL P N LL DN + DF +A+ D + T
Sbjct: 148 HVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTH 192
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 32/160 (20%), Positives = 54/160 (33%), Gaps = 53/160 (33%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV------------------------------FHFS 420
+G G++G V A A+K+ F+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 421 CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNI---------MIDVTSALEYLHF 471
+ + L LEY + G L + I + ++ + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL------FDRIEP-DIGMPEPDAQRFFHQLM---AGVVYLH- 122
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
I H D+KP N LLD+ +SDFG+A + ++
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 36/192 (18%), Positives = 60/192 (31%), Gaps = 42/192 (21%)
Query: 361 PNVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHF 419
+ S + D + +G G++G VYKA AIK
Sbjct: 10 GTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL 69
Query: 420 SCSNEDF-----R--------------------------ALVLEYTTNGSLEKVLYSSNY 448
E R L+ EY N L+K + N
Sbjct: 70 EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNP 127
Query: 449 ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH-----LSDFGIA 503
+ + + + + + + + H S +H DLKP N LL + + + DFG+A
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
Query: 504 KLLTGEDQSMTQ 515
+ + T
Sbjct: 185 RAFGIPIRQFTH 196
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 35/165 (21%), Positives = 66/165 (40%), Gaps = 46/165 (27%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK----VF-----------------HFSCSN------- 423
IG GS+G V +A + AIK VF + +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 424 ------EDFRA--LVLEY--TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
E F +VLE + +K+ + Y+ ++ + ++ ++ ++Y+H
Sbjct: 121 VIPKDVEKFDELYVVLEIADS---DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH--- 173
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
S I+H DLKP N L++ + + DFG+A+ + + +Q
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 42/189 (22%), Positives = 66/189 (34%), Gaps = 75/189 (39%)
Query: 392 LIGRGSFGSVYKARLQDGME----FAIKVF------------------------------ 417
++G+G +G V++ R G FA+KV
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 418 ---HFSCSNEDFRALVLEYTTNGSL------EKVL-------YSSNYILDILQRLNIMID 461
++ L+LEY + G L E + Y + +
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA--------------E 129
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTL 519
++ AL +LH II+ DLKP N +L+ + L+DFG+ K + T T
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVK--LTDFGLCKESIHDGTV---THTF 181
Query: 520 A-IIGYMAP 527
I YMAP
Sbjct: 182 CGTIEYMAP 190
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 24/75 (32%), Positives = 33/75 (44%), Gaps = 7/75 (9%)
Query: 457 NIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL--SDFGIAKLLTGEDQSMT 514
NIM + SAL YLH + I H D+KP N L N + DFG++K +
Sbjct: 172 NIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 515 QTQTLAI--IGYMAP 527
T ++AP
Sbjct: 229 YGMTTKAGTPYFVAP 243
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 34/165 (20%), Positives = 54/165 (32%), Gaps = 59/165 (35%)
Query: 392 LIGRGSFGSVYKA-RLQDGMEFAIKV---------------------------------- 416
IG G FG +Y A + A V
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 417 ---------FHFS----CSNEDFRALVLEYTTNG-SLEKVLYSSNYILDILQRLNIMIDV 462
F+ S +R +V+E G L+K + N L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160
Query: 463 TSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAK 504
LEY+H +H D+K N LL + + V +L+D+G++
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 37/183 (20%), Positives = 62/183 (33%), Gaps = 54/183 (29%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKV------------F--------HFS------ 420
+G G+FG VY+ ++ A+K F F+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 421 ----CSNEDFRALVLEYTTNGSLEKVLYSS------NYILDILQRLNIMIDVTSALEYL- 469
R +++E G L+ L + L +L L++ D+ +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 470 --HFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524
HF IH D+ N LL VA + DFG+A+ + + + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 525 MAP 527
M P
Sbjct: 212 MPP 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 33/157 (21%), Positives = 64/157 (40%), Gaps = 47/157 (29%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSC-SNEDFRA--------------------- 428
+G G+FG V G + A+K+ + + D
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYI-----LDILQRLNIMIDVTSALEYLHFGY 473
+V+EY + G L +YI ++ ++ + + SA++Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQILSAVDYCH--- 128
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
++H DLKP N LLD ++ A ++DFG++ +++ +
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 34/154 (22%), Positives = 62/154 (40%), Gaps = 47/154 (30%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSC-SNEDFRA--------------------- 428
+G G+FG V + G + A+K+ + + D
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYI-----LDILQRLNIMIDVTSALEYLHFGY 473
+V+EY + G L +YI LD + + + S ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGEL------FDYICKNGRLDEKESRRLFQQILSGVDYCH--- 133
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507
++H DLKP N LLD ++ A ++DFG++ +++
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 44/301 (14%), Positives = 88/301 (29%), Gaps = 65/301 (21%)
Query: 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNF---SQSLEFIW 122
SL + +T+ + S + + +K++ +S N + R + + LE
Sbjct: 8 GKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 66
Query: 123 MSDCNISGG----------ISEEIGNLTDLISIDLGGNKLNG----SISITLGKLQKLQF 168
SD + + + L ++ L N + L K L+
Sbjct: 67 FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 126
Query: 169 LSFRGNEL-------------EGSIPNVLCHLAVLFQLDLRGNKLSG----SIPTCFGNL 211
L N L E ++ + L + N+L F +
Sbjct: 127 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 186
Query: 212 TALRNLHLDSNELTS------IPSILWNLKDILYLDFWSNLF----VGPLPSKIGNLKVL 261
L + + N + + L +++ LD N F L + + L
Sbjct: 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSL-QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
+ + + LL +G ++ S N L++L L N +
Sbjct: 247 RELGLN-DCLLSA-----RGAAAVVDAFSKLENI-------------GLQTLRLQYNEIE 287
Query: 321 E 321
Sbjct: 288 L 288
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 41/163 (25%), Positives = 62/163 (38%), Gaps = 52/163 (31%)
Query: 391 NLIGRGSFGSVYKARLQDG---MEFAIKVFHFSCSNEDFRAL------------------ 429
++IG G+FG V KAR++ M+ AIK S +D R
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 430 -------------VLEYTTNGSLEKVL---------------YSSNYILDILQRLNIMID 461
+EY +G+L L S+ L Q L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
V ++YL IH DL N L+ +N VA ++DFG+++
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 4e-07
Identities = 39/167 (23%), Positives = 60/167 (35%), Gaps = 48/167 (28%)
Query: 382 RATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK------------------------- 415
AT + IG G++G+VYKAR G A+K
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 416 ----------------VFHFSCSNEDFRA-LVLEYTTNGSLEKVLYSSNYI-LDILQRLN 457
V S ++ + + LV E+ L L + L +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 458 IMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
+M L++LH + I+H DLKP N L+ L+DFG+A+
Sbjct: 125 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 48/153 (31%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA----------------------- 428
IG+G+F V AR + G E AIK+ + N
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 429 --------LVLEYTTNGSLEKVLYSSNYILDILQRLN------IMIDVTSALEYLHFGYS 474
L++EY + G + +Y++ R+ + SA++Y H
Sbjct: 83 IETEKTLYLIMEYASGGEV------FDYLVA-HGRMKEKEARSKFRQIVSAVQYCH---Q 132
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507
I+H DLK N LLD ++ ++DFG + T
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 4e-07
Identities = 36/158 (22%), Positives = 58/158 (36%), Gaps = 37/158 (23%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDF-----R----------------- 427
IG G++G VYKAR G A+K E R
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 428 ---------ALVLEYTTNGSLEKVLYSSNYI-LDILQRLNIMIDVTSALEYLHFGYSTPI 477
LV E+ L+K + +S + + + + + L + H S +
Sbjct: 69 DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRV 124
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
+H DLKP N L++ L+DFG+A+ ++ T
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 38/183 (20%), Positives = 61/183 (33%), Gaps = 54/183 (29%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKVFHFSCSNEDFRAL----------------- 429
+G G+FG VY+ ++ A+K CS +D
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 430 -------------VLEYTTNGSLEKVLYSS------NYILDILQRLNIMIDVTSALEYL- 469
+LE G L+ L + L +L L++ D+ +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 470 --HFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524
HF IH D+ N LL VA + DFG+A+ + + + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 525 MAP 527
M P
Sbjct: 253 MPP 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 37/189 (19%), Positives = 62/189 (32%), Gaps = 60/189 (31%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKVFHFSCSN---EDFRA--------------- 428
+G FG VYK L AIK E+FR
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 429 ------------LVLEYTTNGSLEKVL---------------YSSNYILDILQRLNIMID 461
++ Y ++G L + L + L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 462 VTSALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
+ + +EYL H +H DL N L+ D + +SD G+ + + D +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 519 LAIIGYMAP 527
L I +MAP
Sbjct: 191 LLPIRWMAP 199
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 34/180 (18%), Positives = 64/180 (35%), Gaps = 49/180 (27%)
Query: 393 IGRGSFGSVYKARLQD---GMEFAIKVFH---FSCSN----------------------- 423
+GRG++G VYKA+ +D ++A+K S S
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 424 ---EDFRALVLEYTTNGSLEKVL--------YSSNYILDILQRLNIMIDVTSALEYLHFG 472
+ L+ +Y + L ++ L +++ + + YLH
Sbjct: 89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-- 145
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAH----LSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+ ++H DLKP N L+ ++D G A+L + + + + Y AP
Sbjct: 146 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 31/166 (18%), Positives = 60/166 (36%), Gaps = 43/166 (25%)
Query: 385 DGFSANNLIGRGSFGSVYKARLQDGMEF-AIK---------------------------- 415
+ + + +G G++ +VYK + + A+K
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 416 ------VFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYL 469
+ H E LV EY L++ L I+++ + + L Y
Sbjct: 62 IVTLHDIIH----TEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 470 HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
H ++H DLKP N L+++ L+DFG+A+ + ++
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 38/163 (23%), Positives = 58/163 (35%), Gaps = 61/163 (37%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK------------------------------------ 415
+G G+FG V+ A + E +K
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 416 -----VFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLN------IMIDVTS 464
+F N+ F LV+E +G L+ L+ +I D RL+ I + S
Sbjct: 92 IKVLDIF----ENQGFFQLVMEKHGSG-LD--LF--AFI-DRHPRLDEPLASYIFRQLVS 141
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507
A+ YL IIH D+K N ++ ++ L DFG A L
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 39/165 (23%), Positives = 58/165 (35%), Gaps = 56/165 (33%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV-----------------------------FHFSC 421
L+G+G FG+V+ L D ++ AIKV
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 422 SN----EDFRA------LVLEYTTNGSLEKVLYSSNYILDILQRL------NIMIDVTSA 465
D+ LVLE + L+ +YI + L V +A
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQ-D--LF--DYITE-KGPLGEGPSRCFFGQVVAA 151
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGE 509
+++ H S ++H D+K N L+D A L DFG LL E
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 35/189 (18%), Positives = 61/189 (32%), Gaps = 57/189 (30%)
Query: 393 IGRGSFGSVYKARLQDGMEF--------AIKVFHFSCSNEDFRAL--------------- 429
+G G+FG V A + A+K+ + +D L
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 430 ----------------VLEYTTNGSL---------------EKVLYSSNYILDILQRLNI 458
++EY + G+L + + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 459 MIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
+ +EYL S IH DL N L+ +N V ++DFG+A+ + D T
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 519 LAIIGYMAP 527
+ +MAP
Sbjct: 220 RLPVKWMAP 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 33/190 (17%), Positives = 60/190 (31%), Gaps = 59/190 (31%)
Query: 391 NLIGRGSFGSVYKARLQDGMEF------AIKVFHFSCSNEDFRAL--------------- 429
+G G+FG V +A + A+K+ + ++ AL
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 430 ----------------VLEYTTNGSL-------------EKVLYSSNYILDILQRLNIMI 460
+ EY G L + +N L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 461 DVTSALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 517
V + +L + IH D+ N LL + VA + DFG+A+ + + + +
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 518 TLAIIGYMAP 527
+ +MAP
Sbjct: 226 ARLPVKWMAP 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 33/165 (20%), Positives = 51/165 (30%), Gaps = 58/165 (35%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLEYTTNGSLEKV-------- 442
L+G G FGSVY + D + AIK + + ++ + +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVE--------KDRISDWGELPNGTRVPMEVVLLK 101
Query: 443 -----------LY----SSNYILDIL----------------QRLN------IMIDVTSA 465
L + + IL L V A
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 466 LEYLHFGYSTPIIHCDLKPHNKLLDDNIV-AHLSDFGIAKLLTGE 509
+ + H + ++H D+K N L+D N L DFG LL
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 33/162 (20%), Positives = 59/162 (36%), Gaps = 44/162 (27%)
Query: 382 RATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK------------------------- 415
+ IG+G+FG V+KAR + G + A+K
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 416 ----------VFHFSCSNEDFRA----LVLEYTTNGSLEKVLYSSNYILDILQRLNIMID 461
+ S + LV ++ + L +L + + + +M
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503
+ + L Y+H I+H D+K N L+ + V L+DFG+A
Sbjct: 133 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 33/96 (34%), Positives = 41/96 (42%), Gaps = 20/96 (20%)
Query: 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELT 225
Q L N++ P V L L +LDL N+L+ +P F LT L L L+ N+L
Sbjct: 33 QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK 91
Query: 226 SIPS-ILWNLK-----------------DILYLDFW 243
SIP NLK DILYL W
Sbjct: 92 SIPRGAFDNLKSLTHIWLLNNPWDCACSDILYLSRW 127
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 5e-05
Identities = 39/132 (29%), Positives = 54/132 (40%), Gaps = 38/132 (28%)
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS----ILWNLKDILYLDFWSNLF 247
+D G L+ S+PT G T + L+L N++T + L L L LD
Sbjct: 13 TVDCSGKSLA-SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLT-RLDLD------ 62
Query: 248 VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDD 305
NN L +P + L L LSL N+L+ SIP +FD+
Sbjct: 63 ---------------------NNQLTVLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDN 100
Query: 306 LVSLESLDLSNN 317
L SL + L NN
Sbjct: 101 LKSLTHIWLLNN 112
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 35/189 (18%), Positives = 60/189 (31%), Gaps = 57/189 (30%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKVFHFSCSNEDFRAL----------------- 429
+G G+FG V +A ++ A+K+ S + AL
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 430 --------------VLEYTTNGSL-----------------EKVLYSSNYILDILQRLNI 458
+ EY G L ++ LD+ L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 459 MIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
V + +L S IH DL N LL + + DFG+A+ + + + +
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 519 LAIIGYMAP 527
+ +MAP
Sbjct: 208 RLPVKWMAP 216
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 35/96 (36%), Positives = 41/96 (42%), Gaps = 20/96 (20%)
Query: 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELT 225
Q L N++ P V HL L QL NKL+ +IPT F LT L L L+ N L
Sbjct: 36 QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK 94
Query: 226 SIPS-ILWNLK-----------------DILYLDFW 243
SIP NLK DI+YL W
Sbjct: 95 SIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYLRNW 130
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-05
Identities = 36/132 (27%), Positives = 56/132 (42%), Gaps = 38/132 (28%)
Query: 192 QLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS----ILWNLKDILYLDFWSNLF 247
++ + +L+ S+P G T + L L++N++T + L NL+ LY +
Sbjct: 16 LVNCQNIRLA-SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQ-LYFN------ 65
Query: 248 VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDD 305
+N L IPT + L L L L N L+ SIP +FD+
Sbjct: 66 ---------------------SNKLTAIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDN 103
Query: 306 LVSLESLDLSNN 317
L SL + L NN
Sbjct: 104 LKSLTHIYLYNN 115
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 7/115 (6%)
Query: 132 ISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLF 191
+ +L + L SI+ L KL KL+ L N + G + + L
Sbjct: 34 LEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91
Query: 192 QLDLRGNKLSG-SIPTCFGNLTALRNLHLDSNELTSIP----SILWNLKDILYLD 241
L+L GNK+ S L L++L L + E+T++ ++ L + YLD
Sbjct: 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 30/103 (29%), Positives = 42/103 (40%), Gaps = 7/103 (6%)
Query: 238 LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297
L LD + G L + L + N L I + L L+ L L NR+ G
Sbjct: 22 LVLDNSRSN-EGKLEGLTDEFEELEFLSTI-NVGLTSI-ANLPKLNKLKKLELSDNRVSG 78
Query: 298 SIPNSFDDLVSLESLDLSNNN---LSEIIPLS-LEKLLYLNIL 336
+ + +L L+LS N LS I PL LE L L++
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 31/119 (26%), Positives = 58/119 (48%), Gaps = 7/119 (5%)
Query: 132 ISEEIG--NLTDLISIDLGGNKLN-GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLA 188
I E+ +D+ + L ++ N G + + ++L+FLS L SI N L L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLN 64
Query: 189 VLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI--LWNLKDILYLDFWSN 245
L +L+L N++SG + L +L+L N++ + +I L L+++ LD ++
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 23/119 (19%), Positives = 52/119 (43%), Gaps = 11/119 (9%)
Query: 210 NLTALRNLHLDSNELT--SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNL---KVLTRI 264
+ ++ L LD++ + + +++ +L + + I NL L ++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKL 69
Query: 265 DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEI 322
+ S N + G + + +L L+L N+++ S L +L+SLDL N ++ +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL 128
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 29/124 (23%), Positives = 49/124 (39%), Gaps = 12/124 (9%)
Query: 56 VLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS 115
+ R S V EL L ++ E + L+ L L + N
Sbjct: 11 LRNRTPSDVKELVLDNSRSNEGKLE----GLTDEFEELEFLSTINVGL-----TSIANLP 61
Query: 116 Q--SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISIT-LGKLQKLQFLSFR 172
+ L+ + +SD +SGG+ +L ++L GNK+ +I L KL+ L+ L
Sbjct: 62 KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121
Query: 173 GNEL 176
E+
Sbjct: 122 NCEV 125
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 37/188 (19%), Positives = 64/188 (34%), Gaps = 56/188 (29%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKVFHFSCSNEDFRAL----------------- 429
+GRG+FG V +A + A+K+ ++ + RAL
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 430 ---------------VLEYTTNGSLEKVLYSS---------------NYILDILQRLNIM 459
++E+ G+L L S L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 460 IDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519
V +E+L S IH DL N LL + V + DFG+A+ + + + +
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 520 AIIGYMAP 527
+ +MAP
Sbjct: 212 LPLKWMAP 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 36/189 (19%), Positives = 62/189 (32%), Gaps = 57/189 (30%)
Query: 393 IGRGSFGSVYKARLQDGMEF--------AIKVFHFSCSNEDFRAL--------------- 429
+G G+FG V A + A+K+ + +D L
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 430 ----------------VLEYTTNGSL---------------EKVLYSSNYILDILQRLNI 458
++EY + G+L ++ L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 459 MIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
V +EYL S IH DL N L+ ++ V ++DFG+A+ + D T
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 519 LAIIGYMAP 527
+ +MAP
Sbjct: 254 RLPVKWMAP 262
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 46/165 (27%)
Query: 382 RATDGFSANNLIGRGSFGSVYKAR-LQDGMEF-AIK------------------------ 415
RA + IG G++G V+KAR L++G F A+K
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 416 --------------VFHFSCSNEDFRA-LVLEYTTNGSLEKVLYSSNYI-LDILQRLNIM 459
V S ++ + + LV E+ L L + ++M
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 460 IDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
+ L++LH S ++H DLKP N L+ + L+DFG+A+
Sbjct: 127 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 5/111 (4%)
Query: 138 NLTDLISIDLGGNKLN-GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196
+ + L K N G I + L+FLS L S+ N L L L +L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI--LWNLKDILYLDFWSN 245
N++ G + L L +L+L N+L I ++ L L+ + LD ++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-06
Identities = 33/140 (23%), Positives = 54/140 (38%), Gaps = 10/140 (7%)
Query: 190 LFQLDLRGNKLS-GSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFV 248
+ +L L K + G I L L L + L S+ S L L + L+ N
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIF 84
Query: 249 GPLPSKIGNLKVLTRIDFSRNNL--LGDIPTTIQGLKSLQFLSLGHNRLQGSIPN----S 302
G L L LT ++ S N L + + ++ L+ L+ L L + + ++ +
Sbjct: 85 GGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT-NLNDYRESV 142
Query: 303 FDDLVSLESLDLSNNNLSEI 322
F L L LD + E
Sbjct: 143 FKLLPQLTYLDGYDREDQEA 162
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 29/133 (21%), Positives = 48/133 (36%), Gaps = 32/133 (24%)
Query: 210 NLTALRNLHLDSNELT--SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS 267
A+R L LD+ + I + ++ +L + + NL
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNL--------- 67
Query: 268 RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN---LSEIIP 324
L L+ L L NR+ G + + L +L L+LS N +S + P
Sbjct: 68 ------------PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP 115
Query: 325 LS-LEKLLYLNIL 336
L LE L L++
Sbjct: 116 LKKLECLKSLDLF 128
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 34/145 (23%), Positives = 53/145 (36%), Gaps = 15/145 (10%)
Query: 58 GRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQ- 116
R + V EL L + E + L+ L + L V N +
Sbjct: 20 NRTPAAVRELVLDNCKSNDGKIE----GLTAEFVNLEFLSLINVGL-----ISVSNLPKL 70
Query: 117 -SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISIT-LGKLQKLQFLSFRGN 174
L+ + +S+ I GG+ L +L ++L GNKL ++ L KL+ L+ L
Sbjct: 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
Query: 175 ---ELEGSIPNVLCHLAVLFQLDLR 196
L +V L L LD
Sbjct: 131 EVTNLNDYRESVFKLLPQLTYLDGY 155
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 7e-05
Identities = 21/71 (29%), Positives = 32/71 (45%), Gaps = 2/71 (2%)
Query: 268 RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 327
+ G I +L+FLSL + L S+ N L L+ L+LS N + + +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLA 91
Query: 328 EKLLYLNILLI 338
EKL L L +
Sbjct: 92 EKLPNLTHLNL 102
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 39/187 (20%), Positives = 64/187 (34%), Gaps = 58/187 (31%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKV-----------F--------HFS------- 420
+G G+FG V+ A + + A+K F
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 421 ---CSNEDFRALVLEYTTNGSLEKVLYSS--------------NYILDILQRLNIMIDVT 463
C+ +V EY +G L + L S L + Q L + V
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 464 SALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
+ + YL HF +H DL N L+ +V + DFG+++ + D +T+
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 521 IIGYMAP 527
I +M P
Sbjct: 223 PIRWMPP 229
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 35/192 (18%), Positives = 61/192 (31%), Gaps = 63/192 (32%)
Query: 393 IGRGSFGSVYKARLQDGMEF--------AIKVFHFSCSNEDFRAL--------------- 429
+G G FG V A + A+K+ + +D L
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 430 ----------------VLEYTTNGSLEKVLYSS---------------NYILDILQRLNI 458
++EY + G+L + L + + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 459 MIDVTSALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
+ +EYL IH DL N L+ +N V ++DFG+A+ + D
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 516 TQTLAIIGYMAP 527
T + +MAP
Sbjct: 263 TNGRLPVKWMAP 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 41/188 (21%), Positives = 66/188 (35%), Gaps = 59/188 (31%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKV-----------F--------HFS------- 420
+G G+FG V+ A + A+K F +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 421 ---CSNEDFRALVLEYTTNGSLEKVL---------------YSSNYILDILQRLNIMIDV 462
C + D +V EY +G L K L + L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 463 TSALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 519
S + YL HF +H DL N L+ N++ + DFG+++ + D T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 520 AIIGYMAP 527
I +M P
Sbjct: 197 LPIRWMPP 204
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 34/163 (20%), Positives = 55/163 (33%), Gaps = 48/163 (29%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK----------------------------------VF 417
+G G++ +VYK G+ A+K V
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYI-----LDILQRLNIMIDVTSALEYLHFG 472
H E+ LV E+ N L+K + S L++ + L + H
Sbjct: 73 H----TENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
I+H DLKP N L++ L DFG+A+ + +
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 43/198 (21%), Positives = 75/198 (37%), Gaps = 55/198 (27%)
Query: 363 VSNMQPQASRRR--FSYQELLRA----TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK 415
+++ S+ R F QEL + + + + +G G++GSV A + G+ A+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 416 -----------------------------------VFHFSCSNEDFRA--LVLEY-TTNG 437
VF + S E+F LV +
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD- 119
Query: 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497
L ++ D +Q ++ + L+Y+H S IIH DLKP N ++++ +
Sbjct: 120 -LNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 173
Query: 498 SDFGIAKLLTGEDQSMTQ 515
DFG+A+ MT
Sbjct: 174 LDFGLAR---HTADEMTG 188
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 45/205 (21%), Positives = 71/205 (34%), Gaps = 52/205 (25%)
Query: 354 QKRATKLPNVSNMQPQASRRRFSYQELLRAT----DGFSANNLIGRGSFGSVYKAR-LQD 408
Q + + NM +F E+ +T + IG G+ G V A
Sbjct: 27 QVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL 86
Query: 409 GMEFAIK-----------------------------------VFHFSCSNEDFRA--LVL 431
AIK VF + E+F+ LV+
Sbjct: 87 DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146
Query: 432 EY-TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD 490
E N L +V+ LD + ++ + +++LH S IIH DLKP N ++
Sbjct: 147 ELMDAN--LCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVK 198
Query: 491 DNIVAHLSDFGIAKLLTGEDQSMTQ 515
+ + DFG+A+ G MT
Sbjct: 199 SDCTLKILDFGLAR-TAGTSFMMTP 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 37/154 (24%), Positives = 56/154 (36%), Gaps = 48/154 (31%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSC-SNEDFRA--------------------- 428
+G GSFG V A + + A+K D
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYI-----LDILQRLNIMIDVTSALEYLHFGY 473
+V+EY G L +YI + + + A+EY H
Sbjct: 76 DVITTPTDIVMVIEYA-GGEL------FDYIVEKKRMTEDEGRRFFQQIICAIEYCH--- 125
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507
I+H DLKP N LLDDN+ ++DFG++ ++T
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 44/164 (26%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK----VF-----------------HFSCSN------- 423
IGRGS+G VY A AIK +F
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 424 ------EDFRA--LVLEY-TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS 474
F +VLE ++ L+K+ + ++ + + I+ ++ ++H
Sbjct: 94 IIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH---E 147
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
+ IIH DLKP N LL+ + + DFG+A+ + E +
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 41/197 (20%), Positives = 66/197 (33%), Gaps = 68/197 (34%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKV------------F--------HFS------ 420
IG G+FG V++AR + + A+K+ F F
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 421 ----CSNEDFRALVLEYTTNGSLEKVLYSS-----------------------NYILDIL 453
C+ L+ EY G L + L S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 454 QRLNIMIDVTSALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
++L I V + + YL F +H DL N L+ +N+V ++DFG+++ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 511 QSMTQTQTLAIIGYMAP 527
I +M P
Sbjct: 229 YYKADGNDAIPIRWMPP 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 36/197 (18%), Positives = 63/197 (31%), Gaps = 68/197 (34%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKVFHFSCSNEDFRAL----------------- 429
+G G FG V KA A+K+ + S + R L
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 430 -------------VLEYTTNGSLEKVLYSS-----------------------NYILDIL 453
++EY GSL L S L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 454 QRLNIMIDVTSALEYL---HFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510
++ ++ ++YL +H DL N L+ + +SDFG+++ + ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 511 QSMTQTQTLAIIGYMAP 527
+ ++Q + +MA
Sbjct: 205 SYVKRSQGRIPVKWMAI 221
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 36/150 (24%), Positives = 58/150 (38%), Gaps = 46/150 (30%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV------FHFSCSNE-------------------- 424
+IG+GSFG V KA + A+K+ FH + E
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 425 -----DFRA---LVLEYTTNGSLEKVLYSSNYI---LDILQRLNIMIDVTSALEYLHFGY 473
FR + E + +L +++ + + L ++++ + L+ LH
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH--- 217
Query: 474 STPIIHCDLKPHNKLLDDNIVAH--LSDFG 501
IIHCDLKP N LL + + DFG
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 33/194 (17%), Positives = 55/194 (28%), Gaps = 62/194 (31%)
Query: 393 IGRGSFGSVYKARLQDGMEF------AIKVFHFSCSNEDFRAL----------------- 429
+G G+FG V A + A+K+ + + AL
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 430 --------------VLEYTTNGSLEKVL----------------------YSSNYILDIL 453
+ EY G L L +L
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 454 QRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513
L V +E+L +H DL N L+ V + DFG+A+ + + +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 514 TQTQTLAIIGYMAP 527
+ + +MAP
Sbjct: 230 VRGNARLPVKWMAP 243
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 44/194 (22%), Positives = 69/194 (35%), Gaps = 53/194 (27%)
Query: 366 MQPQASRRR-FSYQELLRAT----DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK---- 415
M ++ R F E+ +T + IG G+ G V A AIK
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 416 -------------------------------VFHFSCSNEDFRA--LVLEY-TTNGSLEK 441
VF S E+F+ +V+E N L +
Sbjct: 61 PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQ 118
Query: 442 VLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501
V+ LD + ++ + +++LH S IIH DLKP N ++ + + DFG
Sbjct: 119 VIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 502 IAKLLTGEDQSMTQ 515
+A+ G MT
Sbjct: 173 LAR-TAGTSFMMTP 185
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 46/297 (15%), Positives = 97/297 (32%), Gaps = 67/297 (22%)
Query: 66 ELSLSDNYLTSSTPELSFLSSM--SNCKYLKKLDISRNPLD----GFLPRVVGNFSQSLE 119
L LS N L S L + + L++S N L L +++ ++
Sbjct: 26 SLDLSLNNLYSI--STVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 120 FIWMSDCNISGGISEEIGNL-----TDLISIDLGGNKLNGSISITLGKL-----QKLQFL 169
+ +S +S S+E+ + +DLG N + S + + L
Sbjct: 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL 143
Query: 170 SFRGNELE--------GSIPNVLCHLAVLFQLDLRGNKLS----GSIPTCFGNL-TALRN 216
+ RGN+L + + ++ L+LRGN L+ + ++ ++ +
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVN---SLNLRGNNLASKNCAELAKFLASIPASVTS 200
Query: 217 LHLDSNELTS--IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNL--- 271
L L +N L + + + ++ N L
Sbjct: 201 LDLSANLLGLKSYAELAYIFSS--------------------IPNHVVSLNLCLNCLHGP 240
Query: 272 -LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS-------LESLDLSNNNLS 320
L ++ LK LQ + L ++ ++ L + + +D + +
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 29/194 (14%), Positives = 56/194 (28%), Gaps = 26/194 (13%)
Query: 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFG--N 210
+S L + L L +G +L L ++ L S+ +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDILGSD 217
Query: 211 LTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270
L L L L + D F P+ L +
Sbjct: 218 LPNLEKLVLYVG-------VEDYGFDGDMNVFRPLFSKDRFPN-------LKWLGIVDAE 263
Query: 271 LLGDIPTTI---QGLKSLQFLSLGHNRLQGS----IPNSFDDLVSLESLDLSNNNLSEII 323
+ L L+ + + L + + D + L+ +++ N LS+ +
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323
Query: 324 PLSLEKLLYLNILL 337
L+K L + I +
Sbjct: 324 KKELQKSLPMKIDV 337
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 28/165 (16%), Positives = 53/165 (32%), Gaps = 58/165 (35%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV---------------------------------- 416
+G G F +V+ A+ + + A+K+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 417 ---------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYI---LDILQRLNIMIDVTS 464
F+ N +V E +L ++ + L +++ I +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLL 142
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH------LSDFGIA 503
L+Y+H IIH D+KP N L++ ++D G A
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 42/197 (21%), Positives = 73/197 (37%), Gaps = 65/197 (32%)
Query: 368 PQASRRRFSYQELLRA----TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK------- 415
P +R F QE+ + + +G G++G+V A + G + AIK
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63
Query: 416 ----------------------------VFHFSCSNEDFRA--LVLEY-TTNGSLEKVLY 444
VF + +DF LV+ + T+ L K++
Sbjct: 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD--LGKLMK 121
Query: 445 SSNYILDILQRLN------IMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498
++L ++ + L Y+H + IIH DLKP N ++++ +
Sbjct: 122 H--------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKIL 170
Query: 499 DFGIAKLLTGEDQSMTQ 515
DFG+A+ D MT
Sbjct: 171 DFGLAR---QADSEMTG 184
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 35/187 (18%), Positives = 57/187 (30%), Gaps = 67/187 (35%)
Query: 393 IGRGSFGSVYKARLQD-GMEFAIK-----------------------------VFHFSCS 422
+G GSFG V + + G FA+K F+ +
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFY-TTG 73
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEY----LH-------- 470
+E+ + N K +N+ ++ + + +EY LH
Sbjct: 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR 133
Query: 471 ------------FGY----------STPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLT 507
+ Y S I H D+KP N L++ + L DFG AK L
Sbjct: 134 SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193
Query: 508 GEDQSMT 514
+
Sbjct: 194 -PSEPSV 199
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 33/161 (20%), Positives = 60/161 (37%), Gaps = 55/161 (34%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK-------------------------------VFHFS 420
+GRG + V++A + + + +K +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP 103
Query: 421 CSNEDFRALVLEYTTNGSLEKVLYSSN------YILDILQRLNIMIDVTSALEYLHFGYS 474
S ALV E+ N +++ + Y+ +IL+ AL+Y H S
Sbjct: 104 VSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK----------ALDYCH---S 148
Query: 475 TPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMT 514
I+H D+KPHN ++D ++ L D+G+A+ Q
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYN 188
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 38/197 (19%), Positives = 74/197 (37%), Gaps = 66/197 (33%)
Query: 368 PQASRRRFSYQELLRA----TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK------- 415
++ F Q++ + + + +G G++GSV A + G + AIK
Sbjct: 3 SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62
Query: 416 ----------------------------VFHFSCSNEDFRA--LVLEY-TTNGSLEKVLY 444
VF + S +F LV+ + T+ L+K+
Sbjct: 63 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKI-- 118
Query: 445 SSNYILDILQRLN------IMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498
+ + + ++ + L+Y+H S ++H DLKP N ++++ +
Sbjct: 119 -------MGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 499 DFGIAKLLTGEDQSMTQ 515
DFG+A+ D MT
Sbjct: 169 DFGLAR---HADAEMTG 182
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN 492
+ E L + + V +E+L S IH DL N LL +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 229
Query: 493 IVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
V + DFG+A+ + + + + + +MAP
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 42/305 (13%), Positives = 90/305 (29%), Gaps = 45/305 (14%)
Query: 61 SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPL-DGFLPRVVGNFSQSLE 119
D + D + P + +SS + +L+++ + R + D L + +F + +
Sbjct: 77 PHFADFNLVPDGWGGYVYPWIEAMSS--SYTWLEEIRLKRMVVTDDCLELIAKSFK-NFK 133
Query: 120 FIWMSDC-NIS-GGISEEIGNLTDLISIDLGGNKLNG-------SISITLGKLQKLQFLS 170
+ +S C S G++ +L +DL + ++ T L L
Sbjct: 134 VLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC 193
Query: 171 FRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHL-------DSNE 223
++ ++ L L L + T L L +
Sbjct: 194 LASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDV 253
Query: 224 LTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD--------- 274
+ + L K++ L + + LP+ LT ++ S +
Sbjct: 254 YSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC 313
Query: 275 ----------------IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN 318
+ K L+ L + + PN L S+ +
Sbjct: 314 PKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPK 373
Query: 319 LSEII 323
L ++
Sbjct: 374 LESVL 378
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 37/202 (18%), Positives = 71/202 (35%), Gaps = 63/202 (31%)
Query: 364 SNMQPQASRRRFSYQELLRA----TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK--- 415
+ A+ + + ++ + IG G++G V A + + AIK
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 416 VF-----------------HF-------------SCSNEDFRA--LVLEY-TTNGSLEKV 442
F F + + E + +V + T+ L K+
Sbjct: 62 PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKL 119
Query: 443 LYSSNYILDILQRLN------IMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496
L + Q L+ + + L+Y+H S ++H DLKP N LL+
Sbjct: 120 LKT--------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLK 168
Query: 497 LSDFGIAKLLTGEDQS---MTQ 515
+ DFG+A++ + +T+
Sbjct: 169 ICDFGLARVADPDHDHTGFLTE 190
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 45/342 (13%), Positives = 108/342 (31%), Gaps = 31/342 (9%)
Query: 12 DGGMTGDVCYRICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSD 71
+ + T + + + + V D+D + + + ++ L L
Sbjct: 88 MFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDK 147
Query: 72 NYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFS------QSLEFIWMSD 125
++ LS +++C+ +K L + + + + + + L F
Sbjct: 148 CSGFTTD---GLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEF 204
Query: 126 CNIS-GGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVL 184
IS + N L+S+ +G ++ + L+ + +P
Sbjct: 205 AKISPKDLETIARNCRSLVSVKVGDFEILELVGF-FKAAANLEEFCGGSLNEDIGMPEKY 263
Query: 185 CHLAVLFQLDLRGNKLSG--SIPTCFGNLTALRNLHLDSNELTS--IPSILWNLKDILYL 240
+L +L G G +P F +R L L L + +++ ++ L
Sbjct: 264 MNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVL 323
Query: 241 DFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300
+ + + L K L R+ R + + ++L
Sbjct: 324 ETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG------- 376
Query: 301 NSFDDLVSLESLDLSNNNLS----EIIPLSLEKLLYLNILLI 338
LE + + ++++ E I L+ L ++L+
Sbjct: 377 -----CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLL 413
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 33/162 (20%), Positives = 66/162 (40%), Gaps = 43/162 (26%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK----VF-----------------HFSC--------- 421
+G+G++G V+K+ + G A+K F S
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 422 --SNEDFRA--LVLEY-TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
++ R LV +Y T+ L V+ ++ IL+ + + ++ + ++YLH S
Sbjct: 77 VLRADNDRDVYLVFDYMETD--LHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGG 129
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
++H D+KP N LL+ ++DFG+++ +
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 37/162 (22%), Positives = 61/162 (37%), Gaps = 44/162 (27%)
Query: 393 IGRGSFGSVYKAR-LQDGMEFAIK---VF-----------------HF------------ 419
+G G++G V A G AIK F HF
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 420 -SCSNEDFRA--LVLEY-TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
S E+F ++ E T+ L +V+ S +L + A++ LH +
Sbjct: 79 RPDSFENFNEVYIIQELMQTD--LHRVI--STQMLSDDHIQYFIYQTLRAVKVLH---GS 131
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 517
+IH DLKP N L++ N + DFG+A+++ ++
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 30/140 (21%), Positives = 53/140 (37%), Gaps = 47/140 (33%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFR--AL----VLEYTTNG------- 437
+G G+FG V + + + +A+KV + + + A +L+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNNNI 98
Query: 438 ----------------------SLEKVLYSSNYI---LDILQRLNIMIDVTSALEYLHFG 472
SL +++ +NY ++ ++ I++ AL YL
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKL--YCIEILKALNYLR-- 154
Query: 473 YSTPIIHCDLKPHNKLLDDN 492
+ H DLKP N LLDD
Sbjct: 155 -KMSLTHTDLKPENILLDDP 173
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 527 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.98 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.98 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.97 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.97 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.97 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.96 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.95 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.93 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.93 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.92 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.91 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.91 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.91 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.91 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.91 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.91 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.9 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.9 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.9 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.9 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.9 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.9 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.9 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.9 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.9 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.9 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.9 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.9 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.9 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.9 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.89 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.89 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.89 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.89 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.89 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.89 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.89 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.89 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.89 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.89 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.89 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.89 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.89 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.89 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.89 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.89 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.89 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.89 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.88 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.88 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.88 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.88 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.88 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.88 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.88 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.88 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.88 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.88 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.88 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.88 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.88 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.88 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.88 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.88 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.88 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.88 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.88 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.88 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.88 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.88 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.88 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.88 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.88 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.88 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.87 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.87 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.87 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.87 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.87 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.87 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.87 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.87 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.87 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.87 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.87 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.87 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.87 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.87 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.87 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.87 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.87 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.87 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.87 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.87 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.87 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.87 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.87 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.87 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.87 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.87 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.87 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.87 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.87 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.87 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.87 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.86 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.86 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.86 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.86 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.86 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.86 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.86 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.86 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.86 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.86 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.86 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.86 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.86 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.86 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.86 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.86 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.86 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.86 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.86 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.86 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.86 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.86 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.86 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.86 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.85 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.85 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.85 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.85 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.85 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.85 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.85 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.85 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.85 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.85 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.85 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.85 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.85 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.85 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.85 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.85 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.85 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.85 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.85 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.85 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.85 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.85 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.85 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.85 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.85 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.85 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.85 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.85 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.85 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.85 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.85 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.85 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.85 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.85 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.85 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.85 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.85 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.85 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.85 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.85 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.85 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.84 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.84 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.84 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.84 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.84 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.84 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.84 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.84 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.84 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.84 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.84 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.84 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.84 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.84 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.84 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.84 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.84 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.84 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.84 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.84 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.84 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.84 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.84 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.84 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.84 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.84 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.84 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.83 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.83 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.83 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.83 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.83 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.83 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.83 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.83 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.83 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.83 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.83 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.83 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.83 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.83 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.82 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.82 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.81 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.81 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.81 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.81 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.81 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.79 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.78 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.62 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.36 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.33 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.24 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.07 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.06 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.98 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.83 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.71 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.49 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.47 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.42 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.85 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.71 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.64 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.46 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.19 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.8 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.78 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.73 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.74 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 90.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 87.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 83.45 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=368.28 Aligned_cols=325 Identities=31% Similarity=0.446 Sum_probs=270.5
Q ss_pred hcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc-------ccceEEcccccccC-CCCCCc--------
Q 035895 20 CYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS-------IVDELSLSDNYLTS-STPELS-------- 82 (527)
Q Consensus 20 ~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~-------~l~~L~Ls~N~l~~-~~~~~~-------- 82 (527)
|..+..++ ++|++++.+|..|.++++|++|++++|.+.+.+|. .++.|+|++|.+++ .+..+.
T Consensus 293 ~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~ 372 (768)
T 3rgz_A 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 372 (768)
T ss_dssp CTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSE
T ss_pred cCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcE
Confidence 56777777 78888888888888888888888888877655552 36677777777763 222110
Q ss_pred -----------ccccCCC--CCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeec
Q 035895 83 -----------FLSSMSN--CKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGG 149 (527)
Q Consensus 83 -----------~~~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 149 (527)
.+..+.. +++|++|++++|++++.+|..+..+. +|+.|++++|.+++..|..+..+++|++|++++
T Consensus 373 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 451 (768)
T 3rgz_A 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451 (768)
T ss_dssp EECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred EEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCC
Confidence 0112222 67788888888888888888888775 799999999999888888899999999999999
Q ss_pred CcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC-Cc
Q 035895 150 NKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-IP 228 (527)
Q Consensus 150 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-lp 228 (527)
|++++..|..+..+++|+.|++++|++++.+|..+..+++|++|++++|++++.+|..|+.+++|++|++++|++++ +|
T Consensus 452 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 531 (768)
T 3rgz_A 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred CcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCC
Confidence 99988888888899999999999999988889899999999999999999998899999999999999999999985 78
Q ss_pred hhhhCCCCccEEEccCCcccccCCccc-----------------------------------------------------
Q 035895 229 SILWNLKDILYLDFWSNLFVGPLPSKI----------------------------------------------------- 255 (527)
Q Consensus 229 ~~~~~l~~L~~l~l~~n~~~~~~p~~~----------------------------------------------------- 255 (527)
..+..+++|+.|++++|.+.+.+|..+
T Consensus 532 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (768)
T 3rgz_A 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611 (768)
T ss_dssp GGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTC
T ss_pred HHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccc
Confidence 888889999999999988887766543
Q ss_pred -----------------cCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCc
Q 035895 256 -----------------GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN 318 (527)
Q Consensus 256 -----------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 318 (527)
+.++.|++|||++|+++|.+|..|+.+++|+.|+|++|+++|.+|..|+.+++|+.|||++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 335678899999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCccchhhhccCCeeEeeeeeeec
Q 035895 319 LSEIIPLSLEKLLYLNILLIVVVILAL 345 (527)
Q Consensus 319 l~~~~p~~~~~l~~L~~L~~~~~~~~~ 345 (527)
++|.+|..+..++.|+.|+++.+.+..
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccc
Confidence 999999999999999999999887753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=363.01 Aligned_cols=330 Identities=31% Similarity=0.441 Sum_probs=232.8
Q ss_pred ccccccchhhhcchhccc-CCCceeecCchhhhcC-CCCCEEEcccccccccccc------ccceEEcccccccC-CCCC
Q 035895 10 QLDGGMTGDVCYRICTID-SQNKLVGIVSITIFNL-STLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTS-STPE 80 (527)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l-~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~-~~~~ 80 (527)
.+.+..+...+..+..++ ++|++++.+|..+.++ ++|++|+|++|.+.+.+|. .++.|+|++|.+++ ++.
T Consensus 258 ~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~- 336 (768)
T 3rgz_A 258 QFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM- 336 (768)
T ss_dssp CCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCH-
T ss_pred cccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCH-
Confidence 344445555677889999 9999999999888776 9999999999999877664 47899999999984 332
Q ss_pred CcccccCCCCCCCCEEEcccCCCCcccChhHhhcccc--------------------------ccEEEcccCccccccch
Q 035895 81 LSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQS--------------------------LEFIWMSDCNISGGISE 134 (527)
Q Consensus 81 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~--------------------------L~~L~Ls~n~l~~~~~~ 134 (527)
..+..+++|++|++++|++++.+|..+..+..+ |+.|++++|.+++.+|.
T Consensus 337 ----~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~ 412 (768)
T 3rgz_A 337 ----DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412 (768)
T ss_dssp ----HHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCG
T ss_pred ----HHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCH
Confidence 125677888888888888877777766655333 45555555555555566
Q ss_pred hhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccC
Q 035895 135 EIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTAL 214 (527)
Q Consensus 135 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 214 (527)
.+..+++|++|++++|++++..|..++.+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..|+++++|
T Consensus 413 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 492 (768)
T 3rgz_A 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492 (768)
T ss_dssp GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred HHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCC
Confidence 66666666666666666666666666666666666666666666666666666777777777777766666667777777
Q ss_pred ceeeCCCCCCCC-CchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhh-------------
Q 035895 215 RNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ------------- 280 (527)
Q Consensus 215 ~~L~L~~N~l~~-lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------------- 280 (527)
++|++++|++++ +|..+..+++|+.|++++|.+.+.+|..++.+++|++|++++|+++|.+|..+.
T Consensus 493 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~ 572 (768)
T 3rgz_A 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572 (768)
T ss_dssp CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCS
T ss_pred CEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccc
Confidence 777777777763 666666677777777777777777777777777777777777776665554332
Q ss_pred ---------------------------------------------------------cCCCCCEEEcccccceeecCCCC
Q 035895 281 ---------------------------------------------------------GLKSLQFLSLGHNRLQGSIPNSF 303 (527)
Q Consensus 281 ---------------------------------------------------------~l~~L~~L~L~~N~l~~~~p~~~ 303 (527)
.+++|++|+|++|+++|.+|..|
T Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l 652 (768)
T 3rgz_A 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652 (768)
T ss_dssp CEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGG
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHH
Confidence 23556677777777777777777
Q ss_pred CCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 304 DDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 304 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
+.+++|+.|+|++|++++.+|..+..++.|+.|+++.+.+.
T Consensus 653 ~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~ 693 (768)
T 3rgz_A 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693 (768)
T ss_dssp GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCE
T ss_pred hccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCccc
Confidence 77777777777777777777777777777777777766654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=322.70 Aligned_cols=319 Identities=19% Similarity=0.202 Sum_probs=252.2
Q ss_pred cchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc-------cccceEEcccccccCCCCCCcccccCCCCCC
Q 035895 21 YRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS-------SIVDELSLSDNYLTSSTPELSFLSSMSNCKY 92 (527)
Q Consensus 21 ~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~-------~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~ 92 (527)
..+..+| ++|+++++.|..|.++++|++|++++|.+.+.++ ..++.|+|++|.++...+. .|.++++
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~ 104 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETG-----AFNGLAN 104 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTT-----TTTTCTT
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChh-----hccCccc
Confidence 5677788 8889999888899999999999999998764443 2478899999988876443 5788889
Q ss_pred CCEEEcccCCCCcccChh--HhhccccccEEEcccCccccccchh-hcCCcCCcEEEeecCcccccCcccccCC--CCCC
Q 035895 93 LKKLDISRNPLDGFLPRV--VGNFSQSLEFIWMSDCNISGGISEE-IGNLTDLISIDLGGNKLNGSISITLGKL--QKLQ 167 (527)
Q Consensus 93 L~~L~Ls~N~l~~~~~~~--~~~~~~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~ 167 (527)
|++|++++|++++..|.. +..+. +|++|+|++|.+++..|.. +..+++|++|++++|++++..+..+..+ .+|+
T Consensus 105 L~~L~L~~n~l~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~ 183 (455)
T 3v47_A 105 LEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183 (455)
T ss_dssp CCEEECTTSCCBTHHHHSSTTTTCT-TCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEE
T ss_pred CCEEeCCCCCCCccccCcccccCcc-cCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccc
Confidence 999999999888744443 65554 7999999999998877765 7888999999999999888777776655 4555
Q ss_pred EEeccCcccccccChh--------hhcCcccCeeeeecccCCCCCCccc-------------------------------
Q 035895 168 FLSFRGNELEGSIPNV--------LCHLAVLFQLDLRGNKLSGSIPTCF------------------------------- 208 (527)
Q Consensus 168 ~L~l~~N~l~~~~p~~--------~~~l~~L~~L~L~~N~l~~~~p~~~------------------------------- 208 (527)
.|++++|.+.+..+.. +..+++|+.|++++|++++..|..+
T Consensus 184 ~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~ 263 (455)
T 3v47_A 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD 263 (455)
T ss_dssp EEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCC
T ss_pred ccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhcc
Confidence 5556555555433222 1234556666666666554333322
Q ss_pred ------cC--CccCceeeCCCCCCCCC-chhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhh
Q 035895 209 ------GN--LTALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI 279 (527)
Q Consensus 209 ------~~--l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 279 (527)
.. .++|++|++++|+++++ |..+..+++|+.|++++|.+.+..|..|..+++|++|++++|.+.+..|..|
T Consensus 264 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 343 (455)
T 3v47_A 264 PDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF 343 (455)
T ss_dssp CCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGG
T ss_pred CcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHh
Confidence 11 25799999999999884 6678889999999999999999889999999999999999999988888999
Q ss_pred hcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeeec
Q 035895 280 QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILAL 345 (527)
Q Consensus 280 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~~ 345 (527)
.++++|++|++++|++++..|..|..+++|++|++++|+++++++..+..++.|+.|+++.+.+..
T Consensus 344 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 409 (455)
T 3v47_A 344 ENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 409 (455)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence 999999999999999998889999999999999999999999888888999999999998877754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.17 Aligned_cols=325 Identities=22% Similarity=0.254 Sum_probs=269.7
Q ss_pred Cccccccchhhh---cchhccc-CCCceeecCchhhhcCCCCCEEEcccccc----------------------------
Q 035895 9 RQLDGGMTGDVC---YRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYV---------------------------- 56 (527)
Q Consensus 9 ~~~~~~~~~~~~---~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~---------------------------- 56 (527)
-+-|+...|..| .++..++ ++|.++|.+|.+|.+|++|++|||++|.+
T Consensus 66 ~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l 145 (636)
T 4eco_A 66 LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145 (636)
T ss_dssp GGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHH
T ss_pred cccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhH
Confidence 355533366667 4788888 89999999999999999999999999943
Q ss_pred --------------------------------------------------cccccc------ccceEEcccccccC----
Q 035895 57 --------------------------------------------------LGRLSS------IVDELSLSDNYLTS---- 76 (527)
Q Consensus 57 --------------------------------------------------~~~~~~------~l~~L~Ls~N~l~~---- 76 (527)
.+ +|. .++.|+|++|.+++
T Consensus 146 ~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~ 224 (636)
T 4eco_A 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENIC 224 (636)
T ss_dssp HHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBS
T ss_pred HHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccc
Confidence 23 343 37889999999987
Q ss_pred --------------CCCCCcccccCC--CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCc-ccc-ccchhhcC
Q 035895 77 --------------STPELSFLSSMS--NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCN-ISG-GISEEIGN 138 (527)
Q Consensus 77 --------------~~~~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~-l~~-~~~~~~~~ 138 (527)
++. .+. ++++|++|+|++|++.+.+|..+..+. +|++|++++|. +++ .+|..++.
T Consensus 225 ~~~~~~~~~~~~~~ip~------~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~n~~l~~~~lp~~~~~ 297 (636)
T 4eco_A 225 EAWENENSEYAQQYKTE------DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP-EMQLINVACNRGISGEQLKDDWQA 297 (636)
T ss_dssp SSCSCTTSHHHHHHTTS------CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCS-SCCEEECTTCTTSCHHHHHHHHHH
T ss_pred ccccccccchhcccCch------hhhhcccCCCCEEEecCCcCCccChHHHhcCC-CCCEEECcCCCCCccccchHHHHh
Confidence 443 456 889999999999999999998888875 79999999998 888 78888877
Q ss_pred C------cCCcEEEeecCcccccCcc--cccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccC
Q 035895 139 L------TDLISIDLGGNKLNGSISI--TLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGN 210 (527)
Q Consensus 139 l------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 210 (527)
+ ++|++|++++|+++ .+|. .++.+++|+.|++++|+++|.+| .|..+++|+.|++++|+++ .+|..|..
T Consensus 298 L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 374 (636)
T 4eco_A 298 LADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCG 374 (636)
T ss_dssp HHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEE
T ss_pred hhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhh
Confidence 6 89999999999998 6777 89999999999999999998888 8999999999999999998 67888999
Q ss_pred Ccc-CceeeCCCCCCCCCchhhhCCC--CccEEEccCCcccccCCcccc-------CCCCCCEEEccCCCCCCCChhhhh
Q 035895 211 LTA-LRNLHLDSNELTSIPSILWNLK--DILYLDFWSNLFVGPLPSKIG-------NLKVLTRIDFSRNNLLGDIPTTIQ 280 (527)
Q Consensus 211 l~~-L~~L~L~~N~l~~lp~~~~~l~--~L~~l~l~~n~~~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~ 280 (527)
+++ |++|++++|+++.+|..+..+. +|+.|++++|.+.+..|..+. .+++|++|++++|++....+..+.
T Consensus 375 l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~ 454 (636)
T 4eco_A 375 FTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454 (636)
T ss_dssp ECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHH
T ss_pred hcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHc
Confidence 999 9999999999999998776654 899999999999998888888 788999999999999865555567
Q ss_pred cCCCCCEEEcccccceeecCCCCCCCC-------CCCEEeCCCCcccccCccchh--hhccCCeeEeeeeeeec
Q 035895 281 GLKSLQFLSLGHNRLQGSIPNSFDDLV-------SLESLDLSNNNLSEIIPLSLE--KLLYLNILLIVVVILAL 345 (527)
Q Consensus 281 ~l~~L~~L~L~~N~l~~~~p~~~~~l~-------~L~~L~ls~N~l~~~~p~~~~--~l~~L~~L~~~~~~~~~ 345 (527)
.+++|++|+|++|+++...+..+.... +|+.|++++|+++. +|..+. .++.|+.|+++.+.+..
T Consensus 455 ~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~l~~L~~L~Ls~N~l~~ 527 (636)
T 4eco_A 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK 527 (636)
T ss_dssp TTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCB-CCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred cCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCc-cChhhhhccCCCcCEEECCCCCCCC
Confidence 789999999999999843333444333 88999999998884 566665 88888888888776643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.06 Aligned_cols=308 Identities=20% Similarity=0.201 Sum_probs=265.8
Q ss_pred CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccC
Q 035895 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRN 101 (527)
Q Consensus 28 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N 101 (527)
++++++.++.. + .++++.|+|++|.+.+..+. .++.|+|++|.++.+.+. .|.++++|++|+|++|
T Consensus 19 ~~~~l~~ip~~-~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 19 HRKRFVAVPEG-I--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG-----AFNNLFNLRTLGLRSN 90 (477)
T ss_dssp CSCCCSSCCSC-C--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEECCSS
T ss_pred CCCCcCcCCCC-C--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChh-----hhhCCccCCEEECCCC
Confidence 34556655442 2 25789999999988765443 478899999988876543 5788999999999999
Q ss_pred CCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccC
Q 035895 102 PLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP 181 (527)
Q Consensus 102 ~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 181 (527)
+++++.+..|..+. +|++|+|++|.+++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|.+++..+
T Consensus 91 ~l~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 91 RLKLIPLGVFTGLS-NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp CCCSCCTTSSTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred cCCccCcccccCCC-CCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 99987666676664 79999999999998889999999999999999999998888899999999999999999997777
Q ss_pred hhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC-CchhhhCCCCccEEEccCCcccccCCccccCCCC
Q 035895 182 NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260 (527)
Q Consensus 182 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~ 260 (527)
..|..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+ +|.......+|+.|++++|.+.+..+..+..+++
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 249 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTT
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccc
Confidence 789999999999999999998888899999999999999987655 7777777779999999999988665578899999
Q ss_pred CCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeee
Q 035895 261 LTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVV 340 (527)
Q Consensus 261 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~ 340 (527)
|++|+|++|.+.+..+..|.++++|++|+|++|++++..|..|..+++|+.|++++|+++++.+..|..++.|+.|+++.
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 329 (477)
T 2id5_A 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329 (477)
T ss_dssp CCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCS
T ss_pred cCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccC
Confidence 99999999999988888899999999999999999999999999999999999999999998888889999999999888
Q ss_pred eeee
Q 035895 341 VILA 344 (527)
Q Consensus 341 ~~~~ 344 (527)
+.+.
T Consensus 330 N~l~ 333 (477)
T 2id5_A 330 NPLA 333 (477)
T ss_dssp SCEE
T ss_pred CCcc
Confidence 7764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=325.23 Aligned_cols=324 Identities=21% Similarity=0.222 Sum_probs=267.5
Q ss_pred cchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccC
Q 035895 15 MTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSM 87 (527)
Q Consensus 15 ~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~ 87 (527)
++.++...+..+| ++|+++++.|.+|.++++|++|+|++|.+.+..|. .++.|+|++|.++...+. .|
T Consensus 27 iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~ 101 (606)
T 3t6q_A 27 IPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET-----AL 101 (606)
T ss_dssp CCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTT-----TT
T ss_pred CcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChh-----hh
Confidence 3444555678888 89999999999999999999999999988766553 478999999999876553 57
Q ss_pred CCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCC
Q 035895 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQ 167 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 167 (527)
.++++|++|++++|++++..|..+..+. +|++|++++|.+++...+.+..+++|++|++++|++++..+..++.+++|+
T Consensus 102 ~~l~~L~~L~L~~n~i~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 180 (606)
T 3t6q_A 102 SGPKALKHLFFIQTGISSIDFIPLHNQK-TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180 (606)
T ss_dssp SSCTTCCEEECTTSCCSCGGGSCCTTCT-TCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCC
T ss_pred cccccccEeeccccCcccCCcchhccCC-cccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccc
Confidence 8899999999999999987666676664 799999999999876555556689999999999999988888888999998
Q ss_pred --EEeccCcccccccChhhhcC---------------------------------------------------cccCeee
Q 035895 168 --FLSFRGNELEGSIPNVLCHL---------------------------------------------------AVLFQLD 194 (527)
Q Consensus 168 --~L~l~~N~l~~~~p~~~~~l---------------------------------------------------~~L~~L~ 194 (527)
.|++++|.+.+..|..|... .+|+.|+
T Consensus 181 ~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~ 260 (606)
T 3t6q_A 181 NLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260 (606)
T ss_dssp SEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEE
T ss_pred eeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEE
Confidence 88999998887766554321 1677888
Q ss_pred eecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCC
Q 035895 195 LRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274 (527)
Q Consensus 195 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 274 (527)
+++|.+++..+..|+++++|++|++++|+++.+|..+..+++|++|++++|.+.+..|..+..+++|++|++++|.+.+.
T Consensus 261 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 340 (606)
T 3t6q_A 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340 (606)
T ss_dssp CTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCB
T ss_pred eecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccc
Confidence 88888888888888999999999999999999988888888999999999988888888888888899999988888766
Q ss_pred Chh-hhhcCCCCCEEEcccccceeec--CCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 275 IPT-TIQGLKSLQFLSLGHNRLQGSI--PNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 275 ~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
+|. .+..+++|++|++++|++++.. |..+..+++|+.|++++|.+++..|..+..++.|+.|+++.+.+.
T Consensus 341 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp CCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred cchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 654 4888888888888888888766 778888888888888888888888888888888888888766553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=328.27 Aligned_cols=312 Identities=20% Similarity=0.214 Sum_probs=266.5
Q ss_pred hhcchhccc-CCCceeecCchhhhcCCCCCEEEccccc-ccc-ccc------------cccceEEcccccccCCCCCCcc
Q 035895 19 VCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNY-VLG-RLS------------SIVDELSLSDNYLTSSTPELSF 83 (527)
Q Consensus 19 ~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~-~~~------------~~l~~L~Ls~N~l~~~~~~~~~ 83 (527)
.+..+..++ ++|++.+.+|..|.++++|++|++++|. +.+ .+| ..++.|+|++|.++.++..
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~--- 323 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE--- 323 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH---
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch---
Confidence 456788888 8899999999999999999999999998 877 555 4688999999999854430
Q ss_pred cccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcC-CcEEEeecCcccccCcccccC
Q 035895 84 LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD-LISIDLGGNKLNGSISITLGK 162 (527)
Q Consensus 84 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~ 162 (527)
..+.++++|++|++++|+++|.+| .+..+. +|+.|++++|.++ .+|..+..+++ |++|++++|+++ .+|..+..
T Consensus 324 -~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~ 398 (636)
T 4eco_A 324 -TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398 (636)
T ss_dssp -HHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCT
T ss_pred -hhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhh
Confidence 146788999999999999998888 776664 7999999999998 77888999999 999999999998 56777776
Q ss_pred CC--CCCEEeccCcccccccChhhh-------cCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhC
Q 035895 163 LQ--KLQFLSFRGNELEGSIPNVLC-------HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWN 233 (527)
Q Consensus 163 l~--~L~~L~l~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~ 233 (527)
++ +|+.|++++|.+.+..|..|. .+++|+.|++++|+++..++..+..+++|++|++++|+++.+|...+.
T Consensus 399 ~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~ 478 (636)
T 4eco_A 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478 (636)
T ss_dssp TCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSE
T ss_pred cccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhc
Confidence 54 899999999999998888888 788999999999999976666677899999999999999998876544
Q ss_pred C--------CCccEEEccCCcccccCCcccc--CCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEc------cccccee
Q 035895 234 L--------KDILYLDFWSNLFVGPLPSKIG--NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSL------GHNRLQG 297 (527)
Q Consensus 234 l--------~~L~~l~l~~n~~~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~ 297 (527)
. ++|+.|++++|.+. .+|..+. .+++|++|+|++|++++ +|..+..+++|++|++ ++|++.+
T Consensus 479 ~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~ 556 (636)
T 4eco_A 479 DENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR 556 (636)
T ss_dssp ETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCC
T ss_pred cccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccc
Confidence 2 28999999999998 6788887 99999999999999997 8889999999999999 5677888
Q ss_pred ecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeee
Q 035895 298 SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 298 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
.+|..|..+++|+.|++++|++ +.+|..+. +.|+.|+++.+.+
T Consensus 557 ~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l 599 (636)
T 4eco_A 557 EWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPN 599 (636)
T ss_dssp CCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTT
T ss_pred cChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCC
Confidence 9999999999999999999999 45566555 6889999887755
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=313.04 Aligned_cols=298 Identities=19% Similarity=0.188 Sum_probs=273.5
Q ss_pred hhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCC
Q 035895 19 VCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCK 91 (527)
Q Consensus 19 ~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~ 91 (527)
+-..+..+| ++|+++++.+..|.++++|++|+|++|.+.+..+. .++.|+|++|.++.++.. .|.+++
T Consensus 30 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~ 104 (477)
T 2id5_A 30 IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG-----VFTGLS 104 (477)
T ss_dssp CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT-----SSTTCT
T ss_pred CCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc-----cccCCC
Confidence 345678888 99999999999999999999999999998776553 478999999999987654 478999
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEec
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
+|++|+|++|++++..|..+..+. +|+.|++++|.+++..+..|..+++|++|++++|++++..+..+..+++|+.|++
T Consensus 105 ~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 183 (477)
T 2id5_A 105 NLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183 (477)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCT-TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEE
T ss_pred CCCEEECCCCccccCChhHccccc-cCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeC
Confidence 999999999999998888888775 7999999999999999999999999999999999999888888999999999999
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch-hhhCCCCccEEEccCCccccc
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGP 250 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~l~l~~n~~~~~ 250 (527)
++|.+.+..+..|..+++|+.|++++|.+.+.+|..+....+|+.|++++|+++.+|. .+..+++|+.|++++|.+.+.
T Consensus 184 ~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 263 (477)
T 2id5_A 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI 263 (477)
T ss_dssp ESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCcc
Confidence 9999998888899999999999999999888787777777799999999999999985 678899999999999999998
Q ss_pred CCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccccc
Q 035895 251 LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322 (527)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 322 (527)
.+..|..+++|++|+|++|++.+..|..|.++++|++|++++|++++..+..|..+++|+.|++++|++...
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp CTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred ChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 889999999999999999999999999999999999999999999988888899999999999999999754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.20 Aligned_cols=317 Identities=20% Similarity=0.235 Sum_probs=243.9
Q ss_pred hcchhccc-CCCceeecCchhhhcCCCCC--EEEcccccccccccc----------------------------------
Q 035895 20 CYRICTID-SQNKLVGIVSITIFNLSTLK--VFDVDNNYVLGRLSS---------------------------------- 62 (527)
Q Consensus 20 ~~~~~~~~-s~N~l~~~~~~~~~~l~~L~--~L~Ls~N~~~~~~~~---------------------------------- 62 (527)
+..+..++ ++|+++++.+..|.++++|+ .|++++|.+.+..+.
T Consensus 152 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~ 231 (606)
T 3t6q_A 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231 (606)
T ss_dssp CTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEE
T ss_pred CcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhhee
Confidence 55666666 66677777677777777777 667777665543321
Q ss_pred -----------------------ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhcccccc
Q 035895 63 -----------------------IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119 (527)
Q Consensus 63 -----------------------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~ 119 (527)
.++.|++++|.++.+++. .|..+++|++|++++|+++. +|..+..+. +|+
T Consensus 232 ~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~-lp~~l~~l~-~L~ 304 (606)
T 3t6q_A 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN-----TFHCFSGLQELDLTATHLSE-LPSGLVGLS-TLK 304 (606)
T ss_dssp CCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT-----TTTTCTTCSEEECTTSCCSC-CCSSCCSCT-TCC
T ss_pred chhhccccccccChhHhchhhcCceeEEEeecCccCccCHH-----HhccccCCCEEeccCCccCC-CChhhcccc-cCC
Confidence 234455666666554432 36778888888888888884 566666654 788
Q ss_pred EEEcccCccccccchhhcCCcCCcEEEeecCcccccCcc-cccCCCCCCEEeccCccccccc--ChhhhcCcccCeeeee
Q 035895 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSI--PNVLCHLAVLFQLDLR 196 (527)
Q Consensus 120 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~L~ 196 (527)
+|++++|.+++..|..+..+++|++|++++|.+.+..+. .+..+++|+.|++++|.+++.. |..+..+++|+.|+++
T Consensus 305 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~ 384 (606)
T 3t6q_A 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384 (606)
T ss_dssp EEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECC
T ss_pred EEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECC
Confidence 888888888887788888888888888888888754443 4788888888888888887665 6778888888888888
Q ss_pred cccCCCCCCccccCCccCceeeCCCCCCCCC-c-hhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCC
Q 035895 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSI-P-SILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274 (527)
Q Consensus 197 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l-p-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 274 (527)
+|++.+..|..|..+++|++|++++|+++.. | ..+..+++|+.|++++|.+.+..|..+..+++|++|++++|.+.+.
T Consensus 385 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 464 (606)
T 3t6q_A 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464 (606)
T ss_dssp SCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGG
T ss_pred CCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcc
Confidence 8888888888888888888888888888764 3 3367788888888888888888888888888888888888888762
Q ss_pred ---ChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 275 ---IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 275 ---~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
.+..+..+++|++|++++|++++..|..|..+++|+.|++++|++++..|..+..++.| .|+++.+.+.
T Consensus 465 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~ 536 (606)
T 3t6q_A 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536 (606)
T ss_dssp EECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCC
T ss_pred ccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCccc
Confidence 33568888888888888888888888888888888888888888888888888888888 8887776654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.35 Aligned_cols=317 Identities=20% Similarity=0.221 Sum_probs=245.5
Q ss_pred chhhh---cchhccc-CCCceeecCchhhhcCCCCCEEEc-cccccccc-------------------------------
Q 035895 16 TGDVC---YRICTID-SQNKLVGIVSITIFNLSTLKVFDV-DNNYVLGR------------------------------- 59 (527)
Q Consensus 16 ~~~~~---~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~L-s~N~~~~~------------------------------- 59 (527)
.|..| .++..++ ++|.++|.+|.+|.+|++|+.||| ++|.+.|.
T Consensus 315 ~GV~C~~~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~ 394 (876)
T 4ecn_A 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394 (876)
T ss_dssp TTEEECTTSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCC
T ss_pred CceEecCCCCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhcc
Confidence 66667 4788888 999999999999999999999999 88865433
Q ss_pred ---------------------------------------------ccc------ccceEEcccccccC------------
Q 035895 60 ---------------------------------------------LSS------IVDELSLSDNYLTS------------ 76 (527)
Q Consensus 60 ---------------------------------------------~~~------~l~~L~Ls~N~l~~------------ 76 (527)
+|. .++.|+|++|.|++
T Consensus 395 ~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~ 474 (876)
T 4ecn_A 395 DQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS 474 (876)
T ss_dssp CGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred CcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCccccccccccc
Confidence 343 36788899988887
Q ss_pred ------CCCCCcccccCC--CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCc-ccc-ccchhhcCCc------
Q 035895 77 ------STPELSFLSSMS--NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCN-ISG-GISEEIGNLT------ 140 (527)
Q Consensus 77 ------~~~~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~-l~~-~~~~~~~~l~------ 140 (527)
++. .+. ++++|++|+|++|++.+.+|..+..+. +|+.|+|++|+ +++ .+|..+..++
T Consensus 475 n~~~g~iP~------~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~-~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l 547 (876)
T 4ecn_A 475 DYAKQYENE------ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP-ELQSLNIACNRGISAAQLKADWTRLADDEDTG 547 (876)
T ss_dssp HHHHHHTTS------CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCS-SCCEEECTTCTTSCHHHHHHHHHHHHHCTTTT
T ss_pred ccccccCCh------hhhhccCCCCCEEECcCCCCCccChHHHhCCC-CCCEEECcCCCCcccccchHHHHhhhhccccc
Confidence 333 344 888899999999988888888888775 79999999997 887 6777766665
Q ss_pred -CCcEEEeecCcccccCcc--cccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCcc-Cce
Q 035895 141 -DLISIDLGGNKLNGSISI--TLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTA-LRN 216 (527)
Q Consensus 141 -~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~ 216 (527)
+|++|+|++|+++ .+|. .++.+++|+.|++++|+++ .+| .|..+++|+.|+|++|+++ .+|..+.++++ |+.
T Consensus 548 ~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~ 623 (876)
T 4ecn_A 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEG 623 (876)
T ss_dssp TTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCE
T ss_pred CCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCE
Confidence 8899999999888 6666 7888899999999999888 777 7888889999999999888 67778888888 999
Q ss_pred eeCCCCCCCCCchhhhCCC--CccEEEccCCcccccCCccc---c--CCCCCCEEEccCCCCCCCChhhhhcCCCCCEEE
Q 035895 217 LHLDSNELTSIPSILWNLK--DILYLDFWSNLFVGPLPSKI---G--NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLS 289 (527)
Q Consensus 217 L~L~~N~l~~lp~~~~~l~--~L~~l~l~~n~~~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 289 (527)
|++++|+++.+|..+..+. +|+.|++++|.+.+.+|... . .+++|+.|++++|.+....+..+..+++|+.|+
T Consensus 624 L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~ 703 (876)
T 4ecn_A 624 LGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703 (876)
T ss_dssp EECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEE
T ss_pred EECcCCCCCcCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEE
Confidence 9999999888887766554 38888888888877655322 2 334788888888888744444455788888888
Q ss_pred cccccceeecCCC-CCCC-------CCCCEEeCCCCcccccCccchh--hhccCCeeEeeeeeeec
Q 035895 290 LGHNRLQGSIPNS-FDDL-------VSLESLDLSNNNLSEIIPLSLE--KLLYLNILLIVVVILAL 345 (527)
Q Consensus 290 L~~N~l~~~~p~~-~~~l-------~~L~~L~ls~N~l~~~~p~~~~--~l~~L~~L~~~~~~~~~ 345 (527)
|++|+++ .+|.. +... ++|+.|+|++|+++ .+|..+. .++.|+.|+++.+.+..
T Consensus 704 Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~ 767 (876)
T 4ecn_A 704 LSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS 767 (876)
T ss_dssp CCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred CCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc
Confidence 8888887 44443 3322 27888888888887 4566665 78888888887766543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.49 Aligned_cols=137 Identities=23% Similarity=0.232 Sum_probs=95.6
Q ss_pred hhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCC
Q 035895 18 DVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNC 90 (527)
Q Consensus 18 ~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l 90 (527)
++...+..++ ++|+++++.+.+|.++++|++|+|++|.+.+..+. .++.|+|++|.++...+. .|.++
T Consensus 29 ~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l 103 (606)
T 3vq2_A 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG-----SFSGL 103 (606)
T ss_dssp TSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTT-----SSTTC
T ss_pred CCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChh-----hcCCc
Confidence 3345677777 77888888887888888888888888877665443 367788888887776443 46777
Q ss_pred CCCCEEEcccCCCCcccChhHhhccccccEEEcccCcccc-ccchhhcCCcCCcEEEeecCcccccCcccc
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISG-GISEEIGNLTDLISIDLGGNKLNGSISITL 160 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 160 (527)
++|++|++++|++++..+..+..+. +|++|++++|.+++ .+|..+.++++|++|++++|++++..+..+
T Consensus 104 ~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 104 TSLENLVAVETKLASLESFPIGQLI-TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp TTCCEEECTTSCCCCSSSSCCTTCT-TCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccCCEEEccCCccccccccccCCCC-CCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence 7777777777777766556666654 67777777777765 347777777777777777777665544433
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.14 Aligned_cols=112 Identities=18% Similarity=0.163 Sum_probs=81.0
Q ss_pred hhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCC
Q 035895 19 VCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCK 91 (527)
Q Consensus 19 ~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~ 91 (527)
.|..+..+| ++|+++++.|.+|.++++|++|+|++|.+.+..|. .++.|+|++|.++.+++. .+.+++
T Consensus 54 ~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~ 128 (606)
T 3vq2_A 54 NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESF-----PIGQLI 128 (606)
T ss_dssp TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSS-----CCTTCT
T ss_pred CCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccccccc-----ccCCCC
Confidence 356788888 88899999888899999999999999988766553 367888888888776542 356677
Q ss_pred CCCEEEcccCCCCc-ccChhHhhccccccEEEcccCccccccchhh
Q 035895 92 YLKKLDISRNPLDG-FLPRVVGNFSQSLEFIWMSDCNISGGISEEI 136 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~-~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 136 (527)
+|++|++++|++++ .+|..+..+. +|++|++++|.+++..+..+
T Consensus 129 ~L~~L~L~~n~l~~~~lp~~~~~l~-~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 129 TLKKLNVAHNFIHSCKLPAYFSNLT-NLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp TCCEEECCSSCCCCCCCCGGGGTCT-TCCEEECCSSCCCEECTTTT
T ss_pred CCCEEeCCCCcccceechHhHhhcC-CCCEEEccCCcceecChhhh
Confidence 77777777777765 3466666654 57777777776665554433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.45 Aligned_cols=314 Identities=22% Similarity=0.287 Sum_probs=201.9
Q ss_pred cchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccC
Q 035895 15 MTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSM 87 (527)
Q Consensus 15 ~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~ 87 (527)
++.++...+..+| ++|++++++|.+|.++++|++|+|++|.+.+..|. .++.|+|++|+|+.++..
T Consensus 15 ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~------- 87 (520)
T 2z7x_B 15 VPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH------- 87 (520)
T ss_dssp CCCSCCTTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC-------
T ss_pred ccccccccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc-------
Confidence 3333446788888 88888888888888888888888888888766543 467888888888764331
Q ss_pred CCCCCCCEEEcccCCCCcc-cChhHhhccccccEEEcccCccccccchhhcCCcCC--cEEEeecCcc--cccCcccccC
Q 035895 88 SNCKYLKKLDISRNPLDGF-LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL--ISIDLGGNKL--NGSISITLGK 162 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~-~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~ 162 (527)
.+++|++|++++|++++. +|..+..+. +|++|++++|.+++ ..+..+++| ++|++++|.+ .+..|..+..
T Consensus 88 -~l~~L~~L~L~~N~l~~~~~p~~~~~l~-~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~ 162 (520)
T 2z7x_B 88 -PTVNLKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162 (520)
T ss_dssp -CCCCCSEEECCSSCCSSCCCCGGGGGCT-TCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTT
T ss_pred -ccCCccEEeccCCccccccchhhhccCC-cceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccc
Confidence 577788888888888763 567777664 67888887777764 234444555 6666666655 3333333332
Q ss_pred CC------------------------------------------------------------------------------
Q 035895 163 LQ------------------------------------------------------------------------------ 164 (527)
Q Consensus 163 l~------------------------------------------------------------------------------ 164 (527)
+.
T Consensus 163 l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~ 242 (520)
T 2z7x_B 163 FNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242 (520)
T ss_dssp CCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHH
T ss_pred cccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHH
Confidence 11
Q ss_pred -----CCCEEeccCcccccccChhh-----------------------------------------------------hc
Q 035895 165 -----KLQFLSFRGNELEGSIPNVL-----------------------------------------------------CH 186 (527)
Q Consensus 165 -----~L~~L~l~~N~l~~~~p~~~-----------------------------------------------------~~ 186 (527)
+|+.|++++|++.+.+|..+ ..
T Consensus 243 ~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 322 (520)
T 2z7x_B 243 LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSK 322 (520)
T ss_dssp HHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSS
T ss_pred HhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhh
Confidence 45555555555554444433 45
Q ss_pred CcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCC---chhhhCCCCccEEEccCCcccccCCc-cccCCCCCC
Q 035895 187 LAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI---PSILWNLKDILYLDFWSNLFVGPLPS-KIGNLKVLT 262 (527)
Q Consensus 187 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l---p~~~~~l~~L~~l~l~~n~~~~~~p~-~~~~l~~L~ 262 (527)
+++|++|++++|++++..|..++.+++|++|++++|+++++ |..+..+++|++|++++|.+.+.+|. .+..+++|+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 56666666666666666666666666677777777766643 34556666667777776666664443 356666677
Q ss_pred EEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeee
Q 035895 263 RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVI 342 (527)
Q Consensus 263 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~ 342 (527)
+|++++|++++..|..+. ++|++|++++|+++ .+|..+..+++|+.|++++|+++++++..+..++.|+.|+++.+.
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~ 479 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCC
Confidence 777777666655554443 56677777777766 555555566777777777777765444446666667766666655
Q ss_pred e
Q 035895 343 L 343 (527)
Q Consensus 343 ~ 343 (527)
+
T Consensus 480 ~ 480 (520)
T 2z7x_B 480 W 480 (520)
T ss_dssp B
T ss_pred C
Confidence 4
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.86 Aligned_cols=308 Identities=17% Similarity=0.187 Sum_probs=263.4
Q ss_pred CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccC-CCCCCcccccCCCCCCCCEEEccc
Q 035895 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTS-STPELSFLSSMSNCKYLKKLDISR 100 (527)
Q Consensus 28 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~-~~~~~~~~~~~~~l~~L~~L~Ls~ 100 (527)
++++++.++. + .++|++|||++|.+.+..+. .++.|+|++|.+.. +++ ..|.++++|++|+|++
T Consensus 18 ~~~~l~~lp~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~-----~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 18 INRGLHQVPE--L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN-----NTFRGLSSLIILKLDY 88 (455)
T ss_dssp CSSCCSSCCC--C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECT-----TTTTTCTTCCEEECTT
T ss_pred CCCCcccCCC--C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECc-----ccccccccCCEEeCCC
Confidence 5666776655 2 27899999999999876553 47899999998863 222 3578999999999999
Q ss_pred CCCCcccChhHhhccccccEEEcccCccccccchh--hcCCcCCcEEEeecCcccccCccc-ccCCCCCCEEeccCcccc
Q 035895 101 NPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEE--IGNLTDLISIDLGGNKLNGSISIT-LGKLQKLQFLSFRGNELE 177 (527)
Q Consensus 101 N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~ 177 (527)
|++++..|..+..+. +|++|+|++|.+++..+.. +..+++|++|+|++|++++..|.. +..+++|++|++++|.++
T Consensus 89 n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 89 NQFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp CTTCEECTTTTTTCT-TCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CccCccChhhccCcc-cCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 999998898888875 7999999999999755554 899999999999999999887766 889999999999999999
Q ss_pred cccChhhhcC--cccCeeeeecccCCCCCCccc--------cCCccCceeeCCCCCCCC-CchhhhC-------------
Q 035895 178 GSIPNVLCHL--AVLFQLDLRGNKLSGSIPTCF--------GNLTALRNLHLDSNELTS-IPSILWN------------- 233 (527)
Q Consensus 178 ~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~l~~-lp~~~~~------------- 233 (527)
+..|..+..+ ..|+.|++++|.+.+..+..+ ..+++|++|++++|++++ +|..+..
T Consensus 168 ~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~ 247 (455)
T 3v47_A 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247 (455)
T ss_dssp CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECT
T ss_pred ccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeec
Confidence 9888888876 789999999999997665543 367899999999999876 3433321
Q ss_pred --------------------------CCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCE
Q 035895 234 --------------------------LKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQF 287 (527)
Q Consensus 234 --------------------------l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 287 (527)
.++|+.+++++|.+.+..|..++.+++|++|++++|++.+..|..|.++++|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 327 (455)
T 3v47_A 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLK 327 (455)
T ss_dssp TCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCE
Confidence 257889999999999989999999999999999999999888889999999999
Q ss_pred EEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeeec
Q 035895 288 LSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILAL 345 (527)
Q Consensus 288 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~~ 345 (527)
|++++|++++..|..|..+++|++|++++|++++..|..+..++.|+.|+++.+.+..
T Consensus 328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp EECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred EECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence 9999999998888999999999999999999999999999999999999998876643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=311.20 Aligned_cols=315 Identities=20% Similarity=0.221 Sum_probs=247.6
Q ss_pred cchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccC
Q 035895 15 MTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSM 87 (527)
Q Consensus 15 ~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~ 87 (527)
++.+....+..+| ++|.++++++.+|.++++|++|+|++|.+.+..+. .++.|+|++|+|+.++..
T Consensus 46 ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~------- 118 (562)
T 3a79_B 46 VPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC------- 118 (562)
T ss_dssp CCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC-------
T ss_pred CCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc-------
Confidence 4455557788888 88899998888999999999999999988766553 478899999988865432
Q ss_pred CCCCCCCEEEcccCCCCcc-cChhHhhccccccEEEcccCccccccchhhcCCcCC--cEEEeecCcc--cccCcccccC
Q 035895 88 SNCKYLKKLDISRNPLDGF-LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL--ISIDLGGNKL--NGSISITLGK 162 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~-~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~ 162 (527)
.+++|++||+++|++++. .|..+..+. +|++|++++|.+++. .+..+++| ++|++++|++ ++..|..+..
T Consensus 119 -~l~~L~~L~Ls~N~l~~l~~p~~~~~l~-~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~ 193 (562)
T 3a79_B 119 -PMASLRHLDLSFNDFDVLPVCKEFGNLT-KLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193 (562)
T ss_dssp -CCTTCSEEECCSSCCSBCCCCGGGGGCT-TCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEE
T ss_pred -ccccCCEEECCCCCccccCchHhhcccC-cccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccc
Confidence 678899999999998874 357777765 799999999888753 34444555 8888888877 5554444443
Q ss_pred CC------------------------------------------------------------------------------
Q 035895 163 LQ------------------------------------------------------------------------------ 164 (527)
Q Consensus 163 l~------------------------------------------------------------------------------ 164 (527)
+.
T Consensus 194 l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~ 273 (562)
T 3a79_B 194 PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273 (562)
T ss_dssp CCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH
T ss_pred cCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh
Confidence 32
Q ss_pred ---CCCEEeccCcccccccChhh-----------------------------------------------------hcCc
Q 035895 165 ---KLQFLSFRGNELEGSIPNVL-----------------------------------------------------CHLA 188 (527)
Q Consensus 165 ---~L~~L~l~~N~l~~~~p~~~-----------------------------------------------------~~l~ 188 (527)
+|++|++++|.+++.+|..+ ..++
T Consensus 274 ~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~ 353 (562)
T 3a79_B 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353 (562)
T ss_dssp TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCC
T ss_pred hcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCC
Confidence 67777777777776666544 5678
Q ss_pred ccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCc---hhhhCCCCccEEEccCCcccccCCc-cccCCCCCCEE
Q 035895 189 VLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP---SILWNLKDILYLDFWSNLFVGPLPS-KIGNLKVLTRI 264 (527)
Q Consensus 189 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp---~~~~~l~~L~~l~l~~n~~~~~~p~-~~~~l~~L~~L 264 (527)
+|++|++++|++++..|..|+++++|++|++++|+++++| ..+..+++|++|++++|.+.+.+|. .+..+++|++|
T Consensus 354 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L 433 (562)
T 3a79_B 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433 (562)
T ss_dssp CCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEE
T ss_pred CceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEE
Confidence 8999999999999888889999999999999999999765 4577889999999999999884554 58888999999
Q ss_pred EccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 265 DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 265 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
++++|++++..|..+. ++|++|++++|+++ .+|..+..+++|+.|++++|+++++++..+..++.|+.++++.+.+.
T Consensus 434 ~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 510 (562)
T 3a79_B 434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510 (562)
T ss_dssp ECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBC
T ss_pred ECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcC
Confidence 9999999876665543 68999999999998 56776669999999999999999765555888999999998887764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.00 Aligned_cols=322 Identities=22% Similarity=0.234 Sum_probs=198.5
Q ss_pred chhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCC--CCcc--cccCCCC
Q 035895 22 RICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTP--ELSF--LSSMSNC 90 (527)
Q Consensus 22 ~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~--~~~~--~~~~~~l 90 (527)
.+..+| ++|+++++.+.+|.++++|++|++++|.+.+..+. .++.|++++|....... .++. ...|..+
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l 328 (680)
T 1ziw_A 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTC
T ss_pred CCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccC
Confidence 366777 77777777777777788888888887776654432 24555555543321100 0000 0134455
Q ss_pred CCCCEEEcccCCCCcccChhHhhcc---------------------------ccccEEEcccCccccccchhhcCCcCCc
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNFS---------------------------QSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~~---------------------------~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
++|++|++++|++++..+..+..+. .+|+.|++++|.+++..|..|..+++|+
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 408 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCC
Confidence 5566666666665555444444332 2355555555666666666666666666
Q ss_pred EEEeecCcccccCc-ccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCC--CCCCccccCCccCceeeCC
Q 035895 144 SIDLGGNKLNGSIS-ITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS--GSIPTCFGNLTALRNLHLD 220 (527)
Q Consensus 144 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~ 220 (527)
+|++++|++++.++ ..|.++++|+.|++++|++.+..+..|..+++|+.|++++|.+. +..|..|.++++|++|+++
T Consensus 409 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls 488 (680)
T 1ziw_A 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488 (680)
T ss_dssp EEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECC
T ss_pred EEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECC
Confidence 66666666655433 45666666666666666666666666666666666666666665 3456667777777777777
Q ss_pred CCCCCCCch-hhhCCCCccEEEccCCcccccCC--------ccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcc
Q 035895 221 SNELTSIPS-ILWNLKDILYLDFWSNLFVGPLP--------SKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLG 291 (527)
Q Consensus 221 ~N~l~~lp~-~~~~l~~L~~l~l~~n~~~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 291 (527)
+|+++.+|. .+..+++|++|++++|.+.+..+ ..+..+++|++|++++|++....+..|.++++|++|+++
T Consensus 489 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 568 (680)
T 1ziw_A 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECC
Confidence 777776654 35566677777777776654321 235666777777777777765444556777777777777
Q ss_pred cccceeecCCCCCCCCCCCEEeCCCCcccccCccchh-hhccCCeeEeeeeee
Q 035895 292 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE-KLLYLNILLIVVVIL 343 (527)
Q Consensus 292 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~L~~~~~~~ 343 (527)
+|++++..+..|..+++|+.|++++|++++.+|..+. .++.|+.++++.+.+
T Consensus 569 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~ 621 (680)
T 1ziw_A 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCC
T ss_pred CCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCc
Confidence 7777766566666777777777777777776666665 566666666665544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.68 Aligned_cols=160 Identities=28% Similarity=0.298 Sum_probs=126.1
Q ss_pred hcCcccCeeeeecccCCCCC--CccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCC-ccccCCCCC
Q 035895 185 CHLAVLFQLDLRGNKLSGSI--PTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLP-SKIGNLKVL 261 (527)
Q Consensus 185 ~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p-~~~~~l~~L 261 (527)
..+++|+.|++++|++++.. |..+.++++|++|++++|.++++|..+..+++|+.|++++|.+.+..| ..+..+++|
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 423 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTC
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCC
Confidence 35677788888888887554 667788888888888888888877767778888888888888877655 467788888
Q ss_pred CEEEccCCCCCCCChhhhhcCCCCCEEEcccccce-eecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeee
Q 035895 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ-GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVV 340 (527)
Q Consensus 262 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~ 340 (527)
++|++++|.+.+..|..|.++++|++|++++|+++ +.+|..|..+++|+.|++++|++++..|..+..++.|+.|+++.
T Consensus 424 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 503 (570)
T 2z63_A 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503 (570)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence 88888888888777888888888888888888876 56778888888888888888888887788888888888888777
Q ss_pred eeee
Q 035895 341 VILA 344 (527)
Q Consensus 341 ~~~~ 344 (527)
+.+.
T Consensus 504 n~l~ 507 (570)
T 2z63_A 504 NQLK 507 (570)
T ss_dssp SCCS
T ss_pred CcCC
Confidence 6553
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.95 Aligned_cols=311 Identities=19% Similarity=0.209 Sum_probs=246.9
Q ss_pred hhcchhccc-CCCceeecCchhhhcCCCCCEEEccccc-ccc-cccc-------------ccceEEcccccccCCCCCCc
Q 035895 19 VCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNY-VLG-RLSS-------------IVDELSLSDNYLTSSTPELS 82 (527)
Q Consensus 19 ~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~-~~~~-------------~l~~L~Ls~N~l~~~~~~~~ 82 (527)
.+..+..++ ++|++.+.+|..|.+|++|+.|+|++|. +.+ .+|. .++.|+|++|.++.++..
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~-- 566 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPAS-- 566 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCH--
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCCh--
Confidence 346788888 8888899899999999999999999997 776 5553 588899999988854430
Q ss_pred ccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcC-CcEEEeecCcccccCccccc
Q 035895 83 FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD-LISIDLGGNKLNGSISITLG 161 (527)
Q Consensus 83 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~ 161 (527)
..+.++++|++|+|++|+++ .+| .+..+. +|+.|+|++|.++ .+|..+..+++ |++|+|++|+++ .+|..+.
T Consensus 567 --~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~ 639 (876)
T 4ecn_A 567 --ASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639 (876)
T ss_dssp --HHHTTCTTCCEEECTTSCCC-BCC-CCCTTS-EESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCC
T ss_pred --hhhhcCCCCCEEECCCCCcc-cch-hhcCCC-cceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhh
Confidence 14678889999999999988 566 666654 7999999999988 77778888888 999999999988 5667776
Q ss_pred CCCC--CCEEeccCcccccccChhh---h--cCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCC
Q 035895 162 KLQK--LQFLSFRGNELEGSIPNVL---C--HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNL 234 (527)
Q Consensus 162 ~l~~--L~~L~l~~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l 234 (527)
.++. |+.|++++|++.+.+|... . .+++|+.|++++|+++..++..+..+++|+.|+|++|+++.+|..++..
T Consensus 640 ~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~ 719 (876)
T 4ecn_A 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719 (876)
T ss_dssp TTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSC
T ss_pred ccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcc
Confidence 6654 8999999999887665432 2 3447888999999988544445568888999999999998888766543
Q ss_pred C--------CccEEEccCCcccccCCcccc--CCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccc------ccceee
Q 035895 235 K--------DILYLDFWSNLFVGPLPSKIG--NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGH------NRLQGS 298 (527)
Q Consensus 235 ~--------~L~~l~l~~n~~~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~ 298 (527)
. +|+.|++++|++. .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.
T Consensus 720 ~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ 797 (876)
T 4ecn_A 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQ 797 (876)
T ss_dssp TTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCC
T ss_pred ccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccccccccc
Confidence 3 8889999999887 6777776 88899999999999886 788888899999998876 777888
Q ss_pred cCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeee
Q 035895 299 IPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 299 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
+|..|..+++|+.|+|++|++ +.+|..+. +.|+.|+++.+.+
T Consensus 798 ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l 839 (876)
T 4ecn_A 798 WPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPN 839 (876)
T ss_dssp CCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTT
T ss_pred ChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCC
Confidence 888888899999999999998 55666554 5788888887665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=312.51 Aligned_cols=135 Identities=24% Similarity=0.323 Sum_probs=117.0
Q ss_pred cCCccCceeeCCCCCCCCC---chhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh-hhhhcCCC
Q 035895 209 GNLTALRNLHLDSNELTSI---PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP-TTIQGLKS 284 (527)
Q Consensus 209 ~~l~~L~~L~L~~N~l~~l---p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~ 284 (527)
..+++|++|++++|+++.+ |..+..+++|++|++++|.+.+..+. +..+++|++|++++|.+.+..| ..|..+++
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 422 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTT
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCC
Confidence 4678889999999998876 67788899999999999998876554 8899999999999999987766 57889999
Q ss_pred CCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc-ccCccchhhhccCCeeEeeeeeee
Q 035895 285 LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS-EIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 285 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
|++|++++|++.+..|..|.++++|+.|++++|.++ +.+|..+..++.|+.|+++.+.+.
T Consensus 423 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~ 483 (570)
T 2z63_A 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483 (570)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC
T ss_pred CCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccc
Confidence 999999999999888999999999999999999997 578888999999999998876654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=310.13 Aligned_cols=322 Identities=21% Similarity=0.240 Sum_probs=199.8
Q ss_pred chhhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCC
Q 035895 16 TGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMS 88 (527)
Q Consensus 16 ~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~ 88 (527)
+.++..++..+| ++|.++++++..|.++++|++|+|++|.+.+..+. .++.|+|++|.++.+++. +|.
T Consensus 20 p~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-----~~~ 94 (680)
T 1ziw_A 20 PDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK-----TFA 94 (680)
T ss_dssp CSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTT-----TTT
T ss_pred ccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChh-----hhc
Confidence 334446777888 88888888888888888888888888887766553 367888888888876543 467
Q ss_pred CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCccccc--CCCCC
Q 035895 89 NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLG--KLQKL 166 (527)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L 166 (527)
++++|++|++++|++++..|..+..+. +|++|++++|.+++..|..+..+++|++|++++|++++..+..+. .+++|
T Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L 173 (680)
T 1ziw_A 95 FCTNLTELHLMSNSIQKIKNNPFVKQK-NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173 (680)
T ss_dssp TCTTCSEEECCSSCCCCCCSCTTTTCT-TCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEE
T ss_pred cCCCCCEEECCCCccCccChhHccccC-CCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccc
Confidence 788888888888888776666676664 688888888888777777777788888888888877766655443 34667
Q ss_pred CEEeccCcccccccChhhhcC---------------------------cccCeeeeecccCCCCCCccccCCcc--Ccee
Q 035895 167 QFLSFRGNELEGSIPNVLCHL---------------------------AVLFQLDLRGNKLSGSIPTCFGNLTA--LRNL 217 (527)
Q Consensus 167 ~~L~l~~N~l~~~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L 217 (527)
+.|++++|.+++..|..|..+ ++|+.|++++|.+++..|..|.+++. |++|
T Consensus 174 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L 253 (680)
T 1ziw_A 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253 (680)
T ss_dssp SEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEE
T ss_pred cEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEE
Confidence 777777776665555444332 22334444444444444444444432 4444
Q ss_pred eCCCCCCCCCc-hhhhCCCCccEEEccCCcccccCCc---------------------------------cccCCCCCCE
Q 035895 218 HLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPLPS---------------------------------KIGNLKVLTR 263 (527)
Q Consensus 218 ~L~~N~l~~lp-~~~~~l~~L~~l~l~~n~~~~~~p~---------------------------------~~~~l~~L~~ 263 (527)
++++|+++.++ ..+..+++|++|++++|.+.+..|. .|..+++|++
T Consensus 254 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~ 333 (680)
T 1ziw_A 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333 (680)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCE
T ss_pred ECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCE
Confidence 44444444432 2334444444444444444333332 3444555666
Q ss_pred EEccCCCCCCCChhhhhcCCCCCEEEcc----------------------------cccceeecCCCCCCCCCCCEEeCC
Q 035895 264 IDFSRNNLLGDIPTTIQGLKSLQFLSLG----------------------------HNRLQGSIPNSFDDLVSLESLDLS 315 (527)
Q Consensus 264 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~----------------------------~N~l~~~~p~~~~~l~~L~~L~ls 315 (527)
|++++|.+.+..|..|.++++|++|+++ +|++++..|..|..+++|+.|+++
T Consensus 334 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 413 (680)
T 1ziw_A 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413 (680)
T ss_dssp EECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred EECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCC
Confidence 6666666665555555555555554444 444555555666666666666666
Q ss_pred CCcccccCc-cchhhhccCCeeEeeeeee
Q 035895 316 NNNLSEIIP-LSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 316 ~N~l~~~~p-~~~~~l~~L~~L~~~~~~~ 343 (527)
+|.+++.+| ..+..+..|+.|+++.+.+
T Consensus 414 ~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l 442 (680)
T 1ziw_A 414 LNEIGQELTGQEWRGLENIFEIYLSYNKY 442 (680)
T ss_dssp SSCCEEECCSGGGTTCTTCCEEECCSCSE
T ss_pred CCcCccccCcccccCcccccEEecCCCCc
Confidence 666665433 4566666666666655443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.85 Aligned_cols=155 Identities=26% Similarity=0.337 Sum_probs=104.1
Q ss_pred hcCcccCeeeeecccCCCCCC---ccccCCccCceeeCCCCCCCCCch---hhhCCCCccEEEccCCcccccCCccccCC
Q 035895 185 CHLAVLFQLDLRGNKLSGSIP---TCFGNLTALRNLHLDSNELTSIPS---ILWNLKDILYLDFWSNLFVGPLPSKIGNL 258 (527)
Q Consensus 185 ~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~lp~---~~~~l~~L~~l~l~~n~~~~~~p~~~~~l 258 (527)
..+++|+.|++++|++++..| ..++.+++|++|++++|+++++|. .+..+++|++|++++|++. .+|..+..+
T Consensus 331 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~ 409 (549)
T 2z81_A 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP 409 (549)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCC
T ss_pred hcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhccc
Confidence 467778888888888876553 346777888888888888887753 4677788888888888777 567777777
Q ss_pred CCCCEEEccCCCCCCCChhhh------------------hcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc
Q 035895 259 KVLTRIDFSRNNLLGDIPTTI------------------QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 259 ~~L~~L~Ls~N~l~~~~p~~~------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 320 (527)
++|++|++++|.+.+ +|..+ ..+++|++|++++|+++ .+|. ...+++|+.|++++|+++
T Consensus 410 ~~L~~L~Ls~N~l~~-l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~ 486 (549)
T 2z81_A 410 EKMRFLNLSSTGIRV-VKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLK 486 (549)
T ss_dssp TTCCEEECTTSCCSC-CCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCC
T ss_pred ccccEEECCCCCccc-ccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccC
Confidence 777777777777753 23222 24556666666666665 3443 345566666666666666
Q ss_pred ccCccchhhhccCCeeEeeeeee
Q 035895 321 EIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 321 ~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
+.+|..+..++.|+.|+++.+.+
T Consensus 487 ~~~~~~~~~l~~L~~L~l~~N~~ 509 (549)
T 2z81_A 487 SVPDGIFDRLTSLQKIWLHTNPW 509 (549)
T ss_dssp CCCTTGGGGCTTCCEEECCSSCB
T ss_pred CcCHHHHhcCcccCEEEecCCCc
Confidence 66666666666666666665554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=314.42 Aligned_cols=297 Identities=22% Similarity=0.229 Sum_probs=177.6
Q ss_pred hhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc-------cccceEEcccccccCCCCCCcccccCCCC
Q 035895 19 VCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS-------SIVDELSLSDNYLTSSTPELSFLSSMSNC 90 (527)
Q Consensus 19 ~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~-------~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l 90 (527)
....+..+| ++|.++++.+..|.++++|++|||++|...+.++ ..++.|+|++|.++...+. .|.++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~-----~~~~l 96 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD-----AFQGL 96 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT-----SSCSC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh-----HccCC
Confidence 334566666 6777777777777777777777777775443332 1356677777776655332 46666
Q ss_pred CCCCEEEcccCCCCcccChh--HhhccccccEEEcccCccccccc-hhhcCCcCCcEEEeecCcccccCcccccCC--CC
Q 035895 91 KYLKKLDISRNPLDGFLPRV--VGNFSQSLEFIWMSDCNISGGIS-EEIGNLTDLISIDLGGNKLNGSISITLGKL--QK 165 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~--~~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~ 165 (527)
++|++|+|++|.+++..|.. +..+. +|++|+|++|.+++..+ ..|.++++|++|+|++|.+++..+..+..+ ++
T Consensus 97 ~~L~~L~Ls~n~l~~~~~~~~~~~~L~-~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~ 175 (844)
T 3j0a_A 97 FHLFELRLYFCGLSDAVLKDGYFRNLK-ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175 (844)
T ss_dssp SSCCCEECTTCCCSSCCSTTCCCSSCS-SCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCS
T ss_pred cccCEeeCcCCCCCcccccCccccccC-CCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCc
Confidence 77777777777776544433 44443 57777777777665543 456677777777777777766666666655 66
Q ss_pred CCEEeccCcccccccChhhhcCcc------cCeeeeecccCCCCCCccccC-----------------------------
Q 035895 166 LQFLSFRGNELEGSIPNVLCHLAV------LFQLDLRGNKLSGSIPTCFGN----------------------------- 210 (527)
Q Consensus 166 L~~L~l~~N~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~----------------------------- 210 (527)
|+.|++++|.+.+..|..+..+.+ |+.|++++|.+++..|..+..
T Consensus 176 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~ 255 (844)
T 3j0a_A 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255 (844)
T ss_dssp SCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTG
T ss_pred cceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCC
Confidence 666666666666655555444443 666666666655444433321
Q ss_pred ---------CccCceeeCCCCCCCCC-chhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhh
Q 035895 211 ---------LTALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ 280 (527)
Q Consensus 211 ---------l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 280 (527)
.++|+.|++++|.++.+ |..+..+++|+.|++++|.+.+..|..|..+++|++|+|++|.+.+..|..|.
T Consensus 256 ~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 335 (844)
T 3j0a_A 256 DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFY 335 (844)
T ss_dssp GGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCS
T ss_pred ChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhc
Confidence 13455556665555553 33445555566666666655555555555566666666666665555555555
Q ss_pred cCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccc
Q 035895 281 GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 281 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 321 (527)
++++|++|++++|++.+..+..|..+++|+.|++++|.+++
T Consensus 336 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp SCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred CCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 56666666666666555555555555666666666665554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=282.23 Aligned_cols=248 Identities=27% Similarity=0.482 Sum_probs=127.2
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEccc-CCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCC
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISR-NPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 142 (527)
++.|+|++|.+++. ...+..+.++++|++|++++ |.+.+.+|..+..+. +|++|+|++|.+++..|..+..+++|
T Consensus 52 l~~L~L~~~~l~~~---~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L 127 (313)
T 1ogq_A 52 VNNLDLSGLNLPKP---YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp EEEEEEECCCCSSC---EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCT-TCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred EEEEECCCCCccCC---cccChhHhCCCCCCeeeCCCCCcccccCChhHhcCC-CCCEEECcCCeeCCcCCHHHhCCCCC
Confidence 44555555555430 00112344555555555553 555555555554443 45555555555555555555555555
Q ss_pred cEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCc-ccCeeeeecccCCCCCCccccCCccCceeeCCC
Q 035895 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLA-VLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDS 221 (527)
Q Consensus 143 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 221 (527)
++|++++|++++..|..+..+++|++|++++|++++.+|..+..++ .|+.|++++|++++..|..|..++ |++|++++
T Consensus 128 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~ 206 (313)
T 1ogq_A 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSR 206 (313)
T ss_dssp CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCS
T ss_pred CEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcC
Confidence 5555555555555555555555555555555555555555555554 555555555555555555555554 55555555
Q ss_pred CCCCC-CchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecC
Q 035895 222 NELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300 (527)
Q Consensus 222 N~l~~-lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 300 (527)
|++++ +|..+..+++|+.|++++|.+.+.+|. +..+++|++|++++|++++.+|..|..+++|++|++++|++++.+|
T Consensus 207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip 285 (313)
T 1ogq_A 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred CcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence 55543 334444455555555555555444333 4445555555555555554555555555555555555555555554
Q ss_pred CCCCCCCCCCEEeCCCCc
Q 035895 301 NSFDDLVSLESLDLSNNN 318 (527)
Q Consensus 301 ~~~~~l~~L~~L~ls~N~ 318 (527)
.. ..+++|+.|++++|+
T Consensus 286 ~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 286 QG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CS-TTGGGSCGGGTCSSS
T ss_pred CC-ccccccChHHhcCCC
Confidence 43 445555555555554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=282.12 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=224.1
Q ss_pred cchhccc-CCCceee--cCchhhhcCCCCCEEEccc-cccccccccccceEEcccccccCCCCCCcccccCCCCCCCCEE
Q 035895 21 YRICTID-SQNKLVG--IVSITIFNLSTLKVFDVDN-NYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKL 96 (527)
Q Consensus 21 ~~~~~~~-s~N~l~~--~~~~~~~~l~~L~~L~Ls~-N~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L 96 (527)
.++..++ ++|.+++ .+|..|.++++|++|++++ |.+.+.+| ..|.++++|++|
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p-----------------------~~l~~l~~L~~L 106 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP-----------------------PAIAKLTQLHYL 106 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCC-----------------------GGGGGCTTCSEE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCC-----------------------hhHhcCCCCCEE
Confidence 3566677 7777777 6777777888888877774 65554433 246778999999
Q ss_pred EcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCC-CCCEEeccCcc
Q 035895 97 DISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQ-KLQFLSFRGNE 175 (527)
Q Consensus 97 ~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~ 175 (527)
+|++|++++.+|..+..+. +|++|++++|.+++.+|..+..+++|++|++++|++++..|..+..++ +|+.|++++|+
T Consensus 107 ~Ls~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~ 185 (313)
T 1ogq_A 107 YITHTNVSGAIPDFLSQIK-TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp EEEEECCEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred ECcCCeeCCcCCHHHhCCC-CCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe
Confidence 9999999998999998875 799999999999999999999999999999999999999999999998 99999999999
Q ss_pred cccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccc
Q 035895 176 LEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKI 255 (527)
Q Consensus 176 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~ 255 (527)
+++..|..|..+. |+.|++++|++++..|..|..+++|+.|++++|+++..++.+..+++|++|++++|.+.+.+|..+
T Consensus 186 l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred eeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHH
Confidence 9999999999998 999999999999999999999999999999999999877778889999999999999999999999
Q ss_pred cCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccc
Q 035895 256 GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL 295 (527)
Q Consensus 256 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 295 (527)
..+++|++|++++|++++.+|.. ..+++|+.|++++|+.
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~ 303 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKC 303 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSE
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCC
Confidence 99999999999999999999886 8899999999999983
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=309.85 Aligned_cols=309 Identities=21% Similarity=0.236 Sum_probs=270.3
Q ss_pred ccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEccccccc-CCCCCCcccccCCCCCCCCEE
Q 035895 25 TID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLT-SSTPELSFLSSMSNCKYLKKL 96 (527)
Q Consensus 25 ~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~-~~~~~~~~~~~~~~l~~L~~L 96 (527)
.+| ++++++.+++ -.++|++|||++|.+.+..+. .++.|+|++|.+. .+++ ..|.++++|++|
T Consensus 8 ~~dcs~~~L~~vP~----lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~-----~~f~~L~~L~~L 78 (844)
T 3j0a_A 8 IAFYRFCNLTQVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK-----EAFRNLPNLRIL 78 (844)
T ss_dssp EEEESCCCSSCCCS----SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECT-----TTTSSCTTCCEE
T ss_pred EEEccCCCCCCCCC----CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCH-----HHhcCCCCCCEE
Confidence 344 6788888876 458999999999999876553 4789999999543 3323 368999999999
Q ss_pred EcccCCCCcccChhHhhccccccEEEcccCccccccchh--hcCCcCCcEEEeecCcccccCc-ccccCCCCCCEEeccC
Q 035895 97 DISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEE--IGNLTDLISIDLGGNKLNGSIS-ITLGKLQKLQFLSFRG 173 (527)
Q Consensus 97 ~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~ 173 (527)
+|++|++++..|..|..+. +|++|+|++|.+++..|.. +..+++|++|+|++|.+++..+ ..|+.+++|+.|++++
T Consensus 79 ~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~ 157 (844)
T 3j0a_A 79 DLGSSKIYFLHPDAFQGLF-HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157 (844)
T ss_dssp ECTTCCCCEECTTSSCSCS-SCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEES
T ss_pred ECCCCcCcccCHhHccCCc-ccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCC
Confidence 9999999999899998875 7999999999999866655 8999999999999999987654 5799999999999999
Q ss_pred cccccccChhhhcC--cccCeeeeecccCCCCCCccccCCcc------CceeeCCCCCCCC-CchhhhC-----------
Q 035895 174 NELEGSIPNVLCHL--AVLFQLDLRGNKLSGSIPTCFGNLTA------LRNLHLDSNELTS-IPSILWN----------- 233 (527)
Q Consensus 174 N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~------L~~L~L~~N~l~~-lp~~~~~----------- 233 (527)
|.+++..|..+..+ ++|+.|++++|.+.+..|..++.+++ |+.|++++|.++. +|..+..
T Consensus 158 N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~ 237 (844)
T 3j0a_A 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI 237 (844)
T ss_dssp SCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEE
T ss_pred CcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCccccccee
Confidence 99999999999888 89999999999999988888777766 9999999998764 3322211
Q ss_pred ---------------------------CCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCC
Q 035895 234 ---------------------------LKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQ 286 (527)
Q Consensus 234 ---------------------------l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 286 (527)
.++|+.|++++|.+.+..|..|..+++|+.|+|++|.+.+..|..|.++++|+
T Consensus 238 l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 317 (844)
T 3j0a_A 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317 (844)
T ss_dssp CCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCC
T ss_pred cccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCC
Confidence 25799999999999999999999999999999999999999999999999999
Q ss_pred EEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeee
Q 035895 287 FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 287 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
+|+|++|++++..|..|..+++|+.|++++|.++++.+..+..++.|+.|+++.+.+
T Consensus 318 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 374 (844)
T 3j0a_A 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374 (844)
T ss_dssp EEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCS
T ss_pred EEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCC
Confidence 999999999988899999999999999999999999999999999999999987654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=297.75 Aligned_cols=312 Identities=19% Similarity=0.151 Sum_probs=203.3
Q ss_pred ccchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCccccc
Q 035895 14 GMTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSS 86 (527)
Q Consensus 14 ~~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~ 86 (527)
...+..|.....+| ++|+++++++..+ ++|++|+|++|.+.+..+. .++.|+|++|.|+++.+. .
T Consensus 24 ~~~~~~~~~~~~l~ls~~~L~~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-----~ 95 (562)
T 3a79_B 24 SMTPFSNELESMVDYSNRNLTHVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFH-----V 95 (562)
T ss_dssp ---------CCEEECTTSCCCSCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTT-----T
T ss_pred cccccccCCCcEEEcCCCCCccCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHH-----H
Confidence 34455666667788 8999998665433 8999999999999876543 478999999999987553 5
Q ss_pred CCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCcccccc-chhhcCCcCCcEEEeecCcccccCcccccCCCC
Q 035895 87 MSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGI-SEEIGNLTDLISIDLGGNKLNGSISITLGKLQK 165 (527)
Q Consensus 87 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 165 (527)
|.++++|++|||++|+++.+ |.. .+ ++|++|++++|.+++.. |..|.++++|++|++++|++++. .+..+++
T Consensus 96 ~~~l~~L~~L~Ls~N~l~~l-p~~--~l-~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~ 168 (562)
T 3a79_B 96 FLFNQDLEYLDVSHNRLQNI-SCC--PM-ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAH 168 (562)
T ss_dssp TTTCTTCCEEECTTSCCCEE-CSC--CC-TTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTT
T ss_pred hCCCCCCCEEECCCCcCCcc-Ccc--cc-ccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhh
Confidence 88999999999999999964 544 44 58999999999999754 68999999999999999999863 4556666
Q ss_pred C--CEEeccCccc--ccccChhhhcCc-----------------------------------------------------
Q 035895 166 L--QFLSFRGNEL--EGSIPNVLCHLA----------------------------------------------------- 188 (527)
Q Consensus 166 L--~~L~l~~N~l--~~~~p~~~~~l~----------------------------------------------------- 188 (527)
| +.|++++|.+ ++..|..|..+.
T Consensus 169 L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l 248 (562)
T 3a79_B 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248 (562)
T ss_dssp SCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSC
T ss_pred ceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhcc
Confidence 6 9999999998 666665555433
Q ss_pred ----------------------------ccCeeeeecccCCCCCCccc-----cCCcc----------------------
Q 035895 189 ----------------------------VLFQLDLRGNKLSGSIPTCF-----GNLTA---------------------- 213 (527)
Q Consensus 189 ----------------------------~L~~L~L~~N~l~~~~p~~~-----~~l~~---------------------- 213 (527)
+|++|++++|++++.+|..+ .+++.
T Consensus 249 ~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~ 328 (562)
T 3a79_B 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328 (562)
T ss_dssp SSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHH
T ss_pred CcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhh
Confidence 67778888888887777665 33332
Q ss_pred ----CceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCC--hhhhhcCCCCCE
Q 035895 214 ----LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI--PTTIQGLKSLQF 287 (527)
Q Consensus 214 ----L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~ 287 (527)
|+.|++++|.+..++. ...+++|++|++++|.+.+..|..++.+++|++|++++|++.+.. |..|.++++|++
T Consensus 329 ~~~~L~~L~l~~n~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~ 407 (562)
T 3a79_B 329 AEMNIKMLSISDTPFIHMVC-PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407 (562)
T ss_dssp HTCCCSEEEEESSCCCCCCC-CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCE
T ss_pred ccCcceEEEccCCCcccccC-ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCE
Confidence 2223333333222110 034455666666666666555555666666666666666655422 344556666666
Q ss_pred EEcccccceeecC-CCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeee
Q 035895 288 LSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 288 L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
|++++|++++.+| ..|..+++|+.|++++|++++..|..+. ..|+.|+++.+.+
T Consensus 408 L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l 462 (562)
T 3a79_B 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRI 462 (562)
T ss_dssp EECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCC
T ss_pred EECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcC
Confidence 6666666655233 3355555555566655555554444332 3455555554433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=293.37 Aligned_cols=295 Identities=20% Similarity=0.217 Sum_probs=233.9
Q ss_pred hhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc---cccceEEcccccccCCCCCCcccccCCCCCCCC
Q 035895 19 VCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS---SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLK 94 (527)
Q Consensus 19 ~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~---~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~ 94 (527)
.+.++..++ ++|+++++.|.+|.++++|++|||++|.+....+ ..+++|+|++|.+++.+. +..|.++++|+
T Consensus 43 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~l~~L~~L~L~~N~l~~~~~----p~~~~~l~~L~ 118 (520)
T 2z7x_B 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPI----CKEFGNMSQLK 118 (520)
T ss_dssp TCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECCCCCCCSEEECCSSCCSSCCC----CGGGGGCTTCC
T ss_pred ccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCccccCCccEEeccCCccccccc----hhhhccCCcce
Confidence 356788899 9999999999999999999999999999874322 358899999999987432 23577888888
Q ss_pred EEEcccCCCCcccChhHhhccccc--cEEEcccCcc--ccccchhhcCCc------------------------------
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSL--EFIWMSDCNI--SGGISEEIGNLT------------------------------ 140 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L--~~L~Ls~n~l--~~~~~~~~~~l~------------------------------ 140 (527)
+|++++|++++. .+..+. +| +.|++++|.+ .+..|..+..+.
T Consensus 119 ~L~L~~n~l~~~---~~~~l~-~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~ 194 (520)
T 2z7x_B 119 FLGLSTTHLEKS---SVLPIA-HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194 (520)
T ss_dssp EEEEEESSCCGG---GGGGGT-TSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEE
T ss_pred EEEecCcccchh---hccccc-cceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceee
Confidence 888888887652 222222 34 5555555555 333333333321
Q ss_pred -----------------------------------------------------CCcEEEeecCcccccCcccc-------
Q 035895 141 -----------------------------------------------------DLISIDLGGNKLNGSISITL------- 160 (527)
Q Consensus 141 -----------------------------------------------------~L~~L~L~~N~l~~~~~~~~------- 160 (527)
+|++|++++|++++.+|..+
T Consensus 195 L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~ 274 (520)
T 2z7x_B 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274 (520)
T ss_dssp CCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCC
T ss_pred ccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhccccc
Confidence 45555555555554333322
Q ss_pred ----------------------------------------------cCCCCCCEEeccCcccccccChhhhcCcccCeee
Q 035895 161 ----------------------------------------------GKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLD 194 (527)
Q Consensus 161 ----------------------------------------------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 194 (527)
..+++|+.|++++|++++..|..+..+++|+.|+
T Consensus 275 l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 354 (520)
T 2z7x_B 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLI 354 (520)
T ss_dssp CCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEE
T ss_pred CceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEE
Confidence 6788999999999999988999999999999999
Q ss_pred eecccCCC--CCCccccCCccCceeeCCCCCCCC-Cchh-hhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCC
Q 035895 195 LRGNKLSG--SIPTCFGNLTALRNLHLDSNELTS-IPSI-LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270 (527)
Q Consensus 195 L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~-lp~~-~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~ 270 (527)
+++|++++ ..|..|+.+++|++|++++|++++ +|.. +..+++|++|++++|.+.+..|..+. ++|++|++++|+
T Consensus 355 L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~ 432 (520)
T 2z7x_B 355 LQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNK 432 (520)
T ss_dssp CCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSC
T ss_pred ccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCc
Confidence 99999997 456789999999999999999998 8875 67789999999999999888877665 789999999999
Q ss_pred CCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCc
Q 035895 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 271 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
++ .+|..+..+++|++|++++|+++...+..|..+++|+.|++++|+++...+
T Consensus 433 l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 433 IK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 98 788888899999999999999995444459999999999999999987543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=275.04 Aligned_cols=304 Identities=21% Similarity=0.311 Sum_probs=249.9
Q ss_pred ccchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc----cccceEEcccccccCCCCCCcccccCC
Q 035895 14 GMTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS----SIVDELSLSDNYLTSSTPELSFLSSMS 88 (527)
Q Consensus 14 ~~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~----~~l~~L~Ls~N~l~~~~~~~~~~~~~~ 88 (527)
-.....+..+..++ ++|.+..+. .+..+++|++|++++|.+....+ ..++.|+|++|.++.+ +.+.
T Consensus 37 ~~~~~~l~~L~~L~l~~~~i~~~~--~~~~~~~L~~L~l~~n~i~~~~~~~~l~~L~~L~L~~n~i~~~-------~~~~ 107 (347)
T 4fmz_A 37 VVTQEELESITKLVVAGEKVASIQ--GIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDI-------SALQ 107 (347)
T ss_dssp EECHHHHTTCSEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-------GGGT
T ss_pred cccchhcccccEEEEeCCccccch--hhhhcCCccEEEccCCccccchhhhcCCcCCEEEccCCcccCc-------hHHc
Confidence 34445666778888 778887764 38889999999999998765332 2478999999988764 2478
Q ss_pred CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCE
Q 035895 89 NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQF 168 (527)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 168 (527)
.+++|++|++++|++++..+ +..+ ++|+.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.
T Consensus 108 ~l~~L~~L~l~~n~i~~~~~--~~~l-~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~ 181 (347)
T 4fmz_A 108 NLTNLRELYLNEDNISDISP--LANL-TKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYS 181 (347)
T ss_dssp TCTTCSEEECTTSCCCCCGG--GTTC-TTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSE
T ss_pred CCCcCCEEECcCCcccCchh--hccC-CceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCE
Confidence 89999999999999987533 5555 479999999996654444 48899999999999999986544 788999999
Q ss_pred EeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCccc
Q 035895 169 LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFV 248 (527)
Q Consensus 169 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~ 248 (527)
|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|+++.+|. +..+++|++|++++|.+.
T Consensus 182 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~ 256 (347)
T 4fmz_A 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQIS 256 (347)
T ss_dssp EECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred EEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccC
Confidence 9999999985433 8889999999999999986554 8889999999999999999887 888899999999999887
Q ss_pred ccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchh
Q 035895 249 GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 328 (527)
Q Consensus 249 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 328 (527)
+. +.+..+++|++|++++|.+.+. +.+..+++|++|++++|++++..|..|..+++|+.|++++|++++..| +.
T Consensus 257 ~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~ 330 (347)
T 4fmz_A 257 DI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330 (347)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GG
T ss_pred CC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hh
Confidence 64 5688899999999999999864 468899999999999999998888889999999999999999998777 78
Q ss_pred hhccCCeeEeeeeee
Q 035895 329 KLLYLNILLIVVVIL 343 (527)
Q Consensus 329 ~l~~L~~L~~~~~~~ 343 (527)
.++.|+.|+++.+.+
T Consensus 331 ~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 331 SLSKMDSADFANQVI 345 (347)
T ss_dssp GCTTCSEESSSCC--
T ss_pred hhhccceeehhhhcc
Confidence 888999888776553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-32 Score=272.06 Aligned_cols=282 Identities=20% Similarity=0.272 Sum_probs=234.6
Q ss_pred CCCEEEccccccccc---cccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEE
Q 035895 45 TLKVFDVDNNYVLGR---LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFI 121 (527)
Q Consensus 45 ~L~~L~Ls~N~~~~~---~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L 121 (527)
+++.+++++|.+... +++.++.|+|++|.++.+++. .|.++++|++|++++|++++..|..+..+. +|++|
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L 107 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKD-----DFKGLQHLYALVLVNNKISKIHEKAFSPLR-KLQKL 107 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTT-----TTTTCTTCCEEECCSSCCCEECGGGSTTCT-TCCEE
T ss_pred cCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHh-----HhhCCCCCcEEECCCCccCccCHhHhhCcC-CCCEE
Confidence 688899998876532 234678899999998876543 578899999999999999988788887775 79999
Q ss_pred EcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccc--cccChhhhcCcccCeeeeeccc
Q 035895 122 WMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE--GSIPNVLCHLAVLFQLDLRGNK 199 (527)
Q Consensus 122 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~L~~N~ 199 (527)
++++|.++.. |..+. ++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..|..+ +|+.|++++|+
T Consensus 108 ~L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~ 183 (332)
T 2ft3_A 108 YISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK 183 (332)
T ss_dssp ECCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSB
T ss_pred ECCCCcCCcc-Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCC
Confidence 9999999854 44333 78999999999999877778899999999999999986 3667778888 89999999999
Q ss_pred CCCCCCccccCCccCceeeCCCCCCCCCc-hhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhh
Q 035895 200 LSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTT 278 (527)
Q Consensus 200 l~~~~p~~~~~l~~L~~L~L~~N~l~~lp-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 278 (527)
+++ +|..+. ++|++|++++|+++.++ ..+..+++|+.|++++|.+.+..+..+..+++|++|++++|++. .+|..
T Consensus 184 l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 184 LTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp CSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred CCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 986 454443 68999999999999876 56788899999999999999888888999999999999999997 68888
Q ss_pred hhcCCCCCEEEcccccceeecCCCCCCC------CCCCEEeCCCCccc--ccCccchhhhccCCeeEeee
Q 035895 279 IQGLKSLQFLSLGHNRLQGSIPNSFDDL------VSLESLDLSNNNLS--EIIPLSLEKLLYLNILLIVV 340 (527)
Q Consensus 279 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~ls~N~l~--~~~p~~~~~l~~L~~L~~~~ 340 (527)
+..+++|++|++++|++++..+..|... ..|+.|++++|++. ++.|..+..++.|+.++++.
T Consensus 260 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~ 329 (332)
T 2ft3_A 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329 (332)
T ss_dssp GGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC--
T ss_pred hhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccc
Confidence 9999999999999999998777777653 67899999999987 67788888899998887654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.04 Aligned_cols=261 Identities=22% Similarity=0.228 Sum_probs=119.6
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
++.|+|++|.++.+++. .|..+++|++|++++|++++..|..+..+. +|++|++++|.++..++..|..+++|+
T Consensus 71 L~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~l~~~~~~~l~~L~ 144 (390)
T 3o6n_A 71 VELLNLNDLQIEEIDTY-----AFAYAHTIQKLYMGFNAIRYLPPHVFQNVP-LLTVLVLERNDLSSLPRGIFHNTPKLT 144 (390)
T ss_dssp CSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CcEEECCCCcccccChh-----hccCCCCcCEEECCCCCCCcCCHHHhcCCC-CCCEEECCCCccCcCCHHHhcCCCCCc
Confidence 44445555544443321 244445555555555555544444444432 455555555555443333344455555
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCee-------------------eeecccCCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQL-------------------DLRGNKLSGSI 204 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L-------------------~L~~N~l~~~~ 204 (527)
+|++++|++++..+..+..+++|+.|++++|.+++. .+..+++|+.| ++++|.+....
T Consensus 145 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~ 221 (390)
T 3o6n_A 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVR 221 (390)
T ss_dssp EEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEE
T ss_pred EEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccccCCCCcceEEECCCCeeeecc
Confidence 555555555444444445555555555555554432 12334444444 44444444321
Q ss_pred CccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCC
Q 035895 205 PTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKS 284 (527)
Q Consensus 205 p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 284 (527)
.. ..++|+.|++++|.++.++ .+..+++|++|++++|.+.+..|..+..+++|++|++++|++.+ +|..+..+++
T Consensus 222 ~~---~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~ 296 (390)
T 3o6n_A 222 GP---VNVELTILKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPT 296 (390)
T ss_dssp CC---CCSSCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTT
T ss_pred cc---ccccccEEECCCCCCcccH-HHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCC
Confidence 11 1234455555555554432 34444455555555555444444445555555555555554442 3333444445
Q ss_pred CCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeee
Q 035895 285 LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVI 342 (527)
Q Consensus 285 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~ 342 (527)
|++|++++|+++ .+|..+..+++|+.|++++|+++... +..++.|+.|+++.+.
T Consensus 297 L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~ 350 (390)
T 3o6n_A 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHND 350 (390)
T ss_dssp CCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSC
T ss_pred CCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCC
Confidence 555555555544 23333444445555555555544331 3334444444444443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=296.16 Aligned_cols=316 Identities=20% Similarity=0.243 Sum_probs=243.8
Q ss_pred hhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCC
Q 035895 19 VCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCK 91 (527)
Q Consensus 19 ~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~ 91 (527)
+...+..+| ++|+++++.|.+|.++++|++|+|++|.+.+..+. .++.|+|++|.+++.++. .|.+++
T Consensus 24 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~ 98 (549)
T 2z81_A 24 LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS-----WFGPLS 98 (549)
T ss_dssp CCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHH-----HHTTCT
T ss_pred CCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHH-----HhccCC
Confidence 335788888 88899999888999999999999999988766543 478899999998876542 477889
Q ss_pred CCCEEEcccCCCCcc-cChhHhhccccccEEEcccCc-cccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEE
Q 035895 92 YLKKLDISRNPLDGF-LPRVVGNFSQSLEFIWMSDCN-ISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFL 169 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~-~~~~~~~~~~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 169 (527)
+|++|++++|++++. .|..+..+. +|++|++++|. +....+..+..+++|++|++++|++++..|..+..+++|+.|
T Consensus 99 ~L~~L~Ls~n~l~~~~~~~~~~~l~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 177 (549)
T 2z81_A 99 SLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177 (549)
T ss_dssp TCCEEECTTCCCSSSCSSCSCTTCT-TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEE
T ss_pred CCcEEECCCCcccccchhhhhhccC-CccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceE
Confidence 999999999998863 455666664 79999999998 454555788899999999999999998888889999999999
Q ss_pred eccCcccccccChhhhcCcccCeeeeecccCCCCC--Ccc----------------------------------------
Q 035895 170 SFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI--PTC---------------------------------------- 207 (527)
Q Consensus 170 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~---------------------------------------- 207 (527)
++++|.+....+..+..+++|+.|++++|++++.. |..
T Consensus 178 ~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~ 257 (549)
T 2z81_A 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257 (549)
T ss_dssp EEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEE
T ss_pred ecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccc
Confidence 99999886433333467899999999999988631 100
Q ss_pred ------------------------------------------------ccCCccCceeeCCCCCCCCCchhhh-CCCCcc
Q 035895 208 ------------------------------------------------FGNLTALRNLHLDSNELTSIPSILW-NLKDIL 238 (527)
Q Consensus 208 ------------------------------------------------~~~l~~L~~L~L~~N~l~~lp~~~~-~l~~L~ 238 (527)
+..+++|+.|++++|+++.+|..++ .+++|+
T Consensus 258 l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~ 337 (549)
T 2z81_A 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337 (549)
T ss_dssp EESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCC
T ss_pred cccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCcccc
Confidence 0112357777777888888887764 688899
Q ss_pred EEEccCCcccccCC---ccccCCCCCCEEEccCCCCCCCCh--hhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEe
Q 035895 239 YLDFWSNLFVGPLP---SKIGNLKVLTRIDFSRNNLLGDIP--TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLD 313 (527)
Q Consensus 239 ~l~l~~n~~~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 313 (527)
.|++++|.+.+..| ..++.+++|++|++++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|+.|+
T Consensus 338 ~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~ 416 (549)
T 2z81_A 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416 (549)
T ss_dssp EEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEE
T ss_pred EEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEE
Confidence 99999998887664 346788889999999998876433 46888899999999999988 6788888888999999
Q ss_pred CCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 314 LSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 314 ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
+++|+++++..... ..|+.|+++.+.+.
T Consensus 417 Ls~N~l~~l~~~~~---~~L~~L~Ls~N~l~ 444 (549)
T 2z81_A 417 LSSTGIRVVKTCIP---QTLEVLDVSNNNLD 444 (549)
T ss_dssp CTTSCCSCCCTTSC---TTCSEEECCSSCCS
T ss_pred CCCCCcccccchhc---CCceEEECCCCChh
Confidence 99998876443222 46677777766543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-32 Score=281.51 Aligned_cols=299 Identities=27% Similarity=0.376 Sum_probs=203.4
Q ss_pred hhhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc----cccceEEcccccccCCCCCCcccccCCCCCC
Q 035895 18 DVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS----SIVDELSLSDNYLTSSTPELSFLSSMSNCKY 92 (527)
Q Consensus 18 ~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~----~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~ 92 (527)
..|..+..+| ++|.++++++ |.++++|++|++++|.+.+..+ ..++.|+|++|.++..+ .+..+++
T Consensus 65 ~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~-------~~~~l~~ 135 (466)
T 1o6v_A 65 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID-------PLKNLTN 135 (466)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG-------GGTTCTT
T ss_pred hhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChhhcCCCCCCEEECCCCCCCCCh-------HHcCCCC
Confidence 3455666677 6777777655 6777777777777776654332 23667777777766542 2456667
Q ss_pred CCEEEcccCCCCcccCh--------------------hHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcc
Q 035895 93 LKKLDISRNPLDGFLPR--------------------VVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152 (527)
Q Consensus 93 L~~L~Ls~N~l~~~~~~--------------------~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 152 (527)
|++|++++|++.+. +. .+..+ ++|+.|++++|.++.. ..+..+++|++|++++|.+
T Consensus 136 L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~~~~~~~~~~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l 211 (466)
T 1o6v_A 136 LNRLELSSNTISDI-SALSGLTSLQQLSFGNQVTDLKPLANL-TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQI 211 (466)
T ss_dssp CSEEEEEEEEECCC-GGGTTCTTCSEEEEEESCCCCGGGTTC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred CCEEECCCCccCCC-hhhccCCcccEeecCCcccCchhhccC-CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcc
Confidence 77777777766543 11 12222 2566666666666543 2356666677777777766
Q ss_pred cccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhh
Q 035895 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILW 232 (527)
Q Consensus 153 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~ 232 (527)
++..+ ++.+++|+.|++++|.+++. +.+..+++|+.|++++|.+++..| +..+++|+.|++++|.++.+|. +.
T Consensus 212 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~ 284 (466)
T 1o6v_A 212 SDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LA 284 (466)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GT
T ss_pred ccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-cc
Confidence 65444 55667777777777776642 356677777777777777776544 6777777788887777777766 66
Q ss_pred CCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEE
Q 035895 233 NLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESL 312 (527)
Q Consensus 233 ~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 312 (527)
.+++|+.|++++|.+.+..| +..+++|++|++++|++.+..| +..+++|++|++++|++++. ..+..+++|+.|
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 358 (466)
T 1o6v_A 285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL 358 (466)
T ss_dssp TCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred CCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence 77778888888877766443 6777888888888888876555 67778888888888887754 367778888888
Q ss_pred eCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 313 DLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 313 ~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
++++|++++..| +..++.|+.|+++.+.+.
T Consensus 359 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred eCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 888888887766 777788888877766654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.60 Aligned_cols=134 Identities=23% Similarity=0.257 Sum_probs=109.2
Q ss_pred chhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCCCCC
Q 035895 22 RICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCKYLK 94 (527)
Q Consensus 22 ~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~ 94 (527)
.+..+| ++|+|+++.+.+|.++++|++|||++|.+.+..+. .++.|+|++|+|+.+++. .|.++++|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~-----~f~~L~~L~ 127 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG-----AFSGLSSLQ 127 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGG-----GGTTCTTCC
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHH-----HhcCCCCCC
Confidence 567788 89999999999999999999999999988765543 378899999999887653 578899999
Q ss_pred EEEcccCCCCcccChhHhhccccccEEEcccCccccc-cchhhcCCcCCcEEEeecCcccccCccccc
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGG-ISEEIGNLTDLISIDLGGNKLNGSISITLG 161 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 161 (527)
+|+|++|+++++.+..|..+. +|++|+|++|.++.. .|..+..+++|++|++++|++++..+..+.
T Consensus 128 ~L~Ls~N~l~~l~~~~~~~L~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 194 (635)
T 4g8a_A 128 KLVAVETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 194 (635)
T ss_dssp EEECTTSCCCCSTTCCCTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred EEECCCCcCCCCChhhhhcCc-ccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccccc
Confidence 999999999887666677765 799999999998764 577888899999999999988765554443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-32 Score=293.98 Aligned_cols=298 Identities=19% Similarity=0.190 Sum_probs=190.0
Q ss_pred hhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCCCCCE
Q 035895 23 ICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKK 95 (527)
Q Consensus 23 ~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~ 95 (527)
+..++ ++|.+..+++..|.++++|++|+|++|.+.+..+. .++.|+|++|.|+.+++. .|.++++|++
T Consensus 53 l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~ 127 (597)
T 3oja_B 53 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVPLLTV 127 (597)
T ss_dssp CSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCE
T ss_pred ceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH-----HHcCCCCCCE
Confidence 34444 55666666666667777777777777766554432 356677777776665443 3566667777
Q ss_pred EEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcc
Q 035895 96 LDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNE 175 (527)
Q Consensus 96 L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 175 (527)
|+|++|.++++.+..|..+. +|++|+|++|.+++..|..|..+++|++|++++|.+++.. ++.+++|+.|++++|.
T Consensus 128 L~L~~n~l~~l~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 128 LVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNL 203 (597)
T ss_dssp EECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSC
T ss_pred EEeeCCCCCCCCHHHhccCC-CCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCc
Confidence 77777777655444445543 5777777777776666666667777777777777766532 4456666666666666
Q ss_pred cccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccc
Q 035895 176 LEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKI 255 (527)
Q Consensus 176 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~ 255 (527)
+++. .....|+.|++++|.+....+.. .++|+.|+|++|.+++. ..+..+++|+.|++++|.+.+..|..|
T Consensus 204 l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 274 (597)
T 3oja_B 204 LSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPF 274 (597)
T ss_dssp CSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred cccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHh
Confidence 6532 23345666777777666433322 24677777777777664 455666777777777777777767777
Q ss_pred cCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCe
Q 035895 256 GNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335 (527)
Q Consensus 256 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 335 (527)
+.+++|++|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|.+++.. +..++.|+.
T Consensus 275 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~ 349 (597)
T 3oja_B 275 VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKN 349 (597)
T ss_dssp TTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSE
T ss_pred cCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCE
Confidence 777777777777777764 4555666777777777777776 45555666777777777777776543 445556666
Q ss_pred eEeeeeee
Q 035895 336 LLIVVVIL 343 (527)
Q Consensus 336 L~~~~~~~ 343 (527)
|+++.+.+
T Consensus 350 L~l~~N~~ 357 (597)
T 3oja_B 350 LTLSHNDW 357 (597)
T ss_dssp EECCSSCE
T ss_pred EEeeCCCC
Confidence 66666555
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-31 Score=266.14 Aligned_cols=284 Identities=18% Similarity=0.241 Sum_probs=212.8
Q ss_pred CCCCEEEccccccccc---cccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccE
Q 035895 44 STLKVFDVDNNYVLGR---LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120 (527)
Q Consensus 44 ~~L~~L~Ls~N~~~~~---~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~ 120 (527)
.+++.++++++.+... ++..++.|+|++|.++.+++. .|.++++|++|++++|++++..|..+..+. +|++
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~ 104 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDG-----DFKNLKNLHTLILINNKISKISPGAFAPLV-KLER 104 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTT-----TTTTCTTCCEEECCSSCCCCBCTTTTTTCT-TCCE
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChh-----hhccCCCCCEEECCCCcCCeeCHHHhcCCC-CCCE
Confidence 3577888887766432 334577888888888776542 467788888888888888877777777764 6888
Q ss_pred EEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCccccc--ccChhhhcCcccCeeeeecc
Q 035895 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG--SIPNVLCHLAVLFQLDLRGN 198 (527)
Q Consensus 121 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N 198 (527)
|++++|.++.. |..+. ++|++|++++|++++..+..+..+++|+.|++++|.+.. ..+..|..+++|+.|++++|
T Consensus 105 L~Ls~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n 181 (330)
T 1xku_A 105 LYLSKNQLKEL-PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181 (330)
T ss_dssp EECCSSCCSBC-CSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred EECCCCcCCcc-Chhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence 88888888743 33332 678888888888887777778888888888888888753 56777888888888888888
Q ss_pred cCCCCCCccccCCccCceeeCCCCCCCCC-chhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChh
Q 035895 199 KLSGSIPTCFGNLTALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT 277 (527)
Q Consensus 199 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 277 (527)
.++. +|..+. ++|++|++++|+++++ |..+..+++|+.|++++|.+.+..+..+..+++|++|++++|.+. .+|.
T Consensus 182 ~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 257 (330)
T 1xku_A 182 NITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257 (330)
T ss_dssp CCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred cccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCCh
Confidence 8875 444333 6788888888888876 566777888888888888888777777888888888888888887 6777
Q ss_pred hhhcCCCCCEEEcccccceeecCCCCCCC------CCCCEEeCCCCcccc--cCccchhhhccCCeeEeee
Q 035895 278 TIQGLKSLQFLSLGHNRLQGSIPNSFDDL------VSLESLDLSNNNLSE--IIPLSLEKLLYLNILLIVV 340 (527)
Q Consensus 278 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~~~~ 340 (527)
.+..+++|++|++++|++++..+..|... +.|+.|++++|++.. +.|..+..+..++.++++.
T Consensus 258 ~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~ 328 (330)
T 1xku_A 258 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328 (330)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC--
T ss_pred hhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecc
Confidence 78888888888888888887766666543 677888888888764 5667777777777776553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-31 Score=266.56 Aligned_cols=280 Identities=23% Similarity=0.346 Sum_probs=241.4
Q ss_pred hhhhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc----cccceEEcccccccCCCCCCcccccCCCCC
Q 035895 17 GDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS----SIVDELSLSDNYLTSSTPELSFLSSMSNCK 91 (527)
Q Consensus 17 ~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~----~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~ 91 (527)
-..|..+..++ ++|+++++.+ |.++++|++|++++|.+..... ..++.|+|++|.++..++ +..++
T Consensus 62 ~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~~~~~~l~~L~~L~l~~n~i~~~~~-------~~~l~ 132 (347)
T 4fmz_A 62 IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP-------LANLT 132 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEECTTSCCCCCGG-------GTTCT
T ss_pred hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCchHHcCCCcCCEEECcCCcccCchh-------hccCC
Confidence 34577899999 8999998876 9999999999999998865311 258999999999987532 67899
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEec
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
+|++|++++|.....++ .+..+. +|++|++++|.+....+ +..+++|++|++++|.+.+..+ +..+++|+.|++
T Consensus 133 ~L~~L~l~~n~~~~~~~-~~~~l~-~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 206 (347)
T 4fmz_A 133 KMYSLNLGANHNLSDLS-PLSNMT-GLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTA 206 (347)
T ss_dssp TCCEEECTTCTTCCCCG-GGTTCT-TCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred ceeEEECCCCCCccccc-chhhCC-CCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeec
Confidence 99999999996655444 366654 79999999999986554 8899999999999999986544 889999999999
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccC
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~ 251 (527)
++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|++|++++|.++.++ .+..+++|+.|++++|.+.+.
T Consensus 207 ~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~- 280 (347)
T 4fmz_A 207 YVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI- 280 (347)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC-
T ss_pred ccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC-
Confidence 9999986544 8899999999999999997554 899999999999999999985 578899999999999998875
Q ss_pred CccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc
Q 035895 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 252 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 320 (527)
+.+..+++|++|++++|.+.+..|..|.++++|++|++++|++++..| +..+++|+.|++++|+++
T Consensus 281 -~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 281 -SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp -GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred -hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 568899999999999999999999999999999999999999997766 889999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-31 Score=271.27 Aligned_cols=266 Identities=17% Similarity=0.163 Sum_probs=216.4
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
++.|++++|.++.+++. .|..+++|++|++++|.+++..+..+..+. +|++|+|++|.+++..|..|..+++|+
T Consensus 47 l~~l~l~~~~l~~l~~~-----~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~ 120 (390)
T 3o6n_A 47 QKIVTFKNSTMRKLPAA-----LLDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIRYLPPHVFQNVPLLT 120 (390)
T ss_dssp CSEEEEESCEESEECTH-----HHHHCCCCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred ceEEEecCCchhhCChh-----HhcccccCcEEECCCCcccccChhhccCCC-CcCEEECCCCCCCcCCHHHhcCCCCCC
Confidence 34455555555544432 256788999999999999998777888775 799999999999999999999999999
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCce-------
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRN------- 216 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~------- 216 (527)
+|++++|+++...+..|..+++|++|++++|.+++..|..|..+++|+.|++++|++++.. ++.+++|+.
T Consensus 121 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNL 197 (390)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSC
T ss_pred EEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccc
Confidence 9999999999777777899999999999999999888889999999999999999998754 334445555
Q ss_pred ------------eeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCC
Q 035895 217 ------------LHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKS 284 (527)
Q Consensus 217 ------------L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 284 (527)
|++++|.++.+|... .++|+.|++++|.+.+. ..+..+++|++|++++|.+.+..|..|..+++
T Consensus 198 l~~~~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 273 (390)
T 3o6n_A 198 LSTLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 273 (390)
T ss_dssp CSEEECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred ccccCCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcccccc
Confidence 455555554444322 35788888888888764 57888999999999999998888889999999
Q ss_pred CCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 285 LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 285 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
|++|++++|++++ +|..+..+++|+.|++++|++++ +|..+..++.|+.|+++.+.+.
T Consensus 274 L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~ 331 (390)
T 3o6n_A 274 LERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV 331 (390)
T ss_dssp CCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCC
T ss_pred CCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccc
Confidence 9999999999985 56677888999999999999985 5666888899999988876653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-31 Score=286.15 Aligned_cols=284 Identities=20% Similarity=0.205 Sum_probs=251.6
Q ss_pred hcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhc
Q 035895 41 FNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNF 114 (527)
Q Consensus 41 ~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 114 (527)
..+++++.+++++|.+....+. .++.|+|++|.|+.+++. .|..+++|++|+|++|.+++..|..|..+
T Consensus 48 l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 122 (597)
T 3oja_B 48 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY-----AFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122 (597)
T ss_dssp GGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChH-----HhcCCCCCCEEECCCCcCCCCCHHHHcCC
Confidence 4578999999999988765442 488999999999986653 57899999999999999999888888877
Q ss_pred cccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeee
Q 035895 115 SQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLD 194 (527)
Q Consensus 115 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 194 (527)
. +|++|+|++|.+++.++..|..+++|++|+|++|.+++..|..|+.+++|+.|++++|.+++.. +..+++|+.|+
T Consensus 123 ~-~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~ 198 (597)
T 3oja_B 123 P-LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHAN 198 (597)
T ss_dssp T-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEE
T ss_pred C-CCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhh
Confidence 5 7999999999999888888899999999999999999999989999999999999999998652 56788999999
Q ss_pred eecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCC
Q 035895 195 LRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274 (527)
Q Consensus 195 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 274 (527)
+++|.+++ +...++|+.|++++|.++.+|..+. ++|+.|++++|.+.+ +..+..+++|++|+|++|.+.+.
T Consensus 199 l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~ 269 (597)
T 3oja_B 199 VSYNLLST-----LAIPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKI 269 (597)
T ss_dssp CCSSCCSE-----EECCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEE
T ss_pred cccCcccc-----ccCCchhheeeccCCcccccccccC--CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCC
Confidence 99999875 3445689999999999999876543 689999999999987 47899999999999999999999
Q ss_pred ChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 275 IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 275 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
+|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|.+++ +|..+..++.|+.|+++.+.+.
T Consensus 270 ~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~ 337 (597)
T 3oja_B 270 MYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV 337 (597)
T ss_dssp ESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCC
T ss_pred CHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCC
Confidence 99999999999999999999996 57778889999999999999985 6777899999999999987764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-31 Score=263.07 Aligned_cols=266 Identities=19% Similarity=0.188 Sum_probs=236.2
Q ss_pred ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCC
Q 035895 63 IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142 (527)
Q Consensus 63 ~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 142 (527)
.++.++++++.++.++..+ .+.|++|++++|++++..+..+..+. +|++|++++|.+++..|..|..+++|
T Consensus 32 ~l~~l~~~~~~l~~lp~~~--------~~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDL--------PPDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKL 102 (330)
T ss_dssp ETTEEECTTSCCCSCCCSC--------CTTCCEEECCSSCCCCBCTTTTTTCT-TCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred CCeEEEecCCCccccCccC--------CCCCeEEECCCCcCCEeChhhhccCC-CCCEEECCCCcCCeeCHHHhcCCCCC
Confidence 4788999999999876543 26899999999999998777887775 79999999999999889999999999
Q ss_pred cEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCC--CCCccccCCccCceeeCC
Q 035895 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG--SIPTCFGNLTALRNLHLD 220 (527)
Q Consensus 143 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~ 220 (527)
++|++++|+++.. |..+. ++|+.|++++|.+++..+..|..+++|+.|++++|.+.. ..+..|.++++|++|+++
T Consensus 103 ~~L~Ls~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~ 179 (330)
T 1xku_A 103 ERLYLSKNQLKEL-PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179 (330)
T ss_dssp CEEECCSSCCSBC-CSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECC
T ss_pred CEEECCCCcCCcc-Chhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECC
Confidence 9999999999854 44433 799999999999998888889999999999999999964 778899999999999999
Q ss_pred CCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecC
Q 035895 221 SNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300 (527)
Q Consensus 221 ~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 300 (527)
+|.++.+|..+. ++|+.|++++|.+.+..|..+..+++|++|++++|.+.+..+..|..+++|++|++++|+++ .+|
T Consensus 180 ~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp 256 (330)
T 1xku_A 180 DTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256 (330)
T ss_dssp SSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCC
T ss_pred CCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCC
Confidence 999999997664 78999999999999998999999999999999999999888889999999999999999998 788
Q ss_pred CCCCCCCCCCEEeCCCCcccccCccchhhh------ccCCeeEeeeeee
Q 035895 301 NSFDDLVSLESLDLSNNNLSEIIPLSLEKL------LYLNILLIVVVIL 343 (527)
Q Consensus 301 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l------~~L~~L~~~~~~~ 343 (527)
..+..+++|+.|++++|+++++.+..|... ..+..++++.+.+
T Consensus 257 ~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~ 305 (330)
T 1xku_A 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305 (330)
T ss_dssp TTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred hhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcc
Confidence 899999999999999999999888777543 5566676666554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-30 Score=273.25 Aligned_cols=305 Identities=24% Similarity=0.338 Sum_probs=180.1
Q ss_pred cccccchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc----cccceEEcccccccCCCCCCcccc
Q 035895 11 LDGGMTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS----SIVDELSLSDNYLTSSTPELSFLS 85 (527)
Q Consensus 11 ~~~~~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~----~~l~~L~Ls~N~l~~~~~~~~~~~ 85 (527)
+.+.+.......+..++ +++.+..++ .+..+++|++|+|++|.+.+..+ ..++.|++++|.++..++
T Consensus 36 ~~~~i~~~~l~~l~~L~l~~~~i~~l~--~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~------ 107 (466)
T 1o6v_A 36 VTDTVSQTDLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP------ 107 (466)
T ss_dssp TTSEECHHHHHTCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG------
T ss_pred cccccChhHhccccEEecCCCCCccCc--chhhhcCCCEEECCCCccCCchhhhccccCCEEECCCCccccChh------
Confidence 34445545566778888 778887764 37889999999999999876543 358899999999987532
Q ss_pred cCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCC
Q 035895 86 SMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQK 165 (527)
Q Consensus 86 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 165 (527)
+.++++|++|++++|++++..+ +..+ ++|++|++++|.+++.. .+..+++|++|+++ |.+.+.. .+..+++
T Consensus 108 -~~~l~~L~~L~L~~n~l~~~~~--~~~l-~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~ 178 (466)
T 1o6v_A 108 -LANLTNLTGLTLFNNQITDIDP--LKNL-TNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDLK--PLANLTT 178 (466)
T ss_dssp -GTTCTTCCEEECCSSCCCCCGG--GTTC-TTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCCG--GGTTCTT
T ss_pred -hcCCCCCCEEECCCCCCCCChH--HcCC-CCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCch--hhccCCC
Confidence 6789999999999999998643 6665 47999999999988642 35555555555554 2332221 1444555
Q ss_pred CCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCC--------------------ccccCCccCceeeCCCCCCC
Q 035895 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP--------------------TCFGNLTALRNLHLDSNELT 225 (527)
Q Consensus 166 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~l~ 225 (527)
|+.|++++|.+++. ..+..+++|+.|++++|.+++..| +.+..+++|+.|++++|.++
T Consensus 179 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~ 256 (466)
T 1o6v_A 179 LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQIS 256 (466)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred CCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccc
Confidence 55555555554422 224444445555555544443332 23444455555555555555
Q ss_pred CCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCC
Q 035895 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 305 (527)
Q Consensus 226 ~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 305 (527)
+++. +..+++|+.|++++|.+.+..+ +..+++|++|++++|++.+..| +..+++|+.|++++|++++..| +..
T Consensus 257 ~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~ 329 (466)
T 1o6v_A 257 NLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329 (466)
T ss_dssp CCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGG
T ss_pred cchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hcc
Confidence 4443 4444555555555555444322 4455555555555555544322 4555555555555555554433 445
Q ss_pred CCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeee
Q 035895 306 LVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 306 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
+++|+.|++++|.+++. ..+..++.|+.|+++.+.+
T Consensus 330 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred CccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCcc
Confidence 55555555555555543 2445555555555554444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=263.12 Aligned_cols=265 Identities=20% Similarity=0.211 Sum_probs=235.8
Q ss_pred ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCC
Q 035895 63 IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142 (527)
Q Consensus 63 ~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 142 (527)
.++.++++++.++.++..+ .++|++|++++|.+++..|..+..+. +|++|++++|.+++..|..|..+++|
T Consensus 34 ~l~~l~~~~~~l~~ip~~~--------~~~l~~L~l~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L 104 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEI--------SPDTTLLDLQNNDISELRKDDFKGLQ-HLYALVLVNNKISKIHEKAFSPLRKL 104 (332)
T ss_dssp ETTEEECCSSCCSSCCSCC--------CTTCCEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECGGGSTTCTTC
T ss_pred cCCEEECCCCCccccCCCC--------CCCCeEEECCCCcCCccCHhHhhCCC-CCcEEECCCCccCccCHhHhhCcCCC
Confidence 4789999999999876643 26899999999999998888888875 79999999999999999999999999
Q ss_pred cEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCC--CCCCccccCCccCceeeCC
Q 035895 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS--GSIPTCFGNLTALRNLHLD 220 (527)
Q Consensus 143 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~ 220 (527)
++|++++|+++.. |..+. ++|+.|++++|++++..+..|..+++|+.|++++|.++ +..|..|..+ +|+.|+++
T Consensus 105 ~~L~L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~ 180 (332)
T 2ft3_A 105 QKLYISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRIS 180 (332)
T ss_dssp CEEECCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCC
T ss_pred CEEECCCCcCCcc-Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECc
Confidence 9999999999854 44433 89999999999999877788999999999999999996 4778889988 99999999
Q ss_pred CCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecC
Q 035895 221 SNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300 (527)
Q Consensus 221 ~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 300 (527)
+|+++.+|..+. ++|+.|++++|.+.+..+..+..+++|++|++++|.+.+..|..|..+++|++|++++|+++ .+|
T Consensus 181 ~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp 257 (332)
T 2ft3_A 181 EAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257 (332)
T ss_dssp SSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCC
T ss_pred CCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecC
Confidence 999999998665 78999999999999988899999999999999999999988889999999999999999998 788
Q ss_pred CCCCCCCCCCEEeCCCCcccccCccchhhh------ccCCeeEeeeeee
Q 035895 301 NSFDDLVSLESLDLSNNNLSEIIPLSLEKL------LYLNILLIVVVIL 343 (527)
Q Consensus 301 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l------~~L~~L~~~~~~~ 343 (527)
..+..+++|+.|++++|+++++.+..+... ..++.++++.+.+
T Consensus 258 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~ 306 (332)
T 2ft3_A 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306 (332)
T ss_dssp TTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSS
T ss_pred hhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcc
Confidence 889999999999999999999888777654 4566777666554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.39 Aligned_cols=298 Identities=19% Similarity=0.195 Sum_probs=236.9
Q ss_pred cchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc---cccceEEcccccccCCCCCCcccccCCCC
Q 035895 15 MTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS---SIVDELSLSDNYLTSSTPELSFLSSMSNC 90 (527)
Q Consensus 15 ~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~---~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l 90 (527)
.....+.++..+| ++|.++++ | .|..+++|++|++++|.+.+..- ..++.|+|++|.+++++ +.++
T Consensus 36 ~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~~~~l~~L~~L~Ls~N~l~~~~--------~~~l 105 (457)
T 3bz5_A 36 ISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTNLD--------VTPL 105 (457)
T ss_dssp EEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCCSCCC--------CTTC
T ss_pred cChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEccccCCCCCEEECcCCCCceee--------cCCC
Confidence 3444577888888 88999987 3 68999999999999998876421 24789999999998741 5788
Q ss_pred CCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEe
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS 170 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 170 (527)
++|++|++++|+++++ | +..+ ++|++|++++|.+++. + +..+++|++|++++|+..+.. .+..+++|+.|+
T Consensus 106 ~~L~~L~L~~N~l~~l-~--~~~l-~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTKL-D--VSQN-PLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp TTCCEEECCSSCCSCC-C--CTTC-TTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CcCCEEECCCCcCCee-c--CCCC-CcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 9999999999999874 4 5555 4799999999999875 2 778899999999999655444 478899999999
Q ss_pred ccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCccccc
Q 035895 171 FRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGP 250 (527)
Q Consensus 171 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~ 250 (527)
+++|++++ +| +..+++|+.|++++|++++. .++.+++|++|++++|+++++| +..+++|+.|++++|.+.+.
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCc
Confidence 99999986 45 78889999999999999875 3888999999999999999988 77889999999999999887
Q ss_pred CCccccCCC-------CCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCC--------CCCCCCCCCEEeCC
Q 035895 251 LPSKIGNLK-------VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN--------SFDDLVSLESLDLS 315 (527)
Q Consensus 251 ~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--------~~~~l~~L~~L~ls 315 (527)
.+..+..++ +|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|. .+.++++|+.|+++
T Consensus 249 ~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~ 326 (457)
T 3bz5_A 249 DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLN 326 (457)
T ss_dssp CCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECT
T ss_pred CHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECC
Confidence 655555554 45666667776666665 46778889999998887666654 25566788889999
Q ss_pred CCcccccCccchhhhccCCeeEeeeeeee
Q 035895 316 NNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
+|+++++ .+..++.|+.|+++.+.+.
T Consensus 327 ~N~l~~l---~l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 327 NTELTEL---DVSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp TCCCSCC---CCTTCTTCSEEECCSSCCC
T ss_pred CCccccc---ccccCCcCcEEECCCCCCC
Confidence 9998885 3778888888888776654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=268.82 Aligned_cols=255 Identities=19% Similarity=0.229 Sum_probs=214.4
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
+++|+|++|.++.+++. .|.++++|++|++++|++++..|..+..+. +|++|++++|.+++..+..+..+++|+
T Consensus 54 L~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 127 (353)
T 2z80_A 54 VKSLDLSNNRITYISNS-----DLQRCVNLQALVLTSNGINTIEEDSFSSLG-SLEHLDLSYNYLSNLSSSWFKPLSSLT 127 (353)
T ss_dssp CCEEECTTSCCCEECTT-----TTTTCTTCCEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCSSCCHHHHTTCTTCS
T ss_pred CcEEECCCCcCcccCHH-----HhccCCCCCEEECCCCccCccCHhhcCCCC-CCCEEECCCCcCCcCCHhHhCCCccCC
Confidence 44555555555544332 477889999999999999998888888775 799999999999987777799999999
Q ss_pred EEEeecCcccccCc-ccccCCCCCCEEeccCc-ccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCC
Q 035895 144 SIDLGGNKLNGSIS-ITLGKLQKLQFLSFRGN-ELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDS 221 (527)
Q Consensus 144 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 221 (527)
+|++++|++++..+ ..+..+++|+.|++++| .+....+..|..+++|+.|++++|++++..|..|..+++|++|++++
T Consensus 128 ~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~ 207 (353)
T 2z80_A 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207 (353)
T ss_dssp EEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEEC
T ss_pred EEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCC
Confidence 99999999996655 57899999999999999 57766778899999999999999999998899999999999999999
Q ss_pred CCCCCCchhhh-CCCCccEEEccCCcccccCCcccc---CCCCCCEEEccCCCCCC----CChhhhhcCCCCCEEEcccc
Q 035895 222 NELTSIPSILW-NLKDILYLDFWSNLFVGPLPSKIG---NLKVLTRIDFSRNNLLG----DIPTTIQGLKSLQFLSLGHN 293 (527)
Q Consensus 222 N~l~~lp~~~~-~l~~L~~l~l~~n~~~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N 293 (527)
|+++.+|..+. .+++|+.|++++|.+.+..+..+. ....++.++++++.+.+ .+|..+..+++|++|++++|
T Consensus 208 n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N 287 (353)
T 2z80_A 208 KQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287 (353)
T ss_dssp SCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSS
T ss_pred CccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCC
Confidence 99999887654 588999999999999876655443 46678899999998876 46888999999999999999
Q ss_pred cceeecCCCCCCCCCCCEEeCCCCcccccCc
Q 035895 294 RLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 294 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
+++...+..|..+++|+.|++++|++.+..|
T Consensus 288 ~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 288 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 9995444457999999999999999987654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=269.52 Aligned_cols=248 Identities=22% Similarity=0.223 Sum_probs=204.2
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
...++.+++.++.++..++ ++|++|+|++|++++..|..|..+. +|+.|+|++|.+++..+..|..+++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--------~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 126 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--------SNTRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLASLN 126 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--------TTCSEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CcEEEECCCCcCccCCCCC--------CCccEEECcCCcCceECHHHcCCCC-CCCEEECCCCccCCcChhhccCcccCC
Confidence 3467777777777665432 5788899999998888788887765 799999999988888888888899999
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec-ccCCCCCCccccCCccCceeeCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG-NKLSGSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N 222 (527)
+|+|++|++++..+..|..+++|+.|++++|.++...+..|..+++|+.|++++ |.+....+..|.++++|++|++++|
T Consensus 127 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n 206 (452)
T 3zyi_A 127 TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206 (452)
T ss_dssp EEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCC
Confidence 999999998887777788889999999999988877777888889999999988 5565555567888899999999999
Q ss_pred CCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCC
Q 035895 223 ELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS 302 (527)
Q Consensus 223 ~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 302 (527)
+++.+|. +..+++|+.|++++|.+.+..|..|..+++|++|++++|++.+..|..|.++++|+.|+|++|++++..+..
T Consensus 207 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 285 (452)
T 3zyi_A 207 NIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285 (452)
T ss_dssp CCSSCCC-CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTS
T ss_pred ccccccc-ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHH
Confidence 9888864 667788888888888888888888888888888888888888878888888888888888888888777777
Q ss_pred CCCCCCCCEEeCCCCcccc
Q 035895 303 FDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 303 ~~~l~~L~~L~ls~N~l~~ 321 (527)
|..+++|+.|+|++|++.-
T Consensus 286 ~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 286 FTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp STTCTTCCEEECCSSCEEC
T ss_pred hccccCCCEEEccCCCcCC
Confidence 8888888888888887753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=268.09 Aligned_cols=247 Identities=23% Similarity=0.237 Sum_probs=202.9
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
...++.+++.++.++..++ ++++.|+|++|++++..+..|..+. +|+.|+|++|.++.+.+..|.++++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~--------~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~i~~~~~~~l~~L~ 115 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS--------TNTRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIRTIEIGAFNGLANLN 115 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC--------TTCSEEECCSCCCCEECTTTTSSCS-SCCEEECCSSCCCEECGGGGTTCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCC--------CCCcEEEccCCcCCeeCHHHhhCCC-CCCEEECCCCcCCccChhhccCCccCC
Confidence 3466777777777665432 5788889999988887777777764 788999999988888888888899999
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec-ccCCCCCCccccCCccCceeeCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG-NKLSGSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N 222 (527)
+|+|++|++++..+..|..+++|+.|++++|.++...+..|..+++|+.|++++ |.+....+..|.++++|++|++++|
T Consensus 116 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n 195 (440)
T 3zyj_A 116 TLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195 (440)
T ss_dssp EEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTS
T ss_pred EEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCC
Confidence 999999998877777888889999999999988877777888889999999988 4555555567888999999999999
Q ss_pred CCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCC
Q 035895 223 ELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS 302 (527)
Q Consensus 223 ~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 302 (527)
+++.+|. +..+++|+.|++++|.+.+..|..|..+++|++|++++|++.+..|..|.++++|++|+|++|++++..+..
T Consensus 196 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 274 (440)
T 3zyj_A 196 NLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274 (440)
T ss_dssp CCSSCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cCccccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhH
Confidence 9988874 667788888888888888887888888888888888888888877888888888888888888888777777
Q ss_pred CCCCCCCCEEeCCCCccc
Q 035895 303 FDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 303 ~~~l~~L~~L~ls~N~l~ 320 (527)
|..+++|+.|+|++|++.
T Consensus 275 ~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 275 FTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TSSCTTCCEEECCSSCEE
T ss_pred hccccCCCEEEcCCCCcc
Confidence 888888888888888875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-30 Score=277.25 Aligned_cols=332 Identities=23% Similarity=0.236 Sum_probs=261.0
Q ss_pred cCCCccccccchhhhcchhccc-CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCC
Q 035895 6 LNNRQLDGGMTGDVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSST 78 (527)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~ 78 (527)
|+.+.+..+.+. .+.+++.+| ++|+|+++++.+|.+|++|++|+|++|.+.+..+. .++.|+|++|+|++++
T Consensus 62 N~i~~l~~~~f~-~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~ 140 (635)
T 4g8a_A 62 NPLRHLGSYSFF-SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 140 (635)
T ss_dssp SCCCEECTTTTT-TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCST
T ss_pred CCCCCCCHHHHh-CCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCC
Confidence 333444443332 367899999 99999999999999999999999999998765543 4789999999999876
Q ss_pred CCCcccccCCCCCCCCEEEcccCCCCcc-cChhHhhccccccEEEcccCccccccchhhcCCc-----------------
Q 035895 79 PELSFLSSMSNCKYLKKLDISRNPLDGF-LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLT----------------- 140 (527)
Q Consensus 79 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~----------------- 140 (527)
+. .|+++++|++|++++|++++. .|..+..+. .|+.|++++|.+++..+..+..+.
T Consensus 141 ~~-----~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~ 214 (635)
T 4g8a_A 141 NF-----PIGHLKTLKELNVAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 214 (635)
T ss_dssp TC-----CCTTCTTCCEEECCSSCCCCCCCCGGGGGCT-TCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC
T ss_pred hh-----hhhcCcccCeeccccCccccCCCchhhccch-hhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc
Confidence 53 478899999999999999764 466666664 799999999988766554443222
Q ss_pred --------------------------------------------------------------------------------
Q 035895 141 -------------------------------------------------------------------------------- 140 (527)
Q Consensus 141 -------------------------------------------------------------------------------- 140 (527)
T Consensus 215 ~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~ 294 (635)
T 4g8a_A 215 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 294 (635)
T ss_dssp EECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSC
T ss_pred ccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhccc
Confidence
Q ss_pred ----------------------------------CCcEEEeecCcccccCc-------------------ccccCCCCCC
Q 035895 141 ----------------------------------DLISIDLGGNKLNGSIS-------------------ITLGKLQKLQ 167 (527)
Q Consensus 141 ----------------------------------~L~~L~L~~N~l~~~~~-------------------~~~~~l~~L~ 167 (527)
.|+.|++.+|.+....+ .....+++|+
T Consensus 295 ~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~ 374 (635)
T 4g8a_A 295 LDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE 374 (635)
T ss_dssp EEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCC
T ss_pred ccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccc
Confidence 12233333333221111 1122456778
Q ss_pred EEeccCcccccc-------------------------cChhhhcCcccCeeeeecccCCCCCC-ccccCCccCceeeCCC
Q 035895 168 FLSFRGNELEGS-------------------------IPNVLCHLAVLFQLDLRGNKLSGSIP-TCFGNLTALRNLHLDS 221 (527)
Q Consensus 168 ~L~l~~N~l~~~-------------------------~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~ 221 (527)
.|+++.|.+... .+..+..+++|+.++++.|......+ ..|..+++++.++++.
T Consensus 375 ~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~ 454 (635)
T 4g8a_A 375 FLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 454 (635)
T ss_dssp EEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTT
T ss_pred cchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccc
Confidence 888888776421 23346677889999999888766544 5689999999999999
Q ss_pred CCCCCC-chhhhCCCCccEEEccCCccc-ccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeec
Q 035895 222 NELTSI-PSILWNLKDILYLDFWSNLFV-GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI 299 (527)
Q Consensus 222 N~l~~l-p~~~~~l~~L~~l~l~~n~~~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 299 (527)
|.+..+ |..+..++.++.|++++|... +..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..
T Consensus 455 n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~ 534 (635)
T 4g8a_A 455 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 534 (635)
T ss_dssp SCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred cccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCC
Confidence 999986 456677899999999999854 567889999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCEEeCCCCcccccCccchhhh-ccCCeeEeeeeeee
Q 035895 300 PNSFDDLVSLESLDLSNNNLSEIIPLSLEKL-LYLNILLIVVVILA 344 (527)
Q Consensus 300 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l-~~L~~L~~~~~~~~ 344 (527)
|..|..+++|++|||++|++++++|..+..+ .+|+.|+++.+.+.
T Consensus 535 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 535 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred hhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 9999999999999999999999999999988 68999999887764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=261.89 Aligned_cols=141 Identities=28% Similarity=0.464 Sum_probs=114.1
Q ss_pred hhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec------------------------------cCccceeEEEE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------CSNEDFRALVL 431 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ 431 (527)
...++|++.+.||+|+||+||+|+++. .||||+++.. +..++..++||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVm 110 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVT 110 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEE
Confidence 345678889999999999999999764 6999987421 11235578999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|||+||+|.+++...+..+++.++..|+.|||.||+||| +++||||||||+|||+++++.+||+|||+|+.......
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999877777999999999999999999999 89999999999999999999999999999997654333
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
....+..+||+.||||
T Consensus 188 ~~~~~~~~GT~~ymAP 203 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAP 203 (307)
T ss_dssp ------CCCCTTSCCH
T ss_pred ceeecccccCCCccCH
Confidence 2233456799999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=260.95 Aligned_cols=140 Identities=32% Similarity=0.520 Sum_probs=120.1
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||++.. ...+++..++|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999985 5799999999852 12345677899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||||+||+|.+++.+.+ .++..++..|+.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999997653 5788899999999999999999 9999999999999999999999999999999875443
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
........+||+.||||
T Consensus 187 ~~~~~~~~~GTp~YmAP 203 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSP 203 (311)
T ss_dssp TCCCBCCCCSCGGGCCH
T ss_pred CcccccCcccCcccCCH
Confidence 33333456899999998
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=258.13 Aligned_cols=225 Identities=20% Similarity=0.278 Sum_probs=140.5
Q ss_pred CCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEe
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS 170 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 170 (527)
+.++.|+|++|.++. +|..+..+. +|++|+|++|.++ .+|..+..+++|++|+|++|+++ .+|..++.+++|++|+
T Consensus 81 ~~l~~L~L~~n~l~~-lp~~l~~l~-~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 81 PGRVALELRSVPLPQ-FPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TTCCEEEEESSCCSS-CCSCGGGGT-TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cceeEEEccCCCchh-cChhhhhCC-CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 456666666666663 344444443 5666666666666 55556666666666666666666 4455566666666666
Q ss_pred ccCcccccccChhhhc---------CcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEE
Q 035895 171 FRGNELEGSIPNVLCH---------LAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLD 241 (527)
Q Consensus 171 l~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~ 241 (527)
+++|++.+.+|..+.. +++|++|++++|+++ .+|..++.+++|++|++++|+++++|..+..+++|++|+
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELD 235 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEE
Confidence 6666555555554433 666666666666666 455666666666666666666666666666666666666
Q ss_pred ccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc
Q 035895 242 FWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 242 l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 320 (527)
+++|.+.+.+|..++.+++|++|++++|++.+.+|..+..+++|++|++++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 6666666666666666666666666666666666666666666666666666666666666666666666666655443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=253.32 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=190.5
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccc--cchhhcCCcCCc
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGG--ISEEIGNLTDLI 143 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~--~~~~~~~l~~L~ 143 (527)
.++.+++.++.++..+ .++|++|++++|+++.+.+..+..+. +|++|+|++|.++.. .+..+..+++|+
T Consensus 11 ~l~c~~~~l~~ip~~~--------~~~l~~L~L~~n~l~~i~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 81 (306)
T 2z66_A 11 EIRCNSKGLTSVPTGI--------PSSATRLELESNKLQSLPHGVFDKLT-QLTKLSLSSNGLSFKGCCSQSDFGTTSLK 81 (306)
T ss_dssp EEECCSSCCSSCCSCC--------CTTCCEEECCSSCCCCCCTTTTTTCT-TCSEEECCSSCCCEEEEEEHHHHSCSCCC
T ss_pred EEEcCCCCcccCCCCC--------CCCCCEEECCCCccCccCHhHhhccc-cCCEEECCCCccCcccCcccccccccccC
Confidence 4555666666554432 14677777777777754444455543 677777777777633 256666777788
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccC-hhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 222 (527)
+|++++|.+++ ++..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+.+..|..|..+++|++|++++|
T Consensus 82 ~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 82 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp EEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred EEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 88888887774 44557778888888888888775544 56777888888888888887777777888888888888888
Q ss_pred CCCC--CchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecC
Q 035895 223 ELTS--IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 300 (527)
Q Consensus 223 ~l~~--lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 300 (527)
.+++ +|..+..+++|++|++++|.+.+..|..+..+++|++|++++|.+++..+..|..+++|++|++++|++++..|
T Consensus 161 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred ccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence 8775 67777778888888888888887778889999999999999999998878889999999999999999999999
Q ss_pred CCCCCCC-CCCEEeCCCCcccccC
Q 035895 301 NSFDDLV-SLESLDLSNNNLSEII 323 (527)
Q Consensus 301 ~~~~~l~-~L~~L~ls~N~l~~~~ 323 (527)
..+..++ +|+.|++++|+++...
T Consensus 241 ~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 241 QELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp SSCCCCCTTCCEEECTTCCEECSG
T ss_pred HHHHhhhccCCEEEccCCCeeccc
Confidence 9999985 9999999999998653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-30 Score=254.51 Aligned_cols=223 Identities=20% Similarity=0.277 Sum_probs=209.0
Q ss_pred ccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeee
Q 035895 116 QSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDL 195 (527)
Q Consensus 116 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 195 (527)
..++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..++.+++|++|++++|.++ .+|..|..+++|++|++
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 47999999999998 66777888999999999999999 77888999999999999999999 78999999999999999
Q ss_pred ecccCCCCCCccccC---------CccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEc
Q 035895 196 RGNKLSGSIPTCFGN---------LTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDF 266 (527)
Q Consensus 196 ~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~L 266 (527)
++|.+.+.+|..+.. +++|++|++++|+++.+|..+..+++|++|++++|.+.+ +|..++.+++|++|++
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence 999999899987765 999999999999999999999999999999999999985 6778999999999999
Q ss_pred cCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeee
Q 035895 267 SRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVI 342 (527)
Q Consensus 267 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~ 342 (527)
++|++.+.+|..|.++++|++|++++|++.+.+|..|..+++|+.|++++|++.+.+|..+..++.++.+.+....
T Consensus 237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999988766443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=258.82 Aligned_cols=140 Identities=28% Similarity=0.460 Sum_probs=115.5
Q ss_pred CCccccceeccCCceEEEEEEcc------CCcEEEEEEEee-----------------------------ccCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF-----------------------------SCSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~-----------------------------~~~~~~~~~l 429 (527)
++|.+.+.||+|+||+||+|++. +++.||||+++. .|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888899999999999999863 478899999742 2445667899
Q ss_pred EEEeccCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 035895 430 VLEYTTNGSLEKVLYSSN------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl 497 (527)
|||||++|+|.++++..+ ..++|.++..|+.|||+||+||| +++||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 35899999999999999999999 899999999999999999999999
Q ss_pred eecccccccCCCCCccceeccccccccccC
Q 035895 498 SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 498 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|||+|+...............||++||||
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAP 199 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 199 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred CCcccceecCCCCceeecCceecChhhcCH
Confidence 999999976543322222335689999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=258.07 Aligned_cols=140 Identities=24% Similarity=0.410 Sum_probs=116.6
Q ss_pred CCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccCccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCSNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~~~~~~~ 428 (527)
+++++.+.||+|+||+||+|++. +++.||||+++. .|..++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 44677899999999999999862 568899999742 234456678
Q ss_pred EEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 035895 429 LVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI 493 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~ 493 (527)
+|||||++|+|.++|.... ..++|.++..|+.|||+||+||| +++||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 9999999999999996432 35889999999999999999999 99999999999999999999
Q ss_pred cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 494 VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+||+|||+|+.+.........+...||++||||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 216 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCH
Confidence 9999999999977544333333456789999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-31 Score=259.26 Aligned_cols=140 Identities=27% Similarity=0.438 Sum_probs=109.2
Q ss_pred CCccccceeccCCceEEEEEEcc------CCcEEEEEEEee-----------------------------ccCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF-----------------------------SCSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~-----------------------------~~~~~~~~~l 429 (527)
++|.+.+.||+|+||+||+|+++ +++.||||+++. .|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45778899999999999999864 578999999742 2455667899
Q ss_pred EEEeccCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 035895 430 VLEYTTNGSLEKVLYSSN--------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~ 495 (527)
|||||++|+|.++++..+ ..++|.+++.|+.|||.||+||| +++||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 999999999999997542 34889999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCccceeccccccccccC
Q 035895 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 496 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+|||+|+.+.........+...||+.||||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP 229 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 229 (329)
T ss_dssp EECCCC----------------CCCCGGGCCH
T ss_pred EEcccccceeccCCCcceecCcccccccccCh
Confidence 99999999977544333334456789999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=260.40 Aligned_cols=140 Identities=26% Similarity=0.442 Sum_probs=112.7
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALV 430 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv 430 (527)
..+.|++.+.||+|+||+||+|+. .+|+.||||++... +.+++..++|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 457899999999999999999986 57999999998531 2344577899
Q ss_pred EEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 431 LEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+||+|.+++...+ ..+++.+...|+.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999997544 45688888999999999999999 999999999999999999999999999999976432
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
. ...+..+||+.||||
T Consensus 179 ~--~~~~~~~GT~~YmAP 194 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSP 194 (350)
T ss_dssp H--HHHHHHHSCCTTCCH
T ss_pred c--ccccccCCCccccCH
Confidence 1 122345799999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=256.29 Aligned_cols=141 Identities=28% Similarity=0.392 Sum_probs=115.6
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee------------------------ccCccceeEEEEEeccCC
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF------------------------SCSNEDFRALVLEYTTNG 437 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~------------------------~~~~~~~~~lv~ey~~~g 437 (527)
..+.|+..++||+|+||+||+|+. .+|+.||||+++. .+.+++..++|||||+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 345688889999999999999986 5799999999853 123456778999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCCCc---c
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTGEDQS---M 513 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~~~~~---~ 513 (527)
+|.+++...+ .+++.++..|+.||+.||+||| +++||||||||+|||++.++ ++||+|||+|+.+...... .
T Consensus 136 ~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 136 SLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp BHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 9999997654 5899999999999999999999 99999999999999999887 6999999999987543211 1
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....+||+.||||
T Consensus 212 ~~~~~~GT~~YmAP 225 (336)
T 4g3f_A 212 TGDYIPGTETHMAP 225 (336)
T ss_dssp --CCCCCCGGGCCH
T ss_pred cCCccccCccccCH
Confidence 22235799999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=256.71 Aligned_cols=136 Identities=26% Similarity=0.339 Sum_probs=117.2
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
+.|+..+.||+|+||+||+|+. .+|+.||||++... +..++..++|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4599999999999999999986 57999999998531 23456778999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+||+|.+++.+. .+++.++..|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 226 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence 999999999753 5789999999999999999999 99999999999999999999999999999998754322 2
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.+..+||++||||
T Consensus 227 ~~~~~GTp~YmAP 239 (346)
T 4fih_A 227 RKSLVGTPYWMAP 239 (346)
T ss_dssp BCCCCSCGGGCCH
T ss_pred ccccccCcCcCCH
Confidence 2346899999998
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-29 Score=257.64 Aligned_cols=255 Identities=29% Similarity=0.392 Sum_probs=161.1
Q ss_pred cchhccc-CCCceeecCchhhhcCCCCCEEEcccccccc--ccccccceEEcccccccCCCCCCcccccCCCCCCCCEEE
Q 035895 21 YRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLG--RLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLD 97 (527)
Q Consensus 21 ~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~--~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~ 97 (527)
..+..++ ++|+++++++ .+++|+.|++++|.+.+ ..+..++.|++++|.+++++ .+.++++|++|+
T Consensus 91 ~~L~~L~l~~n~l~~lp~----~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~lp-------~~~~l~~L~~L~ 159 (454)
T 1jl5_A 91 PHLESLVASCNSLTELPE----LPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP-------ELQNSSFLKIID 159 (454)
T ss_dssp TTCSEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSSCC-------CCTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCcccc----ccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCCCc-------ccCCCCCCCEEE
Confidence 3555666 6666666432 23667777777777654 23345777777777776533 367788888888
Q ss_pred cccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccc
Q 035895 98 ISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE 177 (527)
Q Consensus 98 Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 177 (527)
+++|++++ +|..+ .+|++|++++|.+++ +| .+..+++|++|++++|++++. |.. .++|+.|++++|.++
T Consensus 160 l~~N~l~~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 160 VDNNSLKK-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILE 228 (454)
T ss_dssp CCSSCCSC-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCS
T ss_pred CCCCcCcc-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECcCCcCC
Confidence 88888876 44432 368888888888876 44 578888888888888888753 322 257888888888887
Q ss_pred cccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccc--cCCccc
Q 035895 178 GSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVG--PLPSKI 255 (527)
Q Consensus 178 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~--~~p~~~ 255 (527)
.+|. +..+++|+.|++++|++++ +|.. +++|+.|++++|+++++|.. .++|+.|++++|.+.+ .+|
T Consensus 229 -~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~~~---~~~L~~L~ls~N~l~~l~~~~--- 296 (454)
T 1jl5_A 229 -ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSGLSELP--- 296 (454)
T ss_dssp -SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSEESCCC---
T ss_pred -cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccCcc---cCcCCEEECcCCccCcccCcC---
Confidence 5563 7788888888888888875 3432 36788888888888877753 3567777777777665 222
Q ss_pred cCCCCCCEEEccCCCCCCCChhhhhcC-CCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccc
Q 035895 256 GNLKVLTRIDFSRNNLLGDIPTTIQGL-KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 256 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 321 (527)
++|++|++++|++.+ ++ .+ ++|++|++++|++++ +|.. +++|+.|++++|++++
T Consensus 297 ---~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~ 351 (454)
T 1jl5_A 297 ---PNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE 351 (454)
T ss_dssp ---TTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred ---CcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc
Confidence 334444444444432 11 11 244555555555543 3322 2444555555555543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=259.29 Aligned_cols=285 Identities=20% Similarity=0.183 Sum_probs=236.7
Q ss_pred CceeecCchhhhcCCCCCEEEccccccccccc----cccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCc
Q 035895 30 NKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS----SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDG 105 (527)
Q Consensus 30 N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~----~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 105 (527)
....+..+..+.++++|++|++++|.+.+... ..++.|+|++|.+++++ +..+++|++|++++|++++
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~--------~~~l~~L~~L~Ls~N~l~~ 99 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTLD--------LSQNTNLTYLACDSNKLTN 99 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCCCTTGGGCTTCSEEECCSSCCSCCC--------CTTCTTCSEEECCSSCCSC
T ss_pred cCcCcccccChhHcCCCCEEEccCCCcccChhhcccCCCCEEEccCCcCCeEc--------cccCCCCCEEECcCCCCce
Confidence 34566677789999999999999999876421 24889999999998752 5788999999999999998
Q ss_pred ccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhh
Q 035895 106 FLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC 185 (527)
Q Consensus 106 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 185 (527)
. | +..+. +|++|++++|.+++. | +..+++|++|++++|++++. .++.+++|+.|++++|...+.+ .+.
T Consensus 100 ~-~--~~~l~-~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~ 167 (457)
T 3bz5_A 100 L-D--VTPLT-KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVT 167 (457)
T ss_dssp C-C--CTTCT-TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCT
T ss_pred e-e--cCCCC-cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccc
Confidence 5 3 56654 799999999999975 3 88999999999999999974 3889999999999999655555 478
Q ss_pred cCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEE
Q 035895 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRID 265 (527)
Q Consensus 186 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~ 265 (527)
.+++|+.|++++|++++. | ++.+++|+.|++++|++++++ +..+++|+.|++++|++.+ +| ++.+++|++|+
T Consensus 168 ~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~~--l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~ 239 (457)
T 3bz5_A 168 PQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239 (457)
T ss_dssp TCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEE
T ss_pred cCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCeec--cccCCCCCEEECcCCcccc-cC--ccccCCCCEEE
Confidence 899999999999999974 4 889999999999999999985 7889999999999999998 56 88999999999
Q ss_pred ccCCCCCCCChhhhhcCC-------CCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccc--------hhhh
Q 035895 266 FSRNNLLGDIPTTIQGLK-------SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS--------LEKL 330 (527)
Q Consensus 266 Ls~N~l~~~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~--------~~~l 330 (527)
+++|++++..+..+..++ +|+.|++++|.+.+.+| +..+++|+.|++++|.+.+.+|.. +..+
T Consensus 240 l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~ 317 (457)
T 3bz5_A 240 CSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQN 317 (457)
T ss_dssp CCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTC
T ss_pred eeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhc
Confidence 999999987766666555 56777777887777776 578899999999999987777653 3444
Q ss_pred ccCCeeEeeeeeee
Q 035895 331 LYLNILLIVVVILA 344 (527)
Q Consensus 331 ~~L~~L~~~~~~~~ 344 (527)
+.|+.|+++.+.+.
T Consensus 318 ~~L~~L~L~~N~l~ 331 (457)
T 3bz5_A 318 PKLVYLYLNNTELT 331 (457)
T ss_dssp TTCCEEECTTCCCS
T ss_pred ccCCEEECCCCccc
Confidence 56666666655553
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=247.12 Aligned_cols=205 Identities=22% Similarity=0.259 Sum_probs=126.3
Q ss_pred CCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCc-ccccCcccccCCCCCCEE
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNK-LNGSISITLGKLQKLQFL 169 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L 169 (527)
++|++|++++|++++..+..+..+. +|++|++++|.+++..|..|..+++|++|++++|+ ++...+..+..+++|+.|
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCC-CCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 4566677777766665555555543 56666666666666666666666666677776665 555556666666666666
Q ss_pred eccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchh-hhCCCCccEEEccCCccc
Q 035895 170 SFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI-LWNLKDILYLDFWSNLFV 248 (527)
Q Consensus 170 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~l~l~~n~~~ 248 (527)
++++|.+++..|..|..+++|++|++++|++++..+..|+.+++|++|++++|+++.+|.. +..+++|+.|++++|.+.
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 6666666665566666666666666666666665555666666666666666666665542 444555555555555555
Q ss_pred ccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccce
Q 035895 249 GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 249 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 296 (527)
+..|..+..+++|++|++++|.+.+..+..|..+++|++|++++|++.
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 555555555555555555555555544445555555555555555554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=252.24 Aligned_cols=140 Identities=26% Similarity=0.421 Sum_probs=111.7
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCcc----ceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNE----DFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~----~~~~lv~e 432 (527)
++|.+.+.||+|+||+||+|++ +|+.||||++... |..+ ...++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 3477889999999999999997 5899999997421 1111 24689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG-----YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~-----~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
||++|+|.++++.. .++|.++.+++.|+++||+|+|.. +.++||||||||+|||+++++++||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999764 578999999999999999999932 23499999999999999999999999999999875
Q ss_pred CCCCc--cceeccccccccccC
Q 035895 508 GEDQS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~--~~~~~~~~t~~y~aP 527 (527)
..... ......+||++||||
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAP 181 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp TTTTEESCC-----CCGGGCCH
T ss_pred CCCCceeeecccccccccccCH
Confidence 43322 122245799999998
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=257.54 Aligned_cols=247 Identities=23% Similarity=0.254 Sum_probs=226.7
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEec
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
....++.+++.++. +|..+ ..+++.|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 55 ~~~~v~c~~~~l~~-iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLSE-VPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCSS-CCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcCc-cCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 46789999999986 45543 358999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCC-CCCCCCch-hhhCCCCccEEEccCCcccc
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDS-NELTSIPS-ILWNLKDILYLDFWSNLFVG 249 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~lp~-~~~~l~~L~~l~l~~n~~~~ 249 (527)
++|++++..+..|..+++|++|+|++|+++...+..|.++++|+.|++++ |.+..+|. .+..+++|++|++++|.+.+
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 99999987788899999999999999999988888999999999999999 66777775 57789999999999999986
Q ss_pred cCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhh
Q 035895 250 PLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 329 (527)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 329 (527)
. | .+..+++|++|+|++|.+.+..|..|.++++|+.|++++|++++..|..|.++++|+.|+|++|+++++++..+..
T Consensus 211 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 211 M-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp C-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred c-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 4 4 5889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCeeEeeeeeee
Q 035895 330 LLYLNILLIVVVILA 344 (527)
Q Consensus 330 l~~L~~L~~~~~~~~ 344 (527)
++.|+.|+++.+.+.
T Consensus 289 l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 289 LRYLVELHLHHNPWN 303 (452)
T ss_dssp CTTCCEEECCSSCEE
T ss_pred ccCCCEEEccCCCcC
Confidence 999999999987764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=252.40 Aligned_cols=137 Identities=29% Similarity=0.426 Sum_probs=114.0
Q ss_pred CCccccceeccCCceEEEEEEc----cCCcEEEEEEEeec-------------------------------cCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL----QDGMEFAIKVFHFS-------------------------------CSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~-------------------------------~~~~~~~~l 429 (527)
++|++.+.||+|+||+||+|+. .+++.||||+++.. +.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5699999999999999999985 25789999987421 223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
|||||+||+|.+++.+.+ .+++.++..++.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999997654 5788899999999999999999 999999999999999999999999999999876433
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .....+||+.||||
T Consensus 180 ~~--~~~~~~GT~~YmAP 195 (304)
T 3ubd_A 180 EK--KAYSFCGTVEYMAP 195 (304)
T ss_dssp -C--CCCSCCCCGGGCCH
T ss_pred Cc--cccccccCcccCCH
Confidence 22 22346799999998
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=250.81 Aligned_cols=277 Identities=19% Similarity=0.223 Sum_probs=223.2
Q ss_pred EEEcccccccc---ccccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcc--cChhHhhccccccEEE
Q 035895 48 VFDVDNNYVLG---RLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGF--LPRVVGNFSQSLEFIW 122 (527)
Q Consensus 48 ~L~Ls~N~~~~---~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~~~~~L~~L~ 122 (527)
.++.+++.+.. .++..++.|+|++|.++.++.. .|.++++|++|++++|+++.. .+..+..+ ++|++|+
T Consensus 11 ~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~-~~L~~L~ 84 (306)
T 2z66_A 11 EIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHG-----VFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT-TSLKYLD 84 (306)
T ss_dssp EEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTT-----TTTTCTTCSEEECCSSCCCEEEEEEHHHHSC-SCCCEEE
T ss_pred EEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHh-----HhhccccCCEEECCCCccCcccCcccccccc-cccCEEE
Confidence 45555555432 2234577888888888766553 468899999999999999853 35666665 4799999
Q ss_pred cccCccccccchhhcCCcCCcEEEeecCcccccCc-ccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCC
Q 035895 123 MSDCNISGGISEEIGNLTDLISIDLGGNKLNGSIS-ITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201 (527)
Q Consensus 123 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 201 (527)
+++|.++. +|..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+.+..|..|..+++|++|++++|.++
T Consensus 85 Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 85 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 99999985 56668999999999999999987665 57899999999999999999888899999999999999999998
Q ss_pred C-CCCccccCCccCceeeCCCCCCCCC-chhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhh
Q 035895 202 G-SIPTCFGNLTALRNLHLDSNELTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI 279 (527)
Q Consensus 202 ~-~~p~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 279 (527)
+ ..|..|..+++|++|++++|+++++ |..+..+++|+.|++++|.+.+..+..+..+++|++|++++|++.+..|..+
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 6 6788999999999999999999997 6678889999999999999998888889999999999999999999999999
Q ss_pred hcCC-CCCEEEcccccceeecCC--CCCCCCCCCEEeCCCCcccccCccchhhhc
Q 035895 280 QGLK-SLQFLSLGHNRLQGSIPN--SFDDLVSLESLDLSNNNLSEIIPLSLEKLL 331 (527)
Q Consensus 280 ~~l~-~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 331 (527)
..++ +|++|++++|.+++.-+. ...-+...+.+.+..+.+....|..+++..
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~~ 298 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 298 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTCB
T ss_pred HhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCce
Confidence 9984 999999999999753210 011122344445556666666666655443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=258.71 Aligned_cols=136 Identities=27% Similarity=0.345 Sum_probs=117.2
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey~ 434 (527)
+.|+..+.||+|+||+||+|+. .+|+.||||++.. .+..++..++|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4599999999999999999986 5799999999853 123456778999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+||+|.+++... .+++.++..|+.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 303 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence 999999998653 4788899999999999999999 99999999999999999999999999999998754322 2
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.+..+||++||||
T Consensus 304 ~~~~~GTp~YmAP 316 (423)
T 4fie_A 304 RKSLVGTPYWMAP 316 (423)
T ss_dssp BCCCEECTTTCCH
T ss_pred ccccccCcCcCCH
Confidence 2346899999998
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-30 Score=257.23 Aligned_cols=271 Identities=18% Similarity=0.188 Sum_probs=230.2
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEE
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 145 (527)
..++++|.++.++..+ .++|++|++++|++++..+..+..+. +|+.|++++|.+++..+..|..+++|++|
T Consensus 35 ~c~~~~~~l~~iP~~~--------~~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 35 ICKGSSGSLNSIPSGL--------TEAVKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp EEECCSTTCSSCCTTC--------CTTCCEEECTTSCCCEECTTTTTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred EeeCCCCCcccccccc--------cccCcEEECCCCcCcccCHHHhccCC-CCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 4788888888876643 25899999999999987776787775 79999999999999889999999999999
Q ss_pred EeecCcccccCcccccCCCCCCEEeccCcccccccC-hhhhcCcccCeeeeecc-cCCCCCCccccCCccCceeeCCCCC
Q 035895 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGN-KLSGSIPTCFGNLTALRNLHLDSNE 223 (527)
Q Consensus 146 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~ 223 (527)
++++|++++..+..++.+++|++|++++|++++..+ ..|..+++|++|++++| .+....|..|+++++|++|++++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 999999998777779999999999999999985444 47899999999999999 5777778899999999999999999
Q ss_pred CCCC-chhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhh---hcCCCCCEEEccccccee--
Q 035895 224 LTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI---QGLKSLQFLSLGHNRLQG-- 297 (527)
Q Consensus 224 l~~l-p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~-- 297 (527)
++++ |..+..+++|++|++++|.+....+..+..+++|++|++++|.+++..+..+ .....++.++++++.+++
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~ 265 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHH
T ss_pred cCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcc
Confidence 9986 7788899999999999999865444445668999999999999987665544 346778889999988875
Q ss_pred --ecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeeec
Q 035895 298 --SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILAL 345 (527)
Q Consensus 298 --~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~~ 345 (527)
.+|..+..+++|+.|++++|+++.+++..+..++.|+.|+++.+.+..
T Consensus 266 l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 266 LFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp HHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred hhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence 367778899999999999999997666667999999999999887643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=254.48 Aligned_cols=247 Identities=23% Similarity=0.260 Sum_probs=226.3
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEec
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
..+.++.+++.++. +|..+ ..+++.|+|++|+++...+..|..+++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 44 ~~~~v~c~~~~l~~-iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLRE-VPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCSS-CCSCC---CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcCc-CCCCC---CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 46789999999986 45543 357999999999999999999999999999999999999988899999999999999
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCC-CCCCCCch-hhhCCCCccEEEccCCcccc
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDS-NELTSIPS-ILWNLKDILYLDFWSNLFVG 249 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~lp~-~~~~l~~L~~l~l~~n~~~~ 249 (527)
++|+++...+..|..+++|++|+|++|+++...+..|.++++|++|++++ |.+..+|. .+.++++|++|++++|.+..
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 199 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence 99999977777899999999999999999988888999999999999999 55666765 57889999999999999884
Q ss_pred cCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhh
Q 035895 250 PLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 329 (527)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 329 (527)
+| .+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+++++.+..+..
T Consensus 200 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 277 (440)
T 3zyj_A 200 -IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277 (440)
T ss_dssp -CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred -cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence 44 4889999999999999999988999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCeeEeeeeeee
Q 035895 330 LLYLNILLIVVVILA 344 (527)
Q Consensus 330 l~~L~~L~~~~~~~~ 344 (527)
+..|+.|+++.+.+.
T Consensus 278 l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 278 LHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTCCEEECCSSCEE
T ss_pred ccCCCEEEcCCCCcc
Confidence 999999999887764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=253.90 Aligned_cols=149 Identities=24% Similarity=0.385 Sum_probs=121.8
Q ss_pred cHHHHhhhcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------
Q 035895 376 SYQELLRATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------ 419 (527)
Q Consensus 376 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------ 419 (527)
+.+.++...++|++.+.||+|+||+||+|++. +++.||||++..
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 33455556678999999999999999999853 246899998742
Q ss_pred -ccCc-cceeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 035895 420 -SCSN-EDFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482 (527)
Q Consensus 420 -~~~~-~~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdl 482 (527)
.|.. .+..++|||||++|+|.++|+... ..+++.++..|+.|||+||+||| +++||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCcc
Confidence 2323 345789999999999999997532 34789999999999999999999 999999999
Q ss_pred CCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 483 k~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+|||+++++.+||+|||+|+.+.........+...||+.||||
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 256 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 256 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence 999999999999999999999987544433334456789999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=242.94 Aligned_cols=136 Identities=27% Similarity=0.458 Sum_probs=103.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.. ..+++..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999986 57999999998521 2234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||| +|+|.+++.+. ..++..++..++.||+.||+|+| +++||||||||+|||+++++.+||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 9999 67999998765 46889999999999999999999 9999999999999999999999999999998765332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.....+||+.||||
T Consensus 167 ---~~~~~~GT~~Y~AP 180 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAP 180 (275)
T ss_dssp -----------CTTSCH
T ss_pred ---ccCCeeECcccCCh
Confidence 22346799999998
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=239.61 Aligned_cols=227 Identities=22% Similarity=0.208 Sum_probs=198.6
Q ss_pred CCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEecc
Q 035895 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172 (527)
Q Consensus 93 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 172 (527)
-++++.+++.++.+ |..+ .++|+.|++++|.+++..+..|..+++|++|++++|.+++..+..|..+++|+.|+++
T Consensus 13 ~~~~~c~~~~l~~i-p~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 88 (285)
T 1ozn_A 13 KVTTSCPQQGLQAV-PVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88 (285)
T ss_dssp SCEEECCSSCCSSC-CTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CeEEEcCcCCcccC-CcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCC
Confidence 36788999988864 5433 4579999999999999888899999999999999999998888899999999999999
Q ss_pred Ccc-cccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchh-hhCCCCccEEEccCCccccc
Q 035895 173 GNE-LEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI-LWNLKDILYLDFWSNLFVGP 250 (527)
Q Consensus 173 ~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~l~l~~n~~~~~ 250 (527)
+|. +....|..|..+++|++|++++|++++..|..|.++++|++|++++|+++.+|.. +..+++|+.|++++|.+.+.
T Consensus 89 ~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (285)
T ss_dssp SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence 997 8877788999999999999999999998899999999999999999999998764 67788899999999988877
Q ss_pred CCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccC
Q 035895 251 LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 323 (527)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 323 (527)
.+..+..+++|++|++++|.+.+..|..|..+++|++|++++|++++..+..|..+++|+.|++++|++....
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCC
Confidence 7777888889999999999888888888888889999999999888766667888888999999999887543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=242.12 Aligned_cols=133 Identities=27% Similarity=0.360 Sum_probs=110.4
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c----CccceeEEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C----SNEDFRALV 430 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~----~~~~~~~lv 430 (527)
|++.+.||+|+||+||+|+. .+++.||+|++... + ..++..++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36678899999999999986 56899999997421 0 113456899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeecccccccC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP--IIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~--iiHrdlk~~nill~-~~~~~kl~Dfg~a~~~~ 507 (527)
||||+||+|.+++.+. ..+++..+..|+.||+.||+||| +++ ||||||||+|||++ +++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999764 46788899999999999999999 776 99999999999998 57999999999998653
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.. .....+||+.||||
T Consensus 184 ~~----~~~~~~GTp~YmAP 199 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAP 199 (290)
T ss_dssp TT----SBEESCSSCCCCCG
T ss_pred CC----ccCCcccCccccCH
Confidence 22 12346799999999
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-28 Score=251.64 Aligned_cols=245 Identities=28% Similarity=0.331 Sum_probs=104.9
Q ss_pred hhccc-CCCceeecCchhhhcCCCCCEEEccccccccc--cccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcc
Q 035895 23 ICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGR--LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDIS 99 (527)
Q Consensus 23 ~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~--~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls 99 (527)
+..++ ++|+++++ | .|.++++|++|++++|.+.+. .+..++.|++++|.++.++ .+.++++|++|+++
T Consensus 133 L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~~lp~~~~~L~~L~L~~n~l~~l~-------~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 133 LEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELP-------ELQNLPFLTAIYAD 203 (454)
T ss_dssp CCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCC-------CCTTCTTCCEEECC
T ss_pred CCEEECcCCCCCCC-c-ccCCCCCCCEEECCCCcCcccCCCcccccEEECcCCcCCcCc-------cccCCCCCCEEECC
Confidence 33344 44444442 2 244444445555544444331 1123444444444444321 13444445555555
Q ss_pred cCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccc
Q 035895 100 RNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179 (527)
Q Consensus 100 ~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 179 (527)
+|++++ +|.. ..+|+.|++++|.++ .+| .+..+++|++|++++|++++. |. .+++|+.|++++|++++
T Consensus 204 ~N~l~~-l~~~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l-~~---~~~~L~~L~l~~N~l~~- 271 (454)
T 1jl5_A 204 NNSLKK-LPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTD- 271 (454)
T ss_dssp SSCCSS-CCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSC-
T ss_pred CCcCCc-CCCC----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcc-cc---cccccCEEECCCCcccc-
Confidence 555443 2221 123455555555444 223 244455555555555554432 11 12445555555555443
Q ss_pred cChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCC
Q 035895 180 IPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259 (527)
Q Consensus 180 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~ 259 (527)
+|.. +++|+.|++++|++++. |.. .++|+.|++++|++++++.. .++|+.|++++|++.+ +|.. ++
T Consensus 272 l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~ 337 (454)
T 1jl5_A 272 LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLCDL---PPSLEELNVSNNKLIE-LPAL---PP 337 (454)
T ss_dssp CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEECCC---CTTCCEEECCSSCCSC-CCCC---CT
T ss_pred cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcccCC---cCcCCEEECCCCcccc-cccc---CC
Confidence 2221 23445555555554431 110 13444555555554443321 1244555555554443 3322 34
Q ss_pred CCCEEEccCCCCCCCChhhhhcCCCCCEEEccccccee--ecCCCCCCC
Q 035895 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG--SIPNSFDDL 306 (527)
Q Consensus 260 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l 306 (527)
+|++|++++|++++ +|. .+++|++|++++|++++ .+|..+..+
T Consensus 338 ~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L 382 (454)
T 1jl5_A 338 RLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL 382 (454)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE
T ss_pred cCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh
Confidence 45555555555542 333 24455555555555544 344444444
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=245.86 Aligned_cols=140 Identities=24% Similarity=0.442 Sum_probs=104.6
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc------------------------------C-----------
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC------------------------------S----------- 422 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~------------------------------~----------- 422 (527)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999986 578999999985310 0
Q ss_pred -ccceeEEEEEeccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 035895 423 -NEDFRALVLEYTTNGSLEKVLYSSNY--ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSD 499 (527)
Q Consensus 423 -~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~D 499 (527)
.+...++|||||+||+|.+++..... ..++..+..|+.||++||+||| +++||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 01135899999999999999976432 3456667889999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCCc----------cceeccccccccccC
Q 035895 500 FGIAKLLTGEDQS----------MTQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~----------~~~~~~~~t~~y~aP 527 (527)
||+|+.+...... ...+..+||+.||||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP 199 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199 (299)
T ss_dssp CCCC--------------------------CCCTTSCH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCH
Confidence 9999987543211 112345799999998
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=250.29 Aligned_cols=254 Identities=19% Similarity=0.181 Sum_probs=207.2
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEE
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 145 (527)
..+++.+.+...... .+..+++|++|+|++|++++..|..+..+. +|++|+|++|.+++..+ +..+++|++|
T Consensus 14 i~~ls~~~l~~~~~~-----~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~--~~~l~~L~~L 85 (317)
T 3o53_A 14 IEKVTDSSLKQALAS-----LRQSAWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTL 85 (317)
T ss_dssp EESCCTTTHHHHHHH-----HHTTGGGCSEEECTTSCCCCCCHHHHTTCT-TCCEEECTTSCCEEEEE--ETTCTTCCEE
T ss_pred EeeccccchhhhHHH-----HhccCCCCCEEECcCCccCcCCHHHhhCCC-cCCEEECCCCcCCcchh--hhhcCCCCEE
Confidence 345555555432211 235567899999999999987777887775 79999999999987665 8899999999
Q ss_pred EeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCC
Q 035895 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225 (527)
Q Consensus 146 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 225 (527)
++++|++++.. ..++|+.|++++|++++..+. .+++|+.|++++|++++..|..|+.+++|++|++++|+++
T Consensus 86 ~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 157 (317)
T 3o53_A 86 DLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157 (317)
T ss_dssp ECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCC
T ss_pred ECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCC
Confidence 99999998644 348999999999999866554 3678999999999999888889999999999999999999
Q ss_pred CCc-hhh-hCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCC
Q 035895 226 SIP-SIL-WNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF 303 (527)
Q Consensus 226 ~lp-~~~-~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 303 (527)
.++ ..+ ..+++|++|++++|.+.+.. ....+++|++|++++|++++. |..|..+++|++|++++|+++ .+|..+
T Consensus 158 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~ 233 (317)
T 3o53_A 158 TVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKAL 233 (317)
T ss_dssp EEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTC
T ss_pred cccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHh
Confidence 864 444 36889999999999988662 234589999999999999864 555999999999999999999 578889
Q ss_pred CCCCCCCEEeCCCCccc-ccCccchhhhccCCeeEee
Q 035895 304 DDLVSLESLDLSNNNLS-EIIPLSLEKLLYLNILLIV 339 (527)
Q Consensus 304 ~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~~~ 339 (527)
..+++|+.|++++|+++ +.+|..+..++.|+.+++.
T Consensus 234 ~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred hcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 99999999999999998 7778888888777766544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=251.91 Aligned_cols=222 Identities=19% Similarity=0.234 Sum_probs=146.9
Q ss_pred CCEEEcccCCCC-cccChhHh-------hccccccEEEcccCccccccchhh--cCCcCCcEEEeecCcccccCcccccC
Q 035895 93 LKKLDISRNPLD-GFLPRVVG-------NFSQSLEFIWMSDCNISGGISEEI--GNLTDLISIDLGGNKLNGSISITLGK 162 (527)
Q Consensus 93 L~~L~Ls~N~l~-~~~~~~~~-------~~~~~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~ 162 (527)
|+.|+|++|.++ ..+|..+. .+ ++|++|+|++|.+++..|..+ ..+++|++|+|++|++++. |..++.
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~ 142 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGI-SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE 142 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTT-SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCc-CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence 555566666653 23343332 23 356666666666666556554 6666777777777777655 555555
Q ss_pred C-----CCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCC--CCccc--cCCccCceeeCCCCCCCCCch----
Q 035895 163 L-----QKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGS--IPTCF--GNLTALRNLHLDSNELTSIPS---- 229 (527)
Q Consensus 163 l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~lp~---- 229 (527)
+ ++|++|++++|++.+..|..|..+++|++|++++|++.+. .|..+ +.+++|++|++++|+++.+|.
T Consensus 143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 222 (312)
T 1wwl_A 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222 (312)
T ss_dssp HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHH
T ss_pred HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHH
Confidence 5 6777777777777666666677777777777777776543 22223 677777777777777775442
Q ss_pred hhhCCCCccEEEccCCcccccCC-ccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCC
Q 035895 230 ILWNLKDILYLDFWSNLFVGPLP-SKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS 308 (527)
Q Consensus 230 ~~~~l~~L~~l~l~~n~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 308 (527)
.+..+++|++|++++|.+.+..| ..+..+++|++|++++|+++ .+|..+. ++|++|++++|++++. |. +..+++
T Consensus 223 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~ 297 (312)
T 1wwl_A 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQ 297 (312)
T ss_dssp HHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCE
T ss_pred HHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCC
Confidence 22456777777777777776654 44556778888888888887 5666555 7788888888888755 55 778888
Q ss_pred CCEEeCCCCcccc
Q 035895 309 LESLDLSNNNLSE 321 (527)
Q Consensus 309 L~~L~ls~N~l~~ 321 (527)
|+.|++++|++++
T Consensus 298 L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 298 VGNLSLKGNPFLD 310 (312)
T ss_dssp EEEEECTTCTTTC
T ss_pred CCEEeccCCCCCC
Confidence 8888888888765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-29 Score=249.93 Aligned_cols=246 Identities=17% Similarity=0.143 Sum_probs=211.4
Q ss_pred CCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccc-cccchhhc-------CCcCCcEEEeecCcccccCcc
Q 035895 87 MSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNIS-GGISEEIG-------NLTDLISIDLGGNKLNGSISI 158 (527)
Q Consensus 87 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~ 158 (527)
+...++|+.|++++|.+ .+|..+.. .|+.|+|++|.++ ...|..+. .+++|++|+|++|++++..|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~---~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTD---IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHH---HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHH---HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 34567799999999999 57776654 3899999999995 45666665 799999999999999988888
Q ss_pred cc--cCCCCCCEEeccCcccccccChhhhcC-----cccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC---Cc
Q 035895 159 TL--GKLQKLQFLSFRGNELEGSIPNVLCHL-----AVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS---IP 228 (527)
Q Consensus 159 ~~--~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~---lp 228 (527)
.+ ..+++|+.|++++|++++. |..+..+ ++|++|++++|++++..|..|+.+++|++|++++|++.+ +|
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 76 8999999999999999977 8888887 999999999999999998999999999999999999876 35
Q ss_pred hhh--hCCCCccEEEccCCcccc---cCCccccCCCCCCEEEccCCCCCCCCh-hhhhcCCCCCEEEcccccceeecCCC
Q 035895 229 SIL--WNLKDILYLDFWSNLFVG---PLPSKIGNLKVLTRIDFSRNNLLGDIP-TTIQGLKSLQFLSLGHNRLQGSIPNS 302 (527)
Q Consensus 229 ~~~--~~l~~L~~l~l~~n~~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~ 302 (527)
..+ ..+++|++|++++|.+.+ .....+..+++|++|++++|++.+..| ..+..+++|++|+|++|+++ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 455 789999999999999873 222445688999999999999998775 56777899999999999998 67777
Q ss_pred CCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeee
Q 035895 303 FDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 303 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
+. ++|+.|++++|++++. |. +..++.|+.|+++.+.+
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l 308 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPF 308 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTT
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCC
Confidence 76 8999999999999987 55 88999999998877654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-30 Score=268.14 Aligned_cols=326 Identities=17% Similarity=0.136 Sum_probs=258.1
Q ss_pred hhhcchhccc-CCCceeec----CchhhhcCCCCCEEEccccccccc--------ccc---ccceEEcccccccCCCCCC
Q 035895 18 DVCYRICTID-SQNKLVGI----VSITIFNLSTLKVFDVDNNYVLGR--------LSS---IVDELSLSDNYLTSSTPEL 81 (527)
Q Consensus 18 ~~~~~~~~~~-s~N~l~~~----~~~~~~~l~~L~~L~Ls~N~~~~~--------~~~---~l~~L~Ls~N~l~~~~~~~ 81 (527)
..|.++..++ ++|+++.. ++..+..+++|++|+|++|.+... ++. .++.|+|++|.++.... .
T Consensus 25 ~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~-~ 103 (461)
T 1z7x_W 25 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC-G 103 (461)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGH-H
T ss_pred hhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHH-H
Confidence 4567888888 88888853 467788899999999999987431 121 58999999999875220 0
Q ss_pred cccccCCCCCCCCEEEcccCCCCcccChhHhhc----cccccEEEcccCcccccc----chhhcCCcCCcEEEeecCccc
Q 035895 82 SFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNF----SQSLEFIWMSDCNISGGI----SEEIGNLTDLISIDLGGNKLN 153 (527)
Q Consensus 82 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~----~~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 153 (527)
.+...+..+++|++|++++|++++..+..+... ..+|+.|++++|.++... +..+..+++|++|++++|.++
T Consensus 104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 183 (461)
T 1z7x_W 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183 (461)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence 122457889999999999999986545444432 236999999999998643 666778899999999999998
Q ss_pred ccCccccc-----CCCCCCEEeccCcccccc----cChhhhcCcccCeeeeecccCCCCC-----CccccCCccCceeeC
Q 035895 154 GSISITLG-----KLQKLQFLSFRGNELEGS----IPNVLCHLAVLFQLDLRGNKLSGSI-----PTCFGNLTALRNLHL 219 (527)
Q Consensus 154 ~~~~~~~~-----~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L 219 (527)
...+..+. ..++|+.|++++|.++.. ++..+..+++|++|++++|.+.... +..+..+++|++|++
T Consensus 184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L 263 (461)
T 1z7x_W 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263 (461)
T ss_dssp HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEEC
Confidence 65444443 367999999999999864 5778889999999999999987532 333456899999999
Q ss_pred CCCCCCC-----CchhhhCCCCccEEEccCCcccccCCcccc-----CCCCCCEEEccCCCCCCC----ChhhhhcCCCC
Q 035895 220 DSNELTS-----IPSILWNLKDILYLDFWSNLFVGPLPSKIG-----NLKVLTRIDFSRNNLLGD----IPTTIQGLKSL 285 (527)
Q Consensus 220 ~~N~l~~-----lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 285 (527)
++|.++. ++..+..+++|++|++++|.+....+..+. ..++|++|++++|.+++. +|..+..+++|
T Consensus 264 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 343 (461)
T 1z7x_W 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343 (461)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred cCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCc
Confidence 9999998 677888899999999999988754443333 236999999999999865 56778889999
Q ss_pred CEEEcccccceeecCCCCCC-----CCCCCEEeCCCCcccc----cCccchhhhccCCeeEeeeeeee
Q 035895 286 QFLSLGHNRLQGSIPNSFDD-----LVSLESLDLSNNNLSE----IIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 286 ~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
++|++++|++++..+..+.. .++|+.|++++|.+++ .+|..+..++.|+.|+++.+.+.
T Consensus 344 ~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 99999999998654443332 6799999999999986 67888999999999999987664
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=260.13 Aligned_cols=137 Identities=28% Similarity=0.464 Sum_probs=118.7
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------------ccCccce
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------------SCSNEDF 426 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------------~~~~~~~ 426 (527)
..++|++.++||+|+||+||+|+. .+|+.||||++.. ...+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 457899999999999999999986 5799999999842 1224567
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.|+|||||+||+|.+++... ..++...+..|+.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+.+
T Consensus 267 lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 78999999999999999765 35788899999999999999999 999999999999999999999999999999987
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ....+||+.||||
T Consensus 343 ~~~~----~~t~~GTp~YmAP 359 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAP 359 (689)
T ss_dssp SSCC----CCSCCSCGGGCCH
T ss_pred CCCC----CCCccCCcCccCH
Confidence 5432 2246799999998
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-27 Score=251.19 Aligned_cols=267 Identities=23% Similarity=0.255 Sum_probs=212.7
Q ss_pred hhccc-CCCceeecCchhhhcCCCCCEEEcccccccccc--ccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcc
Q 035895 23 ICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRL--SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDIS 99 (527)
Q Consensus 23 ~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~--~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls 99 (527)
+..++ ++|.++.+++. +. ++|+.|+|++|.+.... ...++.|+|++|+|++++. .+++|++|+++
T Consensus 42 l~~L~ls~n~L~~lp~~-l~--~~L~~L~L~~N~l~~lp~~l~~L~~L~Ls~N~l~~lp~---------~l~~L~~L~Ls 109 (622)
T 3g06_A 42 NAVLNVGESGLTTLPDC-LP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSLPV---------LPPGLLELSIF 109 (622)
T ss_dssp CCEEECCSSCCSCCCSC-CC--TTCSEEEECSCCCSCCCCCCTTCCEEEECSCCCSCCCC---------CCTTCCEEEEC
T ss_pred CcEEEecCCCcCccChh-hC--CCCcEEEecCCCCCCCCCcCCCCCEEEcCCCcCCcCCC---------CCCCCCEEECc
Confidence 44566 77888866543 33 78999999999886432 2358899999999887543 45789999999
Q ss_pred cCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccc
Q 035895 100 RNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179 (527)
Q Consensus 100 ~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 179 (527)
+|+++++ |. ...+|+.|++++|.++.+ |.. +++|++|++++|++++. |. .+++|+.|++++|.+++
T Consensus 110 ~N~l~~l-~~----~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~- 175 (622)
T 3g06_A 110 SNPLTHL-PA----LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS- 175 (622)
T ss_dssp SCCCCCC-CC----CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-
T ss_pred CCcCCCC-CC----CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-
Confidence 9999874 43 235799999999999864 432 48899999999999864 32 45789999999999985
Q ss_pred cChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCC
Q 035895 180 IPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259 (527)
Q Consensus 180 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~ 259 (527)
+| ..+++|+.|++++|++++ +|.. +++|+.|++++|.++.+|.. +++|+.|++++|.+.+ +| ..++
T Consensus 176 l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~ 241 (622)
T 3g06_A 176 LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LP---VLPS 241 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CC---CCCT
T ss_pred Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CC---CCCC
Confidence 55 456889999999999986 4432 47899999999999998864 4789999999998886 55 4568
Q ss_pred CCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCC
Q 035895 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLN 334 (527)
Q Consensus 260 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 334 (527)
+|++|++++|+++. +|. .+++|+.|+|++|+++ .+|..|..+++|+.|+|++|++++..|..+..+....
T Consensus 242 ~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~~~ 311 (622)
T 3g06_A 242 ELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311 (622)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHHST
T ss_pred cCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhccccc
Confidence 89999999999984 555 6788999999999998 6788899999999999999999999888888776543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=242.47 Aligned_cols=245 Identities=19% Similarity=0.194 Sum_probs=121.8
Q ss_pred CCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccC
Q 035895 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRN 101 (527)
Q Consensus 28 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N 101 (527)
+.+.+...+...+..+++|++|+|++|.+.+..+. .++.|+|++|.+++.. .+..+++|++|++++|
T Consensus 18 s~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------~~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 18 TDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTLDLNNN 90 (317)
T ss_dssp CTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-------EETTCTTCCEEECCSS
T ss_pred cccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-------hhhhcCCCCEEECcCC
Confidence 55666666667777788889999888877654432 2444444444444321 1344455555555555
Q ss_pred CCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccC
Q 035895 102 PLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP 181 (527)
Q Consensus 102 ~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 181 (527)
++++..+. ++|+.|++++|.+++..+.. +++|++|++++|++++..+..+..+++|+.|++++|.+++..+
T Consensus 91 ~l~~l~~~------~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 91 YVQELLVG------PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp EEEEEEEC------TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred ccccccCC------CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 55543211 24555555555555443322 3445555555555554444455555555555555555554444
Q ss_pred hhhh-cCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCC
Q 035895 182 NVLC-HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKV 260 (527)
Q Consensus 182 ~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~ 260 (527)
..+. .+++|++|++++|.+++..+ ...+++|++|++++|+++++|..+..+++|+.|++++|.+.+ +|..+..+++
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~ 238 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQN 238 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTT
T ss_pred HHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccc-hhhHhhcCCC
Confidence 4332 44555555555555543311 122455555555555555544444444444444444444432 3333444444
Q ss_pred CCEEEccCCCCC-CCChhhhhcCCCCCEEEcc
Q 035895 261 LTRIDFSRNNLL-GDIPTTIQGLKSLQFLSLG 291 (527)
Q Consensus 261 L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~ 291 (527)
|+.|++++|.+. +.+|..+..+++|+.|+++
T Consensus 239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 444444444444 3334444444444444444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=252.22 Aligned_cols=235 Identities=20% Similarity=0.193 Sum_probs=195.7
Q ss_pred CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCE
Q 035895 89 NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQF 168 (527)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 168 (527)
.+++|++|+|++|.+++..|..+..+. +|++|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|+.
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 455899999999999987777887765 79999999999987666 8889999999999999886543 388999
Q ss_pred EeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCC-chhhh-CCCCccEEEccCCc
Q 035895 169 LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI-PSILW-NLKDILYLDFWSNL 246 (527)
Q Consensus 169 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l-p~~~~-~l~~L~~l~l~~n~ 246 (527)
|++++|.+++..+. .+++|+.|++++|.+++..|..|+++++|+.|+|++|.++++ |..+. .++.|+.|++++|.
T Consensus 104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 99999999876554 457889999999999988888899999999999999999984 55555 68899999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc-ccCcc
Q 035895 247 FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS-EIIPL 325 (527)
Q Consensus 247 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~ 325 (527)
+.+..+ +..+++|++|+|++|.+++.+| .|..+++|+.|++++|++++ +|..+..+++|+.|++++|++. +.+|.
T Consensus 181 l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 181 IYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred cccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 887633 4468999999999999997555 59999999999999999995 7888999999999999999998 66677
Q ss_pred chhhhccCCeeEe
Q 035895 326 SLEKLLYLNILLI 338 (527)
Q Consensus 326 ~~~~l~~L~~L~~ 338 (527)
.+..++.+..+.+
T Consensus 257 ~~~~l~~L~~l~~ 269 (487)
T 3oja_A 257 FFSKNQRVQTVAK 269 (487)
T ss_dssp HHTTCHHHHHHHH
T ss_pred HHHhCCCCcEEec
Confidence 7777766665543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-27 Score=226.50 Aligned_cols=207 Identities=22% Similarity=0.213 Sum_probs=125.4
Q ss_pred cccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeee
Q 035895 117 SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 196 (527)
+|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 34455555555544444445555555555555555554444455555555555555555554444555555555555555
Q ss_pred cccCCCCCCccccCCccCceeeCCCCCCCC--CchhhhCCCCccEEEccCCcccccCCccccCCCCCC----EEEccCCC
Q 035895 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTS--IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT----RIDFSRNN 270 (527)
Q Consensus 197 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~----~L~Ls~N~ 270 (527)
+|.+.+..+..|+.+++|++|++++|.++. +|..+..+++|++|++++|.+.+..+..+..++.|+ .|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 555555444455555555555555555554 345555555555555555555554445555555555 78888888
Q ss_pred CCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCc
Q 035895 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 271 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
+.+..+..+.. .+|++|++++|++++..+..|..+++|+.|++++|+++...|
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 88655555544 478999999999887777778889999999999998876443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=239.76 Aligned_cols=120 Identities=28% Similarity=0.393 Sum_probs=102.7
Q ss_pred hhhcCCccccceeccCCceEEEEEEcc----CCcEEEEEEEee----------------------------ccCccceeE
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHF----------------------------SCSNEDFRA 428 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~----------------------------~~~~~~~~~ 428 (527)
..-.+.|++.+.||+|+||+||+|+.+ +++.||||++.. ....++..+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 344577999999999999999999753 578899998742 112345778
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccccC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-IVAHLSDFGIAKLLT 507 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-~~~kl~Dfg~a~~~~ 507 (527)
+|||||+||+|.+++. .++..++..++.|++.||+||| +++||||||||+|||++.+ +.+||+|||+|+...
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999999999984 3788889999999999999999 9999999999999999876 899999999998654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=249.77 Aligned_cols=228 Identities=20% Similarity=0.215 Sum_probs=122.7
Q ss_pred CCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccc
Q 035895 45 TLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSL 118 (527)
Q Consensus 45 ~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L 118 (527)
+|+.|+|++|.+.+..|. .++.|+|++|.+++.. .+..+++|++|+|++|.++++.+. ++|
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-------~l~~l~~L~~L~Ls~N~l~~l~~~------~~L 101 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTLDLNNNYVQELLVG------PSI 101 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEE-------ECTTCTTCCEEECCSSEEEEEEEC------TTC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCc-------ccccCCCCCEEEecCCcCCCCCCC------CCc
Confidence 677777777766543332 1333444444433211 134555566666666666543221 346
Q ss_pred cEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhh-cCcccCeeeeec
Q 035895 119 EFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLC-HLAVLFQLDLRG 197 (527)
Q Consensus 119 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~ 197 (527)
+.|++++|.+++..+. .+++|++|+|++|.+++..|..++.+++|+.|++++|.+++..|..+. .+++|+.|+|++
T Consensus 102 ~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~ 178 (487)
T 3oja_A 102 ETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178 (487)
T ss_dssp CEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTT
T ss_pred CEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCC
Confidence 6666666666554443 235566666666666655555555666666666666666655555554 456666666666
Q ss_pred ccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCC-CCCh
Q 035895 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLL-GDIP 276 (527)
Q Consensus 198 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p 276 (527)
|.|++..+ +..+++|+.|+|++|.++++|+.+..+++|+.|++++|.+.+ +|..+..+++|+.|++++|.+. +.+|
T Consensus 179 N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 179 NFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp SCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred Cccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchH
Confidence 66654422 223556666666666666655555555555555555555553 3444555555555555555554 3444
Q ss_pred hhhhcCCCCCEEEcc
Q 035895 277 TTIQGLKSLQFLSLG 291 (527)
Q Consensus 277 ~~~~~l~~L~~L~L~ 291 (527)
..+..++.|+.++++
T Consensus 256 ~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 256 DFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHTTCHHHHHHHHH
T ss_pred HHHHhCCCCcEEecc
Confidence 455555555555543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=239.26 Aligned_cols=138 Identities=30% Similarity=0.422 Sum_probs=113.4
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c------Cccce
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C------SNEDF 426 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~------~~~~~ 426 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||++... + .+.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5699999999999999999986 57999999997421 0 12246
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++|||||+ |+|.+++... ..+++.++..|+.||+.||+||| +++||||||||+|||++.++.+|++|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 789999996 6899998654 46889999999999999999999 999999999999999999999999999999976
Q ss_pred CCCCC--ccceeccccccccccC
Q 035895 507 TGEDQ--SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~--~~~~~~~~~t~~y~aP 527 (527)
..... ....+..+||++||||
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~AP 231 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAP 231 (398)
T ss_dssp -------CCCCCSSCCCCTTCCH
T ss_pred ccCccccccccccceeChHhcCH
Confidence 43211 1223356799999998
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-25 Score=218.71 Aligned_cols=205 Identities=26% Similarity=0.253 Sum_probs=143.2
Q ss_pred CCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEe
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS 170 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 170 (527)
++|++|++++|++++..+..+..+. +|++|++++|.+++..+..|..+++|++|++++|++++..+..|.++++|+.|+
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCT-TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccCHhHhcccc-CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 3567777777777766555565553 577777777777766666677777777777777777766666677777777777
Q ss_pred ccCcccccccChhhhcCcccCeeeeecccCCCC-CCccccCCccCceeeCCCCCCCCCc-hhhhCCCCcc----EEEccC
Q 035895 171 FRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGS-IPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDIL----YLDFWS 244 (527)
Q Consensus 171 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~lp-~~~~~l~~L~----~l~l~~ 244 (527)
+++|.+.+..+..+..+++|++|++++|++++. +|..|+++++|++|++++|++++++ ..+..+..|+ .+++++
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~ 186 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCS
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCC
Confidence 777777665555677777777777777777653 4667777777777777777777654 3344444444 677777
Q ss_pred CcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccccccee
Q 035895 245 NLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297 (527)
Q Consensus 245 n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 297 (527)
|.+.+..+..+.. .+|++|++++|++++..+..|..+++|+.|++++|++..
T Consensus 187 n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 187 NPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp SCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred CcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 7776655554443 378888888888887766777888888888888888874
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-25 Score=234.32 Aligned_cols=255 Identities=25% Similarity=0.262 Sum_probs=211.8
Q ss_pred CCCCEEEccccccccc---cccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccE
Q 035895 44 STLKVFDVDNNYVLGR---LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120 (527)
Q Consensus 44 ~~L~~L~Ls~N~~~~~---~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~ 120 (527)
.+++.|++++|.+... ++..++.|+|++|.|+.++. .+++|++|+|++|+++++ |. . .++|++
T Consensus 40 ~~l~~L~ls~n~L~~lp~~l~~~L~~L~L~~N~l~~lp~---------~l~~L~~L~Ls~N~l~~l-p~---~-l~~L~~ 105 (622)
T 3g06_A 40 NGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPA---------LPPELRTLEVSGNQLTSL-PV---L-PPGLLE 105 (622)
T ss_dssp HCCCEEECCSSCCSCCCSCCCTTCSEEEECSCCCSCCCC---------CCTTCCEEEECSCCCSCC-CC---C-CTTCCE
T ss_pred CCCcEEEecCCCcCccChhhCCCCcEEEecCCCCCCCCC---------cCCCCCEEEcCCCcCCcC-CC---C-CCCCCE
Confidence 4589999999998632 23468999999999997654 358899999999999974 54 2 358999
Q ss_pred EEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccC
Q 035895 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKL 200 (527)
Q Consensus 121 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 200 (527)
|++++|.+++..+ .+++|++|++++|++++. |. .+++|+.|++++|++++ +|. .+.+|+.|++++|+|
T Consensus 106 L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l 173 (622)
T 3g06_A 106 LSIFSNPLTHLPA----LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQL 173 (622)
T ss_dssp EEECSCCCCCCCC----CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EECcCCcCCCCCC----CCCCcCEEECCCCCCCcC-CC---CCCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCC
Confidence 9999999997544 678999999999999864 33 35899999999999985 454 356899999999999
Q ss_pred CCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhh
Q 035895 201 SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQ 280 (527)
Q Consensus 201 ~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 280 (527)
++ +| ..+++|+.|++++|+++.+|.. +++|+.|++++|.+.. +|. .+++|++|++++|.+++ +| .
T Consensus 174 ~~-l~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~ 238 (622)
T 3g06_A 174 TS-LP---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP---V 238 (622)
T ss_dssp SC-CC---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC---C
T ss_pred CC-Cc---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC---C
Confidence 96 45 4578999999999999999864 4789999999999874 443 35789999999999986 55 5
Q ss_pred cCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 281 GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 281 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
.+++|+.|++++|+|+ .+|. .+++|+.|+|++|+++. +|..+..++.|+.|+++.+.+.
T Consensus 239 ~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~-lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 239 LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCS-CCGGGGGSCTTCEEECCSCCCC
T ss_pred CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCc-CCHHHhhccccCEEEecCCCCC
Confidence 6689999999999998 4565 57899999999999994 5788999999999999987774
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-25 Score=214.70 Aligned_cols=204 Identities=26% Similarity=0.305 Sum_probs=156.9
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEec
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
..+.+++++|+++. +|..+ ..+++.|++++|.+++..+..|..+++|++|++++|+++...+..|..+++|++|++
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCC---CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCEEEccCCCCCc-cCCCC---CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 46788888888885 45433 246788888888887777777777888888888888877666666677777777777
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccC
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~ 251 (527)
++|.+++..+..|..+++|++|++++|++++..|..|..+++|++|++++|+++.+|.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---------------------- 150 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPK---------------------- 150 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT----------------------
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCH----------------------
Confidence 7777776666667777777777777777777766777777777777777777766543
Q ss_pred CccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccccc
Q 035895 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322 (527)
Q Consensus 252 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 322 (527)
..|..+++|++|++++|.+.+..+..|.++++|++|++++|++++..+..|..+++|+.|++++|++...
T Consensus 151 -~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 151 -GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp -TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred -hHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 3466778888888888888877777788899999999999999877777788899999999999988654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=214.15 Aligned_cols=202 Identities=23% Similarity=0.300 Sum_probs=169.4
Q ss_pred ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCC
Q 035895 63 IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142 (527)
Q Consensus 63 ~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 142 (527)
..+.++++++.++.++..++ ++|++|++++|++++..+..+..+. +|++|++++|.++...+..|..+++|
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~--------~~l~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~i~~~~~~~l~~L 87 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP--------ADTKKLDLQSNKLSSLPSKAFHRLT-KLRLLYLNDNKLQTLPAGIFKELKNL 87 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC--------TTCSEEECCSSCCSCCCTTSSSSCT-TCCEEECCSSCCSCCCTTTTSSCTTC
T ss_pred CCCEEEccCCCCCccCCCCC--------CCCCEEECcCCCCCeeCHHHhcCCC-CCCEEECCCCccCeeChhhhcCCCCC
Confidence 46789999999998766432 5799999999999987777787765 79999999999998888888999999
Q ss_pred cEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCC
Q 035895 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 143 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 222 (527)
++|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|
T Consensus 88 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 167 (270)
T 2o6q_A 88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNN 167 (270)
T ss_dssp CEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCC
Confidence 99999999999888888999999999999999999888888999999999999999999888888999999999999999
Q ss_pred CCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccce
Q 035895 223 ELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 223 ~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 296 (527)
+++.+|.. .|..+++|++|++++|++.+..+..|..+++|+.|++++|.+.
T Consensus 168 ~l~~~~~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 168 QLKRVPEG-----------------------AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CCSCCCTT-----------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCcEeChh-----------------------HhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 99887642 2444556666666666666555555666666666666666654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=217.23 Aligned_cols=204 Identities=23% Similarity=0.255 Sum_probs=169.2
Q ss_pred CCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCC
Q 035895 87 MSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166 (527)
Q Consensus 87 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 166 (527)
+.++++++++++++|.++.+ |..+ ..+++.|+|++|.+++..+..|..+++|++|+|++|.+++..+. +.+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~~i-p~~~---~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTAL-PPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCSSC-CSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCCcC-CCCC---CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 56778899999999999864 4433 34799999999999988888999999999999999999865443 788899
Q ss_pred CEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCc
Q 035895 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNL 246 (527)
Q Consensus 167 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~ 246 (527)
+.|++++|+++ .+|..+..+++|++|++++|+|++..|..|.++++|++|+|++|+++.+|.
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~----------------- 141 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP----------------- 141 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT-----------------
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccCh-----------------
Confidence 99999999987 677788888888999999998888777888888888888888888887653
Q ss_pred ccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccc
Q 035895 247 FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 247 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 321 (527)
..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|++..
T Consensus 142 ------~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 142 ------GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp ------TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ------hhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 34566778888888888888766677888899999999999998 677777778889999999998753
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-28 Score=252.94 Aligned_cols=321 Identities=18% Similarity=0.194 Sum_probs=194.0
Q ss_pred chhccc-CCCceeecCchh-hhcCCCCCEEEccccccccc----cc------cccceEEcccccccCCCCCCcccccCCC
Q 035895 22 RICTID-SQNKLVGIVSIT-IFNLSTLKVFDVDNNYVLGR----LS------SIVDELSLSDNYLTSSTPELSFLSSMSN 89 (527)
Q Consensus 22 ~~~~~~-s~N~l~~~~~~~-~~~l~~L~~L~Ls~N~~~~~----~~------~~l~~L~Ls~N~l~~~~~~~~~~~~~~~ 89 (527)
++..+| +.|+++...... +..+++|++|+|++|.+... ++ +.++.|+|++|.++..... .+...+..
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~-~l~~~l~~ 82 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH-CVLQGLQT 82 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH-HHHHTTCS
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHH-HHHHHHhh
Confidence 455666 777777655443 77788888888888876531 11 2467777777776542110 00011111
Q ss_pred C-CCCCEEEcccCCCCc----ccChhHhhccccccEEEcccCccccccchhhc-----CCcCCcEEEeecCcccccC---
Q 035895 90 C-KYLKKLDISRNPLDG----FLPRVVGNFSQSLEFIWMSDCNISGGISEEIG-----NLTDLISIDLGGNKLNGSI--- 156 (527)
Q Consensus 90 l-~~L~~L~Ls~N~l~~----~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~--- 156 (527)
. ++|++|++++|+++. .++..+..+. +|+.|++++|.++...+..+. ..++|++|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLP-TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCC-ceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 1 157777777777763 3355555553 677777777777644333332 2456777777777776532
Q ss_pred -cccccCCCCCCEEeccCcccccccChhhh-----cCcccCeeeeecccCCCC----CCccccCCccCceeeCCCCCCCC
Q 035895 157 -SITLGKLQKLQFLSFRGNELEGSIPNVLC-----HLAVLFQLDLRGNKLSGS----IPTCFGNLTALRNLHLDSNELTS 226 (527)
Q Consensus 157 -~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 226 (527)
+..+..+++|+.|++++|.+....+..+. ..++|+.|++++|.++.. ++..+..+++|++|++++|.++.
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 44455667777777777776644333333 245777777777777653 35556667777777777777664
Q ss_pred C------chhhhCCCCccEEEccCCccccc----CCccccCCCCCCEEEccCCCCCCCChhhhhcC-----CCCCEEEcc
Q 035895 227 I------PSILWNLKDILYLDFWSNLFVGP----LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGL-----KSLQFLSLG 291 (527)
Q Consensus 227 l------p~~~~~l~~L~~l~l~~n~~~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~ 291 (527)
. +.....++.|++|++++|.++.. ++..+..+++|++|++++|.+.+..+..+... ++|++|+++
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 2 11222466777777777766643 45556667777777777777654444333322 577777777
Q ss_pred cccceee----cCCCCCCCCCCCEEeCCCCcccccCccchhh-----hccCCeeEeeeeeee
Q 035895 292 HNRLQGS----IPNSFDDLVSLESLDLSNNNLSEIIPLSLEK-----LLYLNILLIVVVILA 344 (527)
Q Consensus 292 ~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~~~~~~~~ 344 (527)
+|.+++. ++..+..+++|+.|++++|.+++..+..+.. .+.|+.|+++.+.+.
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 7777643 3445556677777777777776655544443 456777776665543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=241.06 Aligned_cols=138 Identities=22% Similarity=0.372 Sum_probs=118.2
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey 433 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||++.. .+..++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46799999999999999999986 5799999998743 12345677899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC--CcEEEeecccccccCCCCC
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN--IVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~--~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+||+|.+++......+++.++..|+.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999766567889999999999999999999 9999999999999999854 899999999999875432
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....+||+.||||
T Consensus 312 --~~~~~~GT~~y~AP 325 (573)
T 3uto_A 312 --SVKVTTGTAEFAAP 325 (573)
T ss_dssp --EEEEECSSGGGCCH
T ss_pred --ceeeeEECccccCH
Confidence 22345799999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.5e-26 Score=232.79 Aligned_cols=147 Identities=24% Similarity=0.397 Sum_probs=124.1
Q ss_pred HHHHhhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCc
Q 035895 377 YQELLRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSN 423 (527)
Q Consensus 377 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~ 423 (527)
+.++....++|++.++||+|+||+||+|+.. +++.||||++.. .+..
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445566789999999999999999999975 578999999752 1234
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
++..++|||||+||+|.+++...+..+++..+..++.|++.||+||| +.+||||||||+|||++.++.+||+|||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 56778999999999999999876667899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+....... ...+..+||++||||
T Consensus 223 ~~~~~~~~-~~~~~~~GT~~Y~AP 245 (437)
T 4aw2_A 223 LKLMEDGT-VQSSVAVGTPDYISP 245 (437)
T ss_dssp EECCTTSC-EECCSCCSCGGGCCH
T ss_pred hhcccCCC-cccccccCCcCeeCh
Confidence 87653322 223345799999998
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=215.50 Aligned_cols=205 Identities=26% Similarity=0.290 Sum_probs=131.3
Q ss_pred cccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeee
Q 035895 117 SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 196 (527)
+|+.|++++|.++.. ..+..+++|++|++++|++++. ..+..+++|++|++++|.+++..+..|..+++|++|+++
T Consensus 42 ~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 42 SIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 455555555555421 2345555566666666655542 245556666666666666655555555566666666666
Q ss_pred cccCCCCCCccccCCccCceeeCCCCCCCCCchh-hhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCC
Q 035895 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI-LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI 275 (527)
Q Consensus 197 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 275 (527)
+|++++..+..|+.+++|++|++++|+++++|.. +..+++|+.|++++|.+.+..+..++.+++|++|++++|++.+..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (272)
T 3rfs_A 118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP 197 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC
Confidence 6666655555566666666666666666665443 345556666666666665555566777888888888888888777
Q ss_pred hhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhcc
Q 035895 276 PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLY 332 (527)
Q Consensus 276 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 332 (527)
|..|..+++|++|++++|.+.+ .+++|+.|+++.|.++|.+|..++.+..
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 198 DGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred HHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 7778888888888888887763 3456888888888888888877665543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=220.24 Aligned_cols=225 Identities=20% Similarity=0.212 Sum_probs=187.2
Q ss_pred CCCCEEEcccCCCCcccChh---HhhccccccEEEcccCccccccchhh--cCCcCCcEEEeecCcccccCc----cccc
Q 035895 91 KYLKKLDISRNPLDGFLPRV---VGNFSQSLEFIWMSDCNISGGISEEI--GNLTDLISIDLGGNKLNGSIS----ITLG 161 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~---~~~~~~~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~ 161 (527)
..++.|.+.++.++...-.. +... .+|++|++++|.+++..|..+ ..+++|++|+|++|++++..+ ..+.
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAY-SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHH-SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhccc-CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 35788888888876321111 1122 359999999999999988888 899999999999999987544 4456
Q ss_pred CCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCC---CC-CccccCCccCceeeCCCCCCCCCchh----hhC
Q 035895 162 KLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSG---SI-PTCFGNLTALRNLHLDSNELTSIPSI----LWN 233 (527)
Q Consensus 162 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~---~~-p~~~~~l~~L~~L~L~~N~l~~lp~~----~~~ 233 (527)
.+++|++|++++|.+.+..|..|..+++|++|+|++|++.+ .. +..++.+++|++|++++|+++.+|.. +..
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~ 222 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA 222 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence 79999999999999998888999999999999999999865 22 33457899999999999999988763 467
Q ss_pred CCCccEEEccCCcccccCCccccCC---CCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCC
Q 035895 234 LKDILYLDFWSNLFVGPLPSKIGNL---KVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLE 310 (527)
Q Consensus 234 l~~L~~l~l~~n~~~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 310 (527)
+++|++|++++|.+.+..|..+..+ ++|++|++++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 8999999999999999888888777 69999999999998 5677664 7999999999999964 44 78889999
Q ss_pred EEeCCCCcccc
Q 035895 311 SLDLSNNNLSE 321 (527)
Q Consensus 311 ~L~ls~N~l~~ 321 (527)
.|++++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=229.19 Aligned_cols=147 Identities=26% Similarity=0.424 Sum_probs=123.5
Q ss_pred HHHHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCc
Q 035895 377 YQELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSN 423 (527)
Q Consensus 377 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~ 423 (527)
..+.....++|++.++||+|+||+||+|+. .+|+.||||++.. .+..
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344455678899999999999999999997 4789999999852 1234
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
++..++||||++||+|.+++.+.+..+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 45678999999999999999876667889899999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+....... ......+||++||||
T Consensus 210 ~~~~~~~~-~~~~~~~Gt~~Y~AP 232 (412)
T 2vd5_A 210 LKLRADGT-VRSLVAVGTPDYLSP 232 (412)
T ss_dssp EECCTTSC-EECSSCCSCGGGCCH
T ss_pred eeccCCCc-cccceeccccCcCCH
Confidence 87754322 122345789999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=226.10 Aligned_cols=143 Identities=21% Similarity=0.268 Sum_probs=117.3
Q ss_pred hhcCCccccceeccCCceEEEEEE------ccCCcEEEEEEEee-----------------------------ccCccce
Q 035895 382 RATDGFSANNLIGRGSFGSVYKAR------LQDGMEFAIKVFHF-----------------------------SCSNEDF 426 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~------~~~~~~vavK~~~~-----------------------------~~~~~~~ 426 (527)
...+.|.+.+.||+|+||+||+|. ..+++.||||++.. .+..++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345679999999999999999994 45689999999742 1223456
Q ss_pred eEEEEEeccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----------
Q 035895 427 RALVLEYTTNGSLEKVLYS----SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD----------- 491 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~----------- 491 (527)
.++|||||++|+|.+++.. .+..+++..+..|+.|++.||+||| +++||||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccc
Confidence 7899999999999999975 2456899999999999999999999 999999999999999998
Q ss_pred CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.+||+|||+|+.+.........+..+||++||||
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP 254 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh
Confidence 899999999999765422222233456789999998
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=206.61 Aligned_cols=196 Identities=19% Similarity=0.227 Sum_probs=126.7
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCc-cccccchhhcCCcCCcEEEeec-CcccccCcccccCCCCCCEE
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCN-ISGGISEEIGNLTDLISIDLGG-NKLNGSISITLGKLQKLQFL 169 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L 169 (527)
+|++|++++|+++++.+..+..+. +|+.|++++|. ++.+.+..|..+++|++|++++ |++++..+..|..+++|+.|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~-~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCT-TCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcceEECHHHccCCC-CCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 566777777777665555555543 57777777775 6666666677777777777776 77776666667777777777
Q ss_pred eccCcccccccChhhhcCcccC---eeeeecc-cCCCCCCccccCCccCc-eeeCCCCCCCCCchhhhCCCCccEEEccC
Q 035895 170 SFRGNELEGSIPNVLCHLAVLF---QLDLRGN-KLSGSIPTCFGNLTALR-NLHLDSNELTSIPSILWNLKDILYLDFWS 244 (527)
Q Consensus 170 ~l~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~lp~~~~~l~~L~~l~l~~ 244 (527)
++++|.+++ +|. |..+++|+ .|++++| ++++..+..|.++++|+ +|++++|+++.+|...+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~------------ 176 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF------------ 176 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTT------------
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhc------------
Confidence 777777764 444 66666666 7777777 77666666677777777 77777777766654332
Q ss_pred CcccccCCccccCCCCCCEEEccCCC-CCCCChhhhhcC-CCCCEEEcccccceeecCCCCCCCCCCCEEeCCCC
Q 035895 245 NLFVGPLPSKIGNLKVLTRIDFSRNN-LLGDIPTTIQGL-KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317 (527)
Q Consensus 245 n~~~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 317 (527)
.. ++|++|++++|+ +.+..+..|.++ ++|++|++++|++++. |.. .+++|+.|+++++
T Consensus 177 -----------~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 177 -----------NG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp -----------TT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred -----------CC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 22 456666666663 655555566666 6677777777776643 332 4556667776655
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=211.59 Aligned_cols=210 Identities=20% Similarity=0.239 Sum_probs=162.5
Q ss_pred CCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCC
Q 035895 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQ 167 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 167 (527)
..+++|+.|++++|.++.. + .+..+ ++|++|++++|.+++. +.+..+++|++|++++|++++..+..|..+++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~~~-~-~l~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKSV-Q-GIQYL-PNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHTTCCEEECTTSCCCCC-T-TGGGC-TTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred ccccceeeeeeCCCCcccc-c-ccccC-CCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 4566777777777777643 2 34444 3677777777777653 3677778888888888888777776777888888
Q ss_pred EEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchh-hhCCCCccEEEccCCc
Q 035895 168 FLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI-LWNLKDILYLDFWSNL 246 (527)
Q Consensus 168 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~l~l~~n~ 246 (527)
+|++++|++++..+..|..+++|++|++++|++++..+..|+.+++|++|++++|+++++|.. +..+++|+.|++++|.
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 888888888776666777888888888888888877777778888888888888888877654 4667888888888888
Q ss_pred ccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCC
Q 035895 247 FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSL 309 (527)
Q Consensus 247 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 309 (527)
+.+..|..+..+++|++|++++|.+.+. +++|+.|+++.|.++|.+|..++.+...
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 8877777788999999999999988754 4478899999999999999998876543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=209.98 Aligned_cols=203 Identities=22% Similarity=0.207 Sum_probs=158.9
Q ss_pred hcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCc
Q 035895 136 IGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALR 215 (527)
Q Consensus 136 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 215 (527)
+..+++++++++++|.++.. |..+ .++++.|++++|.+++..|..|..+++|+.|++++|.|++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~i-p~~~--~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTAL-PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSSC-CSCC--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCcC-CCCC--CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 44566667777777776643 3222 25677777777777766666777777777777777777654332 6677777
Q ss_pred eeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccc
Q 035895 216 NLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL 295 (527)
Q Consensus 216 ~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 295 (527)
+|++++|+++.+|..+..+++|++|++++|++.+..|..|..+++|++|++++|++.+..+..|..+++|+.|+|++|++
T Consensus 81 ~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 88888887777777777777788888888877777778899999999999999999988888899999999999999999
Q ss_pred eeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeeeeee
Q 035895 296 QGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 296 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~~~~ 344 (527)
++..+..|..+++|+.|+|++|+++. +|..+..+..|+.+.+..+.+.
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBC
T ss_pred CccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCcc
Confidence 98777788999999999999999985 5666677788999988877663
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=208.57 Aligned_cols=196 Identities=18% Similarity=0.194 Sum_probs=129.3
Q ss_pred cccEEEcccCccccccchhhcCCcCCcEEEeecCc-ccccCcccccCCCCCCEEeccC-cccccccChhhhcCcccCeee
Q 035895 117 SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNK-LNGSISITLGKLQKLQFLSFRG-NELEGSIPNVLCHLAVLFQLD 194 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~ 194 (527)
+|+.|++++|++++..+..|..+++|++|++++|+ +++..+..|..+++|+.|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666665555566666666666666664 5555555555666666666665 555544445555555555555
Q ss_pred eecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCC-cccccCCccccCCCCCC-EEEccCCCCC
Q 035895 195 LRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN-LFVGPLPSKIGNLKVLT-RIDFSRNNLL 272 (527)
Q Consensus 195 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n-~~~~~~p~~~~~l~~L~-~L~Ls~N~l~ 272 (527)
+++|++++ +|. |..+++|+ .|++|++++| .+.+..+..|..+++|+ +|++++|.+.
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~--------------------~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTD--------------------IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCC--------------------SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred CCCCCCcc-ccc-cccccccc--------------------cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 55555554 333 55555554 0014444444 44444455678889999 9999999998
Q ss_pred CCChhhhhcCCCCCEEEccccc-ceeecCCCCCCC-CCCCEEeCCCCcccccCccchhhhccCCeeEe
Q 035895 273 GDIPTTIQGLKSLQFLSLGHNR-LQGSIPNSFDDL-VSLESLDLSNNNLSEIIPLSLEKLLYLNILLI 338 (527)
Q Consensus 273 ~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~ 338 (527)
...+..|.. ++|++|++++|+ +++..+..|.++ ++|+.|++++|+++++++..+. .|+.|.+
T Consensus 170 ~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~---~L~~L~l 233 (239)
T 2xwt_C 170 SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLE---HLKELIA 233 (239)
T ss_dssp EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCT---TCSEEEC
T ss_pred ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhc---cCceeec
Confidence 544455555 899999999995 998888899999 9999999999999987666444 4444443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=224.24 Aligned_cols=144 Identities=26% Similarity=0.420 Sum_probs=120.6
Q ss_pred HHHhhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCcc
Q 035895 378 QELLRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNE 424 (527)
Q Consensus 378 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~ 424 (527)
.++....++|++.++||+|+||+||+|+.. +++.||+|++.. .+..+
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344556788999999999999999999865 689999999742 12345
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
+..++|||||+||+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 5678999999999999998753 4788888999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... ......+||++||||
T Consensus 217 ~~~~~~~-~~~~~~~gt~~Y~AP 238 (410)
T 3v8s_A 217 KMNKEGM-VRCDTAVGTPDYISP 238 (410)
T ss_dssp ECCTTSE-EECCSCCSCGGGCCH
T ss_pred eeccCCc-ccccCCcCCccccCH
Confidence 7754321 122346799999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=217.78 Aligned_cols=139 Identities=32% Similarity=0.424 Sum_probs=112.8
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------cCccceeE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------CSNEDFRA 428 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------~~~~~~~~ 428 (527)
..++|++.++||+|+||+||+|+. .+++.||||++... +..++..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 457899999999999999999986 46899999997521 12345678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+|||||+||+|.+++... ..+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999764 35788899999999999999999 99999999999999999999999999999986432
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.. ......+||++||||
T Consensus 177 ~~--~~~~~~~gt~~y~aP 193 (353)
T 3txo_A 177 NG--VTTATFCGTPDYIAP 193 (353)
T ss_dssp -----------CCGGGCCH
T ss_pred CC--ccccccCCCcCeECh
Confidence 22 122345789999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=212.86 Aligned_cols=155 Identities=41% Similarity=0.599 Sum_probs=128.5
Q ss_pred cccccHHHHhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec------------------------------c
Q 035895 372 RRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------C 421 (527)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------~ 421 (527)
.+.++++++....++|+..+.||+|+||.||+|+.++++.||||++... +
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3567888999999999999999999999999999888999999987431 2
Q ss_pred CccceeEEEEEeccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 035895 422 SNEDFRALVLEYTTNGSLEKVLYSSN---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 422 ~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~ 498 (527)
..++..++||||+++|+|.+++.... ..+++..+..++.+++.||+|||..+..+|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 33456689999999999999997643 248899999999999999999993223399999999999999999999999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++....... .......||++|+||
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aP 204 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAP 204 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCH
T ss_pred cCccccccCcccc-cccccccCCcCccCH
Confidence 9999987753322 223345589999998
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.6e-24 Score=212.35 Aligned_cols=239 Identities=18% Similarity=0.139 Sum_probs=147.5
Q ss_pred EEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCcccccc-chhhcCCcCCcE-
Q 035895 67 LSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGI-SEEIGNLTDLIS- 144 (527)
Q Consensus 67 L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~- 144 (527)
++-++++|+++|..+ .+++++|+|++|+|+.+.+..|.++. +|++|+|++|.+.+.+ +..|.+++++.+
T Consensus 14 v~C~~~~Lt~iP~~l--------~~~l~~L~Ls~N~i~~i~~~~f~~l~-~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~ 84 (350)
T 4ay9_X 14 FLCQESKVTEIPSDL--------PRNAIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEI 84 (350)
T ss_dssp EEEESTTCCSCCTTC--------CTTCSEEEEESCCCSEECTTSSTTCT-TCCEEEEECCTTCCEECTTSBCSCTTCCEE
T ss_pred EEecCCCCCccCcCc--------CCCCCEEEccCCcCCCcCHHHHcCCC-CCCEEECcCCCCCCccChhHhhcchhhhhh
Confidence 444555555554432 14567777777777765445565554 5777777777764433 445667766654
Q ss_pred EEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec-ccCCCCCCccccCCc-cCceeeCCCC
Q 035895 145 IDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG-NKLSGSIPTCFGNLT-ALRNLHLDSN 222 (527)
Q Consensus 145 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~L~~N 222 (527)
+.++.|+++...+..|..+++|+.|++++|+++...+..+.....+..|++.+ |++....+..|..+. .++.|++++|
T Consensus 85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N 164 (350)
T 4ay9_X 85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164 (350)
T ss_dssp EEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred hcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence 55566777777677777777777777777777766555666666677777754 566666666676664 4777888888
Q ss_pred CCCCCchhhhCCCCccEEEccCCcccccC-CccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCC
Q 035895 223 ELTSIPSILWNLKDILYLDFWSNLFVGPL-PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301 (527)
Q Consensus 223 ~l~~lp~~~~~l~~L~~l~l~~n~~~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 301 (527)
+|+.+|...+...+|+.+++++++..+.+ ++.|..+++|++||+++|+++...+..|. +|+.|.+.++.-...+|
T Consensus 165 ~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~~lP- 240 (350)
T 4ay9_X 165 GIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLKKLP- 240 (350)
T ss_dssp CCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCCCCC-
T ss_pred cccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcCcCC-
Confidence 88777776666666777777643333333 34567777777777777777654443333 34444433332222455
Q ss_pred CCCCCCCCCEEeCCCCc
Q 035895 302 SFDDLVSLESLDLSNNN 318 (527)
Q Consensus 302 ~~~~l~~L~~L~ls~N~ 318 (527)
.+..+++|+.++++++.
T Consensus 241 ~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 241 TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CTTTCCSCCEEECSCHH
T ss_pred CchhCcChhhCcCCCCc
Confidence 36667777777776543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=217.90 Aligned_cols=139 Identities=29% Similarity=0.370 Sum_probs=116.7
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRA 428 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~ 428 (527)
..++|++.++||+|+||+||+|+.+ +++.||||++... +..++..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4567999999999999999999864 6889999998531 12345678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+|||||+||+|..++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 130 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999998764 35788899999999999999999 99999999999999999999999999999986432
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+||+.||||
T Consensus 206 ~~~--~~~~~~gt~~Y~aP 222 (396)
T 4dc2_A 206 PGD--TTSTFCGTPNYIAP 222 (396)
T ss_dssp TTC--CBCCCCBCGGGCCH
T ss_pred CCC--ccccccCCcccCCc
Confidence 221 22346789999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=214.03 Aligned_cols=141 Identities=28% Similarity=0.405 Sum_probs=116.8
Q ss_pred hhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccce
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDF 426 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~ 426 (527)
....++|++.+.||+|+||.||+|+.+ +++.||||+++.. +..++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345688999999999999999999974 6899999998531 123456
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||++||+|.+++... ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 78999999999999999764 35788899999999999999999 999999999999999999999999999999865
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... .....+||++|+||
T Consensus 169 ~~~~~--~~~~~~gt~~y~aP 187 (345)
T 1xjd_A 169 MLGDA--KTNTFCGTPDYIAP 187 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCH
T ss_pred ccCCC--cccCCCCCcccCCh
Confidence 32221 12345789999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-24 Score=212.90 Aligned_cols=138 Identities=28% Similarity=0.424 Sum_probs=116.0
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||+||+|+.. +|+.||||+++. .+...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999864 689999999853 12234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||++||+|.+++... ..++..++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+......
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999998754 35788889999999999999999 9999999999999999999999999999998643222
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. .....+||+.||||
T Consensus 160 ~--~~~~~~gt~~y~aP 174 (337)
T 1o6l_A 160 A--TMKTFCGTPEYLAP 174 (337)
T ss_dssp C--CBCCCEECGGGCCG
T ss_pred C--cccccccChhhCCh
Confidence 1 22345789999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=213.82 Aligned_cols=152 Identities=39% Similarity=0.614 Sum_probs=124.0
Q ss_pred ccccHHHHhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEee-----------------------------ccCc
Q 035895 373 RRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF-----------------------------SCSN 423 (527)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~-----------------------------~~~~ 423 (527)
.++.+.++...+++|+..+.||+|+||.||+|+.++++.||||++.. .+..
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34445556678899999999999999999999998899999998642 1234
Q ss_pred cceeEEEEEeccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSN---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Df 500 (527)
++..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+|++||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence 456789999999999999886543 24789999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccceeccccccccccC
Q 035895 501 GIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+++...............||+.|+||
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aP 210 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDP 210 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCH
T ss_pred ccccccccccccccccccCCCccccCH
Confidence 999875433222223345588999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=214.70 Aligned_cols=139 Identities=24% Similarity=0.329 Sum_probs=116.3
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRA 428 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~ 428 (527)
..++|++.+.||+|+||.||+|+.. +++.||||++... +..++..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4678999999999999999999975 5789999997521 12345678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||++||+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999997643 5788899999999999999999 99999999999999999999999999999986432
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+||+.||||
T Consensus 174 ~~~--~~~~~~gt~~y~aP 190 (353)
T 2i0e_A 174 DGV--TTKTFCGTPDYIAP 190 (353)
T ss_dssp TTC--CBCCCCSCGGGCCH
T ss_pred CCc--ccccccCCccccCh
Confidence 221 22345789999998
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-23 Score=198.37 Aligned_cols=179 Identities=27% Similarity=0.317 Sum_probs=114.5
Q ss_pred ccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec
Q 035895 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 197 (527)
.+.++++++.++. +|..+. +++++|+|++|++++..+..|..+++|++|++++|.+++..|..|..+++|++|++++
T Consensus 16 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 4445555555442 222222 3455555555555555555555556666666666666555555556666666666666
Q ss_pred ccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChh
Q 035895 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT 277 (527)
Q Consensus 198 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 277 (527)
|++++..+..|..+++|++|+|++|+++.+|. ..|..+++|++|+|++|++.+..+.
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----------------------~~~~~l~~L~~L~Ls~N~l~~~~~~ 149 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPS-----------------------GVFDRLTKLKELRLNTNQLQSIPAG 149 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT-----------------------TTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcCh-----------------------hHhccCCcccEEECcCCcCCccCHH
Confidence 66665555566666666666666666655442 3355667777777777777766666
Q ss_pred hhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccccc
Q 035895 278 TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322 (527)
Q Consensus 278 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 322 (527)
.|..+++|++|+|++|++++..+..|..+++|+.|++++|++...
T Consensus 150 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 777888888888888888877777788888888888888888764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-23 Score=204.33 Aligned_cols=191 Identities=23% Similarity=0.352 Sum_probs=107.8
Q ss_pred cccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeee
Q 035895 117 SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 196 (527)
+|+.|++++|.++.. + .+..+++|++|++++|++++..+ +..+++|+.|++++|.+++. +.+..+++|+.|+++
T Consensus 42 ~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECC
Confidence 344444444444432 2 34445555555555555543332 45555555555555555432 235555555555555
Q ss_pred cccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh
Q 035895 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276 (527)
Q Consensus 197 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 276 (527)
+|++++. |. +..+++|++|++++|+++.++. +..+++|+.|++++|.+.+..+ +..+++|++|++++|.+++..+
T Consensus 116 ~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 116 STQITDV-TP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP 190 (308)
T ss_dssp TSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG
T ss_pred CCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh
Confidence 5555542 21 5555555555555555555544 4455555555555555544222 5667777777777777765433
Q ss_pred hhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccccc
Q 035895 277 TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322 (527)
Q Consensus 277 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 322 (527)
+..+++|++|++++|++++..| +..+++|+.|++++|++++.
T Consensus 191 --l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp --GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred --hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 6777777777777777775443 67777777888877777653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-25 Score=228.69 Aligned_cols=238 Identities=20% Similarity=0.217 Sum_probs=169.0
Q ss_pred cCCCCCCCCEEEcccCCCCcccChh----HhhccccccEEEcccCc---cccccchhh-------cCCcCCcEEEeecCc
Q 035895 86 SMSNCKYLKKLDISRNPLDGFLPRV----VGNFSQSLEFIWMSDCN---ISGGISEEI-------GNLTDLISIDLGGNK 151 (527)
Q Consensus 86 ~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~~~~~L~~L~Ls~n~---l~~~~~~~~-------~~l~~L~~L~L~~N~ 151 (527)
.+..+++|++|+|++|.++...+.. +..+ ++|++|+|++|. +++.+|..+ ..+++|++|+|++|+
T Consensus 27 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~-~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 27 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASK-KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTC-TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHhcCCCccEEECCCCCCCHHHHHHHHHHHHhC-CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 3455677777788777777653333 2233 367777777753 333444444 677888888888888
Q ss_pred ccc----cCcccccCCCCCCEEeccCcccccccChh----hhcC---------cccCeeeeecccCC-CCCC---ccccC
Q 035895 152 LNG----SISITLGKLQKLQFLSFRGNELEGSIPNV----LCHL---------AVLFQLDLRGNKLS-GSIP---TCFGN 210 (527)
Q Consensus 152 l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~----~~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~ 210 (527)
++. .++..+..+++|+.|+|++|.++...+.. +..+ ++|++|++++|+++ ...| ..+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 876 35666777888888888888886443333 3333 78888888888886 3344 35667
Q ss_pred CccCceeeCCCCCCCC------CchhhhCCCCccEEEccCCccc----ccCCccccCCCCCCEEEccCCCCCCC----Ch
Q 035895 211 LTALRNLHLDSNELTS------IPSILWNLKDILYLDFWSNLFV----GPLPSKIGNLKVLTRIDFSRNNLLGD----IP 276 (527)
Q Consensus 211 l~~L~~L~L~~N~l~~------lp~~~~~l~~L~~l~l~~n~~~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p 276 (527)
+++|++|++++|+++. +|..+..+++|+.|++++|.+. ..+|..+..+++|++|+|++|.+.+. +|
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 7888888888888872 2336667788888888888875 56677788888888889988888765 45
Q ss_pred hhhhc--CCCCCEEEccccccee----ecCCCC-CCCCCCCEEeCCCCcccccCc
Q 035895 277 TTIQG--LKSLQFLSLGHNRLQG----SIPNSF-DDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 277 ~~~~~--l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~~~p 324 (527)
..+.. +++|++|+|++|.+++ .+|..+ ..+++|+.|++++|++++..+
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 66643 8889999999998886 366666 557888999999998887654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=213.77 Aligned_cols=136 Identities=29% Similarity=0.335 Sum_probs=113.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
++|+..+.||+|+||+||+|+.. +++.||||++.. .+...+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46999999999999999999875 789999998632 123345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+ +|+|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 67999998877677899999999999999999999 8999999999999999999999999999998764332
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......||++|+||
T Consensus 212 --~~~~~~gt~~y~aP 225 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAP 225 (311)
T ss_dssp -----CCCCCGGGCCG
T ss_pred --CCcccCCCccccCH
Confidence 12334589999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=211.83 Aligned_cols=139 Identities=27% Similarity=0.400 Sum_probs=118.2
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRAL 429 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~l 429 (527)
...++|++.+.||+|+||.||+|+. .+|+.||||++... +..++..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3467899999999999999999986 67999999997531 223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++...+ .++...+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999987643 5788889999999999999999 999999999999999999999999999999876533
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
. .....+||++|+||
T Consensus 168 ~---~~~~~~gt~~y~aP 182 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAP 182 (328)
T ss_dssp C---GGGTTSSSGGGCCH
T ss_pred C---ccccccCCcceeCc
Confidence 2 22345689999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-24 Score=215.43 Aligned_cols=141 Identities=26% Similarity=0.452 Sum_probs=115.4
Q ss_pred cCCccccceeccCCceEEEEEEc--------cCCcEEEEEEEee-------------------------------ccCcc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL--------QDGMEFAIKVFHF-------------------------------SCSNE 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~-------------------------------~~~~~ 424 (527)
.++|++.+.||+|+||.||+|+. .++..||||+++. .+..+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46789999999999999999975 2456799998742 12344
Q ss_pred ceeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
+..++||||+++|+|.+++.... ..+++.++..++.||+.||+||| +++|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 56789999999999999997643 24788899999999999999999 9999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+.++.+||+|||+|+...............+|+.||||
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 274 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence 99999999999999976543322223344567889998
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-25 Score=223.95 Aligned_cols=237 Identities=20% Similarity=0.245 Sum_probs=136.7
Q ss_pred CCCCEEEcccCCCCcccC----hhHhhccccccEEEcccCccccccchhhcCC-----cCCcEEEeecCcccccCccccc
Q 035895 91 KYLKKLDISRNPLDGFLP----RVVGNFSQSLEFIWMSDCNISGGISEEIGNL-----TDLISIDLGGNKLNGSISITLG 161 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~----~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~ 161 (527)
++|++|||++|.+++..+ ..+..+..+|+.|+|++|.++...+..+..+ ++|++|+|++|++++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 335556666665554433 3333332245566666665555544444443 5566666666665544443222
Q ss_pred ----CC-CCCCEEeccCcccccccChhhhc-----CcccCeeeeecccCCCCCC----ccccCCc-cCceeeCCCCCCCC
Q 035895 162 ----KL-QKLQFLSFRGNELEGSIPNVLCH-----LAVLFQLDLRGNKLSGSIP----TCFGNLT-ALRNLHLDSNELTS 226 (527)
Q Consensus 162 ----~l-~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~ 226 (527)
.+ ++|+.|++++|.+++..+..+.. .++|++|+|++|.++...+ ..+..++ +|++|+|++|+++.
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 22 55666666666665444333322 2356666666666653222 2233333 56666666666654
Q ss_pred Cch-----hhhCC-CCccEEEccCCccccc----CCccccC-CCCCCEEEccCCCCCCCChh----hhhcCCCCCEEEcc
Q 035895 227 IPS-----ILWNL-KDILYLDFWSNLFVGP----LPSKIGN-LKVLTRIDFSRNNLLGDIPT----TIQGLKSLQFLSLG 291 (527)
Q Consensus 227 lp~-----~~~~l-~~L~~l~l~~n~~~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~ 291 (527)
.+. .+... ++|++|++++|.+... ++..+.. .++|++|+|++|.+.+..+. .+..+++|++|+++
T Consensus 182 ~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~ 261 (362)
T 3goz_A 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261 (362)
T ss_dssp SCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEE
T ss_pred hhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEec
Confidence 321 22233 3666666666665542 3344444 35888899999988876553 34667889999999
Q ss_pred ccccee-------ecCCCCCCCCCCCEEeCCCCcccccCccch
Q 035895 292 HNRLQG-------SIPNSFDDLVSLESLDLSNNNLSEIIPLSL 327 (527)
Q Consensus 292 ~N~l~~-------~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 327 (527)
+|.+.+ .++..+..+++|+.||+++|++.+..+..+
T Consensus 262 ~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 262 YDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp HHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred cCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 998432 345678888999999999999887654433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-25 Score=222.65 Aligned_cols=249 Identities=18% Similarity=0.188 Sum_probs=199.2
Q ss_pred EEEcccCCCCcccChhHhhccccccEEEcccCccccccc----hhhcCCc-CCcEEEeecCcccccCcccccCC-----C
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGIS----EEIGNLT-DLISIDLGGNKLNGSISITLGKL-----Q 164 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~ 164 (527)
.++++.|.+++.+|..+. ..++|+.|+|++|.++...+ ..+..++ +|++|+|++|++++..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~~~-~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTS-IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHHHT-SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHHHh-CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 468999999998777654 44579999999999998777 7888898 99999999999998777777765 9
Q ss_pred CCCEEeccCcccccccChhhhc----C-cccCeeeeecccCCCCCCcccc----C-CccCceeeCCCCCCCC-----Cch
Q 035895 165 KLQFLSFRGNELEGSIPNVLCH----L-AVLFQLDLRGNKLSGSIPTCFG----N-LTALRNLHLDSNELTS-----IPS 229 (527)
Q Consensus 165 ~L~~L~l~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~L~~N~l~~-----lp~ 229 (527)
+|+.|++++|.+++..+..+.. + ++|+.|++++|++++..+..+. . .++|++|+|++|.++. ++.
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 9999999999999777665444 4 8999999999999877765543 3 3699999999999984 455
Q ss_pred hhhCCC-CccEEEccCCcccccCCcccc----CC-CCCCEEEccCCCCCCC----Chhhhhc-CCCCCEEEcccccceee
Q 035895 230 ILWNLK-DILYLDFWSNLFVGPLPSKIG----NL-KVLTRIDFSRNNLLGD----IPTTIQG-LKSLQFLSLGHNRLQGS 298 (527)
Q Consensus 230 ~~~~l~-~L~~l~l~~n~~~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~ 298 (527)
.+...+ +|++|++++|.+.+..+..+. .+ ++|++|+|++|.+.+. ++..+.. .++|++|+|++|++++.
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 240 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence 556665 999999999999877765444 44 5999999999999863 4556666 45999999999999864
Q ss_pred cC----CCCCCCCCCCEEeCCCCcccccCcc-------chhhhccCCeeEeeeeeee
Q 035895 299 IP----NSFDDLVSLESLDLSNNNLSEIIPL-------SLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 299 ~p----~~~~~l~~L~~L~ls~N~l~~~~p~-------~~~~l~~L~~L~~~~~~~~ 344 (527)
.+ ..+..+++|+.|++++|.+.++.+. .+..+..|+.|+++.+.+.
T Consensus 241 ~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~ 297 (362)
T 3goz_A 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297 (362)
T ss_dssp CHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred HHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence 33 4567889999999999997665543 4556667777777766654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-25 Score=220.80 Aligned_cols=229 Identities=16% Similarity=0.226 Sum_probs=108.1
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCccccc-cchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEe
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGG-ISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS 170 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 170 (527)
.++.|++++|.+.+..+.. ..+ ++|+.|++++|.+++. ++..+..+++|++|++++|.+++..+..++.+++|+.|+
T Consensus 71 ~l~~L~l~~n~l~~~~~~~-~~~-~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAEH-FSP-FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TCSEEECTTCEECSCCCSC-CCC-BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred cceEEEcCCccccccchhh-ccC-CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 3444444444444433322 122 2344444444444433 344444455555555555555444444444555555555
Q ss_pred ccCc-cccc-ccChhhhcCcccCeeeeecc-cCCCC-CCccccCCc-cCceeeCCCC--CCC--CCchhhhCCCCccEEE
Q 035895 171 FRGN-ELEG-SIPNVLCHLAVLFQLDLRGN-KLSGS-IPTCFGNLT-ALRNLHLDSN--ELT--SIPSILWNLKDILYLD 241 (527)
Q Consensus 171 l~~N-~l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~L~~N--~l~--~lp~~~~~l~~L~~l~ 241 (527)
+++| .+++ .++..+..+++|+.|++++| .+++. ++..+..++ +|++|++++| .++ .+|..+..+++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 5555 3433 13444445555555555555 44432 234444555 5555555555 232 2444444455555555
Q ss_pred ccCCc-ccccCCccccCCCCCCEEEccCCCCCCCChh---hhhcCCCCCEEEcccccceeecCCCCCCCC-CCCEEeCCC
Q 035895 242 FWSNL-FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT---TIQGLKSLQFLSLGHNRLQGSIPNSFDDLV-SLESLDLSN 316 (527)
Q Consensus 242 l~~n~-~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~ 316 (527)
+++|. +++..+..+..+++|++|++++|. +..+. .+..+++|++|++++| ++ ...+..+. .++.|++++
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~ 302 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINC 302 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESC
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEec
Confidence 55555 344444455555666666666654 12222 3555666666666655 21 11222221 244555566
Q ss_pred CcccccCccchh
Q 035895 317 NNLSEIIPLSLE 328 (527)
Q Consensus 317 N~l~~~~p~~~~ 328 (527)
|++++..|..+.
T Consensus 303 n~l~~~~~~~~~ 314 (336)
T 2ast_B 303 SHFTTIARPTIG 314 (336)
T ss_dssp CCSCCTTCSSCS
T ss_pred ccCccccCCccc
Confidence 666665555443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.3e-24 Score=209.61 Aligned_cols=140 Identities=27% Similarity=0.407 Sum_probs=115.8
Q ss_pred hhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCc----cceeEE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSN----EDFRAL 429 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~----~~~~~l 429 (527)
...++|++.+.||+|+||.||+|+.. ++.||||++... +.. ....++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 34567999999999999999999876 789999997421 011 123589
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEecCCCCCCeeeCCCCcEEEee
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST----------PIIHCDLKPHNKLLDDNIVAHLSD 499 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~----------~iiHrdlk~~nill~~~~~~kl~D 499 (527)
||||+++|+|.+++... .+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999999764 4789999999999999999999 77 999999999999999999999999
Q ss_pred cccccccCCCCCccceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+|+...............||+.|+||
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aP 202 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAP 202 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred CCcccccccccCccccccCccCccccCH
Confidence 9999877544332233345689999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-24 Score=213.58 Aligned_cols=139 Identities=32% Similarity=0.425 Sum_probs=115.3
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRA 428 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~ 428 (527)
..++|++.+.||+|+||.||+|+.+ +++.||||+++.. +..++..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3467999999999999999999875 5889999987421 12334668
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||++||+|.+++...+ .++...+..++.+|+.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 116 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999997643 5778888899999999999999 99999999999999999999999999999986432
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+||+.||||
T Consensus 192 ~~~--~~~~~~gt~~y~aP 208 (373)
T 2r5t_A 192 HNS--TTSTFCGTPEYLAP 208 (373)
T ss_dssp CCC--CCCSBSCCCCCCCH
T ss_pred CCC--ccccccCCccccCH
Confidence 221 22345789999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=208.02 Aligned_cols=135 Identities=33% Similarity=0.438 Sum_probs=115.6
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
.++|++.+.||+|+||.||+|+.. +|+.||+|++... +..++..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999864 7899999997521 2234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||++||+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999999764 35788888999999999999999 999999999999999999999999999999876432
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
....+||+.||||
T Consensus 160 ----~~~~~gt~~y~aP 172 (318)
T 1fot_A 160 ----TYTLCGTPDYIAP 172 (318)
T ss_dssp ----BCCCCSCTTTCCH
T ss_pred ----cccccCCccccCH
Confidence 1235689999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=206.24 Aligned_cols=141 Identities=27% Similarity=0.440 Sum_probs=116.3
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey 433 (527)
.++|++.+.||+|+||+||+|+. .+++.||+|++.. .+..++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46789999999999999999986 4689999998632 12334567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999876677899999999999999999999 9999999999999999999999999999998764332111
Q ss_pred c------------eeccccccccccC
Q 035895 514 T------------QTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~------------~~~~~~t~~y~aP 527 (527)
. .....||++|+||
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAP 191 (310)
T ss_dssp --------------CCCCSCGGGCCH
T ss_pred cccccccccccccccccCCCcceeCH
Confidence 0 1134689999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=204.88 Aligned_cols=137 Identities=31% Similarity=0.449 Sum_probs=116.1
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey 433 (527)
.+.|++.+.||+|+||.||+|+. .+++.||||++... +..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35799999999999999999985 67899999997531 2234567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++... .+++.+...++.+++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 9999999999754 5788899999999999999999 89999999999999999999999999999987654322
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......||+.|+||
T Consensus 172 ~~~~~~gt~~y~aP 185 (297)
T 3fxz_A 172 KRSTMVGTPYWMAP 185 (297)
T ss_dssp CBCCCCSCGGGCCH
T ss_pred ccCCccCCcCccCh
Confidence 22345689999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=210.61 Aligned_cols=138 Identities=30% Similarity=0.372 Sum_probs=115.8
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------cCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------CSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------~~~~~~~~l 429 (527)
.++|++.+.||+|+||.||+|+.. +++.||||++... +..++..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999964 6899999998531 123456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||++||+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999998754 35788899999999999999999 999999999999999999999999999999864322
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .....+||+.|+||
T Consensus 164 ~~--~~~~~~gt~~y~aP 179 (345)
T 3a8x_A 164 GD--TTSTFCGTPNYIAP 179 (345)
T ss_dssp TC--CBCCCCSCGGGCCH
T ss_pred CC--cccccCCCccccCc
Confidence 21 22345789999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.4e-24 Score=215.04 Aligned_cols=142 Identities=26% Similarity=0.412 Sum_probs=116.7
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee------------------------------ccCccceeEEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~------------------------------~~~~~~~~~lv~ 431 (527)
..++|++.+.||+|+||.||+|+.. +++.||||+++. .+..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467889999999999999999975 789999998742 123345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++|+|.+++...+..+++.+...++.|++.||+||| +++|+||||||+||++++++.+||+|||+|+.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999876667899999999999999999999 99999999999999999999999999999987543211
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
........+++.|+||
T Consensus 269 ~~~~~~~~~~~~y~aP 284 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAP 284 (377)
T ss_dssp ECCSSCCEEEGGGSCH
T ss_pred eecCCCCCCCcCcCCH
Confidence 1111122357789998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=208.07 Aligned_cols=139 Identities=37% Similarity=0.564 Sum_probs=112.8
Q ss_pred hcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------------cCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------------CSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------------~~~~~~~~l 429 (527)
..++|++.+.||+|+||.||+|+. +++.||||++... .......++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 457899999999999999999976 6789999997421 111224579
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEecCCCCCCeeeCCCCcEEEeec
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST---------PIIHCDLKPHNKLLDDNIVAHLSDF 500 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~---------~iiHrdlk~~nill~~~~~~kl~Df 500 (527)
||||+++|+|.+++.... .++.....++.|++.||+||| +. +|+||||||+||+++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999999997543 478888999999999999999 77 9999999999999999999999999
Q ss_pred ccccccCCCCC------ccceeccccccccccC
Q 035895 501 GIAKLLTGEDQ------SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~------~~~~~~~~~t~~y~aP 527 (527)
|+|+.+..... ........||+.|+||
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 197 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP 197 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred cceeecccccccCccccccccccCCCccceeCc
Confidence 99987653221 1112234689999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=227.39 Aligned_cols=140 Identities=24% Similarity=0.321 Sum_probs=117.2
Q ss_pred hhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee---------------------------------ccCcccee
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF---------------------------------SCSNEDFR 427 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~---------------------------------~~~~~~~~ 427 (527)
...++|++.++||+|+||.||+|+.. +++.||||++.. .....+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34678999999999999999999864 688999999752 12234567
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||++||+|.+++...+ .+++..+..|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 89999999999999997653 5788899999999999999999 9999999999999999999999999999998643
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.... .....+||++||||
T Consensus 494 ~~~~--~~~~~~GT~~Y~AP 511 (674)
T 3pfq_A 494 WDGV--TTKTFCGTPDYIAP 511 (674)
T ss_dssp CTTC--CBCCCCSCSSSCCH
T ss_pred cCCc--ccccccCCCcccCH
Confidence 2221 22346799999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=212.68 Aligned_cols=137 Identities=31% Similarity=0.439 Sum_probs=116.7
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||.||+|+. .+++.||+|++.. .+..++..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46799999999999999999986 4688999998742 12344567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||++||+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 94 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999999754 45788899999999999999999 9999999999999999999999999999999775332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.....+||++||||
T Consensus 170 ---~~~~~~gt~~Y~aP 183 (384)
T 4fr4_A 170 ---QITTMAGTKPYMAP 183 (384)
T ss_dssp ---CBCCCCSCGGGCCG
T ss_pred ---ceeccCCCccccCC
Confidence 22345789999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=207.99 Aligned_cols=141 Identities=29% Similarity=0.493 Sum_probs=114.0
Q ss_pred cCCccccceeccCCceEEEEEEcc----CCcEEEEEEEeec------------------------------cCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFS------------------------------CSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~------------------------------~~~~~~~~l 429 (527)
.+.|++.+.||+|+||.||+|+.. .+..||||++... +...+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356889999999999999999874 3456999997531 233456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++......+++.++..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999876667899999999999999999999 999999999999999999999999999999987543
Q ss_pred CCc-cceeccccccccccC
Q 035895 510 DQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~-~~~~~~~~t~~y~aP 527 (527)
... .......+|+.|+||
T Consensus 205 ~~~~~~~~~~~~t~~y~aP 223 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAP 223 (325)
T ss_dssp --CCEECC---CCGGGSCH
T ss_pred ccceeeccCCCCcccccCH
Confidence 221 222234467789998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=209.85 Aligned_cols=135 Identities=28% Similarity=0.413 Sum_probs=115.7
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||.||+|+.. +|+.||||++.. .+..++..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999864 689999999742 12234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||++||+|.+++...+ .++...+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 99999999999997643 5788889999999999999999 9999999999999999999999999999999764321
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
...+||+.|+||
T Consensus 196 -----~~~~gt~~y~aP 207 (350)
T 1rdq_E 196 -----WTLCGTPEALAP 207 (350)
T ss_dssp -----CCCEECGGGCCH
T ss_pred -----ccccCCccccCH
Confidence 235689999998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-24 Score=210.47 Aligned_cols=140 Identities=24% Similarity=0.396 Sum_probs=116.8
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee------------------------------ccCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~------------------------------~~~~~~~~~lv~e 432 (527)
.++|++.+.||+|+||+||+|+.. +++.||||++.. .+..++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999865 789999998742 1223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+......
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999988643 45789999999999999999999 999999999999999999999999999999876433222
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.......||+.|+||
T Consensus 162 ~~~~~~~gt~~y~aP 176 (323)
T 3tki_A 162 RLLNKMCGTLPYVAP 176 (323)
T ss_dssp CCBCSCCSCGGGSCH
T ss_pred cccCCCccCcCccCc
Confidence 222345689999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=206.50 Aligned_cols=148 Identities=25% Similarity=0.330 Sum_probs=120.4
Q ss_pred ccccHHHHhhhcCC----------ccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------
Q 035895 373 RRFSYQELLRATDG----------FSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------- 420 (527)
Q Consensus 373 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------- 420 (527)
..++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++...
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45666666655543 677789999999999999975 7999999997531
Q ss_pred --------cCccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 035895 421 --------CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN 492 (527)
Q Consensus 421 --------~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~ 492 (527)
+...+..++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence 2234567899999999999999854 35889999999999999999999 8999999999999999999
Q ss_pred CcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 493 IVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 493 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+.+||+|||+++....... ......||++|+||
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP 210 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAP 210 (321)
T ss_dssp CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCH
T ss_pred CcEEEeeeeeeeecccCcc--ccccccCCccccCH
Confidence 9999999999987654321 22345689999998
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=220.74 Aligned_cols=243 Identities=17% Similarity=0.191 Sum_probs=172.8
Q ss_pred CchhhhcCCCCCEEEccccccccccccccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCC---CCcccChhH-
Q 035895 36 VSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNP---LDGFLPRVV- 111 (527)
Q Consensus 36 ~~~~~~~l~~L~~L~Ls~N~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~~- 111 (527)
.+.++..+++|+.|+|++|.+....+..+ ...+..+++|++|+|++|. +++.+|..+
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l-------------------~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~ 84 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWL-------------------SENIASKKDLEIAEFSDIFTGRVKDEIPEALR 84 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHH-------------------HHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHH-------------------HHHHHhCCCccEEeCcccccCccccchhHHHH
Confidence 34566777888888888886654322110 1135566778888887753 334444444
Q ss_pred ------hhccccccEEEcccCcccc----ccchhhcCCcCCcEEEeecCcccccCccccc----CC---------CCCCE
Q 035895 112 ------GNFSQSLEFIWMSDCNISG----GISEEIGNLTDLISIDLGGNKLNGSISITLG----KL---------QKLQF 168 (527)
Q Consensus 112 ------~~~~~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l---------~~L~~ 168 (527)
..+ ++|++|+|++|.++. .+|..+..+++|++|+|++|.++...+..+. .+ ++|+.
T Consensus 85 ~l~~~l~~~-~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~ 163 (386)
T 2ca6_A 85 LLLQALLKC-PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 163 (386)
T ss_dssp HHHHHHTTC-TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCE
T ss_pred HHHHHHhhC-CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcE
Confidence 333 468888888888776 4666777788888888888887644333333 33 78888
Q ss_pred EeccCcccc-cccC---hhhhcCcccCeeeeecccCCC-----CCCccccCCccCceeeCCCCCC-----CCCchhhhCC
Q 035895 169 LSFRGNELE-GSIP---NVLCHLAVLFQLDLRGNKLSG-----SIPTCFGNLTALRNLHLDSNEL-----TSIPSILWNL 234 (527)
Q Consensus 169 L~l~~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l-----~~lp~~~~~l 234 (527)
|++++|+++ +.+| ..+..+++|+.|++++|+++. ..|..+..+++|++|+|++|.+ ..+|..+..+
T Consensus 164 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred EECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 888888886 3344 456678888888888888862 3444778888888888888888 3467777888
Q ss_pred CCccEEEccCCccccc----CCccc--cCCCCCCEEEccCCCCCC----CChhhh-hcCCCCCEEEcccccceee
Q 035895 235 KDILYLDFWSNLFVGP----LPSKI--GNLKVLTRIDFSRNNLLG----DIPTTI-QGLKSLQFLSLGHNRLQGS 298 (527)
Q Consensus 235 ~~L~~l~l~~n~~~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~ 298 (527)
++|+.|++++|.+.+. +|..+ +.+++|++|+|++|.+.+ .+|..+ .++++|++|++++|++++.
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 8888888888887755 45566 348999999999999987 477777 6789999999999998754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=8.5e-23 Score=201.25 Aligned_cols=194 Identities=19% Similarity=0.269 Sum_probs=152.2
Q ss_pred CCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCC
Q 035895 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQ 167 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 167 (527)
..+++|++|++++|.++.+ | .+..+ ++|+.|++++|.+++..+ +..+++|++|++++|++++. ..+..+++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~-~~~~l-~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTI-E-GVQYL-NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGC-TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHcCCcCEEEeeCCCccCc-h-hhhcc-CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 4567788888888887753 3 35554 368888888888876544 77888888888888888754 2577888888
Q ss_pred EEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcc
Q 035895 168 FLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLF 247 (527)
Q Consensus 168 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~ 247 (527)
.|++++|.+++. +. +..+++|+.|++++|++++..+ +..+++|+.|++++|+++.++. +..+++|+.|++++|.+
T Consensus 111 ~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 111 TLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKI 185 (308)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred EEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCcc
Confidence 888888888753 33 7888888888888888876544 7788888888888888888776 77788888888888888
Q ss_pred cccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccccccee
Q 035895 248 VGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297 (527)
Q Consensus 248 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 297 (527)
.+..+ +..+++|++|++++|++.+.. .+..+++|+.|++++|++++
T Consensus 186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 186 SDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred CcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 76543 788999999999999998654 38999999999999999974
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=193.67 Aligned_cols=178 Identities=25% Similarity=0.285 Sum_probs=117.2
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEec
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
..++++++++.++. +|..+ ..+++.|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|++
T Consensus 15 ~~~~l~~~~~~l~~-~p~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 15 GKKEVDCQGKSLDS-VPSGI---PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGTEEECTTCCCSS-CCSCC---CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCeEEecCCCCccc-cCCCC---CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 45666777776664 33332 235777777777777766777777777777777777777777777777777888888
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch-hhhCCCCccEEEccCCccccc
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGP 250 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~l~l~~n~~~~~ 250 (527)
++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+++.+|. .+..+++|+.|++++|.+.+.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 8777776666777777888888888888877777777778888888888887777654 233344444444444444433
Q ss_pred CCccccCCCCCCEEEccCCCCCC
Q 035895 251 LPSKIGNLKVLTRIDFSRNNLLG 273 (527)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~ 273 (527)
.+..+..+++|++|++++|.+..
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCT
T ss_pred CHHHHhCCCCCCEEEeeCCceeC
Confidence 33444445555555555555543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=220.44 Aligned_cols=139 Identities=29% Similarity=0.454 Sum_probs=117.9
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~l 429 (527)
..++|++.++||+|+||.||+|+.. +|+.||||++.. .+..++..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999864 799999999742 1234456789
Q ss_pred EEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 430 VLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||||++||+|.+++...+ ..+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999997653 34889999999999999999999 89999999999999999999999999999987753
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.. .....+||++||||
T Consensus 339 ~~---~~~~~~GT~~Y~AP 354 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAP 354 (576)
T ss_dssp TC---CEECCCSCGGGCCH
T ss_pred Cc---cccccCCCccccCH
Confidence 32 22345789999998
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=207.15 Aligned_cols=222 Identities=16% Similarity=0.134 Sum_probs=183.3
Q ss_pred cccEEEcccCccccccc---hhhcCCcCCcEEEeecCcccccCcccc--cCCCCCCEEeccCcccccccC----hhhhcC
Q 035895 117 SLEFIWMSDCNISGGIS---EEIGNLTDLISIDLGGNKLNGSISITL--GKLQKLQFLSFRGNELEGSIP----NVLCHL 187 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~p----~~~~~l 187 (527)
.++.+.+.++.++...- ..+..+++|++|++++|.+++..|..+ ..+++|+.|++++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 47888888887753211 112345679999999999999888888 899999999999999997655 345679
Q ss_pred cccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC---Cchh--hhCCCCccEEEccCCcccccC--Cc-cccCCC
Q 035895 188 AVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS---IPSI--LWNLKDILYLDFWSNLFVGPL--PS-KIGNLK 259 (527)
Q Consensus 188 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~---lp~~--~~~l~~L~~l~l~~n~~~~~~--p~-~~~~l~ 259 (527)
++|++|++++|++.+..|..|+.+++|++|+|++|++.+ ++.. +..+++|++|++++|.+.... +. .++.++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV 224 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence 999999999999999999999999999999999999875 4333 357899999999999986321 11 357889
Q ss_pred CCCEEEccCCCCCCCChhhhhcC---CCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCee
Q 035895 260 VLTRIDFSRNNLLGDIPTTIQGL---KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336 (527)
Q Consensus 260 ~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 336 (527)
+|++|+|++|++.+..|..+..+ ++|++|+|++|+++ .+|..+. ++|+.|+|++|+++++ |. +..++.|+.|
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L 299 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL 299 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence 99999999999998888887776 69999999999999 6677764 7999999999999986 33 6778889999
Q ss_pred Eeeeeee
Q 035895 337 LIVVVIL 343 (527)
Q Consensus 337 ~~~~~~~ 343 (527)
+++.+.+
T Consensus 300 ~L~~N~l 306 (310)
T 4glp_A 300 TLDGNPF 306 (310)
T ss_dssp ECSSTTT
T ss_pred ECcCCCC
Confidence 8877654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=200.67 Aligned_cols=141 Identities=28% Similarity=0.430 Sum_probs=119.1
Q ss_pred hcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccceeEEEEEec
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~ 434 (527)
..++|++.+.||+|+||.||+|+.+++..||+|++... +..++..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34679999999999999999999988889999997531 23445678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|.+++...+..+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence 999999999876666899999999999999999999 89999999999999999999999999999987654321 22
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....+|+.|+||
T Consensus 162 ~~~~~~~~~y~aP 174 (268)
T 3sxs_A 162 SVGTKFPVKWSAP 174 (268)
T ss_dssp CCSCCCCGGGCCH
T ss_pred ccCCCcCcccCCH
Confidence 2334467789998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=211.86 Aligned_cols=150 Identities=24% Similarity=0.401 Sum_probs=120.6
Q ss_pred ccHHHHhhhcCCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec----------------------------
Q 035895 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS---------------------------- 420 (527)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~---------------------------- 420 (527)
+....+....+.|++.+.||+|+||.||+|++ .+++.||||++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44556666778899999999999999999973 35689999997431
Q ss_pred ---cCc-cceeEEEEEeccCCcHHHHHHhcCC------------------------------------------------
Q 035895 421 ---CSN-EDFRALVLEYTTNGSLEKVLYSSNY------------------------------------------------ 448 (527)
Q Consensus 421 ---~~~-~~~~~lv~ey~~~g~L~~~l~~~~~------------------------------------------------ 448 (527)
+.. ....++|||||++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 112 2347899999999999999976432
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 449 -----------------ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 449 -----------------~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
.+++.....++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1788889999999999999999 99999999999999999999999999999987654433
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
........+|++||||
T Consensus 249 ~~~~~~~~~t~~y~aP 264 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAP 264 (359)
T ss_dssp CEEC--CEECGGGCCH
T ss_pred chhccccCCCceeECh
Confidence 3333445678899998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=204.39 Aligned_cols=138 Identities=28% Similarity=0.417 Sum_probs=115.5
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
.+.|++.+.||+|+||+||+|+..+|+.||+|++... +..++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4679999999999999999999988999999987421 233456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++ +|.+.+......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9985 888888776667899999999999999999999 99999999999999999999999999999987643222
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
..+...+|++|+||
T Consensus 175 -~~~~~~~t~~y~aP 188 (311)
T 3niz_A 175 -SYTHEVVTLWYRAP 188 (311)
T ss_dssp ----CCCCCCTTCCH
T ss_pred -cccCCcccCCcCCH
Confidence 22334678999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-23 Score=201.12 Aligned_cols=152 Identities=33% Similarity=0.482 Sum_probs=125.7
Q ss_pred cccccHHHHhhhcCCcccc------ceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------
Q 035895 372 RRRFSYQELLRATDGFSAN------NLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------- 420 (527)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------- 420 (527)
...+++.++..++..|... +.||+|+||.||+|+. +++.||||++...
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3567888999999888776 8999999999999997 5789999987431
Q ss_pred --------cCccceeEEEEEeccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 035895 421 --------CSNEDFRALVLEYTTNGSLEKVLYSS--NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD 490 (527)
Q Consensus 421 --------~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~ 490 (527)
+...+..++||||+++|+|.+++... ...+++..+..++.+++.||+||| +++|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 12334568999999999999998743 245889999999999999999999 89999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 491 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 491 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++.+|++|||+++...............||+.|+||
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP 204 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence 9999999999999876543322223345689999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=204.77 Aligned_cols=138 Identities=22% Similarity=0.357 Sum_probs=117.2
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee----------------------------ccCccceeEEEEEec
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF----------------------------SCSNEDFRALVLEYT 434 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~ 434 (527)
.+.|++.+.||+|+||.||+|+.. +++.||+|++.. .+...+..++|||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 467999999999999999999864 688999998742 123345778999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEeecccccccCCCCCc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD--NIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~--~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+||+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+|++|||+++......
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 999999999766667899999999999999999999 999999999999999986 7899999999999875432
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......+|++|+||
T Consensus 159 -~~~~~~gt~~y~aP 172 (321)
T 1tki_A 159 -NFRLLFTAPEYYAP 172 (321)
T ss_dssp -EEEEEESCGGGSCH
T ss_pred -ccccccCChhhcCc
Confidence 22335688999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=201.60 Aligned_cols=140 Identities=26% Similarity=0.405 Sum_probs=117.9
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||.||+|+..+++.||+|++.. .+..++..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 467899999999999999999998889999999753 1234456789999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||+++...... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 164 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence 99999999876667899999999999999999999 9999999999999999999999999999998764321 1122
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....+|+.|+||
T Consensus 165 ~~~~~~~~y~aP 176 (269)
T 4hcu_A 165 TGTKFPVKWASP 176 (269)
T ss_dssp TSTTCCGGGCCH
T ss_pred cCcccccccCCH
Confidence 234467789998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=209.55 Aligned_cols=139 Identities=29% Similarity=0.422 Sum_probs=115.6
Q ss_pred cCCccccceeccCCceEEEEEEc----cCCcEEEEEEEeec----------------------------------cCccc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL----QDGMEFAIKVFHFS----------------------------------CSNED 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~----------------------------------~~~~~ 425 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46799999999999999999986 47899999987421 11234
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||||+++|+|.+++...+ .+++.+...++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 5679999999999999997643 5788889999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+..... .......||++|+||
T Consensus 209 ~~~~~~-~~~~~~~gt~~y~aP 229 (355)
T 1vzo_A 209 FVADET-ERAYDFCGTIEYMAP 229 (355)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCH
T ss_pred cccCCC-CcccCcccCcCccCh
Confidence 643221 122345689999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=202.83 Aligned_cols=141 Identities=26% Similarity=0.420 Sum_probs=114.5
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
.++|++.+.||+|+||.||+|+. +++.||||++... .......++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 46799999999999999999987 6889999997421 01123467999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG-----YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~-----~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||+++|+|.+++.. ..+++..+..++.|++.||+|||.. ++++|+||||||+||+++.++.+||+|||+|+..
T Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 86 HYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp CCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred hhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 99999999999954 4588999999999999999999932 2679999999999999999999999999999876
Q ss_pred CCCCCcc--ceeccccccccccC
Q 035895 507 TGEDQSM--TQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~--~~~~~~~t~~y~aP 527 (527)
....... ......||++|+||
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aP 186 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAP 186 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCH
T ss_pred ccccccccccccccccccceeCh
Confidence 5432211 12234689999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=216.20 Aligned_cols=139 Identities=27% Similarity=0.404 Sum_probs=114.8
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~l 429 (527)
..++|++.+.||+|+||.||+|+. .+|+.||||++... +...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999985 57899999987521 223456689
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||||+++|+|.+++... ..+++..+..++.|++.||+||| + ++||||||||+|||++.++.+||+|||+|+....
T Consensus 226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999998754 35788899999999999999999 7 8999999999999999999999999999986433
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+||++||||
T Consensus 302 ~~~--~~~~~~gt~~y~aP 318 (446)
T 4ejn_A 302 DGA--TMKTFCGTPEYLAP 318 (446)
T ss_dssp -------CCSSSCGGGCCH
T ss_pred CCc--ccccccCCccccCH
Confidence 221 22346789999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=211.72 Aligned_cols=141 Identities=27% Similarity=0.515 Sum_probs=105.5
Q ss_pred cCCccccceeccCCceEEEEEEcc----CCcEEEEEEEee------------------------------ccCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHF------------------------------SCSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~------------------------------~~~~~~~~~l 429 (527)
.++|++.+.||+|+||.||+|+.. ++..||||+++. .+...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 356899999999999999999864 577899998742 1233456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999877667899999999999999999999 899999999999999999999999999999877533
Q ss_pred CCc-cceeccccccccccC
Q 035895 510 DQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~-~~~~~~~~t~~y~aP 527 (527)
... .......++++|+||
T Consensus 201 ~~~~~~~~~~~~~~~y~aP 219 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSP 219 (373)
T ss_dssp -------------CTTSCH
T ss_pred CccceeccCCCcCCCccCh
Confidence 211 111223356789998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=202.64 Aligned_cols=138 Identities=27% Similarity=0.442 Sum_probs=110.8
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
+.|++.+.||+|+||.||+|+. .+++.||+|++.. .+..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5699999999999999999985 5689999998742 122345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||++||+|.+++...+ .+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999997653 5788999999999999999999 99999999999999999999999999999987653321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.......||+.|+||
T Consensus 167 -~~~~~~~gt~~y~aP 181 (294)
T 4eqm_A 167 -TQTNHVLGTVQYFSP 181 (294)
T ss_dssp ---------CCSSCCH
T ss_pred -cccCccccCccccCH
Confidence 122235689999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=217.60 Aligned_cols=139 Identities=29% Similarity=0.434 Sum_probs=117.3
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|+..++||+|+||.||+|+.. +|+.||||++.. .+...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999974 699999999842 12234567899
Q ss_pred EEeccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 431 LEYTTNGSLEKVLYSSN---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
|||++||+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987642 35888899999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.... .....+||+.||||
T Consensus 341 ~~~~--~~~~~~GT~~Y~AP 358 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAP 358 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCH
T ss_pred CCCc--ccccccCCccccCh
Confidence 3321 12235789999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=205.71 Aligned_cols=140 Identities=26% Similarity=0.354 Sum_probs=115.5
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------cCccceeEEEEEec
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~ 434 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 36799999999999999999985 67899999987531 12234568999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-----EEEeecccccccCCC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV-----AHLSDFGIAKLLTGE 509 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~-----~kl~Dfg~a~~~~~~ 509 (527)
+|+|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+|+.+...
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99999999876667899999999999999999999 899999999999999998887 999999999976433
Q ss_pred CCcc-----ceeccccccccccC
Q 035895 510 DQSM-----TQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~-----~~~~~~~t~~y~aP 527 (527)
.... ......||+.|+||
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aP 186 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSI 186 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCH
T ss_pred CCCccccccccCCcCCCccccCh
Confidence 2111 12345689999998
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=209.97 Aligned_cols=244 Identities=22% Similarity=0.240 Sum_probs=199.5
Q ss_pred CCCEEEcccCCCCcccChhHhhc-cccccEEEcccCccccccchhhcCCcCCcEEEeecCccccc-CcccccCCCCCCEE
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNF-SQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS-ISITLGKLQKLQFL 169 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~-~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L 169 (527)
.++.+|+++|.+. +..+..+ .+.++.|++++|.+.+..+. +..+++|++|++++|.+++. ++..+..+++|+.|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4789999999887 3444443 24799999999999977666 55799999999999999865 77788999999999
Q ss_pred eccCcccccccChhhhcCcccCeeeeecc-cCCC-CCCccccCCccCceeeCCCC-CCCC--CchhhhCCC-CccEEEcc
Q 035895 170 SFRGNELEGSIPNVLCHLAVLFQLDLRGN-KLSG-SIPTCFGNLTALRNLHLDSN-ELTS--IPSILWNLK-DILYLDFW 243 (527)
Q Consensus 170 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~L~~N-~l~~--lp~~~~~l~-~L~~l~l~ 243 (527)
++++|.+++..+..+..+++|++|++++| .+++ .++..+.++++|++|++++| .++. ++..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999999888899999999999999999 6775 26677889999999999999 9986 678888899 99999999
Q ss_pred CC--ccc-ccCCccccCCCCCCEEEccCCC-CCCCChhhhhcCCCCCEEEccccc-ceeecCCCCCCCCCCCEEeCCCCc
Q 035895 244 SN--LFV-GPLPSKIGNLKVLTRIDFSRNN-LLGDIPTTIQGLKSLQFLSLGHNR-LQGSIPNSFDDLVSLESLDLSNNN 318 (527)
Q Consensus 244 ~n--~~~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ls~N~ 318 (527)
+| .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 99 444 4567778889999999999999 776778899999999999999995 33222235788999999999999
Q ss_pred ccccCccchhhhc-cCCeeEeeeeee
Q 035895 319 LSEIIPLSLEKLL-YLNILLIVVVIL 343 (527)
Q Consensus 319 l~~~~p~~~~~l~-~L~~L~~~~~~~ 343 (527)
+ ....+..+. .+..|.++.+.+
T Consensus 283 i---~~~~~~~l~~~l~~L~l~~n~l 305 (336)
T 2ast_B 283 V---PDGTLQLLKEALPHLQINCSHF 305 (336)
T ss_dssp S---CTTCHHHHHHHSTTSEESCCCS
T ss_pred c---CHHHHHHHHhhCcceEEecccC
Confidence 3 333455543 366666665554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=205.56 Aligned_cols=141 Identities=26% Similarity=0.354 Sum_probs=112.4
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcE----EEEEEEeec-----------------------------cCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGME----FAIKVFHFS-----------------------------CSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~----vavK~~~~~-----------------------------~~~~~~~~l 429 (527)
.++|++.+.||+|+||.||+|+.. +++. ||+|++... +...+..++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL 91 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence 356899999999999999999853 4544 777776321 012345679
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999876567888889999999999999999 899999999999999999999999999999987544
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
..........+|.+|+||
T Consensus 169 ~~~~~~~~~~~~~~y~aP 186 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMAL 186 (325)
T ss_dssp TTCCC-----CCTTTSCH
T ss_pred cccccccCCCCcccccCh
Confidence 333333445678889998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-23 Score=209.85 Aligned_cols=132 Identities=23% Similarity=0.271 Sum_probs=110.1
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeecc-------------------------C----------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC-------------------------S---------------- 422 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~-------------------------~---------------- 422 (527)
.++|++.+.||+|+||+||+|+. +|+.||||++.... .
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45689999999999999999987 68999999986321 0
Q ss_pred -----------------------------------ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 035895 423 -----------------------------------NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALE 467 (527)
Q Consensus 423 -----------------------------------~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 467 (527)
.++..++|||||++|++.+.+.+ ..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 14678999999999976665533 45788999999999999999
Q ss_pred HHhcCCCCCeEecCCCCCCeeeCCCC--------------------cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 468 YLHFGYSTPIIHCDLKPHNKLLDDNI--------------------VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 468 ylH~~~~~~iiHrdlk~~nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+ +++||||||||+|||++.++ .+||+|||+|+..... ..+||+.||||
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 9992 47899999999999999876 9999999999976432 23688999999
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-23 Score=204.53 Aligned_cols=142 Identities=30% Similarity=0.476 Sum_probs=108.0
Q ss_pred HhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEee-------------------------------ccCccceeE
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF-------------------------------SCSNEDFRA 428 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~-------------------------------~~~~~~~~~ 428 (527)
+....++|++.+.||+|+||.||+|+. +++.||||++.. .+...+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 334456799999999999999999986 578999999742 123345678
Q ss_pred EEEEeccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 429 LVLEYTTNGSLEKVLYSSNY--ILDILQRLNIMIDVTSALEYLHFGYSTP--IIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~ylH~~~~~~--iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
+||||+++|+|.+++...+. .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999976432 3788899999999999999999 888 9999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... .......||+.|+||
T Consensus 188 ~~~~~~--~~~~~~~gt~~y~aP 208 (309)
T 3p86_A 188 LKASTF--LSSKSAAGTPEWMAP 208 (309)
T ss_dssp ----------------CCTTSCH
T ss_pred cccccc--cccccCCCCccccCh
Confidence 654321 122345688999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-23 Score=205.53 Aligned_cols=138 Identities=30% Similarity=0.434 Sum_probs=110.9
Q ss_pred cCCccccceeccCCceEEEEEEc----cCCcEEEEEEEeec---------------------------------cCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL----QDGMEFAIKVFHFS---------------------------------CSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~---------------------------------~~~~~~ 426 (527)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.. +..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 47899999987421 123346
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||+++|+|.+++...+ .++......++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 689999999999999997543 5778888899999999999999 899999999999999999999999999999865
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... ......||++|+||
T Consensus 172 ~~~~~--~~~~~~gt~~y~aP 190 (327)
T 3a62_A 172 IHDGT--VTHTFCGTIEYMAP 190 (327)
T ss_dssp ---------CTTSSCCTTSCH
T ss_pred ccCCc--cccccCCCcCccCH
Confidence 32221 12235689999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=199.26 Aligned_cols=140 Identities=19% Similarity=0.263 Sum_probs=116.0
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------cCccceeEEEEEec
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~ 434 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +......++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 35699999999999999999985 67899999987531 12234668999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-----EEEeecccccccCCC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV-----AHLSDFGIAKLLTGE 509 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~-----~kl~Dfg~a~~~~~~ 509 (527)
+|+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+||+++.++. +||+|||+|+.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99999999876667899999999999999999999 999999999999999987766 999999999876543
Q ss_pred CCc-----cceeccccccccccC
Q 035895 510 DQS-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~-----~~~~~~~~t~~y~aP 527 (527)
... .......||+.|+||
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aP 187 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSI 187 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCH
T ss_pred cccccccccCccCCCCCcccCCc
Confidence 221 112345689999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-23 Score=209.11 Aligned_cols=141 Identities=26% Similarity=0.416 Sum_probs=115.6
Q ss_pred cCCccccceeccCCceEEEEEEcc--------CCcEEEEEEEee-------------------------------ccCcc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKVFHF-------------------------------SCSNE 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~-------------------------------~~~~~ 424 (527)
.+.|.+.+.||+|+||.||+|+.. .+..||||++.. .+..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457889999999999999999852 346799999742 12334
Q ss_pred ceeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 56789999999999999997643 34889999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++++.+||+|||+|+...............+|++|+||
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 262 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence 99999999999999877543322233344578889998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-23 Score=209.30 Aligned_cols=140 Identities=21% Similarity=0.339 Sum_probs=113.7
Q ss_pred cCCccccceeccCCceEEEEEEccC------CcEEEEEEEeecc------------------------------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD------GMEFAIKVFHFSC------------------------------------ 421 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~------------------------------------ 421 (527)
.++|++.+.||+|+||.||+|.... ++.||||++....
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998754 4789999964210
Q ss_pred ----Cc----cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--C
Q 035895 422 ----SN----EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD--D 491 (527)
Q Consensus 422 ----~~----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~--~ 491 (527)
.. ....++||||+ +|+|.+++...+..+++..+..|+.|++.||+||| +++|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence 00 13468999999 99999999876667899999999999999999999 89999999999999998 8
Q ss_pred CCcEEEeecccccccCCCCCcc-----ceeccccccccccC
Q 035895 492 NIVAHLSDFGIAKLLTGEDQSM-----TQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~t~~y~aP 527 (527)
++.+||+|||+|+.+....... ......||+.||||
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 230 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI 230 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCH
Confidence 8999999999998765322111 11234589999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.5e-23 Score=201.37 Aligned_cols=142 Identities=25% Similarity=0.410 Sum_probs=115.7
Q ss_pred hhcCCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEe
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey 433 (527)
...++|++.+.||+|+||.||+|+..++..||||++.. .+..++..++||||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 34567999999999999999999999889999999753 12344567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT 176 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence 9999999999875567899999999999999999999 9999999999999999999999999999998764321 11
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......+|+.|+||
T Consensus 177 ~~~~~~~~~~y~aP 190 (283)
T 3gen_A 177 SSVGSKFPVRWSPP 190 (283)
T ss_dssp STTSTTSCGGGCCH
T ss_pred cccCCccCcccCCH
Confidence 12233467789998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-23 Score=201.71 Aligned_cols=137 Identities=26% Similarity=0.446 Sum_probs=112.8
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
++|++.+.||+|+||.||+|+..+++.||+|++... +..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999988999999997431 1234566899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++ +|.+++......+++.....++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 986 999998876667889999999999999999999 89999999999999999999999999999987643221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
..+...+|+.|+||
T Consensus 156 ~~~~~~~t~~y~aP 169 (288)
T 1ob3_A 156 KYTHEIVTLWYRAP 169 (288)
T ss_dssp ------CCCTTCCH
T ss_pred ccccccccccccCc
Confidence 12234578899998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=6.7e-23 Score=205.22 Aligned_cols=144 Identities=24% Similarity=0.403 Sum_probs=116.5
Q ss_pred hhhcCCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec-------------------------------cCc
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS-------------------------------CSN 423 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~-------------------------------~~~ 423 (527)
....++|++.+.||+|+||.||+|+. .+++.||||++... +..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 33457899999999999999999985 24678999997421 223
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNY----------------------ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrd 481 (527)
.+..++||||+++|+|.+++..... .+++..+..++.|++.||+||| +++|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 4566899999999999999976432 2688889999999999999999 89999999
Q ss_pred CCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 482 lk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+||+++.++.+||+|||+++...............+|++|+||
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 243 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence 9999999999999999999999876543332223344578889998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.4e-23 Score=203.54 Aligned_cols=141 Identities=26% Similarity=0.445 Sum_probs=111.3
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeeccC----------------------------------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSCS---------------------------------------- 422 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---------------------------------------- 422 (527)
.++|++.+.||+|+||.||+|+.. +++.||||++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356899999999999999999975 789999999752100
Q ss_pred -----------------------------------------------ccceeEEEEEeccCCcHHHHHHhcC--CCCCHH
Q 035895 423 -----------------------------------------------NEDFRALVLEYTTNGSLEKVLYSSN--YILDIL 453 (527)
Q Consensus 423 -----------------------------------------------~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~ 453 (527)
.+...++|||||++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 0112689999999999999997643 234666
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc----------cceeccccccc
Q 035895 454 QRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS----------MTQTQTLAIIG 523 (527)
Q Consensus 454 ~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~~t~~ 523 (527)
.+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78889999999999999 999999999999999999999999999999987543211 11233568999
Q ss_pred cccC
Q 035895 524 YMAP 527 (527)
Q Consensus 524 y~aP 527 (527)
|+||
T Consensus 242 y~aP 245 (332)
T 3qd2_B 242 YMSP 245 (332)
T ss_dssp GSCH
T ss_pred ccCh
Confidence 9998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-23 Score=211.12 Aligned_cols=141 Identities=24% Similarity=0.385 Sum_probs=112.8
Q ss_pred cCCccccceeccCCceEEEEEEcc------CCcEEEEEEEeec------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHFS------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~------------------------------~~~~~~~ 427 (527)
.++|++.+.||+|+||+||+|+.. +++.||||++... +...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356889999999999999999842 4678999997421 2234566
Q ss_pred EEEEEeccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEe
Q 035895 428 ALVLEYTTNGSLEKVLYSSN------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI---VAHLS 498 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~---~~kl~ 498 (527)
++||||+++|+|.+++...+ ..+++.++..++.|++.||+||| +++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 89999999999999997643 34788899999999999999999 99999999999999999554 59999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+|+...............+|+.||||
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred CCccccccccccccccCCCcCCcccEECH
Confidence 99999865322222222334578899998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.88 E-value=6.8e-23 Score=209.44 Aligned_cols=138 Identities=28% Similarity=0.400 Sum_probs=108.2
Q ss_pred cCCcccc-ceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------c----CccceeEEEEE
Q 035895 384 TDGFSAN-NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------C----SNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------~----~~~~~~~lv~e 432 (527)
.++|.+. ++||+|+||+||+|+. .+++.||||++... + ...+..++|||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 4567776 7899999999999986 46899999997421 0 12345789999
Q ss_pred eccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCC
Q 035895 433 YTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~ 508 (527)
||+||+|.+++...+ ..+++.++..|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999997643 35889999999999999999999 899999999999999987 78999999999987643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.. ..+..+||++||||
T Consensus 217 ~~---~~~~~~gt~~y~aP 232 (400)
T 1nxk_A 217 HN---SLTTPCYTPYYVAP 232 (400)
T ss_dssp -------------CTTCCG
T ss_pred CC---ccccCCCCCCccCH
Confidence 22 12345689999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=198.60 Aligned_cols=137 Identities=26% Similarity=0.402 Sum_probs=113.5
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
++|++.+.||+|+||+||+|+. .+++.||||++... +..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999986 46899999998531 123456689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++ ++.+.+......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9986 666666665567899999999999999999999 89999999999999999999999999999987643322
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......+|++|+||
T Consensus 157 -~~~~~~~t~~y~aP 170 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPP 170 (292)
T ss_dssp -CCCSCCSCGGGCCH
T ss_pred -cccCCccccCCcCh
Confidence 22335678999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-23 Score=207.03 Aligned_cols=144 Identities=26% Similarity=0.421 Sum_probs=116.4
Q ss_pred hhhcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccCcc
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCSNE 424 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~~~ 424 (527)
....++|++.+.||+|+||.||+|+.. +++.||||+++. .+...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344578999999999999999999864 358899999742 12344
Q ss_pred ceeEEEEEeccCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSN-----------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrd 481 (527)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 56789999999999999997632 45788899999999999999999 99999999
Q ss_pred CCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 482 lk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+||+++.++.+||+|||+++...............+|+.|+||
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 245 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence 9999999999999999999999876433222222334578899998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=204.43 Aligned_cols=137 Identities=28% Similarity=0.414 Sum_probs=114.8
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------------~~~~~~~ 427 (527)
.+.|++.+.||+|+||.||+|+.. +|+.||+|++... +...+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 456999999999999999999864 6899999998531 1223456
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeecccc
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI----VAHLSDFGIA 503 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~----~~kl~Dfg~a 503 (527)
++||||++||+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 8999999999999999654 46789999999999999999999 89999999999999998776 7999999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+....... .....||++|+||
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aP 187 (361)
T 2yab_A 167 HEIEDGVE---FKNIFGTPEFVAP 187 (361)
T ss_dssp EECCTTCC---CCCCCSCGGGCCH
T ss_pred eEcCCCCc---cccCCCCccEECc
Confidence 87754321 2345689999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=4.5e-23 Score=201.87 Aligned_cols=141 Identities=27% Similarity=0.430 Sum_probs=111.3
Q ss_pred cCCccccceeccCCceEEEEEEc-----cCCcEEEEEEEeec-----------------------------cC--cccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHFS-----------------------------CS--NEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~-----------------------------~~--~~~~~ 427 (527)
.+.|++.+.||+|+||.||+|++ .+++.||||++... +. .....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 45689999999999999999984 36889999997431 11 12346
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 7999999999999999877666899999999999999999999 9999999999999999999999999999998775
Q ss_pred CCCCc-cceeccccccccccC
Q 035895 508 GEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~-~~~~~~~~t~~y~aP 527 (527)
..... .......++..|+||
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aP 186 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAP 186 (295)
T ss_dssp ----------CTTCGGGGCCH
T ss_pred CCcceeeeccCCCCccceeCc
Confidence 43221 122234467789998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-23 Score=203.51 Aligned_cols=138 Identities=28% Similarity=0.436 Sum_probs=112.3
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCcc----ceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNE----DFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~----~~~~lv~ 431 (527)
.++|++.+.||+|+||.||+|+.. ++.||||++... +... ...++||
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 467999999999999999999876 899999997421 1111 4678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST--------PIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~--------~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
||+++|+|.+++... .+++..+..++.+++.||+||| +. +|+||||||+||+++.++.+||+|||+|
T Consensus 115 e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 115 DYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp CCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred eccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 999999999999654 5788899999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCcc--ceeccccccccccC
Q 035895 504 KLLTGEDQSM--TQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~--~~~~~~~t~~y~aP 527 (527)
+.+....... ......||++|+||
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aP 215 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPP 215 (337)
T ss_dssp EECC---------CCSSCSCGGGCCH
T ss_pred eeeccccccccCCCCCCccCcceeCh
Confidence 8764332211 11234689999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=197.66 Aligned_cols=141 Identities=26% Similarity=0.398 Sum_probs=114.5
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------cCccceeEEEEEe
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey 433 (527)
..+.|++.+.||+|+||.||+|+. .+++.||||++... ....+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 346799999999999999999985 67899999985321 1234566899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCCC
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill---~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
+ +|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||++ ++++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 99999999866667899999999999999999999 9999999999999999 788999999999998765432
Q ss_pred Cc-----cceeccccccccccC
Q 035895 511 QS-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~-----~~~~~~~~t~~y~aP 527 (527)
.. .......+|+.|+||
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCH
T ss_pred cCccCCCCcccccCCCccccch
Confidence 21 112245689999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.3e-23 Score=203.23 Aligned_cols=137 Identities=27% Similarity=0.430 Sum_probs=115.1
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~l 429 (527)
..+.|++.+.||+|+||.||+|+. .+++.||||++.. .+..++..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 357899999999999999999996 6789999998742 1223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+ +|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 87 v~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99999 68999988654 35788899999999999999999 899999999999999999999999999999876543
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. ....+||++|+||
T Consensus 162 ~~---~~~~~gt~~y~aP 176 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAP 176 (336)
T ss_dssp BT---TCCCTTSTTTSCG
T ss_pred cc---cccccCCcCcCCH
Confidence 21 1235689999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=205.46 Aligned_cols=138 Identities=25% Similarity=0.405 Sum_probs=116.2
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey 433 (527)
.+.|++.+.||+|+||.||+|.. .+++.||+|++.. .+..++..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 35799999999999999999986 4689999998753 12334567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEeecccccccCCCCC
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD--NIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~--~~~~kl~Dfg~a~~~~~~~~ 511 (527)
+++|+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+|+.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999766667899999999999999999999 999999999999999974 57899999999998754321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....||++|+||
T Consensus 207 ---~~~~~gt~~y~aP 219 (387)
T 1kob_A 207 ---VKVTTATAEFAAP 219 (387)
T ss_dssp ---EEEECSSGGGCCH
T ss_pred ---eeeeccCCCccCc
Confidence 2234689999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=206.19 Aligned_cols=137 Identities=26% Similarity=0.391 Sum_probs=110.2
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------------~~~~~~~~lv~ 431 (527)
+.|++.+.||+|+||.||+|...+++.||||++... +..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 349999999999999999999888999999997421 12334568999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
| +.+|+|.+++...+ .+++.++..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+|+.+.....
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 57889999997654 5788889999999999999999 99999999999999996 58999999999997754332
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.......+||++||||
T Consensus 210 ~~~~~~~~gt~~y~aP 225 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPP 225 (390)
T ss_dssp ----CCSCCCGGGCCH
T ss_pred cccCCCCCcCCCccCh
Confidence 2223345689999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=210.94 Aligned_cols=137 Identities=26% Similarity=0.461 Sum_probs=116.6
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... +..++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 577999999999999999999864 7999999997421 2234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999998653 45889999999999999999999 9999999999999999999999999999999775432
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ....+||++|+||
T Consensus 171 ~---~~~~~gt~~y~aP 184 (476)
T 2y94_A 171 F---LRTSCGSPNYAAP 184 (476)
T ss_dssp C---BCCCCSCSTTCCH
T ss_pred c---ccccCCCcCeECh
Confidence 1 1235689999998
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-22 Score=200.29 Aligned_cols=236 Identities=17% Similarity=0.137 Sum_probs=188.5
Q ss_pred CEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccC-cccccCCCCCCE-Eec
Q 035895 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSI-SITLGKLQKLQF-LSF 171 (527)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~-L~l 171 (527)
++++.++++++. +|..+ +.+++.|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+ +..|.++++|.. +.+
T Consensus 12 ~~v~C~~~~Lt~-iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVTE-IPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCCS-CCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCCc-cCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 678999999996 56544 457999999999999888889999999999999999986644 567899998875 667
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCC-CCCCCCchh-hhCC-CCccEEEccCCccc
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDS-NELTSIPSI-LWNL-KDILYLDFWSNLFV 248 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~lp~~-~~~l-~~L~~l~l~~n~~~ 248 (527)
+.|+++...|..|..+++|++|++++|+++...+..+....++..|++.+ |+++.+|.. +..+ ..++.|++++|.+.
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 78999988899999999999999999999988888888888899999965 678888753 4444 46889999999998
Q ss_pred ccCCccccCCCCCCEEEccC-CCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCC-cccccCccc
Q 035895 249 GPLPSKIGNLKVLTRIDFSR-NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN-NLSEIIPLS 326 (527)
Q Consensus 249 ~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~~~~p~~ 326 (527)
...+..| ...+|++|++++ |.+....++.|.++++|++|++++|+|+...+..|.+ |+.|.+.++ .++. +| .
T Consensus 168 ~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~~-lP-~ 241 (350)
T 4ay9_X 168 EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLKK-LP-T 241 (350)
T ss_dssp EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCCC-CC-C
T ss_pred CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcCc-CC-C
Confidence 6555444 567899999985 5666555567899999999999999999665555655 455554444 4544 44 4
Q ss_pred hhhhccCCeeEee
Q 035895 327 LEKLLYLNILLIV 339 (527)
Q Consensus 327 ~~~l~~L~~L~~~ 339 (527)
+.++.+|+.+++.
T Consensus 242 l~~l~~L~~l~l~ 254 (350)
T 4ay9_X 242 LEKLVALMEASLT 254 (350)
T ss_dssp TTTCCSCCEEECS
T ss_pred chhCcChhhCcCC
Confidence 7788888887754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=210.59 Aligned_cols=140 Identities=26% Similarity=0.386 Sum_probs=116.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------cCccceeEEEEEec
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~ 434 (527)
.+.|++.+.||+|+||.||+|+. .+++.||||++... +...+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 46799999999999999999985 67899999986431 12345668999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCCCC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill---~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
+|+|.+++......+++..+..|+.||+.||+||| +++||||||||+|||+ +.++.+||+|||+|+.+.....
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 99999999866667899999999999999999999 9999999999999999 5889999999999997754322
Q ss_pred c-----cceeccccccccccC
Q 035895 512 S-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~-----~~~~~~~~t~~y~aP 527 (527)
. .......||..|+||
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aP 182 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASV 182 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCH
T ss_pred ccccccccccccCCCccccCH
Confidence 1 112245689999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=200.27 Aligned_cols=137 Identities=28% Similarity=0.447 Sum_probs=113.8
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cC--ccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CS--NEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~--~~~~~~lv~ 431 (527)
+.|++.+.||+|+||.||+|+.. +++.||||++... +. .....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46899999999999999999865 5899999997531 11 122568999
Q ss_pred EeccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeecccccc
Q 035895 432 EYTTNGSLEKVLYSSNY--ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKL 505 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill----~~~~~~kl~Dfg~a~~ 505 (527)
||+++|+|.+++..... .+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+|+.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976432 3889999999999999999999 9999999999999999 7888899999999988
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... .....+|..|+||
T Consensus 166 ~~~~~~---~~~~~gt~~y~aP 184 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHP 184 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCH
T ss_pred cCCCCc---eeecccCCCccCH
Confidence 754322 2234688999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=201.56 Aligned_cols=141 Identities=26% Similarity=0.454 Sum_probs=113.7
Q ss_pred cCCccccceeccCCceEEEEEEc--------cCCcEEEEEEEee-------------------------------ccCcc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL--------QDGMEFAIKVFHF-------------------------------SCSNE 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~-------------------------------~~~~~ 424 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++.. .+..+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46789999999999999999985 3567899998742 12334
Q ss_pred ceeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 56789999999999999997643 23788899999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+.++.+||+|||+++...............+|+.|+||
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 228 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence 99999999999999877543322222334567889998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=203.92 Aligned_cols=138 Identities=25% Similarity=0.379 Sum_probs=109.7
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------------~~~~~~~~lv 430 (527)
.+.|++.+.||+|+||.||+|...+++.||||++... +..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3569999999999999999999988999999997521 1234466899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|| +.+|+|.+++... ..+++.++..++.|++.||+||| +++|+||||||+|||++ ++.+||+|||+|+......
T Consensus 88 ~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred Ee-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 99 5678999999764 45788899999999999999999 89999999999999997 5789999999998775433
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.........||++|+||
T Consensus 162 ~~~~~~~~~gt~~y~aP 178 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPP 178 (343)
T ss_dssp --------CCCCSSCCH
T ss_pred ccccCCCCcCCcCcCCH
Confidence 32233345689999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=200.65 Aligned_cols=137 Identities=24% Similarity=0.432 Sum_probs=110.4
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
++|++.+.||+|+||.||+|+.. +++.||||++... +..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999865 7899999987421 2234566899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++ |+|.+++...+..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--
Confidence 98 5999998877667899999999999999999999 99999999999999999999999999999986543221
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......+|++|+||
T Consensus 156 ~~~~~~~t~~y~aP 169 (324)
T 3mtl_A 156 TYDNEVVTLWYRPP 169 (324)
T ss_dssp -------CGGGCCH
T ss_pred ccccccCcccccCh
Confidence 22234678999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=204.47 Aligned_cols=137 Identities=26% Similarity=0.351 Sum_probs=107.2
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec----------------------------cCccceeEEEEEec
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~ 434 (527)
.+.|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 467999999999999999999875 7899999997531 22345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--EEEeecccccccCCCCCc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV--AHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~--~kl~Dfg~a~~~~~~~~~ 512 (527)
++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||+|+......
T Consensus 99 ~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 9999999987543 5788899999999999999999 999999999999999987665 9999999998543221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......||++|+||
T Consensus 173 -~~~~~~gt~~y~aP 186 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAP 186 (361)
T ss_dssp ---------CTTSCH
T ss_pred -CCCCCcCCCCcCCh
Confidence 12335689999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-23 Score=214.80 Aligned_cols=144 Identities=19% Similarity=0.377 Sum_probs=117.4
Q ss_pred HhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEE
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLE 432 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~e 432 (527)
+....++|++.+.||+|+||.||+|+..++..||||+++.. +...+..++|||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e 262 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE 262 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEC
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEe
Confidence 34455678999999999999999999988899999997531 112345689999
Q ss_pred eccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++...+ ..+++.+...++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~- 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 338 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence 999999999997542 35788889999999999999999 8999999999999999999999999999998764321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
........+|+.|+||
T Consensus 339 ~~~~~~~~~~~~y~aP 354 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAP 354 (454)
T ss_dssp HHTTCSSSSCGGGSCH
T ss_pred eeccCCCcccccccCH
Confidence 1112234467789998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=199.85 Aligned_cols=142 Identities=25% Similarity=0.419 Sum_probs=115.5
Q ss_pred hcCCccccceeccCCceEEEEEEc------cCCcEEEEEEEee------------------------------ccCccce
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHF------------------------------SCSNEDF 426 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~------------------------------~~~~~~~ 426 (527)
..++|.+.+.||+|+||.||+|+. .+++.||||+++. .+...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 346689999999999999999985 3458899999742 1233456
Q ss_pred eEEEEEeccCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 035895 427 RALVLEYTTNGSLEKVLYSSN-----------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLK 483 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk 483 (527)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence 789999999999999997643 23788889999999999999999 8999999999
Q ss_pred CCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 484 PHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 484 ~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+||++++++.+||+|||+++...............+|+.|+||
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 221 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI 221 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence 99999999999999999999877543322222334567889998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=199.83 Aligned_cols=141 Identities=26% Similarity=0.438 Sum_probs=116.1
Q ss_pred cCCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec-------------------------------cCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS-------------------------------CSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~-------------------------------~~~~~~ 426 (527)
.++|++.+.||+|+||.||+|+. .+++.||||+++.. +..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46789999999999999999974 35689999997521 223456
Q ss_pred eEEEEEeccCCcHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 427 RALVLEYTTNGSLEKVLYSSNY-----------------ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
.++||||+++|+|.+++..... .+++.+...++.|++.||+||| +++|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 6899999999999999976532 3789999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+.++.+|++|||+++...............+|+.|+||
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 216 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence 99999999999999877544332222334567889998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=198.71 Aligned_cols=138 Identities=26% Similarity=0.406 Sum_probs=100.3
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|++.+.||+|+||.||+|+.. +++.||+|++... +..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999864 6899999997531 223456789999
Q ss_pred eccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 433 YTTNGSLEKVLYSSN-----YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
|++ |+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886532 34788888999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ......+|++|+||
T Consensus 160 ~~~~--~~~~~~~t~~y~aP 177 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAP 177 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCH
T ss_pred CCcc--cCCCCcccccccCc
Confidence 3221 12234678999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=200.76 Aligned_cols=150 Identities=24% Similarity=0.389 Sum_probs=120.2
Q ss_pred ccHHHHhhhcCCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec----------------------------
Q 035895 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS---------------------------- 420 (527)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~---------------------------- 420 (527)
+....+....++|++.+.||+|+||.||+|+. .+++.||||++...
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555667899999999999999999973 35689999997421
Q ss_pred ---cC-ccceeEEEEEeccCCcHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 035895 421 ---CS-NEDFRALVLEYTTNGSLEKVLYSSNYI---------------LDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481 (527)
Q Consensus 421 ---~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrd 481 (527)
+. .....++||||+++|+|.+++...... +++..+..++.|++.||+||| +++|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 11 123478999999999999999765322 788889999999999999999 89999999
Q ss_pred CCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 482 lk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+||+++.++.+|++|||+++...............+|++|+||
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 219 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 219 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence 9999999999999999999999876543332233344578899998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-22 Score=202.39 Aligned_cols=138 Identities=26% Similarity=0.428 Sum_probs=112.9
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------cCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------CSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~~~~~~~~l 429 (527)
+.|++.+.||+|+||.||+|+. .+++.||||++... +..++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4589999999999999999986 57899999987421 123456789
Q ss_pred EEEeccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeecccc
Q 035895 430 VLEYTTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV---AHLSDFGIA 503 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~---~kl~Dfg~a 503 (527)
|||||+||+|.+.+... +..+++..+..++.|++.||+||| +++|+||||||+||+++.++. +|++|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887643 234788889999999999999999 999999999999999986544 999999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+....... ......||++|+||
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aP 202 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAP 202 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCH
T ss_pred eEecCCCe--eecCCcCCcCccCH
Confidence 87754321 22345689999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=208.05 Aligned_cols=138 Identities=25% Similarity=0.403 Sum_probs=113.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-------------------------------ccCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-------------------------------~~~~~~~~~lv~ 431 (527)
.+.|++.+.||+|+||.||+|.. .+|+.||+|++.. .+..++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45699999999999999999985 5789999998743 123455678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~---~~~~~kl~Dfg~a~~~~~ 508 (527)
|||+||+|.+.+...+ .+++.++..++.|++.||+||| +++|+||||||+||+++ +++.+||+|||+|+....
T Consensus 90 E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999987653 5788899999999999999999 99999999999999998 468899999999987754
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... ......||++||||
T Consensus 166 ~~~--~~~~~~gt~~Y~AP 182 (444)
T 3soa_A 166 EQQ--AWFGFAGTPGYLSP 182 (444)
T ss_dssp TCC--BCCCSCSCGGGCCH
T ss_pred CCc--eeecccCCcccCCH
Confidence 322 22345689999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8e-23 Score=201.79 Aligned_cols=140 Identities=24% Similarity=0.458 Sum_probs=107.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeeccC--------------------------------cc----ce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSCS--------------------------------NE----DF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~--------------------------------~~----~~ 426 (527)
.+.|++.+.||+|+||.||+|+. .+++.||||++..... .+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36799999999999999999985 6789999999853110 01 12
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||++||+|.+++...+ .+++.+...++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+++.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 389999999999999997543 5788899999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCc-cceeccccccccccC
Q 035895 507 TGEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~-~~~~~~~~t~~y~aP 527 (527)
...... .......||++|+||
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aP 188 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSP 188 (311)
T ss_dssp ---------------CCTTCCH
T ss_pred cccccccccccccCcCcccCCH
Confidence 533221 112234589999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=6.5e-23 Score=203.31 Aligned_cols=146 Identities=22% Similarity=0.374 Sum_probs=117.2
Q ss_pred HHhhhcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccC
Q 035895 379 ELLRATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCS 422 (527)
Q Consensus 379 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~ 422 (527)
++....+.|++.+.||+|+||.||+|+.. +++.||||++.. .+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 44455678999999999999999999754 468899998742 123
Q ss_pred ccceeEEEEEeccCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 035895 423 NEDFRALVLEYTTNGSLEKVLYSSN---------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI 493 (527)
Q Consensus 423 ~~~~~~lv~ey~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~ 493 (527)
..+..++||||+++|+|.+++...+ ..+++..+..++.|++.||+||| +++|+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence 3456789999999999999987532 34578889999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 494 VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+||+|||+++...............+|+.|+||
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccCh
Confidence 9999999999876433222222234567889998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=205.55 Aligned_cols=139 Identities=25% Similarity=0.428 Sum_probs=104.6
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------c--Ccccee
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------C--SNEDFR 427 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~--~~~~~~ 427 (527)
..+.|++.+.||+|+||.||+|.. .+|+.||||++... + ......
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357899999999999999999985 57899999987321 1 112357
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++|||||+ |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 89999998 599999875 35788888999999999999999 9999999999999999999999999999998764
Q ss_pred CCCC-------------------ccceeccccccccccC
Q 035895 508 GEDQ-------------------SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~-------------------~~~~~~~~~t~~y~aP 527 (527)
.... ....+..+||++|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCH
Confidence 2110 1112345789999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=7.4e-23 Score=203.56 Aligned_cols=140 Identities=25% Similarity=0.384 Sum_probs=108.7
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcE----EEEEEEeecc-----------------------------CccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGME----FAIKVFHFSC-----------------------------SNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~----vavK~~~~~~-----------------------------~~~~~~~lv 430 (527)
++|+..+.||+|+||.||+|+.. +++. ||+|.+.... ...+..++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 56899999999999999999853 4443 5888763210 012345789
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999999887777899999999999999999999 8999999999999999999999999999999875443
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.........+|+.|+||
T Consensus 172 ~~~~~~~~~~t~~y~aP 188 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMAL 188 (327)
T ss_dssp C-------CCCGGGSCH
T ss_pred ccccccCCCccccccCh
Confidence 33333344568899998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=201.84 Aligned_cols=138 Identities=28% Similarity=0.467 Sum_probs=113.4
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------cCccceeEEEEEeccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------~~~~~~~~lv~ey~~~ 436 (527)
.++|++.+.||+|+||.||+|+.. +++.||||++... +...+..++|||||+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 356999999999999999999864 6899999997531 2334567899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-C---CcEEEeecccccccCCCCCc
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-N---IVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~---~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+|.+++... ..+++.++..++.+|+.||+||| +++|+||||||+||++.+ + +.+||+|||+++.......
T Consensus 101 g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~- 175 (342)
T 2qr7_A 101 GELLDKILRQ-KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG- 175 (342)
T ss_dssp CBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-
Confidence 9999998754 45788899999999999999999 999999999999999843 2 3599999999987654322
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....++|+.|+||
T Consensus 176 -~~~~~~gt~~y~aP 189 (342)
T 2qr7_A 176 -LLMTPCYTANFVAP 189 (342)
T ss_dssp -CBCCSSCCSSCCCH
T ss_pred -ceeccCCCccccCH
Confidence 12235689999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-22 Score=195.92 Aligned_cols=140 Identities=26% Similarity=0.402 Sum_probs=116.3
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------cCccceeEEEEEec
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~ 434 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 46799999999999999999985 67899999987531 12234568999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCCCC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill---~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
+|+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+||++ ++++.+||+|||+++.......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 89999999866667899999999999999999999 9999999999999999 4789999999999987654322
Q ss_pred cc-----ceeccccccccccC
Q 035895 512 SM-----TQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~-----~~~~~~~t~~y~aP 527 (527)
.. ......||+.|+||
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCH
T ss_pred ccccccccccccccccccCCh
Confidence 11 12345688999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=198.82 Aligned_cols=139 Identities=29% Similarity=0.459 Sum_probs=104.4
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeecc------------------------------CccceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC------------------------------SNEDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~------------------------------~~~~~~~lv~ey 433 (527)
.+.|++.+.||+|+||.||+|+... .||+|++.... ...+..++||||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 4679999999999999999998754 59999975311 123456799999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999999999766667899999999999999999999 8999999999999999999999999999998664322222
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......||+.|+||
T Consensus 178 ~~~~~~gt~~y~aP 191 (289)
T 3og7_A 178 QFEQLSGSILWMAP 191 (289)
T ss_dssp ------CCCTTCCH
T ss_pred cccccCCCccccCc
Confidence 22345688999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=197.34 Aligned_cols=138 Identities=30% Similarity=0.455 Sum_probs=112.2
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------------------
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------------- 420 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------------- 420 (527)
..++|++.+.||+|+||.||+|+. .+++.||||++...
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 357899999999999999999985 56899999987421
Q ss_pred --------------cC--ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 035895 421 --------------CS--NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484 (527)
Q Consensus 421 --------------~~--~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~ 484 (527)
+. .++..++||||+++|+|.+++. ...+++.+...++.|++.||+||| +++|+||||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 165 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP 165 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence 00 1345689999999999987653 346889999999999999999999 89999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 485 HNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 485 ~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+||+++.++.+||+|||+++....... ......||+.|+||
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP 206 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAP 206 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCG
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccCh
Confidence 999999999999999999987654322 22345689999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=202.59 Aligned_cols=146 Identities=28% Similarity=0.386 Sum_probs=118.7
Q ss_pred ccccHHHHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------
Q 035895 373 RRFSYQELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------- 420 (527)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------- 420 (527)
..+++++-....++|++.+.||+|+||.||+|+. .+++.||||++...
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3444444445567899999999999999999986 57899999997420
Q ss_pred --cCccceeEEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC------
Q 035895 421 --CSNEDFRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD------ 491 (527)
Q Consensus 421 --~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~------ 491 (527)
+...+..++||||+ +|+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence 11235678999999 899999997654 34788899999999999999999 999999999999999975
Q ss_pred -------------------CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 -------------------NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 -------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.+||+|||+|+...... ....||+.|+||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aP 228 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAP 228 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCc
Confidence 7899999999998754321 235678999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=197.22 Aligned_cols=140 Identities=23% Similarity=0.433 Sum_probs=114.7
Q ss_pred CCccccceeccCCceEEEEEEc-----cCCcEEEEEEEeec------------------------------cCcc--cee
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHFS------------------------------CSNE--DFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~------------------------------~~~~--~~~ 427 (527)
+.|++.+.||+|+||.||+|++ .+++.||||+++.. +..+ ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3488899999999999999983 46899999997521 1112 456
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 8999999999999999766667899999999999999999999 9999999999999999999999999999998875
Q ss_pred CCCCc-cceeccccccccccC
Q 035895 508 GEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~-~~~~~~~~t~~y~aP 527 (527)
..... .......+|..|+||
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aP 198 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAP 198 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCH
T ss_pred CCCcceeccCCCCCCccccCC
Confidence 43321 122234578889998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.4e-22 Score=193.84 Aligned_cols=140 Identities=30% Similarity=0.501 Sum_probs=107.9
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~l 429 (527)
..++|++.+.||+|+||.||+|+. .+++.||||++... +...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 456799999999999999999986 57899999997421 123456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++......+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999876667899999999999999999999 899999999999999999999999999999876432
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. ......+|+.|+||
T Consensus 166 ~~--~~~~~~~~~~y~aP 181 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISP 181 (278)
T ss_dssp ------------------
T ss_pred CC--cceeccCCCCcCCc
Confidence 21 11234578899998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=199.68 Aligned_cols=140 Identities=29% Similarity=0.415 Sum_probs=116.2
Q ss_pred CCccccceeccCCceEEEEEEc-----cCCcEEEEEEEeec-----------------------------c--CccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHFS-----------------------------C--SNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~-----------------------------~--~~~~~~~ 428 (527)
++|++.+.||+|+||.||+|+. .+++.||||++... + ......+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5689999999999999999983 46889999997421 1 1345578
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+++|+|.+++......+++.++..++.+++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999875566899999999999999999999 89999999999999999999999999999997754
Q ss_pred CCCc-cceeccccccccccC
Q 035895 509 EDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~-~~~~~~~~t~~y~aP 527 (527)
.... .......+|..|+||
T Consensus 180 ~~~~~~~~~~~~~~~~y~aP 199 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAP 199 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCH
T ss_pred CCccceeeccCCccccccCH
Confidence 3221 122234578889998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=212.32 Aligned_cols=142 Identities=25% Similarity=0.444 Sum_probs=117.4
Q ss_pred hhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee----------------------------ccCccceeEEEEE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF----------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~----------------------------~~~~~~~~~lv~e 432 (527)
...++|++.+.||+|+||.||+|+.. ++..||||+++. .+..++..++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34566899999999999999999976 488999999742 2334556789999
Q ss_pred eccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 99999999999864 345889899999999999999999 9999999999999999999999999999999775332
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
........+++.|+||
T Consensus 373 ~~~~~~~~~~~~y~aP 388 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAP 388 (495)
T ss_dssp EECCTTCCCCGGGCCH
T ss_pred eeecCCCcCCcceeCH
Confidence 1122234467789998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-22 Score=200.67 Aligned_cols=138 Identities=27% Similarity=0.421 Sum_probs=106.4
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------cCccceeEEEEEec
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~ 434 (527)
..+.|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 3467999999999999999999975 5789999997531 22345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCCCCC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~~~~ 511 (527)
++|+|.+++... ..+++.+...++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+++......
T Consensus 131 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 131 TGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp CSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 999999998654 45788899999999999999999 899999999999999975 8999999999998764322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......||++|+||
T Consensus 206 --~~~~~~gt~~y~aP 219 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAP 219 (349)
T ss_dssp ---------CGGGSCH
T ss_pred --ccccccCCCCccCH
Confidence 12235689999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=7e-22 Score=194.66 Aligned_cols=137 Identities=29% Similarity=0.403 Sum_probs=112.5
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------------Ccc-
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------------SNE- 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------------~~~- 424 (527)
.+.|++.+.||+|+||+||+|+. .+++.||||++.... ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999996 578999999985210 001
Q ss_pred ----ceeEEEEEeccCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 035895 425 ----DFRALVLEYTTNGSLEKVLYSSNY-ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSD 499 (527)
Q Consensus 425 ----~~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~D 499 (527)
...++||||+. |+|.+++..... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEee
Confidence 14679999997 599999876543 3889999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCCccceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+|+....... .+...+|++|+||
T Consensus 164 fg~a~~~~~~~~---~~~~~gt~~y~aP 188 (308)
T 3g33_A 164 FGLARIYSYQMA---LTPVVVTLWYRAP 188 (308)
T ss_dssp CSCTTTSTTCCC---SGGGGCCCSSCCH
T ss_pred CccccccCCCcc---cCCccccccccCc
Confidence 999987653322 2345689999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=196.90 Aligned_cols=141 Identities=26% Similarity=0.407 Sum_probs=105.0
Q ss_pred hcCCccccceeccCCceEEEEEEcc----CCcEEEEEEEeec-----------------------------cCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFS-----------------------------CSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~-----------------------------~~~~~~~~l 429 (527)
..+.|++.+.||+|+||.||+|+.. .+..||+|++... +..++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 92 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 92 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence 3467899999999999999999864 3467999986421 112345689
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++...+..+++.....++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999876667899999999999999999999 899999999999999999999999999999876533
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .......+|+.|+||
T Consensus 170 ~~-~~~~~~~~~~~y~aP 186 (281)
T 1mp8_A 170 TY-YKASKGKLPIKWMAP 186 (281)
T ss_dssp ----------CCGGGCCH
T ss_pred cc-cccccCCCcccccCh
Confidence 21 122234467789998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-22 Score=196.79 Aligned_cols=136 Identities=27% Similarity=0.407 Sum_probs=113.8
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------------cCccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------------CSNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------------~~~~~~~~ 428 (527)
+.|++.+.||+|+||.||+|+.. +|+.||+|++... +..++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45899999999999999999864 6899999987531 12234568
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeccccc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI----VAHLSDFGIAK 504 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~----~~kl~Dfg~a~ 504 (527)
+||||+++|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999998653 45788899999999999999999 99999999999999998877 89999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... .....||+.|+||
T Consensus 167 ~~~~~~~---~~~~~gt~~y~aP 186 (326)
T 2y0a_A 167 KIDFGNE---FKNIFGTPEFVAP 186 (326)
T ss_dssp ECCTTSC---CCCCCSCTTTCCH
T ss_pred ECCCCCc---cccccCCcCcCCc
Confidence 7753321 2235689999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=202.08 Aligned_cols=137 Identities=26% Similarity=0.478 Sum_probs=114.0
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ 431 (527)
.++|++.+.||+|+||.||+|.. .+++.||+|++... +..++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35699999999999999999986 46899999998531 23345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN---IVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~---~~~kl~Dfg~a~~~~~ 508 (527)
||+++|+|.+.+... ..+++.++..++.||+.||+||| +++|+||||||+||+++.+ +.+||+|||+++....
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999988654 45788899999999999999999 8999999999999999854 4699999999987653
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....||++|+||
T Consensus 184 ~~~---~~~~~gt~~y~aP 199 (362)
T 2bdw_A 184 SEA---WHGFAGTPGYLSP 199 (362)
T ss_dssp CCS---CCCSCSCTTTCCH
T ss_pred Ccc---cccCCCCccccCH
Confidence 321 2235689999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=196.28 Aligned_cols=143 Identities=22% Similarity=0.409 Sum_probs=116.5
Q ss_pred hhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEe
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey 433 (527)
....++|++.+.||+|+||.||+|+..++..||||++... +...+..++||||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 88 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY 88 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEec
Confidence 3345679999999999999999999888889999987531 1123456899999
Q ss_pred ccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 99999999986532 25788899999999999999999 99999999999999999999999999999987753321
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.......++..|+||
T Consensus 165 ~~~~~~~~~~~y~aP 179 (279)
T 1qpc_A 165 TAREGAKFPIKWTAP 179 (279)
T ss_dssp ECCTTCCCCTTTSCH
T ss_pred ccccCCCCccCccCh
Confidence 112233467789998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-22 Score=202.66 Aligned_cols=133 Identities=26% Similarity=0.467 Sum_probs=106.8
Q ss_pred ccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEeccCCc
Q 035895 389 ANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEYTTNGS 438 (527)
Q Consensus 389 ~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey~~~g~ 438 (527)
..+.||+|+||.||+|+. .+|+.||+|++.. .+...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357899999999999986 5789999999753 1234456789999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee--CCCCcEEEeecccccccCCCCCcccee
Q 035895 439 LEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL--DDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 439 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|.+++......+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++....... ..
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~ 246 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK 246 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence 99998776667899999999999999999999 9999999999999999 5678999999999997754322 22
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||++|+||
T Consensus 247 ~~~gt~~y~aP 257 (373)
T 2x4f_A 247 VNFGTPEFLAP 257 (373)
T ss_dssp CCCSSCTTCCH
T ss_pred cccCCCcEeCh
Confidence 34689999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=200.79 Aligned_cols=144 Identities=24% Similarity=0.478 Sum_probs=101.2
Q ss_pred hhhcCCccccceeccCCceEEEEEEccCC----cEEEEEEEeecc-------------------------------Cccc
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQDG----MEFAIKVFHFSC-------------------------------SNED 425 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~----~~vavK~~~~~~-------------------------------~~~~ 425 (527)
....+.|++.+.||+|+||.||+|+.... ..||||++.... ...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34456799999999999999999987543 379999874310 1111
Q ss_pred ------eeEEEEEeccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 035895 426 ------FRALVLEYTTNGSLEKVLYSSN-----YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV 494 (527)
Q Consensus 426 ------~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~ 494 (527)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+||++++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence 1289999999999999986432 24788899999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCCCCCccceeccccccccccC
Q 035895 495 AHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 495 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+||+|||+|+...............+++.|+||
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 208 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL 208 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCH
T ss_pred EEEeeccccccccccccccccccccCcccccCc
Confidence 999999999876543322223334567789998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=208.77 Aligned_cols=119 Identities=29% Similarity=0.444 Sum_probs=93.7
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c-----Cccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C-----SNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~-----~~~~~ 426 (527)
.+.|++.+.||+|+||+||+|+. .+++.||||++... + .....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46799999999999999999986 47899999987421 1 11245
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||+. |+|.+++... ..+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 789999985 6999998654 45888899999999999999999 899999999999999999999999999999976
Q ss_pred C
Q 035895 507 T 507 (527)
Q Consensus 507 ~ 507 (527)
.
T Consensus 207 ~ 207 (458)
T 3rp9_A 207 D 207 (458)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-22 Score=194.17 Aligned_cols=140 Identities=26% Similarity=0.400 Sum_probs=117.3
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||.||+|+..+++.||+|++... +..++..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4578999999999999999999988899999997531 233456789999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+|+|.+++......+++.....++.+++.||+||| +++|+||||||+||+++.++.+|++|||+++...... ....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 162 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence 99999999876667889999999999999999999 9999999999999999999999999999998764321 1112
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....++..|+||
T Consensus 163 ~~~~~~~~y~aP 174 (267)
T 3t9t_A 163 TGTKFPVKWASP 174 (267)
T ss_dssp TSTTCCGGGCCH
T ss_pred ccccccccccCh
Confidence 234467789998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.1e-22 Score=205.85 Aligned_cols=139 Identities=30% Similarity=0.446 Sum_probs=111.3
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCcc-----ce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNE-----DF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~-----~~ 426 (527)
.+.|++.+.||+|+||.||+|+. .+++.||||++... +... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46799999999999999999986 56889999997421 1111 45
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||++ |+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 789999987 5999998653 45889999999999999999999 999999999999999999999999999999976
Q ss_pred CCCCCc--------------------cceeccccccccccC
Q 035895 507 TGEDQS--------------------MTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~--------------------~~~~~~~~t~~y~aP 527 (527)
...... ...+..+||++|+||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 220 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220 (432)
T ss_dssp -------------------------------CCCCCTTCCH
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCH
Confidence 533211 112456789999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-22 Score=202.44 Aligned_cols=139 Identities=26% Similarity=0.456 Sum_probs=103.0
Q ss_pred CccccceeccCCceEEEEEEcc--C--CcEEEEEEEee------------------------------cc-CccceeEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARLQ--D--GMEFAIKVFHF------------------------------SC-SNEDFRALV 430 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~--~--~~~vavK~~~~------------------------------~~-~~~~~~~lv 430 (527)
.|++.+.||+|+||.||+|+.. + +..||||.+.. .+ ..++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3677899999999999999863 2 24689998642 11 223466899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++...+..+++.+...++.|++.||+||| +++|+||||||+||++++++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999876667888899999999999999999 9999999999999999999999999999998764332
Q ss_pred Cc--cceeccccccccccC
Q 035895 511 QS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~--~~~~~~~~t~~y~aP 527 (527)
.. ...+...+|+.|+||
T Consensus 247 ~~~~~~~~~~~~~~~y~aP 265 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMAL 265 (373)
T ss_dssp -----------CCGGGSCH
T ss_pred cccccccCCCCCcccccCh
Confidence 11 122334567889998
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.6e-22 Score=208.17 Aligned_cols=188 Identities=25% Similarity=0.334 Sum_probs=102.3
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEec
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
+|+.|++++|.+++ +|..+. ++|+.|+|++|.|+. +| ..+++|++|+|++|+|++ +|. +.. +|+.|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 66777777777765 344331 356666666666663 33 335666666666666665 333 433 6666666
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccC
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPL 251 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~ 251 (527)
++|.+++ +|. .+++|+.|++++|+|++ +|. .+++|++|+|++|+|+.+|. +
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l-------------------- 178 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-L-------------------- 178 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-C--------------------
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-h--------------------
Confidence 6666664 343 45566666666666654 333 34556666666666665554 2
Q ss_pred CccccCCCCCCEEEccCCCCCCCChhhhhcCCCC-------CEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCc
Q 035895 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSL-------QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 252 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
. ++|++|+|++|+++ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|
T Consensus 179 ----~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 179 ----P--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp ----C--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred ----h--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 2 44555555555544 2333 332 34 55555555555 344444445555555555555555555
Q ss_pred cchhhhc
Q 035895 325 LSLEKLL 331 (527)
Q Consensus 325 ~~~~~l~ 331 (527)
..+..+.
T Consensus 248 ~~l~~l~ 254 (571)
T 3cvr_A 248 ESLSQQT 254 (571)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 5555543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=5.5e-22 Score=194.36 Aligned_cols=140 Identities=26% Similarity=0.415 Sum_probs=111.8
Q ss_pred CCccccceeccCCceEEEEEEccC----CcEEEEEEEee------------------------------c-cCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQD----GMEFAIKVFHF------------------------------S-CSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~------------------------------~-~~~~~~~~l 429 (527)
..|++.+.||+|+||.||+|+..+ ...||+|.+.. . ...++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458888999999999999998532 34689998642 1 123456689
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999876667889999999999999999999 999999999999999999999999999999876433
Q ss_pred CCc--cceeccccccccccC
Q 035895 510 DQS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~--~~~~~~~~t~~y~aP 527 (527)
... ...+...+|+.|+||
T Consensus 182 ~~~~~~~~~~~~~~~~y~aP 201 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMAL 201 (298)
T ss_dssp GGCBC-----CCBCGGGSCH
T ss_pred chhccccccCCCCCccccCh
Confidence 211 122344567889998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.5e-22 Score=197.07 Aligned_cols=132 Identities=27% Similarity=0.387 Sum_probs=98.3
Q ss_pred cceeccCCceEEEEEEcc-CCcEEEEEEEee---------------------------ccCccceeEEEEEeccCCcHHH
Q 035895 390 NNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF---------------------------SCSNEDFRALVLEYTTNGSLEK 441 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~---------------------------~~~~~~~~~lv~ey~~~g~L~~ 441 (527)
.+.||+|+||.||+|+.. +++.||||++.. .+..++..++||||+++|+|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 378999999999999874 689999999753 1233456789999999999999
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeecccccccCCCCCccceecc
Q 035895 442 VLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI---VAHLSDFGIAKLLTGEDQSMTQTQT 518 (527)
Q Consensus 442 ~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~ 518 (527)
++... ..+++.++..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+++....... .....
T Consensus 96 ~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~ 169 (325)
T 3kn6_A 96 RIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTP 169 (325)
T ss_dssp HHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--ccccc
Confidence 99764 45789999999999999999999 99999999999999997655 899999999987643322 22234
Q ss_pred ccccccccC
Q 035895 519 LAIIGYMAP 527 (527)
Q Consensus 519 ~~t~~y~aP 527 (527)
.+|++|+||
T Consensus 170 ~~t~~y~aP 178 (325)
T 3kn6_A 170 CFTLHYAAP 178 (325)
T ss_dssp ---------
T ss_pred CCCcCccCH
Confidence 578999998
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=181.42 Aligned_cols=178 Identities=23% Similarity=0.289 Sum_probs=97.7
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEE
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 145 (527)
.++.+++.++.++..+ .++|++|++++|++++..+..+..+. +|++|++++|.+++..+..|..+++|++|
T Consensus 11 ~v~c~~~~l~~~p~~~--------~~~l~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGI--------PAQTTYLDLETNSLKSLPNGVFDELT-SLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp EEECCSSCCSSCCSCC--------CTTCSEEECCSSCCCCCCTTTTTTCT-TCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred EEEecCCCccCCCCCC--------CCCCcEEEcCCCccCcCChhhhcccc-cCcEEECCCCccCccChhhcCCCCCcCEE
Confidence 4455555555443321 24566666666666655444444443 56666666666665555555666666666
Q ss_pred EeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCC
Q 035895 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225 (527)
Q Consensus 146 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 225 (527)
++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|.+.
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 66666666555555556666666666666665544445556666666666666666555555566666666666666543
Q ss_pred CCchhhhCCCCccEEEccCCcccccCCccccCC
Q 035895 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNL 258 (527)
Q Consensus 226 ~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l 258 (527)
. .++.|++|+++.|.+.|.+|..++.+
T Consensus 162 ~------~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 162 C------TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp C------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred c------CCCCHHHHHHHHHhCCceeeccCccc
Confidence 2 22334444444444444444444433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-22 Score=197.50 Aligned_cols=137 Identities=28% Similarity=0.377 Sum_probs=114.6
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------------cCccc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------------CSNED 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------------~~~~~ 425 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +..++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45699999999999999999985 57899999987532 12234
Q ss_pred eeEEEEEeccCC-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 426 FRALVLEYTTNG-SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 426 ~~~lv~ey~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
..++||||+.+| +|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 567999999777 999998754 35789899999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... .....||++|+||
T Consensus 179 ~~~~~~~---~~~~~gt~~y~aP 198 (335)
T 3dls_A 179 YLERGKL---FYTFCGTIEYCAP 198 (335)
T ss_dssp ECCTTCC---BCEECSCGGGCCH
T ss_pred ECCCCCc---eeccCCCccccCh
Confidence 7754322 2235689999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.4e-22 Score=193.03 Aligned_cols=135 Identities=25% Similarity=0.441 Sum_probs=112.1
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
.++|++.+.||+|+||.||+|+.. +++.||||++... +..++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456999999999999999999875 7899999997531 1234567899
Q ss_pred EEeccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC----------------
Q 035895 431 LEYTTNGSLEKVLYSSN---YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---------------- 491 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---------------- 491 (527)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997532 45789999999999999999999 999999999999999984
Q ss_pred ---CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 ---NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...+|++|||.++...... ...+|..|+||
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aP 199 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLAN 199 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCH
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccCh
Confidence 4489999999998764321 23478889998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5e-22 Score=199.17 Aligned_cols=133 Identities=34% Similarity=0.444 Sum_probs=112.7
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
+.|+..+.||+|+||.||+|+. .+++.||||++... +..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3488899999999999999985 67899999997521 12345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||++ |++.+.+......+++.++..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9998 5888888766667899999999999999999999 899999999999999999999999999999876422
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
....||++|+||
T Consensus 208 ----~~~~gt~~y~aP 219 (348)
T 1u5q_A 208 ----NSFVGTPYWMAP 219 (348)
T ss_dssp ----CCCCSCGGGCCH
T ss_pred ----CcccCCcceeCH
Confidence 234688999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.3e-22 Score=201.70 Aligned_cols=144 Identities=17% Similarity=0.260 Sum_probs=116.8
Q ss_pred hhhcCCccccceeccC--CceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccce
Q 035895 381 LRATDGFSANNLIGRG--SFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDF 426 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G--~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~ 426 (527)
....+.|++.+.||+| +||.||+|+.. +++.||||++... +..++.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3445679999999999 99999999975 7899999998531 223456
Q ss_pred eEEEEEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
.++|||||++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 78999999999999999764 245788899999999999999999 99999999999999999999999999999875
Q ss_pred cCCCCCc-----cceeccccccccccC
Q 035895 506 LTGEDQS-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~-----~~~~~~~~t~~y~aP 527 (527)
....... .......||++|+||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aP 204 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSP 204 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred eccccccccccccccccccccccccCH
Confidence 4322110 111223678899998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=204.31 Aligned_cols=135 Identities=14% Similarity=0.166 Sum_probs=108.6
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc----------------------Ccc----------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC----------------------SNE---------------- 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~----------------------~~~---------------- 424 (527)
...|+..+.||+|+||.||+|+. .+++.||||++.... .++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34589999999999999999996 478999999986411 011
Q ss_pred --------------------ceeEEEEEeccCCcHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeE
Q 035895 425 --------------------DFRALVLEYTTNGSLEKVLYSSNYILDILQR------LNIMIDVTSALEYLHFGYSTPII 478 (527)
Q Consensus 425 --------------------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~ylH~~~~~~ii 478 (527)
...++|||||+ |+|.+++...+..+++..+ ..++.|++.||+||| +++|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 22689999999 8999999865444455555 678899999999999 99999
Q ss_pred ecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 479 Hrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||||||+|||++.++.+||+|||+|+..... .....+|+.|+||
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aP 260 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPR 260 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcCh
Confidence 9999999999999999999999999876421 1134566899998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-22 Score=203.84 Aligned_cols=137 Identities=28% Similarity=0.447 Sum_probs=113.3
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cC--ccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CS--NEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~--~~~~~~lv~ 431 (527)
+.|++.+.||+|+||.||+|+.. +|+.||||++... +. .....++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46899999999999999999865 5899999997531 11 122568999
Q ss_pred EeccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeecccccc
Q 035895 432 EYTTNGSLEKVLYSSNY--ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDFGIAKL 505 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill----~~~~~~kl~Dfg~a~~ 505 (527)
|||++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+|+.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999975432 3889999999999999999999 9999999999999999 7788899999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... .....||..|+||
T Consensus 166 ~~~~~~---~~~~~gt~~y~aP 184 (396)
T 4eut_A 166 LEDDEQ---FVSLYGTEEYLHP 184 (396)
T ss_dssp CCCGGG---SSCSSSCCTTCCH
T ss_pred ccCCCc---cccccCCccccCH
Confidence 653321 2235688999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=7.1e-22 Score=205.13 Aligned_cols=137 Identities=29% Similarity=0.407 Sum_probs=112.3
Q ss_pred hhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cC-ccceeEEEEEe
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CS-NEDFRALVLEY 433 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~-~~~~~~lv~ey 433 (527)
...++|++.+.||+|+||.||+|... ++.||||+++.. +. .+...++||||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 34567899999999999999999875 779999997531 11 22367899999
Q ss_pred ccCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSSNY-ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++|+|.+++...+. .+++.....++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999986543 3688889999999999999999 999999999999999999999999999999865321
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....+++.|+||
T Consensus 343 --~~~~~~~~~y~aP 355 (450)
T 1k9a_A 343 --QDTGKLPVKWTAP 355 (450)
T ss_dssp ------CCCTTTSCH
T ss_pred --ccCCCCCcceeCH
Confidence 1123467889998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=198.36 Aligned_cols=137 Identities=32% Similarity=0.521 Sum_probs=115.7
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------------cCcc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------------CSNE 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------------~~~~ 424 (527)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. +...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 466999999999999999999975 7999999987421 1123
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
+..++||||++||+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||+++
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 4568999999999999998754 35788899999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+..... .....||+.|+||
T Consensus 249 ~~~~~~~---~~~~~gt~~y~aP 268 (365)
T 2y7j_A 249 HLEPGEK---LRELCGTPGYLAP 268 (365)
T ss_dssp ECCTTCC---BCCCCSCGGGCCH
T ss_pred ccCCCcc---cccCCCCCCccCh
Confidence 7754322 2335689999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=8.3e-22 Score=191.21 Aligned_cols=137 Identities=29% Similarity=0.460 Sum_probs=112.0
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~l 429 (527)
+.++|++.+.||+|+||.||+|+. .+++.||+|++.. .+...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 457799999999999999999986 4678999998742 1223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++... ..+++..+..++.+++.|++||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999998754 35788889999999999999999 999999999999999999999999999998765322
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
. .....+|+.|+||
T Consensus 163 ~----~~~~~~~~~y~aP 176 (279)
T 3fdn_A 163 R----RTDLCGTLDYLPP 176 (279)
T ss_dssp ---------CCCCTTCCH
T ss_pred c----ccccCCCCCccCH
Confidence 1 2234678899998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=208.95 Aligned_cols=142 Identities=25% Similarity=0.433 Sum_probs=111.2
Q ss_pred hhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeecc---------------------------CccceeEEEEEec
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC---------------------------SNEDFRALVLEYT 434 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~lv~ey~ 434 (527)
...++|++.+.||+|+||.||+|+...+..||||+++... ..++..++||||+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~ 260 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 260 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhh
Confidence 3456788999999999999999999888889999975311 1224568999999
Q ss_pred cCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++|+|.+++... +..+++.+...++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence 999999999753 245788899999999999999999 9999999999999999999999999999998765322 11
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......+++.|+||
T Consensus 337 ~~~~~~~~~~y~aP 350 (452)
T 1fmk_A 337 ARQGAKFPIKWTAP 350 (452)
T ss_dssp ------CCGGGSCH
T ss_pred cccCCcccccccCH
Confidence 22234467889998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.5e-22 Score=197.85 Aligned_cols=140 Identities=25% Similarity=0.411 Sum_probs=114.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------Cc--------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------SN-------- 423 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------~~-------- 423 (527)
.+.|++.+.||+|+||.||+|+. .+|+.||||++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999987 578999999863210 01
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
.+..++||||+++ +|.+.+......+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 2356899999985 888888766667899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCC--ccceeccccccccccC
Q 035895 504 KLLTGEDQ--SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~--~~~~~~~~~t~~y~aP 527 (527)
+.+..... ........+|++|+||
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aP 197 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPP 197 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred ccccccccccccccCCcccccCccCc
Confidence 87643221 1122345679999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.4e-22 Score=198.31 Aligned_cols=144 Identities=24% Similarity=0.380 Sum_probs=115.6
Q ss_pred hhhcCCccccceeccCCceEEEEEEcc-C-----CcEEEEEEEee-------------------------------ccCc
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQ-D-----GMEFAIKVFHF-------------------------------SCSN 423 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~-----~~~vavK~~~~-------------------------------~~~~ 423 (527)
....++|++.+.||+|+||.||+|+.. + ...||+|++.. .+..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 344578999999999999999999853 2 34799998742 1233
Q ss_pred cceeEEEEEeccCCcHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSS-------------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD 490 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~ 490 (527)
.+..++||||+++|+|.+++... ...+++.....++.|++.||+||| +++|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence 45678999999999999998753 234688899999999999999999 89999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 491 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 491 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.++.+||+|||+++...............+|+.|+||
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 235 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP 235 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCH
Confidence 9999999999999876543322222334567889998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-22 Score=195.54 Aligned_cols=144 Identities=26% Similarity=0.444 Sum_probs=118.7
Q ss_pred HhhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee----------------------------ccCccceeEEE
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF----------------------------SCSNEDFRALV 430 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~----------------------------~~~~~~~~~lv 430 (527)
+....++|++.+.||+|+||.||+|+.. +++.||+|++.. .+..++..++|
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3445677999999999999999999875 588999999743 12345567899
Q ss_pred EEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 431 LEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
|||+++|+|.+++.... ..+++..+..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999997643 45789899999999999999999 899999999999999999999999999999877543
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .......+|+.|+||
T Consensus 165 ~~-~~~~~~~~~~~y~aP 181 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAP 181 (288)
T ss_dssp SS-EEETTEEECGGGCCH
T ss_pred cc-ccccCCccccCcCCh
Confidence 22 222334567889998
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-21 Score=179.55 Aligned_cols=180 Identities=24% Similarity=0.305 Sum_probs=91.1
Q ss_pred CEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccC
Q 035895 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRG 173 (527)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 173 (527)
+.++.+++.++.+ |..+ ..+|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus 10 ~~v~c~~~~l~~~-p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCSSC-CSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCccCC-CCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 4555555555542 2221 22455555555555544444455555555555555555544444444555555555555
Q ss_pred cccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCc
Q 035895 174 NELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPS 253 (527)
Q Consensus 174 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~ 253 (527)
|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|+++++| +.
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-----------------------~~ 142 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVP-----------------------DG 142 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC-----------------------TT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeC-----------------------HH
Confidence 5554433334444455555555555554444444444444444444444444433 23
Q ss_pred cccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCC
Q 035895 254 KIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV 307 (527)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 307 (527)
.+..+++|++|++++|.+.+. +++|++|+++.|+++|.+|..++.++
T Consensus 143 ~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 143 VFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred HhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCceeeccCcccc
Confidence 344555566666666655432 33556666666666666666655544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.4e-22 Score=193.94 Aligned_cols=138 Identities=30% Similarity=0.404 Sum_probs=109.5
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ 431 (527)
.++|++.+.||+|+||.||+|+.. +|+.||||++... +..++..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999874 5899999987321 22345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+++++|.+++... ..+++.....++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999999887643 45788899999999999999999 99999999999999999999999999999987653322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......+|.+|+||
T Consensus 158 --~~~~~~~~~~y~aP 171 (311)
T 4agu_A 158 --YYDDEVATRWYRSP 171 (311)
T ss_dssp ----------GGGCCH
T ss_pred --ccCCCcCCccccCh
Confidence 12234678899998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.2e-22 Score=197.39 Aligned_cols=141 Identities=25% Similarity=0.385 Sum_probs=105.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcE----EEEEEEeecc-----------------------------CccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGME----FAIKVFHFSC-----------------------------SNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~----vavK~~~~~~-----------------------------~~~~~~~l 429 (527)
.++|++.+.||+|+||.||+|+. .+++. ||+|.+.... ...+..++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 46799999999999999999985 34554 4677653210 01234578
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999999877677899999999999999999999 999999999999999999999999999999877543
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
..........+|+.|+||
T Consensus 171 ~~~~~~~~~~~t~~y~aP 188 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMAL 188 (327)
T ss_dssp ---------CCCGGGSCH
T ss_pred cccccccCCCccccccCH
Confidence 333333344567889998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=8e-22 Score=196.58 Aligned_cols=141 Identities=28% Similarity=0.509 Sum_probs=108.0
Q ss_pred cCCccccceeccCCceEEEEEEccC-----CcEEEEEEEeec------------------------------cCccceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD-----GMEFAIKVFHFS------------------------------CSNEDFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~------------------------------~~~~~~~~ 428 (527)
.+.|+..+.||+|+||.||+|+... +..||||+++.. +...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3467888999999999999998642 246999997531 23345678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999876667899999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCc-cceeccccccccccC
Q 035895 509 EDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~-~~~~~~~~t~~y~aP 527 (527)
.... .......+|+.|+||
T Consensus 200 ~~~~~~~~~~~~~~~~y~aP 219 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAP 219 (333)
T ss_dssp -----------CCCGGGSCH
T ss_pred ccccccccCCCCccccccCc
Confidence 3211 112233457789998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.1e-22 Score=200.61 Aligned_cols=138 Identities=22% Similarity=0.303 Sum_probs=107.0
Q ss_pred CCccccceeccCCceEEEEEEcc----CCcEEEEEEEeecc---------------------------------------
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFSC--------------------------------------- 421 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~--------------------------------------- 421 (527)
++|++.+.||+|+||.||+|+.. ++..||||++....
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56999999999999999999975 57889999875310
Q ss_pred -C----ccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC--c
Q 035895 422 -S----NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI--V 494 (527)
Q Consensus 422 -~----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~--~ 494 (527)
. .....++||||+ +|+|.+++...+ .+++.++..++.|++.||+||| +++|+||||||+||+++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence 0 145678999999 999999987544 6899999999999999999999 89999999999999998777 9
Q ss_pred EEEeecccccccCCCCCc-----cceeccccccccccC
Q 035895 495 AHLSDFGIAKLLTGEDQS-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 495 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aP 527 (527)
+||+|||+|+.+...... .......||+.|+||
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 229 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL 229 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCH
Confidence 999999999876432111 111334689999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=6.7e-22 Score=198.24 Aligned_cols=139 Identities=32% Similarity=0.496 Sum_probs=111.3
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec----------------------------------cCcccee
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS----------------------------------CSNEDFR 427 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----------------------------------~~~~~~~ 427 (527)
..+.|++.+.||+|+||.||+|+.. +|+.||||++... +...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4577999999999999999999974 6899999987421 1234456
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++ +|.+++......+++.+...++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 899999986 899988766666788888999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ..+...+|++|+||
T Consensus 164 ~~~~--~~~~~~~t~~y~aP 181 (346)
T 1ua2_A 164 SPNR--AYTHQVVTRWYRAP 181 (346)
T ss_dssp SCCC--CCCCSCCCCTTCCH
T ss_pred CCcc--cCCcccccccccCc
Confidence 3322 22335678999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=192.51 Aligned_cols=141 Identities=30% Similarity=0.454 Sum_probs=111.1
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------c-------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------C------------- 421 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~------------- 421 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 35699999999999999999986 57899999987421 0
Q ss_pred CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 035895 422 SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 422 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
...+..++||||+++|+|.+++...+..+++.+...++.|++.||+||| +++|+||||||+||+++.++.+|++|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 1134568999999999999999876666788888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC------------ccceeccccccccccC
Q 035895 502 IAKLLTGEDQ------------SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~------------~~~~~~~~~t~~y~aP 527 (527)
+++....... ........+|..|+||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 199 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199 (303)
T ss_dssp CCSCTTC-------------------------CTTSCH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCc
Confidence 9987642210 0111234578889998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.4e-22 Score=193.50 Aligned_cols=138 Identities=28% Similarity=0.367 Sum_probs=105.3
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALV 430 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv 430 (527)
..++|++.+.||+|+||.||+|+. .+++.||||++... +..++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356799999999999999999986 57899999987421 2234567899
Q ss_pred EEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 431 LEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYST-PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~-~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
|||+++ +|.+++.. .+..+++..+..++.|++.||+||| ++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 88777654 3456899999999999999999999 87 9999999999999999999999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... .....+|++|+||
T Consensus 161 ~~~~~---~~~~~~t~~y~aP 178 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAP 178 (290)
T ss_dssp ------------CCCCCCSCH
T ss_pred ccccc---ccccCCCccccCh
Confidence 53321 2234578899998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=5.6e-22 Score=191.94 Aligned_cols=140 Identities=24% Similarity=0.396 Sum_probs=115.1
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|++.+.||+|+||.||+|+.. +++.||||++... +..++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999865 7899999997531 122345689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+++|+|.+++... ..+++.+...++.|++.||+||| +.+|+||||||+||+++.++.+|++|||.++........
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999988543 45788899999999999999999 899999999999999999999999999999876432221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.......+|..|+||
T Consensus 162 ~~~~~~~~~~~y~aP 176 (276)
T 2yex_A 162 RLLNKMCGTLPYVAP 176 (276)
T ss_dssp CCBCCCCSCGGGCCG
T ss_pred hcccCCccccCccCh
Confidence 122345678899998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.86 E-value=6.5e-22 Score=200.72 Aligned_cols=134 Identities=19% Similarity=0.218 Sum_probs=107.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------c---Ccc---------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------C---SNE--------------- 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------~---~~~--------------- 424 (527)
.+.|++.+.||+|+||+||+|+. .+|+.||||++... . .++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46688999999999999999996 56899999997521 0 000
Q ss_pred ----------------c-----eeEEEEEeccCCcHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 035895 425 ----------------D-----FRALVLEYTTNGSLEKVLYSSNYI------LDILQRLNIMIDVTSALEYLHFGYSTPI 477 (527)
Q Consensus 425 ----------------~-----~~~lv~ey~~~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~ylH~~~~~~i 477 (527)
+ ..++||||+ +|+|.+++...+.. +++..+..|+.||+.||+||| +++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 0 267999999 68999999754322 225777889999999999999 8999
Q ss_pred EecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 478 iHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+||||||+|||++.++.+||+|||+|+.... ......| ++|+||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aP 271 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPP 271 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccCh
Confidence 9999999999999999999999999986432 1233456 889998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=197.94 Aligned_cols=139 Identities=29% Similarity=0.428 Sum_probs=110.5
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------c--------------
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------C-------------- 421 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------~-------------- 421 (527)
...+.|++.+.||+|+||+||+|+. .+|+.||||++... +
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 3467899999999999999999985 67899999987421 0
Q ss_pred ------------------------CccceeEEEEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 035895 422 ------------------------SNEDFRALVLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYS 474 (527)
Q Consensus 422 ------------------------~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~ 474 (527)
..+...++||||+++ +|.+.+.. .+..+++..+..++.|+++||+||| +
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 159 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---S 159 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 112236799999984 88777753 3456889999999999999999999 9
Q ss_pred CCeEecCCCCCCeeeC-CCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 475 TPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 475 ~~iiHrdlk~~nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+|+||||||+||+++ .++.+||+|||+|+....... .....+|.+|+||
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aP 210 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAP 210 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCH
Confidence 9999999999999998 689999999999997653322 2234578889998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=192.65 Aligned_cols=139 Identities=26% Similarity=0.363 Sum_probs=107.5
Q ss_pred CCcccc-ceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 385 DGFSAN-NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
+.|++. +.||+|+||.||+|+. .+++.||||++... +..++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457774 7899999999999985 57899999998531 123356689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeecccccccCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV---AHLSDFGIAKLLTGE 509 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~---~kl~Dfg~a~~~~~~ 509 (527)
|+++|+|.+++... ..+++.++..++.|++.||+||| +++|+||||||+||+++.++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999764 35788889999999999999999 899999999999999987765 999999999865422
Q ss_pred CCc-----cceeccccccccccC
Q 035895 510 DQS-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~-----~~~~~~~~t~~y~aP 527 (527)
... .......||+.|+||
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aP 190 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAP 190 (316)
T ss_dssp --------------CCSGGGCCH
T ss_pred CccccccccccccccCCcCccCh
Confidence 110 111234588999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.8e-22 Score=194.58 Aligned_cols=135 Identities=26% Similarity=0.417 Sum_probs=112.2
Q ss_pred cCCccccceeccCCceEEEEEEccC-C-------cEEEEEEEee-----------------------------ccCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD-G-------MEFAIKVFHF-----------------------------SCSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~-~-------~~vavK~~~~-----------------------------~~~~~~~ 426 (527)
.++|++.+.||+|+||.||+|+... + ..||+|++.. .+..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3568999999999999999998642 3 4799998742 1233456
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--------EEEe
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV--------AHLS 498 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~--------~kl~ 498 (527)
.++||||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++. +|++
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 68999999999999999876666899999999999999999999 999999999999999998876 9999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++..... ....+|++|+||
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aP 186 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPP 186 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCH
T ss_pred cCcccccccCc------cccCCcCcccCH
Confidence 99999765321 123467889998
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.9e-22 Score=208.43 Aligned_cols=188 Identities=24% Similarity=0.342 Sum_probs=148.7
Q ss_pred ccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCC
Q 035895 63 IVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDL 142 (527)
Q Consensus 63 ~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 142 (527)
.++.|+|++|.|++++..+ +++|++|+|++|+|+. +| ...++|+.|+|++|.|++ +|. +.. +|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l--------~~~L~~L~Ls~N~l~~-ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L 122 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNL--------PPQITVLEITQNALIS-LP----ELPASLEYLDACDNRLST-LPE-LPA--SL 122 (571)
T ss_dssp TCSEEECCSSCCSCCCSCC--------CTTCSEEECCSSCCSC-CC----CCCTTCCEEECCSSCCSC-CCC-CCT--TC
T ss_pred CccEEEeCCCCCCccCHhH--------cCCCCEEECcCCCCcc-cc----cccCCCCEEEccCCCCCC-cch-hhc--CC
Confidence 5789999999999876543 2689999999999995 56 224589999999999997 555 655 99
Q ss_pred cEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCC
Q 035895 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 143 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 222 (527)
++|+|++|++++ +|. .+++|+.|++++|.+++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|
T Consensus 123 ~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N 190 (571)
T 3cvr_A 123 KHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTN 190 (571)
T ss_dssp CEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSS
T ss_pred CEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCC
Confidence 999999999998 444 68999999999999996 665 67899999999999997 566 66 89999999999
Q ss_pred CCCCCchhhhCCCCc-------cEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCC
Q 035895 223 ELTSIPSILWNLKDI-------LYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLK 283 (527)
Q Consensus 223 ~l~~lp~~~~~l~~L-------~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 283 (527)
+|+.+|. +.. +| +.|++++|.+. .+|..+..+++|++|+|++|.+++.+|..+..+.
T Consensus 191 ~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 191 LLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred CCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 9999987 443 55 67777777666 3566666677777777777777666666665543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.7e-22 Score=204.62 Aligned_cols=135 Identities=26% Similarity=0.275 Sum_probs=105.1
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cC------cc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CS------NE 424 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~------~~ 424 (527)
..+.|++.+.||+|+||+||+|+. .+++.||||++... +. ..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999985 56899999998521 00 11
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
...++||||+++ ++.+.+.. .+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 346899999986 46666632 4788889999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... ..+..+||++|+||
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aP 232 (464)
T 3ttj_A 213 TAGTSF---MMTPYVVTRYYRAP 232 (464)
T ss_dssp ----CC---CC----CCCTTCCH
T ss_pred ecCCCc---ccCCCcccccccCH
Confidence 765322 22346789999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.2e-22 Score=198.49 Aligned_cols=139 Identities=19% Similarity=0.288 Sum_probs=112.7
Q ss_pred CCccccceeccCCceEEEEEEcc---------CCcEEEEEEEeec-----------------------------------
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ---------DGMEFAIKVFHFS----------------------------------- 420 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~---------~~~~vavK~~~~~----------------------------------- 420 (527)
++|++.+.||+|+||.||+|+.. +++.||||++...
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 57999999999999999999875 3789999997421
Q ss_pred ----c-CccceeEEEEEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-
Q 035895 421 ----C-SNEDFRALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI- 493 (527)
Q Consensus 421 ----~-~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~- 493 (527)
+ ..++..++||||+ +|+|.+++... +..+++.++..++.|++.||+||| +++|+||||||+||+++.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~ 197 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQ 197 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCC
Confidence 0 1246778999999 99999999865 356899999999999999999999 89999999999999999988
Q ss_pred -cEEEeecccccccCCCCCc-----cceeccccccccccC
Q 035895 494 -VAHLSDFGIAKLLTGEDQS-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 -~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aP 527 (527)
.+||+|||+++.+...... .......||+.|+||
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 237 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM 237 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred ceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence 9999999999876532211 111234688999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=189.00 Aligned_cols=136 Identities=28% Similarity=0.441 Sum_probs=112.9
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeeccC----------------------------------ccceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSCS----------------------------------NEDFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~----------------------------------~~~~~~ 428 (527)
.++|++.+.||+|+||.||+|+. .+++.||+|++..... ..+..+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 46799999999999999999986 5789999999742110 012236
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCc-----EEEeecc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP--IIHCDLKPHNKLLDDNIV-----AHLSDFG 501 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~--iiHrdlk~~nill~~~~~-----~kl~Dfg 501 (527)
+||||+++|+|.+.+......+++..+..++.|++.|++||| +++ |+||||||+||+++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999999999877677899999999999999999999 888 999999999999987776 9999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++..... .....+|+.|+||
T Consensus 175 ~~~~~~~~-----~~~~~g~~~y~aP 195 (287)
T 4f0f_A 175 LSQQSVHS-----VSGLLGNFQWMAP 195 (287)
T ss_dssp TCBCCSSC-----EECCCCCCTTSCG
T ss_pred cccccccc-----ccccCCCccccCc
Confidence 99854321 2335688899998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=197.00 Aligned_cols=138 Identities=30% Similarity=0.362 Sum_probs=112.5
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec----------------------------------cCcccee
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS----------------------------------CSNEDFR 427 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----------------------------------~~~~~~~ 427 (527)
..++|++.+.||+|+||+||+|+.. +++.||||++... +..++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 3578999999999999999999864 6889999997421 1123566
Q ss_pred EEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeccccc
Q 035895 428 ALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD--DNIVAHLSDFGIAK 504 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~--~~~~~kl~Dfg~a~ 504 (527)
++||||++ |+|.+++.... ..+++..+..++.|++.||+||| .+..+||||||||+|||++ .++.+||+|||+|+
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHT-STTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhc-cCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 79999996 59999997654 45889999999999999999999 2357899999999999995 57889999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... .....+|+.|+||
T Consensus 210 ~~~~~-----~~~~~~t~~y~aP 227 (382)
T 2vx3_A 210 QLGQR-----IYQYIQSRFYRSP 227 (382)
T ss_dssp ETTCC-----CCSSCSCGGGCCH
T ss_pred ecccc-----cccccCCccccCh
Confidence 76432 1235678899998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=190.87 Aligned_cols=137 Identities=31% Similarity=0.570 Sum_probs=114.5
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeecc-----------------------------------------C
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFSC-----------------------------------------S 422 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-----------------------------------------~ 422 (527)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 45899999999999999999975 78999999975310 0
Q ss_pred ccceeEEEEEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 035895 423 NEDFRALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 423 ~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
.....++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 167 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFG 167 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcch
Confidence 123468999999999999999754 346889999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++....... .....+|+.|+||
T Consensus 168 ~~~~~~~~~~---~~~~~~~~~y~aP 190 (284)
T 2a19_B 168 LVTSLKNDGK---RTRSKGTLRYMSP 190 (284)
T ss_dssp TCEESSCCSC---CCCCCSCCTTSCH
T ss_pred hheecccccc---ccccCCcccccCh
Confidence 9987754321 2234578899998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=202.06 Aligned_cols=137 Identities=26% Similarity=0.348 Sum_probs=107.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc------------------------------------Cccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC------------------------------------SNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~------------------------------------~~~~~ 426 (527)
.+.|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 46799999999999999999986 568999999975310 01234
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN---IVAHLSDFGIA 503 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~---~~~kl~Dfg~a 503 (527)
.++||||+++|+|.+++... ..+++.++..++.|++.||+||| +++|+||||||+||+++.+ +.+||+|||+|
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred eEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 57999999999999887643 45789999999999999999999 8999999999999999644 46999999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+...... ......||++||||
T Consensus 290 ~~~~~~~---~~~~~~gt~~y~aP 310 (419)
T 3i6u_A 290 KILGETS---LMRTLCGTPTYLAP 310 (419)
T ss_dssp TSCC--------------CTTCCT
T ss_pred eecCCCc---cccccCCCCCccCc
Confidence 9765322 12335689999999
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=194.03 Aligned_cols=141 Identities=27% Similarity=0.436 Sum_probs=114.8
Q ss_pred cCCccccceeccCCceEEEEEEc-----cCCcEEEEEEEeec-----------------------------cCc--ccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHFS-----------------------------CSN--EDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~-----------------------------~~~--~~~~ 427 (527)
.+.|++.+.||+|+||.||+|+. .+++.||||++... +.. ....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999983 46899999997421 111 2256
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+++|+|.+++...+..+++.++..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 8999999999999999877667899999999999999999999 8999999999999999999999999999998875
Q ss_pred CCCCcc-ceeccccccccccC
Q 035895 508 GEDQSM-TQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~-~~~~~~~t~~y~aP 527 (527)
...... ......++..|+||
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aP 217 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAP 217 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCH
T ss_pred ccccccccccCCCCceeEECc
Confidence 432211 11223467789998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.5e-22 Score=191.53 Aligned_cols=137 Identities=29% Similarity=0.428 Sum_probs=109.4
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
+.|.+.+.||+|+||.||+|+. .+++.||+|++... +...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4588999999999999999986 46899999997532 2234566899999
Q ss_pred ccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccC
Q 035895 434 TTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 434 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill---~~~~~~kl~Dfg~a~~~~ 507 (527)
+++|+|.+.+... +..+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 356889999999999999999999 9999999999999999 456889999999998764
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
... ......+|..|+||
T Consensus 179 ~~~---~~~~~~~t~~y~aP 195 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAP 195 (285)
T ss_dssp -----------CTTGGGCCH
T ss_pred Ccc---cCcCcccccCcCCh
Confidence 332 12335688999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=194.82 Aligned_cols=137 Identities=28% Similarity=0.400 Sum_probs=101.1
Q ss_pred cCCcccc-ceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------c----CccceeEEEEE
Q 035895 384 TDGFSAN-NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------C----SNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------~----~~~~~~~lv~e 432 (527)
.++|.+. ++||+|+||.||+|+.. +++.||||++... + ......++|||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 4678885 56999999999999875 6899999997431 0 11344789999
Q ss_pred eccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCC
Q 035895 433 YTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~ 508 (527)
|+++|+|.+++...+ ..+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+++....
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 999999999998653 35889999999999999999999 899999999999999975 45699999999987643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.. .....+|++|+||
T Consensus 184 ~~----~~~~~~t~~y~aP 198 (336)
T 3fhr_A 184 NA----LQTPCYTPYYVAP 198 (336)
T ss_dssp -------------------
T ss_pred cc----cccCCCCcCccCh
Confidence 21 1234578899998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=196.79 Aligned_cols=133 Identities=26% Similarity=0.356 Sum_probs=105.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCcc------c
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNE------D 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~------~ 425 (527)
.+.|+..+.||+|+||.||+|+. .+|+.||||++... +..+ .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999986 57899999997321 0111 2
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||||+ +++|.+++.. ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 348999999 8899999876 35788889999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... .+..++|.+|+||
T Consensus 178 ~~~~-----~~~~~~t~~y~aP 194 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAP 194 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCT
T ss_pred cccc-----cCcCcCCCCcCCH
Confidence 6432 2345688999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=195.99 Aligned_cols=144 Identities=26% Similarity=0.344 Sum_probs=112.4
Q ss_pred HHHHhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec------------------------------------
Q 035895 377 YQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------------ 420 (527)
Q Consensus 377 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------------ 420 (527)
.+++....++|++.+.||+|+||.||+|+..+|+.||||++...
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 44566778999999999999999999999888999999987321
Q ss_pred ----c-----CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 035895 421 ----C-----SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD 491 (527)
Q Consensus 421 ----~-----~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~ 491 (527)
+ ......++||||++ |+|.+.+......+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence 0 11124589999998 5898888776667899999999999999999999 899999999999999999
Q ss_pred CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.+||+|||+++...... ......+|.+|+||
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aP 202 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA---NKTHYVTHRWYRAP 202 (362)
T ss_dssp TCCEEECCTTC------------------CGGGCCH
T ss_pred CCCEEEEecCccccccccc---ccceecccceecCc
Confidence 9999999999998654322 22335678889998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=190.37 Aligned_cols=141 Identities=26% Similarity=0.424 Sum_probs=114.1
Q ss_pred cCCccccc-eeccCCceEEEEEEcc---CCcEEEEEEEeecc-----------------------------CccceeEEE
Q 035895 384 TDGFSANN-LIGRGSFGSVYKARLQ---DGMEFAIKVFHFSC-----------------------------SNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~-~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~-----------------------------~~~~~~~lv 430 (527)
.++|.+.+ .||+|+||.||+|... +++.||||+++... ...+..++|
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv 87 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 87 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence 34566666 9999999999999853 67889999985311 123456899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999766667899999999999999999999 9999999999999999999999999999998775332
Q ss_pred Ccc-ceeccccccccccC
Q 035895 511 QSM-TQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~-~~~~~~~t~~y~aP 527 (527)
... ......+|+.|+||
T Consensus 165 ~~~~~~~~~~~~~~y~aP 182 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAP 182 (287)
T ss_dssp CEECCCCSSCCCGGGCCH
T ss_pred ceeeccccccccccccCH
Confidence 211 12233467889998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=193.20 Aligned_cols=136 Identities=28% Similarity=0.418 Sum_probs=113.8
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------------cCccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------------CSNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------------~~~~~~~~ 428 (527)
+.|++.+.||+|+||.||+|+.. +|+.||+|++... +...+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45899999999999999999864 6899999987531 12234568
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeccccc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI----VAHLSDFGIAK 504 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~----~~kl~Dfg~a~ 504 (527)
+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999754 45788899999999999999999 89999999999999999887 79999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... .....||+.|+||
T Consensus 168 ~~~~~~~---~~~~~gt~~y~aP 187 (321)
T 2a2a_A 168 EIEDGVE---FKNIFGTPEFVAP 187 (321)
T ss_dssp ECCTTCC---CCCCCSCGGGCCH
T ss_pred ecCcccc---ccccCCCCCccCc
Confidence 7654321 2234688999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=190.66 Aligned_cols=141 Identities=25% Similarity=0.416 Sum_probs=112.2
Q ss_pred hcCCccccceeccCCceEEEEEEccC----CcEEEEEEEeec-----------------------------cCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQD----GMEFAIKVFHFS-----------------------------CSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~-----------------------------~~~~~~~~l 429 (527)
..++|++.+.||+|+||.||+|+... +..||+|++... +..++..++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 35679999999999999999998542 346999987531 112344579
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++...+..+++.....++.+++.||+||| +++|+||||||+||+++.++.+|++|||+++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999876667899999999999999999999 999999999999999999999999999999876543
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .......+++.|+||
T Consensus 167 ~~-~~~~~~~~~~~y~aP 183 (281)
T 3cc6_A 167 DY-YKASVTRLPIKWMSP 183 (281)
T ss_dssp -------CCCCCGGGCCH
T ss_pred cc-cccccCCCCcceeCc
Confidence 21 122234467889998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=191.76 Aligned_cols=139 Identities=32% Similarity=0.413 Sum_probs=111.9
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------cCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~ 435 (527)
.+.|++.+.||+|+||.||+|+.. +|+.||||++... +...+..++||||++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 467999999999999999999865 5899999987531 223456689999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+|+|.+++......+++.....++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 182 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KR 182 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CB
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--cc
Confidence 99999999765667899999999999999999999 99999999999999999999999999999987653321 12
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....+|..|+||
T Consensus 183 ~~~~~~~~y~aP 194 (314)
T 3com_A 183 NTVIGTPFWMAP 194 (314)
T ss_dssp CCCCSCGGGCCH
T ss_pred CccCCCCCccCh
Confidence 234578899998
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-22 Score=215.38 Aligned_cols=226 Identities=15% Similarity=0.052 Sum_probs=123.1
Q ss_pred cccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCc-ccccCCCCCCEEeccCcccccccChhhhcCcccCeeee
Q 035895 117 SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSIS-ITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDL 195 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 195 (527)
+|+.|+++++.. ..+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++++...+.++..+..+++|+.|++
T Consensus 271 ~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L 349 (592)
T 3ogk_B 271 KLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRI 349 (592)
T ss_dssp TCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEE
T ss_pred cccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEe
Confidence 566666666432 2455566666677777777766553322 23456667777777633222233444455666777777
Q ss_pred e-----------cccCCCCC-CccccCCccCceeeCCCCCCCC-CchhhhC-CCCccEEEcc----CCccccc-----CC
Q 035895 196 R-----------GNKLSGSI-PTCFGNLTALRNLHLDSNELTS-IPSILWN-LKDILYLDFW----SNLFVGP-----LP 252 (527)
Q Consensus 196 ~-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~-lp~~~~~-l~~L~~l~l~----~n~~~~~-----~p 252 (527)
+ .|.++... +..+..+++|++|+++.|.++. .+..+.. +++|+.|+++ .|.+++. ++
T Consensus 350 ~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~ 429 (592)
T 3ogk_B 350 ERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVR 429 (592)
T ss_dssp ECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHH
T ss_pred ecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHH
Confidence 6 24444321 1123446667777776666654 2233332 5666666664 4444432 22
Q ss_pred ccccCCCCCCEEEccCCC--CCCCChhhhh-cCCCCCEEEccccccee-ecCCCCCCCCCCCEEeCCCCccccc-Cccch
Q 035895 253 SKIGNLKVLTRIDFSRNN--LLGDIPTTIQ-GLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEI-IPLSL 327 (527)
Q Consensus 253 ~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~-~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~ 327 (527)
..+..+++|++|++++|. +++..+..+. .+++|++|++++|++++ .++..+..+++|+.|++++|.+++. ++...
T Consensus 430 ~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 509 (592)
T 3ogk_B 430 SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAV 509 (592)
T ss_dssp HHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHH
T ss_pred HHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHH
Confidence 234556667777775433 4433333333 36667777777776654 2333445566677777777766543 23334
Q ss_pred hhhccCCeeEeeeeee
Q 035895 328 EKLLYLNILLIVVVIL 343 (527)
Q Consensus 328 ~~l~~L~~L~~~~~~~ 343 (527)
..++.|+.|+++.+.+
T Consensus 510 ~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 510 TKLPSLRYLWVQGYRA 525 (592)
T ss_dssp HHCSSCCEEEEESCBC
T ss_pred HhcCccCeeECcCCcC
Confidence 4566666666666554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=187.85 Aligned_cols=136 Identities=29% Similarity=0.355 Sum_probs=113.6
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
+.|++.+.||+|+||.||+|+.. ++..||+|++... +...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45899999999999999999864 5789999987531 22345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCCCC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill---~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
++|+|.+++... ..+++.....++.+++.|++||| +++|+||||||+||++ +.++.+|++|||+++.......
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 89 TGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 999999988754 35788899999999999999999 9999999999999999 7889999999999987653321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....+|++|+||
T Consensus 165 ---~~~~~~t~~y~aP 177 (277)
T 3f3z_A 165 ---MRTKVGTPYYVSP 177 (277)
T ss_dssp ---BCCCCSCTTTCCH
T ss_pred ---hhccCCCCCccCh
Confidence 2234588899998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=200.51 Aligned_cols=135 Identities=24% Similarity=0.317 Sum_probs=111.6
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------------cCccceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------------CSNEDFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------------~~~~~~~~ 428 (527)
...|++.+.||+|+||.||+|+. .+++.||||++... +...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 35699999999999999999975 46899999998421 11235668
Q ss_pred EEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--EEEeecccccc
Q 035895 429 LVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV--AHLSDFGIAKL 505 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~--~kl~Dfg~a~~ 505 (527)
+||||+. |+|.+++.... ..+++..+..++.||+.||+||| +++||||||||+|||++.++. +||+|||+|+.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 69999887654 34889999999999999999999 899999999999999998887 99999999986
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... .....+|++||||
T Consensus 252 ~~~~-----~~~~~gt~~y~aP 268 (429)
T 3kvw_A 252 EHQR-----VYTYIQSRFYRAP 268 (429)
T ss_dssp TTCC-----CCSSCSCGGGCCH
T ss_pred cCCc-----ccccCCCCCccCh
Confidence 5432 1234678999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=204.62 Aligned_cols=136 Identities=26% Similarity=0.429 Sum_probs=112.6
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEee-------------------------------ccCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF-------------------------------SCSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~-------------------------------~~~~~~~~~lv~e 432 (527)
+.|++.+.||+|+||+||+|+.. +++.||||++.. .+...+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 45899999999999999999864 789999999742 1223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~---~~~~~kl~Dfg~a~~~~~~ 509 (527)
||++|+|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+||+++ .++.+||+|||+|+.....
T Consensus 102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999988654 35788899999999999999999 99999999999999995 4578999999999876533
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
. ......||++|+||
T Consensus 178 ~---~~~~~~gt~~y~aP 192 (486)
T 3mwu_A 178 T---KMKDRIGTAYYIAP 192 (486)
T ss_dssp -------CCTTGGGGCCG
T ss_pred C---ccCCCcCCCCCCCH
Confidence 2 12345689999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=193.63 Aligned_cols=145 Identities=21% Similarity=0.391 Sum_probs=105.3
Q ss_pred HhhhcCCccccceeccCCceEEEEEEcc----CCcEEEEEEEeecc-------------------------------Ccc
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFSC-------------------------------SNE 424 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~-------------------------------~~~ 424 (527)
+....+.|++.+.||+|+||.||+|+.. +++.||+|++.... ...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3444567899999999999999999753 35689999975310 011
Q ss_pred -----ceeEEEEEeccCCcHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 035895 425 -----DFRALVLEYTTNGSLEKVLYS-----SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV 494 (527)
Q Consensus 425 -----~~~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~ 494 (527)
...++||||+++|+|.+++.. ....+++.++..++.+++.||+||| +++|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence 134899999999999999853 2345889999999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCCCCCccceeccccccccccC
Q 035895 495 AHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 495 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+||+|||+++...............+++.|+||
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 218 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCc
Confidence 999999999876543222222334467789997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=187.40 Aligned_cols=138 Identities=25% Similarity=0.465 Sum_probs=109.0
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~l 429 (527)
..++|++.+.||+|+||.||+|+.. +++.||||++... +..++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3567999999999999999999975 7899999997421 223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++++|.+++...+ .+++.+...++.|++.||+||| +.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999997643 5788899999999999999999 899999999999999999999999999999876533
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .....+++.|+||
T Consensus 165 ~~---~~~~~~~~~y~aP 179 (276)
T 2h6d_A 165 EF---LRTSCGSPNYAAP 179 (276)
T ss_dssp ---------------CCT
T ss_pred cc---eecccCCccccCH
Confidence 21 1234578889998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.9e-22 Score=195.13 Aligned_cols=148 Identities=28% Similarity=0.416 Sum_probs=114.6
Q ss_pred ccHHHHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCc-
Q 035895 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSN- 423 (527)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~- 423 (527)
++..++....+.|++.+.||+|+||.||+|+. .+++.||||++... +..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 44445555678899999999999999999986 57899999997421 001
Q ss_pred -----cceeEEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 035895 424 -----EDFRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497 (527)
Q Consensus 424 -----~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl 497 (527)
.+..++||||+++|+|.+++.... ..++......++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEE
Confidence 346789999999999999997643 45788888999999999999999 899999999999999999999999
Q ss_pred eecccccccCCCCCccceeccccccccccC
Q 035895 498 SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 498 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|||+++....... ......+|..|+||
T Consensus 171 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 198 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG--RRNTFIGTPYWMAP 198 (326)
T ss_dssp CCCTTTC---------------CCGGGCCH
T ss_pred eeCcCceecCcCcc--ccccccCCccccCh
Confidence 99999987643211 12234578899998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-21 Score=187.26 Aligned_cols=137 Identities=26% Similarity=0.474 Sum_probs=113.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ 431 (527)
.++|++.+.||+|+||.||+|.. .+++.||+|++... +..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999986 46899999997531 22345668999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV---AHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~---~kl~Dfg~a~~~~~ 508 (527)
||+++|+|.+.+... ..+++.....++.+++.|++||| +.+|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999888754 35788899999999999999999 899999999999999976554 99999999987653
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+|++|+||
T Consensus 161 ~~~---~~~~~~~~~y~aP 176 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSP 176 (284)
T ss_dssp SCB---CCCSCSCGGGCCH
T ss_pred Ccc---ccCCCCCcCCcCc
Confidence 321 2235688999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.7e-22 Score=195.41 Aligned_cols=141 Identities=23% Similarity=0.390 Sum_probs=108.7
Q ss_pred cCCccccceeccCCceEEEEEEc------cCCcEEEEEEEeec------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHFS------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~------------------------------~~~~~~~ 427 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999984 35778999997421 2234566
Q ss_pred EEEEEeccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEe
Q 035895 428 ALVLEYTTNGSLEKVLYSSN------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLS 498 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~ 498 (527)
++||||+++|+|.+++.... ..+++.++..++.+++.||+||| +.+|+||||||+||+++. +..+|++
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 89999999999999998653 34788899999999999999999 899999999999999984 4569999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++...............+|+.|+||
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred ccccccccccccccccCCCcCCCcceeCH
Confidence 99999865433222222334578889998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=203.26 Aligned_cols=136 Identities=26% Similarity=0.452 Sum_probs=110.0
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
+.|++.+.||+|+||.||+|+.. ++..||||++... +...+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 35899999999999999999864 7899999997531 223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~~ 509 (527)
||++|+|.+.+... ..+++..+..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+|+.....
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999999988654 35788889999999999999999 999999999999999975 456999999999877543
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
. ......||++|+||
T Consensus 193 ~---~~~~~~gt~~y~aP 207 (494)
T 3lij_A 193 K---KMKERLGTAYYIAP 207 (494)
T ss_dssp B---CBCCCCSCTTTCCH
T ss_pred c---cccccCCCcCeeCH
Confidence 2 12345689999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=185.85 Aligned_cols=133 Identities=20% Similarity=0.375 Sum_probs=111.8
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------cCcc--ceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------CSNE--DFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------~~~~--~~~~lv 430 (527)
.++|++.+.||+|+||.||+|+.+ ++.||||++... +... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457899999999999999999985 889999997521 1122 566899
Q ss_pred EEeccCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 431 LEYTTNGSLEKVLYSSNY-ILDILQRLNIMIDVTSALEYLHFGYSTP--IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~ylH~~~~~~--iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
|||+++|+|.+++..... .+++.++..++.|++.||+||| +++ |+||||||+||+++.++.++++|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999986543 4899999999999999999999 878 9999999999999999999999999876532
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
. ....+|+.|+||
T Consensus 165 ~-------~~~~~t~~y~aP 177 (271)
T 3kmu_A 165 S-------PGRMYAPAWVAP 177 (271)
T ss_dssp C-------TTCBSCGGGSCH
T ss_pred c-------cCccCCccccCh
Confidence 2 124578889998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-22 Score=210.64 Aligned_cols=143 Identities=24% Similarity=0.424 Sum_probs=116.4
Q ss_pred hhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeecc---------------------------CccceeEEEEEe
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC---------------------------SNEDFRALVLEY 433 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~lv~ey 433 (527)
....+.|++.+.||+|+||.||+|++..+..||||+++... ..++..++||||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~ 342 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEY 342 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeeh
Confidence 33456789999999999999999999888889999985311 122456899999
Q ss_pred ccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++|+|.+++... +..+++.+...++.||+.||+||| +++||||||||+|||+++++.+||+|||+++...... .
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 418 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence 9999999999753 245788899999999999999999 9999999999999999999999999999998764321 1
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.......++..||||
T Consensus 419 ~~~~~~~~~~~y~aP 433 (535)
T 2h8h_A 419 TARQGAKFPIKWTAP 433 (535)
T ss_dssp HTTCSTTSCGGGSCH
T ss_pred ecccCCcCcccccCH
Confidence 112234467889998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=211.22 Aligned_cols=140 Identities=26% Similarity=0.421 Sum_probs=108.0
Q ss_pred CCccccc-eeccCCceEEEEEEcc---CCcEEEEEEEeecc-----------------------------CccceeEEEE
Q 035895 385 DGFSANN-LIGRGSFGSVYKARLQ---DGMEFAIKVFHFSC-----------------------------SNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~-~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~-----------------------------~~~~~~~lv~ 431 (527)
+.+.+.+ .||+|+||.||+|..+ ++..||||+++... ...+..++||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~ 414 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 414 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEE
Confidence 3444444 7999999999999764 56789999975311 0123467999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|||++|+|.+++......+++.++..++.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.+.....
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999776667899999999999999999999 89999999999999999999999999999997653322
Q ss_pred cc-ceeccccccccccC
Q 035895 512 SM-TQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~-~~~~~~~t~~y~aP 527 (527)
.. ......+++.||||
T Consensus 492 ~~~~~~~~~~~~~y~AP 508 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAP 508 (613)
T ss_dssp ----------CCTTSCH
T ss_pred eeeeccCCCCccceeCH
Confidence 11 11223356789998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=191.88 Aligned_cols=143 Identities=27% Similarity=0.368 Sum_probs=107.1
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee------------------------------ccCccceeEEE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF------------------------------SCSNEDFRALV 430 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~------------------------------~~~~~~~~~lv 430 (527)
...++|++.+.||+|+||.||+|+. .+++.||||++.. .+..++..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999986 4688999997632 11234566899
Q ss_pred EEeccCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 431 LEYTTNGSLEKVLYS-------SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
|||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999864 2345889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCc---cceeccccccccccC
Q 035895 504 KLLTGEDQS---MTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~---~~~~~~~~t~~y~aP 527 (527)
+........ .......+|+.|+||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAP 195 (303)
T ss_dssp HHCC---------------CCCTTCCH
T ss_pred heeccCCCccchhhhcccCCCccccCH
Confidence 876432111 111234578899998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=190.24 Aligned_cols=138 Identities=23% Similarity=0.410 Sum_probs=110.1
Q ss_pred ccccceeccCCceEEEEEEccC----CcEEEEEEEeec------------------------------cC-ccceeEEEE
Q 035895 387 FSANNLIGRGSFGSVYKARLQD----GMEFAIKVFHFS------------------------------CS-NEDFRALVL 431 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~------------------------------~~-~~~~~~lv~ 431 (527)
|+..+.||+|+||.||+|+..+ +..||+|++... +. .+...++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 5667999999999999998532 337999987421 11 223348999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
||+.+|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999876667889999999999999999999 89999999999999999999999999999986643221
Q ss_pred c--cceeccccccccccC
Q 035895 512 S--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~--~~~~~~~~t~~y~aP 527 (527)
. .......+|..|+||
T Consensus 180 ~~~~~~~~~~~~~~y~aP 197 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTAL 197 (298)
T ss_dssp GCSCCSSCTTCGGGGSCH
T ss_pred cccccCcCCCCCccccCh
Confidence 1 112234567889987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4e-21 Score=191.49 Aligned_cols=135 Identities=21% Similarity=0.336 Sum_probs=111.9
Q ss_pred cCCccccceeccCCceEEEEEEc--cCCcEEEEEEEeec----------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL--QDGMEFAIKVFHFS----------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~----------------------------------~~~~~~~ 427 (527)
.+.|++.+.||+|+||.||+|.. .+++.||||++... +...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35799999999999999999985 46889999997421 1234567
Q ss_pred EEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---------------
Q 035895 428 ALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD--------------- 491 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~--------------- 491 (527)
++||||+ +++|.+++...+ ..+++..+..++.|++.||+||| +++|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 8999999 889999987654 35788899999999999999999 899999999999999987
Q ss_pred ----CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 ----NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.+||+|||+++...... ....+|++|+||
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aP 203 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAP 203 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCH
T ss_pred ccccCCCceEeeCcccccCcccc-----ccccCCccccCh
Confidence 6789999999998754321 234678999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=194.21 Aligned_cols=141 Identities=26% Similarity=0.425 Sum_probs=114.6
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccc----eeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNED----FRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~----~~~lv~ 431 (527)
.++|++.+.||+|+||.||+|+. +++.||||++... +..++ ..++||
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~ 119 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence 46799999999999999999987 4899999997421 11122 678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG-----YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~-----~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||+++|+|.+++... .+++.++..++.+++.||+|||.. ++++|+||||||+||+++.++.+||+|||+++..
T Consensus 120 e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 120 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197 (342)
T ss_dssp CCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred eecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence 999999999999753 578899999999999999999932 2578999999999999999999999999999876
Q ss_pred CCCCCcc--ceeccccccccccC
Q 035895 507 TGEDQSM--TQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~--~~~~~~~t~~y~aP 527 (527)
....... ......+|+.|+||
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aP 220 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAP 220 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCH
T ss_pred cccccccccccccCCcCcccCCH
Confidence 5432211 12334688999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=3.9e-21 Score=186.95 Aligned_cols=136 Identities=28% Similarity=0.453 Sum_probs=114.2
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||.||+|+.. +++.||+|++.. .+..++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999864 678999999742 12234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++|+|.+++...+ .+++.....++.|++.|++||| +.+|+||||||+||+++.++.+|++|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999999987643 5788899999999999999999 9999999999999999999999999999997654321
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 169 ----~~~~~~~~~y~aP 181 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPP 181 (284)
T ss_dssp ----BCCCCSCGGGCCH
T ss_pred ----cccccCCCCcCCH
Confidence 1234578899998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.8e-21 Score=188.02 Aligned_cols=138 Identities=23% Similarity=0.365 Sum_probs=114.7
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
.+.|++.+.||+|+||.||+|+.. +++.||+|++... +..++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356899999999999999999875 5789999987421 2234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++++|.+++... ..+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||+++......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999988654 35788899999999999999999 8999999999999999999999999999998764322
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ......+|..|+||
T Consensus 170 ~--~~~~~~~~~~y~aP 184 (294)
T 2rku_A 170 E--RKKVLCGTPNYIAP 184 (294)
T ss_dssp C--CBCCCCSCCSSCCH
T ss_pred c--ccccccCCCCcCCc
Confidence 1 12234578899998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4e-21 Score=190.19 Aligned_cols=136 Identities=27% Similarity=0.412 Sum_probs=110.2
Q ss_pred ccccceeccCCceEEEEEEc-----cCCcEEEEEEEeec------------------------------cC--ccceeEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-----QDGMEFAIKVFHFS------------------------------CS--NEDFRAL 429 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~------------------------------~~--~~~~~~l 429 (527)
|++.+.||+|+||.||+|.+ .+++.||||++... +. .....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999999864 36889999997531 11 1345689
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++|+|.+++... .+++.++..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999654 4788999999999999999999 999999999999999999999999999999987543
Q ss_pred CCc-cceeccccccccccC
Q 035895 510 DQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~-~~~~~~~~t~~y~aP 527 (527)
... .......+|..|+||
T Consensus 188 ~~~~~~~~~~~~~~~y~aP 206 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAP 206 (318)
T ss_dssp CSEEEC---CCCCGGGCCH
T ss_pred ccccccccCCCCCceeeCh
Confidence 221 112234577889998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4e-21 Score=188.70 Aligned_cols=136 Identities=32% Similarity=0.437 Sum_probs=114.0
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey 433 (527)
+.|+..+.||+|+||.||+|+. .+++.||||++... +..++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 5589999999999999999985 57899999997531 1234566899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++.. ..+++.....++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 174 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 174 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc--
Confidence 999999999854 45789999999999999999999 89999999999999999999999999999987653321
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......+|..|+||
T Consensus 175 ~~~~~~~~~~y~aP 188 (303)
T 3a7i_A 175 KRNTFVGTPFWMAP 188 (303)
T ss_dssp CBCCCCSCGGGCCH
T ss_pred ccCccCCCcCccCH
Confidence 12234678899998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-21 Score=191.29 Aligned_cols=134 Identities=25% Similarity=0.412 Sum_probs=111.0
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------cCc--cceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------CSN--EDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------~~~--~~~~~lv~ey 433 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +.. ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 36799999999999999999985 67899999997521 111 3456899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCCCc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~~~~~ 512 (527)
+++++|.+++.. ++..++..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+|+.......
T Consensus 115 ~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 115 VNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred cCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence 999999998743 678888999999999999999 99999999999999999766 899999999987654322
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....+|..|+||
T Consensus 187 --~~~~~~~~~y~aP 199 (330)
T 3nsz_A 187 --YNVRVASRYFKGP 199 (330)
T ss_dssp --CCSCCSCGGGCCH
T ss_pred --cccccccccccCh
Confidence 2234578889998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=190.50 Aligned_cols=138 Identities=29% Similarity=0.420 Sum_probs=105.1
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeecc-------------------------CccceeEEEEEeccCCc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC-------------------------SNEDFRALVLEYTTNGS 438 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~lv~ey~~~g~ 438 (527)
.++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..++||||+++|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 356889999999999999999875 6889999974210 01234679999999999
Q ss_pred HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-EEEeecccccccCCCCCccce
Q 035895 439 LEKVLYSSNY--ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV-AHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 439 L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~-~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
|.+++...+. .+++.....++.|+++||+|||..+.++|+||||||+||+++.++. +||+|||+++..... .
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~ 160 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----M 160 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----c
Confidence 9999976542 4678888999999999999999333389999999999999998876 799999999865422 1
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....||+.|+||
T Consensus 161 ~~~~gt~~y~aP 172 (307)
T 2eva_A 161 TNNKGSAAWMAP 172 (307)
T ss_dssp ----CCTTSSCH
T ss_pred ccCCCCCceECh
Confidence 234578899998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=187.40 Aligned_cols=134 Identities=31% Similarity=0.505 Sum_probs=103.2
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEee---------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF---------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~---------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||.||+|+.. ++.||||+++. .+..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467999999999999999999975 78999998642 12234566899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEecCCCCCCeeeCC--------CCcEEEee
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP---IIHCDLKPHNKLLDD--------NIVAHLSD 499 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~---iiHrdlk~~nill~~--------~~~~kl~D 499 (527)
|||+++|+|.+++.. ..+++.....++.|++.|++||| +++ |+||||||+||+++. ++.+|++|
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999853 46788899999999999999999 777 999999999999986 77899999
Q ss_pred cccccccCCCCCccceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+++...... .....+|+.|+||
T Consensus 160 fg~~~~~~~~~----~~~~~~~~~y~aP 183 (271)
T 3dtc_A 160 FGLAREWHRTT----KMSAAGAYAWMAP 183 (271)
T ss_dssp CCC-----------------CCGGGSCH
T ss_pred CCccccccccc----ccCCCCccceeCH
Confidence 99998764322 1234578899998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-21 Score=191.92 Aligned_cols=138 Identities=23% Similarity=0.365 Sum_probs=115.1
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
.+.|.+.+.||+|+||.||+|+.. +++.||+|++... +...+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457999999999999999999864 5789999987421 2234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++++|.+++... ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999988654 45788899999999999999999 8999999999999999999999999999998764322
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ......+|..|+||
T Consensus 196 ~--~~~~~~gt~~y~aP 210 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAP 210 (335)
T ss_dssp C--CBCCCCSCCSSCCH
T ss_pred c--cccccCCCccccCH
Confidence 1 12234578899998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=193.09 Aligned_cols=147 Identities=25% Similarity=0.376 Sum_probs=111.5
Q ss_pred ccHHHHhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------------c
Q 035895 375 FSYQELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------------C 421 (527)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------------~ 421 (527)
+.++.+....+.|++.+.||+|+||.||+|+..+++.||||++... +
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444444455679999999999999999999988999999997421 1
Q ss_pred CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 035895 422 SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 422 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
..++..++||| +.+|+|.+++... ..+++.++..++.++++||+||| +.+|+||||||+||++++ +.+||+|||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecc
Confidence 23345679999 5678999999764 35788889999999999999999 899999999999999964 899999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++...............||+.|+||
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aP 197 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPP 197 (313)
T ss_dssp SSCC--------------CCGGGCCH
T ss_pred ccccccCccccccccCCCCCCCcCCH
Confidence 99876543322222345688999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-21 Score=193.22 Aligned_cols=137 Identities=24% Similarity=0.409 Sum_probs=109.3
Q ss_pred CCcccc-ceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEE
Q 035895 385 DGFSAN-NLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv 430 (527)
+.|.+. +.||+|+||.||+|+.. +++.||+|++... +...+..++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 446666 89999999999999864 6899999987531 1234566899
Q ss_pred EEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeccccccc
Q 035895 431 LEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLL 506 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~ 506 (527)
|||+++|+|.+++... ...+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+++..
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999988543 346889999999999999999999 999999999999999987 789999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... .....+|++|+||
T Consensus 185 ~~~~~---~~~~~gt~~y~aP 202 (327)
T 3lm5_A 185 GHACE---LREIMGTPEYLAP 202 (327)
T ss_dssp ------------CCCGGGCCH
T ss_pred CCccc---cccccCCcCccCC
Confidence 53321 2235688999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-21 Score=190.79 Aligned_cols=140 Identities=27% Similarity=0.339 Sum_probs=108.3
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~l 429 (527)
..++|++.+.||+|+||.||+|+.. +++.||+|++... +..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999864 7899999997421 123456689
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
||||+++++|.+++... ..+++.++..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999754 35788899999999999999999 899999999999999999999999999999876533
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. .......+++.|+||
T Consensus 188 ~~-~~~~~~~~~~~y~aP 204 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAP 204 (309)
T ss_dssp ----------CCGGGCCG
T ss_pred cc-ccccccCCCcCccCH
Confidence 21 112234578899998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=4.5e-21 Score=197.24 Aligned_cols=136 Identities=34% Similarity=0.499 Sum_probs=108.1
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------c------CccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------C------SNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------~------~~~~~~~lv~e 432 (527)
..|+..+.||+|+||+||+|+.. +|+.||||++... + ..+...++|||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 35889999999999999999974 6899999987421 0 11123568999
Q ss_pred eccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccccCC
Q 035895 433 YTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-IVAHLSDFGIAKLLTG 508 (527)
Q Consensus 433 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-~~~kl~Dfg~a~~~~~ 508 (527)
|+++ ++.+.+.. .+..+++.....++.||++||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9986 66665542 3456889899999999999999999 9999999999999999954 6789999999997643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+|.+|+||
T Consensus 210 ~~~---~~~~~~t~~y~aP 225 (420)
T 1j1b_A 210 GEP---NVSYICSRYYRAP 225 (420)
T ss_dssp TCC---CCSCCSCTTSCCH
T ss_pred CCC---ceeeeeCCCcCCH
Confidence 322 2235678999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-21 Score=193.52 Aligned_cols=139 Identities=30% Similarity=0.460 Sum_probs=110.0
Q ss_pred hcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALV 430 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv 430 (527)
..++|++.+.||+|+||.||+|+.. +++.||||++... +...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4567999999999999999999864 5899999987421 2234567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+++++|.++.... ..+++..+..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 103 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999998876543 45789999999999999999999 9999999999999999999999999999998764332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ......+|.+|+||
T Consensus 179 ~--~~~~~~~t~~y~aP 193 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAP 193 (331)
T ss_dssp -------CCCCCTTCCH
T ss_pred c--ccCCCcCCccccCc
Confidence 1 12234578899998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-21 Score=195.52 Aligned_cols=144 Identities=31% Similarity=0.391 Sum_probs=110.0
Q ss_pred hhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee----------------------------------ccCccc
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF----------------------------------SCSNED 425 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~----------------------------------~~~~~~ 425 (527)
....+.|++.+.||+|+||.||+|+. .+++.||+|++.. .+..++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34456799999999999999999986 5688999998742 122345
Q ss_pred eeEEEEEeccCCcHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 035895 426 FRALVLEYTTNGSLEKVLYSS---------------------------------------NYILDILQRLNIMIDVTSAL 466 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~l 466 (527)
..++|||||++|+|.+++... ...+++.....++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 678999999999999988421 11124556678999999999
Q ss_pred HHHhcCCCCCeEecCCCCCCeeeCCCC--cEEEeecccccccCCCCC--ccceeccccccccccC
Q 035895 467 EYLHFGYSTPIIHCDLKPHNKLLDDNI--VAHLSDFGIAKLLTGEDQ--SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 467 ~ylH~~~~~~iiHrdlk~~nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~~t~~y~aP 527 (527)
+||| +.+|+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+||
T Consensus 182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 9999 89999999999999998766 899999999987643211 1122345689999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=193.96 Aligned_cols=140 Identities=25% Similarity=0.404 Sum_probs=107.5
Q ss_pred hhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeE
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRA 428 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~ 428 (527)
....+.|++.+.||+|+||+||+|+. .+++.||||++... +..++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34467899999999999999999985 57899999987421 12345668
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-----CCCCcEEEeecccc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL-----DDNIVAHLSDFGIA 503 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill-----~~~~~~kl~Dfg~a 503 (527)
+||||+++ +|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||++ ++++.+||+|||+|
T Consensus 110 lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999985 9999987653 5788899999999999999999 8999999999999999 45566999999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+....... ..+...+|.+|+||
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPP 206 (329)
T ss_dssp HHHC-------------CCTTCCH
T ss_pred cccCCccc--ccCCCcCCccccCH
Confidence 87643221 12334578899998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.5e-21 Score=201.42 Aligned_cols=137 Identities=28% Similarity=0.450 Sum_probs=112.0
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------------------ 420 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------------------ 420 (527)
.+.|++.+.||+|+||+||+|+.. +++.||||++...
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999864 6889999997531
Q ss_pred cCccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEE
Q 035895 421 CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI---VAHL 497 (527)
Q Consensus 421 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~---~~kl 497 (527)
+...+..++|||||++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 12234568999999999999988754 35789999999999999999999 99999999999999998765 6999
Q ss_pred eecccccccCCCCCccceeccccccccccC
Q 035895 498 SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 498 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+|||+|+...... ......||++|+||
T Consensus 191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aP 217 (504)
T 3q5i_A 191 VDFGLSSFFSKDY---KLRDRLGTAYYIAP 217 (504)
T ss_dssp CCCTTCEECCTTS---CBCCCCSCTTTCCH
T ss_pred EECCCCEEcCCCC---ccccccCCcCCCCH
Confidence 9999998775432 12335689999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-21 Score=196.01 Aligned_cols=137 Identities=34% Similarity=0.459 Sum_probs=108.4
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------c------CccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------C------SNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------~------~~~~~~~lv~ey 433 (527)
..|+..+.||+|+||+||+|+...+..||+|++... + ..+...++||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 458999999999999999999877777999986321 1 112236799999
Q ss_pred ccCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeecccccccCCCC
Q 035895 434 TTNGSLEKVLY--SSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 434 ~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-~~~~~kl~Dfg~a~~~~~~~ 510 (527)
++++.+..... .....+++..+..++.|+++||+||| +++|+||||||+||+++ .++.+||+|||+|+......
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 99754443322 23456888889999999999999999 99999999999999999 79999999999998764332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. .....+|.+|+||
T Consensus 197 ~---~~~~~~t~~y~aP 210 (394)
T 4e7w_A 197 P---NVSYICSRYYRAP 210 (394)
T ss_dssp C---CCSSCSCGGGCCH
T ss_pred C---CcccccCcCccCH
Confidence 2 2235678999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.84 E-value=5.2e-21 Score=185.89 Aligned_cols=136 Identities=29% Similarity=0.435 Sum_probs=110.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------------cCccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------------CSNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------------~~~~~~~~ 428 (527)
++|++.+.||+|+||.||+|+.. +++.||+|++... +...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45899999999999999999875 6899999987531 12234568
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeccccc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI----VAHLSDFGIAK 504 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~----~~kl~Dfg~a~ 504 (527)
+||||+++++|.+++... ..+++.++..++.+++.||+||| +++|+||||||+||+++.++ .+|++|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999754 35789999999999999999999 99999999999999998776 89999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... .....+|+.|+||
T Consensus 161 ~~~~~~~---~~~~~~~~~y~aP 180 (283)
T 3bhy_A 161 KIEAGNE---FKNIFGTPEFVAP 180 (283)
T ss_dssp ECC-----------CCCGGGCCH
T ss_pred eccCCCc---ccccCCCcCccCc
Confidence 7643221 2234578899998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.9e-22 Score=210.77 Aligned_cols=127 Identities=20% Similarity=0.179 Sum_probs=93.4
Q ss_pred eeccCCceEEEEEEc-cCCcEEEEEEEee----------------------------------------ccCccceeEEE
Q 035895 392 LIGRGSFGSVYKARL-QDGMEFAIKVFHF----------------------------------------SCSNEDFRALV 430 (527)
Q Consensus 392 ~lg~G~~g~vy~~~~-~~~~~vavK~~~~----------------------------------------~~~~~~~~~lv 430 (527)
..+.|++|.+..++. -.|+.||+|++.. +..+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677776666553 3588999999742 12245678999
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||||+||+|.++|...+ .++.. +|+.||+.||+|+| +++||||||||+|||++++|++||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999997654 45543 48899999999999 9999999999999999999999999999999775432
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ..+..+||++||||
T Consensus 394 ~--~~~t~vGTp~YmAP 408 (569)
T 4azs_A 394 S--WPTNLVQSFFVFVN 408 (569)
T ss_dssp C--CSHHHHHHHHHHHH
T ss_pred c--cccCceechhhccH
Confidence 2 22346799999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-21 Score=203.33 Aligned_cols=136 Identities=29% Similarity=0.479 Sum_probs=114.0
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
+.|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45899999999999999999865 7899999997421 12345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill---~~~~~~kl~Dfg~a~~~~~ 508 (527)
|||++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||+|+.+..
T Consensus 106 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999999998754 45788899999999999999999 8999999999999999 4678999999999987754
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....||++|+||
T Consensus 182 ~~~---~~~~~gt~~y~aP 197 (484)
T 3nyv_A 182 SKK---MKDKIGTAYYIAP 197 (484)
T ss_dssp CCS---HHHHTTGGGTCCH
T ss_pred ccc---cccCCCCccccCc
Confidence 321 2235689999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=196.16 Aligned_cols=136 Identities=27% Similarity=0.429 Sum_probs=112.1
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|++.+.||+|+||.||+|+.. +++.||+|++... +..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356999999999999999999875 7899999997531 123456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST-PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~-~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+++|+|.+++...+ .+++.....++.+++.|++||| +. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999997643 5788889999999999999999 74 8999999999999999999999999999765321
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......||++|+||
T Consensus 186 --~~~~~~gt~~y~aP 199 (360)
T 3eqc_A 186 --MANSFVGTRSYMSP 199 (360)
T ss_dssp --C----CCCCTTCCH
T ss_pred --cccCCCCCCCeECH
Confidence 12234678899998
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.2e-23 Score=220.25 Aligned_cols=322 Identities=11% Similarity=0.067 Sum_probs=173.4
Q ss_pred hhcchhccc-CCCceeecCchhhhcC--CCCCEEEcccccc-cc-ccc------cccceEEcccccccCCCCCCcccccC
Q 035895 19 VCYRICTID-SQNKLVGIVSITIFNL--STLKVFDVDNNYV-LG-RLS------SIVDELSLSDNYLTSSTPELSFLSSM 87 (527)
Q Consensus 19 ~~~~~~~~~-s~N~l~~~~~~~~~~l--~~L~~L~Ls~N~~-~~-~~~------~~l~~L~Ls~N~l~~~~~~~~~~~~~ 87 (527)
.|..+..++ ++|.+++..+..+..+ .+|++|+|++|.- .. .++ +.+++|+|++|.++.....+ +...+
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~-l~~~~ 188 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKW-LHELA 188 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHH-HHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhH-HHHHH
Confidence 355566666 5566555555555443 3366666666541 10 010 24667777777665432110 00112
Q ss_pred CCCCCCCEEEcccCCCCc----ccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCccc----------
Q 035895 88 SNCKYLKKLDISRNPLDG----FLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLN---------- 153 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~----~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---------- 153 (527)
..+++|++|++++|.+++ .++..+..+ ++|+.|++++|.+.+ ++..+..+++|++|+++.....
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~-~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l 266 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNC-RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL 266 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHHHHHC-TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCC
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHHHhhC-CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHh
Confidence 456677777777777752 223333343 367777777777664 4566666666776666542211
Q ss_pred ----------------ccCcccccCCCCCCEEeccCcccccccC-hhhhcCcccCeeeeecccCCCCCCccccCCccCce
Q 035895 154 ----------------GSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRN 216 (527)
Q Consensus 154 ----------------~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 216 (527)
+.++..+..+++|+.|++++|.+++... ..+..+++|+.|+++++-..+.++..+..+++|++
T Consensus 267 ~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~ 346 (592)
T 3ogk_B 267 VFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKR 346 (592)
T ss_dssp CCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCE
T ss_pred hccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCE
Confidence 1123333444455555555555432221 22344555555555522111122222344566666
Q ss_pred eeCC-----------CCCCCC--CchhhhCCCCccEEEccCCcccccCCccccC-CCCCCEEEcc----CCCCCCC----
Q 035895 217 LHLD-----------SNELTS--IPSILWNLKDILYLDFWSNLFVGPLPSKIGN-LKVLTRIDFS----RNNLLGD---- 274 (527)
Q Consensus 217 L~L~-----------~N~l~~--lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~---- 274 (527)
|+++ .|.++. ++.....+++|++|+++.|.+++..+..+.. +++|++|+++ .|.+++.
T Consensus 347 L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~ 426 (592)
T 3ogk_B 347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426 (592)
T ss_dssp EEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH
T ss_pred EEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH
Confidence 6666 244443 2333344666777777666666554445544 6777777775 5566653
Q ss_pred -ChhhhhcCCCCCEEEcccc--cceeecCCCC-CCCCCCCEEeCCCCccccc-CccchhhhccCCeeEeeeeee
Q 035895 275 -IPTTIQGLKSLQFLSLGHN--RLQGSIPNSF-DDLVSLESLDLSNNNLSEI-IPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 275 -~p~~~~~l~~L~~L~L~~N--~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~~~~~~~ 343 (527)
++..+.++++|++|++++| .+++..+..+ ..+++|+.|++++|.+++. ++..+..++.|+.|+++.+.+
T Consensus 427 ~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 3344666777777777643 2443333222 2367788888888887763 344556777888888887764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=191.97 Aligned_cols=139 Identities=26% Similarity=0.350 Sum_probs=112.0
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------cCccceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey 433 (527)
.+.|++.+.||+|+||.||+|+.. +++.||+|++... +..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 456999999999999999999975 5899999987421 2234567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+++|+|.+++......+++.....++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--Q 172 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--H
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--c
Confidence 9999999998776667899999999999999999999 8999999999999999999999999999986432111 1
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......+|..|+||
T Consensus 173 ~~~~~~~~~~y~aP 186 (302)
T 2j7t_A 173 KRDSFIGTPYWMAP 186 (302)
T ss_dssp C-----CCGGGCCH
T ss_pred ccccccCChhhcCC
Confidence 11234578889998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-21 Score=190.20 Aligned_cols=141 Identities=25% Similarity=0.296 Sum_probs=111.5
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cC----ccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CS----NEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~----~~~~~~l 429 (527)
.+.|++.+.||+|+||.||+|+. .+++.||||++... +. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45699999999999999999986 67899999987421 11 2235679
Q ss_pred EEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 430 VLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||||+++|+|.+++.. .+..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999875 3456889999999999999999999 899999999999999999999999999998865
Q ss_pred CCCCCcc-------ceeccccccccccC
Q 035895 507 TGEDQSM-------TQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~-------~~~~~~~t~~y~aP 527 (527)
....... ......+|+.|+||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP 212 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAP 212 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred ccccccccccccccccccccCCcccCCH
Confidence 3211100 01123468889998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=184.01 Aligned_cols=133 Identities=27% Similarity=0.357 Sum_probs=110.1
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------------cCccceeEEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------------CSNEDFRALV 430 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------------~~~~~~~~lv 430 (527)
|++.+.||+|+||.||+|.. .++..||+|++... .......++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 78888999999999999986 56889999987421 0113456899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeecccccccC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP--IIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~--iiHrdlk~~nill~-~~~~~kl~Dfg~a~~~~ 507 (527)
|||+++|+|.+++... ..+++.....++.+++.||+||| +.+ |+||||||+||+++ +++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999764 35788889999999999999999 877 99999999999998 78999999999997654
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+|+.|+||
T Consensus 184 ~~~----~~~~~~t~~y~aP 199 (290)
T 1t4h_A 184 ASF----AKAVIGTPEFMAP 199 (290)
T ss_dssp TTS----BEESCSSCCCCCG
T ss_pred ccc----cccccCCcCcCCH
Confidence 321 2234688999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.4e-21 Score=185.49 Aligned_cols=137 Identities=27% Similarity=0.438 Sum_probs=115.2
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec---------------------------------------cCc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS---------------------------------------CSN 423 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---------------------------------------~~~ 423 (527)
.++|++.+.||+|+||.||+|+.. +++.||||++... +..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 577999999999999999999874 6899999997421 112
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
++..++||||+++|+|.+++... ..+++.....++.+++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 34568999999999999999754 45788899999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccC
Q 035895 504 KLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+....... .....++..|+||
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aP 192 (298)
T 1phk_A 172 CQLDPGEK---LREVCGTPSYLAP 192 (298)
T ss_dssp EECCTTCC---BCCCCSCGGGCCH
T ss_pred hhcCCCcc---cccccCCccccCH
Confidence 87653321 2234578899998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.4e-21 Score=209.77 Aligned_cols=142 Identities=25% Similarity=0.396 Sum_probs=113.0
Q ss_pred hhcCCccccceeccCCceEEEEEEcc----CCcEEEEEEEeec-----------------------------cCccceeE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKVFHFS-----------------------------CSNEDFRA 428 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~-----------------------------~~~~~~~~ 428 (527)
...+.|++.+.||+|+||.||+|+.. .+..||||++... +..++..+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 466 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 466 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence 34467899999999999999999863 3567999986421 11234568
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999999876667899999999999999999999 89999999999999999999999999999987753
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .......+|+.||||
T Consensus 544 ~~~-~~~~~~~~t~~y~aP 561 (656)
T 2j0j_A 544 STY-YKASKGKLPIKWMAP 561 (656)
T ss_dssp -----------CCGGGCCH
T ss_pred Ccc-eeccCCCCCcceeCH
Confidence 322 222334567889998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.84 E-value=5.2e-21 Score=189.83 Aligned_cols=140 Identities=29% Similarity=0.443 Sum_probs=114.9
Q ss_pred hhhcCCccccceeccCCceEEEEEEc--cCCcEEEEEEEeec----------------------------------cC--
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARL--QDGMEFAIKVFHFS----------------------------------CS-- 422 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~----------------------------------~~-- 422 (527)
....++|++.+.||+|+||.||+|+. .+++.||+|++... +.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34567899999999999999999986 46889999987421 00
Q ss_pred ---ccceeEEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 035895 423 ---NEDFRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLS 498 (527)
Q Consensus 423 ---~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~ 498 (527)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence 2345679999998 69999987643 34789899999999999999999 8999999999999999999999999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++...... ......+|..|+||
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aP 188 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAP 188 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCH
T ss_pred cCcccccccCCC---CccccccccceeCH
Confidence 999998764321 22335678899998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.9e-21 Score=185.99 Aligned_cols=140 Identities=25% Similarity=0.361 Sum_probs=112.2
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------c--Ccccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------C--SNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------~--~~~~~~ 427 (527)
.++|++.+.||+|+||.||+|.. .+++.||+|++... + ...+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999996 46899999997421 1 223466
Q ss_pred EEEEEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 428 ALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
++||||+++| |.+++... +..+++.....++.|++.||+||| +++|+||||||+||+++.++.+|++|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 8999999987 76766543 356889899999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.............+|..|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aP 180 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPP 180 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCH
T ss_pred CccccccccccCCCCCCCcCh
Confidence 533222222344588899998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.1e-21 Score=188.64 Aligned_cols=140 Identities=26% Similarity=0.479 Sum_probs=104.3
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRAL 429 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~l 429 (527)
..++|++.+.||+|+||.||+|.. .+|+.||||++.. .+..++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999985 5789999998752 1123456789
Q ss_pred EEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 430 VLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||||+++|+|.+++.. .+..+++.....++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999864 2455788899999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... ......++..|+||
T Consensus 187 ~~~~~--~~~~~~~~~~y~aP 205 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSP 205 (310)
T ss_dssp --------------CCSSCCH
T ss_pred cCCCc--cccccCCCeeEeCh
Confidence 43221 12234578889998
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=189.56 Aligned_cols=133 Identities=24% Similarity=0.261 Sum_probs=82.5
Q ss_pred CEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhc-CCcCCcEEEeecCcccccCcccccCCCCCCEEecc
Q 035895 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIG-NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172 (527)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 172 (527)
+.+++++|.++. +|..+ ...++.|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 21 ~~l~c~~~~l~~-iP~~~---~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSL---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCSS-CCSSC---CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcCc-cCccC---CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 345555555554 23322 22455566666666555555555 66666666666666666666666666666666666
Q ss_pred CcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchh
Q 035895 173 GNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI 230 (527)
Q Consensus 173 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~ 230 (527)
+|+|+...+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+.+|..
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 6666655555666666777777777777666666677777777777777777666653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.7e-21 Score=190.44 Aligned_cols=137 Identities=32% Similarity=0.519 Sum_probs=109.3
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcE--EEEEEEeec-------------------------------cCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGME--FAIKVFHFS-------------------------------CSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~--vavK~~~~~-------------------------------~~~~~~~~lv 430 (527)
++|++.+.||+|+||.||+|+.. ++.. ||+|.+... +..++..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56899999999999999999864 5654 499987531 1223466899
Q ss_pred EEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 035895 431 LEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~ 495 (527)
|||+++|+|.+++...+ ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999997543 35789999999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCCCCCccceeccccccccccC
Q 035895 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 496 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+|||+++..... .......+++.|+||
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aP 210 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAI 210 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccCh
Confidence 99999999854321 112223457789988
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=9.6e-21 Score=184.93 Aligned_cols=189 Identities=24% Similarity=0.359 Sum_probs=108.8
Q ss_pred CEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccC
Q 035895 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRG 173 (527)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 173 (527)
..+.+..+.+++..+. ..+ ++|+.|++++|.++.. + .+..+++|++|++++|++++..+ +..+++|+.|++++
T Consensus 27 ~~~~l~~~~~~~~~~~--~~l-~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 27 IKDNLKKKSVTDAVTQ--NEL-NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHTTCSCTTSEECH--HHH-HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHhcCCCcccccch--hhc-CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 3344555555543222 222 2566666666666543 2 35556666666666666665433 55666666666666
Q ss_pred cccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCc
Q 035895 174 NELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPS 253 (527)
Q Consensus 174 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~ 253 (527)
|.+++ +| .+..+++|+.|++++|++++. ..+..+++|+.|++++|+++.+ .
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-------------------------~ 150 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-------------------------T 150 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-------------------------G
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-------------------------h
Confidence 66653 22 255555566666666655542 2355555555555555555544 3
Q ss_pred cccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccccc
Q 035895 254 KIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322 (527)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 322 (527)
.+..+++|++|++++|++.+..| +..+++|++|++++|++++. | .+..+++|+.|++++|+++..
T Consensus 151 ~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred hhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 35556667777777777665433 66677777777777777643 3 366677777777777776653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.4e-21 Score=194.99 Aligned_cols=134 Identities=27% Similarity=0.320 Sum_probs=108.6
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------------cC----c
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------------CS----N 423 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------------~~----~ 423 (527)
+.|++.+.||+|+||+||+|+. .+++.||||++... +. .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 6799999999999999999985 56899999997421 00 2
Q ss_pred cceeEEEEEeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCC--------
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYST-PIIHCDLKPHNKLLDDNI-------- 493 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~-~iiHrdlk~~nill~~~~-------- 493 (527)
....++||||+ +|++.+.+... ...+++..+..++.|++.||+||| ++ +|+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 34568999999 55666655543 356889999999999999999999 87 999999999999999775
Q ss_pred -----------------------------------------cEEEeecccccccCCCCCccceeccccccccccC
Q 035895 494 -----------------------------------------VAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 494 -----------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+||+|||+|+..... .+...||.+||||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999876432 2234688999998
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=187.64 Aligned_cols=138 Identities=29% Similarity=0.457 Sum_probs=112.7
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ 431 (527)
.++|++.+.||+|+||.||+|+.. +++.||||++... +..++..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 468999999999999999999865 7899999987421 12345678999
Q ss_pred EeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 432 EYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||++ |+|.+++.... ..+++.....++.+++.||+||| +.+|+||||||+||+++.++.+|++|||+++......
T Consensus 82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 157 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157 (299)
T ss_dssp ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence 9998 59999987643 45788889999999999999999 8999999999999999999999999999998764332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ......+|.+|+||
T Consensus 158 ~--~~~~~~~~~~y~aP 172 (299)
T 2r3i_A 158 R--TYTHEVVTLWYRAP 172 (299)
T ss_dssp B--CTTSCBCCCTTCCH
T ss_pred c--ccCcccccccccCc
Confidence 1 12234578889998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=9.4e-21 Score=191.23 Aligned_cols=139 Identities=25% Similarity=0.330 Sum_probs=113.0
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cC-----ccce
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CS-----NEDF 426 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~-----~~~~ 426 (527)
..+.|++.+.||+|+||.||+|+. .+++.||||++... +. ....
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 346799999999999999999985 46889999997421 00 1135
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||++ |+|.+++... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 689999998 4999998653 4788899999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCc-cceeccccccccccC
Q 035895 507 TGEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~-~~~~~~~~t~~y~aP 527 (527)
...... ...+...||++|+||
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aP 200 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAP 200 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCH
T ss_pred CCCCCccccccccccccCCCCC
Confidence 532211 112345689999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-21 Score=192.57 Aligned_cols=136 Identities=26% Similarity=0.403 Sum_probs=114.8
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------------------- 420 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------------------- 420 (527)
.++|++.+.||+|+||.||+|+. +++.||||++...
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999999999 8999999987421
Q ss_pred ---cCccceeEEEEEeccCCcHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeee
Q 035895 421 ---CSNEDFRALVLEYTTNGSLEKV------LYSS-NYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLL 489 (527)
Q Consensus 421 ---~~~~~~~~lv~ey~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill 489 (527)
+..++..++||||+++|+|.++ +... ...+++..+..++.|++.||+||| + ++|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 1123466899999999999988 5432 456889999999999999999999 7 999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+.++.+||+|||.++..... ......+|..|+||
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aP 219 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPP 219 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCG
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCc
Confidence 99999999999999876432 22345678899998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-21 Score=188.84 Aligned_cols=136 Identities=29% Similarity=0.417 Sum_probs=106.0
Q ss_pred hcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccceeEEEEEec
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~ 434 (527)
..++|++.+.||+|+||.||+|+.. |+.||||++... ....+..++||||+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 3567999999999999999999875 789999987421 12234678999999
Q ss_pred cCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSSNY-ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++|+|.+++...+. .+++.....++.+++.|++||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 99999999975432 3788889999999999999999 8999999999999999999999999999998654321
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
....+++.|+||
T Consensus 172 --~~~~~~~~y~aP 183 (278)
T 1byg_A 172 --DTGKLPVKWTAP 183 (278)
T ss_dssp ------CCTTTSCH
T ss_pred --cCCCccccccCH
Confidence 123467789988
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=189.46 Aligned_cols=135 Identities=23% Similarity=0.356 Sum_probs=109.1
Q ss_pred cCCccccceeccCCceEEEEEEcc-CC-cEEEEEEEeec----------------------------------cCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DG-MEFAIKVFHFS----------------------------------CSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~-~~vavK~~~~~----------------------------------~~~~~~~ 427 (527)
.+.|++.+.||+|+||.||+|+.. ++ +.||+|+++.. +...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 367999999999999999999864 44 78999997421 1123466
Q ss_pred EEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-----------------
Q 035895 428 ALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL----------------- 489 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill----------------- 489 (527)
++||||+ +|++.+.+.... ..+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccc
Confidence 8999999 567767665543 46889999999999999999999 9999999999999999
Q ss_pred --CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 --DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+.++.+||+|||+++...... ....||+.|+||
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aP 208 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPP 208 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCH
T ss_pred cccCCCcEEEeecCccccccccc-----cCCcCCCcccCC
Confidence 567899999999998754321 234688999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-20 Score=187.40 Aligned_cols=137 Identities=26% Similarity=0.309 Sum_probs=113.7
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-------------------------------------Ccc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-------------------------------------SNE 424 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-------------------------------------~~~ 424 (527)
..+.|++.+.||+|+||.||+|+. .+++.||||++.... ..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 356799999999999999999985 578999999975321 123
Q ss_pred ceeEEEEEeccC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeccc
Q 035895 425 DFRALVLEYTTN-GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGI 502 (527)
Q Consensus 425 ~~~~lv~ey~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-~~~~~kl~Dfg~ 502 (527)
+..++||||+.+ ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 456799999986 8999998754 35788889999999999999999 99999999999999999 789999999999
Q ss_pred ccccCCCCCccceeccccccccccC
Q 035895 503 AKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 503 a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++...... .....+|+.|+||
T Consensus 197 ~~~~~~~~----~~~~~gt~~y~aP 217 (320)
T 3a99_A 197 GALLKDTV----YTDFDGTRVYSPP 217 (320)
T ss_dssp CEECCSSC----BCCCCSCGGGSCH
T ss_pred cccccccc----ccCCCCCccCCCh
Confidence 98775322 2234588999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-21 Score=188.09 Aligned_cols=139 Identities=29% Similarity=0.467 Sum_probs=112.2
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------c--CccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------C--SNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~--~~~~~~~l 429 (527)
.++|++.+.||+|+||.||+|+.. +++.||+|++... + ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 567999999999999999999864 7899999997521 1 12346789
Q ss_pred EEEeccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCeeeCCCCcEEEeecc
Q 035895 430 VLEYTTNGSLEKVLYSS---NYILDILQRLNIMIDVTSALEYLHFGYSTP-----IIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~-----iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
||||+++|+|.+++... ...+++.....++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998753 234889999999999999999999 777 9999999999999999999999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++....... ......+|..|+||
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aP 185 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSP 185 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCH
T ss_pred hheeeccccc--cccccCCCccccCh
Confidence 9987643221 11234578889998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=4e-21 Score=190.07 Aligned_cols=144 Identities=26% Similarity=0.418 Sum_probs=111.2
Q ss_pred HHHhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------cCccce
Q 035895 378 QELLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------CSNEDF 426 (527)
Q Consensus 378 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------~~~~~~ 426 (527)
++.....++|++.+.||+|+||.||+|+... .||+|++... +..++.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444556789999999999999999998754 5999987531 122345
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++||||+++|+|.+++...+..+++.++..++.+++.||+||| +++|+||||||+||+++ ++.+|++|||+++..
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 68999999999999999776666888899999999999999999 89999999999999998 679999999998765
Q ss_pred CCCCC---ccceeccccccccccC
Q 035895 507 TGEDQ---SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~---~~~~~~~~~t~~y~aP 527 (527)
..... ........||+.|+||
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aP 203 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAP 203 (319)
T ss_dssp --------CCSCBCCSGGGGTSCH
T ss_pred ccccccccccccccCCCcccccCh
Confidence 32111 1112234578899998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.6e-21 Score=187.32 Aligned_cols=135 Identities=27% Similarity=0.470 Sum_probs=112.6
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
++|++.+.||+|+||.||+|+.. +|+.||+|++... +...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46899999999999999999864 7899999997531 22345668999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCCCC
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL---DDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill---~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
++|+|.+++...+ .+++.....++.|++.||+||| +.+|+||||||+||++ ++++.+|++|||+++.....
T Consensus 89 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 89 SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999986543 5788889999999999999999 8999999999999999 78899999999999865322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......+|++|+||
T Consensus 163 --~~~~~~~~~~y~aP 176 (304)
T 2jam_A 163 --IMSTACGTPGYVAP 176 (304)
T ss_dssp --TTHHHHSCCCBCCT
T ss_pred --ccccccCCCCccCh
Confidence 11234578899998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=183.93 Aligned_cols=138 Identities=29% Similarity=0.410 Sum_probs=110.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
+.|....+||+|+||.||+|+. .+++.||||++... +...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4455667999999999999985 56889999987531 22345668999999
Q ss_pred cCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCCCC
Q 035895 435 TNGSLEKVLYSSNY--ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 435 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~~~~~~~~ 511 (527)
++|+|.+++..... ..++.....++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999976532 3567778889999999999999 899999999999999987 89999999999987643221
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
......+|..|+||
T Consensus 179 --~~~~~~~~~~y~aP 192 (295)
T 2clq_A 179 --CTETFTGTLQYMAP 192 (295)
T ss_dssp ----CCCCCCGGGCCH
T ss_pred --cccccCCCccccCh
Confidence 12234578899998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.8e-21 Score=186.50 Aligned_cols=141 Identities=25% Similarity=0.380 Sum_probs=111.1
Q ss_pred hcCCccccc-eeccCCceEEEEEEc---cCCcEEEEEEEeecc------------------------------CccceeE
Q 035895 383 ATDGFSANN-LIGRGSFGSVYKARL---QDGMEFAIKVFHFSC------------------------------SNEDFRA 428 (527)
Q Consensus 383 ~~~~~~~~~-~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~------------------------------~~~~~~~ 428 (527)
..+.|++.+ .||+|+||.||+|.. .+++.||||++.... ...+..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 345688877 999999999999954 346889999975311 1234567
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+++|+|.+++... ..+++.+...++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999764 35788899999999999999999 89999999999999999999999999999987754
Q ss_pred CCCcc-ceeccccccccccC
Q 035895 509 EDQSM-TQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~-~~~~~~~t~~y~aP 527 (527)
..... ......+++.|+||
T Consensus 170 ~~~~~~~~~~~~~~~~y~aP 189 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAP 189 (291)
T ss_dssp TCSEEEC----CCCGGGCCH
T ss_pred CCCcccccccCCCCceeeCh
Confidence 32211 11223456889998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.6e-21 Score=187.00 Aligned_cols=141 Identities=24% Similarity=0.331 Sum_probs=105.3
Q ss_pred cCCccccceeccCCceEEEEEEcc--CC--cEEEEEEEeecc-------------------------------CccceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ--DG--MEFAIKVFHFSC-------------------------------SNEDFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~--~~--~~vavK~~~~~~-------------------------------~~~~~~~ 428 (527)
.++|++.+.||+|+||.||+|++. ++ ..||||+++... ...+..+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 356999999999999999999853 33 368999874210 1122357
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+||||+++|+|.+++......+++.....++.+++.||+||| +++|+||||||+||+++.++.+|++|||+++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999876566889999999999999999999 89999999999999999999999999999987754
Q ss_pred CCCcc-ceeccccccccccC
Q 035895 509 EDQSM-TQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~-~~~~~~~t~~y~aP 527 (527)
..... ......+|..|+||
T Consensus 174 ~~~~~~~~~~~~~~~~y~aP 193 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAP 193 (291)
T ss_dssp -CCEEEC-----CCGGGCCH
T ss_pred cccchhhhccCCCCceeeCc
Confidence 32211 12234467789998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=189.34 Aligned_cols=138 Identities=26% Similarity=0.377 Sum_probs=111.1
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec------------------------------cC-----cccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS------------------------------CS-----NEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~------------------------------~~-----~~~~~ 427 (527)
.++|++.+.||+|+||.||+|+.. +|+.||||++... +. .....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999864 6899999997421 01 12457
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||+. |+|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 89999998 599998875 35788899999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcc--------ceeccccccccccC
Q 035895 508 GEDQSM--------TQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~--------~~~~~~~t~~y~aP 527 (527)
...... ......||.+|+||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAP 191 (353)
T ss_dssp ----------------CCCCCCGGGCCH
T ss_pred cccccccCccccccchhhccccccccCC
Confidence 321110 11234678999998
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=201.48 Aligned_cols=191 Identities=24% Similarity=0.326 Sum_probs=111.8
Q ss_pred CCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEe
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS 170 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 170 (527)
..+..++++.+.+....+. ..+ .+|+.|++++|.+... + .+..+++|+.|+|++|++++..+ +..+++|+.|+
T Consensus 21 ~~l~~l~l~~~~i~~~~~~--~~L-~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVTQ--NEL-NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHTTCSCTTSEECH--HHH-TTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHhccCCCcccccch--hcC-CCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3455556666666655432 233 3577777777776643 2 46667777777777777765444 66677777777
Q ss_pred ccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCccccc
Q 035895 171 FRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGP 250 (527)
Q Consensus 171 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~ 250 (527)
|++|.+.+ +| .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.++.+ ..+..+++|+.|++++|.+.+.
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCc
Confidence 77777663 22 566666677777777766642 3466666666677666666665 3445555555555555555544
Q ss_pred CCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccccccee
Q 035895 251 LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297 (527)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 297 (527)
.| +..+++|+.|+|++|++++. | .+..+++|+.|+|++|++.+
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEEC
T ss_pred hh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcC
Confidence 33 55555555555555555432 2 35555555555555555543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=189.39 Aligned_cols=144 Identities=25% Similarity=0.388 Sum_probs=102.8
Q ss_pred HHhhhcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------cC-------
Q 035895 379 ELLRATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------CS------- 422 (527)
Q Consensus 379 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~~------- 422 (527)
......++|++.+.||+|+||.||+|+. .+++.||||++... +.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3456678999999999999999999986 46899999987421 00
Q ss_pred ccceeEEEEEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEe
Q 035895 423 NEDFRALVLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLS 498 (527)
Q Consensus 423 ~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~ 498 (527)
.....++||||+++ +|...+.. ....+++.....++.+++.|++|+| .++++|+||||||+||+++. ++.+||+
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 01126799999987 55444332 3456788888999999999999999 45889999999999999996 8999999
Q ss_pred ecccccccCCCCCccceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||+++....... .....+|++|+||
T Consensus 175 Dfg~a~~~~~~~~---~~~~~gt~~y~aP 200 (360)
T 3e3p_A 175 DFGSAKKLSPSEP---NVAYICSRYYRAP 200 (360)
T ss_dssp CCTTCBCCCTTSC---CCSTTSCGGGCCH
T ss_pred eCCCceecCCCCC---cccccCCcceeCH
Confidence 9999987754322 2234678999998
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=189.13 Aligned_cols=156 Identities=25% Similarity=0.226 Sum_probs=94.7
Q ss_pred CCCEEEcccCCCCcccChhHh-hccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEe
Q 035895 92 YLKKLDISRNPLDGFLPRVVG-NFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS 170 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~-~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 170 (527)
.++.|+|++|+|++..+..+. .+ .+|+.|+|++|.|+++.+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l-~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 118 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRL-TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCCCCccChhhhhhcc-cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence 355666666666655444443 33 3566666666666665556666666666666666666665555666666666666
Q ss_pred ccCcccccccChhhhcCcccCeeeeecccCCCCCCccc---cCCccCceeeCCCCCCCCCch-hhhCCCC--ccEEEccC
Q 035895 171 FRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCF---GNLTALRNLHLDSNELTSIPS-ILWNLKD--ILYLDFWS 244 (527)
Q Consensus 171 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~lp~-~~~~l~~--L~~l~l~~ 244 (527)
|++|++++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+.+|. .+..++. ++.|++.+
T Consensus 119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~ 198 (361)
T 2xot_A 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCS
T ss_pred CCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecC
Confidence 66666665556666666666666666666665544444 456667777777777766653 3444444 35666666
Q ss_pred Cccc
Q 035895 245 NLFV 248 (527)
Q Consensus 245 n~~~ 248 (527)
|.+.
T Consensus 199 N~~~ 202 (361)
T 2xot_A 199 NPLE 202 (361)
T ss_dssp SCEE
T ss_pred CCcc
Confidence 6554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=191.04 Aligned_cols=134 Identities=25% Similarity=0.280 Sum_probs=102.0
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCcc------c
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNE------D 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~------~ 425 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999985 46899999997531 1111 2
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||||+++ +|.+.+.. .+++.+...++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 56899999985 78888753 4788888999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... ..+...+|+.|+||
T Consensus 177 ~~~~~---~~~~~~gt~~y~aP 195 (371)
T 2xrw_A 177 AGTSF---MMTPYVVTRYYRAP 195 (371)
T ss_dssp ----------------CTTCCH
T ss_pred ccccc---ccCCceecCCccCH
Confidence 64321 12335688999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-20 Score=186.39 Aligned_cols=141 Identities=26% Similarity=0.311 Sum_probs=103.3
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------c--------Cc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------C--------SN 423 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~--------~~ 423 (527)
....|++.+.||+|+||.||+|+. .+++.||||++... + ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 345689999999999999999996 57899999987321 0 12
Q ss_pred cceeEEEEEeccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEee
Q 035895 424 EDFRALVLEYTTNGSLEKVLYS--SNYILDILQRLNIMIDVTSALEYLHFGYSTP--IIHCDLKPHNKLLDDNIVAHLSD 499 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~--iiHrdlk~~nill~~~~~~kl~D 499 (527)
....++||||+. |+|.+++.. ....+++.++..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 234689999996 699998865 3446899999999999999999999 888 99999999999999999999999
Q ss_pred cccccccCCCCCcc----------ceeccccccccccC
Q 035895 500 FGIAKLLTGEDQSM----------TQTQTLAIIGYMAP 527 (527)
Q Consensus 500 fg~a~~~~~~~~~~----------~~~~~~~t~~y~aP 527 (527)
||+++......... ......+|+.|+||
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP 219 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219 (337)
T ss_dssp CTTCBCCSSCC---------------------------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCCh
Confidence 99998765322110 11134578899998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.9e-21 Score=206.59 Aligned_cols=133 Identities=26% Similarity=0.400 Sum_probs=103.9
Q ss_pred ceeccCCceEEEEEEc---cCCcEEEEEEEeecc------------------------------CccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARL---QDGMEFAIKVFHFSC------------------------------SNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~------------------------------~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||.||+|.+ ..++.||||+++... ...+..++|||||++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 5799999999999965 346789999985321 1123457999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc-ccee
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS-MTQT 516 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 516 (527)
+|.+++... ..+++.++..|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+...... ...+
T Consensus 455 ~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 455 PLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 999999754 45789999999999999999999 899999999999999999999999999999977543221 2223
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...+|+.|+||
T Consensus 531 ~~~~t~~y~AP 541 (635)
T 4fl3_A 531 HGKWPVKWYAP 541 (635)
T ss_dssp ----CGGGSCH
T ss_pred CCCCceeeeCh
Confidence 34467889998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=6.3e-21 Score=189.11 Aligned_cols=136 Identities=27% Similarity=0.353 Sum_probs=110.3
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------------cCcccee
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------------CSNEDFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------------~~~~~~~ 427 (527)
++|++.+.||+|+||.||+|+. .+++.||||++... +...+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 5699999999999999999986 46899999987421 0012336
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeccccc
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI---VAHLSDFGIAK 504 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~---~~kl~Dfg~a~ 504 (527)
++||||+++|+|.+++... ..+++.....++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 8999999999999988643 46788889999999999999999 99999999999999998655 49999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... ......||+.|+||
T Consensus 166 ~~~~~~---~~~~~~gt~~y~aP 185 (322)
T 2ycf_A 166 ILGETS---LMRTLCGTPTYLAP 185 (322)
T ss_dssp ECCCCH---HHHHHHSCCTTCCH
T ss_pred eccccc---ccccccCCcCccCc
Confidence 764321 11234578899998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=4.1e-21 Score=193.93 Aligned_cols=134 Identities=26% Similarity=0.377 Sum_probs=94.9
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cC------cc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CS------NE 424 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~------~~ 424 (527)
..+.|++.+.||+|+||.||+|.. .+|+.||||++... +. ..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347899999999999999999985 57899999997421 00 11
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
...++||||+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 3468999999 6899998864 45788899999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... .+...+|.+|+||
T Consensus 181 ~~~~~-----~~~~~~t~~y~aP 198 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAP 198 (367)
T ss_dssp ---------------CCCTTCCH
T ss_pred ccccc-----CCCcCcCcCccCh
Confidence 75432 2335688999998
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.4e-20 Score=172.58 Aligned_cols=152 Identities=19% Similarity=0.246 Sum_probs=99.0
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccCh-hHhhccccccEEEcccCccccccchhhcCCcCCcE
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPR-VVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLIS 144 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 144 (527)
.+++++|.++.++..+ .+.+++|+|++|++++..|. .|..+. +|+.|+|++|.|++..+..|..+++|++
T Consensus 15 ~l~~s~n~l~~iP~~~--------~~~~~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 85 (220)
T 2v70_A 15 TVDCSNQKLNKIPEHI--------PQYTAELRLNNNEFTVLEATGIFKKLP-QLRKINFSNNKITDIEEGAFEGASGVNE 85 (220)
T ss_dssp EEECCSSCCSSCCSCC--------CTTCSEEECCSSCCCEECCCCCGGGCT-TCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred EeEeCCCCcccCccCC--------CCCCCEEEcCCCcCCccCchhhhccCC-CCCEEECCCCcCCEECHHHhCCCCCCCE
Confidence 4555555555544332 13356777777777765442 344443 5777777777776666666777777777
Q ss_pred EEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCC
Q 035895 145 IDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNEL 224 (527)
Q Consensus 145 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 224 (527)
|+|++|++++..+..|..+++|+.|++++|++++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|++++|.+
T Consensus 86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 77777777766666667777777777777777766666677777777777777777766666777777777777777766
Q ss_pred CC
Q 035895 225 TS 226 (527)
Q Consensus 225 ~~ 226 (527)
..
T Consensus 166 ~c 167 (220)
T 2v70_A 166 NC 167 (220)
T ss_dssp EC
T ss_pred cC
Confidence 53
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.5e-21 Score=197.11 Aligned_cols=140 Identities=27% Similarity=0.438 Sum_probs=105.4
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEeccC
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTTN 436 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~~ 436 (527)
..+|+..++||+|+||+||.....+++.||||++... +...+..++|||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 3458889999999999977666678899999987421 123456789999997
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeecccccccCCCCC
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-----NIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-----~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+|.+++..........++..++.||+.||+||| +++|+||||||+||+++. ...+||+|||+|+.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 5999999866544444456789999999999999 899999999999999942 34688999999987753322
Q ss_pred c-cceeccccccccccC
Q 035895 512 S-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~-~~~~~~~~t~~y~aP 527 (527)
. ...+...||++||||
T Consensus 179 ~~~~~~~~~gt~~y~AP 195 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAP 195 (432)
T ss_dssp -------CCSCTTSCCG
T ss_pred ceeeccccCCCcCccCh
Confidence 1 222345689999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.4e-21 Score=196.26 Aligned_cols=135 Identities=18% Similarity=0.214 Sum_probs=104.8
Q ss_pred hcCCccccceeccCCceEEEEEE-ccCCcEEEEEEEeeccC--------------------c------------------
Q 035895 383 ATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCS--------------------N------------------ 423 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~--------------------~------------------ 423 (527)
....|...++||+|+||+||+|+ ..+|+.||||++..... +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34457888999999999999999 46799999999862100 0
Q ss_pred ---------------------cceeEEEEEeccCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 035895 424 ---------------------EDFRALVLEYTTNGSLEKVLYS------SNYILDILQRLNIMIDVTSALEYLHFGYSTP 476 (527)
Q Consensus 424 ---------------------~~~~~lv~ey~~~g~L~~~l~~------~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~ 476 (527)
....+++|++ .+|+|.+++.. .+..+++..+..++.|++.||+||| +++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 0012455555 46899998842 2344677788899999999999999 999
Q ss_pred eEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 477 iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||||||||+|||++.++.+||+|||+++..... ....+| ++||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aP 276 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPP 276 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCc
Confidence 999999999999999999999999999875422 223456 889998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.9e-21 Score=207.43 Aligned_cols=130 Identities=25% Similarity=0.412 Sum_probs=106.9
Q ss_pred CCccccceeccCCceEEEEEEcc--CCcEEEEEEEeec------------------------------cCccce-----e
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ--DGMEFAIKVFHFS------------------------------CSNEDF-----R 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~------------------------------~~~~~~-----~ 427 (527)
+.|++.+.||+|+||.||+|+.. +++.||||++... +...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999864 6899999987421 111112 5
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++||||++|++|.+++.. .+++.++..|+.||+.||+|+| +++||||||||+||+++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 899999999999987743 5889999999999999999999 8999999999999999976 89999999998764
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
.. ....||++||||
T Consensus 233 ~~------~~~~gt~~y~aP 246 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAP 246 (681)
T ss_dssp CC------SCCCCCTTTSCT
T ss_pred cC------CccCCCccccCH
Confidence 32 234689999999
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.7e-20 Score=179.47 Aligned_cols=173 Identities=23% Similarity=0.335 Sum_probs=144.4
Q ss_pred CCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCC
Q 035895 87 MSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166 (527)
Q Consensus 87 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 166 (527)
+..+++|+.|++++|.++.. + .+..+ ++|+.|++++|.+++..+ +..+++|++|++++|++++. ..+..+++|
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l-~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L 114 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYL-PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKL 114 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGC-TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcC-CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCC
Confidence 45678999999999999875 4 35555 489999999999997665 89999999999999999864 348999999
Q ss_pred CEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCc
Q 035895 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNL 246 (527)
Q Consensus 167 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~ 246 (527)
+.|++++|++++. +.+..+++|+.|++++|++++. ..+..+++|++|++++|+++.++.
T Consensus 115 ~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~----------------- 173 (291)
T 1h6t_A 115 KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP----------------- 173 (291)
T ss_dssp CEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-----------------
T ss_pred CEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-----------------
Confidence 9999999999864 5689999999999999999975 578999999999999999988753
Q ss_pred ccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccccccee
Q 035895 247 FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG 297 (527)
Q Consensus 247 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 297 (527)
+..+++|++|++++|.+++ +| .+..+++|+.|++++|+++.
T Consensus 174 --------l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 --------LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp --------GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred --------hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 3455667777777777764 34 37788888888888888874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=186.96 Aligned_cols=137 Identities=29% Similarity=0.357 Sum_probs=100.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ 431 (527)
.++|+..+.||+|+||.||+|.. .+|+.||||++... +..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46799999999999999999987 47899999997531 12345668999
Q ss_pred EeccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 432 EYTTNGSLEKVLYS----SNYILDILQRLNIMIDVTSALEYLHFGYST-PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 432 ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~-~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
||+++ +|.+++.. ....+++.....++.+++.|++||| +. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 88777653 2456788889999999999999999 77 9999999999999999999999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ......||..|+||
T Consensus 177 ~~~~---~~~~~~gt~~y~aP 194 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAP 194 (327)
T ss_dssp ---------------------
T ss_pred cccc---ccccCCCCccccCc
Confidence 4322 12234588899998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=8.1e-21 Score=194.55 Aligned_cols=138 Identities=24% Similarity=0.404 Sum_probs=97.0
Q ss_pred Cccc-cceeccCCceEEEEEEcc---CCcEEEEEEEeec---------------------------c--CccceeEEEEE
Q 035895 386 GFSA-NNLIGRGSFGSVYKARLQ---DGMEFAIKVFHFS---------------------------C--SNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~-~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~---------------------------~--~~~~~~~lv~e 432 (527)
.|++ .++||+|+||.||+|+.. +++.||||++... + ......++|||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 3665 458999999999999965 5789999987421 1 23456789999
Q ss_pred eccCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeec
Q 035895 433 YTTNGSLEKVLYSSN--------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL----DDNIVAHLSDF 500 (527)
Q Consensus 433 y~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill----~~~~~~kl~Df 500 (527)
|+++ +|.+++.... ..+++..+..|+.|++.||+||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9975 8888775321 23788889999999999999999 9999999999999999 67899999999
Q ss_pred ccccccCCCCCc-cceeccccccccccC
Q 035895 501 GIAKLLTGEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~~-~~~~~~~~t~~y~aP 527 (527)
|+|+........ .......||++|+||
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aP 204 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAP 204 (405)
T ss_dssp TCCC----------------CCCTTCCH
T ss_pred CCceecCCCCcccccCCCceecCcccCc
Confidence 999876532211 122345689999998
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6.9e-20 Score=171.23 Aligned_cols=151 Identities=23% Similarity=0.260 Sum_probs=96.8
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEE
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 145 (527)
.+++++|.++.++..+ .++|++|++++|+++++.+..|..+. +|+.|+|++|.|++..|..|..+++|++|
T Consensus 15 ~v~c~~~~l~~iP~~l--------~~~l~~L~l~~n~i~~i~~~~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 85 (220)
T 2v9t_B 15 IVDCRGKGLTEIPTNL--------PETITEIRLEQNTIKVIPPGAFSPYK-KLRRIDLSNNQISELAPDAFQGLRSLNSL 85 (220)
T ss_dssp EEECTTSCCSSCCSSC--------CTTCCEEECCSSCCCEECTTSSTTCT-TCCEEECCSSCCCEECTTTTTTCSSCCEE
T ss_pred EEEcCCCCcCcCCCcc--------CcCCCEEECCCCcCCCcCHhHhhCCC-CCCEEECCCCcCCCcCHHHhhCCcCCCEE
Confidence 3455555555544332 14566777777777665555555543 56666666666666666666666677777
Q ss_pred EeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCC
Q 035895 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225 (527)
Q Consensus 146 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 225 (527)
+|++|+|+...+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|.+.
T Consensus 86 ~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 86 VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 77777766655555666667777777777666666666666666777777777666666666666666666666666654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.6e-20 Score=196.68 Aligned_cols=190 Identities=21% Similarity=0.268 Sum_probs=154.0
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEE
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 145 (527)
.+.++.+.+.... .+..++.|+.|++++|.+..+ | .+..+ ++|+.|+|++|.+++..+ +..+++|+.|
T Consensus 25 ~l~l~~~~i~~~~-------~~~~L~~L~~L~l~~n~i~~l-~-~l~~l-~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 25 KDNLKKKSVTDAV-------TQNELNSIDQIIANNSDIKSV-Q-GIQYL-PNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHTTCSCTTSEE-------CHHHHTTCCCCBCTTCCCCCC-T-TGGGC-TTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHhccCCCccccc-------chhcCCCCCEEECcCCCCCCC-h-HHccC-CCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 3456666555421 245678899999999999864 3 45555 479999999999987665 8899999999
Q ss_pred EeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCC
Q 035895 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225 (527)
Q Consensus 146 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 225 (527)
+|++|++++. ..+..+++|+.|+|++|.+.+. +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.|+
T Consensus 93 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 93 FLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp ECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred ECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence 9999999863 3688899999999999999853 4588899999999999999875 57889999999999999999
Q ss_pred CCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh
Q 035895 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276 (527)
Q Consensus 226 ~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 276 (527)
.+++ +..+++|+.|++++|.+.+. ..+..+++|+.|+|++|.+.+...
T Consensus 167 ~~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 167 DIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp CCGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred Cchh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence 9876 88889999999999988764 468889999999999999876443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=189.21 Aligned_cols=132 Identities=25% Similarity=0.390 Sum_probs=105.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccce-----
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDF----- 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~----- 426 (527)
.+.|.+.+.||+|+||.||+|+. .+|+.||||++... +...+.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46799999999999999999985 56899999998531 111121
Q ss_pred -eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 427 -RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 427 -~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
.++||||+. |+|.+++. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 289999998 58888773 34789999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... .....+|++|+||
T Consensus 194 ~~~~-----~~~~~~t~~y~aP 210 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAP 210 (371)
T ss_dssp -----------CTTCCCTTSCH
T ss_pred cccC-----cCCcccCccccCH
Confidence 5432 2234678899998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=185.96 Aligned_cols=139 Identities=26% Similarity=0.369 Sum_probs=100.8
Q ss_pred hhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEE
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRAL 429 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~l 429 (527)
...++|+..+.||+|+||.||+|+.. +|+.||||++... +..++..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34577999999999999999999874 7899999997531 223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST-PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~-~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
||||+ ++.+..+.......+++.....++.+++.||+||| +. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999 56777666554567889999999999999999999 74 999999999999999999999999999987643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
.. ......+|+.|+||
T Consensus 178 ~~---~~~~~~~~~~y~aP 193 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAP 193 (318)
T ss_dssp ------------CCTTCCH
T ss_pred Cc---cccccCCCccccCh
Confidence 22 12234578889998
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-22 Score=213.78 Aligned_cols=120 Identities=30% Similarity=0.325 Sum_probs=73.8
Q ss_pred CceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccc
Q 035895 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHN 293 (527)
Q Consensus 214 L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 293 (527)
|+.|+|++|+|+++|. +..+++|+.|++++|.+. .+|..++.+++|++|+|++|++++ +| .|+.+++|++|+|++|
T Consensus 443 L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 443 VRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp CSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred ceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence 5555555555555554 555555555555555555 455566666666666777666664 45 6666777777777777
Q ss_pred cceeec-CCCCCCCCCCCEEeCCCCcccccCccc---hhhhccCCeeE
Q 035895 294 RLQGSI-PNSFDDLVSLESLDLSNNNLSEIIPLS---LEKLLYLNILL 337 (527)
Q Consensus 294 ~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~---~~~l~~L~~L~ 337 (527)
++++.. |..|..+++|+.|+|++|++++.+|.. +..++.|+.|+
T Consensus 519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 776554 666667777777777777776655532 23355565554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=184.28 Aligned_cols=137 Identities=28% Similarity=0.342 Sum_probs=110.0
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------------cC
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------------CS 422 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------------~~ 422 (527)
-.++|++.+.||+|+||.||+|+. .+++.||||+++.. +.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 356799999999999999999986 56899999997421 11
Q ss_pred ccceeEEEEEe-ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeec
Q 035895 423 NEDFRALVLEY-TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDF 500 (527)
Q Consensus 423 ~~~~~~lv~ey-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-~~~~~kl~Df 500 (527)
.++..++|||| +++++|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 22345799999 78999999997643 5789999999999999999999 89999999999999999 8899999999
Q ss_pred ccccccCCCCCccceeccccccccccC
Q 035895 501 GIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+++...... .....+|..|+||
T Consensus 185 g~~~~~~~~~----~~~~~~~~~y~aP 207 (312)
T 2iwi_A 185 GSGALLHDEP----YTDFDGTRVYSPP 207 (312)
T ss_dssp SSCEECCSSC----BCCCCSCTTTSCH
T ss_pred chhhhcccCc----ccccCCcccccCc
Confidence 9998775332 2234578889998
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-19 Score=170.11 Aligned_cols=156 Identities=23% Similarity=0.293 Sum_probs=118.2
Q ss_pred cEEEeecCcccccCcccccCCCCCCEEeccCcccccccC-hhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCC
Q 035895 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP-NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDS 221 (527)
Q Consensus 143 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 221 (527)
+++++++|.++.+ |..+ .+.++.|++++|++++..| ..|..+++|+.|+|++|+|++..+.+|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~~i-P~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNKI-PEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcccC-ccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4778888887753 4333 2345777777777776543 3467777777777777777776666777777777777777
Q ss_pred CCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCC
Q 035895 222 NELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301 (527)
Q Consensus 222 N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 301 (527)
|+++.+| +..|..+++|++|+|++|++.+..|..|.++++|++|+|++|++++..|.
T Consensus 91 N~l~~~~-----------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 91 NRLENVQ-----------------------HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp SCCCCCC-----------------------GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred CccCccC-----------------------HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 7776654 34566778888888888888888888888889999999999999888888
Q ss_pred CCCCCCCCCEEeCCCCcccccCc
Q 035895 302 SFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 302 ~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
.|..+++|+.|++++|++....+
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTTTCTTCCEEECCSCCEECSGG
T ss_pred HhcCCCCCCEEEecCcCCcCCCc
Confidence 89999999999999998876543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-22 Score=214.09 Aligned_cols=204 Identities=18% Similarity=0.126 Sum_probs=152.6
Q ss_pred CCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCc-------------cccccchhhcCCcCCcEEE-eecCccc
Q 035895 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCN-------------ISGGISEEIGNLTDLISID-LGGNKLN 153 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~ 153 (527)
..++.|+.|+|++|+++. +|..++.+. +|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~~-Lp~~i~~l~-~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~ 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTV-LQSELESCK-ELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423 (567)
T ss_dssp STTTTSSSCCCCHHHHHH-HHHHHHHHH-HHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred ccCccceeccCChhhHHh-hHHHHHHHH-HHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence 455667777777777763 566666654 57777765553 3334445555555555555 4444332
Q ss_pred ccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhC
Q 035895 154 GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWN 233 (527)
Q Consensus 154 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~ 233 (527)
.|..+.+++|.++.. |. ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+.+|..+..
T Consensus 424 -----------~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~ 484 (567)
T 1dce_A 424 -----------DLRSKFLLENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAA 484 (567)
T ss_dssp -----------HHHHHHHHHHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGG
T ss_pred -----------hhhhhhhhccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhc
Confidence 233344555555432 11 258999999999997 566 99999999999999999999999999
Q ss_pred CCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCC-hhhhhcCCCCCEEEcccccceeecCCC---CCCCCCC
Q 035895 234 LKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI-PTTIQGLKSLQFLSLGHNRLQGSIPNS---FDDLVSL 309 (527)
Q Consensus 234 l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L 309 (527)
+++|+.|++++|.+++ +| .++.+++|++|+|++|++++.. |..|+.+++|+.|+|++|++++.+|.. +..+++|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 9999999999999997 56 8999999999999999999887 999999999999999999999765532 2347899
Q ss_pred CEEeC
Q 035895 310 ESLDL 314 (527)
Q Consensus 310 ~~L~l 314 (527)
+.|++
T Consensus 563 ~~L~l 567 (567)
T 1dce_A 563 SSILT 567 (567)
T ss_dssp SEEEC
T ss_pred CccCC
Confidence 99875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.8e-20 Score=182.90 Aligned_cols=138 Identities=25% Similarity=0.348 Sum_probs=103.7
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-----------------------------c------------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-----------------------------C------------ 421 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----------------------------~------------ 421 (527)
.+.|++.+.||+|+||.||+|+.. +++.||||++... +
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357899999999999999999875 5899999987421 0
Q ss_pred --CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEe
Q 035895 422 --SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLS 498 (527)
Q Consensus 422 --~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~-~~~~~kl~ 498 (527)
......++||||++ |+|.+++.. ..+++.....++.|++.||+||| +++|+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 12346689999998 599999854 45788889999999999999999 89999999999999997 67899999
Q ss_pred ecccccccCCCCCc-cceeccccccccccC
Q 035895 499 DFGIAKLLTGEDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 499 Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aP 527 (527)
|||+++........ .......+|.+|+||
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCH
T ss_pred cCccccccCCCcccccccccccccccccCc
Confidence 99999876432111 112234568889998
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=169.39 Aligned_cols=153 Identities=24% Similarity=0.327 Sum_probs=121.3
Q ss_pred cEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCC
Q 035895 143 ISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 143 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 222 (527)
+.+++++|.++.+ |..+. ++|+.|++++|++++..+..|..+++|+.|+|++|+|++..|.+|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 5778888888754 43332 67888888888888766667888888888888888888777888888888888888888
Q ss_pred CCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCC
Q 035895 223 ELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS 302 (527)
Q Consensus 223 ~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 302 (527)
+|+.+|. ..|..+++|++|+|++|++.+..|..|.++++|++|+|++|++++..+..
T Consensus 91 ~l~~l~~-----------------------~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 147 (220)
T 2v9t_B 91 KITELPK-----------------------SLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147 (220)
T ss_dssp CCCCCCT-----------------------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cCCccCH-----------------------hHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence 8877654 34566778888888888888888888888888888888888888777778
Q ss_pred CCCCCCCCEEeCCCCcccc
Q 035895 303 FDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 303 ~~~l~~L~~L~ls~N~l~~ 321 (527)
|..+++|+.|++++|++..
T Consensus 148 ~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 148 FSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTTCTTCCEEECCSSCEEC
T ss_pred HhCCCCCCEEEeCCCCcCC
Confidence 8888889999999998864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=193.53 Aligned_cols=137 Identities=27% Similarity=0.397 Sum_probs=99.6
Q ss_pred ccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEeccCCcH
Q 035895 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~~g~L 439 (527)
|...+.||+|+||+||.+...+|+.||||++... +..++..++|||||. |+|
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4556889999999998877778999999987431 123456789999996 699
Q ss_pred HHHHHhcCCCC------CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-------------CcEEEeec
Q 035895 440 EKVLYSSNYIL------DILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-------------IVAHLSDF 500 (527)
Q Consensus 440 ~~~l~~~~~~~------~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-------------~~~kl~Df 500 (527)
.+++....... .+..+..++.||+.||+||| +++|+||||||+||+++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99997643211 22234679999999999999 9999999999999999654 58999999
Q ss_pred ccccccCCCCCcc--ceeccccccccccC
Q 035895 501 GIAKLLTGEDQSM--TQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~~~--~~~~~~~t~~y~aP 527 (527)
|+|+......... ......||++||||
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aP 201 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAP 201 (434)
T ss_dssp TTCEECCC--------------CCTTSCH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCH
Confidence 9999875432211 12235689999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-20 Score=187.62 Aligned_cols=135 Identities=22% Similarity=0.342 Sum_probs=110.3
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------------cC-
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------------CS- 422 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------------~~- 422 (527)
.++|++.+.||+|+||.||+|+. .+++.||||++... +.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 35799999999999999999985 57899999997521 00
Q ss_pred ---ccceeEEEEEeccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeC------C
Q 035895 423 ---NEDFRALVLEYTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYST-PIIHCDLKPHNKLLD------D 491 (527)
Q Consensus 423 ---~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~-~iiHrdlk~~nill~------~ 491 (527)
.....++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++ +|+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcC
Confidence 111568999999 889999997643 45888899999999999999999 87 999999999999994 4
Q ss_pred CCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 492 NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 492 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+.+||+|||+|+..... .+...+|+.|+||
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aP 204 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSP 204 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCH
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCc
Confidence 458999999999876432 1234678999998
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-20 Score=181.46 Aligned_cols=168 Identities=20% Similarity=0.243 Sum_probs=98.9
Q ss_pred CcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCC
Q 035895 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDS 221 (527)
Q Consensus 142 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 221 (527)
++.+++++|.+++.. .+..+++|+.|++++|.++ .+| .+..+++|+.|++++|++++..| +..+++|++|++++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 334444444444322 2344444444444444444 222 34444555555555555544332 45555555555555
Q ss_pred CCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCC
Q 035895 222 NELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301 (527)
Q Consensus 222 N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 301 (527)
|+++++|.... ++|+.|++++|.+.+. +.+..+++|++|++++|++++. | .+..+++|++|++++|++++. .
T Consensus 95 N~l~~l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~ 166 (263)
T 1xeu_A 95 NRLKNLNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--G 166 (263)
T ss_dssp SCCSCCTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--T
T ss_pred CccCCcCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--H
Confidence 55555443222 4555555555555442 2466778888888888888754 4 678888888888888888765 6
Q ss_pred CCCCCCCCCEEeCCCCcccccC
Q 035895 302 SFDDLVSLESLDLSNNNLSEII 323 (527)
Q Consensus 302 ~~~~l~~L~~L~ls~N~l~~~~ 323 (527)
.+..+++|+.|++++|++++..
T Consensus 167 ~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 167 GLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp TSTTCCCCCEEEEEEEEEECCC
T ss_pred HhccCCCCCEEeCCCCcccCCc
Confidence 7788888888888888887653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=180.42 Aligned_cols=137 Identities=26% Similarity=0.445 Sum_probs=112.4
Q ss_pred cCCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec-------------------------------cCccceeEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS-------------------------------CSNEDFRALVL 431 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ 431 (527)
.+.|++.+.||+|+||.||+|+.. +++.||||++... +...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457999999999999999999875 7899999997431 12335668999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~ 508 (527)
||+++++|.+.+...+ .+++.+...++.+++.||+||| +.+|+||||||+||+++. ++.+|++|||+++....
T Consensus 101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999886543 5788899999999999999999 899999999999999975 35799999999987643
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....+|..|+||
T Consensus 177 ~~~---~~~~~~~~~y~aP 192 (287)
T 2wei_A 177 NTK---MKDRIGTAYYIAP 192 (287)
T ss_dssp CSS---CSCHHHHHTTCCH
T ss_pred CCc---cccccCcccccCh
Confidence 321 1234578889998
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-19 Score=167.73 Aligned_cols=135 Identities=23% Similarity=0.196 Sum_probs=74.4
Q ss_pred cCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeC
Q 035895 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHL 219 (527)
Q Consensus 140 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 219 (527)
++|++|+|++|++++..+..|..+++|+.|+|++|+++...+..|..+++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 44555555555555544555555555555555555555444444555556666666666665555555566666666666
Q ss_pred CCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCC
Q 035895 220 DSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274 (527)
Q Consensus 220 ~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 274 (527)
++|+|+.+|..+..+++|+.|++++|.+.+..+..+..+++|++|++++|.+...
T Consensus 120 s~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 120 CCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred cCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 6666665555444444444444444444433344455566666666666666543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-21 Score=207.30 Aligned_cols=322 Identities=15% Similarity=0.112 Sum_probs=172.0
Q ss_pred hhhcchhccc-CCCceeecCchhhh-cCCCCCEEEccccc-cccc-c------ccccceEEcccccccCCCCCCcccccC
Q 035895 18 DVCYRICTID-SQNKLVGIVSITIF-NLSTLKVFDVDNNY-VLGR-L------SSIVDELSLSDNYLTSSTPELSFLSSM 87 (527)
Q Consensus 18 ~~~~~~~~~~-s~N~l~~~~~~~~~-~l~~L~~L~Ls~N~-~~~~-~------~~~l~~L~Ls~N~l~~~~~~~~~~~~~ 87 (527)
..|..+..++ ++|.+++..+..+. .+++|+.|+|++|. +... + -+.+++|+|++|.++...... +....
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~-l~~~~ 180 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHW-LSHFP 180 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGG-GGGSC
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHH-HHHHh
Confidence 3466788888 78888877776665 79999999999883 3221 1 135899999999987643221 11223
Q ss_pred CCCCCCCEEEcccCC--CCcc-cChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCc-------------
Q 035895 88 SNCKYLKKLDISRNP--LDGF-LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNK------------- 151 (527)
Q Consensus 88 ~~l~~L~~L~Ls~N~--l~~~-~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~------------- 151 (527)
..+++|++|++++|. +... ++..+.. .++|+.|++++|.-.+.++..+..+++|++|+++.+.
T Consensus 181 ~~~~~L~~L~l~~~~~~~~~~~l~~l~~~-~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~ 259 (594)
T 2p1m_B 181 DTYTSLVSLNISCLASEVSFSALERLVTR-CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV 259 (594)
T ss_dssp TTCCCCCEEECTTCCSCCCHHHHHHHHHH-CTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH
T ss_pred hcCCcCcEEEecccCCcCCHHHHHHHHHh-CCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHH
Confidence 478899999999987 3211 1111223 3579999999883222356666666667777644331
Q ss_pred -------------cc----ccCcccccCCCCCCEEeccCccccccc-ChhhhcCcccCeeeeecccCCCC-CCccccCCc
Q 035895 152 -------------LN----GSISITLGKLQKLQFLSFRGNELEGSI-PNVLCHLAVLFQLDLRGNKLSGS-IPTCFGNLT 212 (527)
Q Consensus 152 -------------l~----~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~ 212 (527)
+. +.++..+..+++|+.|++++|.+++.. +..+..+++|+.|++++| +... ++.....++
T Consensus 260 ~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~ 338 (594)
T 2p1m_B 260 ALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK 338 (594)
T ss_dssp HHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred HHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence 11 112222234677777777777765332 223456677777777766 3211 111223456
Q ss_pred cCceeeCC---------CCCCCC--CchhhhCCCCccEEEccCCcccccCCcccc-CCCCCCEEEcc--C----CCCCCC
Q 035895 213 ALRNLHLD---------SNELTS--IPSILWNLKDILYLDFWSNLFVGPLPSKIG-NLKVLTRIDFS--R----NNLLGD 274 (527)
Q Consensus 213 ~L~~L~L~---------~N~l~~--lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~ 274 (527)
+|++|+++ .+.++. +......+++|+.|.+..|.+++..+..+. .+++|+.|+++ + |.+++.
T Consensus 339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~ 418 (594)
T 2p1m_B 339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLE 418 (594)
T ss_dssp TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCC
T ss_pred CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCC
Confidence 66666662 233332 111122355555555555555443333332 35555666655 2 333321
Q ss_pred C-----hhhhhcCCCCCEEEcccccceeecCCCCCC-CCCCCEEeCCCCcccccCccch-hhhccCCeeEeeeeee
Q 035895 275 I-----PTTIQGLKSLQFLSLGHNRLQGSIPNSFDD-LVSLESLDLSNNNLSEIIPLSL-EKLLYLNILLIVVVIL 343 (527)
Q Consensus 275 ~-----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~~~~~~~ 343 (527)
. +..+..+++|+.|++++ .+++..+..+.. +++|+.|++++|.+++..+..+ ..++.|+.|+++.+.+
T Consensus 419 ~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 419 PLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp CTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred chhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 1 11244455555555544 333322222222 4455555555555544333322 3445555555554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-19 Score=178.44 Aligned_cols=122 Identities=29% Similarity=0.432 Sum_probs=104.5
Q ss_pred cCCcccc-ceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------c----CccceeEEEEE
Q 035895 384 TDGFSAN-NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------C----SNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------~----~~~~~~~lv~e 432 (527)
.++|.+. +.||+|+||.||+|.. .+++.||+|++... + ......++|||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 4567776 7899999999999986 57899999997531 1 12456789999
Q ss_pred eccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCC
Q 035895 433 YTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~ 508 (527)
|+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+|+....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 172 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence 999999999998653 35889999999999999999999 999999999999999997 78999999999987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.3e-20 Score=185.55 Aligned_cols=132 Identities=25% Similarity=0.388 Sum_probs=105.6
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccc------
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNED------ 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~------ 425 (527)
.+.|...+.||+|+||.||+|+. .+|+.||||++... +...+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999986 57899999997421 01111
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||||++ |+|.+++. ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 2489999998 58887763 24788899999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... .+...+|.+|+||
T Consensus 176 ~~~~-----~~~~~~t~~y~aP 192 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAP 192 (353)
T ss_dssp -------------CCSBCCSCH
T ss_pred CCCC-----ccccccCcCcCCH
Confidence 5422 2234678899998
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.1e-19 Score=167.03 Aligned_cols=153 Identities=21% Similarity=0.236 Sum_probs=116.7
Q ss_pred cceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 64 l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
.+.++.+++.++.++..+ .++|++|+|++|++++..|..+..+. +|+.|+|++|.|+...+..|..+++|+
T Consensus 21 ~~~v~c~~~~l~~ip~~~--------~~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~L~~N~l~~i~~~~~~~l~~L~ 91 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGI--------PTNAQILYLHDNQITKLEPGVFDSLI-NLKELYLGSNQLGALPVGVFDSLTQLT 91 (229)
T ss_dssp TTEEECTTSCCSSCCSCC--------CTTCSEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCEeEccCCCcCccCCCC--------CCCCCEEEcCCCccCccCHHHhhCcc-CCcEEECCCCCCCCcChhhcccCCCcC
Confidence 456777777777766543 26788888888888877777776664 688888888888776667777888888
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNE 223 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 223 (527)
+|+|++|++++..+..|..+++|+.|++++|+++ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|.
T Consensus 92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (229)
T 3e6j_A 92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCC
Confidence 8888888888776767778888888888888887 667777788888888888888887766777788888888888887
Q ss_pred CCC
Q 035895 224 LTS 226 (527)
Q Consensus 224 l~~ 226 (527)
+..
T Consensus 171 ~~c 173 (229)
T 3e6j_A 171 WDC 173 (229)
T ss_dssp BCT
T ss_pred ccC
Confidence 764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-20 Score=197.34 Aligned_cols=138 Identities=31% Similarity=0.437 Sum_probs=110.6
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------c------Cccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------C------SNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~------~~~~~ 426 (527)
.+.|++.+.||+|+||.||+|+. .+|+.||||++... + ...+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47799999999999999999986 56899999986421 1 11455
Q ss_pred eEEEEEeccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeecc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNY--ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIV---AHLSDFG 501 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~---~kl~Dfg 501 (527)
.++|||||+||+|.+++...+. .+++..+..++.+++.||+||| +.+|+||||||+||+++.++. +|++|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 6899999999999999976432 4777788899999999999999 899999999999999986654 9999999
Q ss_pred cccccCCCCCccceeccccccccccC
Q 035895 502 IAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++....... .....+|.+|+||
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~AP 192 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAP 192 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSS
T ss_pred cccccccccc---cccccCCcccCCh
Confidence 9987754321 2345688999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-19 Score=176.55 Aligned_cols=115 Identities=16% Similarity=0.163 Sum_probs=94.4
Q ss_pred hhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeecc---------------------------------------
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSC--------------------------------------- 421 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--------------------------------------- 421 (527)
.....-|++.+.||+|+||.||+|+..+|+.||||+++...
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~ 165 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 165 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCC
Confidence 33445577789999999999999999789999999985210
Q ss_pred ----CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 035895 422 ----SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497 (527)
Q Consensus 422 ----~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl 497 (527)
...+..++||||++||+|.+ +.. + ....++.|++.|++|+| +.+|+||||||+|||++ ++.+||
T Consensus 166 v~~~~~~~~~~lvmE~~~g~~L~~-l~~-----~--~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 166 VPKVYAWEGNAVLMELIDAKELYR-VRV-----E--NPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp SCCEEEEETTEEEEECCCCEEGGG-CCC-----S--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEE
T ss_pred cCeEEeccceEEEEEecCCCcHHH-cch-----h--hHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEE
Confidence 01234579999999999988 421 1 24468999999999999 99999999999999999 999999
Q ss_pred eecccccccC
Q 035895 498 SDFGIAKLLT 507 (527)
Q Consensus 498 ~Dfg~a~~~~ 507 (527)
+|||+|+...
T Consensus 234 ~DFG~a~~~~ 243 (282)
T 1zar_A 234 IDFPQSVEVG 243 (282)
T ss_dssp CCCTTCEETT
T ss_pred EECCCCeECC
Confidence 9999998764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-20 Score=202.21 Aligned_cols=222 Identities=22% Similarity=0.235 Sum_probs=97.3
Q ss_pred CCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEe
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLS 170 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 170 (527)
+.++.|+|++|.+... +.. .++.++|++|.|.+ +++..|++. ..+..+..+++|+.|+
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~------~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~ 230 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQA------LLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALD 230 (727)
T ss_dssp -----------------------------------------------------------------------CCCCCCEEE
T ss_pred CccceEEeeCCCCCcc-hhh------HhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEE
Confidence 4567777777776642 221 25555666665442 234445544 4455666667777777
Q ss_pred ccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCccccc
Q 035895 171 FRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGP 250 (527)
Q Consensus 171 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~ 250 (527)
|++|.+. .+|..+..+++|+.|+|++|.|+ .+|..|+++++|++|+|++|+|+.+|..+..+++|++|++++|.+. .
T Consensus 231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-c
Confidence 7777766 45555556777777777777776 5666677777777777777777777777777777777777777665 5
Q ss_pred CCccccCCCCCCEEEccCCCCCCCChhhhhcCCC-CCEEEcccccceeecCCCCCCCCCCCEEeCCCC--------cccc
Q 035895 251 LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKS-LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN--------NLSE 321 (527)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N--------~l~~ 321 (527)
+|..|+.+++|++|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|.. |+.|+++.| .+.+
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~ 381 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQ 381 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccc
Confidence 5666778888888888888888777777655422 224678888887777654 444556655 3444
Q ss_pred cCccchhhhccCCeeEeeeeee
Q 035895 322 IIPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 322 ~~p~~~~~l~~L~~L~~~~~~~ 343 (527)
..+..+..+..+....++.+.+
T Consensus 382 ~~~~~~~~l~~~~~~~ls~Nil 403 (727)
T 4b8c_D 382 STEHLATDLAKRTFTVLSYNTL 403 (727)
T ss_dssp --------------------CC
T ss_pred cccchhhcccccceeeeecccc
Confidence 4444445555555555555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-20 Score=195.14 Aligned_cols=125 Identities=19% Similarity=0.270 Sum_probs=92.0
Q ss_pred cccceeccCCceEEEEEEccCCcEEEEEEEee-------------------------------------ccCccceeEEE
Q 035895 388 SANNLIGRGSFGSVYKARLQDGMEFAIKVFHF-------------------------------------SCSNEDFRALV 430 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~-------------------------------------~~~~~~~~~lv 430 (527)
...+.||+|+||+||+|+. .++.+|+|+... .+..++..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 467889987521 01123345899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||++||+|.+++.. +..++.|+++||+||| +++|+||||||+|||+++ .+||+|||+|+......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999854 4578999999999999 999999999999999998 99999999999875322
Q ss_pred Ccc-----ceeccccccccccC
Q 035895 511 QSM-----TQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~-----~~~~~~~t~~y~aP 527 (527)
... ......||++||||
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~AP 505 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFD 505 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHH
T ss_pred ccccchhhhhhhhcCCCCcCCH
Confidence 111 11245689999998
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.3e-20 Score=204.45 Aligned_cols=150 Identities=25% Similarity=0.231 Sum_probs=88.5
Q ss_pred cccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccc
Q 035895 98 ISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE 177 (527)
Q Consensus 98 Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 177 (527)
++.|.+. ..|..+..+. .|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+.+++|+.|+|++|.|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~-~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQ-LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ---------------CCC-CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred cccccee-cChhhhccCC-CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 3444444 3445555543 5777777777776 44455556777777777777777 55666777777777777777777
Q ss_pred cccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCC-chhhhCCC-CccEEEccCCcccccCCc
Q 035895 178 GSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI-PSILWNLK-DILYLDFWSNLFVGPLPS 253 (527)
Q Consensus 178 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~-~L~~l~l~~n~~~~~~p~ 253 (527)
.+|..|..+++|++|+|++|.|+ .+|..|+++++|++|+|++|.|++. |..+..+. .+..+++++|.+.+.+|.
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 56777777777777777777776 4566677777777777777777763 33333221 112345566666655554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=171.76 Aligned_cols=170 Identities=21% Similarity=0.268 Sum_probs=93.3
Q ss_pred CCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEE
Q 035895 90 CKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFL 169 (527)
Q Consensus 90 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 169 (527)
+.++..+++++|.+++.. .+..+. +|+.|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|+.|
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~-~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELS-GVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHT-TCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcC-cCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 344555555555555432 233332 455555555555532 2 44555555555555555554333 5555555555
Q ss_pred eccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccc
Q 035895 170 SFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVG 249 (527)
Q Consensus 170 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~ 249 (527)
++++|++++ +|.. .. ++|+.|++++|++ +.+| .+..+++|+.|++++|++.+
T Consensus 91 ~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l------------------------~~~~-~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-PS-ACLSRLFLDNNEL------------------------RDTD-SLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp ECCSSCCSC-CTTC-CC-SSCCEEECCSSCC------------------------SBSG-GGTTCTTCCEEECTTSCCCB
T ss_pred ECCCCccCC-cCcc-cc-CcccEEEccCCcc------------------------CCCh-hhcCcccccEEECCCCcCCC
Confidence 555555543 2221 11 4455555555554 4443 24444444444554444443
Q ss_pred cCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceee
Q 035895 250 PLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298 (527)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 298 (527)
. +.+..+++|++|++++|++.+. ..+..+++|+.|++++|+++..
T Consensus 143 ~--~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 143 I--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred C--hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 2 2456677788888888888765 5678888888888888888754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.6e-19 Score=173.37 Aligned_cols=114 Identities=13% Similarity=0.033 Sum_probs=97.5
Q ss_pred CCccccceeccCCceEEEEEEcc-CCcEEEEEEEeec--------------------------------cCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHFS--------------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--------------------------------~~~~~~~~lv~ 431 (527)
+.|++.+.||+|+||.||+|+.. +++.||||+++.. +..++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56999999999999999999875 5899999997531 12345678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
||++|++|.+++... ....+...++.|++.||+||| +++|+||||||+||+++.++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence 999999999998532 355578889999999999999 9999999999999999999999999887654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-20 Score=201.93 Aligned_cols=319 Identities=15% Similarity=0.108 Sum_probs=212.8
Q ss_pred hhcchhccc-CCC-ceeec-CchhhhcCCCCCEEEccccccccccc----------cccceEEcccccccCCCCCCcccc
Q 035895 19 VCYRICTID-SQN-KLVGI-VSITIFNLSTLKVFDVDNNYVLGRLS----------SIVDELSLSDNYLTSSTPELSFLS 85 (527)
Q Consensus 19 ~~~~~~~~~-s~N-~l~~~-~~~~~~~l~~L~~L~Ls~N~~~~~~~----------~~l~~L~Ls~N~l~~~~~~~~~~~ 85 (527)
.|..+..++ +.| .++.. .+..+.++++|++|+|++|.+.+..+ ..++.|+|++|. ..+... .+..
T Consensus 128 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~-~l~~ 205 (594)
T 2p1m_B 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFS-ALER 205 (594)
T ss_dssp HCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHH-HHHH
T ss_pred hCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHH-HHHH
Confidence 467888888 666 55543 44555689999999999998643211 257899999886 221110 0111
Q ss_pred cCCCCCCCCEEEcccC-CCCcccChhHhhccccccEEEcccCc--------------------------cc----cccch
Q 035895 86 SMSNCKYLKKLDISRN-PLDGFLPRVVGNFSQSLEFIWMSDCN--------------------------IS----GGISE 134 (527)
Q Consensus 86 ~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~~L~~L~Ls~n~--------------------------l~----~~~~~ 134 (527)
.+..+++|++|++++| .+.+ +|..+..+. +|+.|+++.+. +. ..++.
T Consensus 206 l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~-~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~ 283 (594)
T 2p1m_B 206 LVTRCPNLKSLKLNRAVPLEK-LATLLQRAP-QLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPA 283 (594)
T ss_dssp HHHHCTTCCEEECCTTSCHHH-HHHHHHHCT-TCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGG
T ss_pred HHHhCCCCcEEecCCCCcHHH-HHHHHhcCC-cceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHH
Confidence 1245789999999998 4444 566666654 68888765542 11 12333
Q ss_pred hhcCCcCCcEEEeecCcccccC-cccccCCCCCCEEeccCccccc-ccChhhhcCcccCeeeeec---------ccCCCC
Q 035895 135 EIGNLTDLISIDLGGNKLNGSI-SITLGKLQKLQFLSFRGNELEG-SIPNVLCHLAVLFQLDLRG---------NKLSGS 203 (527)
Q Consensus 135 ~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~L~~---------N~l~~~ 203 (527)
.+..+++|++|++++|.+++.. ...+..+++|+.|++++| +.. .++.....+++|+.|++++ +.++..
T Consensus 284 ~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 284 VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp GHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred HHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 3446789999999999976432 223568899999999988 432 2333445688999998843 455432
Q ss_pred CCcccc-CCccCceeeCCCCCCCCC-chhh-hCCCCccEEEcc--C----Cccccc-----CCccccCCCCCCEEEccCC
Q 035895 204 IPTCFG-NLTALRNLHLDSNELTSI-PSIL-WNLKDILYLDFW--S----NLFVGP-----LPSKIGNLKVLTRIDFSRN 269 (527)
Q Consensus 204 ~p~~~~-~l~~L~~L~L~~N~l~~l-p~~~-~~l~~L~~l~l~--~----n~~~~~-----~p~~~~~l~~L~~L~Ls~N 269 (527)
....+. .+++|+.|.++.|.++.. +..+ ..+++|+.|+++ + +.++.. ++..+..+++|++|++++
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~- 441 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG- 441 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-
Confidence 222332 478899999988888763 2233 357889999998 3 344321 122256788999999977
Q ss_pred CCCCCChhhhhc-CCCCCEEEcccccceeecCCCC-CCCCCCCEEeCCCCcccccCcc-chhhhccCCeeEeeeeee
Q 035895 270 NLLGDIPTTIQG-LKSLQFLSLGHNRLQGSIPNSF-DDLVSLESLDLSNNNLSEIIPL-SLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 270 ~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~~~~~~~ 343 (527)
.+++..+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|++++|.+++.... ....++.|+.|+++.+..
T Consensus 442 ~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 666555555655 8899999999999875544444 5678999999999998655443 445688999999887765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-18 Score=157.95 Aligned_cols=110 Identities=15% Similarity=0.177 Sum_probs=49.9
Q ss_pred hhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC-CchhhhCCCCccEEEccCCcccccCCccccCCCCCC
Q 035895 184 LCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLT 262 (527)
Q Consensus 184 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~ 262 (527)
+..+++|++|++++|++++..|..|+.+++|++|++++|+++. .|..+..+++|++|++++|...+.+| .+..+++|+
T Consensus 84 l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~ 162 (197)
T 4ezg_A 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELK 162 (197)
T ss_dssp GTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCC
T ss_pred hhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCC
Confidence 3333344444444444433333334444444444444444433 23333334444444444443222222 355566666
Q ss_pred EEEccCCCCCCCChhhhhcCCCCCEEEcccccce
Q 035895 263 RIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 263 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 296 (527)
+|++++|.+.+ ++ .+..+++|++|++++|++.
T Consensus 163 ~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 163 SLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp EEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred EEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 66666666654 33 5666666777777766654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.8e-18 Score=157.41 Aligned_cols=148 Identities=18% Similarity=0.225 Sum_probs=65.4
Q ss_pred cccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeee
Q 035895 117 SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 196 (527)
+|+.|++++|.++. +| .+..+++|++|++++|.++. ...+..+++|+.|++++|.+++..|..|..+++|++|+++
T Consensus 45 ~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 34444444444442 22 34444444444444444331 1234444444444444444444344444444444444444
Q ss_pred cccCCCCCCccccCCccCceeeCCCCC-CCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCC
Q 035895 197 GNKLSGSIPTCFGNLTALRNLHLDSNE-LTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNL 271 (527)
Q Consensus 197 ~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l 271 (527)
+|++++..|..++.+++|++|++++|. ++.+| .+..+++|+.|++++|.+.+. + .+..+++|++|++++|++
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 444444444444444444444444444 44443 344444444444444444331 1 344444444444444444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=170.58 Aligned_cols=101 Identities=12% Similarity=0.049 Sum_probs=60.9
Q ss_pred CCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCC-EEEcccccceeecCCCCCCCCCCCEE
Q 035895 234 LKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQ-FLSLGHNRLQGSIPNSFDDLVSLESL 312 (527)
Q Consensus 234 l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L 312 (527)
+++|+.+++++|.+....+..|.++++|+.++|++| +..+.+.+|.++.+|+ .+++.+ +++...+..|.++++|+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 344444444444444444455666666666666665 5545555666666666 666666 5555556666666666666
Q ss_pred eCCCCcccccCccchhhhccCCee
Q 035895 313 DLSNNNLSEIIPLSLEKLLYLNIL 336 (527)
Q Consensus 313 ~ls~N~l~~~~p~~~~~l~~L~~L 336 (527)
++++|.++.+.+..|.++..|+.+
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEE
T ss_pred EeCCCccCccchhhhcCCcchhhh
Confidence 666666666666666666666654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.5e-18 Score=167.06 Aligned_cols=238 Identities=17% Similarity=0.120 Sum_probs=127.1
Q ss_pred CCCCCEEEcccCCCC--cccChhHhhccccccEEEcccCccccccchhhcC--------CcCCcEEEeecCcccccCccc
Q 035895 90 CKYLKKLDISRNPLD--GFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGN--------LTDLISIDLGGNKLNGSISIT 159 (527)
Q Consensus 90 l~~L~~L~Ls~N~l~--~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~--------l~~L~~L~L~~N~l~~~~~~~ 159 (527)
+++|++|||++|++. ...+..+ +.++.+.+..|. +.+.+|.+ +++|++|+|.+ .++.+.+.+
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~----~~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~a 119 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY----PNGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAA 119 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS----GGGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTT
T ss_pred hccCeEEecCcceeEEecCccccc----cccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHH
Confidence 677888888888887 2222111 123455555553 34566666 88888888887 777777777
Q ss_pred ccCCCCCCEEeccCcccccccChhhhcCcccCeeeeeccc----CCCCCCccccCCccCc-eeeCCCCCCCCCchhhh--
Q 035895 160 LGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK----LSGSIPTCFGNLTALR-NLHLDSNELTSIPSILW-- 232 (527)
Q Consensus 160 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~----l~~~~p~~~~~l~~L~-~L~L~~N~l~~lp~~~~-- 232 (527)
|.++++|+.+++++|.+....+.+|.++..+..+.+..+. .....+.+|.++..|+ .+.+.. ...+|..++
T Consensus 120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~--~~~l~~~~~~~ 197 (329)
T 3sb4_A 120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGA--MGKLEDEIMKA 197 (329)
T ss_dssp TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECT--TCCHHHHHHHT
T ss_pred hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecC--CCcHHHHHhhc
Confidence 8888888888888887776667777777666666555421 1222333444444433 222221 112222221
Q ss_pred --CCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCC
Q 035895 233 --NLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLE 310 (527)
Q Consensus 233 --~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 310 (527)
...++..+.+.++-...........+++|+.++|++|++....+.+|.++.+|+.+++.+| ++...+..|.++++|+
T Consensus 198 ~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~ 276 (329)
T 3sb4_A 198 GLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA 276 (329)
T ss_dssp TCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred ccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence 1223333333222110000000012455555666555555444455555555666665555 5445555555555565
Q ss_pred -EEeCCCCcccccCccchhhhccCCeeEee
Q 035895 311 -SLDLSNNNLSEIIPLSLEKLLYLNILLIV 339 (527)
Q Consensus 311 -~L~ls~N~l~~~~p~~~~~l~~L~~L~~~ 339 (527)
.+++.+ .++.+.+..|..+..|+.+.+.
T Consensus 277 ~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~ 305 (329)
T 3sb4_A 277 GTLELPA-SVTAIEFGAFMGCDNLRYVLAT 305 (329)
T ss_dssp EEEEECT-TCCEECTTTTTTCTTEEEEEEC
T ss_pred EEEEEcc-cceEEchhhhhCCccCCEEEeC
Confidence 555555 4555555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=6.8e-18 Score=154.11 Aligned_cols=129 Identities=23% Similarity=0.349 Sum_probs=91.8
Q ss_pred CEEEcccCCCCcccChhHhhccccccEEEcccCccccccch-hhcCCcCCcEEEeecCcccccCcccccCCCCCCEEecc
Q 035895 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISE-EIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172 (527)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 172 (527)
+.+++++|.++. +|..+ ..+++.|++++|.+++..+. .|..+++|++|+|++|++++..|..|..+++|+.|+++
T Consensus 11 ~~l~~s~~~l~~-ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCSS-CCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcCc-CccCC---CCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 556666666654 34322 22566666666666655553 36777777777777777777777777777777777777
Q ss_pred CcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC
Q 035895 173 GNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS 226 (527)
Q Consensus 173 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 226 (527)
+|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|++++|.++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 777777777777777788888888888877777778888888888888888775
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=4.6e-17 Score=148.59 Aligned_cols=131 Identities=26% Similarity=0.340 Sum_probs=97.1
Q ss_pred CeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchh--hhCCCCccEEEccCCcccccCCccccCCCCCCEEEccC
Q 035895 191 FQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI--LWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSR 268 (527)
Q Consensus 191 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~--~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~ 268 (527)
+.+++++|.++ .+|..+.. +|++|++++|+++.++.. +..+++|++|++++|.+.+..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 44555555554 23333322 555666666666555432 45556666666666666666677888899999999999
Q ss_pred CCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCc
Q 035895 269 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 269 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|++++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998888889999999999999999999999999999999999999999987644
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=148.23 Aligned_cols=135 Identities=22% Similarity=0.318 Sum_probs=69.3
Q ss_pred CCCCEEEcccCCCC-cccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEE
Q 035895 91 KYLKKLDISRNPLD-GFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFL 169 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~-~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 169 (527)
++|++|++++|.++ +.+|..+..+. +|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|+.|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~-~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFV-NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGG-GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCC-CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 45556666666555 33444444332 455555555555543 445555555555555555554444444445555555
Q ss_pred eccCccccccc-ChhhhcCcccCeeeeecccCCCCCC---ccccCCccCceeeCCCCCCCCCc
Q 035895 170 SFRGNELEGSI-PNVLCHLAVLFQLDLRGNKLSGSIP---TCFGNLTALRNLHLDSNELTSIP 228 (527)
Q Consensus 170 ~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~lp 228 (527)
++++|.+++.. +..+..+++|+.|++++|.+++..+ ..|..+++|++|++++|.+.++|
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 55555554321 1445555555555555555554333 34555555555555555555544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-16 Score=142.86 Aligned_cols=133 Identities=23% Similarity=0.272 Sum_probs=78.9
Q ss_pred cCCcEEEeecCccc-ccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceee
Q 035895 140 TDLISIDLGGNKLN-GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLH 218 (527)
Q Consensus 140 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 218 (527)
++|++|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45666666666665 34455555566666666666665543 4455555555566665555554555555555555555
Q ss_pred CCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh---hhhhcCCCCCEEEcccccc
Q 035895 219 LDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP---TTIQGLKSLQFLSLGHNRL 295 (527)
Q Consensus 219 L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l 295 (527)
+++|+++.+|. +..+..+++|++|++++|.+++..+ ..|..+++|++|++++|.+
T Consensus 102 Ls~N~l~~~~~----------------------~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 102 LSGNKLKDIST----------------------LEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CBSSSCCSSGG----------------------GGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred ccCCccCcchh----------------------HHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 55555555431 1345566667777777777765444 4667777777777777776
Q ss_pred e
Q 035895 296 Q 296 (527)
Q Consensus 296 ~ 296 (527)
.
T Consensus 160 ~ 160 (168)
T 2ell_A 160 Q 160 (168)
T ss_dssp C
T ss_pred h
Confidence 5
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.2e-16 Score=144.07 Aligned_cols=128 Identities=28% Similarity=0.334 Sum_probs=101.4
Q ss_pred CeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCC
Q 035895 191 FQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270 (527)
Q Consensus 191 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~ 270 (527)
+.+++++|.++. +|..+. ++|++|++++|+++.+|..+.++++|+.|++++|.+.+..+..|..+++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 456666666653 333332 46677777777777777666677777777777777776677788899999999999999
Q ss_pred CCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccc
Q 035895 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 271 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 321 (527)
+++..|..|.++++|++|+|++|+++...+..|..+++|+.|++++|++..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 998888899999999999999999997777789999999999999999865
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.1e-17 Score=157.04 Aligned_cols=113 Identities=23% Similarity=0.288 Sum_probs=88.3
Q ss_pred ccccceeccCCceEEEEEEc-cCCcE--EEEEEEeecc-------------------------------C----------
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGME--FAIKVFHFSC-------------------------------S---------- 422 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~--vavK~~~~~~-------------------------------~---------- 422 (527)
|++.+.||+|+||.||+|.. .+|+. ||||+++... .
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67789999999999999998 78888 9999853210 0
Q ss_pred c----------cceeEEEEEeccC-C----cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 035895 423 N----------EDFRALVLEYTTN-G----SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNK 487 (527)
Q Consensus 423 ~----------~~~~~lv~ey~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~ni 487 (527)
+ .+..++||||+.+ | +|.++... .++.....++.|++.|++|+|. +.+||||||||+||
T Consensus 129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHE
Confidence 0 0123599999953 4 78776532 1233456789999999999993 56899999999999
Q ss_pred eeCCCCcEEEeecccccccC
Q 035895 488 LLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 488 ll~~~~~~kl~Dfg~a~~~~ 507 (527)
|+++ .++|+|||+|....
T Consensus 203 Ll~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp EESS--SEEECCCTTCEETT
T ss_pred EEcC--cEEEEECcccccCC
Confidence 9998 99999999998764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-15 Score=153.84 Aligned_cols=258 Identities=11% Similarity=0.055 Sum_probs=141.8
Q ss_pred hhcchhcccCCCceeecCchhhhcCCCCCEEEccccccccccccccceEEcccccccCCCCCCcccccCCCCCCCCEEEc
Q 035895 19 VCYRICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDI 98 (527)
Q Consensus 19 ~~~~~~~~~s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L 98 (527)
.|..+..+.=-|.++.+.+.+|.+. +|+.+++..| ++.+... +|.++ +|+.+++
T Consensus 111 ~~~~l~~i~ip~~i~~I~~~aF~~~-~L~~i~l~~~-------------------i~~I~~~-----aF~~~-~L~~i~l 164 (401)
T 4fdw_A 111 ILKGYNEIILPNSVKSIPKDAFRNS-QIAKVVLNEG-------------------LKSIGDM-----AFFNS-TVQEIVF 164 (401)
T ss_dssp ECSSCSEEECCTTCCEECTTTTTTC-CCSEEECCTT-------------------CCEECTT-----TTTTC-CCCEEEC
T ss_pred ecCCccEEEECCccCEehHhhcccC-CccEEEeCCC-------------------ccEECHH-----hcCCC-CceEEEe
Confidence 3333444443445556666666653 5666665544 2222221 34443 4666666
Q ss_pred ccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCccccc
Q 035895 99 SRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG 178 (527)
Q Consensus 99 s~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 178 (527)
.. .++.+.+..|.++. +|+.+++++|.++.+...+|. ..+|+.+.+..+ ++.+...+|.++++|+.+++..| ++.
T Consensus 165 p~-~l~~I~~~aF~~c~-~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~ 239 (401)
T 4fdw_A 165 PS-TLEQLKEDIFYYCY-NLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VST 239 (401)
T ss_dssp CT-TCCEECSSTTTTCT-TCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCE
T ss_pred CC-CccEehHHHhhCcc-cCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccC
Confidence 54 45544445555443 566666666666655555555 356666666533 55555666666666666666654 443
Q ss_pred ccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCC
Q 035895 179 SIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNL 258 (527)
Q Consensus 179 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l 258 (527)
.-..+|.+ .+|+.+.+. +.++.+.+.+|.++++|+.+++.+|.+..- ......+..|.++
T Consensus 240 I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~------------------~~~~I~~~aF~~c 299 (401)
T 4fdw_A 240 IGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDD------------------PEAMIHPYCLEGC 299 (401)
T ss_dssp ECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCC------------------TTCEECTTTTTTC
T ss_pred cccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCC------------------cccEECHHHhhCC
Confidence 44555666 567777773 445555666777777777777766665411 0111223445555
Q ss_pred CCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhh
Q 035895 259 KVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 330 (527)
Q Consensus 259 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 330 (527)
++|+.++|. +.+......+|.++.+|+.+.+..| ++...+..|.++ +|+.+++++|.+..+.+..|..+
T Consensus 300 ~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~ 368 (401)
T 4fdw_A 300 PKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGF 368 (401)
T ss_dssp TTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCS
T ss_pred ccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCC
Confidence 566666665 3344444455666666666666433 444555566666 66666666666655555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=138.42 Aligned_cols=128 Identities=21% Similarity=0.277 Sum_probs=65.4
Q ss_pred cCCcEEEeecCccc-ccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceee
Q 035895 140 TDLISIDLGGNKLN-GSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLH 218 (527)
Q Consensus 140 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 218 (527)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555554 34444445555555555555555433 3444444455555555544444444444444444444
Q ss_pred CCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh---hhhhcCCCCCEEEcc
Q 035895 219 LDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP---TTIQGLKSLQFLSLG 291 (527)
Q Consensus 219 L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~ 291 (527)
+++|+++++| .+..++.+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 95 ls~N~i~~~~----------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLS----------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHH----------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChH----------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 4444444432 12345555666666666666655444 356666666666654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=139.72 Aligned_cols=126 Identities=21% Similarity=0.289 Sum_probs=110.5
Q ss_pred ccccEEEcccCccc-cccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeee
Q 035895 116 QSLEFIWMSDCNIS-GGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLD 194 (527)
Q Consensus 116 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 194 (527)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|+.|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57999999999998 67888889999999999999999976 7789999999999999999987898898999999999
Q ss_pred eecccCCCC-CCccccCCccCceeeCCCCCCCCCch----hhhCCCCccEEEcc
Q 035895 195 LRGNKLSGS-IPTCFGNLTALRNLHLDSNELTSIPS----ILWNLKDILYLDFW 243 (527)
Q Consensus 195 L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~lp~----~~~~l~~L~~l~l~ 243 (527)
+++|++++. .+..+..+++|++|++++|.++++|. .+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 999999974 34789999999999999999998775 45556666666543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-15 Score=152.83 Aligned_cols=242 Identities=9% Similarity=0.021 Sum_probs=188.7
Q ss_pred CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCE
Q 035895 89 NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQF 168 (527)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 168 (527)
.+..++.+.+.. .++.+....|.+. +|+.+.+..+ ++.+...+|.+. +|+.+.+.. .++.+.+.+|.++++|+.
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~--~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS--QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC--CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred ecCCccEEEECC-ccCEehHhhcccC--CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCe
Confidence 346677777764 4665555666652 5888888766 666777778774 688888875 676677778888888888
Q ss_pred EeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCccc
Q 035895 169 LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFV 248 (527)
Q Consensus 169 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~ 248 (527)
++++.|.++......|. ..+|+.+.+..+ ++.+...+|.++++|+.+++..| ++.++...+.-..|+.+.+ .+.+.
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~~~L~~i~l-p~~i~ 260 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRESGITTVKL-PNGVT 260 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTTCCCSEEEE-ETTCC
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccccccccCCccEEEe-CCCcc
Confidence 88888888866666666 578888888754 77677788888889999998874 6777665444478888888 45566
Q ss_pred ccCCccccCCCCCCEEEccCCCCC-----CCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccC
Q 035895 249 GPLPSKIGNLKVLTRIDFSRNNLL-----GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 323 (527)
Q Consensus 249 ~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 323 (527)
..-+.+|.++++|+.+++.+|.+. ...+.+|.++++|+.+.+. +.++......|.++++|+.+.+..| ++.+.
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 666788999999999999988765 3567789999999999999 5588788899999999999999655 88888
Q ss_pred ccchhhhccCCeeEeeeeee
Q 035895 324 PLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 324 p~~~~~l~~L~~L~~~~~~~ 343 (527)
+..|..+ .|+.+.+..+..
T Consensus 339 ~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 339 FSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp TTSSSSS-CCCEEEECCSSC
T ss_pred HHhCCCC-CCCEEEEcCCCC
Confidence 8999999 999998876543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.5e-16 Score=142.07 Aligned_cols=128 Identities=23% Similarity=0.337 Sum_probs=89.8
Q ss_pred CEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccC
Q 035895 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRG 173 (527)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 173 (527)
+.+++++|.++. +|..+ ..+|+.|+|++|.|+ .+|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 13 ~~l~~~~~~l~~-ip~~~---~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGI---PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCSS-CCSCC---CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCCc-CCCCC---CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 456666666664 33322 235677777777776 4456677777777777777777776666777777777777777
Q ss_pred cccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCC
Q 035895 174 NELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS 226 (527)
Q Consensus 174 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 226 (527)
|++++..|..|..+++|+.|+|++|+|+...+..|..+++|+.|++++|.+..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 77776666677777777777777777776666677777778888887777653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.9e-16 Score=138.36 Aligned_cols=133 Identities=21% Similarity=0.241 Sum_probs=100.8
Q ss_pred CCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEecc
Q 035895 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172 (527)
Q Consensus 93 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 172 (527)
.+.+++++|+++.+ |..+ ..+|+.|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|+.|+++
T Consensus 9 ~~~l~~~~~~l~~~-p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLTSV-PTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCSSC-CTTC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCccC-CCCC---CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 45667777777653 3322 2367777777777776666677778888888888888887766677888888888888
Q ss_pred CcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch
Q 035895 173 GNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS 229 (527)
Q Consensus 173 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~ 229 (527)
+|++++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|.++..++
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 888887666677888888888888888887777777888888888888888876443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=3e-15 Score=134.56 Aligned_cols=133 Identities=26% Similarity=0.301 Sum_probs=94.8
Q ss_pred CCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCC
Q 035895 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN 245 (527)
Q Consensus 166 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n 245 (527)
.+.+++++|+++ .+|..+ .++|+.|++++|++++..+..|..+++|++|++++|+++.+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------ 67 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL------------------ 67 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC------------------
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEe------------------
Confidence 345566666655 233222 24556666666666555555555556666666666555544
Q ss_pred cccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCc
Q 035895 246 LFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 246 ~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
.+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++.+..|
T Consensus 68 -----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 68 -----PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp -----CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred -----ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 34556778889999999999988777788999999999999999997777778889999999999999987654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.8e-18 Score=156.64 Aligned_cols=138 Identities=22% Similarity=0.247 Sum_probs=70.7
Q ss_pred hcCCcCCcEEEeecCcccccCcc------cccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCcccc
Q 035895 136 IGNLTDLISIDLGGNKLNGSISI------TLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFG 209 (527)
Q Consensus 136 ~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 209 (527)
+.....++.++++.+.+++..|. .+..+++|+.|++++|.+++ +| .+..+++|+.|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34445566666666666555443 45555555555555555553 34 4555555555555555555 3344444
Q ss_pred CCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh-hhhhcCCCCCEE
Q 035895 210 NLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP-TTIQGLKSLQFL 288 (527)
Q Consensus 210 ~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 288 (527)
.+++|++|++++|+++++| . +..+++|++|++++|++.+..+ ..+..+++|++|
T Consensus 91 ~~~~L~~L~L~~N~l~~l~-~------------------------~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 91 VADTLEELWISYNQIASLS-G------------------------IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp HHHHCSEEEEEEEECCCHH-H------------------------HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred cCCcCCEEECcCCcCCcCC-c------------------------cccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence 4455555555555555443 2 3334445555555555543221 245555555555
Q ss_pred EcccccceeecCC
Q 035895 289 SLGHNRLQGSIPN 301 (527)
Q Consensus 289 ~L~~N~l~~~~p~ 301 (527)
++++|++.+..|.
T Consensus 146 ~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 146 LLAGNPLYNDYKE 158 (198)
T ss_dssp EECSCHHHHHHHT
T ss_pred EecCCcccccccc
Confidence 5555555544433
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.61 E-value=4.2e-16 Score=140.05 Aligned_cols=135 Identities=18% Similarity=0.151 Sum_probs=90.7
Q ss_pred cCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCC
Q 035895 86 SMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQK 165 (527)
Q Consensus 86 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 165 (527)
.+.++++|++|++++|+++.+ |. +....++|+.|++++|.+++. ..+..+++|++|++++|++++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 356677888888888888854 43 344444677888888877754 56677777777777777777655555567777
Q ss_pred CCEEeccCcccccccCh--hhhcCcccCeeeeecccCCCCCCc----cccCCccCceeeCCCCCCCC
Q 035895 166 LQFLSFRGNELEGSIPN--VLCHLAVLFQLDLRGNKLSGSIPT----CFGNLTALRNLHLDSNELTS 226 (527)
Q Consensus 166 L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~ 226 (527)
|+.|++++|.++ .+|. .+..+++|+.|++++|.++. .|. .+..+++|+.|++++|.+.+
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 777777777775 3444 56667777777777777763 333 36666677777776666544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-16 Score=157.43 Aligned_cols=111 Identities=14% Similarity=0.204 Sum_probs=87.7
Q ss_pred CccccceeccCCceEEEEEEccCCcEEEEEEEeeccC-------------------------------------------
Q 035895 386 GFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCS------------------------------------------- 422 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~------------------------------------------- 422 (527)
-|++.+.||+|+||.||+|..++|+.||||+++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3899999999999999999999999999998642100
Q ss_pred cc------ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---
Q 035895 423 NE------DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI--- 493 (527)
Q Consensus 423 ~~------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~--- 493 (527)
.. ...++||||++|++|.++.. .+ ....++.|++.++.|+| +.+||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-----~~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-----VP--DPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC-----CS--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc-----cH--HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCcc
Confidence 00 01249999999998865431 11 23457899999999999 89999999999999998776
Q ss_pred -------cEEEeeccccccc
Q 035895 494 -------VAHLSDFGIAKLL 506 (527)
Q Consensus 494 -------~~kl~Dfg~a~~~ 506 (527)
.+.|+||+=+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3889999976543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=8.9e-16 Score=137.91 Aligned_cols=133 Identities=22% Similarity=0.237 Sum_probs=67.4
Q ss_pred cCCcCCcEEEeecCcccccCcccccCCC-CCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCc
Q 035895 137 GNLTDLISIDLGGNKLNGSISITLGKLQ-KLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALR 215 (527)
Q Consensus 137 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 215 (527)
.++.+|++|++++|+++.. +. +..+. +|+.|++++|.+++. ..|..+++|++|++++|+|++..|..|..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 3445555555555555532 22 22222 555555555555533 3455555555555555555544444445555555
Q ss_pred eeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChh----hhhcCCCCCEEEcc
Q 035895 216 NLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT----TIQGLKSLQFLSLG 291 (527)
Q Consensus 216 ~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~ 291 (527)
+|++++|+++.+|.. ..+..+++|++|++++|.+.. +|. .+..+++|++|+++
T Consensus 92 ~L~L~~N~i~~~~~~----------------------~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~ 148 (176)
T 1a9n_A 92 ELILTNNSLVELGDL----------------------DPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQ 148 (176)
T ss_dssp EEECCSCCCCCGGGG----------------------GGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTE
T ss_pred EEECCCCcCCcchhh----------------------HhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCC
Confidence 666655555555430 123444555555555555542 333 25556666666666
Q ss_pred cccce
Q 035895 292 HNRLQ 296 (527)
Q Consensus 292 ~N~l~ 296 (527)
+|.+.
T Consensus 149 ~n~~~ 153 (176)
T 1a9n_A 149 KVKLK 153 (176)
T ss_dssp ECCHH
T ss_pred cCCHH
Confidence 65543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-17 Score=152.71 Aligned_cols=129 Identities=22% Similarity=0.252 Sum_probs=107.1
Q ss_pred ccccEEEcccCccccccch------hhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcc
Q 035895 116 QSLEFIWMSDCNISGGISE------EIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAV 189 (527)
Q Consensus 116 ~~L~~L~Ls~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 189 (527)
..++.++++.+.+++..|. .+..+++|++|++++|++++ +| .+..+++|+.|++++|.++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3688888888888887776 89999999999999999997 55 8899999999999999998 67888888999
Q ss_pred cCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch--hhhCCCCccEEEccCCcccc
Q 035895 190 LFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS--ILWNLKDILYLDFWSNLFVG 249 (527)
Q Consensus 190 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~l~l~~n~~~~ 249 (527)
|+.|++++|++++ +| .+..+++|++|++++|+++.+|. .+..+++|++|++++|.+.+
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 9999999999997 44 68999999999999999998764 44445555555554444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=2.6e-14 Score=127.55 Aligned_cols=109 Identities=26% Similarity=0.274 Sum_probs=90.7
Q ss_pred CceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccc
Q 035895 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHN 293 (527)
Q Consensus 214 L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 293 (527)
.+++++++|.++.+|..+. +.+++|++++|.+.+..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 4566777777777765542 56677777777777777788899999999999999999888888999999999999999
Q ss_pred cceeecCCCCCCCCCCCEEeCCCCcccccCc
Q 035895 294 RLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 294 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
++++..+..|..+++|+.|+|++|+++...+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9998777889999999999999999976543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.2e-14 Score=125.49 Aligned_cols=107 Identities=24% Similarity=0.228 Sum_probs=88.0
Q ss_pred ceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccccc
Q 035895 215 RNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR 294 (527)
Q Consensus 215 ~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 294 (527)
+.+++++|+++.+|..+. +.|+.|++++|.+.+..|..|..+++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 566667777766666443 566777777777777777888899999999999999998777778999999999999999
Q ss_pred ceeecCCCCCCCCCCCEEeCCCCcccccC
Q 035895 295 LQGSIPNSFDDLVSLESLDLSNNNLSEII 323 (527)
Q Consensus 295 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 323 (527)
|++..+..|..+++|+.|+|++|++....
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred cceeCHHHhccccCCCEEEeCCCCccccc
Confidence 99777777999999999999999997643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=5.6e-14 Score=125.33 Aligned_cols=108 Identities=22% Similarity=0.194 Sum_probs=69.4
Q ss_pred ccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec
Q 035895 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 197 (527)
.+.+++++|.++. +|..+ .++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4455555555553 22222 24566666666666666666666666777777777777655555666777777777777
Q ss_pred ccCCCCCCccccCCccCceeeCCCCCCCCCc
Q 035895 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIP 228 (527)
Q Consensus 198 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp 228 (527)
|+|++..+..|..+++|++|+|++|.++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 7777666666777777777777777776544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.3e-14 Score=125.05 Aligned_cols=108 Identities=25% Similarity=0.273 Sum_probs=67.4
Q ss_pred cEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecc
Q 035895 119 EFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198 (527)
Q Consensus 119 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 198 (527)
+.+++++|.++. +|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 445555555542 232222 45666666666666555666666666666666666666555555666777777777777
Q ss_pred cCCCCCCccccCCccCceeeCCCCCCCCCch
Q 035895 199 KLSGSIPTCFGNLTALRNLHLDSNELTSIPS 229 (527)
Q Consensus 199 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~ 229 (527)
+|++..+..|..+++|++|+|++|.+...+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 7776666667777777777777777776554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-14 Score=145.51 Aligned_cols=85 Identities=19% Similarity=0.215 Sum_probs=38.5
Q ss_pred ccCceeeCCCCCCCC-----CchhhhCCCCccEEEccCCcccc----cCCccccCCCCCCEEEccCCCCCCC----Chhh
Q 035895 212 TALRNLHLDSNELTS-----IPSILWNLKDILYLDFWSNLFVG----PLPSKIGNLKVLTRIDFSRNNLLGD----IPTT 278 (527)
Q Consensus 212 ~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~l~l~~n~~~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 278 (527)
++|++|+|++|.|+. ++..+...++|++|++++|.+.. .++..+...+.|++|+|++|.++.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 445555555555543 12222333334444444433321 1123334445566666666665432 2223
Q ss_pred hhcCCCCCEEEcccccce
Q 035895 279 IQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 279 ~~~l~~L~~L~L~~N~l~ 296 (527)
+...++|++|+|++|.|+
T Consensus 235 L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 235 AREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHCSSCCEEECTTSSCC
T ss_pred HHhCCCCCEEeccCCCCC
Confidence 344455556666555554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.6e-11 Score=122.18 Aligned_cols=290 Identities=13% Similarity=0.093 Sum_probs=167.8
Q ss_pred ceeecCchhhhcCCCCCEEEccccccccccc------cccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCC
Q 035895 31 KLVGIVSITIFNLSTLKVFDVDNNYVLGRLS------SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLD 104 (527)
Q Consensus 31 ~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~------~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 104 (527)
.++.+...+|.++++|+.+.+..+ +...-. ..|+.++|..+ ++.+... +|.++++|+.+.+..+ +.
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~-----aF~~c~~L~~i~~p~~-l~ 129 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRC-----TFSGCYALKSILLPLM-LK 129 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT-----TTTTCTTCCCCCCCTT-CC
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccch-----hhcccccchhhcccCc-ee
Confidence 577788888888888888888754 221111 23666777644 4444332 4677777777666543 33
Q ss_pred cccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhh
Q 035895 105 GFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVL 184 (527)
Q Consensus 105 ~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 184 (527)
.+....|.... +...... ..+..+...+|.++.+|+.+.+..+. ..+....|.++.+|+.+.+..| ++......|
T Consensus 130 ~i~~~aF~~~~--~~~~~~~-~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F 204 (394)
T 4fs7_A 130 SIGVEAFKGCD--FKEITIP-EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCF 204 (394)
T ss_dssp EECTTTTTTCC--CSEEECC-TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTT
T ss_pred eecceeeeccc--ccccccC-ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhh
Confidence 33333343321 2222211 12222334566666667777665443 3345556666666666666554 333344455
Q ss_pred hcCcccCeeeeecccC---------------------CCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEcc
Q 035895 185 CHLAVLFQLDLRGNKL---------------------SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFW 243 (527)
Q Consensus 185 ~~l~~L~~L~L~~N~l---------------------~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~ 243 (527)
.++..|+.+.+..+.. +.....+|.++..|+.+.+..+...--...+.....+..+...
T Consensus 205 ~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~ 284 (394)
T 4fs7_A 205 AECILLENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYG 284 (394)
T ss_dssp TTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEEC
T ss_pred ccccccceeecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccC
Confidence 5655555555544322 2222334555555555555544322112234444555555444
Q ss_pred CCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccC
Q 035895 244 SNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 323 (527)
Q Consensus 244 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 323 (527)
.+.+ ....|..+.+|+.+.+..+ +...-..+|.++.+|+.+++..+ ++.....+|.++.+|+.+++..| ++.+.
T Consensus 285 ~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~ 358 (394)
T 4fs7_A 285 SVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIG 358 (394)
T ss_dssp SSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred ceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEeh
Confidence 3322 2345667778888888654 55455667888888888888654 66666778888888888888766 77777
Q ss_pred ccchhhhccCCeeEee
Q 035895 324 PLSLEKLLYLNILLIV 339 (527)
Q Consensus 324 p~~~~~l~~L~~L~~~ 339 (527)
...|.++..|+.+.+.
T Consensus 359 ~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 359 ANAFQGCINLKKVELP 374 (394)
T ss_dssp TTTBTTCTTCCEEEEE
T ss_pred HHHhhCCCCCCEEEEC
Confidence 7788888888877654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-13 Score=138.56 Aligned_cols=187 Identities=13% Similarity=0.140 Sum_probs=89.7
Q ss_pred CCCCEEEcccCCCCcccChhHhhc----cccccEEEcccCccccccchhh-cCCcCCcEEEeecCcccccCcccc-----
Q 035895 91 KYLKKLDISRNPLDGFLPRVVGNF----SQSLEFIWMSDCNISGGISEEI-GNLTDLISIDLGGNKLNGSISITL----- 160 (527)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~~~----~~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~----- 160 (527)
+.|+.|+|++|.++......+... ..+|+.|+|++|.++......+ ..+++|++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 446666666666654332333222 1246666666666543222222 234456666666666653322222
Q ss_pred cCCCCCCEEeccCccccc----ccChhhhcCcccCeeeeecccCCCC----CCccccCCccCceeeCCCCCCCCCchhhh
Q 035895 161 GKLQKLQFLSFRGNELEG----SIPNVLCHLAVLFQLDLRGNKLSGS----IPTCFGNLTALRNLHLDSNELTSIPSILW 232 (527)
Q Consensus 161 ~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~lp~~~~ 232 (527)
...++|+.|+|++|.++. .++..+...++|++|+|++|.|+.. ++..+...++|++|+|++|.|+....
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~--- 228 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA--- 228 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHH---
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHH---
Confidence 134556666666666543 1233334455566666666655431 12334445556666666665543211
Q ss_pred CCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCC-----CCEEE--cccccce
Q 035895 233 NLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKS-----LQFLS--LGHNRLQ 296 (527)
Q Consensus 233 ~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-----L~~L~--L~~N~l~ 296 (527)
..++..+...+.|++|+|++|.++..-...+..+.. |+.+. +..|.+.
T Consensus 229 ----------------~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 229 ----------------LALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp ----------------HHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred ----------------HHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 012233344566777777777776544444444321 55555 5555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.5e-12 Score=127.31 Aligned_cols=102 Identities=21% Similarity=0.243 Sum_probs=56.7
Q ss_pred eeeecc-cCCCCCCccccCCccCceeeCCC-CCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCC
Q 035895 193 LDLRGN-KLSGSIPTCFGNLTALRNLHLDS-NELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNN 270 (527)
Q Consensus 193 L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~ 270 (527)
++++++ ++++ +|. +..+++|+.|+|++ |+|+.+| +..|+.+++|++|+|++|+
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~-----------------------~~~~~~l~~L~~L~l~~N~ 67 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLE-----------------------LRDLRGLGELRNLTIVKSG 67 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEEC-----------------------GGGSCSCCCCSEEECCSSC
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcC-----------------------hhHhccccCCCEEECCCCc
Confidence 455555 5553 344 55555555555553 5555544 4445555556666666666
Q ss_pred CCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc
Q 035895 271 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 271 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 320 (527)
+++..|..|.++++|++|+|++|+|++..+..|..++ |+.|+|++|.+.
T Consensus 68 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred cceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 6555555556666666666666666554444454444 666666666554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.5e-12 Score=127.32 Aligned_cols=105 Identities=18% Similarity=0.161 Sum_probs=78.9
Q ss_pred EEEcccC-ccccccchhhcCCcCCcEEEeec-CcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec
Q 035895 120 FIWMSDC-NISGGISEEIGNLTDLISIDLGG-NKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197 (527)
Q Consensus 120 ~L~Ls~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 197 (527)
.++++++ +++. +|. +..+++|++|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3466666 6664 444 77777788888875 788777777788888888888888888877777788888888888888
Q ss_pred ccCCCCCCccccCCccCceeeCCCCCCCCC
Q 035895 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSI 227 (527)
Q Consensus 198 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l 227 (527)
|+|++.++..|..++ |+.|+|++|.+...
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 888877766776665 88888888887753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.4e-10 Score=117.88 Aligned_cols=298 Identities=12% Similarity=0.125 Sum_probs=201.9
Q ss_pred hcchhcccCCCceeecCchhhhcCCCCCEEEccccccccccc-------cccceEEcccccccCCC--------------
Q 035895 20 CYRICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS-------SIVDELSLSDNYLTSST-------------- 78 (527)
Q Consensus 20 ~~~~~~~~s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~-------~~l~~L~Ls~N~l~~~~-------------- 78 (527)
|..+..+.=.+.++.+...+|.++++|+.+++..+- . .+. ..++.+.+..+ ++.+.
T Consensus 70 c~~L~~i~lp~~i~~I~~~aF~~c~~L~~i~lp~~l-~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~ 146 (394)
T 4fs7_A 70 CRKVTEIKIPSTVREIGEFAFENCSKLEIINIPDSV-K-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITI 146 (394)
T ss_dssp CTTEEEEECCTTCCEECTTTTTTCTTCCEECCCTTC-C-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEEC
T ss_pred CCCceEEEeCCCccCcchhHhhCCCCCcEEEeCCCc-e-EccchhhcccccchhhcccCc-eeeecceeeeccccccccc
Confidence 667777764466889999999999999999997662 1 111 01222222211 11100
Q ss_pred -CCCc--ccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCccccc
Q 035895 79 -PELS--FLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS 155 (527)
Q Consensus 79 -~~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 155 (527)
.... -..+|.+|++|+.+.+..+ +..+....|.... +|+.+.+..+ ++.+...+|.++..|+.+.+..+...
T Consensus 147 ~~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~-~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-- 221 (394)
T 4fs7_A 147 PEGVTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCG-KLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-- 221 (394)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT-TCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--
T ss_pred CccccccchhhhcccCCCcEEecCCc-cceeccccccCCC-CceEEEcCCC-ceEeCchhhccccccceeecCCCceE--
Confidence 0000 0135777888888888755 3334445555543 6888877766 55566777788888888877766543
Q ss_pred CcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCC
Q 035895 156 ISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLK 235 (527)
Q Consensus 156 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~ 235 (527)
....+....+|+.+.+..+ ++..-...|.++..|+.+.+..+... ....+|..+..++.+....+.+.. ..+..+.
T Consensus 222 i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~ 297 (394)
T 4fs7_A 222 LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCS 297 (394)
T ss_dssp ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT--TTTTTCT
T ss_pred eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc--ccccccc
Confidence 2223334567777777543 33344567888999999999887554 677889999999999887765322 3456778
Q ss_pred CccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCC
Q 035895 236 DILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315 (527)
Q Consensus 236 ~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 315 (527)
+|..+.+..+ +...-..+|.++.+|+.++|.. .+...-..+|.++.+|+.+.+..| ++.....+|.++++|+.+++.
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~-~v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPY-LVEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCC-cccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 8999888654 5555667899999999999975 466566789999999999999877 776778899999999999997
Q ss_pred CCcccccCccchhhhccCC
Q 035895 316 NNNLSEIIPLSLEKLLYLN 334 (527)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~ 334 (527)
.+ ++. +...|.++..|+
T Consensus 375 ~~-~~~-~~~~F~~c~~L~ 391 (394)
T 4fs7_A 375 KR-LEQ-YRYDFEDTTKFK 391 (394)
T ss_dssp GG-GGG-GGGGBCTTCEEE
T ss_pred CC-CEE-hhheecCCCCCc
Confidence 54 332 345566666554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.07 E-value=3.1e-09 Score=107.79 Aligned_cols=104 Identities=14% Similarity=0.157 Sum_probs=57.4
Q ss_pred hCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCE
Q 035895 232 WNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311 (527)
Q Consensus 232 ~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 311 (527)
.++..|+.+.+..+. ...-...|.+++.|+.+.+. +.+......+|.++.+|+.+.+..+ ++.....+|.++.+|+.
T Consensus 262 ~~c~~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~ 338 (394)
T 4gt6_A 262 DSCAYLASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLER 338 (394)
T ss_dssp TTCSSCCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred eecccccEEeccccc-ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCE
Confidence 344555555553332 22334455666666666664 3344344455666666666666543 44455556666666666
Q ss_pred EeCCCCcccccCccchhhhccCCeeEee
Q 035895 312 LDLSNNNLSEIIPLSLEKLLYLNILLIV 339 (527)
Q Consensus 312 L~ls~N~l~~~~p~~~~~l~~L~~L~~~ 339 (527)
+.+..+ ++.+....|.++..|+.+.+.
T Consensus 339 i~ip~s-v~~I~~~aF~~C~~L~~i~~~ 365 (394)
T 4gt6_A 339 IAIPSS-VTKIPESAFSNCTALNNIEYS 365 (394)
T ss_dssp EEECTT-CCBCCGGGGTTCTTCCEEEES
T ss_pred EEECcc-cCEEhHhHhhCCCCCCEEEEC
Confidence 666433 555555666666666665544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.9e-08 Score=101.93 Aligned_cols=244 Identities=15% Similarity=0.160 Sum_probs=142.5
Q ss_pred cCCCCCCCCEEEcccCC---CCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccC
Q 035895 86 SMSNCKYLKKLDISRNP---LDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGK 162 (527)
Q Consensus 86 ~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 162 (527)
+|.+|++|+.+.++.|. ++.+-...|.... .|+.+.+..+ ++.+...+|..+.+|+.+.+..+ +..+....|..
T Consensus 82 AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~-~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~ 158 (394)
T 4gt6_A 82 AFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCS-ELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSY 158 (394)
T ss_dssp TTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCT-TCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred HhhCCccCceEeecCCCCCeeeEechhhchhcc-cceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceec
Confidence 56777777777776653 5544444454443 4666555443 44455666777777777777543 33355566777
Q ss_pred CCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhC---------
Q 035895 163 LQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWN--------- 233 (527)
Q Consensus 163 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~--------- 233 (527)
+.+|+.+.+..+ ++..-..+|.+ ..|+.+.+..+-. .....+|.++.++.......+....+...+..
T Consensus 159 c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (394)
T 4gt6_A 159 CYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYAL 235 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEE
T ss_pred ccccccccccce-eeEeccccccc-cceeEEEECCccc-ccccchhhhccccceecccccccccccceeecccccccccc
Confidence 777777777654 33233444543 4566666655432 24455666666666666655554433322111
Q ss_pred -----CCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCC
Q 035895 234 -----LKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS 308 (527)
Q Consensus 234 -----l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 308 (527)
...+..+.+. +.+...-..+|..+..|+.+.+..+.. .....+|.++.+|+.+.+. +.++......|.++.+
T Consensus 236 ~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~ 312 (394)
T 4gt6_A 236 IRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCIS 312 (394)
T ss_dssp EECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTT
T ss_pred cccccccccceEEcC-CcceEcccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCC
Confidence 1112222221 222333345677777777777765443 2445667777788877775 4455566677777788
Q ss_pred CCEEeCCCCcccccCccchhhhccCCeeEee
Q 035895 309 LESLDLSNNNLSEIIPLSLEKLLYLNILLIV 339 (527)
Q Consensus 309 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~ 339 (527)
|+.+++..+ ++.+....|..+..|+.+.+.
T Consensus 313 L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 313 LKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 888887654 666666777777777776653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-07 Score=95.46 Aligned_cols=292 Identities=13% Similarity=0.083 Sum_probs=153.3
Q ss_pred cchhcccCCCceeecCchhhhcCCCCCEEEcccccccccccc------ccceEEcccccccCCCCCCcccccCCCCCCCC
Q 035895 21 YRICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSS------IVDELSLSDNYLTSSTPELSFLSSMSNCKYLK 94 (527)
Q Consensus 21 ~~~~~~~s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~------~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~ 94 (527)
..+..+.=...++.+...+|.++.+|+.+++..+ +. .+.. .+..+.+..+ ++.+... +|.++ +|+
T Consensus 46 ~~i~~v~ip~~vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~c~l~~i~~~~~-l~~I~~~-----aF~~~-~L~ 116 (379)
T 4h09_A 46 DRISEVRVNSGITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFADTKLQSYTGMER-VKKFGDY-----VFQGT-DLD 116 (379)
T ss_dssp GGCSEEEECTTEEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTCCCCEEEECTT-CCEECTT-----TTTTC-CCS
T ss_pred cCCEEEEeCCCccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcCCCCceEECCce-eeEeccc-----eeccC-Ccc
Confidence 3444444345688888999999999999999755 22 1111 2334444322 3333222 35444 677
Q ss_pred EEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCccccc------------CcccccC
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS------------ISITLGK 162 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------~~~~~~~ 162 (527)
.+++..+ ++......|... +++.+.+..+ ++.+....|..+.+++.+.+..+..... ....+..
T Consensus 117 ~i~lp~~-~~~i~~~~F~~~--~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (379)
T 4h09_A 117 DFEFPGA-TTEIGNYIFYNS--SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA 192 (379)
T ss_dssp EEECCTT-CCEECTTTTTTC--CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred cccCCCc-cccccccccccc--eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence 7777654 333333334332 4555555433 4445556677777777777665443211 1112233
Q ss_pred CCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch-hhhCCCCccEEE
Q 035895 163 LQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLD 241 (527)
Q Consensus 163 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~l~ 241 (527)
...+..+.+....- ......+.....|+.+.+..+ +......+|.++..|+.+.+..+ ++.+.. .+.++..|..+.
T Consensus 193 ~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~ 269 (379)
T 4h09_A 193 AKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLN 269 (379)
T ss_dssp TCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEE
T ss_pred ccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccc
Confidence 33444444332221 133345555666666665543 33344556666666766666554 444433 334455555555
Q ss_pred ccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccc
Q 035895 242 FWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 242 l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 321 (527)
+..+ +.......|.++++|+.+.+..+.+......+|.++.+|+.+.|..+ ++.....+|.++.+|+.+.+..+ ++.
T Consensus 270 l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~ 346 (379)
T 4h09_A 270 FYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITL 346 (379)
T ss_dssp ECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCE
T ss_pred cccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCE
Confidence 5332 33333445566666666666655555444556666666666666543 44444556666666666666433 444
Q ss_pred cCccchhhhc
Q 035895 322 IIPLSLEKLL 331 (527)
Q Consensus 322 ~~p~~~~~l~ 331 (527)
+-...|.++.
T Consensus 347 I~~~aF~~c~ 356 (379)
T 4h09_A 347 IESGAFEGSS 356 (379)
T ss_dssp ECTTTTTTSS
T ss_pred EchhHhhCCC
Confidence 4444554443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=2.7e-09 Score=101.75 Aligned_cols=119 Identities=14% Similarity=0.090 Sum_probs=89.8
Q ss_pred HhhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec------------------------------cCccceeEE
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------CSNEDFRAL 429 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------~~~~~~~~l 429 (527)
+....++|+.....+.|+++.||++... +..+++|+.... +...+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3455678999999999999999999865 678999997521 112345679
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG------------------------------------- 472 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~------------------------------------- 472 (527)
||||++|.++.+.+.. ......++.+++++++.||..
T Consensus 88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999876321 112346788999999999951
Q ss_pred -------------------CCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 473 -------------------YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 473 -------------------~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
....++|+|++|.||+++++..+.|.||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998766667999998764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.87 E-value=4.2e-10 Score=112.30 Aligned_cols=64 Identities=14% Similarity=0.199 Sum_probs=31.6
Q ss_pred CCCCCEEEccCCCCCCCChhhhh---cCCCCCEEEcccccceee----cCCCCCCCCCCCEEeCCCCcccc
Q 035895 258 LKVLTRIDFSRNNLLGDIPTTIQ---GLKSLQFLSLGHNRLQGS----IPNSFDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 258 l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~ 321 (527)
+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.+.+. ++..+..+++|+.|++++|.+++
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 45555555555555432222222 345566666666655532 22222344566666666665543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=2.4e-09 Score=106.86 Aligned_cols=63 Identities=22% Similarity=0.314 Sum_probs=40.5
Q ss_pred cCCCCCEEEcccccceeecCCCC---CCCCCCCEEeCCCCccccc----CccchhhhccCCeeEeeeeee
Q 035895 281 GLKSLQFLSLGHNRLQGSIPNSF---DDLVSLESLDLSNNNLSEI----IPLSLEKLLYLNILLIVVVIL 343 (527)
Q Consensus 281 ~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~~~~~~~ 343 (527)
.+++|++|+|.+|.+....+..+ ..+++|++|+|+.|.+++. ++..+..+++|+.|+++.+.+
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 46778888888777753221111 2466788888888887763 344456677788887776654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.83 E-value=8.6e-09 Score=97.89 Aligned_cols=117 Identities=15% Similarity=0.050 Sum_probs=82.2
Q ss_pred hhhcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCccceeEEEEE
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNEDFRALVLE 432 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~lv~e 432 (527)
.....+|.+..+.+.|..+.||++...+|..+++|+.... ....+..++|||
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445667665544566679999998877888999986421 011234589999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY--------------------------------------- 473 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~--------------------------------------- 473 (527)
|++|.++. ... .+ ...++.++++.++.+|...
T Consensus 96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 99998884 211 12 2346677888888888321
Q ss_pred ----------------CCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 474 ----------------STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 474 ----------------~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
...++|+|++|.||++++++.+.+.|||.+..-
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 122999999999999987766779999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.71 E-value=7.9e-07 Score=89.41 Aligned_cols=130 Identities=16% Similarity=0.190 Sum_probs=84.3
Q ss_pred CccccCCccCceeeCCCCCCCCCc-hhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCC
Q 035895 205 PTCFGNLTALRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLK 283 (527)
Q Consensus 205 p~~~~~l~~L~~L~L~~N~l~~lp-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 283 (527)
..+|....+|+.+.+..+ ++.++ ..+.++..|..+.+..+ +...-...|.++..|+.+.+..+ +.......|.++.
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 344555566666666543 33333 34455667777776554 44444566777777777777543 4444456777788
Q ss_pred CCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEe
Q 035895 284 SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLI 338 (527)
Q Consensus 284 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~ 338 (527)
+|+.+.+.++.++......|.++.+|+.+.+..+ ++.+....|.++..|+.+.+
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 8888888777777666777888888888887644 66666677777777765543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.49 E-value=2.1e-07 Score=93.00 Aligned_cols=114 Identities=15% Similarity=0.184 Sum_probs=82.9
Q ss_pred cccceeccCCceEEEEEEccCCcEEEEEEEe--ec--------------------------------cCcc---ceeEEE
Q 035895 388 SANNLIGRGSFGSVYKARLQDGMEFAIKVFH--FS--------------------------------CSNE---DFRALV 430 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~--~~--------------------------------~~~~---~~~~lv 430 (527)
...+.++.|.++.||++...+ ..+++|+.. .. +... +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999998765 567787654 10 1111 236899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY------------------------------------- 473 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~------------------------------------- 473 (527)
|||++|..+.+.. -..++..++..++.++++.|+.+|...
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998774311 123567777888999999999999420
Q ss_pred ------------------CCCeEecCCCCCCeeeCCCCc--EEEeecccccc
Q 035895 474 ------------------STPIIHCDLKPHNKLLDDNIV--AHLSDFGIAKL 505 (527)
Q Consensus 474 ------------------~~~iiHrdlk~~nill~~~~~--~kl~Dfg~a~~ 505 (527)
...+||+|+++.||+++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999987653 68999999874
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=6.7e-08 Score=86.89 Aligned_cols=90 Identities=13% Similarity=0.109 Sum_probs=46.0
Q ss_pred CCCCCCCCEEEcccC-CCCcccCh----hHhhccccccEEEcccCccccc----cchhhcCCcCCcEEEeecCccccc--
Q 035895 87 MSNCKYLKKLDISRN-PLDGFLPR----VVGNFSQSLEFIWMSDCNISGG----ISEEIGNLTDLISIDLGGNKLNGS-- 155 (527)
Q Consensus 87 ~~~l~~L~~L~Ls~N-~l~~~~~~----~~~~~~~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-- 155 (527)
+...+.|++|+|++| .+...-.. .+... ++|++|+|++|.|... +...+...+.|++|+|++|.|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~-~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTN-TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTC-CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhC-CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 455677777777777 77542111 11221 3466666666666421 223334445566666666665532
Q ss_pred --CcccccCCCCCCEEec--cCcccc
Q 035895 156 --ISITLGKLQKLQFLSF--RGNELE 177 (527)
Q Consensus 156 --~~~~~~~l~~L~~L~l--~~N~l~ 177 (527)
+...+...++|+.|+| ++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2233444455555555 455554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.44 E-value=3.5e-08 Score=93.47 Aligned_cols=60 Identities=27% Similarity=0.334 Sum_probs=26.7
Q ss_pred cccEEEcccCccccc--cchhhcCCcCCcEEEeecCcccccCcccccCCC--CCCEEeccCccccc
Q 035895 117 SLEFIWMSDCNISGG--ISEEIGNLTDLISIDLGGNKLNGSISITLGKLQ--KLQFLSFRGNELEG 178 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~ 178 (527)
+|+.|+|++|.|+++ +|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+.+
T Consensus 171 ~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 171 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp TCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred CCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 455555555555442 233444455555555555555432 1122222 44445555554443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=1e-07 Score=85.60 Aligned_cols=91 Identities=21% Similarity=0.236 Sum_probs=42.8
Q ss_pred hcCCcCCcEEEeecC-ccccc----CcccccCCCCCCEEeccCcccccc----cChhhhcCcccCeeeeecccCCCC---
Q 035895 136 IGNLTDLISIDLGGN-KLNGS----ISITLGKLQKLQFLSFRGNELEGS----IPNVLCHLAVLFQLDLRGNKLSGS--- 203 (527)
Q Consensus 136 ~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~--- 203 (527)
+...+.|++|+|++| .+... +...+...++|++|+|++|.+... +...+...+.|++|+|++|.|...
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 344445555555555 44321 122333445555555555555421 122333344555555555555422
Q ss_pred -CCccccCCccCceeeC--CCCCCCC
Q 035895 204 -IPTCFGNLTALRNLHL--DSNELTS 226 (527)
Q Consensus 204 -~p~~~~~l~~L~~L~L--~~N~l~~ 226 (527)
+...+...++|++|+| ++|.++.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCH
Confidence 2233444555666666 5566553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.40 E-value=6.8e-08 Score=91.51 Aligned_cols=104 Identities=25% Similarity=0.359 Sum_probs=68.2
Q ss_pred hcCCcCCcE--EEeecCccc---ccCcccccCCCCCCEEeccCccccc--ccChhhhcCcccCeeeeecccCCCCCCccc
Q 035895 136 IGNLTDLIS--IDLGGNKLN---GSISITLGKLQKLQFLSFRGNELEG--SIPNVLCHLAVLFQLDLRGNKLSGSIPTCF 208 (527)
Q Consensus 136 ~~~l~~L~~--L~L~~N~l~---~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 208 (527)
|...+.|.. ++++.|+.. +.++.....+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444445554 666777433 2223333467788888888888876 4456677888888888888888764 234
Q ss_pred cCCc--cCceeeCCCCCCCC-Cc-------hhhhCCCCccEEE
Q 035895 209 GNLT--ALRNLHLDSNELTS-IP-------SILWNLKDILYLD 241 (527)
Q Consensus 209 ~~l~--~L~~L~L~~N~l~~-lp-------~~~~~l~~L~~l~ 241 (527)
..+. +|++|+|++|.+.+ +| ..+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 78888888888875 44 2355677888776
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.85 E-value=2.7e-05 Score=75.55 Aligned_cols=110 Identities=22% Similarity=0.240 Sum_probs=77.0
Q ss_pred cceeccCCceEEEEEEccCCcEEEEEEEeec------------------------------cCcc---ceeEEEEEeccC
Q 035895 390 NNLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------CSNE---DFRALVLEYTTN 436 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------~~~~---~~~~lv~ey~~~ 436 (527)
.+.++.|.+..||++. ..+++|+.... .... ...++||||++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 4568999999999864 46788874210 0011 134789999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG-------------------------------------------- 472 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~-------------------------------------------- 472 (527)
.++...... .++..++..++.++++.++.+|..
T Consensus 101 ~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 101 VPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp EECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred eECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 888653321 245556667777777777777731
Q ss_pred -----------CCCCeEecCCCCCCeeeCC--CCcEEEeeccccccc
Q 035895 473 -----------YSTPIIHCDLKPHNKLLDD--NIVAHLSDFGIAKLL 506 (527)
Q Consensus 473 -----------~~~~iiHrdlk~~nill~~--~~~~kl~Dfg~a~~~ 506 (527)
....++|+|++|.||++++ ...+.+.||+.+..-
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999997 456789999998753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.71 E-value=1.8e-05 Score=69.58 Aligned_cols=83 Identities=12% Similarity=0.127 Sum_probs=38.7
Q ss_pred CCcEEEeecCcccccCcccccCCCCCCEEeccCcc-cccccChhhhcC----cccCeeeeeccc-CCCCCCccccCCccC
Q 035895 141 DLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNE-LEGSIPNVLCHL----AVLFQLDLRGNK-LSGSIPTCFGNLTAL 214 (527)
Q Consensus 141 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 214 (527)
.|++||++++.|+..--..+.++++|+.|+|++|. ++..--..+..+ ++|++|+|++|. |+..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34444444444443222334455555555555553 332212223332 246666666653 443222234556666
Q ss_pred ceeeCCCCC
Q 035895 215 RNLHLDSNE 223 (527)
Q Consensus 215 ~~L~L~~N~ 223 (527)
+.|+++++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00021 Score=69.27 Aligned_cols=33 Identities=30% Similarity=0.433 Sum_probs=26.9
Q ss_pred CCCeEecCCCCCCeeeCC---CCc-EEEeeccccccc
Q 035895 474 STPIIHCDLKPHNKLLDD---NIV-AHLSDFGIAKLL 506 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~---~~~-~kl~Dfg~a~~~ 506 (527)
...++|+|++|.||+++. ++. +.|.||+.+..-
T Consensus 189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 456799999999999987 455 479999988753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.63 E-value=3e-05 Score=68.11 Aligned_cols=82 Identities=16% Similarity=0.281 Sum_probs=35.3
Q ss_pred CCCEEEcccCCCCcccChhHhhccccccEEEcccCc-cccccchhhcCC----cCCcEEEeecCc-ccccCcccccCCCC
Q 035895 92 YLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCN-ISGGISEEIGNL----TDLISIDLGGNK-LNGSISITLGKLQK 165 (527)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~ 165 (527)
.|+.||++++.++..--..+..+ ++|+.|+|++|. |+..--..+..+ ++|++|+|++|. |+..--..+..+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~-~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGL-QYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTC-SCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred eEeEEeCcCCCccHHHHHHhcCC-CCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 46666666666554322233333 245555555553 332222223322 235555555542 44222223334444
Q ss_pred CCEEeccCc
Q 035895 166 LQFLSFRGN 174 (527)
Q Consensus 166 L~~L~l~~N 174 (527)
|+.|+++++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 555554444
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00055 Score=64.83 Aligned_cols=119 Identities=18% Similarity=0.104 Sum_probs=74.9
Q ss_pred hhhcCCccccceeccCCce-EEEEEEcc-CCcEEEEEEEee---------------------------ccCccceeEEEE
Q 035895 381 LRATDGFSANNLIGRGSFG-SVYKARLQ-DGMEFAIKVFHF---------------------------SCSNEDFRALVL 431 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g-~vy~~~~~-~~~~vavK~~~~---------------------------~~~~~~~~~lv~ 431 (527)
.....+|+. +.+..|..| .||+.... ++..+.+|+-.. .+...+..++||
T Consensus 21 ~~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 21 DADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp HHHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 334556654 355666666 68988764 456788997431 223456778999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF---------------------------------------- 471 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~---------------------------------------- 471 (527)
|+++|.++.+...... .....++.++++.++-||.
T Consensus 100 e~l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp ECCCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred EeeCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9999988776542210 0112233333333333331
Q ss_pred ---------------CCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 472 ---------------GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 472 ---------------~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
.....++|+|+.+.||++++++.+-|.||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1122379999999999999877777999998865
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00064 Score=66.68 Aligned_cols=32 Identities=25% Similarity=0.315 Sum_probs=28.8
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
...+||+|+++.||+++.++.+.+.||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 57899999999999998888999999998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00049 Score=61.51 Aligned_cols=63 Identities=22% Similarity=0.224 Sum_probs=27.9
Q ss_pred CCCCCEEEcccC-CCCcc----cChhHhhccccccEEEcccCccccc----cchhhcCCcCCcEEEeecCccc
Q 035895 90 CKYLKKLDISRN-PLDGF----LPRVVGNFSQSLEFIWMSDCNISGG----ISEEIGNLTDLISIDLGGNKLN 153 (527)
Q Consensus 90 l~~L~~L~Ls~N-~l~~~----~~~~~~~~~~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 153 (527)
-+.|++|+|++| .|... +-+.+.. ...|+.|+|++|.|... +.+.+..-+.|++|+|+.|.|.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~-N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACN-SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTT-CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhh-CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 345666666664 55421 1111111 12455555555555421 1222333344555555555554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0015 Score=64.54 Aligned_cols=32 Identities=19% Similarity=0.218 Sum_probs=26.8
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
...+||+|+.+.||+++++..+.|.||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 46789999999999999654578999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.003 Score=63.46 Aligned_cols=31 Identities=19% Similarity=0.253 Sum_probs=26.6
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
...++|+|+.|.||+++.+ .+++.||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 5678999999999999866 489999987764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0021 Score=53.53 Aligned_cols=36 Identities=28% Similarity=0.286 Sum_probs=19.1
Q ss_pred CCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcc
Q 035895 284 SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319 (527)
Q Consensus 284 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 319 (527)
+|++|+|++|+|+...++.|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 345555555555544444555555555555555554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.00054 Score=61.24 Aligned_cols=61 Identities=16% Similarity=0.189 Sum_probs=31.4
Q ss_pred cccEEEcccC-cccc----ccchhhcCCcCCcEEEeecCcccccC----cccccCCCCCCEEeccCcccc
Q 035895 117 SLEFIWMSDC-NISG----GISEEIGNLTDLISIDLGGNKLNGSI----SITLGKLQKLQFLSFRGNELE 177 (527)
Q Consensus 117 ~L~~L~Ls~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~ 177 (527)
.|+.|+|++| .|.. .+.+++..-..|++|+|++|.|...- ...+..-+.|+.|+|+.|.|.
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 5666777664 5542 12334444555666666666665321 122233455666666666554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0023 Score=53.28 Aligned_cols=55 Identities=22% Similarity=0.276 Sum_probs=29.6
Q ss_pred EEEcccCCCC-cccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcc
Q 035895 95 KLDISRNPLD-GFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152 (527)
Q Consensus 95 ~L~Ls~N~l~-~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 152 (527)
.+|.+++.++ ..+|.. ++.+|+.|+|++|+|+.+.+..|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~---lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA---FPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSC---CCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCC---CCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 113322 233466666666666655555556666666666666654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.013 Score=55.84 Aligned_cols=31 Identities=23% Similarity=0.332 Sum_probs=27.5
Q ss_pred ccccceeccCCceEEEEEEccCCcEEEEEEE
Q 035895 387 FSANNLIGRGSFGSVYKARLQDGMEFAIKVF 417 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~ 417 (527)
....+.+|.|..+.||+.+..+|+.|.+|+.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~ 47 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKAL 47 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEe
Confidence 4556789999999999999999999999984
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.021 Score=55.11 Aligned_cols=111 Identities=13% Similarity=0.068 Sum_probs=68.1
Q ss_pred ccceeccCCceEEEEEEccCCcEEEEEEEeec-----------------------------cCccceeEEEEEeccCCcH
Q 035895 389 ANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYTTNGSL 439 (527)
Q Consensus 389 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~~~g~L 439 (527)
..+.|+.|.+..+|+.... +..+++|+.... +..++..++||||++|..+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3467999999999999864 568889975321 1123457899999998754
Q ss_pred H--------H---HHHhcCC---------------------CCCHHHHH---HHHH----------------HHHHH-HH
Q 035895 440 E--------K---VLYSSNY---------------------ILDILQRL---NIMI----------------DVTSA-LE 467 (527)
Q Consensus 440 ~--------~---~l~~~~~---------------------~~~~~~~~---~i~~----------------~i~~~-l~ 467 (527)
. . .++.... .-+|.... ++.. .+.+. .+
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 1 1 1222111 01354321 1111 11111 12
Q ss_pred HHh-cCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 035895 468 YLH-FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFG 501 (527)
Q Consensus 468 ylH-~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg 501 (527)
.+. +...+.+||+|+.+.|++++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 332 12357799999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.74 E-value=0.033 Score=53.80 Aligned_cols=44 Identities=25% Similarity=0.357 Sum_probs=31.9
Q ss_pred HHHHHHHHhc----CCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 462 VTSALEYLHF----GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 462 i~~~l~ylH~----~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
+...+++++. .....+||+|+.+.||++++++.+.+.||+.+..
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3444555542 1245789999999999999876668999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.061 Score=51.48 Aligned_cols=31 Identities=23% Similarity=0.296 Sum_probs=25.8
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
...++|+|+.+.||+ ..++.+.+.||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 445899999999999 5567789999988764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.22 E-value=0.22 Score=48.52 Aligned_cols=32 Identities=19% Similarity=0.264 Sum_probs=28.1
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
...++|+|+.+.||++++++.+.+.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45689999999999999888899999988764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.91 E-value=0.17 Score=50.70 Aligned_cols=29 Identities=28% Similarity=0.324 Sum_probs=24.6
Q ss_pred eEecCCCCCCeee------CCCCcEEEeecccccc
Q 035895 477 IIHCDLKPHNKLL------DDNIVAHLSDFGIAKL 505 (527)
Q Consensus 477 iiHrdlk~~nill------~~~~~~kl~Dfg~a~~ 505 (527)
++|+|+.+.||++ +++..+.+.||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999988763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=90.96 E-value=0.2 Score=50.44 Aligned_cols=31 Identities=16% Similarity=0.281 Sum_probs=27.9
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
...++|+|++|.||+++.++ +++.||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 78899999999999998776 99999988775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=87.36 E-value=0.64 Score=44.86 Aligned_cols=32 Identities=28% Similarity=0.297 Sum_probs=27.9
Q ss_pred CCCeEecCCCCCCeeeCCC----CcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDN----IVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~----~~~kl~Dfg~a~~ 505 (527)
...+||+|+.+.||+++.+ +.+.+.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 5679999999999999874 6889999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=83.45 E-value=1 Score=43.11 Aligned_cols=30 Identities=20% Similarity=0.169 Sum_probs=25.9
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
...+||+|+++.||+++ + .+.+.||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 45689999999999999 4 899999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 527 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-30 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-29 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-27 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-25 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-25 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-24 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-24 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-24 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-24 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-23 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-23 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-22 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-22 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-22 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-22 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-21 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-21 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-05 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-20 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-20 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-19 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-19 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-07 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-19 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-19 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-18 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-05 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-18 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-17 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-17 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-17 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-17 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-16 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-16 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-16 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-15 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-14 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-14 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 35/167 (20%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFH------------------------------FS 420
IG GSFG+VYK + + A+K+ +
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 421 CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
S A+V ++ SL L+ ++++ ++I ++YLH IIH
Sbjct: 72 YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
DLK +N L +++ + DFG+A + + S Q I +MAP
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (286), Expect = 4e-29
Identities = 39/199 (19%), Positives = 73/199 (36%), Gaps = 49/199 (24%)
Query: 375 FSYQELLRATDGFSAN---------NLIGRGSFGSVYKARL----QDGMEFAIKV----- 416
F++++ A F+ +IG G FG V L + + AIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 417 -------------------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILD 451
+ ++ E+ NGSL+ L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 452 ILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
++Q + ++ + + ++YL +H DL N L++ N+V +SDFG+++ L +
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 512 SMTQTQTLAIIG---YMAP 527
T T L + AP
Sbjct: 184 DPTYTSALGGKIPIRWTAP 202
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-27
Identities = 40/184 (21%), Positives = 66/184 (35%), Gaps = 37/184 (20%)
Query: 378 QELLRATDGFSANNL-IGRGSFGSVYKARLQ---DGMEFAIKVFHFSCSNEDFRA----- 428
++L D ++ +G G+FGSV + + ++ AIKV D
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 429 ------------------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTS 464
LV+E G L K L + + ++ V+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IG 523
++YL +H DL N LL + A +SDFG++K L +D T +
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 524 YMAP 527
+ AP
Sbjct: 178 WYAP 181
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 6e-27
Identities = 33/165 (20%), Positives = 65/165 (39%), Gaps = 32/165 (19%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFH---------------------------FSCSN 423
+G G FG V+ + A+K ++
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 424 EDFRALVLEYTTNGSLEKVLYSSNYI-LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
++ ++ EY NGSL L + + I L I + L++ + + ++ IH DL
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+ N L+ D + ++DFG+A+L+ +++ + I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-25
Identities = 40/174 (22%), Positives = 62/174 (35%), Gaps = 35/174 (20%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV-------------------------- 416
D + +G G+FG VYKA+ + + A KV
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 417 ---FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
+ E+ +++E+ G+++ V+ L Q + AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
IIH DLK N L + L+DFG++ T Q +MAP
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAP 179
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (260), Expect = 1e-25
Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 38/192 (19%)
Query: 366 MQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKARLQD-GMEFAIKV-------- 416
M P +Y + + + +G G +G VY+ + + A+K
Sbjct: 2 MDPS----SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV 57
Query: 417 --------------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSN-YILDILQR 455
C+ E ++ E+ T G+L L N + +
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 456 LNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
L + ++SA+EYL IH DL N L+ +N + ++DFG+++L+TG D
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 173
Query: 516 TQTLAIIGYMAP 527
I + AP
Sbjct: 174 AGAKFPIKWTAP 185
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 36/165 (21%), Positives = 63/165 (38%), Gaps = 32/165 (19%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKV----------------------------FHFSCS 422
+G G FG V + + + AIK+ + C+
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+ ++ EY NG L L + Q L + DV A+EYL +H DL
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 126
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
N L++D V +SDFG+++ + +D+ + + + + P
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 170
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-25
Identities = 38/176 (21%), Positives = 67/176 (38%), Gaps = 38/176 (21%)
Query: 383 ATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV------------------------- 416
D F + +G G+ G V+K G+ A K+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF 471
F+ + ++ ++ +E+ GSL++VL + + + I V L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 122
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I+H D+KP N L++ L DFG++ L + + + T YM+P
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGT---RSYMSP 172
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-24
Identities = 45/185 (24%), Positives = 62/185 (33%), Gaps = 42/185 (22%)
Query: 382 RATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA------------ 428
RA D + IG GS+G K R DG K + E +
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 429 ---------------------LVLEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTS 464
+V+EY G L V+ LD L +M +T
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 465 ALEYLH--FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAII 522
AL+ H ++H DLKP N LD L DFG+A++L +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TP 178
Query: 523 GYMAP 527
YM+P
Sbjct: 179 YYMSP 183
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-24
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 37/179 (20%)
Query: 382 RATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV------------------------ 416
+ + F ++G GSF +V AR L E+AIK+
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 417 --------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEY 468
+F+ +++ L Y NG L K + D ++ SALEY
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LH IIH DLKP N LL++++ ++DFG AK+L+ E + + Y++P
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-24
Identities = 37/171 (21%), Positives = 64/171 (37%), Gaps = 32/171 (18%)
Query: 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-CSNEDFRA--------------- 428
+ +G+G FG V+ AIK S E F
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 429 -----------LVLEYTTNGSLEKVLYSSNYILDIL-QRLNIMIDVTSALEYLHFGYSTP 476
+V EY + GSL L L Q +++ + S + Y+
Sbjct: 77 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+H DL+ N L+ +N+V ++DFG+A+L+ +++ + I + AP
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAP 183
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 34/174 (19%), Positives = 61/174 (35%), Gaps = 35/174 (20%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------- 416
+ + +G G++G V A A+K+
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 417 ---FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
F+ + + L LEY + G L + + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I H D+KP N LLD+ +SDFG+A + ++ + + Y+AP
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 5e-24
Identities = 34/172 (19%), Positives = 62/172 (36%), Gaps = 38/172 (22%)
Query: 390 NNLIGRGSFGSVYKARLQD---GMEFAIKVFHFSCSNEDFRA------------------ 428
+ +G G+FG+V K Q A+K+ ++ +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 429 ------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP 476
LV+E G L K L + + + + ++ V+ ++YL +
Sbjct: 72 RMIGICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 477 IIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
+H DL N LL A +SDFG++K L ++ + + AP
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (249), Expect = 5e-24
Identities = 43/177 (24%), Positives = 64/177 (36%), Gaps = 43/177 (24%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFS---------------------- 420
FS IG GSFG+VY AR +++ AIK +S
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 421 ----------CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH 470
E LV+EY + + + L ++ + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132
Query: 471 FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S +IH D+K N LL + + L DFG A ++ + + T +MAP
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTP---YWMAP 180
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 100 bits (250), Expect = 8e-24
Identities = 32/168 (19%), Positives = 58/168 (34%), Gaps = 38/168 (22%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV-----------------------------FHFSC 421
+G G+FG V++ G FA K H +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 422 SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
+++ ++ E+ + G L + + + + + + M V L ++H +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 482 LKPHNKLL--DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LKP N + + L DFG+ L + T T + AP
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAP 194
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 1e-23
Identities = 34/195 (17%), Positives = 58/195 (29%), Gaps = 62/195 (31%)
Query: 392 LIGRGSFGSVYKARLQD------GMEFAIKV----------------------------- 416
++G G+FG V A ++ A+K+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 417 --FHFSCSNEDFRALVLEYTTNGSLEKVLYSSN----------------------YILDI 452
+C+ L+ EY G L L S +L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 453 LQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512
L V +E+L +H DL N L+ V + DFG+A+ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 513 MTQTQTLAIIGYMAP 527
+ + + +MAP
Sbjct: 221 VVRGNARLPVKWMAP 235
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 2e-23
Identities = 34/165 (20%), Positives = 59/165 (35%), Gaps = 32/165 (19%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKV----------------------------FHFSCS 422
IG G FG V+ + + AIK + C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+ LV E+ +G L L + + L + +DV + YL +IH DL
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDL 127
Query: 483 KPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
N L+ +N V +SDFG+ + + + + + + + +P
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-VKWASP 171
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 2e-23
Identities = 41/166 (24%), Positives = 60/166 (36%), Gaps = 38/166 (22%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
IG+G FG V G + A+K + + F A
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 429 ------LVLEYTTNGSLEKVLYSSNY-ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
+V EY GSL L S +L L +DV A+EYL +H D
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 128
Query: 482 LKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
L N L+ ++ VA +SDFG+ K + + + + AP
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAP 169
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 3e-23
Identities = 40/177 (22%), Positives = 71/177 (40%), Gaps = 39/177 (22%)
Query: 387 FSANNLIGRGSFGSVYKARLQDG-----MEFAIKV------------------------- 416
+ +IG G FG VYK L+ + AIK
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF 471
S ++ EY NG+L+K L + +LQ + ++ + + ++YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLAIIGYMAP 527
+ +H DL N L++ N+V +SDFG++++L + + T + I + AP
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (239), Expect = 6e-23
Identities = 40/176 (22%), Positives = 65/176 (36%), Gaps = 41/176 (23%)
Query: 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKV--------------------------- 416
+ F +G+G FG+VY AR Q A+KV
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF 471
+ + L+LEY G++ + L + D + + ++ +AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S +IH D+KP N LL ++DFG + + T T + Y+ P
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGT---LDYLPP 173
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 9e-23
Identities = 38/175 (21%), Positives = 60/175 (34%), Gaps = 43/175 (24%)
Query: 390 NNLIGRGSFGSVYKARL-QDGMEFAIK--------------------------------- 415
+ IGRGSF +VYK + +E A
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 416 --VFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
+ + + LV E T+G+L+ L ++ I + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 474 STPIIHCDLKPHNKLLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+ PIIH DLK N + + D G+A L + T +MAP
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTP---EFMAP 182
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.5 bits (239), Expect = 1e-22
Identities = 39/211 (18%), Positives = 65/211 (30%), Gaps = 62/211 (29%)
Query: 376 SYQELLRATDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVF------------ 417
L + IG G+FG V++AR + A+K+
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 418 ------------------HFSCSNEDFRALVLEYTTNGSLEKVLYSSNY----------- 448
C+ L+ EY G L + L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 449 ------------ILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496
L ++L I V + + YL +H DL N L+ +N+V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 497 LSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
++DFG+++ + D I +M P
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPP 211
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 1e-22
Identities = 40/174 (22%), Positives = 62/174 (35%), Gaps = 42/174 (24%)
Query: 393 IGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFR------------------------- 427
IG+G FG V++ + G E A+K+F FR
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 428 -------ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH-----FGYST 475
LV +Y +GSL L + Y + + + + + S L +LH
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI--IGYMAP 527
I H DLK N L+ N ++D G+A ++ + YMAP
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 96.7 bits (240), Expect = 2e-22
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 38/168 (22%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV-----------------------------FHFSC 421
+G G+FG V++ G F K H +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 422 SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCD 481
++ L+LE+ + G L + + +Y + + +N M L+++H I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 482 LKPHNKLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+KP N + + + + DFG+A L ++ T T + AP
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT---AEFAAP 197
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 3e-22
Identities = 37/184 (20%), Positives = 64/184 (34%), Gaps = 40/184 (21%)
Query: 379 ELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------- 416
+L+ T+ F ++G G+FG+VYK + +G + I V
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 417 -------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVT 463
C + L+ + G L + + LN + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 464 SALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIG 523
+ YL ++H DL N L+ ++DFG+AKLL E++ I
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 524 YMAP 527
+MA
Sbjct: 179 WMAL 182
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 3e-22
Identities = 35/191 (18%), Positives = 58/191 (30%), Gaps = 57/191 (29%)
Query: 391 NLIGRGSFGSVYKARL------QDGMEFAIKV---------------------------- 416
+G G+FG V +A M A+K+
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 417 ---FHFSCSNEDFRALVLEYTTNGSLEKVLYSS-----------------NYILDILQRL 456
+C+ ++ EY G L L LD+ L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 457 NIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516
+ V + +L S IH DL N LL + + DFG+A+ + + + +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 517 QTLAIIGYMAP 527
+ +MAP
Sbjct: 206 NARLPVKWMAP 216
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.0 bits (228), Expect = 2e-21
Identities = 44/167 (26%), Positives = 64/167 (38%), Gaps = 37/167 (22%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHF-----------------------------S 420
IG+G+ G+VY A + G E AI+ + S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 421 CSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
D +V+EY GSL V+ + D Q + + ALE+LH S +IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 481 DLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
D+K N LL + L+DFG +T E + +MAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAP 185
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 3e-21
Identities = 42/192 (21%), Positives = 69/192 (35%), Gaps = 55/192 (28%)
Query: 385 DGFSANNLIGRGSFGSVYKARLQDG---MEFAIKV------------------------- 416
+ ++IG G+FG V KAR++ M+ AIK
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 417 ------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYI---------------LDILQR 455
+C + + L +EY +G+L L S + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 456 LNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
L+ DV ++YL IH DL N L+ +N VA ++DFG+++ +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 516 TQTLAIIGYMAP 527
+ +MA
Sbjct: 187 RLP---VRWMAI 195
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 4e-21
Identities = 36/168 (21%), Positives = 56/168 (33%), Gaps = 37/168 (22%)
Query: 392 LIGRGSFGSVYKARL----QDGMEFAIKVFH----------------------------- 418
IG G FG V++ + AIK
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 419 FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
E+ +++E T G L L Y LD+ + +++AL YL S +
Sbjct: 74 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526
H D+ N L+ N L DFG+++ + L I +MA
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKWMA 177
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 90.1 bits (223), Expect = 9e-21
Identities = 38/183 (20%), Positives = 60/183 (32%), Gaps = 47/183 (25%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------- 416
+ + ++GRG V + E+A+K+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 417 ------------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTS 464
+ F LV + G L L + L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 465 ALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524
+ LH I+H DLKP N LLDD++ L+DFG + L ++ T Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT---PSY 175
Query: 525 MAP 527
+AP
Sbjct: 176 LAP 178
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 1e-20
Identities = 39/170 (22%), Positives = 60/170 (35%), Gaps = 40/170 (23%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIK-----------------------------VFHFSC 421
++G G G V + + +FA+K V+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 78
Query: 422 SNEDFRALVLEYTTNGSLEKVLYS-SNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHC 480
+ +V+E G L + + + IM + A++YLH S I H
Sbjct: 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHR 135
Query: 481 DLKPHNKLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
D+KP N L N + L+DFG AK T + T T Y+AP
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT---PYYVAP 182
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 2e-20
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 14/224 (6%)
Query: 113 NFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR 172
+ + + + LT+L S+ N+++ + + L LS
Sbjct: 170 PLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLN 227
Query: 173 GNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILW 232
GN+L+ L L L LDL N++S P LT L L L +N++++I L
Sbjct: 228 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LA 282
Query: 233 NLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGH 292
L + L+ N S I NLK LT + NN+ P + L LQ L +
Sbjct: 283 GLTALTNLELNENQL--EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338
Query: 293 NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS-LEKLLYLNI 335
N++ +S +L ++ L +N +S++ PL+ L ++ L +
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGL 380
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.0 bits (175), Expect = 3e-14
Identities = 38/227 (16%), Positives = 75/227 (33%), Gaps = 56/227 (24%)
Query: 87 MSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISID 146
++ L+ L + N + P +L+ + ++ + + +LT+L +D
Sbjct: 193 LAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 147 LGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIP--------------------NVLCH 186
L N+++ L L KL L N++ P + + +
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 187 LAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNL 246
L L L L N +S P +LT L+ L +N+++ + S+
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSL---------------- 347
Query: 247 FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHN 293
NL + + N + P + L + L L
Sbjct: 348 ---------ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.6 bits (169), Expect = 2e-13
Identities = 43/222 (19%), Positives = 85/222 (38%), Gaps = 16/222 (7%)
Query: 1 MWSEKLNNRQLDGGMTGDVCYRICTIDSQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRL 60
+ +N+ D + + I + N++ I + L+ L ++ N L +
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDI--TPLGILTNLDELSLNGNQ-LKDI 234
Query: 61 SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEF 120
++ +L+D L ++ ++S L+ +S L +L + N + P +
Sbjct: 235 GTLASLTNLTDLDLANN--QISNLAPLSGLTKLTELKLGANQISNISP-----LAGLTAL 287
Query: 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSI 180
+ I NL +L + L N ++ + L KLQ L F N++
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD-- 343
Query: 181 PNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222
+ L +L + L N++S P NLT + L L+
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 4e-08
Identities = 60/303 (19%), Positives = 102/303 (33%), Gaps = 43/303 (14%)
Query: 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLP---------RVVGNF 114
V L + S + + L +++ S N L P ++ N
Sbjct: 46 VTTLQADRLGIKS-------IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 98
Query: 115 SQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGN 174
+ + N++G +L S T+ + L L+
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 175 ELEGSIPNVLCHLAVLFQLDLRGNKLS-GSIPTCFGNLTALRNLHLDSNELTSIPSILWN 233
G+ L LA L L+ + S + LT L +L +N+++ I +
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL-GI 217
Query: 234 LKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHN 293
L ++ L N + +L LT +D + N + P + GL L L LG N
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273
Query: 294 RLQGSIP--------------------NSFDDLVSLESLDLSNNNLSEIIPLS-LEKLLY 332
++ P + +L +L L L NN+S+I P+S L KL
Sbjct: 274 QISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQR 333
Query: 333 LNI 335
L
Sbjct: 334 LFF 336
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 6e-07
Identities = 50/237 (21%), Positives = 76/237 (32%), Gaps = 27/237 (11%)
Query: 116 QSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNE 175
+ + I + + L +L I+ N+L L L KL + N+
Sbjct: 44 DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 176 LEGSIPNVLCHLAVLFQ----------------LDLRGNKLSGSIPTCFGNLTALRNLHL 219
+ P R S +I L
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 220 DSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTI 279
+ L NL + LD SN S + L L + + N + P I
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLGI 217
Query: 280 QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS-LEKLLYLNI 335
+L LSL N+L+ + L +L LDL+NN +S + PLS L KL L +
Sbjct: 218 L--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKL 270
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 18/79 (22%), Positives = 34/79 (43%), Gaps = 5/79 (6%)
Query: 257 NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
L + + N+ + + L + L ++ SI + L +L ++ SN
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 317 NNLSEIIPLS-LEKLLYLN 334
N L++I PL L KL+ +
Sbjct: 76 NQLTDITPLKNLTKLVDIL 94
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 6e-20
Identities = 35/175 (20%), Positives = 63/175 (36%), Gaps = 40/175 (22%)
Query: 390 NNLIGRGSFGSVYKARLQD----GMEFAIKV----------------------------- 416
N +IGRG FG VY L D + A+K
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 417 --FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS 474
+E +VL Y +G L + + + + + + V +++L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148
Query: 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI--IGYMAP 527
+H DL N +LD+ ++DFG+A+ + ++ +T A + +MA
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 8e-20
Identities = 30/186 (16%), Positives = 62/186 (33%), Gaps = 48/186 (25%)
Query: 387 FSANNLIGRGSFGSVYKARL------QDGMEFAIKVF----------------------- 417
+ + +G+GSFG VY+ + AIK
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 418 -------HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYI---------LDILQRLNIMID 461
S +++E T G L+ L S + + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 462 VTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI 521
+ + YL+ + +H DL N ++ ++ + DFG+ + + D + L
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 522 IGYMAP 527
+ +M+P
Sbjct: 199 VRWMSP 204
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 9e-20
Identities = 28/158 (17%), Positives = 57/158 (36%), Gaps = 34/158 (21%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV----------------------------FHFSCS 422
+GRG FG V++ + K H S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
+ + ++ E+ + + + + +S + L+ + ++ + V AL++LH S I H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 483 KPHNKLLD--DNIVAHLSDFGIAKLLTGEDQSMTQTQT 518
+P N + + + +FG A+ L D
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.3 bits (218), Expect = 1e-19
Identities = 35/167 (20%), Positives = 62/167 (37%), Gaps = 40/167 (23%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------- 416
+ FS + +IGRG FG VY R G +A+K
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 417 --------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEY 468
++ D + +L+ G L L S + + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515
+H + +++ DLKP N LLD++ +SD G+A + + +
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 166
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 1e-19
Identities = 32/171 (18%), Positives = 48/171 (28%), Gaps = 39/171 (22%)
Query: 393 IGRGSFGSVYKARL----QDGMEFAIKVFH------------------------------ 418
+G GSFG V + + A+K
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 419 -FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+ +V E GSL L + + V + YL S
Sbjct: 76 LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 132
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI-IGYMAP 527
IH DL N LL + + DFG+ + L D + + + AP
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 86.9 bits (214), Expect = 1e-19
Identities = 37/168 (22%), Positives = 65/168 (38%), Gaps = 37/168 (22%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRA---------------------- 428
IG G++G VYKA+ G FA+K +E +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 429 ---------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479
LV E+ + L+K+L L+ + + ++ + + + Y H ++H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
DLKP N L++ ++DFG+A+ T + + Y AP
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAP 169
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 3e-19
Identities = 48/245 (19%), Positives = 84/245 (34%), Gaps = 5/245 (2%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152
LD+ N + N L + + + IS L L + L N+L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLT 212
LQ+L+ ++ S+ N L + V+ L K SG F +
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMK 150
Query: 213 ALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLL 272
L + + +T+IP + L N + + L L ++ S N++
Sbjct: 151 KLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 273 GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLY 332
++ L+ L L +N+L +P D ++ + L NNN+S I Y
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 333 LNILL 337
Sbjct: 268 NTKKA 272
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 3e-18
Identities = 53/286 (18%), Positives = 97/286 (33%), Gaps = 20/286 (6%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
L L L +N +T N K L L + N + P LE
Sbjct: 29 LPPDTALLDLQNNKITEIKD-----GDFKNLKNLHTLILINNKISKISPGAFAPLV-KLE 82
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179
+++S + + L +L + K+ S+ L ++ + L + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGI 141
Query: 180 IPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTS-IPSILWNLKDIL 238
+ L + + ++ +IP G +L LHLD N++T + L L ++
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298
L N + N L + + N L +P + K +Q + L +N +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 299 IPNSF------DDLVSLESLDLSNNNLS--EIIPLSLEKLLYLNIL 336
N F S + L +N + EI P + + +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.7 bits (169), Expect = 1e-13
Identities = 58/290 (20%), Positives = 95/290 (32%), Gaps = 26/290 (8%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
NK+ I NL L + NN + L L S +L L
Sbjct: 39 QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV-KLERLYLSKNQLKELPEK 97
Query: 88 SNCKYLKKLDISRNPLDGFLPRVVGNFSQ-SLEFIWMSDCNISGGISEEIGNLTDLISID 146
++L + N + V +Q + + + SG + + L I
Sbjct: 98 MPKTL-QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156
Query: 147 LGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPT 206
+ + +I G L L GN++ L L L +L L N +S
Sbjct: 157 IADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213
Query: 207 CFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDF 266
N LR LHL++N+L +P L + K I + +N N+ + DF
Sbjct: 214 SLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN-----------NISAIGSNDF 262
Query: 267 SRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS--IPNSFDDLVSLESLDL 314
S +SL N +Q P++F + ++ L
Sbjct: 263 CPPGYNTK-------KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.8 bits (120), Expect = 1e-07
Identities = 25/123 (20%), Positives = 44/123 (35%), Gaps = 5/123 (4%)
Query: 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLG 273
LR + L +P L D LD +N NLK L + N +
Sbjct: 12 LRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 274 DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYL 333
P L L+ L L N+L+ +P + + L + N ++++ L +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTL--QELRVHENEITKVRKSVFNGLNQM 126
Query: 334 NIL 336
++
Sbjct: 127 IVV 129
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 85.2 bits (210), Expect = 5e-19
Identities = 36/182 (19%), Positives = 69/182 (37%), Gaps = 42/182 (23%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNED----------------- 425
+D + ++G G V+ AR L+ + A+KV + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 426 -------------------FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSAL 466
+V+EY +L ++++ + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-IIGYM 525
+ H IIH D+KP N ++ + DFGIA+ + S+TQT + Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 526 AP 527
+P
Sbjct: 182 SP 183
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 6e-19
Identities = 37/196 (18%), Positives = 64/196 (32%), Gaps = 56/196 (28%)
Query: 385 DGFSANNLIGRGSFGSVYKAR------LQDGMEFAIKVFHFSCSNEDFRA---------- 428
D +GRG+FG V +A A+K+ ++ + RA
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 429 ----------------------LVLEYTTNGSLEKVLYSSNY---------------ILD 451
+++E+ G+L L S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 452 ILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511
+ + V +E+L S IH DL N LL + V + DFG+A+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 512 SMTQTQTLAIIGYMAP 527
+ + + +MAP
Sbjct: 190 YVRKGDARLPLKWMAP 205
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 6e-19
Identities = 43/176 (24%), Positives = 65/176 (36%), Gaps = 41/176 (23%)
Query: 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFH--------------------------- 418
++ +IG GSFG VY+A+L G AIK
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 419 ----FSCSNEDFRALVLEYTTNGSLEKVLY--SSNYILDILQRLNIMIDVTSALEYLHFG 472
+E + LVL+Y + + L ++ M + +L Y+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 473 YSTPIIHCDLKP-HNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S I H D+KP + L D V L DFG AK L + +++ + Y AP
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 85.1 bits (210), Expect = 6e-19
Identities = 30/175 (17%), Positives = 54/175 (30%), Gaps = 35/175 (20%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV-------------------------- 416
D + +++G G+F V A + AIK
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 417 ----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG 472
+ L+++ + G L + + ++ V A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
LD++ +SDFG++K+ T T GY+AP
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP---GYVAP 178
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 3e-18
Identities = 35/178 (19%), Positives = 59/178 (33%), Gaps = 37/178 (20%)
Query: 384 TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV-------------------------- 416
++ + IG G++G V A + + AIK
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 417 ----FHFSCSNEDFRALVLEYTTNGSLEKVLYS--SNYILDILQRLNIMIDVTSALEYLH 470
+ + Y + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 471 FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLAIIGYMAP 527
S ++H DLKP N LL+ + DFG+A++ D + T+ +A Y AP
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 4e-18
Identities = 36/191 (18%), Positives = 65/191 (34%), Gaps = 57/191 (29%)
Query: 391 NLIGRGSFGSVYKARL--------QDGMEFAIKVF------------------------- 417
+G G+FG V A + A+K+
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 418 ------HFSCSNEDFRALVLEYTTNGSLEKVL---------------YSSNYILDILQRL 456
+C+ + +++EY + G+L + L ++ L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 457 NIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516
+ V +EYL S IH DL N L+ ++ V ++DFG+A+ + D T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 517 QTLAIIGYMAP 527
+ +MAP
Sbjct: 196 NGRLPVKWMAP 206
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (201), Expect = 5e-18
Identities = 47/262 (17%), Positives = 85/262 (32%), Gaps = 10/262 (3%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
+ + + L N ++ S C+ L L + N L + +
Sbjct: 30 IPAASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQ 84
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179
+ + L L ++ L L L LQ+L + N L+
Sbjct: 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL 144
Query: 180 IPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI-PSILWNLKDIL 238
+ L L L L GN++S F L +L L L N + + P +L ++
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 239 YLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298
L ++N + L+ L + + N + D LQ + + S
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCS 263
Query: 299 IPNSFDDLVSLESLDLSNNNLS 320
+P L + L+ N+L
Sbjct: 264 LPQR---LAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (184), Expect = 8e-16
Identities = 44/244 (18%), Positives = 74/244 (30%), Gaps = 2/244 (0%)
Query: 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152
+++ + N + S+ + G +L
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 153 NGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLT 212
T L +L L L+ P + LA L L L+ N L F +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 213 ALRNLHLDSNELTSIP-SILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNL 271
L +L L N ++S+P L + L N P +L L + NNL
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 272 LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 331
+ L++LQ+L L N L+ S++ + +P L
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 332 YLNI 335
+
Sbjct: 273 LKRL 276
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 1e-13
Identities = 41/248 (16%), Positives = 83/248 (33%), Gaps = 6/248 (2%)
Query: 28 SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSM 87
N++ + + + L + + +N + ++ L+L + S +L +
Sbjct: 40 HGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPA 99
Query: 88 --SNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145
L L + L + +L+++++ D + + +L +L +
Sbjct: 100 TFHGLGRLHTLHLD-RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158
Query: 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP 205
L GN+++ L L L N + P+ L L L L N LS
Sbjct: 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218
Query: 206 TCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRID 265
L AL+ L L+ N + S+ LP ++ +
Sbjct: 219 EALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLK---R 275
Query: 266 FSRNNLLG 273
+ N+L G
Sbjct: 276 LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (149), Expect = 3e-11
Identities = 48/221 (21%), Positives = 75/221 (33%), Gaps = 2/221 (0%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166
L V + + I++ IS + +L + L N L + L L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 167 QFLSFRGNELEGSI-PNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225
+ L N S+ P L L L L L P F L AL+ L+L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 226 SI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKS 284
++ +L ++ +L N L L R+ +N + P + L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 285 LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 325
L L L N L + L +L+ L L++N
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 4e-08
Identities = 49/207 (23%), Positives = 72/207 (34%), Gaps = 24/207 (11%)
Query: 125 DCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVL 184
C G + +G I L GN+++ + + + L L N L
Sbjct: 17 SCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 185 CHLAVLFQLDLRGNKLSGSI-PTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFW 243
LA+L QLDL N S+ P F L L LHLD L + L+ L +
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 244 SNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF 303
+ N L T + L +L L L NR+ +F
Sbjct: 137 QD-----------------------NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173
Query: 304 DDLVSLESLDLSNNNLSEIIPLSLEKL 330
L SL+ L L N ++ + P + L
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDL 200
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 5e-05
Identities = 35/154 (22%), Positives = 59/154 (38%), Gaps = 5/154 (3%)
Query: 185 CHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIP-SILWNLKDILYLDFW 243
C+ L ++P + + + L N ++ +P + +++ L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 244 SNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDI-PTTIQGLKSLQFLSLGHNRLQGSIPNS 302
SN+ + L +L ++D S N L + P T GL L L L LQ P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 303 FDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
F L +L+ L L +N L + + L L L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 8e-18
Identities = 37/175 (21%), Positives = 62/175 (35%), Gaps = 37/175 (21%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA--------------- 428
+ F IG G++G VYKAR G A+K E +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 429 ----------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG 472
LV E+ + + S+ + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S ++H DLKP N L++ L+DFG+A+ ++ T + Y AP
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 171
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 1e-17
Identities = 44/172 (25%), Positives = 66/172 (38%), Gaps = 41/172 (23%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------------- 416
+ +G G F +VYKAR AIK
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 417 -FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYST 475
+ ++ +LV ++ LE ++ ++ +L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I+H DLKP+N LLD+N V L+DFG+AK + T + Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAP 169
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 1e-17
Identities = 39/177 (22%), Positives = 65/177 (36%), Gaps = 40/177 (22%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------- 416
+ F + ++G+GSFG V+ A + FAIK
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 417 ------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH 470
+ ++ V+EY G L + S + D+ + ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 471 FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
S I++ DLK N LLD + ++DFG+ K D Y+AP
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAP 172
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.9 bits (199), Expect = 2e-17
Identities = 42/170 (24%), Positives = 62/170 (36%), Gaps = 42/170 (24%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------------F 417
+G GSFG V+ R +G +A+KV
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 418 HFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPI 477
+ + ++++Y G L L + +V ALEYLH S I
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
I+ DLKP N LLD N ++DFG AK + ++ Y+AP
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAP 170
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.2 bits (192), Expect = 8e-17
Identities = 35/175 (20%), Positives = 49/175 (28%), Gaps = 46/175 (26%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV---------------------------------- 416
L+G G FGSVY + D + AIK
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 417 ---FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGY 473
D L+LE + L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 474 STPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+ ++H D+K N L+D + L DFG LL T Y P
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 77.9 bits (191), Expect = 2e-16
Identities = 30/175 (17%), Positives = 58/175 (33%), Gaps = 43/175 (24%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV----------------------------FHFSCS 422
IG GSFG +++ L + + AIK ++
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 423 NEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDL 482
LV++ SLE +L + + + ++ +H +++ D+
Sbjct: 72 EGLHNVLVIDL-LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDI 127
Query: 483 KPHNKLLDDNIVAH-----LSDFGIAKLL--TGEDQSMTQTQTLAIIG---YMAP 527
KP N L+ + + DFG+ K Q + + + G YM+
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 76.8 bits (188), Expect = 4e-16
Identities = 39/184 (21%), Positives = 62/184 (33%), Gaps = 41/184 (22%)
Query: 381 LRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV----------------------- 416
LR + + IG GSFG +Y + G E AIK+
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 62
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF 471
+ + D+ +V+E SLE + + + L + + S +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH- 120
Query: 472 GYSTPIIHCDLKPHN---KLLDDNIVAHLSDFGIAKLLTGED-----QSMTQTQTLAIIG 523
S IH D+KP N L + ++ DFG+AK
Sbjct: 121 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 524 YMAP 527
Y +
Sbjct: 179 YASI 182
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 4e-16
Identities = 39/187 (20%), Positives = 63/187 (33%), Gaps = 47/187 (25%)
Query: 382 RATDGFSANNLIGRGSFGSVYKAR--LQDGMEFAIKVFHFSCSNEDFRA----------- 428
RA + IG G++G V+KAR G A+K E
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 429 ----------------------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMI 460
LV E+ + + ++M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 461 DVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 520
+ L++LH S ++H DLKP N L+ + L+DFG+A++ + + + TL
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL- 179
Query: 521 IIGYMAP 527
Y AP
Sbjct: 180 --WYRAP 184
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 76.0 bits (186), Expect = 9e-16
Identities = 35/197 (17%), Positives = 71/197 (36%), Gaps = 41/197 (20%)
Query: 362 NVSNMQPQASRRRFSYQELLRATDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKVFH-- 418
+V+ +P+ S+ D + +GRG + V++A + + + +K+
Sbjct: 12 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 71
Query: 419 ---------------------------FSCSNEDFRALVLEYTTNGSLEKVLYSSNYILD 451
ALV E+ N +++ + L
Sbjct: 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LT 127
Query: 452 ILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGED 510
M ++ AL+Y H S I+H D+KPHN ++D ++ L D+G+A+
Sbjct: 128 DYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 511 QSMTQTQTLAIIGYMAP 527
+ + + + P
Sbjct: 185 EYNVRVASR---YFKGP 198
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.9 bits (185), Expect = 9e-16
Identities = 61/257 (23%), Positives = 103/257 (40%), Gaps = 5/257 (1%)
Query: 85 SSMSNCKYLKKLDISRNPLDGF--LPRVVGNFSQSLEFIWMSDC-NISGGISEEIGNLTD 141
+ + + LD+S L +P + N L F+++ N+ G I I LT
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201
L + + ++G+I L +++ L L F N L G++P + L L + GN++S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 202 GSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVL 261
G+IP +G+ + L S + L S + S +
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 262 TRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321
T+ N L + K+L L L +NR+ G++P L L SL++S NNL
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 322 IIPLSLEKLLYLNILLI 338
IP L ++
Sbjct: 283 EIP-QGGNLQRFDVSAY 298
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.6 bits (127), Expect = 2e-08
Identities = 15/67 (22%), Positives = 28/67 (41%), Gaps = 1/67 (1%)
Query: 119 EFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG 178
+ + + I G + + + L L S+++ N L G I G LQ+ ++ N+
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC 305
Query: 179 SIPNVLC 185
P C
Sbjct: 306 GSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.2 bits (126), Expect = 2e-08
Identities = 18/62 (29%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 194 DLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSN--LFVGPL 251
DLR N++ G++P L L +L++ N L NL+ + +N L PL
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
Query: 252 PS 253
P+
Sbjct: 310 PA 311
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 75.6 bits (185), Expect = 2e-15
Identities = 43/210 (20%), Positives = 68/210 (32%), Gaps = 46/210 (21%)
Query: 355 KRATKLPNVSNMQPQASRRRFSYQELLRAT----DGFSANNLIGRGSFGSVYKAR-LQDG 409
K+ ++ +V +A E D F +G GSFG V + + G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 410 MEFAIKV--------------------------------FHFSCSNEDFRALVLEYTTNG 437
+A+K+ FS + +V+EY G
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHL 497
+ L + EYLH S +I+ DLKP N L+D +
Sbjct: 127 EMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182
Query: 498 SDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
+DFG AK + G ++ +AP
Sbjct: 183 TDFGFAKRVKGRTWTLCG-----TPEALAP 207
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 2e-15
Identities = 37/162 (22%), Positives = 62/162 (38%), Gaps = 37/162 (22%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------- 416
+ F L+G+G+FG V R G +A+K+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 417 -----FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHF 471
++ D V+EY G L L S + + ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 472 GYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513
S +++ D+K N +LD + ++DFG+ K + +M
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.7 bits (175), Expect = 3e-15
Identities = 19/149 (12%), Positives = 42/149 (28%), Gaps = 39/149 (26%)
Query: 391 NLIGRGSFGSVYKARLQDGMEFAIKVFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYIL 450
L+G G +V+ + E +K ++ +Y + S+
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 451 DILQRLN-----------------------------------IMIDVTSALEYLHFGYST 475
LQ+L ++ + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HR 122
Query: 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504
I+H DL +N L+ + + + DF +
Sbjct: 123 GIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (181), Expect = 4e-15
Identities = 35/179 (19%), Positives = 62/179 (34%), Gaps = 46/179 (25%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA--------------------- 428
IG+G+FG V+KAR + G + A+K E F
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 429 ------------------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLH 470
LV ++ + + + + +M + L L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML---LNGLY 131
Query: 471 FGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAI--IGYMAP 527
+ + I+H D+K N L+ + V L+DFG+A+ + S T + + Y P
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.7 bits (177), Expect = 8e-15
Identities = 29/169 (17%), Positives = 58/169 (34%), Gaps = 38/169 (22%)
Query: 391 NLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRA--------------------- 428
IG G++G+V+KA+ + A+K +E +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 429 ----------LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPII 478
LV E+ + + + + + + L + H ++
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHS---RNVL 123
Query: 479 HCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
H DLKP N L++ N L++FG+A+ + + + + Y P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPP 170
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 3e-14
Identities = 41/180 (22%), Positives = 65/180 (36%), Gaps = 43/180 (23%)
Query: 385 DGFSANNLIGRGSFGSVYKARL----QDGMEFAIKV------------------------ 416
+ F ++G G++G V+ R G +A+KV
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 417 ----------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSAL 466
H++ E L+L+Y G L L + + ++ AL
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLAL 142
Query: 467 EYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526
E+LH II+ D+K N LLD N L+DFG++K ++ I YMA
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.9 bits (173), Expect = 3e-14
Identities = 38/183 (20%), Positives = 59/183 (32%), Gaps = 47/183 (25%)
Query: 385 DGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKV--------------------------- 416
D + +G G F V K R G+++A K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 417 --------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEY 468
H N+ L+LE G L + L + + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128
Query: 469 LHFGYSTPIIHCDLKPHNKLLDDN----IVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGY 524
LH S I H DLKP N +L D + DFG+A + ++ T +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT---PEF 182
Query: 525 MAP 527
+AP
Sbjct: 183 VAP 185
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 6e-14
Identities = 39/198 (19%), Positives = 67/198 (33%), Gaps = 53/198 (26%)
Query: 372 RRRFSYQELLRATDGFSAN----NLIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDF 426
R F QE+ + A +G G++G+V A + G + AIK + +E F
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 427 RA-------------------------------------LVLEYTTNGSLEKVLYSSNYI 449
LV+ + + +
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEK 117
Query: 450 LDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509
L + ++ + L Y+H + IIH DLKP N ++++ + DFG+A+ E
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
Query: 510 DQSMTQTQTLAIIGYMAP 527
T + Y AP
Sbjct: 175 -----MTGYVVTRWYRAP 187
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.0 bits (165), Expect = 5e-13
Identities = 34/170 (20%), Positives = 55/170 (32%), Gaps = 40/170 (23%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKVFHFSCSNEDFRALVLE------------------ 432
IG G+ G V A AIK N+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 433 -YTTNGSLEKVL-------YSSNYILDILQR-------LNIMIDVTSALEYLHFGYSTPI 477
+T +LE+ + ++Q ++ + +++LH S I
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGI 140
Query: 478 IHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527
IH DLKP N ++ + + DFG+A+ S T + Y AP
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAP 187
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.6 bits (161), Expect = 2e-12
Identities = 31/181 (17%), Positives = 57/181 (31%), Gaps = 47/181 (25%)
Query: 392 LIGRGSFGSVYKAR-LQDGMEFAIKV---------------------------------- 416
+G G F +V+ A+ + + A+K+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 417 ---------FHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALE 467
F+ N +V E L + + + ++ I + L+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 468 YLHFGYSTPIIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMA 526
Y+H IIH D+KP N L++ + +L IA L T ++ Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 527 P 527
P
Sbjct: 198 P 198
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 2e-11
Identities = 42/193 (21%), Positives = 69/193 (35%), Gaps = 49/193 (25%)
Query: 375 FSYQELLRA----TDGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK-------------- 415
F QEL + + + + +G G++GSV A + G+ A+K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 416 ---------------------VFHFSCSNEDFRALVLEYTTNGSLEKVLYSSNYILDILQ 454
VF + S E+F + L G+ + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122
Query: 455 RLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514
++ + L+Y+H S IIH DLKP N ++++ + DFG+A+ E
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179
Query: 515 QTQTLAIIGYMAP 527
T Y AP
Sbjct: 180 AT-----RWYRAP 187
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 7e-11
Identities = 40/180 (22%), Positives = 57/180 (31%), Gaps = 3/180 (1%)
Query: 140 TDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNK 199
D + L N L TL +L L+ EL + L VL LDL N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQ 88
Query: 200 LSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLK 259
L + + L L ++ L N P +
Sbjct: 89 LQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 260 VLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 319
L ++ + NNL + GL++L L L N L +IP F L L N
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 4e-10
Identities = 44/203 (21%), Positives = 70/203 (34%), Gaps = 7/203 (3%)
Query: 135 EIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLD 194
E+ + + ++ L ++ L K L N L L L QL+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 195 LRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSK 254
L + + G L L L L N+L S+P + L + LD N
Sbjct: 62 LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 255 IGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDL 314
+ L L + N L P + L+ LSL +N L + L +L++L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 315 SNNNLSEIIP--LSLEKLLYLNI 335
N+L I L + +
Sbjct: 180 QENSLYTIPKGFFGSHLLPFAFL 202
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 2e-08
Identities = 31/211 (14%), Positives = 59/211 (27%), Gaps = 7/211 (3%)
Query: 86 SMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISI 145
+S +++ + L + + + + +S+ + + T L +
Sbjct: 5 EVSKVASHLEVNCDKRNLT----ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 146 DLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP 205
+L +L L L L N+L+ A+ S +
Sbjct: 61 NLDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 206 TCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRID 265
G + T P +L + L +N + L+ L +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 266 FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296
N+L IP G L F L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 1e-06
Identities = 41/188 (21%), Positives = 68/188 (36%), Gaps = 9/188 (4%)
Query: 60 LSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLE 119
L L LS+N L + + +++ L +L++ R L + + +
Sbjct: 29 LPKDTTILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAELTKLQV----DGTLPVL 79
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179
N + L L +D+ N+L L L +LQ L +GNEL+
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 180 IPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILY 239
P +L L +L L N L+ L L L L N L +IP + + +
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPF 199
Query: 240 LDFWSNLF 247
N +
Sbjct: 200 AFLHGNPW 207
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 6e-08
Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 171 FRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI 230
+ N I ++ L +L++ NKL +P L L N L +P +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAEVPEL 322
Query: 231 LWNLKDILYLDFWSNLF--VGPLPSKIGNLKV 260
NLK L N +P + +L++
Sbjct: 323 PQNLK---QLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 2e-07
Identities = 24/105 (22%), Positives = 41/105 (39%), Gaps = 11/105 (10%)
Query: 232 WNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLG 291
L ++ ++ N + S L ++ S N L+ ++P L+ L
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIAS 312
Query: 292 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEI--IPLSLEKLLYLN 334
N L +P +L+ L + N L E IP S+E L +N
Sbjct: 313 FNHLA-EVPEL---PQNLKQLHVEYNPLREFPDIPESVED-LRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 3e-07
Identities = 20/93 (21%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 195 LRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSK 254
N S I + +L L++ +N+L +P++ L+ L N +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAE-VPEL 322
Query: 255 IGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQF 287
NLK L N L P + ++ L+
Sbjct: 323 PQNLKQL---HVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 7e-06
Identities = 18/70 (25%), Positives = 33/70 (47%), Gaps = 5/70 (7%)
Query: 266 FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 325
+ N +I + SL+ L++ +N+L +P LE L S N+L+E +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPE 321
Query: 326 SLEKLLYLNI 335
+ L L++
Sbjct: 322 LPQNLKQLHV 331
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 24/122 (19%), Positives = 38/122 (31%), Gaps = 33/122 (27%)
Query: 120 FIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGS 179
S I L +++ NKL EL
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL---------------------IELPAL 302
Query: 180 IPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILY 239
P L +L N L+ +P N L+ LH++ N L P I +++D L
Sbjct: 303 PPR-------LERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVED-LR 350
Query: 240 LD 241
++
Sbjct: 351 MN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 15/51 (29%), Positives = 23/51 (45%), Gaps = 4/51 (7%)
Query: 185 CHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLK 235
C +L+L LS S+P +L +L N LT +P + +LK
Sbjct: 35 CLDRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLTELPELPQSLK 81
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 7e-08
Identities = 33/120 (27%), Positives = 50/120 (41%), Gaps = 7/120 (5%)
Query: 215 RNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274
R LHL +LT + L L + +LD N P+ + L+ L + S N +
Sbjct: 1 RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LE 56
Query: 275 IPTTIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEI--IPLSLEKLL 331
+ L LQ L L +NRLQ + L L+L N+L + I L ++L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 2e-07
Identities = 21/118 (17%), Positives = 34/118 (28%), Gaps = 6/118 (5%)
Query: 193 LDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLP 252
L L L+ + L + +L L N L ++P L L+ + L N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 253 SKIGNLKVLTRIDFSRNNLLG-DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSL 309
+ N L + L L+L N L + L +
Sbjct: 61 VANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 8e-07
Identities = 25/117 (21%), Positives = 44/117 (37%), Gaps = 6/117 (5%)
Query: 123 MSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPN 182
++ +++ + + L + +DL N+L L L+ L+ L N LE
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGV 61
Query: 183 VLCHLAVLFQLDLRGNKL-SGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDIL 238
L +L L N+L + + L L+L N L I L ++L
Sbjct: 62 ANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 4e-05
Identities = 27/126 (21%), Positives = 45/126 (35%), Gaps = 13/126 (10%)
Query: 67 LSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDC 126
L L+ LT L + + LD+S N L P + +
Sbjct: 3 LHLAHKDLTV-------LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQAS 51
Query: 127 NISGGISEEIGNLTDLISIDLGGNKLNGSISI-TLGKLQKLQFLSFRGNELEGSIPNVLC 185
+ + + + NL L + L N+L S +I L +L L+ +GN L +
Sbjct: 52 DNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQE 110
Query: 186 HLAVLF 191
LA +
Sbjct: 111 RLAEML 116
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 1e-07
Identities = 37/214 (17%), Positives = 76/214 (35%), Gaps = 22/214 (10%)
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
L + I I G + + ++ T L + LS G + +I + +L L L+L+
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 198 NKLSG--------SIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVG 249
N+++ I + L+N+ + + L + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 250 PLPSKIGNLKVLTRIDFSRNNLLGDIP-------TTIQGLKSLQFLSLGHNRLQGSIPNS 302
L + + ++ + N I T + L L L N++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 303 FDDLVSLESLDLSNNNLSEIIPLS-LEKLLYLNI 335
L +L + L NN +S++ PL+ L + +
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 35/211 (16%), Positives = 69/211 (32%), Gaps = 23/211 (10%)
Query: 121 IWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSI 180
I N++ +++ +L + ++ G + +I + L L L + N++
Sbjct: 24 IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA 79
Query: 181 PNVLCHLAVLFQLDLRGNKLSGSIP---------------TCFGNLTALRNLHLDSNELT 225
P +L K +I T L L NL + +L
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
Query: 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSL 285
I +I + + NL LT + N + P + L +L
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNL 197
Query: 286 QFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
+ L +N++ P + +L + L+N
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.003
Identities = 28/192 (14%), Positives = 62/192 (32%), Gaps = 23/192 (11%)
Query: 64 VDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPL------DGFLPRVVGNFSQS 117
+ LS +T+ + + L L++ N + S +
Sbjct: 43 ITTLSAFGTGVTT-------IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGN 95
Query: 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE 177
+ + + ++ + L G + + L ++ + L+ N
Sbjct: 96 PLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQY 155
Query: 178 G-------SIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSI 230
S L +L+ L L NK+S P +L L +HL +N+++ +
Sbjct: 156 LSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP- 212
Query: 231 LWNLKDILYLDF 242
L N ++ +
Sbjct: 213 LANTSNLFIVTL 224
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 1e-07
Identities = 33/199 (16%), Positives = 66/199 (33%), Gaps = 14/199 (7%)
Query: 138 NLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197
+ I +L + ++ T +L + + ++++ + +L + +L L G
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGN 257
NKL+ P L NL + S S I
Sbjct: 78 NKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 258 LKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 317
L L +++ T+ + + I L L++L LS N
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN 188
Query: 318 NLSEIIPLS-LEKLLYLNI 335
++S++ L+ L+ L L +
Sbjct: 189 HISDLRALAGLKNLDVLEL 207
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 1e-06
Identities = 21/118 (17%), Positives = 35/118 (29%), Gaps = 9/118 (7%)
Query: 232 WNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNL----LGDIPTTIQGLKSLQF 287
I VL + + ++ + T+ SL+
Sbjct: 342 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401
Query: 288 LSLGHNRLQGSIPNSFDDLV-----SLESLDLSNNNLSEIIPLSLEKLLYLNILLIVV 340
L L +N L + + V LE L L + SE + L+ L L V+
Sbjct: 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 5/88 (5%)
Query: 261 LTRIDFSRNNLL-GDIPTTIQGLKSLQFLSLGHNRLQG----SIPNSFDDLVSLESLDLS 315
+ +D L + L+ Q + L L I ++ +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 316 NNNLSEIIPLSLEKLLYLNILLIVVVIL 343
+N L ++ + + L I + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 8e-06
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 141 DLISIDLGGNKLNGS-ISITLGKLQKLQFLSFRGNELEG----SIPNVLCHLAVLFQLDL 195
D+ S+D+ +L+ + + L LQ+ Q + L I + L L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 196 RGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWN 233
R N+L C + + L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 11/92 (11%)
Query: 93 LKKLDISRNPL-DGFLPRVVGNFSQSLEFIWMSDCNISG----GISEEIGNLTDLISIDL 147
++ LDI L D ++ Q + + + DC ++ IS + L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLL-QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 148 GGNKLNGSISITLGKL-----QKLQFLSFRGN 174
N+L + + K+Q LS +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 16/90 (17%), Positives = 28/90 (31%), Gaps = 5/90 (5%)
Query: 236 DILYLDFWSN-LFVGPLPSKIGNLKVLTRIDFSRNNL----LGDIPTTIQGLKSLQFLSL 290
DI LD L + L+ + L DI + ++ +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 291 GHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320
N L + + S + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 5e-04
Identities = 15/81 (18%), Positives = 31/81 (38%), Gaps = 9/81 (11%)
Query: 116 QSLEFIWMSDCNISG----GISEEIGNLTDLISIDLGGNKLNGSISITLGKLQK-----L 166
L +W++DC++S ++ + L +DL N L + + L + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 167 QFLSFRGNELEGSIPNVLCHL 187
+ L + + L L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 18/68 (26%), Positives = 28/68 (41%), Gaps = 4/68 (5%)
Query: 280 QGLKSLQFLSLGHNRLQG----SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
Q L+ L L + S+ + SL LDLSNN L + L L + +
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 336 LLIVVVIL 343
L+ ++L
Sbjct: 426 CLLEQLVL 433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 2e-06
Identities = 46/255 (18%), Positives = 91/255 (35%), Gaps = 17/255 (6%)
Query: 94 KKLDISRNPL-DGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKL 152
+ LD++ L R++ + + ++E + + +DL + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFR---CPRSFMDQPLAE-HFSPFRVQHMDLSNSVI 58
Query: 153 NG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG--NKLSGSIPTCFG 209
++ L + KLQ LS G L I N L + L +L+L G ++ T
Sbjct: 59 EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118
Query: 210 NLTALRNLHLDSNELTSIPSILWNLKDILY-------LDFWSNLFVGPLPSKIGNLKVLT 262
+ + L L+L + + + + + NL L + + L
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 263 RIDFSRNNLLGD-IPTTIQGLKSLQFLSLGH-NRLQGSIPNSFDDLVSLESLDLSNNNLS 320
+D S + +L + L LQ LSL + ++ +L++L +
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238
Query: 321 EIIPLSLEKLLYLNI 335
+ L E L +L I
Sbjct: 239 GTLQLLKEALPHLQI 253
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 2e-05
Identities = 30/282 (10%), Positives = 82/282 (29%), Gaps = 25/282 (8%)
Query: 56 VLGRL-SSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNF 114
V GRL S V +++ E ++ +D+S + ++ + +
Sbjct: 16 VTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR------VQHMDLSNSVIEVSTLHGILSQ 69
Query: 115 SQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGN 174
L+ + + +S I + ++L+ ++L G ++ + +
Sbjct: 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 129
Query: 175 ELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNL 234
+ + LSG + + +
Sbjct: 130 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL------------ 177
Query: 235 KDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD-IPTTIQGLKSLQFLSLGHN 293
+ S + + L L + SR + + + +L+ L +
Sbjct: 178 --VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235
Query: 294 RLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNI 335
G++ + +L L ++ ++ + I ++ I
Sbjct: 236 VPDGTLQLLKE---ALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.0 bits (107), Expect = 3e-06
Identities = 32/166 (19%), Positives = 66/166 (39%), Gaps = 4/166 (2%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEI-GNLTDLISIDLGGNKLNGSISITLGKLQK 165
L + + + ++D + S+ + G L L+ ++L N+L G
Sbjct: 20 LKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 166 LQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELT 225
+Q L N+++ + L L L+L N++S +P F +L +L +L+L SN
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 226 SIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNL 271
+ W + + PSK+ ++++ D +
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.0 bits (107), Expect = 3e-06
Identities = 33/164 (20%), Positives = 61/164 (37%), Gaps = 4/164 (2%)
Query: 140 TDLISIDLGGNKLNGSISITL-GKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGN 198
+ L N+L S L G+L L L + N+L G PN + + +L L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 199 KLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNL 258
K+ F L L+ L+L N+++ + + + L ++
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148
Query: 259 KVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS 302
+ L + + P+ ++ +Q L H+ + S NS
Sbjct: 149 EWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 32/120 (26%), Positives = 50/120 (41%), Gaps = 1/120 (0%)
Query: 215 RNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGD 274
+ L IP + L L+ L G L L +++ RN L G
Sbjct: 11 TTVDCTGRGLKEIPRDIPLHTTELLLNDN-ELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 275 IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLN 334
P +G +Q L LG N+++ F L L++L+L +N +S ++P S E L L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 4e-06
Identities = 29/133 (21%), Positives = 51/133 (38%), Gaps = 5/133 (3%)
Query: 194 DLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPS 253
+L+ ++ + LD L S P L + L+ S++ L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPD-LVAQNIDVVLNRRSSMAAT-LRI 59
Query: 254 KIGNLKVLTRIDFSRNNLLG--DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 311
N+ L ++ S N L D+ + +Q +L+ L+L N L+ + LE
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 312 LDLSNNNLSEIIP 324
L L N+LS+
Sbjct: 120 LWLDGNSLSDTFR 132
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 1e-05
Identities = 41/198 (20%), Positives = 76/198 (38%), Gaps = 16/198 (8%)
Query: 138 NLTDLISIDLGGNKLNGSISIT-LGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196
L + + LG + ++S T L ++ LQ ++G + +L L Q++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIG 256
N+L+ T NLT L ++ +++N++ I + F + + +
Sbjct: 71 NNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 257 NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 316
NL L I L + Q + +L +LE LD+S+
Sbjct: 129 NLNRLELSSN-------TISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISS 181
Query: 317 NNLSEIIPLS-LEKLLYL 333
N +S+I L+ L L L
Sbjct: 182 NKVSDISVLAKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 2e-05
Identities = 23/224 (10%), Positives = 49/224 (21%), Gaps = 7/224 (3%)
Query: 107 LPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166
+ + + ++ + + DL I++ N + I +
Sbjct: 20 VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS-----GSIPTCFGNLTALRNLHLDS 221
N + L + L +
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 222 NELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQG 281
S + + + L N ++ NNL G
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 282 LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 325
L + R+ ++L L + S NL ++ L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 24/217 (11%), Positives = 44/217 (20%), Gaps = 5/217 (2%)
Query: 125 DCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVL 184
C S + I + KL L+ + N++ I +
Sbjct: 14 LCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73
Query: 185 CHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWS 244
+ +L + + L
Sbjct: 74 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 133
Query: 245 NLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLG----HNRLQGSIP 300
+ + N V + L + I N +P
Sbjct: 134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELP 193
Query: 301 -NSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336
+ F LD+S + + LE L L
Sbjct: 194 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 1e-04
Identities = 11/67 (16%), Positives = 27/67 (40%), Gaps = 2/67 (2%)
Query: 270 NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 329
L+ ++ + L L ++ I N L +++D S+N + ++ L +
Sbjct: 6 ELIEQAAQYTNAVR-DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLR 63
Query: 330 LLYLNIL 336
L ++
Sbjct: 64 RLKTLLV 70
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 5e-04
Identities = 27/136 (19%), Positives = 45/136 (33%), Gaps = 6/136 (4%)
Query: 190 LFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVG 249
+LDLRG K+ I L + NE+ + L+ + L +N
Sbjct: 20 DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF-PLLRRLKTLLVNNNRICR 77
Query: 250 PLPSKIGNLKVLTRIDFSRNNLLG-DIPTTIQGLKSLQFLSLGH---NRLQGSIPNSFDD 305
L LT + + N+L+ + LKSL +L + +
Sbjct: 78 IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYK 137
Query: 306 LVSLESLDLSNNNLSE 321
+ + LD L E
Sbjct: 138 VPQVRVLDFQKVKLKE 153
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.002
Identities = 19/88 (21%), Positives = 30/88 (34%), Gaps = 2/88 (2%)
Query: 208 FGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFS 267
+ N R L L ++ I ++ L +DF N L+ L + +
Sbjct: 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 71
Query: 268 RNNLLGDIPTTIQGLKSLQFLSLGHNRL 295
N + Q L L L L +N L
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSL 99
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.002
Identities = 8/60 (13%), Positives = 20/60 (33%), Gaps = 5/60 (8%)
Query: 184 LCHLAVLFQLDLRGNKLSGSIPTC-----FGNLTALRNLHLDSNELTSIPSILWNLKDIL 238
L L L+ N++ + L L L+ N + ++ ++++
Sbjct: 269 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 328
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.0 bits (84), Expect = 0.002
Identities = 24/151 (15%), Positives = 47/151 (31%), Gaps = 9/151 (5%)
Query: 193 LDLRGNKLSGSIP------TCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNL 246
+ +L G IP L A ++L L +N + I S L ++++ L NL
Sbjct: 23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS-LSGMENLRILSLGRNL 81
Query: 247 FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDL 306
+ + + N + + + + + + L
Sbjct: 82 I--KKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAAL 139
Query: 307 VSLESLDLSNNNLSEIIPLSLEKLLYLNILL 337
LE L L+ N L + Y ++
Sbjct: 140 DKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 527 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.96 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.96 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.96 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.95 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.95 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.95 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.95 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.95 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.95 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.95 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.95 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.95 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.95 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.95 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.94 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.94 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.94 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.94 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.94 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.94 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.94 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.94 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.94 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.94 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.94 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.93 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.93 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.93 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.93 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.92 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.92 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.92 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.91 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.91 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.91 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.91 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.91 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.9 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.9 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.9 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.89 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.89 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.88 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.87 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.81 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.56 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.55 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.41 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.6 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.59 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.51 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.1 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.98 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.89 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.42 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.61 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 88.25 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=4.6e-31 Score=258.97 Aligned_cols=251 Identities=27% Similarity=0.461 Sum_probs=196.9
Q ss_pred ceEEcccccccCCCCCCcccccCCCCCCCCEEEccc-CCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCc
Q 035895 65 DELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISR-NPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLI 143 (527)
Q Consensus 65 ~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 143 (527)
+.|+|++|.+++. .++++.+.++++|++|||++ |+++|.+|..+..+. +|++|+|++|++.+..+..+..+..|+
T Consensus 53 ~~L~L~~~~l~g~---~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~-~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 53 NNLDLSGLNLPKP---YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp EEEEEECCCCSSC---EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCT-TCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEECCCCCCCCC---CCCChHHhcCcccccccccccccccccccccccccc-ccchhhhccccccccccccccchhhhc
Confidence 3444555544431 11224577888888888886 788888888888875 788888888888888888888888888
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCccc-CeeeeecccCCCCCCccccCCccCceeeCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVL-FQLDLRGNKLSGSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 222 (527)
.+++++|.+.+.+|..+..+++|+.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+.++..+ .++++++
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSS
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 88888888888888888888888888888888888888888877775 778888888888888888777544 6888887
Q ss_pred CCCC-CchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCC
Q 035895 223 ELTS-IPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 301 (527)
Q Consensus 223 ~l~~-lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 301 (527)
.... +|..+..++.++.+++++|.+.+.+| .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+++|.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 7765 56667778888888888888876654 577788888888888888888888888888888888888888888874
Q ss_pred CCCCCCCCCEEeCCCCc-cccc
Q 035895 302 SFDDLVSLESLDLSNNN-LSEI 322 (527)
Q Consensus 302 ~~~~l~~L~~L~ls~N~-l~~~ 322 (527)
+..+++|+.+++++|+ +.|.
T Consensus 287 -~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 287 -GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp -STTGGGSCGGGTCSSSEEEST
T ss_pred -cccCCCCCHHHhCCCccccCC
Confidence 5778888888888886 5553
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=6.8e-31 Score=257.74 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=222.5
Q ss_pred chhccc-CCCceee--cCchhhhcCCCCCEEEccc-cccccccccccceEEcccccccCCCCCCcccccCCCCCCCCEEE
Q 035895 22 RICTID-SQNKLVG--IVSITIFNLSTLKVFDVDN-NYVLGRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLD 97 (527)
Q Consensus 22 ~~~~~~-s~N~l~~--~~~~~~~~l~~L~~L~Ls~-N~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~ 97 (527)
|+..+| +.|.++| .+|..+.+|++|++|||++ |.+.|.+| ..+.++++|++||
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP-----------------------~~i~~L~~L~~L~ 107 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP-----------------------PAIAKLTQLHYLY 107 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCC-----------------------GGGGGCTTCSEEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccc-----------------------cccccccccchhh
Confidence 577777 7777776 3677888888888888875 66665544 2467889999999
Q ss_pred cccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCC-CEEeccCccc
Q 035895 98 ISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL-QFLSFRGNEL 176 (527)
Q Consensus 98 Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~N~l 176 (527)
|++|++.+..+..+.... .|+.+++++|.+.+.+|..+..++.|+++++++|.+.+.+|..+..+.++ +.+++++|++
T Consensus 108 Ls~N~l~~~~~~~~~~~~-~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 108 ITHTNVSGAIPDFLSQIK-TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp EEEECCEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred hccccccccccccccchh-hhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence 999999998888887765 79999999999999999999999999999999999999999999888886 8899999999
Q ss_pred ccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCcccc
Q 035895 177 EGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIG 256 (527)
Q Consensus 177 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~ 256 (527)
++..|..+..+..+ .++++++.+.+.+|..+..+++|+.+++++|.++..++.+..++.|+.|++++|++++.+|..++
T Consensus 187 ~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~ 265 (313)
T d1ogqa_ 187 TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265 (313)
T ss_dssp EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHh
Confidence 99999998887654 79999999999999999999999999999999998877888899999999999999999999999
Q ss_pred CCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccc-ee
Q 035895 257 NLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL-QG 297 (527)
Q Consensus 257 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~ 297 (527)
++++|++|+|++|+++|.+|. ++.+++|+.+++++|+. .|
T Consensus 266 ~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 266 QLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp GCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred CCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence 999999999999999998884 68899999999999984 44
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.9e-30 Score=247.92 Aligned_cols=140 Identities=24% Similarity=0.389 Sum_probs=118.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||++... +.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999986 57899999997531 223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
||+||+|.+++... ..+++.++..++.|++.||+||| +++||||||||+|||+++++.+||+|||+|+.+......
T Consensus 84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999998643 46889999999999999999999 999999999999999999999999999999987544333
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
...+..+||+.||||
T Consensus 160 ~~~~~~~GT~~Y~AP 174 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAP 174 (271)
T ss_dssp CCBCCCCSCGGGSCT
T ss_pred ccccceeeCcCccCH
Confidence 333456799999999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-30 Score=249.66 Aligned_cols=140 Identities=28% Similarity=0.475 Sum_probs=113.3
Q ss_pred hcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec------------------------------cCccceeEEEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~------------------------------~~~~~~~~lv~e 432 (527)
..++|++.+.||+|+||+||+|+++. .||||+++.. +..++..++|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~E 83 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ 83 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEe
Confidence 35679999999999999999998754 6999997531 112345689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
||++|+|.+++...+..+++.++..|+.|||+||+||| +++||||||||+|||++.++.+||+|||+|+........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877677899999999999999999999 899999999999999999999999999999887543333
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
...+...||+.||||
T Consensus 161 ~~~~~~~gt~~y~AP 175 (276)
T d1uwha_ 161 HQFEQLSGSILWMAP 175 (276)
T ss_dssp -----CCCCGGGCCH
T ss_pred ccccccccCcccCCH
Confidence 333456789999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-29 Score=242.93 Aligned_cols=139 Identities=32% Similarity=0.513 Sum_probs=115.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv~ 431 (527)
++|++.+.||+|+||+||+|+. .+|+.||||++.. .+.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999986 5789999999742 123456778999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|||+||+|.+++... ..+++.++..++.|++.||+|+| +++||||||||+||++++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999988754 35788899999999999999999 99999999999999999999999999999998764433
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.......+||+.||||
T Consensus 164 ~~~~~~~~GT~~Y~AP 179 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSP 179 (288)
T ss_dssp ------CCCCGGGCCH
T ss_pred ccccccccCCccccCc
Confidence 3333446799999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.6e-29 Score=241.13 Aligned_cols=140 Identities=26% Similarity=0.405 Sum_probs=111.1
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||+||+|++.+++.||||++.. .|..++..++|||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 357899999999999999999998889999999742 2344567789999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccce
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 515 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 515 (527)
+|+|.+++......+++..+..|+.|||.||+|+| +++|+||||||+|||+++++.+||+|||+|+....... ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 99999999877777899999999999999999999 99999999999999999999999999999998754332 222
Q ss_pred eccccccccccC
Q 035895 516 TQTLAIIGYMAP 527 (527)
Q Consensus 516 ~~~~~t~~y~aP 527 (527)
....||+.||||
T Consensus 160 ~~~~gt~~y~aP 171 (263)
T d1sm2a_ 160 TGTKFPVKWASP 171 (263)
T ss_dssp -----CTTSCCH
T ss_pred cceecCcccCCh
Confidence 345688999998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.1e-29 Score=237.03 Aligned_cols=136 Identities=29% Similarity=0.462 Sum_probs=117.1
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||+||+|+. .+++.||||++.. .+.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46799999999999999999987 4689999999742 12345677899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||||++|+|.+++...+ .+++.++..++.||+.||+||| +++||||||||+|||+++++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999997543 5788899999999999999999 9999999999999999999999999999998765332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.....||+.||||
T Consensus 161 ----~~~~~Gt~~Y~AP 173 (263)
T d2j4za1 161 ----RTTLCGTLDYLPP 173 (263)
T ss_dssp ----CEETTEEGGGCCH
T ss_pred ----ccccCCCCcccCH
Confidence 2345799999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-29 Score=242.24 Aligned_cols=141 Identities=23% Similarity=0.426 Sum_probs=118.0
Q ss_pred hcCCccccceeccCCceEEEEEEccCCcEEEEEEEeec---------------------------cCccceeEEEEEecc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS---------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~lv~ey~~ 435 (527)
..++|++.+.||+|+||+||+|++++++.||||+++.. +..++..++|||||+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence 34678999999999999999999988899999998531 112345689999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 436 NGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 436 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+|+|.+++.... ..+++.++..|+.||++||+||| +++|+||||||+|||+++++.+||+|||+|+.+.... ...
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTA 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EEC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-ccc
Confidence 999999875432 35899999999999999999999 8999999999999999999999999999999875432 222
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.+...||++||||
T Consensus 167 ~~~~~gt~~y~AP 179 (272)
T d1qpca_ 167 REGAKFPIKWTAP 179 (272)
T ss_dssp CTTCCCCTTTSCH
T ss_pred ccccCCcccccCh
Confidence 3345688999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1e-28 Score=238.49 Aligned_cols=136 Identities=32% Similarity=0.444 Sum_probs=116.4
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||++... +..++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 3599999999999999999985 57999999997531 22345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+||+|.+++.+ ..++..++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence 99999998765 35888899999999999999999 99999999999999999999999999999998754332 2
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
....+||+.||||
T Consensus 173 ~~~~~gt~~Y~aP 185 (293)
T d1yhwa1 173 RSTMVGTPYWMAP 185 (293)
T ss_dssp BCCCCSCGGGCCH
T ss_pred ccccccCCCccCh
Confidence 2345799999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.3e-29 Score=243.03 Aligned_cols=145 Identities=24% Similarity=0.360 Sum_probs=111.2
Q ss_pred HhhhcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEeec--------------------------------c
Q 035895 380 LLRATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHFS--------------------------------C 421 (527)
Q Consensus 380 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~--------------------------------~ 421 (527)
++...++|++.+.||+|+||+||+|+.. +++.||||+++.. .
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3333467999999999999999999853 3578999997421 1
Q ss_pred CccceeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 035895 422 SNEDFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHN 486 (527)
Q Consensus 422 ~~~~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~n 486 (527)
..++..++|||||++|+|.+++.... ..+++.++..++.||++||+||| +++||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccc
Confidence 22345689999999999999997532 24788899999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 487 KLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 487 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+++++.+||+|||+|+...........+...||+.||||
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 205 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 205 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence 99999999999999999976544333333446789999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=2.5e-29 Score=242.67 Aligned_cols=143 Identities=25% Similarity=0.440 Sum_probs=120.0
Q ss_pred hhhcCCccccceeccCCceEEEEEEcc-CCcEEEEEEEee----------------------------ccCccceeEEEE
Q 035895 381 LRATDGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKVFHF----------------------------SCSNEDFRALVL 431 (527)
Q Consensus 381 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~----------------------------~~~~~~~~~lv~ 431 (527)
+...++|++.+.||+|+||+||+|+.. +++.||||+++. .+..++..++||
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 334567899999999999999999875 689999999742 234556778999
Q ss_pred EeccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 432 EYTTNGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 432 ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||++|+|.+++... ...+++..+..|+.||+.||+||| +++||||||||+|||+++++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999998754 456899999999999999999999 8999999999999999999999999999999875432
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
....+...||+.||||
T Consensus 170 -~~~~~~~~g~~~y~aP 185 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAP 185 (287)
T ss_dssp -SEEETTEEECGGGCCH
T ss_pred -ceeeccccccccccCh
Confidence 2233345578899998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.1e-28 Score=240.96 Aligned_cols=138 Identities=28% Similarity=0.425 Sum_probs=117.9
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||++.. .+.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 56799999999999999999986 5799999999852 12345577899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||||+||+|.+++...+ .++...+..++.|++.||+|+| +++||||||||+|||++++|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999987654 5788888899999999999999 9999999999999999999999999999999764332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. .....+||++||||
T Consensus 160 ~--~~~~~~GT~~Y~aP 174 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAP 174 (337)
T ss_dssp C--CBCCCEECGGGCCG
T ss_pred c--ccccceeCHHHhhh
Confidence 2 23346799999999
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.5e-29 Score=239.57 Aligned_cols=138 Identities=28% Similarity=0.354 Sum_probs=117.2
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------cCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------CSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ey~ 434 (527)
+.|++.+.||+|+||+||+|+. .+++.||||++... +..++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999986 57899999998531 22345678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
++|+|.+++.+.+..+++.++..++.|++.||+||| +++||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 999999998776667899999999999999999999 9999999999999999999999999999998754221 11
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.....||+.||||
T Consensus 167 ~~~~~Gt~~y~AP 179 (288)
T d2jfla1 167 RDSFIGTPYWMAP 179 (288)
T ss_dssp HTCCCSCCTTCCH
T ss_pred ccccccccccCCH
Confidence 2245689999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.2e-28 Score=240.46 Aligned_cols=141 Identities=24% Similarity=0.436 Sum_probs=115.6
Q ss_pred cCCccccceeccCCceEEEEEEccC------CcEEEEEEEee-------------------------------ccCccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD------GMEFAIKVFHF-------------------------------SCSNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~-------------------------------~~~~~~~ 426 (527)
.++|++.++||+|+||+||+|+... ...||+|++.. .+..++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578999999999999999998642 23699998632 2334566
Q ss_pred eEEEEEeccCCcHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 035895 427 RALVLEYTTNGSLEKVLYSSN----------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKP 484 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~ 484 (527)
.++|||||++|+|.+++.... ..+++..+..|+.||+.||+||| +++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 789999999999999997543 23788899999999999999999 99999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 485 HNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 485 ~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+||+++.++.+||+|||+|+...............||+.||||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 235 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence 9999999999999999999987544433333345689999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.8e-29 Score=236.33 Aligned_cols=141 Identities=29% Similarity=0.436 Sum_probs=103.8
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c--CccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C--SNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~--~~~~~~~lv 430 (527)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. + ..++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999986 57899999997431 1 112456899
Q ss_pred EEeccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcC--CCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 431 LEYTTNGSLEKVLYS---SNYILDILQRLNIMIDVTSALEYLHFG--YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ylH~~--~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
||||++|+|.+++.+ .+..+++..+..++.|++.||+|||.. ...+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 245689999999999999999999931 124599999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+..... ......||++||||
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~AP 183 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSP 183 (269)
T ss_dssp C-------------CCCSCCCH
T ss_pred cccCCC--ccccCCCCcccCCH
Confidence 754322 22346789999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=2.2e-26 Score=224.44 Aligned_cols=260 Identities=19% Similarity=0.264 Sum_probs=192.9
Q ss_pred cccceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcC
Q 035895 62 SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTD 141 (527)
Q Consensus 62 ~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 141 (527)
..++.|+|++|+|+.+++. +|.++++|++|++++|.+....|..|..+. .|+.|++++|+++..+.. ....
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~-----~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~-~L~~L~l~~n~l~~l~~~---~~~~ 101 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDG-----DFKNLKNLHTLILINNKISKISPGAFAPLV-KLERLYLSKNQLKELPEK---MPKT 101 (305)
T ss_dssp TTCCEEECCSSCCCCBCTT-----TTTTCTTCCEEECCSSCCCCBCTTTTTTCT-TCCEEECCSSCCSBCCSS---CCTT
T ss_pred CCCCEEECcCCcCCCcChh-----HhhccccccccccccccccccchhhhhCCC-ccCEecccCCccCcCccc---hhhh
Confidence 3456666666666665542 467788888888888888877777777664 688888888888754432 2356
Q ss_pred CcEEEeecCcccccCcccccCCCCCCEEeccCcccc--cccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeC
Q 035895 142 LISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELE--GSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHL 219 (527)
Q Consensus 142 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 219 (527)
++.|++.+|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|.++. +|..+ +++|+.|++
T Consensus 102 l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l 178 (305)
T d1xkua_ 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHL 178 (305)
T ss_dssp CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEEC
T ss_pred hhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEEC
Confidence 788888888888777777777788888888777543 3345667788888888888888874 34332 567888888
Q ss_pred CCCCCCCC-chhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceee
Q 035895 220 DSNELTSI-PSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS 298 (527)
Q Consensus 220 ~~N~l~~l-p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 298 (527)
++|..+.. +..+..++.++.|++++|.+.+..+..+..+++|++|+|++|.++ .+|..|..+++|++|+|++|+|+..
T Consensus 179 ~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257 (305)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred CCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCcc
Confidence 88888774 556777788888888888888888888888889999999999887 5677888899999999999988855
Q ss_pred cCCCC------CCCCCCCEEeCCCCccc--ccCccchhhhccCC
Q 035895 299 IPNSF------DDLVSLESLDLSNNNLS--EIIPLSLEKLLYLN 334 (527)
Q Consensus 299 ~p~~~------~~l~~L~~L~ls~N~l~--~~~p~~~~~l~~L~ 334 (527)
....| ..+.+|+.|++++|++. .+.|..|..+....
T Consensus 258 ~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~ 301 (305)
T d1xkua_ 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301 (305)
T ss_dssp CTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGG
T ss_pred ChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCc
Confidence 44343 45678889999999875 45666666555443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.5e-29 Score=243.95 Aligned_cols=137 Identities=27% Similarity=0.414 Sum_probs=115.4
Q ss_pred hcCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCccceeEEEE
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNEDFRALVL 431 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~~lv~ 431 (527)
..++|++.+.||+|+||+||+|+. .+|+.||+|+++.. +..++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356799999999999999999996 57899999997531 23455678999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYS-TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~-~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+||+|.+++.+.+ .+++..+..++.|++.||+||| + ++||||||||+|||+++++++||+|||+|+.+....
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999997654 5788889999999999999999 6 489999999999999999999999999999764321
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.+..+||++||||
T Consensus 160 ----~~~~~GT~~Y~AP 172 (322)
T d1s9ja_ 160 ----ANSFVGTRSYMSP 172 (322)
T ss_dssp ----C---CCSSCCCCH
T ss_pred ----cccccCCccccCc
Confidence 2345799999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.2e-28 Score=230.11 Aligned_cols=139 Identities=26% Similarity=0.425 Sum_probs=121.1
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEeccC
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTTN 436 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~~ 436 (527)
++|++.+.||+|+||+||+|+.++++.||||+++. .+..++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 67999999999999999999999899999999753 23445677899999999
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccee
Q 035895 437 GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 516 (527)
Q Consensus 437 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 516 (527)
|+|..++......+++..+..++.|+++||+||| +++|+||||||+||++++++.+||+|||+|+.+..... ...+
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~ 159 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSV 159 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeec
Confidence 9999998877777889999999999999999999 89999999999999999999999999999987754332 2333
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...+|+.||||
T Consensus 160 ~~~~t~~y~aP 170 (258)
T d1k2pa_ 160 GSKFPVRWSPP 170 (258)
T ss_dssp CSCCCGGGCCH
T ss_pred ccCCCCCcCCc
Confidence 45689999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=4e-28 Score=241.76 Aligned_cols=136 Identities=29% Similarity=0.466 Sum_probs=116.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------------ccCcccee
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------------SCSNEDFR 427 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------------~~~~~~~~ 427 (527)
.++|++.++||+|+||.||+|+. .+|+.||||++.. .+..++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 57899999999999999999986 5799999999742 12234567
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++|||||+||+|.+++... ..+++.++..++.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 8999999999999999764 35688888999999999999999 9999999999999999999999999999999775
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
... .....||+.||||
T Consensus 159 ~~~----~~~~~GT~~y~AP 174 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAP 174 (364)
T ss_dssp SSC----CCSCCSCGGGCCH
T ss_pred CCc----ccccccccccchh
Confidence 432 2235689999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=2.4e-28 Score=237.14 Aligned_cols=140 Identities=25% Similarity=0.469 Sum_probs=104.9
Q ss_pred CCccccceeccCCceEEEEEEcc-CC---cEEEEEEEee------------------------------ccCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DG---MEFAIKVFHF------------------------------SCSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~------------------------------~~~~~~~~~lv 430 (527)
+.|++.+.||+|+||+||+|+.+ ++ ..||||++.. .+..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45778899999999999999874 23 3589998632 23455677899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||||++|+|.+++......+++.++..++.|||+||+||| +++||||||||+|||++.++.+||+|||+|+.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999998876677899999999999999999999 8999999999999999999999999999999875432
Q ss_pred Ccc---ceeccccccccccC
Q 035895 511 QSM---TQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~---~~~~~~~t~~y~aP 527 (527)
... ......+|+.||||
T Consensus 183 ~~~~~~~~~~~~~t~~y~aP 202 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAP 202 (299)
T ss_dssp -------------CGGGSCH
T ss_pred CcceeeecccccCCccccCH
Confidence 221 12234578899998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=6.9e-28 Score=235.45 Aligned_cols=135 Identities=33% Similarity=0.441 Sum_probs=115.9
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||+++. .+..++..++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46799999999999999999996 5799999999852 12345677899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||||+||+|..++... ..++......++.||+.||+|+| +++||||||||+|||++.++.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999999999988754 45677788889999999999999 9999999999999999999999999999999875322
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
+..+||+.||||
T Consensus 159 -----~~~~Gt~~Y~AP 170 (316)
T d1fota_ 159 -----YTLCGTPDYIAP 170 (316)
T ss_dssp -----CCCCSCTTTCCH
T ss_pred -----ccccCcccccCH
Confidence 235799999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.8e-28 Score=233.05 Aligned_cols=140 Identities=26% Similarity=0.441 Sum_probs=115.1
Q ss_pred CCccccce-eccCCceEEEEEEcc---CCcEEEEEEEeec-----------------------------cCccceeEEEE
Q 035895 385 DGFSANNL-IGRGSFGSVYKARLQ---DGMEFAIKVFHFS-----------------------------CSNEDFRALVL 431 (527)
Q Consensus 385 ~~~~~~~~-lg~G~~g~vy~~~~~---~~~~vavK~~~~~-----------------------------~~~~~~~~lv~ 431 (527)
++|.+.+. ||+|+||+||+|..+ ++..||||+++.. +...+..++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 45677775 999999999999753 4568999997421 11234568999
Q ss_pred EeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 035895 432 EYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 432 ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|||++|+|.+++...+..+++.++..++.||++||+||| +++||||||||+||+++.++.+||+|||+|+.+.....
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999999998776677899999999999999999999 99999999999999999999999999999998754432
Q ss_pred c-cceeccccccccccC
Q 035895 512 S-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~-~~~~~~~~t~~y~aP 527 (527)
. .......||+.||||
T Consensus 165 ~~~~~~~~~gt~~y~aP 181 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAP 181 (285)
T ss_dssp EECCCCSSCCCGGGCCH
T ss_pred ccccccccccCccccCh
Confidence 2 222345688999998
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=5.5e-26 Score=228.44 Aligned_cols=294 Identities=26% Similarity=0.339 Sum_probs=210.3
Q ss_pred cchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc----cccceEEcccccccCCCCCCcccccCCCCCCCCE
Q 035895 21 YRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS----SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKK 95 (527)
Q Consensus 21 ~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~----~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~ 95 (527)
..+..++ +++.|+.+. .+..|++|++|||++|.+.+..+ ..++.|++++|.++.++ .++.+++|+.
T Consensus 44 ~~l~~L~l~~~~I~~l~--gl~~L~nL~~L~Ls~N~l~~l~~l~~L~~L~~L~L~~n~i~~i~-------~l~~l~~L~~ 114 (384)
T d2omza2 44 DQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADIT-------PLANLTNLTG 114 (384)
T ss_dssp TTCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG-------GGTTCTTCCE
T ss_pred CCCCEEECCCCCCCCcc--ccccCCCCCEEeCcCCcCCCCccccCCccccccccccccccccc-------cccccccccc
Confidence 3455555 555555542 34556666666666666543321 13556666666665432 2455666666
Q ss_pred EEcccCCCCcccChhHhhccccccEEEcccCccc-----------------------------------------cccch
Q 035895 96 LDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNIS-----------------------------------------GGISE 134 (527)
Q Consensus 96 L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~-----------------------------------------~~~~~ 134 (527)
|++++|.+++..+... . ..+..+....|.+. .....
T Consensus 115 L~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (384)
T d2omza2 115 LTLFNNQITDIDPLKN--L-TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191 (384)
T ss_dssp EECCSSCCCCCGGGTT--C-TTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG
T ss_pred cccccccccccccccc--c-ccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccc
Confidence 6666666654322111 1 12222222222111 11234
Q ss_pred hhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccC
Q 035895 135 EIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTAL 214 (527)
Q Consensus 135 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 214 (527)
.+..+++++.+++++|.+++..+ +...++|+.|++++|+++. + +.+..+++|+.|++++|++++..+ ++.+++|
T Consensus 192 ~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L 265 (384)
T d2omza2 192 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKL 265 (384)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred ccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccC
Confidence 56677889999999999987654 4667899999999999974 3 468889999999999999987543 7888999
Q ss_pred ceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccccc
Q 035895 215 RNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR 294 (527)
Q Consensus 215 ~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 294 (527)
++|++++|+++++++ +..+..+..+.+..|.+.+ +..+..++.++.|++++|++++.. .+..+++|++|++++|+
T Consensus 266 ~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~ 340 (384)
T d2omza2 266 TELKLGANQISNISP-LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNK 340 (384)
T ss_dssp SEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSC
T ss_pred CEeeccCcccCCCCc-ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCC
Confidence 999999999998875 6678889999999998875 345788999999999999998753 38899999999999999
Q ss_pred ceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEeeee
Q 035895 295 LQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIVVV 341 (527)
Q Consensus 295 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~~~ 341 (527)
+++ ++ .|.++++|+.|++++|++++++| +.+++.|+.|+++.+
T Consensus 341 l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 341 VSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 985 34 68999999999999999998766 788999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.94 E-value=7.1e-28 Score=238.49 Aligned_cols=138 Identities=22% Similarity=0.368 Sum_probs=118.0
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEe
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey 433 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||++.. .+.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46799999999999999999986 5799999999742 12345678899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEeecccccccCCCCC
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD--DNIVAHLSDFGIAKLLTGEDQ 511 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~--~~~~~kl~Dfg~a~~~~~~~~ 511 (527)
|+||+|.+++......+++..+..|+.||+.||+||| +++||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999999766667899999999999999999999 99999999999999996 468999999999998754322
Q ss_pred ccceeccccccccccC
Q 035895 512 SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 512 ~~~~~~~~~t~~y~aP 527 (527)
.....||+.||||
T Consensus 182 ---~~~~~gT~~Y~aP 194 (350)
T d1koaa2 182 ---VKVTTGTAEFAAP 194 (350)
T ss_dssp ---EEEECSCTTTCCH
T ss_pred ---cceecCcccccCH
Confidence 2345689999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.94 E-value=1e-27 Score=237.58 Aligned_cols=137 Identities=25% Similarity=0.413 Sum_probs=117.8
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee-----------------------------ccCccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF-----------------------------SCSNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~-----------------------------~~~~~~~~~lv~ey~ 434 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||+++. .+.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5699999999999999999986 5799999999753 123456778999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEeecccccccCCCCCc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD--DNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~--~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+||+|.+.+...+..+++.++..|+.||+.||+||| +++||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 999999988766667899999999999999999999 99999999999999998 678999999999998764322
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....||++||||
T Consensus 185 --~~~~~gt~~y~aP 197 (352)
T d1koba_ 185 --VKVTTATAEFAAP 197 (352)
T ss_dssp --EEEECSSGGGCCH
T ss_pred --eeeccCcccccCH
Confidence 2335689999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.7e-28 Score=232.84 Aligned_cols=141 Identities=28% Similarity=0.510 Sum_probs=110.3
Q ss_pred cCCccccceeccCCceEEEEEEccCC-----cEEEEEEEee------------------------------ccCccceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDG-----MEFAIKVFHF------------------------------SCSNEDFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~vavK~~~~------------------------------~~~~~~~~~ 428 (527)
.+.|+..++||+|+||+||+|.++.. ..||||+++. .+..++..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688999999999999999987532 4799999742 233456678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
+|||||.+|++.+++......+++.++..++.||+.|++||| +++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999998877778999999999999999999999 99999999999999999999999999999998754
Q ss_pred CCC-ccceeccccccccccC
Q 035895 509 EDQ-SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~-~~~~~~~~~t~~y~aP 527 (527)
... ........||+.||||
T Consensus 163 ~~~~~~~~~~~~gt~~Y~AP 182 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAP 182 (283)
T ss_dssp -----------CCCGGGSCH
T ss_pred CCccceEeccCCCCccccCH
Confidence 322 2233345689999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=8.4e-28 Score=233.97 Aligned_cols=132 Identities=32% Similarity=0.416 Sum_probs=112.7
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec--------------------------------cCccceeEEEEE
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS--------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~--------------------------------~~~~~~~~lv~e 432 (527)
.|+..+.||+|+||+||+|+. .+++.||||+++.. +..++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 389999999999999999985 57899999997531 223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
||++|++..++.. +..+++.++..++.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 9999999776654 346899999999999999999999 999999999999999999999999999999875422
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
....||+.||||
T Consensus 169 ---~~~~GT~~Y~AP 180 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAP 180 (309)
T ss_dssp ---CCCCSCGGGCCH
T ss_pred ---CccccCccccCH
Confidence 235689999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.3e-27 Score=232.19 Aligned_cols=138 Identities=28% Similarity=0.436 Sum_probs=117.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee---------------------------------ccCccceeEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF---------------------------------SCSNEDFRAL 429 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~---------------------------------~~~~~~~~~l 429 (527)
.++|++.+.||+|+||+||+|+. .+++.||||+++. .+.+++..++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 36899999999999999999986 4789999999852 1223456789
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
|||||++|+|.+++...+ .++..++..++.||+.||+||| +++||||||||+|||+++++.+|++|||+|+.....
T Consensus 81 vmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999997543 5788889999999999999999 999999999999999999999999999999876433
Q ss_pred CCccceeccccccccccC
Q 035895 510 DQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~~~~~~~~~t~~y~aP 527 (527)
.. ..+...||+.||||
T Consensus 157 ~~--~~~~~~gt~~y~aP 172 (320)
T d1xjda_ 157 DA--KTNTFCGTPDYIAP 172 (320)
T ss_dssp TC--CBCCCCSCGGGCCH
T ss_pred cc--cccccCCCCCcCCH
Confidence 22 23345789999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4e-28 Score=233.46 Aligned_cols=139 Identities=25% Similarity=0.448 Sum_probs=111.5
Q ss_pred cCCccccceeccCCceEEEEEEccCCcEEEEEEEee----------------------------ccCccceeEEEEEecc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYTT 435 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~~ 435 (527)
.++|++.+.||+|+||+||+|+.++++.||||+++. .+ .++..++|||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~-~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEE-ecCCeEEEEEecC
Confidence 467999999999999999999998888999999742 12 2345689999999
Q ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 035895 436 NGSLEKVLYSS-NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMT 514 (527)
Q Consensus 436 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 514 (527)
+|+|..++... ...+++.++..|+.+|+.||+||| +++|+||||||+|||+|+++++||+|||+|+.+.... ...
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence 99999888653 345899999999999999999999 8999999999999999999999999999999775332 223
Q ss_pred eeccccccccccC
Q 035895 515 QTQTLAIIGYMAP 527 (527)
Q Consensus 515 ~~~~~~t~~y~aP 527 (527)
.+...+|+.||||
T Consensus 171 ~~~~~gt~~y~aP 183 (285)
T d1fmka3 171 RQGAKFPIKWTAP 183 (285)
T ss_dssp -----CCGGGSCH
T ss_pred eccccccccccCh
Confidence 3345689999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=1.4e-27 Score=232.36 Aligned_cols=136 Identities=25% Similarity=0.375 Sum_probs=104.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEee------------------------------ccCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~------------------------------~~~~~~~~~lv~ey 433 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||++.. .+.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 5599999999999999999986 4789999999742 12344567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCCCC
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~---~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|+||+|.+++... ..+++.++..++.|++.||+||| +++||||||||+||++. +++.+||+|||+|+......
T Consensus 89 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999754 46899999999999999999999 99999999999999994 57899999999998765332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ....+||+.||||
T Consensus 165 ~---~~~~~GT~~y~AP 178 (307)
T d1a06a_ 165 V---LSTACGTPGYVAP 178 (307)
T ss_dssp -----------CTTSCH
T ss_pred e---eeeeeeCccccCc
Confidence 1 2235699999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.8e-27 Score=224.19 Aligned_cols=133 Identities=27% Similarity=0.354 Sum_probs=109.7
Q ss_pred ccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c----CccceeEEE
Q 035895 387 FSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C----SNEDFRALV 430 (527)
Q Consensus 387 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~----~~~~~~~lv 430 (527)
|+..+.||+|+||+||+|+. .+++.||+|++... + ..+...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36677899999999999986 46889999987421 0 112346899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeecccccccC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTP--IIHCDLKPHNKLLD-DNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~--iiHrdlk~~nill~-~~~~~kl~Dfg~a~~~~ 507 (527)
||||++|+|.+++.+. ..+++..+..++.||++||+||| +++ ||||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999754 35788889999999999999999 777 99999999999996 57999999999998754
Q ss_pred CCCCccceeccccccccccC
Q 035895 508 GEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~~~~~~~~~t~~y~aP 527 (527)
... ....+||+.||||
T Consensus 167 ~~~----~~~~~GT~~Y~aP 182 (270)
T d1t4ha_ 167 ASF----AKAVIGTPEFMAP 182 (270)
T ss_dssp TTS----BEESCSSCCCCCG
T ss_pred CCc----cCCcccCccccCH
Confidence 321 2346799999999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.94 E-value=4.1e-27 Score=225.55 Aligned_cols=136 Identities=27% Similarity=0.438 Sum_probs=116.8
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------------------cCcc
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------------------CSNE 424 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------------------~~~~ 424 (527)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. +.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999986 57899999997421 1234
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
+..++|||||+||+|.+++... ..+++.++..++.||++||+||| +++||||||||+||+++.++.+||+|||+|+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 5668999999999999999764 46899999999999999999999 9999999999999999999999999999999
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
.+.... ..+...||..|+||
T Consensus 159 ~~~~~~---~~~~~~gt~~y~~P 178 (277)
T d1phka_ 159 QLDPGE---KLREVCGTPSYLAP 178 (277)
T ss_dssp ECCTTC---CBCCCCSCGGGCCH
T ss_pred EccCCC---ceeeeeccCCCCCH
Confidence 875432 22345689999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.3e-25 Score=218.92 Aligned_cols=264 Identities=20% Similarity=0.205 Sum_probs=223.6
Q ss_pred ceEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcE
Q 035895 65 DELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLIS 144 (527)
Q Consensus 65 ~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 144 (527)
+.++=+++.++++|..++ +++++|+|++|+|+.+.+..|..+. +|++|++++|.+....|..|.++++|++
T Consensus 13 ~~~~C~~~~L~~lP~~l~--------~~l~~L~Ls~N~i~~l~~~~f~~l~-~L~~L~l~~n~~~~i~~~~f~~l~~L~~ 83 (305)
T d1xkua_ 13 RVVQCSDLGLEKVPKDLP--------PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLER 83 (305)
T ss_dssp TEEECTTSCCCSCCCSCC--------TTCCEEECCSSCCCCBCTTTTTTCT-TCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CEEEecCCCCCccCCCCC--------CCCCEEECcCCcCCCcChhHhhccc-cccccccccccccccchhhhhCCCccCE
Confidence 344555556666665432 5799999999999987666787775 7999999999999988999999999999
Q ss_pred EEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCC--CCCCccccCCccCceeeCCCC
Q 035895 145 IDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS--GSIPTCFGNLTALRNLHLDSN 222 (527)
Q Consensus 145 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N 222 (527)
|++++|+++..... ....+..|++++|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|
T Consensus 84 L~l~~n~l~~l~~~---~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n 160 (305)
T d1xkua_ 84 LYLSKNQLKELPEK---MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160 (305)
T ss_dssp EECCSSCCSBCCSS---CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred ecccCCccCcCccc---hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccC
Confidence 99999999865432 3468899999999999777777888888899998888654 344567889999999999999
Q ss_pred CCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCC
Q 035895 223 ELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS 302 (527)
Q Consensus 223 ~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 302 (527)
.++.+|..+ .++|+.|++++|......+..|..++.+++|++++|.+.+..+..|.++++|++|+|++|+|+ .+|..
T Consensus 161 ~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~ 237 (305)
T d1xkua_ 161 NITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237 (305)
T ss_dssp CCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred CccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccc
Confidence 999998654 578999999999999999999999999999999999999988999999999999999999998 56889
Q ss_pred CCCCCCCCEEeCCCCcccccCccch------hhhccCCeeEeeeeee
Q 035895 303 FDDLVSLESLDLSNNNLSEIIPLSL------EKLLYLNILLIVVVIL 343 (527)
Q Consensus 303 ~~~l~~L~~L~ls~N~l~~~~p~~~------~~l~~L~~L~~~~~~~ 343 (527)
|..+++|++|+|++|+|+.+....| ..+..|+.|+++.+.+
T Consensus 238 l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~ 284 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284 (305)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred cccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence 9999999999999999998755444 4567788888876654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=1.4e-27 Score=232.33 Aligned_cols=146 Identities=27% Similarity=0.425 Sum_probs=117.5
Q ss_pred HHhhhcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccC
Q 035895 379 ELLRATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCS 422 (527)
Q Consensus 379 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~ 422 (527)
+++...++|++.+.||+|+||+||+|+.+ +++.||||+++. .+.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999853 457899999742 233
Q ss_pred ccceeEEEEEeccCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 035895 423 NEDFRALVLEYTTNGSLEKVLYSSN-----------------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIH 479 (527)
Q Consensus 423 ~~~~~~lv~ey~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiH 479 (527)
..+..++||||+++|+|.+++.... ..+++.++..|+.|++.||+|+| +++|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 4456789999999999999986422 23788899999999999999999 999999
Q ss_pred cCCCCCCeeeCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 480 CDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 480 rdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|||||+|||+|.++.+||+|||+|+...........+...+|++||||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP 211 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence 999999999999999999999999876543333333445688999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.1e-27 Score=231.15 Aligned_cols=138 Identities=28% Similarity=0.397 Sum_probs=114.8
Q ss_pred cCCcccc-ceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------c----CccceeEEEEE
Q 035895 384 TDGFSAN-NLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------C----SNEDFRALVLE 432 (527)
Q Consensus 384 ~~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------~----~~~~~~~lv~e 432 (527)
.++|++. ++||+|+||+||+|+. .+++.||||+++.. + ..+...++|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 4679886 4699999999999985 67899999997531 0 12345789999
Q ss_pred eccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCC
Q 035895 433 YTTNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD---NIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 433 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~---~~~~kl~Dfg~a~~~~~ 508 (527)
||+||+|.+++...+ ..+++.++..|+.||+.||+||| +++|+||||||+|||+++ ++.+|++|||+|+....
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccC
Confidence 999999999997643 46889999999999999999999 999999999999999975 56799999999997754
Q ss_pred CCCccceeccccccccccC
Q 035895 509 EDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~~~~~~~~~t~~y~aP 527 (527)
... .....||++||||
T Consensus 167 ~~~---~~~~~gt~~y~aP 182 (335)
T d2ozaa1 167 HNS---LTTPCYTPYYVAP 182 (335)
T ss_dssp CCC---CCCCSCCCSSCCC
T ss_pred CCc---cccccCCcccCCc
Confidence 322 2345689999999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.94 E-value=4.9e-27 Score=232.55 Aligned_cols=135 Identities=28% Similarity=0.414 Sum_probs=116.1
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee--------------------------------ccCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF--------------------------------SCSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~--------------------------------~~~~~~~~~lv 430 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||++.. .+...+..++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 36799999999999999999986 5799999999752 11234566899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+.+|+|.+++...+ .++......++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+....
T Consensus 120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 99999999999987654 5788899999999999999999 9999999999999999999999999999999875332
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
....||+.||||
T Consensus 196 -----~~~~Gt~~Y~AP 207 (350)
T d1rdqe_ 196 -----WTLCGTPEALAP 207 (350)
T ss_dssp -----CCCEECGGGCCH
T ss_pred -----ccccCccccCCH
Confidence 235689999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.6e-27 Score=227.38 Aligned_cols=140 Identities=26% Similarity=0.421 Sum_probs=113.1
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeec----------------------------cCcc----ceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS----------------------------CSNE----DFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----------------------------~~~~----~~~~lv~e 432 (527)
++|.+.+.||+|+||.||+|++ +|+.||||+++.. |..+ ...++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4577889999999999999986 5889999997421 1111 24689999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFG-----YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~-----~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
||++|+|.+++++. .++|.++..++.++|.|++|+|.. ++++||||||||+|||+++++.+||+|||+++...
T Consensus 82 y~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 99999999999764 578999999999999999999932 34799999999999999999999999999999875
Q ss_pred CCCCc--cceeccccccccccC
Q 035895 508 GEDQS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~~--~~~~~~~~t~~y~aP 527 (527)
..... .......||++||||
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aP 181 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp TTTTEECC----CCSCGGGCCH
T ss_pred CCCcceeccccceecccCcCCh
Confidence 43221 122345689999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.7e-27 Score=224.77 Aligned_cols=133 Identities=27% Similarity=0.399 Sum_probs=107.2
Q ss_pred ceeccCCceEEEEEEcc---CCcEEEEEEEeec------------------------------cCccceeEEEEEeccCC
Q 035895 391 NLIGRGSFGSVYKARLQ---DGMEFAIKVFHFS------------------------------CSNEDFRALVLEYTTNG 437 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~------------------------------~~~~~~~~lv~ey~~~g 437 (527)
+.||+|+||+||+|.++ +++.||||+++.. +...+..++|||||++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 57999999999999864 3568999997421 11223467999999999
Q ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc-ccee
Q 035895 438 SLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS-MTQT 516 (527)
Q Consensus 438 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 516 (527)
+|.+++... ..+++..+..|+.||+.||+||| +++||||||||+|||++.++.+|++|||+|+.+...... ....
T Consensus 93 ~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 93 PLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred cHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999998754 45889999999999999999999 899999999999999999999999999999987543322 2223
Q ss_pred ccccccccccC
Q 035895 517 QTLAIIGYMAP 527 (527)
Q Consensus 517 ~~~~t~~y~aP 527 (527)
...||+.||||
T Consensus 169 ~~~gt~~y~AP 179 (277)
T d1xbba_ 169 HGKWPVKWYAP 179 (277)
T ss_dssp --CCCGGGCCH
T ss_pred ccCCCceecCc
Confidence 45689999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.3e-26 Score=224.33 Aligned_cols=136 Identities=27% Similarity=0.413 Sum_probs=114.7
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-----------------------------------cCccceeE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-----------------------------------CSNEDFRA 428 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-----------------------------------~~~~~~~~ 428 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||++... +.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5699999999999999999986 57999999997421 23345678
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeccccc
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI----VAHLSDFGIAK 504 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~----~~kl~Dfg~a~ 504 (527)
+|||||+||+|.+++...+ .+++.++..++.|++.||+||| +++||||||||+||+++.++ .+|++|||+|+
T Consensus 90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 9999999999999997643 5889999999999999999999 99999999999999998766 59999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
....... .....+|+.||||
T Consensus 166 ~~~~~~~---~~~~~~t~~y~AP 185 (293)
T d1jksa_ 166 KIDFGNE---FKNIFGTPEFVAP 185 (293)
T ss_dssp ECTTSCB---CSCCCCCGGGCCH
T ss_pred hcCCCcc---ccccCCCCcccCH
Confidence 8753322 2235688999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.8e-26 Score=225.93 Aligned_cols=138 Identities=22% Similarity=0.358 Sum_probs=116.3
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEee----------------------------ccCccceeEEEEEec
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF----------------------------SCSNEDFRALVLEYT 434 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~----------------------------~~~~~~~~~lv~ey~ 434 (527)
.+.|++.+.||+|+||+||+|.. .+++.||||++.. ...+++..++|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 36699999999999999999986 5789999999753 123456778999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEeecccccccCCCCCc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD--NIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~--~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
+||+|.+++...+..+++.+...|+.||+.||+||| +++|+||||||+|||++. ...+|++|||+++.......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 999999999776667899999999999999999999 999999999999999984 45899999999987653321
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....+|++||||
T Consensus 160 --~~~~~~t~~y~ap 172 (321)
T d1tkia_ 160 --FRLLFTAPEYYAP 172 (321)
T ss_dssp --EEEEESCGGGSCH
T ss_pred --ccccccccccccc
Confidence 2235678899997
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.9e-27 Score=228.15 Aligned_cols=140 Identities=25% Similarity=0.380 Sum_probs=111.5
Q ss_pred CCccccceeccCCceEEEEEEcc-CCc----EEEEEEEeecc-----------------------------CccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIKVFHFSC-----------------------------SNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~-----------------------------~~~~~~~lv 430 (527)
++|++.++||+|+||+||+|++. +|+ .||+|+++... ..++..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 46999999999999999999864 444 58888874211 112345789
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
|||+.+|+|.+.+......+++..+..++.|||.||+||| +++||||||||+||+++.++.+||+|||+|+......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 9999999999998887778999999999999999999999 8999999999999999999999999999999876544
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
.........||+.||||
T Consensus 166 ~~~~~~~~~gt~~y~AP 182 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMAL 182 (317)
T ss_dssp C--------CCTTTSCH
T ss_pred ccccccccccCccccCh
Confidence 33333445689999998
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=1.2e-24 Score=218.46 Aligned_cols=281 Identities=29% Similarity=0.436 Sum_probs=221.7
Q ss_pred hhhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc----cccceEEcccccccCCCCCCcc---------
Q 035895 18 DVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS----SIVDELSLSDNYLTSSTPELSF--------- 83 (527)
Q Consensus 18 ~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~----~~l~~L~Ls~N~l~~~~~~~~~--------- 83 (527)
+.+..+..+| ++|+|+++++ |.+|++|++|++++|.+.+..+ ..++.|++++|.++........
T Consensus 63 ~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (384)
T d2omza2 63 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140 (384)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEE
T ss_pred ccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5677899999 9999999865 8999999999999999875433 2478899999888764321100
Q ss_pred ---------------------------cccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhh
Q 035895 84 ---------------------------LSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEI 136 (527)
Q Consensus 84 ---------------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 136 (527)
...+...+.........|.... ...+..+ ++++.+++++|.+++..| +
T Consensus 141 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l-~~~~~l~l~~n~i~~~~~--~ 215 (384)
T d2omza2 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKL-TNLESLIATNNQISDITP--L 215 (384)
T ss_dssp EEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCC--CGGGGGC-TTCSEEECCSSCCCCCGG--G
T ss_pred cccccccccccccccccccccccccchhhhhcccccccccccccccccc--ccccccc-cccceeeccCCccCCCCc--c
Confidence 0011122233334444443332 2334444 479999999999997655 4
Q ss_pred cCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCce
Q 035895 137 GNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRN 216 (527)
Q Consensus 137 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 216 (527)
..+++|++|++++|+++.. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++.. .+..++.++.
T Consensus 216 ~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~ 289 (384)
T d2omza2 216 GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTN 289 (384)
T ss_dssp GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred cccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccc
Confidence 6678999999999999853 367889999999999999986543 788999999999999998654 3788999999
Q ss_pred eeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccce
Q 035895 217 LHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 217 L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 296 (527)
+.++.|.++.++. +..++.++.+++++|++.+.. .+..+++|++|++++|++++ +| .+.++++|++|++++|+++
T Consensus 290 l~~~~n~l~~~~~-~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 290 LELNENQLEDISP-ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp EECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCC
T ss_pred ccccccccccccc-cchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCC
Confidence 9999999998764 677899999999999998753 38899999999999999975 44 6999999999999999999
Q ss_pred eecCCCCCCCCCCCEEeCCCCc
Q 035895 297 GSIPNSFDDLVSLESLDLSNNN 318 (527)
Q Consensus 297 ~~~p~~~~~l~~L~~L~ls~N~ 318 (527)
+..| +.++++|+.|+|++|.
T Consensus 365 ~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 365 DLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp BCGG--GTTCTTCSEEECCCEE
T ss_pred CChh--hccCCCCCEeeCCCCc
Confidence 7665 8999999999999983
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.8e-27 Score=227.52 Aligned_cols=143 Identities=22% Similarity=0.381 Sum_probs=117.6
Q ss_pred hhcCCccccceeccCCceEEEEEEcc------CCcEEEEEEEee------------------------------ccCccc
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKVFHF------------------------------SCSNED 425 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~------------------------------~~~~~~ 425 (527)
...++|++.+.||+|+||.||+|.+. +++.||||+++. .+..++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33467889999999999999999863 357899999752 234456
Q ss_pred eeEEEEEeccCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN---------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAH 496 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~k 496 (527)
..++|||||++|+|.+++...+ ..+++..+..++.++|+||.||| +++|+||||||+|||+++++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence 6789999999999999886431 23688899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCCCCCccceeccccccccccC
Q 035895 497 LSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 497 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+|||+|+.+.............+|+.||||
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred EeecccceeccCCcceeeccceecccccCCH
Confidence 9999999977544333334445689999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.2e-26 Score=224.64 Aligned_cols=142 Identities=25% Similarity=0.439 Sum_probs=119.3
Q ss_pred hcCCccccceeccCCceEEEEEEc------cCCcEEEEEEEee-------------------------------ccCccc
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARL------QDGMEFAIKVFHF-------------------------------SCSNED 425 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~-------------------------------~~~~~~ 425 (527)
..++|++.+.||+|+||.||+|++ .+++.||||+++. .|..++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 346789999999999999999975 3467899999752 233445
Q ss_pred eeEEEEEeccCCcHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 035895 426 FRALVLEYTTNGSLEKVLYSSN-----------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKL 488 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nil 488 (527)
..++|||||++|+|.++++... ..+++..+..++.||+.|++||| +++||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence 6789999999999999987532 24788899999999999999999 999999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 489 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 489 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
++.++.+|++|||+++...........+...||+.||||
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP 216 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence 999999999999999987654444444556789999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.8e-27 Score=223.32 Aligned_cols=140 Identities=26% Similarity=0.413 Sum_probs=105.3
Q ss_pred cCCccccceeccCCceEEEEEEccC----CcEEEEEEEeec-----------------------------cCccceeEEE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQD----GMEFAIKVFHFS-----------------------------CSNEDFRALV 430 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~-----------------------------~~~~~~~~lv 430 (527)
.++|++.+.||+|+||+||+|+... +..||||+++.. +..++..++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 3579999999999999999998642 456899986321 1124567899
Q ss_pred EEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 035895 431 LEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~ 510 (527)
||||++|++.+++......+++.++..++.||++||+|+| +++||||||||+||++++++.+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999998877777899999999999999999999 9999999999999999999999999999999765432
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. ...+...||+.||||
T Consensus 163 ~-~~~~~~~gt~~y~ap 178 (273)
T d1mp8a_ 163 Y-YKASKGKLPIKWMAP 178 (273)
T ss_dssp ---------CCGGGCCH
T ss_pred c-eeccceecCcccchh
Confidence 2 223345678999998
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1e-24 Score=210.16 Aligned_cols=202 Identities=22% Similarity=0.269 Sum_probs=91.3
Q ss_pred CCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEee-cCcccccCcccccCCCCCCEEec
Q 035895 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLG-GNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 93 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
+++|+|++|+|+.+.+..|..+. +|++|++++|.+..+.+..+..+..++.++.. .|.++...+..|.++++|+.|++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~-~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEECcCCcCCCCCHHHhhccc-cccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 44555555555444333444332 34444444444444444444444444444432 33344444444444555555555
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch-hhhCCCCccEEEccCCccccc
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGP 250 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~l~l~~n~~~~~ 250 (527)
++|.+....+..+....+|+.+++++|+|+++.+.+|..+++|+.|++++|+++.+|. .+.++++|+.++++.|++.+.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 5554443344444444445555555555544444444444455555555555444322 223333444444444444333
Q ss_pred CCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccc
Q 035895 251 LPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL 295 (527)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 295 (527)
.|..|..+++|++|++++|++.+..|..|.++++|++|++++|++
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l 237 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCC
Confidence 344444444444444444444444444444444444444444443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.1e-26 Score=223.53 Aligned_cols=141 Identities=26% Similarity=0.416 Sum_probs=112.0
Q ss_pred cCCccccceeccCCceEEEEEEcc--------CCcEEEEEEEee-------------------------------ccCcc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKVFHF-------------------------------SCSNE 424 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~-------------------------------~~~~~ 424 (527)
.+.|++.+.||+|+||.||+|+.. ++..||||+++. .|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 457889999999999999999853 235799998742 24455
Q ss_pred ceeEEEEEeccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSN---------------YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLL 489 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill 489 (527)
+..++|||||++|+|.+++.... ..+++.++..++.|++.||+|+| +++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 67789999999999999997543 34789999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccceeccccccccccC
Q 035895 490 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 490 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+.++.+||+|||+++...............+|+.||||
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 206 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence 99999999999999987544333333345688999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.4e-26 Score=223.15 Aligned_cols=138 Identities=28% Similarity=0.401 Sum_probs=113.6
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. +..++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 67999999997421 223456789999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+.++.+..........+++.++..++.|++.||+||| +++||||||||+|||++.++.+|++|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99876555444444567899999999999999999999 99999999999999999999999999999987754322
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
......||+.|+||
T Consensus 158 -~~~~~~gt~~y~ap 171 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAP 171 (298)
T ss_dssp -CTTCCBCCCTTCCH
T ss_pred -cceeecccceeeeh
Confidence 22335688999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.92 E-value=4e-26 Score=219.25 Aligned_cols=139 Identities=22% Similarity=0.417 Sum_probs=108.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc--------------------------------C----cccee
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC--------------------------------S----NEDFR 427 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~--------------------------------~----~~~~~ 427 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||+++... . .....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5699999999999999999985 579999999985311 0 11236
Q ss_pred EEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 035895 428 ALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLT 507 (527)
Q Consensus 428 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~ 507 (527)
++|||||+||+|.+++...+ .+++.++..++.||+.||+||| +++||||||||+||+++.++.++++|||.++...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 79999999999999886543 5789999999999999999999 9999999999999999999999999999988664
Q ss_pred CCCC-ccceeccccccccccC
Q 035895 508 GEDQ-SMTQTQTLAIIGYMAP 527 (527)
Q Consensus 508 ~~~~-~~~~~~~~~t~~y~aP 527 (527)
.... .......+||+.||||
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aP 183 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSP 183 (277)
T ss_dssp ----------------TTCCH
T ss_pred cccccccccccccCcccccCH
Confidence 3221 1223345789999998
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.4e-25 Score=212.80 Aligned_cols=225 Identities=21% Similarity=0.218 Sum_probs=191.0
Q ss_pred CEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEecc-
Q 035895 94 KKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFR- 172 (527)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~- 172 (527)
..++.++++++. +|..+ +.++++|+|++|+|+.+.+..|.++++|++|++++|++....+..+..+..+..++..
T Consensus 14 ~~v~c~~~~L~~-iP~~i---p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 14 VTTSCPQQGLQA-VPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp CEEECCSSCCSS-CCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCCCCCCc-cCCCC---CCCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc
Confidence 345677777775 45543 3578999999999998888899999999999999999999888888899999998765
Q ss_pred CcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch-hhhCCCCccEEEccCCcccccC
Q 035895 173 GNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS-ILWNLKDILYLDFWSNLFVGPL 251 (527)
Q Consensus 173 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~l~l~~n~~~~~~ 251 (527)
.|.+....|..|.++++|++|++++|.+....+..+..+++|+.+++++|+++.+|. .+..++.|+.|++++|.+.+..
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 567777778889999999999999999988888889999999999999999999865 4556788888888888888888
Q ss_pred CccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccccc
Q 035895 252 PSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 322 (527)
Q Consensus 252 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 322 (527)
+..|..+++|+++++++|++++..|..|.++++|++|++++|++.+..|..|..+++|+.|++++|++...
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 88888888888888888888888888888888888888888888887778888888888888888888754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=1.2e-25 Score=217.47 Aligned_cols=139 Identities=19% Similarity=0.275 Sum_probs=114.6
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------cCccceeEEEEEecc
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~~ 435 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||++... .......++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 4699999999999999999995 57899999987431 12234567999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeecccccccCCCC
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-----NIVAHLSDFGIAKLLTGED 510 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-----~~~~kl~Dfg~a~~~~~~~ 510 (527)
+|+|.+++...+..++......++.|++.||+|+| +++||||||||+||+++. ++.+|++|||+|+.+....
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 68999999877777899999999999999999999 999999999999999974 5789999999999865321
Q ss_pred Cc-----cceeccccccccccC
Q 035895 511 QS-----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~-----~~~~~~~~t~~y~aP 527 (527)
.. .......||+.||||
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aP 182 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSI 182 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCH
T ss_pred cccceeecccCceEEchhhcCH
Confidence 11 112245699999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.5e-26 Score=216.67 Aligned_cols=135 Identities=27% Similarity=0.305 Sum_probs=111.8
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------------cCccce
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------------CSNEDF 426 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------------~~~~~~ 426 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||++... +..++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4699999999999999999986 57899999987421 112345
Q ss_pred eEEEEEeccC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeccccc
Q 035895 427 RALVLEYTTN-GSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDD-NIVAHLSDFGIAK 504 (527)
Q Consensus 427 ~~lv~ey~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~-~~~~kl~Dfg~a~ 504 (527)
.++||||+.+ +++.+++... ..+++.++..++.|+++||+||| +++||||||||+||+++. ++.+|++|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence 6799999986 6888887654 46788899999999999999999 999999999999999985 5899999999998
Q ss_pred ccCCCCCccceeccccccccccC
Q 035895 505 LLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 505 ~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
...... .+...||+.||||
T Consensus 160 ~~~~~~----~~~~~GT~~y~aP 178 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPP 178 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCH
T ss_pred eccccc----ccccccCCCcCCH
Confidence 764321 2346789999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.5e-26 Score=217.98 Aligned_cols=140 Identities=24% Similarity=0.320 Sum_probs=106.6
Q ss_pred CCccccceeccCCceEEEEEEcc--C--CcEEEEEEEeec-------------------------------cCccceeEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ--D--GMEFAIKVFHFS-------------------------------CSNEDFRAL 429 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~--~--~~~vavK~~~~~-------------------------------~~~~~~~~l 429 (527)
++|++.+.||+|+||+||+|+.. + ...||||++... +..++..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 56999999999999999999853 2 247899986421 112345579
Q ss_pred EEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 035895 430 VLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGE 509 (527)
Q Consensus 430 v~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~ 509 (527)
|||||++|++.+++......+++..+..++.|+|.||+||| +++|+||||||+||+++.++.+||+|||+++.+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 99999999999988876667899999999999999999999 899999999999999999999999999999987543
Q ss_pred CCc-cceeccccccccccC
Q 035895 510 DQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 510 ~~~-~~~~~~~~t~~y~aP 527 (527)
... .......++.+||||
T Consensus 165 ~~~~~~~~~~~~~~~~~aP 183 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAP 183 (273)
T ss_dssp CCEEEC-----CCGGGCCH
T ss_pred CCcceecCccccCcccCCH
Confidence 322 222234578899998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.9e-26 Score=220.09 Aligned_cols=133 Identities=32% Similarity=0.453 Sum_probs=108.3
Q ss_pred ccceeccCCceEEEEEEc-cCCcEEEEEEEee----------------------------------ccCccceeEEEEEe
Q 035895 389 ANNLIGRGSFGSVYKARL-QDGMEFAIKVFHF----------------------------------SCSNEDFRALVLEY 433 (527)
Q Consensus 389 ~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~----------------------------------~~~~~~~~~lv~ey 433 (527)
..++||+|+||+||+|+. .+|+.||||++.. .+..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999996 5689999998742 12234567899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
|.+|++..+.. .+..+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 99987776653 4456777788899999999999999 99999999999999999999999999999987654322
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....+||+.||||
T Consensus 156 ~~~~~~gt~~y~aP 169 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAP 169 (299)
T ss_dssp CCCCSCCCCTTCCH
T ss_pred cccceecChhhccH
Confidence 22335689999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.2e-25 Score=217.15 Aligned_cols=135 Identities=27% Similarity=0.482 Sum_probs=110.8
Q ss_pred cceeccCCceEEEEEEccC----CcEEEEEEEee------------------------------ccC-ccceeEEEEEec
Q 035895 390 NNLIGRGSFGSVYKARLQD----GMEFAIKVFHF------------------------------SCS-NEDFRALVLEYT 434 (527)
Q Consensus 390 ~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~------------------------------~~~-~~~~~~lv~ey~ 434 (527)
.++||+|+||+||+|++.. ...||||+++. .|. .+...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998643 23689998742 112 234678999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc--
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS-- 512 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~-- 512 (527)
++|+|.+++.......++..++.++.|++.||.|+| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877777888889999999999999999 999999999999999999999999999999976543221
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
...+...||..|+||
T Consensus 189 ~~~~~~~gt~~y~aP 203 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMAL 203 (311)
T ss_dssp TCTTCSSCCGGGSCH
T ss_pred eecccccccccccCh
Confidence 122234578999998
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.5e-24 Score=204.31 Aligned_cols=201 Identities=23% Similarity=0.262 Sum_probs=160.8
Q ss_pred CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCE
Q 035895 89 NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQF 168 (527)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 168 (527)
....+.+.|.+++.++. +|..+ ++++++|+|++|.|+++.+..|.++++|++|+|++|+|+... .++.+++|+.
T Consensus 8 ~~~~~~~v~C~~~~L~~-iP~~l---p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~ 81 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTA-LPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGT 81 (266)
T ss_dssp CSTTCCEEECTTSCCSS-CCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCE
T ss_pred ccCCCeEEEccCCCCCe-eCcCc---CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccc
Confidence 44566777888888886 45543 346888888888888777788888888999999998887543 3567888888
Q ss_pred EeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCccc
Q 035895 169 LSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFV 248 (527)
Q Consensus 169 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~ 248 (527)
|++++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++.+|.
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~------------------- 141 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP------------------- 141 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT-------------------
T ss_pred ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceecc-------------------
Confidence 888888887 446677888888888888888887777778888888888888888777653
Q ss_pred ccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCccc
Q 035895 249 GPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 249 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 320 (527)
..+..++.|+.+++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 142 ----~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 142 ----GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ----TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ----ccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 44566778888899999998888888889999999999999998 67877888899999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=3.8e-25 Score=214.90 Aligned_cols=139 Identities=27% Similarity=0.402 Sum_probs=112.4
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec----------------------------cCccceeEEEEEecc
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS----------------------------CSNEDFRALVLEYTT 435 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~lv~ey~~ 435 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||++... ....+..++||||+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 4599999999999999999986 57899999987531 123456678999994
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCCCCCc
Q 035895 436 NGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLD---DNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 436 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~---~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|++.+.+...+..+++..+..++.|++.||+|+| +++||||||||+||+++ .+..+|++|||+|+.+......
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 87 -PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp -CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred -CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 5777777666677899999999999999999999 99999999999999985 4567999999999987543221
Q ss_pred -----cceeccccccccccC
Q 035895 513 -----MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 -----~~~~~~~~t~~y~aP 527 (527)
.......||+.||||
T Consensus 163 ~~~~~~~~~~~~gt~~y~aP 182 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASI 182 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCH
T ss_pred cceeccccCCcCCCccccCH
Confidence 122345689999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.8e-25 Score=217.99 Aligned_cols=137 Identities=32% Similarity=0.520 Sum_probs=110.7
Q ss_pred CCccccceeccCCceEEEEEEcc-CCc--EEEEEEEee-------------------------------ccCccceeEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQ-DGM--EFAIKVFHF-------------------------------SCSNEDFRALV 430 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~-------------------------------~~~~~~~~~lv 430 (527)
++|++.++||+|+||+||+|+++ ++. .||||++.. .+..++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888999999999999999875 444 578887642 12234567899
Q ss_pred EEeccCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcE
Q 035895 431 LEYTTNGSLEKVLYSS---------------NYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVA 495 (527)
Q Consensus 431 ~ey~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~ 495 (527)
|||+++|+|.++++.. ...+++.++..++.|||+|++|+| +++||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999998643 246899999999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCCCCCccceeccccccccccC
Q 035895 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 496 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
||+|||+|+...... ......+|..|+||
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aP 195 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAI 195 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCH
T ss_pred EEccccccccccccc---cccceecCCcccch
Confidence 999999998654221 12234578899998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=7.8e-26 Score=214.72 Aligned_cols=136 Identities=29% Similarity=0.410 Sum_probs=107.5
Q ss_pred hcCCccccceeccCCceEEEEEEccCCcEEEEEEEee---------------------------cc-CccceeEEEEEec
Q 035895 383 ATDGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHF---------------------------SC-SNEDFRALVLEYT 434 (527)
Q Consensus 383 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~---------------------------~~-~~~~~~~lv~ey~ 434 (527)
..++|++.+.||+|+||.||+|+.+ |+.||||+++. .| ..++..++||||+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3467889999999999999999985 78999999743 12 2234568999999
Q ss_pred cCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSSN-YILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++|+|.+++...+ ..+++..++.|+.||+.|++||| +++|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 9999999997543 35799999999999999999999 8999999999999999999999999999998764321
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
....+|..||||
T Consensus 158 --~~~~~~~~y~aP 169 (262)
T d1byga_ 158 --DTGKLPVKWTAP 169 (262)
T ss_dssp ------CCTTTSCH
T ss_pred --ccccccccCCCh
Confidence 223567889998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5e-25 Score=214.68 Aligned_cols=140 Identities=27% Similarity=0.398 Sum_probs=114.7
Q ss_pred hhcCCccccceeccCCceEEEEEEc-cC-CcEEEEEEEeecc--------------------------------------
Q 035895 382 RATDGFSANNLIGRGSFGSVYKARL-QD-GMEFAIKVFHFSC-------------------------------------- 421 (527)
Q Consensus 382 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~-~~~vavK~~~~~~-------------------------------------- 421 (527)
++.+.|++.+.||+|+||+||+|+. ++ ++.||||+++...
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3457899999999999999999986 44 6779999974310
Q ss_pred -CccceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 035895 422 -SNEDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDF 500 (527)
Q Consensus 422 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Df 500 (527)
......+++|||+.+|.+..........+++.....++.|++.||+||| +++||||||||+|||+++++.+|++||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence 0123457999999998887666656667888888999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCccceeccccccccccC
Q 035895 501 GIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 501 g~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
|+++...... ......||+.||||
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~AP 184 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAP 184 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCH
T ss_pred hhhhhhcccc---cCCCcccChhhcCc
Confidence 9998754322 23346789999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.91 E-value=2.3e-25 Score=215.05 Aligned_cols=137 Identities=24% Similarity=0.400 Sum_probs=111.2
Q ss_pred CCccccceeccCCceEEEEEEccCCcEEEEEEEeec-------------------------------cCccceeEEEEEe
Q 035895 385 DGFSANNLIGRGSFGSVYKARLQDGMEFAIKVFHFS-------------------------------CSNEDFRALVLEY 433 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~ey 433 (527)
+.|++.+.||+|+||+||+|+.++|+.||||++... +..++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 679999999999999999999999999999998431 2234566899999
Q ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 035895 434 TTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 434 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
+.++.+..+.. ....++..+...++.||+.||+||| +++||||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 99877766654 4467899999999999999999999 89999999999999999999999999999987653322
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
......+++.|+||
T Consensus 156 ~~~~~~~~~~y~~p 169 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAP 169 (286)
T ss_dssp ------CCCTTCCH
T ss_pred ccceecccchhhhH
Confidence 22234578889987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=8.9e-25 Score=216.91 Aligned_cols=136 Identities=33% Similarity=0.486 Sum_probs=108.3
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------c------CccceeEEEEEe
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------C------SNEDFRALVLEY 433 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------~------~~~~~~~lv~ey 433 (527)
.|+..++||+|+||+||+|+. .+|+.||||++... + ..+.+.++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 488889999999999999996 57999999997431 0 112346799999
Q ss_pred ccCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 035895 434 TTNGSLEKVLY--SSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI-VAHLSDFGIAKLLTGED 510 (527)
Q Consensus 434 ~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~-~~kl~Dfg~a~~~~~~~ 510 (527)
|++|.+..+.. .....+++.++..++.||+.||+||| +++||||||||+|||++.++ .+||+|||+|+.+....
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 98765444332 23456899999999999999999999 99999999999999999764 89999999998875433
Q ss_pred CccceeccccccccccC
Q 035895 511 QSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 511 ~~~~~~~~~~t~~y~aP 527 (527)
. .....||..|+||
T Consensus 178 ~---~~~~~gt~~y~aP 191 (350)
T d1q5ka_ 178 P---NVSYICSRYYRAP 191 (350)
T ss_dssp C---CCSCCSCTTSCCH
T ss_pred c---cccccccccccCh
Confidence 2 2234688899997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.90 E-value=1.2e-24 Score=214.16 Aligned_cols=133 Identities=25% Similarity=0.399 Sum_probs=110.0
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec---------------------------c--CccceeEEEEEec
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS---------------------------C--SNEDFRALVLEYT 434 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---------------------------~--~~~~~~~lv~ey~ 434 (527)
++|++.+.||+|+||+||+|+. .+|+.||||++... + ......++|||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 5799999999999999999986 57899999997421 1 1234578999999
Q ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccccCCCCCcc
Q 035895 435 TNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDN-IVAHLSDFGIAKLLTGEDQSM 513 (527)
Q Consensus 435 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~-~~~kl~Dfg~a~~~~~~~~~~ 513 (527)
++|+|..+. ..++..++..++.||+.||+||| +++||||||||+|||++.+ +.+|++|||+|+.......
T Consensus 115 ~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-- 185 (328)
T d3bqca1 115 NNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 185 (328)
T ss_dssp CSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--
T ss_pred CCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCc--
Confidence 999997653 35788889999999999999999 9999999999999999865 5699999999997754322
Q ss_pred ceeccccccccccC
Q 035895 514 TQTQTLAIIGYMAP 527 (527)
Q Consensus 514 ~~~~~~~t~~y~aP 527 (527)
.....+|..|+||
T Consensus 186 -~~~~~~t~~y~aP 198 (328)
T d3bqca1 186 -YNVRVASRYFKGP 198 (328)
T ss_dssp -CCSCCSCGGGCCH
T ss_pred -ccccccCccccCc
Confidence 2335678899998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.2e-24 Score=213.53 Aligned_cols=139 Identities=24% Similarity=0.323 Sum_probs=108.8
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec------------------------------cCcc----ceeE
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS------------------------------CSNE----DFRA 428 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~------------------------------~~~~----~~~~ 428 (527)
.+.|++.+.||+|+||+||+|+. .+|+.||||++... +..+ ...+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35699999999999999999985 68999999998531 0011 1224
Q ss_pred EEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 035895 429 LVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTG 508 (527)
Q Consensus 429 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~ 508 (527)
++|||+.+|+|.+++... .+++.....++.|++.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 566778899999999754 5789899999999999999999 99999999999999999999999999999987643
Q ss_pred CCCc-cceeccccccccccC
Q 035895 509 EDQS-MTQTQTLAIIGYMAP 527 (527)
Q Consensus 509 ~~~~-~~~~~~~~t~~y~aP 527 (527)
.... ......+||+.|+||
T Consensus 162 ~~~~~~~~~~~~gt~~y~aP 181 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAP 181 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCG
T ss_pred CCccceeeccccccceechH
Confidence 3221 122345689999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.6e-24 Score=212.11 Aligned_cols=139 Identities=29% Similarity=0.424 Sum_probs=113.3
Q ss_pred cCCccccceeccCCceEEEEEEc----cCCcEEEEEEEeec----------------------------------cCccc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL----QDGMEFAIKVFHFS----------------------------------CSNED 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~----------------------------------~~~~~ 425 (527)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .....
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 46799999999999999999974 35889999987421 11234
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||||+.+|+|.+++...+ .+.......++.|++.|++|+| +++||||||||+||+++.++.+||+|||+|+.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 5679999999999999997654 3566778889999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+....... .....|++.|+||
T Consensus 179 ~~~~~~~~-~~~~~g~~~~~~p 199 (322)
T d1vzoa_ 179 FVADETER-AYDFCGTIEYMAP 199 (322)
T ss_dssp CCGGGGGG-GCGGGSCCTTCCH
T ss_pred hccccccc-ccccccccccchh
Confidence 75332221 2235678889987
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.8e-23 Score=198.01 Aligned_cols=177 Identities=24% Similarity=0.204 Sum_probs=127.9
Q ss_pred CCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccC
Q 035895 165 KLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWS 244 (527)
Q Consensus 165 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~ 244 (527)
++++|+|++|+|++..+..|.++++|++|+|++|+|+.. | .++.+++|++|+|++|+++.+|..+..++.|+.|++++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~ 109 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSF 109 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCS
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccccccccccccccccccccccccccc
Confidence 445555555555444344455555555555555555432 1 23445555555555555555555555555556666666
Q ss_pred CcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCc
Q 035895 245 NLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 324 (527)
Q Consensus 245 n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 324 (527)
|.+.+..+..+..+.++++|++++|.+....+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|
T Consensus 110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp 188 (266)
T d1p9ag_ 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (266)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccC
Confidence 6555555667788899999999999999888888999999999999999999888899999999999999999998 567
Q ss_pred cchhhhccCCeeEeeeeeee
Q 035895 325 LSLEKLLYLNILLIVVVILA 344 (527)
Q Consensus 325 ~~~~~l~~L~~L~~~~~~~~ 344 (527)
..+..+..|+.|+++.+++.
T Consensus 189 ~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 189 KGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTTCCCSEEECCSCCBC
T ss_pred hhHCCCCCCCEEEecCCCCC
Confidence 77788999999998877653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.8e-24 Score=208.87 Aligned_cols=140 Identities=25% Similarity=0.408 Sum_probs=109.6
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c--------Cc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C--------SN 423 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~--------~~ 423 (527)
.+.|++.+.||+|+||+||+|+. ++|+.||||++... + ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57799999999999999999996 57999999987421 0 01
Q ss_pred cceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 035895 424 EDFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIA 503 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a 503 (527)
++..++|||||+++.+.... .....++......++.|++.||+||| +++|+||||||+|||++.++.+|++|||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 23467999999987766443 34456788888899999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCc--cceeccccccccccC
Q 035895 504 KLLTGEDQS--MTQTQTLAIIGYMAP 527 (527)
Q Consensus 504 ~~~~~~~~~--~~~~~~~~t~~y~aP 527 (527)
+.+...... ......+||++|+||
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aP 190 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPP 190 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCH
T ss_pred eecccccccccccccceecCHHHhhH
Confidence 876533211 112235689999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1e-23 Score=209.07 Aligned_cols=133 Identities=26% Similarity=0.334 Sum_probs=105.3
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCc------cc
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSN------ED 425 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~------~~ 425 (527)
.+.|++.+.||+|+||+||+|+. .+|+.||||+++.. +.. ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999985 57999999997521 111 12
Q ss_pred eeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 426 FRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 426 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||||| +++|..+... ..+++.....++.|++.||+||| +++||||||||+|||++.++.+|++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 358999999 5688887754 35889999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccC
Q 035895 506 LTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 506 ~~~~~~~~~~~~~~~t~~y~aP 527 (527)
..... +...+|+.||||
T Consensus 171 ~~~~~-----~~~~~t~~y~aP 187 (346)
T d1cm8a_ 171 ADSEM-----TGYVVTRWYRAP 187 (346)
T ss_dssp CCSSC-----CSSCSCGGGCCT
T ss_pred cCCcc-----ccccccccccCH
Confidence 75332 345688999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.6e-23 Score=202.61 Aligned_cols=137 Identities=23% Similarity=0.348 Sum_probs=112.1
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------cCccceeEEEEE
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------CSNEDFRALVLE 432 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~~~~~~~~lv~e 432 (527)
+.|++.+.||+|+||+||+|+. .+++.||||+++.. +...+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 57899999998531 223456679999
Q ss_pred eccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 035895 433 YTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLLTGEDQS 512 (527)
Q Consensus 433 y~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~~~~~~~ 512 (527)
|+.++++..++... ..+++..+..++.|++.||+||| +++||||||||+|||++.++.+|++|||.|+........
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999998877644 46788888999999999999999 999999999999999999999999999999987543321
Q ss_pred cceeccccccccccC
Q 035895 513 MTQTQTLAIIGYMAP 527 (527)
Q Consensus 513 ~~~~~~~~t~~y~aP 527 (527)
.....++..|+||
T Consensus 158 --~~~~~~~~~~~~p 170 (292)
T d1unla_ 158 --YSAEVVTLWYRPP 170 (292)
T ss_dssp --CCSCCSCGGGCCH
T ss_pred --ceeeccccchhhh
Confidence 1223456667765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.2e-23 Score=206.76 Aligned_cols=134 Identities=25% Similarity=0.365 Sum_probs=107.4
Q ss_pred cCCccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc------------------------------------Cccce
Q 035895 384 TDGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC------------------------------------SNEDF 426 (527)
Q Consensus 384 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~------------------------------------~~~~~ 426 (527)
.+.|++.+.||+|+||+||+|+. .+|+.||||++.... .++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999985 679999999974210 01123
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.+++|||+.+|+|.+++.. ..++..++..++.||+.||+||| +++|+||||||+|||++.++.+|++|||+|...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 3577888999999999854 35889999999999999999999 999999999999999999999999999999865
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
... .....||..|+||
T Consensus 172 ~~~-----~~~~~g~~~y~ap 187 (348)
T d2gfsa1 172 DDE-----MTGYVATRWYRAP 187 (348)
T ss_dssp TGG-----GSSSCHHHHTSCH
T ss_pred Ccc-----cccccccccccCc
Confidence 422 2234578889987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.4e-22 Score=201.32 Aligned_cols=133 Identities=25% Similarity=0.257 Sum_probs=99.4
Q ss_pred CCccccceeccCCceEEEEEEc-cCCcEEEEEEEeec-------------------------------c------Cccce
Q 035895 385 DGFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFS-------------------------------C------SNEDF 426 (527)
Q Consensus 385 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~-------------------------------~------~~~~~ 426 (527)
+.|++.+.||+|+||+||+|+. .+|+.||||++... + .....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999986 47999999998521 0 12246
Q ss_pred eEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 035895 427 RALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAKLL 506 (527)
Q Consensus 427 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~~ 506 (527)
.++|||||.++.+.. +. ..+++.+...++.||+.||+||| +++|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 789999998765543 32 35788889999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCccceeccccccccccC
Q 035895 507 TGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 507 ~~~~~~~~~~~~~~t~~y~aP 527 (527)
.... ..+...+|+.|+||
T Consensus 170 ~~~~---~~~~~~~t~~y~aP 187 (355)
T d2b1pa1 170 GTSF---MMTPYVVTRYYRAP 187 (355)
T ss_dssp --------------CCTTCCH
T ss_pred cccc---ccccccccccccCh
Confidence 4322 23345688999998
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=5.7e-20 Score=172.10 Aligned_cols=217 Identities=13% Similarity=0.069 Sum_probs=136.9
Q ss_pred CCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCccccc-CcccccCCCCCCEEec
Q 035895 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS-ISITLGKLQKLQFLSF 171 (527)
Q Consensus 93 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l 171 (527)
.+.++.+++.++. +|..+ +.++++|+|++|.|+.+.+..|.++++|++|++++|.+... .+..|.++++++.+++
T Consensus 10 ~~~i~c~~~~l~~-iP~~l---~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 10 NRVFLCQESKVTE-IPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp SSEEEEESCSCSS-CCSCS---CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCEEEEeCCCCCC-cCCCC---CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 3678888888874 45433 34688888888888877777788888888888888887653 3556778888888876
Q ss_pred cC-cccccccChhhhcCcccCeeeeecccCCCCCCc-cccCCccCceeeCCCCCCCCCchh-hhCC-CCccEEEccCCcc
Q 035895 172 RG-NELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPT-CFGNLTALRNLHLDSNELTSIPSI-LWNL-KDILYLDFWSNLF 247 (527)
Q Consensus 172 ~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~lp~~-~~~l-~~L~~l~l~~n~~ 247 (527)
.. |.+....+..|.++++|+.|++++|++....+. .+..+..+..+..+++.+..++.. +..+ ..+..+++.+|++
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred cccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccc
Confidence 54 677767777788888888888888888654332 234455566666677777766532 2222 2455566666665
Q ss_pred cccCCccccCCCCCCEE-EccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeC
Q 035895 248 VGPLPSKIGNLKVLTRI-DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDL 314 (527)
Q Consensus 248 ~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 314 (527)
....+..+. ...+..+ ++++|+++...+..|.++++|++|++++|+++...+..|.++++|+.+++
T Consensus 166 ~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 166 QEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 543333332 2333333 34555555444445566666666666666665444445555555555444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.5e-19 Score=169.22 Aligned_cols=218 Identities=17% Similarity=0.097 Sum_probs=162.6
Q ss_pred eEEcccccccCCCCCCcccccCCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccc-cchhhcCCcCCcE
Q 035895 66 ELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGG-ISEEIGNLTDLIS 144 (527)
Q Consensus 66 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~ 144 (527)
.++.++..++.+|..++ +++++|||++|+|+.+.+..|.++. +|++|++++|.+... .+..|..++++++
T Consensus 12 ~i~c~~~~l~~iP~~l~--------~~l~~L~Ls~n~i~~l~~~~f~~l~-~L~~L~ls~n~~~~~i~~~~f~~l~~l~~ 82 (242)
T d1xwdc1 12 VFLCQESKVTEIPSDLP--------RNAIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHE 82 (242)
T ss_dssp EEEEESCSCSSCCSCSC--------SCCSEEEEESCCCCEECTTTTTTCT-TCCEEEEESCTTCCEECSSSEESCTTCCE
T ss_pred EEEEeCCCCCCcCCCCC--------CCCCEEECcCCcCCccChhHhhccc-hhhhhhhccccccceeecccccccccccc
Confidence 45556666666655431 4678888888888876556666664 788888888887653 4567888888888
Q ss_pred EEeec-CcccccCcccccCCCCCCEEeccCcccccccCh-hhhcCcccCeeeeecccCCCCCCccccCCc-cCceeeCCC
Q 035895 145 IDLGG-NKLNGSISITLGKLQKLQFLSFRGNELEGSIPN-VLCHLAVLFQLDLRGNKLSGSIPTCFGNLT-ALRNLHLDS 221 (527)
Q Consensus 145 L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~ 221 (527)
+.+.. |++....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++.+....+..|..++ .++.|++++
T Consensus 83 l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~ 162 (242)
T d1xwdc1 83 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 162 (242)
T ss_dssp EEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred ccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccc
Confidence 88764 677777778888899999999999888643332 334556666667778888877777787765 788899999
Q ss_pred CCCCCCchhhhCCCCccEEE-ccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccc
Q 035895 222 NELTSIPSILWNLKDILYLD-FWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGH 292 (527)
Q Consensus 222 N~l~~lp~~~~~l~~L~~l~-l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 292 (527)
|+++.++...++...+..+. +.+|++....+..|.++++|++|++++|+++...+..|.++++|+.+++.+
T Consensus 163 n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 163 NGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp SCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 99999888777777776665 566667665566789999999999999999876666788888887776644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=1.9e-20 Score=168.78 Aligned_cols=109 Identities=16% Similarity=0.201 Sum_probs=85.6
Q ss_pred cccceeccCCceEEEEEEccCCcEEEEEEEeeccC-----------------------------------c--------c
Q 035895 388 SANNLIGRGSFGSVYKARLQDGMEFAIKVFHFSCS-----------------------------------N--------E 424 (527)
Q Consensus 388 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~-----------------------------------~--------~ 424 (527)
.+.+.||+|+||+||+|+..+|+.||||+++.... . .
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988999999998642100 0 0
Q ss_pred ceeEEEEEeccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 425 DFRALVLEYTTNGSLEKVLYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 425 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
...++||||++++.+.+ ++......++.|++++++|+| +++|+||||||+|||++++ .++++|||.|+
T Consensus 83 ~~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG~a~ 150 (191)
T d1zara2 83 EGNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150 (191)
T ss_dssp ETTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred cCCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECCCcc
Confidence 12258999999866543 222334578999999999999 9999999999999999965 58999999998
Q ss_pred ccCC
Q 035895 505 LLTG 508 (527)
Q Consensus 505 ~~~~ 508 (527)
....
T Consensus 151 ~~~~ 154 (191)
T d1zara2 151 EVGE 154 (191)
T ss_dssp ETTS
T ss_pred cCCC
Confidence 7643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=5.2e-19 Score=163.87 Aligned_cols=203 Identities=22% Similarity=0.346 Sum_probs=104.0
Q ss_pred EEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCc
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGN 174 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 174 (527)
.++++.+++++..+ ..++. +|+.|++++|.|+.. +.+..+++|++|++++|++++..+ +..+++|+.+++++|
T Consensus 23 ~~~l~~~~~~d~~~--~~~l~-~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 23 KIAAGKSNVTDTVT--QADLD-GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHTTCSSTTSEEC--HHHHH-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHhCCCCcCCcCC--HHHcC-CcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 34455555554432 22332 566666666666543 235666666666666666654332 556666666666666
Q ss_pred ccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCcc
Q 035895 175 ELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSK 254 (527)
Q Consensus 175 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~ 254 (527)
.++. + +.+.+++.|+.++++++...+. ..+...+.++.+.++++.+...+. +...++|++|++++|.+... ..
T Consensus 96 ~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~~--~~ 168 (227)
T d1h6ua2 96 PLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDL--TP 168 (227)
T ss_dssp CCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--GG
T ss_pred cccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchhhh-hccccccccccccccccccc--hh
Confidence 6552 2 2355566666666666655432 224445556666666665554332 23344444444444443321 12
Q ss_pred ccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCC
Q 035895 255 IGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315 (527)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 315 (527)
++++++|+.|++++|++.+ +| .+.++++|++|++++|++++..| ++++++|+.|+++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred hcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 4455555555555555543 22 24555555555555555553321 4455555555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=6e-18 Score=166.66 Aligned_cols=262 Identities=23% Similarity=0.274 Sum_probs=129.4
Q ss_pred hhccc-CCCceeecCchhhhcCCCCCEEEccccccccccc---cccceEEcccccccCCCCCCcccccCCCCCCCCEEEc
Q 035895 23 ICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVLGRLS---SIVDELSLSDNYLTSSTPELSFLSSMSNCKYLKKLDI 98 (527)
Q Consensus 23 ~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~---~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L 98 (527)
+..+| ++|.++.+++ .+++|++|+|++|.+.. +| ..++.|++++|.++.++. + .+.|++||+
T Consensus 40 l~~LdLs~~~L~~lp~----~~~~L~~L~Ls~N~l~~-lp~~~~~L~~L~l~~n~l~~l~~-l--------p~~L~~L~L 105 (353)
T d1jl5a_ 40 AHELELNNLGLSSLPE----LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSD-L--------PPLLEYLGV 105 (353)
T ss_dssp CSEEECTTSCCSCCCS----CCTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCS-C--------CTTCCEEEC
T ss_pred CCEEEeCCCCCCCCCC----CCCCCCEEECCCCCCcc-cccchhhhhhhhhhhcccchhhh-h--------ccccccccc
Confidence 34455 5555554432 23455666666665542 22 235556666665554321 0 124556666
Q ss_pred ccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCccccc
Q 035895 99 SRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEG 178 (527)
Q Consensus 99 s~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 178 (527)
++|.+..+ |. +..+ .+|+.|++++|.+..... ....+..+.+..+... ....+..++.++.|++++|....
T Consensus 106 ~~n~l~~l-p~-~~~l-~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 106 SNNQLEKL-PE-LQNS-SFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp CSSCCSSC-CC-CTTC-TTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS
T ss_pred cccccccc-cc-hhhh-ccceeecccccccccccc----ccccccchhhcccccc--ccccccccccceecccccccccc
Confidence 66665542 32 2222 246666666555543221 1234445555444443 22345667777788877776653
Q ss_pred ccC------------------hhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEE
Q 035895 179 SIP------------------NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYL 240 (527)
Q Consensus 179 ~~p------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l 240 (527)
... ..+..++.|+.+++++|.... .|. ...++..+.+.+|.+...+... ..+...
T Consensus 177 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~~~~---~~l~~~ 249 (353)
T d1jl5a_ 177 LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLPELP---QSLTFL 249 (353)
T ss_dssp CCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCCCCC---TTCCEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccc-ccc---cccccccccccccccccccccc---cccccc
Confidence 211 112233444444444444332 111 1223334444444443322211 112222
Q ss_pred EccCCcccc----------------cCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCC
Q 035895 241 DFWSNLFVG----------------PLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFD 304 (527)
Q Consensus 241 ~l~~n~~~~----------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 304 (527)
++..+.+.+ .++.....+++|++|++++|++. .+|. .+++|+.|+|++|+|+ .+|..
T Consensus 250 ~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~-- 322 (353)
T d1jl5a_ 250 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL-- 322 (353)
T ss_dssp ECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC--
T ss_pred ccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc--
Confidence 222221111 11112233567888888888887 4554 3567888888888887 45543
Q ss_pred CCCCCCEEeCCCCccccc
Q 035895 305 DLVSLESLDLSNNNLSEI 322 (527)
Q Consensus 305 ~l~~L~~L~ls~N~l~~~ 322 (527)
+++|+.|++++|+++.+
T Consensus 323 -~~~L~~L~L~~N~L~~l 339 (353)
T d1jl5a_ 323 -PQNLKQLHVEYNPLREF 339 (353)
T ss_dssp -CTTCCEEECCSSCCSSC
T ss_pred -cCCCCEEECcCCcCCCC
Confidence 45788888888888753
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=4.8e-19 Score=164.14 Aligned_cols=205 Identities=21% Similarity=0.317 Sum_probs=170.0
Q ss_pred ccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec
Q 035895 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 197 (527)
+..++++.+.+++.. .+..+.+|++|++.+|.|+.. + .+..+++|+.|++++|++++..| +..+++|+.+++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 344567778777543 456788999999999999864 3 58899999999999999986543 89999999999999
Q ss_pred ccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChh
Q 035895 198 NKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPT 277 (527)
Q Consensus 198 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 277 (527)
|.++. + ..+..+++|+.++++++....++. +.....+..+.++.+.+... ..+..+++|++|++++|.+.+. .
T Consensus 95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~ 167 (227)
T d1h6ua2 95 NPLKN-V-SAIAGLQSIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--T 167 (227)
T ss_dssp CCCSC-C-GGGTTCTTCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--G
T ss_pred ccccc-c-ccccccccccccccccccccccch-hccccchhhhhchhhhhchh--hhhccccccccccccccccccc--h
Confidence 99984 3 358899999999999999988754 45567888899988877643 3477889999999999998743 3
Q ss_pred hhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCeeEee
Q 035895 278 TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNILLIV 339 (527)
Q Consensus 278 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~~~ 339 (527)
.+.++++|++|++++|++++. + .|+++++|+.|++++|+++++.| +..++.|+.|+++
T Consensus 168 ~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 168 PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 489999999999999999854 3 38899999999999999998654 7889999999876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.78 E-value=1.6e-19 Score=179.55 Aligned_cols=135 Identities=20% Similarity=0.261 Sum_probs=101.5
Q ss_pred CccccceeccCCceEEEEEEc-cCCcEEEEEEEeecc-----------------------------------------Cc
Q 035895 386 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKVFHFSC-----------------------------------------SN 423 (527)
Q Consensus 386 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-----------------------------------------~~ 423 (527)
.|++.+.||+|+||+||+|+. .+|+.||||+++... ..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 399999999999999999986 579999999975310 01
Q ss_pred cceeEEEEEeccCCcHHHH--HHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC------cE
Q 035895 424 EDFRALVLEYTTNGSLEKV--LYSSNYILDILQRLNIMIDVTSALEYLHFGYSTPIIHCDLKPHNKLLDDNI------VA 495 (527)
Q Consensus 424 ~~~~~lv~ey~~~g~L~~~--l~~~~~~~~~~~~~~i~~~i~~~l~ylH~~~~~~iiHrdlk~~nill~~~~------~~ 495 (527)
....+.+|+++..+..... .......+.......++.||+.|++|||+ ..+|+||||||+|||++.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 1233466777665543222 22334567888889999999999999992 38899999999999997654 49
Q ss_pred EEeecccccccCCCCCccceeccccccccccC
Q 035895 496 HLSDFGIAKLLTGEDQSMTQTQTLAIIGYMAP 527 (527)
Q Consensus 496 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 527 (527)
+++|||.|+..... ....+||+.|+||
T Consensus 172 kl~dfg~s~~~~~~-----~~~~~gt~~y~aP 198 (362)
T d1q8ya_ 172 KIADLGNACWYDEH-----YTNSIQTREYRSP 198 (362)
T ss_dssp EECCCTTCEETTBC-----CCSCCSCGGGCCH
T ss_pred eEeecccccccccc-----cccccccccccCh
Confidence 99999999876432 1235688999998
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=2e-19 Score=162.09 Aligned_cols=133 Identities=22% Similarity=0.312 Sum_probs=104.9
Q ss_pred CCEEEcccCCCCcccChhHhhccccccEEEcccCcccc-ccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEec
Q 035895 93 LKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISG-GISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSF 171 (527)
Q Consensus 93 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 171 (527)
.+++|.++++++. +|..+ +.++++|+|++|+|++ ..+..|.++++|++|+|++|++.+..+..|..+++|+.|++
T Consensus 10 ~~~v~Cs~~~L~~-iP~~l---p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 10 GTTVDCTGRGLKE-IPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp TTEEECTTSCCSS-CCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCEEEEeCCCcCc-cCCCC---CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 3567777777775 34432 3467777777777764 44666788888888888888888888888888888888888
Q ss_pred cCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCch
Q 035895 172 RGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPS 229 (527)
Q Consensus 172 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~ 229 (527)
++|+|+...|.+|.++++|++|+|++|+|+++.|++|..+++|++|+|++|.+...+.
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 8888887777888888888888888888888888888888999999999988876544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.2e-18 Score=159.22 Aligned_cols=162 Identities=27% Similarity=0.388 Sum_probs=70.5
Q ss_pred cccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeee
Q 035895 117 SLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196 (527)
Q Consensus 117 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 196 (527)
+|+.|++++|.++... .+..+++|++|++++|++++.. .++.+++|+.|++++|++++ +| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccccc
Confidence 3455555555444321 2344444444554444444322 13344444444444444442 22 23444444444444
Q ss_pred cccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh
Q 035895 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276 (527)
Q Consensus 197 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 276 (527)
+|.+.. ...+..++.++.+++++|.++..+ .+..+++|+++++++|++++ ++
T Consensus 121 ~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~-------------------------~~~~l~~L~~l~l~~n~l~~-i~ 172 (210)
T d1h6ta2 121 HNGISD--INGLVHLPQLESLYLGNNKITDIT-------------------------VLSRLTKLDTLSLEDNQISD-IV 172 (210)
T ss_dssp TSCCCC--CGGGGGCTTCCEEECCSSCCCCCG-------------------------GGGGCTTCSEEECCSSCCCC-CG
T ss_pred cccccc--cccccccccccccccccccccccc-------------------------cccccccccccccccccccc-cc
Confidence 444332 112334444444444444443321 23334455555555555543 22
Q ss_pred hhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCC
Q 035895 277 TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS 315 (527)
Q Consensus 277 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 315 (527)
.+.++++|+.|++++|+++. +| .|.++++|+.|+|+
T Consensus 173 -~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 173 -PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp -GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred -cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 14455555555555555542 22 34555555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=5.4e-19 Score=160.23 Aligned_cols=176 Identities=28% Similarity=0.426 Sum_probs=98.9
Q ss_pred EcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCC
Q 035895 122 WMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLS 201 (527)
Q Consensus 122 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 201 (527)
.++.+.+++.++ ...++++++|++++|.++.. ..++.+++|++|++++|++++..| +.++++|+.|++++|.+.
T Consensus 24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~ 97 (199)
T d2omxa2 24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 97 (199)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc
Confidence 445555544332 23445566666666665532 124455555555555555553222 555555555555555554
Q ss_pred CCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhc
Q 035895 202 GSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQG 281 (527)
Q Consensus 202 ~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 281 (527)
.. + .+.+++.|+.|++++|.+..++ .+..+++|+.|++++|++.. ++ .+..
T Consensus 98 ~~-~-~l~~l~~L~~L~l~~~~~~~~~-------------------------~~~~l~~L~~L~l~~n~l~~-~~-~l~~ 148 (199)
T d2omxa2 98 DI-T-PLANLTNLTGLTLFNNQITDID-------------------------PLKNLTNLNRLELSSNTISD-IS-ALSG 148 (199)
T ss_dssp CC-G-GGTTCTTCSEEECCSSCCCCCG-------------------------GGTTCTTCSEEECCSSCCCC-CG-GGTT
T ss_pred cc-c-cccccccccccccccccccccc-------------------------ccchhhhhHHhhhhhhhhcc-cc-cccc
Confidence 32 1 2455555555555555544432 34556677777777777653 33 4667
Q ss_pred CCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccCccchhhhccCCee
Q 035895 282 LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLYLNIL 336 (527)
Q Consensus 282 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 336 (527)
+++|++|++.+|++++.. .|.++++|+.|++++|+++++. .+..+++|+.|
T Consensus 149 ~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~L 199 (199)
T d2omxa2 149 LTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDIS--VLAKLTNLESL 199 (199)
T ss_dssp CTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEE
T ss_pred cccccccccccccccCCc--cccCCCCCCEEECCCCCCCCCc--cccCCCCCCcC
Confidence 777777777777776432 3667777777777777776642 35566666543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=5.7e-19 Score=159.12 Aligned_cols=174 Identities=21% Similarity=0.249 Sum_probs=122.0
Q ss_pred ccEEEcccCccccccchhhcCCcCCcEEEeecCcccc-cCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeee
Q 035895 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNG-SISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 196 (527)
.+.++.++++++. +|..+. +++++|+|++|+|++ ..+..|..+++|+.|++++|.+....+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 5677888888874 344332 567888888888865 445567778888888888888877777777778888888888
Q ss_pred cccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCCh
Q 035895 197 GNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIP 276 (527)
Q Consensus 197 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 276 (527)
+|+|+.+.|.+|.++++|++|+|++|+|+.+| |+.|..+++|++|+|++|.+....+
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~-----------------------~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVM-----------------------PGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEEC-----------------------TTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cccccccCHHHHhCCCcccccccCCccccccC-----------------------HHHhcCCcccccccccccccccccc
Confidence 88887777777888888888888777777665 3456677778888888888765433
Q ss_pred hhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccc
Q 035895 277 TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 277 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 321 (527)
..+ -...++.+.+..|.++...|..+ ..++.++|+.|++.-
T Consensus 144 ~~~-~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 144 LAW-FAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp GHH-HHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred hHH-HhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcC
Confidence 221 11235566677777776666554 456677888888753
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=4.8e-18 Score=155.18 Aligned_cols=164 Identities=24% Similarity=0.321 Sum_probs=107.4
Q ss_pred CCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEcc
Q 035895 164 QKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFW 243 (527)
Q Consensus 164 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~ 243 (527)
.+|+.|++++|.++.. + .+..+++|++|++++|+|++.. .++.+++|++|++++|+++.+| .+..+++|+.++++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECT
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-cccccccccccccc
Confidence 3444444444444321 1 2344445555555555554322 1344555555555555555554 24445555555555
Q ss_pred CCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccceeecCCCCCCCCCCCEEeCCCCcccccC
Q 035895 244 SNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 323 (527)
Q Consensus 244 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 323 (527)
+|.+.. ...+..++.++.+++++|.+++ +..+..+++|+++++++|++++.. .+.++++|+.|++++|+++++
T Consensus 121 ~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l- 193 (210)
T d1h6ta2 121 HNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISDL- 193 (210)
T ss_dssp TSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCBC-
T ss_pred cccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCCC-
Confidence 554432 2346778889999999999874 346788999999999999998643 388999999999999999875
Q ss_pred ccchhhhccCCeeEeee
Q 035895 324 PLSLEKLLYLNILLIVV 340 (527)
Q Consensus 324 p~~~~~l~~L~~L~~~~ 340 (527)
| .+..+++|+.|+++.
T Consensus 194 ~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 194 R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G-GGTTCTTCSEEEEEE
T ss_pred h-hhcCCCCCCEEEccC
Confidence 4 588999999998864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.6e-17 Score=150.37 Aligned_cols=178 Identities=25% Similarity=0.360 Sum_probs=109.1
Q ss_pred EEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCc
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGN 174 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 174 (527)
.+.++.+.+++.++. ..+ .+++.|++++|.++.. +.++.+++|++|++++|++++..+ ++++++|+.|++++|
T Consensus 22 ~~~l~~~~~~~~~~~--~~l-~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 22 KTVLGKTNVTDTVSQ--TDL-DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHTTCSSTTSEECH--HHH-TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHhCCCCCCCccCH--HHh-cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 344556666554332 223 2577777777777643 346677788888888888776443 777888888888888
Q ss_pred ccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCcc
Q 035895 175 ELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSK 254 (527)
Q Consensus 175 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~ 254 (527)
.+.. ++ .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++..+|. +..+++++.|++.+|.+.+. ..
T Consensus 95 ~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~-l~~~~~L~~L~l~~n~l~~l--~~ 167 (199)
T d2omxa2 95 QIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDISA-LSGLTSLQQLNFSSNQVTDL--KP 167 (199)
T ss_dssp CCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCC--GG
T ss_pred cccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccccc-ccccccccccccccccccCC--cc
Confidence 7763 33 377788888888888877643 346777888888888888776652 44444455555544444332 12
Q ss_pred ccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEE
Q 035895 255 IGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFL 288 (527)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 288 (527)
++++++|++|++++|++++ ++ .+.++++|+.|
T Consensus 168 l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 4455555555555555543 22 34555555543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.68 E-value=9.5e-16 Score=150.59 Aligned_cols=257 Identities=26% Similarity=0.297 Sum_probs=176.5
Q ss_pred hhhcchhccc-CCCceeecCchhhhcCCCCCEEEccccccc--cccccccceEEcccccccCCCCCCcccccCCCCCCCC
Q 035895 18 DVCYRICTID-SQNKLVGIVSITIFNLSTLKVFDVDNNYVL--GRLSSIVDELSLSDNYLTSSTPELSFLSSMSNCKYLK 94 (527)
Q Consensus 18 ~~~~~~~~~~-s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~--~~~~~~l~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~ 94 (527)
+..+.+..++ ++|+|+.++ .. +.+|+.|++++|.+. ..+|+.++.|++++|.++.++. +..+++|+
T Consensus 55 ~~~~~L~~L~Ls~N~l~~lp-~~---~~~L~~L~l~~n~l~~l~~lp~~L~~L~L~~n~l~~lp~-------~~~l~~L~ 123 (353)
T d1jl5a_ 55 ELPPHLESLVASCNSLTELP-EL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE-------LQNSSFLK 123 (353)
T ss_dssp SCCTTCSEEECCSSCCSSCC-CC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSSCCC-------CTTCTTCC
T ss_pred CCCCCCCEEECCCCCCcccc-cc---hhhhhhhhhhhcccchhhhhccccccccccccccccccc-------hhhhccce
Confidence 4556788888 999999764 33 568999999999875 3455679999999999987643 46789999
Q ss_pred EEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCccccc------------------C
Q 035895 95 KLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS------------------I 156 (527)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------------~ 156 (527)
.|++++|.+....+ . ...+..+.+..+... ....+..++.++.+++++|.+... .
T Consensus 124 ~L~l~~~~~~~~~~-~----~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~ 196 (353)
T d1jl5a_ 124 IIDVDNNSLKKLPD-L----PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEE 196 (353)
T ss_dssp EEECCSSCCSCCCC-C----CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSS
T ss_pred eecccccccccccc-c----cccccchhhcccccc--ccccccccccceecccccccccccccccccccccccccccccc
Confidence 99999999886432 2 235667776666543 234456677777777777765421 1
Q ss_pred cccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCC---------------
Q 035895 157 SITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDS--------------- 221 (527)
Q Consensus 157 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~--------------- 221 (527)
...+..++.|+.+++++|.... .|. ...++..+.+.++.+... +... ..+...++..
T Consensus 197 ~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~~~---~~l~~~~~~~~~~~~l~~l~~~~~~ 268 (353)
T d1jl5a_ 197 LPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PELP---QSLTFLDVSENIFSGLSELPPNLYY 268 (353)
T ss_dssp CCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CCCC---TTCCEEECCSSCCSEESCCCTTCCE
T ss_pred cccccccccccccccccccccc-ccc---cccccccccccccccccc-cccc---ccccccccccccccccccccchhcc
Confidence 1235678899999999998763 443 334566777777777632 2222 2233333333
Q ss_pred -----CCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEcccccce
Q 035895 222 -----NELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 222 -----N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 296 (527)
+.+..++ ..+++|++|++++|++. .+|.. +++|++|++++|+++ .+|.. +.+|++|++++|+++
T Consensus 269 ~~~~~~~~~~~~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 269 LNASSNEIRSLC---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR 337 (353)
T ss_dssp EECCSSCCSEEC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred cccccCcccccc---ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC
Confidence 3333332 23468999999999987 45643 678999999999998 46643 568999999999998
Q ss_pred eecCCCCCCCCCCCEEeCC
Q 035895 297 GSIPNSFDDLVSLESLDLS 315 (527)
Q Consensus 297 ~~~p~~~~~l~~L~~L~ls 315 (527)
.+|+.. .+|+.|.+.
T Consensus 338 -~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 338 -EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp -SCCCCC---TTCCEEECC
T ss_pred -CCCccc---cccCeeECc
Confidence 567643 356776654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=4.7e-16 Score=148.64 Aligned_cols=199 Identities=21% Similarity=0.208 Sum_probs=108.3
Q ss_pred ccEEEcccCccccccchhhcCCcCCcEEEeecCccccc-CcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeee
Q 035895 118 LEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGS-ISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLR 196 (527)
Q Consensus 118 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 196 (527)
+..+.+++..+..... ......+|++||++++.++.. +...+..+++|++|++++|.+....+..+..+++|+.|+++
T Consensus 25 ~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 3444444444432221 222344566666666655432 23345556666666666666655555556666666666666
Q ss_pred cc-cCCCC-CCccccCCccCceeeCCCC-CCCC--CchhhhC-CCCccEEEccCCc--ccc-cCCccccCCCCCCEEEcc
Q 035895 197 GN-KLSGS-IPTCFGNLTALRNLHLDSN-ELTS--IPSILWN-LKDILYLDFWSNL--FVG-PLPSKIGNLKVLTRIDFS 267 (527)
Q Consensus 197 ~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~--lp~~~~~-l~~L~~l~l~~n~--~~~-~~p~~~~~l~~L~~L~Ls 267 (527)
++ .++.. +...+.++++|++|+++++ .++. ++..+.. .+.|+.|++++.. +.. .+...+..+++|++|+++
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~ 183 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence 63 33311 1112344566666666664 3332 2222222 3456666665432 211 122223456777788887
Q ss_pred CC-CCCCCChhhhhcCCCCCEEEcccc-cceeecCCCCCCCCCCCEEeCCCC
Q 035895 268 RN-NLLGDIPTTIQGLKSLQFLSLGHN-RLQGSIPNSFDDLVSLESLDLSNN 317 (527)
Q Consensus 268 ~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N 317 (527)
+| .+++.....+..+++|++|+++++ .+++.....++.+++|+.|+++++
T Consensus 184 ~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 75 355555666777778888888774 566555556677778888888776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.6e-15 Score=131.94 Aligned_cols=128 Identities=20% Similarity=0.136 Sum_probs=89.2
Q ss_pred ccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCE
Q 035895 208 FGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQF 287 (527)
Q Consensus 208 ~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 287 (527)
|.++.++++|+|++|+|+.+|..+..+++|+.|++++|.+... +.+..+++|++|++++|+++...+..+..+++|++
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence 4455556666666666666655445556666666666665533 23677888888888888888666666778888888
Q ss_pred EEcccccceeecC-CCCCCCCCCCEEeCCCCcccccCc---cchhhhccCCeeE
Q 035895 288 LSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIP---LSLEKLLYLNILL 337 (527)
Q Consensus 288 L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~L~ 337 (527)
|++++|+++.... ..+..+++|+.|++++|+++.... ..+..+++|+.|+
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 8888888874322 457788889999999998876542 3567777887776
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.1e-16 Score=163.22 Aligned_cols=321 Identities=17% Similarity=0.150 Sum_probs=177.2
Q ss_pred chhccc-CCCceeecC-chhhhcCCCCCEEEcccccccc----cc------ccccceEEcccccccCCCCCCcccccC-C
Q 035895 22 RICTID-SQNKLVGIV-SITIFNLSTLKVFDVDNNYVLG----RL------SSIVDELSLSDNYLTSSTPELSFLSSM-S 88 (527)
Q Consensus 22 ~~~~~~-s~N~l~~~~-~~~~~~l~~L~~L~Ls~N~~~~----~~------~~~l~~L~Ls~N~l~~~~~~~~~~~~~-~ 88 (527)
.+..+| ++|+++... ...+..++++++|+|++|.++. .+ .+.+++|+|++|.|+..... .+...+ .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~-~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH-CVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH-HHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHH-HHHHHHhc
Confidence 345556 667776543 3345666777777777776541 01 12366677777766421000 000111 1
Q ss_pred CCCCCCEEEcccCCCCccc----ChhHhhccccccEEEcccCccccccchh-----------------------------
Q 035895 89 NCKYLKKLDISRNPLDGFL----PRVVGNFSQSLEFIWMSDCNISGGISEE----------------------------- 135 (527)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~----~~~~~~~~~~L~~L~Ls~n~l~~~~~~~----------------------------- 135 (527)
...+|++|+|++|+++... +..+... ++|+.|++++|.++......
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~-~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 160 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTL-PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 160 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSC-TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhcc-ccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcc
Confidence 2245677777777665421 1222222 35677777776654211100
Q ss_pred ----hcCCcCCcEEEeecCcccccC----cccc-cCCCCCCEEeccCcccccc----cChhhhcCcccCeeeeecccCCC
Q 035895 136 ----IGNLTDLISIDLGGNKLNGSI----SITL-GKLQKLQFLSFRGNELEGS----IPNVLCHLAVLFQLDLRGNKLSG 202 (527)
Q Consensus 136 ----~~~l~~L~~L~L~~N~l~~~~----~~~~-~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 202 (527)
+.....++.++++++.+.... ...+ ..-.....+++..+.+... ....+.....++.+++++|++..
T Consensus 161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~ 240 (460)
T d1z7xw1 161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 240 (460)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence 111223444444444332100 0000 1112334455554443311 11234455677888888887632
Q ss_pred -----CCCccccCCccCceeeCCCCCCCCCc-----hhhhCCCCccEEEccCCcccccCCcc-----ccCCCCCCEEEcc
Q 035895 203 -----SIPTCFGNLTALRNLHLDSNELTSIP-----SILWNLKDILYLDFWSNLFVGPLPSK-----IGNLKVLTRIDFS 267 (527)
Q Consensus 203 -----~~p~~~~~l~~L~~L~L~~N~l~~lp-----~~~~~l~~L~~l~l~~n~~~~~~p~~-----~~~l~~L~~L~Ls 267 (527)
..+..+.....++.+++++|.+...+ ..+...+.+..++++.|.+....... ......|+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~ 320 (460)
T d1z7xw1 241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 320 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred cccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccc
Confidence 12333455678899999999887532 23456778888999888775321111 1234578899999
Q ss_pred CCCCCCCChh----hhhcCCCCCEEEcccccceee----cCCCC-CCCCCCCEEeCCCCccccc----CccchhhhccCC
Q 035895 268 RNNLLGDIPT----TIQGLKSLQFLSLGHNRLQGS----IPNSF-DDLVSLESLDLSNNNLSEI----IPLSLEKLLYLN 334 (527)
Q Consensus 268 ~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~----~p~~~-~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~ 334 (527)
+|.++..... .+...++|++|+|++|+++.. ++..+ ...+.|++|+|++|+++.. ++..+..++.|+
T Consensus 321 ~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~ 400 (460)
T d1z7xw1 321 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400 (460)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred ccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCC
Confidence 9888754333 345667899999999988642 22222 2456799999999998753 344566778899
Q ss_pred eeEeeeeeee
Q 035895 335 ILLIVVVILA 344 (527)
Q Consensus 335 ~L~~~~~~~~ 344 (527)
.|+++.+.+.
T Consensus 401 ~L~Ls~N~i~ 410 (460)
T d1z7xw1 401 ELDLSNNCLG 410 (460)
T ss_dssp EEECCSSSCC
T ss_pred EEECCCCcCC
Confidence 9998877664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=1.4e-14 Score=119.69 Aligned_cols=80 Identities=26% Similarity=0.314 Sum_probs=41.1
Q ss_pred EEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCC
Q 035895 144 SIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNE 223 (527)
Q Consensus 144 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 223 (527)
+|+|++|+++.. + .++.+++|++|++++|+|+ .+|+.|..+++|+.|++++|+|++. | .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 455555555532 2 2455555555555555554 3444455555555555555555532 2 25555555555555555
Q ss_pred CCCCc
Q 035895 224 LTSIP 228 (527)
Q Consensus 224 l~~lp 228 (527)
++.+|
T Consensus 77 i~~~~ 81 (124)
T d1dcea3 77 LQQSA 81 (124)
T ss_dssp CCSSS
T ss_pred cCCCC
Confidence 55443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.6e-16 Score=159.18 Aligned_cols=85 Identities=19% Similarity=0.161 Sum_probs=59.9
Q ss_pred hcchhccc-CCCceee----cCchhhhcCCCCCEEEcccccccc--------c---cccccceEEcccccccCCCCCCcc
Q 035895 20 CYRICTID-SQNKLVG----IVSITIFNLSTLKVFDVDNNYVLG--------R---LSSIVDELSLSDNYLTSSTPELSF 83 (527)
Q Consensus 20 ~~~~~~~~-s~N~l~~----~~~~~~~~l~~L~~L~Ls~N~~~~--------~---~~~~l~~L~Ls~N~l~~~~~~~~~ 83 (527)
+..++.++ ++|.++. .+..++..+++|+.|||++|.+.. . ....++.|+|++|.++..... .+
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~-~l 104 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG-VL 104 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH-HH
T ss_pred CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccc-cc
Confidence 33455566 7777763 234567899999999999998741 1 123589999999998753211 12
Q ss_pred cccCCCCCCCCEEEcccCCCCc
Q 035895 84 LSSMSNCKYLKKLDISRNPLDG 105 (527)
Q Consensus 84 ~~~~~~l~~L~~L~Ls~N~l~~ 105 (527)
...+..+++|++|++++|.+..
T Consensus 105 ~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 105 SSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp HHHTTSCTTCCEEECCSSBCHH
T ss_pred cchhhccccccccccccccchh
Confidence 2356788999999999998764
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.3e-15 Score=129.81 Aligned_cols=114 Identities=19% Similarity=0.143 Sum_probs=52.6
Q ss_pred CCCCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecCcccccCcccccCCCCC
Q 035895 87 MSNCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGNKLNGSISITLGKLQKL 166 (527)
Q Consensus 87 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 166 (527)
|.++.+|++|||++|+|+.+ +..+..+ ++|+.|+|++|.|+.. +. +..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l-~~L~~L~Ls~N~i~~l--~~------------------------~~~l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATL-DQFDAIDFSDNEIRKL--DG------------------------FPLLRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGT-TCCSEEECCSSCCCEE--CC------------------------CCCCSSC
T ss_pred ccCcCcCcEEECCCCCCCcc-Ccccccc-ccCCEEECCCCCCCcc--CC------------------------cccCcch
Confidence 44555566666666666543 3332222 2344444444444422 12 3344444
Q ss_pred CEEeccCcccccccChhhhcCcccCeeeeecccCCCCCC-ccccCCccCceeeCCCCCCCCCc
Q 035895 167 QFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIP-TCFGNLTALRNLHLDSNELTSIP 228 (527)
Q Consensus 167 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~lp 228 (527)
+.|++++|+++...+..+..+++|+.|++++|+|+.... ..+..+++|++|++++|.++..|
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~ 128 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCcccccc
Confidence 444444444443333334444444445555444443211 23455555555555555555444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=6.2e-15 Score=140.74 Aligned_cols=183 Identities=15% Similarity=0.216 Sum_probs=89.9
Q ss_pred CCCCCCEEEcccCCCCcccChhHhhccccccEEEcccCccccccchhhcCCcCCcEEEeecC-ccccc-CcccccCCCCC
Q 035895 89 NCKYLKKLDISRNPLDGFLPRVVGNFSQSLEFIWMSDCNISGGISEEIGNLTDLISIDLGGN-KLNGS-ISITLGKLQKL 166 (527)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L 166 (527)
...+|++||+++|.++......+....++|++|+|++|.++...+..+..+++|++|+++++ .++.. +...+..+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 34567778887777654322222222246777777777766666666666777777777763 44421 11223456667
Q ss_pred CEEeccCc-ccccc-cChhhhc-CcccCeeeeeccc--CCCC-CCccccCCccCceeeCCCCCCCCCchhhhCCCCccEE
Q 035895 167 QFLSFRGN-ELEGS-IPNVLCH-LAVLFQLDLRGNK--LSGS-IPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYL 240 (527)
Q Consensus 167 ~~L~l~~N-~l~~~-~p~~~~~-l~~L~~L~L~~N~--l~~~-~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l 240 (527)
++|+++++ .++.. ++..+.. .+.|+.|+++++. ++.. +...+.++++|++|++++|.
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~----------------- 186 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV----------------- 186 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT-----------------
T ss_pred cccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccccc-----------------
Confidence 77777664 23211 1112222 3456666665431 2211 11122344555555555542
Q ss_pred EccCCcccccCCccccCCCCCCEEEccCC-CCCCCChhhhhcCCCCCEEEcccc
Q 035895 241 DFWSNLFVGPLPSKIGNLKVLTRIDFSRN-NLLGDIPTTIQGLKSLQFLSLGHN 293 (527)
Q Consensus 241 ~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N 293 (527)
.++......+..+++|++|++++| .+++.....++.+++|+.|+++++
T Consensus 187 -----~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 187 -----MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp -----TCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred -----CCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 122223333444455555555552 333333334455555555555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.3e-14 Score=119.91 Aligned_cols=57 Identities=26% Similarity=0.433 Sum_probs=24.2
Q ss_pred EEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCC
Q 035895 168 FLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSI 227 (527)
Q Consensus 168 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l 227 (527)
+|++++|+++ .++ .+..++.|++|++++|+|+. +|+.|+.+++|++|++++|+|+.+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l 58 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc
Confidence 3444444444 222 13444444444444444442 233344444444444444444443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=5.5e-16 Score=152.51 Aligned_cols=186 Identities=18% Similarity=0.180 Sum_probs=96.4
Q ss_pred hcCCcCCcEEEeecCccccc----CcccccCCCCCCEEeccCcccccccCh-------------hhhcCcccCeeeeecc
Q 035895 136 IGNLTDLISIDLGGNKLNGS----ISITLGKLQKLQFLSFRGNELEGSIPN-------------VLCHLAVLFQLDLRGN 198 (527)
Q Consensus 136 ~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~-------------~~~~l~~L~~L~L~~N 198 (527)
+...++|++|+|++|.++.. +...+...++|+.|++++|.+...-.. .....+.|+.+++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 34445566666666655432 122233455566666666554311000 0123345566666666
Q ss_pred cCCCC----CCccccCCccCceeeCCCCCCCC------CchhhhCCCCccEEEccCCccccc----CCccccCCCCCCEE
Q 035895 199 KLSGS----IPTCFGNLTALRNLHLDSNELTS------IPSILWNLKDILYLDFWSNLFVGP----LPSKIGNLKVLTRI 264 (527)
Q Consensus 199 ~l~~~----~p~~~~~l~~L~~L~L~~N~l~~------lp~~~~~l~~L~~l~l~~n~~~~~----~p~~~~~l~~L~~L 264 (527)
.+... +...+...+.|++|++++|.++. +...+...+.|+.|++++|.+... +...+..+++|++|
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L 248 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhh
Confidence 55421 11223445566666666666653 112234455566666666654321 23445566777777
Q ss_pred EccCCCCCCCChh----hhhc--CCCCCEEEcccccceee----cCCCC-CCCCCCCEEeCCCCcccc
Q 035895 265 DFSRNNLLGDIPT----TIQG--LKSLQFLSLGHNRLQGS----IPNSF-DDLVSLESLDLSNNNLSE 321 (527)
Q Consensus 265 ~Ls~N~l~~~~p~----~~~~--l~~L~~L~L~~N~l~~~----~p~~~-~~l~~L~~L~ls~N~l~~ 321 (527)
+|++|.+.+.-.. .+.. .+.|++|++++|+|+.. +...+ .++++|+.|++++|++..
T Consensus 249 ~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 8877777543222 2222 24677788888777532 12222 145677788888887754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=1.9e-14 Score=141.37 Aligned_cols=238 Identities=18% Similarity=0.249 Sum_probs=117.0
Q ss_pred hhhhcCCCCCEEEccccccccc--------c--ccccceEEcccccccCCCCCCc-----ccccCCCCCCCCEEEcccCC
Q 035895 38 ITIFNLSTLKVFDVDNNYVLGR--------L--SSIVDELSLSDNYLTSSTPELS-----FLSSMSNCKYLKKLDISRNP 102 (527)
Q Consensus 38 ~~~~~l~~L~~L~Ls~N~~~~~--------~--~~~l~~L~Ls~N~l~~~~~~~~-----~~~~~~~l~~L~~L~Ls~N~ 102 (527)
.++...++|+.|+|++|.+... + ...++.++++++.........+ +...+..+++|++|||++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 4567788899999998876321 1 1235666766665443221110 11234556677777777776
Q ss_pred CCccc----ChhHhhccccccEEEcccCccccccchh-------------hcCCcCCcEEEeecCccccc----Cccccc
Q 035895 103 LDGFL----PRVVGNFSQSLEFIWMSDCNISGGISEE-------------IGNLTDLISIDLGGNKLNGS----ISITLG 161 (527)
Q Consensus 103 l~~~~----~~~~~~~~~~L~~L~Ls~n~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~----~~~~~~ 161 (527)
++... ...+... ++|+.|++++|.+...-... ....+.|+.+++++|+++.. +...+.
T Consensus 105 i~~~~~~~l~~~l~~~-~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~ 183 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKH-TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183 (344)
T ss_dssp CCTTTHHHHHHHHHHC-TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred cccccccchhhhhccc-ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh
Confidence 65421 1122222 35666777666654211111 12344555555555555421 112233
Q ss_pred CCCCCCEEeccCcccccc-----cChhhhcCcccCeeeeecccCCCC----CCccccCCccCceeeCCCCCCCCCc-hhh
Q 035895 162 KLQKLQFLSFRGNELEGS-----IPNVLCHLAVLFQLDLRGNKLSGS----IPTCFGNLTALRNLHLDSNELTSIP-SIL 231 (527)
Q Consensus 162 ~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~lp-~~~ 231 (527)
..+.|+.|++++|++... +...+..+++|+.|+|++|.++.. +...+..+++|++|++++|.|+... ..
T Consensus 184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~- 262 (344)
T d2ca6a1 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA- 262 (344)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH-
T ss_pred hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH-
Confidence 445555555555555321 122234444555555555554321 1223344445555555555544310 00
Q ss_pred hCCCCccEEEccCCcccccCCcccc--CCCCCCEEEccCCCCCCC----Chhhhh-cCCCCCEEEcccccce
Q 035895 232 WNLKDILYLDFWSNLFVGPLPSKIG--NLKVLTRIDFSRNNLLGD----IPTTIQ-GLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 232 ~~l~~L~~l~l~~n~~~~~~p~~~~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~ 296 (527)
+-..+. ..+.|++|++++|++... +...+. ++++|++|++++|++.
T Consensus 263 -------------------l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 263 -------------------VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp -------------------HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred -------------------HHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 111111 124577788888776532 222332 5677888888888775
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.43 E-value=2.2e-15 Score=135.62 Aligned_cols=112 Identities=22% Similarity=0.166 Sum_probs=48.6
Q ss_pred hhhhcCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCC
Q 035895 182 NVLCHLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVL 261 (527)
Q Consensus 182 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L 261 (527)
..+..+++|++|+|++|+|+.. + .+..+++|++|++++|+|+.+|.....++.|+.|++++|.+... +.+..+++|
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L 117 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKLVNL 117 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred hHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccccccccccccccccccccccccccc--ccccccccc
Confidence 3444444555555555554432 2 24445555555555555544443222222233333333322211 113334445
Q ss_pred CEEEccCCCCCCCCh-hhhhcCCCCCEEEccccccee
Q 035895 262 TRIDFSRNNLLGDIP-TTIQGLKSLQFLSLGHNRLQG 297 (527)
Q Consensus 262 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 297 (527)
++|++++|+++.... ..+..+++|+.|++++|++..
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccchhccccccccccCCCccceeecCCCcccc
Confidence 555555555543211 244555555555555555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.41 E-value=7.3e-15 Score=132.15 Aligned_cols=110 Identities=22% Similarity=0.248 Sum_probs=58.9
Q ss_pred chhhcCCcCCcEEEeecCcccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCCCccccCCc
Q 035895 133 SEEIGNLTDLISIDLGGNKLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSIPTCFGNLT 212 (527)
Q Consensus 133 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 212 (527)
+..+..+++|++|+|++|+|+.. + .+..+++|+.|++++|.++ .+|..+..++.|+.|++++|+|+.. +.+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence 34455555566666666665532 2 3555566666666666655 3444444455566666666666532 2355566
Q ss_pred cCceeeCCCCCCCCCch--hhhCCCCccEEEccCCcc
Q 035895 213 ALRNLHLDSNELTSIPS--ILWNLKDILYLDFWSNLF 247 (527)
Q Consensus 213 ~L~~L~L~~N~l~~lp~--~~~~l~~L~~l~l~~n~~ 247 (527)
+|++|++++|+++.++. .+..+++|+.|++++|.+
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCcc
Confidence 66666666666665542 233444444444444443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=6.1e-13 Score=114.45 Aligned_cols=104 Identities=18% Similarity=0.130 Sum_probs=50.9
Q ss_pred cEEEcccCccccccchhhcCCcCCcEEEeecC-cccccCcccccCCCCCCEEeccCcccccccChhhhcCcccCeeeeec
Q 035895 119 EFIWMSDCNISGGISEEIGNLTDLISIDLGGN-KLNGSISITLGKLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRG 197 (527)
Q Consensus 119 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 197 (527)
+.++.+++.+. ..|..+..+++|++|++++| .++.+.+..|.++++|+.|++++|+|+...|.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34555555544 23444455555555555433 25444444555555555555555555544444555555555555555
Q ss_pred ccCCCCCCccccCCccCceeeCCCCCC
Q 035895 198 NKLSGSIPTCFGNLTALRNLHLDSNEL 224 (527)
Q Consensus 198 N~l~~~~p~~~~~l~~L~~L~L~~N~l 224 (527)
|+|+...+..|..+ +|+.|+|++|.+
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred CCCcccChhhhccc-cccccccCCCcc
Confidence 55554433344333 355555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=5.1e-12 Score=108.54 Aligned_cols=106 Identities=19% Similarity=0.112 Sum_probs=77.7
Q ss_pred CceeeCCCCCCCCCchhhhCCCCccEEEccCCc-ccccCCccccCCCCCCEEEccCCCCCCCChhhhhcCCCCCEEEccc
Q 035895 214 LRNLHLDSNELTSIPSILWNLKDILYLDFWSNL-FVGPLPSKIGNLKVLTRIDFSRNNLLGDIPTTIQGLKSLQFLSLGH 292 (527)
Q Consensus 214 L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~-~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 292 (527)
...++.+++.+.++|..+..+++|+.|++++|+ +....++.|.++++|+.|++++|+++...|.+|.++++|++|+|++
T Consensus 10 ~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 344555555555555555555556666665443 4444456788889999999999999888888899999999999999
Q ss_pred ccceeecCCCCCCCCCCCEEeCCCCccc
Q 035895 293 NRLQGSIPNSFDDLVSLESLDLSNNNLS 320 (527)
Q Consensus 293 N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 320 (527)
|+|+...+..|..+ +|+.|+|++|++.
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCcccChhhhccc-cccccccCCCccc
Confidence 99986656666554 6999999999884
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=4.1e-09 Score=90.54 Aligned_cols=67 Identities=21% Similarity=0.190 Sum_probs=40.7
Q ss_pred CCCCCCEEeccCcccccccChhhhcCcccCeeeeecccCCCCC--CccccCCccCceeeCCCCCCCCCch
Q 035895 162 KLQKLQFLSFRGNELEGSIPNVLCHLAVLFQLDLRGNKLSGSI--PTCFGNLTALRNLHLDSNELTSIPS 229 (527)
Q Consensus 162 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~lp~ 229 (527)
.+..+..++...+... .++..+..++.|++|+|++|+|+... +..+..+++|+.|+|++|.++.+++
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~ 108 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE 108 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGG
T ss_pred hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchh
Confidence 3344444444444332 34445566777777777777776543 3445667777777777777777654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=4.7e-09 Score=90.18 Aligned_cols=89 Identities=20% Similarity=0.183 Sum_probs=41.9
Q ss_pred cCcccCeeeeecccCCCCCCccccCCccCceeeCCCCCCCCCchhhhCCCCccEEEccCCcccccCCccccCCCCCCEEE
Q 035895 186 HLAVLFQLDLRGNKLSGSIPTCFGNLTALRNLHLDSNELTSIPSILWNLKDILYLDFWSNLFVGPLPSKIGNLKVLTRID 265 (527)
Q Consensus 186 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~l~l~~n~~~~~~p~~~~~l~~L~~L~ 265 (527)
.+..+..++..++.+. .++..+..+++|++|+|++|+|+.++. ++..+..+++|+.|+
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~---------------------~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDD---------------------MSSIVQKAPNLKILN 97 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSG---------------------GGTHHHHSTTCCCCC
T ss_pred hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCch---------------------hHHHHhhCCcccccc
Confidence 3333444444443332 233344456666666666666665532 112233445555555
Q ss_pred ccCCCCCCCChhhhhcCCCCCEEEcccccce
Q 035895 266 FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 296 (527)
Q Consensus 266 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 296 (527)
+++|.++...+-.+....+|+.|++++|.+.
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcC
Confidence 5555555333323333344555555555554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.59 E-value=3.1e-05 Score=65.82 Aligned_cols=86 Identities=15% Similarity=0.095 Sum_probs=37.1
Q ss_pred CCCCCCEEEcccC-CCCcccC----hhHhhccccccEEEcccCccccc----cchhhcCCcCCcEEEeecCccccc----
Q 035895 89 NCKYLKKLDISRN-PLDGFLP----RVVGNFSQSLEFIWMSDCNISGG----ISEEIGNLTDLISIDLGGNKLNGS---- 155 (527)
Q Consensus 89 ~l~~L~~L~Ls~N-~l~~~~~----~~~~~~~~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~---- 155 (527)
+.+.|++|+|+++ .++...- ..+... +.|+.|+|++|.+... +...+...+.|++|+|++|.++..
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n-~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNS-KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTC-SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhC-CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 3466777777653 3432100 111111 2355555555555421 122333344555555555555421
Q ss_pred CcccccCCCCCCEEeccCcc
Q 035895 156 ISITLGKLQKLQFLSFRGNE 175 (527)
Q Consensus 156 ~~~~~~~l~~L~~L~l~~N~ 175 (527)
+...+...++|+.|++++|.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~ 111 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQR 111 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCS
T ss_pred HHHHHHhCCcCCEEECCCCc
Confidence 11123334445555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.51 E-value=2.1e-05 Score=66.92 Aligned_cols=61 Identities=16% Similarity=0.182 Sum_probs=29.0
Q ss_pred cccEEEcccC-ccccc----cchhhcCCcCCcEEEeecCcccccC----cccccCCCCCCEEeccCcccc
Q 035895 117 SLEFIWMSDC-NISGG----ISEEIGNLTDLISIDLGGNKLNGSI----SITLGKLQKLQFLSFRGNELE 177 (527)
Q Consensus 117 ~L~~L~Ls~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~ 177 (527)
+|+.|+|+++ .++.. +-..+...+.|++|+|++|.+.... ...+...+.|+.|++++|.+.
T Consensus 16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 5666666653 34321 1233444555666666666554211 112233445555555555554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.42 E-value=0.00068 Score=61.51 Aligned_cols=30 Identities=27% Similarity=0.325 Sum_probs=25.9
Q ss_pred CeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 476 PIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 476 ~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
.++|+|+.|.||++++++.+-+.||+.+..
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEEeeccCcceeecCCceEEEeechhccc
Confidence 379999999999999876677999988764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.10 E-value=0.0005 Score=62.11 Aligned_cols=31 Identities=16% Similarity=0.190 Sum_probs=26.7
Q ss_pred CCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 475 TPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 475 ~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..+||+|+.|.||+++++..+-|.||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3479999999999999877778999998865
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.98 E-value=0.00025 Score=59.87 Aligned_cols=12 Identities=17% Similarity=0.324 Sum_probs=7.2
Q ss_pred CCCCCCEEEccc
Q 035895 89 NCKYLKKLDISR 100 (527)
Q Consensus 89 ~l~~L~~L~Ls~ 100 (527)
+.+.|++|+|++
T Consensus 15 ~~~~L~~L~L~~ 26 (166)
T d1io0a_ 15 NDPDLEEVNLNN 26 (166)
T ss_dssp TCTTCCEEECTT
T ss_pred cCCCCcEEEcCC
Confidence 445666666665
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.89 E-value=0.00015 Score=61.28 Aligned_cols=60 Identities=22% Similarity=0.264 Sum_probs=27.5
Q ss_pred ccCCCCCCEEeccCcccccc----cChhhhcCcccCeeeeecccCCCC----CCccccCCccCceeeC
Q 035895 160 LGKLQKLQFLSFRGNELEGS----IPNVLCHLAVLFQLDLRGNKLSGS----IPTCFGNLTALRNLHL 219 (527)
Q Consensus 160 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L 219 (527)
+...++|+.|++++|.+... +-..+...+.++.+++++|.+... +...+...++|+.++|
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L 109 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRI 109 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEEC
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEee
Confidence 33455555555555555422 112233445555555555555321 1123444555655444
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.42 E-value=0.0048 Score=59.45 Aligned_cols=31 Identities=19% Similarity=0.245 Sum_probs=26.2
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
...++|+|+.|.|||++++. ++|.||-+|..
T Consensus 222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CCEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred CcceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 34689999999999998764 89999988764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.61 E-value=0.046 Score=50.75 Aligned_cols=30 Identities=23% Similarity=0.237 Sum_probs=24.4
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 035895 474 STPIIHCDLKPHNKLLDDNIVAHLSDFGIAKL 505 (527)
Q Consensus 474 ~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~~ 505 (527)
..++||+|+.+.|||++++ ..+.||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4578999999999999754 45899988764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.59 E-value=0.065 Score=49.28 Aligned_cols=32 Identities=28% Similarity=0.338 Sum_probs=28.4
Q ss_pred CCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 035895 473 YSTPIIHCDLKPHNKLLDDNIVAHLSDFGIAK 504 (527)
Q Consensus 473 ~~~~iiHrdlk~~nill~~~~~~kl~Dfg~a~ 504 (527)
...++||+|+.+.||+++.+...-|.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 46789999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=88.25 E-value=0.56 Score=44.24 Aligned_cols=27 Identities=19% Similarity=0.362 Sum_probs=20.1
Q ss_pred ceeccCCceEEEEEEccC--------CcEEEEEEE
Q 035895 391 NLIGRGSFGSVYKARLQD--------GMEFAIKVF 417 (527)
Q Consensus 391 ~~lg~G~~g~vy~~~~~~--------~~~vavK~~ 417 (527)
+.|+.|-.-.+|++...+ .+.|.+++.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~ 82 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY 82 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEec
Confidence 578889999999998643 345777765
|